PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Volkow, ND; Frieden, TR; Hyde, PS; Cha, SS				Volkow, Nora D.; Frieden, Thomas R.; Hyde, Pamela S.; Cha, Stephen S.			Medication-Assisted Therapies - Tackling the Opioid-Overdose Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEATHS		[Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA; [Hyde, Pamela S.] Subst Abuse & Mental Hlth Serv Adm, Rockville, MD USA; [Cha, Stephen S.] Ctr Medicare Serv, Ctr Medicaid & CHIP Serv, Baltimore, MD USA; [Cha, Stephen S.] Ctr Medicaid Serv, Ctr Medicaid & CHIP Serv, Baltimore, MD USA; [Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Centers for Disease Control & Prevention - USA	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.			Frieden, Thomas/0000-0002-4759-2256	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Centers for Disease Control and Prevention (CDC), 2013, ADDR PRESCR DRUG AB; Clark RE, 2013, JAMA INTERN MED, V173, P1571, DOI 10.1001/jamainternmed.2013.9059; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Knudsen HK, 2011, J ADDICT MED, V5, P21, DOI 10.1097/ADM.0b013e3181d41ddb; Schwartz RP, 2013, AM J PUBLIC HEALTH, V103, P917, DOI 10.2105/AJPH.2012.301049	5	670	671	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2063	2066		10.1056/NEJMp1402780	http://dx.doi.org/10.1056/NEJMp1402780			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24758595				2022-12-24	WOS:000336434000003
J	Bonawitz, ND; Kim, JI; Tobimatsu, Y; Ciesielski, PN; Anderson, NA; Ximenes, E; Maeda, J; Ralph, J; Donohoe, BS; Ladisch, M; Chapple, C				Bonawitz, Nicholas D.; Kim, Jeong Im; Tobimatsu, Yuki; Ciesielski, Peter N.; Anderson, Nickolas A.; Ximenes, Eduardo; Maeda, Junko; Ralph, John; Donohoe, Bryon S.; Ladisch, Michael; Chapple, Clint			Disruption of Mediator rescues the stunted growth of a lignin-deficient Arabidopsis mutant	NATURE			English	Article							DOWN-REGULATION; SALICYLIC-ACID; CELL-WALL; BIOSYNTHESIS; DEPOSITION; REGULATOR; 3-HYDROXYLASE; ACCUMULATION; SELAGINELLA; EXPRESSION	Lignin is a phenylpropanoid-derived heteropolymer important for the strength and rigidity of the plant secondary cell wall(1,2). Genetic disruption of lignin biosynthesis has been proposed as a means to improve forage and bioenergy crops, but frequently results in stunted growth and developmental abnormalities, the mechanisms of which are poorly understood(3). Here we show that the phenotype of a lignin-deficient Arabidopsis mutant is dependent on the transcriptional co-regulatory complex, Mediator. Disruption of the Mediator complex subunits MED5a (also known as REF4) and MED5b (also known as RFR1) rescues the stunted growth, lignin deficiency and widespread changes in gene expression seen in the phenylpropanoid pathway mutant ref8, without restoring the synthesis of guaiacyl and syringyl lignin subunits. Cell walls of rescued med5a/5b ref8 plants instead contain a novel lignin consisting almost exclusively of p-hydroxyphenyl lignin subunits, and moreover exhibit substantially facilitated polysaccharide saccharification. These results demonstrate that guaiacyl and syringyl lignin subunits are largely dispensable for normal growth and development, implicate Mediator in an active transcriptional process responsible for dwarfing and inhibition of lignin biosynthesis, and suggest that the transcription machinery and signalling pathways responding to cell wall defects may be important targets to include in efforts to reduce biomass recalcitrance.	[Bonawitz, Nicholas D.; Kim, Jeong Im; Anderson, Nickolas A.; Maeda, Junko; Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tobimatsu, Yuki; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ciesielski, Peter N.; Donohoe, Bryon S.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Ximenes, Eduardo; Ladisch, Michael] Purdue Univ, Dept Agr & Biol Engn, W Lafayette, IN 47907 USA; [Ximenes, Eduardo; Ladisch, Michael] Purdue Univ, Renewable Resources Engn Lab, W Lafayette, IN 47907 USA; [Ralph, John] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI 53706 USA; [Ralph, John] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA; [Ralph, John] Univ Wisconsin, Wisconsin Energy Inst, Madison, WI 53726 USA; [Ladisch, Michael] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chapple, C (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	chapple@purdue.edu	Chapple, Clint CS/Q-5456-2017; Tobimatsu, Yuki/S-9248-2019; Ralph, John/C-3161-2009	Chapple, Clint CS/0000-0002-5195-562X; Tobimatsu, Yuki/0000-0002-7578-7392; Ralph, John/0000-0002-6093-4521; Ximenes, Eduardo/0000-0001-9087-0218	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) [DE-FG02-07ER15905]; Life Sciences Research Foundation; US DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64944]; Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - US DOE, Office of Science, Office of Basic Energy Sciences [DE-SC0000997]; US DOE [DE-FG02-06ER64301]; Purdue University Office of Agricultural Research Programs; Bioinformatics Core at Purdue University	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE)(United States Department of Energy (DOE)); Life Sciences Research Foundation; US DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - US DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US DOE(United States Department of Energy (DOE)); Purdue University Office of Agricultural Research Programs; Bioinformatics Core at Purdue University	This work was primarily funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DOE) through grant DE-FG02-07ER15905 to C. C. N.D.B. was supported in part by a fellowship from the Life Sciences Research Foundation. Y.T. and J.R. were funded by the US DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64944). J.I.K., P.N.C. and B. S. D. were supported as part of the Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center funded by the US DOE, Office of Science, Office of Basic Energy Sciences, award number DE-SC0000997. E. X. and M. L. were supported by the US DOE through grant DE-FG02-06ER64301 to M. L. and C. C. and by the Purdue University Office of Agricultural Research Programs. The authors acknowledge the support of the Bioinformatics Core at Purdue University.	Abdulrazzak N, 2006, PLANT PHYSIOL, V140, P30, DOI 10.1104/pp.105.069690; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Bonawitz ND, 2012, J BIOL CHEM, V287, P5434, DOI 10.1074/jbc.M111.312298; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; CHAPPLE CCS, 1992, PLANT CELL, V4, P1413, DOI 10.1105/tpc.4.11.1413; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; CLIFFORD MN, 1974, J CHROMATOGR, V94, P321, DOI 10.1016/S0021-9673(01)92389-1; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Franke R, 2002, PLANT J, V30, P47, DOI 10.1046/j.1365-313X.2002.01267.x; Gallego-Giraldo L, 2011, P NATL ACAD SCI USA, V108, P20814, DOI 10.1073/pnas.1117873108; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Imura Y, 2012, PLANT CELL PHYSIOL, V53, P287, DOI 10.1093/pcp/pcs002; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Knight H, 2009, PLANT J, V58, P97, DOI 10.1111/j.1365-313X.2008.03763.x; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lu FC, 1998, J AGR FOOD CHEM, V46, P547, DOI 10.1021/jf970676m; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; QUIDEAU S, 1992, J AGR FOOD CHEM, V40, P1108, DOI 10.1021/jf00019a003; Ralph J, 2006, J BIOL CHEM, V281, P8843, DOI 10.1074/jbc.M511598200; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Ruegger M, 2001, GENETICS, V159, P1741; Schilmiller AL, 2009, PLANT J, V60, P771, DOI 10.1111/j.1365-313X.2009.03996.x; Stout J, 2008, GENETICS, V178, P2237, DOI 10.1534/genetics.107.083881; Tobimatsu Y, 2012, CHEMSUSCHEM, V5, P676, DOI 10.1002/cssc.201100573; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Wagner A, 2011, PLANT J, V67, P119, DOI 10.1111/j.1365-313X.2011.04580.x; Wathugala DL, 2012, NEW PHYTOL, V195, P217, DOI 10.1111/j.1469-8137.2012.04138.x; Weng JK, 2011, PLANT CELL, V23, P2708, DOI 10.1105/tpc.110.081547; Weng JK, 2010, PLANT CELL, V22, P1033, DOI 10.1105/tpc.109.073528	38	244	252	9	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					376	+		10.1038/nature13084	http://dx.doi.org/10.1038/nature13084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24670657				2022-12-24	WOS:000336121200042
J	Gigerenzer, G				Gigerenzer, Gerd			THE ART OF RISK COMMUNICATION Breast cancer screening pamphlets mislead women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BENEFITS		[Gigerenzer, Gerd] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany; [Gigerenzer, Gerd] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society; Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/M-5595-2013; Gigerenzer, Gerd/A-6250-2012	Gigerenzer, Gerd/0000-0002-6163-5419				Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975	5	39	39	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2014	348								g2636	10.1136/bmj.g2636	http://dx.doi.org/10.1136/bmj.g2636			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DN	24770369	Green Submitted			2022-12-24	WOS:000335155400001
J	Palmore, TN; Henderson, DK				Palmore, Tara N.; Henderson, David K.			Carbapenem-Resistant Enterobacteriaceae: A Call for Cultural Change	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Palmore, Tara N.; Henderson, David K.] NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Henderson, DK (corresponding author), NIH, Ctr Clin, Bldg 10,Room 6-1480,10 Ctr Dr, Bethesda, MD 20892 USA.	dkh@nih.gov			CLINICAL CENTER [ZIACL004042, ZIACL004041] Funding Source: NIH RePORTER	CLINICAL CENTER		Balint Peter, 2009, Orv Hetil, V150, P1430, DOI 10.1556/OH.2009.HO2256; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Centers for Disease Control and Prevention, 2013, GUID CONTR CARB RES; Diekema DJ, 2013, CLIN INFECT DIS, V56, P1614, DOI 10.1093/cid/cit038; Holmes O W, 1974, Am J Obstet Gynecol, V119, P852; Holmes OW., 1843, NEW ENGL Q J MED, V1, P503; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Palmore TN, 2011, INFECT CONT HOSP EP, V32, P1166, DOI 10.1086/662710; Semmelweis IF., 1861, AETIOLOGIE BEGRIFF P; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Tamma PD, 2013, INFECT CONT HOSP EP, V34, P990, DOI 10.1086/671731	11	7	7	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					567	+		10.7326/M13-1910	http://dx.doi.org/10.7326/M13-1910			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733200				2022-12-24	WOS:000335143700008
J	Iacobuzio-Donahue, CA; Herman, JM				Iacobuzio-Donahue, Christine A.; Herman, Joseph M.			Autophagy, p53, and Pancreatic Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, David Rubenstein Ctr Pancreat Canc Res, New York, NY 10021 USA; [Herman, Joseph M.] Johns Hopkins Univ Hosp, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine	Iacobuzio-Donahue, CA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.		Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023				Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215	5	34	36	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1352	1353		10.1056/NEJMcibr1400189	http://dx.doi.org/10.1056/NEJMcibr1400189			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693896				2022-12-24	WOS:000333830000016
J	McNulty, EJ; Hung, YY; Almers, LM; Go, AS; Yeh, RW				McNulty, Edward J.; Hung, Yun-Yi; Almers, Lucy M.; Go, Alan S.; Yeh, Robert W.			Population Trends From 2000-2011 in Nuclear Myocardial Perfusion Imaging Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							UNITED-STATES		[McNulty, Edward J.] Kaiser Permanente Med Ctr, Div Cardiol, San Francisco, CA 94115 USA; [Hung, Yun-Yi; Almers, Lucy M.; Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Yeh, Robert W.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Kaiser Permanente; Kaiser Permanente; Harvard University; Massachusetts General Hospital	McNulty, EJ (corresponding author), Kaiser Permanente Med Ctr, 2200 OFarrell Blvd, San Francisco, CA 94115 USA.	edward.j.mcnulty@kp.org	Yeh, Robert/AAJ-3463-2020; Go, Alan S./AAE-7745-2019	Almers, Lucy/0000-0002-8357-9550				Andrus BW, 2012, CIRC-CARDIOVASC QUAL, V5, P31, DOI 10.1161/CIRCOUTCOMES.111.961813; Brindis RG, 2005, J AM COLL CARDIOL, V46, P1587, DOI 10.1016/j.jacc.2005.08.029; Levin DC, 2013, J AM COLL RADIOL, V10, P198, DOI 10.1016/j.jacr.2012.08.009; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	5	34	34	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1248	1249		10.1001/jama.2014.472	http://dx.doi.org/10.1001/jama.2014.472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668108	Bronze			2022-12-24	WOS:000333340500030
J	Hadziselimovic, N; Vukojevic, V; Peter, F; Milnik, A; Fastenrath, M; Fenyves, BG; Hieber, P; Demougin, P; Vogler, C; de Quervain, DJF; Papassotiropoulos, A; Stetak, A				Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Fastenrath, Matthias; Fenyves, Bank Gabor; Hieber, Petra; Demougin, Philippe; Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila			Forgetting Is Regulated via Musashi-Mediated Translational Control of the Arp2/3 Complex	CELL			English	Article							RNA-BINDING PROTEIN; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; ACTIN POLYMERIZATION; C. ELEGANS; MEMORY; MECHANISMS; PLASTICITY; DROSOPHILA; DYNAMICS	A plastic nervous system requires the ability not only to acquire and store but also to forget. Here, we report that musashi (msi-1) is necessary for time-dependent memory loss in C. elegans. Tissue-specific rescue demonstrates that MSI-1 function is necessary in the AVA interneuron. Using RNA-binding protein immunoprecipitation (IP), we found that MSI-1 binds to mRNAs of three subunits of the Arp2/3 actin branching regulator complex in vivo and downregulates ARX-1, ARX-2, and ARX-3 translation upon associative learning. The role of msi-1 in forgetting is also reflected by the persistence of learning-induced GLR-1 synaptic size increase in msi-1 mutants. We demonstrate that memory length is regulated cooperatively through the activation of adducin (add-1) and by the inhibitory effect of msi-1. Thus, a GLR-1/MSI-1/Arp2/3 pathway induces forgetting and represents a novel mechanism of memory decay by linking translational control to the structure of the actin cytoskeleton in neurons.	[Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Hieber, Petra; Demougin, Philippe; Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, CH-4055 Basel, Switzerland; [Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Milnik, Annette; Hieber, Petra; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Dept Psychol, Div Mol Neurosci, CH-4055 Basel, Switzerland; [Hadziselimovic, Nils; Vukojevic, Vanja; Peter, Fabian; Hieber, Petra; Demougin, Philippe; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland; [Fastenrath, Matthias; de Quervain, Dominique J. -F.] Univ Basel, Dept Psychol, Div Cognit Neurosci, CH-4055 Basel, Switzerland; [Fenyves, Bank Gabor] Semmelweis Univ, Dept Med Chem, H-1094 Budapest, Hungary; [Vogler, Christian; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas; Stetak, Attila] Univ Basel, Univ Psychiat Clin, CH-4055 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; Semmelweis University; University of Basel	Stetak, A (corresponding author), Univ Basel, Transfac Res Platform Mol & Cognit Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.	a.stetak@unibas.ch	Fenyves, Bank/AAE-8175-2021	Fenyves, Bank/0000-0003-2374-7513; Papassotiropoulos, Andreas/0000-0002-2210-9651; Vogler, Christian/0000-0003-3922-109X; de Quervain, Dominique/0000-0001-7131-2464; Vukojevic, Vanja/0000-0001-5303-9492; Milnik, Annette/0000-0002-3933-3289	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Forschungsfonds of the University of Basel [DPE2112]; Swiss National Science Foundation [CRSIK0_122691, CRSI33_130080]	National Institutes of Health Office of Research Infrastructure Programs; Forschungsfonds of the University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are grateful to Anne Spang and Jean Pieters for generously sharing methods, reagents, and instruments and to Alex Hajnal for his valuable comments on the manuscript and for laser ablation tools. We also like to thank the Caenorhabditis Genetic Center (supported by the National Institutes of Health Office of Research Infrastructure Programs grant P40 OD010440) for providing nematode strains. The Forschungsfonds of the University of Basel (DPE2112 to A.S.) and the Swiss National Science Foundation (Sinergia grants CRSIK0_122691 and CRSI33_130080 to D.J.-F.d.Q. and A.P.) supported this work.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; BRENNER S, 1974, GENETICS, V77, P71; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHALFIE M, 1985, J NEUROSCI, V5, P956; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hirota Y, 1999, MECH DEVELOP, V87, P93, DOI 10.1016/S0925-4773(99)00143-4; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Horisawa K, 2009, FEBS LETT, V583, P2429, DOI 10.1016/j.febslet.2009.06.045; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Inoue A, 2013, CELL REP, V3, P808, DOI 10.1016/j.celrep.2013.02.019; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miyanoiri Y, 2003, J BIOL CHEM, V278, P41309, DOI 10.1074/jbc.M306210200; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019; Vukojevic V, 2012, EMBO J, V31, P1453, DOI 10.1038/emboj.2012.14; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yoda A, 2000, GENES CELLS, V5, P885, DOI 10.1046/j.1365-2443.2000.00378.x	40	62	64	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1153	1166		10.1016/j.cell.2014.01.054	http://dx.doi.org/10.1016/j.cell.2014.01.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630719	Bronze			2022-12-24	WOS:000332945100007
J	Tang, RY; Li, G; Yu, JQ				Tang, Ri-Yuan; Li, Gang; Yu, Jin-Quan			Conformation-induced remote meta-C-H activation of amines	NATURE			English	Article							CARBON-HYDROGEN BONDS; ROOM-TEMPERATURE; OLEFINATION; OXYGENATION; SELECTIVITY; REACTIVITY; CATALYSTS; TEMPLATE; ARENES	Achieving site selectivity in carbon-hydrogen (C-H) functionalization reactions is a long-standing challenge in organic chemistry. The small differences in intrinsic reactivity of C-H bonds in any given organic molecule can lead to the activation of undesired C-H bonds by a non-selective catalyst. One solution to this problem is to distinguish C-H bonds on the basis of their location in the molecule relative to a specific functional group. In this context, the activation of C-H bonds five or six bonds away from a functional group by cyclometallation has been extensively studied(1-13). However, the directed activation of C-Hbonds that are distal to(more than six bonds away) functional groups has remained challenging, especially when the target C-H bond is geometrically inaccessible to directed metallation owing to the ring strain encountered in cyclometallation(14,15). Here we report a recyclable template that directs the olefination and acetoxylation of distal meta-C-H bonds-as far as 11 bonds away-of anilines and benzylicamines. This template is able to direct the meta-selective C-H functionalization of bicyclic heterocycles via a highly strained, tricyclic-cyclophane-like palladated intermediate. X-ray and nuclear magnetic resonance studies reveal that the conformational biases induced by a single fluorine substitution in the template can be enhanced by using a ligand to switch from ortho- to meta-selectivity.	[Tang, Ri-Yuan; Li, Gang; Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Tang, Ri-Yuan/J-5332-2015; Li, Gang/I-2960-2012; Li, Gang/ABF-3486-2021	Tang, Ri-Yuan/0000-0002-5764-8858; Li, Gang/0000-0001-5229-554X; Li, Gang/0000-0001-5229-554X	Scripps Research Institute; NIH (NIGMS) [1R01 GM102265]; National Natural Science Foundation of China [21202121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102265] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge The Scripps Research Institute and the NIH (NIGMS, 1R01 GM102265) for their financial support. R.-Y.T. is a visiting scholar from Wenzhou University and is sponsored by the National Natural Science Foundation of China (21202121).	Ackermann L, 2011, ORG LETT, V13, P4153, DOI 10.1021/ol201563r; Banks JW, 1999, J CHEM SOC PERK T 2, P2409, DOI 10.1039/a907452j; Boele MDK, 2002, J AM CHEM SOC, V124, P1586, DOI 10.1021/ja0176907; BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Hartung C. G., 2004, MODERN ARENE CHEM, P330, DOI DOI 10.1002/3527601767.CH10; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Hull KL, 2007, J AM CHEM SOC, V129, P11904, DOI 10.1021/ja074395z; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Jun CH, 1999, SYNLETT, P1; KAKIUCHI F, 1995, B CHEM SOC JPN, V68, P62, DOI 10.1246/bcsj.68.62; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Park SH, 2011, ORG LETT, V13, P2372, DOI 10.1021/ol200600p; Paul S, 2010, ORGANOMETALLICS, V29, P4424, DOI 10.1021/om100789n; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; SCHWARZ H, 1989, ACCOUNTS CHEM RES, V22, P282, DOI 10.1021/ar00164a004; Wan L, 2013, J AM CHEM SOC, V135, P18056, DOI 10.1021/ja410760f; Wang DH, 2010, SCIENCE, V327, P315, DOI 10.1126/science.1182512; Ye MC, 2011, J AM CHEM SOC, V133, P6964, DOI 10.1021/ja2021075; Zhang YH, 2009, J AM CHEM SOC, V131, P5072, DOI 10.1021/ja900327e	30	400	406	13	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					215	220		10.1038/nature12963	http://dx.doi.org/10.1038/nature12963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24622200	Green Accepted			2022-12-24	WOS:000332651800035
J	Du, DJ; Wang, Z; James, NR; Voss, JE; Klimont, E; Ohene-Agyei, T; Venter, H; Chiu, W; Luisi, BF				Du, Dijun; Wang, Zhao; James, Nathan R.; Voss, Jarrod E.; Klimont, Ewa; Ohene-Agyei, Thelma; Venter, Henrietta; Chiu, Wah; Luisi, Ben F.			Structure of the AcrAB-TolC multidrug efflux pump	NATURE			English	Article							CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; MEMBRANE PROTEIN; SYSTEM; CHANNEL; CRYSTALLOGRAPHY; REFINEMENT; COMPONENT; SOFTWARE; COMPLEX	The capacity of numerous bacterial species to tolerate antibiotics and other toxic compounds arises in part from the activity of energy-dependent transporters. In Gram-negative bacteria, many of these transporters form multicomponent 'pumps' that span both inner and outer membranes and are driven energetically by a primary or secondary transporter component(1-7). A model system for such a pump is the acridine resistance complex of Escherichia Coli(1). This pump assembly comprises the outer-membrane channel TolC, the secondary transporter AcrB located in the inner membrane, and the periplasmic AcrA, which bridges these two integral membrane proteins. The AcrAB-TolC efflux pump is able to transport vectorially a diverse array of compounds with little chemical similarity, thus conferring resistance to a broad spectrum of antibiotics. Homologous complexes are found in many Gram-negative species, including in animal and plant pathogens. Crystal structures are available for the individual components of the pump(2-7) and have provided insights into substrate recognition, energy coupling and the transduction of conformational changes associated with the transport process. However, how the subunits are organized in the pump, their stoichiometry and the details of their interactions are not known. Here we present the pseudo-atomic structure of a complete multidrug efflux pump in complex with a modulatory protein partner(8) from E. Coli. The model defines the quaternary organization of the pump, identifies key domain interactions, and suggests a cooperative process for channel assembly and opening. These findings illuminate the basis for drug resistance in numerous pathogenic bacterial species.	[Du, Dijun; James, Nathan R.; Voss, Jarrod E.; Klimont, Ewa; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Wang, Zhao; Chiu, Wah] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Ohene-Agyei, Thelma] Dept Pharmacol, Cambridge CB2 1PD, England; [Venter, Henrietta] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia	University of Cambridge; Baylor College of Medicine; University of South Australia	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	dd339@cam.ac.uk; bfl20@cam.ac.uk	wang, zhao/E-1996-2016; wang, zhao/E-7013-2015; Venter, Rietie/E-4795-2013	Venter, Rietie/0000-0001-5569-7755; James, Nathan/0000-0003-1147-6285; Wang, Zhao/0000-0003-4897-9986	Wellcome Trust; Human Frontier Science Program; National Institutes of Health [P41GM103832]; Herschel Smith scholarship; Cambridge Trust scholarship; Adam Glinsman award; Faculty for the Future Fellowship from the Schlumberger Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herschel Smith scholarship; Cambridge Trust scholarship; Adam Glinsman award; Faculty for the Future Fellowship from the Schlumberger Foundation(Schlumberger); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Wellcome Trust and Human Frontier Science Program (B. L.) and partly by a National Institutes of Health grant (P41GM103832 to W. C.). J.E.V. is supported by a Herschel Smith scholarship. T.O.-A. is the recipient of a Cambridge Trust scholarship, an Adam Glinsman award and a Faculty for the Future Fellowship from the Schlumberger Foundation. We thank M. Pos for kindly providing pBAD-AcrAB-TolC. We thank L. Packman for mass-spectrometric analyses and S. J. Ludtke, M. F. Schmid, M. Pos and R. van Veen for helpful advice and discussions. We are grateful to the staff at the Diamond Light Source for access to facilities and invaluable help.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Berthaud A, 2012, J AM CHEM SOC, V134, P10080, DOI 10.1021/ja301667n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Du D., 2013, MICROBIAL EFFLUX PUM; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ge Q, 2009, J BACTERIOL, V191, P4365, DOI 10.1128/JB.00204-09; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Hobbs EC, 2012, P NATL ACAD SCI USA, V109, P16696, DOI 10.1073/pnas.1210093109; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Janganan TK, 2013, MOL MICROBIOL, V88, P590, DOI 10.1111/mmi.12211; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Murray SC, 2013, STRUCTURE, V21, P900, DOI 10.1016/j.str.2013.04.016; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Narita S, 2003, BIOCHEM BIOPH RES CO, V308, P922, DOI 10.1016/S0006-291X(03)01512-2; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2011, CHEM BIOL, V18, P454, DOI 10.1016/j.chembiol.2011.02.011; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Trepout S, 2010, BBA-BIOMEMBRANES, V1798, P1953, DOI 10.1016/j.bbamem.2010.06.019; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Welch A, 2010, BIOCHEM J, V430, P355, DOI 10.1042/BJ20091860; Xu YB, 2012, J BIOL CHEM, V287, P11740, DOI 10.1074/jbc.M111.329375; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048	52	372	379	6	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					512	+		10.1038/nature13205	http://dx.doi.org/10.1038/nature13205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24747401	Green Accepted			2022-12-24	WOS:000336126000043
J	Cortez, D; Marin, R; Toledo-Flores, D; Froidevaux, L; Liechti, A; Waters, PD; Grutzner, F; Kaessmann, H				Cortez, Diego; Marin, Ray; Toledo-Flores, Deborah; Froidevaux, Laure; Liechti, Angelica; Waters, Paul D.; Gruetzner, Frank; Kaessmann, Henrik			Origins and functional evolution of Y chromosomes across mammals	NATURE			English	Article							SEX-DETERMINING REGION; DETERMINING GENE; W-CHROMOSOME; DNA-SEQUENCE; LONG ARM; MOUSE; IDENTIFICATION; PLATYPUS; EXPRESSION; ALIGNMENT	Y chromosomes underlie sex determination in mammals, but their repeat-rich nature has hampered sequencing and associated evolutionary studies. Here we trace Y evolution across 15 representative mammals on the basis of high-throughput genome and transcriptome sequencing. We uncover three independent sex chromosome originations in mammals and birds (the outgroup). The original placental and marsupial (therian) Y, containing the sex-determining gene SRY, emerged in the therian ancestor approximately 180 million years ago, in parallel with the first of five monotreme Y chromosomes, carrying the probable sex-determining gene AMH. The avian W chromosome arose approximately 140 million years ago in the bird ancestor. The small Y/W gene repertoires, enriched in regulatory functions, were rapidly defined following stratification (recombination arrest) and erosion events and have remained considerably stable. Despite expression decreases in therians, Y/W genes show notable conservation of proto-sex chromosome expression patterns, although various Y genes evolved testis-specificities through differential regulatory decay. Thus, although some genes evolved novel functions through spatial/temporal expression shifts, most Y genes probably endured, at least initially, because of dosage constraints.	[Cortez, Diego; Marin, Ray; Froidevaux, Laure; Liechti, Angelica; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Cortez, Diego; Marin, Ray; Kaessmann, Henrik] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Toledo-Flores, Deborah; Gruetzner, Frank] Univ Adelaide, Robinson Res Inst, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Waters, Paul D.] UNSW Australia, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of Lausanne; Swiss Institute of Bioinformatics; Robinson Research Institute; University of Adelaide; University of New South Wales Sydney	Cortez, D (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	diegoclaudio.cortezquezada@unil.ch; henrik.kaessmann@unil.ch	Grutzner, Frank/ABB-2820-2021; Kaessmann, Henrik/B-4989-2013; Grutzner, Frank/AAD-5834-2020; Waters, Paul D/B-7871-2015	Grutzner, Frank/0000-0002-3088-7314; Kaessmann, Henrik/0000-0001-7563-839X; Waters, Paul D/0000-0002-4689-8747	Mexican National Council for Science and Technology (CONACyT); ARC; European Research Council [242597]; Swiss National Science Foundation [130287]	Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ARC(Australian Research Council); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank K. Harshman and the Lausanne Genomics Technology Facility for high-throughput sequencing support; I. Xenarios and the Vital-IT computational facility for computational support; S. Paabo for great ape DNA samples; C. Roos for marmoset DNA samples; P. Jensen for chicken samples; E. Tsend-Ayush for help in determining the complete sequence of the AMHY gene in platypus; P. Gonzalez-Rubio for help with figure designs; M. Cardoso-Moreira, F. Carelli, A. Necsulea and M. Warnefors for comments on the manuscript; the Kaessmann group in general for discussions; and the Marmoset Genome Sequencing Consortium for making the marmoset genome assembly and annotation data available and for granting permission to use them for the analyses described in this study before publication. D. T. F. was supported by the Mexican National Council for Science and Technology (CONACyT). P. D. W. was supported by an ARC fellowship. F. G. was supported by an ARC fellowship. This research was supported by grants from the European Research Council (Starting Independent Grant: 242597, SexGenTransEvolution) and the Swiss National Science Foundation (Grant: 130287) to H.K.	Adolfsson S, 2013, MOL BIOL EVOL, V30, P806, DOI 10.1093/molbev/mst009; AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Berlin S, 2006, J MOL EVOL, V62, P66, DOI 10.1007/s00239-005-0067-6; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; Carvalho AB, 2013, GENOME RES, V23, P1894, DOI 10.1101/gr.156034.113; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chang TC, 2013, P NATL ACAD SCI USA, V110, P12373, DOI 10.1073/pnas.1221104110; CHARLESWORTH B, 1978, P NATL ACAD SCI USA, V75, P5618, DOI 10.1073/pnas.75.11.5618; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Chen N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-183; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Cutting A, 2013, DEV DYNAM, V242, P380, DOI 10.1002/dvdy.23944; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goto H, 2009, J MOL EVOL, V68, P134, DOI 10.1007/s00239-008-9189-y; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall NM, 2003, MAMM GENOME, V14, P437, DOI 10.1007/s00335-002-3068-4; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes JF, 2012, BIOESSAYS, V34, P1035, DOI 10.1002/bies.201200066; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Julien P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001328; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Katsura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045488; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim HS, 2000, MOL CELLS, V10, P512; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; Kortschak RD, 2009, REPROD FERT DEVELOP, V21, P964, DOI 10.1071/RD09084; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; Marais GAB, 2010, GENOME BIOL EVOL, V2, P347, DOI 10.1093/gbe/evq026; MARDON G, 1989, CELL, V56, P765, DOI 10.1016/0092-8674(89)90680-6; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Mazeyrat S, 1998, HUM MOL GENET, V7, P1713, DOI 10.1093/hmg/7.11.1713; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; Moghadam HK, 2012, P NATL ACAD SCI USA, V109, P8207, DOI 10.1073/pnas.1202721109; Moreira MAM, 2002, J MOL EVOL, V55, P92, DOI 10.1007/s00239-001-2308-7; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Murtagh VJ, 2012, GENOME RES, V22, P498, DOI 10.1101/gr.120790.111; Nam K, 2008, GENETICS, V180, P1131, DOI 10.1534/genetics.108.090324; Park C, 2010, MOL BIOL EVOL, V27, P2446, DOI 10.1093/molbev/msq143; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Rens W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r243; Delgado CLR, 2009, CHROMOSOME RES, V17, P917, DOI 10.1007/s10577-009-9079-1; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Schriml LM, 1999, BIOTECHNIQUES, V27, P608, DOI 10.2144/99273pf01; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENOMICS, V83, P140, DOI 10.1016/S0888-7543(03)00216-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsend-Ayush E, 2012, CHROMOSOME RES, V20, P127, DOI 10.1007/s10577-011-9270-z; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; WELLER PA, 1995, HUM MOL GENET, V4, P859, DOI 10.1093/hmg/4.5.859; Western PS, 1999, DEV DYNAM, V216, P411; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Wilkerson AJP, 2008, GENOMICS, V92, P329, DOI 10.1016/j.ygeno.2008.06.012; Wilson MA, 2009, ANNU REV GENOM HUM G, V10, P333, DOI 10.1146/annurev-genom-082908-150105; Wilson MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000568; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043997; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhou Q, 2012, SCIENCE, V337, P341, DOI 10.1126/science.1225385	92	310	320	8	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					488	+		10.1038/nature13151	http://dx.doi.org/10.1038/nature13151			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759410				2022-12-24	WOS:000334741600029
J	Kaur, AW; Ackels, T; Kuo, TH; Cichy, A; Dey, S; Hays, C; Kateri, M; Logan, DW; Marton, TF; Spehr, M; Stowers, L				Kaur, Angeldeep W.; Ackels, Tobias; Kuo, Tsung-Han; Cichy, Annika; Dey, Sandeepa; Hays, Cristen; Kateri, Maria; Logan, Darren W.; Marton, Tobias F.; Spehr, Marc; Stowers, Lisa			Murine Pheromone Proteins Constitute a Context-Dependent Combinatorial Code Governing Multiple Social Behaviors	CELL			English	Article							MAJOR URINARY PROTEINS; IN-HOUSE MICE; AGGRESSIVE-BEHAVIOR; VOMERONASAL NEURONS; BINDING-PROTEINS; SCENT MARKS; GENE FAMILY; MOUSE; ODORS; SIGNATURE	During social interactions, an individual's behavior is largely governed by the subset of signals emitted by others. Discrimination of "self'' from "other'' regulates the territorial urine countermarking behavior of mice. To identify the cues for this social discrimination and understand how they are interpreted, we designed an olfactory-dependent countermarking assay. We find major urinary proteins (MUPs) sufficient to elicit countermarking, and unlike other vomeronasal ligands that are detected by specifically tuned sensory neurons, MUPs are detected by a combinatorial strategy. A chemosensory signature of "self'' that modulates behavior is developed via experience through exposure to a repertoire of MUPs. In contrast, aggression can be elicited by MUPs in an experience-independent but contextdependent manner. These findings reveal that individually emitted chemical cues can be interpreted based on their combinatorial permutation and relative ratios, and they can transmit both fixed and learned information to promote multiple behaviors.	[Kaur, Angeldeep W.; Kuo, Tsung-Han; Dey, Sandeepa; Hays, Cristen; Logan, Darren W.; Marton, Tobias F.; Stowers, Lisa] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Ackels, Tobias; Cichy, Annika; Spehr, Marc] Rhein Westfal TH Aachen, Dept Chemosensat, Inst Biol 2, D-52074 Aachen, Germany; [Kateri, Maria] Rhein Westfal TH Aachen, Inst Stat, D-52056 Aachen, Germany; [Logan, Darren W.] Welcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Marton, Tobias F.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	Scripps Research Institute; RWTH Aachen University; RWTH Aachen University; Wellcome Trust Sanger Institute; University of California System; University of California San Francisco	Stowers, L (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	stowers@scripps.edu	Spehr, Marc/B-3140-2011; Spehr, Marc/AAK-3162-2021; Stowers, Lisa/K-6137-2015	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Kateri, Maria/0000-0002-6746-7858; Ackels, Tobias/0000-0002-4964-1162; Logan, Darren/0000-0003-1545-5510; Stowers, Lisa/0000-0002-4403-1269; Cichy, Annika/0000-0002-4620-7854	Skaggs Foundation; Ellison Medical Foundation; NIH-NIDCD [R01 DC006885, R01 DC009413]; Deutsche Forschungsgemeinschaft [SP724/7-1]; Volkswagen Foundation [83533]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009413, R01DC006885] Funding Source: NIH RePORTER	Skaggs Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Spencer, C.H. Engelhardt, and S. Lipartowski for excellent technical assistance. C. Dulac, L.B. Vosshall, and C.I. Bargmann provided critical advice on the manuscript. This work was supported by the Skaggs Foundation (to T.-H.K. and L.S.), the Ellison Medical Foundation (to L.S.), the NIH-NIDCD (R01 DC006885 and R01 DC009413 to L.S.), the Deutsche Forschungsgemeinschaft (SP724/7-1 to M.S.), and the Volkswagen Foundation (83533 to M.S.). M.S. is a Lichtenberg Professor of the Volkswagen Foundation.	Adams DB, 2006, NEUROSCI BIOBEHAV R, V30, P304, DOI 10.1016/j.neubiorev.2005.09.004; Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; Beynon RJ, 2004, PEPTIDES, V25, P1553, DOI 10.1016/j.peptides.2003.12.025; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Flower DR, 1996, BIOCHEM J, V318, P1; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Humphries RE, 1999, ANIM BEHAV, V58, P1177, DOI 10.1006/anbe.1999.1252; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Janotova K, 2011, J CHEM ECOL, V37, P647, DOI 10.1007/s10886-011-9966-8; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kaur A, 2013, METHODS MOL BIOL, V1068, P189, DOI 10.1007/978-1-62703-619-1_13; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; KNOPF JL, 1983, MOL CELL BIOL, V3, P2232, DOI 10.1128/MCB.3.12.2232; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Logan DW, 2012, CURR BIOL, V22, P1998, DOI 10.1016/j.cub.2012.08.041; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301, DOI 10.1113/jphysiol.1979.sp012620; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nevison CM, 2003, P ROY SOC B-BIOL SCI, V270, P1957, DOI 10.1098/rspb.2003.2452; Nevison CM, 2000, P ROY SOC B-BIOL SCI, V267, P687, DOI 10.1098/rspb.2000.1057; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Rich TJ, 1999, ANIM BEHAV, V58, P1027, DOI 10.1006/anbe.1999.1217; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; Stowers L, 2013, CURR OPIN NEUROBIOL, V23, P339, DOI 10.1016/j.conb.2013.01.007; SZOKA PR, 1978, GENETICS, V90, P597; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; Xia J, 2006, EUR J NEUROSCI, V24, P3333, DOI 10.1111/j.1460-9568.2006.05244.x	51	122	123	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					676	688		10.1016/j.cell.2014.02.025	http://dx.doi.org/10.1016/j.cell.2014.02.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766811	Green Accepted, Bronze			2022-12-24	WOS:000335392100016
J	Huber, KVM; Salah, E; Radic, B; Gridling, M; Elkins, JM; Stukalov, A; Jemth, AS; Gokturk, C; Sanjiv, K; Stromberg, K; Pham, T; Berglund, UW; Colinge, J; Bennett, KL; Loizou, JI; Helleday, T; Knapp, S; Superti-Furga, G				Huber, Kilian V. M.; Salah, Eidarus; Radic, Branka; Gridling, Manuela; Elkins, Jonathan M.; Stukalov, Alexey; Jemth, Ann-Sofie; Gokturk, Camilla; Sanjiv, Kumar; Stromberg, Kia; Pham, Therese; Berglund, Ulrika Warpman; Colinge, Jacques; Bennett, Keiryn L.; Loizou, Joanna I.; Helleday, Thomas; Knapp, Stefan; Superti-Furga, Giulio			Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy	NATURE			English	Article							CELL LUNG-CANCER; SMALL-MOLECULE INHIBITION; HUMAN MUTT HOMOLOG; RAS-TRANSFORMATION; OXIDATIVE STRESS; MESSENGER-RNA; HMTH1; OVEREXPRESSION; TUMORIGENESIS; CRIZOTINIB	Activated RAS GTPase signalling is a critical driver of oncogenic transformation and malignant disease. Cellular models of RAS-dependent cancers have been used to identify experimental small molecules, such as SCH51344, but their molecular mechanism of action remains generally unknown. Here, using a chemical proteomic approach, we identify the target of SCH51344 as the human mutT homologue MTH1 (also known as NUDT1), a nucleotide pool sanitizing enzyme. Loss-of-function of MTH1 impaired growth of KRAS tumour cells, whereas MTH1 overexpression mitigated sensitivity towards SCH51344. Searching for more drug-like inhibitors, we identified the kinase inhibitor crizotinib as a nanomolar suppressor of MTH1 activity. Surprisingly, the clinically used (R)-enantiomer of the drug was inactive, whereas the (S)-enantiomer selectively inhibited MTH1 catalytic activity. Enzymatic assays, chemical proteomic profiling, kinome-wide activity surveys and MTH1 co-crystal structures of both enantiomers provide a rationale for this remarkable stereospecificity. Disruption of nucleotide pool homeostasis via MTH1 inhibition by (S)-crizotinib induced an increase in DNA single-strand breaks, activated DNA repair in human colon carcinoma cells, and effectively suppressed tumour growth in animal models. Our results propose (S)-crizotinib as an attractive chemical entity for further pre-clinical evaluation, and small-molecule inhibitors of MTH1 in general as a promising novel class of anticancer agents.	[Huber, Kilian V. M.; Radic, Branka; Gridling, Manuela; Stukalov, Alexey; Colinge, Jacques; Bennett, Keiryn L.; Loizou, Joanna I.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Salah, Eidarus; Elkins, Jonathan M.; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Jemth, Ann-Sofie; Gokturk, Camilla; Sanjiv, Kumar; Stromberg, Kia; Pham, Therese; Berglund, Ulrika Warpman; Helleday, Thomas] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, S-17121 Stockholm, Sweden	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Oxford; Karolinska Institutet	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Huber, Kilian V. M./L-6921-2015; Colinge, Jacques/D-1578-2017; Superti-Furga, Giulio/F-4755-2015; Stukalov, Alexey/AAS-3208-2021; Colinge, Jacques/Z-2613-2019; Knapp, Stefan/AAG-2347-2019	Huber, Kilian V. M./0000-0002-1103-5300; Colinge, Jacques/0000-0003-2466-4824; Superti-Furga, Giulio/0000-0002-0570-1768; Stukalov, Alexey/0000-0002-4981-8124; Colinge, Jacques/0000-0003-2466-4824; Knapp, Stefan/0000-0001-5995-6494; Jemth, Ann-Sofie/0000-0002-7550-1833; Radic Sarikas, Branka/0000-0002-3597-0483; Warpman Berglund, Ulrika/0000-0002-6372-1396; Pham, Therese M/0000-0002-5577-6039; Elkins, Jon/0000-0003-2858-8929; Loizou, Joanna/0000-0003-1853-0424; Bennett, Keiryn L./0000-0001-9356-7708; Helleday, Thomas/0000-0002-7384-092X	Austrian Academy of Sciences; GEN-AU initiative of the Austrian Federal Ministry for Science and Research; European Union; SGC, a registered charity [1097737]; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Takeda; AbbVie; Novartis Research Foundation; Boehringer Ingelheim; Ontario Ministry of Research and Innovation; Wellcome Trust [092809/Z/10/Z]; European Union [278568]; Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; European Research Council; Swedish Cancer Society; European Union FP7 Career Integration Grant [PCIG11-GA-2012-321602]; FWF Grant [P24766-B20]	Austrian Academy of Sciences; GEN-AU initiative of the Austrian Federal Ministry for Science and Research; European Union(European Commission); SGC, a registered charity; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Novartis Research Foundation; Boehringer Ingelheim(Boehringer Ingelheim); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); European Union FP7 Career Integration Grant; FWF Grant(Austrian Science Fund (FWF))	The team at CeMM was supported by the Austrian Academy of Sciences, the GEN-AU initiative of the Austrian Federal Ministry for Science and Research, and "ASSET", a project funded by the European Union within FP7. S. K., E. S. and J.M.E. are grateful for financial support from the SGC, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, Takeda, AbbVie, the Novartis Research Foundation, Boehringer Ingelheim, the Ontario Ministry of Research and Innovation and the Wellcome Trust (Grant No. 092809/Z/10/Z). E. S. was supported by the European Union FP7 Grant No. 278568 "PRIMES". T. H. was supported by the Torsten and Ragnar Soderberg Foundation, the Knut and Alice Wallenberg Foundation, the Swedish Research Council, the European Research Council and the Swedish Cancer Society. J. I. L. was supported by the European Union FP7 Career Integration Grant (PCIG11-GA-2012-321602) and an FWF Grant (P24766-B20). We are grateful to D. Treiber, J. Hunt, P. Gallant and G. Pallares from DiscoveRx for the KdELECT and scanMAX studies. We thank W. Lindner and N. Maier for chiral HPLC analyses, R. Lichtenecker for NMR measurements, A. C. Muller for the annotation of the MS/MS spectrum, M. Brehme for help with the figures, and H. Pickersgill and G. Vladimer for critically reading the manuscript. We are very grateful to the following colleagues for the respective reagents: S. Lowe for the miR30 vectors and pMLP-p53; R. Weinberg for pLKO.1 shMTH1 and pBABE-puro plasmids; W. Berger for SW480, DLD1 and SW620 cells; R. Oehler for PANC1 cells; W. Hahn and A. Gad for BJ-hTERT, BJ-hTERT-SV40T, BJ-hTERT-SV40T-KRASV12 cells, B. Vogelstein for p53<SUP>-/-</SUP> and p21<SUP>-/-</SUP> HCT116 cells; C. Gasche for LoVo and HCT15 cells; A. Nussenzweig for Atm wild type and Atm<SUP>-/-</SUP> mouse embryonic fibroblasts.	Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Hutt Andrew J., 2007, Drug Metabolism and Drug Interactions, V22, P79; Kennedy CH, 1998, FEBS LETT, V429, P17, DOI 10.1016/S0014-5793(98)00505-5; KUMAR CC, 1995, CANCER RES, V55, P5106; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Okamoto K, 1996, INT J CANCER, V65, P437, DOI 10.1002/(SICI)1097-0215(19960208)65:4<437::AID-IJC7>3.0.CO;2-Y; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Sakumi K, 2003, CANCER RES, V63, P902; Speina E, 2005, JNCI-J NATL CANCER I, V97, P384, DOI 10.1093/jnci/dji058; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Walsh AB, 1997, ONCOGENE, V15, P2553, DOI 10.1038/sj.onc.1201424; Xu J, 2012, BLOOD, V119, P1032, DOI 10.1182/blood-2011-06-358960; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	33	273	291	5	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					222	+		10.1038/nature13194	http://dx.doi.org/10.1038/nature13194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695225	Green Accepted			2022-12-24	WOS:000333979900039
J	Niwa, S; Yu, LJ; Takeda, K; Hirano, Y; Kawakami, T; Wang-Otomo, ZY; Miki, K				Niwa, Satomi; Yu, Long-Jiang; Takeda, Kazuki; Hirano, Yu; Kawakami, Tomoaki; Wang-Otomo, Zheng-Yu; Miki, Kunio			Structure of the LH1-RC complex from Thermochromatium tepidum at 3.0 angstrom	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYNTHETIC REACTION-CENTER; RC-LH1 CORE COMPLEX; RHODOSPIRILLUM-RUBRUM; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURE; RHODOPSEUDOMONAS-VIRIDIS; PROJECTION STRUCTURE; CALCIUM-IONS; PROTEIN	The light-harvesting core antenna (LH1) and the reaction centre (RC) of purple photosynthetic bacteria form a supramolecular complex (LH1-RC) to use sunlight energy in a highly efficient manner. Here we report the first near-atomic structure, to our knowledge, of a LH1-RC complex, namely that of a Ca2+-bound complex from Thermochromatium tepidum, which reveals detailed information on the arrangement and interactions of the protein subunits and the cofactors. The RC is surrounded by 16 heterodimers of the LH1 alpha beta-subunit that form a completely closed structure. The Ca2+ ions are located at the periplasmic side of LH1. Thirty-two bacteriochlorophyll and 16 spirilloxanthin molecules in the LH1 ring form an elliptical assembly. The geometries of the pigment assembly involved in the absorption characteristics of the bacteriochlorophyll in LH1 and excitation energy transfer among the pigments are reported. In addition, possible ubiquinone channels in the closed LH1 complex are proposed based on the atomic structure.	[Niwa, Satomi; Takeda, Kazuki; Hirano, Yu; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Yu, Long-Jiang; Kawakami, Tomoaki; Wang-Otomo, Zheng-Yu] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan	Kyoto University; Ibaraki University	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	wang@ml.ibaraki.ac.jp; miki@kuchem.kyoto-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Takeda, Kazuki/0000-0002-4094-6816; Niwa, Satomi/0000-0002-2648-8257; , Wang-Otomo/0000-0003-1676-2002	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ibaraki University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurata Memorial Hitachi Science and Technology Foundation; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ibaraki University	We thank S. Takaichi for analysing the pigment compositions in LH1-RC and dry cells; F. Sekine for sequencing the genes encoding RC proteins; T. Nozawa for his support and interest at the initial stage; Y. Kimura, Masayuki Kobayashi and J.-R. Shen for their discussion; H. Suzuki, Dorina, M. Nakamura, F. Oh-hata and Miho Kobayashi for their contributions to the early stage of crystallization and data collection, and the Kao Corporation for kindly providing LDAO. This work was supported by a Grant-in-Aid for Scientific Research on the Priority Area "Structures of Biological Macromolecular Assemblies" and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by funds from the Takeda Science Foundation, the Kurata Memorial Hitachi Science and Technology Foundation (to Z.-Y.W.-O.), and the Targeted Proteins Research Program and the Photon and Quantum Basic Research Coordinated Development Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. M.), and by a postdoctoral fellowship from Ibaraki University (to L.-J.Y.). This work was performed using the synchrotron beamline BL44XU at SPring-8 under the Cooperative Research Program of the Institute for Protein Research, Osaka University and the beamlines at the KEK Photon Factory. We are grateful to A. Nakagawa, E. Yamashita, N. Matsugaki and Y. Yamada for their assistance in the data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aird A, 2007, BIOPHYS J, V92, P23, DOI 10.1529/biophysj.106.084715; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Comayras R, 2005, J BIOL CHEM, V280, P11214, DOI 10.1074/jbc.M412089200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DAVIS CM, 1995, J BIOL CHEM, V270, P5793, DOI 10.1074/jbc.270.11.5793; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fathir I, 1997, PHOTOSYNTH RES, V51, P71, DOI 10.1023/A:1005718404736; Fathir I, 1998, PHOTOSYNTH RES, V58, P193, DOI 10.1023/A:1006146713751; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; Kimura Y, 2008, J BIOL CHEM, V283, P13867, DOI 10.1074/jbc.M800256200; Kimura Y, 2012, BBA-BIOENERGETICS, V1817, P1022, DOI 10.1016/j.bbabio.2012.03.016; Kimura Y, 2009, J BIOL CHEM, V284, P93, DOI 10.1074/jbc.M806840200; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MADIGAN MT, 1984, SCIENCE, V225, P313, DOI 10.1126/science.225.4659.313; Mascle-Allemand C, 2008, BBA-BIOENERGETICS, V1777, P1552, DOI 10.1016/j.bbabio.2008.09.010; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Richter MF, 2007, P NATL ACAD SCI USA, V104, P20280, DOI 10.1073/pnas.0704599105; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Rowe JJ., 1973, CHEM ANAL THERMAL WA, DOI [10.3133/b1303, DOI 10.3133/B1303]; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring Simon, 2009, V28, P941; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; Suzuki H, 2007, BBA-BIOENERGETICS, V1767, P1057, DOI 10.1016/j.bbabio.2007.06.002; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walz T, 1997, J MOL BIOL, V265, P107, DOI 10.1006/jmbi.1996.0714; Yu LJ, 2010, PHOTOSYNTH RES, V106, P215, DOI 10.1007/s11120-010-9596-y	46	151	156	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					228	+		10.1038/nature13197	http://dx.doi.org/10.1038/nature13197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24670637				2022-12-24	WOS:000333979900040
J	Leclerc-Madlala, S				Leclerc-Madlala, Suzanne Madlala			Silver bullets, glass beads, and strengthening Africa's HIV response	LANCET			English	Editorial Material									Global Hlth Bur, Off HIV AIDS, USAID, Washington, DC 20036 USA	United States Agency for International Development (USAID)	Leclerc-Madlala, S (corresponding author), Global Hlth Bur, Off HIV AIDS, USAID, Washington, DC 20036 USA.	Sleclerc-madlala@usaid.gov						Airhihenbuwa C, 1999, J HLTH ED, V1, P267; Ezo MO, 2008, S AFRICAN J PHILOS, V27, P386; Green E, 2011, AIDS BEHAV CULTURE; Kippax S, 2012, AM J PUBLIC HEALTH, V102, P789, DOI 10.2105/AJPH.2011.300594; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369	5	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1203	1204		10.1016/S0140-6736(14)60593-6	http://dx.doi.org/10.1016/S0140-6736(14)60593-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24712031				2022-12-24	WOS:000334104600013
J	Darrow, JJ; Avorn, J; Kesselheim, AS				Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.			New FDA Breakthrough- Drug Category Implications for Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							USER FEE ACT; EARLY ACCESS; FOOD; SAFETY; APPROVAL; DEADLINES; INDUSTRY	In July 2012, the FDA Safety and Innovation Act created the breakthrough therapy designation to expedite development of therapies for serious diseases when evidence suggests substantial superiority over existing options. The authors discuss implications of the new designation. U.S. pharmaceutical regulations are based on the principle that patients should not be exposed to new prescription drugs until their efficacy and safety have been shown. Since 1962, the Food and Drug Administration (FDA) and Congress have balanced the efficient review of investigational drugs with the need to withhold judgment until sufficient evidence is available to clarify the benefit-risk relationship. Misjudging these competing interests in either direction causes important problems. On the one hand, the evidentiary hurdles of the FDA are often criticized by pharmaceutical companies and patient advocacy groups for slowing access to promising therapies. On the other hand, ...	[Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Darrow, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017; Darrow, J J/R-8365-2019	Kesselheim, Aaron/0000-0002-8867-2666; Darrow, J J/0000-0002-7351-4243				[Anonymous], 2006, FED REGISTER, V71, P75148; [Anonymous], 1992, DRUG CLASS PRI REV P; [Anonymous], 1992, FED REGISTER, V57, P58958; [Anonymous], 1990, FED REGISTER, V55, P20857; [Anonymous], 1979, FDA CONSUM, P25; [Anonymous], 2013, FED REGISTER, V78, P3005; [Anonymous], 1987, FED REGISTER, V52, P19476; [Anonymous], 1988, FED REGISTER, V53, P41517; [Anonymous], 1991, EXP ACC INV THER HIV; Avorn J, 2007, NEW ENGL J MED, V356, P1697, DOI 10.1056/NEJMp078041; Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Basu S, 2012, NEW ENGL J MED, V367, P485, DOI 10.1056/NEJMp1204170; Bompey N, 2013, FRIENDS CANC RES; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Carpenter D, 2003, HLTH AFF MILLW S, pW3; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Carpenter D, 2012, AM J POLIT SCI, V56, P98, DOI 10.1111/j.1540-5907.2011.00544.x; CRAWFORD SY, 1992, AM J HOSP PHARM, V49, P2383, DOI 10.1093/ajhp/49.10.2383; Department of Health and Human Services Food and Drug Administration, 2011, PROP WITHD APPR BREA; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Etzioni, 1968, ACTIVE SOC THEORY SO; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; Food and Drug Administration, 2004, GUID IND FAST TRACK; Food and Drug Administration, 2013, DUMM NDA APPR REC 19; Food and Drug Administration, 2010, MYL GEMTZ OZ MARK WI; Food and Drug Administration, FREQ ASK QUEST BREAK; Food and Drug Administration, 2006, GUID IND FAST TRACK; Food and Drug Administration, 2012, FY 2012 INN DRUG APP; Food and Drug Administration, 2013, FAST TRACK BREAKTH T; Food and Drug Administration (FDA), 1988, FED REGISTER, V53, P41516; Grabowski H, 2008, J LAW ECON, V51, P377, DOI 10.1086/589934; Grady D, 2013, NY TIMES, pB4; Harris G, 2010, NY TIMES, pA11; Hirschler B., 2010, REUTERS; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Kaitin K I, 1997, Am J Ther, V4, P167, DOI 10.1097/00045391-199705000-00002; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Kessler DA, 1996, FOOD DRUG LAW J, V51, P207; Lexchin J, 2012, ARCH INTERN MED, V172, P1680, DOI 10.1001/archinternmed.2012.4444; Mayer M, 2006, CLIN TRIALS, V3, P149, DOI 10.1191/1740774506cn144oa; McClellan M, 2012, HILL; McCrimmon KK, 2013, HLTH POLICY SOLUTION; Moore TJ, 2014, JAMA INTERN MED, V174, P90, DOI 10.1001/jamainternmed.2013.11813; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007; Olson MK, 2013, J RISK UNCERTAINTY, V47, P1, DOI 10.1007/s11166-013-9169-5; Reaves N, 2009, ANN C PENNS EC ASS; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; Schultz WB, 2007, NEW ENGL J MED, V357, P2217, DOI 10.1056/NEJMp078212; Sherman RE, 2013, NEW ENGL J MED, V369, P1877, DOI 10.1056/NEJMp1311439; Shulman SR, 1996, PHARMACOECONOMICS, V9, P121, DOI 10.2165/00019053-199609020-00004; Shulman SR, 1995, FOOD DRUG LAW J, V50, P503; Steenburg C, 2006, FOOD DRUG LAW J, V61, P295; Zelenay JL, 2005, FOOD DRUG LAW J, V60, P261	54	85	85	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1252	1258		10.1056/NEJMhle1311493	http://dx.doi.org/10.1056/NEJMhle1311493			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD7EW	24670173	Bronze			2022-12-24	WOS:000333426000014
J	Hoffecker, JF; Elias, SA; O'Rourke, DH				Hoffecker, John F.; Elias, Scott A.; O'Rourke, Dennis H.			Out of Beringia?	SCIENCE			English	Editorial Material							DISPERSAL; AMERICA		[Hoffecker, John F.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Elias, Scott A.] Royal Holloway Univ London, Dept Geog, Egham TW20 0EX, Surrey, England; [O'Rourke, Dennis H.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	University of Colorado System; University of Colorado Boulder; University of London; Royal Holloway University London; Utah System of Higher Education; University of Utah	Hoffecker, JF (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	john.hoffecker@colorado.edu		HOFFECKER, JOHN/0000-0001-6132-3012; Elias, Scott/0000-0002-1498-1060				[Anonymous], 1937, OUTLINE HIST ARCTIC; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Brubaker LB, 2005, J BIOGEOGR, V32, P833, DOI 10.1111/j.1365-2699.2004.01203.x; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Elias SA, 2008, QUATERNARY SCI REV, V27, P2473, DOI 10.1016/j.quascirev.2008.09.011; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Hoffecker J. F., 2007, HUMAN ECOLOGY BERING; Pitulko Vladimir, 2013, PALEOAMERICAN ODYSSE, P13; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Thery-Parisot I., 2005, ZOOARCHAEOLOGY FATS, P50; Westbrook R., 2012, GSA ANN M CHARL NC 4, P180; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	15	46	48	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					979	980		10.1126/science.1250768	http://dx.doi.org/10.1126/science.1250768			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2DZ	24578571				2022-12-24	WOS:000332309600030
J	Egan, AG; Blind, E; Dunder, K; de Graeff, PA; Hummer, BT; Bourcier, T; Rosebraugh, C				Egan, Amy G.; Blind, Eberhard; Dunder, Kristina; de Graeff, Pieter A.; Hummer, B. Timothy; Bourcier, Todd; Rosebraugh, Curtis			Pancreatic Safety of Incretin-Based Drugs - FDA and EMA Assessment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								After evaluating a safety signal regarding pancreatitis and pancreatic cancer in patients using incretin-based drugs, the Food and Drug Administration and the European Medicines Agency conclude that assertions of a causal association are inconsistent with the data. With approximately 25.8 million diabetic patients in the United States and 33 million in the European Union alone, the growing prevalence of diabetes worldwide poses a major public health challenge. Both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are committed to ensuring the safety of drug products marketed for the treatment of diabetes, and postmarketing reports of pancreatitis and pancreatic cancer in patients taking certain antidiabetic medications have been of concern to both agencies. Working in parallel, the agencies have reviewed nonclinical toxicology studies, clinical trial data, and epidemiologic data pertaining to blood glucose-lowering ...	[Egan, Amy G.; Hummer, B. Timothy; Bourcier, Todd; Rosebraugh, Curtis] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Blind, Eberhard] European Med Agcy, London, England; [Dunder, Kristina] Lakemedelsverket, Uppsala, Sweden; [de Graeff, Pieter A.] Dutch Med Evaluat Board, Utrecht, Netherlands	US Food & Drug Administration (FDA); Medical Products Agency	Egan, AG (corresponding author), US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.			Blind, Eberhard/0000-0003-4359-4198				Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Engel SS, 2013, DIABETES THER, V4, P119, DOI 10.1007/s13300-013-0024-0; European Medicines Agency, 2013, ASS REP GLP 1 BAS TH; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	5	350	363	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					794	797		10.1056/NEJMp1314078	http://dx.doi.org/10.1056/NEJMp1314078			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571751				2022-12-24	WOS:000332013000004
J	Wolfe, SM				Wolfe, Sidney M.			THE WASHINGTON BRIEF Increased heart attacks in men using testosterone: the UK importantly lags far behind the US in prescribing testosterone	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EVENTS		Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	Swolfe@citizen.org						[Anonymous], 2014, COMMUNICATION; Avorn J, 2005, POWERFUL MED BENEFIT; Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Layton JB, 2014, J CLIN ENDOCR METAB; US Food and Drug Administration, 2014, FDA EV RISK STROK HE; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108	8	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2014	348								g1789	10.1136/bmj.g1789	http://dx.doi.org/10.1136/bmj.g1789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UF	24578515	Green Published, Bronze			2022-12-24	WOS:000332210200003
J	Gillick, MR				Gillick, Muriel R.			When Frail Elderly Adults Get Sick: Alternatives to Hospitalization	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; PROGRAM		[Gillick, Muriel R.] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Gillick, MR (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	muriel_gillick@hphc.org						Alexcih L, 2010, INDIVIDUALS LIVING C; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; D'Souza S, 2013, BMJ-BRIT MED J, V346; Fox MT, 2012, J AM GERIATR SOC, V60, P2237, DOI 10.1111/jgs.12028; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Fromme EK, 2012, JAMA-J AM MED ASSOC, V307, P34, DOI 10.1001/jama.2011.1956; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Meret-Hanke LA, 2011, GERONTOLOGIST, V51, P774, DOI 10.1093/geront/gnr040	10	5	7	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					201	202		10.7326/M13-1793	http://dx.doi.org/10.7326/M13-1793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA2VE	24658696				2022-12-24	WOS:000330951500008
J	Pershing, S; Enns, EA; Matesic, B; Owens, DK; Goldhaber-Fiebert, JD				Pershing, Suzann; Enns, Eva A.; Matesic, Brian; Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.			Cost-Effectiveness of Treatment of Diabetic Macular Edema	ANNALS OF INTERNAL MEDICINE			English	Article							RANIBIZUMAB PLUS PROMPT; INTRAVITREAL BEVACIZUMAB; DEFERRED LASER; VISUAL IMPAIRMENT; RANDOMIZED-TRIAL; UTILITY VALUES; FOLLOW-UP; TRIAMCINOLONE; PHOTOCOAGULATION; RETINOPATHY	Background: Macular edema is the most common cause of vision loss among patients with diabetes. Objective: To determine the cost-effectiveness of different treatments of diabetic macular edema (DME). Design: Markov model. Data Sources: Published literature and expert opinion. Target Population: Patients with clinically significant DME. Time Horizon: Lifetime. Perspective: Societal. Intervention: Laser treatment, intraocular injections of triamcinolone or a vascular endothelial growth factor (VEGF) inhibitor, or a combination of both. Outcome Measures: Discounted costs, gains in quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: All treatments except laser monotherapy substantially reduced costs, and all treatments except triamcinolone monotherapy increased QALYs. Laser treatment plus a VEGF inhibitor achieved the greatest benefit, gaining 0.56 QALYs at a cost of $ 6975 for an ICER of $ 12 410 per QALY compared with laser treatment plus triamcinolone. Monotherapy with a VEGF inhibitor achieved similar outcomes to combination therapy with laser treatment plus a VEGF inhibitor. Laser monotherapy and triamcinolone monotherapy were less effective and more costly than combination therapy. Results of Sensitivity Analysis: VEGF inhibitor monotherapy was sometimes preferred over laser treatment plus a VEGF inhibitor, depending on the reduction in quality of life with loss of visual acuity. When the VEGF inhibitor bevacizumab was as effective as ranibizumab, it was preferable because of its lower cost. Limitation: Long-term outcome data for treated and untreated diseases are limited. Conclusion: The most effective treatment of DME is VEGF inhibitor injections with or without laser treatment. This therapy compares favorably with cost-effective interventions for other conditions.	Stanford Univ, Stanford Hlth Policy, Ctr Hlth Policy, Stanford, CA 94305 USA; Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Byers Eye Inst, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Pershing, S (corresponding author), 2452 Watson Court, Palo Alto, CA 94303 USA.	pershing@stanford.edu		Enns, Eva/0000-0003-0693-7358; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA094303, R33CA094303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Agency for Healthcare Research and Quality.	Ahmadieh H, 2008, GRAEF ARCH CLIN EXP, V246, P483, DOI 10.1007/s00417-007-0688-0; Alcon, TRIES SUSP TRIAMC AC; [Anonymous], 1987, Int Ophthalmol Clin, V27, P265; Arevalo JF, 2007, OPHTHALMOLOGY, V114, P743, DOI 10.1016/j.ophtha.2006.12.028; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bandello F, 2011, 47 EUR ASS STUD DIAB; Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610; Brown MM, 1999, AM J OPHTHALMOL, V128, P324, DOI 10.1016/S0002-9394(99)00146-4; Brown MM, 2001, BRIT J OPHTHALMOL, V85, P327, DOI 10.1136/bjo.85.3.327; Browning DJ, 2010, DIABETIC RETINOPATHY: EVIDENCE-BASED MANAGEMENT, P141, DOI 10.1007/978-0-387-85900-2_7; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Medicare & Medicaid Services, MED OUTP ADD A B UPD; Centers for Medicare & Medicaid Services, MED ASP DRUG PRIC FI; Clark A, 2008, CLIN EXP OPHTHALMOL, V36, P526, DOI 10.1111/j.1442-9071.2008.01827.x; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Day S, 2011, AM J OPHTHALMOL, V152, P266, DOI 10.1016/j.ajo.2011.01.053; Dewan V, 2012, OPHTHALMOLOGY, V119, P1679, DOI 10.1016/j.ophtha.2012.01.049; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Enns EA, 2013, 34 ANN M SOC MED DEC; Faghihi H, 2008, EUR J OPHTHALMOL, V18, P941, DOI 10.1177/112067210801800614; Fong DS, 2007, ARCH OPHTHALMOL-CHIC, V125, P469; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; Gangnon RE, 2008, INVEST OPHTH VIS SCI, V49, P5041, DOI 10.1167/iovs.08-2231; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Genentech, 2013, LUC PACK INS; Genentech, 2012, LUC PACK INS; Gillies MC, 2006, OPHTHALMOLOGY, V113, P1533, DOI 10.1016/j.ophtha.2006.02.065; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Goyal S, 2011, GRAEF ARCH CLIN EXP, V249, P15, DOI 10.1007/s00417-010-1452-4; Hurley Susan F, 2008, Cost Eff Resour Alloc, V6, P12, DOI 10.1186/1478-7547-6-12; Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015; Javitt JC, 2007, OPHTHALMOLOGY, V114, P238, DOI 10.1016/j.ophtha.2006.07.054; KLEIN R, 1991, OCULAR PROBLEMS DIAB, P1; Klein R, 2009, OPHTHALMOLOGY, V116, P497, DOI 10.1016/j.ophtha.2008.10.016; Knudtson MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P243, DOI 10.1001/archopht.124.2.243; Levinson DR, 2011, DEP HLTH HUMAN SERVI; Lloyd A, 2008, DIABETIC MED, V25, P618, DOI 10.1111/j.1464-5491.2008.02430.x; Lovestam-Adrian M, 2007, DIABETES RES CLIN PR, V77, P141, DOI 10.1016/j.diabres.2006.10.026; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitchell P, 2012, BRIT J OPHTHALMOL, V96, P688, DOI 10.1136/bjophthalmol-2011-300726; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; National Institute for Health and Clinical Excellence 2011 Hypertension, 2011, NAT I HLTH CLIN EXC; Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2175, DOI 10.1016/j.ophtha.2009.04.023; Ockrim ZK, 2008, BRIT J OPHTHALMOL, V92, P795, DOI 10.1136/bjo.2007.131771; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Physicians' Desk Reference, 2010, PHYS DESK REF RED BO; Pollack A., 2011, NY TIMES; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; RUIZ MS, 2001, NO TIME LOSE GETTING; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Schmier JK, 2006, RETINA-J RET VIT DIS, V26, P1056, DOI 10.1097/01.iae.0000254890.48272.5a; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Sharma S, 2005, CAN J OPHTHALMOL, V40, P369, DOI 10.1016/S0008-4182(05)80079-1; Sharma S, 2000, Curr Opin Ophthalmol, V11, P175, DOI 10.1097/00055735-200006000-00004; Sharma S, 2000, CAN J OPHTHALMOL, V35, P267, DOI 10.1016/S0008-4182(00)80077-0; Sharma S, 2001, CURR OPIN OPHTHALMOL, V12, P230, DOI 10.1097/00055735-200106000-00016; Shea AM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1748, DOI 10.1001/archopht.126.12.1748; Soheilian M, 2009, OPHTHALMOLOGY, V116, P1142, DOI 10.1016/j.ophtha.2009.01.011; Solaiman KAM, 2010, RETINA-J RET VIT DIS, V30, P1638, DOI 10.1097/IAE.0b013e3181e1ed07; U. S. Bureau of Labor Statistics, 2009, EMPLOYMENT EARNINGS; U.S. Census Bureau, 2012, CONS PRIC IND CPIO M; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Xu L, 2008, GRAEF ARCH CLIN EXP, V246, P923, DOI 10.1007/s00417-008-0773-z; Yilmaz T, 2009, OPHTHALMOLOGY, V116, P902, DOI 10.1016/j.ophtha.2009.02.002	77	46	47	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					18	+		10.7326/M13-0768	http://dx.doi.org/10.7326/M13-0768			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24573663	Green Accepted			2022-12-24	WOS:000330249700003
J	Selvin, E; Parrinello, CM; Sacks, DB; Coresh, J				Selvin, Elizabeth; Parrinello, Christina M.; Sacks, David B.; Coresh, Josef			Trends in Prevalence and Control of Diabetes in the United States, 1988-1994 and 1999-2010	ANNALS OF INTERNAL MEDICINE			English	Article							FASTING PLASMA-GLUCOSE; NATIONAL-HEALTH; ATHEROSCLEROSIS RISK; GLYCATED HEMOGLOBIN; ADULTS; US; MELLITUS; A1C; CLASSIFICATION; COMORBIDITIES	Background: Trends in the prevalence and control of diabetes defined by hemoglobin A(1c) (HbA(1c)) levels are important for health care policy and planning. Objective: To update trends in the prevalence of diabetes, prediabetes, and glycemic control. Design: Cross-sectional. Setting: NHANES (National Health and Nutrition Examination Survey) in 1988-1994 and 1999-2010. Participants: Adults aged 20 years or older. Measurements: We used calibrated HbA(1c) levels to define undiagnosed diabetes (>= 6.5%); prediabetes (5.7% to 6.4%); and, among persons with diagnosed diabetes, glycemic control (<7.0% or <8.0%). Trends in HbA(1c) categories were compared with fasting glucose levels (>= 7.0 mmol/L [>= 126 mg/dL] and 5.6 to 6.9 mmol/L [100 to 125 mg/dL]). Results: In 2010, approximately 21 million U. S. adults aged 20 years or older had total confirmed diabetes (self-reported diabetes or diagnostic levels for both fasting glucose and calibrated HbA(1c)). During 2 decades, the prevalence of total confirmed diabetes in-creased, but the prevalence of undiagnosed diabetes remained fairly stable, reducing the proportion of total diabetes cases that are undiagnosed to 11% in 2005-2010. The prevalence of prediabetes was lower when defined by calibrated HbA(1c) levels than when defined by fasting glucose levels but has increased from 5.8% in 1988-1994 to 12.4% in 2005-2010 when defined by HbA(1c) levels. Glycemic control improved overall, but total diabetes prevalence was greater and diabetes was less controlled among non-Hispanic blacks and Mexican Americans compared with non-Hispanic whites. Limitation: Cross-sectional design. Conclusion: Over the past 2 decades, the prevalence of total diabetes has increased substantially. However, the proportion of undiagnosed diabetes cases decreased, suggesting improvements in screening and diagnosis. Among the growing number of persons with diagnosed diabetes, glycemic control improved but remains a challenge, particularly among non-Hispanic blacks and Mexican Americans.	[Selvin, Elizabeth] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Johns Hopkins Univ, Baltimore, MD USA; NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; National Institutes of Health (NIH) - USA	Selvin, E (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu		Sacks, David/0000-0003-3100-0735	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK089174]; National Heart, Lung, and Blood Institute [T32 HL007024]; Intramural Program of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institute of Diabetes and Digestive and Kidney Diseases (grant R01 DK089174) to Dr. Selvin. Ms. Parrinello was supported by the National Heart, Lung, and Blood Institute (grant T32 HL007024). Dr. Sacks was supported by the Intramural Program of the National Institutes of Health.	Abraham TM, 2013, DIABETES CARE, V36, P2139, DOI 10.2337/dc13-0792; Albano A., 2014, PACKAGE EQUATE; Albano AD, 2011, EQUATE R PACKAGE OBS; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; American Diabetes Association, 2010, DIABETES CARE S1, V33, P692, DOI [10.2337/dc10-S011, DOI 10.2337/DC10-S011]; [Anonymous], 2010, DATA DOC COD FREQ PL; [Anonymous], 2008, DATA DOC COD FREQ PL; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bower JK, 2013, DIABETES CARE, V36, P569, DOI 10.2337/dc12-0404; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Centers for Disease Control and Prevention, 2012, UPDAT ADVIS NHANES H; Centers for Disease Control and Prevention, 2011, MAPS TRENDS DIAGN DI; Centers for Disease Control and Prevention, 1996, LAB PROC USES 3 NAT; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1014; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Debnath S, 2012, CLIN NEPHROL, V77, P332, DOI 10.5414/CN107487; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Gross AL, 2012, J CLIN EXP NEUROPSYC, V34, P758, DOI 10.1080/13803395.2012.681628; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Kalyani RR, 2010, DIABETES CARE, V33, P1055, DOI 10.2337/dc09-1597; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 1996, ANAL REP GUID 3 NAT; Pankow JS, 2007, DIABETES CARE, V30, P325, DOI 10.2337/dc06-1457; PERNEGER TV, 1994, ANN INTERN MED, V121, P912, DOI 10.7326/0003-4819-121-12-199412150-00002; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Ryerson B, 2003, DIABETES CARE, V26, P206, DOI 10.2337/diacare.26.1.206; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Schneider ALC, 2013, DIABETES CARE, V36, P1153, DOI 10.2337/dc12-1168; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Vincent G. K., 2010, CURRENT POPULATION R, VP25, P1; World Health Organization, 2011, USE GLYC HACM HBA1C; World Health Organization, 2008, WAIST CIRC WAIST FLI; Zhang XZ, 2010, J AM GERIATR SOC, V58, P724, DOI 10.1111/j.1532-5415.2010.02786.x	43	382	387	1	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					517	+		10.7326/M13-2411	http://dx.doi.org/10.7326/M13-2411			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24733192	Green Accepted			2022-12-24	WOS:000335143700001
J	Seo, J; Giusti-Rodriguez, P; Zhou, Y; Rudenko, A; Cho, S; Ota, KT; Park, C; Patzke, H; Madabhushi, R; Pan, L; Mungenast, AE; Guan, JS; Delalle, I; Tsai, LH				Seo, Jinsoo; Giusti-Rodriguez, Paola; Zhou, Ying; Rudenko, Andrii; Cho, Sukhee; Ota, Kristie T.; Park, Christine; Patzke, Holger; Madabhushi, Ram; Pan, Ling; Mungenast, Alison E.; Guan, Ji-Song; Delalle, Ivana; Tsai, Li-Huei			Activity-Dependent p25 Generation Regulates Synaptic Plasticity and A beta-Induced Cognitive Impairment	CELL			English	Article							ALZHEIMERS-DISEASE; MEMORY FORMATION; TRANSGENIC MICE; AMPA RECEPTORS; CDK5; PROTEIN; P35; ACTIVATION; PHOSPHORYLATION; NEURODEGENERATION	Cyclin-dependent kinase 5 regulates numerous neuronal functions with its activator, p35. Under neurotoxic conditions, p35 undergoes proteolytic cleavage to liberate p25, which has been implicated in various neurodegenerative diseases. Here, we show that p25 is generated following neuronal activity under physiological conditions in a GluN2B- and CaMKII alpha-dependent manner. Moreover, we developed a knockin mouse model in which endogenous p35 is replaced with a calpain-resistant mutant p35 (Delta p35KI) to prevent p25 generation. The Dp35KI mice exhibit impaired long-term depression and defective memory extinction, likely mediated through persistent GluA1 phosphorylation at Ser845. Finally, crossing the Dp35KI mice with the 5XFAD mouse model of Alzheimer's disease ( AD) resulted in an amelioration of beta-amyloid (Ab)-induced synaptic depression and cognitive impairment. Together, these results reveal a physiological role of p25 production in synaptic plasticity and memory and provide new insights into the function of p25 in A beta-associated neurotoxicity and AD-like pathology.	[Seo, Jinsoo; Giusti-Rodriguez, Paola; Zhou, Ying; Rudenko, Andrii; Cho, Sukhee; Ota, Kristie T.; Park, Christine; Patzke, Holger; Madabhushi, Ram; Pan, Ling; Mungenast, Alison E.; Guan, Ji-Song; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Seo, Jinsoo; Giusti-Rodriguez, Paola; Zhou, Ying; Rudenko, Andrii; Cho, Sukhee; Ota, Kristie T.; Park, Christine; Patzke, Holger; Madabhushi, Ram; Pan, Ling; Mungenast, Alison E.; Guan, Ji-Song; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Tsai, Li-Huei] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Tsai, Li-Huei] MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Rudenko, Andrey/AAG-4696-2020; Seo, Jinsoo/AAD-4950-2019	Rudenko, Andrey/0000-0001-6858-3650; Seo, Jinsoo/0000-0001-6432-6964; Guan, Ji-Song/0000-0001-5219-0289; Delalle, Ivana/0000-0002-1873-3064; Mungenast, Alison/0000-0003-1020-0471	National Institutes of Health [R01 NS051874, F31GM80055-03]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM080055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Neve for packaging the recombinant herpes simplex viruses; J. Giraud and E. Cornejo for early observations; Z. Xie for assistance in developing the cloning strategy to generate the Delta p35KI mouse; W. Xu, S. Su, A. Nott, and A. Bero for helpful comments on the manuscript; and members of the Tsai lab for fruitful advice and discussions. We also thank M. Taylor for animal maintenance. This work was partially supported by the National Institutes of Health (grants R01 NS051874 to L.-H.T. and F31GM80055-03 to P.G.-R.) and the Howard Hughes Medical Institute.	Angelo M, 2003, EUR J NEUROSCI, V18, P423, DOI 10.1046/j.1460-9568.2003.02746.x; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Crews L, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.2; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; Dhavan R, 2002, J NEUROSCI, V22, P7879; Engmann O, 2011, BIOL PSYCHIAT, V70, P159, DOI 10.1016/j.biopsych.2011.04.011; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; Jawhar S., 2012, NEUROBIOL AGING, V33, pe129, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.027, DOI 10.1016/j.neurobiolaging.2010.05.027]; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Ko J, 2001, J NEUROSCI, V21, P6758; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; Mukerjee N, 2000, ARCH BIOCHEM BIOPHYS, V379, P337, DOI 10.1006/abbi.2000.1889; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	60	59	60	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					486	498		10.1016/j.cell.2014.01.065	http://dx.doi.org/10.1016/j.cell.2014.01.065			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725413	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000334304500020
J	Navar-Boggan, AM; Pencina, MJ; Williams, K; Sniderman, AD; Peterson, ED				Navar-Boggan, Ann Marie; Pencina, Michael J.; Williams, Ken; Sniderman, Allan D.; Peterson, Eric D.			Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE The new 2014 blood pressure (BP) guideline released by the panel members appointed to the Eighth Joint National Committee (JNC 8; 2014 BP guideline) proposed less restrictive BP targets for adults aged 60 years or older and for those with diabetes and chronic kidney disease. OBJECTIVE To estimate the proportion of US adults potentially affected by recent changes in recommendations for management of hypertension. DESIGN Cross-sectional, nationally representative survey. PARTICIPANTS Using data from the National Health and Nutrition Examination Survey between 2005 and 2010 (n = 16 372), we evaluated hypertension control and treatment recommendations for US adults. MAIN OUTCOMES AND MEASURES Proportion of adults estimated to meet guideline-based BP targets under the 2014 BP guideline and under the previous seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guideline. RESULTS The proportion of younger adults (18-59 years) with treatment-eligible hypertension under the JNC 7 guideline was 20.3%(95% CI, 19.1%-21.4%) and decreased to 19.2%(95% CI, 18.1%-20.4%) under the 2014 BP guideline. Larger declines were observed among older adults (>= 60 years), decreasing from 68.9%(95% CI, 66.9%-70.8%) under JNC 7 to 61.2%(95% CI, 59.3%-63.0%) under the 2014 BP guideline. The proportion of adults with treatment-eligible hypertension who met BP goals increased slightly for younger adults, from 41.2%(95% CI, 38.1%-44.3%) under JNC 7 to 47.5%(95% CI, 44.4%-50.6%) under the 2014 BP guideline, and more substantially for older adults, from 40.0%(95% CI, 37.8%-42.3%) under JNC 7 to 65.8% (95% CI, 63.7%-67.9%) under the 2014 BP guideline. Overall, 1.6%(95% CI, 1.3%-1.9%) of US adults aged 18-59 years and 27.6%(95% CI, 25.9%-29.3%) of adults aged 60 years or older were receiving BP-lowering medication and meeting more stringent JNC 7 targets. These patients may be eligible for less stringent or no BP therapy with the 2014 BP guideline. CONCLUSIONS AND RELEVANCE Compared with the JNC 7 guideline, the 2014 BP guideline from the panel members appointed to the JNC 8 was associated with a reduction in the proportion of US adults recommended for hypertension treatment and a substantial increase in the proportion of adults considered to have achieved goal BP, primarily in older adults.	[Navar-Boggan, Ann Marie] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; [Pencina, Michael J.] Duke Univ, DCRI, Durham, NC 27710 USA; [Williams, Ken] KenAnCo Biostat, San Antonio, TX USA; [Sniderman, Allan D.] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University; McGill University; Royal Victoria Hospital; Duke University	Navar-Boggan, AM (corresponding author), Duke Univ, Med Ctr, Div Cardiol, 2301 Erwin Rd, Durham, NC 27710 USA.	ann.navar@duke.edu	Peterson, Eric David/ABF-5033-2021		Duke Clinical Research Institute	Duke Clinical Research Institute	This research was supported in part by Duke Clinical Research Institute's research funds and unrestricted grants from M. Jean de Granpre and Louis and Sylvia Vogel.	Centers for Disease Control and Prevention, ABOUT THE NATIONAL H; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Johnson CL, 2013, VITAL HEALTH STAT, V2; Ogihara T, 2004, HYPERTENS RES, V27, P657, DOI 10.1291/hypres.27.657; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981; Yoon Paula W, 2012, MMWR Suppl, V61, P19	8	81	84	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1424	1429		10.1001/jama.2014.2531	http://dx.doi.org/10.1001/jama.2014.2531			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24682242	Bronze, Green Published			2022-12-24	WOS:000333935000018
J	Zhu, SY; Rezvani, M; Harbell, J; Mattis, AN; Wolfe, AR; Benet, LZ; Willenbring, H; Ding, S				Zhu, Saiyong; Rezvani, Milad; Harbell, Jack; Mattis, Aras N.; Wolfe, Alan R.; Benet, Leslie Z.; Willenbring, Holger; Ding, Sheng			Mouse liver repopulation with hepatocytes generated from human fibroblasts	NATURE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR RECEPTORS; DEFINED FACTORS; IN-VIVO; EXPRESSION; MICE; TRANSPLANTATION; CONVERSION; INDUCTION; DIFFERENTIATION	Human induced pluripotent stem cells (iPSCs) have the capability of revolutionizing research and therapy of liver diseases by providing a source of hepatocytes for autologous cell therapy and disease modelling. However, despite progress in advancing the differentiation of iPSCs into hepatocytes (iPSC-Heps) in vitro(1-3), cells that replicate the ability of human primary adult hepatocytes (aHeps) to proliferate extensively in vivo have not been reported. This deficiency has hampered efforts to recreate human liver diseases in mice, and has cast doubt on the potential of iPSC-Heps for liver cell therapy. The reason is that extensive post-transplant expansion is needed to establish and sustain a therapeutically effective liver cell mass in patients, a lesson learned from clinical trials of aHep transplantation(4). Here, as a solution to this problem, we report the generation of human fibroblast-derived hepatocytes that can repopulate mouse livers. Unlike current protocols for deriving hepatocytes from human fibroblasts, ours did not generate iPSCs but cut short reprogramming to pluripotency to generate an induced multipotent progenitor cell (iMPC) state from which endoderm progenitor cells and subsequently hepatocytes (iMPC-Heps) could be efficiently differentiated. For this purpose we identified small molecules that aided endoderm and hepatocyte differentiation without compromising proliferation. After transplantation into an immune-deficient mouse model of human liver failure, iMPC-Heps proliferated extensively and acquired levels of hepatocyte function similar to those of aHeps. Unfractionated iMPC-Heps did not form tumours, most probably because they never entered a pluripotent state. Our results establish the feasibility of significant liver repopulation of mice with human hepatocytes generated in vitro, which removes a long-standing roadblock on the path to autologous liver cell therapy.	[Zhu, Saiyong; Ding, Sheng] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Rezvani, Milad; Mattis, Aras N.; Willenbring, Holger] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Harbell, Jack; Willenbring, Holger] Univ Calif San Francisco, Div Transplantat, Dept Surg, San Francisco, CA 94143 USA; [Mattis, Aras N.; Willenbring, Holger] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94110 USA; [Mattis, Aras N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Wolfe, Alan R.; Benet, Leslie Z.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Willenbring, H (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA.	willenbringh@stemcell.ucsf.edu; sheng.ding@gladstone.ucsf.edu	Benet, Leslie Z/K-8286-2016; Mattis, Aras/C-5558-2014; Wolfe, Alan R./A-6853-2009	Wolfe, Alan R./0000-0002-0932-4146; Rezvani, Milad/0000-0002-9550-8725	California Institute for Regenerative Medicine (CIRM) [RN2-00950]; National Institutes of Health (NIH) [P30 DK26743]; CIRM [TG2-01160, TG2-01153]; NIH; Gladstone Institutes; German Academic Exchange Service; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064610] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000487, UH3TR000487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Gladstone Institutes' Bioinformatics Core for data analysis, A. Grimm for discussion, and P. Derish for manuscript editing. H. W. is supported by funding from the California Institute for Regenerative Medicine (CIRM; RN2-00950) and the National Institutes of Health (NIH; P30 DK26743). S. D. is supported by funding from CIRM, NIH and the Gladstone Institutes. S.Z. is supported by CIRM research training grant TG2-01160. M. R. is a research fellow in the Biomedical Exchange Program funded by the German Academic Exchange Service. J.H. is an Ethicon-Society of University Surgeons Fellow. A.N.M. is supported by CIRM research training grant TG2-01153.	Andreou ER, 1998, ARCH BIOCHEM BIOPHYS, V357, P137, DOI 10.1006/abbi.1998.0792; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Leeder JS, 2005, J PHARMACOL EXP THER, V314, P626, DOI 10.1124/jpet.105.086504; Li J, 2013, ARTERIOSCL THROM VAS, V33, P1366, DOI 10.1161/ATVBAHA.112.301167; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; LIEBER A, 1995, P NATL ACAD SCI USA, V92, P6210, DOI 10.1073/pnas.92.13.6210; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Mwinyi J, 2010, MOL PHARMACOL, V78, P886, DOI 10.1124/mol.110.065540; Puppi J, 2012, CELL TRANSPLANT, V21, P1, DOI 10.3727/096368911X566208; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Willenbring H, 2008, CANCER CELL, V14, P59, DOI 10.1016/j.ccr.2008.05.004; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	37	186	205	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					93	97		10.1038/nature13020	http://dx.doi.org/10.1038/nature13020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24572354	Green Accepted, Green Submitted			2022-12-24	WOS:000333609900049
J	Neubauer, S; Redwood, C				Neubauer, Stefan; Redwood, Charles			New Mechanisms and Concepts for Cardiac-Resynchronization Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEART		[Neubauer, Stefan; Redwood, Charles] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England	University of Oxford	Neubauer, S (corresponding author), Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England.			Neubauer, Stefan/0000-0001-9017-5645				Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Holzmeister J, 2011, LANCET, V378, P722, DOI 10.1016/S0140-6736(11)61228-2; Kirk JA, 2013, J CLIN INVEST; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659	5	11	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 20	2014	370	12					1164	1166		10.1056/NEJMcibr1315508	http://dx.doi.org/10.1056/NEJMcibr1315508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD2HA	24645952				2022-12-24	WOS:000333054000016
J	Urbach, DR; Govindarajan, A; Saskin, R; Wilton, AS; Baxter, NN				Urbach, David R.; Govindarajan, Anand; Saskin, Refik; Wilton, Andrew S.; Baxter, Nancy N.			Introduction of Surgical Safety Checklists in Ontario, Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTOPERATIVE ADVERSE EVENTS; QUALITY IMPROVEMENT PROGRAM; PATIENT SAFETY; IMPLEMENTATION; MORTALITY; OUTCOMES; SURGERY; POPULATION; INDICATORS; CARE	BackgroundEvidence from observational studies that the use of surgical safety checklists results in striking improvements in surgical outcomes led to the rapid adoption of such checklists worldwide. However, the effect of mandatory adoption of surgical safety checklists is unclear. A policy encouraging the universal adoption of checklists by hospitals in Ontario, Canada, provided a natural experiment to assess the effectiveness of checklists in typical practice settings. MethodsWe surveyed all acute care hospitals in Ontario to determine when surgical safety checklists were adopted. Using administrative health data, we compared operative mortality, rate of surgical complications, length of hospital stay, and rates of hospital readmission and emergency department visits within 30 days after discharge among patients undergoing a variety of surgical procedures before and after adoption of a checklist. ResultsDuring 3-month periods before and after adoption of a surgical safety checklist, a total of 101 hospitals performed 109,341 and 106,370 procedures, respectively. The adjusted risk of death during a hospital stay or within 30 days after surgery was 0.71% (95% confidence interval [CI], 0.66 to 0.76) before implementation of a surgical checklist and 0.65% (95% CI, 0.60 to 0.70) afterward (odds ratio, 0.91; 95% CI, 0.80 to 1.03; P=0.13). The adjusted risk of surgical complications was 3.86% (95% CI, 3.76 to 3.96) before implementation and 3.82% (95% CI, 3.71 to 3.92) afterward (odds ratio, 0.97; 95% CI, 0.90 to 1.03; P=0.29). ConclusionsImplementation of surgical safety checklists in Ontario, Canada, was not associated with significant reductions in operative mortality or complications. (Funded by the Canadian Institutes of Health Research.) Public reporting of adherence to surgical safety checklists was mandated for all hospitals in Ontario, beginning in July 2010. In this study of administrative data, checklist introduction was not associated with significant reductions in operative mortality or complications. A study published in 2009 showed that implementation of the 19-item World Health Organization (WHO) Surgical Safety Checklist substantially reduced the rate of surgical complications, from 11.0% to 7.0%, and reduced the rate of in-hospital death from 1.5% to 0.8%.(1) The WHO estimated that at least 500,000 deaths per year could be prevented through worldwide implementation of this checklist.(2) This dramatic effect of a relatively simple and accessible intervention resulted in its widespread adoption. In the United Kingdom, a nationwide program was implemented by the National Health Service within weeks after publication of the WHO study,(3) and almost 6000 hospitals ...	[Urbach, David R.; Govindarajan, Anand; Saskin, Refik; Wilton, Andrew S.; Baxter, Nancy N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Urbach, David R.; Govindarajan, Anand; Baxter, Nancy N.] Dept Surg, Toronto, ON, Canada; [Urbach, David R.; Baxter, Nancy N.] Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Urbach, David R.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Govindarajan, Anand] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Baxter, Nancy N.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Dept Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Urbach, DR (corresponding author), 200 Elizabeth St,10-214, Toronto, ON M5G 2C4, Canada.	david.urbach@uhn.ca	Callahan, Charles D/L-1641-2013; Baxter, Nancy N/E-7020-2015	Baxter, Nancy N/0000-0003-4793-4620	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research.	[Anonymous], SURG SAF CHECKL HOW; [Anonymous], 2003, CAN CLASS HLTH INT; [Anonymous], SURG SAF CHECKL; [Anonymous], PATIENT SAFETY; [Anonymous], 2009, PAT SAF AL WHO SURG; [Anonymous], 2013, PUBL REP PAT SAF PER; [Anonymous], 2008, J HOPK ACG CAS MIX S; Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Best WR, 2002, J AM COLL SURGEONS, V194, P257, DOI 10.1016/S1072-7515(01)01183-8; Bliss LA, 2012, J AM COLL SURGEONS, V215, P766, DOI 10.1016/j.jamcollsurg.2012.07.015; Borchard A, 2012, ANN SURG, V256, P925, DOI 10.1097/SLA.0b013e3182682f27; Cima RR, 2011, SURGERY, V150, P943, DOI 10.1016/j.surg.2011.06.020; Conley DM, 2011, J AM COLL SURGEONS, V212, P873, DOI 10.1016/j.jamcollsurg.2011.01.052; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Helmio P, 2011, CLIN OTOLARYNGOL, V36, P242, DOI 10.1111/j.1749-4486.2011.02315.x; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; Kaafarani HMA, 2009, AM J SURG, V198, pS63, DOI 10.1016/j.amjsurg.2009.08.008; Levy SM, 2012, SURGERY, V152, P331, DOI 10.1016/j.surg.2012.05.034; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Nilsson L, 2010, ACTA ANAESTH SCAND, V54, P176, DOI 10.1111/j.1399-6576.2009.02109.x; North Carolina Quality Center, WHO SURG SAF CHECKL; Oregon Association of Hospitals and Health Systems, SPRINT SURG SAF; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Sewell M, 2011, INT ORTHOP, V35, P897, DOI 10.1007/s00264-010-1112-7; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Takala RSK, 2011, ACTA ANAESTH SCAND, V55, P1206, DOI 10.1111/j.1399-6576.2011.02525.x; Tu JV, 1998, CAN MED ASSOC J, V159, P221; van Klei WA, 2012, ANN SURG, V255, P44, DOI 10.1097/SLA.0b013e31823779ae; Vogts N, 2011, NEW ZEAL MED J, V124, P48; World Health Organization, PAT SAF SURG SAF WEB; World Health Organization, IMPL MAN SURG SAF CH; World Health Organization, SAF SURG SAV LIV; Yinong YX, 2011, ARCH SURG-CHICAGO, V146, P1368, DOI 10.1001/archsurg.2011.762; ZEGER SL, 1989, BIOMETRICS, V45, P347; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	37	394	403	2	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1029	1038		10.1056/NEJMsa1308261	http://dx.doi.org/10.1056/NEJMsa1308261			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620866	Bronze			2022-12-24	WOS:000332689100010
J	Blyth, A				Blyth, Andrew			Thoracic Trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	8	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2014	348								g1137	10.1136/bmj.g1137	http://dx.doi.org/10.1136/bmj.g1137			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6JC	24609501				2022-12-24	WOS:000332627300001
J	Hanmer, J; Lu, X; Rosenthal, GE; Cram, P				Hanmer, Janel; Lu, Xin; Rosenthal, Gary E.; Cram, Peter			Insurance Status and the Transfer of Hospitalized Patients An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT; CHEST-PAIN; PREFERENCES; TRIAGE; EMTALA; RACE; REVASCULARIZATION; CENTERS; NEED	Background: There is little objective evidence to support concerns that patients are transferred between hospitals based on insurance status. Objective: To examine the relationship between patients' insurance coverage and interhospital transfer. Design: Data analyzed from the 2010 Nationwide Inpatient Sample. Patients: All patients aged 18 to 64 years discharged alive from U.S. acute care hospitals with 1 of 5 common diagnoses (biliary tract disease, chest pain, pneumonia, septicemia, and skin or subcutaneous infection). Measurements: For each diagnosis, the proportion of hospitalized patients who were transferred to another acute care hospital based on insurance coverage (private, Medicare, Medicaid, or uninsured) was compared. Logistic regression was used to estimate the odds of transfer for uninsured patients (reference category, privately insured) while patient-and hospital-level factors were adjusted for. All analyses incorporated sampling and poststratification weights. Results: Among 315 748 patients discharged from 1051 hospitals with any of the 5 diagnoses, the percentage of patients transferred to another acute care hospital varied from 1.3% (skin infection) to 5.1% (septicemia). In unadjusted analyses, uninsured patients were significantly less likely to be transferred for 3 diagnoses (P < 0.05). In adjusted analyses, uninsured patients were significantly less likely to be transferred than privately insured patients for 4 diagnoses: biliary tract disease (odds ratio, 0.73 [95% CI, 0.55 to 0.96]), chest pain (odds ratio, 0.63 [CI, 0.44 to 0.89]), septicemia (odds ratio, 0.76 [CI, 0.64 to 0.91]), and skin infections (odds ratio, 0.64 [CI, 0.46 to 0.89]). Women were significantly less likely to be transferred than men for all diagnoses. Limitation: This analysis relied on administrative data and lacked clinical detail. Conclusion: Uninsured patients (and women) were significantly less likely to undergo interhospital transfer. Differences in transfer rates may contribute to health care disparities.	Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; Univ Iowa, Carver Coll Med, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA USA; Iowa City Vet Affairs Med Ctr, Iowa City, IA USA; Univ Toronto, Toronto, ON, Canada; [Cram, Peter] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON M5G 2C4, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto	Hanmer, J (corresponding author), Univ Pittsburgh, Med Ctr, Montefiore Hosp, Suite W93,200 Lothrop St, Pittsburgh, PA 15213 USA.	hanmerjz@upmc.edu	Cram, Peter/K-4472-2014	Cram, Peter/0000-0002-1910-346X	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000442] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR062133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.	American Hospital Association, 2008, AM HOSP ASS ANN SURV; Babu MA, 2011, NEUROSURGERY, V69, P659, DOI 10.1227/NEU.0b013e31821bc667; Barnett H, 2010, PROF CASE MANAG, V15, P280, DOI 10.1097/NCM.0b013e3181e2d114; Boulware LE, 2005, AM J TRANSPLANT, V5, P1503, DOI 10.1111/j.1600-6143.2005.00860.x; Constantinescu F, 2009, ARTHRIT RHEUM-ARTHR, V61, P413, DOI 10.1002/art.24338; Cooke CR, 2011, MED CARE, V49, P662, DOI 10.1097/MLR.0b013e31821d98b2; Cram P, 2008, MED CARE, V46, P467, DOI 10.1097/MLR.0b013e31816c43d9; Durbin DR, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.3.e8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gurwitz JH, 2002, AM J MED, V112, P528, DOI 10.1016/S0002-9343(02)01072-0; HCUP Nationwide Inpatient Sample (NIS), HLTH CAR COST UT PRO; Healthcare Cost and Utilization Project (HCUP), HEALTHC COST UT PROJ; Healthcare Cost and Utilization Project National Institutes of Health, 2013, DESCR DAT EL HEALTHC; HIMMELSTEIN DU, 1984, AM J PUBLIC HEALTH, V74, P494, DOI 10.2105/AJPH.74.5.494; Houchens R, 2001, HCUP METHOD SERIES R; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Kamoie B E, 2000, J Health Law, V33, P25; Kao DP, 2012, ARCH INTERN MED, V172, P891, DOI 10.1001/archinternmed.2012.1290; KELLERMANN AL, 1990, AM J PUBLIC HEALTH, V80, P864, DOI 10.2105/AJPH.80.7.864; KELLERMANN AL, 1988, AM J PUBLIC HEALTH, V78, P1287, DOI 10.2105/AJPH.78.10.1287; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; Lee Tiana Mayere, 2004, Ann Health Law, V13, P145; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lopez L, 2010, ACAD EMERG MED, V17, P801, DOI 10.1111/j.1553-2712.2010.00823.x; McCarthy JJ, 2013, COMMON PROBLEMS ACUT; Mumma BE, 2011, ANN EMERG MED, V57, P551, DOI 10.1016/j.annemergmed.2010.09.026; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; Popescu I, 2007, JAMA-J AM MED ASSOC, V297, P2489, DOI 10.1001/jama.297.22.2489; Ravn-Fischer A, 2012, AM J EMERG MED, V30, P1515, DOI 10.1016/j.ajem.2011.12.020; Rosenbaum S, 2012, HEALTH AFFAIR, V31, P1749, DOI 10.1377/hlthaff.2012.0517; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; SCHIFF RL, 1986, NEW ENGL J MED, V314, P552, DOI 10.1056/NEJM198602273140905; Smith JM, 2002, J NATL MED ASSOC, V94, P426; Strickler Jeffery, 2006, JONAS Healthc Law Ethics Regul, V8, P77, DOI 10.1097/00128488-200607000-00005; Thakur NA, 2010, J ORTHOP TRAUMA, V24, P336, DOI 10.1097/BOT.0b013e3181b18b89; White A, 2011, SEEING PATIENTS UNCO; Wong MD, 2004, AM J MED, V116, P613, DOI 10.1016/j.amjmed.2003.09.051	37	19	19	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					81	+		10.7326/M12-1977	http://dx.doi.org/10.7326/M12-1977			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	297SQ	24592493	Green Accepted			2022-12-24	WOS:000330275600014
J	Suva, ML; Rheinbay, E; Gillespie, SM; Patel, AP; Wakimoto, H; Rabkin, SD; Riggi, N; Chi, AS; Cahill, DP; Nahed, BV; Curry, WT; Martuza, RL; Rivera, MN; Rossetti, N; Kasif, S; Beik, S; Kadri, S; Tirosh, I; Wortman, I; Shalek, AK; Rozenblatt-Rosen, O; Regev, A; Louis, DN; Bernstein, BE				Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Patel, Anoop P.; Wakimoto, Hiroaki; Rabkin, Samuel D.; Riggi, Nicolo; Chi, Andrew S.; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Rivera, Miguel N.; Rossetti, Nikki; Kasif, Simon; Beik, Samantha; Kadri, Sabah; Tirosh, Itay; Wortman, Ivo; Shalek, Alex K.; Rozenblatt-Rosen, Orit; Regev, Aviv; Louis, David N.; Bernstein, Bradley E.			Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells	CELL			English	Article							INITIATING CELLS; CHROMATIN STATE; SELF-RENEWAL; CANCER; ENHANCERS; GLIOMA; TUMORIGENICITY; PLURIPOTENCY; LEUKEMIA; GENOME	Developmental fate decisions are dictated by master transcription factors (TFs) that interact with cis-regulatory elements to direct transcriptional programs. Certain malignant tumors may also depend on cellular hierarchies reminiscent of normal development but superimposed on underlying genetic aberrations. In glioblastoma (GBM), a subset of stem-like tumorpropagating cells (TPCs) appears to drive tumor progression and underlie therapeutic resistance yet remain poorly understood. Here, we identify a core set of neurodevelopmental TFs (POU3F2, SOX2, SALL2, and OLIG2) essential for GBM propagation. These TFs coordinately bind and activate TPC-specific regulatory elements and are sufficient to fully reprogram differentiated GBM cells to "induced'' TPCs, recapitulating the epigenetic landscape and phenotype of native TPCs. We reconstruct a network model that highlights critical interactions and identifies candidate therapeutic targets for eliminating TPCs. Our study establishes the epigenetic basis of a developmental hierarchy in GBM, provides detailed insight into underlying gene regulatory programs, and suggests attendant therapeutic strategies.	[Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Patel, Anoop P.; Regev, Aviv; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Riggi, Nicolo; Rivera, Miguel N.; Rossetti, Nikki; Louis, David N.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Riggi, Nicolo; Rivera, Miguel N.; Rossetti, Nikki; Louis, David N.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Patel, Anoop P.; Wakimoto, Hiroaki; Rabkin, Samuel D.; Riggi, Nicolo; Chi, Andrew S.; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Rivera, Miguel N.; Rossetti, Nikki; Louis, David N.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Suva, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Riggi, Nicolo; Rivera, Miguel N.; Rossetti, Nikki; Beik, Samantha; Kadri, Sabah; Tirosh, Itay; Wortman, Ivo; Rozenblatt-Rosen, Orit; Regev, Aviv; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Patel, Anoop P.; Wakimoto, Hiroaki; Rabkin, Samuel D.; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Div Neurooncol, Boston, MA 02114 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Chi, Andrew S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kasif, Simon] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Kasif, Simon] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Shalek, Alex K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT)	Suva, ML (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	suva.mario@mgh.harvard.edu; bernstein.bradley@mgh.harvard.edu	Rozenblatt-Rosen, Orit/HDN-4182-2022; Suva, Mario/AAY-7798-2020; Shalek, Alex/Y-2434-2019; rabkin, samuel/C-2443-2012; Wakimoto, Hiroaki/H-4533-2019; Nahed, Brian/E-4239-2014	Suva, Mario/0000-0001-9898-5351; Shalek, Alex/0000-0001-5670-8778; rabkin, samuel/0000-0003-2344-2795; Wakimoto, Hiroaki/0000-0001-8225-241X; Nahed, Brian/0000-0001-8537-106X; Cahill, Daniel/0000-0003-2552-6546; Gillespie, Shawn/0000-0003-1913-0860; Kadri, Sabah/0000-0003-0365-6550	Oncosuisse [BIL-KFS02590- 02-2010]; National Brain Tumor Society [NS032677]; HHMI; Howard Hughes Medical Institute; Starr Cancer Consortium; Harvard Stem Cell Institute; Klarman Family Foundation; NATIONAL CANCER INSTITUTE [R01CA160762, P50CA165962, K12CA090354] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032677] Funding Source: NIH RePORTER	Oncosuisse; National Brain Tumor Society; HHMI(Howard Hughes Medical Institute); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Starr Cancer Consortium; Harvard Stem Cell Institute; Klarman Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Timothy Durham, Noam Shoresh, Mia Caplan Uziel, and Jing Gao for computational assistance and Charles Epstein, Meital Hatan, and the Broad Institute Genome Sequencing Platform for help with data production.We thank Leslie Gaffney and Bang Wong for graphical work; David Dombkowski for flow cytometry; James Kim for histology sections; Erica Shefler, Dave Gennert, and John Trombetta for support; and Pinky Bautista and Yukako Yagi for slide scanning.We thank Rahul Satija, Leah Escalante, Brian Liau, Richard Koche, and Russel Ryan for fruitful discussions and Stephen Elledge for the pINDUCER vectors.M.L.S.is supported by Oncosuisse grant BIL-KFS02590- 02-2010, the Medic Foundation, and a grant from the National Brain Tumor Society.R.L.M.is supported by R01 grant NS032677.M.N.R.is supported by awards from the Burroughs Wellcome Fund and HHMI.This research was supported by funds from the Howard Hughes Medical Institute, the Starr Cancer Consortium, the Burroughs Wellcome Fund, the Harvard Stem Cell Institute, and the Klarman Family Foundation.	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrett LE, 2012, CANCER CELL, V21, P11, DOI 10.1016/j.ccr.2011.11.025; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lodato MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003288; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mimasu S, 2010, BIOCHEMISTRY-US, V49, P6494, DOI 10.1021/bi100299r; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Natsume A, 2013, CANCER RES, V73, P4559, DOI 10.1158/0008-5472.CAN-13-0109; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	54	555	565	4	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					580	594		10.1016/j.cell.2014.02.030	http://dx.doi.org/10.1016/j.cell.2014.02.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24726434	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000335392100009
J	Kruse, E; Agol, E				Kruse, Ethan; Agol, Eric			KOI-3278: A Self-Lensing Binary Star System	SCIENCE			English	Article							WHITE-DWARFS; NLTT 11748; KEPLER; EVOLUTION	Over 40% of Sun-like stars are bound in binary or multistar systems. Stellar remnants in edge-on binary systems can gravitationally magnify their companions, as predicted 40 years ago. By using data from the Kepler spacecraft, we report the detection of such a "self-lensing" system, in which a 5-hour pulse of 0.1% amplitude occurs every orbital period. The white dwarf stellar remnant and its Sun-like companion orbit one another every 88.18 days, a long period for a white dwarf-eclipsing binary. By modeling the pulse as gravitational magnification (microlensing) along with Kepler's laws and stellar models, we constrain the mass of the white dwarf to be similar to 63% of the mass of our Sun. Further study of this system, and any others discovered like it, will help to constrain the physics of white dwarfs and binary star evolution.	[Kruse, Ethan; Agol, Eric] Univ Washington, Dept Astron, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kruse, E (corresponding author), Univ Washington, Dept Astron, Box 351580, Seattle, WA 98195 USA.	eakruse@uw.edu		Kruse, Ethan/0000-0002-0493-1342; Agol, Eric/0000-0002-0802-9145	NSF; NSF [AST 0645416]; NASA [NNH05ZDA001C, 12-OSS12-0011]	NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	E.K. was funded by an NSF Graduate Student Research Fellowship. E. A. acknowledges funding by NSF Career grant AST 0645416; NASA Astrobiology Institute's Virtual Planetary Laboratory, supported by NASA under cooperative agreement NNH05ZDA001C; and NASA Origins of Solar Systems grant 12-OSS12-0011. Solar image courtesy of NASA/Solar Dynamics Observatory (SDO) and the Helioseismic and Magnetic Imager (HMI) science teams. The Kepler data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). The code used for analysis is provided in a repository at https://github.com/ethankruse/koi3278. The authors welcome requests for additional information regarding the material presented in this paper.	Agol E, 2003, ASTROPHYS J, V594, P449, DOI 10.1086/376833; Agol E, 2002, ASTROPHYS J, V579, P430, DOI 10.1086/342880; Bergeron P, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/28; Bressan A, 2012, MON NOT R ASTRON SOC, V427, P127, DOI 10.1111/j.1365-2966.2012.21948.x; Burke CJ, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/19; Carter JA, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/132; Davidson C., 1920, PHILOS T R SOC A, V220, P291, DOI DOI 10.1098/RSTA.1920.0009; Einstein A, 1936, Science, V84, P506, DOI 10.1126/science.84.2188.506; Farmer AJ, 2003, ASTROPHYS J, V592, P1151, DOI 10.1086/375806; Holberg JB, 2013, MON NOT R ASTRON SOC, V435, P2077, DOI 10.1093/mnras/stt1433; Ivanova N, 2013, ASTRON ASTROPHYS REV, V21, DOI 10.1007/s00159-013-0059-2; Kaplan DL, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/167; Kepler SO, 2007, MON NOT R ASTRON SOC, V375, P1315, DOI 10.1111/j.1365-2966.2006.11388.x; MAEDER A, 1973, ASTRON ASTROPHYS, V26, P215; Marsh TR, 2001, MON NOT R ASTRON SOC, V324, P547, DOI 10.1046/j.1365-8711.2001.04293.x; Muirhead PS, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/111; Paczynski B, 1996, ANNU REV ASTRON ASTR, V34, P419, DOI 10.1146/annurev.astro.34.1.419; Parsons SG, 2012, MON NOT R ASTRON SOC, V420, P3281, DOI 10.1111/j.1365-2966.2011.20251.x; Perryman MAC, 2001, ASTRON ASTROPHYS, V369, P339, DOI 10.1051/0004-6361:20010085; Provencal JL, 1998, ASTROPHYS J, V494, P759, DOI 10.1086/305238; Rebassa-Mansergas A, 2012, MON NOT R ASTRON SOC, V423, P320, DOI 10.1111/j.1365-2966.2012.20880.x; Rowe JF, 2010, ASTROPHYS J LETT, V713, pL150, DOI 10.1088/2041-8205/713/2/L150; Sahu KC, 2003, ASTROPHYS J, V584, P1042, DOI 10.1086/345776; Schneider P., 2006, SAAS FEE ADVANCED CO, V33; Steinfadt JDR, 2010, ASTROPHYS J LETT, V716, pL146, DOI 10.1088/2041-8205/716/2/L146; Tenenbaum P, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/6; Wambsganss Joachim, 1998, Living Rev Relativ, V1, P12, DOI 10.12942/lrr-1998-12; Zorotovic M, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220321	28	44	44	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					275	277		10.1126/science.1251999	http://dx.doi.org/10.1126/science.1251999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744369	Green Submitted			2022-12-24	WOS:000334474500028
J	Revesz, RL; Howard, PH; Arrow, K; Goulder, LH; Kopp, RE; Livermore, MA; Oppenheimer, M; Sterner, T				Revesz, Richard L.; Howard, Peter H.; Arrow, Kenneth; Goulder, Lawrence H.; Kopp, Robert E.; Livermore, Michael A.; Oppenheimer, Michael; Sterner, Thomas			Improve economic models of climate change	NATURE			English	Editorial Material									[Revesz, Richard L.; Howard, Peter H.] NYU, Sch Law, New York, NY 10003 USA; [Arrow, Kenneth; Goulder, Lawrence H.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Kopp, Robert E.] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08903 USA; [Livermore, Michael A.] Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; [Oppenheimer, Michael] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Oppenheimer, Michael] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Sterner, Thomas] Univ Gothenburg, Dept Econ, Gothenburg, Sweden	New York University; Stanford University; Rutgers State University New Brunswick; University of Virginia; Princeton University; Princeton University; University of Gothenburg	Revesz, RL (corresponding author), NYU, Sch Law, New York, NY 10003 USA.	richard.revesz@nyu.edu	Sterner, Thomas/AGZ-2537-2022	Kopp, Robert/0000-0003-4016-9428; Livermore, Michael/0000-0002-2403-1173; Oppenheimer, Michael/0000-0002-9708-5914				[Anonymous], 2013, TECHN UPD SOC COST C; [Anonymous], 2010, SOC COST CARB REG IM; Fankhauser S, 2005, RESOUR ENERGY ECON, V27, P1, DOI 10.1016/j.reseneeco.2004.03.003; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kopp RE, 2012, ECONOMICS-KIEL, V6, DOI 10.5018/economics-ejournal.ja.2012-15; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Sterner T, 2008, REV ENV ECON POLICY, V2, P61, DOI 10.1093/reep/rem024; Weitzman M. L., 1998, ENV EC MGMT, V36, P201	10	128	130	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					173	175		10.1038/508173a	http://dx.doi.org/10.1038/508173a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE4UK	24724186	Bronze			2022-12-24	WOS:000333979900016
J	Chivian, E				Chivian, Eric			Why doctors and their organisations must help tackle climate change: an essay by Eric Chivian	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Chivian, E (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	eric_chivian@hms.harvard.edu							0	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 2	2014	348								g2407	10.1136/bmj.g2407	http://dx.doi.org/10.1136/bmj.g2407			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TP	24696173				2022-12-24	WOS:000333977000005
J	Ramasamy, SK; Kusumbe, AP; Wang, L; Adams, RH				Ramasamy, Saravana K.; Kusumbe, Anjali P.; Wang, Lin; Adams, Ralf H.			Endothelial Notch activity promotes angiogenesis and osteogenesis in bone	NATURE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION; NOGGIN; VEGF; PROTOCOL; LIGANDS; CULTURE; JAGGED1; MARROW	Blood vessel growth in the skeletal system and osteogenesis seem to be coupled, suggesting the existence of molecular crosstalk between endothelial and osteoblastic cells(1,2). Understanding the nature of the mechanisms linking angiogenesis and bone formation should be of great relevance for improved fracture healing or prevention of bone mass loss. Here we show that vascular growth in bone involves a specialized, tissue-specific form of angiogenesis. Notch signalling promotes endothelial cell proliferation and vessel growth in postnatal long bone, which is the opposite of the well-established function of Notch and its ligand Dll4 in the endothelium of other organs and tumours(3,4). Endothelial-cell-specific and inducible genetic disruption of Notch signalling in mice not only impaired bone vessel morphology and growth, but also led to reduced osteogenesis, shortening of long bones, chondrocyte defects, loss of trabeculae and decreased bone mass. On the basis of a series of genetic experiments, we conclude that skeletal defects in these mutants involved defective angiocrine release of Noggin from endothelial cells, which is positively regulated by Notch. Administration of recombinant Noggin, a secreted antagonist of bone morphogenetic proteins, restored bone growth and mineralization, chondrocyte maturation, the formation of trabeculae and osteoprogenitor numbers in endothelial-cell-specific Notch pathway mutants. These findings establish a molecular framework coupling angiogenesis, angiocrine signals and osteogenesis, which may prove significant for the development of future therapeutic applications.	[Ramasamy, Saravana K.; Kusumbe, Anjali P.; Wang, Lin; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; University of Munster	Adams, RH (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	ralf.adams@mpi-muenster.mpg.de	Adams, Ralf H/AAE-9274-2019	Ramasamy, Saravana/0000-0003-2658-2945	Max Planck Society; University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council [AdG 339409 AngioBone]	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council(European Research Council (ERC)European Commission)	We thank A. Duarte, F. Radtke and T. Honjo for floxed Dll4 and Rbpj mutant mice, A. Borgscheiper for technical assistance, M. Stehling for endothelial cell sorting, D. Zeuschner for electron microscopy. Funding was provided by the Max Planck Society, the University of Munster, the DFG cluster of excellence 'Cells in Motion', and the European Research Council (AdG 339409 AngioBone).	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Canalis E, 2012, ENDOCRINOLOGY, V153, P1616, DOI 10.1210/en.2011-1604; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Izumi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041116; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kuhn A, 2002, J INVEST DERMATOL, V119, P1388, DOI 10.1046/j.1523-1747.2002.19647.x; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; SKAWINA A, 1994, J ANAT, V185, P369; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Suzuki H, 2005, ARCH HISTOL CYTOL, V68, P371, DOI 10.1679/aohc.68.371; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P97, DOI 10.1302/0301-620X.42B1.97; Tylzanowski P, 2006, DEV DYNAM, V235, P1599, DOI 10.1002/dvdy.20782; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	28	503	560	21	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					376	+		10.1038/nature13146	http://dx.doi.org/10.1038/nature13146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24647000	Green Accepted			2022-12-24	WOS:000333029000038
J	He, J; Li, SH; Deng, YQ; Fu, HY; Laforteza, BN; Spangler, JE; Homs, A; Yu, JQ				He, Jian; Li, Suhua; Deng, Youqian; Fu, Haiyan; Laforteza, Brian N.; Spangler, Jillian E.; Homs, Anna; Yu, Jin-Quan			Ligand-Controlled C(sp(3))-H Arylation and Olefination in Synthesis of Unnatural Chiral alpha-Amino Acids	SCIENCE			English	Article							C-H BONDS; COUPLING REACTIONS; FUNCTIONALIZATION; HYDROGENATION; ACTIVATION; DERIVATIVES	The use of ligands to tune the reactivity and selectivity of transition metal catalysts for C(sp(3))-H bond functionalization is a central challenge in synthetic organic chemistry. Herein, we report a rare example of catalyst-controlled C(sp(3))-H arylation using pyridine and quinoline derivatives: The former promotes exclusive monoarylation, whereas the latter activates the catalyst further to achieve diarylation. Successive application of these ligands enables the sequential diarylation of a methyl group in an alanine derivative with two different aryl iodides, affording a wide range of beta-Ar-beta-Ar'-alpha-amino acids with excellent levels of diastereoselectivity (diastereomeric ratio > 20:1). Both configurations of the beta-chiral center can be accessed by choosing the order in which the aryl groups are installed. The use of a quinoline derivative as a ligand also enables C(sp(3))-H olefination of a protected alanine.	[He, Jian; Li, Suhua; Deng, Youqian; Fu, Haiyan; Laforteza, Brian N.; Spangler, Jillian E.; Homs, Anna; Yu, Jin-Quan] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	He, Jian/R-9985-2016; He, Jian/F-6399-2014; Deng, Youqian/B-9333-2012	He, Jian/0000-0002-3388-3239; 	Scripps Research Institute; NIH (National Institute of General Medical Sciences) [2R01GM084019]; Bristol-Myers Squibb; Sichuan University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); Sichuan University(Sichuan University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge The Scripps Research Institute, the NIH (National Institute of General Medical Sciences, grant 2R01GM084019), and Bristol-Myers Squibb for financial support. H. F. is a visiting scholar sponsored by Sichuan University. J.H. developed C(sp3)-H arylation and olefination and conducted most of the experiments; S. L. synthesized quinoline ligands; Y.D., H. F., B.N.L., and J.E.S. performed large-scale reactions; A. H. obtained the crystal structures shown in Fig. 6; and J.-Q.Y. directed the project. Metrical parameters for the structures of 7f, intermediate A, and intermediate B are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-985675, -985676, and -985677, respectively. A provisional patent application has been filed and is available under patent application no. U.S. 61/946165.	Baudoin O, 2011, CHEM SOC REV, V40, P4902, DOI 10.1039/c1cs15058h; Burk MJ, 1998, J AM CHEM SOC, V120, P657, DOI 10.1021/ja9731074; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Ferreira PMT, 2008, EUR J ORG CHEM, V2008, P4676, DOI 10.1002/ejoc.200800602; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; Gutekunst WR, 2011, J AM CHEM SOC, V133, P19076, DOI 10.1021/ja209205x; Hasegawa N, 2011, J AM CHEM SOC, V133, P8070, DOI 10.1021/ja2001709; Jazzar R, 2010, CHEM-EUR J, V16, P2654, DOI 10.1002/chem.200902374; Tran LD, 2012, ANGEW CHEM INT EDIT, V51, P5188, DOI 10.1002/anie.201200731; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; NOYORI R, 1990, ACCOUNTS CHEM RES, V23, P345, DOI 10.1021/ar00178a005; Reddy BVS, 2006, ORG LETT, V8, P3391, DOI 10.1021/ol061389j; Rodriguez N, 2013, CHEM SCI, V4, P175, DOI 10.1039/c2sc21162a; Roseblade SJ, 2007, ACCOUNTS CHEM RES, V40, P1402, DOI 10.1021/ar700113g; Shang R, 2013, J AM CHEM SOC, V135, P6030, DOI 10.1021/ja402806f; Simmons EM, 2012, NATURE, V483, P70, DOI 10.1038/nature10785; Tang WJ, 2003, CHEM REV, V103, P3029, DOI 10.1021/cr020049i; Wang DH, 2008, J AM CHEM SOC, V130, P7190, DOI 10.1021/ja801355s; Wang LQ, 2009, ORG LETT, V11, P1079, DOI 10.1021/ol802865c; Wasa M, 2012, J AM CHEM SOC, V134, P18570, DOI 10.1021/ja309325e; Wasa M, 2010, ISR J CHEM, V50, P605, DOI 10.1002/ijch.201000038; Wasa M, 2009, J AM CHEM SOC, V131, P9886, DOI 10.1021/ja903573p; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Zaitsev VG, 2005, J AM CHEM SOC, V127, P13154, DOI 10.1021/ja054549f; Zhang SY, 2013, J AM CHEM SOC, V135, P12135, DOI 10.1021/ja406484v	25	379	381	5	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1216	1220		10.1126/science.1249198	http://dx.doi.org/10.1126/science.1249198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626923	Green Accepted			2022-12-24	WOS:000332728500029
J	Parker, JL; Newstead, S				Parker, Joanne L.; Newstead, Simon			Molecular basis of nitrate uptake by the plant nitrate transporter NRT1.1	NATURE			English	Article							PEPTIDE TRANSPORTERS; CRYSTAL-STRUCTURE; PROTEIN; MECHANISM; ARABIDOPSIS; SYSTEM; CHL1; OVEREXPRESSION; RECONSTITUTION; OPTIMIZATION	The NRT1/PTR family of proton-coupled transporters are responsible for nitrogen assimilation in eukaryotes and bacteria through the uptake of peptides. However, in most plant species members of this family have evolved to transport nitrate as well as additional secondary metabolites and hormones. In response to falling nitrate levels, NRT1.1 is phosphorylated on an intracellular threonine that switches the transporter from a low-affinity to high-affinity state. Here we present both the apo and nitrate-bound crystal structures of Arabidopsis thaliana NRT1.1, which together with in vitro binding and transport data identify a key role for His 356 in nitrate binding. Our data support a model whereby phosphorylation increases structural flexibility and in turn the rate of transport. Comparison with peptide transporters further reveal show the NRT1/PTR family has evolved to recognize diverse nitrogenous ligands, while maintaining elements of a conserved coupling mechanism within this superfamily of nutrient transporters.	[Parker, Joanne L.; Newstead, Simon] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Newstead, Simon] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England	University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Parker, JL (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	joanne.parker@bioch.ox.ac.uk; simon.newstead@bioch.ox.ac.uk		Parker, Joanne/0000-0003-2964-2720; Newstead, Simon/0000-0001-7432-2270	Medical Research Council (MRC) [G0900399]; Royal Society [RG110211, IE111401]; Medical Research Council [G0900399] Funding Source: researchfish; Wellcome Trust [102890/Z/13/Z] Funding Source: researchfish; MRC [G0900399] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Flaig for help with additional access to beamline IO4 and we thank Diamond Light Source for access to beam lines I02, I03, I04 and I04-1 (MX7345) that contributed to the results presented here. This research was funded through the Medical Research Council (MRC) Career Development Award grant G0900399 and Royal Society grants (RG110211 and IE111401) to S.N.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], PYMOL MOL GRAPHICS S; Baaske P., 2011, J BIOMOL TECH, V22, pS55; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; Chandrasekaran A, 2006, J NEUROCHEM, V98, P1551, DOI 10.1111/J.1471-4159.2006.03975.X; Chen XZ, 1999, J BIOL CHEM, V274, P2773, DOI 10.1074/jbc.274.5.2773; Chiang CS, 2004, J BIOL CHEM, V279, P30150, DOI 10.1074/jbc.M405192200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; FOUCAUD C, 1992, J BIOL CHEM, V267, P22087; Guettou F, 2013, EMBO REP, V14, P804, DOI 10.1038/embor.2013.107; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Madej MG, 2013, P NATL ACAD SCI USA, V110, pE4831, DOI 10.1073/pnas.1319754110; Nakajima H, 1997, APPL ENVIRON MICROB, V63, P2213, DOI 10.1128/AEM.63.6.2213-2217.1997; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Seresht AK, 2013, APPL MICROBIOL BIOT, V97, P3939, DOI 10.1007/s00253-012-4263-1; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Tsay YF, 2011, PLANT CELL MONOGR, V19, P223, DOI 10.1007/978-3-642-13431-9_9; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Ugolev Y, 2013, J BIOL CHEM, V288, P32160, DOI 10.1074/jbc.M113.502971; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Yan HC, 2013, CELL REP, V3, P716, DOI 10.1016/j.celrep.2013.03.007; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139	57	241	263	9	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					68	+		10.1038/nature13116	http://dx.doi.org/10.1038/nature13116			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572366	Green Accepted			2022-12-24	WOS:000332224400043
J	Butkus, R; Doherty, R; Daniel, H				Butkus, Renee; Doherty, Robert; Daniel, Hilary		Amer Coll Phys	Reducing Firearm-Related Injuries and Deaths in the United States: Executive Summary of a Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							STORAGE PRACTICES; GUN VIOLENCE; ADOLESCENT SUICIDE; MENTAL-ILLNESS; RISK; HOMICIDE; OWNERSHIP; PREVENTION; RATES; CARE		[Butkus, Renee; Doherty, Robert; Daniel, Hilary; Amer Coll Phys] Amer Coll Physicians, Washington, DC 20001 USA	American College of Physicians	Butkus, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	rbutkus@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	*AGCY HEAT RES, 2010, MENTAL DISORDERS SUB; Albright TL, 2003, J AM BOARD FAM PRACT, V16, P40, DOI 10.3122/jabfm.16.1.40; ALPERS P, 2014, GUNS US TOTAL NUMBER; *AM BAR ASS, 2011, REGULATION FIREARMS; *AM PSY ASS, 2013, FIREARM ACCESS ACTS; Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; [Anonymous], 2013, NONF INJ REP 2001 20; [Anonymous], 2014, INJ PREV CONTR DAT S; Bangalore S, 2013, AM J MED, V126, P873, DOI 10.1016/j.amjmed.2013.04.012; Barber C, 2011, ACCIDENT ANAL PREV, V43, P724, DOI 10.1016/j.aap.2010.10.018; BERGER SE, 2009, TARASOFF DUTY WARN C; Beronio K, 2013, ASPE ISSUE BRIEF AFF; *BRADY HENDGUN, 1993, BRADY HANDGUN VIOLEN; BRENT DA, 1988, ARCH GEN PSYCHIAT, V45, P581, DOI 10.1001/archpsyc.1988.01800300079011; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; BRENT DA, 1993, AM J DIS CHILD, V147, P1066, DOI 10.1001/archpedi.1993.02160340052013; Butkus R, 2014, ANN INTERN MED, V160, P821, DOI 10.7326/M13-1960; Carbone PS, 2005, ARCH PEDIAT ADOL MED, V159, P1049, DOI 10.1001/archpedi.159.11.1049; *CDCP, 2013, FASTSTATS SUICIDE SE; *CDCP, 2013, NONFATAL INJURY REPO; Centers for Disease Control and Prevention, 2013, FASTSTATS SUIC SELF; *CNN, 2011, POLL AM OVERWHELMING; Cook P.J., 1997, GUNS AM NATL SURVEY; COOK PJ, 2013, REDUCING GUN VIOLENC, V22, P31; COOPER A, 2011, HOMICIDE TRENDS US; Corrigan PW, 2005, PSYCHIAT RES, V136, P153, DOI 10.1016/j.psychres.2005.06.005; Cummings P, 1997, AM J PUBLIC HEALTH, V87, P974, DOI 10.2105/AJPH.87.6.974; Cummings P, 1998, JAMA-J AM MED ASSOC, V280, P471, DOI 10.1001/jama.280.5.471; DANIELS A, 2014, SMART PHONES SMART T; DuRant RH, 2007, PEDIATRICS, V119, pE1271, DOI 10.1542/peds.2006-1485; DUTTON S, 2013, BACKGROUND CHECK SUP; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; *FED BUR INVES, 2010, NATL INSTANT CRIMINA; *FIR INJ CTR, 2014, FIREARM INJURY US PH; Fisher CE, 2013, ANN INTERN MED, V159, P423, DOI 10.7326/0003-4819-159-5-201309030-00679; Frattaroli S, 2013, ANN INTERN MED, V158, P697, DOI 10.7326/0003-4819-158-9-201305070-00597; Friedman RA, 2006, NEW ENGL J MED, V355, P2064, DOI 10.1056/NEJMp068229; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Gardner W, 2010, PEDIATRICS, V125, P945, DOI 10.1542/peds.2009-1964; GREENBERG A, 2013, LIBERATOR TEST FIRIN; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Hepburn L, 2004, J TRAUMA, V56, P676, DOI 10.1097/01.TA.0000068996.01096.39; Herbert PB, 2002, J AM ACAD PSYCHIATRY, V30, P275; Hoyert DL, 2012, NATL VITAL STAT REPO, V61, P40; HOYERT DL, 2012, REPORT, V2, P1; Institute of Medicine and National Research Council, 2013, PRIORITIES RES REDUC; *INTELLIGUN, 2014, KODIAK INDUSTRIES WE; Johnson RM, 2006, ARCH PEDIAT ADOL MED, V160, P788, DOI 10.1001/archpedi.160.8.788; KAISER HJ FAM FDN, 2014, NUMBER DEATHS DUE IN; Kapp MB, 2013, ANN INTERN MED, V159, P421, DOI 10.7326/0003-4819-159-5-201309030-00682; Karp A, 2007, SMALL ARMS SURVEY 20; KEATING D, 2013, GUN DEATHS SHAPED RA; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kellermann AL, 1998, J TRAUMA, V45, P263, DOI 10.1097/00005373-199808000-00010; KELLERMANN AL, 1986, NEW ENGL J MED, V314, P1557, DOI 10.1056/NEJM198606123142406; KELLERMANN AL, 1992, J TRAUMA, V33, P1, DOI 10.1097/00005373-199207000-00001; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; Kleck G, 1998, JAMA-J AM MED ASSOC, V280, P473, DOI 10.1001/jama.280.5.473; Koper CS, 2004, UPDATED ASSESSMENT F; Koper CS, 2007, CRIME GUN RISK FACTO; KOPER CS, 2013, REDUCING GUN VIOLENC, P160; KROUSE WJ, 2012, HOW MANY GUNS ARE US, V8, P9; Laine C, 2013, ANN INTERN MED, V158, P493, DOI 10.7326/0003-4819-158-6-201303190-00586; Large M, 2009, SCHIZOPHRENIA BULL, V35, P1012, DOI 10.1093/schbul/sbn040; *LAW CTR PREV GUN, 2013, CAL MODEL TWENTY YEA; *LAW CTR PREV GUN, 2013, 2013 STATE SCORECARD; LEE AD, 2013, BACKGROUND CHECKS FI; LIU EC, 2013, SUBMISSION MENTAL HE; LoConte NK, 2008, AM J ALZHEIMERS DIS, V23, P313, DOI 10.1177/1533317508317061; LUO M, 2013, NEW YORK TIMES 0928, pA1; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; *MAY AGA ILL, 2013, REPORTING LOST STOLE; *MAY AGA ILL GUN, 2011, FATAL GAPS HOW MISSI; *MAY AGAIN ILL GUN, 2013, COALITION REPORT MOV; MAY JP, 1993, J GEN INTERN MED, V8, P380, DOI 10.1007/BF02600078; MCGONIGAL MD, 1993, J TRAUMA, V35, P532, DOI 10.1097/00005373-199310000-00006; Miller M, 2006, INJURY PREV, V12, P178, DOI 10.1136/ip.2005.010850; Miller M, 2005, ACCIDENT ANAL PREV, V37, P661, DOI 10.1016/j.aap.2005.02.003; MILLER TR, 2012, CHILDRENS SAFETY NET; Mozaffarian D, 2013, JAMA-J AM MED ASSOC, V309, P551, DOI 10.1001/jama.2013.38; Mulvey EP, 2006, J CONSULT CLIN PSYCH, V74, P743, DOI 10.1037/0022-006X.74.4.743; Nance ML, 1997, J PEDIATR SURG, V32, P949, DOI 10.1016/S0022-3468(97)90375-4; Nelson DE, 1996, JAMA-J AM MED ASSOC, V275, P1744, DOI 10.1001/jama.275.22.1744; *NICS IMPR AMEN, 2007, NICS IMPROVEMENT AME; Nordstrom D L, 2001, Inj Prev, V7, P112, DOI 10.1136/ip.7.2.112; *NY STAT PSY ASS, 2013, NYSPA ISSUES PRESS R; Parker GF, 2010, PSYCHIAT SERV, V61, P478, DOI 10.1176/appi.ps.61.5.478; PEREZ E, 2013, ATF TEST SHOWS 3D GU; *PEW RES CTR PEOP, 2013, GUN CONTROL DEBATE; Phillips CD, 2013, AM J PUBLIC HEALTH, V103, P86, DOI 10.2105/AJPH.2012.300807; *POL EXECUT RES, 2010, GUNS CRIME BREAKING; Preventing firearm violence: a public health imperative, 1995, ANN INTERN MED, V122, P311; *PUB SAF SEC AMEN, 2013, HR 1565; *QUINN UN, 2013, OVERWHELMING SUPPORT; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Richmond TS, 2004, J TRAUMA, V57, P1356, DOI 10.1097/01.TA.0000141886.22472.F5; Romero M, 2003, INJURY PREV, V9, P367, DOI 10.1136/ip.9.4.367; Rosengart M, 2005, INJURY PREV, V11, P77, DOI 10.1136/ip.2004.007062; Roth J, 1997, IMPACT EVALUATION PU; Simpson JR, 2007, J AM ACAD PSYCHIATRY, V35, P330; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; SPERRY T, 2013, US REQUIRES GRP REMO; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; SWANSON JW, 1994, VIOLENCE MENTAL DISO; Torrey E, 2008, SHORTAGE PUBLIC HOSP; *TREAT ADV CTR, 2005, TREATMENT ADVOCACY C; Umhau JC, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-146; *UND FIR, 1988, UNDETECTABLE FIREARM; *UND FIR MOD, 2013, UNDETECTABLE FIREARM; *US BUR ALC, 2014, DONT LIE FOR OTHER G; *US BUR ALC, 2013, 3D PRINTING TECHNOL; *US BUR ALC, 2000, FOLLOWING GUN ENFORC; *US CENS BUR, 2011, US CENSUS BUR POPUL; *US DEPT JUST, 2012, FIREARMS STOLEN DURI; *US GOV ACC, 2012, GUN CONTROL SHARING; *VIOL POL CTR, 2011, GUN DEATHS OUTPACE M; *WASH POST ABC NEW, 2013, WOULD YOU SUPPORT OP; Weinberger SE, 2012, NEW ENGL J MED, V367, P1557, DOI 10.1056/NEJMsb1209858; West BA, 2013, MMWR-MORBID MORTAL W, V62, P176; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106; WINTEMUTE GJ, 2013, INJURY PREV, P1; WINTEMUTE GJ, 2013, J URBAN HEALTH; WYOM DEPT HLTH, 2012, REPORT SUICIDE WYOMI	123	46	46	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					858	+		10.7326/M14-0216	http://dx.doi.org/10.7326/M14-0216			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24722815				2022-12-24	WOS:000337374900021
J	Graham, SM; Sismanidis, C; Menzies, HJ; Marais, BJ; Detjen, AK; Black, RE				Graham, Stephen M.; Sismanidis, Charalambos; Menzies, Heather J.; Marais, Ben J.; Detjen, Anne K.; Black, Robert E.			Importance of tuberculosis control to address child survival	LANCET			English	Editorial Material							SEVERE PNEUMONIA; MORTALITY; MENINGITIS; AFRICA		[Graham, Stephen M.] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Graham, Stephen M.; Detjen, Anne K.] Int Union TB & Lung Dis, Paris, France; [Sismanidis, Charalambos] WHO, Global TB Programme, CH-1211 Geneva, Switzerland; [Menzies, Heather J.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Marais, Ben J.] Univ Sydney, Sydney Emerging Infect Dis & Biosecur Inst SEIB, Sydney Med Sch, Sydney, NSW 2006, Australia; [Marais, Ben J.] Univ Sydney, Childrens Hosp Westmead, Sydney Med Sch, Sydney, NSW 2006, Australia; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; World Health Organization; Centers for Disease Control & Prevention - USA; University of Sydney; University of Sydney; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Graham, SM (corresponding author), Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Flemington Rd, Parkville, Vic 3052, Australia.	steve.graham@rch.org.au	Marais, Ben/AAX-2626-2021	Graham, Stephen/0000-0003-3525-2294	World Health Organization [001] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline	World Health Organization(World Health Organization); Intramural CDC HHS		Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Chisti MJ, PLOS ONE IN PRESS; De Maayer T, 2011, ARCH DIS CHILD; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; Drobac PC, 2012, PEDIATRICS, V130, pE373, DOI 10.1542/peds.2011-3048; Gomes VF, 2011, THORAX, V66, P163, DOI 10.1136/thx.2010.141309; Li N, 2013, AIDS; LINCOLN EM, 1961, ARCH ENVIRON HEALTH, V3, P444, DOI 10.1080/00039896.1961.10663049; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marais BJ, 2013, LANCET INFECT DIS, V13, P287, DOI 10.1016/S1473-3099(13)70031-8; Mathad JS, 2012, CLIN INFECT DIS, V55, P1532, DOI 10.1093/cid/cis732; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Nantongo JM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-16; Schoeman JF, 2013, HAND CLINIC, V112, P1135, DOI 10.1016/B978-0-444-52910-7.00033-7; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2013, GLOB UPD HIV TREATM; Wolzak NK, 2012, J TROP PEDIATRICS, V58, P491, DOI 10.1093/tropej/fms031; World Health Organization, 2013, ROADM CHILDH TUB ZER, P39; World Health Organization, 2013, XPERT MTBRIF ASSAY D; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742	22	83	84	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1605	1607		10.1016/S0140-6736(14)60420-7	http://dx.doi.org/10.1016/S0140-6736(14)60420-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24671079	Green Accepted			2022-12-24	WOS:000335495400032
J	Tonelli, M; Riella, M				Tonelli, Marcello; Riella, Miguel			Chronic kidney disease and the ageing population	LANCET			English	Editorial Material							UNITED-STATES; DIALYSIS; OUTCOMES; TRANSPLANTATION; MANAGEMENT		[Tonelli, Marcello] Univ Alberta, Fac Med, Edmonton, AB T6G 2C3, Canada; [Riella, Miguel] Catholic Univ Parana, Fac Med, Curitiba, Parana, Brazil	University of Alberta; Pontificia Universidade Catolica do Parana	Tonelli, M (corresponding author), Univ Alberta, Fac Med, Edmonton, AB T6G 2C3, Canada.	sophie@worldkidneyday.org	Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187				Chandna SM, 2011, NEPHROL DIAL TRANSPL, V26, P1608, DOI 10.1093/ndt/gfq630; Gill J, 2008, AM J KIDNEY DIS, V52, P541, DOI 10.1053/j.ajkd.2008.05.017; Knoll GA, 2013, AM J KIDNEY DIS, V61, P790, DOI 10.1053/j.ajkd.2012.08.049; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Wiener JM, 2002, INT J EPIDEMIOL, V31, P776, DOI 10.1093/ije/31.4.776	9	20	20	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 12	2014	383	9925					1278	1279		10.1016/S0140-6736(14)60155-0	http://dx.doi.org/10.1016/S0140-6736(14)60155-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LQ	24630776				2022-12-24	WOS:000334104900008
J	Qi, QB; Chu, AY; Kang, JH; Huang, JY; Rose, LM; Jensen, MK; Liang, LM; Curhan, GC; Pasquale, LR; Wiggs, JL; De Vivo, I; Chan, AT; Choi, HK; Tamimi, RM; Ridker, PM; Hunter, DJ; Willett, WC; Rimm, EB; Chasman, DI; Hu, FB; Qi, L				Qi, Qibin; Chu, Audrey Y.; Kang, Jae H.; Huang, Jinyan; Rose, Lynda M.; Jensen, Majken K.; Liang, Liming; Curhan, Gary C.; Pasquale, Louis R.; Wiggs, Janey L.; De Vivo, Immaculata; Chan, Andrew T.; Choi, Hyon K.; Tamimi, Rulla M.; Ridker, Paul M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Chasman, Daniel I.; Hu, Frank B.; Qi, Lu			Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; REPRODUCIBILITY; VALIDITY; OBESITY; DISEASE; WOMEN; VARIANTS; QUALITY	Objective To examine the interactions between genetic predisposition and consumption of fried food in relation to body mass index (BMI) and obesity. Design Prospective cohort study. Setting Health professionals in the United States. Participants 9623 women from the Nurses' Health Study, 6379 men from the Health Professionals Follow-up Study, and a replication cohort of 21 421 women from the Women's Genome Health Study. Main outcome measure Repeated measurement of BMI over follow-up. Results There was an interaction between fried food consumption and a genetic risk score based on 32 BMI-associated variants on BMI in both the Nurses' Health Study and Health Professionals Follow-up Study (P <= 0.001 for interaction). Among participants in the highest third of the genetic risk score, the differences in BMI between individuals who consumed fried foods four or more times a week and those who consumed fried foods less than once a week amounted to 1.0 (SE 0.2) in women and 0.7 (SE 0.2) in men, whereas the corresponding differences were 0.5 (SE 0.2) and 0.4 (SE 0.2) in the lowest third of the genetic risk score. The gene-diet interaction was replicated in the Women's Genome Health Study (P<0.001 for interaction). Viewed differently, the genetic association with adiposity was strengthened with higher consumption of fried foods. In the combined three cohorts, the differences in BMI per 10 risk alleles were 1.1 (SE 0.2), 1.6 (SE 0.3), and 2.2 (SE 0.6) for fried food consumption less than once, one to three times, and four or more times a week (P<0.001 for interaction); and the odds ratios (95% confidence intervals) for obesity per 10 risk alleles were 1.61 (1.40 to 1.87), 2.12 (1.73 to 2.59), and 2.72 (2.12 to 3.48) across the three categories of consumption (P=0.002 for interaction). In addition, the variants in or near genes highly expressed or known to act in the central nervous system showed significant interactions with fried food consumption, with the FTO (fat mass and obesity associated) variant showing the strongest result (P<0.001 for interaction). Conclusion Our findings suggest that consumption of fried food could interact with genetic background in relation to obesity, highlighting the particular importance of reducing fried food consumption in individuals genetically predisposed to obesity.	[Qi, Qibin; Jensen, Majken K.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Harvard Univ, Dept Nutr, Sch Publ Hlth, Boston, MA 02115 USA; [Qi, Qibin] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Chu, Audrey Y.; Rose, Lynda M.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Chu, Audrey Y.; Kang, Jae H.; Rose, Lynda M.; Curhan, Gary C.; Pasquale, Louis R.; De Vivo, Immaculata; Chan, Andrew T.; Choi, Hyon K.; Tamimi, Rulla M.; Ridker, Paul M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Chasman, Daniel I.; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kang, Jae H.; Curhan, Gary C.; Pasquale, Louis R.; De Vivo, Immaculata; Chan, Andrew T.; Choi, Hyon K.; Tamimi, Rulla M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Huang, Jinyan; Liang, Liming; Curhan, Gary C.; De Vivo, Immaculata; Tamimi, Rulla M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02115 USA; [Pasquale, Louis R.; Wiggs, Janey L.] Harvard Univ, Dept Ophthalmol, Sch Med, Mass Eye & Ear Infirm, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Sect Rheumatol, Boston, MA 02118 USA; [Choi, Hyon K.] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Dis, Boston, MA 02115 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Qi, L (corresponding author), Harvard Univ, Dept Nutr, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	nhlqi@channing.harvard.edu	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; De Vivo, Immaculata/0000-0002-7185-7402; Jensen, Majken Karoline/0000-0003-4729-7545; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health [DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, P30DK46200, U01CA137088, U54CA155626, DK58845, DK098311, U01HG004728, EY015473, CA134958, DK70756, DK46200, HL043851, HL080467, CA047988]; Merck Research Laboratories, North Wales, PA; Amgen; American Heart Association Scientist Development Award [0730094N]; Arthur Ashley Williams Foundation; Harvard Ophthalmology Scholar Award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence; NATIONAL CANCER INSTITUTE [R01CA047988, U54CA155626, U01CA049449, R01CA134958, U01CA137088, R01CA049449, P01CA087969] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981, R01HL080467, R01HL043851, R01HL088521, R01HL034594, R01HL073168] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399, U01HG004728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, P01DK070756, K24DK098311, K24DK080140, R01DK091718, R01DK058845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories, North Wales, PA(Merck & Company); Amgen(Amgen); American Heart Association Scientist Development Award(American Heart Association); Arthur Ashley Williams Foundation; Harvard Ophthalmology Scholar Award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, P30DK46200, U01CA137088, U54CA155626, DK58845, DK098311, U01HG004728, EY015473, CA134958, DK70756 and DK46200 from the National Institutes of Health, with additional support for genotyping from Merck Research Laboratories, North Wales, PA. The Women's Genome Health Study is supported by HL043851, HL080467 and CA047988 from the National Institutes of Health, with collaborative scientific support and funding for genotyping provided by Amgen. LQ is a recipient of the American Heart Association Scientist Development Award (0730094N). LRP is supported by the Arthur Ashley Williams Foundation and a Harvard Ophthalmology Scholar Award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence. ATC is a Damon Runyon Cancer Foundation Clinical Investigator. The funding sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; [Anonymous], AGR INFORM B; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Corella D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052344; Corella D, 2011, J NUTR, V141, P2219, DOI 10.3945/jn.111.143826; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Dai Q, 2002, CANCER EPIDEM BIOMAR, V11, P801; Donfrancesco C, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-53; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fillion L, 1998, INT J FOOD SCI NUTR, V49, P157, DOI 10.3109/09637489809089395; Galeone C, 2005, BRIT J CANCER, V92, P2065, DOI 10.1038/sj.bjc.6602542; Greenfield JR, 2003, J CLIN ENDOCR METAB, V88, P5381, DOI 10.1210/jc.2003-030851; Guallar-Castillon P, 2007, AM J CLIN NUTR, V86, P198, DOI 10.1093/ajcn/86.1.198; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Pokorn Jan, 2003, Forum Nutr, V56, P348; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Sayon-Orea C, 2013, NUTR METAB CARDIOVAS, V23, P144, DOI 10.1016/j.numecd.2011.03.014; Silventoinen K, 2009, AM J CLIN NUTR, V90, P1096, DOI 10.3945/ajcn.2009.27689; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Soriguer F, 2003, AM J CLIN NUTR, V78, P1092, DOI 10.1093/ajcn/78.6.1092; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van Vliet-Ostaptchouk Jana V, 2012, Curr Nutr Rep, V1, P184; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Williams MJA, 1999, J AM COLL CARDIOL, V33, P1050, DOI 10.1016/S0735-1097(98)00681-0; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wosje KS, 2010, AM J CLIN NUTR, V92, P294, DOI 10.3945/ajcn.2009.28925; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401	56	172	175	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1610	10.1136/bmj.g1610	http://dx.doi.org/10.1136/bmj.g1610			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24646652	Green Published, hybrid			2022-12-24	WOS:000333414500002
J	Weich, S; Pearce, HL; Croft, P; Singh, S; Crome, I; Bashford, J; Frisher, M				Weich, Scott; Pearce, Hannah Louise; Croft, Peter; Singh, Swaran; Crome, Ilana; Bashford, James; Frisher, Martin			Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TERM BENZODIAZEPINE USE; OLDER-PEOPLE; NONADHERENCE; METAANALYSIS; INSOMNIA; IMPACT; RISKS; BIAS	Objective To test the hypothesis that people taking anxiolytic and hypnotic drugs are at increased risk of premature mortality, using primary care prescription records and after adjusting for a wide range of potential confounders. Design Retrospective cohort study. Setting 273 UK primary care practices contributing data to the General Practice Research Database. Participants 34 727 patients aged 16 years and older first prescribed anxiolytic or hypnotic drugs, or both, between 1998 and 2001, and 69 418 patients with no prescriptions for such drugs (controls) matched by age, sex, and practice. Patients were followed-up for a mean of 7.6 years (range 0.1-13.4 years). Main outcome All cause mortality ascertained from practice records. Results Physical and psychiatric comorbidities and prescribing of non-study drugs were significantly more prevalent among those prescribed study drugs than among controls. The age adjusted hazard ratio for mortality during the whole follow-up period for use of any study drug in the first year after recruitment was 3.46 (95% confidence interval 3.34 to 3.59) and 3.32 (3.19 to 3.45) after adjusting for other potential confounders. Dose-response associations were found for all three classes of study drugs (benzodiazepines, Z drugs (zaleplon, zolpidem, and zopiclone), and other drugs). After excluding deaths in the first year, there were approximately four excess deaths linked to drug use per 100 people followed for an average of 7.6 years after their first prescription. Conclusions In this large cohort of patients attending UK primary care, anxiolytic and hypnotic drugs were associated with significantly increased risk of mortality over a seven year period, after adjusting for a range of potential confounders. As with all observational findings, however, these results are prone to bias arising from unmeasured and residual confounding.	[Weich, Scott; Singh, Swaran] Univ Warwick, Div Mental Hlth & Wellbeing, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Pearce, Hannah Louise; Bashford, James; Frisher, Martin] Keele Univ, Sch Pharm, Keele ST5 5BG, Staffs, England; [Croft, Peter] Keele Univ, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Crome, Ilana] South Staffordshire & Shropshire Healthcare NHS F, Acad Psychiat Unit, St Georges Hosp, Stafford, Staffs, England	University of Warwick; Keele University; Keele University; St Georges University London	Weich, S (corresponding author), Univ Warwick, Div Mental Hlth & Wellbeing, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	s.weich@warwick.ac.uk		Weich, Scott/0000-0002-7552-7697; Singh, Swaran/0000-0003-3454-2089	Medical Research Council Funding Source: Medline; National Institute for Health Research [NF-SI-0509-10183] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Belleville G, 2010, CAN J PSYCHIAT, V55, P558, DOI 10.1177/070674371005500904; Berry S. D., 2013, JAMA INTERN MED, V4, P1; Billioti de Gage S., 2012, BMJ-BRIT MED J, V27, P345; BMA and Royal Pharmaceutical Society of Great Britain, 2012, BRIT NATL FORMULARY; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Fischer MA, 2010, J GEN INTERN MED, V25, P284, DOI 10.1007/s11606-010-1253-9; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Gisev N, 2011, CAN J PSYCHIAT, V56, P377, DOI 10.1177/070674371105600609; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Hartz A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001413; Hausken AM, 2007, PHARMACOEPIDEM DR S, V16, P913, DOI 10.1002/pds.1417; Huedo-Medina TB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8343; Kao CH, 2012, J CLIN PSYCHIAT, V73, P1264, DOI [10.4088/JCP.11m07333, 10.4088/JCP.12lr07984a]; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kripke DF, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-42; Kripke DF, 2008, J SLEEP RES, V17, P245, DOI 10.1111/j.1365-2869.2008.00685.x; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kripke DF, 1998, BIOL PSYCHIAT, V43, P687, DOI 10.1016/S0006-3223(97)00292-8; Kripke DF, 2000, SLEEP MED REV, V4, P5, DOI 10.1053/smrv.1999.0076; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Mallon L, 2009, SLEEP MED, V10, P279, DOI 10.1016/j.sleep.2008.12.004; Neutel C. Ineke, 1995, Annals of Epidemiology, V5, P239; NHS Prescription Services, 2012, CENTR NERV SYST NAT; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; Royal College of General Practitioners and Royal College of Psychiatrists, 2013, ADD MED CONS STAT 20; SAVITZ DA, 1989, AM J EPIDEMIOL, V129, P1062, DOI 10.1093/oxfordjournals.aje.a115210; Solomon MD, 2010, J GEN INTERN MED, V25, P280, DOI 10.1007/s11606-010-1286-0; Tiihonen J, 2012, ARCH GEN PSYCHIAT, V69, P476, DOI 10.1001/archgenpsychiatry.2011.1532; Tsimtsiou Z, 2009, BRIT J GEN PRACT, V59, P409, DOI 10.3399/bjgp09X420923; Vinkers DJ, 2003, JAMA-J AM MED ASSOC, V290, P2942, DOI 10.1001/jama.290.22.2942; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca	37	123	124	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1996	10.1136/bmj.g1996	http://dx.doi.org/10.1136/bmj.g1996			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647164	Green Published, hybrid			2022-12-24	WOS:000333414500008
J	Milo, A; Bess, EN; Sigman, MS				Milo, Anat; Bess, Elizabeth N.; Sigman, Matthew S.			Interrogating selectivity in catalysis using molecular vibrations	NATURE			English	Article							GAUSSIAN-BASIS SETS; INFRARED-SPECTRA; HECK ARYLATIONS; ATOMS LI; PARAMETERS	The delineation of molecular properties that underlie reactivity and selectivity is at the core of physical organic chemistry(1-5), and this knowledge can be used to inform the design of improved synthetic methods or identify new chemical transformations(6-9). For this reason, the mathematical representation of properties affecting reactivity and selectivity trends, that is, molecular parameters, is paramount. Correlations produced by equating these molecular parameters with experimental outcomes are often defined as free-energy relationships and can be used to evaluate the origin of selectivity and to generate new, experimentally testable hypotheses(6,10-12). The premise behind successful correlations of this type is that a systematically perturbed molecular property affects a transition-state interaction between the catalyst, substrate and any reaction components involved in the determination of selectivity(10,11). Classic physical organic molecular descriptors, such as Hammett(4), Taft(3) or Charton(5) parameters, seek to independently probe isolated electronic or steric effects(3-6,13,14). However, these parameters cannot address simultaneous, non-additive variations to more than one molecular property, which limits their utility. Here we report a parameter system based on the vibrational response of a molecule to infrared radiation that can be used to mathematically model and predict selectivity trends for reactions with interlinked steric and electronic effects at positions of interest. The disclosed parameter system is mechanistically derived and should find broad use in the study of chemical and biological systems.	[Milo, Anat; Bess, Elizabeth N.; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sigman, MS (corresponding author), Univ Utah, Dept Chem, 315 South 1400 E, Salt Lake City, UT 84112 USA.	sigman@chem.utah.edu	Bess, Elizabeth N/P-6570-2018; milo, anat/C-3255-2015	Bess, Elizabeth N/0000-0003-0349-0423; milo, anat/0000-0003-1552-8193	US National Science Foundation [CHE-0749506]; Center for High Performance Computing at the University of Utah; Division Of Chemistry [1110599] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Center for High Performance Computing at the University of Utah; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the US National Science Foundation (CHE-0749506). We thank S.J. Miller and S. Yoganathan for discussions and for providing the peptide catalyst used in these studies. The support and resources of the Center for High Performance Computing at the University of Utah are gratefully acknowledged.	[Anonymous], 1995, DATA ANAL CHEM; [Anonymous], 2009, GAUSS 09 REV C 01; [Anonymous], 2012, MATLAB STUD VERS V 7; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Baldi P., 2001, BIOINFORMATICS MACHI, P5; Benigni R, 2001, J CHEM INF COMP SCI, V41, P727, DOI 10.1021/ci000308+; Benigni R, 1999, J CHEM INF COMP SCI, V39, P558, DOI 10.1021/ci980223x; Bess E. N., 2012, ASYMMETRIC SYNTHESIS, P363; Bess EN, 2013, ORG LETT, V15, P646, DOI 10.1021/ol303465c; CHARTON M, 1975, J AM CHEM SOC, V97, P3694, DOI 10.1021/ja00846a023; CHARTON M, 1976, J ORG CHEM, V41, P2217, DOI 10.1021/jo00874a035; CHARTON M, 1975, J AM CHEM SOC, V97, P3691, DOI 10.1021/ja00846a022; CHARTON M, 1975, J AM CHEM SOC, V97, P1552, DOI 10.1021/ja00839a047; CHARTON M, 1960, CAN J CHEM, V38, P2493, DOI 10.1139/v60-338; CHARTON M, 1977, J ORG CHEM, V42, P2528, DOI 10.1021/jo00434a048; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Curtin D. Y., 1954, REC CHEM PROG, V15, P110; Dearden J. C., 2006, SMITH WILLIAMS INTRO, P185; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Dunitz JD, 2008, ANGEW CHEM INT EDIT, V47, P4208, DOI 10.1002/anie.200800063; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Gustafson JL, 2010, ORG LETT, V12, P2794, DOI 10.1021/ol100927m; Hammett LP, 1935, CHEM REV, V17, P125, DOI 10.1021/cr60056a010; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Harper KC, 2013, J ORG CHEM, V78, P2813, DOI 10.1021/jo4002239; Harper KC, 2013, J AM CHEM SOC, V135, P2482, DOI 10.1021/ja4001807; Harper KC, 2012, NAT CHEM, V4, P366, DOI [10.1038/nchem.1297, 10.1038/NCHEM.1297]; Harper KC, 2011, SCIENCE, V333, P1875, DOI 10.1126/science.1206997; JACOBSEN EN, 1991, J AM CHEM SOC, V113, P6703, DOI 10.1021/ja00017a069; JAFFE HH, 1953, CHEM REV, V53, P191, DOI 10.1021/cr60165a003; Jensen KH, 2010, J ORG CHEM, V75, P7194, DOI 10.1021/jo1013806; Mei TS, 2013, J AM CHEM SOC, V135, P6830, DOI 10.1021/ja402916z; Meyer MP, 2012, ADV PHYS ORG CHEM, V46, P57, DOI 10.1016/B978-0-12-398484-5.00002-X; Miller JJ, 2008, ANGEW CHEM INT EDIT, V47, P771, DOI 10.1002/anie.200704257; Peng CS, 2013, P NATL ACAD SCI USA, V110, P9243, DOI 10.1073/pnas.1303235110; Pino A, 2003, QSAR COMB SCI, V22, P191, DOI 10.1002/qsar.200390011; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Shahlaei M, 2013, CHEM REV, V113, P8093, DOI 10.1021/cr3004339; Sigman MS, 2009, J ORG CHEM, V74, P7633, DOI 10.1021/jo901698t; TAFT RW, 1952, J AM CHEM SOC, V74, P3120, DOI 10.1021/ja01132a049; TAFT RW, 1953, J AM CHEM SOC, V75, P4538, DOI 10.1021/ja01114a044; Valero R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2982923; Verloop A., 1983, PESTIC CHEM HUM WELF, P339; Verloop A., 1976, DRUG DESIGN, V3, P133; Verloop A., 1987, QSAR DRUG DESIGN TOX, P97; Verloop A., 1977, PHARMACOCHEM LIB, V2, P63; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208; Williams A, 2003, FREE ENERGY RELATION; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	51	95	96	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					210	+		10.1038/nature13019	http://dx.doi.org/10.1038/nature13019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24622199				2022-12-24	WOS:000332651800034
J	Daughtridge, GW; Archibald, T; Conway, PH				Daughtridge, Giffin W.; Archibald, Traci; Conway, Patrick H.			Quality Improvement of Care Transitions and the Trend of Composite Hospital Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Daughtridge, Giffin W.] Univ Penn, Philadelphia, PA 19104 USA; [Archibald, Traci; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	University of Pennsylvania; Centers for Medicare & Medicaid Services; Cincinnati Children's Hospital Medical Center	Conway, PH (corresponding author), Ctr Medicare & Medicaid Serv, Mailstop S3-02-01,7500 Secur Blvd, Baltimore, MD 21244 USA.	patrick.conway@cms.hhs.gov						Baier RR, 2013, AM J MANAG CARE, V19, P450; Baugh CW, 2013, NEW ENGL J MED, V369, P302, DOI 10.1056/NEJMp1304493; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Centers for Medicare & Medicaid Services (CMS), 2013, QUALITY IMPROVEMENT; Feng ZL, 2012, HEALTH AFFAIR, V31, P1251, DOI 10.1377/hlthaff.2012.0129	5	14	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1013	1014		10.1001/jama.2014.509	http://dx.doi.org/10.1001/jama.2014.509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618959				2022-12-24	WOS:000332575800015
J	Andrews, CD; Spreen, WR; Mohri, H; Moss, L; Ford, S; Gettie, A; Russell-Lodrigue, K; Bohm, RP; Cheng-Mayer, C; Hong, Z; Markowitz, M; Ho, DD				Andrews, Chasity D.; Spreen, William R.; Mohri, Hiroshi; Moss, Lee; Ford, Susan; Gettie, Agegnehu; Russell-Lodrigue, Kasi; Bohm, Rudolf P.; Cheng-Mayer, Cecilia; Hong, Zhi; Markowitz, Martin; Ho, David D.			Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus	SCIENCE			English	Article							ANTIRETROVIRAL-NAIVE ADULTS; ONCE-DAILY DOLUTEGRAVIR; HIV-1 INFECTION; DOUBLE-BLIND; PREEXPOSURE PROPHYLAXIS; RALTEGRAVIR; TRANSMISSION; PREVENTION; CHEMOPROPHYLAXIS; TENOFOVIR	GSK1265744 (GSK744) is an integrase strand-transfer inhibitor that has been formulated as a long-acting (LA) injectable suitable for monthly to quarterly clinical administration. GSK744 LA was administered at two time points 4 weeks apart beginning 1 week before virus administration, and macaques were challenged weekly for 8 weeks. GSK744 LA, at plasma concentrations achievable with quarterly injections in humans, protected all animals against repeated low-dose challenges. In a second experiment, macaques were given GSK744 LA 1 week before virus administration and challenged repeatedly until infection occurred. Protection decreased over time and correlated with the plasma drug levels. With a quarterly dosing schedule in humans, our results suggest that GSK744 LA could potentially decrease adherence problems associated with daily preexposure prophylaxis (PrEP).	[Andrews, Chasity D.; Mohri, Hiroshi; Gettie, Agegnehu; Cheng-Mayer, Cecilia; Markowitz, Martin; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Spreen, William R.; Moss, Lee; Ford, Susan; Hong, Zhi] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; [Russell-Lodrigue, Kasi; Bohm, Rudolf P.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	Rockefeller University; GlaxoSmithKline; Tulane University	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	dho@adarc.org	Russell-Lodrigue, Kasi E/G-7084-2016	Russell-Lodrigue, Kasi E/0000-0003-3719-0779	NIH [R0-AI100724, 1DP1-DA033263]; Tulane National Primate Research Center [2P51-OD11104-52]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA033263] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by NIH grants R0-AI100724 and 1DP1-DA033263 and Tulane National Primate Research Center grant 2P51-OD11104-52. We thank D. A. Margolis, A. Rinehart, J. C. Pottage Jr., Y. Huang, K. Meyers, and N. Padte for helpful discussions; J. Blanchard for veterinary services; M. Boente-Carrera, L. Tsai, and F. Yu for technical assistance; and G. Bowers, Y. L. Yueh, G. Tabolt, and P. Savina for PK, analytical, and statistical support. W. R. S., L. M., and S. F. are full-time employees of and hold shares in GlaxoSmithKline, Z.H. is a full-time employee of and holds shares in GlaxoSmithKline and serves on the ViiV Healthcare Board, and D. D. H. is a paid consultant to GlaxoSmithKline. The GenBank accession numbers for integrase sequences described in table S3 are KJ415285 to KJ415297.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Johns BA, 2013, J MED CHEM, V56, P5901, DOI 10.1021/jm400645w; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lou Y., 2013, 53 INT C ANT AG CHEM; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Moghimi SM, 2001, PHARMACOL REV, V53, P283; MORDENTI J, 1986, J PHARM SCI, V75, P1028, DOI 10.1002/jps.2600751104; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Spreen W, 2013, HIV CLIN TRIALS, V14, P192, DOI 10.1310/hct1405-192; Spreen W, 2012, 19 INT AIDS C WASH D; Spreen W., 2013, 7 INT AIDS SOC C HIV; Spreen WR, 2013, CURR OPIN HIV AIDS, V8, P565, DOI 10.1097/COH.0000000000000002; Stellbrink HJ, 2013, AIDS, V27, P1771, DOI 10.1097/QAD.0b013e3283612419; Subbarao S, 2007, J MED PRIMATOL, V36, P238, DOI 10.1111/j.1600-0684.2007.00241.x; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2013, 2013 UNAIDS REP GLOB; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	29	119	138	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1151	1154		10.1126/science.1248707	http://dx.doi.org/10.1126/science.1248707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24594934	Green Accepted			2022-12-24	WOS:000332331500052
J	Lee, JY; Yang, JG; Zhitnitsky, D; Lewinson, O; Rees, DC				Lee, Jonas Y.; Yang, Janet G.; Zhitnitsky, Daniel; Lewinson, Oded; Rees, Douglas C.			Structural Basis for Heavy Metal Detoxification by an Atm1-Type ABC Exporter	SCIENCE			English	Article							BINDING CASSETTE TRANSPORTER; CRYSTAL-STRUCTURE; P-GLYCOPROTEIN; GLUTATHIONE; MEMBRANE; CFTR; DISRUPTION; LOCALIZES; TOLERANCE; PROTEINS	Although substantial progress has been achieved in the structural analysis of exporters from the superfamily of adenosine triphosphate (ATP)-binding cassette (ABC) transporters, much less is known about how they selectively recognize substrates and how substrate binding is coupled to ATP hydrolysis. We have addressed these questions through crystallographic analysis of the Atm1/ABCB7/HMT1/ABCB6 ortholog from Novosphingobium aromaticivorans DSM 12444, NaAtm1, at 2.4 angstrom resolution. Consistent with a physiological role in cellular detoxification processes, functional studies showed that glutathione derivatives can serve as substrates for NaAtm1 and that its overexpression in Escherichia coli confers protection against silver and mercury toxicity. The glutathione binding site highlights the articulated design of ABC exporters, with ligands and nucleotides spanning structurally conserved elements to create adaptable interfaces accommodating conformational rearrangements during the transport cycle.	[Lee, Jonas Y.; Yang, Janet G.; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Lee, Jonas Y.; Yang, Janet G.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Zhitnitsky, Daniel; Lewinson, Oded] Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res, Dept Microbiol, IL-32000 Haifa, Israel	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Yang, Janet/P-2003-2015; Zhitnitsky, Daniel/AAD-6639-2020	Zhitnitsky, Daniel/0000-0002-7360-7247	NIH [GM45162]; Gordon and Betty Moore Foundation; Beckman Institute; Sanofi-Aventis Bioengineering Research Program at Caltech; Office of Basic Energy Research; National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045162, R01GM045162, P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Sanofi-Aventis Bioengineering Research Program at Caltech; Office of Basic Energy Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM45162. We gratefully acknowledge the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program at Caltech for their generous support of the Molecular Observatory at Caltech, and the staff at Beamline 12-2, Stanford Synchrotron Radiation Lightsource (SSRL), for their assistance with data collection. SSRL is operated for the U.S. Department of Energy and supported by its Office of Basic Energy Research and by National Institute of General Medical Sciences grant P41GM103393 and National Center for Research Resources grant P41RR001209. We thank G. Meloni, J. Kaiser, J. Hoy, R. Lill, S. Molik, I. Booth, S. Conway, and A. Laganowsky for stimulating discussions and providing reagents. Coordinates and structure factors have been deposited in the Protein Data Bank of the Research Collaboratory for Structural Bioinformatics, with IDs 4MRN, 4MRP, 4MRR, 4MRS, and 4MRV for NaAtm1 in apo form and in complexes with GSH, selenomethionine, GSSG, and GS-Hg, respectively.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bekri S, 2000, BLOOD, V96, P3256; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Lill R, 2001, RES MICROBIOL, V152, P331, DOI 10.1016/S0923-2508(01)01204-9; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Qi WB, 2012, J AM CHEM SOC, V134, P10745, DOI 10.1021/ja302186j; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	38	117	122	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1133	1136		10.1126/science.1246489	http://dx.doi.org/10.1126/science.1246489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604198	Green Accepted			2022-12-24	WOS:000332331500047
J	Clancy, CE; Xiang, YK				Clancy, Colleen E.; Xiang, Yang K.			BIOLOGICAL TECHNIQUES Wrapped around the heart	NATURE			English	Editorial Material									[Clancy, Colleen E.; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Clancy, CE (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	ceclancy@ucdavis.edu						Jia ZH, 2011, CIRC-ARRHYTHMIA ELEC, V4, P753, DOI 10.1161/CIRCEP.111.964247; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329; Zhou X, 2012, METHOD ENZYMOL, V504, P317, DOI 10.1016/B978-0-12-391857-4.00016-1	4	0	0	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					43	44		10.1038/507043a	http://dx.doi.org/10.1038/507043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24598634				2022-12-24	WOS:000332224400035
J	Schiebinger, L				Schiebinger, Londa			Scientific research must take gender into account	NATURE			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Schiebinger, L (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	schieb@stanford.edu		Schiebinger, Londa/0000-0003-3438-3081					0	36	36	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					9	9		10.1038/507009a	http://dx.doi.org/10.1038/507009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24598604	Bronze			2022-12-24	WOS:000332224400014
J	Jones-Smith, JC; Dow, WH; Chichlowska, K				Jones-Smith, Jessica C.; Dow, William H.; Chichlowska, Kristal			Association Between Casino Opening or Expansion and Risk of Childhood Overweight and Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVENTION; POVERTY; HEALTH; BMI	IMPORTANCE Economic resources have been inversely associated with risk of childhood overweight/obesity. Few studies have evaluated whether this association is a direct effect of economic resources or is attributable to unmeasured confounding or reverse causation. American Indian-owned casinos have resulted in increased economic resources for some tribes and provide an opportunity to test whether these resources are associated with overweight/obesity. OBJECTIVE To assess whether openings or expansions of American Indian-owned casinos were associated with childhood overweight/obesity risk. DESIGN, SETTING, AND PARTICIPANTS We used repeated cross-sectional anthropometric measurements from fitness testing of American Indian children (aged 7-18 years) from 117 school districts that encompassed tribal lands in California between 2001 and 2012. Children in school districts encompassing American Indian tribal lands that either gained or expanded a casino were compared with children in districts with tribal lands that did not gain or expand a casino. MAIN OUTCOMES AND MEASURES Per capita annual income, median annual household income, percentage of population in poverty, total population, child overweight/obesity (body mass index [BMI] >= 85th age- and sex-specific percentile) and BMI z score. RESULTS Of the 117 school districts, 57 gained or expanded a casino, 24 had a preexisting casino but did not expand, and 36 never had a casino. The mean slots per capita was 7 (SD, 12) and the median was 3 (interquartile range [IQR], 0.3-8). Among districts where a casino opened or expanded, the mean change in slots per capita was 13 (SD, 19) and the median was 3 (IQR, 1-11). Forty-eight percent of the anthropometric measurements were classified as overweight/obese (11 048/22 863). Every casino slot machine per capita gained was associated with an increase in per capita annual income (beta = $541; 95% CI, $245-$836) and a decrease in percentage in poverty (beta = -0.6%; 95% CI, -1.1% to -0.20%) among American Indians living on tribal lands. Among American Indian children, every slot machine per capita gained was associated with a decreased probability of overweight/obesity by 0.19 percentage points (95% CI, -0.26 to -0.11 percentage points) and a decrease in BMI z score (beta = -0.003; 95% CI, -0.005 to -0.0002). CONCLUSIONS AND RELEVANCE In this study, opening or expanding a casino was associated with increased economic resources and decreased risk of childhood overweight/obesity. Given the limitations of an ecological study, further research is needed to better understand the mechanisms behind this association.	[Jones-Smith, Jessica C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Human Nutr, Baltimore, MD 21218 USA; [Dow, William H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley	Jones-Smith, JC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room E2545, Baltimore, MD 21218 USA.	jjoness@jhsph.edu		Jones-Smith, Jessica/0000-0001-8962-1695; Dow, William/0000-0002-4080-1668	National Institute of Child Health and Human Development [K99 HD073327]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD073327, R24HD042854, R00HD073327] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this project was provided by grant K99 HD073327 from the National Institute of Child Health and Human Development.	Akee R, 2013, AM ECON J-APPL ECON, V5, P1, DOI 10.1257/app.5.2.1; Angeles G, 2005, SOCIOL METHOD RES, V34, P76, DOI 10.1177/0049124104273069; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Bruckner TA, 2011, INT J EPIDEMIOL, V40, P1083, DOI 10.1093/ije/dyr073; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; California Department of Education, CAL PHYS FITN TEST M; California Department of Education, PFT RES; California Gambling Control Commission, RAT TRIB STAT GAM CO; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Economos CD, 2013, PREV MED, V57, P322, DOI 10.1016/j.ypmed.2013.06.001; Evans W, 2006, IMPACT LOCAL LABOR M; Evans WN, 2002, 9198 NBER; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Gelman A., 2007, DATA ANAL USING REGR; Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018; Hruschka DJ, 2012, AM J HUM BIOL, V24, P277, DOI 10.1002/ajhb.22231; Johnston LD, 2013, SCH POLICIES PRACTIC; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Lakdawalla D., 2002, NBER WORKING PAPERS, V8946; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Madsen KA, 2010, PEDIATRICS, V126, P434, DOI 10.1542/peds.2009-3411; Martin J, 2006, IMPACT ANAL TRIBAL G; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; US Census Bureau, GEOGR TIGER LIN SHAP; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wolfe B, 2012, DEMOGRAPHY, V49, P499, DOI 10.1007/s13524-012-0098-8	30	17	17	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					929	936		10.1001/jama.2014.604	http://dx.doi.org/10.1001/jama.2014.604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC0FS	24595777	Bronze, Green Accepted			2022-12-24	WOS:000332170800021
J	Carlsson, S; Assel, M; Sjoberg, D; Ulmert, D; Hugosson, J; Lilja, H; Vickers, A				Carlsson, Sigrid; Assel, Melissa; Sjoberg, Daniel; Ulmert, David; Hugosson, Jonas; Lilja, Hans; Vickers, Andrew			Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTION; DIAGNOSIS; MORTALITY; SERUM; RISK; MEN	Objective To determine the relative risks of prostate cancer incidence, metastasis, and mortality associated with screening by serum prostate specific antigen (PSA) levels at age 60. Design Population based cohort study. Setting General male population of Sweden taking part in a screening trial in Gothenburg or participating in a cardiovascular study, the Malmo Preventive Project. Participants The screened group consisted of 1756 men aged 57.5-62.5 participating in the screening arm of the Gothenburg randomized prostate cancer screening trial since 1995. The unscreened group consisted of 1162 men, born in 1921, participating in the Malmo Preventive Project, with PSA levels measured retrospectively in stored blood samples from 1981. Intervention PSA screening versus no screening. Main outcome measures Incidence rate ratios for the effect of screening on prostate cancer diagnosis, metastasis, and death by PSA levels at age 60. Results The distribution of PSA levels was similar between the two cohorts. Differences in benefits by baseline PSA levels were large. Among men with baseline levels measured, 71.7% (1646/2295) had a PSA level <2 ng/mL. For men aged 60 with PSA level <2 ng/mL, there was an increase in incidence of 767 cases per 10 000 without a decrease in prostate cancer mortality. For men with PSA levels >= 2 ng/mL, the reduction in cancer mortality was large, with only 23 men needing to be screened and six diagnosed to avoid one prostate cancer death by 15 years. Conclusions The ratio of benefits to harms of PSA screening varies noticeably with blood PSA levels at age 60. For men with a PSA level <1 ng/mL at age 60, no further screening is recommended. Continuing to screen men with PSA levels >2 ng/mL at age 60 is beneficial, with the number needed to screen and treat being extremely favourable. Screening men with a PSA level of 1-2 ng/mL is an individual decision to be based on a discussion between patient and doctor.	[Carlsson, Sigrid; Hugosson, Jonas] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Urol, Gothenburg, Sweden; [Carlsson, Sigrid; Ulmert, David; Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Assel, Melissa; Sjoberg, Daniel; Vickers, Andrew] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10065 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med GU Oncol, New York, NY 10065 USA; [Lilja, Hans] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Lilja, Hans] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Lilja, Hans] Lund Univ, Dept Lab Med Malmo, Malmo, Sweden	University of Gothenburg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Oxford; Tampere University; Lund University	Lilja, H (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA.	liljah@mskcc.org	Lilja, Hans/S-9703-2019	Lilja, Hans/0000-0001-5871-7846; Carlsson, Sigrid/0000-0003-3553-5710; Vickers, Andrew/0000-0003-1525-6503; Sjoberg, Daniel/0000-0003-0862-2018	Swedish Cancer Society; Sweden America Foundation; Swedish Council for Working Life and Social Research; Swedish Society for Medical Research; Swedish Prostate Cancer Foundation; David H Koch Prostate Cancer Foundation Young Investigator Award; Tegger Foundation; Bertha Kamprad Foundation; National Cancer Institute [R01CA160816, R01 CA175491, P50-CA92629]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research Oxford Biomedical Research Centre programme; Swedish Cancer Society [11-0624]; TEKES in Finland; Fundacion Federico; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA160816, R01CA175491, P50CA092629] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Sweden America Foundation; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Society for Medical Research; Swedish Prostate Cancer Foundation; David H Koch Prostate Cancer Foundation Young Investigator Award; Tegger Foundation; Bertha Kamprad Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research Oxford Biomedical Research Centre programme(National Institute for Health Research (NIHR)); Swedish Cancer Society(Swedish Cancer Society); TEKES in Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Fundacion Federico; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SC was supported by grants from the Swedish Cancer Society, the Sweden America Foundation, the Swedish Council for Working Life and Social Research, the Swedish Society for Medical Research, and the Swedish Prostate Cancer Foundation. DU was supported by the David H Koch Prostate Cancer Foundation Young Investigator Award, The Tegger Foundation, and The Bertha Kamprad Foundation. This work was further supported by the National Cancer Institute (R01CA160816, R01 CA175491, and P50-CA92629), the Sidney Kimmel Center for Prostate and Urologic Cancers, and David H Koch through the Prostate Cancer Foundation, the National Institute for Health Research Oxford Biomedical Research Centre programme, Swedish Cancer Society (project No 11-0624), a FiDiPro-programme award from TEKES in Finland, and Fundacion Federico. Role of the funding source: none.	Bratt O, 2010, SCAND J UROL NEPHROL, V44, P384, DOI 10.3109/00365599.2010.498793; Bul M, 2011, EUR UROL, V59, P498, DOI 10.1016/j.eururo.2011.01.001; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jonsson H, 2011, INT J CANCER, V129, P1881, DOI 10.1002/ijc.25846; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Lilja H, 2011, CANCER-AM CANCER SOC, V117, P1210, DOI 10.1002/cncr.25568; Loeb S, 2012, EUR UROL, V61, P1, DOI 10.1016/j.eururo.2011.07.067; MITRUNEN K, 1995, CLIN CHEM, V41, P1115; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schwartz KL, 2003, CANCER CAUSE CONTROL, V14, P761, DOI 10.1023/A:1026321923883; Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641; van Leeuwen PJ, 2010, CANCER-AM CANCER SOC, V116, P4857, DOI 10.1002/cncr.25474; Vickers AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4521; Whittemore AS, 2005, J UROLOGY, V174, P872, DOI 10.1097/01.ju.0000169262.18000.8a; WHITTEMORE AS, 1995, J NATL CANCER I, V87, P354, DOI 10.1093/jnci/87.5.354; Zhu XY, 2012, EUR UROL, V61, P652, DOI 10.1016/j.eururo.2011.11.029	17	52	53	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2014	348								g2296	10.1136/bmj.g2296	http://dx.doi.org/10.1136/bmj.g2296			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9MF	24682399	Green Published, hybrid			2022-12-24	WOS:000333588500002
J	Vohra, P				Vohra, Pankaj			PERSONAL VIEW India should worry about underdiagnosis and overdiagnosis of coeliac disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Max Super Special Hosp, Delhi 110021, India		Vohra, P (corresponding author), Max Super Special Hosp, Press Enclave Marg, Delhi 110021, India.	pankajvohramd@yahoo.com						Makharia GK, 2011, J GASTROEN HEPATOL, V26, P894, DOI 10.1111/j.1440-1746.2010.06606.x; Mooney PD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1561	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g2046	10.1136/bmj.g2046	http://dx.doi.org/10.1136/bmj.g2046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647342				2022-12-24	WOS:000333414500009
J	Paulson, T				Paulson, Tom			DRUG DEVELOPMENT Searching for patterns	NATURE			English	Editorial Material																		Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829	5	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S10	S11		10.1038/507S10a	http://dx.doi.org/10.1038/507S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611170	Bronze			2022-12-24	WOS:000332224400005
J	Sun, J; Bankston, JR; Payandeh, J; Hinds, TR; Zagotta, WN; Zheng, N				Sun, Ji; Bankston, John R.; Payandeh, Jian; Hinds, Thomas R.; Zagotta, William N.; Zheng, Ning			Crystal structure of the plant dual-affinity nitrate transporter NRT1.1	NATURE			English	Article							GLUCOSE TRANSPORTERS; CHL1 FUNCTIONS; ARABIDOPSIS; MECHANISM; PROTEIN; MEMBRANE; REVEALS; ENCODES; SYSTEM; DIMER	Nitrate is a primary nutrient for plant growth, but its levels in soil can fluctuate by several orders of magnitude. Previous studies have identified Arabidopsis NRT1.1 as a dual-affinity nitrate transporter that can take up nitrate over a wide range of concentrations. The mode of action of NRT1.1 is controlled by phosphorylation of a key residue, Thr 101; however, how this post-translational modification switches the transporter between two affinity states remains unclear. Here we report the crystal structure of unphosphorylated NRT1.1, which reveals an unexpected homodimer in the inward-facing conformation. In this low-affinity state, the Thr 101 phosphorylation site is embedded in a pocket immediately adjacent to the dimer interface, linking the phosphorylation status of the transporter to its oligomeric state. Using a cell-based fluorescence resonance energy transfer assay, we show that functional NRT1.1 dimerizes in the cell membrane and that the phosphomimetic mutation of Thr 101 converts the protein into a monophasic high-affinity transporter by structurally decoupling the dimer. Together with analyses of the substrate transport tunnel, our results establish a phosphorylation-controlled dimerization switch that allows NRT1.1 to uptake nitrate with two distinct affinity modes.	[Sun, Ji; Payandeh, Jian; Hinds, Thomas R.; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Bankston, John R.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Bankston, John/I-7429-2019	Bankston, John/0000-0002-9478-2335; Sun, Ji/0000-0002-9302-3177	Howard Hughes Medical Institute; National Institutes of Health [R01EY10329, NS074545]; National Science Foundation; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS074545] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the beamline staff of the Advanced Light Source at the University of California at Berkeley. We also thank members of the Zheng laboratory, Zagotta laboratory, Xu laboratory and H. Zheng for discussion and help. This work is supported by the Howard Hughes Medical Institute (N. Z.), National Institutes of Health (R01EY10329 to W. N. Z., NS074545 to J.R.B.) and the National Science Foundation (N.Z.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hou ZJ, 2010, J BIOL CHEM, V285, P4732, DOI 10.1074/jbc.M109.086033; Huang NC, 1996, PLANT CELL, V8, P2183, DOI 10.1105/tpc.8.12.2183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Munos S, 2004, PLANT CELL, V16, P2433, DOI 10.1105/tpc.104.024380; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; PESSINO A, 1991, J BIOL CHEM, V266, P20213; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Taraska JW, 2010, NEURON, V66, P170, DOI 10.1016/j.neuron.2010.02.002; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Yan HC, 2013, CELL REP, V3, P716, DOI 10.1016/j.celrep.2013.03.007; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	40	194	212	6	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					73	+		10.1038/nature13074	http://dx.doi.org/10.1038/nature13074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572362	Green Accepted			2022-12-24	WOS:000332224400044
J	Orentlicher, D; Pope, TM; Rich, BA				Orentlicher, David; Pope, Thaddeus Mason; Rich, Ben A.			The Changing Legal Climate for Physician Aid in Dying	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Orentlicher, David] Indiana Univ, Hall Ctr Law & Hlth, Robert H McKinney Sch Law, Indianapolis, IN 46202 USA; [Pope, Thaddeus Mason] Hamline Univ, Sch Law, Hlth Law Inst, St Paul, MN USA; [Rich, Ben A.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Mitchell Hamline School of Law; University of California System; University of California Davis	Orentlicher, D (corresponding author), Indiana Univ, Hall Ctr Law & Hlth, Robert H McKinney Sch Law, 530 W New York St, Indianapolis, IN 46202 USA.	dorentli@iu.edu	Pope, Thaddeus/K-9452-2019	Pope, Thaddeus/0000-0002-7163-505X				American Public Health Association, POL STAT DAT; CANTOR NL, 1977, RUTGERS LAW REV, V30, P243; Ganzini L, 2009, J PAIN SYMPTOM MANAG, V38, P807, DOI 10.1016/j.jpainsymman.2009.04.026; GELFAND G, 1987, WISC LAW REV, P737; Hall M. A., 2013, HLTH CARE LAW ETHICS; Orentlicher D, 1996, NEW ENGL J MED, V335, P663, DOI 10.1056/NEJM199608293350912	6	12	12	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1961	1962		10.1001/jama.2014.4117	http://dx.doi.org/10.1001/jama.2014.4117			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UA	24733479	Green Published			2022-12-24	WOS:000336122800011
J	Du, JN; Skubi, KL; Schultz, DM; Yoon, TP				Du, Juana; Skubi, Kazimer L.; Schultz, Danielle M.; Yoon, Tehshik P.			A Dual-Catalysis Approach to Enantioselective [2+2] Photocycloadditions Using Visible Light	SCIENCE			English	Article							LEWIS-ACID CATALYSIS; PHOTOCHEMICAL-REACTIONS; CHIRAL SENSITIZER; ORGANIC-SYNTHESIS; COMPLEXES; CHEMISTRY	In contrast to the wealth of catalytic systems that are available to control the stereochemistry of thermally promoted cycloadditions, few similarly effective methods exist for the stereocontrol of photochemical cycloadditions. A major unsolved challenge in the design of enantioselective catalytic photocycloaddition reactions has been the difficulty of controlling racemic background reactions that occur by direct photoexcitation of substrates while unbound to catalyst. Here, we describe a strategy for eliminating the racemic background reaction in asymmetric [2 + 2] photocycloadditions of alpha, beta-unsaturated ketones to the corresponding cyclobutanes by using a dual-catalyst system consisting of a visible light-absorbing transition-metal photocatalyst and a stereocontrolling Lewis acid cocatalyst. The independence of these two catalysts enables broader scope, greater stereochemical flexibility, and better efficiency than previously reported methods for enantioselective photochemical cycloadditions.	[Du, Juana; Skubi, Kazimer L.; Schultz, Danielle M.; Yoon, Tehshik P.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yoon, TP (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	tyoon@chem.wisc.edu		Skubi, Kazimer/0000-0002-9689-1842	NIH [GM095666, GM105149]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095666, F32GM105149] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. S. Dolinar and I. A. Guzei for determining absolute stereochemistry by x-ray crystallography. Metrical parameters for the structures of 3c and S3 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-988977 and 988978, respectively. Funding for this work was provided by an NIH research grant (GM095666) and a postdoctoral fellowship to D. M. S. (GM105149).	Allen AE, 2012, CHEM SCI, V3, P633, DOI 10.1039/c2sc00907b; Aspinall HC, 2002, CHEM REV, V102, P1807, DOI 10.1021/cr010288q; Bach T, 2000, ANGEW CHEM INT EDIT, V39, P2302, DOI 10.1002/1521-3773(20000703)39:13<2302::AID-ANIE2302>3.0.CO;2-6; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; DEMUTH M, 1986, ANGEW CHEM INT EDIT, V25, P1117, DOI 10.1002/anie.198611171; Du J, 2009, J AM CHEM SOC, V131, P14604, DOI 10.1021/ja903732v; FOURNIER F, 1986, CAN J CHEM, V64, P881, DOI 10.1139/v86-146; Guo H, 2010, ANGEW CHEM INT EDIT, V49, P7782, DOI 10.1002/anie.201003619; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; Hoveyda AH, 1998, CHEM BIOL, V5, pR187, DOI 10.1016/S1074-5521(98)90155-7; HUBERT AJ, 1967, J CHEM SOC C, P1984, DOI 10.1039/j39670001984; INOUE Y, 1992, CHEM REV, V92, P741, DOI 10.1021/cr00013a001; Iriondo-Alberdi J, 2007, EUR J ORG CHEM, V2007, P4801, DOI 10.1002/ejoc.200700239; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Kacprzynski MA, 2004, J AM CHEM SOC, V126, P10676, DOI 10.1021/ja0478779; KALYANASUNDARAM K, 1982, COORDIN CHEM REV, V46, P159, DOI 10.1016/0010-8545(82)85003-0; Kuhn W, 1930, NATURWISSENSCHAFTEN, V18, P183, DOI 10.1007/BF01501575; Le Bel JA, 1874, B SOC CHIM FR, V22, P337; Maturi MM, 2013, CHEM-EUR J, V19, P7461, DOI 10.1002/chem.201300203; Mikami K, 2002, ANGEW CHEM INT EDIT, V41, P3555, DOI 10.1002/1521-3773(20021004)41:19<3554::AID-ANIE3554>3.0.CO;2-P; Muller C, 2011, J AM CHEM SOC, V133, P16689, DOI 10.1021/ja207480q; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; Ojima I., 2010, CATALYTIC ASYMMETRIC; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; RAU H, 1983, CHEM REV, V83, P535, DOI 10.1021/cr00057a003; TODA F, 1995, J CHEM SOC CHEM COMM, P621, DOI 10.1039/c39950000621; TOLBERT LM, 1982, J AM CHEM SOC, V104, P1742, DOI 10.1021/ja00370a053; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V1	28	392	394	14	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					392	396		10.1126/science.1251511	http://dx.doi.org/10.1126/science.1251511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763585	Green Accepted			2022-12-24	WOS:000334867800035
J	Birbeck, GL; Hanna, MG; Griggs, RC				Birbeck, Gretchen L.; Hanna, Michael G.; Griggs, Robert C.			Global Opportunities and Challenges for Clinical Neuroscience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Birbeck, Gretchen L.; Griggs, Robert C.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Birbeck, Gretchen L.] Chikankata Hosp, Epilepsy Care Team, Mazabuka, Zambia; [Hanna, Michael G.] UCL, Inst Neurol, London, England	University of Rochester; University of London; University College London	Birbeck, GL (corresponding author), Univ Rochester, Dept Neurol, 265 Crittenden Blvd, Rochester, NY 14642 USA.	gretchen_birbeck@urmc.rochester.edu		Griggs, Robert/0000-0001-7988-4854; Hanna, Michael/0000-0003-0825-4075	Medical Research Council [MR/K000608/1] Funding Source: Medline; MRC [MR/K000608/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Birbeck GL, 2013, BMC MED, V11, DOI [10.1186/1741-7015-11-223, 10.1186/1741-7015-11-226]; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Minisman G, 2012, J NEUROL SCI, V313, P1, DOI 10.1016/j.jns.2011.10.004; National Institutes of Health (NIH), NIH GRANTS POL CONS; Sun GH, 2012, NEW ENGL J MED, V367, P687, DOI 10.1056/NEJMp1206643; World Health Organization (WHO), 17 NEGL TROP DIS	8	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1609	1610		10.1001/jama.2014.2744	http://dx.doi.org/10.1001/jama.2014.2744			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756506				2022-12-24	WOS:000334693900016
J	Scully, T				Scully, Tony			SOCIETY AT LARGE	NATURE			English	Editorial Material																			0	34	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S50	S51		10.1038/508S50a	http://dx.doi.org/10.1038/508S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740125	Bronze			2022-12-24	WOS:000334403000002
J	O'Dowd, A				O'Dowd, Adrian			BMJ AWARDS 2014 Diabetes Team of the Year: adaptable and supportive	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2708	10.1136/bmj.g2708	http://dx.doi.org/10.1136/bmj.g2708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24736317				2022-12-24	WOS:000334742100025
J	Ellison, AM				Ellison, Aaron M.			Political borders should not hamper wildlife	NATURE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Ellison, AM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	aellison@fas.harvard.edu		Ellison, Aaron/0000-0003-4151-6081					0	10	10	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					9	9		10.1038/508009a	http://dx.doi.org/10.1038/508009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695280	Bronze			2022-12-24	WOS:000333609900018
J	Martinez-Garcia, A; Sigman, DM; Ren, HJ; Anderson, RF; Straub, M; Hodell, DA; Jaccard, SL; Eglinton, TI; Haug, GH				Martinez-Garcia, Alfredo; Sigman, Daniel M.; Ren, Haojia; Anderson, Robert F.; Straub, Marietta; Hodell, David A.; Jaccard, Samuel L.; Eglinton, Timothy I.; Haug, Gerald H.			Iron Fertilization of the Subantarctic Ocean During the Last Ice Age	SCIENCE			English	Article							SOUTHERN-OCEAN; ATMOSPHERIC CO2; INTERGLACIAL CHANGES; NITRATE UTILIZATION; NITROGEN-FIXATION; SURFACE NITRATE; GLACIAL PERIOD; INDIAN SECTOR; CLIMATE; PRODUCTIVITY	John H. Martin, who discovered widespread iron limitation of ocean productivity, proposed that dust-borne iron fertilization of Southern Ocean phytoplankton caused the ice age reduction in atmospheric carbon dioxide (CO2). In a sediment core from the Subantarctic Atlantic, we measured foraminifera-bound nitrogen isotopes to reconstruct ice age nitrate consumption, burial fluxes of iron, and proxies for productivity. Peak glacial times and millennial cold events are characterized by increases in dust flux, productivity, and the degree of nitrate consumption; this combination is uniquely consistent with Subantarctic iron fertilization. The associated strengthening of the Southern Ocean's biological pump can explain the lowering of CO2 at the transition from mid-climate states to full ice age conditions as well as the millennial-scale CO2 oscillations.	[Martinez-Garcia, Alfredo; Straub, Marietta; Eglinton, Timothy I.; Haug, Gerald H.] ETH, Inst Geol, CH-8092 Zurich, Switzerland; [Sigman, Daniel M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ren, Haojia] Acad Sinica, Res Ctr Environm Changes, Taipei 11529, Taiwan; [Anderson, Robert F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Hodell, David A.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Jaccard, Samuel L.] Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland; [Jaccard, Samuel L.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; Academia Sinica - Taiwan; Columbia University; University of Cambridge; University of Bern; University of Bern	Martinez-Garcia, A (corresponding author), ETH, Inst Geol, CH-8092 Zurich, Switzerland.	alfredo.martinez-garcia@erdw.ethz.ch	Jaccard, Samuel/G-3447-2014; Sigman, Daniel M/A-2649-2008; Martínez-García, Alfredo/A-6244-2010	Jaccard, Samuel/0000-0002-5793-0896; Sigman, Daniel M/0000-0002-7923-1973; Martínez-García, Alfredo/0000-0002-7206-5079; Hodell, David/0000-0001-8537-1588; Anderson, Robert/0000-0002-8472-2494; REN, HAO-JIA/0000-0002-1769-4243; Straub, Marietta/0000-0002-1156-4085; Eglinton, Timothy/0000-0001-5060-2155	Swiss National Science Foundation [PZ00P2_142424, PP00P2_144811]; UK Natural Environment Research Council; NSF [OCE-1060947, OCE-0823507]; Princeton University; MacArthur Foundation; Directorate For Geosciences [1060947] Funding Source: National Science Foundation; Natural Environment Research Council [NE/H009930/1] Funding Source: researchfish; NERC [NE/H009930/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Princeton University(Princeton University); MacArthur Foundation; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by Swiss National Science Foundation Ambizione grant PZ00P2_142424 (A.M.-G.), Swiss National Science Foundation grant PP00P2_144811 (S.L.J.), the UK Natural Environment Research Council (D.A.H.), NSF grants OCE-1060947 (D.M.S.) and OCE-0823507 (R.F.A.), the Grand Challenges Program of Princeton University (D.M.S.), and the MacArthur Foundation (D.M.S.). This research used samples provided by the Integrated Ocean Drilling Program (IODP).	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Altabet MA, 1989, GLOBAL BIOGEOCHEM CY, V3, P107, DOI 10.1029/GB003i002p00107; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Bereiter B, 2012, P NATL ACAD SCI USA, V109, P9755, DOI 10.1073/pnas.1204069109; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; DEANGELIS M, 1987, NATURE, V325, P318, DOI 10.1038/325318a0; DESCOMBES HJ, 2008, PALEOCEANOGRAPHY, V0023; DiFiore PJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003216; DiFiore PJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044090; FRANCOIS R, 1993, PALEOCEANOGRAPHY, V8, P611, DOI 10.1029/93PA00784; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Francois R, 1992, PALEOCEANOGRAPHY, V7, P589, DOI 10.1029/92PA01573; Garcia H. E, 2010, WORLD OCEAN ATLAS 20; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; KNOX F, 1984, J GEOPHYS RES-ATMOS, V89, P4629, DOI 10.1029/JD089iD03p04629; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lambert F, 2012, CLIM PAST, V8, P609, DOI 10.5194/cp-8-609-2012; Lamy F, 2014, SCIENCE, V343, P403, DOI 10.1126/science.1245424; Lourey MJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001973; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; McCartney M. S., 1977, DEEP SEA RES S, P103; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Ren H, 2009, SCIENCE, V323, P244, DOI 10.1126/science.1165787; Ren HJ, 2012, LIMNOL OCEANOGR, V57, P1011, DOI 10.4319/lo.2012.57.4.1011; Robinson RS, 2008, QUATERNARY SCI REV, V27, P1076, DOI 10.1016/j.quascirev.2008.02.005; Robinson RS, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001114; Sachs JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000862; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; SIEGENTHALER U, 1984, NATURE, V308, P624, DOI 10.1038/308624a0; Straub M, 2013, NATURE, V501, P200, DOI 10.1038/nature12397; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561	44	274	282	6	317	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1347	1350		10.1126/science.1246848	http://dx.doi.org/10.1126/science.1246848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653031				2022-12-24	WOS:000333108500035
J	Vivante, A; Twig, G; Tirosh, A; Skorecki, K; Calderon-Margalit, R				Vivante, Asaf; Twig, Gilad; Tirosh, Amir; Skorecki, Karl; Calderon-Margalit, Ronit			Childhood History of Resolved Glomerular Disease and Risk of Hypertension During Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							NEPHROTIC SYNDROME; FOLLOW-UP; GLOMERULONEPHRITIS; ADOLESCENTS		[Vivante, Asaf; Twig, Gilad] IDF Med Corps, Talpiot Med Leadership Program, Tel Hashomer, Israel; [Tirosh, Amir] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, IL-32000 Haifa, Israel; [Skorecki, Karl] Technion Israel Inst Technol, Res Inst, IL-32000 Haifa, Israel; [Calderon-Margalit, Ronit] Hadassah Hebrew Univ, Braun Sch Publ Hlth, Jerusalem, Israel	Harvard University; Brigham & Women's Hospital; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hadassah University Medical Center	Vivante, A (corresponding author), Chaim Sheba Med Ctr, IDF Med Corps, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel.	asafvivante@gmail.com	Twig, Gilad/C-4373-2018	Twig, Gilad/0000-0003-2829-3645; Tirosh, Amir/0000-0003-2210-5906				KOSKIMIES O, 1982, ARCH DIS CHILD, V57, P544, DOI 10.1136/adc.57.7.544; PERLMAN LV, 1965, J AMER MED ASSOC, V194, P63, DOI 10.1001/jama.194.1.63; POTTER EV, 1982, NEW ENGL J MED, V307, P725, DOI 10.1056/NEJM198209163071205; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; TROMPETER RS, 1985, LANCET, V1, P368; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85	6	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1155	1157		10.1001/jama.2013.284310	http://dx.doi.org/10.1001/jama.2013.284310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643607	Bronze			2022-12-24	WOS:000333010100022
J	Brown, JR; Sox, HC; Goodman, DC				Brown, Jeremiah R.; Sox, Harold C.; Goodman, David C.			Financial Incentives to Improve Quality Skating to the Puck or Avoiding the Penalty Box?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Brown, Jeremiah R.; Sox, Harold C.; Goodman, David C.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College	Brown, JR (corresponding author), Dartmouth Hitchcock Med Ctr, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, One Med Ctr Dr,HB 7505, Lebanon, NH 03756 USA.	jbrown@dartmouth.edu	Goodman, David/AAG-7497-2020		AHRQ HHS [K01 HS018443] Funding Source: Medline; NHLBI NIH HHS [R01 HL119664] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Calikoglu S, 2012, HEALTH AFFAIR, V31, P2649, DOI 10.1377/hlthaff.2012.0357; Lyu H, 2013, JAMA SURG, V148, P362, DOI 10.1001/2013.jamasurg.270; The Medicare Payment Advisory Commission, C MED HLTH CAR DEL S	4	20	20	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1009	1010		10.1001/jama.2014.421	http://dx.doi.org/10.1001/jama.2014.421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618957	Green Accepted			2022-12-24	WOS:000332575800013
J	Willyard, C				Willyard, Cassandra			POLIO The eradication endgame	NATURE			English	Editorial Material							VACCINE											Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Mangal TD, 2013, AM J EPIDEMIOL, V178, P1579, DOI 10.1093/aje/kwt203; Resik S, 2013, NEW ENGL J MED, V368, P416, DOI 10.1056/NEJMoa1202541	3	5	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S14	S15		10.1038/507S14a	http://dx.doi.org/10.1038/507S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611172	Bronze			2022-12-24	WOS:000332224400007
J	Friedman, AK; Walsh, JJ; Juarez, B; Ku, SM; Chaudhury, D; Wang, J; Li, XT; Dietz, DM; Pan, NN; Vialou, VF; Neve, RL; Yue, ZY; Han, MH				Friedman, Allyson K.; Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.; Chaudhury, Dipesh; Wang, Jing; Li, Xianting; Dietz, David M.; Pan, Nina; Vialou, Vincent F.; Neve, Rachael L.; Yue, Zhenyu; Han, Ming-Hu			Enhancing Depression Mechanisms in Midbrain Dopamine Neurons Achieves Homeostatic Resilience	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT STRESS; REWARD CIRCUIT; I-H; CHANNELS; SUSCEPTIBILITY; INHIBITION; BDNF	Typical therapies try to reverse pathogenic mechanisms. Here, we describe treatment effects achieved by enhancing depression-causing mechanisms in ventral tegmental area (VTA) dopamine (DA) neurons. In a social defeat stress model of depression, depressed (susceptible) mice display hyperactivity of VTA DA neurons, caused by an up-regulated hyperpolarization-activated current (I-h). Mice resilient to social defeat stress, however, exhibit stable normal firing of these neurons. Unexpectedly, resilient mice had an even larger Ih, which was observed in parallel with increased potassium (K+) channel currents. Experimentally further enhancing Ih or optogenetically increasing the hyperactivity of VTA DA neurons in susceptible mice completely reversed depression-related behaviors, an antidepressant effect achieved through resilience-like, projection-specific homeostatic plasticity. These results indicate a potential therapeutic path of promoting natural resilience for depression treatment.	[Friedman, Allyson K.; Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.; Chaudhury, Dipesh; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Neurosci Program, New York, NY 10029 USA; [Wang, Jing; Li, Xianting; Pan, Nina; Yue, Zhenyu] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Dietz, David M.; Vialou, Vincent F.; Yue, Zhenyu; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Dietz, David M.; Vialou, Vincent F.; Yue, Zhenyu; Han, Ming-Hu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Neve, Rachael L.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT)	Han, MH (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ming-hu.han@mssm.edu	Dietz, David/AAW-4574-2021; vialou, vincent/F-2968-2013; Han, Ming-Hu/G-8836-2012; Dietz, David/J-9458-2015	Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Dietz, David/0000-0002-6927-9236; Walsh, Jessica/0000-0001-8466-8451; Juarez, Barbara/0000-0001-7897-8031; Li, Xianting/0000-0002-3153-0931	National Institute of Mental Health [R01 MH092306]; National Research Service Award [F31 MH095425, T32 MH 087004, F32 MH096464]; Johnson & Johnson-International Mental Health Research Organization (IMHRO) Rising Star Translational Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096678, P50MH096890, F31MH108326, F31MH095425, T32MH020016, R01MH092306, T32MH087004, F32MH096464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022445] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson & Johnson-International Mental Health Research Organization (IMHRO) Rising Star Translational Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank E. J. Nestler for his continuing support of this work. We also thank S. J. Russo, H. P. Xu, J. L. Cao, F. Henn, and E. J. Nestler for their helpful discussion and G. R. Tibbs and P. A. Goldstein from Weill Cornell Medical College for providing the HCN2 plasmid. This work was supported by the National Institute of Mental Health (R01 MH092306: S. M. K., D. C., M.-H. H.), National Research Service Award (F31 MH095425 to J. J. W.; T32 MH 087004 to B. J.; F32 MH096464 to A. K. F.), and Johnson & Johnson-International Mental Health Research Organization (IMHRO) Rising Star Translational Research Award (M.-H.H.).	Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Carey TA, 2011, CLIN PSYCHOL REV, V31, P236, DOI 10.1016/j.cpr.2010.04.004; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Frye MA, 2011, NEW ENGL J MED, V364, P51, DOI 10.1056/NEJMcp1000402; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kumar S, 2008, COGNITIVE THER RES, V32, P734, DOI 10.1007/s10608-008-9190-1; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Nakatani Y, 2013, J PHARMACOL SCI, V123, P203, DOI 10.1254/jphs.13116SC; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Whalley K, 2013, NAT REV NEUROSCI, V14, DOI 10.1038/nrn3637; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019	33	266	280	6	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					313	319		10.1126/science.1249240	http://dx.doi.org/10.1126/science.1249240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744379	Green Accepted			2022-12-24	WOS:000334474500040
J	Tanne, JH				Tanne, Janice Hopkins			Some progress and some missed targets in the TB epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Alami NN, 2014, MMWR-MORBID MORTAL W, V63, P229; World Health Organization, GLOB TUB REP 2013	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2014	348								g2626	10.1136/bmj.g2626	http://dx.doi.org/10.1136/bmj.g2626			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GS	24740907				2022-12-24	WOS:000334742600008
J	Taylor, C; Kavanagh, P; Zuckerman, B				Taylor, Catherine; Kavanagh, Patricia; Zuckerman, Barry			Sickle Cell Trait-Neglected Opportunities in the Era of Genomic Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Taylor, Catherine] Boston Med Ctr, Boston Combined Residency Pediat, Boston, MA USA; [Taylor, Catherine] Boston Childrens Hosp, Boston, MA USA; [Kavanagh, Patricia; Zuckerman, Barry] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Kavanagh, Patricia; Zuckerman, Barry] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston Medical Center; Harvard University; Boston Children's Hospital; Boston Medical Center; Boston University	Zuckerman, B (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, 771 Albany St,Dowling Third Floor, Boston, MA 02118 USA.	barry.zuckerman@bmc.org			PHS HHS [U38MC2215] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Divison of Blood Disorders, WHAT YOU SHOULD KNOW; Davis LB, 2010, FERTIL STERIL, V93, P1793, DOI 10.1016/j.fertnstert.2008.12.053; Desposito F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e22; Kavanagh PL, 2008, AM J MED GENET C, V148C, P15, DOI 10.1002/ajmg.c.30160; NHS Commisioning Board, CLIN COMM POL PREIMP; PAULING L, 1968, UCLA LAW REV, V15, P267; Smith LA, 2006, PEDIATRICS, V117, P1763, DOI 10.1542/peds.2005-1611; Treadwell MJ, 2006, J NATL MED ASSOC, V98, P704	8	22	22	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1495	1496		10.1001/jama.2014.2157	http://dx.doi.org/10.1001/jama.2014.2157			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24604073				2022-12-24	WOS:000334306000014
J	Gonzales, G				Gonzales, Gilbert			Same-Sex Marriage - A Prescription for Better Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Research suggests that discriminatory environments and bans on same-sex marriage are detrimental to health and that legalizing same-sex marriage contributes to better health for LGBT people, as well as improving access to insurance for LGBT people and their children. The past year has proved to be a pivotal one for lesbian, gay, bisexual, and transgender (LGBT) Americans. When 2013 began, same-sex couples were allowed to marry only in 9 states plus Washington, D.C., and even when they were legally married by states, the federal government did not recognize their relationships, in accordance with the Defense of Marriage Act (DOMA). As of February 2014, same-sex couples can legally wed in 17 states (and enter civil unions or domestic partnerships in 3 others), and their unions are federally recognized, thanks to a set of court decisions and new laws passed by ...	[Gonzales, Gilbert] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [Gonzales, Gilbert] Univ Minnesota, State Hlth Access Data Assistance Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gonzales, G (corresponding author), Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA.							Gonzales G, 2014, AM J PUBLIC HEALTH, V104, pE95, DOI 10.2105/AJPH.2013.301577; Gonzales G, 2013, PEDIATRICS, V132, P703, DOI 10.1542/peds.2013-0988; Hatzenbuehler ML, 2012, AM J PUBLIC HEALTH, V102, P285, DOI 10.2105/AJPH.2011.300382; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Wight RG, 2013, AM J PUBLIC HEALTH, V103, P339, DOI 10.2105/AJPH.2012.301113	5	22	22	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 10	2014	370	15					1373	1376		10.1056/NEJMp1400254	http://dx.doi.org/10.1056/NEJMp1400254			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6IW	24716677				2022-12-24	WOS:000334095200003
J	Pollard, AJ; Riordan, A; Ramsay, M				Pollard, Andrew J.; Riordan, Andrew; Ramsay, Mary			Group B meningococcal vaccine: recommendations for UK use	LANCET			English	Editorial Material							4CMENB VACCINE; ROUTINE INFANT; IMMUNOGENICITY; MULTICOMPONENT; VACCINATIONS; TOLERABILITY; IMMUNIZATION; ADOLESCENTS; RECOMBINANT; DISEASE		[Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford OX3 9DU, England; [Riordan, Andrew] Alder Hey Childrens NHS Fdn, Liverpool, Merseyside, England; [Ramsay, Mary] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England	University of Oxford; Alder Hey Children's NHS Foundation Trust; Public Health England	Pollard, AJ (corresponding author), Univ Oxford, Dept Paediat, Oxford OX3 9DU, England.	andrew.pollard@paediatrics.ox.ac.uk	Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640				Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Health Protection Agency, 2012, INV MEN INF LAB REP; Joint Committee on Vaccination and Immunisation, 2013, JCVI INT POS STAT US; Mekalanos JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007588; Moxon R, 2013, LANCET, V382, P369, DOI 10.1016/S0140-6736(13)61572-X; Vesikari T, 2013, LANCET, V381, P825, DOI 10.1016/S0140-6736(12)61961-8; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1	10	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1103	1104		10.1016/S0140-6736(14)60226-9	http://dx.doi.org/10.1016/S0140-6736(14)60226-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4MH	24661533				2022-12-24	WOS:000333956000006
J	Bloem, BR; Munneke, M				Bloem, Bastiaan R.; Munneke, Marten			Revolutionising management of chronic disease: the ParkinsonNet approach	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; HEALTH-CARE; MULTIDISCIPLINARY CARE; EPDA CHARTER; ROTTERDAM; PEOPLE; IMPACT; PHYSIOTHERAPY; SATISFACTION; EXPERIENCE		[Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Bloem, Bastiaan R.; Munneke, Marten] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Munneke, Marten] Nijmegen Ctr Evidence Based Practice, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Bloem, BR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	bas.bloem@radboudumc.nl	Munneke, Marten/N-3583-2014; Bloem, Bastiaan/H-8013-2014	Bloem, Bastiaan/0000-0002-6371-3337				Bloem BR, 2012, EUR J NEUROL, V19, P402, DOI 10.1111/j.1468-1331.2011.03532.x; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Findley LJ, 2002, BRIT MED J, V324, P1466, DOI 10.1136/bmj.324.7352.1466; Gage H, 2003, J NEUROL NEUROSUR PS, V74, P163, DOI 10.1136/jnnp.74.2.163; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; Hass CJ, 2010, LANCET NEUROL, V9, P20, DOI 10.1016/S1474-4422(09)70331-X; Hoeksema N, 2011, ONDERZOEK NAAR MEERW, P1; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Keus SHJ, 2004, J NEUROL, V251, P680, DOI 10.1007/s00415-004-0402-7; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Munneke M, 2010, LANCET NEUROL, V9, P46, DOI 10.1016/S1474-4422(09)70327-8; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Nijkrake MJ, 2010, MOVEMENT DISORD, V25, P823, DOI 10.1002/mds.22813; Nijkrake MJ, 2009, MOVEMENT DISORD, V24, P282, DOI 10.1002/mds.22377; Parashos SA, 2013, LANCET NEUROL, V12, P932, DOI 10.1016/S1474-4422(13)70145-5; Post B, 2011, Pract Neurol, V11, P58, DOI 10.1136/jnnp.2011.241604; Stocchi F, 2013, EUR J NEUROL, V20, P461, DOI 10.1111/j.1468-1331.2012.03876.x; Tomlinson CL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5004; van der Eijk M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2476; van der Eijk M, 2012, PARKINSONISM RELAT D, V18, P1011, DOI 10.1016/j.parkreldis.2012.05.017; van der Eijk M, 2011, PARKINSONISM RELAT D, V17, P360, DOI 10.1016/j.parkreldis.2011.02.012; van der Marck MA, 2013, LANCET NEUROL, V12, P947, DOI 10.1016/S1474-4422(13)70196-0; Weerkamp NJ, 2012, J AM GERIATR SOC, V60, P2277, DOI 10.1111/jgs.12027; Wensing M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-67	26	80	80	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g1838	10.1136/bmj.g1838	http://dx.doi.org/10.1136/bmj.g1838			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647365				2022-12-24	WOS:000333414500004
J	Eisenstein, M				Eisenstein, Michael			PUBLIC HEALTH An injection of trust	NATURE			English	Editorial Material							VACCINATION; VACCINES; RISK											Atwell JE, 2013, PEDIATRICS, V132, P624, DOI 10.1542/peds.2013-0878; DeStefano F, 2013, J PEDIATR-US, V163, P561, DOI 10.1016/j.jpeds.2013.02.001; European Centre for Disease Prevention and Control, 2013, RISK ASS WILD TYP PO; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Larson HJ, 2013, LANCET INFECT DIS, V13, P606, DOI 10.1016/S1473-3099(13)70108-7; O'Leary ST, 2012, PEDIATRICS, V129, P248, DOI 10.1542/peds.2011-1111; Omer SB, 2012, NEW ENGL J MED, V367, P1170, DOI 10.1056/NEJMc1209037; van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400	8	11	11	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S17	S19		10.1038/507S17a	http://dx.doi.org/10.1038/507S17a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611174				2022-12-24	WOS:000332224400009
J	Siegel, AM; Sisti, DA; Caplan, AL				Siegel, Andrew M.; Sisti, Dominic A.; Caplan, Arthur L.			Pediatric Euthanasia in Belgium Disturbing Developments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Siegel, Andrew M.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sisti, Dominic A.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Caplan, Arthur L.] NYU, Div Med Eth, Langone Med Ctr, New York, NY USA	University of Pennsylvania; University of Pennsylvania; New York University; NYU Langone Medical Center	Siegel, AM (corresponding author), Univ Penn, Dept Psychiat, Perelman Sch Med, 3535 Market St,Second Floor, Philadelphia, PA 19104 USA.	andrew.siegel@uphs.upenn.edu		Siegel, Andrew/0000-0002-8605-2519; Sisti, Dominic/0000-0002-2282-9253				Casell, 2004, NATURE SUFFERING GOA; Dan B, 2014, LANCET, V383, P671, DOI 10.1016/S0140-6736(14)60110-0; Jennings B, 2013, HASTINGS CTR GUIDELI; Orentlicher D, 2014, JAMA-J AM MED ASSOC, V311, P1961, DOI 10.1001/jama.2014.4117; Pousset G, 2011, ARCH DIS CHILD, V96, P948, DOI 10.1136/adc.2009.182139; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Verhagen E, 2005, NEW ENGL J MED, V352, P959, DOI 10.1056/NEJMp058026	7	30	32	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2014	311	19					1963	1964		10.1001/jama.2014.4257	http://dx.doi.org/10.1001/jama.2014.4257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH4UA	24743867				2022-12-24	WOS:000336122800012
J	Carvunis, AR; Ideker, T				Carvunis, Anne-Ruxandra; Ideker, Trey			Siri of the Cell: What Biology Could Learn from the iPhone	CELL			English	Article							GENE ONTOLOGY; SYSTEMS; NETWORK	Modern genomics is very efficient at mapping genes and gene networks, but how to transform these maps into predictive models of the cell remains unclear. Recent progress in computer science, embodied by intelligent agents such as Siri, inspires an approach for moving from networks to multiscale models able to predict a range of cellular phenotypes and answer biological questions.	[Carvunis, Anne-Ruxandra; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu		Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Ideker, Trey/0000-0002-1708-8454	National Institutes of General Medical Sciences [P41 GM103504, P50 GM085764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, P41GM103504] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Janusz Dutkowski, Michael Yu, Michael Kramer, Hannah Carter, Salvatore Loguercio, Benjamin Good, Bing Ren, Andrew Su, Gary Siuzdak, Benjamin Kellman, Heidi Kayser, and our anonymous reviewers for important discussions and comments in preparation for this Essay. This work was supported by the National Institutes of General Medical Sciences grants P41 GM103504 and P50 GM085764.	Alterovitz G, 2010, NAT BIOTECHNOL, V28, P128, DOI 10.1038/nbt0210-128; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berner ES., 2007, CLIN DECISION SUPPOR; Brachman R.J., 2004, KNOWLEDGE REPRESENTA, P336; Bray, 2009, WETWARE COMPUTER EVE; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Cohen K Bretonnel, 2013, Proc Conf Assoc Comput Linguist Meet, V2013, P3; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fung Y.C., 1993, BIOMECHANICS MECH PR; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; Guzzoni D, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY, WORKSHOPS PROCEEDINGS, P417, DOI 10.1109/WI-IATW.2006.27; Hooke Robert, 1665, MICROGRAPHIA SOME PH; Kauffman Stuart A., 1993; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Koller D., 2009, PROBABILISTIC GRAPHI; MATHEWS CK, 1993, J BACTERIOL, V175, P6377, DOI 10.1128/jb.175.20.6377-6381.1993; McPherson A, 2009, INTRO MACROMOLECULAR; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Pollack G.H., 2001, CELLS GELS ENGINES L; REDDY GPV, 1977, P NATL ACAD SCI USA, V74, P3152, DOI 10.1073/pnas.74.8.3152; Robinson P.N., 2011, INTRO BIOONTOLOGIES; Spaulding A, 2011, LECT NOTES ARTIF INT, V6738, P627, DOI 10.1007/978-3-642-21869-9_128; Thompson D. W., 1917, GROWTH FORM; Walhout A.J.M., 2013, HDB SYSTEMS BIOL CON; Wren JD, 2011, BIOINFORMATICS, V27, P2025, DOI 10.1093/bioinformatics/btr327	28	22	22	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					534	538		10.1016/j.cell.2014.03.009	http://dx.doi.org/10.1016/j.cell.2014.03.009			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766803	Bronze, Green Accepted			2022-12-24	WOS:000335392100005
J	Palucka, K; Banchereau, J				Palucka, Karolina; Banchereau, Jacques			SnapShot: Cancer Vaccines	CELL			English	Editorial Material							DENDRITIC CELLS		[Palucka, Karolina] Baylor Res Inst, Baylor Inst Immunol Res, Ralph M Steinman Ctr Canc Vaccines, Dallas, TX 75204 USA; [Banchereau, Jacques] Jackson Lab, Farmington, CT 06030 USA	Baylor Scott & White Health; Baylor University Medical Center; Jackson Laboratory	Palucka, K (corresponding author), Baylor Res Inst, Baylor Inst Immunol Res, Ralph M Steinman Ctr Canc Vaccines, Dallas, TX 75204 USA.							Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Le DT, 2012, SEMIN ONCOL, V39, P311, DOI 10.1053/j.seminoncol.2012.02.008; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Sousa CRE, 2011, SEMIN IMMUNOL, V23, P1, DOI 10.1016/j.smim.2011.02.003; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	8	15	15	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					516	516		10.1016/j.cell.2014.03.044	http://dx.doi.org/10.1016/j.cell.2014.03.044			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725415	Bronze			2022-12-24	WOS:000334304500023
J	Iinuma, R; Ke, YG; Jungmann, R; Schlichthaerle, T; Woehrstein, JB; Yin, P				Iinuma, Ryosuke; Ke, Yonggang; Jungmann, Ralf; Schlichthaerle, Thomas; Woehrstein, Johannes B.; Yin, Peng			Polyhedra Self-Assembled from DNA Tripods and Characterized with 3D DNA-PAINT	SCIENCE			English	Article							SINGLE-STRANDED-DNA; SUPERRESOLUTION MICROSCOPY; NANOSTRUCTURES; MOLECULE; ORIGAMI; BINDING; DESIGN; SHAPES	DNA self-assembly has produced diverse synthetic three-dimensional polyhedra. These structures typically have a molecular weight no greater than 5 megadaltons. We report a simple, general strategy for one-step self-assembly of wireframe DNA polyhedra that are more massive than most previous structures. A stiff three-arm-junction DNA origami tile motif with precisely controlled angles and arm lengths was used for hierarchical assembly of polyhedra. We experimentally constructed a tetrahedron (20 megadaltons), a triangular prism (30 megadaltons), a cube (40 megadaltons), a pentagonal prism (50 megadaltons), and a hexagonal prism (60 megadaltons) with edge widths of 100 nanometers. The structures were visualized by means of transmission electron microscopy and three-dimensional DNA-PAINT super-resolution fluorescent microscopy of single molecules in solution.	[Iinuma, Ryosuke; Ke, Yonggang; Jungmann, Ralf; Schlichthaerle, Thomas; Woehrstein, Johannes B.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ke, Yonggang] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ke, Yonggang] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jungmann, Ralf; Woehrstein, Johannes B.; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	py@hms.harvard.edu	Jungmann, Ralf/A-6357-2015	Jungmann, Ralf/0000-0003-4607-3312; Schlichthaerle, Thomas/0000-0003-4444-2575	Office of Naval Research (ONR) [N000141110914]; ONR [N000141010827, N000141310593]; Army Research Office [W911NF1210238]; National Institutes of Health (NIH) [1DP2OD007292, 1R01EB018659, 5R21HD072481]; National Science Foundation (NSF) [CCF1054898, CCF1317291, CCF1162459, CMMI1333215]; JSR corporation; Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund; Alexander von Humboldt Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD072481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER	Office of Naval Research (ONR)(Office of Naval Research); ONR(Office of Naval Research); Army Research Office; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); JSR corporation(JSR Corporation); Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Woo and W. Shih for discussions. This work is supported by an Office of Naval Research (ONR) Young Investigator Program Award (N000141110914), ONR grants (N000141010827 and N000141310593), an Army Research Office grant (W911NF1210238), a National Institutes of Health (NIH) Director's New Innovator Award (1DP2OD007292), a NIH Transformative Research Award (1R01EB018659), a NIH grant (5R21HD072481), a National Science Foundation (NSF) Faculty Early Career Development Award (CCF1054898), a NSF Expedition in Computing Award (CCF1317291), NSF grants (CCF1162459, CMMI1333215), a gift from JSR corporation, and a Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund to P.Y. R. I. acknowledges support from JSR corporation. R.J. acknowledges support from the Alexander von Humboldt Foundation through a Feodor-Lynen Fellowship. R. I., Y.K., and R.J. contributed equally. R. I. and Y.K. designed the system, conducted the experiments, analyzed the data, and wrote the paper. R.J. designed and performed the super-resolution study, analyzed the data, and wrote the paper. T. S. and J.B.W. performed the super-resolution experiments and analyzed the data. P.Y. conceived, designed, and supervised the study; interpreted the data; and wrote the paper. All authors commented on and approved the manuscript.	Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Bhatia D, 2009, ANGEW CHEM INT EDIT, V48, P4134, DOI 10.1002/anie.200806000; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Erben CM, 2007, J AM CHEM SOC, V129, P6992, DOI 10.1021/ja071493b; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; Linko V, 2013, CURR OPIN BIOTECH, V24, P555, DOI 10.1016/j.copbio.2013.02.001; Nie Z, 2013, CHEM COMMUN, V49, P2807, DOI 10.1039/c3cc39177a; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schmied JJ, 2013, NANO LETT, V13, P781, DOI 10.1021/nl304492y; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Smith DM, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/360954; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yang H, 2009, NAT CHEM, V1, P390, DOI [10.1038/NCHEM.290, 10.1038/nchem.290]; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zimmermann J, 2008, ANGEW CHEM INT EDIT, V47, P3626, DOI 10.1002/anie.200702682	39	249	268	15	471	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					65	69		10.1126/science.1250944	http://dx.doi.org/10.1126/science.1250944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24625926	Green Accepted			2022-12-24	WOS:000333746100052
J	Katsnelson, A				Katsnelson, Alla			DRUG DEVELOPMENT The modelling challenge	NATURE			English	Editorial Material																		Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Moore H, 2013, NEUROSCI BIOBEHAV R, V37, P2087, DOI 10.1016/j.neubiorev.2013.09.011	2	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S8	S9		10.1038/508S8a	http://dx.doi.org/10.1038/508S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695336				2022-12-24	WOS:000333609900008
J	Canestrari, D; Bolopo, D; Turlings, TCJ; Roder, G; Marcos, JM; Baglione, V				Canestrari, Daniela; Bolopo, Diana; Turlings, Ted C. J.; Roeder, Gregory; Marcos, Jose M.; Baglione, Vittorio			From Parasitism to Mutualism: Unexpected Interactions Between a Cuckoo and Its Host	SCIENCE			English	Article							GREAT-SPOTTED-CUCKOOS; BROOD PARASITISM; CARRION CROWS; OUTCOMES; AGENTS; BIRDS	Avian brood parasites lay eggs in the nests of other birds, which raise the unrelated chicks and typically suffer partial or complete loss of their own brood. However, carrion crows Corvus corone corone can benefit from parasitism by the great spotted cuckoo Clamator glandarius. Parasitized nests have lower rates of predation-induced failure due to production of a repellent secretion by cuckoo chicks, but among nests that are successful, those with cuckoo chicks fledge fewer crows. The outcome of these counterbalancing effects fluctuates between parasitism and mutualism each season, depending on the intensity of predation pressure.	[Canestrari, Daniela] Univ Oviedo, Dept Biol Organisms & Syst, Oviedo, Spain; [Canestrari, Daniela] Univ Oviedo, Consejo Super Invest Cient, Unidad Mixta Invest Biodivesidad, Res Unit Biodivers, Oviedo, Spain; [Bolopo, Diana; Marcos, Jose M.; Baglione, Vittorio] Univ Valladolid, Dept Agroforestry, Valladolid, Spain; [Turlings, Ted C. J.; Roeder, Gregory] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Baglione, Vittorio] Sustainable Forest Management Res Inst, Palencia, Spain	University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Universidad de Valladolid; University of Neuchatel	Canestrari, D (corresponding author), Univ Oviedo, Dept Biol Organisms & Syst, Oviedo, Spain.	canestraridaniela@uniovi.es	Baglione, Vittorio/D-6456-2014; Bolopo, Diana/K-3413-2017; Canestrari, Daniela/F-9696-2016; Turlings, Ted CJ/E-8671-2012; Bolopo, Diana/AAU-2798-2020	Bolopo, Diana/0000-0002-7989-534X; Canestrari, Daniela/0000-0001-9112-0208; Turlings, Ted CJ/0000-0002-8315-785X; Bolopo, Diana/0000-0002-7989-534X; Baglione, Vittorio/0000-0001-8464-7861; Roder, Gregory/0000-0002-7110-294X	Spanish Plan Nacional I+D [CGL2008-01829BOS, SEJ2007-29836-E, CGL2011-27260]; Junta of Castilla y Leon [VA059A11-2]	Spanish Plan Nacional I+D; Junta of Castilla y Leon	We thank three anonymous referees for helpful comments; M. Soler for discussions; H. Robles and J. C. Seoane for statistical advice; and G. Robles, C. Nunez, and B. Gonzalez for help in the field. Funding was provided by Spanish Plan Nacional I+D (grants CGL2008-01829BOS, SEJ2007-29836-E, and CGL2011-27260) and Junta of Castilla y Leon (grant VA059A11-2) to V.B. Data are available from DRYAD (DOI:10.5061/dryad.j81r0).	Baglione V, 2005, J ANIM ECOL, V74, P842, DOI 10.1111/j.1365-2656.2005.00983.x; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Canestrari D, 2008, ANIM BEHAV, V75, P403, DOI 10.1016/j.anbehav.2007.05.005; Canestrari D, 2009, ANIM BEHAV, V77, P1337, DOI 10.1016/j.anbehav.2009.02.009; Cheney KL, 2005, BIOL LETTERS, V1, P162, DOI 10.1098/rsbl.2004.0288; Cramp S, 1994, BIRDS W PALEARTIC, VVIII; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DEREYNA LA, 1998, PARASITIC BIRDS THEI, P129; Hatchwell BJ, 1999, AM NAT, V154, P205, DOI 10.1086/303227; Kilner RM, 2011, BIOL REV, V86, P836, DOI 10.1111/j.1469-185X.2010.00173.x; Kruger O, 2011, P ROY SOC B-BIOL SCI, V278, P2777, DOI 10.1098/rspb.2010.2629; Landa A, 1997, J WILDLIFE MANAGE, V61, P510, DOI 10.2307/3802609; LEHNER PN, 1976, J WILDLIFE MANAGE, V40, P145, DOI 10.2307/3800169; SCHAFER EW, 1983, ARCH ENVIRON CON TOX, V12, P355, DOI 10.1007/BF01059413; Siepielski AM, 2007, P ROY SOC B-BIOL SCI, V274, P1799, DOI 10.1098/rspb.2007.0449; SMITH NG, 1968, NATURE, V219, P690, DOI 10.1038/219690a0; SOLER M, 1991, CONDOR, V93, P49, DOI 10.2307/1368605; SOLER M, 1994, CONDOR, V96, P802, DOI 10.2307/1369485; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler M., 2001, AVIAN SCI, V1, P1; Spottiswoode CN, 2012, EVOLUTION OF PARENTAL CARE, P226; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M	22	62	63	4	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1350	1352		10.1126/science.1249008	http://dx.doi.org/10.1126/science.1249008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653032				2022-12-24	WOS:000333108500036
J	Noronha, AM; Brozak, S				Noronha, Anne Marie; Brozak, Steve			FEATURE A 21st century nosocomial issue with endoscopes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PSEUDOMONAS-AERUGINOSA INFECTIONS; DISPOSABLE-SHEATH SYSTEM; OUTBREAKS		[Noronha, Anne Marie; Brozak, Steve] WBB Secur, Clark, NJ 07066 USA		Noronha, AM (corresponding author), WBB Secur, 67 Walnut Ave, Clark, NJ 07066 USA.	sbrozak@wbbsec.com						Aumeran C, 2011, ENDOSKOPIE HEUTE, V24, P124, DOI 10.1055/s-0030-1255647; Baker EH, 1999, LARYNGOSCOPE, V109, P636, DOI 10.1097/00005537-199904000-00022; Banerjee S, 2008, GASTROINTEST ENDOSC, V67, P781, DOI 10.1016/j.gie.2008.01.027; Bommarito M., 2013, APIC 2013 ANN C 9 JU; Carter K. C., 2005, CHILDBED FEVER SCI B; Centers for Disease Control and Prevention (CDC), 2014, NOT FIELD NEW DELH M; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P675; Cetre JC, 2005, J HOSP INFECT, V61, P39, DOI 10.1016/j.jhin.2004.12.020; Corne P, 2005, J HOSP INFECT, V61, P20, DOI 10.1016/j.jhin.2005.01.024; Department of Veterans Affairs Office of Inspector General, 2009, HEALTHC INSP FOLL CO; Emergency Care Research Institute (ECRI), 2013, 2014 TOP 10 HLTH TEC; French GL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8330; Gonzalez-Candelas F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-217; Gupta D, 2012, J BIOMED RES, V26, P241, DOI 10.7555/JBR.26.20120050; Herve R, 2013, J HOSP INFECT, V83, P22, DOI 10.1016/j.jhin.2012.08.008; Krebs A, 2007, UROLOGY, V70, P883, DOI 10.1016/j.urology.2007.06.1112; Larson JL, 2003, INFECT CONT HOSP EP, V24, P825, DOI 10.1086/502144; Lawrentschuk N, 2005, UROLOGY, V66, P1310, DOI 10.1016/j.urology.2005.06.118; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Routh CH, 1848, LANCET, V2, P642; Ryan K, 2013, WICHITA EAGLE   0716; Sabnis RB, 2014, CURR OPIN UROL, V24, P195, DOI 10.1097/MOU.0000000000000034; Seoane-Vazquez E, 2006, CURR MED RES OPIN, V22, P2007, DOI 10.1185/030079906X121048; Smiley D, 2012, MIAMI HERALD    1121; Society of Gastroenterology Nurses and Associates Inc., 2012, STAND INF CONTR REPR; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; Tosh PK, 2011, INFECT CONT HOSP EP, V32, P1179, DOI 10.1086/662712; U.K. Department of Health, 2013, CHOIC FRAM LOC POL P; Winter SCA, 2002, CLIN OTOLARYNGOL, V27, P81, DOI 10.1046/j.1365-2273.2002.00534.x	30	7	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2014	348								g2047	10.1136/bmj.g2047	http://dx.doi.org/10.1136/bmj.g2047			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7AZ	24647343				2022-12-24	WOS:000333414500010
J	Nolan, JP; Pullinger, R				Nolan, Jerry P.; Pullinger, Rick			Hypovolaemic Shock	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													Nolan, Jerry P./ABF-2561-2020	Nolan, Jerry/0000-0003-3141-3812				American College of Surgeons Committee on Trauma, 2008, ADVANCED TRAUMA LIFE; Finfer S, 2004, NEW ENGL J MED, V350, P2247; National Institute for Health and Clinical Excellence, 2004, PRE HOSPITAL INITIAT; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	4	0	1	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2014	348								g1139					13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6JC	24609389				2022-12-24	WOS:000332627300002
J	Srinivasan, V; Pierik, AJ; Lill, R				Srinivasan, Vasundara; Pierik, Antonio J.; Lill, Roland			Crystal Structures of Nucleotide-Free and Glutathione-Bound Mitochondrial ABC Transporter Atm1	SCIENCE			English	Article							LINKED SIDEROBLASTIC ANEMIA; IRON-SULFUR PROTEINS; BINDING CASSETTE TRANSPORTER; P-GLYCOPROTEIN; BIOGENESIS; MUTATION; ATAXIA; METABOLISM; MATURATION; REQUIRES	The yeast mitochondrial ABC transporter Atm1, in concert with glutathione, functions in the export of a substrate required for cytosolic-nuclear iron-sulfur protein biogenesis and cellular iron regulation. Defects in the human ortholog ABCB7 cause the sideroblastic anemia XLSA/A. Here, we report the crystal structures of free and glutathione-bound Atm1 in inward-facing, open conformations at 3.06- and 3.38-angstrom resolution, respectively. The glutathione binding site includes a residue mutated in XLSA/A and is located close to the inner membrane surface in a large cavity. The two nucleotide-free adenosine 5'-triphosphate binding domains do not interact yet are kept in close vicinity through tight interaction of the two C-terminal alpha-helices of the Atm1 dimer. The resulting protein stabilization may be a common structural feature of all ABC exporters.	[Srinivasan, Vasundara; Pierik, Antonio J.; Lill, Roland] Univ Marburg, Inst Zytobiol, D-35032 Marburg, Germany; [Srinivasan, Vasundara; Lill, Roland] LOEWE Zentrum Synthet Mikrobiol SynMikro, D-35043 Marburg, Germany; [Lill, Roland] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany	Philipps University Marburg; Max Planck Society	Srinivasan, V (corresponding author), Univ Marburg, Inst Zytobiol, Robert Koch Str 6, D-35032 Marburg, Germany.	vasundara.srinivasan@staff.uni-marburg.de; lill@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518	Deutsche Forschungsgemeinschaft [SFB 593, SFB 987, GRK 1216]; von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft; Feldberg Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft(Max Planck Society); Feldberg Foundation	We thank U. Linne for mass spectrometry, S. Freibert for help with thermophoresis, M. Stumpfig and N. Herlerth for expert technical assistance, D. C. Rees for discussion, and the beamline staff for support at the X06SA beamline, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland. R.L. acknowledges generous support from Deutsche Forschungsgemeinschaft (SFB 593, SFB 987, and GRK 1216), von Behring-Rontgen Stiftung, LOEWE program of state Hessen, Max-Planck Gesellschaft, and the Feldberg Foundation. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB accession codes 4MYC and 4MYH).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Bekri S, 2000, BLOOD, V96, P3256; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Burke MA, 2007, TRANSL RES, V150, P73, DOI 10.1016/j.trsl.2007.03.002; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; D'Hooghe M, 2012, EUR J PAEDIATR NEURO, V16, P730, DOI 10.1016/j.ejpn.2012.02.003; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Honisch U, 2003, J BACTERIOL, V185, P1895, DOI 10.1128/JB.185.6.1895-1902.2003; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; LILL R, 2003, ABC PROTEINS BACTERI, P515; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Maguire A, 2001, BRIT J HAEMATOL, V115, P910, DOI 10.1046/j.1365-2141.2001.03015.x; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nikpour M, 2013, LEUKEMIA, V27, P889, DOI 10.1038/leu.2012.298; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Qi WB, 2012, J AM CHEM SOC, V134, P10745, DOI 10.1021/ja302186j; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	39	145	148	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1137	1140		10.1126/science.1246729	http://dx.doi.org/10.1126/science.1246729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604199				2022-12-24	WOS:000332331500048
J	Reperant, LA; Kuiken, T; Grenfell, BT; Osterhaus, ADME				Reperant, Leslie A.; Kuiken, Thijs; Grenfell, Bryan T.; Osterhaus, Albert D. M. E.			The immune response and within-host emergence of pandemic influenza virus	LANCET			English	Article							DIVERSE MALARIA INFECTIONS; RESPIRATORY DROPLET; TRANSMISSION; HUMANS; COMPETITION; DYNAMICS; FERRETS	Zoonotic influenza viruses that are a few mutations away from pandemic viruses circulate in animals, and can evolve into airborne-transmissible viruses in human beings. Paradoxically, such viruses only occasionally emerge in people; the four influenza pandemics that occurred in the past 100 years were caused by zoonotic viruses that acquired efficient transmissibility. Emergence of a pandemic virus in people can happen when transmissible viruses evolve in individuals with zoonotic influenza and replicate to titres allowing transmission. We postulate that this step in the genesis of a pandemic virus only occasionally occurs in human beings, because the immune response triggered by zoonotic influenza virus also controls transmissible mutants that emerge during infection. Therefore, an impaired immune response might be needed for within-host emergence of a pandemic virus and replication to titres allowing transmission. Immunocompromised individuals-eg, those with comorbidities, of advanced age, or receiving immunosuppressive treatment-could be at increased risk of generating transmissible viruses and initiating chains of human-to-human infection.	[Reperant, Leslie A.; Kuiken, Thijs; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, NL-3000 CA Rotterdam, Netherlands; [Reperant, Leslie A.; Osterhaus, Albert D. M. E.] Artemis Res Inst One Hlth Europe, Utrecht, Netherlands; [Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Reperant, LA (corresponding author), Erasmus MC, Dept Virosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	l.reperant@erasmusmc.nl		Kuiken, Thijs/0000-0001-5501-9049; Reperant, Leslie/0000-0002-7212-1595	EU [302060, 278976, 223498]; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH, Department of Homeland Security contract [HSHQDC-12-C-00058]; Bill & Melinda Gates Foundation	EU(European Commission); RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, NIH, Department of Homeland Security contract; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank Guus Rimmelzwaan (Department of Viroscience, Erasmus Medical Centre, Netherlands), and Derek Smith and Judy Fonville (Department of Zoology, University of Cambridge, UK) for productive discussions. LAR was supported by EU FP7 Marie-Curie International Incoming Fellowship #302060; TK by EU FP7 ANTIGONE project #278976; BTG by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, NIH, Department of Homeland Security contract HSHQDC-12-C-00058, and the Bill & Melinda Gates Foundation; and ADMEO by EU FP7 EMPERIE project #223498 and EU FP7 ANTIGONE project #278976. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Cheng VCC, 2011, J INFECTION, V62, P394, DOI 10.1016/j.jinf.2011.02.007; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Reperant LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043115; Reperant LA, 2012, VACCINE, V30, P4419, DOI 10.1016/j.vaccine.2012.04.049; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Thornburg NJ, 2013, J CLIN INVEST, V123, P4405, DOI 10.1172/JCI69377; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van der Vries E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003343; Wodarz D, 2004, P ROY SOC B-BIOL SCI, V271, P1101, DOI 10.1098/rspb.2003.2664; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455	22	16	17	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2077	2081		10.1016/S0140-6736(13)62425-3	http://dx.doi.org/10.1016/S0140-6736(13)62425-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	24767965				2022-12-24	WOS:000346353600029
J	Gulland, A				Gulland, Anne			BMJ AWARDS 2014 Cancer Care Team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk						Health & Social Care Information Centre, 2012, STATISTICS ON SMOKIN	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2014	348								g2824	10.1136/bmj.g2824	http://dx.doi.org/10.1136/bmj.g2824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DI	24764571				2022-12-24	WOS:000335154900003
J	Anthes, E				Anthes, Emily			Marginal gains	NATURE			English	Editorial Material							UNITED-STATES; OBESITY; METAANALYSIS; WEIGHT; TRIAL											Daniel TO, 2013, PSYCHOL SCI, V24, P2339, DOI 10.1177/0956797613488780; Haines J, 2013, JAMA PEDIATR, V167, P1072, DOI 10.1001/jamapediatrics.2013.2356; Hampp C, 2013, PHARMACOTHERAPY, V33, P1299, DOI 10.1002/phar.1342; Hart CN, 2013, PEDIATRICS, V132, pE1473, DOI 10.1542/peds.2013-1274; Ho M, 2012, PEDIATRICS, V130, pE1647, DOI 10.1542/peds.2012-1176; Jensen MD, 2013, J AM COLL CARDIOL; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	10	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S54	S56		10.1038/508S54a	http://dx.doi.org/10.1038/508S54a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740127	Bronze			2022-12-24	WOS:000334403000004
J	Gierisch, JM; Myers, ER; Schmit, KM; Crowley, MJ; McCrory, DC; Chatterjee, R; Coeytaux, RR; Kendrick, A; Sanders, GD				Gierisch, Jennifer M.; Myers, Evan R.; Schmit, Kristine M.; Crowley, Matthew J.; McCrory, Douglas C.; Chatterjee, Ranee; Coeytaux, Remy R.; Kendrick, Amy; Sanders, Gillian D.			Prioritization of Research Addressing Management Strategies for Ductal Carcinoma In Situ	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST; THERAPY; CANCER; RISK	Ductal carcinoma in situ is a common finding in women having mammography screening, and there is considerable uncertainty about the balance of harms and benefits of different management options. This article outlines the process for developing a prioritized research agenda for the Patient-Centered Outcomes Research Institute as informed by a diverse group of stakeholders on the management of ductal carcinoma in situ. Evidence gaps were identified by reviewing existing literature and engaging diverse stakeholders to refine these gaps. Stakeholders ranked evidence gaps by importance from their perspectives using a forced-ranking prioritization method. PubMed was searched for relevant recent studies, and ClinicalTrials.gov was searched for relevant ongoing trials for the 10 highest-ranked evidence gaps. Strengths and limitations of different study designs were assessed to address gaps. Stakeholders prioritized evidence gaps related to incorporation of patient-centered outcomes into future research, development of better methods to predict risk for invasive cancer, evaluation of a strategy of active surveillance, and testing of decision-making tools. The degree to which prioritized evidence gaps may have already been addressed is uncertain because a comprehensive systematic review has not been done.	Duke Clin Res Inst, Duke Evidence Synth Grp, Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; Duke Univ, Sch Med, Durham, NC 27701 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Gierisch, JM (corresponding author), Duke Univ, Med Ctr, Dept Med, Campus Box 104427 DUMC, Durham, NC 27701 USA.	j.gierisch@dm.duke.edu	Gierisch, Jennifer/GLU-1269-2022	Kendrick, Amy/0000-0001-8769-1702; Gierisch, Jennifer/0000-0002-5057-4964	PCORI	PCORI(Patient-Centered Outcomes Research Institute - PCORI)	By a contract from PCORI.	Allegra CJ, 2010, J NATL CANCER I, V102, P161, DOI 10.1093/jnci/djp485; American Cancer Society, 2013, CANCER FACTS FIGURE; Bijker N, 2001, J CLIN ONCOL, V19, P2263, DOI 10.1200/JCO.2001.19.8.2263; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; Emdin SO, 2006, ACTA ONCOL, V45, P536, DOI 10.1080/02841860600681569; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Goodwin A, 2009, COCHRANE DATABASE SY; Ip S, 2013, FUTURE RESEARCH NEED, V13-EHC016-EF; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; National Institute for Health and Clinical Excellence, 2009, NICE CLINICAL GUIDEL, V80; National Research Council, 2013, DELIVERING HIGH QUAL; Sanders GD, 2010, FUTURE RESEARCH NEED, V11-EHC006-EF; Staley H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007847.pub2; Virnig BA, 2009, EVID REP TECHNOL ASS, P1; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482	16	27	27	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					484	+		10.7326/M13-2548	http://dx.doi.org/10.7326/M13-2548			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24567146				2022-12-24	WOS:000334093800006
J	Howard, SJ; Davies, SC				Howard, Simon J.; Davies, Sally C.			Chief medical officer urges action to tackle overweight and obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howard, Simon J.; Davies, Sally C.] Off Chief Med Officer, Dept Hlth, London, England		Howard, SJ (corresponding author), Off Chief Med Officer, Dept Hlth, London, England.	sjhoward@doctors.org.uk	Howard, Simon/I-4976-2015	Howard, Simon/0000-0002-6317-0942				[Anonymous], 2012, ECONOMIST; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Cetateanu A, 2014, HEALTH PLACE, V27, P68, DOI 10.1016/j.healthplace.2014.01.007; Davies SC, 2014, ANN REPORT CHIEF MED; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Jeffery AN, 2005, BRIT MED J, V330, P23, DOI 10.1136/bmj.38315.451539.F7; Matthews D, 2010, BBC HIST MAGAZIN FEB; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Myska S., 2013, BBC NEWS; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	11	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2014	348								g2375	10.1136/bmj.g2375	http://dx.doi.org/10.1136/bmj.g2375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LW	24677657				2022-12-24	WOS:000333587600004
J	Collins, S; Ramsay, M; Slack, MPE; Campbell, H; Flynn, S; Litt, D; Ladhani, SN				Collins, Sarah; Ramsay, Mary; Slack, Mary P. E.; Campbell, Helen; Flynn, Sally; Litt, David; Ladhani, Shamez N.			Risk of Invasive Haemophilus influenzae Infection During Pregnancy and Association With Adverse Fetal Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STREPTOCOCCUS-PNEUMONIAE; B DISEASE; ENGLAND; VACCINE; SEPSIS; BURDEN; IMPACT	IMPORTANCE Unencapsulated Haemophilus influenzae frequently causes noninvasive upper respiratory tract infections in children but can also cause invasive disease, especially in older adults. A number of studies have reported an increased incidence in neonates and suggested that pregnant women may have an increased susceptibility to invasive unencapsulated H influenzae disease. OBJECTIVE To describe the epidemiology, clinical characteristics, and outcomes of invasive H influenzae disease in women of reproductive age during a 4-year period. DESIGN, SETTING, AND PARTICIPANTS Public Health England conducts enhanced national surveillance of invasive H influenzae disease in England and Wales. Clinical questionnaires were sent prospectively to general practitioners caring for all women aged 15 to 44 years with laboratory-confirmed invasive H influenzae disease during 2009-2012, encompassing 45 215 800 woman-years of follow-up. The final outcome was assessed in June 2013. EXPOSURES Invasive H influenzae disease confirmed by positive culture from a normally sterile site. MAIN OUTCOMES AND MEASURES The primary outcome was H influenzae infection and the secondary outcomes were pregnancy-related outcomes. RESULTS In total, 171 women had laboratory-confirmed invasive H influenzae infection, which included 144 (84.2%; 95% CI, 77.9%-89.3%) with unencapsulated, 11 (6.4%; 95% CI, 3.3%-11.2%) with serotype b, and 16 (9.4%; 95% CI, 5.4%-14.7%) with other encapsulated serotypes. Questionnaire response rate was 100%. Overall, 75 of 171 women (43.9%; 95% CI, 36.3%-51.6%) were pregnant at the time of infection, most of whom were previously healthy and presented with unencapsulated H influenzae bacteremia. The incidence rate of invasive unencapsulated H influenzae disease was 17.2 (95% CI, 12.2-24.1; P < .001) times greater among pregnant women (2.98/100 000 woman-years) compared with nonpregnant women (0.17/100 000 woman-years). Unencapsulated H influenzae infection during the first 24 weeks of pregnancy was associated with fetal loss (44/47; 93.6% [95% CI, 82.5%-98.7%]) and extremely premature birth (3/47; 6.4% [95% CI, 1.3%-17.5%]). Unencapsulated H influenzae infection during the second half of pregnancy was associated with premature birth in 8 of 28 cases (28.6%; 95% CI, 13.2%-48.7%) and stillbirth in 2 of 28 cases (7.1%; 95% CI, 0.9%-23.5%). The incidence rate ratio for pregnancy loss was 2.91 (95% CI, 2.13-3.88) for all serotypes of H influenzae and 2.90 (95% CI, 2.11-3.89) for unencapsulated H influenzae compared with the background rate for pregnant women. CONCLUSIONS AND RELEVANCE Among women in England and Wales, pregnancy was associated with a greater risk of invasive H influenzae infection. These infections were associated with poor pregnancy outcomes.	[Collins, Sarah; Ramsay, Mary; Campbell, Helen; Ladhani, Shamez N.] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England; [Slack, Mary P. E.; Flynn, Sally; Litt, David] Publ Hlth England, Resp & Vaccine Preventable Bacterial Reference Un, London NW9 5EQ, England; [Ladhani, Shamez N.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England	Public Health England; Public Health England; St Georges University London	Ladhani, SN (corresponding author), Publ Hlth England, Hlth Protect Serv, Immunisat Hepatitis & Blood Safety Dept, 61 Colindale Ave, London NW9 5EQ, England.	shamez.ladhani@phe.gov.uk	; Ramsay, Mary Elizabeth/S-8281-2016	Collins, Sarah/0000-0001-9989-8794; Ladhani, Shamez/0000-0002-0856-2476; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014; Berndsen MR, 2012, CLIN MICROBIOL INFEC, V18, P918, DOI 10.1111/j.1469-0691.2011.03700.x; Calner PA, 2012, WEST J EMERG MED, V13, P133, DOI 10.5811/westjem.2011.7.6783; Cherpes Thomas L, 2002, Infect Dis Obstet Gynecol, V10, P161, DOI 10.1155/S1064744902000170; Collins S, 2013, CLIN INFECT DIS, V57, P1715, DOI 10.1093/cid/cit579; Department of Health, 2011, AB STAT; Deutscher M, 2011, CLIN INFECT DIS, V53, P114, DOI 10.1093/cid/cir325; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; Gkentzi D, 2013, J PUBLIC HEALTH-HEID, V21, P491, DOI 10.1007/s10389-013-0576-5; Gkentzi D, 2012, CURR OPIN INFECT DIS, V25, P266, DOI 10.1097/QCO.0b013e32835310a4; Heath PT, 2001, PEDIATR INFECT DIS J, V20, P300, DOI 10.1097/00006454-200103000-00016; Hoffman JA, 2003, PEDIATRICS, V112, P1095, DOI 10.1542/peds.112.5.1095; Jackson KA, 2010, EPIDEMIOL INFECT, V138, P1503, DOI 10.1017/S0950268810000294; Ladhani S, 2007, EPIDEMIOL INFECT, V135, P861, DOI 10.1017/S0950268806007382; Ladhani S, 2010, EMERG INFECT DIS, V16, P455, DOI 10.3201/eid1603.090290; Ladhani S, 2009, J INFECTION, V58, P3, DOI 10.1016/j.jinf.2008.10.007; Ladhani SN, 2013, CLIN INFECT DIS, V56, P633, DOI 10.1093/cid/cis934; Ladhani SN, 2012, EMERG INFECT DIS, V18, P725, DOI 10.3201/eid1805.111738; Martinez MA, 1999, EUR J CLIN MICROBIOL, V18, P890, DOI 10.1007/s100960050425; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Office for National Statistics, 2009, ANN TABL 5 CONC NUMB; Office for National Statistics, 2011, ANN TABL 5 CONC NUMB; Office for National Statistics, 2010, ANN TABL 5 CONC NUMB; Office for National Statistics, 1938, TABL 1 SUMM KEY LIV; Office for National Statistics, TABL B MID 1971 MID; Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000; Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089; PRIMHAK RA, 1993, ARCH DIS CHILD-FETAL, V69, P317, DOI 10.1136/adc.69.3_Spec_No.317; Public Health England, HAEM INFL ENH SURV; QUENTIN R, 1993, J CLIN MICROBIOL, V31, P1111, DOI 10.1128/JCM.31.5.1111-1116.1993; Royal College of Obstetricians and Gynaecologists, BACT SEPS PREGN; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Singh J, 2000, PEDIATR INFECT DIS J, V19, P260, DOI 10.1097/00006454-200003000-00021; Smith B, 2009, SCAND J INFECT DIS, V41, P21, DOI 10.1080/00365540802468094; TAKALA AK, 1991, ARCH DIS CHILD-FETAL, V66, P437, DOI 10.1136/adc.66.4_Spec_No.437; Trotter C L, 2003, Commun Dis Public Health, V6, P55; WALLACE RJ, 1983, REV INFECT DIS, V5, P123; Warren S, 2010, J MED MICROBIOL, V59, P370, DOI 10.1099/jmm.0.016543-0	38	31	31	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1125	1132		10.1001/jama.2014.1878	http://dx.doi.org/10.1001/jama.2014.1878			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1RC	24643602	Bronze			2022-12-24	WOS:000333010100017
J	Shetty, P				Shetty, Priya			PRODUCTION Vaccines from the East	NATURE			English	Editorial Material																		[Anonymous], 2009, CAS STUD GLOB HLTH; Bound K., 2013, CHINAS ABSORPTIVE ST; Cyranoski D, 2005, NATURE, V435, P138, DOI 10.1038/435138a; The Royal Society, 2011, KNOWL NETW NAT GLOB	4	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S12	S13		10.1038/507S12a	http://dx.doi.org/10.1038/507S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611171	Bronze			2022-12-24	WOS:000332224400006
J	Fu, Y; Lim, S; Urano, D; Tunc-Ozdemir, M; Phan, NG; Elston, TC; Jones, AM				Fu, Yan; Lim, Sungmin; Urano, Daisuke; Tunc-Ozdemir, Meral; Phan, Nguyen G.; Elston, Timothy C.; Jones, Alan M.			Reciprocal Encoding of Signal Intensity and Duration in a Glucose-Sensing Circuit	CELL			English	Article							PROTEIN-KINASE INHIBITORS; HETEROTRIMERIC G-PROTEIN; ARABIDOPSIS-THALIANA; HYPOCOTYL ELONGATION; CELL-PROLIFERATION; INFORMATION; GROWTH; ROOTS	Cells continuously adjust their behavior in response to changing environmental conditions. Both intensity and duration of external signals are critical factors in determining what response is initiated. To understand how intracellular signaling networks process such multidimensional information, we studied the AtRGS1-mediated glucose response system of Arabidopsis. By combining experiments with mathematical modeling, we discovered a reciprocal dose and duration response relying on the orchestrated action of three kinases (AtWNK1, AtWNK8, and AtWNK10) acting on distinct timescales and activation thresholds. Specifically, we find that high concentrations of D-glucose rapidly signal through AtWNK8 and AtWNK10, whereas low, sustained sugar concentration slowly activate the pathway through AtWNK1, allowing the cells to respond similarly to transient, high-intensity signals and sustained, low-intensity signals. This "dose-duration reciprocity" allows encoding of both the intensity and persistence of glucose as an important energy resource and signaling molecule.	[Fu, Yan; Lim, Sungmin; Urano, Daisuke; Tunc-Ozdemir, Meral; Phan, Nguyen G.; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Fu, Yan; Elston, Timothy C.; Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Elston, TC (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	timothy_elston@med.unc.edu; alan_jones@unc.edu	Phan, Nguyen/I-3381-2013	Phan, Nguyen/0000-0001-7662-9014; Urano, Daisuke/0000-0003-4541-1076	NIGMS [R01GM065989, R01GM079271]; NSF [MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-05er15671]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM079271] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Ariko Urano, Jing Yang, and Tony Purdue for their technical assistance and Dr. Joshua B. Kelley, Dr. Matthew Pena, Dr. Alejandro Colaneri, Dr. Susanne Wolfenstetter, and Dr. Jianping Huang for useful discussions. This work was supported by grants from the NIGMS(R01GM065989) and NSF (MCB-0718202) to A.M.J. and NIGMS (R01GM079271) to T.C.E. The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy through the grant DE-FG02-05er15671 to A.M.J. funded technical support in this study.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Booker KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012833; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen Y., 2005, FRET DATA ANAL ALGOR; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gupta A, 2012, PLANT PHYSIOL, V159, P1463, DOI 10.1104/pp.112.195776; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Lilley JLS, 2012, PLANT PHYSIOL, V160, P2261, DOI 10.1104/pp.112.205575; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Phan N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22814; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rue P, 2012, PROG BIOPHYS MOL BIO, V110, P106, DOI 10.1016/j.pbiomolbio.2012.05.003; Singhania R., 2011, THESIS VIRGINIA TECH; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Yagi YI, 2009, BIOCHEMISTRY-US, V48, P10255, DOI 10.1021/bi900666n; Zhang YQ, 2010, J PLANT PHYSIOL, V167, P1130, DOI 10.1016/j.jplph.2010.03.007	32	57	59	3	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1084	1095		10.1016/j.cell.2014.01.013	http://dx.doi.org/10.1016/j.cell.2014.01.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581502	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000332083900023
J	Stessman, HA; Bernier, R; Eichler, EE				Stessman, Holly A.; Bernier, Raphael; Eichler, Evan E.			A Genotype-First Approach to Defining the Subtypes of a Complex Disease	CELL			English	Article							DE-NOVO MUTATIONS; CLUSTER-ANALYSIS; AUTISM; CHILDREN; DISORDERS; PHENOTYPE; DISCOVERY	Medical genetics typically entails the detailed characterization of a patient's phenotypes followed by genotyping to discover the responsible gene or mutation. Here, we propose that the systematic discovery of genetic variants associated with complex diseases such as autism are progressing to a point where a reverse strategy may be fruitful in assigning the pathogenic effects of many different genes and in determining whether particular genotypes manifest as clinically recognizable phenotypes. This "genotype-first" approach for complex disease necessitates the development of large, highly integrated networks of researchers, clinicians, and patient families, with the promise of improved therapies for subsets of patients.	[Stessman, Holly A.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu		Stessman, Holly/0000-0002-0764-3493	U.S. National Institute of Mental Health (NIMH) [MH101221]; Simons Foundation Autism Research Initiative (SFARI) [303241]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Autism Research Initiative (SFARI); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in part, by U.S. National Institute of Mental Health (NIMH) grant MH101221 and by the Simons Foundation Autism Research Initiative (SFARI) 303241 to E.E.E. E.E.E. is an investigator of the Howard Hughes Medical Institute. E.E.E. is on the scientific advisory boards (SABs) of DNAnexus, Inc. and was an SAB member of Pacific Biosciences, Inc. (2009-2013) and SynapDx Corp. (2011-2013).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Bitsika V, 2008, J INTELL DISABIL RES, V52, P973, DOI 10.1111/j.1365-2788.2008.01123.x; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Charman T, 2005, J CHILD PSYCHOL PSYC, V46, P500, DOI 10.1111/j.1469-7610.2004.00377.x; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Fountain C, 2012, PEDIATRICS, V129, pE1112, DOI 10.1542/peds.2011-1601; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Johnson Helen M, 2011, Med Health R I, V94, P124; La Malfa G, 2004, J INTELL DISABIL RES, V48, P262, DOI 10.1111/j.1365-2788.2003.00567.x; Lord C, 2012, J CONSULT CLIN PSYCH, V80, P477, DOI 10.1037/a0027214; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; McGovern CW, 2005, J CHILD PSYCHOL PSYC, V46, P401, DOI 10.1111/j.1469-7610.2004.00361.x; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pellicano E, 2012, AJIDD-AM J INTELLECT, V117, P156, DOI 10.1352/1944-7558-117.2.156; PERCY A, 1990, NEUROL CLIN, V8, P659, DOI 10.1016/S0733-8619(18)30341-4; Sacco R, 2012, AUTISM RES, V5, P137, DOI 10.1002/aur.1226; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Schulze TG, 2004, HUM HERED, V58, P131, DOI 10.1159/000083539; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241	35	150	150	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					872	877		10.1016/j.cell.2014.02.002	http://dx.doi.org/10.1016/j.cell.2014.02.002			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581488	Green Accepted, Bronze			2022-12-24	WOS:000332083900006
J	Sherwood, MW; Wang, Y; Curtis, JP; Peterson, ED; Rao, SV				Sherwood, Matthew W.; Wang, Yongfei; Curtis, Jeptha P.; Peterson, Eric D.; Rao, Sunil V.			Patterns and Outcomes of Red Blood Cell Transfusion in Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; RESTRICTIVE TRANSFUSION; INCREASED MORTALITY; CRITICALLY-ILL; IMPACT; RISK; ASSOCIATION; ANEMIA; CRIT	IMPORTANCE Studies have shown variation in the use of red blood cell transfusion among patients with acute coronary syndromes. There are no definitive data for the efficacy of transfusion in improving outcomes, and concerning data exist about possible association with harm. Current transfusion practices in patients undergoing percutaneous coronary intervention (PCI) are not well understood. OBJECTIVE To determine the current patterns of blood transfusion among patients undergoing PCI and the association of transfusion with adverse cardiac outcomes across hospitals in the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of all patient visits from the CathPCI Registry from July 2009 to March 2013 that included PCI, excluding those with missing data on bleeding complications or who underwent in-hospital coronary artery bypass graft surgery (N = 2 258 711 visits). MAIN OUTCOMES AND MEASURES Transfusion rates in the overall population and by hospital (N = 1431) were the primary outcomes. The association of transfusion with myocardial infarction, stroke, and death after accounting for a patient's propensity for transfusion was also measured. RESULTS The overall rate of transfusion was 2.14% (95% CI, 2.13%-2.16%) and quarterly transfusion rates slightly declined from July 2009 to March 2013 (from 2.11% [95% CI, 2.03%-2.19%] to 2.04% [95% CI, 1.97%-2.12%]; P<.001). Patients who were more likely to receive transfusion were older (mean, 70.5 vs 64.6 years), were women (56.3% vs 32.5%), and had hypertension (86.4% vs 82.0%), diabetes (44.8% vs 34.6%), advanced renal dysfunction (8.7% vs 2.3%), prior myocardial infarction (33.0% vs 30.2%), or prior heart failure (27.0% vs 11.8%). Overall, 96.3% of sites gave a transfusion to less than 5% of patients and 3.7% of sites gave a transfusion to 5% of patients or more. Variation in hospital risk-standardized rates of transfusion persisted after adjustment, and hospitals showed variability in their transfusion thresholds. Receipt of transfusion was associated with myocardial infarction (42 803 events; 4.5% vs 1.8%; odds ratio [OR], 2.60; 95% CI, 2.57-2.63), stroke (5011 events; 2.0% vs 0.2%; OR, 7.72; 95% CI, 7.47-7.98), and in-hospital death (31 885 events; 12.5% vs 1.2%; OR, 4.63; 95% CI, 4.57-4.69), irrespective of bleeding complications. CONCLUSIONS AND RELEVANCE Among patients undergoing PCI at US hospitals, there was considerable variation in blood transfusion practices, and receipt of transfusion was associated with increased risk of in-hospital adverse cardiac events. These observational findings may warrant a randomized trial of transfusion strategies for patients undergoing PCI.	[Sherwood, Matthew W.; Peterson, Eric D.; Rao, Sunil V.] Duke Clin Res Inst, Durham, NC 27715 USA; [Wang, Yongfei; Curtis, Jeptha P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Duke University; Yale University	Sherwood, MW (corresponding author), Duke Clin Res Inst, 2400 Pratt St,POB 17969, Durham, NC 27715 USA.	matthew.sherwood@dm.duke.edu	Peterson, Eric David/ABF-5033-2021; Sherwood, Matthew/AAW-5115-2020	Sherwood, Matthew/0000-0002-4305-5883	American College of Cardiology Foundation's NCDR; American College of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007101] Funding Source: NIH RePORTER	American College of Cardiology Foundation's NCDR; American College of Cardiology(General Electric); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the American College of Cardiology Foundation's NCDR. The analytic work for this investigator-initiated study was performed by the Yale Center for Outcomes Research, with financial support from the American College of Cardiology.	Aronson D, 2008, AM J CARDIOL, V102, P115, DOI 10.1016/j.amjcard.2008.03.027; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Chatterjee S, 2013, JAMA INTERN MED, V173, P132, DOI 10.1001/2013.jamainternmed.1001; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Freudenberger Ronald S, 2003, Curr Opin Crit Care, V9, P356, DOI 10.1097/00075198-200310000-00004; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HILL SR, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002042.PUB2; Jolicoeur EM, 2009, EUR HEART J, V30, P2575, DOI 10.1093/eurheartj/ehp279; Marso SP, 2010, JAMA-J AM MED ASSOC, V303, P2156, DOI 10.1001/jama.2010.708; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Moscucci M, 1998, AM J CARDIOL, V81, P702, DOI 10.1016/S0002-9149(97)01018-7; Moussa I, 2013, HEART, V99, P297, DOI 10.1136/heartjnl-2012-303379; Nikolsky E, 2009, JACC-CARDIOVASC INTE, V2, P624, DOI 10.1016/j.jcin.2009.05.004; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Pilgrim T, 2012, CIRC-CARDIOVASC INTE, V5, P202, DOI 10.1161/CIRCINTERVENTIONS.111.965749; Rao SV, 2007, EUR HEART J, V28, P1193, DOI 10.1093/eurheartj/ehm019; Rao SV, 2010, AM HEART J, V159, P710, DOI 10.1016/j.ahj.2010.02.017; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Shishehbor MH, 2009, JACC-CARDIOVASC INTE, V2, P46, DOI 10.1016/j.jcin.2008.09.011; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Yang G, 2005, J AM COLL CARDIOL, V46, P1490, DOI 10.1016/j.jacc.2005.06.072	28	59	61	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					836	843		10.1001/jama.2014.980	http://dx.doi.org/10.1001/jama.2014.980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570247	Green Accepted, Bronze			2022-12-24	WOS:000331793700023
J	Reyes-Fox, M; Steltzer, H; Trlica, MJ; McMaster, GS; Andales, AA; LeCain, DR; Morgan, JA				Reyes-Fox, Melissa; Steltzer, Heidi; Trlica, M. J.; McMaster, Gregory S.; Andales, Allan A.; LeCain, Dan R.; Morgan, Jack A.			Elevated CO2 further lengthens growing season under warming conditions	NATURE			English	Article							CLIMATE-CHANGE; FLOWERING TIME; CARBON-DIOXIDE; PHENOLOGY; GRASSLAND; RESPONSES; PLANTS	Observations of a longer growing season through earlier plant growth in temperate to polar regions have been thought to be a response to climate warming(1-5). However, data from experimental warming studies indicate that many species that initiate leaf growth and flowering earlier also reach seed maturation and senesce earlier, shortening their active and reproductive periods(6-10). A conceptual model to explain this apparent contradiction(11), and an analysis of the effect of elevated CO2-which can delay annual life cycle events(12-14)-on changing season length, have not been tested. Here we show that experimental warming in a temperate grassland led to a longer growing season through earlier leaf emergence by the first species to leaf, often a grass, and constant or delayed senescence by other species that were the last to senesce, supporting the conceptual model. Elevated CO2 further extended growing, but not reproductive, season length in the warmed grassland by conserving water, which enabled most species to remain active longer. Our results suggest that a longer growing season, especially in years or biomes where water is a limiting factor, is not due to warming alone, but also to higher atmospheric CO2 concentrations that extend the active period of plant annual life cycles.	[Reyes-Fox, Melissa] ARS, USDA, Soil Plant Nutrient Res Unit, Ft Collins, CO 80526 USA; [Reyes-Fox, Melissa; McMaster, Gregory S.] Northern Plains Area, Ft Collins, CO 80526 USA; [Steltzer, Heidi] Ft Lewis Coll, Dept Biol, Durango, CO 81301 USA; [Trlica, M. J.] Colorado State Univ, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA; [McMaster, Gregory S.] ARS, USDA, Agr Syst Res Unit, Ft Collins, CO 80526 USA; [Andales, Allan A.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; [LeCain, Dan R.; Morgan, Jack A.] ARS, USDA, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA); Colorado State University; United States Department of Agriculture (USDA); Colorado State University; United States Department of Agriculture (USDA)	Steltzer, H (corresponding author), Ft Lewis Coll, Dept Biol, Durango, CO 81301 USA.	Melissa.reyes@ars.usda.gov; steltzer_h@fortlewis.edu	Andales, Allan A/M-8328-2013		US Department of Agriculture Agricultural Research Center (USDA-ARS) Climate Change, Soils & Emissions Program; US Department of Energy's Office of Science through the Terrestrial Ecosystem Science Program; National Science Foundation (DEB) [1021559]; Colorado State University; Direct For Biological Sciences [1021559] Funding Source: National Science Foundation	US Department of Agriculture Agricultural Research Center (USDA-ARS) Climate Change, Soils & Emissions Program; US Department of Energy's Office of Science through the Terrestrial Ecosystem Science Program; National Science Foundation (DEB)(National Science Foundation (NSF)); Colorado State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The following individuals contributed to the installation and maintenance of the Prairie Heating and CO<INF>2</INF> Enrichment (PHACE) project: D. Smith, D. Blumenthal, E. Pendall, E. Hardy, L. Griffith, A. Hansen, K. Corp, V. Banuelos, G. Tinnin, M. West, C. Brooks, M. Busick, D. Milchunas, G. Dunn and L. Ahuja. Funding for this work was supported by the US Department of Agriculture Agricultural Research Center (USDA-ARS) Climate Change, Soils & Emissions Program, by the US Department of Energy's Office of Science through the Terrestrial Ecosystem Science Program, by the National Science Foundation (DEB no. 1021559) and by Colorado State University. D. Inouye provided comments that improved the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Aldridge G, 2011, J ECOL, V99, P905, DOI 10.1111/j.1365-2745.2011.01826.x; Ball JT., 1987, PROGR PHOTOSYNTHESIS, P221; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Fay PA, 2012, NAT CLIM CHANGE, V2, P742, DOI [10.1038/nclimate1573, 10.1038/NCLIMATE1573]; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Hoffmann AA, 2010, J ECOL, V98, P927, DOI 10.1111/j.1365-2745.2010.01667.x; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Hovenden MJ, 2008, NEW PHYTOL, V178, P815, DOI 10.1111/j.1469-8137.2008.02419.x; Hoye TT, 2013, NAT CLIM CHANGE, V3, P759, DOI [10.1038/nclimate1909, 10.1038/NCLIMATE1909]; Kim Y, 2012, REMOTE SENS ENVIRON, V121, P472, DOI 10.1016/j.rse.2012.02.014; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Post ES, 2008, ECOLOGY, V89, P363, DOI 10.1890/06-2138.1; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Springer CJ, 2007, NEW PHYTOL, V176, P243, DOI 10.1111/j.1469-8137.2007.02196.x; Steltzer H, 2009, SCIENCE, V324, P886, DOI 10.1126/science.1171542; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100	27	114	121	6	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					259	+		10.1038/nature13207	http://dx.doi.org/10.1038/nature13207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24759322	Green Published			2022-12-24	WOS:000337032400048
J	Adli, M; Hegerl, U				Adli, Mazda; Hegerl, Ulrich			Do we underestimate the benefits of antidepressants?	LANCET			English	Editorial Material							INITIAL SEVERITY; DEPRESSION; EFFICACY; METAANALYSIS		[Adli, Mazda] Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany; [Adli, Mazda] Fliedner Klin Berlin, D-10117 Berlin, Germany; [Hegerl, Ulrich] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Adli, M (corresponding author), Charite, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany.	mazda.adli@charite.de	Adli, Mazda/GYV-2083-2022	Hegerl, Ulrich/0000-0002-3039-7470				Cuijpers P, 2012, CLIN PSYCHOL REV, V32, P280, DOI 10.1016/j.cpr.2012.01.003; Fountoulakis KN, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-26; Guideline Group Unipolar Depression, 2009, S3 GUIDELINE NATIONA; Hegerl U, 2012, J AFFECT DISORDERS, V138, P183, DOI 10.1016/j.jad.2011.05.015; Hegerl U, 2010, INT J NEUROPSYCHOPH, V13, P31, DOI 10.1017/S1461145709000224; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kleinman A, 2012, LANCET, V379, P608, DOI 10.1016/S0140-6736(12)60258-X; Kobak KA, 2010, J CLIN PSYCHOPHARM, V30, P193, DOI 10.1097/JCP.0b013e3181d20912; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; NICE, 2004, CLINICAL PRACTICE GU; NICE, 2009, NATIONAL CLINICAL PR, V90	11	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1361	1362		10.1016/S0140-6736(14)60534-1	http://dx.doi.org/10.1016/S0140-6736(14)60534-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3LI	24759238				2022-12-24	WOS:000335318400004
J	Miller, MS; Palese, P				Miller, Matthew S.; Palese, Peter			Peering into the Crystal Ball: Influenza Pandemics and Vaccine Efficacy	CELL			English	Article							ANTIBODY-RESPONSES; SYSTEMS BIOLOGY; VIRUS VACCINES; HUMANS; TRANSMISSION; IMMUNIZATION; PATTERNS; H5N1; HA	The looming threat of a new influenza virus pandemic has fueled ambitious efforts to devise more predictive parameters for assessing the risks associated with emergent virus strains. At the same time, a comprehensive understanding of critical factors that can accurately predict the outcome of vaccination is sorely needed in order to improve the effectiveness of influenza virus vaccines. Will new studies aimed at identifying adaptations required for virus transmissibility and systems-level analyses of influenza virus vaccine responses provide an improved framework for predictive models of viral adaptation and vaccine efficacy?	[Miller, Matthew S.; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, Div Infect Dis, New York, NY 10029 USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Miller, MS (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, Div Infect Dis, New York, NY 10029 USA.	matthew.miller@mssm.edu; peter.palese@mssm.edu		Miller, Matthew/0000-0003-3426-5069; Palese, Peter/0000-0002-0337-5823	Canadian Institutes of Health Research Postdoctoral Fellowship; NIH [P01 AI097092-01, HHSN266200700010C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We apologize to our colleagues whose work could not be cited due to space limitations. M.S.M. is supported, in part, by a Canadian Institutes of Health Research Postdoctoral Fellowship. P.P. is supported, in part, by NIH P01 AI097092-01 and HHSN266200700010C.	Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Krammer F, 2014, NAT IMMUNOL, V15, P3, DOI 10.1038/ni.2761; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Stern AM, 2005, HEALTH AFFAIR, V24, P611, DOI 10.1377/hlthaff.24.3.611; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Wolinetz CD, 2012, SCIENCE, V336, P1525, DOI 10.1126/science.1223995; Zaraket H, 2013, J VIROL, V87, P4826, DOI 10.1128/JVI.03110-12	23	20	21	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					294	299		10.1016/j.cell.2014.03.023	http://dx.doi.org/10.1016/j.cell.2014.03.023			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725400	Bronze			2022-12-24	WOS:000334304500005
J	Herbert, N; George, A; Masham Ilton; Sharma, V; Oliver, M; Oxley, A; Raviglione, M; Zumla, AI				Herbert, Nick; George, Andrew; Baroness Masham of Ilton; Sharma, Virendra; Oliver, Matt; Oxley, Aaron; Raviglione, Mario; Zumla, Alimuddin I.			World TB Day 2014: finding the missing 3 million	LANCET			English	Editorial Material							MTB/RIF ASSAY; TUBERCULOSIS		[Herbert, Nick; George, Andrew; Sharma, Virendra] Houses Parliament, All Party Parliamentary Grp Global TB, London, England; [Oliver, Matt; Oxley, Aaron] RESULTS UK, London, England; [Raviglione, Mario] WHO, Global TB Dept, CH-1211 Geneva, Switzerland; [Zumla, Alimuddin I.] UCL, Div Infect & Immun, UCL Royal Free Campus, London NW3 2PF, England; [Zumla, Alimuddin I.] UCL Hosp NHS Fdn Trust, London NW3 2PF, England	World Health Organization; University of London; University College London; University of London; University College London	Zumla, AI (corresponding author), UCL, Div Infect & Immun, UCL Royal Free Campus, London NW3 2PF, England.		ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; RAVIGLIONE, Mario/0000-0002-9331-2067				Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Bates M, 2013, TROP MED INT HEALTH, V18, P1134, DOI 10.1111/tmi.12145; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; O'Grady J, 2012, CLIN INFECT DIS, V55, P1171, DOI 10.1093/cid/cis631; Pietersen E, 2014, LANCET, V383, P1230, DOI 10.1016/S0140-6736(13)62675-6; Raviglione M, 2013, 3 STOP TB PARTN COOR; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	12	42	43	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1016	1018		10.1016/S0140-6736(14)60422-0	http://dx.doi.org/10.1016/S0140-6736(14)60422-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24656187				2022-12-24	WOS:000333521200005
J	Deschene, ER; Myung, P; Rompolas, P; Zito, G; Sun, TY; Taketo, MM; Saotome, I; Greco, V				Deschene, Elizabeth R.; Myung, Peggy; Rompolas, Panteleimon; Zito, Giovanni; Sun, Thomas Yang; Taketo, Makoto M.; Saotome, Ichiko; Greco, Valentina			beta-Catenin Activation Regulates Tissue Growth Non-Cell Autonomously in the Hair Stem Cell Niche	SCIENCE			English	Article							FOLLICLE MORPHOGENESIS; TRANSIENT ACTIVATION; EMBRYONIC EPIDERMIS; MAINTENANCE; INITIATION; RENEWAL; PHASE; CYCLE	Wnt/beta-catenin signaling is critical for tissue regeneration. However, it is unclear how beta-catenin controls stem cell behaviors to coordinate organized growth. Using live imaging, we show that activation of beta-catenin specifically within mouse hair follicle stem cells generates new hair growth through oriented cell divisions and cellular displacement. beta-Catenin activation is sufficient to induce hair growth independently of mesenchymal dermal papilla niche signals normally required for hair regeneration. Wild-type cells are co-opted into new hair growths by beta-catenin mutant cells, which non-cell autonomously activate Wnt signaling within the neighboring wild-type cells via Wnt ligands. This study demonstrates a mechanism by which Wnt/beta-catenin signaling controls stem cell-dependent tissue growth non-cell autonomously and advances our understanding of the mechanisms that drive coordinated regeneration.	[Deschene, Elizabeth R.; Rompolas, Panteleimon; Zito, Giovanni; Sun, Thomas Yang; Saotome, Ichiko; Greco, Valentina] Yale Univ, Dept Genet, Yale Stem Cell Ctr, Yale Canc Ctr,Sch Med, New Haven, CT 06510 USA; [Myung, Peggy; Greco, Valentina] Yale Univ, Dept Dermatol, Sch Med, New Haven, CT 06510 USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Yale University; Yale University; Kyoto University	Greco, V (corresponding author), Yale Univ, Dept Genet, Yale Stem Cell Ctr, Yale Canc Ctr,Sch Med, New Haven, CT 06510 USA.	valentina.greco@yale.edu	, Zito/O-3836-2019; Sun, Thomas/AAG-4824-2020; Zito, Giovanni/AAC-3639-2022	, Zito/0000-0002-0482-6729; Sun, Thomas Yang/0000-0001-7436-0138; Rompolas, Panteleimon/0000-0001-9135-7651	American Cancer Society [RSG-12-059-02]; Yale Spore Grant National Cancer Institute, NIH [2P50CA121974]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [1R01AR063663-01]; Yale Stem Cell Center Lo Fellowship; NIH Predoctoral Program in Cellular and Molecular Biology [TG32 GM007223]; CT Innovations [13-SCA-YALE-20]; Rheumatic Diseases Research Core Centers [5 P30 AR053495-07]; NATIONAL CANCER INSTITUTE [P50CA121974, P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR066790, R01AR063663, P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Yale Spore Grant National Cancer Institute, NIH; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Yale Stem Cell Center Lo Fellowship; NIH Predoctoral Program in Cellular and Molecular Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CT Innovations; Rheumatic Diseases Research Core Centers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ito, J. Lim, K. Politi, A. Habermann, and D. Gonzalez for insights and equipment; E. Fuchs for the K14 Delta N beta-catenin construct and K14-H2B-GFP;Lef1-RFP mice; and G. Gu for K19Cre<SUP>ER</SUP> and M. Taketo for beta-catn<SUP>flox(Ex3)/+</SUP> mice. This work is supported by grants to V.G. by the American Cancer Society, grant no. RSG-12-059-02; Yale Spore Grant National Cancer Institute, NIH, grant no. 2P50CA121974; and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, grant no. 1R01AR063663-01. E.D. was supported by the Yale Stem Cell Center Lo Fellowship and the NIH Predoctoral Program in Cellular and Molecular Biology, grant no. TG32 GM007223. P.R. and G.Z. are New York Stem Cell Foundation-Druckenmiller Fellows. P.R. is supported by the CT Innovations, grant no. 13-SCA-YALE-20. Intravital microscopy was done in the In Vivo Imaging Facility at Yale School of Medicine supported by the Rheumatic Diseases Research Core Centers, grant no. 5 P30 AR053495-07. K14-H2B-GFP;Lef1-RFP mice and the K14 Delta N beta-catenin construct are available from E. Fuchs under a material transfer agreement with Rockefeller University. beta-catn<SUP>flox(Ex3)/+</SUP> mice are available from M. Taketo under a material transfer agreement with Banyu-Merck. We declare no conflict of interest.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Baker CM, 2010, DEV BIOL, V343, P40, DOI 10.1016/j.ydbio.2010.04.005; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chi WY, 2010, J INVEST DERMATOL, V130, P2664, DOI 10.1038/jid.2010.176; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DasGupta R, 2002, J CELL BIOL, V158, P331, DOI 10.1083/jcb.200204134; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Myung PS, 2013, J INVEST DERMATOL, V133, P31, DOI 10.1038/jid.2012.230; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rompolas P., 2013, SEMIN CELL DEV BIOL, V2013; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Tortelote GG, 2013, DEV BIOL, V374, P164, DOI 10.1016/j.ydbio.2012.10.013; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459	30	82	83	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1353	1356		10.1126/science.1248373	http://dx.doi.org/10.1126/science.1248373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653033	Green Accepted, Green Published			2022-12-24	WOS:000333108500037
J	Murray, TH				Murray, Thomas H.			Stirring the Simmering "Designer Baby" Pot	SCIENCE			English	Editorial Material							PREIMPLANTATION GENETIC DIAGNOSIS; POLICY		[Murray, Thomas H.] Hastings Ctr, Garrison, NY USA; [Murray, Thomas H.] Natl Univ Singapore, Ctr Biomed Eth, Singapore 117597, Singapore	National University of Singapore	Murray, TH (corresponding author), Hastings Ctr, Garrison, NY USA.	murrayt@thehastingscenter.org						Baruch S, 2008, FERTIL STERIL, V89, P1053, DOI 10.1016/j.fertnstert.2007.05.048; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Committee on Ethics American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V109, P475; Ethics Comm Amer Soc Reprod Med, 2001, FERTIL STERIL, V75, P861; Ethics Committee of the American Society for Reproduc- tive Medicine, 2013, FERTIL STERIL, V100, P54; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Glover Jonathan, 2007, CHOOSING CHILDREN GE; Gregg A. R., 2013, J AM COLL MED GENET, V15, P395; Hudson KL, 2006, FERTIL STERIL, V85, P1638, DOI 10.1016/j.fertnstert.2006.01.014; Human Fertilisation and Embryology Authority, 2003, SEX SELECTION OPTION; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Murray T. H., 1996, THE WORTH OF A CHILD; Robertson JA, 2003, J MED ETHICS, V29, P213, DOI 10.1136/jme.29.4.213; STEINBOCK B, 1994, HASTINGS CENT REP, V24, P15; Wojcick A., 2013, U.S. Patent, Patent No. [8,543,339, 8543339]	15	7	8	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1208	1210		10.1126/science.1248080	http://dx.doi.org/10.1126/science.1248080			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626919				2022-12-24	WOS:000332728500024
J	Scully, T				Scully, Tony			THE AGE OF VACCINES	NATURE			English	Editorial Material																			0	9	9	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S2	S3		10.1038/507S2a	http://dx.doi.org/10.1038/507S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611167	Bronze			2022-12-24	WOS:000332224400002
J	Mailankody, S; Prasad, V				Mailankody, Sham; Prasad, Vinay			Comparative Effectiveness Questions in Oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INCREASED SURVIVAL; PROSTATE-CANCER		[Mailankody, Sham; Prasad, Vinay] NCI, Med Oncol Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mailankody, S (corresponding author), NCI, Med Oncol Serv, Bethesda, MD 20892 USA.			Prasad, Vinayak/0000-0002-6110-8221				De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Experts in Chronic Myeloid Leukemia, 2013, BLOOD, V121, P4439; Hall S. S., 2013, NEW YORK MAGAZINE; Small EJ, 2004, J CLIN ONCOL, V22, P1025, DOI 10.1200/JCO.2004.06.037; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	5	34	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1478	1481		10.1056/NEJMp1400104	http://dx.doi.org/10.1056/NEJMp1400104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF3HE	24738667				2022-12-24	WOS:000334601600004
J	Sarpatwari, A; Avorn, J; Kesselheim, AS				Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			Using a Drug-Safety Tool to Prevent Competition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sarpatwari, Ameet] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Regulations.gov, 2013, Prometheus Laboratories Inc.-citizen petition, Patent No. 7141018; Thomas Katie, 2013, NY TIMES, pB1	2	24	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1476	1478		10.1056/NEJMp1400488	http://dx.doi.org/10.1056/NEJMp1400488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF3HE	24738666				2022-12-24	WOS:000334601600003
J	Bhandari, N				Bhandari, Neena			INFECTIOUS DISEASE After eradication: India's post-polio problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												neena@india-voice.com						[Anonymous], 2010, TIMES INDIA; Chan M, 2014, WHO DIRECTOR GEN CEL; HALSTEAD LS, 1985, ORTHOPEDICS, V8, P845; March of Dimes, 2000, MARCH DIMES, P9; March of Dimes Steering Committee on Post-Polio Syndrome, 2002, MARCH DIM INT C POST; Ministry of Health and Family Welfare Government of India, 2011, POL ER IND PROGR CUR; National Institute of Neurological Disorders and Stroke, 2012, NIH PUBLICATION; Raymond M, 1875, COMPTES RENDUS SOC B, V127, P158; UNICEF, 2012, 200 000 ZER JOURN PO	9	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2275	10.1136/bmj.g2275	http://dx.doi.org/10.1136/bmj.g2275			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TK	24687315				2022-12-24	WOS:000333976100004
J	Rothberg, MB; Pekow, PS; Priya, A; Lindenauer, PK				Rothberg, Michael B.; Pekow, Penelope S.; Priya, Aruna; Lindenauer, Peter K.			Variation in Diagnostic Coding of Patients With Pneumonia and Its Association With Hospital Risk-Standardized Mortality Rates A Cross-sectional Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							COMORBIDITY MEASURES; ACUTE EXACERBATIONS; PERFORMANCE; MODELS; CARE	Background: Most U.S. hospitals publicly report 30-day risk-standardized mortality rates for pneumonia. Rates exclude severe cases, which may be assigned a secondary diagnosis of pneumonia and a principal diagnosis of sepsis or respiratory failure. By assigning sepsis and respiratory failure codes more liberally, hospitals might improve their reported performance. Objective: To examine the effect of the definition of pneumonia on hospital mortality rates. Design: Cross-sectional study. Setting: 329 U. S. hospitals. Patients: Adults hospitalized for pneumonia (as a principal diagnosis or secondary diagnosis paired with a principal diagnosis of sepsis or respiratory failure) between 2007 and 2010. Measurements: Proportion of patients with pneumonia coded with a principal diagnosis of sepsis or respiratory failure and risk-standardized mortality rates excluding versus including a principal diagnosis of sepsis or respiratory failure. Results: When the definition of pneumonia was limited to patients with a principal diagnosis of pneumonia, the risk-standardized mortality rate was significantly better than the mean in 4.3% of hospitals and significantly worse in 6.4%. When the definition was broadened to include patients with a principal diagnosis of sepsis or respiratory failure, this rate was better than the mean in 11.9% of hospitals and worse in 22.8% and the outlier status of 28.3% of hospitals changed. Among hospitals in the highest quintile of proportion of patients coded with a principal diagnosis of sepsis or respiratory failure, outlier status under the broader definition improved in 7.6% and worsened in 40.9%. Among those in the lowest quintile, 20.0% improved and none worsened. Limitation: Only inpatient mortality was studied. Conclusion: Variation in use of the principal diagnosis of sepsis or respiratory failure may bias efforts to compare hospital performance regarding pneumonia outcomes.	Cleveland Clin, Inst Med, Cleveland, OH 44195 USA; Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Massachusetts, Amherst, MA 01003 USA	Cleveland Clinic Foundation; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Rothberg, MB (corresponding author), Cleveland Clin, Dept Med, Inst Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	rothbem@ccf.org			Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018723] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	[Anonymous], 1985, Fed Regist, V50, P31038; Borzecki AM, 2010, MED CARE, V48, P1117, DOI 10.1097/MLR.0b013e3181ef9d53; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Disease Control and Prevention, 2011, ICD 9 CM OFF GUID CO; Centers for Medicare & Medicaid Services, 2012, 30 DAY DEATH READM M; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ettinger WH, 2008, AM J MED QUAL, V23, P90, DOI 10.1177/1062860607313141; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Goldman LE, 2011, HEALTH SERV RES, V46, P1946, DOI 10.1111/j.1475-6773.2011.01300.x; Krumholz H, 2007, RISK ADJUSTMENT MODE; Kupfer JM, 2013, JAMA-J AM MED ASSOC, V309, P2213, DOI 10.1001/jama.2013.5009; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Rahn Ada C, 2011, Med Econ, V88, P26; Rothberg MB, 2010, JAMA-J AM MED ASSOC, V303, P2035, DOI 10.1001/jama.2010.672; Ryan AM, 2009, INQUIRY-J HEALTH CAR, V46, P274, DOI 10.5034/inquiryjrnl_46.03.274; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	19	48	49	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 18	2014	160	6					380	+		10.7326/M13-1419	http://dx.doi.org/10.7326/M13-1419			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MW	24723078	Green Accepted			2022-12-24	WOS:000333521300014
J	Beuschlein, F; Fassnacht, M; Assie, G; Calebiro, D; Stratakis, CA; Osswald, A; Ronchi, CL; Wieland, T; Sbiera, S; Faucz, FR; Schaak, K; Schmittfull, A; Schwarzmayr, T; Barreau, O; Vezzosi, D; Rizk-Rabin, M; Zabel, U; Szarek, E; Salpea, P; Forlino, A; Vetro, A; Zuffardi, O; Kisker, C; Diener, S; Meitinger, T; Lohse, MJ; Reincke, M; Bertherat, J; Strom, TM; Allolio, B				Beuschlein, Felix; Fassnacht, Martin; Assie, Guillaume; Calebiro, Davide; Stratakis, Constantine A.; Osswald, Andrea; Ronchi, Cristina L.; Wieland, Thomas; Sbiera, Silviu; Faucz, Fabio R.; Schaak, Katrin; Schmittfull, Anett; Schwarzmayr, Thomas; Barreau, Olivia; Vezzosi, Delphine; Rizk-Rabin, Marthe; Zabel, Ulrike; Szarek, Eva; Salpea, Paraskevi; Forlino, Antonella; Vetro, Annalisa; Zuffardi, Orsetta; Kisker, Caroline; Diener, Susanne; Meitinger, Thomas; Lohse, Martin J.; Reincke, Martin; Bertherat, Jerome; Strom, Tim M.; Allolio, Bruno			Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEIN-KINASE-A; ADRENOCORTICAL TUMORS; REGULATORY SUBUNIT; SOMATIC MUTATIONS; CARNEY COMPLEX; GENE; HYPERPLASIA; EXPRESSION; MANAGEMENT; RECEPTOR	BackgroundCorticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. MethodsWe performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. ResultsExome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617AC in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. ConclusionsGenetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.) Corticotropin-independent Cushing's syndrome occurs with adrenocortical tumors or hyperplasia. The authors report that germline duplications of PRKACA lead to bilateral adrenal hyperplasia, whereas somatic mutations lead to unilateral cortisol-producing adrenal adenomas. Endogenous hypercortisolism, referred to as Cushing's syndrome, is associated with substantial morbidity and mortality.(1) When Cushing's syndrome is severe, patients have catabolic symptoms such as muscle weakness, skin fragility, osteoporosis, and severe metabolic sequelae.(2) Hypersecretion of cortisol can be driven by an excess of pituitary or ectopic corticotropin or can be due to adrenocortical tumors or hyperplasias with corticotropin-independent cortisol production. Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing's syndrome, some degree of cortisol excess is present, ...	[Beuschlein, Felix; Fassnacht, Martin; Osswald, Andrea; Sbiera, Silviu; Schaak, Katrin; Reincke, Martin] Univ Munich, Med Klin & Poliklin IV, Munich, Germany; [Meitinger, Thomas; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Meitinger, Thomas; Strom, Tim M.] Munich Heart Alliance, Deutsch Zentrum Herz Kreislauf Forsch, Munich, Germany; [Fassnacht, Martin; Sbiera, Silviu; Allolio, Bruno] Univ Wurzburg, Dept Med 1, Endocrine & Diabet Unit, Univ Hosp, D-97070 Wurzburg, Germany; [Fassnacht, Martin; Lohse, Martin J.; Allolio, Bruno] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Calebiro, Davide; Zabel, Ulrike; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Calebiro, Davide; Kisker, Caroline; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Calebiro, Davide; Kisker, Caroline; Lohse, Martin J.] Univ Wurzburg, Deutsch Forschungsgemeinschaft Res Ctr Expt Biome, D-97070 Wurzburg, Germany; [Ronchi, Cristina L.] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Wieland, Thomas; Schmittfull, Anett; Schwarzmayr, Thomas; Diener, Susanne; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Assie, Guillaume; Barreau, Olivia; Vezzosi, Delphine; Rizk-Rabin, Marthe; Bertherat, Jerome] Univ Paris 05, Ctr Natl Rech Scientif, Unit Mixte Rech 8104, INSERM Unite 1016,Inst Cochin,Fac Med,Sorbonne Pa, Paris, France; [Assie, Guillaume; Barreau, Olivia; Bertherat, Jerome] Hop Cochin, Assistance Publique Hop Paris, Referral Ctr Rare Adrenal Dis, Dept Endocrinol, F-75674 Paris, France; [Stratakis, Constantine A.; Faucz, Fabio R.; Szarek, Eva; Salpea, Paraskevi] NICHHD, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Forlino, Antonella; Zuffardi, Orsetta] Univ Pavia, Dipartimento Med Mol, I-27100 Pavia, Italy; [Vetro, Annalisa] Policlin San Matteo, Fdn Ist Ricovoro & Cura Carattere Sci, Biotechnol Res Lab, I-27100 Pavia, Italy	University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pavia; IRCCS Fondazione San Matteo	Fassnacht, M (corresponding author), Univ Hosp Wurzburg, Dept Med 1, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany.	fassnacht_m@ukw.de	Sbiera, Silviu/E-8128-2019; Kisker, Caroline/T-1724-2019; Vetro, Annalisa/J-8203-2018; Fassnacht, Martin/N-9614-2019; Faucz, Fabio R/C-1607-2009; Forlino, Antonella/H-5385-2015; Stratakis, Constantine/AAP-4745-2020; vezzosi, delphine/G-2734-2017; Meitinger, Thomas/O-1318-2015; Lohse, Martin J/A-7160-2012; Rizk-Rabin, Marthe/A-1698-2018	Sbiera, Silviu/0000-0002-6271-5533; Vetro, Annalisa/0000-0003-2437-7526; Fassnacht, Martin/0000-0001-6170-6398; Forlino, Antonella/0000-0002-6385-1182; Lohse, Martin J/0000-0002-0599-3510; Faucz, Fabio/0000-0001-7959-9842; Meitinger, Thomas/0000-0002-8838-8403; zuffardi, orsetta/0000-0002-1466-4559; calebiro, davide/0000-0002-3811-1553; Beuschlein, Felix/0000-0001-7826-3984; Kisker, Caroline/0000-0002-0216-6026; Ronchi, Cristina/0000-0001-5020-2071; Rizk-Rabin, Marthe/0000-0003-1558-737X; BERTHERAT, Jerome/0000-0003-2551-3008; Assie, Guillaume/0000-0001-9590-0906	European Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the European Commission Seventh Framework Program and others.	Bertherat J, 2003, CANCER RES, V63, P5308; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Bimpaki EI, 2009, EUR J ENDOCRINOL, V161, P153, DOI 10.1530/EJE-09-0027; Bonaglia MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002173; Bonnet S, 2011, J CLIN ENDOCR METAB, V96, pE419, DOI 10.1210/jc.2010-1885; Calebiro D, 2006, MOL ENDOCRINOL, V20, P3196, DOI 10.1210/me.2005-0493; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Carney JA, 2011, AM J SURG PATHOL, V35, P1311, DOI 10.1097/PAS.0b013e31821ec4ce; Collier LS, 2004, GENETICS, V167, P783, DOI 10.1534/genetics.103.024992; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Herbst KJ, 2011, MOL CELL BIOL, V31, P4063, DOI 10.1128/MCB.05459-11; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Horvath A, 2010, HUM MUTAT, V31, P369, DOI 10.1002/humu.21178; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Kobayashi H, 2000, ENDOCR J, V47, P461, DOI 10.1507/endocrj.47.461; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 1999, NEW ENGL J MED, V341, P1577, DOI 10.1056/NEJM199911183412104; Lacroix A, 2010, CLIN ENDOCRINOL, V73, P1, DOI 10.1111/j.1365-2265.2009.03689.x; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Louiset E, 2009, J CLIN ENDOCR METAB, V94, P2406, DOI 10.1210/jc.2009-0031; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Meoli E, 2008, CANCER RES, V68, P3133, DOI 10.1158/0008-5472.CAN-08-0064; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Ronchi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073959; Ronchi CL, 2012, NEOPLASIA, V14, P206, DOI 10.1593/neo.111758; Stratakis CA, 2013, MOL CELL ENDOCRINOL, V371, P208, DOI 10.1016/j.mce.2013.01.015; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Terzolo M, 2012, CLIN ENDOCRINOL, V76, P12, DOI 10.1111/j.1365-2265.2011.04253.x; Vincent-Dejean C, 2008, EUR J ENDOCRINOL, V158, P829, DOI 10.1530/EJE-07-0819; Wilmot Roussel H, 2013, J CLIN ENDOCRINOL ME, V98, pE1109; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	37	265	273	2	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1019	1028		10.1056/NEJMoa1310359	http://dx.doi.org/10.1056/NEJMoa1310359			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24571724	Green Accepted, Green Published			2022-12-24	WOS:000332689100009
J	Sharifi, N				Sharifi, Nima			Steroid Receptors Aplenty in Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE; MUTATION	The up-regulation of glucocorticoid receptors in prostate cancers treated with enzalutamide, an androgen antagonist, may drive resistance to the drug. Cancer cells use diverse means to avoid being damaged by drugs. Often, the development of new treatment strategies in clinical oncology is made possible by discovering the mechanisms of drug resistance by tumors. However, the development of treatments that target such mechanisms is particularly challenging when an intact mechanism is required for a human to sustain life. A recent study by Arora and colleagues(1) suggests that a shift may occur in advanced prostate cancer from the expression of a steroid receptor that is not required for life to another that is and that this shift allows the cancer ...	Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Sharifi, N (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.							Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; MARCELLI M, 1991, J CLIN INVEST, V87, P1123, DOI 10.1172/JCI115076; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506	5	27	28	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					970	971		10.1056/NEJMcibr1315706	http://dx.doi.org/10.1056/NEJMcibr1315706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597872				2022-12-24	WOS:000332309800016
J	Clement, A; DiNezio, P				Clement, Amy; DiNezio, Pedro			The Tropical Pacific Ocean-Back in the Driver's Seat?	SCIENCE			English	Editorial Material							EQUATORIAL PACIFIC; VARIABILITY; HIATUS		[Clement, Amy] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [DiNezio, Pedro] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of Miami; University of Hawaii System; University of Hawaii Manoa	Clement, A (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	aclement@rsmas.miami.edu						Ault TR, 2013, GEOPHYS RES LETT, V40, P3450, DOI 10.1002/grl.50647; Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Deser C, 2004, J CLIMATE, V17, P3109, DOI 10.1175/1520-0442(2004)017<3109:PICVLB>2.0.CO;2; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; England M. H., 2014, CLIMATE CHANGE, P1758, DOI [10.1038/ nclimate2106, DOI 10.1038/NCLIMATE2106,1758]; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Okumura YM, 2013, J CLIMATE, V26, P9791, DOI 10.1175/JCLI-D-13-00448.1; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Shukla P.R., 2022, CLIMATE CHANGE 2013; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Trenberth KE, 2014, J CLIMATE, V27, P3129, DOI 10.1175/JCLI-D-13-00294.1; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Trenberth KE, 2009, CURR OPIN ENV SUST, V1, P19, DOI 10.1016/j.cosust.2009.06.001	16	30	31	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					976	978		10.1126/science.1248115	http://dx.doi.org/10.1126/science.1248115			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578569				2022-12-24	WOS:000332309600028
J	Sorup, S; Benn, CS; Poulsen, A; Krause, TG; Aaby, P; Ravn, H				Sorup, Signe; Benn, Christine S.; Poulsen, Anja; Krause, Tyra G.; Aaby, Peter; Ravn, Henrik			Live Vaccine Against Measles, Mumps, and Rubella and the Risk of Hospital Admissions for Nontargeted Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIPHTHERIA-TETANUS-PERTUSSIS; FEMALE-MALE MORTALITY; RANDOMIZED-TRIAL; CHILDHOOD VACCINATION; DANISH; CHILDREN; DISEASE; BIRTH; IMMUNIZATION; SURVIVAL	IMPORTANCE In low-income countries, live measles vaccine reduces mortality from causes other than measles infection. Such nonspecific effects of vaccines might also be important for the health of children in high-income settings. OBJECTIVE To examine whether the live vaccine against measles, mumps, and rubella (MMR) is associated with lower rates of hospital admissions for infections among children in Denmark. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study of Danish children born 1997-2006 and followed up from ages 11 months to 2 years (last follow-up, August 31, 2008). Nationwide Danish registers provided data on vaccinations and hospital admissions. The recommended vaccination schedule was inactivated vaccine against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) administered at ages 3, 5, and 12 months and MMR at age 15 months. MAIN OUTCOMES AND MEASURES Incidence rate ratios (IRRs) of hospital admissions for any infection, comparing receipt of MMR vs DTaP-IPV-Hib as the most recent vaccine. Risks, risk difference, and number needed to vaccinate were calculated for receiving MMR on time. RESULTS The study included 495 987 children contributing with 56 889 hospital admissions for any type of infection during 509 427 person-years (rate, 11.2 per 100 person-years). Receiving the live MMR vaccine after the inactivated DTaP-IPV-Hib-vaccine was associated with a lower rate of hospital admissions for any infection. [GRAPHICS] The risk of admission for an infection between ages 16 months and 24 months was 4.6% (95% CI, 4.5%-4.7%) for receiving MMR on time and 5.1% (95% CI, 5.0%-5.2%) for not receiving MMR on time. The risk difference was 0.5 percentage point (95% CI, 0.4-0.6), and the number needed to vaccinate with MMR before age 16 months to prevent 1 infectious disease admission was 201 (95% CI, 159-272). CONCLUSIONS AND RELEVANCE In a cohort of Danish children, receipt of live MMR vs inactivated DTaP-IPV-Hib as the most recent vaccine was associated with a lower rate of hospital admissions for any infections. These findings require replication in other high-income populations.	[Sorup, Signe; Benn, Christine S.; Aaby, Peter; Ravn, Henrik] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen S, Denmark; [Benn, Christine S.] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Benn, Christine S.] Odense Univ Hosp, DK-5000 Odense, Denmark; [Benn, Christine S.; Aaby, Peter; Ravn, Henrik] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Poulsen, Anja] Rigshosp, Child & Adolescent Clin, DK-2100 Copenhagen, Denmark; [Krause, Tyra G.] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen S, Denmark	Statens Serum Institut; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; Statens Serum Institut	Sorup, S (corresponding author), Statens Serum Inst, Bandim Hlth Project, CVIVA, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	sgs@ssi.dk		Sorup, Signe/0000-0003-1942-683X; Aaby, Peter/0000-0001-8331-1389; Poulsen, Anja/0000-0002-9656-1552	Health Foundation [2009B132]; Rosalie Petersen Foundation; Novo Nordisk Foundation; European Research Council (ERC) [ERC-StG-243149]; Danish National Research Foundation (DNRF) [DNRF108]	Health Foundation; Rosalie Petersen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC)(European Research Council (ERC)European Commission); Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond)	This work was supported by the Health Foundation (2009B132 [Dr Sorup]); the Rosalie Petersen Foundation (Dr Sorup); and the Novo Nordisk Foundation (research professorship grant [Dr Aaby]). Dr Benn holds a European Research Council (ERC) Starting Grant (ERC-StG-243149). The Danish National Research Foundation (DNRF) supports the Research Center for Vitamins and Vaccines (DNRF108).	Aaby P, 2006, VACCINE, V24, P2764, DOI 10.1016/j.vaccine.2006.01.004; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, PEDIATR INFECT DIS J, V22, P798, DOI 10.1097/01.inf.0000083821.33187.b5; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000761; Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000707; Aaby P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3769; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Carrillo-Santisteve P, 2012, CLIN MICROBIOL INFEC, V18, P50, DOI 10.1111/j.1469-0691.2012.03982.x; Cook R, 2007, STAT BIOL HEALTH, P161; Davis K, 2002, HEALTH POLICY, V59, P119, DOI 10.1016/S0168-8510(01)00202-0; Farrington CP, 2009, TROP MED INT HEALTH, V14, P977, DOI 10.1111/j.1365-3156.2009.02302.x; Frolich A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-252; Garly ML, 2004, PEDIATR INFECT DIS J, V23, P1086, DOI 10.1097/01.inf.0000145700.77286.94; Hviid A, 2005, JAMA-J AM MED ASSOC, V294, P699, DOI 10.1001/jama.294.6.699; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kamper-Jorgensen M, 2006, ARCH DIS CHILD, V91, P401, DOI 10.1136/adc.2005.085787; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martins CL, 2014, J INFECT DIS, V209, P1731, DOI 10.1093/infdis/jit804; Mullooly JP, 2011, VACCINE, V29, P7611, DOI 10.1016/j.vaccine.2011.08.022; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Stowe J, 2009, VACCINE, V27, P1422, DOI 10.1016/j.vaccine.2008.12.038; VANBALEN H, 1981, LANCET, V1, P764; Wojcik OP, 2013, VACCINE, V31, P955, DOI 10.1016/j.vaccine.2012.11.100	38	114	114	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					826	835		10.1001/jama.2014.470	http://dx.doi.org/10.1001/jama.2014.470			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570246				2022-12-24	WOS:000331793700022
J	Sammons, JS				Sammons, Julia Shaklee			Ready or Not: Responding to Measles in the Postelimination Era	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sammons, Julia Shaklee] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sammons, Julia Shaklee] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Sammons, Julia Shaklee] Childrens Hosp Philadelphia, Dept Infect Prevent & Control, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sammons, JS (corresponding author), Childrens Hosp Philadelphia, 34th St & Civ Ctr Blvd,Main Bldg,A Level, Philadelphia, PA 19104 USA.	sammonsj@email.chop.edu						[Anonymous], 2012, RED BOOK REPORT COMM; [Anonymous], MANUAL SURVEILLANCE; [Anonymous], EP PREV VACC PREV DI; Asma S, 2014, MMWR-MORBID MORTAL W, V63, P277; Black CL, 2013, MMWR-MORBID MORTAL W, V62, P733; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Perry RT, 2004, J INFECT DIS, V189, pS4, DOI 10.1086/377712; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Wallace G, 2013, MMWR-MORBID MORTAL W, V62, P741	10	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	2014	161	2					145	+		10.7326/M14-0892	http://dx.doi.org/10.7326/M14-0892			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3PJ	24763975				2022-12-24	WOS:000339764600024
J	Bhan, MK; Glass, RI; Ella, KM; Bhandari, N; Boslego, J; Greenberg, HB; Mohan, K; Curlin, G; Rao, TS				Bhan, Maharaj K.; Glass, Roger I.; Ella, Krishna M.; Bhandari, Nita; Boslego, John; Greenberg, Harry B.; Mohan, Krishna; Curlin, George; Rao, T. S.			Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development	LANCET			English	Editorial Material									[Bhan, Maharaj K.] Govt India, Minist Sci & Technol, New Delhi 110017, India; [Rao, T. S.] Govt India, Dept Biotechnol, New Delhi 110017, India; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Curlin, George] NIAID, NIH, Bethesda, MD 20892 USA; [Ella, Krishna M.; Mohan, Krishna] Bharat Biotech Int, Hyderabad, Andhra Pradesh, India; [Bhandari, Nita] Soc Appl Studies, New Delhi, India; [Boslego, John] PATH, Vaccine Dev Global Program, Seattle, WA USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Stanford, CA USA	Department of Biotechnology (DBT) India; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University	Bhan, MK (corresponding author), Govt India, Minist Sci & Technol, New Delhi 110017, India.	rajkbhan@gmail.com		greenberg, harry/0000-0002-2128-9080				Bhandari N, 2014, LANCET; BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203; Glass RI, 2005, J INFECT DIS, V192, pS30, DOI 10.1086/431498; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Tate JE, 2009, VACCINE, V27, pF18, DOI 10.1016/j.vaccine.2009.08.098; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	6	14	15	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2180	2183		10.1016/S0140-6736(14)60191-4	http://dx.doi.org/10.1016/S0140-6736(14)60191-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ7VG	24629993				2022-12-24	WOS:000337906600032
J	Butkus, R; Weissman, A				Butkus, Renee; Weissman, Arlene			Internists' Attitudes Toward Prevention of Firearm Injury	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIANS	Background: Professional organizations have called for the medical community's attention to the prevention of firearm injury. However, little is known about physicians' attitudes and practices in preventing firearm injury. Objective: To determine internists' attitudes and practices about firearms and to assess whether opinions differ according to whether there are gun owners in a physician's home. Design: Cross-sectional survey. Setting: Internal medicine practices. Participants: 573 internists representative of American College of Physicians' members. Measures: Respondents' experiences and reported practice behaviors related to firearms and their opinions about contributors and public policies related to firearm violence, as well as physician education and training in firearm safety. Results: The survey response rate was 56.5%. Eighty-five percent of respondents believed that firearm injury is a public health issue, and 71% believed that it is a bigger problem today than a decade ago. Seventy-six percent of respondents believed that stricter gun control legislation would help reduce the risks for gun-related injuries or deaths. Although 66% of respondents believed that physicians should have the right to counsel patients on preventing deaths and injuries from firearms, 58% reported never asking whether patients have guns in their homes. Limitations: The generalizability of these findings to non-American College of Physicians' member internists and other physicians is unknown. Responses may not reflect actual behavior. Conclusion: Most respondents believed that firearm-related violence is a public health issue and favored policy initiatives aimed at reducing it. Although most internists supported a physician's right to counsel patients about gun safety, few reported currently doing it.	[Butkus, Renee] Amer Coll Physicians, Washington, DC 20001 USA; Amer Coll Physicians, Philadelphia, PA USA	American College of Physicians; American College of Physicians	Butkus, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW, Washington, DC 20001 USA.	rbutkus@acponline.org						Albright TL, 2003, J AM BOARD FAM PRACT, V16, P40, DOI 10.3122/jabfm.16.1.40; American Academy of Orthopaedic Surgeons, 1996, AM AC ORTH SURG B; American Public Health Association, 1998, POL STAT HANDG INJ R; [Anonymous], 2014, INJ PREV CONTR DAT S; Bronson DL., 2012, STAT ACP RED FIR REL; Bronson DL., 2013, COMMUNICATION   0405; Carbone PS, 2005, ARCH PEDIAT ADOL MED, V159, P1049, DOI 10.1001/archpedi.159.11.1049; Cassel CK, 1998, ANN INTERN MED, V128, P224, DOI 10.7326/0003-4819-128-3-199802010-00009; Centers for Disease Control and Prevention, 2013, FASTSTATS SUIC SELF; Gardner W, 2010, PEDIATRICS, V125, P945, DOI 10.1542/peds.2009-1964; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Laine C, 2013, ANN INTERN MED, V158, P493, DOI 10.7326/0003-4819-158-6-201303190-00586; Pew Research Center for the People and the Press, 2013, GUN CONTR DEB SEV OP; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf	14	35	35	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					821	U33		10.7326/M13-1960	http://dx.doi.org/10.7326/M13-1960			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24722784				2022-12-24	WOS:000337374900015
J	Stevenson, DG; Huskamp, HA				Stevenson, David G.; Huskamp, Haiden A.			Integrating Care at the End of Life Should Medicare Advantage Include Hospice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PALLIATIVE CARE		[Stevenson, David G.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37215 USA; [Huskamp, Haiden A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Vanderbilt University; Harvard University; Harvard Medical School	Stevenson, DG (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 W End Ave,Ste 1200, Nashville, TN 37215 USA.	david.stevenson@vanderbilt.edu			NIA NIH HHS [K01 AG038481] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG038481] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Dahlin CM, 2010, INT J PALLIAT NURS, V16, P420, DOI 10.12968/ijpn.2010.16.9.78633; Harrison S, 2013, PRESENTED AT MEDICAR; Spettell CM, 2009, J PALLIAT MED, V12, P827, DOI 10.1089/jpm.2009.0089; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624	5	11	11	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1493	1494		10.1001/jama.2014.1018	http://dx.doi.org/10.1001/jama.2014.1018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24633593	Green Accepted			2022-12-24	WOS:000334306000013
J	Griggs, D				Griggs, Dave			Streamline IPCC reports	NATURE			English	Editorial Material									[Griggs, Dave] Monash Univ, Monash Sustainabil Inst, Melbourne, Vic 3004, Australia	Monash University	Griggs, D (corresponding author), Monash Univ, Monash Sustainabil Inst, Melbourne, Vic 3004, Australia.	dave.griggs@monash.edu		Griggs, David/0000-0002-9461-9933				Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Parry ML, 2007, CLIMATE CHANGE 2007; Shukla P.R., 2022, CLIMATE CHANGE 2013; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1	4	5	5	4	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					171	173		10.1038/508171a	http://dx.doi.org/10.1038/508171a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE4UK	24724185	Bronze			2022-12-24	WOS:000333979900015
J	Perkins, GD; Gates, S				Perkins, Gavin D.; Gates, Simon			Is adrenaline safe and effective as a treatment for out of hospital cardiac arrest?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; BLOOD-FLOW; EPINEPHRINE; SURVIVAL; TRIAL; OUTCOMES; COUNCIL; PLACEBO; CARE		[Perkins, Gavin D.; Gates, Simon] Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Perkins, Gavin D.] Heart England NHS Fdn Trust, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England	University of Warwick; Heart of England NHS Foundation Trust	Perkins, GD (corresponding author), Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	g.d.perkins@warwick.ac.uk	Perkins, Gavin/E-7613-2010	Perkins, Gavin/0000-0003-3027-7548	Department of Health [12/127/126] Funding Source: Medline; National Institute for Health Research [12/127/126] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Burnett AM, 2012, RESUSCITATION, V83, P1021, DOI 10.1016/j.resuscitation.2012.03.018; Fries M, 2006, RESUSCITATION, V71, P248, DOI 10.1016/j.resuscitation.2006.02.023; Frontanes A, 2011, RESUSCITATION, V82, P427, DOI 10.1016/j.resuscitation.2010.11.020; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Hayakawa K, 2011, RESUSCITATION, V82, P874, DOI 10.1016/j.resuscitation.2011.02.045; HERLITZ J, 1995, RESUSCITATION, V29, P195, DOI 10.1016/0300-9572(94)00851-6; Holmberg M, 2002, RESUSCITATION, V54, P37, DOI 10.1016/S0300-9572(02)00048-5; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Machida M, 2012, J CARDIOL, V60, P503, DOI 10.1016/j.jjcc.2012.07.001; Nakahara S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6829; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Olasveengen TM, 2012, RESUSCITATION, V83, P327, DOI 10.1016/j.resuscitation.2011.11.011; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ong MEH, 2007, ANN EMERG MED, V50, P635, DOI 10.1016/j.annemergmed.2007.03.028; Patanwala AE, 2013, MINERVA ANESTESIOL; Ristagno G, 2009, CRIT CARE MED, V37, P1408, DOI 10.1097/CCM.0b013e31819cedc9; SAFAR P, 1964, J Iowa Med Soc, V54, P629; Sasson C, 2011, RESUSCITATION, V82, P674, DOI 10.1016/j.resuscitation.2011.02.002; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sun SJ, 2010, CRIT CARE MED, V38, P2175, DOI 10.1097/CCM.0b013e3181eedad6; Woodhouse SP, 1995, RESUSCITATION, V30, P243, DOI 10.1016/0300-9572(95)00890-X	23	20	20	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2014	348								g2435	10.1136/bmj.g2435	http://dx.doi.org/10.1136/bmj.g2435			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SB	24709574				2022-12-24	WOS:000334348300009
J	Pencheva, N; Buss, CG; Posada, J; Merghoub, T; Tavazoie, SF				Pencheva, Nora; Buss, Colin G.; Posada, Jessica; Merghoub, Taha; Tavazoie, Sohail F.			Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation	CELL			English	Article							BREAST-CANCER METASTASIS; INHIBITOR; SURVIVAL; LXR; RESISTANCE; GENE	Melanoma metastasis is a devastating outcome lacking an effective preventative therapeutic. We provide pharmacologic, molecular, and genetic evidence establishing the liver-X nuclear hormone receptor (LXR) as a therapeutic target in melanoma. Oral administration of multiple LXR agonists suppressed melanoma invasion, angiogenesis, tumor progression, and metastasis. Molecular and genetic experiments revealed these effects to be mediated by LXR beta, which elicits these outcomes through transcriptional induction of tumoral and stromal apolipoprotein-E (ApoE). LXR beta agonism robustly suppressed tumor growth and metastasis across a diverse mutational spectrum of melanoma lines. LXR beta targeting significantly prolonged animal survival, suppressed the progression of established metastases, and inhibited brain metastatic colonization. Importantly, LXR beta activation displayed melanoma-suppressive cooperativity with the frontline regimens dacarbazine, B-Raf inhibition, and the anti-CTLA-4 antibody and robustly inhibited melanomas that had acquired resistance to B-Raf inhibition or dacarbazine. We present a promising therapeutic approach that uniquely acts by transcriptionally activating a metastasis suppressor gene.	[Pencheva, Nora; Buss, Colin G.; Posada, Jessica; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Merghoub, Taha/ABD-8362-2021; Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685	Rita Allen foundation; Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Rita Allen foundation; Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the members of our laboratory who thoughtfully contributed to past drafts of this manuscript. We thank Masoud Tavazoie, Siavash Kurdistani, Richard Carvajal, Charles Rice, and Fred Cross for providing insightful comments on previous manuscript versions. We thank Marija Drobnjak, Jordana Ray-Kirton, and Umesh Bhanot for greatly assisting with clinical sample processing and procurement. We are grateful to David Mangelsdorf for developing the LXRa and LXR beta-null mice and making them available through the Jackson Laboratory. ApoE-null mice were generously provided by Jan Breslow. The B-Raf<SUP>V600E/+</SUP>; Pten<SUP>-/-</SUP>; CDKN2A<SUP>-/-</SUP> primary mouse melanoma cells were kindly provided by Marcus Bosenberg, and the SK-Mel-239 parental and vemurafenib-resistant cell lines were a generous gift from Poulikos Poulikakos. We express gratitude to Marcus Bosenberg's, Martin McMahon's, and David Dankort's groups for making the Tyr::CreER; B-Raf<SUP>V600E/+</SUP>; Pten<SUP>lox/+</SUP> mouse model available through the Jackson Laboratory. S.F.T. was supported by the Rita Allen foundation and is a DOD Era of Hope Scholar. N.P. is an Anderson Cancer Center fellow. This work was partly funded by the Melanoma Research Alliance and the Melanoma Research Foundation. S.F.T. is a cofounder and shareholder of Rgenix and is a member of its scientific advisory board.	APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lucas R., 2006, ENV BURDEN DIS SERIE; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; SONG C, 1994, P NATL ACAD SCI USA, V91, P10809, DOI 10.1073/pnas.91.23.10809; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	35	117	128	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					986	1001		10.1016/j.cell.2014.01.038	http://dx.doi.org/10.1016/j.cell.2014.01.038			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581497	Bronze			2022-12-24	WOS:000332083900016
J	Harris, R				Harris, Russell			Screening Is Only Part of the Answer to Breast Cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MAMMOGRAPHY		[Harris, Russell] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Res Ctr Excellence Clin Prevent Serv, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Harris, R (corresponding author), Univ N Carolina, Sheps Ctr Hlth Serv Res, 725 Martin Luther King Blvd,CB 7590, Chapel Hill, NC 27599 USA.	rharris@med.unc.edu						Ahn J, 2007, ARCH INTERN MED, V167, P2091, DOI 10.1001/archinte.167.19.2091; Bardia A, 2006, ARCH INTERN MED, V166, P2478, DOI 10.1001/archinte.166.22.2478; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Esserman L, 2014, ANN INTERN MED; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singer Natasha, 2011, NEW YORK TIMES  0206, pBU1	9	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					861	863		10.7326/M14-0616	http://dx.doi.org/10.7326/M14-0616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24711098				2022-12-24	WOS:000337374900023
J	Deuse, T; Hua, XQ; Wang, D; Maegdefessel, L; Heeren, J; Scheja, L; Bolanos, JP; Rakovic, A; Spin, JM; Stubbendorff, M; Ikeno, F; Langer, F; Zeller, T; Schulte-Uentrop, L; Stoehr, A; Itagaki, R; Haddad, F; Eschenhagen, T; Blankenberg, S; Kiefmann, R; Reichenspurner, H; Velden, J; Klein, C; Yeung, A; Robbins, RC; Tsao, PS; Schrepfer, S				Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Maegdefessel, Lars; Heeren, Joerg; Scheja, Ludger; Bolanos, Juan P.; Rakovic, Aleksandar; Spin, Joshua M.; Stubbendorff, Mandy; Ikeno, Fumiaki; Laenger, Florian; Zeller, Tanja; Schulte-Uentrop, Leonie; Stoehr, Andrea; Itagaki, Ryo; Haddad, Francois; Eschenhagen, Thomas; Blankenberg, Stefan; Kiefmann, Rainer; Reichenspurner, Hermann; Velden, Joachim; Klein, Christine; Yeung, Alan; Robbins, Robert C.; Tsao, Philip S.; Schrepfer, Sonja			Dichloroacetate prevents restenosis in preclinical animal models of vessel injury	NATURE			English	Article							MITOCHONDRIA; APOPTOSIS; MECHANISMS; DISEASE; CELLS	Despite the introduction of antiproliferative drug-eluting stents, coronary heart disease remains the leading cause of death in the United States(1). In-stent restenosis and bypass graft failure are characterized by excessive smooth muscle cell (SMC) proliferation(2,3) and concomitant myointima formation with luminal obliteration. Here we show that during the development of myointimal hyperplasia in human arteries, SMCs show hyperpolarization of their mitochondrial membrane potential (Delta Psi m) and acquire a temporary state with a high proliferative rate and resistance to apoptosis. Pyruvate dehydrogenase kinase isoform 2 (PDK2) was identified as a key regulatory protein, and its activation proved necessary for relevant myointima formation. Pharmacologic PDK2 blockade with dichloroacetate or lentiviral PDK2 knockdown prevented Delta Psi m hyperpolarization, facilitated apoptosis and reduced myointima formation in injured human mammary and coronary arteries, rat aortas, rabbit iliac arteries and swine (pig) coronary arteries. In contrast to several commonly used antiproliferative drugs, dichloroacetate did not prevent vessel re-endothelialization. Targeting myointimal Delta Psi m and alleviating apoptosis resistance is a novel strategy for the prevention of proliferative vascular diseases.	[Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Stubbendorff, Mandy; Itagaki, Ryo; Schrepfer, Sonja] Univ Heart Ctr Hamburg, TSI Lab, D-20246 Hamburg, Germany; [Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Stubbendorff, Mandy; Zeller, Tanja; Schulte-Uentrop, Leonie; Stoehr, Andrea; Itagaki, Ryo; Eschenhagen, Thomas; Blankenberg, Stefan; Kiefmann, Rainer; Reichenspurner, Hermann; Schrepfer, Sonja] Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr Hamburg CVRC, D-20246 Hamburg, Germany; [Deuse, Tobias; Hua, Xiaoqin; Wang, Dong; Stubbendorff, Mandy; Zeller, Tanja; Schulte-Uentrop, Leonie; Stoehr, Andrea; Itagaki, Ryo; Eschenhagen, Thomas; Blankenberg, Stefan; Kiefmann, Rainer; Reichenspurner, Hermann; Schrepfer, Sonja] Univ Med Ctr Hamburg Eppendorf, Partner Site Hamburg Kiel Luebeck, DZHK German Ctr Cardiovasc Res, D-20246 Hamburg, Germany; [Deuse, Tobias; Reichenspurner, Hermann; Schrepfer, Sonja] Univ Heart Ctr Hamburg, D-20246 Hamburg, Germany; [Maegdefessel, Lars] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden; [Heeren, Joerg; Scheja, Ludger] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Bolanos, Juan P.] Univ Salamanca, CSIC, Inst Funct Biol & Genom, Salamanca 37007, Spain; [Rakovic, Aleksandar; Klein, Christine] Med Univ Lubeck, Inst Neurogenet, D-23562 Lubeck, Germany; [Spin, Joshua M.; Ikeno, Fumiaki; Haddad, Francois; Yeung, Alan; Tsao, Philip S.] Stanford Univ, Stanford, CA 94305 USA; [Spin, Joshua M.; Ikeno, Fumiaki; Haddad, Francois; Yeung, Alan; Robbins, Robert C.; Tsao, Philip S.; Schrepfer, Sonja] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Laenger, Florian] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany; [Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany; [Schulte-Uentrop, Leonie; Kiefmann, Rainer] Univ Med Ctr Hamburg Eppendorf, Dept Anaesthesiol, D-20246 Hamburg, Germany; [Stoehr, Andrea; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Expt Pharmacol & Toxicol, D-20246 Hamburg, Germany; [Velden, Joachim] Univ Hosp Erlangen, Inst Pathol, Dept Nephropathol, D-91054 Erlangen, Germany; [Robbins, Robert C.; Schrepfer, Sonja] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Tsao, Philip S.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Lubeck; Stanford University; Stanford University; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Schrepfer, S (corresponding author), Univ Heart Ctr Hamburg, TSI Lab, Martinistr 52, D-20246 Hamburg, Germany.	schrepfer@stanford.edu	Klein, Christine/AGK-8003-2022; Bolaños, Juan Pedro/M-9518-2019; Maegdefessel, Lars/AAW-8243-2020; Stoehr, Andrea/F-7452-2018; Maegdefessel, Lars/C-2955-2015	Bolaños, Juan Pedro/0000-0002-3949-6862; Stoehr, Andrea/0000-0003-3573-1818; Maegdefessel, Lars/0000-0001-5228-2634; Spin, Joshua/0000-0002-4256-9161; Klein, Christine/0000-0003-2102-3431; Zeller, Tanja/0000-0003-3379-2641; IKENO, FUMIAKI/0000-0003-2905-0311; Laenger, Florian/0000-0003-1191-4855	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [SCHR992/3-1, SCHR992/4-1]; International Society for Heart and Lung Transplantation (ISHLT); Forderverein des Universitaren Herzzentrums Hamburg; Hermann and Lilly Schilling Foundation; MINECO [SAF2013-41177-R]; NIH [NIH 1R01HL105299]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105299] Funding Source: NIH RePORTER	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); International Society for Heart and Lung Transplantation (ISHLT); Forderverein des Universitaren Herzzentrums Hamburg; Hermann and Lilly Schilling Foundation; MINECO(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. Pahrmann for performing all cell cultures and for her technical assistance. We thank J. Thoms for performing immunoblots, H. Wiebold for assistance in organ chamber experiments, J. Lyons and her team for her assistance with the swine study, and S. Ehret, A. Deng and M. Resch for their technical assistance. We thank the UKE Imaging Facility (UMIF, B. Zobiak) and the UKE Animal Facility. Ethicon (Norderstedt, Germany) provided surgical suture materials. We also thank A. Treszl and G. Schoen for their statistical analyses. This study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG), SCHR992/3-1 and SCHR992/4-1 to S.S.), the International Society for Heart and Lung Transplantation (ISHLT, to S. S.), the Forderverein des Universitaren Herzzentrums Hamburg ( to S. S.), the Hermann and Lilly Schilling Foundation ( to C. K.), the MINECO (SAF2013-41177-R, to J. P. B.) and the NIH (NIH 1R01HL105299, to P.S.T.).	Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mitra AK, 2005, CAN J PHYSIOL PHARM, V83, P701, DOI 10.1139/Y05-080; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Novak K, 1998, NAT MED, V4, P989, DOI 10.1038/1965; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	16	64	67	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					641	+		10.1038/nature13232	http://dx.doi.org/10.1038/nature13232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24747400	Green Published, Green Accepted			2022-12-24	WOS:000336457100053
J	Marder, SR				Marder, Stephen R.			PERSPECTIVE Retreat from the radical	NATURE			English	Editorial Material							SCHIZOPHRENIA; METAANALYSIS; THERAPY		[Marder, Stephen R.] Univ Calif Los Angeles, Semel Inst Neurosci, Los Angeles, CA 90095 USA; [Marder, Stephen R.] VA Desert Pacific Mental Illness Res Educ & Clin, Los Angeles, CA USA	University of California System; University of California Los Angeles	Marder, SR (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci, Los Angeles, CA 90095 USA.	smarder@mednet.ucla.edu						Bespalov Anton, 2012, Handb Exp Pharmacol, P419, DOI 10.1007/978-3-642-25758-2_14; Eack SM, 2010, ARCH GEN PSYCHIAT, V67, P674, DOI 10.1001/archgenpsychiatry.2010.63; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Morris SE, 2011, SCHIZOPHR RES, V127, P1, DOI 10.1016/j.schres.2011.01.027; Penades R, 2013, BIOL PSYCHIAT, V73, P1015, DOI 10.1016/j.biopsych.2013.01.017; Stafford MR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f185	6	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S18	S18		10.1038/508S18a	http://dx.doi.org/10.1038/508S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695331	Bronze			2022-12-24	WOS:000333609900013
J	Moss, H; O'Neill, D				Moss, Hilary; O'Neill, Desmond			Aesthetic deprivation in clinical settings	LANCET			English	Editorial Material									[O'Neill, Desmond] Tallaght Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland; [Moss, Hilary] Tallaght Hosp, Natl Ctr Arts & Hlth, Dublin 24, Ireland	Trinity College Dublin; Trinity College Dublin	O'Neill, D (corresponding author), Tallaght Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland.	doneill@tcd.ie	MOSS, HILARY/I-2921-2016; MOSS, HILARY/S-7810-2017; O'Neill, Desmond/D-1486-2013	MOSS, HILARY/0000-0003-4813-2910; MOSS, HILARY/0000-0003-4813-2910; O'Neill, Desmond/0000-0002-5542-9897				Cuypers K, 2012, J EPIDEMIOL COMMUN H, V66, P698, DOI 10.1136/jech.2010.113571; Eco U., 2011, IRAN MED J; Moss H, 2014, J ADV NURS, V70, P121, DOI 10.1111/jan.12175; Saito Y., 2007, EVERYDAY AESTHETICS; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Wikstrom Britt-Maj, 2002, Clin Nurs Res, V11, P22, DOI 10.1177/1054773802011001003	6	25	25	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1032	1033		10.1016/S0140-6736(14)60507-9	http://dx.doi.org/10.1016/S0140-6736(14)60507-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24665475				2022-12-24	WOS:000333521200013
J	Cappellini, E; Collins, MJ; Gilbert, MTP				Cappellini, Enrico; Collins, Matthew J.; Gilbert, M. Thomas P.			Unlocking Ancient Protein Palimpsests	SCIENCE			English	Editorial Material							KINETICS		[Cappellini, Enrico; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Collins, Matthew J.] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6845, Australia	University of Copenhagen; University of York - UK; Curtin University	Cappellini, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark.	ecappellini@googlemail.com	Collins, Matthew J/A-7534-2008; Gilbert, Marcus TP/A-8936-2013; Collins, Matthew James/O-1095-2019; Cappellini, Enrico/F-9346-2013	Collins, Matthew J/0000-0003-4226-5501; Gilbert, Marcus TP/0000-0002-5805-7195; Collins, Matthew James/0000-0003-4226-5501; Cappellini, Enrico/0000-0001-7885-7811				Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Buckley M, 2011, ARCHAEOL ANTHROP SCI, V3, P271, DOI 10.1007/s12520-011-0066-z; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Corthals A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041244; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/nmeth.2834, 10.1038/NMETH.2834]; Ostrom PH, 2000, GEOCHIM COSMOCHIM AC, V64, P1043, DOI 10.1016/S0016-7037(99)00381-6; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Renard BY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014167; Tomiak PJ, 2013, QUAT GEOCHRONOL, V16, P87, DOI 10.1016/j.quageo.2012.07.001; van Doorn NL, 2012, RAPID COMMUN MASS SP, V26, P2319, DOI 10.1002/rcm.6351; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	13	47	48	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1320	1322		10.1126/science.1249274	http://dx.doi.org/10.1126/science.1249274			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653025				2022-12-24	WOS:000333108500023
J	Jack, A				Jack, Andrew			HEALTH SPENDING DECISIONS Should healthcare be guaranteed for cancer but not diabetes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Organisation for Economic Co-operation and Development (OECD), 2013, OUT POCK EXP HLTH; Pearson M., HLTH SYSTEMS COST EV; Solimano G, 2010, UNIVERSAL HLTH COVER; The Nuffield Trust, 2012, RAT HLTH CAR IS IT T	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1812	10.1136/bmj.g1812	http://dx.doi.org/10.1136/bmj.g1812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HV	24594666				2022-12-24	WOS:000332623400008
J	Heymann, DL; Dar, OA				Heymann, David L.; Dar, Osman A.			Prevention is better than cure for emerging infectious diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Heymann, David L.; Dar, Osman A.] Publ Hlth England, London SE1 8UG, England; [Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Heymann, David L.; Dar, Osman A.] Chatham House Ctr Global Hlth Secur, London, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Publ Hlth England, London SE1 8UG, England.	david.heymann@phe.org.uk						American Veterinary Medical Association, 2008, ON HLTH NEW PROF IMP; [Anonymous], 2010, PEOPL PATH OUR PLAN, V1; Centers for Disease Control and Prevention, 2010, OP ON HLTH POL PERSP; Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1; Delgado C., 1999, 28 INT FOOD POL RES; Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232; Evidence and lessons from Latin America (ELLA), IMPR ENV MAN EXTR EN; Hall D, 2011, IMPLEMENTATION ONE H; Hancock J, 2008, ASSESSMENT LIKELY IM; Heymann DL, 2013, MICROBIOL SPECTR, V1, DOI 10.1128/microbiolspec.OH-0011-2012; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kakkar M, 2011, LANCET INFECT DIS, V11, P808, DOI 10.1016/S1473-3099(11)70298-5; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Marsh, 2008, EC SOC IMP EM INF DI; One Health Global Network, WHATS IS ON HLTH; Public Health England, EMERGING INFECT; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Rodier G, 2007, EMERG INFECT DIS, V13, P1447, DOI 10.3201/eid1310.070732; Thorns CJ, 2000, REV SCI TECH OIE, V19, P226, DOI 10.20506/rst.19.1.1219; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; World Bank, 2012, PEOPL PATH OUR PLAN, V2; World Health Organization, GLOB AL RESP; World Organisation for Animal Health, ON WORLD ON HLTH	24	24	25	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2014	348								g1499	10.1136/bmj.g1499	http://dx.doi.org/10.1136/bmj.g1499			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZU	24563451	Green Accepted			2022-12-24	WOS:000332155100002
J	Jones, A; Cremin, I; Abdullah, F; Idoko, J; Cherutich, P; Kilonzo, N; Rees, H; Hallett, T; O'Reilly, K; Koechlin, F; Schwartlander, B; de Zalduondo, B; Kim, S; Jay, J; Huh, J; Piot, P; Dybul, M				Jones, Alexandra; Cremin, Ide; Abdullah, Fareed; Idoko, John; Cherutich, Peter; Kilonzo, Nduku; Rees, Helen; Hallett, Timothy; O'Reilly, Kevin; Koechlin, Florence; Schwartlander, Bernhard; de Zalduondo, Barbara; Kim, Susan; Jay, Jonathan; Huh, Jacqueline; Piot, Peter; Dybul, Mark			Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention	LANCET			English	Article							SUB-SAHARAN AFRICA; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; POSTTRIAL FOLLOW-UP; REPORTED CONDOM USE; MALE CIRCUMCISION; ANTIRETROVIRAL THERAPY; PREEXPOSURE PROPHYLAXIS; BEHAVIOR-CHANGE; SOUTH-AFRICA	Large declines in HIV incidence have been reported since 2001, and scientific advances in HIV prevention provide strong hope to reduce incidence further. Now is the time to replace the quest for so-called silver bullets with a public health approach to combination prevention that understands that risk is not evenly distributed and that effective interventions can vary by risk profile. Different countries have different microepidemics, with very different levels of transmission and risk groups, changing over time. Therefore, focus should be on high-transmission geographies, people at highest risk for HIV, and the package of interventions that are most likely to have the largest effect in each different microepidemic. Building on the backbone of behaviour change, condom use, and medical male circumcision, as well as expanded use of antiretroviral drugs for infected people and pre-exposure prophylaxis for uninfected people at high risk of infection, it is now possible to consider the prospect of what would be one of the most remarkable achievements in the history of public health: reduction of HIV transmission from a pandemic to low-level endemicity.	[Jones, Alexandra; Kim, Susan; Jay, Jonathan; Huh, Jacqueline; Dybul, Mark] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Cremin, Ide; Hallett, Timothy] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Abdullah, Fareed] SANAC, Pretoria, South Africa; [Idoko, John] Natl Agcy Control AIDS, Abuja, Nigeria; [Cherutich, Peter] Natl AIDS STD Control Programme NASCOP, Nairobi, Kenya; [Kilonzo, Nduku] Liverpool Voluntary Counselling & Testing Care &, Nairobi, Kenya; [Rees, Helen] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, ZA-2050 Johannesburg, South Africa; [O'Reilly, Kevin; Koechlin, Florence] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Schwartlander, Bernhard] UNAIDS, Dept Evidence Strategy & Results, Geneva, Switzerland; [de Zalduondo, Barbara] UNAIDS, Off Deputy Execut Director Programme, Geneva, Switzerland; [Piot, Peter] London Sch Hyg & Trop Med, Directors Off, London WC1, England; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Georgetown University; Imperial College London; University of Witwatersrand; World Health Organization; UNAIDS; UNAIDS; University of London; London School of Hygiene & Tropical Medicine	Dybul, M (corresponding author), Geneva Secretariat, Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1214 Geneva, Switzerland.	mark.dybul@theglobalfund.org		Cremin, Ide/0000-0003-2560-6247; Abdullah, Fareed/0000-0002-1118-9430; Jay, Jonathan/0000-0002-7543-4247; Hallett, Timothy/0000-0002-9681-0424; Rees, Helen/0000-0003-1442-6734; Jones, Alexandra/0000-0001-5039-144X	Bill & Melinda Gates Foundation; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Bill & Melinda Gates Foundation provided grant support for some of the activities described in this paper. No funding bodies had any role in the design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Stephen Becker, Blair Hanewall, Salif Sow, and Wilson Mok of the Bill & Melinda Gates Foundation for their support, insights, review, and comment on early versions of the manuscript.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; [Anonymous], 2012, TELEGRAPH; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Barnighausen T, 2012, P NATL ACAD SCI USA, V109, P21271, DOI 10.1073/pnas.1209017110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Beksinska M, 2011, CONTRACEPTION, V83, P316, DOI 10.1016/j.contraception.2010.07.022; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Buse K, 2008, J ROY SOC MED, V101, P572, DOI 10.1258/jrsm.2008.08k036; Carey RF, 1999, SEX TRANSM DIS, V26, P216, DOI 10.1097/00007435-199904000-00006; *CDCP, 2012, CDC FACT SHEET NEW I; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Coffey PS, 2006, CONTRACEPTION, V73, P588, DOI 10.1016/j.contraception.2005.10.017; Cohen J, 2011, SCIENCE, V334, P1338, DOI 10.1126/science.334.6061.1338; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Dickson KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001133; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Foege WH, 2011, CAL MILBANK BOOK HEA, V21, P1; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; *GLOB IND AN, 2012, COND GLOB STRAT BUS; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI50, DOI 10.1136/sti.2006.023606; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; *INT PLANN PAR FED, 2012, PEOPL LIV HIV STIGM; International Partnership for Microbicides, RING STUD; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Johnson LF, 2012, J R SOC INTERFACE, V9, P1544, DOI 10.1098/rsif.2011.0826; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; *KEN NAT AIDS CONT, 2009, AN HIV PREV RESP MOD; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Kong XR, 2012, AM J EPIDEMIOL, V176, P875, DOI 10.1093/aje/kws179; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; McIntyre JA, 2011, JAIDS-J ACQ IMM DEF, V58, P506, DOI 10.1097/QAI.0b013e318237af5d; *MEAS DHS INT ICF, DHS OV; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mugglin C, 2012, 19 C RETR OPP INF SE; NACC and NASCOP, 2012, KEN AIDS EP UPD 2012; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V58, pE23, DOI 10.1097/QAI.0b013e318227af37; Padian NS, 2011, JAIDS-J ACQ IMM DEF, V56, P199, DOI 10.1097/QAI.0b013e31820bb448; Parikh UM, 2012, CLIN INFECT DIS, V55, P303, DOI 10.1093/cid/cis373; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Schackman BR, 2010, JAIDS-J ACQ IMM DEF, V55, pS27, DOI 10.1097/QAI.0b013e3181f9c1da; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Shelton JD, 2010, LANCET, V375, P964, DOI 10.1016/S0140-6736(10)60416-3; Shisana O., 2009, S AFRICAN NATL HIV P; SIGALL H, 1970, J EXP SOC PSYCHOL, V6, P1, DOI 10.1016/0022-1031(70)90072-7; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; STOVER J, 2013, 17 INT C AIDS STIS A; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; TANSER F, 2011, 18 C RETR OPP INF BO; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2012, PEPFAR BLUEPR CREAT; Umalusi, 2008, STAT INF REP SIRI; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2010, GLOB REP REP GLOB AI, P120; van de Vijver DAMC, 2013, AIDS, V27, P2943, DOI 10.1097/01.aids.0000433237.63560.20; Weir SS, 1999, J EPIDEMIOL COMMUN H, V53, P417, DOI 10.1136/jech.53.7.417; WELLER S, 2002, COCHRANE DB SYST REV, V1; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Wheelock A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001234; WHO, 2013, GLOB UPD HIV TREATM; WHO UNODC UNAIDS, 2012, TECHN GUID COUNTR TA; WHO (World Health Organization), 2009, COUNTR EXP SCAL UP M; Woosley RL, 2007, CLIN PHARMACOL THER, V81, P129, DOI 10.1038/sj.clpt.6100014; World Health Organization, 2008, OP GUID SCAL MAL CIR; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020; ZABA B, 2008, 17 INT AIDS C MEX AU; ZENILMAN JM, 1995, SEX TRANSM DIS, V22, P15, DOI 10.1097/00007435-199501000-00003	108	83	84	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					272	279		10.1016/S0140-6736(13)62230-8	http://dx.doi.org/10.1016/S0140-6736(13)62230-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL8JI	24740087				2022-12-24	WOS:000339384100029
J	Biller-Andorno, N; Juni, P; Kalager, M				Biller-Andorno, Nikola; Jueni, Peter; Kalager, Mette			Abolishing Mammography Screening Programs? A View from the Swiss Medical Board	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BENEFITS		[Biller-Andorno, Nikola] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland; [Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Jueni, Peter] Univ Bern, Clin Trials Unit Bern, Dept Clin Res, Bern, Switzerland; [Biller-Andorno, Nikola] Harvard Univ, Sch Med, Div Med Eth, Dept Global Hlth & Social Med, Boston, MA USA	University of Zurich; University of Bern; University of Bern; Harvard University; Harvard Medical School	Biller-Andorno, N (corresponding author), Univ Zurich, Inst Biomed Eth, Zurich, Switzerland.		Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Biller-Andorno, Nikola/0000-0001-7661-1324				Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	5	182	192	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2014	370	21					1965	1967		10.1056/NEJMp1401875	http://dx.doi.org/10.1056/NEJMp1401875			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UZ	24738641	Green Published			2022-12-24	WOS:000336125500002
J	Olszak, T; Neves, JF; Dowds, CM; Baker, K; Glickman, J; Davidson, NO; Lin, CS; Jobin, C; Brand, S; Sotlar, K; Wada, K; Katayama, K; Nakajima, A; Mizuguchi, H; Kawasaki, K; Nagata, K; Muller, W; Snapper, SB; Schreiber, S; Kaser, A; Zeissig, S; Blumberg, RS				Olszak, Torsten; Neves, Joana F.; Dowds, C. Marie; Baker, Kristi; Glickman, Jonathan; Davidson, Nicholas O.; Lin, Chyuan-Sheng; Jobin, Christian; Brand, Stephan; Sotlar, Karl; Wada, Koichiro; Katayama, Kazufumi; Nakajima, Atsushi; Mizuguchi, Hiroyuki; Kawasaki, Kunito; Nagata, Kazuhiro; Mueller, Werner; Snapper, Scott B.; Schreiber, Stefan; Kaser, Arthur; Zeissig, Sebastian; Blumberg, Richard S.			Protective mucosal immunity mediated by epithelial CD1d and IL-10	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TRIGLYCERIDE TRANSFER PROTEIN; KILLER T-CELLS; ULCERATIVE-COLITIS; CYTOPLASMIC TAIL; BARRIER FUNCTION; MICE; GENE; EXPRESSION; MOLECULES	The mechanisms by which mucosal homeostasis is maintained are of central importance to inflammatory bowel disease. Critical to these processes is the intestinal epithelial cell (IEC), which regulates immune responses at the interface between the commensal microbiota and the host(1,2). CD1d presents self and microbial lipid antigens to natural killer T (NKT) cells, which are involved in the pathogenesis of colitis in animal models and human inflammatory bowel disease(3-8). As CD1d crosslinking on model IECs results in the production of the important regulatory cytokine interleukin (IL)-10 (ref. 9), decreased epithelial CD1d expression-as observed ininflammatory bowel disease(10,11)-may contribute substantially to intestinal inflammation. Here we show in mice that whereas bone-marrow-derived CD1d signals contribute to NKT-cell-mediated intestinal inflammation, engagement of epithelial CD1 delicits protective effects through the activation of STAT3 and STAT3-dependent transcription of IL-10, heat shock protein 110 (HSP110; also known as HSP105), and CD1d itself. All of these epithelial elements are critically involved in controlling CD1d-mediated intestinal inflammation. This is demonstrated by severe NKT-cell-mediated colitis upon IEC-specific deletion of IL-10, CD1d, and its critical regulator microsomal triglyceride transfer protein (MTP)(12,13), as well as deletion of HSP110 in the radioresistant compartment. Our studies thus uncover a novel pathway of IEC-dependent regulation of mucosal homeostasis and highlight a critical role of IL-10 in the intestinal epithelium, with broad implications for diseases such as inflammatory bowel disease.	[Olszak, Torsten; Neves, Joana F.; Baker, Kristi; Snapper, Scott B.; Zeissig, Sebastian; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Dowds, C. Marie; Schreiber, Stefan; Zeissig, Sebastian] Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, D-24105 Kiel, Germany; [Glickman, Jonathan] GI Pathol, Miraca Life Sci, Newton, MA 02464 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Lin, Chyuan-Sheng] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Jobin, Christian] Univ Florida, Dept Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, D-81377 Munich, Germany; [Sotlar, Karl] Univ Munich, Inst Pathol, D-80377 Munich, Germany; [Wada, Koichiro; Katayama, Kazufumi] Osaka Univ, Dept Pharmacol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Nakajima, Atsushi] Yokohama City Univ, Div Gastroenterol, Sch Med, Yokohama, Kanagawa 2360027, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Lab Biochem & Mol Biol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Kawasaki, Kunito; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan; [Mueller, Werner] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Snapper, Scott B.] Childrens Hosp, Dept Med, Div Pediat Gastroenterol Hepatol & Nutr, Boston, MA 02115 USA; [Kaser, Arthur] Univ Cambridge, Addenbrooke Hosp, Div Gastroenterol, Cambridge CB2 0QQ, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital; Washington University (WUSTL); Columbia University; State University System of Florida; University of Florida; University of Munich; University of Munich; Osaka University; Yokohama City University; Osaka University; Kyoto Sangyo University; University of Manchester; Harvard University; Boston Children's Hospital; University of Cambridge	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.	szeissig@1med.uni-kiel.de; rblumberg@partners.org	Muller, Werner/B-9044-2008; Zeissig, Sebastian/B-6297-2012; Neves, Joana F/J-9406-2014	Muller, Werner/0000-0002-1297-9725; Zeissig, Sebastian/0000-0001-5124-0897; Neves, Joana F/0000-0001-5842-4162; Baker, Kristi/0000-0002-2993-3889; Mizuguchi, Hiroyuki/0000-0003-0594-8178; Dowds, C Marie/0000-0002-7170-0667	National Institutes of Health (NIH) [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center [DK0034854]; European Research Council (ERC Starting Grant) [336528]; Deutsche Forschungsgemeinschaft (DFG) [ZE 814/4-1, ZE 814/5-1, ZE 814/6-1]; Crohn's and Colitis Foundation of America; European Commission (Marie Curie International Reintegration Grant) [256363]; DFG Excellence Cluster "Inflammation at Interfaces"; DFG [OL 324/1-1, BR 1912/6-1]; Washington University DDRCC [HL38180, DK56260, P30DK52574]; HDDC Pilot and Feasibility Grant; NCI [P30CA013696]; Else Kroener-Fresenius-Stiftung (Else Kroener-Exzellenzstipendium) [2010_EKES.32]; Japan Society for Promotion of Science [24659823]; ERC under the European Community's Seventh Framework Programme (FP7/ERC) [260961]; National Institute for Health Research Cambridge Biomedical Research Centre; Austrian Science Fund; START [Y446-B18]; Innsbruck Medical University [MFI 2007-407]; Addenbrooke's Charitable Trust, CiCRA; European Community's Seventh Framework Programme (FP7) under grant agreement SysmedIBD [305564]; NIH [HL59561, DK034854, AI50950]; Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research; Ministry of Science [P21530-B18]; Austrian Science Fund (FWF) [P 21530] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180, P01HL059561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050950, R01AI050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051362, R37DK044319, R01DK053056, P30DK034854, R01DK088199, P30DK052574, R01DK044319, R01DK056260] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; European Research Council (ERC Starting Grant)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Crohn's and Colitis Foundation of America; European Commission (Marie Curie International Reintegration Grant); DFG Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Washington University DDRCC; HDDC Pilot and Feasibility Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Else Kroener-Fresenius-Stiftung (Else Kroener-Exzellenzstipendium); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERC under the European Community's Seventh Framework Programme (FP7/ERC); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Austrian Science Fund(Austrian Science Fund (FWF)); START(Austrian Science Fund (FWF)); Innsbruck Medical University; Addenbrooke's Charitable Trust, CiCRA; European Community's Seventh Framework Programme (FP7) under grant agreement SysmedIBD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank H.-C. Hung for technical assistance with microinjection, Y. Xie for performing osmium staining, A. Bedynek and M. Friedrich for performing immunohistochemistry of the human biopsies, F. A. Zhu for assistance with antigen presentation assays, D. Shouval, M. Sablon and D. Perez for animal care and husbandry, K. Tashiro for technical assistance with adenovirus preparation, V. M. Thiele for technical assistance, J. Cusick for help with manuscript preparation, and S. E. Plevy for discussions and reagents. This work was supported by: National Institutes of Health (NIH) (grants DK044319, DK051362, DK053056, DK088199) and the Harvard Digestive Diseases Center (DK0034854) (R. S. B.); the European Research Council (ERC Starting Grant agreement no. 336528), the Deutsche Forschungsgemeinschaft (DFG) (ZE 814/4-1, ZE 814/5-1, ZE 814/6-1), the Crohn's and Colitis Foundation of America (Postdoctoral Fellowship Award), the European Commission (Marie Curie International Reintegration Grant no. 256363) and the DFG Excellence Cluster "Inflammation at Interfaces" (S.Z.); the DFG (OL 324/1-1) (T.O.); HL38180, DK56260, Washington University DDRCC P30DK52574 (morphology core) (N.O.D.); HDDC Pilot and Feasibility Grant (K. B.); NCI P30CA013696 (C.-S.L.), the DFG (BR 1912/6-1) and the Else Kroener-Fresenius-Stiftung (Else Kroener-Exzellenzstipendium 2010_EKES.32) (S. B.); Grant-in-Aid for Challenging Exploratory Research 24659823 from Japan Society for Promotion of Science (K. W.); the ERC under the European Community's Seventh Framework Programme (FP7/2007-2013/ERC Grant agreement no. 260961), the National Institute for Health Research Cambridge Biomedical Research Centre, the Austrian Science Fund and Ministry of Science P21530-B18 and START Y446-B18, Innsbruck Medical University (MFI 2007-407) and the Addenbrooke's Charitable Trust, CiCRA (A. K.); the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement SysmedIBD (no. 305564) (W. M., S. S.); the NIH (grants HL59561, DK034854, AI50950), the Helmsley Charitable Trust and the Wolpow Family Chair in IBD Treatment and Research (S. B. S.). PBS57-loaded and unloaded mouse CD1d tetramer was obtained through the NIH Tetramer Facility. The authors thank M. A. Exley and S. P. Colgan for discussions.	Behar SM, 1999, J IMMUNOL, V162, P161; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen ZG, 2008, J IMMUNOL, V180, P6085, DOI 10.4049/jimmunol.180.9.6085; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Colgan SP, 2003, J CLIN INVEST, V112, P745, DOI 10.1172/JC1200317241; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Furuta GT, 2005, AM J PHYSIOL-GASTR L, V289, pG890, DOI 10.1152/ajpgi.00015.2005; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Liao CM, 2012, GASTROENTEROLOGY, V142, P326, DOI 10.1053/j.gastro.2011.10.030; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakamura J, 2008, STROKE, V39, P2853, DOI 10.1161/STROKEAHA.107.506188; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Park SH, 1998, J IMMUNOL, V160, P3128; Perera L, 2007, INFLAMM BOWEL DIS, V13, P298, DOI 10.1002/ibd.20026; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wingender G, 2008, AM J PHYSIOL-GASTR L, V294, pG1, DOI 10.1152/ajpgi.00437.2007; Yamagishi N, 2009, FEBS J, V276, P5870, DOI 10.1111/j.1742-4658.2009.07311.x; Yue SC, 2005, P NATL ACAD SCI USA, V102, P11811, DOI 10.1073/pnas.0503366102; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	38	139	146	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					497	+		10.1038/nature13150	http://dx.doi.org/10.1038/nature13150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24717441	Green Published, Green Accepted			2022-12-24	WOS:000336126000040
J	van Groenigen, KJ; Qi, X; Osenberg, CW; Luo, YQ; Hungate, BA				van Groenigen, Kees Jan; Qi, Xuan; Osenberg, Craig W.; Luo, Yiqi; Hungate, Bruce A.			Faster Decomposition Under Increased Atmospheric CO2 Limits Soil Carbon Storage	SCIENCE			English	Article							ELEVATED CO2; ORGANIC-MATTER; GLOBAL CHANGE; ENRICHMENT; ROOTS; PLANT; GRASSLANDS; COMMUNITY; ADDITIONS; MODEL	Soils contain the largest pool of terrestrial organic carbon (C) and are a major source of atmospheric carbon dioxide (CO2). Thus, they may play a key role in modulating climate change. Rising atmospheric CO2 is expected to stimulate plant growth and soil C input but may also alter microbial decomposition. The combined effect of these responses on long-term C storage is unclear. Combining meta-analysis with data assimilation, we show that atmospheric CO2 enrichment stimulates both the input (+19.8%) and the turnover of C in soil (+16.5%). The increase in soil C turnover with rising CO2 leads to lower equilibrium soil C stocks than expected from the rise in soil C input alone, indicating that it is a general mechanism limiting C accumulation in soil.	[van Groenigen, Kees Jan; Hungate, Bruce A.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [van Groenigen, Kees Jan] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Bot, Dublin 2, Ireland; [Qi, Xuan; Luo, Yiqi] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Osenberg, Craig W.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Luo, Yiqi] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Northern Arizona University; Trinity College Dublin; University of Oklahoma System; University of Oklahoma - Norman; State University System of Florida; University of Florida; Tsinghua University; Northern Arizona University	van Groenigen, KJ (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA.	cjvangroenigen@nau.edu	van groenigen, kees jan/ABF-2075-2021; van Groenigen, Kees Jan/Q-7081-2018	van groenigen, kees jan/0000-0002-9165-3925; van Groenigen, Kees Jan/0000-0002-9165-3925; Osenberg, Craig/0000-0003-1918-7904	Biological and Environmental Research program, Office of Science, U.S. Department of Energy; Western Regional Center of the National Institute for Climatic Change Research; Irish Research Council; Marie Curie Actions under the Seventh Framework Program (FP7); U.S. Department of Energy, Terrestrial Ecosystem Sciences [DE SC0008270]	Biological and Environmental Research program, Office of Science, U.S. Department of Energy; Western Regional Center of the National Institute for Climatic Change Research; Irish Research Council(Irish Research Council for Science, Engineering and Technology); Marie Curie Actions under the Seventh Framework Program (FP7); U.S. Department of Energy, Terrestrial Ecosystem Sciences(United States Department of Energy (DOE))	This research was supported by the Biological and Environmental Research program, Office of Science, U.S. Department of Energy; the Western Regional Center of the National Institute for Climatic Change Research; and the Irish Research Council, cofunded by Marie Curie Actions under the Seventh Framework Program (FP7). X.Q. and Y.L. received financial support from the U.S. Department of Energy, Terrestrial Ecosystem Sciences grant DE SC0008270. We thank M. Hoosbeek, K. Sturner, A. Talhelm, and D. Zak for sharing unpublished data with us. Many thanks go to T. Xu for assisting us with writing the Matlab code. The data reported in this paper are available online as supplementary materials.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Arora VK, 2013, J CLIMATE, V26, P5289, DOI 10.1175/JCLI-D-12-00494.1; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; DALENBERG JW, 1989, SOIL BIOL BIOCHEM, V21, P443, DOI 10.1016/0038-0717(89)90157-0; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Dijkstra FA, 2007, ECOL LETT, V10, P1046, DOI 10.1111/j.1461-0248.2007.01095.x; Drake JE, 2011, ECOL LETT, V14, P349, DOI 10.1111/j.1461-0248.2011.01593.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Hungate BA, 1996, PLANT SOIL, V187, P135, DOI 10.1007/BF00017086; Hungate BA, 2009, GLOBAL CHANGE BIOL, V15, P2020, DOI 10.1111/j.1365-2486.2009.01866.x; Luo YQ, 2011, GLOBAL CHANGE BIOL, V17, P843, DOI 10.1111/j.1365-2486.2010.02265.x; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Paterson E, 2008, SOIL BIOL BIOCHEM, V40, P2434, DOI 10.1016/j.soilbio.2008.06.005; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Perveen N, 2014, GLOBAL CHANGE BIOL, V20, P1174, DOI 10.1111/gcb.12493; Phillips RP, 2012, ECOL LETT, V15, P1042, DOI 10.1111/j.1461-0248.2012.01827.x; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sillen WMA, 2012, BIOGEOSCIENCES, V9, P2247, DOI 10.5194/bg-9-2247-2012; Smith P, 2004, SOIL USE MANAGE, V20, P264, DOI 10.1079/SUM2004239; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; van Groenigen KJ, 2011, NATURE, V475, P214, DOI 10.1038/nature10176; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Wullschleger SD, 2002, PLANT CELL ENVIRON, V25, P319, DOI 10.1046/j.1365-3040.2002.00796.x; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x	28	206	215	24	595	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					508	509		10.1126/science.1249534	http://dx.doi.org/10.1126/science.1249534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24762538				2022-12-24	WOS:000335157700040
J	Hick, JL; Hanfling, D; Courtney, B; Lurie, N				Hick, John L.; Hanfling, Dan; Courtney, Brooke; Lurie, Nicole			Rationing Salt Water - Disaster Planning and Daily Care Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hick, John L.] Univ Minnesota, Dept Emergency Med, Minneapolis, MN 55455 USA; [Hick, John L.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Hanfling, Dan] George Washington Univ, Dept Emergency Med, Washington, DC USA; [Lurie, Nicole] Dept Hlth & Human Serv, Off Assistant Secretary Preparedness & Response, Washington, DC USA; [Hanfling, Dan] Inova Hlth Syst, Falls Church, VA USA; [Courtney, Brooke] US FDA, Off Counterterrorism & Emerging Threats, Silver Spring, MD USA	University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; George Washington University; Inova Health System; US Food & Drug Administration (FDA)	Hick, JL (corresponding author), Univ Minnesota, Dept Emergency Med, Minneapolis, MN 55455 USA.							[Anonymous], 2014, DRUG SHORT PUBL HLTH; [Anonymous], 2012, COP MIT EFF SHORT EM, DOI [10.1056/NEJMp1401833, DOI 10.1056/NEJMP1401833]; Hanfling D., 2012, CRISIS STANDARDS CAR; Lee J., MODERN HEALTHCARE	4	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2014	370	17					1573	1576		10.1056/NEJMp1401833	http://dx.doi.org/10.1056/NEJMp1401833			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4TG	24645847				2022-12-24	WOS:000336120500002
J	Trivedi, BP				Trivedi, Bijal P.			Dissecting appetite	NATURE			English	Editorial Material							NEURAL CIRCUIT; NUCLEUS; HUNGER											Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022	8	8	9	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S64	S65		10.1038/508S64a	http://dx.doi.org/10.1038/508S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740131				2022-12-24	WOS:000334403000008
J	Antman, EM; Jessup, M				Antman, Elliott M.; Jessup, Mariell			Clinical Practice Guidelines for Chronic Cardiovascular Disorders: A Roadmap for the Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Antman, Elliott M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Jessup, Mariell] Univ Penn, Sch Med, Penn Heart & Vasc Ctr, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania	Antman, EM (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu		Jessup, Mariell/0000-0002-3010-0112				Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Food and Drug Administration Center for Drug Evaluation and Research, 2013, GUIDANCE FOR INDUSTR; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; World Health Organization, THE TOP 10 CAUSES OF	6	8	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1195	1196		10.1001/jama.2014.1742	http://dx.doi.org/10.1001/jama.2014.1742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668097				2022-12-24	WOS:000333340500017
J	Minteer, BA; Collins, JP; Love, KE; Puschendorf, R				Minteer, Ben A.; Collins, James P.; Love, Karen E.; Puschendorf, Robert			Avoiding (Re) extinction	SCIENCE			English	Editorial Material							POPULATIONS; FROGS; DNA		[Minteer, Ben A.; Collins, James P.; Love, Karen E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Puschendorf, Robert] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England	Arizona State University; Arizona State University-Tempe; University of Plymouth	Minteer, BA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	ben.minteer@asu.edu	Puschendorf, Robert/B-6280-2011	Puschendorf, Robert/0000-0002-8105-171X				Athreya Ramana, 2006, Indian Birds, V2, P82; Bolanos F, 2002, AMBIENTICO, V107, P12; Brengtson S. A., 1984, AUK, V101, P1; Collar NJ, 1999, IBIS, V141, P358, DOI 10.1111/j.1474-919X.1999.tb04406.x; Collins J.P., 2009, EXTINCTION OUR TIMES; Fuller Errol, 2003, GREAT AUK EXTINCTION; Garcia-Rodriguez A, 2012, DIVERS DISTRIB, V18, P204, DOI 10.1111/j.1472-4642.2011.00862.x; Mendoza AM, 2012, MOL ECOL RESOUR, V12, P470, DOI 10.1111/j.1755-0998.2011.03107.x; Nishida K., 2006, BRENESIA, V66, P78; NORTON DA, 1994, TAXON, V43, P181, DOI 10.2307/1222876; Phillips BL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1290; Prunier J, 2012, MOL ECOL RESOUR, V12, P524, DOI 10.1111/j.1755-0998.2012.03116.x; Rodriguez-Estrella R, 2006, BIODIVERS CONSERV, V15, P1621, DOI 10.1007/s10531-004-4308-6; Scheffers BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022531	14	73	81	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					260	261		10.1126/science.1250953	http://dx.doi.org/10.1126/science.1250953			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744362				2022-12-24	WOS:000334474500021
J	Katz, DL				Katz, D. L.			Obesity is not a disease	NATURE			English	Editorial Material									[Katz, D. L.] Yale Univ, Prevent Res Ctr, New Haven, CT 06520 USA	Yale University	Katz, DL (corresponding author), Yale Univ, Prevent Res Ctr, New Haven, CT 06520 USA.	davkatz7@gmail.com		Katz, David/0000-0001-6845-6192				Cannon C. P., 2009, CLIN CORNERSTONE, V9, P69; Cannon Christopher P, 2009, Clin Cornerstone, V9, P55; Diamond J., 1999, NY TIMES; Gill T P, 1999, Asia Pac J Clin Nutr, V8, P75, DOI 10.1046/j.1440-6047.1999.00060.x; Katz D. L., 2013, US NEWS WORLD REPORT; Katz DL, 2014, CHILD OBES, V10, P1, DOI 10.1089/chi.2014.1012; Kraschnewski JL, 2013, MED CARE, V51, P186, DOI 10.1097/MLR.0b013e3182726c33; Moss M., 2013, NEW YORK TIMES MAGAZ; Nawaz H, 2001, AM J PREV MED, V21, P73, DOI 10.1016/S0749-3797(01)00317-8; Nawaz H, 1999, AM J PUBLIC HEALTH, V89, P764, DOI 10.2105/AJPH.89.5.764	10	24	25	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S57	S57		10.1038/508S57a	http://dx.doi.org/10.1038/508S57a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740128				2022-12-24	WOS:000334403000005
J	Rawlins, MD				Rawlins, Michael D.			MEDICAL LEGISLATION The "Saatchi bill" will allow responsible innovation in treatment	BMJ-BRITISH MEDICAL JOURNAL			English	News Item									Royal Soc Med, London W1G 0AE, England		Rawlins, MD (corresponding author), Royal Soc Med, London W1G 0AE, England.	m.d.rawlins@ncl.ac.uk						Department of Health, 1959, LEG ENC MED INN; Fialova J, 2014, DERMATOL THER, V27, P105, DOI 10.1111/dth.12065	2	9	10	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2014	348								g2771	10.1136/bmj.g2771	http://dx.doi.org/10.1136/bmj.g2771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF5GN	24735990				2022-12-24	WOS:000334742100018
J	Lienhardt, C				Lienhardt, Christian			Fundamental research is the key to eliminating TB	NATURE			English	Editorial Material									WHO, Global TB Programme, CH-1211 Geneva, Switzerland	World Health Organization	Lienhardt, C (corresponding author), WHO, Global TB Programme, CH-1211 Geneva, Switzerland.	lienhardtc@who.int	Lienhardt, Christian/AAU-4969-2021	Lienhardt, Christian/0000-0003-0233-893X	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)			0	9	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					401	401		10.1038/507401a	http://dx.doi.org/10.1038/507401a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD6WN	24670725	Bronze			2022-12-24	WOS:000333402000004
J	Bourzac, K				Bourzac, Katherine			INFECTIOUS DISEASE Beating the big three	NATURE			English	Editorial Material																			0	17	20	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S4	S7		10.1038/507S4a	http://dx.doi.org/10.1038/507S4a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611168	Bronze			2022-12-24	WOS:000332224400003
J	Vadodaria, KC; Gage, FH				Vadodaria, Krishna C.; Gage, Fred H.			SnapShot: Adult Hippocampal Neurogenesis	CELL			English	Editorial Material							NEURONS		[Vadodaria, Krishna C.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Vadodaria, KC (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Vadodaria, Krishna C./H-1711-2017	Vadodaria, Krishna C./0000-0002-3455-0209				Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage F, 2008, COLD SPRING HARBOR M, V52; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002	8	35	36	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5								10.1016/j.cell.2014.02.029	http://dx.doi.org/10.1016/j.cell.2014.02.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3QY	24581504	Bronze			2022-12-24	WOS:000349544600001
J	Czuczman, MA; Fattouh, R; van Rijn, JM; Canadien, V; Osborne, S; Muise, AM; Kuchroo, VK; Higgins, DE; Brumell, JH				Czuczman, Mark A.; Fattouh, Ramzi; van Rijn, Jorik M.; Canadien, Veronica; Osborne, Suzanne; Muise, Aleixo M.; Kuchroo, Vijay K.; Higgins, Darren E.; Brumell, John H.			Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread	NATURE			English	Article							PLASMA-MEMBRANE; HOST-CELLS; PHOSPHOLIPASES-C; INFECTION; CLEARANCE; SURVIVAL; ROLES; ACTIN; MICE	Efferocytosis, the process by which dying or dead cells are removed by phagocytosis, has an important role in development, tissue homeostasis and innate immunity(1). Efferocytosis is mediated, in part, by receptors that bind to exofacial phosphatidylserine (PS) on cells or cellular debris after loss of plasma membrane asymmetry. Here we show that a bacterial pathogen, Listeria monocytogenes, can exploit efferocytosis to promote cell-to-cell spread during infection. These bacteria can escape the phagosome in host cells by using the poreforming toxin listeriolysin O (LLO) and two phospholipase C enzymes(2). Expression of the cell surface protein ActA allows L. monocytogenes to activate host actin regulatory factors and undergo actin-based motility in the cytosol, eventually leading to formation of actin-rich protrusions at the cell surface. Here we show that protrusion formation is associated with plasma membrane damage due to LLO's poreforming activity. LLO also promotes the release of bacteria-containing protrusions from the host cell, generating membrane-derived vesicles with exofacial PS. The PS-binding receptor TIM-4 (encoded by the Timd4 gene) contributes to efficient cell-to-cell spread by L. monocytogenes in macrophages in vitro and growth of these bacteria is impaired in Timd4(-/-) mice. Thus, L. monocytogenes promotes its dissemination in a host by exploiting efferocytosis. Our results indicate that PS-targeted therapeutics may be useful in the fight against infections by L. monocytogenes and other bacteria that use similar strategies of cell-to-cell spread during infection.	[Czuczman, Mark A.; Fattouh, Ramzi; Canadien, Veronica; Osborne, Suzanne; Muise, Aleixo M.; Brumell, John H.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Czuczman, Mark A.; Brumell, John H.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [van Rijn, Jorik M.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [van Rijn, Jorik M.] Univ Med Ctr Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Muise, Aleixo M.] Hosp Sick Children, Dept Paediat, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Muise, Aleixo M.; Brumell, John H.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Muise, Aleixo M.; Brumell, John H.] Hosp Sick Children, Sickkids IBD Ctr, Toronto, ON M5G 1X8, Canada; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Brumell, JH (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada.	john.brumell@sickkids.ca	van Rijn, Jorik/ABF-4613-2020	van Rijn, Jorik/0000-0003-2865-4455; Fattouh, Ramzi/0000-0001-6573-6367	Canadian Foundation for Innovation; Ontario Innovation Trust; Canadian Institutes of Health Research; Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada; Research Training Committee at the Hospital for Sick Children; Arthritis Society of Canada [RG11/013]; US Public Health Service grant from the National Institutes of Health [AI053669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096138] Funding Source: NIH RePORTER	Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology; Crohn's and Colitis Foundation of Canada; Research Training Committee at the Hospital for Sick Children; Arthritis Society of Canada; US Public Health Service grant from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to S. Gray-Owen, S. Grinstein and D. Portnoy for providing reagents and advice and to D. Holmyard for help with electron microscopy. J.H.B. holds the Pitblado Chair in Cell Biology. Infrastructure for the Brumell laboratory was provided by a Leader's Opportunity Fund grant from the Canadian Foundation for Innovation and the Ontario Innovation Trust. R. F. was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research in partnership with the Canadian Association of Gastroenterology and the Crohn's and Colitis Foundation of Canada. S.O. was supported by a postdoctoral fellowship from the Research Training Committee at the Hospital for Sick Children. This work was supported by an operating grant from The Arthritis Society of Canada (#RG11/013) to J.H.B. and a US Public Health Service grant (AI053669) from the National Institutes of Health to D.E.H.	Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Appelberg R, 2000, INFECT IMMUN, V68, P912, DOI 10.1128/IAI.68.2.912-914.2000; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Cassidy SKB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002628; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Drevets DA, 1999, INFECT IMMUN, V67, P3512, DOI 10.1128/IAI.67.7.3512-3517.1999; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Friedrich N, 2012, MICROBIOL MOL BIOL R, V76, P707, DOI 10.1128/MMBR.00024-12; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Keyel PA, 2011, J CELL SCI, V124, P2414, DOI 10.1242/jcs.076182; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Mostowy S, 2012, ADV IMMUNOL, V113, P19, DOI 10.1016/B978-0-12-394590-7.00007-5; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; Nomura T, 2007, MICROBIOL-SGM, V153, P2250, DOI 10.1099/mic.0.2007/005843-0; Pust S, 2005, EMBO J, V24, P1287, DOI 10.1038/sj.emboj.7600595; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Schnupf P, 2006, CELL MICROBIOL, V8, P353, DOI 10.1111/j.1462-5822.2005.00631.x; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Shen A, 2005, MOL MICROBIOL, V57, P1460, DOI 10.1111/j.1365-2958.2005.04780.x; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326	39	90	95	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					230	+		10.1038/nature13168	http://dx.doi.org/10.1038/nature13168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24739967	Green Submitted, Green Accepted			2022-12-24	WOS:000335454300040
J	Paul, BD; Sbodio, JI; Xu, RS; Vandiver, MS; Cha, JY; Snowman, AM; Snyder, SH				Paul, Bindu D.; Sbodio, Juan I.; Xu, Risheng; Vandiver, M. Scott; Cha, Jiyoung Y.; Snowman, Adele M.; Snyder, Solomon H.			Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington's disease	NATURE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HYDROGEN-SULFIDE; OXIDATIVE STRESS; H2S; SULFHYDRATION; CYSTEINE; MICE; DYSFUNCTION; MODEL	Huntington's disease is an autosomal dominant disease associated with a mutation in the gene encoding huntingtin (Htt) leading to expanded polyglutamine repeats of mutant Htt (mHtt) that elicit oxidative stress, neurotoxicity, and motor and behavioural changes(1). Huntington's disease is characterized by highly selective and profound damage to the corpus striatum, which regulates motor function. Striatal selectivity of Huntington's disease may reflect the striatally selective small G protein Rhes binding to mHtt and enhancing its neurotoxicity(2). Specific molecular mechanisms by which mHtt elicits neurodegeneration have been hard to determine. Here we show a major depletion of cystathionine gamma-lyase (CSE), the biosynthetic enzyme for cysteine, in Huntington's disease tissues, which may mediate Huntington's disease pathophysiology. The defect occurs at the transcriptional level and seems to reflect influences of mHtt on specificity protein 1, a transcriptional activator for CSE. Consistent with the notion of loss of CSE as a pathogenic mechanism, supplementation with cysteine reverses abnormalities in cultures of Huntington's disease tissues and in intact mouse models of Huntington's disease, suggesting therapeutic potential.	[Paul, Bindu D.; Sbodio, Juan I.; Xu, Risheng; Vandiver, M. Scott; Cha, Jiyoung Y.; Snowman, Adele M.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; [Xu, Risheng; Vandiver, M. Scott; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			United States Public Health Service [MH18501]; CHDI; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); CHDI; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. C. Troncoso and O. Pletnikova for providing the human post-mortemtissue samples; D. Krainc for the constructsCMV-SP1 and TAF4; M. MacDonald for the striatal Q7 and Q111 cell lines; and the Cure Huntington's Disease Initiative (CHDI) for the Q175 mice tissues. This work was supported by United States Public Health Service Grant MH18501 to S. H. S. and by the CHDI. M. S. V. and R. X. are supported by the National Institutes of Health Medical Scientist Training Program Award.	ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Cyr M, 2005, NEUROIMAGE, V26, P83, DOI 10.1016/j.neuroimage.2005.01.039; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Droge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fox JH, 2004, J NEUROCHEM, V91, P413, DOI 10.1111/j.1471-4159.2004.02726.x; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Subramaniam S, 2011, NEUROPHARMACOLOGY, V60, P1187, DOI 10.1016/j.neuropharm.2010.10.025; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2011, J BIOL CHEM, V286, P26450, DOI 10.1074/jbc.M111.266643; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030	30	254	261	4	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					96	+		10.1038/nature13136	http://dx.doi.org/10.1038/nature13136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670645	Green Accepted			2022-12-24	WOS:000335199100046
J	Boyce, JW; Tomlinson, SM; McCubbin, FM; Greenwood, JP; Treiman, AH				Boyce, J. W.; Tomlinson, S. M.; McCubbin, F. M.; Greenwood, J. P.; Treiman, A. H.			The Lunar Apatite Paradox	SCIENCE			English	Article							WATER; CHLORINE; HYDROXYL; DELIVERY; FLUORINE; HYDROGEN; OLIVINE; LIQUID; SYSTEM; MANTLE	Recent discoveries of water-rich lunar apatite are more consistent with the hydrous magmas of Earth than the otherwise volatile-depleted rocks of the Moon. Paradoxically, this requires H-rich minerals to form in rocks that are otherwise nearly anhydrous. We modeled existing data from the literature, finding that nominally anhydrous minerals do not sufficiently fractionate H from F and Cl to generate H-rich apatite. Hydrous apatites are explained as the products of apatite-induced low magmatic fluorine, which increases the H/F ratio in melt and apatite. Mare basalts may contain hydrogen-rich apatite, but lunar magmas were most likely poor in hydrogen, in agreement with the volatile depletion that is both observed in lunar rocks and required for canonical giant-impact models of the formation of the Moon.	[Boyce, J. W.; Tomlinson, S. M.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [McCubbin, F. M.] Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Greenwood, J. P.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA	University of California System; University of California Los Angeles; University of New Mexico; Wesleyan University	Boyce, JW (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA.	jwboyce@alum.mit.edu	Boyce, Jeremy W/A-7514-2008; McCubbin, Francis/AAG-1095-2020		NASA Cosmochemistry grant [NNX13AG40G, NNX12AH64G]; NASA Lunar Advanced Science for Exploration Research grant [NNX13AK32G]; NASA Lunar Advanced Science for Exploration Research [NNX11AB29G]	NASA Cosmochemistry grant; NASA Lunar Advanced Science for Exploration Research grant; NASA Lunar Advanced Science for Exploration Research	J.W.B. acknowledges support from NASA Cosmochemistry grant NNX13AG40G; A. H. T. and J.W.B. acknowledge support from NASA Cosmochemistry grant NNX12AH64G to A. H. T. F. M. M. acknowledges support from NASA Lunar Advanced Science for Exploration Research grant NNX13AK32G. J.P.G. acknowledges support from NASA Lunar Advanced Science for Exploration Research NNX11AB29G and J. Eckert (Yale) for assistance with the electron-probe microanalysis. All data used in the modeling and testing of the model for this paper are available in the supplementary materials or in the published, refereed journal articles that are cited in the references section. J. W. B., F. M. M., and A. H. T. conceived of the solution to the lunar apatite paradox. S. M. T. and J. W. B. wrote the numerical model. J. P. G. provided essential tests of the model. All authors contributed to the writing of the paper.	Anand M, 2006, GEOCHIM COSMOCHIM AC, V70, P246, DOI 10.1016/j.gca.2005.08.018; Anand M., 2013, MINERAL MAG, V77, P589; Barnes JJ, 2013, CHEM GEOL, V337, P48, DOI 10.1016/j.chemgeo.2012.11.015; Beaty D., 1978, P LUNAR PLANET SCI C, V9, P58; Beyer C, 2012, EARTH PLANET SC LETT, V337, P1, DOI 10.1016/j.epsl.2012.05.003; Boyce JW, 2012, AM MINERAL, V97, P1116, DOI 10.2138/am.2012.3965; Boyce JW, 2010, NATURE, V466, P466, DOI 10.1038/nature09274; Elardo SM, 2014, METEORIT PLANET SCI, V49, P261, DOI 10.1111/maps.12239; Fabbrizio A, 2013, GEOCHIM COSMOCHIM AC, V121, P684, DOI 10.1016/j.gca.2013.05.026; Greenwood JP, 2011, NAT GEOSCI, V4, P79, DOI 10.1038/NGEO1050; Hauri EH, 2006, EARTH PLANET SC LETT, V248, P715, DOI 10.1016/j.epsl.2006.06.014; Hauri EH, 2011, SCIENCE, V333, P213, DOI 10.1126/science.1204626; Huh M., 2011, AM GEOPH UN FALL M A, V1, P2534; Hui HJ, 2013, NAT GEOSCI, V6, P177, DOI 10.1038/ngeo1735; Mathez EA, 2005, GEOCHIM COSMOCHIM AC, V69, P1275, DOI 10.1016/j.gca.2004.08.035; McCubbin FM, 2011, GEOCHIM COSMOCHIM AC, V75, P5073, DOI 10.1016/j.gca.2011.06.017; Mccubbin FM, 2010, AM MINERAL, V95, P1141, DOI 10.2138/am.2010.3448; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; O'Leary JA, 2010, EARTH PLANET SC LETT, V297, P111, DOI 10.1016/j.epsl.2010.06.011; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; ROEDER PL, 1970, CONTRIB MINERAL PETR, V29, P275, DOI 10.1007/BF00371276; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; Tartese R, 2013, EARTH PLANET SC LETT, V361, P480, DOI 10.1016/j.epsl.2012.11.015; Taylor SR, 2006, REV MINERAL GEOCHEM, V60, P657, DOI 10.2138/rmg.2006.60.7; Toplis MJ, 2005, CONTRIB MINERAL PETR, V149, P22, DOI 10.1007/s00410-004-0629-4; Vander Kaaden K., 2012, P LUNAR PLANET SCI C, V43; Webster JD, 2009, GEOCHIM COSMOCHIM AC, V73, P559, DOI 10.1016/j.gca.2008.10.034	29	125	128	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					400	402		10.1126/science.1250398	http://dx.doi.org/10.1126/science.1250398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24652938				2022-12-24	WOS:000334867800037
J	Holmes, D				Holmes, David			Abdisalan Noor: mapping malaria	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1375	1375		10.1016/S0140-6736(14)60669-3	http://dx.doi.org/10.1016/S0140-6736(14)60669-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3LI	24759240				2022-12-24	WOS:000335318400012
J	Page, L				Page, Leigh			FEATURE The end of life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-LIFE				Page, L (corresponding author), 2525 North Talman Ave, Chicago, IL USA.	leighpage@comcast.net						American Association of Neurological Surgeons (AANS), INF CONS; American Medical Association (AMA) Council on Ethical and Judicial Affairs, 2008, 5A08 CEJA AMA; Astrow AB, 2011, NEW ENGL J MED, V364, P1885, DOI 10.1056/NEJMp1102392; Bergman J, 2013, JAMA SURG, V148, P215, DOI 10.1001/jamasurg.2013.1568; Davison SN, 2010, CLIN J AM SOC NEPHRO, V5, P195, DOI 10.2215/CJN.05960809; Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055; National Hospice and Palliative Care Organization (NHPCO), 2006, TALK TREATM OPT PALL	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2014	348								g2261	10.1136/bmj.g2261	http://dx.doi.org/10.1136/bmj.g2261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9LN	24671982				2022-12-24	WOS:000333586700003
J	Watson, JD				Watson, James D.			Type 2 diabetes as a redox disease	LANCET			English	Article							EXERCISE; METFORMIN; PATHWAY; INSULIN; CANCER; HEALTH		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Watson, JD (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	berejka@cshl.edu						Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Gomez-Cabrera MC, 2012, AM J PHYSIOL-ENDOC M, V302, pE476, DOI 10.1152/ajpendo.00567.2011; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; GERSTER H, 1989, J AM COLL NUTR, V8, P636; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Koenner AC, 2009, PHYSIOL BEHAV, V97, P632, DOI 10.1016/j.physbeh.2009.03.027; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nardai G, 2005, BIOCHEM BIOPH RES CO, V334, P787, DOI 10.1016/j.bbrc.2005.06.172; Petersen AC, 2012, ACTA PHYSIOL, V204, P382, DOI 10.1111/j.1748-1716.2011.02344.x; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Sharma Morali D, 2008, Endocr Pract, V14, P373; Sharoff CG, 2010, AM J PHYSIOL-ENDOC M, V298, pE815, DOI 10.1152/ajpendo.00517.2009; Smith JC, 2013, J ALZHEIMERS DIS, V37, P197, DOI 10.3233/JAD-130467; TIIDUS PM, 1995, SPORTS MED, V20, P12, DOI 10.2165/00007256-199520010-00002; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	32	136	150	4	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					841	843		10.1016/S0140-6736(13)62365-X	http://dx.doi.org/10.1016/S0140-6736(13)62365-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24581668				2022-12-24	WOS:000332398700031
J	Hocevar, SN; Paddock, CD; Spak, CW; Rosenblatt, R; Diaz-Luna, H; Castillo, I; Luna, S; Friedman, GC; Antony, S; Stoddard, RA; Tiller, RV; Peterson, T; Blau, DM; Sriram, RR; da Silva, A; de Almeida, M; Benedict, T; Goldsmith, CS; Zaki, SR; Visvesvara, GS; Kuehnert, MJ				Hocevar, Susan N.; Paddock, Christopher D.; Spak, Cedric W.; Rosenblatt, Randall; Diaz-Luna, Hector; Castillo, Isabel; Luna, Sergio; Friedman, Glen C.; Antony, Suresh; Stoddard, Robyn A.; Tiller, Rebekah V.; Peterson, Tammie; Blau, Dianna M.; Sriram, Rama R.; da Silva, Alexandre; de Almeida, Marcos; Benedict, Theresa; Goldsmith, Cynthia S.; Zaki, Sherif R.; Visvesvara, Govinda S.; Kuehnert, Matthew J.		Microsporidia Transplant Transmiss	Microsporidiosis Acquired Through Solid Organ Transplantation A Public Health Investigation	ANNALS OF INTERNAL MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; SUBUNIT RIBOSOMAL-RNA; IN-VITRO CULTURE; ENCEPHALITOZOON-CUNICULI; ENTEROCYTOZOON-BIENEUSI; IMMUNOCOMPETENT SUBJECTS; PATIENT; AIDS; BRUCELLA; INFECTION	Background: Encephalitozoon cuniculi, a microsporidial species most commonly recognized as a cause of renal, respiratory, and central nervous system, infections in immunosuppressed patients, was identified as the cause of a temporally associated cluster of febrile illness among 3 solid organ transplant recipients from a common donor. Objective: To confirm the source of the illness, assess donor and recipient risk factors, and provide therapy recommendations for ill recipients. Design: Public health investigation. Setting: Two transplant hospitals and community interview with the deceased donor's family. Patients: Three transplant recipients and the organ donor. Measurements: Specimens were tested for microsporidia by using culture, immunofluorescent antibody, polymerase chain reaction, immunohistochemistry, and electron microscopy. Donor medical records were reviewed and a questionnaire was developed to assess for microsporidial infection. Results: Kidneys and lungs were procured from the deceased donor and transplanted to 3 recipients who became ill with fever 7 to 10 weeks after the transplant. Results of urine culture, serologic, and polymerase chain reaction testing were positive for E. cuniculi of genotype III in each recipient; the organism was also. identified in biopsy or autopsy specimens in all recipients. The donor had positive serologic test results for E. cuniculi. Surviving recipients received albendazole. Donor assessment did not identify factors for suspected E. cuniculi infection. Limitation: Inability to detect organism by culture or polymerase chain reaction in donor due to lack of autopsy specimens. Conclusion: Microsporidiosis is now recognized as an emerging transplant-associated disease and should be considered in febrile transplant recipients when tests for routinely encountered agents are unrevealing. Donor-derived disease is critical to assess when multiple recipients from a common donor are ill.	[Hocevar, Susan N.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Baylor Univ, Med Ctr, Dallas, TX USA; Southwest Transplant Alliance, Dallas, TX USA; Las Palmas Med Ctr, El Paso, TX USA	Centers for Disease Control & Prevention - USA; Baylor University; Baylor University Medical Center	Hocevar, SN (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A35, Atlanta, GA 30333 USA.	lgc7@cdc.gov	Tiller, Rebekah/GRJ-1844-2022		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ambrosioni J, 2010, BONE MARROW TRANSPL, V45, P1249, DOI 10.1038/bmt.2009.315; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; BROWN SL, 1981, J CLIN MICROBIOL, V13, P398, DOI 10.1128/JCM.13.2.398-400.1981; BUCHANAN TM, 1980, J CLIN MICROBIOL, V11, P691, DOI 10.1128/JCM.11.6.691-693.1980; Carlson James R, 2004, Arch Pathol Lab Med, V128, pe41; Carrington M, 2012, J CLIN MICROBIOL, V50, P2173, DOI 10.1128/JCM.00573-12; Croppo GP, 1997, J PARASITOL, V83, P66, DOI 10.2307/3284318; da Silva AJ, 1999, MOL DIAGN, V4, P57, DOI 10.1016/S1084-8592(99)80050-2; daSilva AJ, 1997, ARCH PATHOL LAB MED, V121, P874; DaSilva AJ, 1996, J CLIN MICROBIOL, V34, P986, DOI 10.1128/JCM.34.4.986-987.1996; Decraene V, 2012, EPIDEMIOL INFECT, V140, P519, DOI 10.1017/S095026881100077X; DEGROOTE MA, 1995, J INFECT DIS, V171, P1375, DOI 10.1093/infdis/171.5.1375; Del Aguila C, 2001, J EUKARYOT MICROBIOL, p75S; del Aguila C, 2001, J CLIN MICROBIOL, V39, P1105, DOI 10.1128/JCM.39.3.1105-1108.2001; Desoubeaux G, 2013, TRANSPL INFECT DIS, V15, pE250, DOI 10.1111/tid.12158; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Didier ES, 2000, MICROBES INFECT, V2, P709, DOI 10.1016/S1286-4579(00)00354-3; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Didier ES, 1998, CLIN INFECT DIS, V27, P1, DOI 10.1086/514607; Didier ES, 1996, J CLIN MICROBIOL, V34, P2835, DOI 10.1128/JCM.34.11.2835-2837.1996; Dither ES, 2005, EXPERT REV ANTI-INFE, V3, P419; Franzen C, 1995, CLIN INFECT DIS, V21, P1480, DOI 10.1093/clinids/21.6.1480; Galvan AL, 2011, J CLIN MICROBIOL, V49, P1301, DOI 10.1128/JCM.01833-10; Garcia LS, 2002, J CLIN MICROBIOL, V40, P1892, DOI 10.1128/JCM.40.6.1892-1901.2002; Gross U, 2003, PARASITOL RES, V90, pS14, DOI 10.1007/s00436-002-0753-x; Hinic V, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-22; Kakrania R, 2006, EYE, V20, P1314, DOI 10.1038/sj.eye.6702178; Kucerova-Pospisilova Z, 1998, FOLIA PARASIT, V45, P108; Lanternier F, 2009, TRANSPL INFECT DIS, V11, P83, DOI 10.1111/j.1399-3062.2008.00347.x; Lobo ML, 2012, INT J PARASITOL, V42, P197, DOI 10.1016/j.ijpara.2011.12.002; Meissner EG, 2012, EMERG INFECT DIS, V18, P1155, DOI 10.3201/eid1807.120047; Mofenson Lynne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Nagpal A, 2013, TRANSPL INFECT DIS, V15, P526, DOI 10.1111/tid.12119; Pragle A., 2008, Morbidity and Mortality Weekly Report, V57, P603; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2010, EMERG INFECT DIS, V16, P335, DOI 10.3201/eid1602.090964; Scaglia M, 1998, CLIN INFECT DIS, V26, P174, DOI 10.1086/516264; vanGool T, 1997, J INFECT DIS, V175, P1020, DOI 10.1086/513963; VISVESVARA GS, 1995, J CLIN MICROBIOL, V33, P930, DOI 10.1128/JCM.33.4.930-936.1995; Vrioni G, 2008, CLIN INFECT DIS, V46, pE131, DOI 10.1086/588482	43	38	41	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					213	220		10.7326/M13-2226	http://dx.doi.org/10.7326/M13-2226			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727839	Green Accepted			2022-12-24	WOS:000331666500001
J	McLeod, DSA; Caturegli, P; Cooper, DS; Matos, PG; Hutfless, S				McLeod, Donald S. A.; Caturegli, Patrizio; Cooper, David S.; Matos, Peter G.; Hutfless, Susan			Variation in Rates of Autoimmune Thyroid Disease by Race/Ethnicity in US Military Personnel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SURVEY NHANES-III; NATIONAL-HEALTH; PREVALENCE		[McLeod, Donald S. A.] QIMR Berghofer Med Res Inst, Dept Populat Hlth, Herston, Qld, Australia; [Caturegli, Patrizio] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Cooper, David S.] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD USA; [Matos, Peter G.] US Army, Joint Munit Command Headquarters AMSJM HRS, Rock Isl, IL USA; [Hutfless, Susan] Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD USA	QIMR Berghofer Medical Research Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	McLeod, DSA (corresponding author), Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, QIMR Locked Bag 2000, Herston, Qld 4029, Australia.	donald.mcleod@qimrberghofer.edu.au	McLeod, Donald/ABC-6047-2021; McLeod, Donald/O-1051-2019; McLeod, Donald S. A./C-4242-2014	McLeod, Donald/0000-0003-1131-020X; McLeod, Donald S. A./0000-0003-1131-020X; Hutfless, Susan/0000-0002-6311-2611				Belin RM, 2004, J CLIN ENDOCR METAB, V89, P6077, DOI 10.1210/jc.2004-0431; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Holm IA, 2005, ARCH INTERN MED, V165, P1606, DOI 10.1001/archinte.165.14.1606; McLeod DSA, 2012, ENDOCRINE, V42, P252, DOI 10.1007/s12020-012-9703-2; Nelson JP, 2008, NICOTINE TOB RES, V10, P775, DOI 10.1080/14622200802027123; US Census Bureau, NAT INT EST 2000 201	6	60	65	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1563	1565		10.1001/jama.2013.285606	http://dx.doi.org/10.1001/jama.2013.285606			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24737370				2022-12-24	WOS:000334306000025
J	Denzel, MS; Storm, NJ; Gutschmidt, A; Baddi, R; Hinze, Y; Jarosch, E; Sommer, T; Hoppe, T; Antebi, A				Denzel, Martin S.; Storm, Nadia J.; Gutschmidt, Aljona; Baddi, Ruth; Hinze, Yvonne; Jarosch, Ernst; Sommer, Thomas; Hoppe, Thorsten; Antebi, Adam			Hexosamine Pathway Metabolites Enhance Protein Quality Control and Prolong Life	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSGENIC CAENORHABDITIS-ELEGANS; HEAT-SHOCK FACTOR; C. ELEGANS; AUTOPHAGY GENES; LONGEVITY; ER; DEGRADATION; DISEASE; SPAN	Aging entails a progressive decline in protein homeostasis, which often leads to age-related diseases. The endoplasmic reticulum (ER) is the site of protein synthesis and maturation for secreted and membrane proteins. Correct folding of ER proteins requires covalent attachment of N-linked glycan oligosaccharides. Here, we report that increased synthesis of N-glycan precursors in the hexosamine pathway improves ER protein homeostasis and extends lifespan in C. elegans. Addition of the N-glycan precursor N-acetylglucosamine to the growth medium slows aging in wild-type animals and alleviates pathology of distinct neurotoxic disease models. Our data suggest that reduced aggregation of metastable proteins and lifespan extension depend on enhanced ER-associated protein degradation, proteasomal activity, and autophagy. Evidently, hexosamine pathway activation or N-acetylglucosamine supplementation induces distinct protein quality control mechanisms, which may allow therapeutic intervention against age-related and proteotoxic diseases.	[Denzel, Martin S.; Storm, Nadia J.; Baddi, Ruth; Hinze, Yvonne; Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Antebi, Adam] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gutschmidt, Aljona; Hoppe, Thorsten; Antebi, Adam] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respo, D-50674 Cologne, Germany; [Gutschmidt, Aljona; Hoppe, Thorsten] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Jarosch, Ernst; Sommer, Thomas] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Sommer, Thomas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Max Planck Society; Baylor College of Medicine; University of Cologne; University of Cologne; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin	Antebi, A (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany.	antebi@age.mpg.de	Denzel, Martin/C-9047-2014; Hoppe, Thorsten/AAC-7880-2020	Denzel, Martin/0000-0002-5691-3349; Hoppe, Thorsten/0000-0002-4734-9352; Jarosch, Ernst/0000-0002-5897-3492	EMBO fellowship; Marie-Curie Career Integration Grant; Max Planck Society; BMBF/Sybacol; Deutsche Forschungsgemeinschaft (DFG)/CECAD; DFG; DIP8 grant [2014376]; CECAD [FOR885, KFO286, SFB635]; German-Israel Project Cooperation DIP;  [JA 1830/1-2];  [SFB 740];  [1365]	EMBO fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie Career Integration Grant; Max Planck Society(Max Planck SocietyFoundation CELLEX); BMBF/Sybacol; Deutsche Forschungsgemeinschaft (DFG)/CECAD(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DIP8 grant; CECAD; German-Israel Project Cooperation DIP; ; ; 	We thank the Caenorhabditis Genetics Center for strains. We also thank Dr. Claudia Knief and Dr. Richard Reinhardt from the Max Planck Genome Centre Cologne for whole-genome sequencing and Dr. Assa Yeroslaviz for support with bioinformatic analyses. This work was supported by an EMBO fellowship and a Marie-Curie Career Integration Grant (M.S.D.); by the Max Planck Society, BMBF/Sybacol, and Deutsche Forschungsgemeinschaft (DFG)/CECAD (A.A.); by grants from the DFG, the DIP8 grant 2014376, CECAD FOR885, KFO286, and SFB635 (T.H.); and by grants JA 1830/1-2 and SFB 740, Priority Program 1365, and the German-Israel Project Cooperation DIP (T.S. and E.J.).	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernasconi R, 2012, MOL CELL, V46, P809, DOI 10.1016/j.molcel.2012.04.017; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BRENNER S, 1974, GENETICS, V77, P71; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fredriksson A, 2012, AGING CELL, V11, P634, DOI 10.1111/j.1474-9726.2012.00823.x; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson WG, 2000, J ANAT, V196, P609, DOI 10.1046/j.1469-7580.2000.19640609.x; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Plemper RK, 1999, J CELL SCI, V112, P4123; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Saito Y, 1999, J BIOCHEM-TOKYO, V125, P130, DOI 10.1093/oxfordjournals.jbchem.a022249; Schipanski A, 2013, GENETICS, V193, P865, DOI 10.1534/genetics.112.149088; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shintani T, 2010, BIOCHEM BIOPH RES CO, V391, P1775, DOI 10.1016/j.bbrc.2009.12.154; Shore DE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002792; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Zhao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064228; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	46	149	157	0	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1167	1178		10.1016/j.cell.2014.01.061	http://dx.doi.org/10.1016/j.cell.2014.01.061			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630720	Bronze, Green Published			2022-12-24	WOS:000332945100008
J	Jordan-Young, RM; Sonksen, PH; Karkazis, K				Jordan-Young, Rebecca M.; Soenksen, Peter H.; Karkazis, Katrina			Sex, health, and athletes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OUT-OF-BOUNDS; ANDROGEN EXCESS; HYPERANDROGENISM; MANAGEMENT; DISORDERS; CRITIQUE; POLICIES; WOMEN		[Jordan-Young, Rebecca M.] Columbia Univ, Barnard Coll, New York, NY USA; [Soenksen, Peter H.] St Thomas Hosp, London, England; [Soenksen, Peter H.] Kings Coll London, London WC2R 2LS, England; [Soenksen, Peter H.] Univ Southampton, Southampton, Hants, England; [Karkazis, Katrina] Stanford Univ, Stanford, CA 93405 USA	Columbia University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Southampton; Stanford University	Karkazis, K (corresponding author), Stanford Univ, 1215 Welch Rd, Stanford, CA 93405 USA.	karkazis@stanford.edu	Karkazis, Katrina/AAE-7276-2019	Karkazis, Katrina/0000-0001-9103-2881	Divn Of Social and Economic Sciences [1331123] Funding Source: National Science Foundation	Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		[Anonymous], SPORT TRANS MAK SPOR; [Anonymous], 2010, GUARDIAN; Archer JS, 2004, BEST PRACT RES CL OB, V18, P737, DOI 10.1016/j.bpobgyn.2004.05.007; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Bermon S., 2012, GEND VER; Bermon S, 2013, AM J BIOETHICS, V13, P63, DOI 10.1080/15265161.2013.776129; Carmina E, 2006, J CLIN ENDOCR METAB, V91, P2, DOI 10.1210/jc.2005-1457; Cook CJ, 2013, PHYSIOL BEHAV, V116, P8, DOI 10.1016/j.physbeh.2013.03.013; Fenichel P, 2013, J CLIN ENDOCR METAB, V98, pE1055, DOI 10.1210/jc.2012-3893; FIFA, 2011, GEND VER; Genel M, 2010, PEDIATR RES, V68, P149, DOI 10.1203/00006450-201011001-00289; Goodman N F, 2001, Endocr Pract, V7, P120; Government of India Ministry of Youth and Sports, 2013, STAND OP PROC ID CIR; Healy ML, 2014, CLIN ENDOCRINOL; International Association of Athletics Federations, 2011, IAAF REG GOV ELIG FE; International Association of Athletics Federations, 2011, HYP REG EXPL NOT; International Olympic Committee, 2014, IOC REG FEM HYP; Karkazis K, 2012, AM J BIOETHICS, V12, P3, DOI 10.1080/15265161.2012.680533; King NMP, 2013, AM J BIOETHICS, V13, P13, DOI 10.1080/15265161.2013.828126; Ljungqvist A, 2012, GENDER VER SPORT; Melmed S., 2011, WILLIAMS TXB ENDOCRI, V12th; Riepe FG, 2002, HORM RES, V58, P196, DOI 10.1159/000065492; Wunsch L, 2012, BJU INT, V110, pE958, DOI 10.1111/j.1464-410X.2012.11181.x; Xavier NA, 2012, J CLIN ENDOCR METAB, V97, P3902, DOI 10.1210/jc.2012-2792	24	25	25	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2926	10.1136/bmj.g2926	http://dx.doi.org/10.1136/bmj.g2926			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24776640				2022-12-24	WOS:000335471000005
J	Wood, J; Freemantle, N; King, M; Nazareth, I				Wood, John; Freemantle, Nick; King, Michael; Nazareth, Irwin			Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Wood, John; Freemantle, Nick; Nazareth, Irwin] UCL, Res Dept Primary Care, London NW3 2PF, England; [Wood, John; Freemantle, Nick; Nazareth, Irwin] UCL, Populat Hlth & PRIMENT Clin Trials Unit, London NW3 2PF, England; [King, Michael] UCL, Div Psychiat, London W1W 7EJ, England; [King, Michael] UCL, PRIMENT Clin Trials Unit, London W1W 7EJ, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Wood, J (corresponding author), UCL, Res Dept Primary Care, London NW3 2PF, England.	john.x.wood@ucl.ac.uk		Nazareth, Irwin/0000-0003-2146-9628; Freemantle, Nick/0000-0001-5807-5740	National Institute for Health Research [NF-SI-0611-10210] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Dorrance AM, 2009, HYPERTENSION, V54, P451, DOI 10.1161/HYPERTENSIONAHA.109.135855; Fisher RA, 1966, DESIGN EXPT, P21; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Sedgewick P., 2010, BMJ-BRIT MED J, V340, pc2458; Tukey JW, 1991, STAT SCI, V6, P100, DOI [DOI 10.1214/SS/1177011945, 10.1214/ss/1177011945]; Xie MG, 2013, INT STAT REV, V81, P3, DOI 10.1111/insr.12000	7	47	47	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2215	10.1136/bmj.g2215	http://dx.doi.org/10.1136/bmj.g2215			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TK	24687314	Green Published, Bronze			2022-12-24	WOS:000333976100003
J	MacGregor, GA; Hashem, KM				MacGregor, Graham A.; Hashem, Kawther M.			Action on sugar-lessons from UK salt reduction programme	LANCET			English	Editorial Material							BODY-WEIGHT; OBESITY; FOOD; HEALTH		[MacGregor, Graham A.; Hashem, Kawther M.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England	University of London; Queen Mary University London	MacGregor, GA (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	g.macgregor@qmul.ac.uk						[Anonymous], 2013, LANCET, V381, P963, DOI 10.1016/S0140-6736(13)60695-9; [Anonymous], 2011, NAT DIET NUTR SURV H; Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food Standards Agency, 2007, LOW INC DIET NUTR SU; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2012; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Sutherland J, 2013, BRIT J NUTR, V110, P552, DOI 10.1017/S0007114512005430; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; UK Government's Foresight Programme, 2007, FORESIGHT TACKLING O; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; World Health Organization, 2014, WHO OP PUBL CONS DRA; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	24	53	54	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					929	931		10.1016/S0140-6736(14)60200-2	http://dx.doi.org/10.1016/S0140-6736(14)60200-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24629282				2022-12-24	WOS:000333520700004
J	Olsen, Y; Sharfstein, JM				Olsen, Yngvild; Sharfstein, Joshua M.			Chronic Pain, Addiction, and Zohydro	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Olsen, Yngvild] Inst Behav Resources, Baltimore, MD 21205 USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Maryland Department of Health & Mental Hygiene	Olsen, Y (corresponding author), Inst Behav Resources, Baltimore, MD 21205 USA.							Centers for Disease Control and Prevention (CDC), 2013, POL IMP PRESCR PAINK; Centers for Disease Control and Prevention (CDC), 2011, PUBL HLTH GRAND ROUN; FDA Commissioner Margaret A, 2014, COMMUNICATION   0403; Federation of State Medical Boards of the United States, 2014, PAIN MAN POL BOARD B; Severtson SG, 2013, J PAIN, V14, P1122, DOI 10.1016/j.jpain.2013.04.011	5	20	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2061	2063		10.1056/NEJMp1404181	http://dx.doi.org/10.1056/NEJMp1404181			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24758596				2022-12-24	WOS:000336434000002
J	Zhang, KH; Zhang, J; Gao, ZG; Zhang, DD; Zhu, L; Han, GW; Moss, SM; Paoletta, S; Kiselev, E; Lu, WZ; Fenalti, G; Zhang, WR; Muller, CE; Yang, HY; Jiang, HL; Cherezov, V; Katritch, V; Jacobson, KA; Stevens, RC; Wu, BL; Zhao, Q				Zhang, Kaihua; Zhang, Jin; Gao, Zhan-Guo; Zhang, Dandan; Zhu, Lan; Han, Gye Won; Moss, Steven M.; Paoletta, Silvia; Kiselev, Evgeny; Lu, Weizhen; Fenalti, Gustavo; Zhang, Wenru; Mueller, Christa E.; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Katritch, Vsevolod; Jacobson, Kenneth A.; Stevens, Raymond C.; Wu, Beili; Zhao, Qiang			Structure of the human P2Y(12) receptor in complex with an antithrombotic drug	NATURE			English	Article							ACTIVE METABOLITE; NUCLEOTIDE RECEPTORS; CRYSTAL-STRUCTURE; AMINO-ACIDS; PROTEIN; IDENTIFICATION; CLOPIDOGREL; ANTAGONISTS; INHIBITION; PRASUGREL	P2Y receptors (P2YRs), a family of purinergic G-protein-coupled receptors (GPCRs), are activated by extracellular nucleotides. There are a total of eight distinct functional P2YRs expressed in human, which are subdivided into P2Y1-like receptors and P2Y(12)-like receptors(1). Their ligands are generally charged molecules with relatively low bioavailability and stability in vivo(2), which limits our understanding of this receptor family. P2Y(12)R regulates platelet activation and thrombus formation(3,4), and several antithrombotic drugs targeting P2Y(12)R-including the prodrugs clopidogrel (Plavix) and prasugrel (Effient) that are metabolized and bind covalently, and the nucleoside analogue ticagrelor (Brilinta) that acts directly on the receptor-have been approved for the prevention of stroke and myocardial infarction. However, limitations of these drugs (for example, a very long half-life of clopidogrel action and a characteristic adverse effect profile of ticagrelor) 5,6 suggest that there is an unfulfilled medical need for developing a new generation of P2Y(12)R inhibitors(7,8). Here we report the 2.6 angstrom resolution crystal structure of human P2Y(12)R in complex with a non-nucleotide reversible antagonist, AZD1283. The structure reveals a distinct straight conformation of helix V, which sets P2Y(12)R apart from all other known class A GPCR structures. With AZD1283 bound, the highly conserved disulphide bridge in GPCRs between helix III and extracellular loop 2 is not observed and appears to be dynamic. Along with the details of the AZD1283-binding site, analysis of the extracellular interface reveals an adjacent ligand-binding region and suggests that both pockets could be required for dinucleotide binding. The structure provides essential insights for the development of improved P2Y(12)R ligands and allosteric modulators as drug candidates.	[Zhang, Kaihua; Zhang, Jin; Zhang, Dandan; Zhu, Lan; Lu, Weizhen; Zhang, Wenru; Wu, Beili; Zhao, Qiang] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Gao, Zhan-Guo; Moss, Steven M.; Paoletta, Silvia; Kiselev, Evgeny; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Han, Gye Won; Fenalti, Gustavo; Cherezov, Vadim; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Mueller, Christa E.] PharmaCtr Bonn, Inst Pharmaceut, D-53121 Bonn, Germany; [Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University	Zhao, Q (corresponding author), Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	zhaoq@simm.ac.cn	Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; Müller, Christa Elisabeth/C-7748-2014; Jacobson, Kenneth Alan/A-1530-2009; Zhang, Kaihua/AAD-7882-2022; Katritch, Vsevolod/Y-2721-2019; Katritch, Vsevolod/Q-8357-2016; Han, Gye Won/GLQ-8673-2022; Stevens, Raymond/K-7272-2015	Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Müller, Christa Elisabeth/0000-0002-0013-6624; Jacobson, Kenneth Alan/0000-0001-8104-1493; Zhang, Kaihua/0000-0003-3734-3624; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725; Zhang, Dandan/0000-0002-8863-5806	National Basic Research Program of China [2012CB910400, 2012CB518000]; National Institutes of Health (NIH) [R01 AI100604, U54 GM094618]; National Science Foundation of China [31370729, 31170683]; National Institute of General Medical Sciences Postdoctoral Research Associate program; NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031126, ZIADK031116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of General Medical Sciences Postdoctoral Research Associate program; NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China grants 2012CB910400 and 2012CB518000 (B. W., Q.Z.), National Institutes of Health (NIH) grants R01 AI100604 (B. W., Q.Z.) and U54 GM094618 (V. C., V. K., R. C. S.; Target GPCR-87), National Science Foundation of China grants 31370729 and 31170683 (B. W., Q.Z.), the National Institute of General Medical Sciences Postdoctoral Research Associate program (E. K.) and the NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program (K.A.J.). The authors thank AstraZeneca for their gift of AZD1283, and thank S. Nylander, F. Giordanetto and H. van Giezen for careful review and scientific feedback on the manuscript, A. Walker for assistance with manuscript preparation, and C. Wang and D. Wacker for help on collection of X-ray diffraction data.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Algaier I, 2008, J THROMB HAEMOST, V6, P1908, DOI 10.1111/j.1538-7836.2008.03136.x; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Bach P, 2013, J MED CHEM, V56, P7015, DOI 10.1021/jm400820m; Bach P, 2013, EUR J MED CHEM, V65, P360, DOI 10.1016/j.ejmech.2013.04.007; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cattaneo M, 2005, SEMIN THROMB HEMOST, V31, P168, DOI 10.1055/s-2005-869522; Cattaneo M, 2003, P NATL ACAD SCI USA, V100, P1978, DOI 10.1073/pnas.0437879100; Cattaneo M, 2011, BLOOD, V117, P2102, DOI 10.1182/blood-2010-08-263111; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Ding Z, 2009, J THROMB HAEMOST, V7, P232, DOI 10.1111/j.1538-7836.2008.03202.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hasegawa M, 2005, THROMB HAEMOSTASIS, V94, P593, DOI 10.1160/TH05-03-0208; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; Ignatovica V, 2012, FEBS J, V279, P180, DOI 10.1111/j.1742-4658.2011.08410.x; Jacobson KA, 2010, DRUG DISCOV TODAY, V15, P570, DOI 10.1016/j.drudis.2010.05.011; Jagroop IA, 2003, PLATELETS, V14, P15, DOI 10.1080/0953710021000062914; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Mao YY, 2010, EUR J PHARMACOL, V644, P10, DOI 10.1016/j.ejphar.2010.06.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nylander S, 2004, BRIT J PHARMACOL, V142, P1325, DOI 10.1038/sj.bjp.0705885; Ohlmann P, 2013, PURINERG SIGNAL, V9, P59, DOI 10.1007/s11302-012-9329-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	36	276	288	7	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					115	118		10.1038/nature13083	http://dx.doi.org/10.1038/nature13083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670650	Green Accepted			2022-12-24	WOS:000335199100050
J	Omatsu, Y; Seike, M; Sugiyama, T; Kume, T; Nagasawa, T				Omatsu, Yoshiki; Seike, Masanari; Sugiyama, Tatsuki; Kume, Tsutomu; Nagasawa, Takashi			Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation	NATURE			English	Article							BONE-MARROW NICHE; STEM-CELLS; PROGENITORS; MAINTENANCE; MICE; DISTINCT; MUSCLE; MICROENVIRONMENT; DIFFERENTIATION; REPOPULATION	Haematopoietic stem and progenitor cells are maintained by special microenvironments known as niches in bone marrow(1-6). Many studies have identified diverse candidate cells that constitute niches for haematopoietic stem cells in the marrow, including osteoblasts(7-10), endothelial cells(11-14), Schwann cells(15), alpha-smooth muscle actin-expressing macrophages(16) and mesenchymal progenitors such as CXC chemokine ligand (CXCL) 12-abundant reticular (CAR) cells(17,18), stem cell factor-expressing cells(13), nestin-expressing cells(19) and platelet-derived growth factor receptor-alpha (PDGFR-alpha)(+)Sca-1(+)CD45(-)Ter119(-) (P alpha S) cells(20). However, the molecular basis of the formation of the niches remains unclear. Here we find that the transcription factor Foxc1 is preferentially expressed in the adipo-osteogenic progenitor CAR cells essential for haematopoietic stem and progenitor cell maintenance in vivo(5,13,18) in the developing and adult bone marrow. When Foxc1 was deleted in all marrow mesenchymal cells or CAR cells, from embryogenesis onwards, osteoblasts appeared normal, but haematopoietic stem and progenitor cells were markedly reduced and marrow cavities were occupied by adipocytes (yellow adipose marrow) with reduced CAR cells. Inducible deletion of Foxc1 in adult mice depleted haematopoietic stem and progenitor cells and reduced CXCL12 and stem cell factor expression in CAR cells but did not induce a change to yellow marrow. These data suggest a role for Foxc1 in inhibiting adipogenic processes in CAR progenitors. Foxc1 might also promote CAR cell development, upregulating CXCL12 and stem cell factor expression. This study identifies Foxc1 as a specific transcriptional regulator essential for development and maintenance of the mesenchymal niches for haematopoietic stem and progenitor cells.	[Omatsu, Yoshiki; Seike, Masanari; Sugiyama, Tatsuki; Nagasawa, Takashi] Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068501, Japan; [Omatsu, Yoshiki; Seike, Masanari; Sugiyama, Tatsuki; Nagasawa, Takashi] Japan Sci & Technol Agcy JST, CREST, Sakyo Ku, Kyoto 6068507, Japan; [Kume, Tsutomu] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA	Kyoto University; Northwestern University; Feinberg School of Medicine	Nagasawa, T (corresponding author), Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068501, Japan.	tnagasa@frontier.kyoto-u.ac.jp		Nagasawa, Takashi/0000-0002-1085-0960; Sugiyama, Tatsuki/0000-0002-9349-0824; Omatsu, Yoshiki/0000-0002-6212-0441	JST, CREST; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	We appreciate the technical assistance provided by K. Kawaguchi and G. Kondoh, and thank I. Sasagawa for secretarial assistance. This research was supported by JST, CREST and the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI.	Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KODAMA H, 1994, EXP HEMATOL, V22, P979; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sasman A, 2012, GENESIS, V50, P766, DOI 10.1002/dvg.22036; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	40	157	161	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					536	+		10.1038/nature13071	http://dx.doi.org/10.1038/nature13071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24590069				2022-12-24	WOS:000334741600039
J	Evans, T; Wade, CM; Chapman, FA; Johnson, AD; Loose, M				Evans, Teri; Wade, Christopher M.; Chapman, Frank A.; Johnson, Andrew D.; Loose, Matthew			Acquisition of Germ Plasm Accelerates Vertebrate Evolution	SCIENCE			English	Article							CELL DEVELOPMENT; URODELE AMPHIBIANS; EMBRYOS; SPECIFICATION; MAMMALS; ORIGIN; TURTLE; GENES; VASA	Primordial germ cell (PGC) specification occurs either by induction from pluripotent cells (epigenesis) or by a cell-autonomous mechanism mediated by germ plasm (preformation). Among vertebrates, epigenesis is basal, whereas germ plasm has evolved convergently across lineages and is associated with greater speciation. We compared protein-coding sequences of vertebrate species that employ preformation with their sister taxa that use epigenesis and demonstrate that genes evolve more rapidly in species containing germ plasm. Furthermore, differences in rates of evolution appear to cause phylogenetic incongruence in protein-coding sequence comparisons between vertebrate taxa. Our results support the hypothesis that germ plasm liberates constraints on somatic development and that enhanced evolvability drives the evolution of germ plasm.	[Evans, Teri; Wade, Christopher M.; Johnson, Andrew D.; Loose, Matthew] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Chapman, Frank A.] Univ Florida, Program Fisheries & Aquat Sci, Gainesville, FL 32653 USA	University of Nottingham; State University System of Florida; University of Florida	Johnson, AD (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England.	andrew.d.johnson@nottingham.ac.uk; matt.loose@nottingham.ac.uk		Wade, Christopher/0000-0002-1269-9694; Loose, Matthew/0000-0002-5264-0929; Johnson, Andrew/0000-0002-5183-2072; Forey, Teri/0000-0001-5663-9821	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham; MRC [G1100025, MR/L001047/1, G0700078] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [974247] Funding Source: researchfish; Medical Research Council [MR/L001047/1, G1100025, G0700078] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All data are available from the authors' Web site at www.nottingham.ac.uk/similar to plzloose/phyloinc and are deposited at http://datadryad.org (DOI: 10.5061/dryad.rd70f). The authors thank B. Crother, G. Morgan, and M. Blythe for helpful discussion. Sequencing was carried out at the Genome Centre, Queen Mary, University of London by L. Bhaw-Rosun and M. Struegbig. This work was supported by the Biotechnology and Biological Sciences Research Council, Medical Research Council, and University of Nottingham.	Bachvarova RF, 2009, EVOL DEV, V11, P603, DOI 10.1111/j.1525-142X.2009.00366.x; Bachvarova RF, 2009, EVOL DEV, V11, P525, DOI 10.1111/j.1525-142X.2009.00360.x; Crother BI, 2007, J THEOR BIOL, V248, P322, DOI 10.1016/j.jtbi.2007.05.035; Davalos LM, 2012, BIOL REV, V87, P991, DOI 10.1111/j.1469-185X.2012.00240.x; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Fan X, 2007, DEV GENES EVOL, V217, P807, DOI 10.1007/s00427-007-0191-y; Frankenberg S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-56; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hubert J., 1985, Biology of Reptilia, V14, P41; Hughes S, 2001, J MOL EVOL, V53, P70, DOI 10.1007/s002390010194; Johnson AD, 2003, EVOL DEV, V5, P414, DOI 10.1046/j.1525-142X.2003.03048.x; Johnson AD, 2003, PHILOS T ROY SOC B, V358, P1371, DOI 10.1098/rstb.2003.1331; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Leitch HG, 2013, CURR TOP DEV BIOL, V104, P149, DOI 10.1016/B978-0-12-416027-9.00005-X; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Sutasurya L. A., 1979, PRIMORDIAL GERM CELL; Swiers G, 2010, DEV BIOL, V343, P138, DOI 10.1016/j.ydbio.2010.04.002; Telford MJ, 2005, CURR BIOL, V15, pR296, DOI 10.1016/j.cub.2005.04.001; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615	23	35	35	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					200	203		10.1126/science.1249325	http://dx.doi.org/10.1126/science.1249325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723612				2022-12-24	WOS:000334096300036
J	Groschel, S; Sanders, MA; Hoogenboezem, R; de Wit, E; Bouwman, BAM; Erpelinck, C; van der Velden, VHJ; Havermans, M; Avellino, R; van Lom, K; Rombouts, EJ; van Duin, M; Dohner, K; Beverloo, HB; Bradner, JE; Dohner, H; Lowenberg, B; Valk, PJM; Bindels, EMJ; de Laat, W; Delwel, R				Groeschel, Stefan; Sanders, Mathijs A.; Hoogenboezem, Remco; de Wit, Elzo; Bouwman, Britta A. M.; Erpelinck, Claudia; van der Velden, Vincent H. J.; Havermans, Marije; Avellino, Roberto; van Lom, Kirsten; Rombouts, Elwin J.; van Duin, Mark; Doehner, Konstanze; Beverloo, H. Berna; Bradner, James E.; Doehner, Hartmut; Lowenberg, Bob; Valk, Peter J. M.; Bindels, Eric M. J.; de Laat, Wouter; Delwel, Ruud			A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia	CELL			English	Article							HEMATOPOIETIC-CELLS; MUTATIONS; ACTIVATION; LOCUS; HAPLOINSUFFICIENCY; ABNORMALITIES; LANDSCAPE	Chromosomal rearrangements without gene fusions have been implicated in leukemogenesis by causing deregulation of proto-oncogenes via relocation of cryptic regulatory DNA elements. AML with inv(3)/t(3;3) is associated with aberrant expression of the stem-cell regulator EVI1. Applying functional genomics and genome-engineering, we demonstrate that both 3q rearrangements reposition a distal GATA2 enhancer to ectopically activate EVI1 and simultaneously confer GATA2 functional haploinsufficiency, previously identified as the cause of sporadic familial AML/MDS and MonoMac/Emberger syndromes. Genomic excision of the ectopic enhancer restored EVI1 silencing and led to growth inhibition and differentiation of AML cells, which could be replicated by pharmacologic BET inhibition. Our data show that structural rearrangements involving the chromosomal repositioning of a single enhancer can cause deregulation of two unrelated distal genes, with cancer as the outcome.	[Groeschel, Stefan; Sanders, Mathijs A.; Hoogenboezem, Remco; Erpelinck, Claudia; Havermans, Marije; Avellino, Roberto; van Lom, Kirsten; Rombouts, Elwin J.; van Duin, Mark; Lowenberg, Bob; Valk, Peter J. M.; Bindels, Eric M. J.; Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; [Groeschel, Stefan; Doehner, Konstanze; Doehner, Hartmut] Ulm Univ Hosp, Dept Internal Med 2, D-89081 Ulm, Germany; [de Wit, Elzo; Bouwman, Britta A. M.; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [de Wit, Elzo; Bouwman, Britta A. M.; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van der Velden, Vincent H. J.] Erasmus Univ, Med Ctr, Dept Immunol, NL-3015 CN Rotterdam, Netherlands; [Beverloo, H. Berna] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Beverloo, H. Berna] Dutch Working Grp Hematooncol Genome Diagnost, NL-3015 GE Rotterdam, Netherlands; [Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Ulm University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Delwel, R (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands.	h.delwel@erasmusmc.nl	Valk, Peter/AAX-2823-2020; Döhner, Hartmut/C-8933-2016	Döhner, Hartmut/0000-0003-2116-5536; de Laat, Wouter/0000-0002-6393-595X; de Wit, Elzo/0000-0003-2883-1415; Bouwman, Britta/0000-0002-9827-9497	Deutsche Forschungsgemeinschaft [GR 3955/1-1]; Lady Tata Memorial Trust; Association for International Cancer Research; Center for Translational Molecular Medicine (CTMM) [GR03O-102]; EHA Research Fellowship; Worldwide Cancer Research [12-1309] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lady Tata Memorial Trust; Association for International Cancer Research; Center for Translational Molecular Medicine (CTMM); EHA Research Fellowship; Worldwide Cancer Research	We thank J. Qi for providing JQ1; I. P. Touw, P. van Strien, K. Eiwen, J. van Galen, A. C. Bijkerk, P. Hogenbirk-Hupkes, J. Koenders, F. Cornelissen, H. van de Werken, and other members of the Department of Hematology at the Erasmus MC for their support; E. Simons for editorial assistance. We thank L. Cong and F. Zhang from the Broad Institute for their support with the CRISPR/Cas9 toolbox. This work was financially supported by grants from the Deutsche Forschungsgemeinschaft (GR 3955/1-1, S. Groschel), the Lady Tata Memorial Trust, Association for International Cancer Research (E. Bindels), the Center for Translational Molecular Medicine (CTMM; GR03O-102, M. Sanders) and an EHA Research Fellowship (S. Groschel).	BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Pater E, 2013, J EXP MED, V210, P2843, DOI 10.1084/jem.20130751; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Hsu AP, 2013, BLOOD, V121, P3830, DOI 10.1182/blood-2012-08-452763; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lugthart S, 2010, J CLIN ONCOL, V28, P3890, DOI 10.1200/JCO.2010.29.2771; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2013, MITELMAN DATABASE CH; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; POLACK A, 1993, EMBO J, V12, P3913, DOI 10.1002/j.1460-2075.1993.tb06069.x; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wieser R, 2003, HAEMATOLOGICA, V88, P25	35	395	409	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					369	381		10.1016/j.cell.2014.02.019	http://dx.doi.org/10.1016/j.cell.2014.02.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24703711	Bronze			2022-12-24	WOS:000334304500011
J	Noonan, D				Noonan, David			LANGUAGE Lost in translation	NATURE			English	Editorial Material																			0	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S4	S5		10.1038/508S4a	http://dx.doi.org/10.1038/508S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695334	Bronze			2022-12-24	WOS:000333609900006
J	Napolitano, LM; Angus, DC; Uyeki, TM				Napolitano, Lena M.; Angus, Derek C.; Uyeki, Timothy M.			Critically Ill Patients With Influenza A(H1N1)pdm09 Virus Infection in 2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Napolitano, Lena M.] Univ Michigan Hosp, Univ Michigan Hlth Syst, Dept Surg Surg Crit Care & Trauma, Ann Arbor, MI 48109 USA; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Angus, Derek C.] UPMC Hlth Syst, CRISMA Ctr, Dept Crit Care Med, Pittsburgh, PA USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Napolitano, LM (corresponding author), Univ Michigan, Dept Surg, 1500 E Med Ctr Dr,1C340A UH, Ann Arbor, MI 48109 USA.	lenan@umich.edu	Angus, Derek C/E-9671-2012; Napolitano, Lena/AAZ-8651-2021		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Arriola CS, 2014, MMWR-MORBID MORTAL W, V63, P148; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beaute J, 2012, EURO SURVEILL, V17; CDC, ANT MED SUMM CLIN; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Hui DS, 2013, ANTIVIR RES, V98, P410, DOI 10.1016/j.antiviral.2013.03.019; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Masclans JR, 2013, CLIN MICROBIOL INFEC, V19, P249, DOI 10.1111/j.1469-0691.2012.03797.x; Pham T, 2013, AM J RESP CRIT CARE, V187, P276, DOI 10.1164/rccm.201205-0815OC; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23	10	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1289	1290		10.1001/jama.2014.2116	http://dx.doi.org/10.1001/jama.2014.2116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24566924	Green Accepted			2022-12-24	WOS:000333645400008
J	Xu, B; Ohtani, M; Yamaguchi, M; Toyooka, K; Wakazaki, M; Sato, M; Kubo, M; Nakano, Y; Sano, R; Hiwatashi, Y; Murata, T; Kurata, T; Yoneda, A; Kato, K; Hasebe, M; Demura, T				Xu, Bo; Ohtani, Misato; Yamaguchi, Masatoshi; Toyooka, Kiminori; Wakazaki, Mayumi; Sato, Mayuko; Kubo, Minoru; Nakano, Yoshimi; Sano, Ryosuke; Hiwatashi, Yuji; Murata, Takashi; Kurata, Tetsuya; Yoneda, Arata; Kato, Ko; Hasebe, Mitsuyasu; Demura, Taku			Contribution of NAC Transcription Factors to Plant Adaptation to Land	SCIENCE			English	Article							VASCULAR-RELATED NAC-DOMAIN6; SECONDARY WALL BIOSYNTHESIS; CONDUCTING TISSUES; WOOD FORMATION; XYLEM; ARABIDOPSIS; GENE; EXPRESSION; EVOLUTION; TRANSPORT	The development of cells specialized for water conduction or support is a striking innovation of plants that has enabled them to colonize land. The NAC transcription factors regulate the differentiation of these cells in vascular plants. However, the path by which plants with these cells have evolved from their nonvascular ancestors is unclear. We investigated genes of the moss Physcomitrella patens that encode NAC proteins. Loss-of-function mutants formed abnormal water-conducting and supporting cells, as well as malformed sporophyte cells, and overexpression induced ectopic differentiation of water-conducting-like cells. Our results show conservation of transcriptional regulation and cellular function between moss and Arabidopsis thaliana water-conducting cells. The conserved genetic basis suggests roles for NAC proteins in the adaptation of plants to land.	[Xu, Bo; Yamaguchi, Masatoshi; Nakano, Yoshimi; Sano, Ryosuke; Kurata, Tetsuya; Yoneda, Arata; Kato, Ko; Demura, Taku] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Ohtani, Misato; Toyooka, Kiminori; Wakazaki, Mayumi; Sato, Mayuko; Demura, Taku] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Kubo, Minoru; Hiwatashi, Yuji; Murata, Takashi; Hasebe, Mitsuyasu] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan	Nara Institute of Science & Technology; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Ohtani, M (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan.	misato@psc.riken.jp; demura@bs.naist.jp	Nakano, Yoshimi/AAC-8626-2020; Toyooka, Kiminori/B-5027-2011; Wakazaki, Mayumi/D-4581-2017; Kubo, Minoru/AAH-1689-2019; Demura, Taku/ABE-7871-2021; Sato, Mayuko/D-4601-2017; Yamaguchi, Masatoshi/F-2183-2011	Nakano, Yoshimi/0000-0002-4515-1633; Kubo, Minoru/0000-0001-8691-6252; Sato, Mayuko/0000-0002-9876-5612; Yamaguchi, Masatoshi/0000-0002-1396-5376; Murata, Takashi/0000-0002-1543-0439; Hasebe, Mitsuyasu/0000-0001-7425-8758; Xu, Bo/0000-0001-7264-7127; HIWATASHI, YUJI/0000-0002-3996-0549	RIKEN Biomass Engineering Program, Japan Society for the Promotion of Science KAKENHI [22370020, 24114002, 25291062, 22128002]; MEXT NC-CARP project; Grants-in-Aid for Scientific Research [24114001] Funding Source: KAKEN	RIKEN Biomass Engineering Program, Japan Society for the Promotion of Science KAKENHI; MEXT NC-CARP project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. L. Bowman (Monash University), K. Sakakibara (University of Tokyo), J. C. Mortimer (RIKEN), and I. Smith (NAIST) for critically reading the manuscript; N.-H. Chua (Rockefeller University) for providing the pER8 vector; T. Nomura (RIKEN) for valuable discussion; H. Endo (NAIST), A. Ihara, and K. Hashimoto (RIKEN) for technical assistance; T. Kuriyama and M. Matsui (RIKEN) for their contribution to A. thaliana transformation; and E. Nakamoto and T. Sakamoto (NAIST) for the RNA-seq experiment. Nucleotide sequences for PpVNS genes were deposited in the National Center for Biotechnology Information (accession nos. AB898081 to AB898088), and raw RNA-seq data were deposited in the DNA Data Bank of Japan Sequence Read Archive (DRA) database (accession no. DRA001341). This work was supported in part by the RIKEN Biomass Engineering Program, Japan Society for the Promotion of Science KAKENHI, grant numbers 22370020, 24114002, and 25291062 to T. D. and 22128002 to M. H., and by Grants-in-Aid from the MEXT NC-CARP project to T. D. The pER8 vector is available for noncommercial purposes from N. H. Chua under a materials transfer agreement with Rockefeller University.	Avci U, 2008, PLANT J, V56, P303, DOI 10.1111/j.1365-313X.2008.03592.x; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HEBANT C, 1977, CONDUCT TISSUES BRYO; Hornblad E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kenrick P, 2000, PHILOS T R SOC B, V355, P847, DOI 10.1098/rstb.2000.0619; KENRICK P, 1997, ORIGIN EARLY DIVERS; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kubo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077356; LAL M, 1981, PROTOPLASMA, V107, P79, DOI 10.1007/BF01275609; Lesniewicz K, 2013, PLANT CELL PHYSIOL, V54, P1064, DOI 10.1093/pcp/pct061; Ligrone R, 2000, PHILOS T ROY SOC B, V355, P795, DOI 10.1098/rstb.2000.0616; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Roberts AW, 2007, PLANT MOL BIOL, V63, P207, DOI 10.1007/s11103-006-9083-1; ROCKLAND LB, 1960, ANAL CHEM, V32, P1375, DOI 10.1021/ac60166a055; Sakakibara K, 2003, DEVELOPMENT, V130, P4835, DOI 10.1242/dev.00644; SCHEIRER DC, 1980, B TORREY BOT CLUB, V107, P298, DOI 10.2307/2484153; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tansley AG, 1901, ANN BOT-LONDON, V15, P1; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vidali L, 2010, PLANT CELL, V22, P1868, DOI 10.1105/tpc.109.073288; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; WIENCKE C, 1983, Z PFLANZENPHYSIOL, V112, P337, DOI 10.1016/S0044-328X(83)80051-8; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; Yamaguchi M, 2011, PLANT J, V66, P579, DOI 10.1111/j.1365-313x.2011.04514.x; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013; Zhao CS, 2000, PLANT PHYSIOL, V123, P1185, DOI 10.1104/pp.123.3.1185; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhu TT, 2012, EVOLUTION, V66, P1833, DOI 10.1111/j.1558-5646.2011.01553.x; Zimmer AD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-498; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	44	153	161	11	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1505	1508		10.1126/science.1248417	http://dx.doi.org/10.1126/science.1248417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24652936				2022-12-24	WOS:000333471000046
J	Wunsch, H; Christiansen, CF; Johansen, MB; Olsen, M; Ali, N; Angus, DC; Sorensen, HT				Wunsch, Hannah; Christiansen, Christian F.; Johansen, Martin B.; Olsen, Morten; Ali, Naeem; Angus, Derek C.; Sorensen, Henrik Toft			Psychiatric Diagnoses and Psychoactive Medication Use Among Nonsurgical Critically Ill Patients Receiving Mechanical Ventilation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NATIONAL-COMORBIDITY-SURVEY; CARE-UNIT SURVIVORS; LONG-TERM OUTCOMES; CRITICAL ILLNESS; INTENSIVE-CARE; SEVERE SEPSIS; PROSPECTIVE COHORT; OLDER AMERICANS; DEPRESSION	IMPORTANCE The relationship between critical illness and psychiatric illness is unclear. OBJECTIVE To assess psychiatric diagnoses and medication prescriptions before and after critical illness. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study in Denmark of critically ill patients in 2006-2008 with follow-up through 2009, and 2 matched comparison cohorts from hospitalized patients and from the general population. EXPOSURES Critical illness defined as intensive care unit admission with mechanical ventilation. MAIN OUTCOMES AND MEASURES Adjusted prevalence ratios (PRs) of psychiatrist-diagnosed psychiatric illnesses and prescriptions for psychoactive medications in the 5 years before critical illness. For patients with no psychiatric history, quarterly cumulative incidence (risk) and adjusted hazard ratios (HRs) for diagnoses and medications in the following year, using Cox regression. RESULTS Among 24 179 critically ill patients, 6.2% had 1 or more psychiatric diagnoses in the prior 5 years vs 5.4% for hospitalized patients (adjusted PR, 1.31; 95% CI, 1.22-1.42; P<.001) and 2.4% for the general population (adjusted PR, 2.57; 95% CI, 2.41-2.73; P<.001). Five-year preadmission psychoactive prescription rates were similar to hospitalized patients: 48.7% vs 48.8% (adjusted PR, 0.97; 95% CI, 0.95-0.99; P<.001) but were higher than the general population (33.2%; adjusted PR, 1.40; 95% CI, 1.38-1.42; P<.001). Among the 9912 critical illness survivors with no psychiatric history, the absolute risk of new psychiatric diagnoses was low but higher than hospitalized patients: 0.5% vs 0.2% over the first 3 months (adjusted HR, 3.42; 95% CI, 1.96-5.99; P<.001), and the general population cohort (0.02%; adjusted HR, 21.77; 95% CI, 9.23-51.36; P<.001). Risk of new psychoactive medication prescriptions was also increased in the first 3 months: 12.7% vs 5.0% for the hospital cohort (adjusted HR, 2.45; 95% CI, 2.19-2.74; P<.001) and 0.7% for the general population (adjusted HR, 21.09; 95% CI, 17.92-24.82; P<.001). These differences had largely resolved by 9 to 12 months after discharge. CONCLUSIONS AND RELEVANCE Prior psychiatric diagnoses are more common in critically ill patients than in hospital and general population cohorts. Among survivors of critical illness, new psychiatric diagnoses and psychoactive medication use is increased in the months after discharge. Our data suggest both a possible role of psychiatric disease in predisposing patients to critical illness and an increased but transient risk of new psychiatric diagnoses and treatment after critical illness.	[Wunsch, Hannah] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Wunsch, Hannah] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Christiansen, Christian F.; Johansen, Martin B.; Olsen, Morten; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Christiansen, Christian F.] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care, DK-8200 Aarhus N, Denmark; [Ali, Naeem] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA	Columbia University; Columbia University; Aarhus University; Aarhus University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Christiansen, CF (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus N, Denmark.	cc@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Christiansen, Christian Fynbo/B-5870-2014; Johansen, Martin Nygård/L-6845-2014; Angus, Derek C/E-9671-2012; Christiansen, Christian/ABE-9423-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Christiansen, Christian Fynbo/0000-0002-0727-953X; Johansen, Martin Nygård/0000-0001-9790-0985; Christiansen, Christian/0000-0002-0727-953X; ALI, NORA'AINI/0000-0003-1391-2757				Abrams TE, 2010, ARCH SURG-CHICAGO, V145, P947, DOI 10.1001/archsurg.2010.190; Blichert-Hansen Linea, 2013, Clin Epidemiol, V5, P9, DOI 10.2147/CLEP.S37763; Christensen Steffen, 2011, Clin Epidemiol, V3, P203, DOI 10.2147/CLEP.S20247; Christiansen CF, 2011, ACTA ANAESTH SCAND, V55, P962, DOI 10.1111/j.1399-6576.2011.02480.x; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Davydow DS, 2013, AM J GERIAT PSYCHIAT, V21, P887, DOI 10.1016/j.jagp.2013.01.017; Davydow DS, 2009, INTENS CARE MED, V35, P796, DOI 10.1007/s00134-009-1396-5; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Friese RS, 2008, CRIT CARE MED, V36, P697, DOI 10.1097/CCM.0B013E3181643F29; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2012, AM J RESP CRIT CARE, V185, P835, DOI 10.1164/rccm.201109-1660OC; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Martin JL, 2012, AM J GERIAT PSYCHIAT, V20, P477, DOI 10.1097/JGP.0b013e31824877c1; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Munk-Olsen T, 2011, NEW ENGL J MED, V364, P332, DOI 10.1056/NEJMoa0905882; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nelson JE, 2004, CRIT CARE MED, V32, P1527, DOI 10.1097/01.CCM.0000129485.08835.5A; Olsen M, 2011, CARDIOL YOUNG, V21, P197, DOI 10.1017/S1047951110001769; Parikh SV, 1997, CAN J PSYCHIAT, V42, P929, DOI 10.1177/070674379704200903; Pedersen CB, 2006, DAN MED BULL, V53, P441; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rosted E, 2013, GERIATR NURS, V34, P477, DOI 10.1016/j.gerinurse.2013.08.001; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Stuart M, 2001, GERONTOLOGIST, V41, P474, DOI 10.1093/geront/41.4.474; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; VERHAAK PFM, 1993, BRIT J GEN PRACT, V43, P203; Weinert CR, 2001, CHEST, V119, P547, DOI 10.1378/chest.119.2.547; Weinert C, 2006, PSYCHOSOMATICS, V47, P399, DOI 10.1176/appi.psy.47.5.399; Wunsch H, 2010, CRIT CARE, V14, DOI 10.1186/cc8863; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Zisberg A, 2012, DRUG AGING, V29, P565, DOI 10.2165/11632350-000000000-00000	39	85	87	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2014	311	11					1133	1142		10.1001/jama.2014.2137	http://dx.doi.org/10.1001/jama.2014.2137			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD1RC	24643603				2022-12-24	WOS:000333010100018
J	Gronewold, AD; Stow, CA				Gronewold, Andrew D.; Stow, Craig A.			Water Loss from the Great Lakes	SCIENCE			English	Editorial Material							SUPERIOR		[Gronewold, Andrew D.; Stow, Craig A.] NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI 48105 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Gronewold, AD (corresponding author), NOAA, Great Lakes Environm Res Lab, 2205 Commonwealth Blvd, Ann Arbor, MI 48105 USA.	drew.gronewold@noaa.gov	Stow, Craig/AAG-8109-2020	Gronewold, Andrew/0000-0002-3576-2529; Stow, Craig/0000-0001-6171-7855				[Anonymous], 2013, INT JOINT COMM ADV G; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Assel RA, 2004, B AM METEOROL SOC, V85, P1143, DOI 10.1175/BAMS-85-8-1143; Gronewold AD, 2013, CLIMATIC CHANGE, V120, P697, DOI 10.1007/s10584-013-0840-2; Heinmiller BT, 2007, GOVERNANCE, V20, P655, DOI 10.1111/j.1468-0491.2007.00376.x; Holman KD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050468; Laird NF, 2002, J HYDROMETEOROL, V3, P3, DOI 10.1175/1525-7541(2002)003<0003:VOSALH>2.0.CO;2; Lamon EC, 2010, J GREAT LAKES RES, V36, P172, DOI 10.1016/j.jglr.2009.11.009; Meteorological Service of Canada (MSC), MET SERV CAN MSC DLY; NOAA NCDC, SURF LAND DAIL COOP; NOAA NCDC, INT SURF DAT DAT SET; QUINN FH, 1985, J GREAT LAKES RES, V11, P400, DOI 10.1016/S0380-1330(85)71784-4; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Spence C, 2013, J HYDROMETEOROL, V14, P1647, DOI 10.1175/JHM-D-12-0170.1; Willis JK, 2012, SCIENCE, V336, P550, DOI 10.1126/science.1220366	15	78	78	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1084	1085		10.1126/science.1249978	http://dx.doi.org/10.1126/science.1249978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604186				2022-12-24	WOS:000332331500030
J	Dover, C				Dover, Caroline			PERSONAL VIEW Spurious syndromes: we create disease by giving every illness a name	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TROCHANTERIC PAIN SYNDROME; DIAGNOSIS; BURSITIS		Royal Shrewsbury Hosp, Oswestry Shrewsbury Sch Surg, Shrewsbury SY3 8XQ, Salop, England		Dover, C (corresponding author), Royal Shrewsbury Hosp, Oswestry Shrewsbury Sch Surg, Shrewsbury SY3 8XQ, Salop, England.							Alvarez-Nemegyei J, 2004, JCR-J CLIN RHEUMATOL, V10, P123, DOI 10.1097/01.rhu.0000129089.57719.16; [Anonymous], 2013, CAMBRIDGE DICT ONLIN; Asher R, 1972, TALKING SENSE PITMAN; Bird PA, 2001, ARTHRITIS RHEUM, V44, P2138, DOI 10.1002/1529-0131(200109)44:9<2138::AID-ART367>3.0.CO;2-M; Blank E, 2012, ORTHOPEDICS, V35, pE1022, DOI 10.3928/01477447-20120621-14; Geraci A, 2011, TMJ, V61, P74; Helman C G, 1981, J R Coll Gen Pract, V31, P548; KARPINSKI MRK, 1985, J BONE JOINT SURG BR, V67, P762; LEONARD MH, 1958, JAMA-J AM MED ASSOC, V168, P175, DOI 10.1001/jama.1958.63000020003007a; Romano TJ, 2006, J MUSCULOSKELET PAIN, V14, P65; Sayegh Fares, 2004, Acta Orthop Belg, V70, P423; Stegemann H, 1923, ARCH KLIN CHIR, V125, P718; Strauss EJ, 2010, SPORTS MED ARTHROSC, V18, P113, DOI 10.1097/JSA.0b013e3181e0b2ff; Tibor LM, 2008, ARTHROSCOPY, V24, P1407, DOI 10.1016/j.arthro.2008.06.019; Williams BS, 2009, ANESTH ANALG, V108, P1662, DOI 10.1213/ane.0b013e31819d6562	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1828	10.1136/bmj.g1828	http://dx.doi.org/10.1136/bmj.g1828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HV	24594759				2022-12-24	WOS:000332623400009
J	Takala, H; Bjorling, A; Berntsson, O; Lehtivuori, H; Niebling, S; Hoernke, M; Kosheleva, I; Henning, R; Menzel, A; Ihalainen, JA; Westenhoff, S				Takala, Heikki; Bjorling, Alexander; Berntsson, Oskar; Lehtivuori, Heli; Niebling, Stephan; Hoernke, Maria; Kosheleva, Irina; Henning, Robert; Menzel, Andreas; Ihalainen, Janne A.; Westenhoff, Sebastian			Signal amplification and transduction in phytochrome photosensors	NATURE			English	Article							STRUCTURAL DYNAMICS; CRYSTAL-STRUCTURE; BACTERIOPHYTOCHROME; PHOTOCONVERSION; REVEALS; PROTEIN; SIMILARITY; KINASES; BINDING; DOMAIN	Sensory proteins must relay structural signals from the sensory site over large distances to regulatory output domains. Phytochromes are a major family of red-light-sensing kinases that control diverse cellular functions in plants, bacteria and fungi(1-9). Bacterial phytochromes consist of a photosensory core and a carboxy-terminal regulatory domain(10,11). Structures of photosensory cores are reported in the resting state(12-18) and conformational responses to light activation have been proposed in the vicinity of the chromophore(19-23). However, the structure of the signalling state and the mechanism of downstream signal relay through the photosensory core remain elusive. Here we report crystal and solution structures of the resting and activated states of the photosensory core of the bacteriophytochrome from Deinococcus radiodurans. The structures show an open and closed form of the dimeric protein for the activated and resting states, respectively. This nanometre-scale rearrangement is controlled by refolding of an evolutionarily conserved 'tongue', which is in contact with the chromophore. The findings reveal an unusual mechanism in which atomic-scale conformational changes around the chromophore are first amplified into ana angstrom-scale distance change in the tongue, and further grow into a nanometre-scale conformational signal. The structural mechanism is a blueprint for understanding how phytochromes connect to the cellular signalling network.	[Takala, Heikki; Lehtivuori, Heli; Ihalainen, Janne A.] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla 40014, Finland; [Takala, Heikki; Bjorling, Alexander; Berntsson, Oskar; Niebling, Stephan; Hoernke, Maria; Westenhoff, Sebastian] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden; [Kosheleva, Irina; Henning, Robert] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	University of Jyvaskyla; University of Gothenburg; University of Chicago; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Ihalainen, JA (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla 40014, Finland.	janne.ihalainen@jyu.fi; westenho@chem.gu.se	Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020; Menzel, Andreas/C-4388-2012	Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Menzel, Andreas/0000-0002-0489-609X; Lehtivuori, Heli/0000-0002-7450-2578; Ihalainen, Janne/0000-0002-8741-1587; Berntsson, Oskar/0000-0003-1843-6278; Hoernke, Maria/0000-0003-2008-411X; Niebling, Stephan/0000-0001-6582-5984	European Community [312284 CALIPSO]; National Institutes of Health, National Institute of General Medical Sciences [1R24GM111072]; Foundation of Strategic Research, Sweden; Swedish Research Council [279944]; European Research Council [279944]; Finnish Academy [138063]; Finnish Cultural Foundation [0131067]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072] Funding Source: NIH RePORTER	European Community(European Commission); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Foundation of Strategic Research, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Finnish Academy(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge beamline access at BM29 and ID23-1 at the ESRF, cSAXS at the Swiss Light Source (funded by the European Community's FP7 grant agreement no. 312284 CALIPSO), and BioCARS at the Advanced Photon Source, Argonne National Laboratory (supported by National Institutes of Health, National Institute of General Medical Sciences grant 1R24GM111072 and in part through collaboration with P. Anfinrud). K. Forest and R. Vierstra are acknowledged for the donation of the plasmids. J. Ylanne and his group are acknowledged for advice on crystallography, and H. Hakkanen and A. Liukkonen for their assistance. We thank M.-A. Mroginski for providing force-field parameter files for the biliverdin. We acknowledge V. Chukharev and N. V. Tkachenko for the facilities for transient absorption spectroscopy measurements. We also acknowledge grants to S. W. by the Foundation of Strategic Research, Sweden, and the Swedish and European Research Councils, agreement number 279944, support to J.A.I. by Finnish Academy grant 138063, and to H.T. by the Finnish Cultural Foundation grant 0131067.	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Andersson M, 2009, STRUCTURE, V17, P1265, DOI 10.1016/j.str.2009.07.007; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; BUTLER WL, 1959, P NATL ACAD SCI USA, V45, P1703, DOI 10.1073/pnas.45.12.1703; Cammarata M, 2008, NAT METHODS, V5, P881, DOI [10.1038/nmeth.1255, 10.1038/NMETH.1255]; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Evans K, 2006, J MOL BIOL, V364, P655, DOI 10.1016/j.jmb.2006.09.045; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Liu HG, 2012, J APPL CRYSTALLOGR, V45, P587, DOI 10.1107/S0021889812015786; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Westenhoff S, 2010, NAT METHODS, V7, P775, DOI 10.1038/nmeth1010-775c; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	35	244	247	2	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					245	+		10.1038/nature13310	http://dx.doi.org/10.1038/nature13310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24776794	Green Accepted			2022-12-24	WOS:000335454300043
J	Bass, C				Bass, Christopher			Complex regional pain syndrome medicalises limb pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-BACK-PAIN; PSYCHOSOCIAL FACTORS; START BACK; MANAGEMENT		John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford	Bass, C (corresponding author), John Radcliffe Hosp, Oxford OX3 9DU, England.	Christopher.bass@oxfordhealth.nhs.uk						Atherton K, 2006, EMERG MED J, V23, P195, DOI 10.1136/emj.2005.027102; Beerthuizen A, 2011, EUR J PAIN, V15, P971, DOI 10.1016/j.ejpain.2011.02.008; Blyth FM, 2007, PAIN, V129, P8, DOI 10.1016/j.pain.2007.03.009; Bruehl S, 2007, PAIN, V129, P1, DOI 10.1016/j.pain.2007.02.017; Creed F, 2006, WORLD PSYCHIATRY, V5, P146; Croft P., 2011, CHRONIC PAIN EPIDEMI, DOI 10.1093/acprof:oso/9780199235766.001.0001; de Asla R, 2011, J BONE JOINT SURG AM, V93, p[e116, 1], DOI DOI 10.2106/JBJS.K; Department of Health, 2008, LONG TERM COND POS P; Gupta A, 2007, RHEUMATOLOGY, V46, P666, DOI 10.1093/rheumatology/kel363; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Haviland MG, 2010, PSYCHIAT RES, V177, P335, DOI 10.1016/j.psychres.2009.08.017; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Holm LW, 2008, PLOS MED, V5, P760, DOI 10.1371/journal.pmed.0050105; Kouyanou K, 1997, PSYCHOSOM MED, V59, P597, DOI 10.1097/00006842-199711000-00007; Main CJ, 2012, PHYSIOTHERAPY, V98, P110, DOI 10.1016/j.physio.2011.03.003; Munglani R, 2012, PAIN NEWS, V10, P16; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; Page LA, 2003, J ROY SOC MED, V96, P223, DOI 10.1258/jrsm.96.5.223; Pearce JMS, 2005, SPINAL CORD, V43, P263, DOI 10.1038/sj.sc.3101709; Ring D, 2010, J HAND SURG-AM, V35A, P1345, DOI 10.1016/j.jhsa.2010.06.007; Roditi D, 2011, PSYCHOL RES BEHAV MA, V4, P41, DOI 10.2147/PRBM.S15375; Schott G D, 2007, Pract Neurol, V7, P145; Singh HP, 2006, J HAND SURG-BRIT EUR, V31B, P611, DOI 10.1016/j.jhsb.2006.08.009; Vranceanu AM, 2011, J HAND THER, V24, P118, DOI 10.1016/j.jht.2010.12.002; Williams Amanda C de C, 2011, Br J Gen Pract, V61, P638, DOI 10.3399/bjgp11X601479	25	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2014	348								g2631	10.1136/bmj.g2631	http://dx.doi.org/10.1136/bmj.g2631			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5PN	24776533				2022-12-24	WOS:000335471000001
J	Arie, S				Arie, Sophie			Has Britain solved its teenage pregnancy problem? Teenage pregnancy rates have been falling dramatically for several years. Sophie Arie looks at why-and whether the trend will last	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADOLESCENT PREGNANCY; CONTRACEPTIVE USE; UNITED-STATES; COUNTRIES; SERVICES											[Anonymous], VITAL HLTH STAT; [Anonymous], 2014, N DEVON J       0324; Arie S, 2014, BMJ-BRIT MED J, V348, pg1926; Ballinski T, 2011, LIFESITENEWS    0113; Boden JM, 2008, J CHILD PSYCHOL PSYC, V49, P151, DOI 10.1111/j.1469-7610.2007.01830.x; Connolly A, 2013, GUIDELINES PRACTICE, P16; Cromer BA, 1999, FAM PLANN PERSPECT, V31, P287, DOI 10.2307/2991539; Darroch JE, 2001, FAM PLANN PERSPECT, V33, P244, DOI 10.2307/3030191; Grimes D, 2000, 16 WORLD C INT FED G; Guttmacher Institute, 2012, FACTS AM TEENS SOURC; Health Communities, TEEN PREGN; McIvor J, 2014, BBC NEWS; NICE, LONG ACT REV CONTR C; Office for National Statistics Statistics Bulletin, 2012, CONC ENGL WAL; Organisation for Economic Development, 2013, SHAR BIRTHS OUTS WED; Santelli JS, 2007, AM J PUBLIC HEALTH, V97, P150, DOI 10.2105/AJPH.2006.089169; Santelli JS, 2009, J ADOLESCENT HEALTH, V45, P25, DOI 10.1016/j.jadohealth.2009.04.017; Williams R, 2011, GUARDIAN; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2385	19	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2014	348								g2561	10.1136/bmj.g2561	http://dx.doi.org/10.1136/bmj.g2561			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF5GH	24733734	Green Published			2022-12-24	WOS:000334741500002
J	Anthes, E				Anthes, Emily			AGEING Live faster, die younger	NATURE			English	Editorial Material							NONAFFECTIVE PSYCHOSIS; TELOMERE LENGTH; NAIVE PATIENTS; SCHIZOPHRENIA; HYPOTHESIS											Fernandez-Egea E, 2011, PSYCHOSOM MED, V73, P643, DOI 10.1097/PSY.0b013e318230343f; Fernandez-Egea E, 2009, SCHIZOPHRENIA BULL, V35, P437, DOI 10.1093/schbul/sbn169; Kirkpatrick B, 2008, SCHIZOPHRENIA BULL, V34, P1024, DOI 10.1093/schbul/sbm140; Kochunov P, 2013, BIOL PSYCHIAT, V73, P482, DOI 10.1016/j.biopsych.2012.10.002; Nieratschker V, 2013, SCHIZOPHR RES, V149, P116, DOI 10.1016/j.schres.2013.06.043; Spelman LM, 2007, DIABETIC MED, V24, P481, DOI 10.1111/j.1464-5491.2007.02092.x	6	15	15	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S16	S17		10.1038/508S16a	http://dx.doi.org/10.1038/508S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695330				2022-12-24	WOS:000333609900012
J	Brunet, M				Brunet, Martin			Targets for dementia diagnoses will lead to overdiagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; ENGLAND		Binscombe Med Ctr, Godalming GU7 3PR, Surrey, England		Brunet, M (corresponding author), Binscombe Med Ctr, Godalming GU7 3PR, Surrey, England.	martin@binscombe.net						Brunet M, EARLY DIAGNOSIS DEME; Brunet MD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8588; Department of Health, 2014, PUTT DEM MAP; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Herefordshire Clinical Commissioning Group, 2013, GP NEWS         0924; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; NHS England, 2014, DEM PREV CALC; UK National Screening Committee, 2010, ALZH DIS UK NSC POL	9	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g2224	10.1136/bmj.g2224	http://dx.doi.org/10.1136/bmj.g2224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24690626				2022-12-24	WOS:000333976300004
J	McCartney, M				McCartney, Margaret			Why the Sun's breast check campaign may actually harm women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-EXAMINATION					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Breakthrough Cancer, SIGN SYMPT; CoppaFeel, BOOK CHECK; Kosters JP, 2008, COCHRANE DB SYST REV, V3; NHS Choices, SHOULD I CHECK MY BR; Parsons R., 2014, MARKETING WEEK; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Thornton H, 2008, EUR J CANCER, V44, P2118, DOI 10.1016/j.ejca.2008.08.015	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2014	348								g2447	10.1136/bmj.g2447	http://dx.doi.org/10.1136/bmj.g2447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TL	24690629				2022-12-24	WOS:000333976300008
J	Eun, SH; Shi, Z; Cui, KR; Zhao, KJ; Chen, X				Eun, Suk Ho; Shi, Zhen; Cui, Kairong; Zhao, Keji; Chen, Xin			A Non-Cell Autonomous Role of E(z) to Prevent Germ Cells from Turning on a Somatic Cell Marker	SCIENCE			English	Article							DROSOPHILA TESTIS; SELF-RENEWAL; DIRECT CONVERSION; GENE-EXPRESSION; STEM-CELLS; NICHE; LESSONS; POLYCOMB; FATE; LINE	In many metazoans, germ cells are separated from somatic lineages early in development and maintain their identity throughout life. Here, we show that a Polycomb group (PcG) component, Enhancer of Zeste [E(z)], a histone transferase that generates trimethylation at lysine 27 of histone H3, maintains germline identity in Drosophila adult testes. We find excessive early-stage somatic gonadal cells in E(z) mutant testes, which originate from both overproliferative cyst stem cells and germ cells turning on an early-stage somatic cell marker. Using complementary lineage-tracing experiments in E(z) mutant testes, a portion of excessive early-stage somatic gonadal cells are found to originate from early-stage germ cells, including germline stem cells. Moreover, knocking down E(z) specifically in somatic cells caused this change, which suggests a non-cell autonomous role of E(z) to antagonize somatic identity in germ cells.	[Eun, Suk Ho; Shi, Zhen; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chen, X (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	xchen32@jhu.edu			National Institute of Child Health and Human Development (NIH) [R00HD055052, R01HD065816]; David and Lucile Packard Foundation; March of Dimes [05-FY09-88]; Johns Hopkins University; Division of Intramural Research, NHLBI, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); March of Dimes(March of Dimes); Johns Hopkins University(Johns Hopkins University); Division of Intramural Research, NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C. Choi for technical assistance and D. Drummond-Barbosa, M. Van Doren, H. Zhao, Y. Yamashita, and the Chen laboratory members for suggestions. ChIP-Seq libraries were sequenced at National Heart, Lung, and Blood Institute (NHLBI) Sequencing and Computation Core facility (NIH); the GEO accession number is GSE53238. Supported by National Institute of Child Health and Human Development (NIH) grants R00HD055052 and R01HD065816, the David and Lucile Packard Foundation, March of Dimes #05-FY09-88, Johns Hopkins University start-up (X. C.), and Division of Intramural Research, NHLBI, NIH (K.Z.).	Blackwell TK, 2004, CURR BIOL, V14, pR229, DOI 10.1016/j.cub.2004.02.052; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Iovino N, 2013, DEV CELL, V26, P431, DOI 10.1016/j.devcel.2013.06.021; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; JONES RS, 1990, GENETICS, V126, P185; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Leatherman JL, 2003, BIOESSAYS, V25, P326, DOI 10.1002/bies.10247; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Lehmann R, 2012, CELL STEM CELL, V10, P729, DOI 10.1016/j.stem.2012.05.016; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Patel T, 2012, CELL REP, V2, P1178, DOI 10.1016/j.celrep.2012.09.020; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Tarayrah L, 2013, DEVELOPMENT, V140, P1014, DOI 10.1242/dev.089433; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Van Doren M, 1998, CURR BIOL, V8, P243	30	33	34	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1513	1516		10.1126/science.1246514	http://dx.doi.org/10.1126/science.1246514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675960	Green Accepted			2022-12-24	WOS:000333471000048
J	Blazeby, JM; Byrne, J; Welbourn, R				Blazeby, Jane M.; Byrne, James; Welbourn, Richard			UNCERTAINTIES PAGE What is the most effective operation for adults with severe and complex obesity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							Y GASTRIC BYPASS; QUALITY-OF-LIFE; BARIATRIC SURGERY; SLEEVE		[Blazeby, Jane M.] Univ Bristol, Ctr Surg Res, Sch Social & Community Med, Bristol BS8 2PR, Avon, England; [Blazeby, Jane M.] Univ Hosp Bristol NHS Fdn Trust, Div Surg Head & Neck, Bristol, Avon, England; [Byrne, James] Univ Hosp Southampton NHS Trust, Dept Upper Gastrointestinal Surg, Southampton, Hants, England; [Welbourn, Richard] Musgrove Pk Hosp, Dept Upper Gastrointestinal & Bariatr Surg, Taunton, Somerset, England	University of Bristol; University of Bristol; Musgrove Park Hospital	Blazeby, JM (corresponding author), Univ Bristol, Ctr Surg Res, Sch Social & Community Med, Bristol BS8 2PR, Avon, England.	j.m.blazeby@bris.ac.uk		Byrne, james/0000-0003-3517-5110	National Institute for Health Research [09/127/53] Funding Source: researchfish; Department of Health [09/127/53] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Angrisani L, 2007, SURG OBES RELAT DIS, V3, P127, DOI 10.1016/j.soard.2006.12.005; Bal BS, 2012, NAT REV ENDOCRINOL, V8, P544, DOI 10.1038/nrendo.2012.48; Birkmeyer NJO, 2010, JAMA-J AM MED ASSOC, V304, P435, DOI 10.1001/jama.2010.1034; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Coulman KD, 2013, OBES REV, V14, P707, DOI 10.1111/obr.12041; DeMaria EJ, 2010, SURG OBES RELAT DIS, V6, P347, DOI 10.1016/j.soard.2009.11.015; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Helmio M, 2012, SURG ENDOSC, V26, P2521, DOI 10.1007/s00464-012-2225-4; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Kehagias I, 2011, OBES SURG, V21, P1650, DOI 10.1007/s11695-011-0479-x; Nguyen NT, 2009, ANN SURG, V250, P631, DOI 10.1097/SLA.0b013e3181b92480; NHS Commissioning Board, 2013, CLIN COMM POL COMPL; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Raj PP, 2012, OBES SURG, V22, P422, DOI 10.1007/s11695-011-0507-x; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Soreide K, 2013, LANCET, V382, P1140, DOI 10.1016/S0140-6736(13)61455-5; Welbourn R, 2011, NATL BARIATRIC SURG	18	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2014	348								g1763	10.1136/bmj.g1763	http://dx.doi.org/10.1136/bmj.g1763			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZW	24633209				2022-12-24	WOS:000333033200001
J	Held, I				Held, Isaac			Simplicity Amid Complexity	SCIENCE			English	Editorial Material							CLIMATE; LATITUDE; FUTURE		NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Held, I (corresponding author), NOAA, Geophys Fluid Dynam Lab, Forrestal Campus, Princeton, NJ 08540 USA.	isaac.held@noaa.gov						Abbot DS, 2009, J ATMOS SCI, V66, P519, DOI 10.1175/2008JAS2840.1; Clement A, 2014, SCIENCE, V343, P976, DOI 10.1126/science.1248115; Garfinkel CI, 2013, J CLIMATE, V26, P2077, DOI 10.1175/JCLI-D-12-00301.1; Hegerl G, 2014, SCIENCE, V343, P844, DOI 10.1126/science.1249368; Held IM, 2005, B AM METEOROL SOC, V86, P1609, DOI 10.1175/BAMS-86-11-1609; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Son SW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014271; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Vecchi GA, 2014, SCIENCE, V343, P618, DOI 10.1126/science.1247759	12	27	28	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1206	1207		10.1126/science.1248447	http://dx.doi.org/10.1126/science.1248447			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626917				2022-12-24	WOS:000332728500022
J	Kovats, S; Depledge, M; Haines, A; Fleming, LE; Wilkinson, P; Shonkoff, SB; Scovronick, N				Kovats, Sari; Depledge, Michael; Haines, Andy; Fleming, Lora E.; Wilkinson, Paul; Shonkoff, Seth B.; Scovronick, Noah			The health implications of fracking	LANCET			English	Editorial Material							DRINKING-WATER WELLS; SHALE; QUALITY		[Kovats, Sari; Haines, Andy; Wilkinson, Paul; Scovronick, Noah] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Depledge, Michael] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Exeter, Devon, England; [Fleming, Lora E.] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Truro, England; [Shonkoff, Seth B.] Hth Energy, Oakland, CA USA; [Shonkoff, Seth B.] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of London; London School of Hygiene & Tropical Medicine; University of Exeter; University of Exeter; University of California System; University of California Berkeley	Kovats, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Keppel St, London WC1E 7HT, England.	sari.kovats@lshtm.ac.uk	Fleming, Lora E/ABH-1310-2021	Fleming, Lora E/0000-0003-1076-9967; Wilkinson, Paul/0000-0001-7456-259X; Depledge, Michael/0000-0002-7216-0439; Haines, Andy/0000-0002-8053-4605; Kovats, Sari/0000-0002-4823-8099; Scovronick, Noah/0000-0003-1410-3337				Broderick J, 2012, HAS US SHALE GAS RED; Brufatto C., 2003, OILFIELD REV, V15, P62; Esswein EJ, 2013, J OCCUP ENVIRON HYG, V10, P347, DOI 10.1080/15459624.2013.788352; Fontenot BE, 2013, ENVIRON SCI TECHNOL, V47, P10032, DOI 10.1021/es4011724; HM Government, 2012, GOV RESP ROYAL AC EN; Jackson RB, 2013, P NATL ACAD SCI USA, V110, P11250, DOI 10.1073/pnas.1221635110; Kassotis CD, 2014, ENDOCRINOLOGY, V155, P897, DOI 10.1210/en.2013-1697; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Roy AA, 2014, J AIR WASTE MANAGE, V64, P19, DOI 10.1080/10962247.2013.826151; Royal Society and Royal Academy of Engineering, 2012, SHALE GAS EXTRACTION; Screen Australia, 2013, REV INT GAM AND MULT; Warner NR, 2013, ENVIRON SCI TECHNOL, V47, P11849, DOI 10.1021/es402165b	13	47	50	0	215	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					757	758		10.1016/S0140-6736(13)62700-2	http://dx.doi.org/10.1016/S0140-6736(13)62700-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3EV	24581655				2022-12-24	WOS:000332398700004
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			The Perpetual Challenge of Antimicrobial Resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fauci, Anthony S.; Marston, Hilary D.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov	Hassali, Mohamed Azmi/A-6895-2011	Hassali, Mohamed Azmi/0000-0001-9575-403X				Broad Institute, ACT GROUP DAT; Centers for Disease Control and Prevention, THREAT REP 2013; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Jerse AE, 2014, VACCINE, V32, P1579, DOI 10.1016/j.vaccine.2013.08.067; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; National Institutes of Health, 2014, NIAIDS ANT RES PROGR; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280	9	68	73	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2014	311	18					1853	1854		10.1001/jama.2014.2465	http://dx.doi.org/10.1001/jama.2014.2465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0GT	24652442				2022-12-24	WOS:000335798100013
J	Ralston, KS; Solga, MD; Mackey-Lawrence, NM; Somlata; Bhattacharya, A; Petri, WA				Ralston, Katherine S.; Solga, Michael D.; Mackey-Lawrence, Nicole M.; Somlata; Bhattacharya, Alok; Petri, William A., Jr.			Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion	NATURE			English	Article							CYTOPATHOGENIC MECHANISMS; TARGET-CELLS; PHAGOCYTOSIS; ADHERENCE; INTERNALIZATION; MICROSCOPY; ANTIBODIES; SYNAPSE	Entamoeba histolytica is the causative agent of amoebiasis, a potentially fatal diarrhoeal disease in the developing world. The parasite was named "histolytica'' for its ability to destroy host tissues, which is probably driven by direct killing of human cells. The mechanism of human cell killing has been unclear, although the accepted model was that the parasites use secreted toxic effectors to kill cells before ingestion(1). Here we report the discovery that amoebae kill by ingesting distinct pieces of living human cells, resulting in intracellular calcium elevation and eventual cell death. After cell killing, amoebae detach and cease ingestion. Ingestion of human cell fragments is required for cell killing, and also contributes to invasion of intestinal tissue. The internalization of fragments of living human cells is reminiscent of trogocytosis (from Greek trogo, nibble) observed between immune cells(2-6), but amoebic trogocytosis differs because it results in death. The ingestion of live cell material and the rejection of corpses illuminate a stark contrast to the established model of dead cell clearance in multicellular organisms(7). These findings change the model for tissue destruction in amoebiasis and suggest an ancient origin of trogocytosis as a form of intercellular exchange.	[Ralston, Katherine S.; Mackey-Lawrence, Nicole M.; Petri, William A., Jr.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Solga, Michael D.; Petri, William A., Jr.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Somlata; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Petri, William A., Jr.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; Jawaharlal Nehru University, New Delhi; University of Virginia	Petri, WA (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA 22908 USA.	wap3g@virginia.edu	Petri, William/AAL-3642-2020; Petri, William A./D-3639-2019	Petri, William/0000-0002-7268-1218; Ralston, Katherine/0000-0002-1604-7634; , SOMLATA/0000-0003-1928-5280	Howard Hughes Medical Institute from the Life Sciences Research Foundation; Hartwell Foundation; NIH [AI07046-32, 5R01 AI-26649]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026649, T32AI007046, T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007769] Funding Source: NIH RePORTER	Howard Hughes Medical Institute from the Life Sciences Research Foundation; Hartwell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. A. Redick and S. J. Guillot for assistance with sample preparation for electron microscopy and D. A. Zemo of Olympus for assistance with multiphoton microscopy. We thank the University of Virginia Research Histology Core for assistance with preparation of frozen sections. We thank J. E. Casanova, J. D. Castle, J. Lannigan, K. S. Ravichandran and R. P. Taylor for helpful discussions. The artwork (Extended Data Fig. 1) was prepared by A. Impagliazzo. K. S. R. was supported by a Howard Hughes Medical Institute Postdoctoral Fellowship from the Life Sciences Research Foundation, and a Postdoctoral Fellowship from the Hartwell Foundation. N.M.M.-L. was supported by NIH Training Grant AI07046-32. This work was supported by NIH grant 5R01 AI-26649 to W.A.P.	Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Boettner DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040008; BROWN T, 1979, J MED MICROBIOL, V12, P363, DOI 10.1099/00222615-12-3-363; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; GONZALEZRUIZ A, 1994, J CLIN PATHOL, V47, P236, DOI 10.1136/jcp.47.3.236; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; HUDSON L, 1974, NATURE, V251, P60, DOI 10.1038/251060a0; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Korpe PS, 2013, CLIN INFECT DIS, V56, P988, DOI 10.1093/cid/cis1044; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LEJEUNE A, 1987, BIOL CELL, V59, P239, DOI 10.1111/j.1768-322X.1987.tb00536.x; LEJEUNE A, 1992, BIOL CELL, V74, P211, DOI 10.1016/0248-4900(92)90027-X; Mann BJ, 2002, INT REV CYTOL, V216, P59; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; MCCOY JJ, 1994, GLYCOCONJUGATE J, V11, P432, DOI 10.1007/BF00731279; Mondal D, 2006, T ROY SOC TROP MED H, V100, P1032, DOI 10.1016/j.trstmh.2005.12.012; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakada-Tsukui K, 2009, CELL MICROBIOL, V11, P1471, DOI 10.1111/j.1462-5822.2009.01341.x; Ralston KS, 2011, TRENDS PARASITOL, V27, P253, DOI 10.1016/j.pt.2011.02.006; RAVDIN JI, 1980, J EXP MED, V152, P377, DOI 10.1084/jem.152.2.377; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; SAFFER LD, 1991, INFECT IMMUN, V59, P4681, DOI 10.1128/IAI.59.12.4681-4683.1991; Sateriale A, 2012, INFECT IMMUN, V80, P4456, DOI 10.1128/IAI.00671-12; Somlata, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1199; Williams M, 2012, DEV DYNAM, V241, P270, DOI 10.1002/dvdy.23711	28	137	140	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					526	+		10.1038/nature13242	http://dx.doi.org/10.1038/nature13242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24717428	Green Accepted			2022-12-24	WOS:000334741600037
J	Klose, CSN; Flach, M; Mohle, L; Rogell, L; Hoyler, T; Ebert, K; Fabiunke, C; Pfeifer, D; Sexl, V; Fonseca-Pereira, D; Domingues, RG; Veiga-Fernandes, H; Arnold, SJ; Busslinger, M; Dunay, IR; Tanriver, Y; Diefenbach, A				Klose, Christoph S. N.; Flach, Melanie; Moehle, Luisa; Rogell, Leif; Hoyler, Thomas; Ebert, Karolina; Fabiunke, Carola; Pfeifer, Dietmar; Sexl, Veronika; Fonseca-Pereira, Diogo; Domingues, Rita G.; Veiga-Fernandes, Henrique; Arnold, Sebastian J.; Busslinger, Meinrad; Dunay, Ildiko R.; Tanriver, Yakup; Diefenbach, Andreas			Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages	CELL			English	Article							NATURAL-KILLER-CELL; ROR-GAMMA-T; TRANSCRIPTION FACTOR GATA3; TISSUE INDUCER CELLS; TOXOPLASMA-GONDII; INFLAMMATORY MONOCYTES; INTERFERON-GAMMA; NKP46(+) CELLS; ID PROTEINS; BET	Innate lymphoid cells (ILCs) are a recently recognized group of lymphocytes that have important functions in protecting epithelial barriers against infections and in maintaining organ homeostasis. ILCs have been categorized into three distinct groups, transcriptional circuitry and effector functions of which strikingly resemble the various T helper cell subsets. Here, we identify a common, Id2-expressing progenitor to all interleukin 7 receptor-expressing, "helper-like" ILC lineages, the CHILP. Interestingly, the CHILP differentiated into ILC2 and ILC3 lineages, but not into conventional natural killer (cNK) cells that have been considered an ILC1 subset. Instead, the CHILP gave rise to a peculiar NKp46(+) IL-7R alpha(+) ILC lineage that required T-bet for specification and was distinct of cNK cells or other ILC lineages. Such ILC1s coproduced high levels of IFN-gamma and TNF and protected against infections with the intracellular parasite Toxoplasma gondii. Our data significantly advance our understanding of ILC differentiation and presents evidence for a new ILC lineage that protects barrier surfaces against intracellular infections.	[Klose, Christoph S. N.; Flach, Melanie; Rogell, Leif; Hoyler, Thomas; Ebert, Karolina; Fabiunke, Carola; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Klose, Christoph S. N.; Flach, Melanie; Rogell, Leif; Hoyler, Thomas; Ebert, Karolina; Fabiunke, Carola; Tanriver, Yakup] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Dept Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Moehle, Luisa; Dunay, Ildiko R.] Univ Magdeburg, Inst Med Microbiol, D-39120 Magdeburg, Germany; [Rogell, Leif] Max Planck Inst Immunbiol & Epigenet, D-79108 Freiburg, Germany; [Pfeifer, Dietmar] Univ Med Ctr Freiburg, Genom Lab, Dept Hematol Oncol & Stem Cell Transplantat, D-79106 Freiburg, Germany; [Sexl, Veronika] Univ Vet Med Vienna, Inst Pharmacol & Toxicol, A-1210 Vienna, Austria; [Fonseca-Pereira, Diogo; Domingues, Rita G.; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; [Klose, Christoph S. N.; Ebert, Karolina; Fabiunke, Carola; Arnold, Sebastian J.; Tanriver, Yakup] Univ Freiburg, Med Ctr, Div Renal, D-79106 Freiburg, Germany; [Arnold, Sebastian J.] Univ Freiburg, Ctr Biol Signalling Studies, BIOSS, D-79104 Freiburg, Germany; [Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1020 Vienna, Austria	Johannes Gutenberg University of Mainz; University of Freiburg; Otto von Guericke University; Max Planck Society; University of Freiburg; University of Veterinary Medicine Vienna; Universidade de Lisboa; University of Freiburg; University of Freiburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Diefenbach, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	diefenbach@uni-mainz.de	Tanriver, Yakup/AAU-7064-2020; da Fonseca Pereira, Diogo/O-9894-2019; Diefenbach, Andreas/T-2589-2018; Fonseca-Pereira, Diogo/U-1275-2018; Busslinger, Meinrad J./J-1249-2016; Klose, Christoph/ABE-6396-2020; Sexl, Veronika/B-8657-2016	Diefenbach, Andreas/0000-0002-9176-9530; Fonseca-Pereira, Diogo/0000-0002-7400-9804; Busslinger, Meinrad J./0000-0002-9111-9351; Sexl, Veronika/0000-0001-9363-0412; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Mohle, Luisa/0000-0002-4535-9952; Hoyler, Thomas/0000-0003-4798-3692; Tanriver, Yakup/0000-0002-4806-2548; Arnold, Sebastian J./0000-0002-2688-9210	ERC [311377, 207057]; EMBO; Deutsche Forschungsgemeinschaft [SFB992/B02, SPP1646-DI764/3, TA436/2-1, TA436/3-1]; Deutsche Forschungsgemeinschaft (Emmy Noether Stipend) [AR732/1-1]; Boehringer Ingelheim Fonds; Fundacao para a Ciencia e Tecnologia, Portugal; MOTIVATE Promotionskolleg; Else-Kroner-Fresenius Stiftung; Boehringer Ingelheim;  [FWF-SFB28]	ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Emmy Noether Stipend)(German Research Foundation (DFG)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MOTIVATE Promotionskolleg; Else-Kroner-Fresenius Stiftung; Boehringer Ingelheim(Boehringer Ingelheim); 	We thank G. Hacker for support; the members of the Diefenbach laboratory and M. Hofmann for valuable discussions, A. Triantafyllopoulou for critically reading and commenting on the manuscript, K. Oberle, N. Goppert, and D. Kautz for excellent technical assistance. We are thankful to C. Johner for providing mouse lines. We are grateful to D. Herchenbach, K. Geiger, and M. Follo for cell sorting. The work was supported by ERC Starting Grants (#311377 to A.D. and #207057 to H.V.F.), EMBO (to H.V.F.), the Deutsche Forschungsgemeinschaft (SFB992/B02, SPP1646-DI764/3 to A.D., TA436/2-1, TA436/3-1 to Y.T., and an Emmy Noether Stipend AR732/1-1 to S.J.A.), the Boehringer Ingelheim Fonds (to M.F.), the Fundacao para a Ciencia e Tecnologia, Portugal (D.F.P., R.D.G and H.V.F.), the FWF-SFB28 (to V.S.), MOTIVATE Promotionskolleg funded by the Else-Kroner-Fresenius Stiftung (to C.F.), and by Boehringer Ingelheim (to M.B.).	Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides M.G., 2014, NATURE; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Diefenbach A, 2013, EUR J MICROBIOL IMMU, V3, P143, DOI 10.1556/EuJMI.3.2013.3.1; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GAZZINELLI RT, 1993, P NATL ACAD SCI USA, V90, P6115, DOI 10.1073/pnas.90.13.6115; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stewart CA, 2007, EUR J IMMUNOL, V37, P1442, DOI 10.1002/eji.200737354; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Verykokakis M, 2013, J IMMUNOL, V191, P5973, DOI 10.4049/jimmunol.1301521; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	45	734	755	1	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					340	356		10.1016/j.cell.2014.03.030	http://dx.doi.org/10.1016/j.cell.2014.03.030			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725403	Bronze			2022-12-24	WOS:000334304500009
J	Ubel, PA; Jagsi, R				Ubel, Peter A.; Jagsi, Reshma			Promoting Population Health through Financial Stewardship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Health care costs are straining budgets throughout the developed world, threatening the fiscal solvency of governments, employers, and individuals. Many countries are trying to restrain health care spending through top-down approaches, such as price regulation and even refusal to reimburse for interventions that are not cost-effective. Still controversial is the role that physicians should play in controlling health care costs. For instance, the Choosing Wisely campaign of the American Board of Internal Medicine Foundation encourages physicians to avoid interventions that "may be unnecessary, and in some instances can cause harm," but it does not ask physicians to contemplate trading off . . . Financial stewardship of health care resources promotes population health by increasing access to affordable care, reducing pressure on health care institutions to cut back on important services, and freeing up resources for other activities that improve health.	[Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Ubel, Peter A.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Ubel, Peter A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Jagsi, Reshma] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA	Duke University; Duke University; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ubel, PA (corresponding author), Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA.			Jagsi, Reshma/0000-0001-6562-1228				Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Muennig P, 2011, AM J PUBLIC HEALTH, V101, P512, DOI 10.2105/AJPH.2010.200063; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025	5	24	23	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1280	1281		10.1056/NEJMp1401335	http://dx.doi.org/10.1056/NEJMp1401335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE2VA	24693887				2022-12-24	WOS:000333830000004
J	Eisenberg, MS; Bobrow, BJ; Rea, T				Eisenberg, Mickey S.; Bobrow, Bentley J.; Rea, Tom			Fulfilling the Promise of "Anyone, Anywhere" to Perform CPR	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSISTED CARDIOPULMONARY-RESUSCITATION; HOSPITAL CARDIAC-ARREST; SURVIVAL; INSTRUCTIONS		[Eisenberg, Mickey S.; Rea, Tom] Univ Washington, Dept Med, Seattle, WA USA; [Eisenberg, Mickey S.; Rea, Tom] King Cty Emergency Med Serv, Seattle, WA USA; [Bobrow, Bentley J.] Univ Arizona, Coll Med, Dept Emergency Med, Maricopa Med Ctr, Phoenix, AZ USA; [Bobrow, Bentley J.] Arizona Dept Hlth Serv, Bur Emergency Med Serv & Trauma Syst, Phoenix, AZ 85007 USA	University of Washington; University of Washington Seattle; University of Arizona; Arizona Department of Health Services	Bobrow, BJ (corresponding author), Arizona Dept Hlth Serv, Bur Emergency Med Serv & Trauma Syst, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA.	bentley.bobrow@azdhs.gov						Bobrow BJ, 2008, CIRCULATION, V118, P2550, DOI 10.1161/CIRCULATIONAHA.108.799940; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Lerner EB, 2012, CIRCULATION, V125, P648, DOI 10.1161/CIR.0b013e31823ee5fc; Lewis M, 2013, CIRCULATION, V128, P1522, DOI 10.1161/CIRCULATIONAHA.113.002627; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Resuscitation Academy, RESOURCES; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Song KJ, 2014, RESUSCITATION, V85, P34, DOI 10.1016/j.resuscitation.2013.06.004; Valenzuela TD, 1997, CIRCULATION, V96, P3308	10	2	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1197	1198		10.1001/jama.2014.1485	http://dx.doi.org/10.1001/jama.2014.1485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668098				2022-12-24	WOS:000333340500018
J	Eroglu, E; Burkard, TR; Jiang, YR; Saini, N; Homem, CCF; Reichert, H; Knoblich, JA				Eroglu, Elif; Burkard, Thomas R.; Jiang, Yanrui; Saini, Nidhi; Homem, Catarina C. F.; Reichert, Heinrich; Knoblich, Juergen A.			SWI/SNF Complex Prevents Lineage Reversion and Induces Temporal Patterning in Neural Stem Cells	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; DROSOPHILA-BRAIN-TUMOR; REGULATES SELF-RENEWAL; TRANSCRIPTION FACTORS; PROGENITOR CELLS; NEUROBLAST LINEAGES; FACS PURIFICATION; MOSAIC ANALYSIS; DOMAIN PROTEIN; NERVOUS-SYSTEM	Members of the SWI/SNF chromatin-remodeling complex are among the most frequently mutated genes in human cancer, but how they suppress tumorigenesis is currently unclear. Here, we use Drosophila neuroblasts to demonstrate that the SWI/SNF component Osa (ARID1) prevents tumorigenesis by ensuring correct lineage progression in stem cell lineages. We show that Osa induces a transcriptional program in the transit-amplifying population that initiates temporal patterning, limits self-renewal, and prevents dedifferentiation. We identify the Prdm protein Hamlet as a key component of this program. Hamlet is directly induced by Osa and regulates the progression of progenitors through distinct transcriptional states to limit the number of transit-amplifying divisions. Our data provide a mechanistic explanation for the widespread tumor suppressor activity of SWI/SNF. Because the Hamlet homologs Evi1 and Prdm16 are frequently mutated in cancer, this mechanism could well be conserved in human stem cell lineages.	[Eroglu, Elif; Burkard, Thomas R.; Homem, Catarina C. F.; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Jiang, Yanrui; Saini, Nidhi; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Basel	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404; Burkard, Thomas/0000-0002-0884-2929; Eroglu, Elif/0000-0003-3952-3178; Homem, Catarina/0000-0003-4243-0298	Austrian Academy of Sciences; Austrian Science Fund (FWF) [I_552-B19, I_1281_B19, Z_153_B09]; European Research Council; Austrian Science Fund (FWF) [I 1281, Z 153] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank I. Reichardt, M. Lancaster, and H. Harzer for critical comments on the manuscript; A. W. Moore, C.Y. Lee, Y.N. Jan, S. Thor, S.X. Hou, U. Walldorf, the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center, the Developmental Studies Hybridoma Bank, and TriP at Harvard Medical School (NIH/NIGMS R01-GM084947) for fly stocks and reagents; F. Mauri for the help with generating Dpn antibody; H. Harzer for generating the rabbit Pros antibody; J. Steinmann for the help with the shmiR design; M. Madalinski for peptide synthesis and affinity purification; G. Schmauss and T. Lendl for FACS support; P. Pasierbek for bio-optics support; and CSF NGS unit for next-generation sequencing. Work in J.A.K.'s lab is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF, grants I_552-B19, I_1281_B19, and Z_153_B09), and an advanced grant of the European Research Council.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Bayraktar OA, 2013, NATURE, V498, P449, DOI 10.1038/nature12266; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brand AH, 2011, NEURON, V70, P719, DOI 10.1016/j.neuron.2011.05.016; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Endo K, 2012, NAT NEUROSCI, V15, P224, DOI 10.1038/nn.2998; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Harris RE, 2011, DEV CELL, V20, P72, DOI 10.1016/j.devcel.2010.11.019; Harzer H, 2013, NAT PROTOC, V8, P1088, DOI 10.1038/nprot.2013.062; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Homem CCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079588; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Klein T, 1997, DEVELOPMENT, V124, P3123; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Liu C, 2012, CURR OPIN NEUROBIOL, V22, P844, DOI 10.1016/j.conb.2012.04.012; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma Y, 1998, MECH DEVELOP, V73, P169, DOI 10.1016/S0925-4773(98)00050-1; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Moore AW, 2004, GENE DEV, V18, P623, DOI 10.1101/gad.1170904; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Richter C, 2011, NAT CELL BIOL, V13, P1029, DOI 10.1038/ncb2306; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Song Y, 2011, GENE DEV, V25, P2644, DOI 10.1101/gad.171959.111; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Vazquez M, 1999, DEVELOPMENT, V126, P733; Weng M, 2011, CURR OPIN NEUROBIOL, V21, P36, DOI 10.1016/j.conb.2010.09.005; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xiao Q, 2012, DEVELOPMENT, V139, P2670, DOI 10.1242/dev.081687; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779; Zeng XK, 2013, DEVELOPMENT, V140, P3532, DOI 10.1242/dev.096891; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045; Zhu SJ, 2011, P NATL ACAD SCI USA, V108, P20615, DOI 10.1073/pnas.1118595109	94	96	98	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1259	1273		10.1016/j.cell.2014.01.053	http://dx.doi.org/10.1016/j.cell.2014.01.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630726	Green Accepted, hybrid			2022-12-24	WOS:000332945100015
J	Moniz, MH; Davis, MM; Chang, T				Moniz, Michelle H.; Davis, Matthew M.; Chang, Tammy			Attitudes About Mandated Coverage of Birth Control Medication and Other Health Benefits in a US National Sample	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Moniz, Michelle H.] Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Chang, Tammy] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Moniz, MH (corresponding author), Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, 2800 Plymouth Rd,Bldg 10 G016, Ann Arbor, MI 48109 USA.	mmoniz@med.umich.edu		Chang, Tammy/0000-0002-3580-9438				Butler AS, 2009, REVIEW OF THE HHS FAMILY PLANNING PROGRAM: MISSION, MANAGEMENT, AND MEASUREMENT OF RESULTS, P1; Eckholm E., 2014, NEW YORK TIMES; Eilperin J., 2014, WASHINGTON POST; Gossett DR, 2013, JAMA-J AM MED ASSOC, V309, P1997, DOI 10.1001/jama.2013.4262; Public Religion Research Institute, 2012, SURV MAJ CATH THINK; Zimmer EA, 2013, JAMA-J AM MED ASSOC, V309, P1999, DOI 10.1001/jama.2013.3730	6	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2539	2541		10.1001/jama.2014.4766	http://dx.doi.org/10.1001/jama.2014.4766			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	24756439	Bronze			2022-12-24	WOS:000337757000029
J	Barrett, KT; Metrano, AJ; Rablen, PR; Miller, SJ				Barrett, Kimberly T.; Metrano, Anthony J.; Rablen, Paul R.; Miller, Scott J.			Spontaneous transfer of chirality in an atropisomerically enriched two-axis system	NATURE			English	Article							TERTIARY AROMATIC AMIDES; KINETIC RESOLUTION; AXIAL CHIRALITY; DRUG DISCOVERY; ROTATION; ENANTIOMERIZATION; BARRIERS; EQUILIBRATION; SEPARATION; CATALYSIS	One of the most well-recognized stereogenic elements in a chiral molecule is an sp(3)-hybridized carbon atom that is connected to four different substituents. Axes of chirality can also exist about bonds with hindered barriers of rotation; molecules containing such axes are known as atropisomers(1). Understanding the dynamics of these systems can be useful, for example, in the design of single-atropisomer drugs(2) or molecular switches and motors(3). For molecules that exhibit a single axis of chirality, rotation about that axis leads to racemization as the system reaches equilibrium. Here we report a two-axis system for which an enantioselective reaction produces four stereoisomers (two enantiomeric pairs): following a catalytic asymmetric transformation, we observe a kinetically controlled product distribution that is perturbed from the system's equilibrium position. As the system undergoes isomerization, one of the diastereomeric pairs drifts spontaneously to a higher enantiomeric ratio. In a compensatory manner, the enantiomeric ratio of the other diastereomeric pair decreases. These observations are made for a class of unsymmetrical amides that exhibits two asymmetric axes-one axis is defined through a benzamide substructure, and the other axis is associated with differentially N,N-disubstituted amides. The stereodynamics of these substrates provides an opportunity to observe a curious interplay of kinetics and thermodynamics intrinsic to a system of stereoisomers that is constrained to a situation of partial equilibrium.	[Barrett, Kimberly T.; Metrano, Anthony J.; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Rablen, Paul R.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA	Yale University; Swarthmore College	Miller, SJ (corresponding author), Yale Univ, Dept Chem, POB 208107, New Haven, CT 06520 USA.	scott.miller@yale.edu	Metrano, Anthony/B-1895-2013; Miller, Scott/N-7761-2017	Metrano, Anthony/0000-0002-2599-8917; Miller, Scott/0000-0001-7817-1318; Rablen, Paul/0000-0002-1300-1999	National Institute of General Medical Sciences of the NIH [GM-068649]; National Science Foundation; Yale University Faculty of Arts and Sciences High Performance Computing Center; National Science Foundation [CNS 08-21132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068649, R37GM068649] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Yale University Faculty of Arts and Sciences High Performance Computing Center; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the National Institute of General Medical Sciences of the NIH (GM-068649) for support. We also thank L. Guard for X-ray crystallography. A.J.M. was supported by the National Science Foundation Graduate Research Fellowship Program. All computational work was supported by the facilities and staff of the Yale University Faculty of Arts and Sciences High Performance Computing Center, and by the National Science Foundation under grant number CNS 08-21132, which partially funded acquisition of the facilities.	Ahmed A, 1998, TETRAHEDRON, V54, P13277, DOI 10.1016/S0040-4020(98)00814-X; Barrett KT, 2013, J AM CHEM SOC, V135, P2963, DOI 10.1021/ja400082x; Bragg RA, 2002, CHEM-EUR J, V8, P1279, DOI 10.1002/1521-3765(20020315)8:6<1279::AID-CHEM1279>3.3.CO;2-Z; Bringmann G, 2005, ANGEW CHEM INT EDIT, V44, P5384, DOI 10.1002/anie.200462661; Campomanes P, 2002, J PHYS CHEM A, V106, P2623, DOI 10.1021/jp013127z; CHUPP JP, 1967, J ORG CHEM, V32, P2297, DOI 10.1021/jo01282a045; Clayden J, 1998, ANGEW CHEM INT EDIT, V37, P1937, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1937::AID-ANIE1937>3.0.CO;2-4; Clayden J, 2009, ANGEW CHEM INT EDIT, V48, P6398, DOI 10.1002/anie.200901719; Cox C, 2000, ACCOUNTS CHEM RES, V33, P849, DOI 10.1021/ar990165g; CUYEGKENG MA, 1987, CHEM BER-RECL, V120, P803, DOI 10.1002/cber.19871200519; Eliel E. L., 1994, STEREOCHEMISTRY ORGA, V425; Erol S, 2012, CHIRALITY, V24, P493, DOI 10.1002/chir.22007; Feringa BL, 2007, J ORG CHEM, V72, P6635, DOI 10.1021/jo070394d; HIRSCH R, 1992, CHEM BER-RECL, V125, P975, DOI 10.1002/cber.19921250432; IWAMURA H, 1988, ACCOUNTS CHEM RES, V21, P175, DOI 10.1021/ar00148a007; Keith JM, 2001, ADV SYNTH CATAL, V343, P5, DOI 10.1002/1615-4169(20010129)343:1<5::AID-ADSC5>3.0.CO;2-I; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Klussmann M, 2006, NATURE, V441, P621, DOI 10.1038/nature04780; LaPlante SR, 2014, J MED CHEM, V57, P1944, DOI 10.1021/jm401202a; LaPlante SR, 2011, J MED CHEM, V54, P7005, DOI 10.1021/jm200584g; LaPlante SR, 2011, CHEMMEDCHEM, V6, P505, DOI 10.1002/cmdc.201000485; Lee WK, 2009, ACCOUNTS CHEM RES, V42, P224, DOI 10.1021/ar8000662; MANNSCHRECK A, 1967, J MOL SPECTROSC, V23, P15, DOI 10.1016/0022-2852(67)90044-6; Oki M., 1983, TOPICS STEREOCHEMIST, V1; Pirkle William H., 1993, Journal of Chromatography, V648, P101, DOI 10.1016/0021-9673(93)83291-Y; Reichert S, 2007, ORG LETT, V9, P899, DOI 10.1021/ol0700660; REIST M, 1995, CHIRALITY, V7, P396, DOI 10.1002/chir.530070603; Wang JB, 2011, SCIENCE, V331, P1429, DOI 10.1126/science.1199844; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	29	116	118	5	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					71	75		10.1038/nature13189	http://dx.doi.org/10.1038/nature13189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24747399	Green Accepted, Green Submitted			2022-12-24	WOS:000335199100041
J	Farrell, M; Buchbinder, R; Hall, W				Farrell, Michael; Buchbinder, Rachelle; Hall, Wayne			Should doctors prescribe cannabinoids?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHEMOTHERAPY-INDUCED NAUSEA; RANDOMIZED CONTROLLED-TRIAL; CENTRAL NEUROPATHIC PAIN; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; CANCER-PATIENTS; SPASTICITY; NABILONE; METAANALYSIS; NABIXIMOLS		[Farrell, Michael] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2031, Australia; [Buchbinder, Rachelle] Cabrini Hosp, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Hall, Wayne] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	University of New South Wales Sydney; Cabrini Health; Monash University; Monash University; University of Queensland	Farrell, M (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2031, Australia.	michael.farrell@unsw.edu.au	Farrell, Michael P/A-4769-2012; Hall, Wayne D/A-3283-2008; Buchbinder, Rachelle/G-2952-2011	Farrell, Michael P/0000-0001-7008-8130; Hall, Wayne D/0000-0003-1984-0096; Buchbinder, Rachelle/0000-0002-0597-0933				Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; Christie MJ, 2006, BRIT J PHARMACOL, V148, P385, DOI 10.1038/sj.bjp.0706756; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Collin C, 2010, NEUROL RES, V32, P451, DOI 10.1179/016164109X12590518685660; Corey-Bloom J, 2012, CAN MED ASSOC J, V184, P1143, DOI 10.1503/cmaj.110837; Dyer O, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4755; Eddy, 2010, 75700 C RES SERV; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Institute of Medicine (US). Division of Neuroscience and Behavioral Health, 1999, MARIJUANA MED ASSESS; Johnson JR, 2010, J PAIN SYMPTOM MANAG, V39, P167, DOI 10.1016/j.jpainsymman.2009.06.008; Kalant H, 2001, Pain Res Manag, V6, P80; Langford RM, 2013, J NEUROL, V260, P984, DOI 10.1007/s00415-012-6739-4; Lutge EE, 2013, COCHRANE DB SYST REV, V4; Lynch ME, 2011, BRIT J CLIN PHARMACO, V72, P735, DOI 10.1111/j.1365-2125.2011.03970.x; Martin-Sanchez E, 2009, PAIN MED, V10, P1353, DOI 10.1111/j.1526-4637.2009.00703.x; Nascimento SD, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/149468; Navari RM, 2009, DRUGS, V69, P515, DOI 10.2165/00003495-200969050-00002; Phillips TJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014433; Pini LA, 2012, J HEADACHE PAIN, V13, P677, DOI 10.1007/s10194-012-0490-1; Podda G, 2012, EXPERT OPIN BIOL TH, V12, P1517, DOI 10.1517/14712598.2012.721765; Portenoy RK, 2012, J PAIN, V13, P438, DOI 10.1016/j.jpain.2012.01.003; Richards BL, 2011, COCHRANE DB SYST REV, V1; Rintala DH, 2010, AM J PHYS MED REHAB, V89, P840, DOI 10.1097/PHM.0b013e3181f1c4ec; Rocha FCM, 2008, EUR J CANCER CARE, V17, P431, DOI 10.1111/j.1365-2354.2008.00917.x; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; Russo E, 2006, MED HYPOTHESES, V66, P234, DOI 10.1016/j.mehy.2005.08.026; Selvarajah D, 2010, DIABETES CARE, V33, P128, DOI 10.2337/dc09-1029; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Snedecor SJ, 2013, J PAIN RES, V6, P539, DOI 10.2147/JPR.S45966; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P31; Toth C, 2012, PAIN, V153, P2073, DOI 10.1016/j.pain.2012.06.024; Tramer MR, 2001, BMJ-BRIT MED J, V323, P16, DOI 10.1136/bmj.323.7303.16; Wade DT, 2010, MULT SCLER J, V16, P707, DOI 10.1177/1352458510367462; Wade DT, 2004, MULT SCLER, V10, P434, DOI 10.1191/1352458504ms1082oa; Wade DT, 2003, CLIN REHABIL, V17, P21, DOI 10.1191/0269215503cr581oa; Ware MA, 2010, ANESTH ANALG, V110, P604, DOI 10.1213/ANE.0b013e3181c76f70	37	9	10	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2014	348								g2737	10.1136/bmj.g2737	http://dx.doi.org/10.1136/bmj.g2737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG1DH	24760158				2022-12-24	WOS:000335154800003
J	Murphy, LJ; Robertson, KN; Harroun, SG; Brosseau, CL; Werner-Zwanziger, U; Moilanen, J; Tuononen, HM; Clyburne, JAC				Murphy, Luke J.; Robertson, Katherine N.; Harroun, Scott G.; Brosseau, Christa L.; Werner-Zwanziger, Ulrike; Moilanen, Jani; Tuononen, Heikki M.; Clyburne, Jason A. C.			A Simple Complex on the Verge of Breakdown: Isolation of the Elusive Cyanoformate Ion	SCIENCE			English	Article							CRYSTAL-STRUCTURE; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; ETHYLENE BIOSYNTHESIS; CYANIDE; BICARBONATE; METABOLISM; CARBONATE; MECHANISM; HORMONE; OXIDASE	Why does cyanide not react destructively with the proximal iron center at the active site of 1-aminocyclopropane-1-carboxylic acid (ACC) oxidase, an enzyme central to the biosynthesis of ethylene in plants? It has long been postulated that the cyanoformate anion, [NCCO2](-), forms and then decomposes to carbon dioxide and cyanide during this process. We have now isolated and crystallographically characterized this elusive anion as its tetraphenylphosphonium salt. Theoretical calculations show that cyanoformate has a very weak C-C bond and that it is thermodynamically stable only in low dielectric media. Solution stability studies have substantiated the latter result. We propose that cyanoformate shuttles the potentially toxic cyanide away from the low dielectric active site of ACC oxidase before breaking down in the higher dielectric medium of the cell.	[Murphy, Luke J.; Robertson, Katherine N.; Harroun, Scott G.; Brosseau, Christa L.; Clyburne, Jason A. C.] St Marys Univ, Dept Chem, Atlantic Ctr Green Chem, Halifax, NS B3H 3C3, Canada; [Werner-Zwanziger, Ulrike] Dalhousie Univ, Dept Chem, Halifax, NS B3H 4J3, Canada; [Werner-Zwanziger, Ulrike] Dalhousie Univ, Inst Mat Res, Halifax, NS B3H 4J3, Canada; [Moilanen, Jani; Tuononen, Heikki M.] Univ Jyvaskyla, Dept Chem, FI-40014 Jyvaskyla, Finland	Saint Marys University - Canada; Dalhousie University; Dalhousie University; University of Jyvaskyla	Tuononen, HM (corresponding author), Univ Jyvaskyla, Dept Chem, POB 35, FI-40014 Jyvaskyla, Finland.	heikki.m.tuononen@jyu.fi; jason.clyburne@smu.ca	Moilanen, Jani Olavi/G-6614-2016; Harroun, Scott G./ABG-3694-2021	Moilanen, Jani Olavi/0000-0002-2096-593X; Tuononen, Heikki/0000-0002-4820-979X; Harroun, Scott/0000-0003-3370-5341	Natural Sciences and Engineering Research Council of Canada; Academy of Finland; Canada Research Chairs Program; Canadian Foundation for Innovation; Nova Scotia Research and Innovation Trust Fund; Technology Industries of Finland Centennial Foundation; University of Jyvaskyla; GreenCentre Canada; Encana Corporation; Magnus Ehrnrooth Foundation; Springboard	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Academy of Finland(Academy of Finland); Canada Research Chairs Program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Nova Scotia Research and Innovation Trust Fund; Technology Industries of Finland Centennial Foundation; University of Jyvaskyla; GreenCentre Canada; Encana Corporation; Magnus Ehrnrooth Foundation; Springboard	We thank the Natural Sciences and Engineering Research Council of Canada (through the Discovery Grants Program to J.A.C.C.) and the Academy of Finland (through its Research Fellowship to H. M. T.). J.A.C.C. acknowledges generous support from the Canada Research Chairs Program, the Canadian Foundation for Innovation, and the Nova Scotia Research and Innovation Trust Fund. H. M. T. acknowledges generous support from the Academy of Finland, the Technology Industries of Finland Centennial Foundation, and the University of Jyvaskyla. This work was also supported in part by GreenCentre Canada, Encana Corporation (Deep Panuke Education and Training and Research and Development Fund), Springboard, and the Magnus Ehrnrooth Foundation (postdoctoral scholarship to J.M.). We are grateful to NMR-3 (Dalhousie University) for NMR data acquisition, Canadian Microanalytical Services for elemental analyses, and the Finnish Grid Infrastructure consortium for central processing unit time. We also thank E. Plettner for her helpful discussions and T. S. Cameron and A. Linden for their crystallographic insights. Metrical parameters for the structure of tetraphenylphosphonium cyanoformate are available free of charge from the Cambridge Crystallographic Data Centre, under reference number CCDC 986380.	ADAMS DO, 1981, TRENDS BIOCHEM SCI, V6, P161, DOI 10.1016/0968-0004(81)90059-1; Alabugin IV, 2010, SCIENCE, V330, DOI 10.1126/science.1196188; ALCOCK NW, 1985, ACTA CRYSTALLOGR C, V41, P1549, DOI 10.1107/S0108270185008502; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Bassan A, 2006, CHEM-EUR J, V12, P8835, DOI 10.1002/chem.200501459; Bernsdorf A, 2012, Z KRIST-NEW CRYST ST, V227, P85, DOI 10.1524/ncrs.2012.0038; Braga D, 2002, CHEM-EUR J, V8, P1173, DOI 10.1002/1521-3765(20020301)8:5<1173::AID-CHEM1173>3.0.CO;2-K; Brunhuber NMW, 2000, BIOCHEMISTRY-US, V39, P10730, DOI 10.1021/bi0000162; BURG SP, 1965, SCIENCE, V148, P1190, DOI 10.1126/science.148.3674.1190; Dilley DR, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt031; DRUCK U, 1984, Z KRISTALLOGR, V167, P131, DOI 10.1524/zkri.1984.167.1-2.131; Duong HA, 2004, CHEM COMMUN, P112, DOI 10.1039/b311350g; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; GarciaMoreno B, 1997, BIOPHYS CHEM, V64, P211, DOI 10.1016/S0301-4622(96)02238-7; Himmel D, 2014, ANGEW CHEM INT EDIT, V53, P370, DOI 10.1002/anie.201300461; Holbrey JD, 2003, CHEM COMMUN, P28, DOI 10.1039/b211519k; KITAURA K, 1976, INT J QUANTUM CHEM, V10, P325, DOI 10.1002/qua.560100211; Kockerling M, 1999, Z KRIST-NEW CRYST ST, V214, P460; Kuhn N, 1999, Z NATURFORSCH B, V54, P427; Ling I, 2010, CRYSTENGCOMM, V12, P4321, DOI 10.1039/c002832k; MacIntosh IS, 2010, ORGANOMETALLICS, V29, P2063, DOI 10.1021/om901097r; Mani F, 2006, GREEN CHEM, V8, P995, DOI 10.1039/b602051h; MILLER FA, 1952, ANAL CHEM, V24, P1253, DOI 10.1021/ac60068a007; MILLER JM, 1980, PLANT PHYSIOL, V65, P1199, DOI 10.1104/pp.65.6.1199; Mirica LM, 2008, P NATL ACAD SCI USA, V105, P1814, DOI 10.1073/pnas.0711626105; MOROKUMA K, 1971, J CHEM PHYS, V55, P1236, DOI 10.1063/1.1676210; PEISER GD, 1984, P NATL ACAD SCI-BIOL, V81, P3059, DOI 10.1073/pnas.81.10.3059; Pirrung MC, 1999, ACCOUNTS CHEM RES, V32, P711, DOI 10.1021/ar960003+; PURCELL KF, 1969, J AM CHEM SOC, V91, P3487, DOI 10.1021/ja01041a013; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; SCHWEIZER EE, 1989, ACTA CRYSTALLOGR C, V45, P1236, DOI 10.1107/S0108270189000363; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Shoukry MM, 2014, CENT EUR J CHEM, V12, P318, DOI 10.2478/s11532-013-0374-5; Smith JM, 2000, PHYSIOL PLANTARUM, V109, P180, DOI 10.1034/j.1399-3054.2000.100210.x; YIP WK, 1988, PLANT PHYSIOL, V88, P473, DOI 10.1104/pp.88.2.473; ZHANG XZ, 1995, ANGEW CHEM INT EDIT, V34, P1858, DOI 10.1002/anie.199518581; Zhou H, 2008, J ORG CHEM, V73, P8039, DOI 10.1021/jo801457r; ZIEGLER T, 1977, THEOR CHIM ACTA, V46, P1, DOI 10.1007/BF02401406	39	35	36	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					75	78		10.1126/science.1250808	http://dx.doi.org/10.1126/science.1250808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700853	Green Accepted			2022-12-24	WOS:000333746100054
J	Catto, G; Cork, N; Williams, G				Catto, Graeme; Cork, Nick; Williams, Gareth			Should medical students be taught alternative medicine?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPLEMENTARY; CAM		[Catto, Graeme] Guys Hosp, Coll Med, London SE1 9RT, England; [Cork, Nick] Univ Cambridge, Sch Clin Med, Cambridge CB2 0SP, England; [Williams, Gareth] Univ Bristol, Bristol BS8 1TH, Avon, England	Guy's & St Thomas' NHS Foundation Trust; University of Cambridge; University of Bristol	Catto, G (corresponding author), Guys Hosp, Coll Med, London SE1 9RT, England.	president@collegeofmedicine.org.uk; nicholascork@gmail.com						[Anonymous], 1989, HOM PHARM US MON; Chalmers I, 2003, ANN AM ACAD POLIT SS, V589, P22, DOI 10.1177/0002716203254762; College of Medicine, 2013, CONST COLL MED; Epel E, 2009, ANN NY ACAD SCI, V1172, P34, DOI 10.1111/j.1749-6632.2009.04414.x; Ernst E., 2011, EVID-BASED COMPL ALT, V2011, P3; Ernst E, 2011, BRIT J GEN PRACT, V61, P404, DOI 10.3399/bjgp11X578070; Flexner A., 1910, MEDICAL ED US CANADA; General Medical Council, 2009, TOM DOCT OUTC STAND; General Medical Council, 2009, TOMORROWS DOCTORS; Ho D., 2013, FOCUS ALTERNAT COMPL, V18, P176; Leggatt J, 2008, TELEGRAPH; Moses GM, 2010, AUST PRESCR, V33, P177; National Cancer Institute, 2013, COMPL ALT MED CANC T; National Institute for Clinical Excellence, 2006, PARK DIS DIAGN MAN P; National Institute for Health and Care Excellence (NICE, 2009, LOW BACK PAIN EARL M; NICE, 2008, ANT CAR NICE CLIN GU; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Posadzki P, 2012, INT J CLIN PRACT, V66, P1178, DOI 10.1111/ijcp.12026; Posadzki P, 2013, CLIN MED, V13, P126, DOI 10.7861/clinmedicine.13-2-126; Posadzki P, 2013, BRIT J CLIN PHARMACO, V75, P603, DOI 10.1111/j.1365-2125.2012.04350.x; Roberts I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3879; *SEL COMM SCI TECH, 2000, 6 SEL COMM SCI TECHN; Smith KR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000074; The Royal London Hospital for Integrated Medicine, 2013, INT COMPL MED EV PRA	24	3	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2014	348								g2417	10.1136/bmj.g2417	http://dx.doi.org/10.1136/bmj.g2417			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD9MF	24682533				2022-12-24	WOS:000333588500005
J	Rosenberg, SM; Queitsch, C				Rosenberg, Susan M.; Queitsch, Christine			Combating Evolution to Fight Disease	SCIENCE			English	Editorial Material							DNA BREAKS; CANCER; MUTATION; GENOMES; REPAIR		[Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Queitsch, Christine] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Washington; University of Washington Seattle	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu		Rosenberg, Susan M./0000-0003-1444-473X	NCI NIH HHS [R01 CA085777, DP1 CA174424, R01-CA85777, DP1-CA174424] Funding Source: Medline; NIGMS NIH HHS [R35 GM122598, R01 GM053158, R01-GM53158] Funding Source: Medline; NIH HHS [DP2 OD008371, DP2-OD008371] Funding Source: Medline; NATIONAL CANCER INSTITUTE [DP1CA174424, R01CA085777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122598, R01GM053158] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008371] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cowen LE, 2013, CURR OPIN MICROBIOL, V16, P377, DOI 10.1016/j.mib.2013.03.005; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Lindquist S, 2009, COLD SH Q B, V74, P103, DOI 10.1101/sqb.2009.74.043; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shor E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003680	15	33	34	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1088	1089		10.1126/science.1247472	http://dx.doi.org/10.1126/science.1247472			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604189	Green Accepted			2022-12-24	WOS:000332331500033
J	Willett, SD; McCoy, SW; Perron, JT; Goren, L; Chen, CY				Willett, Sean D.; McCoy, Scott W.; Perron, J. Taylor; Goren, Liran; Chen, Chia-Yu			Dynamic Reorganization of River Basins	SCIENCE			English	Article							LANDSCAPE EVOLUTION; DRAINAGE PATTERNS; EROSION; CAPTURE; UPLIFT; MODEL; REARRANGEMENT; ESCARPMENT; TOPOGRAPHY; TECTONICS	River networks evolve as migrating drainage divides reshape river basins and change network topology by capture of river channels. We demonstrate that a characteristic metric of river network geometry gauges the horizontal motion of drainage divides. Assessing this metric throughout a landscape maps the dynamic states of entire river networks, revealing diverse conditions: Drainage divides in the Loess Plateau of China appear stationary; the young topography of Taiwan has migrating divides driving adjustment of major basins; and rivers draining the ancient landscape of the southeastern United States are reorganizing in response to escarpment retreat and coastal advance. The ability to measure the dynamic reorganization of river basins presents opportunities to examine landscape-scale interactions among tectonics, erosion, and ecology.	[Willett, Sean D.; McCoy, Scott W.; Goren, Liran; Chen, Chia-Yu] Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland; [McCoy, Scott W.; Perron, J. Taylor] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT)	Willett, SD (corresponding author), Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland.	swillett@erdw.ethz.ch	Willett, Sean D/B-1716-2008	Goren, Liran/0000-0002-4704-5009; Chen, Chia-Yu/0000-0002-3837-5858	Canadian Institute for Advanced Research (CIFAR); CIFAR postdoctoral fellowship; U.S. National Science Foundation [EAR-0951672]; Swiss National Research Foundation; Division Of Earth Sciences [0951672] Funding Source: National Science Foundation	Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); CIFAR postdoctoral fellowship; U.S. National Science Foundation(National Science Foundation (NSF)); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	S.D.W., S.W.M., and J.T.P. thank the Canadian Institute for Advanced Research (CIFAR) for research support and members of the Earth System Evolution Program of CIFAR for discussions. S.W.M. was supported by a CIFAR postdoctoral fellowship and by the U.S. National Science Foundation through award EAR-0951672 to J.T.P. C.-Y.C. was supported by the Swiss National Research Foundation. Data are archived in the supplementary materials.	Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; Bonnet S, 2009, NAT GEOSCI, V2, P766, DOI 10.1038/NGEO666; Brocard G, 2012, AM J SCI, V312, P449, DOI 10.2475/05.2012.01; Castelltort S, 2012, NAT GEOSCI, V5, P744, DOI [10.1038/ngeo1582, 10.1038/NGEO1582]; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; D W M, 1889, Science, V13, P108; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Davis W.M., 1903, GEOLSOCPHILABULL, V3, P213; Davis W. M., 1899, GEOGR J, V14, P481, DOI [10.2307/1774538, DOI 10.2307/1774538]; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; Goren L, 2014, EARTH SURF PROC LAND, V39, P522, DOI 10.1002/esp.3514; Hack J.T., 1957, STUDIES LONGITUDINAL, V294, P45; Hancock GS, 2002, GEOL SOC AM BULL, V114, P1131; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hovius N, 1996, BASIN RES, V8, P29, DOI 10.1111/j.1365-2117.1996.tb00113.x; HOWARD AD, 1965, AM J SCI, V263, P302, DOI 10.2475/ajs.263.4.302; HOWARD AD, 1990, WATER RESOUR RES, V26, P2107, DOI 10.1029/WR026i009p02107; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; HOWARD AD, 1971, GEOL SOC AM BULL, V82, P1355, DOI 10.1130/0016-7606(1971)82[1355:SMOSC]2.0.CO;2; Johnson DW, 1907, SCIENCE, V25, P428, DOI 10.1126/science.25.637.428-a; Kirby E, 2012, J STRUCT GEOL, V44, P54, DOI 10.1016/j.jsg.2012.07.009; Matmon A, 2003, GEOLOGY, V31, P155, DOI 10.1130/0091-7613(2003)031<0155:TASURO>2.0.CO;2; MONTGOMERY DR, 1988, NATURE, V336, P232, DOI 10.1038/336232a0; Mudd SM, 2014, J GEOPHYS RES-EARTH, V119, P138, DOI 10.1002/2013JF002981; Nicholson S. W., 2005, PRELIMINARY INTEGRAT; Pelletier JD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020802; Perron JT, 2013, EARTH SURF PROC LAND, V38, P570, DOI 10.1002/esp.3302; Perron JT, 2012, NATURE, V492, P100, DOI 10.1038/nature11672; Perron JT, 2009, NATURE, V460, P502, DOI 10.1038/nature08174; PITMAN WC, 1972, GEOL SOC AM BULL, V83, P619, DOI 10.1130/0016-7606(1972)83[619:SSITNA]2.0.CO;2; Portenga E.W., 2011, GSA TODAY, V21, P4, DOI [DOI 10.1130/G111A.1, 10.1130/G111A.1]; Prince PS, 2013, EARTH SURF PROC LAND, V38, P1685, DOI 10.1002/esp.3406; Prince PS, 2011, GEOLOGY, V39, P823, DOI 10.1130/G32008.1; Pritchard D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040928; Reiners PW, 2006, ANNU REV EARTH PL SC, V34, P419, DOI 10.1146/annurev.earth.34.031405.125202; Rigon R, 1996, WATER RESOUR RES, V32, P3367, DOI 10.1029/96WR02397; Rodriguez Iturbe I., 2001, FRACTAL RIVER BASINS, P564; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; Rowley DB, 2013, SCIENCE, V340, P1560, DOI 10.1126/science.1229180; Royden L, 2013, J GEOPHYS RES-EARTH, V118, P497, DOI 10.1002/jgrf.20031; Seidl MA, 1996, BASIN RES, V8, P301, DOI 10.1046/j.1365-2117.1996.00266.x; SEPKOSKI JJ, 1974, SYST ZOOL, V23, P165, DOI 10.2307/2412130; Spotila JA, 2004, BASIN RES, V16, P41, DOI 10.1111/j.1365-2117.2003.00219.x; Sullivan C. L., 2008, THESIS U VERMONT; Suppe J, 1981, MEMOIR GEOL SOC CHIN, V4, P67; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Waters JM, 2001, EVOLUTION, V55, P1844; Whipple KX, 2001, AM J SCI, V301, P313, DOI 10.2475/ajs.301.4-5.313; Willett SD, 2001, AM J SCI, V301, P455, DOI 10.2475/ajs.301.4-5.455; Xiong LY, 2014, GEOMORPHOLOGY, V209, P18, DOI 10.1016/j.geomorph.2013.12.009; Yan M. J., 2014, RESTORATION DEV DEGR; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	53	367	384	17	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1117	+	1248765	10.1126/science.1248765	http://dx.doi.org/10.1126/science.1248765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604204				2022-12-24	WOS:000332331500040
J	McMinn, PC				McMinn, Peter C.			Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Human enterovirus 71 (EV71), which can cause brain-stem encephalitis, has caused approximately 2000 deaths in the past decade. New vaccines represent an exciting development in the global response to the emergence of EV71 as a cause of severe neurologic disease. Hand, foot, and mouth disease is a common childhood exanthem caused by enteroviruses that belong to the human enterovirus A species of the family Picornaviridae most commonly, human enterovirus 71 (EV71) and coxsackievirus A16. Although the clinical signs of hand, foot, and mouth disease associated with various enteroviruses are indistinguishable, EV71 epidemics are a cause for public health concern because they place young children (<5 years of age) at increased risk for severe neurologic disease.(1) EV71 was first identified in the United States in 1969.(1) Despite causing epidemics of severe neurologic disease in Bulgaria in 1975 and in Hungary ...	Univ Sydney, Sydney Med Sch, Infect Dis & Immunol Dept, Sydney, NSW 2006, Australia	University of Sydney	McMinn, PC (corresponding author), Univ Sydney, Sydney Med Sch, Infect Dis & Immunol Dept, Sydney, NSW 2006, Australia.							Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	5	22	25	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					792	794		10.1056/NEJMp1400601	http://dx.doi.org/10.1056/NEJMp1400601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571750				2022-12-24	WOS:000332013000003
J	Ginsburg, G				Ginsburg, Geoffrey			Gather and use genetic data in health care	NATURE			English	Editorial Material							GENOMIC MEDICINE; WARFARIN		Duke Univ, Durham, NC 27706 USA	Duke University	Ginsburg, G (corresponding author), Duke Univ, Durham, NC 27706 USA.	geoffrey.ginsburg@duke.edu						Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Lynch JA, 2013, GENET MED, V15, P630, DOI 10.1038/gim.2013.5; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Van Driest SL, 2014, CLIN PHARMACOL THER, V95, P423, DOI 10.1038/clpt.2013.229; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	10	35	36	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					451	453		10.1038/508451a	http://dx.doi.org/10.1038/508451a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF5GI	24765668	Bronze			2022-12-24	WOS:000334741600011
J	Papa, A; Wan, LX; Bonora, M; Salmena, L; Song, MS; Hobbs, RM; Lunardi, A; Webster, K; Ng, C; Newton, RH; Knoblauch, N; Guarnerio, J; Ito, K; Turka, LA; Beck, AH; Pinton, P; Bronson, RT; Wei, WY; Pandolfi, PP				Papa, Antonella; Wan, Lixin; Bonora, Massimo; Salmena, Leonardo; Song, Min Sup; Hobbs, Robin M.; Lunardi, Andrea; Webster, Kaitlyn; Ng, Christopher; Newton, Ryan H.; Knoblauch, Nicholas; Guarnerio, Jlenia; Ito, Keisuke; Turka, Laurence A.; Beck, Andy H.; Pinton, Paolo; Bronson, Roderick T.; Wei, Wenyi; Pandolfi, Pier Paolo			Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function	CELL			English	Article							LHERMITTE-DUCLOS-DISEASE; TUMOR-SUPPRESSOR; PHOSPHATASE-ACTIVITY; COWDEN-DISEASE; SOMA SIZE; GENE; MICE; MUTATIONS; PHOSPHORYLATION; SUSCEPTIBILITY	PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P-3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo-and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous Pten(C124S/+) and Pten(G129E/+) cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten(+/-) counterparts, whereas this difference is no longer apparent between Pten(C124S/-) and Pten(-/-) cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.	[Papa, Antonella; Salmena, Leonardo; Song, Min Sup; Hobbs, Robin M.; Lunardi, Andrea; Webster, Kaitlyn; Ng, Christopher; Guarnerio, Jlenia; Ito, Keisuke; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Canc Res Inst, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA; [Wan, Lixin; Knoblauch, Nicholas; Beck, Andy H.; Wei, Wenyi] Harvard Univ, Dept Pathol, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02115 USA; [Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Dept Morphol, Surg & Expt Med Sect Gen Pathol, I-44124 Ferrara, Italy; [Newton, Ryan H.; Turka, Laurence A.] Harvard Univ, Dept Med, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Ferrara; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Canc Res Inst, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Bonora, Massimo/AAC-3609-2022; Pinton, Paolo/J-8025-2012; Hobbs, Robin/I-2577-2014	Bonora, Massimo/0000-0002-5752-3318; Pinton, Paolo/0000-0001-7108-6508; Ng, Christopher/0000-0001-8815-7958; Webster, Kaitlyn/0000-0001-9902-0500; Pandolfi, Pier Paolo/0000-0002-5352-5295; Papa, Antonella/0000-0001-8653-7121; Hobbs, Robin/0000-0002-3853-2614; Knoblauch, Nicholas/0000-0002-2890-6520; Salmena, Leonardo/0000-0003-4023-658X	American-Italian Cancer Foundation Post-Doctoral Fellowship; Italian Association for Cancer Research [14442]; NIH [U01-CA 141496]; NATIONAL CANCER INSTITUTE [U01CA141496, R00CA139009, R01CA082328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, R01DK100689] Funding Source: NIH RePORTER	American-Italian Cancer Foundation Post-Doctoral Fellowship; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank Pandolfi lab members for critical comments and Thomas Garvey for editing the manuscript.The authors are indebted to SuJung Song and Dimitrios Anastosiou for insightful discussion.A.P.was supported in part by the American-Italian Cancer Foundation Post-Doctoral Fellowship.M.B.and P.P.are supported by the Italian Association for Cancer Research (AIRC, grant number 14442).This work was supported by NIH grant U01-CA 141496 to P.P.P.L.A.T.has a family member employed by, and owns equity in, Novartis.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; [Anonymous], 2012, J CELL BIOL; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bai F, 2006, MOL CELL BIOL, V26, P4564, DOI 10.1128/MCB.00266-06; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Kato H, 2000, CLIN CANCER RES, V6, P3937; Koksal AC, 2011, J BIOL CHEM, V286, P14373, DOI 10.1074/jbc.M111.226357; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Sotelo NS, 2012, J CELL BIOCHEM, V113, P2661, DOI 10.1002/jcb.24141; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tamura M, 1999, CANCER RES, V59, P442; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wang H, 2010, P NATL ACAD SCI USA, V107, P5142, DOI 10.1073/pnas.0912524107; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	42	194	203	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					595	610		10.1016/j.cell.2014.03.027	http://dx.doi.org/10.1016/j.cell.2014.03.027			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766807	Green Accepted, Bronze			2022-12-24	WOS:000335392100010
J	Woodroffe, R; Hedges, S; Durant, SM				Woodroffe, Rosie; Hedges, Simon; Durant, Sarah M.			To Fence or Not to Fence	SCIENCE			English	Editorial Material							POPULATIONS		[Woodroffe, Rosie; Durant, Sarah M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hedges, Simon; Durant, Sarah M.] Wildlife Conservat Soc, Bronx, NY 10460 USA	Zoological Society of London; Wildlife Conservation Society	Woodroffe, R (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	rosie.woodroffe@ioz.ac.uk	Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878				BENSHAHAR R, 1993, J TROP ECOL, V9, P249, DOI 10.1017/S0266467400007252; Cassidy L, 2013, AFR J ECOL, V51, P513, DOI 10.1111/aje.12061; Creel S, 2013, ECOL LETT, V16, P1413, DOI 10.1111/ele.12145; Davies-Mostert HT, 2013, J APPL ECOL, V50, P1358, DOI 10.1111/1365-2664.12129; Ewen John G., 2011, Conservation Evidence, V8, P58; Hoole A, 2010, GEOFORUM, V41, P304, DOI 10.1016/j.geoforum.2009.10.009; Jackson CR, 2012, WILDLIFE RES, V39, P31, DOI 10.1071/WR11070; Naess MW, 2013, INT J SUST DEV WORLD, V20, P123, DOI 10.1080/13504509.2013.779615; Nath C.D., 1998, ELEPHANT HUMAN CONFL; Packer C, 2013, Ecol Lett, V16, pe4, DOI 10.1111/ele.12171; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Shrader AM, 2010, BIODIVERS CONSERV, V19, P2235, DOI 10.1007/s10531-010-9836-7; Southern African Development Community, 2012, PHAK DECL AD NONG AP; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Woodroffe R., 2005, PEOPLE WILDLIFE CONF	15	83	84	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					46	48		10.1126/science.1246251	http://dx.doi.org/10.1126/science.1246251			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700847	Green Published			2022-12-24	WOS:000333746100044
J	Chang, WC; Guo, YS; Wang, C; Butch, SE; Rosenzweig, AC; Boal, AK; Krebs, C; Bollinger, JM				Chang, Wei-chen; Guo, Yisong; Wang, Chen; Butch, Susan E.; Rosenzweig, Amy C.; Boal, Amie K.; Krebs, Carsten; Bollinger, J. Martin, Jr.			Mechanism of the C5 Stereoinversion Reaction in the Biosynthesis of Carbapenem Antibiotics	SCIENCE			English	Article							BETA-LACTAM ANTIBIOTICS; KETOGLUTARATE DIOXYGENASE TAUD; NONHEME IRON OXYGENASES; SPIN FE(IV) COMPLEX; ESCHERICHIA-COLI; SYNTHASE CARC; ALIPHATIC HALOGENASE; ENZYMES; SUBSTRATE; EPIMERIZATION	The bicyclic beta-lactam/2-pyrrolidine precursor to all carbapenem antibiotics is biosynthesized by attachment of a carboxymethylene unit to C5 of L-proline followed by beta-lactam ring closure. Carbapenem synthase (CarC), an Fe(II) and 2-(oxo)glutarate (Fe/2OG)-dependent oxygenase, then inverts the C5 configuration. Here we report the structure of CarC in complex with its substrate and biophysical dissection of its reaction to reveal the stereoinversion mechanism. An Fe(IV)-oxo intermediate abstracts the hydrogen (H center dot) from C5, and tyrosine 165, a residue not visualized in the published structures of CarC lacking bound substrate, donates H center dot to the opposite face of the resultant radical. The reaction oxidizes the Fe(II) cofactor to Fe(III), limiting wild-type CarC to one turnover, but substitution of the H center dot-donating tyrosine disables stereoinversion and confers to CarC the capacity for catalytic substrate oxidation.	[Chang, Wei-chen; Guo, Yisong; Butch, Susan E.; Boal, Amie K.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Wang, Chen; Boal, Amie K.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Rosenzweig, Amy C.; Boal, Amie K.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Rosenzweig, Amy C.; Boal, Amie K.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Northwestern University	Chang, WC (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	oscarntu@gmail.com; akb20@psu.edu; ckrebs@psu.edu; jmb21@psu.edu	Krebs, Carsten/D-4773-2009; Guo, Yisong/C-7785-2009; Bollinger, Joseph/C-1425-2016	Krebs, Carsten/0000-0002-3302-7053; Guo, Yisong/0000-0002-4132-3565; CHANG, WEI-CHEN/0000-0002-2341-9846	National Institutes of Health [GM 058518, GM 100011, GM 069657]; U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069657, R00GM100011, K99GM100011, R01GM058518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession code 4OJ8. This work was supported by grants from the National Institutes of Health (GM 058518 to A.C.R., GM 100011 to A.K.B., and GM 069657 to C.K. and J.M.B.). Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract no. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). We thank E. Y. Tamanaha for assistance in the kinetic analysis.	[Anonymous], 2013, NATURE, V495, P141; Avenoza A, 2003, J ORG CHEM, V68, P2889, DOI 10.1021/jo026804+; Bodner MJ, 2010, J AM CHEM SOC, V132, P12, DOI 10.1021/ja907320n; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; BOLLINGER JM, 1995, METHOD ENZYMOL, V258, P278; Borowski T, 2006, J COMPUT CHEM, V27, P740, DOI 10.1002/jcc.20384; Bradley JS, 1999, INT J ANTIMICROB AG, V11, P93, DOI 10.1016/S0924-8579(98)00094-6; BYCROFT BW, 1989, J CHEM SOC CHEM COMM, P423, DOI 10.1039/c39890000423; Clifton IJ, 2003, J BIOL CHEM, V278, P20843, DOI 10.1074/jbc.M213054200; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Coulthurst SJ, 2005, NAT REV MICROBIOL, V3, P295, DOI 10.1038/nrmicro1128; Demain AL, 1999, ANTON LEEUW INT J G, V75, P5, DOI 10.1023/A:1001738823146; Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Gerratana B, 2004, BIOCHEMISTRY-US, V43, P15936, DOI 10.1021/bi0483662; Gerratana B, 2003, BIOCHEMISTRY-US, V42, P7836, DOI 10.1021/bi034361d; GROVES JT, 1985, J CHEM EDUC, V62, P928, DOI 10.1021/ed062p928; Hamed RB, 2013, NAT PROD REP, V30, P21, DOI 10.1039/c2np20065a; Hamed RB, 2012, J AM CHEM SOC, V134, P471, DOI 10.1021/ja208318d; Hamed RB, 2011, NAT CHEM, V3, P365, DOI [10.1038/NCHEM.1011, 10.1038/nchem.1011]; Hamed RB, 2010, CHEM COMMUN, V46, P1413, DOI 10.1039/b924519g; Hamed RB, 2009, CHEMBIOCHEM, V10, P246, DOI 10.1002/cbic.200800652; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; KAHAN JS, 1979, J ANTIBIOT, V32, P1; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Li RF, 2000, J AM CHEM SOC, V122, P9296, DOI 10.1021/ja001723l; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; McCusker KP, 2009, P NATL ACAD SCI USA, V106, P19791, DOI 10.1073/pnas.0910660106; McGowan S. J., 1996, MOL MICROBIOL, V22, P415; Nangia A., 1996, J CHEM SOC P1, V2, P943; PARKER WL, 1982, J ANTIBIOT, V35, P653, DOI 10.7164/antibiotics.35.653; PFAENDLER HR, 1981, J AM CHEM SOC, V103, P4526, DOI 10.1021/ja00405a039; Phelan RM, 2013, J AM CHEM SOC, V135, P7496, DOI 10.1021/ja311078s; Phelan RM, 2012, ACS CHEM BIOL, V7, P835, DOI 10.1021/cb200504g; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Sleeman MC, 2004, CHEMBIOCHEM, V5, P879, DOI 10.1002/cbic.200300908; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Stapon A, 2003, J AM CHEM SOC, V125, P8486, DOI 10.1021/ja034248a; Topf M, 2004, J AM CHEM SOC, V126, P9932, DOI 10.1021/ja047899v; WOODWARD RB, 1980, PHILOS T ROY SOC B, V289, P239, DOI 10.1098/rstb.1980.0042; Zhou J, 2001, J AM CHEM SOC, V123, P7388, DOI 10.1021/ja004025+	44	77	77	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1140	1144		10.1126/science.1248000	http://dx.doi.org/10.1126/science.1248000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604200	Green Accepted			2022-12-24	WOS:000332331500049
J	Jurecic, A				Jurecic, Ann			The art of medicine Life writing in the genomic age	LANCET			English	Editorial Material									Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Jurecic, A (corresponding author), Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA.	ann.jurecic@rutgers.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					776	777		10.1016/S0140-6736(14)60394-9	http://dx.doi.org/10.1016/S0140-6736(14)60394-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AC3EV	24592454				2022-12-24	WOS:000332398700014
J	Sedgwick, P; Hoope, C				Sedgwick, Philip; Hoope, Carwyn			Placebo controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip; Hoope, Carwyn] Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Hooper, Carwyn/AAM-1819-2021; Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175; Hooper, Carwyn/0000-0001-5147-3842				Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7951	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2014	348								g1635	10.1136/bmj.g1635	http://dx.doi.org/10.1136/bmj.g1635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZU	24563452				2022-12-24	WOS:000332155100003
J	Bluestein, D; Slepian, MJ				Bluestein, Danny; Slepian, Marvin J.			Sticking with Synthetic Tissue Sealants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HYDROGELS	A recent report describes a new agent for the sealing and repair of tissues in animal models. This flowable, blood-resistant tissue glue is intended for use in surgical therapeutics. Tissue reanastomosis and wound closure are vital steps in surgery. Similarly, in percutaneous intervention, localized hemostasis is essential. Traditionally, sutures and staples have been used for tissue approximation and closure. Despite their basic efficacy, these tools have limitations that include the added trauma to tissue during placement and the difficulty of deployment in small spaces and tight geometries. Lang et al.(1) describe a new tool for tissue sealing and repair: a fluid, blood-resistant tissue glue for use in surgical and minimally invasive cardiovascular therapeutic procedures. This glue is a hydrophobic light-activated adhesive (HLAA) that consists of a biocompatible, biodegradable hydrophobic ...	[Bluestein, Danny] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Slepian, Marvin J.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arizona	Bluestein, D (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.		Bluestein, Danny/P-4073-2014; Slepian, Marvin/ABG-8305-2020	Slepian, Marvin/0000-0002-7864-6691				Lang N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006557; Ramakumar S, 2002, J ENDOUROL, V16, P489, DOI 10.1089/089277902760367458; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; Watts D.C., 2013, BIOMATERIALS SCI INT, V3rd, P889	4	3	4	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1556	1559		10.1056/NEJMcibr1400477	http://dx.doi.org/10.1056/NEJMcibr1400477			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738673				2022-12-24	WOS:000334601600015
J	Simpson, SJ; Raubenheimer, D				Simpson, Stephen J.; Raubenheimer, David			Tricks of the trade	NATURE			English	Editorial Material									[Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	University of Sydney	Simpson, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	stephen.simpson@sydney.edu.au; david.raubenheimer@sydney.edu.au		Simpson, Stephen J./0000-0003-0256-7687; Raubenheimer, David/0000-0001-9050-1447				Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Gosby AK, 2014, OBES REV, V15, P183, DOI 10.1111/obr.12131; Simpson S. J., 2012, 0ATURE NUTR UNIFYING; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009	4	30	30	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S66	S66		10.1038/508S66a	http://dx.doi.org/10.1038/508S66a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740132				2022-12-24	WOS:000334403000009
J	Marx, V				Marx, Vivien			SHARP SHOOTERS	NATURE			English	Editorial Material																		Deye JA, 2012, HEALTH PHYS, V103, P662, DOI 10.1097/HP.0b013e3182609bb7; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; PEGGS S, 2002, P EPAC PAR FRANC, P2754; Suit H, 2003, ACTA ONCOL, V42, P800, DOI 10.1080/02841860310017676; Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104	5	22	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					133	138		10.1038/508133a	http://dx.doi.org/10.1038/508133a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD9UL	24695279	Bronze			2022-12-24	WOS:000333609900057
J	Venkitaraman, AR				Venkitaraman, Ashok R.			Cancer Suppression by the Chromosome Custodians, BRCA1 and BRCA2	SCIENCE			English	Editorial Material							HOMOLOGY-DIRECTED REPAIR; RAD51 FILAMENT FORMATION; DNA-DAMAGE RESPONSE; BREAST-CANCER; TUMOR SUPPRESSION; OPEN-LABEL; E3 LIGASE; SUSCEPTIBILITY GENE; MUTATION CARRIERS; PHASE-II	Germline mutations in BRCA1 and BRCA2 predispose to common humanmalignancies, most notably tumors of the breast and ovaries. The proteins encoded by these genes have been implicated in a plethora of biochemical interactions and biological functions, confounding attempts to coherently explain how their inactivation promotes carcinogenesis. Here, I argue that tumor suppression by BRCA1 and BRCA2 originates from their fundamental role in controlling the assembly and activity of macromolecular complexes that monitor chromosome duplication, maintenance, and segregation across the cell cycle. A tumor-suppressive role for the BRCA proteins as "chromosome custodians" helps to explain the clinical features of cancer susceptibility after their inactivation, provides foundations for the rational therapy of BRCA-deficient cancers, and offers general insights into the mechanisms opposing early steps in human carcinogenesis.	Univ Cambridge, Med Res Council Canc Unit, Cambridge CB2 0XZ, England	University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, Med Res Council Canc Unit, Hills Rd, Cambridge CB2 0XZ, England.	arv22@mrc-cu.cam.ac.uk			Medical Research Council [MC_UU_12022/8] Funding Source: researchfish; MRC [MC_UU_12022/1, MC_U105359877, MC_UU_12022/8, G1001522, G1001521] Funding Source: UKRI; Medical Research Council [MC_UU_12022/1, G1001521, G1001522, MC_U105359877] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Byrski T, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3231; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chandramouly G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3404; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Elledge SJ, 2002, CANCER CELL, V1, P129, DOI 10.1016/S1535-6108(02)00041-7; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Filipponi D, 2013, CANCER CELL, V24, P528, DOI 10.1016/j.ccr.2013.08.022; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedman LS, 1998, CANCER RES, V58, P1338; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Jeyasekharan AD, 2013, NAT STRUCT MOL BIOL, V20, P1191, DOI 10.1038/nsmb.2666; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kaye SB, 2012, J CLIN ONCOL, V30, P372, DOI 10.1200/JCO.2011.36.9215; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Lee JM, 2014, ANN ONCOL, V25, P32, DOI 10.1093/annonc/mdt384; Lee M, 2011, ONCOGENE, V30, P3360, DOI 10.1038/onc.2011.55; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Lucas AL, 2013, CLIN CANCER RES, V19, P3396, DOI 10.1158/1078-0432.CCR-12-3020; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Menzel T, 2011, EMBO REP, V12, P705, DOI 10.1038/embor.2011.99; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mondal G, 2012, DEV CELL, V23, P137, DOI 10.1016/j.devcel.2012.05.008; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rajendra E, 2010, NUCLEIC ACIDS RES, V38, P82, DOI 10.1093/nar/gkp873; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Reczek CR, 2013, J CELL BIOL, V201, P693, DOI 10.1083/jcb.201302145; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Rhei E, 1998, CANCER RES, V58, P3193; Rowley M, 2011, GASTROENTEROLOGY, V140, P1303, DOI 10.1053/j.gastro.2010.12.039; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Shive HR, 2010, P NATL ACAD SCI USA, V107, P19350, DOI 10.1073/pnas.1011630107; Shivji MKK, 2009, P NATL ACAD SCI USA, V106, P13254, DOI 10.1073/pnas.0906208106; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Willems-Jones A, 2012, BJU INT, V110, pE1181, DOI 10.1111/j.1464-410X.2012.11519.x; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yu VPCC, 2000, GENE DEV, V14, P1400; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	115	166	175	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1470	1475		10.1126/science.1252230	http://dx.doi.org/10.1126/science.1252230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675954				2022-12-24	WOS:000333471000037
J	Siraj, AS; Santos-Vega, M; Bouma, MJ; Yadeta, D; Carrascal, DR; Pascual, M				Siraj, A. S.; Santos-Vega, M.; Bouma, M. J.; Yadeta, D.; Ruiz Carrascal, D.; Pascual, M.			Altitudinal Changes in Malaria Incidence in Highlands of Ethiopia and Colombia	SCIENCE			English	Article							CLIMATE-CHANGE; AFRICAN HIGHLANDS; TEMPERATURE; RESURGENCE; TRANSMISSION; ASSOCIATION; EPIDEMICS; RISK; AIR	The impact of global warming on insect-borne diseases and on highland malaria in particular remains controversial. Temperature is known to influence transmission intensity through its effects on the population growth of the mosquito vector and on pathogen development within the vector. Spatiotemporal data at a regional scale in highlands of Colombia and Ethiopia supplied an opportunity to examine how the spatial distribution of the disease changes with the interannual variability of temperature. We provide evidence for an increase in the altitude of malaria distribution in warmer years, which implies that climate change will, without mitigation, result in an increase of the malaria burden in the densely populated highlands of Africa and South America.	[Siraj, A. S.] Univ Denver, Dept Geog & Environm, Denver, CO 80208 USA; [Santos-Vega, M.; Pascual, M.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Bouma, M. J.] Univ London, London Sch Hyg & Trop Med, London WC1 E7HT, England; [Yadeta, D.] Oromia Reg Hlth Bur, Addis Ababa, Ethiopia; [Ruiz Carrascal, D.] Columbia Univ City New York, Int Res Inst Climate & Soc, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ruiz Carrascal, D.] Escuela Ingn Antioquia, Envigado, Antioquia, Colombia; [Pascual, M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Denver; University of Michigan System; University of Michigan; University of London; London School of Hygiene & Tropical Medicine; Columbia University; Howard Hughes Medical Institute	Pascual, M (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 2019 Kraus Nat Sci Bldg,830 North Univ, Ann Arbor, MI 48109 USA.	pascual@umich.edu		Siraj, Amir/0000-0002-9275-0380; Ruiz-Carrascal, Daniel/0000-0003-0987-5017	WHO (Roll Back Malaria/WHO)	WHO (Roll Back Malaria/WHO)	We thank the Colombian National Institute of Health and the Oromia Health Bureau (Ethiopia) for supplying the malaria data reported for the Antioquia and Debre Zeit regions respectively; we also thank the Colombian Institute for Hydrology and Meteorology and the Ethiopian National Meteorological Agency for providing climate data, and the Colombian Statistical Institute and the Ethiopian Central Statistics Agency for cartographic and demographic information. We express our sincere thanks to A. Mekuria, A. Yeshiwondem, D. Dengela, A. Hailemariam, A. Woyessa, S. Chibsa, and the field and laboratory health workers in Ethiopia for their active involvement in the data collection and to the World Health Organization (WHO) Office for Ethiopia, Ministry of Health, and Center for National Health Development in Ethiopia for their technical support during the data collection. We are indebted to A. Nega Tulu for sharing the malaria data of Debre Zeit before 1993. We are also grateful to K. Ebi and R. Santiago Nicholls for their support in obtaining the pre-1990 malaria data for Anori, Colombia. The Ethiopian malaria data entry and Global Positioning System data collection were funded by a grant from WHO (Roll Back Malaria/WHO). M. P. is an investigator of the Howard Hughes Medical Institute. Data from this study can be found at the Dryad Repository (doi:10.5061/dryad.dp78p).	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; [Anonymous], 2009, WORLD MAL REP 2009; Barry R. G., 1992, MOUNTAIN WEATHER CLI, P206; Bouma MJ, 2011, TRENDS PARASITOL, V27, P421, DOI 10.1016/j.pt.2011.07.003; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Bouma MJ, 2003, T ROY SOC TROP MED H, V97, P133, DOI 10.1016/S0035-9203(03)90099-X; BOUMA MJ, 1994, LANCET, V343, P1440, DOI 10.1016/S0140-6736(94)92569-0; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Cox J., 1999, MAPPING MALARIA RISK; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DE ZULUETA J, 1961, East Afr Med J, V38, P1; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hirsch A, 1883, HDB GEOGRAPHICAL HIS, VI; LAVERAN A, 1893, PALUDISM; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Molineaux L., 1988, P913; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Pascual M, 2009, ECOLOGY, V90, P906, DOI 10.1890/08-0730.1; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707; PRICE MF, 1994, MOUNTAIN ENV CHANGIN, P431; Ruiz D, 2012, CLIMATIC CHANGE, V112, P717, DOI 10.1007/s10584-011-0228-0; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Stern DI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024524; Tulu AN, 1996, T ROY SOC TROP MED H, V90, P556, DOI 10.1016/S0035-9203(96)90322-3; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	38	184	187	6	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1154	1158		10.1126/science.1244325	http://dx.doi.org/10.1126/science.1244325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604201				2022-12-24	WOS:000332331500053
J	Artenstein, AW; Poland, GA				Artenstein, Andrew W.; Poland, Gregory A.			PERSPECTIVE Elimination round	NATURE			English	Editorial Material									[Artenstein, Andrew W.] Tufts Univ, Sch Med, Dept Med, Baystate Hlth, Springfield, MA 01199 USA; [Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN USA	Tufts University; Mayo Clinic	Artenstein, AW (corresponding author), Tufts Univ, Sch Med, Dept Med, Baystate Hlth, Springfield, MA 01199 USA.	artenstein@baystatehealth.org						Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Mundel T, 2013, NEW ENGL J MED, V369, P2045, DOI 10.1056/NEJMe1311591; WHO, 2013, AL GLOB RESP GAR IMP	5	2	2	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S16	S16		10.1038/507S16a	http://dx.doi.org/10.1038/507S16a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611173	Bronze			2022-12-24	WOS:000332224400008
J	Ehrlich, S; Calafat, AM; Humblet, O; Smith, T; Hauser, R				Ehrlich, Shelley; Calafat, Antonia M.; Humblet, Olivier; Smith, Thomas; Hauser, Russ			Handling of Thermal Receipts as a Source of Exposure to Bisphenol A	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ehrlich, Shelley; Smith, Thomas; Hauser, Russ] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Calafat, Antonia M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Humblet, Olivier] Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Ehrlich, S (corresponding author), Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shelley.ehrlich@cchmc.org	Calafat, Antonia/B-8076-2012; Ehrlich, Shelley/L-6991-2015; Calafat, Antonia/N-1183-2019; Calafat, Antonia/GOP-1115-2022	Calafat, Antonia/0000-0002-9796-7482	Intramural CDC HHS [CC999999] Funding Source: Medline; NIOSH CDC HHS [T42 OH008416, 2 T42 OH008416-05] Funding Source: Medline; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008416] Funding Source: NIH RePORTER	Intramural CDC HHS; NIOSH CDC HHS; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))		Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Carwile JL, 2011, JAMA-J AM MED ASSOC, V306, P2218, DOI 10.1001/jama.2011.1721; Centers for Disease Control and Prevention, 2013, 4 CDCP; Ehrlich S, 2012, HUM REPROD, V27, P3583, DOI 10.1093/humrep/des328	6	116	117	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					859	860		10.1001/jama.2013.283735	http://dx.doi.org/10.1001/jama.2013.283735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570250	Green Accepted			2022-12-24	WOS:000331793700027
J	Raya-Rivera, AM; Esquiliano, D; Fierro-Pastrana, R; Lopez-Bayghen, E; Valencia, P; Ordorica-Flores, R; Soker, S; Yoo, JJ; Atala, A				Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo; Soker, Shay; Yoo, James J.; Atala, Anthony			Tissue-engineered autologous vaginal organs in patients: a pilot cohort study	LANCET			English	Article							KUSTER-HAUSER-SYNDROME; IN-VITRO; VAGINOPLASTY; RECONSTRUCTION; AGENESIS; GRAFT; MANAGEMENT; OUTCOMES; VIVO	Background Several disorders might require vaginal reconstruction, such as congenital abnormalities, injury, or cancer. Reconstructive techniques for which non-vaginal tissue is used can be associated with complications. We assessed the use of engineered vaginal organs in four patients with vaginal aplasia caused by Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS). Methods We invited to participate four consecutive patients who presented over a 3-year period with congenital vaginal aplasia due to MRKHS. Patients were aged 13-18 years. We obtained a vulvar biopsy of autologous tissue from every patient. We cultured, expanded, and seeded epithelial and muscle cells onto biodegradable scaffolds. The organs were constructed and allowed to mature in an incubator in a facility approved for human-tissue manufacturing. We used a perineal approach to surgically implant these organs. We recorded history, physical examination, vaginoscopy, serial tissue biopsies, MRIs, and self-administered Female Sexual Function Index questionnaire results for all patients, with a follow-up of up to 8 years. Findings We noted no long-term postoperative surgical complications. Yearly serial biopsies showed a tri-layered structure, consisting of an epithelial cell-lined lumen surrounded by matrix and muscle, with expected components of vaginal tissue present. Immunohistochemical analysis confirmed the presence of phenotypically normal smooth muscle and epithelia. The MRIs, which showed the extent of the vaginal aplasia before surgery, showed the engineered organs and the absence of abnormalities after surgery, which was confirmed with yearly vaginoscopy. A validated self-administered Female Sexual Function Index questionnaire showed variables in the normal range in all areas tested, such as desire, arousal, lubrication, orgasm, satisfaction, and painless intercourse. Interpretation Vaginal organs, engineered from the patient's own cells and implanted, showed normal structural and functional variables with a follow-up of up to 8 years. These technologies could be useful in patients requiring vaginal reconstruction.	[Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo] Childrens Hosp Mexico Federico Gomez HIMFG, Tissue Engn Lab, Mexico City, DF, Mexico; [Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo] Metropolitan Autonomous Univ, Mexico City, DF, Mexico; [Raya-Rivera, Atlantida M.; Esquiliano, Diego; Fierro-Pastrana, Reyna; Lopez-Bayghen, Esther; Valencia, Pedro; Ordorica-Flores, Ricardo] IPN, CINVESTAV, Mexico City 07738, DF, Mexico; [Soker, Shay; Yoo, James J.; Atala, Anthony] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA	Hospital Infantil de Mexico Federico Gomez; Universidad Autonoma Metropolitana - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Wake Forest University; Wake Forest Baptist Medical Center	Atala, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	aatala@wakehealth.edu	Lopez-Bayghen, Esther/A-8006-2008; Yoo, James J./L-4850-2017; ORDORICA-FLORES, RICARDO/AAL-1712-2021; ORDORICA-FLORES, Ricardo Manuel/AAL-5935-2021	Lopez-Bayghen, Esther/0000-0002-2849-7587; ORDORICA-FLORES, RICARDO/0000-0001-6329-7356; 				Aittomaki K, 2001, FERTIL STERIL, V76, P624, DOI 10.1016/S0015-0282(01)01963-X; Ansaloni L, 2007, Hernia, V11, P321, DOI 10.1007/s10029-007-0225-4; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Burgu Berk, 2007, J Pediatr Urol, V3, P316, DOI 10.1016/j.jpurol.2006.09.008; Chen KL, 2010, P NATL ACAD SCI USA, V107, P3346, DOI 10.1073/pnas.0909367106; Davies MC, 2005, BJU INT, V95, P1293, DOI 10.1111/j.1464-410X.2005.05522.x; de Filippo RE, 2003, TISSUE ENG, V9, P301, DOI 10.1089/107632703764664765; De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1016/S0022-5347(05)64414-X; De Philippo RE, 2008, TRANSPLANTATION, V86, P208, DOI 10.1097/TP.0b013e31817f1686; Ding JX, 2013, GYNECOL OBSTET INVES, V75, P93, DOI 10.1159/000343233; Dornelas J, 2012, EUR J OBSTET GYN R B, V163, P204, DOI 10.1016/j.ejogrb.2012.04.018; Gartner LP, 2009, COLOR ATLAS HISTOLOG, P372; HENDREN WH, 1994, J UROLOGY, V152, P752, DOI 10.1016/S0022-5347(17)32698-8; Kimberley N, 2012, J PEDIATR ADOL GYNEC, V25, P54, DOI 10.1016/j.jpag.2011.08.003; Lankford JC, 2013, J MIDWIFERY WOM HEAL, V58, P546, DOI 10.1111/jmwh.12020; Lin WC, 2003, HUM REPROD, V18, P604, DOI 10.1093/humrep/deg095; MCCRAW JB, 1976, PLAST RECONSTR SURG, V58, P176, DOI 10.1097/00006534-197608000-00006; McQuillan SK, 2014, INT UROGYNECOL J, V25, P299, DOI 10.1007/s00192-013-2221-9; MORLEY GW, 1976, CANCER, V38, P581, DOI 10.1002/1097-0142(197607)38:1<581::AID-CNCR2820380182>3.0.CO;2-Y; MORTON KE, 1986, BRIT J OBSTET GYNAEC, V93, P50, DOI 10.1111/j.1471-0528.1986.tb07813.x; MORTON KE, 1986, BRIT J OBSTET GYNAEC, V93, P970, DOI 10.1111/j.1471-0528.1986.tb08018.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Oppelt P, 2006, HUM REPROD, V21, P792, DOI 10.1093/humrep/dei381; Panici PB, 2007, HUM REPROD, V22, P2025, DOI 10.1093/humrep/dem096; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Schober Justine M, 2007, J Pediatr Urol, V3, P167, DOI 10.1016/j.jpurol.2006.07.010; Shi L, 2013, INT J BURNS TRAUMA, V3, P173; Vecchietti G, 1965, Attual Ostet Ginecol, V11, P131; WISER WL, 1984, SURG GYNECOL OBSTET, V159, P108; Zhao MX, 2009, ANN PLAS SURG, V63, P645, DOI 10.1097/SAP.0b013e31819adfab; Zhou JH, 2010, FERTIL STERIL, V94, P2281, DOI 10.1016/j.fertnstert.2010.02.010; Zhu L, 2013, J SEX MED, V10, P1652, DOI 10.1111/jsm.12143	35	129	139	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					329	336		10.1016/S0140-6736(14)60542-0	http://dx.doi.org/10.1016/S0140-6736(14)60542-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	24726478				2022-12-24	WOS:000339722400030
J	Berkley, S				Berkley, Seth			Improving access to vaccines through tiered pricing	LANCET			English	Editorial Material									GAVI Alliance, CH-1202 Geneva, Switzerland		Berkley, S (corresponding author), GAVI Alliance, 2 Chemin Mines, CH-1202 Geneva, Switzerland.	sberkley@gavialliance.org						Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; Danzon P, 2003, 037 BROOK; GAVI Alliance, 2009, GAVI ALL GRAD POL; GAVI Alliance, 2013, COUNTR EL POL; GAVI Alliance, 2013, GLOB LEV IND; Glassman A, 2012, GLOBAL HLTH NEW BOTT; Lee LA, 2013, VACCINE S, V31S, pB61, DOI DOI 10.1016/J.VACCINE.2012.11.035]; Lopert R, 2002, LANCET, V359, P2105, DOI 10.1016/S0140-6736(02)08911-0; Plahte J, 2005, LANCET INFECT DIS, V5, P58, DOI 10.1016/S1473-3099(04)01255-1; World Bank, WE CLASS COUNTR; Yadav P., 2010, DIFFERENTIAL PRICING	11	21	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 28	2014	383	9936					2265	2267		10.1016/S0140-6736(13)62424-1	http://dx.doi.org/10.1016/S0140-6736(13)62424-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK8DO	24636625				2022-12-24	WOS:000338657600031
J	Juni, P; Zwahlen, M				Jueni, Peter; Zwahlen, Marcel			It Is Time to Initiate Another Breast Cancer Screening Trial	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY		[Jueni, Peter; Zwahlen, Marcel] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland	University of Bern	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016; Zwahlen, Marcel/AFF-8559-2022	Juni, Peter/0000-0002-5985-0670; Zwahlen, Marcel/0000-0002-6772-6346				Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Swiss Medical Board, 2013, SYST MAMM SCREEN	7	11	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					864	U101		10.7326/M14-0569	http://dx.doi.org/10.7326/M14-0569			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24711124				2022-12-24	WOS:000337374900024
J	Kang, EJ; Wu, GM; Ma, H; Li, Y; Tippner-Hedges, R; Tachibana, M; Sparman, M; Wolf, DP; Scholer, HR; Mitalipov, S				Kang, Eunju; Wu, Guangming; Ma, Hong; Li, Ying; Tippner-Hedges, Rebecca; Tachibana, Masahito; Sparman, Michelle; Wolf, Don P.; Schoeler, Hans R.; Mitalipov, Shoukhrat			Nuclear reprogramming by interphase cytoplasm of two-cell mouse embryos	NATURE			English	Article							STEM-CELLS; ZYGOTES; TRANSPLANTATION; BLASTOMERES; ACTIVATION; COMPLEX; OOCYTES; GENE; MICE	Successful mammalian cloning using somatic cell nuclear transfer (SCNT) into unfertilized, metaphase II (MII)-arrested oocytes attests to the cytoplasmic presence of reprogramming factors capable of inducing totipotency in somatic cell nuclei(1-3). However, these poorly defined maternal factors presumably decline sharply after fertilization, as the cytoplasm of pronuclear-stage zygotes is reportedly inactive(4,5). Recent evidence suggests that zygotic cytoplasm, if maintained at metaphase, can also support derivation of embryonic stem (ES) cells after SCNT6-8, albeit at low efficiency. This led to the conclusion that critical oocyte reprogramming factors present in the metaphase but not in the interphase cytoplasm are 'trapped' inside the nucleus during interphase and effectively removed during enucleation(9). Here we investigated the presence of reprogramming activity in the cytoplasm of interphase two-cell mouse embryos (I2C). First, the presence of candidate reprogramming factors was documented in both intact and enucleated metaphase and interphase zygotes and two-cell embryos. Consequently, enucleation did not provide a likely explanation for the inability of interphase cytoplasm to induce reprogramming. Second, when we carefully synchronized the cell cycle stage between the transplanted nucleus (ES cell, fetal fibroblast or terminally differentiated cumulus cell) and the recipient I2C cytoplasm, the reconstructed SCNT embryos developed into blastocysts and ES cells capable of contributing to traditional germline and tetraploid chimaeras. Last, direct transfer of cloned embryos, reconstructed with ES cell nuclei, into recipients resulted in live offspring. Thus, the cytoplasm of I2C supports efficient reprogramming, with cell cycle synchronization between the donor nucleus and recipient cytoplasm as the most critical parameter determining success. The ability to use interphase cytoplasm in SCNT could aid efforts to generate autologous human ES cells for regenerative applications, as donated or discarded embryos are more accessible than unfertilized MII oocytes.	[Kang, Eunju; Ma, Hong; Li, Ying; Tippner-Hedges, Rebecca; Tachibana, Masahito; Sparman, Michelle; Wolf, Don P.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Wu, Guangming; Schoeler, Hans R.] Max Planck Inst Mol Biomed, D-48149 Munster, Germany	Oregon Health & Science University; Oregon National Primate Research Center; Max Planck Society	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136; Wu, Guangming/0000-0003-1923-7609	National Institutes of Health [R01HD063276, R01HD057121, R01HD059946, R01EY021214, P51OD011092]; Leducq Fondation; Collins Medical Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057121, R01HD063276, R01HD059946] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Fondation; Collins Medical Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the Small Lab Animal Unit at Oregon National Primate Research Center for providing expertise and services that contributed to this project. We are indebted to E. Wolff, A. Sugawara, C. Ramsey, H.-S. Lee, J. Woodward, D. Melquizo Sanchis, C. Van Dyken and B. Manson for their technical support. The study was supported by grants from the National Institutes of Health (R01HD063276, R01HD057121, R01HD059946, R01EY021214, P51OD011092) and funds from the Leducq Fondation and the Collins Medical Trust.	CHEONG HT, 1993, BIOL REPROD, V48, P958, DOI 10.1095/biolreprod48.5.958; Eckardt S, 2005, REPRODUCTION, V129, P547, DOI 10.1530/rep.1.00673; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Egli D, 2009, CURR BIOL, V19, P1403, DOI 10.1016/j.cub.2009.06.065; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gurdon J.B., 2011, COLD SPRING HARB PER, V1, P3; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Riaz A, 2011, CELL RES, V21, P770, DOI 10.1038/cr.2010.180; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; STICE SL, 1994, MOL REPROD DEV, V38, P61, DOI 10.1002/mrd.1080380111; STICE SL, 1988, BIOL REPROD, V39, P657, DOI 10.1095/biolreprod39.3.657; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; TSUNODA Y, 1987, J EXP ZOOL, V242, P147, DOI 10.1002/jez.1402420205; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2000, NAT GENET, V24, P108, DOI 10.1038/72749; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	30	34	35	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					101	+		10.1038/nature13134	http://dx.doi.org/10.1038/nature13134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670652	Green Accepted			2022-12-24	WOS:000335199100047
J	Rhee, C; Gohil, S; Klompas, M				Rhee, Chanu; Gohil, Shruti; Klompas, Michael			Regulatory Mandates for Sepsis Care - Reasons for Caution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Sepsis, the syndrome of dysregulated inflammation that occurs with severe infection, affects millions of people worldwide each year. Multiple studies suggest that the incidence of sepsis is dramatically increasing. According to the Centers for Disease Control and Prevention (CDC), for example, sepsis rates doubled between 2000 and 2008.(1) In 2010, sepsis was the 11th leading cause of death in the United States,(2) and in 2011, it was the single most expensive condition treated in hospitals.(3) This apparent explosion in sepsis is spurring high-profile initiatives to promote earlier recognition and better treatment. Standardized screening protocols, bundled order sets, and algorithms for . . . The attention and resources being dedicated to improving sepsis care are welcome. The policy response to this apparent epidemic, however, ought to be tempered by recognition that we do not yet have reliable tools for measuring sepsis incidence.	[Rhee, Chanu; Klompas, Michael] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Rhee, Chanu; Klompas, Michael] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Rhee, Chanu; Klompas, Michael] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Gohil, Shruti] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; University of California System; University of California Irvine	Rhee, C (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.		Rhee, Chanu/AAO-8368-2020; Klompas, Michael/Z-2415-2019		NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000147] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR000147] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Hall Margaret Jean, 2011, NCHS Data Brief, P1; Lagu T, 2012, CRIT CARE MED, V40, P2932; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Murphy SL, 2012, NATL VITAL STAT REPO, V60; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007	5	148	157	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2014	370	18					1673	1676		10.1056/NEJMp1400276	http://dx.doi.org/10.1056/NEJMp1400276			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG4QM	24738642	Green Accepted, Green Submitted			2022-12-24	WOS:000335405200003
J	Krajewski, WW; Fu, X; Wilkinson, M; Cronin, NB; Dillingham, MS; Wigley, DB				Krajewski, Wojciech W.; Fu, Xin; Wilkinson, Martin; Cronin, Nora B.; Dillingham, Mark S.; Wigley, Dale B.			Structural basis for translocation by AddAB helicase-nuclease and its arrest at chi sites	NATURE			English	Article							RECBCD ENZYME; BACTERIOPHAGE-LAMBDA; CRYSTAL-STRUCTURES; DNA TRANSLOCATION; RECA PROTEIN; RECOGNITION; RECOMBINATION; MECHANISM; MOTOR; SEQUENCE	In bacterial cells, processing of double-stranded DNA breaks for repair by homologous recombination is dependent upon the recombination hotspot sequence chi (Chi)(1,2) and is catalysed by either an AddAB-or RecBCD-type helicase-nuclease (reviewed in refs 3, 4). These enzyme complexes unwind and digest the DNA duplex from the broken end until they encounter a chi sequence(5), whereupon they produce a 3' single-stranded DNA tail onto which they initiate loading of the RecA protein(6). Consequently, regulation of the AddAB/RecBCD complex by chi is a key control point in DNA repair and other processes involving genetic recombination. Here we report crystal structures of Bacillus subtilis AddAB in complex with different chi-containing DNA substrates either with or without a non-hydrolysable ATP analogue. Comparison of these structures suggests a mechanism for DNA translocation and unwinding, suggests how the enzyme binds specifically to chi sequences, and explains how chi recognition leads to the arrest of AddAB (and RecBCD) translocation that is observed in single-molecule experiments(7-9).	[Krajewski, Wojciech W.; Fu, Xin; Wilkinson, Martin; Cronin, Nora B.; Wigley, Dale B.] Chester Beatty Labs, Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Dillingham, Mark S.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Bristol	Wigley, DB (corresponding author), Chester Beatty Labs, Inst Canc Res, Div Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	Dale.Wigley@icr.ac.uk		Cronin, Nora/0000-0002-4249-7313; Dillingham, Mark/0000-0002-4612-7141; Martin, Wilkinson/0000-0001-5490-613X	Royal Society; Wellcome Trust; European Research Council; Cancer Research UK; EMBO; Cancer Research UK [12799] Funding Source: researchfish	Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	We thank the European Synchrotron Radiation Facility and Diamond synchrotrons for access to beamlines. The work was funded by the Royal Society, the Wellcome Trust and the European Research Council (M.S.D.), Cancer Research UK (D.B.W.) and EMBO (W.W.K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carrasco C, 2013, P NATL ACAD SCI USA, V110, pE2562, DOI 10.1073/pnas.1303035110; Chedin F, 1998, MOL MICROBIOL, V29, P1369, DOI 10.1046/j.1365-2958.1998.01018.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; Handa N, 2012, P NATL ACAD SCI USA, V109, P8901, DOI 10.1073/pnas.1206076109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; LAM ST, 1974, GENETICS, V77, P425; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; Saikrishnan K, 2012, EMBO J, V31, P1568, DOI 10.1038/emboj.2012.9; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; THALER DS, 1989, GENOME, V31, P53, DOI 10.1139/g89-013; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Wong CJ, 2006, J MOL BIOL, V362, P26, DOI 10.1016/j.jmb.2006.07.016; Wu CG, 2010, NAT STRUCT MOL BIOL, V17, P1210, DOI 10.1038/nsmb.1901; Yang L, 2012, P NATL ACAD SCI USA, V109, P8907, DOI 10.1073/pnas.1206081109; Yeeles JTP, 2011, NUCLEIC ACIDS RES, V39, P2271, DOI 10.1093/nar/gkq1124; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108	33	37	38	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					416	+		10.1038/nature13037	http://dx.doi.org/10.1038/nature13037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24670664	Green Accepted, Green Submitted			2022-12-24	WOS:000334403000056
J	Bryson, JB; Machado, CB; Crossley, M; Stevenson, D; Bros-Facer, V; Burrone, J; Greensmith, L; Lieberam, I				Bryson, J. Barney; Machado, Carolina Barcellos; Crossley, Martin; Stevenson, Danielle; Bros-Facer, Virginie; Burrone, Juan; Greensmith, Linda; Lieberam, Ivo			Optical Control of Muscle Function by Transplantation of Stem Cell-Derived Motor Neurons in Mice	SCIENCE			English	Article							IN-VITRO; UNITS	Damage to the central nervous system caused by traumatic injury or neurological disorders can lead to permanent loss of voluntary motor function and muscle paralysis. Here, we describe an approach that circumvents central motor circuit pathology to restore specific skeletal muscle function. We generated murine embryonic stem cell-derived motor neurons that express the light-sensitive ion channel channelrhodopsin-2, which we then engrafted into partially denervated branches of the sciatic nerve of adult mice. These engrafted motor neurons not only reinnervated lower hind-limb muscles but also enabled their function to be restored in a controllable manner using optogenetic stimulation. This synthesis of regenerative medicine and optogenetics may be a successful strategy to restore muscle function after traumatic injury or disease.	[Bryson, J. Barney; Bros-Facer, Virginie; Greensmith, Linda] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disord, London, England; [Machado, Carolina Barcellos; Crossley, Martin; Stevenson, Danielle; Burrone, Juan; Lieberam, Ivo] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England; [Greensmith, Linda] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London, England	University of London; University College London; University of London; King's College London; University of London; University College London	Greensmith, L (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disord, London, England.	l.greensmith@ucl.ac.uk; ivo.lieberam@kcl.ac.uk		Burrone, Juan/0000-0003-1233-668X; Bryson, J. Barney/0000-0001-5486-0258; Lieberam, Ivo/0000-0003-3539-3054; Barcellos Machado, Carolina/0000-0003-4420-6097	Thierry Latran Foundation; Medical Research Council [G0900585]; Biotechnology and Biological Sciences Research Council [G1001234]; King's Health Partners; Association Francaise contre les Myopathies; Brain Research Trust; European Community; MRC [MR/K000608/1, G0901899, G0900585] Funding Source: UKRI; Medical Research Council [G0901899, MR/K000608/1, 985557, 1247820] Funding Source: researchfish	Thierry Latran Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King's Health Partners; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Brain Research Trust; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Keck, D. Kullman, and G. Schiavo for constructive feedback on the manuscript and the Thierry Latran Foundation for supporting this study. I. L. is funded by the Medical Research Council (G0900585), the Biotechnology and Biological Sciences Research Council (G1001234), King's Health Partners, and the Association Francaise contre les Myopathies. L. G. is the Graham Watts Senior Research Fellow, funded by The Brain Research Trust, and is supported by the European Community's Seventh Framework Programme (FP7/2007-2013). J.B. is a Wellcome Trust Investigator. The data reported in this paper are tabulated in the supplementary materials. We declare no conflicts of interest. I. L., C. B. M., M. C., and D. S. developed and characterized ESCs, prepared EBs, and purified motor neurons; M. C. and J.B. performed in vitro physiology; J.B.B. performed surgery, in vivo physiology, and histology and drafted the manuscript; V.B.-F. and D. S. assisted with surgery and histology; and L. G. and I. L. developed the original concept, designed and oversaw the study, and revised the manuscript.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Carrascal L, 2005, BRAIN RES REV, V49, P377, DOI 10.1016/j.brainresrev.2005.02.003; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Gernandt B., 1946, ACTA PHYSIOL SCAND, V12, P255, DOI 10.1111/j.1748-1716.1946.tb00385.x; GLENN WWL, 1985, NEUROSURGERY, V17, P974, DOI 10.1227/00006123-198512000-00021; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Machado CB, 2014, DEVELOPMENT, V141, P784, DOI 10.1242/dev.097188; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Onders RP, 2009, SURG ENDOSC, V23, P1433, DOI 10.1007/s00464-008-0223-3; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; THOMPSON WJ, 1985, CELL MOL NEUROBIOL, V5, P167, DOI 10.1007/BF00711091; Tonnesen J, 2013, BEHAV BRAIN RES, V255, P35, DOI 10.1016/j.bbr.2013.07.007; Towne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072691; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650	20	118	123	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					94	97		10.1126/science.1248523	http://dx.doi.org/10.1126/science.1248523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700859	Green Accepted			2022-12-24	WOS:000333746100060
J	Wright, J				Wright, Jessica			GENETICS Unravelling complexity	NATURE			English	Editorial Material							SCHIZOPHRENIA; MUTATIONS											Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rees E, 2014, MOL PSYCHIATR, V19, P37, DOI 10.1038/mp.2013.156; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742	5	6	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					S6	S7		10.1038/508S6a	http://dx.doi.org/10.1038/508S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695335	Bronze			2022-12-24	WOS:000333609900007
J	Desai, BS; Chadha, A; Cook, B				Desai, Bela S.; Chadha, Abhishek; Cook, Boaz			The stum Gene Is Essential for Mechanical Sensing in Proprioceptive Neurons	SCIENCE			English	Article							MECHANOSENSORY TRANSDUCTION; PROJECTIONS; PHORMIA; CNS	Animal locomotion depends on proprioceptive feedback, which is generated by mechanosensory neurons. We performed a genetic screen for impaired walking in Drosophila and isolated a gene, stumble (stum). The Stum protein has orthologs in animals ranging from nematodes to mammals and is predicted to contain two transmembrane domains. Expression of the mouse orthologs of stum in mutant flies rescued their phenotype, which demonstrates functional conservation. Dendrites of stum-expressing neurons in legs were stretched by both flexion and extension of corresponding joints. Joint angles that induced dendritic stretching also elicited elevation of cellular Ca2+ levels-not seen in stum mutants. Thus, we have identified an evolutionarily conserved gene, stum, which is required for transduction of mechanical stimuli in a specific subpopulation of Drosophila proprioceptive neurons that sense joint angles.	[Desai, Bela S.; Chadha, Abhishek; Cook, Boaz] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Cook, B (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	bcook@scripps.edu		Desai, Bela/0000-0001-7343-6233				Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; MERRITT DJ, 1992, J COMP NEUROL, V322, P16, DOI 10.1002/cne.903220103; MURPHEY RK, 1989, J COMP NEUROL, V290, P185, DOI 10.1002/cne.902900203; MURPHEY RK, 1989, J NEUROSCI, V9, P3209; Shimono K, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-37; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685	12	16	18	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1256	1259		10.1126/science.1247761	http://dx.doi.org/10.1126/science.1247761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626929				2022-12-24	WOS:000332728500038
J	Brown, K				Brown, Katherine			The UK chancellor should resist industry lobbying to scrap annual rise in alcohol duty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Alcohol Studies, London SW1H 0QS, England		Brown, K (corresponding author), Inst Alcohol Studies, London SW1H 0QS, England.	kbrown@ias.org.uk		Severi, Katherine/0000-0002-4282-0272				Curtis L, 2013, UNIT COSTS HLTH SOCI; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; Health and Social Care Information Centre, 2013, STAT ALC ENGL 2013; Health and Social Care Information Centre, 2012, STAT ALC ENGL 2012; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Home Office, 2012, GOV ALC STRAT; Office for National Statistics, 2012, DRINK HAB AD GREAT B	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2014	348								g2060	10.1136/bmj.g2060	http://dx.doi.org/10.1136/bmj.g2060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZS	24622487				2022-12-24	WOS:000333032800003
J	Huff, JT; Zilberman, D				Huff, Jason T.; Zilberman, Daniel			Dnmt1-Independent CG Methylation Contributes to Nucleosome Positioning in Diverse Eukaryotes	CELL			English	Article							DNA METHYLATION; IN-VITRO; GENOME; METHYLTRANSFERASES; CHROMATIN; DNMT3A; ORGANIZATION; EVOLUTION; INSIGHTS; PLANTS	Dnmt1 epigenetically propagates symmetrical CG methylation in many eukaryotes. Their genomes are typically depleted of CG dinucleotides because of imperfect repair of deaminated methylcytosines. Here, we extensively survey diverse species lacking Dnmt1 and show that, surprisingly, symmetrical CG methylation is nonetheless frequently present and catalyzed by a different DNA methyltransferase family, Dnmt5. Numerous Dnmt5-containing organisms that diverged more than a billion years ago exhibit clustered methylation, specifically in nucleosome linkers. Clustered methylation occurs at unprecedented densities and directly disfavors nucleosomes, contributing to nucleosome positioning between clusters. Dense methylation is enabled by a regime of genomic sequence evolution that enriches CG dinucleotides and drives the highest CG frequencies known. Species with linker methylation have small, transcriptionally active nuclei that approach the physical limits of chromatin compaction. These features constitute a previously unappreciated genome architecture, in which dense methylation influences nucleosome positions, likely facilitating nuclear processes under extreme spatial constraints.	[Huff, Jason T.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zilberman, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	danielz@berkeley.edu		Zilberman, Daniel/0000-0002-0123-8649; Huff, Jason/0000-0002-0088-1640	Arnold and Mabel Beckman Foundation; National Institutes of Health [T32HG000047]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000047] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Schuman at the National Center for Marine Algae and Microbiota for biological materials, the Fungal Genetics Stock Center for C. neoformans strains, the Vincent J. Coates Genomics Sequencing Laboratory for sequencing, A. Zemach, T.-F. Hsieh, and S. Branco for experimental advice, T. Nishimura for computational help, and R. Fischer, A. Plocik, and S. Roy for their critical reading of our manuscript. This work was supported by a Young Investigator award from the Arnold and Mabel Beckman Foundation (to D.Z.) and a National Institutes of Health Trainee appointment on grant number T32HG000047 (to J.T.H.).	Chang GS, 2012, GENOME RES, V22, P1098, DOI 10.1101/gr.131649.111; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Coleman-Derr D, 2012, Cold Spring Harb Symp Quant Biol, V77, P147, DOI 10.1101/sqb.2012.77.014944; Collings CK, 2013, NUCLEIC ACIDS RES, V41, P2918, DOI 10.1093/nar/gks893; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Felle M, 2011, NUCLEIC ACIDS RES, V39, P6956, DOI 10.1093/nar/gkr263; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Gan L, 2011, CURR BIOL, V21, P1578, DOI 10.1016/j.cub.2011.08.021; GLASNER W, 1995, J MOL BIOL, V245, P1; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Huff JT, 2012, CURR OPIN GENET DEV, V22, P132, DOI 10.1016/j.gde.2012.01.007; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Inagaki S, 2010, EMBO J, V29, P3496, DOI 10.1038/emboj.2010.227; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Jiang Y, 2011, ANAL BIOCHEM, V415, P84, DOI 10.1016/j.ab.2011.03.037; Jimenez-Useche I, 2013, SCI REP-UK, V3, DOI 10.1038/srep02121; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Okuwaki M, 2004, J BIOL CHEM, V279, P2904, DOI 10.1074/jbc.M310111200; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; Perez A, 2012, BIOPHYS J, V102, P2140, DOI 10.1016/j.bpj.2012.03.056; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Ponger L, 2005, MOL BIOL EVOL, V22, P1119, DOI 10.1093/molbev/msi098; Robertson AK, 2004, BIOCHEM BIOPH RES CO, V322, P110, DOI 10.1016/j.bbrc.2004.07.083; Schubeler D, 2012, SCIENCE, V338, P756, DOI 10.1126/science.1227243; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Shen L, 2010, NUCLEIC ACIDS RES, V38, P6054, DOI 10.1093/nar/gkq456; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeshima H, 2006, J BIOCHEM, V139, P503, DOI 10.1093/jb/mvj044; Takeshima H, 2008, J MOL BIOL, V383, P810, DOI 10.1016/j.jmb.2008.03.001; Teves SS, 2012, METHODS MOL BIOL, V833, P421, DOI 10.1007/978-1-61779-477-3_25; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Veluchamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3091; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Zemach A, 2010, CURR BIOL, V20, pR780, DOI 10.1016/j.cub.2010.07.007; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	55	105	111	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1286	1297		10.1016/j.cell.2014.01.029	http://dx.doi.org/10.1016/j.cell.2014.01.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630728	Bronze, Green Accepted			2022-12-24	WOS:000332945100017
J	Lewis, SL				Lewis, Simon L.			Scientist-versus-activist debates mislead the public	NATURE			English	Editorial Material									[Lewis, Simon L.] UCL, London WC1E 6BT, England; [Lewis, Simon L.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Leeds	Lewis, SL (corresponding author), UCL, London WC1E 6BT, England.	s.l.lewis@leeds.ac.uk		Lewis, Simon/0000-0002-8066-6851				2010, NATURE, V468, P7	1	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					409	409		10.1038/506409a	http://dx.doi.org/10.1038/506409a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0DN	24572388	Bronze			2022-12-24	WOS:000332165100005
J	Jayasekera, CR; Barry, M; Roberts, LR; Nguyen, MH				Jayasekera, Channa R.; Barry, Michele; Roberts, Lewis R.; Nguyen, Mindie H.			Treating Hepatitis C in Lower-Income Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jayasekera, Channa R.; Nguyen, Mindie H.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Jayasekera, Channa R.; Barry, Michele; Nguyen, Mindie H.] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA; [Barry, Michele] Stanford Univ, Ctr Innovat Global Hlth, Stanford, CA 94305 USA; [Roberts, Lewis R.] Mayo Clin, Div Gastroenterol & Hepatol, Dept Med, Rochester, MN USA	Stanford University; Stanford University; Stanford University; Mayo Clinic	Jayasekera, CR (corresponding author), Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.			Roberts, Lewis/0000-0001-7885-8574				Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472; Hagan LM, 2013, J VIRAL HEPATITIS, V20, P847, DOI 10.1111/jvh.12111; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0	5	59	63	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2014	370	20					1869	1871		10.1056/NEJMp1400160	http://dx.doi.org/10.1056/NEJMp1400160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH4UH	24720680				2022-12-24	WOS:000336123600001
J	Zhou, LM; Tian, YH; Myneni, RB; Ciais, P; Saatchi, S; Liu, YY; Piao, SL; Chen, HS; Vermote, EF; Song, CH; Hwang, TH				Zhou, Liming; Tian, Yuhong; Myneni, Ranga B.; Ciais, Philippe; Saatchi, Sassan; Liu, Yi Y.; Piao, Shilong; Chen, Haishan; Vermote, Eric F.; Song, Conghe; Hwang, Taehee			Widespread decline of Congo rainforest greenness in the past decade	NATURE			English	Article							MICROWAVE EMISSION; VEGETATION INDEXES; TROPICAL FORESTS; CLIMATE; MODIS; DROUGHT; GRACE; WATER; PRODUCTS; DYNAMICS	Tropical forests are global epicentres of biodiversity and important modulators of climate change(1), and are mainly constrained by rainfall patterns(1-3). The severe short-term droughts that occurred recently in Amazonia have drawn attention to the vulnerability of tropical forests to climatic disturbances(4-9). The central African rainforests, the second-largest on Earth, have experienced a long-term drying trend(10,11) whose impacts on vegetation dynamics remain mostly unknown because in situ observations are very limited. The Congolese forest, with its drier conditions and higher percentage of semi-evergreen trees(12,13), may be more tolerant to short-term rainfall reduction than are wetter tropical forests(11), but for a long-term drought there may be critical thresholds of water availability below which higher-biomass, closed-canopy forests transition to more open, lower-biomass forests(1,2,14). Here we present observational evidence for a widespread decline in forest greenness over the past decade based on analyses of satellite data (optical, thermal, microwave and gravity) from several independent sensors over the Congo basin. This decline in vegetation greenness, particularly in the northern Congolese forest, is generally consistent with decreases in rainfall, terrestrial water storage, water content in aboveground woody and leaf biomass, and the canopy backscatter anomaly caused by changes in structure and moisture in upper forest layers. It is also consistent with increases in photosynthetically active radiation and land surface temperature. These multiple lines of evidence indicate that this large-scale vegetation browning, or loss of photosynthetic capacity, may be partially attributable to the long-term drying trend. Our results suggest that a continued gradual decline of photosynthetic capacity and moisture content driven by the persistent drying trend could alter the composition and structure of the Congolese forest to favour the spread of drought-tolerant species(1,2,14).	[Zhou, Liming] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA; [Tian, Yuhong] NOAA, IMSG, NESDIS, Ctr Satellite Applicat & Res,STAR, College Pk, MD 20740 USA; [Myneni, Ranga B.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Ciais, Philippe] UVSQ, CEA, CNRS, LSCE, F-91191 Gif Sur Yvette, France; [Saatchi, Sassan] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Liu, Yi Y.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Liu, Yi Y.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Piao, Shilong] Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Chen, Haishan] Nanjing Univ Informat Sci & Technol, Minist Educ, Key Lab Meteorol Disaster, Nanjing 210044, Jiangsu, Peoples R China; [Vermote, Eric F.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Song, Conghe] Univ N Carolina, Dept Geog, Chapel Hill, NC 29599 USA; [Song, Conghe] Anhui Agr Univ, Sch Forestry & Landscape Architecture, Hefei 230036, Anhui, Peoples R China; [Hwang, Taehee] Univ N Carolina, Inst Environm, Chapel Hill, NC 29599 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; National Oceanic Atmospheric Admin (NOAA) - USA; Boston University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of New South Wales Sydney; Peking University; Nanjing University of Information Science & Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of North Carolina; University of North Carolina Chapel Hill; Anhui Agricultural University; University of North Carolina; University of North Carolina Chapel Hill	Zhou, LM (corresponding author), SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA.	lzhou@albany.edu	Chen, Haishan/W-3747-2018; Vermote, Eric/K-3733-2012; Myneni, Ranga B./AAU-6088-2021; Liu, Yi/H-9226-2013; Song, Conghe/E-3087-2016; Keyes, Dennis/AAZ-9285-2021; Myneni, Ranga B/F-5129-2012; Ciais, Philippe/A-6840-2011; Liu, Yi/M-7169-2015; Saatchi, Sassan/AAQ-2649-2021; Zhou, Liming/A-2688-2012	Chen, Haishan/0000-0002-2403-3187; Song, Conghe/0000-0002-4099-4906; Myneni, Ranga B/0000-0002-0234-6393; Ciais, Philippe/0000-0001-8560-4943; Liu, Yi/0000-0001-9059-8269; Zhou, Liming/0000-0002-7009-2487	NOAA NESDIS [NA11NES4400010]; University at Albany, State University of New York; NASA's Earth Science Division; National Natural Science Foundation of China [41230422]	NOAA NESDIS(National Oceanic Atmospheric Admin (NOAA) - USA); University at Albany, State University of New York; NASA's Earth Science Division; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the NOAA NESDIS project (NA11NES4400010) and by the startup funds provided by the University at Albany, State University of New York. R. B. M. was funded by NASA's Earth Science Division. The views, opinions, and findings contained in this report are those of the authors and should not be construed as an official NOAA or US Government position, policy, or decision. H. C. is supported by the National Natural Science Foundation of China (grant number 41230422).	Adams J., 1998, DISTRIBUTION VARIETY; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Andela N, 2013, BIOGEOSCIENCES, V10, P6657, DOI 10.5194/bg-10-6657-2013; [Anonymous], 2011, MODIS VEGETATION CON; Asefi-Najafabady S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0306; Atkinson PM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049118; Brando PM, 2010, P NATL ACAD SCI USA, V107, P14685, DOI 10.1073/pnas.0908741107; Crowley JW, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027070; de Wasseige C, 2003, AGR FOREST METEOROL, V119, P181, DOI 10.1016/S0168-1923(03)00138-2; Enquist BJ, 2011, GLOBAL CHANGE BIOL, V17, P1408, DOI 10.1111/j.1365-2486.2010.02326.x; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; Halldor B., 1997, 971 MCGILL U CTR CLI; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; JACKSON TJ, 1991, REMOTE SENS ENVIRON, V36, P203, DOI 10.1016/0034-4257(91)90057-D; Jones MO, 2011, REMOTE SENS ENVIRON, V115, P1102, DOI 10.1016/j.rse.2010.12.015; KERR YH, 1990, IEEE T GEOSCI REMOTE, V28, P384, DOI 10.1109/36.54364; King MD, 2003, IEEE T GEOSCI REMOTE, V41, P442, DOI 10.1109/TGRS.2002.808226; Kirdyashev K. P., 1979, Radio Engineering and Electronic Physics, V24, P37; Landerer FW, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011453; Lee H, 2011, REMOTE SENS ENVIRON, V115, P3530, DOI 10.1016/j.rse.2011.08.015; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Liu YY, 2013, GLOBAL ECOL BIOGEOGR, V22, P692, DOI 10.1111/geb.12024; Liu YY, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048684; Liu Y, 2008, ACTA METEOROL SIN, V22, P22; Lucht Wolfgang, 2006, Carbon Balance Manag, V1, P6, DOI 10.1186/1750-0680-1-6; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Reager JT, 2013, WATER RESOUR RES, V49, P3314, DOI 10.1002/wrcr.20264; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Samanta A, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI440.1; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Shi JC, 2008, REMOTE SENS ENVIRON, V112, P4285, DOI 10.1016/j.rse.2008.07.015; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; Tyrrell M.L., 2012, MANAGING EST CARB, P377; Valentini R, 2013, BIOGEOSCIENCES DISCU, V10, P8343, DOI DOI 10.5194/bgd-10-8343-2013; van Leeuwen TT, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001488; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Xu LA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046824; Zhou LM, 2013, EARTH INTERACT, V17, DOI 10.1175/2012EI000510.1	51	254	258	14	433	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					86	+		10.1038/nature13265	http://dx.doi.org/10.1038/nature13265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24759324				2022-12-24	WOS:000335199100044
J	DeWeerdt, S				DeWeerdt, Sarah			A complicated relationship status	NATURE			English	Editorial Material							GUT MICROBIOTA; OBESITY											Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Ridaura V. K., 2013, SCIENCE, V34; Schele E, 2013, ENDOCRINOLOGY, V154, P3643, DOI 10.1210/en.2012-2151; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228	13	15	31	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S61	S63		10.1038/508S61a	http://dx.doi.org/10.1038/508S61a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740130	Bronze			2022-12-24	WOS:000334403000007
J	Owens, B				Owens, Brian			The changing colour of fat	NATURE			English	Editorial Material																		Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Lichtenbelt WV, 2014, TRENDS ENDOCRIN MET, V25, P165, DOI 10.1016/j.tem.2014.01.001; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	7	10	10	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S52	S53		10.1038/508S52a	http://dx.doi.org/10.1038/508S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740126	Bronze			2022-12-24	WOS:000334403000003
J	Willyard, C				Willyard, Cassandra			The family roots of obesity	NATURE			English	Editorial Material							CONGENITAL LEPTIN DEFICIENCY; MUTATIONS; EXPOSURE; DYSFUNCTION; CHILDHOOD; GENETICS; HUMANS; FTO											Farooqi IS, 2000, ARCH DIS CHILD, V83, P31, DOI 10.1136/adc.83.1.31; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Lubrano-Berthelier C, 2003, ANN NY ACAD SCI, V994, P49, DOI 10.1111/j.1749-6632.2003.tb03161.x; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29	16	43	45	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					S58	S60		10.1038/508S58a	http://dx.doi.org/10.1038/508S58a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF0KP	24740129	Bronze			2022-12-24	WOS:000334403000006
J	Olsen, Y; Sharfstein, JM				Olsen, Yngvild; Sharfstein, Joshua M.			Confronting the Stigma of Opioid Use Disorder- and Its Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Olsen, Yngvild] Inst Behav Resources Inc, Baltimore, MD 21218 USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Maryland Department of Health & Mental Hygiene	Olsen, Y (corresponding author), Inst Behav Resources Inc, 2104 Maryland Ave, Baltimore, MD 21218 USA.	yngvild.olsen@gmail.com						Carrieri MP, 2006, CLIN INFECT DIS, V43, pS197, DOI 10.1086/508184; Centers for Disease Control and Prevention, DRUG OVERDOSE IN THE; Gibson A, 2008, ADDICTION, V103, P462, DOI 10.1111/j.1360-0443.2007.02090.x; Legal Action Center, 2011, LEGALITY OF DENYING; National Institute on Drug Abuse, 2012, MEDICATION ASSISTED; Schwartz RP, 2013, AM J PUBLIC HEALTH, V103, P917, DOI 10.2105/AJPH.2012.301049; White, 2011, NARCOTICS ANONYMOUS; White W, 2009, LONG TERM STRATEGIES	8	185	189	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1393	1394		10.1001/jama.2014.2147	http://dx.doi.org/10.1001/jama.2014.2147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4EP	24577059				2022-12-24	WOS:000333935000010
J	Lasser, KE; Hanchate, AD; McCormick, D; Manze, MG; Chu, C; Kressin, NR				Lasser, Karen E.; Hanchate, Amresh D.; McCormick, Danny; Manze, Meredith G.; Chu, Chieh; Kressin, Nancy R.			The effect of Massachusetts health reform on 30 day hospital readmissions: retrospective analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICARE BENEFICIARIES; 30-DAY READMISSION; HEART-FAILURE; CARE; INSURANCE; ADULTS; ACCESS; OUTCOMES; DISPARITIES; MORTALITY	Objectives To analyse changes in overall readmission rates and disparities in such rates, among patients aged 18-64 (those most likely to have been affected by reform), using all payer inpatient discharge databases (hospital episode statistics) from Massachusetts and two control states (New York and New Jersey). Design Difference in differences analysis to identify the post-reform change, adjusted for secular changes unrelated to reform. Setting US hospitals in Massachusetts, New York, and New Jersey. Participants Adults aged 18-64 admitted for any cause, excluding obstetrical. Main outcome measure Readmissions at 30 days after an index admission. Results After adjustment for known confounders, including age, sex, comorbidity, hospital ownership, teaching hospital status, and nurse to census ratio, the odds of all cause readmission in Massachusetts was slightly increased compared with control states post-reform (odds ratio 1.02, 95% confidence interval 1.01 to 1.04, P<0.05). Racial and ethnic disparities in all cause readmission rates did not change in Massachusetts compared with control states. In analyses limited to Massachusetts only, there were minimal overall differences in changes in readmission rates between counties with differing baseline uninsurance rates, but black people in counties with the highest uninsurance rates had decreased odds of readmission (0.91, 0.84 to 1.00) compared with black people in counties with lower uninsurance rates. Similarly, white people in counties with the highest uninsurance rates had decreased odds of readmission (0.96, 0.94 to 0.99) compared with white people in counties with lower uninsurance rates. Conclusions In the United States, and in Massachusetts in particular, extending health insurance coverage alone seems insufficient to improve readmission rates. Additional efforts are needed to reduce hospital readmissions and disparities in this outcome.	[Lasser, Karen E.; Hanchate, Amresh D.; Chu, Chieh; Kressin, Nancy R.] Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; [Hanchate, Amresh D.; Kressin, Nancy R.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [McCormick, Danny] Harvard Univ, Sch Med, Dept Med, Cambridge Hlth Alliance, Cambridge, MA 02138 USA; [Manze, Meredith G.] CUNY, Sch Publ Hlth, New York, NY 10021 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Cambridge Health Alliance; City University of New York (CUNY) System	Lasser, KE (corresponding author), Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA.	karen.lasser@bmc.org		Hanchate, Amresh/0000-0002-7038-4463; Kressin, Nancy/0000-0003-2767-4286	US National Institutes of Health [1R21NS062677, 1U01HL105342-01]; Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service [RCS 02-066-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062677] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007705] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rx foundation; Department of Veterans Affairs, Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research has been funded by US National Institutes of Health grants (1R21NS062677, ADH, principal investigator, and 1U01HL105342-01, NRK, principal investigator) and a grant from the Rx foundation. NRK is supported in part by a senior research career scientist award from the Department of Veterans Affairs, Health Services Research and Development Service (RCS 02-066-1). The views expressed in this article are those of the authors and do not necessarily represent the views of the National Institutes of Health, the Rx foundation, Boston University, or the Department of Veterans Affairs.	Abadie A, 2005, REV ECON STUD, V72, P1, DOI 10.1111/0034-6527.00321; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Baker DW, 2002, MED CARE, V40, P1126, DOI 10.1097/00005650-200211000-00013; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; Burke RE, 2013, J HOSP MED, V8, P102, DOI 10.1002/jhm.1990; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2007, BEH RISK FACT SURV S; CMS.gov, READM RED PROGR 2013; *COMM CONS UN BOAR, 2002, CAR COV TOO LITTL TO; Cook A, 2007, HLTH INSURANCE COVER; DeVoe JE, 2003, AM J PUBLIC HEALTH, V93, P786, DOI 10.2105/AJPH.93.5.786; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; FRANKS P, 1993, AM J PUBLIC HEALTH, V83, P1295, DOI 10.2105/AJPH.83.9.1295; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Freeman JD, 2008, MED CARE, V46, P1023, DOI 10.1097/MLR.0b013e318185c913; Galbraith AA, 2013, HEALTH AFFAIR, V32, P974, DOI 10.1377/hlthaff.2012.0864; Hanchate AD, 2012, MED CARE, V50, P569, DOI 10.1097/MLR.0b013e31824e319f; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Healthcare Cost and Utilization Project, CLIN CLASS SOFTW CCS; HealthCare.gov, ESS HLTH BEN; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hersh AM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000116; Hyams T, MASSACHUSETTS HLTH R; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; KFF, SUMM AFF CAR ACT; kff.org, MASS HLTH CAR REF 6; kff.org, STAT MARK PROF MASS; Long SK, 2011, HEALTH SERV RES, V46, P365, DOI 10.1111/j.1475-6773.2010.01211.x; Long SK, 2009, HEALTH AFFAIR, V28, pW578, DOI 10.1377/hlthaff.28.4.w578; MA Division of Health Care Finance and Policy, 2009, FY2007 INP HOSP DISC; Mass.gov, MIN CRED COV; Mass.gov, HLTH CAR REF GEN INF; Massachusetts Medical Society. Massachusetts Medical Society's, 2013, MASS MED SOC 2013 PH; McCormick D, 2012, J GEN INTERN MED, V27, P1548, DOI 10.1007/s11606-012-2173-7; McDonough JE, 2008, HEALTH AFFAIR, V27, pW285, DOI 10.1377/hlthaff.27.4.w285; Medicare.gov, 30 DAY DEATH READM M; National Conference of State Legislatures, HLTH REF STAT EX; QualityNet, 2012, READM MEAS OV PUBL R; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Williams MV, 2013, JAMA-J AM MED ASSOC, V309, P394, DOI 10.1001/jama.2012.233964; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Zhu J, 2010, J GEN INTERN MED, V25, P1356, DOI 10.1007/s11606-010-1482-y	53	20	20	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2014	348								g2329	10.1136/bmj.g2329	http://dx.doi.org/10.1136/bmj.g2329			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4TK	24687184	Green Published, hybrid			2022-12-24	WOS:000333976100005
J	Ye, F; Lagarrigue, F; Ginsberg, MH				Ye, Feng; Lagarrigue, Frederic; Ginsberg, Mark H.			SnapShot: Talin and the Modular Nature of the Integrin Adhesome	CELL			English	Editorial Material							ACTIVATION; ADHESION; SWITCH		[Ye, Feng; Lagarrigue, Frederic; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ye, F (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.			Lagarrigue, Frederic/0000-0002-4660-8666	NHLBI NIH HHS [R01 HL117807, R01 HL106489, P01 HL031950, P01 HL078784] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, R01HL117807, P01HL078784, R01HL106489] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Lee HS, 2013, MOL BIOL CELL, V24, P1354, DOI 10.1091/mbc.E12-09-0695; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050	9	19	19	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6								10.1016/j.cell.2014.02.048	http://dx.doi.org/10.1016/j.cell.2014.02.048			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3RH	24630731	Green Accepted, Bronze			2022-12-24	WOS:000349545500001
J	Fitzpatrick, MC; Hampson, K; Cleaveland, S; Mzimbiri, I; Lankester, F; Lembo, T; Meyers, LA; Paltiel, D; Galvani, AP				Fitzpatrick, Meagan C.; Hampson, Katie; Cleaveland, Sarah; Mzimbiri, Imam; Lankester, Felix; Lembo, Tiziana; Meyers, Lauren A.; Paltiel, David; Galvani, Alison P.			Cost-Effectiveness of Canine Vaccination to Prevent Human Rabies in Rural Tanzania	ANNALS OF INTERNAL MEDICINE			English	Article							POSTEXPOSURE PROPHYLAXIS; TRANSMISSION DYNAMICS; DOG-POPULATION; STRATEGIES; AFRICA; ELIMINATION; ECONOMICS; COVERAGE; DISEASE	Background: The annual mortality rate of human rabies in rural Africa is 3.6 deaths per 100 000 persons. Rabies can be prevented with prompt postexposure prophylaxis, but this is costly and often inaccessible in rural Africa. Because 99% of human exposures occur through rabid dogs, canine vaccination also prevents transmission of rabies to humans. Objective: To evaluate the cost-effectiveness of rabies control through annual canine vaccination campaigns in rural sub-Saharan Africa. Design: We model transmission dynamics in dogs and wildlife and assess empirical uncertainty in the biological variables to make probability-based evaluations of cost-effectiveness. Data Sources: Epidemiologic variables from a contact-tracing study and literature and cost data from ongoing vaccination campaigns. Target Population: Two districts of rural Tanzania: Ngorongoro and Serengeti. Time Horizon: 10 years. Perspective: Health policymaker. Intervention: Vaccination coverage ranging from 0% to 95% in increments of 5%. Outcome Measures: Life-years for health outcomes and 2010 U.S. dollars for economic outcomes. Results of Base-Case Analysis: Annual canine vaccination campaigns were very cost-effective in both districts compared with no canine vaccination. In Serengeti, annual campaigns with as much as 70% coverage were cost-saving. Results of Sensitivity Analysis: Across a wide range of variable assumptions and levels of societal willingness to pay for life-years, the optimal vaccination coverage for Serengeti was 70%. In Ngorongoro, although optimal coverage depended on willingness to pay, vaccination campaigns were always cost-effective and lifesaving and therefore preferred. Limitation: Canine vaccination was very cost-effective in both districts, but there was greater uncertainty about the optimal coverage in Ngorongoro. Conclusion: Annual canine rabies vaccination campaigns conferred extraordinary value and dramatically reduced the health burden of rabies.	Sch Publ Hlth, New Haven, CT USA; Yale Univ, New Haven, CT 06520 USA; Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; Lincoln Pk Zoo, Serengeti Hlth Initiat, Chicago, IL USA; [Lankester, Felix] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; Univ Texas Austin, Austin, TX 78712 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Yale University; University of Glasgow; University of Glasgow; Washington State University; University of Texas System; University of Texas Austin; The Santa Fe Institute	Fitzpatrick, MC (corresponding author), Yale Univ, Sch Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	meagan.fitzpatrick@yale.edu	Fitzpatrick, Meagan C/K-5083-2012	Fitzpatrick, Meagan C/0000-0002-5248-2668; Paltiel, A. David/0000-0002-4861-3290; Hampson, Katie/0000-0001-5392-6884; Lankester, Felix/0000-0002-0802-0693; Cleaveland, Sarah/0000-0002-0456-0959; Meyers, Lauren/0000-0002-5828-8874	National Institutes of Health; National Institute of General Medical Sciences [U01 GM087719]; National Institute of Allergy and Infectious Diseases, Multidisciplinary Parasitology Training Program [T32AI007404]; Lindsay Fellowship for Research in Africa; Wellcome Trust; National Institute on Drug Abuse [R01 DA015612]; National Science Foundation and National Institutes of Health [DEB0225453, DEB0513994]; Lincoln Park Zoo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER; Medical Research Council [G0901135] Funding Source: researchfish; MRC [G0901135] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases, Multidisciplinary Parasitology Training Program; Lindsay Fellowship for Research in Africa; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation and National Institutes of Health; Lincoln Park Zoo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	By the National Institute of General Medical Sciences (U01 GM087719, Models of Infectious Disease Agent Study) and the Miriam Burnett Trust (Ms. Fitzpatrick and Dr. Galvani). Ms. Fitzpatrick also received support from the National Institute of Allergy and Infectious Diseases, Multidisciplinary Parasitology Training Program (T32AI007404), and Lindsay Fellowship for Research in Africa. Support for Dr. Hampson was provided by the Wellcome Trust. Dr. Paltiel received support from the National Institute on Drug Abuse (R01 DA015612). Vaccination campaigns were conducted and field data were generated with the support of the National Science Foundation and National Institutes of Health (DEB0225453 and DEB0513994), the Wellcome Trust, and Lincoln Park Zoo.	[Anonymous], 2001, NATL BURDEN DIS STUD; [Anonymous], 2011, TANZ GLOB HLTH IN ST; Beyer HL, 2012, VACCINE, V30, P1014, DOI 10.1016/j.vaccine.2011.12.052; BOGEL K, 1990, B WORLD HEALTH ORGAN, V68, P281; Brainerd E., 2001, DEATH MARKET; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; BROOKS R, 1990, VET REC, V127, P592; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; Coleman PG, 1996, VACCINE, V14, P185, DOI 10.1016/0264-410X(95)00197-9; Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; Fitzpatrick MC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001796; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Hampson K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000982; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Kaare M, 2009, VACCINE, V27, P152, DOI 10.1016/j.vaccine.2008.09.054; Kayali U, 2003, B WORLD HEALTH ORGAN, V81, P739; Kitala PM, 2002, EPIDEMIOL INFECT, V129, P215, DOI 10.1017/S0950268802006957; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Laurenson MK, 2005, CONSERVATION AND DEVELOPMENT INTERVENTIONS AT THE WILDLIFE/LIVESTOCK INTERFACE, P141; Lembo T, 2008, J APPL ECOL, V45, P1246, DOI 10.1111/j.1365-2664.2008.01468.x; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; McNeil Donald G., 2009, NEW YORK TIMES; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P481, DOI 10.2165/00019053-199814050-00003; Minke JM, 2009, VET MICROBIOL, V133, P283, DOI 10.1016/j.vetmic.2008.06.024; Quiambao BP, 2005, VACCINE, V23, P1709, DOI 10.1016/j.vaccine.2004.09.027; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Schneider MC, 2007, CAD SAUDE PUBLICA, V23, P2049, DOI 10.1590/S0102-311X2007000900013; Shim E, 2009, VACCINE, V27, P7167, DOI 10.1016/j.vaccine.2009.09.027; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X9801800209; WHO, 2005, WHO TECH REP SER, V931, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO Rabies vaccines, 2007, WEEKLY EPIDEMIOLOGIC, V82, P425; World health organization, 2010, CHOOS INT AR COST EF; Zinsstag J, 2009, P NATL ACAD SCI USA, V106, P14996, DOI 10.1073/pnas.0904740106	38	64	64	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					91	+		10.7326/M13-0542	http://dx.doi.org/10.7326/M13-0542			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24592494	Green Accepted			2022-12-24	WOS:000330275600015
J	Gornall, J				Gornall, Jonathan			New way to call time on high strength, cheap alcohol	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jonathangornall@mac.com			European Community [266813]	European Community(European Commission)	This feature is funded by the European Community's Seventh Framework Programme (FP7/2007-2013), under grant agreement No 266813-Addictions and Lifestyle in Contemporary Europe - Reframing Addictions Project (ALICE RAP). Participant organisations in ALICE RAP can be seen at www.alicerap.eu/about-alice-rap/partners.html. Provenance and peer review: Commissioned; not externally peer reviewed.	Baker N, 2014, HANSARD         0213; Davenport R., 2014, LICENCE NEWS    0307; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7571; Griffiths A, 2014, COMMUNICATION; Sheron N, 2014, ALASTAIR CAMPBE 0117	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2014	348								g2572	10.1136/bmj.g2572	http://dx.doi.org/10.1136/bmj.g2572			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SI	24727179				2022-12-24	WOS:000334349200010
J	Sinha, R; Fearfield, L				Sinha, Rishika; Fearfield, Louise			Zosteriform Metastases from Malignant Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 30-year-old man with a history of metastatic malignant melanoma presented with painful and itchy papulonodular lesions on the right side of his trunk (Panel A) that had developed over a period of 7 days. A computed tomographic scan showed extensive metastatic disease with necrosis throughout the right axilla and right lateral chest wall. The lesions were adjacent to the site of excision of the primary melanoma. The dermatomal distribution prompted a diagnosis of herpes zoster infection, and acyclovir was administered but with little response. A dermatologist made a diagnosis of zosteriform metastases caused by the metastatic malignant melanoma, although . . . A 30-year-old man with a history of metastatic malignant melanoma presented with painful and itchy papulonodular lesions on the right side of his trunk that had developed over a period of 7 days. A CT scan showed extensive metastatic disease with necrosis.	[Sinha, Rishika] Chelsea & Westminster Hosp, London, England; [Fearfield, Louise] Royal Marsden Hosp, London SW3 6JJ, England	Imperial College London; Royal Marsden NHS Foundation Trust	Sinha, R (corresponding author), Chelsea & Westminster Hosp, London, England.	rs280@doctors.org.uk							0	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14								10.1056/NEJMicm1305647	http://dx.doi.org/10.1056/NEJMicm1305647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693919				2022-12-24	WOS:000333830000001
J	Bomfleur, B; McLoughlin, S; Vajda, V				Bomfleur, Benjamin; McLoughlin, Stephen; Vajda, Vivi			Fossilized Nuclei and Chromosomes Reveal 180 Million Years of Genomic Stasis in Royal Ferns	SCIENCE			English	Article							OSMUNDA OSMUNDACEAE; ADDITIONAL EVIDENCE; SOUTHERN SWEDEN; PLANTS; SIZE; ANTARCTICA; POLYPLOIDY; VOLCANISM	Rapidly permineralized fossils can provide exceptional insights into the evolution of life over geological time. Here, we present an exquisitely preserved, calcified stem of a royal fern (Osmundaceae) from Early Jurassic lahar deposits of Sweden in which authigenic mineral precipitation from hydrothermal brines occurred so rapidly that it preserved cytoplasm, cytosol granules, nuclei, and even chromosomes in various stages of cell division. Morphometric parameters of interphase nuclei match those of extant Osmundaceae, indicating that the genome size of these reputed "living fossils" has remained unchanged over at least 180 million years-a paramount example of evolutionary stasis.	[Bomfleur, Benjamin; McLoughlin, Stephen] Swedish Museum Nat Hist, Dept Palaeobiol, SE-10405 Stockholm, Sweden; [Vajda, Vivi] Lund Univ, Dept Geol, SE-22362 Lund, Sweden	Swedish Museum of Natural History; Lund University	Bomfleur, B (corresponding author), Swedish Museum Nat Hist, Dept Palaeobiol, POB 50007, SE-10405 Stockholm, Sweden.	benjamin.bomfleur@nrm.se; steve.mcloughlin@nrm.se	Vajda, Vivi/N-7693-2018	Vajda, Vivi/0000-0003-2987-5559; Bomfleur, Benjamin/0000-0002-2186-4970	Swedish Research Council (VR); Lund University Carbon Cycle Centre (LUCCI); Royal Swedish Academy of Sciences	Swedish Research Council (VR)(Swedish Research Council); Lund University Carbon Cycle Centre (LUCCI); Royal Swedish Academy of Sciences	We thank E. M. Friis and S. Bengtson (Stockholm) and F. Marone and M. Stampanoni (Villigen) for assistance with SRXTM analyses at the Swiss Light Source, Paul Scherrer Institute (Villigen); G. Grimm (Stockholm) for assistance with statistical analyses; B. Bremer and G. Larsson (Stockholm) for providing live material of Osmunda; M. A. Gandolfo Nixon and J. L. Svitko (Ithaca, New York) for permission to use images from the Cornell University Plant Anatomy Collection (CUPAC; http://cupac.bh.cornell.edu/); the members of Tjornarps Sockengille (Tjornarp) for access to the fossil locality; A.-L. Decombeix (Montpellier), I. Bergelin (Lund), C. H. Haufler (Lawrence, Kansas), N. Tian (Shenyang), Y.-D. Wang (Nanjing), and T. E. Wood (Flagstaff, Arizona) for discussion; and two anonymous referees for constructive comments. This research was jointly supported by the Swedish Research Council (VR), Lund University Carbon Cycle Centre (LUCCI), and the Royal Swedish Academy of Sciences. The material is curated at the Swedish Museum of Natural History (Stockholm, Sweden) under accession nos. S069649 to S069658 and S089687 to S089693.	Ahlberg A., 2003, GEOL SURV DEN GREENL, V1, P527, DOI [DOI 10.34194/GEUSB.V1.4682, 10.34194/geusb.v1.4682]; Augustsson C, 2001, GFF, V123, P23, DOI 10.1080/11035890101231023; Barker MS, 2010, BIOSCIENCE, V60, P177, DOI 10.1525/bio.2010.60.3.4; Bergelin I, 2009, GFF, V131, P165, DOI 10.1080/11035890902851278; BRACKHANES SD, 1978, SCIENCE, V200, P1383, DOI 10.1126/science.200.4348.1383; DEMAGGIO AE, 1971, BIOSCIENCE, V21, P313, DOI 10.2307/1295880; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; HEWITSON WALTER, 1962, ANN MISSOURI BOT GARD, V49, P57, DOI 10.2307/2394741; Leitch I.J., 2013, PHYS STRUCTURE BEHAV, V2, P307, DOI [DOI 10.1007/978-3-7091-1160-4_19, DOI 10.1007/978-3-7091-1160-4_]; Lomax BH, 2014, NEW PHYTOL, V201, P636, DOI 10.1111/nph.12523; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MILLER C N JR, 1971, Contributions from the Museum of Paleontology University of Michigan, V23, P105; NIKLAS KJ, 1982, AM J BOT, V69, P325, DOI 10.2307/2443136; Phipps CJ, 1998, AM J BOT, V85, P888, DOI 10.2307/2446424; Rothwell GW, 2002, AM J BOT, V89, P352, DOI 10.3732/ajb.89.2.352; Serbet R, 1999, INT J PLANT SCI, V160, P425, DOI 10.1086/314134; Simova I, 2012, P ROY SOC B-BIOL SCI, V279, P867, DOI 10.1098/rspb.2011.1284; Tian Ning, 2008, Palaeoworld, V17, P183, DOI 10.1016/j.palwor.2008.10.004; Tsutsumi C, 2011, SYST BOT, V36, P836, DOI 10.1600/036364411X604859	19	89	95	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1376	1377		10.1126/science.1249884	http://dx.doi.org/10.1126/science.1249884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653037	Green Submitted			2022-12-24	WOS:000333108500044
J	Havard, J				Havard, John			PERSONAL VIEW It's time to change the catheter: this ubiquitous but flawed medical device is letting patients down	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-TRACT-INFECTION; TERM CATHETERIZATION; NURSING-HOMES; COMPLICATIONS; PREVALENCE; MORBIDITY; BLADDER; SILVER		Saxmundham Hlth, Saxmundham IP17 1DY, Suffolk, England		Havard, J (corresponding author), Saxmundham Hlth, Saxmundham IP17 1DY, Suffolk, England.	john.havard@gp-d83053.nhs.uk						Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Feneley RCL, 2012, BJU INT, V109, P1746, DOI 10.1111/j.1464-410X.2011.10753.x; Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Johnson JR, 1999, ANTIMICROB AGENTS CH, V43, P2990, DOI 10.1128/AAC.43.12.2990; KohlerOckmore J, 1996, BRIT J UROL, V77, P347, DOI 10.1046/j.1464-410X.1996.09074.x; Kunin C., 1997, DETECTION PREVENTION; KUNIN CM, 1992, AM J EPIDEMIOL, V135, P291; Leuck AM, 2012, J UROLOGY, V187, P1662, DOI 10.1016/j.juro.2011.12.113; Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4; STICKLER DJ, 1994, J HOSP INFECT, V28, P177, DOI 10.1016/0195-6701(94)90101-5; WARREN JW, 1989, ARCH INTERN MED, V149, P1535, DOI 10.1001/archinte.149.7.1535; Wilde MH, 2010, J WOUND OSTOMY CONT, V37, P301, DOI 10.1097/WON.0b013e3181d73ac4	13	3	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g1932	10.1136/bmj.g1932	http://dx.doi.org/10.1136/bmj.g1932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24620353				2022-12-24	WOS:000333032100008
J	Acuna, V; Datry, T; Marshall, J; Barcelo, D; Dahm, CN; Ginebreda, A; McGregor, G; Sabater, S; Tockner, K; Palmer, MA				Acuna, V.; Datry, T.; Marshall, J.; Barcelo, D.; Dahm, C. N.; Ginebreda, A.; McGregor, G.; Sabater, S.; Tockner, K.; Palmer, M. A.			Why Should We Care About Temporary Waterways?	SCIENCE			English	Editorial Material							RIVER; CONNECTIVITY; VALUES		[Acuna, V.; Barcelo, D.; Sabater, S.] Catalan Inst Water Res, Girona 17003, Spain; [Datry, T.] Natl Res Inst Sci & Technol Environm & Agr IRSTEA, F-69626 Villeurbanne, France; [Marshall, J.; McGregor, G.] Queensland Dept Sci Informat Technol Innovat & Ar, Brisbane, Qld 4001, Australia; [Marshall, J.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Barcelo, D.; Ginebreda, A.] Spanish Council Sci Res IDAEA CSIC, Inst Environm Assessment & Water Res, Dept Environm Chem, Water & Soil Qual Res Grp, Barcelona 08034, Spain; [Dahm, C. N.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Sabater, S.] Univ Girona, Inst Aquat Ecol, Girona 17071, Spain; [Tockner, K.] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; [Tockner, K.] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Palmer, M. A.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Palmer, M. A.] Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA	Institut Catala de Recerca de l'Aigua (ICRA); AgroParisTech; INRAE; Griffith University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); University of New Mexico; Universitat de Girona; Free University of Berlin; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University System of Maryland; University of Maryland College Park	Palmer, MA (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	mpalmer@umd.edu	Sabater, Sergi/A-7549-2008; Tockner, Klement/G-9265-2011; Acuña, Vicenç/L-6608-2014; BARCELO, DAMIA/O-4558-2016; Palmer, Margaret A/F-9648-2013	Sabater, Sergi/0000-0003-3730-0261; Acuña, Vicenç/0000-0002-4485-6703; BARCELO, DAMIA/0000-0002-8873-0491; Palmer, Margaret A/0000-0003-1468-7993; Marshall, Jonathan/0000-0002-7177-4543; McGregor, Glenn/0000-0002-0084-4356; Ginebreda, Antonio/0000-0003-4714-2850; Tockner, Klement/0000-0002-0038-8151	Direct For Biological Sciences [1639145, 1052875] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Acuna V, 2010, GLOBAL CHANGE BIOL, V16, P2638, DOI 10.1111/j.1365-2486.2010.02170.x; [Anonymous], 2000, OFFICIAL J EUROPEA L, V327, P1; Barma D., 2012, HYDROLOGICAL MODELLI, P93; Burke T., 2012, WATER ACT 2007 BASIN, P245; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; Doyle MW, 2011, ENVIRON SCI TECHNOL, V45, P354, DOI 10.1021/es101273f; Elmore AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074819; EPA, 2013, EC AN PROP REV DEF W; Fonseca J.E., 2013, MERGING SCI MANAGEME, P119; Fritz KM, 2013, J AM WATER RESOUR AS, V49, P867, DOI 10.1111/jawr.12040; Jaeger KL, 2012, RIVER RES APPL, V28, P1843, DOI 10.1002/rra.1554; Julian JP, 2012, GEOMORPHOLOGY, V177, P194, DOI 10.1016/j.geomorph.2012.07.029; Lang M, 2012, WETLANDS, V32, P461, DOI 10.1007/s13157-012-0279-7; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Lindberg TT, 2011, P NATL ACAD SCI USA, V108, P20929, DOI 10.1073/pnas.1112381108; Munne A, 2004, ENVIRON MANAGE, V34, P711, DOI 10.1007/s00267-003-0098-y; Munoz I., 2012, LLO BREGAT STORY POL, P93; Nikolaidis NP, 2013, WATER POLICY, V15, P830, DOI 10.2166/wp.2013.158; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Snelder TH, 2013, HYDROL EARTH SYST SC, V17, P2685, DOI 10.5194/hess-17-2685-2013; Steward AL, 2012, FRONT ECOL ENVIRON, V10, P202, DOI 10.1890/110136; Wigington PJ, 2006, FRONT ECOL ENVIRON, V4, P513, DOI 10.1890/1540-9295(2006)4[513:CSDOIS]2.0.CO;2	22	218	219	2	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1080	1081		10.1126/science.1246666	http://dx.doi.org/10.1126/science.1246666			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604183				2022-12-24	WOS:000332331500027
J	Ladizinski, B; Sankey, C				Ladizinski, Barry; Sankey, Christopher			Vanishing Lung Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 41-year-old man with a smoking history of 30 pack-years presented with chronic chest pain, dyspnea, and cough. Physical examination revealed cachexia, with decreased apical breath sounds and hyperresonance to percussion in both lungs. A 41-year-old man with a smoking history of 30 pack-years presented with chronic chest pain, dyspnea, and cough. His vital signs were normal, and laboratory studies were unremarkable, including his level of (1)-antitrypsin, which was normal. Physical examination revealed cachexia, with decreased apical breath sounds and hyperresonance to percussion in both lungs. Chest radiography showed extensive bullous lung disease in the apex and upper lobes of both lungs (Panel A, arrows; Panel B), which was suggestive of vanishing lung syndrome; air-liquid levels were seen in the left lung (Panels A, B, and C, asterisk). Computed tomography of the ...	[Ladizinski, Barry] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Sankey, Christopher] Yale Univ, New Haven, CT USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University	Ladizinski, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.		Sankey, Chris/AAX-3972-2021	Sankey, Chris/0000-0002-7327-7460					0	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					E14	E14		10.1056/NEJMicm1305898	http://dx.doi.org/10.1056/NEJMicm1305898			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571779				2022-12-24	WOS:000332013000001
J	Pradel, A; Maisey, JG; Tafforeau, P; Mapes, RH; Mallatt, J				Pradel, Alan; Maisey, John G.; Tafforeau, Paul; Mapes, Royal H.; Mallatt, Jon			A Palaeozoic shark with osteichthyan-like branchial arches	NATURE			English	Article							EVOLUTION; JAW; CHONDRICHTHYAN; ORIGIN	The evolution of serially arranged, jointed endoskeletal supports internal to the gills-the visceral branchial arches-represents one of the key events in early jawed vertebrate (gnathostome) history, because it provided the morphological basis for the subsequent evolution of jaws. However, until now little was known about visceral arches in early gnathostomes, and theories about gill arch evolution were driven by information gleaned mostly from both modern cartilaginous (chondrichthyan) and bony (osteichthyan) fishes. New fossil discoveries can profoundly affect our understanding of evolutionary history, by revealing hitherto unseen combinations of primitive and derived characters. Here we describe a 325 million year (Myr)-old Palaeozoic shark-like fossil that represents, to our knowledge, the earliest identified chondrichthyan in which the complete gill skeleton is three-dimensionally preserved in its natural position. Its visceral arch arrangement is remarkably osteichthyan-like, suggesting that this may represent the common ancestral condition for crown gnathostomes. Our findings thus reinterpret the polarity of some arch features of the crown jawed vertebrates and invert the classic hypothesis, in which modern sharks retain the ancestral condition. This study underscores the importance of early chondrichthyans in resolving the evolutionary history of jawed vertebrates.	[Pradel, Alan; Maisey, John G.] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Mapes, Royal H.] Ohio Univ, Dept Geol Sci, Athens, OH 45701 USA; [Mallatt, Jon] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	American Museum of Natural History (AMNH); European Synchrotron Radiation Facility (ESRF); University System of Ohio; Ohio University; Washington State University	Pradel, A (corresponding author), Amer Museum Nat Hist, Dept Vertebrate Paleontol, Cent Pk West 79th St, New York, NY 10024 USA.	apradel@amnh.org; maisey@amnh.org		Tafforeau, Paul/0000-0002-5962-1683	H. R. & E. Axelrod Research Chair in paleoichthyology at the AMNH	H. R. & E. Axelrod Research Chair in paleoichthyology at the AMNH	We thank staff at the ID19 beamline at the ESRF for assistance, and F. Ippolito (AMNH) for photographs of the specimens. The main work was supported by the H. R. & E. Axelrod Research Chair in paleoichthyology at the AMNH.	Carvalho M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062389; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Beer G., 1937, DEV VERTEBRATE SKULL; DICK J R F, 1978, Transactions of the Royal Society of Edinburgh, V70, P63; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; GEGENBAUR C, 1879, ELEMENTS COMPARATIVE; Grogan ED, 2000, J MORPHOL, V243, P219, DOI 10.1002/(SICI)1097-4687(200003)243:3<219::AID-JMOR1>3.0.CO;2-1; Heidtke Ulrich H.J., 2001, Mainzer Geowissenschaftliche Mitteilungen, V30, P105; Holmgren N., 1942, ADA ZOOL [STOCKHOLM], V23, P129; Janvier P., 1996, EARLY VERTEBRATES; JARVIK E, 1980, BASIC STRUCT EVOLUTI, V1; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lane JA, 2012, J PALEONTOL, V86, P886, DOI 10.1666/11-139.1; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; Mallatt J, 1996, ZOOL J LINN SOC-LOND, V117, P329, DOI 10.1111/j.1096-3642.1996.tb01658.x; Mallatt J, 1997, ACTA ZOOL-STOCKHOLM, V78, P279, DOI 10.1111/j.1463-6395.1997.tb01012.x; MAPES RH, 1979, CARBONIFEROUS PERMAI; NELSON G J, 1968, Nobel Symposium, P129; Nelson G. J., 1969, B AM MUS NAT HIST, V141, P477; NIELSEN E, 1942, STUDIES TRIASSIC FIS, V1; PATTERSON C, 1981, ANNU REV ECOL SYST, V12, P195, DOI 10.1146/annurev.es.12.110181.001211; Pradel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066988; Pradel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024938; Shirai S., 1992, SQUALEAN PHYLOGENY N; Watson D. M. S., 1937, Philosophical Transactions London, V228B, P49, DOI 10.1098/rstb.1937.0009; ZANGERL R, 1975, Palaeontology (Oxford), V18, P333; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; [No title captured]	30	37	37	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					608	+		10.1038/nature13195	http://dx.doi.org/10.1038/nature13195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24739974				2022-12-24	WOS:000336457100056
J	Creasey, KM; Zhai, JX; Borges, F; Van Ex, F; Regulski, M; Meyers, BC; Martienssen, RA				Creasey, Kate M.; Zhai, Jixian; Borges, Filipe; Van Ex, Frederic; Regulski, Michael; Meyers, Blake C.; Martienssen, Robert A.			miRNAs trigger widespread epigenetically activated siRNAs from transposons in Arabidopsis	NATURE			English	Article							DNA METHYLATION; SMALL RNA; PLANTS; BIOGENESIS; MICRORNAS; TARGETS; DEMETHYLATION; METHYLOME; ENDOSPERM; ELEMENTS	In plants, post-transcriptional gene silencing (PTGS) is mediated by DICER-LIKE 1 (DCL1)-dependent microRNAs (miRNAs), which also trigger 21-nucleotide secondary short interfering RNAs (siRNAs) via RNA-DEPENDENT RNA POLYMERASE 6 (RDR6), DCL4 and ARGONAUTE 1 (AGO1)(1-3), whereas transcriptional gene silencing (TGS) of transposons is mediated by 24-nucleotide heterochromatic (het) siRNAs, RDR2, DCL3 and AGO4 (ref. 4). Transposons can also give rise to abundant 21-nucleotide 'epigenetically activated' small interfering RNAs (easiRNAs) in DECREASED DNA METHYLATION 1 (ddm1) and DNA METHYLTRANSFERASE 1 (met1) mutants, as well as in the vegetative nucleus of pollen grains(5) and in dedifferentiated plant cell cultures(6). Here we show that easiRNAs in Arabidopsis thaliana resemble secondary siRNAs, in that thousands of transposon transcripts are specifically targeted by more than 50 miRNAs for cleavage and processing by RDR6. Loss of RDR6, DCL4 or DCL1 in a ddm1 background results in loss of 21-nucleotide easiRNAs and severe infertility, but 24-nucleotide hetsi-RNAs are partially restored, supporting an antagonistic relationship between PTGS and TGS. Thus miRNA-directed easiRNA biogenesis is a latent mechanism that specifically targets transposon transcripts, but only when they are epigenetically reactivated during reprogramming of the germ line. This ancient recognition mechanism may have been retained both by transposons to evade long-term heterochromatic silencing and by their hosts for genome defence.	[Creasey, Kate M.; Borges, Filipe; Van Ex, Frederic; Regulski, Michael; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Zhai, Jixian; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DC 19711 USA; [Zhai, Jixian; Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DC 19711 USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Cold Spring Harbor, NY 11724 USA; [Martienssen, Robert A.] IBENS, Chaire Blaise Pascal, F-75230 Paris, France	Cold Spring Harbor Laboratory; University of Delaware; University of Delaware; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Zhai, Jixian/HCH-9272-2022; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Borges, Filipe/0000-0002-7388-2118; Zhai, Jixian/0000-0002-0217-0666; Van Ex, Frederic/0000-0003-2481-0115	DuPont Pioneer; Belgian American Educational Foundation; University of Delaware Graduate fellowship; National Institutes of Health [RO1GM067014]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3033]; Cancer Center Support Grant [5PP30CA045508]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	DuPont Pioneer; Belgian American Educational Foundation; University of Delaware Graduate fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Colot, O. Voinnet and A. Sarazin for sharing unpublished data and for discussions, J. Simorowski for plant genetics and J. Kendall for computational advice. We thank R.K. Slotkin for sharing data before publication. K.M.C. and M.R. were supported, in part, by a research collaboration with DuPont Pioneer. F.V.E. was supported by a fellowship from the Belgian American Educational Foundation. J.Z. was supported by a University of Delaware Graduate fellowship. Research in the Martienssen laboratory is supported by a grant from the National Institutes of Health (RO1GM067014 to R.A.M.) and by the Howard Hughes Medical Institute and Gordon and Betty Moore Foundation (GBMF3033). The authors acknowledge that this work was performed with assistance from the Cold Spring Harbor Laboratory Shared Resources, which are funded, in part, by the Cancer Center Support Grant (5PP30CA045508).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jauvion V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029785; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Mari-Ordonez A, 2013, NAT GENET, V45, P1029, DOI 10.1038/ng.2703; McCue AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002474; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schwab R, 2013, EMBO REP, V14, P615, DOI 10.1038/embor.2013.58; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	33	192	201	2	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					411	+		10.1038/nature13069	http://dx.doi.org/10.1038/nature13069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24670663	Green Accepted			2022-12-24	WOS:000334403000055
J	Weissmueller, S; Manchado, E; Saborowski, M; Morris, JP; Wagenblast, E; Davis, CA; Moon, SH; Pfister, NT; Tschaharganeh, DF; Kitzing, T; Aust, D; Markert, EK; Wu, JM; Grimmond, SM; Pilarsky, C; Prives, C; Biankin, AV; Lowe, SW				Weissmueller, Susann; Manchado, Eusebio; Saborowski, Michael; Morris, John P.; Wagenblast, Elvin; Davis, Carrie A.; Moon, Sung-Hwan; Pfister, Neil T.; Tschaharganeh, Darjus F.; Kitzing, Thomas; Aust, Daniela; Markert, Elke K.; Wu, Jianmin; Grimmond, Sean M.; Pilarsky, Christian; Prives, Carol; Biankin, Andrew V.; Lowe, Scott W.			Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor beta Signaling	CELL			English	Article							TUMOR-SUPPRESSOR P53; LI-FRAUMENI-SYNDROME; NF-Y; MOUSE MODELS; GAIN; INVASION; MUTATION; COMPLEX; P63; P73	Missense mutations in the p53 tumor suppressor inactivate its antiproliferative properties but can also promote metastasis through a gain-of-function activity. We show that sustained expression of mutant p53 is required to maintain the prometastatic phenotype of a murine model of pancreatic cancer, a highly metastatic disease that frequently displays p53 mutations. Transcriptional profiling and functional screening identified the platelet-derived growth factor receptor b (PDGFRb) as both necessary and sufficient to mediate these effects. Mutant p53 induced PDGFRb through a cell-autonomous mechanism involving inhibition of a p73/NF-Y complex that represses PDGFRb expression in p53-deficient, noninvasive cells. Blocking PDGFRb signaling by RNA interference or by small molecule inhibitors prevented pancreatic cancer cell invasion in vitro and metastasis formation in vivo. Finally, high PDGFRb expression correlates with poor disease-free survival in pancreatic, colon, and ovarian cancer patients, implicating PDGFRb as a prognostic marker and possible target for attenuating metastasis in p53 mutant tumors.	[Weissmueller, Susann; Wagenblast, Elvin; Davis, Carrie A.; Lowe, Scott W.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Weissmueller, Susann; Manchado, Eusebio; Saborowski, Michael; Morris, John P.; Tschaharganeh, Darjus F.; Kitzing, Thomas; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Moon, Sung-Hwan; Pfister, Neil T.; Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Aust, Daniela; Pilarsky, Christian] Tech Univ Dresden, Dept Visceral Thorac & Vasc Surg, D-01062 Dresden, Germany; [Markert, Elke K.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Wu, Jianmin; Biankin, Andrew V.] Garvan Inst Med Res, Canc Div, Kinghorn Canc Ctr, Sydney, NSW 2010, Australia; [Wu, Jianmin] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Santa Lucia, Qld 4072, Australia; [Grimmond, Sean M.; Biankin, Andrew V.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow G61 1BD, Lanark, Scotland; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Columbia University; Technische Universitat Dresden; Institute for Advanced Study - USA; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Queensland; University of Glasgow; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	lowes@mskcc.org	Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019; Wu, Jianmin/G-3629-2010	Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Pilarsky, Christian/0000-0002-7968-3283; Wagenblast, Elvin/0000-0002-0709-2759; Wu, Jianmin/0000-0002-8876-128X; Biankin, Andrew/0000-0002-0362-5597	Annette Kade Fellowship from the Watson School of Biological Sciences; Jane Coffin Childs Memorial Fund for Medical Research; National Cancer Institute [CA 013106]; NATIONAL CANCER INSTITUTE [P01CA013106, P01CA129243, P01CA087497, P30CA008748] Funding Source: NIH RePORTER; Cancer Research UK [17263] Funding Source: researchfish	Annette Kade Fellowship from the Watson School of Biological Sciences; Jane Coffin Childs Memorial Fund for Medical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	We thank K. Funa for sharing plasmids, A. Lujambio, M. Taylor, J. Ahn, and other members of the Lowe laboratory for critical discussions and/or technical help, APGI for providing clinical data, and J.P. Morton for providing cell lines. We thank C.J. Sherr and L. Dow for their advice on experimental design and for editing the manuscript. S.W. is the recipient of the Annette Kade Fellowship from the Watson School of Biological Sciences. E.M. is supported by The Jane Coffin Childs Memorial Fund for Medical Research. S.W.L. is the Geoffrey Beene Chair of Cancer Biology and a Howard Hughes Medical Institute investigator. This work was supported by a grant from the National Cancer Institute (CA 013106).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; BALLAGI AE, 1995, BIOCHEM BIOPH RES CO, V210, P165, DOI 10.1006/bbrc.1995.1642; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Dai YJ, 2010, EXPERT OPIN THER PAT, V20, P885, DOI 10.1517/13543776.2010.493559; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Garofalo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067581; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Hackzell A, 2002, J BIOL CHEM, V277, P39769, DOI 10.1074/jbc.M204483200; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoehler T, 2013, BRIT J CANCER, V109, P1408, DOI 10.1038/bjc.2013.409; Ishisaki A, 1997, EUR J BIOCHEM, V246, P142, DOI 10.1111/j.1432-1033.1997.t01-2-00142.x; Joerger AC, 2007, ADV CANCER RES, V97, P1, DOI 10.1016/S0065-230X(06)97001-8; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lehmann BD, 2012, J CLIN ONCOL, V30, P3648, DOI 10.1200/JCO.2012.44.0412; LEVESQUE MA, 1995, CANCER-AM CANCER SOC, V75, P1327, DOI 10.1002/1097-0142(19950315)75:6<1327::AID-CNCR2820750615>3.0.CO;2-P; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lewis NL, 2009, J CLIN ONCOL, V27, P5262, DOI 10.1200/JCO.2009.21.8487; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Masciarelli S., 2013, ONCOGENE; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Montalbetti N, 2013, MOL ASPECTS MED, V34, P270, DOI 10.1016/j.mam.2013.01.002; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Serra E, 1998, NUCLEIC ACIDS RES, V26, P3800, DOI 10.1093/nar/26.16.3800; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Wolff NC, 2003, BLOOD, V101, P5010, DOI 10.1182/blood-2002-10-3059	45	327	334	0	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					382	394		10.1016/j.cell.2014.01.066	http://dx.doi.org/10.1016/j.cell.2014.01.066			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725405	Bronze, Green Accepted			2022-12-24	WOS:000334304500012
J	Dobson, F				Dobson, Frank			Perils of launching a new vaccination campaign	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patelm@parliament.uk						Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2327	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2014	348								g2449	10.1136/bmj.g2449	http://dx.doi.org/10.1136/bmj.g2449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4TX	24699385				2022-12-24	WOS:000333978000012
J	Vinther, J; Stein, M; Longrich, NR; Harper, DAT				Vinther, Jakob; Stein, Martin; Longrich, Nicholas R.; Harper, David A. T.			A suspension-feeding anomalocarid from the Early Cambrian	NATURE			English	Article							SIRIUS PASSET LAGERSTATTE; NORTH GREENLAND; BURGESS SHALE; BONY FISHES; PLANKTON; FOOD; WHALES; ORIGIN; EVOLUTION; BOUNDARY	Large, actively swimming suspension feeders evolved several times in Earth's history, arising independently from groups as diverse as sharks, rays and stem teleost fishes(1), and in mysticete whales(2). However, animals occupying this niche have not been identified from the early Palaeozoic era. Anomalocarids, a group of stem arthropods that were the largest nektonic animals of the Cambrian and Ordovician periods, are generally thought to have been apex predators(3-5). Here we describe new material from Tamisiocaris borealis(6), an anomalocarid from the Early Cambrian (Series 2) Sirius Passet Fauna of North Greenland, and propose that its frontal appendage is specialized for suspension feeding. The appendage bears long, slender and equally spaced ventral spines furnished with dense rows of long and fine auxiliary spines. This suggests that T. borealis was a microphagous suspension feeder, using its appendages for sweep-net capture of food items down to 0.5 mm, within the size range of mesozooplankton such as copepods. Our observations demonstrate that large, nektonic suspension feeders first evolved during the Cambrian explosion, as part of an adaptive radiation of anomalocarids. The presence of nektonic suspension feeders in the Early Cambrian, together with evidence for a diverse pelagic community containing phytoplankton(7,8) and mesozooplankton(7,9,10), indicate the existence of a complex pelagic ecosystem(11) supported by high primary productivity and nutrient flux(12,13). Cambrian pelagic ecosystems seem to have been more modern than previously believed. [GRAPHICS] .	[Vinther, Jakob] Univ Bristol, Sch Earth Sci, Bristol BS8, Avon, England; [Vinther, Jakob] Univ Bristol, Sch Biol Sci, Bristol BS8, Avon, England; [Stein, Martin] Univ Copenhagen, Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark; [Longrich, Nicholas R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Harper, David A. T.] Univ Durham, Dept Earth Sci, Palaeoecosyst Grp, Durham DH1 3LE, England	University of Bristol; University of Bristol; University of Copenhagen; University of Bath; Durham University	Vinther, J (corresponding author), Univ Bristol, Sch Earth Sci, Woodland Rd, Bristol BS8, Avon, England.	jakob.vinther@bristol.ac.uk	Vinther, Jakob/GZG-4679-2022; Harper, David/AAX-7473-2020; Harper, David A.T./C-6888-2012	Harper, David/0000-0003-1315-9494; Harper, David A.T./0000-0003-1315-9494; Stein, Martin/0000-0002-8218-8232; Longrich, Nicholas/0000-0002-9586-8907; Vinther, Jakob/0000-0002-3584-9616	Geocenter Denmark; Agouron Institute; Carlsberg Foundation	Geocenter Denmark; Agouron Institute(Pfizer); Carlsberg Foundation(Carlsberg Foundation)	Our expeditions to North Greenland were financed by Geocenter Denmark, the Agouron Institute and the Carlsberg Foundation. We are grateful for discussions with members of the Bristol Palaeobiology group, E. Sperling, C. Hull, M. Matz and M. Friedman. M. S. was supported by the Carlsberg Foundation. We thank POLOG for logistic support. A. T. Nielsen and M. P. Smith assisted in the field in 2009. S. Powell assisted with figures. S. L. Jakobsen and A. T. Nielsen facilitated work and curation of the collected material at the Statens Naturhistoriske Museum, Copenhagen.	Barkley E., 1954, Zeitschrift fuer Fischerei, VBeiheft 1, Walforschung 1, Enhalt IV, P65; BOYD CM, 1984, J CRUSTACEAN BIOL, V4, P123, DOI 10.1163/1937240X84X00543; Brasier M.D., 1991, Historical Biology, V5, P85; Briggs D.E.G., 1979, Palaeontology (Oxford), V22, P631; Budy P, 2005, T AM FISH SOC, V134, P1228, DOI 10.1577/T04-159.1; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; Chen YY, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.214.3291; COOK PJ, 1984, NATURE, V308, P231, DOI 10.1038/308231a0; Daley AC, 2013, PALAEONTOLOGY, V56, P971, DOI 10.1111/pala.12029; Daley AC, 2012, NATURWISSENSCHAFTEN, V99, P501, DOI 10.1007/s00114-012-0910-8; Daley AC, 2010, PALAEONTOLOGY, V53, P721, DOI 10.1111/j.1475-4983.2010.00955.x; Daley AC, 2010, J PALEONTOL, V84, P352, DOI 10.1666/09-136R1.1; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Friedman M, 2012, P ROY SOC B-BIOL SCI, V279, P944, DOI 10.1098/rspb.2011.1381; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; GELLER W, 1981, OECOLOGIA, V49, P316, DOI 10.1007/BF00347591; Gould S. J., 1989, WONDERFUL LIFE BURGE; Harvey THP, 2008, NATURE, V452, P868, DOI 10.1038/nature06724; Harvey THP, 2012, P NATL ACAD SCI USA, V109, P1589, DOI 10.1073/pnas.1115244109; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Ineson JR, 2011, CAN J EARTH SCI, V48, P1259, DOI 10.1139/E11-018; JENKIN PM, 1957, PHILOS T ROY SOC B, V240, P401, DOI 10.1098/rstb.1957.0004; JERLING HL, 1995, J EXP MAR BIOL ECOL, V188, P243, DOI 10.1016/0022-0981(95)00007-E; Jorgensen CB., 1966, BIOL SUSPENSION FEED; Kruta I, 2011, SCIENCE, V331, P70, DOI 10.1126/science.1198793; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Nemoto T., 1970, P241; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Peel JS, 2011, B GEOSCI, V86, P535, DOI 10.3140/bull.geosci.1269; Peters SE, 2012, NATURE, V484, P363, DOI 10.1038/nature10969; PIVORUNAS A, 1979, AM SCI, V67, P432; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; Stein M, 2010, LETHAIA, V43, P258, DOI 10.1111/j.1502-3931.2009.00189.x; Tanaka H, 2006, J FISH BIOL, V68, P1041, DOI 10.1111/j.0022-1112.2006.00988.x; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; Vannier J, 2007, P ROY SOC B-BIOL SCI, V274, P627, DOI 10.1098/rspb.2006.3761; Vannier J, 2009, P ROY SOC B-BIOL SCI, V276, P2567, DOI 10.1098/rspb.2009.0361; VIDAL G, 1982, NATURE, V297, P57, DOI 10.1038/297057a0; Vinther J, 2011, PALAEONTOLOGY, V54, P711, DOI 10.1111/j.1475-4983.2011.01034.x; Werth AJ, 2013, J EXP BIOL, V216, P1152, DOI 10.1242/jeb.078931; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096	42	102	103	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					496	+		10.1038/nature13010	http://dx.doi.org/10.1038/nature13010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670770	Green Submitted, Green Accepted			2022-12-24	WOS:000333402000040
J	Jaremko, L; Jaremko, M; Giller, K; Becker, S; Zweckstetter, M				Jaremko, Lukasz; Jaremko, Mariusz; Giller, Karin; Becker, Stefan; Zweckstetter, Markus			Structure of the Mitochondrial Translocator Protein in Complex with a Diagnostic Ligand	SCIENCE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA; CHOLESTEROL TRANSPORT; AFFINITY BINDING; TSPO; MEMBRANES; IDENTIFICATION; SEQUENCE; TARGET	The 18-kilodalton translocator protein TSPO is found in mitochondrial membranes and mediates the import of cholesterol and porphyrins into mitochondria. In line with the role of TSPO in mitochondrial function, TSPO ligands are used for a variety of diagnostic and therapeutic applications in animals and humans. We present the three-dimensional high-resolution structure of mammalian TSPO reconstituted in detergent micelles in complex with its high-affinity ligand PK11195. The TSPO-PK11195 structure is described by a tight bundle of five transmembrane alpha helices that form a hydrophobic pocket accepting PK11195. Ligand-induced stabilization of the structure of TSPO suggests a molecular mechanism for the stimulation of cholesterol transport into mitochondria.	[Jaremko, Lukasz; Jaremko, Mariusz; Giller, Karin; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Jaremko, Lukasz; Zweckstetter, Markus] Deutsch Zentrum Neurodegenerat Erkrankungen, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37073 Gottingen, Germany	Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen	Becker, S (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	sabe@nmr.mpibpc.mpg.de; markus.zweckstetter@dzne.de	Jaremko, Lukasz/A-3101-2009; Jaremko, Lukasz/GQB-5017-2022	Jaremko, Lukasz/0000-0001-7684-9359; Zweckstetter, Markus/0000-0002-2536-6581; Jaremko, Mariusz/0000-0002-0787-702X	Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej); EU; Deutsche Forschungsgemeinschaft Collaborative Research Center [803]; European Research Council (ERC) [282008]	Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej); EU(European Commission); Deutsche Forschungsgemeinschaft Collaborative Research Center(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission)	The 3D structure of the mTSPO-PK11195 complex has been deposited at the Protein Data Bank (accession code 2mgy). Supported by the START and Ventures Programme of the Foundation for Polish Science (Fundacja na rzecz Nauki Polskiej) cofinanced by the EU European Regional Development Fund (M.J. and L.J.) and by Deutsche Forschungsgemeinschaft Collaborative Research Center 803, Project A11, and the European Research Council (ERC grant agreement 282008) (M.Z.).	Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Fan J, 2012, CURR MOL MED, V12, P369; FARGES R, 1994, MOL PHARMACOL, V46, P1160; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Gatliff J, 2012, CURR MOL MED, V12, P356; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Joseph-Liauzun E, 1998, J BIOL CHEM, V273, P2146, DOI 10.1074/jbc.273.4.2146; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Lee YS, 2012, ACS CHEM NEUROSCI, V3, P325, DOI 10.1021/cn3000108; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Morrison EA, 2012, BBA-BIOMEMBRANES, V1818, P814, DOI 10.1016/j.bbamem.2011.12.020; Murail S, 2008, BBA-BIOMEMBRANES, V1778, P1375, DOI 10.1016/j.bbamem.2008.03.012; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Scarf AM, 2009, J MED CHEM, V52, P581, DOI 10.1021/jm8011678; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Veenman L, 2012, CURR MOL MED, V12, P398; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385	27	183	186	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1363	1366		10.1126/science.1248725	http://dx.doi.org/10.1126/science.1248725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653034	Green Accepted			2022-12-24	WOS:000333108500040
J	Nilsen, TW				Nilsen, Timothy W.			Internal mRNA Methylation Finally Finds Functions	SCIENCE			English	Editorial Material									Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Nilsen, TW (corresponding author), Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	twn@case.edu						Bokar JA, 1997, RNA, V3, P1233; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	7	59	61	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1207	1208		10.1126/science.1249340	http://dx.doi.org/10.1126/science.1249340			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626918				2022-12-24	WOS:000332728500023
J	Stohr, K				Stoehr, Klaus			PERSPECTIVE Ill prepared for a pandemic	NATURE			English	Editorial Material							INFLUENZA		[Stoehr, Klaus] Novartis Vaccines & Diagnost, Policy, Cambridge, MA 02139 USA	Novartis	Stohr, K (corresponding author), Novartis Vaccines & Diagnost, Policy, Cambridge, MA 02139 USA.	klaus.stohr@novartis.com						Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Settembre EC, 2014, HUM VACC IMMUNOTHER, V10, P600, DOI 10.4161/hv.27600	4	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S20	S21		10.1038/507S20a	http://dx.doi.org/10.1038/507S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611175	Bronze			2022-12-24	WOS:000332224400010
J	Wlodarska, M; Thaiss, CA; Nowarski, R; Henao-Mejia, J; Zhang, JP; Brown, EM; Frankel, G; Levy, M; Katz, MN; Philbrick, WM; Elinav, E; Finlay, BB; Flavell, RA				Wlodarska, Marta; Thaiss, Christoph A.; Nowarski, Roni; Henao-Mejia, Jorge; Zhang, Jian-Ping; Brown, Eric M.; Frankel, Gad; Levy, Maayan; Katz, Meirav N.; Philbrick, William M.; Elinav, Eran; Finlay, B. Brett; Flavell, Richard A.			NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion	CELL			English	Article							INTESTINAL INFLAMMATION; CITROBACTER-RODENTIUM; ADAPTIVE IMMUNITY; LIVER-DISEASE; MUCIN; INFECTION; AUTOPHAGY; MICE; CASPASE-1; PROTEINS	Mucusproduction by goblet cells of the large intestine serves as a crucial antimicrobial protective mechanism at the interface between the eukaryotic and prokaryotic cells of the mammalian intestinal ecosystem. However, the regulatory pathways involved in goblet cell-induced mucus secretion remain largely unknown. Here, we demonstrate that the NLRP6 inflammasome, a recently described regulator of colonic microbiota composition and biogeographical distribution, is a critical orchestrator of goblet cell mucin granule exocytosis. NLRP6 deficiency leads to defective autophagy in goblet cells and abrogated mucus secretion into the large intestinal lumen. Consequently, NLRP6 inflammasome-deficient mice are unable to clear enteric pathogens from the mucosal surface, rendering them highly susceptible to persistent infection. This study identifies an innate immune regulatory pathway governing goblet cell mucus secretion, linking nonhematopoietic inflammasome signaling to autophagy and highlighting the goblet cell as a critical innate immune player in the control of intestinal host-microbial mutualism.	[Wlodarska, Marta; Brown, Eric M.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Wlodarska, Marta; Brown, Eric M.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Thaiss, Christoph A.; Levy, Maayan; Katz, Meirav N.; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Nowarski, Roni; Henao-Mejia, Jorge; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Zhang, Jian-Ping; Philbrick, William M.] Yale Univ, Sch Med, Ctr Endocrinol & Metab, New Haven, CT 06520 USA; [Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Katz, Meirav N.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-64239 Tel Aviv, Israel; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of British Columbia; University of British Columbia; Weizmann Institute of Science; Yale University; Yale University; Imperial College London; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of British Columbia; Howard Hughes Medical Institute	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il; bfinlay@interchange.ubc.ca; richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110	Weizmann Institute; Department of Veterinary Resources; Canadian Institutes of Health Research (CIHR); Charles Best Canada graduate scholarship; Boehringer Ingelheim Fonds PhD Fellowship; Friends of Tel Aviv Sourasky Medical Center Foundation; Yael and Rami Ungar, Israel; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Estate of Jack Gitlitz; Estate of Lydia Hershkovich; European Research Council; Kenneth Rainin Foundation; German-Israel Binational Foundation; Israel Science Foundation; Minerva Foundation; Alon Foundation; CIHR; US Department of Defense; Blavatnik Family Foundation; MRC [MR/J006874/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	Weizmann Institute; Department of Veterinary Resources; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Charles Best Canada graduate scholarship; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Friends of Tel Aviv Sourasky Medical Center Foundation; Yael and Rami Ungar, Israel; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Estate of Jack Gitlitz; Estate of Lydia Hershkovich; European Research Council(European Research Council (ERC)European Commission); Kenneth Rainin Foundation; German-Israel Binational Foundation; Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Alon Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); US Department of Defense(United States Department of Defense); Blavatnik Family Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the Elinav, Finlay, and Flavell labs and Zamir Halpern, Tel Aviv Sourasky Medical Center, for fruitful scientific discussions. We thank Akiko Iwasaki, Yale University School of Medicine, for kindly providing LC3 reporter mice. We thank the Weizmann Institute management and Alon Harmelin, director of the Department of Veterinary Resources, for providing financial and infrastructural support. We thank M. Graham and X. Liu, CCMI EM Core Facility, Yale School of Medicine. M.W. is supported through the Canadian Institutes of Health Research (CIHR) doctoral award-Frederick Banting and Charles Best Canada graduate scholarship. C.A.T. is the recipient of a Boehringer Ingelheim Fonds PhD Fellowship. M.N.K. was supported by a travel grant from the Friends of Tel Aviv Sourasky Medical Center Foundation. E.E. is supported by Yael and Rami Ungar, Israel, Abisch Frenkel Foundation for the Promotion of Life Sciences, the Gurwin Family Fund for Scientific Research, Leona M. and Harry B. Helmsley Charitable Trust, Crown Endowment Fund for Immunological Research, Estate of Jack Gitlitz, Estate of Lydia Hershkovich, grants funded by the European Research Council, the Kenneth Rainin Foundation, the German-Israel Binational Foundation, the Israel Science Foundation, the Minerva Foundation, and the Alon Foundation scholar award. B.B.F. is supported by operating grants from CIHR and is the UBC Peter Wall Distinguished Professor. R.A.F. is supported by grants from the US Department of Defense and the Blavatnik Family Foundation and is a Howard Hughes Medical Institute (HHMI) investigator.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Elinav E, 2013, MUCOSAL IMMUNOL, V6, P4, DOI 10.1038/mi.2012.115; Elinav Eran, 2013, Methods Mol Biol, V1040, P185, DOI 10.1007/978-1-62703-523-1_14; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; Gill N, 2011, CELL MICROBIOL, V13, P660, DOI 10.1111/j.1462-5822.2011.01578.x; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Henao-Mejia J, 2013, J AUTOIMMUN, V46, P66, DOI 10.1016/j.jaut.2013.07.001; Henao-Mejia J, 2013, ADV IMMUNOL, V117, P73, DOI 10.1016/B978-0-12-410524-9.00003-7; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Inoue J, 2012, ARCH BIOCHEM BIOPHYS, V521, P95, DOI 10.1016/j.abb.2012.03.019; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Rodriguez-Pineiro AM, 2012, J PROTEOME RES, V11, P1879, DOI 10.1021/pr2010988; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; TYTGAT KMAJ, 1994, GASTROENTEROLOGY, V107, P1352, DOI 10.1016/0016-5085(94)90537-1; Ushio H, 2011, J ALLERGY CLIN IMMUN, V127, P1267, DOI 10.1016/j.jaci.2010.12.1078; van der Sluis M, 2008, LAB INVEST, V88, P634, DOI 10.1038/labinvest.2008.28; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285	44	449	474	7	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1045	1059		10.1016/j.cell.2014.01.026	http://dx.doi.org/10.1016/j.cell.2014.01.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581500	Bronze, Green Accepted			2022-12-24	WOS:000332083900020
J	White, NJ				White, Nicholas J.			Malaria: a molecular marker of artemisinin resistance	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; CAMBODIA; CLEARANCE		Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand	Mahidol University	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand.	nickw@tropmedres.ac	White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978	Wellcome Trust [093956] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2014, STAT REP ART RES; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4	12	17	20	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1439	1440		10.1016/S0140-6736(14)60656-5	http://dx.doi.org/10.1016/S0140-6736(14)60656-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3NI	24766952				2022-12-24	WOS:000335325800004
J	Costa, LM; Marshall, E; Tesfaye, M; Silverstein, KAT; Mori, M; Umetsu, Y; Otterbach, SL; Papareddy, R; Dickinson, HG; Boutiller, K; VandenBosch, KA; Ohki, S; Gutierrez-Marcos, JF				Costa, Liliana M.; Marshall, Eleanor; Tesfaye, Mesfin; Silverstein, Kevin A. T.; Mori, Masashi; Umetsu, Yoshitaka; Otterbach, Sophie L.; Papareddy, Ranjith; Dickinson, Hugh G.; Boutiller, Kim; VandenBosch, Kathryn A.; Ohki, Shinya; Gutierrez-Marcos, Jose F.			Central Cell-Derived Peptides Regulate Early Embryo Patterning in Flowering Plants	SCIENCE			English	Article							APICAL-BASAL AXIS; DOUBLE FERTILIZATION; STOMATAL DENSITY; GENE-EXPRESSION; ARABIDOPSIS; EMBRYOGENESIS; ENDOSPERM; COMMUNICATION; INFECTION; ORIGIN	Plant embryogenesis initiates with the establishment of an apical-basal axis; however, the molecular mechanisms accompanying this early event remain unclear. Here, we show that a small cysteine-rich peptide family is required for formation of the zygotic basal cell lineage and proembryo patterning in Arabidopsis. EMBRYO SURROUNDING FACTOR 1 (ESF1) peptides accumulate before fertilization in central cell gametes and thereafter in embryo-surrounding endosperm cells. Biochemical and structural analyses revealed cleavage of ESF1 propeptides to form biologically active mature peptides. Further, these peptides act in a non-cell-autonomous manner and synergistically with the receptor-like kinase SHORT SUSPENSOR to promote suspensor elongation through the YODA mitogen-activated protein kinase pathway. Our findings demonstrate that the second female gamete and its sexually derived endosperm regulate early embryonic patterning in flowering plants.	[Costa, Liliana M.; Dickinson, Hugh G.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Marshall, Eleanor; Otterbach, Sophie L.; Papareddy, Ranjith; Gutierrez-Marcos, Jose F.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Tesfaye, Mesfin; Silverstein, Kevin A. T.; VandenBosch, Kathryn A.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Lab Plant Gene Technol, Nonoichi, Ishikawa 9218836, Japan; [Umetsu, Yoshitaka; Ohki, Shinya] Japan Adv Inst Sci & Technol JAIST, Ctr Nano Mat & Technol CNMT, Nomi, Ishikawa 9231292, Japan; [Boutiller, Kim] Plant Res Int, NL-6700 AP Wageningen, Netherlands	University of Oxford; University of Warwick; University of Minnesota System; University of Minnesota Twin Cities; Ishikawa Prefecture University; Japan Advanced Institute of Science & Technology (JAIST)	Gutierrez-Marcos, JF (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	j.f.gutierrez-marcos@warwick.ac.uk	Papareddy, Ranjith Kumar/ABB-6920-2021; Otterbach, Sophie/C-8513-2015; Otterbach, Sophie Lisa/CAI-5079-2022; Gutierrez-Marcos, Jose/AAE-2229-2020	Otterbach, Sophie/0000-0001-7636-2698; Gutierrez-Marcos, Jose/0000-0002-5441-9080	Royal Society; ESF/RTD Framework COST action [FA0903]; Biotechnology and Biological Sciences Research Council [BB/F008082, BB/L003023/1, BB/L003023]; NSF [IOB-0516811]; Nanotechnology Platform Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BBSRC [BB/L003023/1] Funding Source: UKRI	Royal Society(Royal Society of London); ESF/RTD Framework COST action; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); Nanotechnology Platform Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank H. Prescott, A. Sarmiento, D. Garcia, and E. Caamano for technical assistance. We also thank T. Laux, W. Lukowitz, I. Moore, B. Scheres, A. Schnittger, M. Bayer, and D. Weijers for seed stocks and valuable suggestions. We acknowledge funding from the Royal Society, ESF/RTD Framework COST action (FA0903), and Biotechnology and Biological Sciences Research Council grants (BB/F008082, BB/L003023/1 and BB/L003023). The work at the University of Minnesota was supported by NSF award IOB-0516811. NMR experiments were partly supported by Nanotechnology Platform Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. K. S. and M. T. acknowledge the Minnesota Supercomputing Institute for computational resources and systems support used in microarray analysis. M. T. and K. S. performed microarray experiments and data analysis. E. M validated the array data, generated most transgenic lines, and conducted genetic analyses. L. M. C designed and performed genetic experiments, generated the LhG4 transactivation lines, and performed immunodetection. S.L.O. and R. P. performed the ovule culture experiments. K. B. identified the suspensor-specific At2g30560 gene and generated pGRP-GUS:GFP lines. M. M. expressed ESF1 peptides. M. M., Y.U. and S.O. purified synthetic wild-type and mutant ESF1 peptides and performed solution NMR structural analysis. J.G-M., K. V., S.O., and M. M. conceived and supervised the study. J.G-M. and L. M. C. wrote the paper with input from S.O. All authors have reviewed and approved the paper, and the authors disclose no conflicts of interest.	Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Breuninger H, 2008, DEV CELL, V14, P867, DOI 10.1016/j.devcel.2008.03.008; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Costa LM, 2012, CURR BIOL, V22, P160, DOI 10.1016/j.cub.2011.11.059; Dodeman VL, 1997, J EXP BOT, V48, P1493, DOI 10.1093/jexbot/48.313.1493; FRIEDMAN WE, 1994, AM J BOT, V81, P1468, DOI 10.2307/2445320; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Gutierrez-Marcos JF, 2004, PLANT CELL, V16, P1288, DOI 10.1105/tpc.019778; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Kawashima T, 2010, TRENDS PLANT SCI, V15, P23, DOI 10.1016/j.tplants.2009.11.002; Kiyohara S, 2012, PLANT CELL PHYSIOL, V53, P1989, DOI 10.1093/pcp/pcs136; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Ohki S, 2008, J BIOMOL NMR, V42, P271, DOI 10.1007/s10858-008-9283-x; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Petricka JJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000497; Rademacher EH, 2012, DEV CELL, V22, P211, DOI 10.1016/j.devcel.2011.10.026; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992; TRIVERS RL, 1974, AM ZOOL, V14, P249; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; YEUNG EC, 1993, PLANT CELL, V5, P1371, DOI 10.1105/tpc.5.10.1371; Zhang ZJ, 2011, SEX PLANT REPROD, V24, P161, DOI 10.1007/s00497-010-0160-x	36	115	137	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					168	172		10.1126/science.1243005	http://dx.doi.org/10.1126/science.1243005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723605				2022-12-24	WOS:000334096300027
J	Couch, FJ; Nathanson, KL; Offit, K				Couch, Fergus J.; Nathanson, Katherine L.; Offit, Kenneth			Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention	SCIENCE			English	Editorial Material							GENOME-WIDE ASSOCIATION; EARLY-ONSET BREAST; HIGH FAMILIAL RISK; MUTATION CARRIERS; OVARIAN-CANCER; UNCERTAIN SIGNIFICANCE; GENETIC SUSCEPTIBILITY; SALPINGO-OOPHORECTOMY; CLINICAL-SIGNIFICANCE; ORAL-CONTRACEPTIVES	The cloning of the breast cancer susceptibility genes BRCA1 and BRCA2 nearly two decades ago helped set in motion an avalanche of research exploring how genomic information can be optimally applied to identify and clinically care for individuals with a high risk of developing cancer. Genetic testing for mutations in BRCA1, BRCA2, and other breast cancer susceptibility genes has since proved to be a valuable tool for determining eligibility for enhanced screening and prevention strategies, as well as for identifying patients most likely to benefit from a targeted therapy. Here, we discuss the landscape of inherited mutations and sequence variants in BRCA1 and BRCA2, the complexities of determining disease risk when the pathogenicity of sequence variants is uncertain, and current strategies for clinical management of women who carry BRCA1/2 mutations.	[Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol & Lab Med, Rochester, MN 55905 USA; [Nathanson, Katherine L.] Univ Penn, Div Translat Med & Human Genet, Dept Med, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Canc Biol & Genet Program, Dept Med,Sloan Kettering Inst, New York, NY 10065 USA; [Offit, Kenneth] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Offit, Kenneth] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA	Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Couch, FJ (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol & Lab Med, Rochester, MN 55905 USA.	couch.fergus@mayo.edu			NCI NIH HHS [R01 CA135509, CA016520, U01 CA116167, P30 CA008748, R01 CA128978, P30 CA016520, P50 CA116201, 3P30CA008748-47, R01 CA116167, CA135509, CA116167, CA116201, U01CA164947, CA128978, U01 CA164947] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA116201, P30CA008748, R01CA128978, R01CA135509, U01CA116167, P30CA016520, U01CA164947] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Antoniou AC, 2010, CANCER RES, V70, P9742, DOI 10.1158/0008-5472.CAN-10-1907; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Biswas K, 2012, HUM MOL GENET, V21, P3993, DOI 10.1093/hmg/dds222; Bombard Y, 2013, JAMA-J AM MED ASSOC, V310, P795, DOI 10.1001/jama.2013.276573; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bubien V, 2013, J MED GENET, V50, P255, DOI 10.1136/jmedgenet-2012-101339; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Chang SH, 2011, NAT MED, V17, P1275, DOI 10.1038/nm.2459; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Collett K, 2005, CANCER EPIDEM BIOMAR, V14, P1108, DOI 10.1158/1055-9965.EPI-04-0394; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Curtin N, 2014, BIOCHEM SOC T, V42, P82, DOI 10.1042/BST20130187; De Lorenzo SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00228; Domchek SM, 2013, J CLIN ONCOL, V31, P1267, DOI 10.1200/JCO.2012.46.9403; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Finch A, 2006, JAMA-J AM MED ASSOC, V296, P185, DOI 10.1001/jama.296.2.185; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Gaudet MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001183; Gayther SA, 1997, AM J HUM GENET, V60, P1239; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Gronwald J, 2006, INT J CANCER, V118, P2281, DOI 10.1002/ijc.21536; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081; Haile RW, 2006, CANCER EPIDEM BIOMAR, V15, P1863, DOI 10.1158/1055-9965.EPI-06-0258; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hall A. E., 2013, J PUBLIC HLTH, V2013; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Hermsen BBJ, 2007, BRIT J CANCER, V96, P1335, DOI 10.1038/sj.bjc.6603725; Iversen ES, 2011, CANCER EPIDEM BIOMAR, V20, P1078, DOI 10.1158/1055-9965.EPI-10-1214; Judkins T, 2012, CANCER-AM CANCER SOC, V118, P5210, DOI 10.1002/cncr.27556; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; King MC, 2014, SCIENCE, V343, P1462, DOI 10.1126/science.1251900; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lehman CD, 2005, CANCER, V103, P1898, DOI 10.1002/cncr.20971; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Maxwell KN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3591; McLaughlin JR, 2007, LANCET ONCOL, V8, P26, DOI 10.1016/S1470-2045(06)70983-4; Metcalfe KA, 2008, INT J CANCER, V122, P2017, DOI 10.1002/ijc.23340; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2002, JNCI-J NATL CANCER I, V94, P1773, DOI 10.1093/jnci/94.23.1773; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; Offit K, 2006, J NATL CANCER I, V98, P1675, DOI 10.1093/jnci/djj500; Offit K, 2011, HUM GENET, V130, P3, DOI 10.1007/s00439-011-1028-3; Offit K, 2010, J CLIN ONCOL, V28, P4665, DOI 10.1200/JCO.2010.31.2926; Olivier RI, 2006, GYNECOL ONCOL, V100, P20, DOI 10.1016/j.ygyno.2005.08.038; Pashayan N, 2013, J INTERN MED, V274, P451, DOI 10.1111/joim.12094; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Purrington KS, 2014, CARCINOGENESIS, V35, P1012, DOI 10.1093/carcin/bgt404; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rebbeck TR, 2011, CANCER RES, V71, P5792, DOI 10.1158/0008-5472.CAN-11-0773; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; Robson ME, 2011, J CLIN ONCOL, V29, P3724, DOI 10.1200/JCO.2011.37.2540; Rosen EM, 2014, CURR DRUG TARGETS, V15, P17, DOI 10.2174/1389450114666140106095432; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Sawyer S, 2012, J CLIN ONCOL, V30, P4330, DOI 10.1200/JCO.2012.41.7469; Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037; Stadler ZK, 2014, J CLIN ONCOL, V32, P687, DOI 10.1200/JCO.2013.49.7271; Stadler ZK, 2010, HEMATOL ONCOL CLIN N, V24, P973, DOI 10.1016/j.hoc.2010.06.009; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Wang XS, 2010, HUM MOL GENET, V19, P2886, DOI 10.1093/hmg/ddq174; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Weitzel JN, 2013, J CLIN ONCOL, V31, P210, DOI 10.1200/JCO.2011.41.0027; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu CC, 2006, CANCER RES, V66, P8287, DOI 10.1158/0008-5472.CAN-05-4247	94	228	235	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1466	1470		10.1126/science.1251827	http://dx.doi.org/10.1126/science.1251827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675953	Green Accepted			2022-12-24	WOS:000333471000036
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: NICE's traffic light system for febrile children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTIONS; ENGLAND; DISEASE					destwo@yahoo.co.uk						[Anonymous], 2013, FEVERISH ILLNESS CHI; Collins S, 2013, CLIN INFECT DIS, V57, P1715, DOI 10.1093/cid/cit579; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; De S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f866; Gill PJ, 2013, ARCH DIS CHILD, V98, P328, DOI 10.1136/archdischild-2012-302383; Health Protection Scotland, MEN INF; Roggen I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002712; Spinks A, 2013, ANTIBIOTICS PEOPLE S; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	10	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g2056	10.1136/bmj.g2056	http://dx.doi.org/10.1136/bmj.g2056			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24618116				2022-12-24	WOS:000333032100012
J	Colak, D; Zaninovic, N; Cohen, MS; Rosenwaks, Z; Yang, WY; Gerhardt, J; Disney, MD; Jaffrey, SR				Colak, Dilek; Zaninovic, Nikica; Cohen, Michael S.; Rosenwaks, Zev; Yang, Wang-Yong; Gerhardt, Jeannine; Disney, Matthew D.; Jaffrey, Samie R.			Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; FULL MUTATION; NONCODING RNAS; FMR1 LOCUS; IN-VITRO; EXPRESSION; LONG; METHYLATION; GENE; INSTABILITY	Epigenetic gene silencing is seen in several repeat-expansion diseases. In fragile X syndrome, the most common genetic form of mental retardation, a CGG trinucleotide-repeat expansion adjacent to the fragile X mental retardation 1 (FMR1) gene promoter results in its epigenetic silencing. Here, we show that FMR1 silencing is mediated by the FMR1 mRNA. The FMR1 mRNA contains the transcribed CGG-repeat tract as part of the 5' untranslated region, which hybridizes to the complementary CGG-repeat portion of the FMR1 gene to form an RNA . DNA duplex. Disrupting the interaction of the mRNA with the CGG-repeat portion of the FMR1 gene prevents promoter silencing. Thus, our data link trinucleotide-repeat expansion to a form of RNA-directed gene silencing mediated by direct interactions of the trinucleotide-repeat RNA and DNA.	[Colak, Dilek; Cohen, Michael S.; Jaffrey, Samie R.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Zaninovic, Nikica; Rosenwaks, Zev] Cornell Univ, Weill Cornell Med Coll, Ctr Reprod Med & Infertil, New York, NY 10065 USA; [Yang, Wang-Yong; Disney, Matthew D.] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Gerhardt, Jeannine] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Cornell University; Cornell University; Scripps Research Institute; State University System of Florida; University of Florida; Yeshiva University; Albert Einstein College of Medicine	Jaffrey, SR (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu		Jaffrey, Samie/0000-0003-3615-6958; Disney, Matthew/0000-0001-8486-1796	Tri-Institutional Stem Cell Initiative (Tri-I SCI) [2008-019]; New York Stem Cell Foundation-Druckenmiller Fellowship; Life Sciences Research Foundation Fellowship; Tri-I SCI postdoctoral fellowship; FRAXA postdoctoral fellowship; NIH [R01 MH80420, R01 GM079235]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306, R21NS087859] Funding Source: NIH RePORTER	Tri-Institutional Stem Cell Initiative (Tri-I SCI); New York Stem Cell Foundation-Druckenmiller Fellowship; Life Sciences Research Foundation Fellowship; Tri-I SCI postdoctoral fellowship; FRAXA postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Jaffrey lab for helpful comments and suggestions, E. Ferretti for assistance with chromatin immunoprecipitation, Q. Zhan for help with hESC cultures, S. L. Nolin and C. Dobkin for PCR on premutation lines. hESC lines are available from N.Z. and Z.R. (Weill Cornell Medical College hESC lines, nizanin@med.cornell.edu, zrosenw@med.cornell.edu) and S.R.J. (SI-214 hESC line, srj2003@med.cornell.edu), subject to approval by the Embryonic Stem Cell Research Oversight Committee (ESCRO) of Weill Cornell Medical College. M. D. D. previously consulted for SMaRT (Small Molecule Approach to Targeting RNA) Therapeutics. A patent (U. S. Patent and Trademark Office application no. 61/694,977) was filed on 30 August 2012 by the Scripps Research Institute governing composition and use of 1f and 1a. This work was supported by the Tri-Institutional Stem Cell Initiative (Tri-I SCI) grant 2008-019 (S.R.J., N.Z., and Z.R.), New York Stem Cell Foundation-Druckenmiller Fellowship (D. C.), Life Sciences Research Foundation Fellowship and Tri-I SCI postdoctoral fellowship (M. S. C.), and a FRAXA postdoctoral fellowship (W.-Y.Y.). Portions of this project not involving non-NIH registry stem cells were supported by NIH R01 MH80420 (S.R.J.) and NIH R01 GM079235 (M.D.D.).	Alisch RS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-18; Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brouwer JR, 2007, EXP CELL RES, V313, P244, DOI 10.1016/j.yexcr.2006.10.002; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Disney MD, 2012, ACS CHEM BIOL, V7, P1711, DOI 10.1021/cb300135h; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Evans-Galea MV, 2013, TRENDS MOL MED, V19, P655, DOI 10.1016/j.molmed.2013.07.007; FENG Y, 1995, AM J HUM GENET, V56, P106; Gerhardt J, 2014, MOL CELL, V53, P19, DOI 10.1016/j.molcel.2013.10.029; GRABCZYK E, 1995, J BIOL CHEM, V270, P1791, DOI 10.1074/jbc.270.4.1791; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Sandberg G, 1997, NUCLEIC ACIDS RES, V25, P2883, DOI 10.1093/nar/25.14.2883; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017	27	207	211	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1002	1005		10.1126/science.1245831	http://dx.doi.org/10.1126/science.1245831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578575	Green Accepted			2022-12-24	WOS:000332309600040
J	Coia, JE; Leanord, AT; Reilly, J				Coia, John E.; Leanord, Alistair T.; Reilly, Jacqui			Screening for meticillin resistant Staphylococcus aureus (MRSA): who, when, and how?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DECOLONIZATION; ERADICATION; PREVENTION; MUPIROCIN		[Coia, John E.] Glasgow Royal Infirm, Dept Clin Microbiol, Glasgow G4 0SF, Lanark, Scotland; [Leanord, Alistair T.; Reilly, Jacqui] NHS Natl Serv Scotland, Glasgow G2 6QE, Lanark, Scotland; [Reilly, Jacqui] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland	University of Glasgow; NHS National Services Scotland; Glasgow Caledonian University	Coia, JE (corresponding author), Glasgow Royal Infirm, Dept Clin Microbiol, Glasgow G4 0SF, Lanark, Scotland.	john.coia@ggc.scot.nhs.uk	Coia, John/AAP-5379-2020	Coia, John/0000-0002-4966-8453; Reilly, Jacqui/0000-0003-2946-6720				Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; Cooper B S, 2003, Health Technol Assess, V7, P1; Currie K, 2012, J HOSP INFECT, V80, P140, DOI 10.1016/j.jhin.2011.11.015; Gilpin DP, 2010, J HOSP INFECT, V75, P93, DOI 10.1016/j.jhin.2009.11.025; Harbarth S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.04.042; Health Protection Scotland National Services Scotland, 2011, FIN REP, V1; Matheson A, 2012, INFECT CONT HOSP EP, V33, P803, DOI 10.1086/666639; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; Ritchie K, 2007, CLIN COST EFFECTIVEN; Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296; Shenoy ES, 2013, CLIN INFECT DIS, V57, P176, DOI 10.1093/cid/cit206; Simor AE, 2007, CLIN INFECT DIS, V44, P178, DOI 10.1086/510392; Xue Yifan, 2012, JBI Libr Syst Rev, V10, P3487	15	11	14	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2014	348								g1697	10.1136/bmj.g1697	http://dx.doi.org/10.1136/bmj.g1697			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UF	24578514				2022-12-24	WOS:000332210200002
J	Grotwinkel, JT; Wild, K; Segnitz, B; Sinning, I				Grotwinkel, Jan Timo; Wild, Klemens; Segnitz, Bernd; Sinning, Irmgard			SRP RNA Remodeling by SRP68 Explains Its Role in Protein Translocation	SCIENCE			English	Article							SIGNAL-RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM; GTPASE ACTIVATION; RIBOSOME; RECEPTOR; COMPLEX; IDENTIFICATION; MUTAGENESIS; NUCLEOLUS; DOMAIN	The signal recognition particle (SRP) is central to membrane protein targeting; SRP RNA is essential for SRP assembly, elongation arrest, and activation of SRP guanosine triphosphatases. In eukaryotes, SRP function relies on the SRP68-SRP72 heterodimer. We present the crystal structures of the RNA-binding domain of SRP68 (SRP68-RBD) alone and in complex with SRP RNA and SRP19. SRP68-RBD is a tetratricopeptide-like module that binds to a RNA three-way junction, bends the RNA, and inserts an alpha-helical arginine-rich motif (ARM) into the major groove. The ARM opens the conserved 5f RNA loop, which in ribosome-bound SRP establishes a contact to ribosomal RNA. Our data provide the structural basis for eukaryote-specific, SRP68-driven RNA remodeling required for protein translocation.	[Grotwinkel, Jan Timo; Wild, Klemens; Segnitz, Bernd; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Biochem Ctr BZH, INF 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB638, GRK1188]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grants SFB638 and GRK1188. We thank J. Kopp and C. Siegmann from the BZH/Cluster of Excellence: CellNetworks crystallization platform for support in protein crystallization; E. Hurt and S. Amlacher for C. thermophilum cDNA; and M. Becker, G. Bange, and R. Beckmann for stimulating discussions. Data collection was performed at ESRF (European Synchrotron Radiation Facilty, Grenoble). I. S. is an investigator of the Cluster of Excellence: CellNetworks. Coordinates and structure factors are deposited in the RCSB Protein Data Bank with the accession numbers 4P3E, 4P3F, and 4P3G for hSRP RNA-SRP19-SRP68-RBD, hSRP68-RBD, and ctSRP68-RBD, respectively.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iakhiaeva E, 2006, PROTEIN SCI, V15, P1290, DOI 10.1110/ps.051861406; Iakhiaeva E, 2009, PROTEIN SCI, V18, P2183, DOI 10.1002/pro.232; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Kuglstatter A, 2002, NAT STRUCT BIOL, V9, P740, DOI 10.1038/nsb843; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Menichelli E, 2007, J MOL BIOL, V367, P187, DOI 10.1016/j.jmb.2006.12.056; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; Rosenblad MA, 2009, RNA BIOL, V6, P508, DOI 10.4161/rna.6.5.9753; SCOULICA E, 1987, EUR J BIOCHEM, V163, P519, DOI 10.1111/j.1432-1033.1987.tb10899.x; Shen K, 2013, J BIOL CHEM, V288, P36385, DOI 10.1074/jbc.M113.513614; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Voigts-Hoffmann F, 2013, MOL CELL, V52, P643, DOI 10.1016/j.molcel.2013.10.005; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WEEKS KM, 1993, SCIENCE, V261, P1574, DOI 10.1126/science.7690496; Wild K, 2010, ACTA CRYSTALLOGR D, V66, P295, DOI 10.1107/S0907444910000879; Yin J, 2007, RNA BIOL, V4, P154, DOI 10.4161/rna.4.3.5428	33	31	31	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					101	104		10.1126/science.1249094	http://dx.doi.org/10.1126/science.1249094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700861				2022-12-24	WOS:000333746100062
J	Cruz-Martin, A; El-Danaf, RN; Osakada, F; Sriram, B; Dhande, OS; Nguyen, PL; Callaway, EM; Ghosh, A; Huberman, AD				Cruz-Martin, Alberto; El-Danaf, Rana N.; Osakada, Fumitaka; Sriram, Balaji; Dhande, Onkar S.; Nguyen, Phong L.; Callaway, Edward M.; Ghosh, Anirvan; Huberman, Andrew D.			A dedicated circuit links direction-selective retinal ganglion cells to the primary visual cortex	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; MOUSE; MOTION; MICE; IDENTIFICATION; PREFERENCES; PROJECTIONS; EXPRESSION; EXCITATION; REVEALS	How specific features in the environment are represented within the brain is an important unanswered question in neuroscience. A subset of retinal neurons, called direction-selective ganglion cells (DSGCs), are specialized for detecting motion along specific axes of the visual field(1). Despite extensive study of the retinal circuitry that endows DSGCs with their unique tuning properties(2,3), their downstream circuitry in the brain and thus their contribution to visual processing has remained unclear. In mice, several different types of DSGCs connect to the dorsal lateral geniculate nucleus (dLGN)(4-6), the visual thalamic structure that harbours cortical relay neurons. Whether direction-selective information computed at the level of the retina is routed to cortical circuits and integrated with other visual channels, however, is unknown. Here we show that there is a di-synaptic circuit linking DSGCs with the superficial layers of the primary visual cortex (V1) by using viral trans-synaptic circuit mapping(7,8) and functional imaging of visually driven calcium signals in thalamocortical axons. This circuit pools information from several types of DSGCs, converges in a specialized subdivision of the dLGN, and delivers direction-tuned and orientation-tuned signals to superficial V1. Notably, this circuit is anatomically segregated from the retino-geniculo-cortical pathway carrying non-direction-tuned visual information to deeper layers of V1, such as layer 4. Thus, the mouse harbours several functionally specialized, parallel retino-geniculo-cortical pathways, one of which originates with retinal DSGCs and delivers direction-and orientation-tuned information specifically to the superficial layers of the primary visual cortex. These data provide evidence that direction and orientation selectivity of some V1 neurons may be influenced by the activation of DSGCs.	[Cruz-Martin, Alberto; El-Danaf, Rana N.; Dhande, Onkar S.; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Cruz-Martin, Alberto; El-Danaf, Rana N.; Sriram, Balaji; Dhande, Onkar S.; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Osakada, Fumitaka; Callaway, Edward M.; Huberman, Andrew D.] Salk Inst Biol Studies, La Jolla, CA 92097 USA; [Ghosh, Anirvan] F Hoffmann La Roche & Cie AG, Neurosci Discovery, CH-4070 Basel, Switzerland; [Huberman, Andrew D.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Roche Holding; University of California System; University of California San Diego	Huberman, AD (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	ahuberman@ucsd.edu	Callaway, Edward/D-4336-2011; Cruz Martin, Alberto/ABE-7562-2021; Cruz-Martín, Alberto/AAO-5320-2020	Callaway, Edward/0000-0002-6366-5267; Osakada, Fumitaka/0000-0002-9078-1458; Cruz-Martin, Alberto/0000-0002-3271-7220; dhande, onkar/0000-0001-7584-9672	Vision Core [P30 EY019005]; Knights Templar Eye Foundation; Japan Society for the Promotion of Science; Kanae Foundation; Uehara Memorial Foundation; Naito Foundation; NINDS Circuits Training Grant; Gatsby Charitable Trusts; NIH [EY022577, MH063912, R01EY022157]; Whitehall Foundation; Ziegler Foundation for the Blind; Pew Charitable Trusts; McKnight Foundation; NATIONAL EYE INSTITUTE [P30EY019005, R01EY022157, R01EY022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	Vision Core; Knights Templar Eye Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NINDS Circuits Training Grant; Gatsby Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Ziegler Foundation for the Blind; Pew Charitable Trusts; McKnight Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the Kleinfeld laboratory for helpful advice, F. Rieke and M. Turner for example DSGC recording, and the Salk Viral Vector and Biophotonics staff. This work was supported by Vision Core P30 EY019005, the Knights Templar Eye Foundation (O.S.D.), Japan Society for the Promotion of Science (F.O.), Kanae Foundation (F.O.), Uehara Memorial Foundation (F.O.), Naito Foundation (F.O.), NINDS Circuits Training Grant (R.N.E.), Gatsby Charitable Trusts (E. M. C. and A. G.), NIH EY022577 and MH063912 (E. M. C.), Whitehall Foundation (A. D. H.), Ziegler Foundation for the Blind (A. D. H.), Pew Charitable Trusts (A. D. H.), The McKnight Foundation (A. D. H.), and NIH R01EY022157 (A.D.H.).	Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; Beier KT, 2013, J NEUROSCI, V33, P35, DOI 10.1523/JNEUROSCI.0245-12.2013; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chalupa L.M., 2003, VISUAL NEUROSCIENCES; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Grubb MS, 2004, VISION RES, V44, P3365, DOI 10.1016/j.visres.2004.09.003; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; Land PW, 2004, BRAIN RES, V996, P251, DOI 10.1016/j.brainres.2003.10.032; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Morin LP, 1999, VISUAL NEUROSCI, V16, P1037, DOI 10.1017/S0952523899166069; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Rivlin-Etzion M, 2012, NEURON, V76, P518, DOI 10.1016/j.neuron.2012.08.041; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454	39	204	205	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					358	+		10.1038/nature12989	http://dx.doi.org/10.1038/nature12989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24572358	Green Accepted			2022-12-24	WOS:000333029000034
J	Smemo, S; Tena, JJ; Kim, KH; Gamazon, ER; Sakabe, NJ; Gomez-Marin, C; Aneas, I; Credidio, FL; Sobreira, DR; Wasserman, NF; Lee, JH; Puviindran, V; Tam, D; Shen, M; Son, JE; Vakili, NA; Sung, HK; Naranjo, S; Acemel, RD; Manzanares, M; Nagy, A; Cox, NJ; Hui, CC; Gomez-Skarmeta, JL; Nobrega, MA				Smemo, Scott; Tena, Juan J.; Kim, Kyoung-Han; Gamazon, Eric R.; Sakabe, Noboru J.; Gomez-Marin, Carlos; Aneas, Ivy; Credidio, Flavia L.; Sobreira, Debora R.; Wasserman, Nora F.; Lee, Ju Hee; Puviindran, Vijitha; Tam, Davis; Shen, Michael; Son, Joe Eun; Vakili, Niki Alizadeh; Sung, Hoon-Ki; Naranjo, Silvia; Acemel, Rafael D.; Manzanares, Miguel; Nagy, Andras; Cox, Nancy J.; Hui, Chi-Chung; Luis Gomez-Skarmeta, Jose; Nobrega, Marcelo A.			Obesity-associated variants within FTO form long-range functional connections with IRX3	NATURE			English	Article							GENE-EXPRESSION; MASS; DATABASE; TISSUE; VERTEBRATE; CHILDHOOD; ELEMENTS; BROWSER; NEURONS; REVEAL	Genome-wide association studies (GWAS) have reproducibly associated variants within introns of FTO with increased risk for obesity and type 2 diabetes (T2D)(1-3). Although the molecular mechanisms linking these noncoding variants with obesity are not immediately obvious, subsequent studies in mice demonstrated that FTO expression levels influence body mass and composition phenotypes(4-6). However, no direct connection between the obesity-associated variants and FTO expression or function has been made(7-9). Here we show that the obesity-associated noncoding sequences within FTO are functionally connected, at megabase distances, with the homeobox gene IRX3. The obesity-associated FTO region directly interacts with the promoters of IRX3 as well as FTO in the human, mouse and zebrafish genomes. Furthermore, long-range enhancers within this region recapitulate aspects of IRX3 expression, suggesting that the obesity-associated interval belongs to the regulatory landscape of IRX3. Consistent with this, obesity-associated single nucleotide polymorphisms are associated with expression of IRX3, but not FTO, in human brains. A direct link between IRX3 expression and regulation of body mass and composition is demonstrated by a reduction in body weight of 25 to 30% in Irx3-deficient mice, primarily through the loss of fat mass and increase in basal metabolic rate with browning of white adipose tissue. Finally, hypothalamic expression of a dominant negative form of Irx3 reproduces the metabolic phenotypes of Irx3 deficient mice. Our data suggest that IRX3 is a functional long-range target of obesity-associated variants within FTO and represents a novel determinant of body mass and composition.	[Smemo, Scott; Sakabe, Noboru J.; Aneas, Ivy; Credidio, Flavia L.; Sobreira, Debora R.; Wasserman, Nora F.; Shen, Michael; Cox, Nancy J.; Nobrega, Marcelo A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Tena, Juan J.; Gomez-Marin, Carlos; Naranjo, Silvia; Acemel, Rafael D.; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo CABD, Consejo Super Invest Cient, Seville 41013, Spain; [Kim, Kyoung-Han; Lee, Ju Hee; Puviindran, Vijitha; Tam, Davis; Vakili, Niki Alizadeh; Hui, Chi-Chung] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5S 1A8, Canada; [Kim, Kyoung-Han; Lee, Ju Hee; Puviindran, Vijitha; Tam, Davis; Vakili, Niki Alizadeh; Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Med Genet Sect, Dept Med, Chicago, IL 60637 USA; [Son, Joe Eun; Sung, Hoon-Ki; Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5T 3H7, Canada; [Manzanares, Miguel] Ctr Nacl Invest Cardiovasc CNIC, Cardiovasc Dev & Repair Dept, Madrid 28029, Spain	University of Chicago; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Chicago; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Nobrega, MA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	cchui@sickkids.ca; jlgomska@upo.es; nobrega@uchicago.edu	Sung, Hoon-Ki/A-1922-2016; Kim, Kyoung-Han/AAZ-4908-2021; Gómez-Marín, Carlos/AAX-2173-2021; Naranjo, Silvia/P-9845-2016; Tena, Juan J/M-2265-2014; Manzanares, Miguel/E-1702-2015; Manzanares, Miguel/AAZ-8305-2021; Tena, Juan J./Q-5995-2019; Son, Joe/AAB-7384-2020; Acemel, Rafael Dominguez/AAM-1957-2020; Gamazon, Eric/I-6873-2018; Gomez-Skarmeta, Jose Luis/B-5268-2014; Nagy, Andras/G-6465-2013	Sung, Hoon-Ki/0000-0001-6677-9385; Naranjo, Silvia/0000-0002-4529-3332; Tena, Juan J/0000-0001-8165-7984; Manzanares, Miguel/0000-0003-4849-2836; Manzanares, Miguel/0000-0003-4849-2836; Tena, Juan J./0000-0001-8165-7984; Acemel, Rafael Dominguez/0000-0003-4120-0140; Gamazon, Eric/0000-0003-4204-8734; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Nagy, Andras/0000-0003-4311-0413; Son, Joe/0000-0003-3066-2796; Gomez-Marin, Carlos/0000-0001-9724-2919; Kim, Kyoung-Han/0000-0002-0433-656X	National Institutes of Health [DK093972, HL119967, HL114010, DK020595, MH101820, MH090937, DK20595]; Spanish Ministerio de Economia y Competitividad [BFU2010-14839, CSD2007-00008]; Andalusian Government [CVI-3488]; Canadian Institute of Health Research; Heart and Stroke Foundation of Canada; NIH [T32HL007381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381, R01HL114010, R01HL119967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, R01DK093972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101820, R01MH090937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Economia y Competitividad(Spanish Government); Andalusian Government; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank F. Gage, C. Marchetto, B. Ren and F. Jin for their generosity in sharing reagents and data. This work was funded by grants from the National Institutes of Health (DK093972, HL119967, HL114010 and DK020595) to M.A.N. and (MH101820, MH090937 and DK20595) to N.J.C. J.L.G.-S. was funded by grants from the Spanish Ministerio de Economia y Competitividad (BFU2010-14839, CSD2007-00008) and the Andalusian Government (CVI-3488). C.-C. H. was supported by a grant from the Canadian Institute of Health Research. K.-H. K. is supported by a fellowship from the Heart and Stroke Foundation of Canada. S. S. is supported by an NIH postdoctoral training grant (T32HL007381)	Bosse A, 1997, MECH DEVELOP, V69, P169, DOI 10.1016/S0925-4773(97)00165-2; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Elbein SC, 2012, AM J HUM GENET, V91, P466, DOI 10.1016/j.ajhg.2012.08.002; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li ZJ, 2012, DEVELOPMENT, V139, P4152, DOI 10.1242/dev.081190; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rozen S, 2000, Methods Mol Biol, V132, P365; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Smith RN, 2012, BIOINFORMATICS, V28, P3163, DOI 10.1093/bioinformatics/bts577; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhou X., 2012, CURR PROTOC BIOINFOR, V40, DOI DOI 10.10.1-10.10.14	50	772	791	3	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					371	+		10.1038/nature13138	http://dx.doi.org/10.1038/nature13138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646999	Green Submitted, Green Accepted			2022-12-24	WOS:000333029000037
J	Jacob, Y; Bergamin, E; Donoghue, MTA; Mongeon, V; LeBlanc, C; Voigt, P; Underwood, CJ; Brunzelle, JS; Michaels, SD; Reinberg, D; Couture, JF; Martienssen, RA				Jacob, Yannick; Bergamin, Elisa; Donoghue, Mark T. A.; Mongeon, Vanessa; LeBlanc, Chantal; Voigt, Philipp; Underwood, Charles J.; Brunzelle, Joseph S.; Michaels, Scott D.; Reinberg, Danny; Couture, Jean-Francois; Martienssen, Robert A.			Selective Methylation of Histone H3 Variant H3.1 Regulates Heterochromatin Replication	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; ARABIDOPSIS-THALIANA; DNA-REPLICATION; CAF-1 MUTANTS; CHROMATIN; MAINTENANCE; DEPOSITION; GENE; FASCIATA1	Histone variants have been proposed to act as determinants for posttranslational modifications with widespread regulatory functions. We identify a histone-modifying enzyme that selectively methylates the replication-dependent histone H3 variant H3.1. The crystal structure of the SET domain of the histone H3 lysine-27 (H3K27) methyltransferase ARABIDOPSIS TRITHORAX-RELATED PROTEIN 5 (ATXR5) in complex with a H3.1 peptide shows that ATXR5 contains a bipartite catalytic domain that specifically "reads" alanine-31 of H3.1. Variation at position 31 between H3.1 and replication-independent H3.3 is conserved in plants and animals, and threonine-31 in H3.3 is responsible for inhibiting the activity of ATXR5 and its paralog, ATXR6. Our results suggest a simple model for the mitotic inheritance of the heterochromatic mark H3K27me1 and the protection of H3.3-enriched genes against heterochromatization during DNA replication.	[Jacob, Yannick; Donoghue, Mark T. A.; LeBlanc, Chantal; Underwood, Charles J.; Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Bergamin, Elisa; Mongeon, Vanessa; Couture, Jean-Francois] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Voigt, Philipp; Reinberg, Danny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, Howard Hughes Med Inst, New York, NY 10016 USA; [Brunzelle, Joseph S.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Michaels, Scott D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Martienssen, Robert A.] Ecole Normale Super, Inst Biol, F-75005 Paris, France	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Ottawa; Howard Hughes Medical Institute; New York University; Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Couture, JF (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada.	jean-francois.couture@uottawa.ca; martiens@cshl.edu	Underwood, Charles J/AAM-9246-2020; Michaels, Scott/D-5458-2009	Underwood, Charles J/0000-0001-5730-6279; Reinberg, Danny/0000-0003-4288-2016; Bergamin, Elisa/0000-0001-5277-5156; Voigt, Philipp/0000-0003-4366-0490; Michaels, Scott/0000-0001-5248-3487	Louis-Berlinguet postdoctoral fellowship (Fonds Quebecois de la Recherche en Sante/Genome Quebec); Deutsche Akademie der Naturforscher Leopoldina [LPDS 2009-5]; Empire State Training Program in Stem Cell Research (NYSTEM) [C026880]; NIH [GM064844, R37GM037120, GM075060, GM067014]; Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada [191666]; Howard Hughes Medical Institute-Gordon; Betty Moore Foundation; NSF [DBI-1025830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, R01GM075060, R01GM067014, R37GM037120] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1025830] Funding Source: National Science Foundation	Louis-Berlinguet postdoctoral fellowship (Fonds Quebecois de la Recherche en Sante/Genome Quebec); Deutsche Akademie der Naturforscher Leopoldina; Empire State Training Program in Stem Cell Research (NYSTEM); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Institute-Gordon; Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Calarco for critically reading the manuscript and J. Goodrich, C. Kohler, S. E. Jacobsen, D. J. Patel., and T. Schalch for materials and advice. Y.J. was supported by a Louis-Berlinguet postdoctoral fellowship (Fonds Quebecois de la Recherche en Sante/Genome Quebec). P.V. is supported by fellowships from the Deutsche Akademie der Naturforscher Leopoldina (LPDS 2009-5) and the Empire State Training Program in Stem Cell Research (NYSTEM, contract no. C026880). Work in the Reinberg laboratory is supported by grants from the NIH (GM064844 and R37GM037120) and the Howard Hughes Medical Institute. S.D.M. is supported by a grant from the NIH (GM075060). J.F.C. is supported by grants from the Canadian Institute of Health Research (BMA-355900) and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant 191666) and acknowledges an Ontario Early Research Award and a Canada Research Chair in Structural Biology and Epigenetics. This work was supported by the Howard Hughes Medical Institute-Gordon and Betty Moore Foundation and by grants from the NSF (DBI-1025830) and the NIH (GM067014) to R.A.M. R.A.M. acknowledges a Chaire Blaise Pascal (Region Ile-de-France) at IBENS, Paris. The Protein Data Bank (PDB) accession number for the RcATXR5-H3.1-AdoHcy ternary structure is 4030.pdb.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Exner V, 2006, DEVELOPMENT, V133, P4163, DOI 10.1242/dev.02599; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Jacob Y, 2010, NATURE, V466, P987, DOI 10.1038/nature09290; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ono T, 2006, GENES CELLS, V11, P153, DOI 10.1111/j.1365-2443.2006.00928.x; Ramirez-Parra E, 2007, PLANT PHYSIOL, V144, P105, DOI 10.1104/pp.106.094979; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Rigal M, 2011, BBA-GENE REGUL MECH, V1809, P452, DOI 10.1016/j.bbagrm.2011.04.001; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stroud H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002808; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658	27	111	120	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1249	1253		10.1126/science.1248357	http://dx.doi.org/10.1126/science.1248357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626927	Green Accepted			2022-12-24	WOS:000332728500036
J	Cai, X; Chen, JQ; Xu, H; Liu, SQ; Jiang, QX; Halfmann, R; Chen, ZJJ				Cai, Xin; Chen, Jueqi; Xu, Hui; Liu, Siqi; Jiang, Qiu-Xing; Halfmann, Randal; Chen, Zhijian J.			Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune Defense and Inflammasome Activation	CELL			English	Article							CYCLIC GMP-AMP; RIG-I; CRYSTAL-STRUCTURE; PYRIN DOMAIN; PROTEIN; FORMS; RECEPTORS; MECHANISM; COMPLEX; NLRP3	Pathogens and cellular danger signals activate sensors such as RIG-I and NLRP3 to produce robust immune and inflammatory responses through respective adaptor proteins MAVS and ASC, which harbor essential N-terminal CARD and PYRIN domains, respectively. Here, we show that CARD and PYRIN function as bona fide prions in yeast and that their prion forms are inducible by their respective upstream activators. Likewise, a yeast prion domain can functionally replace CARD and PYRIN in mammalian cell signaling. Mutations in MAVS and ASC that disrupt their prion activities in yeast also abrogate their ability to signal in mammalian cells. Furthermore, fibers of recombinant PYRIN can convert ASC into functional polymers capable of activating caspase-1. Remarkably, a conserved fungal NOD-like receptor and prion pair can functionally reconstitute signaling of NLRP3 and ASC PYRINs in mammalian cells. These results indicate that prion-like polymerization is a conserved signal transduction mechanism in innate immunity and inflammation.	[Cai, Xin; Chen, Jueqi; Xu, Hui; Liu, Siqi; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Xu, Hui; Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Halfmann, Randal] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Halfmann, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	randal.halfmann@utsouthwestern.edu; zhijian.chen@utsouthwestern.edu	Jiang, Qiu-Xing/AAI-8579-2020; Chen, Jueqi/O-2655-2018; Chen, Zhijian/C-6039-2012; Jiang, Qiu-Xing/ABF-1143-2021	Chen, Jueqi/0000-0001-7164-8988; Chen, Zhijian/0000-0002-8475-8251; Halfmann, Randal/0000-0002-6592-1471; Cai, Xin/0000-0001-5238-6193	NIH [AI-093967, GM-63692, DP5-OD009152]; Welch Foundation [I-1389]; International Student Fellowship from Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); International Student Fellowship from Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Daniel Holmes and Sorna Kamara for technical assistance. We thank Hao Wu for FAS plasmid, Susan Lindquist for NM plasmid, and Susan Liebman for kar1 deficient yeast strain used for cytoduction. This work was supported by grants from the NIH (AI-093967 and GM-63692) and the Welch Foundation (I-1389) to Z.J.C., and the NIH Director's Early Independence Award (DP5-OD009152) to R.H. X.C. was supported by an International Student Fellowship from Howard Hughes Medical Institute (HHMI). Z.J.C. is an HHMI investigator.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Daskalov A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034854; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Saupe SJ, 2011, SEMIN CELL DEV BIOL, V22, P460, DOI 10.1016/j.semcdb.2011.02.019; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seuring C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001451; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	37	376	388	2	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1207	1222		10.1016/j.cell.2014.01.063	http://dx.doi.org/10.1016/j.cell.2014.01.063			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630723	Green Accepted, Bronze			2022-12-24	WOS:000332945100011
J	Hodgkinson, A; Idaghdour, Y; Gbeha, E; Grenier, JC; Hip-Ki, E; Bruat, V; Goulet, JP; de Malliard, T; Awadalla, P				Hodgkinson, Alan; Idaghdour, Youssef; Gbeha, Elias; Grenier, Jean-Christophe; Hip-Ki, Elodie; Bruat, Vanessa; Goulet, Jean-Philippe; de Malliard, Thibault; Awadalla, Philip			High-Resolution Genomic Analysis of Human Mitochondrial RNA Sequence Variation	SCIENCE			English	Article							DNA MUTATIONS; TRANSCRIPTOME; HETEROPLASMY; IDENTIFICATION	Mutations in the mitochondrial genome are associated with multiple diseases and biological processes; however, little is known about the extent of sequence variation in the mitochondrial transcriptome. By ultra-deeply sequencing mitochondrial RNA (>6000x) from the whole blood of similar to 1000 individuals from the CARTaGENE project, we identified remarkable levels of sequence variation within and across individuals, as well as sites that show consistent patterns of posttranscriptional modification. Using a genome-wide association study, we find that posttranscriptional modification of functionally important sites in mitochondrial transfer RNAs (tRNAs) is under strong genetic control, largely driven by a missense mutation in MRPP3 that explains similar to 22% of the variance. These results reveal a major nuclear genetic determinant of posttranscriptional modification in mitochondria and suggest that tRNA posttranscriptional modification may affect cellular energy production.	[Hodgkinson, Alan; Idaghdour, Youssef; Gbeha, Elias; Grenier, Jean-Christophe; Hip-Ki, Elodie; Bruat, Vanessa; de Malliard, Thibault; Awadalla, Philip] Univ Montreal, CHU St Justine Res Ctr, Dept Pediat, Fac Med, Montreal, PQ H3T 1C5, Canada; [Idaghdour, Youssef; Goulet, Jean-Philippe; de Malliard, Thibault; Awadalla, Philip] CARTaGENE, Montreal, PQ H3V 1A2, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Awadalla, P (corresponding author), Univ Montreal, CHU St Justine Res Ctr, Dept Pediat, Fac Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	philip.awadalla@umontreal.ca	Awadalla, Philip/AAC-4896-2021	Grenier, Jean-Christophe/0000-0001-7937-5160; Hodgkinson, Alan/0000-0003-1636-491X	Fonds de la recherche en sante du Quebec (FRSQ); Genome Quebec; Reseau de medecine genetique appliquee (RMGA); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Canadian Foundation of Innovation; Canadian Partnership Against Cancer	Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Genome Quebec; Reseau de medecine genetique appliquee (RMGA); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); Canadian Foundation of Innovation(Canada Foundation for Innovation); Canadian Partnership Against Cancer	A. H., Y.I., and P. A. designed the study. P. A. provided samples; E. G. and E.H.-K. processed samples for sequencing and genotyping; J.-C.G. and V. B. aligned sequencing data. Y.I., A. H., T.d.M., and J.-C.G. performed quality control on sequencing data, and Y.I. and J.-P.G. performed quality control on genotyping data. J.-P.G. compiled phenotype data from the CARTaGENE project. A. H. and Y.I. performed the analysis. A. H., Y.I., and P. A. wrote the manuscript. We thank E. Shoubridge, I. Thiffault, G. Gibson, J. Novembre, and E. Stone for comments on the study; C. Prive for help with study design on the Ion Torrent platform; and the CARTaGENE team for assistance with data collection. We acknowledge financial support from Fonds de la recherche en sante du Quebec (FRSQ), Genome Quebec, Reseau de medecine genetique appliquee (RMGA), Fonds quebecois de la recherche sur la nature et les technologies (FQRNT), Canadian Foundation of Innovation, and the Canadian Partnership Against Cancer. A. H. is an FRSQ Research Fellow and Y.I. is a Banting Postdoctoral Fellow. Requests for data published here should be submitted to the CARTaGENE program at access@cartagene.qc.ca, or the corresponding author, citing this study. The authors declare no conflict of interests.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Awadalla P, 2013, INT J EPIDEMIOL, V42, P1285, DOI 10.1093/ije/dys160; Bar-Yaacov D, 2013, GENOME RES, V23, P1789, DOI 10.1101/gr.161265.113; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Findeiss S, 2011, BIOL CHEM, V392, P305, DOI 10.1515/BC.2011.043; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	24	67	67	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					413	415		10.1126/science.1251110	http://dx.doi.org/10.1126/science.1251110			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763589				2022-12-24	WOS:000334867800041
J	He, B; Doubrovinski, K; Polyakov, O; Wieschaus, E				He, Bing; Doubrovinski, Konstantin; Polyakov, Oleg; Wieschaus, Eric			Apical constriction drives tissue-scale hydrodynamic flow to mediate cell elongation	NATURE			English	Article							PARTICLE-TRACKING MICRORHEOLOGY; DROSOPHILA GASTRULATION; ADHERENS JUNCTIONS; MORPHOGENESIS; EMBRYO; INVAGINATION; MECHANICS; TRANSPORT; MEMBRANE; CLEAVAGE	Epithelial folding mediated by apical constriction converts flat epithelial sheets into multilayered, complex tissue structures and is used throughout development inmost animals(1). Little is known, however, about how forces produced near the apical surface of the tissue are transmitted within individual cells to generate the global changes in cell shape that characterize tissue deformation. Here we apply particle tracking velocimetry in gastrulating Drosophila embryos to measure the movement of cytoplasm and plasma membrane during ventral furrow formation(2,3). We find that cytoplasmic redistribution during the lengthening phase of ventral furrow formation can be precisely described by viscous flows that quantitatively match the predictions of hydrodynamics. Cell membranes move with the ambient cytoplasm, with little resistance to, or driving force on, the flow. Strikingly, apical constriction produces similar flow patterns in mutant embryos that fail to form cells before gastrulation ('acellular' embryos), such that the global redistribution of cytoplasm mirrors the summed redistribution occurring in individual cells of wild-type embryos. Our results indicate that during the lengthening phase of ventral furrow formation, hydrodynamic behaviour of the cytoplasm provides the predominant mechanism transmitting apically generated forces deep into the tissue and that cell individualization is dispensable. [GRAPHICS] .	[He, Bing; Doubrovinski, Konstantin; Wieschaus, Eric] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Polyakov, Oleg] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Wieschaus, Eric] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Wieschaus, E (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	efw@princeton.edu			National Institutes of Health (National Institute of Child Health and Human Development) [5R37HD15587]; Howard Hughes Medical Institute; New Jersey Commission on Cancer Research Fellowship; National Institutes of Health [P50 GM 071508]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New Jersey Commission on Cancer Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Thiberge (Imaging core facility) for two-photon microscopy. We thank N. Wingreen, C. Brangwynne, C. Brody, H. Stone, S. Little, S. Di Talia, Y.-C. Wang and Y. Yan for their suggestions on the manuscript. We thank all members of the Wieschaus and Schupbach laboratories for discussions. This work was supported by the National Institutes of Health (National Institute of Child Health and Human Development grant 5R37HD15587) to E.F.W. and by the Howard Hughes Medical Institute. B.H. was supported by the New Jersey Commission on Cancer Research Fellowship. The Imaging core facility was supported by National Institutes of Health Grant P50 GM 071508.	Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brodland G. Wayne, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P121, DOI 10.1080/10255840601124704; BRODLAND GW, 1994, J BIOMECH ENG-T ASME, V116, P146, DOI 10.1115/1.2895713; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Goldstein RE, 2008, P NATL ACAD SCI USA, V105, P3663, DOI 10.1073/pnas.0707223105; Happel J., 1965, LOW REYNOLDS NUMBER; HARDIN J, 1988, DEVELOPMENT, V103, P211; KAPLAN DR, 1991, BIOSCIENCE, V41, P693, DOI 10.2307/1311764; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Niwayama R, 2011, P NATL ACAD SCI USA, V108, P11900, DOI 10.1073/pnas.1101853108; Oda H, 2001, J CELL SCI, V114, P493; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; PEIFER M, 1994, DEVELOPMENT, V120, P369; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; Pozrikidis C, 2001, J COMPUT PHYS, V169, P250, DOI 10.1006/jcph.2000.6582; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sadler TW, 2005, AM J MED GENET C, V135C, P2, DOI 10.1002/ajmg.c.30049; Savin T, 2005, BIOPHYS J, V88, P623, DOI 10.1529/biophysj.104.04245; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SWEETON D, 1991, DEVELOPMENT, V112, P775; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724	37	137	137	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					392	+		10.1038/nature13070	http://dx.doi.org/10.1038/nature13070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24590071	Green Accepted			2022-12-24	WOS:000334403000051
J	Warren, TK; Wells, J; Panchal, RG; Stuthman, KS; Garza, NL; Van Tongeren, SA; Dong, L; Retterer, CJ; Eaton, BP; Pegoraro, G; Honnold, S; Bantia, S; Kotian, P; Chen, XL; Taubenheim, BR; Welch, LS; Minning, DM; Babu, YS; Sheridan, WP; Bavari, S				Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina			Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430	NATURE			English	Article							SMALL-MOLECULE INHIBITOR; EBOLA-VIRUS INFECTION; NONHUMAN-PRIMATES; HEMORRHAGIC-FEVER; MARBURG-VIRUS; POSTEXPOSURE PROTECTION; ANTIVIRAL ACTIVITY; MOUSE MODEL; REPLICATION; CHALLENGE	Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever. Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90% (ref. 1). Licensed therapeutic or vaccine products are not available to treat filovirus diseases. Candidate therapeutics previously shown to be efficacious in non-human primate disease models are based on virus-specific designs and have limited broad-spectrum antiviral potential. Here we show that BCX4430, a novel synthetic adenosine analogue, inhibits infection of distinct filoviruses in human cells. Biochemical, reporter-based and primer-extension assays indicate that BCX4430 inhibits viral RNA polymerase function, acting as a non-obligate RNA chain terminator. Post-exposure intramuscular administration of BCX4430 protects against Ebola virus and Marburg virus disease in rodent models. Most importantly, BCX4430 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48 hours after infection. In addition, BCX4430 exhibits broad-spectrum antiviral activity against numerous viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses. This is the first report, to our knowledge, of non-human primate protection from filovirus disease by a synthetic drug-like small molecule. We provide additional pharmacological characterizations supporting the potential development of BCX4430 as a countermeasure against human filovirus diseases and other viral diseases representing major public health threats.	[Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Welch, Lisa S.; Bavari, Sina] US Army Med Res Inst Infect Dis USAMRIID, Therapeut Discovery Ctr, Div Mol & Translat Sci, Ft Detrick, MD 21702 USA; [Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Babu, Yarlagadda S.; Sheridan, William P.] BioCryst Pharmaceut Inc, Durham, NC 27703 USA; [Minning, Dena M.] MedExpert Consulting Inc, Indialantic, FL 32903 USA		Bavari, S (corresponding author), US Army Med Res Inst Infect Dis USAMRIID, Therapeut Discovery Ctr, Div Mol & Translat Sci, Ft Detrick, MD 21702 USA.	sina.bavari.civ@mail.mil	Eaton, Brett/G-1796-2019; Bavari, Sina/L-3642-2019; Panchal, Rekha/None; Pegoraro, Gianluca/K-4233-2016	Eaton, Brett/0000-0002-3060-2913; Bavari, Sina/0000-0001-8424-5635; Panchal, Rekha/0000-0001-8621-9078; Sheridan, William/0000-0001-8320-1323; Pegoraro, Gianluca/0000-0003-2843-9464	Science and Technology Office for Chemical and Biological Defense of the Defense Threat Reduction Agency [TMTI0048_09_RD_T, CB3675]; National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272201100019I]; BioQual Inc. under NIAID [HHSN27220110005I]; University of Alabama Birmingham under NIAID [HHSN272201100016I]	Science and Technology Office for Chemical and Biological Defense of the Defense Threat Reduction Agency; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BioQual Inc. under NIAID; University of Alabama Birmingham under NIAID	J. Kuhn and J. Huggins provided insightful discussions and critically reviewed the manuscript. R. Kincaid and G. Feuerstein provided advice and guidance for BCX4430 development efforts. These studies were in part supported by The Joint Science and Technology Office for Chemical and Biological Defense of the Defense Threat Reduction Agency (proposal #TMTI0048_09_RD_T and CB3675) to S. Bavari. S. Radoshitzky assisted with the EBOV minigenome replicon assay. J. Reifman was essential to algorithm development of HCI image assessments. C. Basler provided the BHK-21-derived cell line constitutively expressing the T7 RNA polymerase. Plasmids encoding viral products and the EBOV minigenome replicon were provided by P. Kranzusch and S. Whelan. Neutral-red uptake antiviral assays were conducted by: D. L. Barnard, G. W. Day, B. Gowan, J. G. Julander, B. Tarbet, D. F. Smee and J. D. Morrey of Utah State University under National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN272201100019I, BioQual Inc. under NIAID contract HHSN27220110005I, and at the University of Alabama Birmingham under NIAID contract HHSN272201100016I. Cell-based metabolism studies were conducted by C. Parker, X. Cheng, R. Upshaw and Y. Luo. A. Nalca, E. E. Zumbrun, H. Bloomfield, D. Dyer and J. Yeager assisted with virus aerosolization. C. Cooper provided assistance with the culture of human macrophage cell culture and R. Zamani provided assistance with high-content image assessments. S. Tritsch assisted with Nipah virus antiviral assays. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army.	Alves DA, 2010, VET PATHOL, V47, P831, DOI 10.1177/0300985810378597; Aman MJ, 2009, ANTIVIR RES, V83, P245, DOI 10.1016/j.antiviral.2009.06.001; Barnard DL, 2001, ANTIVIR CHEM CHEMOTH, V12, P241, DOI 10.1177/095632020101200405; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bray M, 2002, ANTIVIR RES, V55, P151, DOI 10.1016/S0166-3542(02)00018-9; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; HUGGINS JW, 1989, REV INFECT DIS, V11, pS750; Kinch MS, 2009, AM J TRANSL RES, V1, P87; Kobinger GP, 2011, J INFECT DIS, V204, P200, DOI 10.1093/infdis/jir077; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Kuhn JH, 2008, FILOVIRUSES COMPENDI; Lou H, 2003, VIROLOGY, V317, P65, DOI 10.1016/j.virol.2003.08.038; Muhlberger E, 1999, J VIROL, V73, P2333; Panchal RG, 2012, ANTIVIR RES, V93, P23, DOI 10.1016/j.antiviral.2011.10.011; Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357; SMITH DH, 1982, LANCET, V1, P816; Smither S. J., 2014, ANTIVIRAL RES; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2009, J VIROL, V83, P6404, DOI 10.1128/JVI.00126-09; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202; Warren TK, 2010, ANTIMICROB AGENTS CH, V54, P2152, DOI 10.1128/AAC.01315-09	29	387	430	5	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					402	+		10.1038/nature13027	http://dx.doi.org/10.1038/nature13027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24590073	Green Published, Bronze			2022-12-24	WOS:000334403000053
J	Martin, I; Kim, JW; Lee, BD; Kang, HC; Xu, JC; Jia, H; Stankowski, J; Kim, MS; Zhong, J; Kumar, M; Andrabi, SA; Xiong, YL; Dickson, DW; Wszolek, ZK; Pandey, A; Dawson, TM; Dawson, VL				Martin, Ian; Kim, Jungwoo Wren; Lee, Byoung Dae; Kang, Ho Chul; Xu, Jin-Chong; Jia, Hao; Stankowski, Jeannette; Kim, Min-Sik; Zhong, Jun; Kumar, Manoj; Andrabi, Shaida A.; Xiong, Yulan; Dickson, Dennis W.; Wszolek, Zbigniew K.; Pandey, Akhilesh; Dawson, Ted M.; Dawson, Valina L.			Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson's Disease	CELL			English	Article							REPEAT KINASE 2; TRANSLATIONAL REPRESSION; NEURONAL TOXICITY; GTP-BINDING; MUTATIONS; TDP-43; 4E-BP; AUTOPHOSPHORYLATION; DROSOPHILA; MODEL	Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial and sporadic Parkinson's disease (PD). Elevated LRRK2 kinase activity and neurodegeneration are linked, but the phosphosubstrate that connects LRRK2 kinase activity to neurodegeneration is not known. Here, we show that ribosomal protein s15 is a key pathogenic LRRK2 substrate in Drosophila and human neuron PD models. Phosphodeficient s15 carrying a threonine 136 to alanine substitution rescues dopamine neuron degeneration and age-related locomotor deficits in G2019S LRRK2 transgenic Drosophila and substantially reduces G2019S LRRK2-mediated neurite loss and cell death in human dopamine and cortical neurons. Remarkably, pathogenic LRRK2 stimulates both cap-dependent and cap-independent mRNA translation and induces a bulk increase in protein synthesis in Drosophila, which can be prevented by phosphodeficient T136A s15. These results reveal a novel mechanism of PD pathogenesis linked to elevated LRRK2 kinase activity and aberrant protein synthesis in vivo.	[Martin, Ian; Kim, Jungwoo Wren; Lee, Byoung Dae; Kang, Ho Chul; Xu, Jin-Chong; Jia, Hao; Stankowski, Jeannette; Kumar, Manoj; Andrabi, Shaida A.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21205 USA; [Martin, Ian; Lee, Byoung Dae; Kang, Ho Chul; Xu, Jin-Chong; Stankowski, Jeannette; Kumar, Manoj; Andrabi, Shaida A.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kim, Jungwoo Wren; Jia, Hao; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kim, Min-Sik; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Kim, Min-Sik; Zhong, Jun; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Lee, Byoung Dae] Kyung Hee Univ, Dept Neurosci, Age Related & Brain Dis Res Ctr, Seoul 130701, South Korea; [Kang, Ho Chul] Ajou Univ, Sch Med, Dept Physiol, Suwon 443749, South Korea; [Martin, Ian; Kim, Jungwoo Wren; Jia, Hao; Stankowski, Jeannette; Andrabi, Shaida A.; Pandey, Akhilesh; Dawson, Ted M.; Dawson, Valina L.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Pandey, Akhilesh] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA; [Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kyung Hee University; Ajou University; Mayo Clinic; Mayo Clinic	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21205 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Kim, Min-Sik/M-3488-2016; Kim, Min-Sik/N-5010-2018; Wszolek, Zbigniew K./AAB-1431-2019; Zhong, Jun/D-1662-2010; Dawson, Valina/Y-9757-2019	Kim, Min-Sik/0000-0001-7317-5360; Kim, Min-Sik/0000-0001-7317-5360; Zhong, Jun/0000-0003-3148-4143; Dawson, Valina/0000-0002-2915-3970; Dickson, Dennis W/0000-0001-7189-7917; Kim, J. Wren/0000-0002-0957-7821	Merck KGAA; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [P50NS038377]; JPB Foundation; MDSCRF [2007-MSCRFI-0420-00, 2009-MSCRFII-0125-00, 2013-MSCRFII-0105-00]; NIH/NINDS [P50 NS072187]; New York Stem Cell Foundation-Druckenmiller Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, P50NS038377] Funding Source: NIH RePORTER	Merck KGAA(Merck & Company); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); JPB Foundation; MDSCRF; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); New York Stem Cell Foundation-Druckenmiller Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation and their direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and The Johns Hopkins University School of Medicine and the Foundations' Parkinson's Disease Programs. The authors acknowledge the Johns Hopkins Stem Cell Core Facility for providing a subset of the human neurons used in this study. Funding for a portion of the research described in this article was provided by Merck KGAA. Under a licensing agreement between Merck KGAA and The Johns Hopkins University, Dr. Dawson and the University shared fees received by the University on licensing of some of the reagents described in this article. Dr. Dawson also was a paid consultant to Merck KGAA. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict of interest policies. Mayo Clinic and Dr. Wszolek have a financial interest in a technology (LRRK2 gene) referenced in this manuscript. This technology has been licensed to a commercial entity and Mayo Clinic and Dr. Wszolek receive royalties from that license. Dr. Wszolek's annual royalties are less than $200 per year. This work was also supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) P50NS038377, the JPB Foundation, and the MDSCRF 2007-MSCRFI-0420-00, 2009-MSCRFII-0125-00, MDSCRF 2013-MSCRFII-0105-00 to T.M.D. and V.L.D., NIH/NINDS P50 NS072187 to D.D. and Z.K.W., and a New York Stem Cell Foundation-Druckenmiller Fellowship to I.M. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; [Anonymous], 2011, REPROD HEALTH MATTER, V19, P4, DOI DOI 10.3389/C0NF.FNINF.V0L.58; Belin S., 2010, CURR PROTOC CELL BIO; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Khairulina J, 2010, BIOCHIMIE, V92, P820, DOI 10.1016/j.biochi.2010.02.031; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Li XJ, 2010, J BIOL CHEM, V285, P29569, DOI 10.1074/jbc.M110.127639; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nuytemans K, 2013, NEUROLOGY, V80, P982, DOI 10.1212/WNL.0b013e31828727d4; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Trancikova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047784; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	38	169	170	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					472	485		10.1016/j.cell.2014.01.064	http://dx.doi.org/10.1016/j.cell.2014.01.064			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725412	Green Accepted, Bronze			2022-12-24	WOS:000334304500019
J	Sinha, A; Hughes, KR; Modrzynska, KK; Otto, TD; Pfander, C; Dickens, NJ; Religa, AA; Bushell, E; Graham, AL; Cameron, R; Kafsack, BFC; Williams, AE; Llinas, M; Berriman, M; Billker, O; Waters, AP				Sinha, Abhinav; Hughes, Katie R.; Modrzynska, Katarzyna K.; Otto, Thomas D.; Pfander, Claudia; Dickens, Nicholas J.; Religa, Agnieszka A.; Bushell, Ellen; Graham, Anne L.; Cameron, Rachael; Kafsack, Bjorn F. C.; Williams, April E.; Llinas, Manuel; Berriman, Matthew; Billker, Oliver; Waters, Andrew P.			A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium	NATURE			English	Article							MALARIA PARASITE; TRANSCRIPTION-FACTOR; BERGHEI; MICROARRAYS; GENERATION; FALCIPARUM; SELECTION; SEQUENCE; TOOLKIT; GENES	Commitment to and completion of sexual development are essential for malaria parasites (protists of the genus Plasmodium) to be transmitted through mosquitoes(1). The molecular mechanism(s) responsible for commitment have been hitherto unknown. Here we show that PbAP2-G, a conserved member of the apicomplexan AP2 (ApiAP2) family of DNA-binding proteins, is essential for the commitment of asexually replicating forms to sexual development in Plasmodium berghei, a malaria parasite of rodents. PbAP2-G was identified from mutations in its encoding gene, PBANKA_143750, which account for the loss of sexual development frequently observed in parasites transmitted artificially by blood passage. Systematic gene deletion of conserved ApiAP2 genes in Plasmodium confirmed the role of PbAP2-G and revealed a second ApiAP2 member (PBANKA_103430, here termed PbAP2-G2) that significantly modulates but does not abolish gametocytogenesis, indicating that a cascade of ApiAP2 proteins are involved in commitment to the production and maturation of gametocytes. The data suggest a mechanism of commitment to gametocytogenesis in Plasmodium consistent with a positive feedback loop involving PbAP2-G that could be exploited to prevent the transmission of this pernicious parasite.	[Sinha, Abhinav; Hughes, Katie R.; Dickens, Nicholas J.; Religa, Agnieszka A.; Graham, Anne L.; Cameron, Rachael; Waters, Andrew P.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Modrzynska, Katarzyna K.; Otto, Thomas D.; Pfander, Claudia; Bushell, Ellen; Berriman, Matthew; Billker, Oliver] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Kafsack, Bjorn F. C.; Williams, April E.; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Williams, April E.; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of Glasgow; Wellcome Trust Sanger Institute; Princeton University; Princeton University	Billker, O (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	OB4@sanger.ac.uk; Andy.Waters@glasgow.ac.uk	Bushell, Ellen/AAA-9295-2019; Berriman, Matthew/A-7618-2011; Otto, Thomas/ABE-7632-2020; Dickens, Nicholas/G-1445-2013; Cameron, Rachael/E-9331-2013	Berriman, Matthew/0000-0002-9581-0377; Kafsack, Bjorn F.C./0000-0003-0089-1096; Pfander, Claudia/0000-0002-9574-9553; Otto, Thomas/0000-0002-1246-7404; Dickens, Nicholas/0000-0003-0492-5855; Cameron, Rachael/0000-0002-7793-857X; Billker, Oliver/0000-0003-1716-168X; Hughes, Katie/0000-0002-3597-1056; Williams, April/0000-0001-9281-8528	Wellcome Trust [083811/Z/07/Z, 085349, 098051]; Evimalar [242095]; Medical Research Council [G0501670]; National Institutes of Health [R01 AI076276]; Centre for Quantitative Biology [P50GM071508]; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; MRC [G0501670] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, P50GM071508] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Evimalar; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Quantitative Biology; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. McBride for technical assistance with mosquito transmissions; A. R. Gomes, J. Tripathi, D. Vaughan and the III flow cytometry facility for assistance; C. Cairney and N. Keith at the Beatson Institute for use of their Agilent microarray scanner; and A. Cortes and D. Baker for reading of the manuscript. A. P. W. is funded by the Wellcome Trust (ref.083811/Z/07/Z). The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). A. S. was a student of the University of Glasgow Wellcome Trust 4-year PhD Programme Molecular Functions in Disease. A. P. W., O.B. and M. B. are members of Evimalar (ref. 242095), which funds the work of T.D.O. Work at the Sanger Institute was funded by grants from the Wellcome Trust (098051) and the Medical Research Council (G0501670). M. L. is funded by the National Institutes of Health (R01 AI076276) and the Centre for Quantitative Biology (P50GM071508). B. F. C. K. was supported by a Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation.	Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Burrill DR, 2011, GENE DEV, V25, P434, DOI 10.1101/gad.1994911; Cameron A, 2013, EVOL APPL, V6, P365, DOI 10.1111/eva.12005; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; DEARSLY AL, 1990, PARASITOLOGY, V100, P359, DOI 10.1017/S0031182000078628; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Ikadai H, 2013, P NATL ACAD SCI USA, V110, pE1676, DOI 10.1073/pnas.1217712110; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1991, ACT LEIDENS, V60, P43; JANSE CJ, 1992, EXP PARASITOL, V74, P1, DOI 10.1016/0014-4894(92)90133-U; Kafsack BFC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-187; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orr RY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-103; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Pfander Claudia, 2013, Methods Mol Biol, V923, P127; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Ponzi M, 2009, CELL MICROBIOL, V11, P1272, DOI 10.1111/j.1462-5822.2009.01331.x; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; R Development Core Team, 2012, R LANG ENV STAT COMP; Shiels BR, 1999, PARASITOL TODAY, V15, P241, DOI 10.1016/S0169-4758(99)01451-9; Sinden R., 1997, MOL BIOL INSECT DIS; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	44	247	249	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					253	+		10.1038/nature12970	http://dx.doi.org/10.1038/nature12970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24572359	Green Accepted			2022-12-24	WOS:000332651800043
J	Wang, ZV; Deng, YF; Gao, NG; Pedrozo, Z; Li, DL; Morales, CR; Criollo, A; Luo, X; Tan, W; Jiang, N; Lehrman, MA; Rothermel, BA; Lee, AH; Lavandero, S; Mammen, PPA; Ferdous, A; Gillette, TG; Scherer, PE; Hill, JA				Wang, Zhao V.; Deng, Yingfeng; Gao, Ningguo; Pedrozo, Zully; Li, Dan L.; Morales, Cyndi R.; Criollo, Alfredo; Luo, Xiang; Tan, Wei; Jiang, Nan; Lehrman, Mark A.; Rothermel, Beverly A.; Lee, Ann-Hwee; Lavandero, Sergio; Mammen, Pradeep P. A.; Ferdous, Anwarul; Gillette, Thomas G.; Scherer, Philipp E.; Hill, Joseph A.			Spliced X-Box Binding Protein 1 Couples the Unfolded Protein Response to Hexosamine Biosynthetic Pathway	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA-REPERFUSION INJURY; BETA-N-ACETYLGLUCOSAMINE; LINKS ER STRESS; O-GLCNAC; ISCHEMIA/REPERFUSION INJURY; XBP1; PROTECTION; SURVIVAL; HEART	The hexosamine biosynthetic pathway (HBP) generates uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) for glycan synthesis and O-linked GlcNAc (O-GlcNAc) protein modifications. Despite the established role of the HBP in metabolism and multiple diseases, regulation of the HBP remains largely undefined. Here, we show that spliced X-box binding protein 1 (Xbp1s), the most conserved signal transducer of the unfolded protein response (UPR), is a direct transcriptional activator of the HBP. We demonstrate that the UPR triggers HBP activation via Xbp1s-dependent transcription of genes coding for key, rate-limiting enzymes. We further establish that this previously unrecognized UPR-HBP axis is triggered in a variety of stress conditions. Finally, we demonstrate a physiologic role for the UPR-HBP axis by showing that acute stimulation of Xbp1s in heart by ischemia/reperfusion confers robust cardioprotection in part through induction of the HBP. Collectively, these studies reveal that Xbp1s couples the UPR to the HBP to protect cells under stress.	[Wang, Zhao V.; Pedrozo, Zully; Li, Dan L.; Morales, Cyndi R.; Criollo, Alfredo; Luo, Xiang; Tan, Wei; Jiang, Nan; Rothermel, Beverly A.; Lavandero, Sergio; Mammen, Pradeep P. A.; Ferdous, Anwarul; Gillette, Thomas G.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Deng, Yingfeng; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Rothermel, Beverly A.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Pedrozo, Zully; Criollo, Alfredo; Lavandero, Sergio] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Pedrozo, Zully; Criollo, Alfredo; Lavandero, Sergio] Univ Chile, Fac Ciencias Quim & Farmaceut, Ctr Estud Mol Celula, Santiago, Chile; [Pedrozo, Zully; Criollo, Alfredo; Lavandero, Sergio] Univ Chile, Fac Med, Santiago 7, Chile; [Pedrozo, Zully; Lavandero, Sergio] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Santiago 7, Chile; [Criollo, Alfredo] Univ Chile, Fac Odontol, Dental Sci Res Inst, Santiago, Chile; [Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Cornell University	Hill, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA.	joseph.hill@utsouthwestern.edu	Pedrozo, Zully/I-1069-2013; Pedrozo, Zully/AAN-5350-2021; Lavandero, Sergio/B-6001-2013; Deng, Yingfeng/AAB-8962-2019; Scherer, Philipp E/K-7819-2012	Lavandero, Sergio/0000-0003-4258-1483; Deng, Yingfeng/0000-0003-1314-5105; Scherer, Philipp E/0000-0003-0680-3392; Wang, Zhao/0000-0002-9904-9538; Criollo, Alfredo/0000-0002-2737-7751	National Institutes of Health (NIH) [HL-080144, HL-0980842, HL-100401, DK-55758, DK-088761, DK-099110, GM-038545, HL-102478-02, HL-072016, HL-097768]; Cancer Prevention Research Institute of Texas (CPRIT) [RP110486P3]; American Heart Association (AHA) DeHaan Foundation [0970518N]; Fondation Leducq [11CVD04]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile [FONDAP 15130011, Redes 120003]; AHA [10POST4320009]; American Diabetes Association (ADA) [7-08-MN-53]; Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT [3110039]; PEW Latin American Fellows Program in Biomedical Science; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023729] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120732, R01HL080144, R01HL097768, R01HL102478, U01HL100401, R01HL072016, P30HL101254, T32HL007360, R01HL090842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088761, R01DK099110, R01DK055758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM038545, R01GM038545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); American Heart Association (AHA) DeHaan Foundation(American Heart Association); Fondation Leducq(Leducq Foundation); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; AHA(American Heart Association); American Diabetes Association (ADA)(American Diabetes Association); Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PEW Latin American Fellows Program in Biomedical Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Herman May and Yongli Kong for technical assistance. We thank Dr. Gary Wright (Department of Pharmacology, Quillen College of Medicine, East Tennessee State University) for kindly providing equipment for the Langendorff experiments. This work was supported by grants from the National Institutes of Health (NIH) (HL-080144, HL-0980842, and HL-100401 to J.A.H.; DK-55758, DK-088761, and DK-099110 to P. E. S.; GM-038545 to M. A. L.; HL-102478-02 to P. P. A. M.; and HL-072016 and HL-097768 to B. A. R.), the Cancer Prevention Research Institute of Texas (CPRIT) (RP110486P3), the American Heart Association (AHA) DeHaan Foundation (0970518N), and the Fondation Leducq (11CVD04), and the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (FONDAP 15130011 to S. L., Z.P., and A.C.; Redes 120003 to S. L. and J.A.H.). Z. V. W. was supported by a postdoctoral fellowship from the AHA (10POST4320009). Y.D. was supported by a postdoctoral fellowship from the American Diabetes Association (ADA) (7-08-MN-53). Z. P. was supported by a postdoctoral fellowship from the Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT (3110039). A. C. was supported by The PEW Latin American Fellows Program in Biomedical Science.	Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Darley-Usmar VM, 2012, J MOL CELL CARDIOL, V52, P538, DOI 10.1016/j.yjmcc.2011.08.009; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hess DA, 2011, GASTROENTEROLOGY, V141, P1463, DOI 10.1053/j.gastro.2011.06.045; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Lazarus BD, 2009, INT J BIOCHEM CELL B, V41, P2134, DOI 10.1016/j.biocel.2009.03.008; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Palorini R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.257; Petrovski G, 2011, ANTIOXID REDOX SIGN, V14, P2191, DOI 10.1089/ars.2010.3486; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Severino A, 2007, J AM COLL CARDIOL, V50, P1029, DOI 10.1016/j.jacc.2007.06.006; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zou LY, 2012, J BIOL CHEM, V287, P34419, DOI 10.1074/jbc.M112.393207	46	253	257	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1179	1192		10.1016/j.cell.2014.01.014	http://dx.doi.org/10.1016/j.cell.2014.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630721	Bronze, Green Accepted			2022-12-24	WOS:000332945100009
J	Ehn, M; Thornton, JA; Kleist, E; Sipila, M; Junninen, H; Pullinen, I; Springer, M; Rubach, F; Tillmann, R; Lee, B; Lopez-Hilfiker, F; Andres, S; Acir, IH; Rissanen, M; Jokinen, T; Schobesberger, S; Kangasluoma, J; Kontkanen, J; Nieminen, T; Kurten, T; Nielsen, LB; Jorgensen, S; Kjaergaard, HG; Canagaratna, M; Dal Maso, M; Berndt, T; Petaja, T; Wahner, A; Kerminen, VM; Kulmala, M; Worsnop, DR; Wildt, J; Mentel, TF				Ehn, Mikael; Thornton, Joel A.; Kleist, Einhard; Sipila, Mikko; Junninen, Heikki; Pullinen, Iida; Springer, Monika; Rubach, Florian; Tillmann, Ralf; Lee, Ben; Lopez-Hilfiker, Felipe; Andres, Stefanie; Acir, Ismail-Hakki; Rissanen, Matti; Jokinen, Tuija; Schobesberger, Siegfried; Kangasluoma, Juha; Kontkanen, Jenni; Nieminen, Tuomo; Kurten, Theo; Nielsen, Lasse B.; Jorgensen, Solvejg; Kjaergaard, Henrik G.; Canagaratna, Manjula; Dal Maso, Miikka; Berndt, Torsten; Petaja, Tuukka; Wahner, Andreas; Kerminen, Veli-Matti; Kulmala, Markku; Worsnop, Douglas R.; Wildt, Juergen; Mentel, Thomas F.			A large source of low-volatility secondary organic aerosol	NATURE			English	Article							MASTER CHEMICAL MECHANISM; MASS-SPECTROMETER; SULFURIC-ACID; HIGH-RESOLUTION; ALPHA-PINENE; ATMOSPHERIC CHEMISTRY; PHASE; GAS; SIZE; OXIDATION	Forests emit large quantities of volatile organic compounds (VOCs) to the atmosphere. Their condensable oxidation products can form secondary organic aerosol, a significant and ubiquitous component of atmospheric aerosol(1,2), which is known to affect the Earth's radiation balance by scattering solar radiation and by acting as cloud condensation nuclei(3). The quantitative assessment of such climate effects remains hampered by a number of factors, including an incomplete understanding of how biogenic VOCs contribute to the formation of atmospheric secondary organic aerosol. The growth of newly formed particles from sizes of less than three nanometres up to the sizes of cloud condensation nuclei (about one hundred nanometres) in many continental ecosystems requires abundant, essentially nonvolatile organic vapours(4-6), but the sources and compositions of such vapours remain unknown. Here we investigate the oxidation of VOCs, in particular the terpene alpha-pinene, under atmospherically relevant conditions in chamber experiments. We find that a direct pathway leads from several biogenic VOCs, such as monoterpenes, to the formation of large amounts of extremely low-volatility vapours. These vapours format significant mass yield in the gas phase and condense irreversibly onto aerosol surfaces to produce secondary organic aerosol, helping to explain the discrepancy between the observed atmospheric burden of secondary organic aerosol and that reported by many model studies(2). We further demonstrate how these low-volatility vapours can enhance, or even dominate, the formation and growth of aerosol particles over forested regions, providing a missing link between biogenic VOCs and their conversion to aerosol particles. Our findings could help to improve assessments of biosphere-aerosol-climate feedback mechanisms(6-8), and the air quality and climate effects of biogenic emissions generally.	[Ehn, Mikael; Pullinen, Iida; Springer, Monika; Rubach, Florian; Tillmann, Ralf; Andres, Stefanie; Acir, Ismail-Hakki; Wahner, Andreas; Mentel, Thomas F.] Forschungszentrum Julich, Inst Energy & Climate Res IEK 8, D-52425 Julich, Germany; [Ehn, Mikael; Thornton, Joel A.; Sipila, Mikko; Junninen, Heikki; Rissanen, Matti; Jokinen, Tuija; Schobesberger, Siegfried; Kangasluoma, Juha; Kontkanen, Jenni; Nieminen, Tuomo; Petaja, Tuukka; Kerminen, Veli-Matti; Kulmala, Markku; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Thornton, Joel A.; Lee, Ben; Lopez-Hilfiker, Felipe] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Kleist, Einhard; Wildt, Juergen] Forschungszentrum Julich, Inst Bio & Geosci IBG 2, D-52425 Julich, Germany; [Jokinen, Tuija; Berndt, Torsten] Inst Tropospher Res TROPOS, D-04318 Leipzig, Germany; [Nieminen, Tuomo] Univ Helsinki, Helsinki Inst Phys, FIN-00014 Helsinki, Finland; [Kurten, Theo] Univ Helsinki, Dept Chem, FIN-00014 Helsinki, Finland; [Nielsen, Lasse B.; Jorgensen, Solvejg; Kjaergaard, Henrik G.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen O, Denmark; [Canagaratna, Manjula; Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Dal Maso, Miikka] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	Helmholtz Association; Research Center Julich; University of Helsinki; University of Washington; University of Washington Seattle; Helmholtz Association; Research Center Julich; Leibniz Institut fur Tropospharenforschung (TROPOS); Helsinki Institute of Physics; University of Helsinki; University of Helsinki; University of Copenhagen; Aerodyne Research; Tampere University	Ehn, M (corresponding author), Forschungszentrum Julich, Inst Energy & Climate Res IEK 8, D-52425 Julich, Germany.	mikael.ehn@helsinki.fi	kangasluoma, juha/W-7450-2019; Dal Maso, Miikka/A-7980-2008; Kerminen, Veli-Matti/M-9026-2014; Acir, Ismail/AAQ-1770-2020; Mentel, Thomas F/A-3576-2011; Jokinen, Tuija/B-3365-2014; Schobesberger, Siegfried/L-4454-2014; Nieminen, Tuomo J/D-1618-2011; Kangasluoma, Juha/AAY-7941-2021; Kontkanen, Jenni/AAL-1368-2020; Kjaergaard, Henrik G/H-4333-2014; Lee, Ben H/G-7007-2014; Ehn, Mikael/N-2571-2016; Jorgensen, Solvejg/A-1246-2011; Nieminen, Tuomo/AAB-8686-2020; Worsnop, Douglas R/D-2817-2009; Wahner, Andreas/J-4129-2012; Kurtén, Theo C/G-2120-2012; Kulmala, Markku T/I-7671-2016; Thornton, Joel A/C-1142-2009; Petäjä, Tuukka/A-8009-2008; Tillmann, Ralf/I-9203-2012; Sipilä, Mikko/G-3024-2010; Tillmann, Ralf/AAM-5619-2021; Junninen, Heikki/C-2157-2014	Dal Maso, Miikka/0000-0003-3040-3612; Acir, Ismail/0000-0001-7250-1427; Mentel, Thomas F/0000-0003-0810-3541; Jokinen, Tuija/0000-0002-1280-1396; Schobesberger, Siegfried/0000-0002-5777-4897; Kangasluoma, Juha/0000-0002-1639-1187; Kontkanen, Jenni/0000-0002-5373-3537; Kjaergaard, Henrik G/0000-0002-7275-8297; Lee, Ben H/0000-0002-5057-2168; Ehn, Mikael/0000-0002-0215-4893; Jorgensen, Solvejg/0000-0002-0255-1338; Nieminen, Tuomo/0000-0002-2713-715X; Worsnop, Douglas R/0000-0002-8928-8017; Wahner, Andreas/0000-0001-8948-1928; Kurtén, Theo C/0000-0002-6416-4931; Kulmala, Markku T/0000-0003-3464-7825; Thornton, Joel A/0000-0002-5098-4867; Petäjä, Tuukka/0000-0002-1881-9044; Tillmann, Ralf/0000-0003-0648-6622; Sipilä, Mikko/0000-0002-8594-7003; Tillmann, Ralf/0000-0003-0648-6622; Rissanen, Matti/0000-0003-0463-8098; Rubach, Florian/0000-0002-6144-2799; Junninen, Heikki/0000-0001-7178-9430	Emil Aaltonen foundation; US Department of Energy, Office of Science [DE-SC0006867]; ERC Advanced Grant EU-FP7-ATMNUCLE [227463]; EU-FP7 project PEGASOS [265148]; Academy of Finland [251427, 266388]; Academy of Finland Center of Excellence programme [1118615]	Emil Aaltonen foundation; US Department of Energy, Office of Science(United States Department of Energy (DOE)); ERC Advanced Grant EU-FP7-ATMNUCLE; EU-FP7 project PEGASOS; Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence programme(Academy of Finland)	M.E. was supported by the Emil Aaltonen foundation; J.A.T. was supported by the US Department of Energy, Office of Science (DE-SC0006867). This work was supported by the ERC Advanced Grant EU-FP7-ATMNUCLE (project no. 227463), the EU-FP7 project PEGASOS (project no. 265148), the Academy of Finland (project no. 251427 and 266388) and by the Academy of Finland Center of Excellence programme (project no. 1118615). We thank M. Kajos, S. Schallhart and T. Ruuskanen for measurement support, O. Kupiainen for collision rate calculations, and the tofTools team for analysis tools for mass spectra.	Atkinson R, 1997, J PHYS CHEM REF DATA, V26, P521, DOI 10.1063/1.556011; Berndt T, 2005, SCIENCE, V307, P698, DOI 10.1126/science.1104054; Bertram TH, 2011, ATMOS MEAS TECH, V4, P1471, DOI 10.5194/amt-4-1471-2011; Capouet M, 2006, ATMOS CHEM PHYS, V6, P1455, DOI 10.5194/acp-6-1455-2006; Carslaw KS, 2010, ATMOS CHEM PHYS, V10, P1701, DOI 10.5194/acp-10-1701-2010; Crounse JD, 2013, J PHYS CHEM LETT, V4, P3513, DOI 10.1021/jz4019207; Crounse JD, 2012, J PHYS CHEM A, V116, P5756, DOI 10.1021/jp211560u; Crounse JD, 2011, PHYS CHEM CHEM PHYS, V13, P13607, DOI 10.1039/c1cp21330j; DeCarlo PF, 2006, ANAL CHEM, V78, P8281, DOI 10.1021/ac061249n; Donahue NM, 2012, ATMOS CHEM PHYS, V12, P615, DOI 10.5194/acp-12-615-2012; Ehn M, 2012, ATMOS CHEM PHYS, V12, P5113, DOI 10.5194/acp-12-5113-2012; Ehn M, 2011, AEROSOL SCI TECH, V45, P522, DOI 10.1080/02786826.2010.547890; EISELE FL, 1993, J GEOPHYS RES-ATMOS, V98, P9001, DOI 10.1029/93JD00031; Gautrois M, 1999, J CHROMATOGR A, V848, P239, DOI 10.1016/S0021-9673(99)00424-0; Grieshop AP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029987; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hall WA, 2012, AEROSOL SCI TECH, V46, P983, DOI 10.1080/02786826.2012.685114; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; Hildebrandt L, 2009, ATMOS CHEM PHYS, V9, P2973, DOI 10.5194/acp-9-2973-2009; Jang MS, 2002, SCIENCE, V298, P814, DOI 10.1126/science.1075798; Jayne JT, 2000, AEROSOL SCI TECH, V33, P49, DOI 10.1080/027868200410840; Jenkin ME, 1997, ABSTR PAP AM CHEM S, V214, P116; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Jokinen T, 2012, ATMOS CHEM PHYS, V12, P4117, DOI 10.5194/acp-12-4117-2012; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kangasluoma J, 2013, AEROSOL SCI TECH, V47, P556, DOI 10.1080/02786826.2013.773393; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kokkola H., 2013, ATMOS CHEM PHYS DISC, V13, P14613; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kuwata KT, 2007, J PHYS CHEM A, V111, P5032, DOI 10.1021/jp0704113; Kwan AJ, 2012, ATMOS CHEM PHYS, V12, P7499, DOI 10.5194/acp-12-7499-2012; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; Matsunaga A, 2010, AEROSOL SCI TECH, V44, P881, DOI 10.1080/02786826.2010.501044; Mauldin RL, 2012, NATURE, V488, P193, DOI 10.1038/nature11278; Mauldin RL, 1999, J GEOPHYS RES-ATMOS, V104, P5801, DOI 10.1029/98JD02612; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Mereau R, 2001, PHYS CHEM CHEM PHYS, V3, P4712, DOI 10.1039/b105824j; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; Nieminen T, 2010, ATMOS CHEM PHYS, V10, P9773, DOI 10.5194/acp-10-9773-2010; Paasonen P, 2013, NAT GEOSCI, V6, P438, DOI [10.1038/NGEO1800, 10.1038/ngeo1800]; Pankow JF, 2003, ATMOS ENVIRON, V37, P3323, DOI 10.1016/S1352-2310(03)00346-7; Parrish DD, 2012, ATMOS CHEM PHYS, V12, P11485, DOI 10.5194/acp-12-11485-2012; Pathak RK, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007436; Peeters J, 2009, PHYS CHEM CHEM PHYS, V11, P5935, DOI 10.1039/b908511d; Peeters J, 2012, J PHYS CHEM A, V116, P6134, DOI 10.1021/jp211447q; Raatikainen T, 2010, ATMOS CHEM PHYS, V10, P2063, DOI 10.5194/acp-10-2063-2010; Riipinen I, 2011, ATMOS CHEM PHYS, V11, P3865, DOI 10.5194/acp-11-3865-2011; Saunders SM, 2003, ATMOS CHEM PHYS, V3, P161, DOI 10.5194/acp-3-161-2003; Sharma S, 2010, J PHYS CHEM A, V114, P5689, DOI 10.1021/jp9098792; Shilling JE, 2008, ATMOS CHEM PHYS, V8, P2073, DOI 10.5194/acp-8-2073-2008; Shiraiwa M, 2013, P NATL ACAD SCI USA, V110, P11746, DOI 10.1073/pnas.1307501110; Silva G., 2010, ENVIRON SCI TECHNOL, V44, P250, DOI DOI 10.1021/ES900924D; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Spracklen DV, 2011, ATMOS CHEM PHYS, V11, P12109, DOI 10.5194/acp-11-12109-2011; Spracklen DV, 2008, PHILOS T R SOC A, V366, P4613, DOI 10.1098/rsta.2008.0201; SU T, 1973, J AM CHEM SOC, V95, P7609, DOI 10.1021/ja00804a011; Tobias HJ, 2001, J PHYS CHEM A, V105, P6129, DOI 10.1021/jp004631r; Vaden TD, 2011, P NATL ACAD SCI USA, V108, P2190, DOI 10.1073/pnas.1013391108; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Vereecken L, 2007, PHYS CHEM CHEM PHYS, V9, P5241, DOI 10.1039/b708023a; Vereecken L, 2004, CHEM PHYS LETT, V393, P432, DOI 10.1016/j.cplett.2004.06.076; Vereecken L, 2010, PHYS CHEM CHEM PHYS, V12, P12608, DOI 10.1039/c0cp00387e; Vereecken L, 2012, CHEM SOC REV, V41, P6259, DOI 10.1039/c2cs35070j; Viggiano AA, 1997, J PHYS CHEM A, V101, P8275, DOI 10.1021/jp971768h; Virtanen A, 2010, NATURE, V467, P824, DOI 10.1038/nature09455; Wang L, 2010, NAT GEOSCI, V3, P238, DOI 10.1038/NGEO778; Worsnop D. R., 2011, AEROSOL SCI TECHNOL, V45, pi; Yatavelli RLN, 2012, AEROSOL SCI TECH, V46, P1313, DOI 10.1080/02786826.2012.712236; Yatavelli RLN, 2010, AEROSOL SCI TECH, V44, P61, DOI 10.1080/02786820903380233; Young PJ, 2009, ATMOS CHEM PHYS, V9, P2793, DOI 10.5194/acp-9-2793-2009; Zhao J, 2013, ATMOS CHEM PHYS, V13, P7631, DOI 10.5194/acp-13-7631-2013; Ziemann PJ, 2002, J PHYS CHEM A, V106, P4390, DOI 10.1021/jp012925m	76	1036	1060	64	1445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					476	+		10.1038/nature13032	http://dx.doi.org/10.1038/nature13032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572423				2022-12-24	WOS:000332165100035
J	Treutlein, B; Brownfield, DG; Wu, AR; Neff, NF; Mantalas, GL; Espinoza, FH; Desai, TJ; Krasnow, MA; Quake, SR				Treutlein, Barbara; Brownfield, Doug G.; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Espinoza, F. Hernan; Desai, Tushar J.; Krasnow, Mark A.; Quake, Stephen R.			Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq	NATURE			English	Article							STEM-CELLS; EXPRESSION; REVEALS; LANDSCAPE; ALIGNMENT	The mammalian lung is a highly branched network in which the distal regions of the bronchial tree transform during development into a densely packed honeycomb of alveolar air sacs that mediate gas exchange. Although this transformation has been studied by marker expression analysis and fate-mapping, the mechanisms that control the progression of lung progenitors along distinct lineages into mature alveolar cell types are still incompletely known, in part because of the limited number of lineage markers(1-3) and the effects of ensemble averaging in conventional transcriptome analysis experiments on cell populations(1-5). Here we show that single-cell transcriptome analysis circumvents these problems and enables direct measurement of the various cell types and hierarchies in the developing lung. We used microfluidic single-cell RNA sequencing (RNA-seq) on 198 individual cells at four different stages encompassing alveolar differentiation to measure the transcriptional states which define the developmental and cellular hierarchy of the distal mouse lung epithelium. We empirically classified cells into distinct groups by using an unbiased genome-wide approach that did not require a priori knowledge of the underlying cell types or the previous purification of cell populations. The results confirmed the basic outlines of the classical model of epithelial cell-type diversity in the distal lung and led to the discovery of many previously unknown cell-type markers, including transcriptional regulators that discriminate between the different populations. We reconstructed the molecular steps during maturation of bipotential progenitors along both alveolar lineages and elucidated the full life cycle of the alveolar type 2 cell lineage. This single-cell genomics approach is applicable to any developing or mature tissue to robustly delineate molecularly distinct cell types, define progenitors and lineage hierarchies, and identify lineage-specific regulatory factors.	[Treutlein, Barbara; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Sch Med, Stanford, CA 94305 USA; [Treutlein, Barbara; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Sch Med, Stanford, CA 94305 USA; [Treutlein, Barbara; Brownfield, Doug G.; Wu, Angela R.; Neff, Norma F.; Mantalas, Gary L.; Espinoza, F. Hernan; Krasnow, Mark A.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Brownfield, Doug G.; Espinoza, F. Hernan; Krasnow, Mark A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Desai, Tushar J.] Stanford Univ, Div Pulm & Crit Care Med, Dept Internal Med, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Sch Med, Stanford, CA 94305 USA.	tdesai@stanford.edu; krasnow@stanford.edu; quake@stanford.edu	Wu, Angela/ABF-9819-2020	Wu, Angela/0000-0002-3531-4830; Snyder, Michael/0000-0003-0784-7987; Treutlein, Barbara/0000-0002-3299-5597; Espinoza, Francisco/0000-0002-1855-1914; Brownfield, Doug/0000-0003-4769-1518	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant [U01HL099995]; National Institutes of Health (NIH) [T32HD007249]; Parker B. Francis Foundation Fellowship; NIH [5KO8HL084095, U01HL099999]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, K08HL084095, U01HL099999] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) Progenitor Cell Biology Consortium Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank W. Koh and B. Passarelli for help and discussions regarding bioinformatic pipelines and statistical analysis, S. I. Gonzalez for help with immunofluorescence, and J. G. Camp and members of the Krasnow laboratory for critical discussion and reading of the manuscript. This work was supported by National Heart, Lung, and Blood Institute (NHLBI) U01HL099995 Progenitor Cell Biology Consortium Grant (B. T., M. A. K., S. R. Q.), by National Institutes of Health (NIH) T32HD007249 (D. G. B.), by a Parker B. Francis Foundation Fellowship and NIH 5KO8HL084095 Award (T. J. D.), and by NIH grant U01HL099999 (A. R. W., N.F.N.). M. A. K. and S. R. Q. are investigators of the Howard Hughes Medical Institute.	Babraham institute, FASTQC; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Gonzalez R, 2005, AM J PHYSIOL-LUNG C, V288, pL179, DOI 10.1152/ajplung.00272.2004; Greif DM, 2012, DEV CELL, V23, P482, DOI 10.1016/j.devcel.2012.07.009; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schreiber S. L., 2008, CSH PROTOCOLS; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Team R.C, R LANG ENV STAT COMP; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198; Wang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014085; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zemke AC, 2009, AM J RESP CELL MOL, V40, P340, DOI 10.1165/rcmb.2007-0380OC; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	41	849	896	8	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					371	+		10.1038/nature13173	http://dx.doi.org/10.1038/nature13173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24739965	Green Accepted			2022-12-24	WOS:000336121200041
J	Salman, RAS; White, PM; Counsell, CE; du Plessis, J; van Beijnum, J; Josephson, CB; Wilkinson, T; Wedderburn, CJ; Chandy, Z; St George, EJ; Sellar, RJ; Warlow, CP				Salman, Rustam Al-Shahi; White, Philip M.; Counsell, Carl E.; du Plessis, Johann; van Beijnum, Janneke; Josephson, Colin B.; Wilkinson, Tim; Wedderburn, Catherine J.; Chandy, Zoe; St George, E. Jerome; Sellar, Robin J.; Warlow, Charles P.		Scottish Audit Intracranial Vasc	Outcome After Conservative Management or Intervention for Unruptured Brain Arteriovenous Malformations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTRACRANIAL VASCULAR MALFORMATION; POPULATION-BASED COHORT; CONTROLLED-TRIALS; RANDOMIZED-TRIAL; CLINICAL-TRIALS; HEMORRHAGE; THERAPY; ARUBA; SIVMS; RISK	IMPORTANCE Whether conservative management is superior to interventional treatment for unruptured brain arteriovenous malformations (bAVMs) is uncertain because of the shortage of long-term comparative data. OBJECTIVE To compare the long-term outcomes of conservative management vs intervention for unruptured bAVM. DESIGN, SETTING, AND POPULATION Population-based inception cohort study of 204 residents of Scotland aged 16 years or older who were first diagnosed as having an unruptured bAVM during 1999-2003 or 2006-2010 and followed up prospectively for 12 years. EXPOSURES Conservative management (no intervention) vs intervention (any endovascular embolization, neurosurgical excision, or stereotactic radiosurgery alone or in combination). MAIN OUTCOMES AND MEASURES Cox regression analyses, with multivariable adjustment for prognostic factors and baseline imbalances if hazards were proportional, to compare rates of the primary outcome (death or sustained morbidity of any cause by Oxford Handicap Scale [OHS] score >= 2 for >= 2 successive years [0 = no symptoms and 6 = death]) and the secondary outcome (nonfatal symptomatic stroke or death due to bAVM, associated arterial aneurysm, or intervention). RESULTS Of 204 patients, 103 underwent intervention. Those who underwent intervention were younger, more likely to have presented with seizure, and less likely to have large bAVMs than patients managed conservatively. During a median follow-up of 6.9 years (94% completeness), the rate of progression to the primary outcome was lower with conservative management during the first 4 years of follow-up (36 vs 39 events; 9.5 vs 9.8 per 100 person-years; adjusted hazard ratio, 0.59; 95% CI, 0.35-0.99), but rates were similar thereafter. The rate of the secondary outcome was lower with conservative management during 12 years of follow-up (14 vs 38 events; 1.6 vs 3.3 per 100 person-years; adjusted hazard ratio, 0.37; 95% CI, 0.19-0.72). CONCLUSIONS AND RELEVANCE Among patients aged 16 years or older diagnosed as having unruptured bAVM, use of conservative management compared with intervention was associated with better clinical outcomes for up to 12 years. Longer follow-up is required to understand whether this association persists.	[Salman, Rustam Al-Shahi; Wilkinson, Tim; Chandy, Zoe; Sellar, Robin J.; Warlow, Charles P.] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [White, Philip M.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Counsell, Carl E.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland; [du Plessis, Johann; St George, E. Jerome] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; [van Beijnum, Janneke] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Josephson, Colin B.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Wedderburn, Catherine J.] UCL, Inst Global Hlth, London, England	University of Edinburgh; Newcastle University - UK; University of Aberdeen; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Calgary; University of London; University College London	Salman, RAS (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Bramwell Dott Bldg, Edinburgh EH4 2XU, Midlothian, Scotland.	Rustam.Al-Shahi@ed.ac.uk	Macleod, Malcolm Robert/B-2052-2010; Wilkinson, Tim/L-5184-2019; Wardlaw, Joanna M/Y-3456-2019; McGonigal, Aileen/V-3292-2018; Wedderburn, Catherine/GZA-8421-2022; Leach, John Paul/AGU-8942-2022; Lueck, Christian Joseph/O-4031-2016; van+Beijnum, Janneke/ACA-2245-2022	Macleod, Malcolm Robert/0000-0001-9187-9839; Wilkinson, Tim/0000-0001-8952-0982; Wardlaw, Joanna M/0000-0002-9812-6642; McGonigal, Aileen/0000-0001-6775-5318; Leach, John Paul/0000-0003-2086-9937; Lueck, Christian Joseph/0000-0003-1537-7612; Razvi, Saif/0000-0003-2307-550X; Kwan, Joseph/0000-0003-4635-3322; Wedderburn, Catherine/0000-0002-4887-1644; White, Philip/0000-0001-6007-6013; Whiteley, William/0000-0002-4816-8991; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Williams, Anna/0000-0002-6329-382X; Sudlow, Cathie/0000-0002-7725-7520; Ironside, James/0000-0001-5869-2108; Connick, Peter/0000-0002-3892-8037	Medical Research Council [G84/5176, G108/613, G1002605]; Chief Scientist Office of the Scottish Government [K/MRS/50/C2704, CZB/4/35]; Stroke Association [TSA04/01]; Netherlands Organisation for Scientific Research; Netherlands Heart Foundation [2002B138]; MRC [G108/613, G1002605, G0902303] Funding Source: UKRI; Medical Research Council [G0902303] Funding Source: researchfish; National Institute for Health Research [ACF-2012-18-019] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government; Stroke Association; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Medical Research Council (grants G84/5176, G108/613, and G1002605); the Chief Scientist Office of the Scottish Government (grants K/MRS/50/C2704 and CZB/4/35); the Stroke Association (grant TSA04/01); the Netherlands Organisation for Scientific Research; and the Netherlands Heart Foundation (grant 2002B138).	Al-Shahi R, 2003, STROKE, V34, P1163, DOI 10.1161/01.STR.0000069018.90456.C9; Al-Shahi R, 2003, STROKE, V34, P1156, DOI 10.1161/01.STR.0000069012.23858.69; Al-Shahi R, 2005, PRACT NEUROL, V5, P194; Atkinson RP, 2001, STROKE, V32, P1430; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Barr JC, 2012, NEUROSURG CLIN N AM, V23, P63, DOI 10.1016/j.nec.2011.09.010; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Davies JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.5.FOCUS12107; Halim AX, 2004, STROKE, V35, P1697, DOI 10.1161/01.STR.0000130988.44824.29; Jayaraman MV, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010173; Josephson CB, 2012, NEUROLOGY, V79, P500, DOI 10.1212/WNL.0b013e3182635696; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Mohr JP, 2012, STROKE, V43, P1744, DOI 10.1161/STROKEAHA.112.653584; Ogilvy CS, 2001, STROKE, V32, P1458, DOI 10.1161/01.STR.32.6.1458; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Ross J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003436.pub3; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; Stapf C, 2006, CURR OPIN NEUROL, V19, P63, DOI 10.1097/01.wco.0000200546.14668.78; Starke RM, 2009, BRIT J NEUROSURG, V23, P376, DOI 10.1080/02688690902977662; van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632; Beijnum J, 2009, BRAIN, V132, P537, DOI 10.1093/brain/awn318; Wedderburn CJ, 2008, LANCET NEUROL, V7, P223, DOI 10.1016/S1474-4422(08)70026-7	28	139	139	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2014	311	16					1661	1669		10.1001/jama.2014.3200	http://dx.doi.org/10.1001/jama.2014.3200			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF4OU	24756516	Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000334693900026
J	Slager, J; Kjos, M; Attaiech, L; Veening, JW				Slager, Jelle; Kjos, Morten; Attaiech, Laetitia; Veening, Jan-Willem			Antibiotic-Induced Replication Stress Triggers Bacterial Competence by Increasing Gene Dosage near the Origin	CELL			English	Article							DNA-DAMAGE RESPONSE; STREPTOCOCCUS-PNEUMONIAE; BACILLUS-SUBTILIS; TRANSCRIPTOME ANALYSIS; SOS RESPONSE; CELL-DEATH; TRANSFORMATION; EXPRESSION; PHEROMONE; EVOLUTION	Streptococcus pneumoniae (pneumococcus) kills nearly 1 million children annually, and the emergence of antibiotic-resistant strains poses a serious threat to human health. Because pneumococci can take up DNA from their environment by a process called competence, genes associated with antibiotic resistance can rapidly spread. Remarkably, competence is activated in response to several antibiotics. Here, we demonstrate that antibiotics targeting DNA replication cause an increase in the copy number of genes proximal to the origin of replication (oriC). As the genes required for competence initiation are located near oriC, competence is thereby activated. Transcriptome analyses show that antibiotics targeting DNA replication also upregulate origin-proximal gene expression in other bacteria. This mechanism is a direct, intrinsic consequence of replication fork stalling. Our data suggest that evolution has conserved the oriC-proximal location of important genes in bacteria to allow for a robust response to replication stress without the need for complex gene-regulatory pathways.	[Slager, Jelle; Kjos, Morten; Attaiech, Laetitia; Veening, Jan-Willem] Univ Groningen, Ctr Synthet Biol, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, NL-9747 AG Groningen, Netherlands	University of Groningen	Veening, JW (corresponding author), Univ Groningen, Ctr Synthet Biol, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	j.w.veening@rug.nl	Attaiech, Laetitia/M-6593-2014	Attaiech, Laetitia/0000-0002-6188-1839; Kjos, Morten/0000-0003-4448-9082; Veening, Jan-Willem/0000-0002-3162-6634; Slager, Jelle/0000-0002-8226-4303	FEBS long-term fellowship; EMBO long-term fellowship; EMBO Young Investigator Program; VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW); ERC [337399-PneumoCell]	FEBS long-term fellowship; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	We thank George Wright for providing HPUra and HBEMAU and Jean-Pierre Claverys for plasmids. We thank Anne de Jong for bioinformatics support and Antoine van Oijen, Jan Kok, and Oscar Kuipers for comments. M.K. is supported by a FEBS long-term fellowship, and L.A. is supported by an EMBO long-term fellowship. Work in the Veening lab is supported by the EMBO Young Investigator Program, a VIDI fellowship (864.12.001) from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW), and ERC starting grant 337399-PneumoCell.	Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Boutry C, 2013, J BACTERIOL, V195, P696, DOI 10.1128/JB.01605-12; BROWN NC, 1970, P NATL ACAD SCI USA, V67, P1454, DOI 10.1073/pnas.67.3.1454; Cassone M, 2012, J BIOL CHEM, V287, P38449, DOI 10.1074/jbc.M112.391482; Charpentier X, 2012, CURR OPIN MICROBIOL, V15, P570, DOI 10.1016/j.mib.2012.08.001; Charpentier X, 2011, J BACTERIOL, V193, P1114, DOI 10.1128/JB.01146-10; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; Cornick JE, 2012, MICROBES INFECT, V14, P573, DOI 10.1016/j.micinf.2012.01.012; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Engelmoer DJP, 2011, EVOLUTION, V65, P3475, DOI 10.1111/j.1558-5646.2011.01402.x; Gmuender H, 2001, GENOME RES, V11, P28, DOI 10.1101/gr.157701; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kerkhoven R, 2004, BIOINFORMATICS, V20, P1812, DOI 10.1093/bioinformatics/bth159; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Kjos M, 2014, MOL MICROBIOL, V91, P1088, DOI 10.1111/mmi.12517; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee MS, 1998, APPL ENVIRON MICROB, V64, P4796; Lewis RJ, 1996, BIOESSAYS, V18, P661, DOI 10.1002/bies.950180810; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrer E, 2006, ANTIMICROB AGENTS CH, V50, P269, DOI 10.1128/AAC.50.1.269-278.2006; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Martin B, 2013, MOL MICROBIOL, V87, P394, DOI 10.1111/mmi.12104; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Martin-Galiano AJ, 2003, ANTIMICROB AGENTS CH, V47, P1257, DOI 10.1128/AAC.47.4.1257-1261.2003; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Price MN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-19; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Prudhomme M, 2005, MOL BIOL STREPTOCOCC, P519; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Sangurdekar DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-583; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Stevens KE, 2011, MBIO, V2, DOI 10.1128/mBio.00071-11; Su'etsugu M, 2011, MOL CELL, V41, P720, DOI 10.1016/j.molcel.2011.02.024; Tarantino PM, 1999, J MED CHEM, V42, P2035, DOI 10.1021/jm980693i; TOMASZ A, 1966, P NATL ACAD SCI USA, V55, P58, DOI 10.1073/pnas.55.1.58; van der Veen S, 2010, MICROBIOL-SGM, V156, P374, DOI 10.1099/mic.0.035196-0; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wecke T, 2011, J ANTIMICROB CHEMOTH, V66, P2689, DOI 10.1093/jac/dkr373; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Yamane T, 2012, INT J UROL, V19, P360, DOI 10.1111/j.1442-2042.2011.02933.x	58	137	142	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					395	406		10.1016/j.cell.2014.01.068	http://dx.doi.org/10.1016/j.cell.2014.01.068			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725406	Bronze, Green Published			2022-12-24	WOS:000334304500013
J	Fairfax, BP; Humburg, P; Makino, S; Naranbhai, V; Wong, D; Lau, E; Jostins, L; Plant, K; Andrews, R; Mcgee, C; Knight, JC				Fairfax, Benjamin P.; Humburg, Peter; Makino, Seiko; Naranbhai, Vivek; Wong, Daniel; Lau, Evelyn; Jostins, Luke; Plant, Katharine; Andrews, Robert; Mcgee, Chris; Knight, Julian C.			Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; INTERFERON-GAMMA; DISEASE; RESPONSES; LOCI; RISK; POPULATION; IDENTIFICATION; METAANALYSIS; INDUCTION	To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon-gamma (IFN-gamma) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN-beta cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants.	[Fairfax, Benjamin P.; Humburg, Peter; Makino, Seiko; Naranbhai, Vivek; Wong, Daniel; Lau, Evelyn; Jostins, Luke; Plant, Katharine; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Andrews, Robert; Mcgee, Chris] Univ Cambridge, Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Wellcome Trust Sanger Institute	Fairfax, BP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	bfairfax@well.ox.ac.uk; julian@well.ox.ac.uk	Lau, Evelyn/HGU-8290-2022; Knight, Julian/C-7242-2009; Humburg, Peter/A-4191-2009; Knight, Julian Charles/W-2399-2019	Lau, Evelyn/0000-0003-3281-8360; Knight, Julian/0000-0002-0377-5536; Humburg, Peter/0000-0002-3331-6496; Knight, Julian Charles/0000-0002-0377-5536; Naranbhai, Vivek/0000-0003-4281-8882; Fairfax, Benjamin/0000-0001-7413-5002	Wellcome Trust [074318, 088891, 090532/Z/09/Z]; European Research Council (ERC) under the European Union [281824]; Medical Research Council [98082]; National Institute for Health and Research Oxford Biomedical Research Centre; MRC [G1001708] Funding Source: UKRI; Medical Research Council [G1001708] Funding Source: researchfish; National Institute for Health Research [CL-2012-13-004, ACF-2008-13-017] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); European Research Council (ERC) under the European Union(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health and Research Oxford Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Gene expression and ChIP-seq data are available through ArrayExpress. Genotyping data have been deposited at the European Genome-phenome Archive (EGA) and are available on request (EGAS00000000109). We are very grateful to all the volunteers who participated in this study together with members of the Knight laboratory for their support. We also thank G. McVean and D. Kwiatkowski for support of this study and helpful suggestions. This work was supported by the Wellcome Trust [grants 074318 (J.C.K.), 088891 (B.P.F.), and 090532/Z/09/Z (core facilities Wellcome Trust Centre for Human Genetics including High-Throughput Genomics Group)], the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 281824 (J.C.K.), the Medical Research Council (98082, J.C.K.), and the National Institute for Health and Research Oxford Biomedical Research Centre.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amisten S, 2007, EUR HEART J, V28, P13, DOI 10.1093/eurheartj/ehl410; Bandiera S, 2005, MOL PHARMACOL, V67, P435, DOI 10.1124/mol.104.006056; Baron JM, 1998, BIOCHEM PHARMACOL, V56, P1105, DOI 10.1016/S0006-2952(98)00105-1; Biswas S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-244; Chevillard G, 2011, CELL MOL LIFE SCI, V68, P3337, DOI 10.1007/s00018-011-0747-x; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Cullell-Young M, 2001, IMMUNOGENETICS, V53, P136, DOI 10.1007/s002510100312; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaffney DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003501; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Kruger E, 2012, CURR OPIN IMMUNOL, V24, P77, DOI 10.1016/j.coi.2012.01.005; Leek J. T., COMBAT SVA SURROGATE; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marinho S, 2012, ANN ALLERG ASTHMA IM, V108, P402, DOI 10.1016/j.anai.2012.03.002; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Watling D, 2008, P NATL ACAD SCI USA, V105, P6051, DOI 10.1073/pnas.0710814105; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	65	466	469	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1118	+	1246949	10.1126/science.1246949	http://dx.doi.org/10.1126/science.1246949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604202	Green Accepted			2022-12-24	WOS:000332331500041
J	Kazi, DS; Garber, AM; Shah, RU; Dudley, RA; Mell, MW; Rhee, C; Moshkevich, S; Boothroyd, DB; Owens, DK; Hlatky, MA				Kazi, Dhruv S.; Garber, Alan M.; Shah, Rashmee U.; Dudley, R. Adams; Mell, Matthew W.; Rhee, Ceron; Moshkevich, Solomon; Boothroyd, Derek B.; Owens, Douglas K.; Hlatky, Mark A.			Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							SIROLIMUS-ELUTING STENTS; PLATO PLATELET INHIBITION; ARTERY-BYPASS SURGERY; TIMI 38 TRIAL; CYP2C19 GENOTYPE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; CLINICAL-OUTCOMES; FOCUSED UPDATE; CLOPIDOGREL	Background: The choice of antiplatelet therapy after acute coronary syndrome (ACS) is complicated: Ticagrelor and prasugrel are novel alternatives to clopidogrel, patients with some genotypes may not respond to clopidogrel, and low-cost generic formulations of clopidogrel are available. Objective: To determine the most cost-effective strategy for dual antiplatelet therapy after percutaneous coronary intervention for ACS. Design: Decision-analytic model. Data Sources: Published literature, Medicare claims, and life tables. Target Population: Patients having percutaneous coronary intervention for ACS. Time Horizon: Lifetime. Perspective: Societal. Intervention: Five strategies were examined: generic clopidogrel, prasugrel, ticagrelor, and genotyping for polymorphisms of CYP2C19 with carriers of loss-of-function alleles receiving either ticagrelor (genotyping with ticagrelor) or prasugrel (genotyping with prasugrel) and noncarriers receiving clopidogrel. Outcome Measures: Direct medical costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: The clopidogrel strategy produced $179301 in costs and 9.428 QALYs. Genotyping with prasugrel was superior to prasugrel alone, with an ICER of $35 800 per QALY relative to clopidogrel. Genotyping with ticagrelor was more effective than genotyping with prasugrel ($30 200 per QALY relative to clopidogrel). Ticagrelor was the most effective strategy ($52 600 per QALY relative to genotyping with ticagrelor).. Results of Sensitivity Analysis: Stronger associations between genotype and thrombotic outcomes rendered ticagrelor substantially less cost-effective ($104 800 per QALY). Genotyping with prasugrel was the preferred therapy among patients who could not tolerate ticagrelor. Limitation: No randomized trials have directly compared genotyping strategies or prasugrel with ticagrelor. Conclusion: Genotype-guided personalization may improve the cost-effectiveness of prasugrel and ticagrelor after percutaneous coronary intervention for ACS, but ticagrelor for all patients may be an economically reasonable alternative in some settings.	Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA; Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Harvard Univ, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Ctr Primary Care Outcomes Res, Grad Sch Business, Stanford, CA USA; Ctr Hlth Policy, Stanford, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Kazi, DS (corresponding author), San Francisco Gen Hosp, Div Cardiol, 1001 Potrero Ave,Room 5G1, San Francisco, CA 94110 USA.	kazi@alumni.stanford.edu		Hlatky, Mark/0000-0003-4686-9441; Boothroyd, Derek Brian/0000-0001-5387-6995; Shah, Rashmee/0000-0002-7823-8540	American Heart Association; U.S. Department of Veterans Affairs; Stanford University; University of California San Francisco	American Heart Association(American Heart Association); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Stanford University(Stanford University); University of California San Francisco(University of California System)	American Heart Association, U.S. Department of Veterans Affairs, Stanford University, and University of California San Francisco.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Anderson JL, 2011, J AM COLL CARDIOL, V57, pE215, DOI 10.1016/j.jacc.2011.02.011; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; [Anonymous], 2010, TOP 20 GLOB HLTH PRO; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Bhatt DL, 2013, CHARISMA GENOMICS; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Centers for Medicare & Medicaid Services, MED AN REV MEDPAR FI; Centers for Medicare & Medicaid Services, DEN FIL; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Chieffo A, 2007, CIRCULATION, V116, P158, DOI 10.1161/CIRCULATIONAHA.107.692178; COHEN DJ, 1994, CIRCULATION, V89, P1859, DOI 10.1161/01.CIR.89.4.1859; Coleman CI, 2012, CURR MED RES OPIN, V28, P49, DOI 10.1185/03007995.2011.639752; Committee on the Assessment of the US Drug Safety System, 2007, FUT DRUG SAF PROM PR; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Davies Andrew, 2013, J Med Econ, V16, P510, DOI 10.3111/13696998.2013.768998; de la Torre-Hernandez JM, 2008, J AM COLL CARDIOL, V51, P986, DOI 10.1016/j.jacc.2007.10.057; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Garber AM, 2009, NEW ENGL J MED, V360, P1925, DOI 10.1056/NEJMp0901355; Garg P, 2008, J AM COLL CARDIOL, V51, P1844, DOI 10.1016/j.jacc.2008.01.042; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2012, CIRCULATION, V125, P1276, DOI 10.1161/CIRCULATIONAHA.111.031195; Harmsze AM, 2012, PHARMACOGENET GENOM, V22, P169, DOI 10.1097/FPC.0b013e32834ff6e3; Healthcare Cost and Utilization Project, 2008, OV NAT INP SAMPL; Held C, 2011, J AM COLL CARDIOL, V57, P672, DOI 10.1016/j.jacc.2010.10.029; Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203; Hlatky MA, 2013, J AM COLL CARDIOL, V61, P295, DOI 10.1016/j.jacc.2012.10.018; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Kaul Sanjay, 2010, Arch Intern Med, V170, P1010, DOI 10.1001/archinternmed.2010.139; King 3rd SB, 2008, J AM COLL CARDIOL, V51, P172; Ko DT, 2010, CIRCULATION, V121, P2635, DOI 10.1161/CIRCULATIONAHA.109.926881; Ko DT, 2010, CIRC-CARDIOVASC INTE, V3, P140, DOI 10.1161/CIRCINTERVENTIONS.109.928721; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Li Y, 2012, J THROMB HAEMOST, V10, P199, DOI 10.1111/j.1538-7836.2011.04570.x; Lipscomb J., 1996, COST EFFECTIVENESS H, P214; Longworth Louise, 2005, Eur J Health Econ, V6, P347, DOI 10.1007/s10198-005-0309-y; Lopez-Jimenez F, 2002, AM HEART J, V144, P687, DOI 10.1067/mhj.2002.124835; Machecourt J, 2007, J AM COLL CARDIOL, V50, P501, DOI 10.1016/j.jacc.2007.04.051; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Mahoney EM, 2010, CIRCULATION, V121, P71, DOI 10.1161/CIRCULATIONAHA.109.900704; Mauskopf Josephine A, 2012, J Med Econ, V15, P166, DOI 10.3111/13696998.2011.637590; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehran R, 2011, TRANSC CARD THER C S; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; New Drug Application (NDA), NEW DRUG APPL NDA; Nikolic E, 2013, EUR HEART J, V34, P220, DOI 10.1093/eurheartj/ehs149; Orford JL, 2002, J AM COLL CARDIOL, V40, P1567, DOI 10.1016/S0735-1097(02)02374-4; Panattoni L, 2012, PHARMACOECONOMICS, V30, P1067, DOI 10.2165/11595080-000000000-00000; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Park DW, 2011, J AM COLL CARDIOL, V58, P2630, DOI 10.1016/j.jacc.2011.08.057; Parodi G, 2011, JAMA-J AM MED ASSOC, V306, P1215, DOI 10.1001/jama.2011.1332; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Reese ES, 2012, PHARMACOTHERAPY, V32, P323, DOI 10.1002/j.1875-9114.2012.01048; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Saia F, 2006, J AM COLL CARDIOL, V48, P1312, DOI 10.1016/j.jacc.2006.03.063; Schleinitz MD, 2005, ANN INTERN MED, V142, P251, DOI 10.7326/0003-4819-142-4-200502150-00007; Schleinitz MD, 2004, AM J MED, V116, P797, DOI 10.1016/j.amjmed.2004.01.014; Scirica BM, 2011, J AM COLL CARDIOL, V57, P1908, DOI 10.1016/j.jacc.2010.11.056; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Sorich MJ, 2013, CLIN PHARMACOL THER, V94, P376, DOI 10.1038/clpt.2013.100; Storey RF, 2010, J AM COLL CARDIOL, V56, P185, DOI 10.1016/j.jacc.2010.01.062; Thomson R, 2000, LANCET, V355, P956, DOI 10.1016/S0140-6736(00)90012-6; Torrance GW., 1996, COST EFFECTIVENESS H, P54; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; U.S. Department of Commerce Bureau of Economic Analysis, 2013, NAT EC ACC GROSS DOM; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Williams DO, 2006, CIRCULATION, V114, P2154, DOI 10.1161/CIRCULATIONAHA.106.667915; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Woodward C, 2009, CAN MED ASSOC J, V180, P807, DOI 10.1503/cmaj.090483; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zabalza M, 2012, HEART, V98, P100, DOI 10.1136/hrt.2011.227652	95	66	66	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4					221	232		10.7326/M13-1999	http://dx.doi.org/10.7326/M13-1999			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB3BO	24727840	Green Published			2022-12-24	WOS:000331666500002
J	Cao, YN; He, MH; Gao, ZB; Peng, Y; Li, YL; Li, L; Zhou, WW; Li, XC; Zhong, X; Lei, YM; Su, TW; Wang, H; Jiang, YR; Yang, L; Wei, W; Yang, X; Jiang, XL; Liu, L; He, J; Ye, JN; Wei, Q; Li, YR; Wang, WQ; Wang, J; Ning, G				Cao, Yanan; He, Minghui; Gao, Zhibo; Peng, Ying; Li, Yanli; Li, Lin; Zhou, Weiwei; Li, Xiangchun; Zhong, Xu; Lei, Yiming; Su, Tingwei; Wang, Hang; Jiang, Yiran; Yang, Lin; Wei, Wei; Yang, Xu; Jiang, Xiuli; Liu, Li; He, Juan; Ye, Junna; Wei, Qing; Li, Yingrui; Wang, Weiqing; Wang, Jun; Ning, Guang			Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome	SCIENCE			English	Article							ACUTE REGULATORY PROTEIN; CRYSTAL-STRUCTURE; GENE; HYPERPLASIA; SUBUNIT; NETWORK; TUMORS	Adrenal Cushing's syndromeis caused by excess production of glucocorticoid from adrenocortical tumors and hyperplasias, which leads to metabolic disorders. We performed whole-exome sequencing of 49 blood-tumor pairs and RNA sequencing of 44 tumors from cortisol-producing adrenocortical adenomas (ACAs), adrenocorticotropic hormone-independent macronodular adrenocortical hyperplasias (AIMAHs), and adrenocortical oncocytomas (ADOs). We identified a hotspot in the PRKACA gene with a L205R mutation in 69.2%(27 out of 39) of ACAs and validated in 65.5% of a total of 87 ACAs. Our data revealed that the activating L205R mutation, which locates in the P+1 loop of the protein kinase A (PKA) catalytic subunit, promoted PKA substrate phosphorylation and target gene expression. Moreover, we discovered the recurrently mutated gene DOT1L in AIMAHs and CLASP2 in ADOs. Collectively, these data highlight potentially functional mutated genes in adrenal Cushing's syndrome.	[Cao, Yanan; Peng, Ying; Li, Yanli; Zhou, Weiwei; Zhong, Xu; Su, Tingwei; Jiang, Yiran; Wei, Wei; Jiang, Xiuli; He, Juan; Ye, Junna; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Key Lab Endocrine Tumors,Rui Jin Hosp, Shanghai 200030, Peoples R China; [He, Minghui; Gao, Zhibo; Li, Lin; Li, Xiangchun; Lei, Yiming; Wang, Hang; Yang, Lin; Yang, Xu; Liu, Li; Li, Yingrui; Wang, Jun] BGI Shenzhen, BGI Shanghai, Shenzhen, Peoples R China; [Wei, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Macau, Peoples R China; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ning, Guang] Chinese Acad Sci, Shanghai Inst Biol Sci SIBS, Inst Hlth Sci, Lab Endocrinol & Metab, Shanghai, Peoples R China; [Ning, Guang] Shanghai Jiao Tong Univ, Sch Med SJTUSM, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Beijing Genomics Institute (BGI); Shanghai Jiao Tong University; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Wang, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Key Lab Endocrine Tumors,Rui Jin Hosp, Shanghai 200030, Peoples R China.	wqingw@hotmail.com; wangj@genomics.org.cn; guangning@medmail.com.cn	Ye, Junna/ABF-6141-2020; Wei, Weijun/AAZ-3551-2021; Li, Yingrui/K-1064-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Cao, Yanan/0000-0002-3848-7040; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Natural Science Foundation of China grants [30900702, 81130016, 81270859]; Guangdong Innovative Research Team Program grant [2009010016]	Natural Science Foundation of China grants(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program grant	Supported by Natural Science Foundation of China grants 30900702, 81130016, and 81270859, and by Guangdong Innovative Research Team Program grant 2009010016. The sequencing data have been deposited in the European Genome-phenome Archive (accession no. EGAS00001000712).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603; Berthon A, 2012, MOL CELL ENDOCRINOL, V351, P87, DOI 10.1016/j.mce.2011.09.009; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gaujoux S, 2010, CLIN CANCER RES, V16, P5133, DOI 10.1158/1078-0432.CCR-10-1497; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Meimaridou E, 2013, ENDOCR DEV, V24, P57, DOI 10.1159/000342504; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Sarkar D, 2001, J CLIN ENDOCR METAB, V86, P1653, DOI 10.1210/jc.86.4.1653; Stratakis CA, 2007, NAT CLIN PRACT ENDOC, V3, P748, DOI 10.1038/ncpendmet0648; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030	25	151	158	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					913	917		10.1126/science.1249480	http://dx.doi.org/10.1126/science.1249480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24700472				2022-12-24	WOS:000336233800051
J	Qiu, ZZ; Dubin, AE; Mathur, J; Tu, B; Reddy, K; Miraglia, LJ; Reinhardt, J; Orth, AP; Patapoutian, A				Qiu, Zhaozhu; Dubin, Adrienne E.; Mathur, Jayanti; Tu, Buu; Reddy, Kritika; Miraglia, Loren J.; Reinhardt, Juergen; Orth, Anthony P.; Patapoutian, Ardem			SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel	CELL			English	Article							ENDOTHELIAL-CELLS; CHLORIDE CHANNELS; CL-CHANNEL; LYMPHOCYTES; PHYSIOLOGY; PANNEXINS; INCREASE; TAURINE; CALCIUM; EFFLUX	Maintenance of a constant cell volume in response to extracellular or intracellular osmotic changes is critical for cellular homeostasis. Activation of a ubiquitous volume-regulated anion channel (VRAC) plays a key role in this process; however, its molecular identity in vertebrates remains unknown. Here, we used a cell-based fluorescence assay and performed a genome-wide RNAi screen to find components of VRAC. We identified SWELL1 (LRRC8A), a member of a four-transmembrane protein family with unknown function, as essential for hypotonicity-induced iodide influx. SWELL1 is localized to the plasma membrane, and its knockdown dramatically reduces endogenous VRAC currents and regulatory cell volume decrease in various cell types. Furthermore, point mutations in SWELL1 cause a significant change in VRAC anion selectivity, demonstrating that SWELL1 is an essential VRAC component. These findings enable further molecular characterization of the VRAC channel complex and genetic studies for understanding the function of VRAC in normal physiology and disease.	[Qiu, Zhaozhu; Mathur, Jayanti; Tu, Buu; Reddy, Kritika; Miraglia, Loren J.; Orth, Anthony P.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Qiu, Zhaozhu; Dubin, Adrienne E.; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Reinhardt, Juergen] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	Novartis; Howard Hughes Medical Institute; Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Howard Hughes Med Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	ardem@scripps.edu			NIH [R01 DE022115]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022115] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Paul Groot-Kormelink for information on the HEK-YFP cell line; Yingyao Zhou and Jeff Janes for help with RNAi screen data analysis; Michael Bandell, Jie Xu, Swetha Murthy, Matt Petrus, Albert Parker, Angelica Romero, and Myleen Medina for technical assistance; Qiangfeng Zhang for 3D structural modeling; and members of the Patapoutian lab for valuable discussions. This work was supported by a grant from the NIH (R01 DE022115 to A.P.). A.P. is a Howard Hughes Medical Institute investigator.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; ACKERMAN MJ, 1994, J GEN PHYSIOL, V103, P153, DOI 10.1085/jgp.103.2.153; Cahalan M D, 1988, Soc Gen Physiol Ser, V43, P281; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; DOROSHENKO P, 1992, J PHYSIOL-LONDON, V449, P197, DOI 10.1113/jphysiol.1992.sp019082; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Falktoft B, 2004, J MEMBRANE BIOL, V201, P59, DOI 10.1007/s00232-004-0705-6; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; GRINSTEIN S, 1982, J GEN PHYSIOL, V80, P801, DOI 10.1085/jgp.80.6.801; Helix N, 2003, J MEMBRANE BIOL, V196, P83, DOI 10.1007/s00232-003-0627-x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Jackson PS, 1996, KIDNEY INT, V49, P1695, DOI 10.1038/ki.1996.250; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kaczmarek LK, 1997, PHYSIOL REV, V77, P627, DOI 10.1152/physrev.1997.77.3.627; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kubota K, 2004, FEBS LETT, V564, P147, DOI 10.1016/S0014-5793(04)00332-1; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; LEWIS RS, 1993, J GEN PHYSIOL, V101, P801, DOI 10.1085/jgp.101.6.801; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Manolopoulos VG, 1997, AM J PHYSIOL-CELL PH, V273, pC214, DOI 10.1152/ajpcell.1997.273.1.C214; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; NILIUS B, 1994, J GEN PHYSIOL, V103, P787, DOI 10.1085/jgp.103.5.787; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 1998, J GEN PHYSIOL, V112, P365, DOI 10.1085/jgp.112.3.365; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Shen MR, 2000, J PHYSIOL-LONDON, V529, P385, DOI 10.1111/j.1469-7793.2000.00385.x; Siebert AP, 2013, J BIOL CHEM, V288, P6140, DOI 10.1074/jbc.M112.409789; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	36	354	363	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					447	458		10.1016/j.cell.2014.03.024	http://dx.doi.org/10.1016/j.cell.2014.03.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725410	Green Accepted, Bronze			2022-12-24	WOS:000334304500017
J	Sun, C; Wang, LQ; Huang, SD; Heynen, GJJE; Prahallad, A; Robert, C; Haanen, J; Blank, C; Wesseling, J; Willems, SM; Zecchin, D; Hobor, S; Bajpe, PK; Lieftink, C; Mateus, C; Vagner, S; Grernrum, W; Hofland, I; Schlicker, A; Wessels, LFA; Beijersbergen, RL; Bardelli, A; Di Nicolantonio, F; Eggermont, AMM; Bernards, R				Sun, Chong; Wang, Liqin; Huang, Sidong; Heynen, Guus J. J. E.; Prahallad, Anirudh; Robert, Caroline; Haanen, John; Blank, Christian; Wesseling, Jelle; Willems, Stefan M.; Zecchin, Davide; Hobor, Sebastijan; Bajpe, Prashanth K.; Lieftink, Cor; Mateus, Christina; Vagner, Stephan; Grernrum, Wipawadee; Hofland, Ingrid; Schlicker, Andreas; Wessels, Lodewyk F. A.; Beijersbergen, Roderick L.; Bardelli, Alberto; Di Nicolantonio, Federica; Eggermont, Alexander M. M.; Bernards, Rene			Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; IMPROVED SURVIVAL; BRAF INHIBITOR; RAF INHIBITION; C-JUN; CANCER; EXPRESSION; CELLS; EGFR; DIFFERENTIATION	Treatment of BRAF(V600E) mutant melanoma by small molecule drugs that target the BRAF or MEK kinases can be effective, but resistance develops invariably(1,2). In contrast, colon cancers that harbour the same BRAF(V600E) mutation are intrinsically resistant to BRAF inhibitors, due to feedback activation of the epidermal growth factor receptor (EGFR)(3,4). Here we show that 6 out of 16 melanoma tumours analysed acquired EGFR expression after the development of resistance to BRAF or MEK inhibitors. Using a chromatin-regulator-focused short hairpin RNA (shRNA) library, we find that suppression of sex determining region Y-box 10(SOX10) in melanoma causes activation of TGF-beta signalling, thus leading to upregulation of EGFR and platelet-derived growth factor receptor-beta (PDGFRB), which confer resistance to BRAF and MEK inhibitors. Expression of EGFR in melanoma or treatment with TGF-beta results in a slow-growth phenotype with cells displaying hallmarks of oncogene-induced senescence. However, EGFR expression or exposure to TGF-beta becomes beneficial for proliferation in the presence of BRAF or MEK inhibitors. In a heterogeneous population of melanoma cells having varying levels of SOX10 suppression, cells with low SOX10 and consequently high EGFR expression are rapidly enriched in the presence of drug, but this is reversed when the drug treatment is discontinued. We find evidence for SOX10 loss and/or activation of TGF-beta signalling in 4 of the 6 EGFR-positive drug-resistant melanoma patient samples. Our findings provide a rationale for why some BRAF or MEK inhibitor-resistant melanoma patients may regain sensitivity to these drugs after a 'drug holiday' and identify patients with EGFR-positive melanoma as a group that may benefit from re-treatment after a drug holiday.	[Sun, Chong; Wang, Liqin; Huang, Sidong; Heynen, Guus J. J. E.; Prahallad, Anirudh; Willems, Stefan M.; Bajpe, Prashanth K.; Lieftink, Cor; Grernrum, Wipawadee; Schlicker, Andreas; Wessels, Lodewyk F. A.; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Canc Syst Biol Ctr, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Sun, Chong; Wang, Liqin; Huang, Sidong; Heynen, Guus J. J. E.; Prahallad, Anirudh; Haanen, John; Blank, Christian; Wesseling, Jelle; Willems, Stefan M.; Bajpe, Prashanth K.; Lieftink, Cor; Grernrum, Wipawadee; Hofland, Ingrid; Schlicker, Andreas; Wessels, Lodewyk F. A.; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr Netherlands, NL-1066 CX Amsterdam, Netherlands; [Huang, Sidong] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada; [Robert, Caroline; Mateus, Christina; Vagner, Stephan; Eggermont, Alexander M. M.] Inst Gustave Roussy, F-94800 Villejuif, France; [Haanen, John; Blank, Christian] Netherlands Canc Inst, Div Med Oncol, Canc Syst Biol Ctr, NL-1066 CX Amsterdam, Netherlands; [Wesseling, Jelle; Hofland, Ingrid] Netherlands Canc Inst, Div Pathol, Canc Syst Biol Ctr, NL-1066 CX Amsterdam, Netherlands; [Willems, Stefan M.] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Zecchin, Davide; Bardelli, Alberto; Di Nicolantonio, Federica] Univ Turin, Dept Oncol, I-10060 Turin, Italy; [Zecchin, Davide; Hobor, Sebastijan; Bardelli, Alberto; Di Nicolantonio, Federica] IRCCS, Candiolo Canc Inst FPO, I-10060 Turin, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol IFOM, I-20139 Milan, Italy	Netherlands Cancer Institute; Netherlands Cancer Institute; McGill University; UNICANCER; Gustave Roussy; Netherlands Cancer Institute; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IFOM - FIRC Institute of Molecular Oncology	Bernards, R (corresponding author), Netherlands Canc Inst, Canc Syst Biol Ctr, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Sun, Chong/AAB-4859-2021; Di Nicolantonio, Federica/A-2503-2011; Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022; Vagner, Stephan/G-3664-2013; Robert, Caroline/G-6157-2018; BARDELLI, Alberto/J-9721-2018	Sun, Chong/0000-0001-9008-2158; Di Nicolantonio, Federica/0000-0001-9618-2010; Haanen, John/0000-0001-5884-7704; Robert, Caroline/0000-0002-9493-0238; Huang, Sidong/0000-0002-2838-4726; Schlicker, Andreas/0000-0002-6588-7883; vagner, stephan/0000-0003-1452-7164; Beijersbergen, Roderick/0000-0003-0116-4130; BARDELLI, Alberto/0000-0003-1647-5070; Wesseling, Jelle/0000-0002-8940-2676; Bernards, Rene/0000-0001-8677-3423; Wang, Liqin/0000-0002-9881-6432	European Research Council (ERC); Dutch Cancer Society (KWF); EU COLTHERES project; Netherlands Organization for Scientific Research (NWO) to Cancer Genomics Netherlands (CGC.NL); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS grant 'Farmacogenomica-5 per mille 2009 MIUR'; AIRC MFAG [11349]; AIRC IG grant [12812]; Canadian Institutes of Health Research (CIHR) [MOP-130540]	European Research Council (ERC)(European Research Council (ERC)European Commission); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); EU COLTHERES project; Netherlands Organization for Scientific Research (NWO) to Cancer Genomics Netherlands (CGC.NL)(Netherlands Organization for Scientific Research (NWO)); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS grant 'Farmacogenomica-5 per mille 2009 MIUR'; AIRC MFAG(Fondazione AIRC per la ricerca sul cancro); AIRC IG grant(Fondazione AIRC per la ricerca sul cancro); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank the NKI Core Facilities for Genomics and Molecular Pathology & Biobanking for tumour tissue and support in DNA sequencing. We thank S. Roy for collecting clinical data and N. Kamsu Kom for tissue preparation. This work was supported by grants from the European Research Council (ERC), the Dutch Cancer Society (KWF), the EU COLTHERES project and grants by the Netherlands Organization for Scientific Research (NWO) to Cancer Genomics Netherlands (CGC.NL). Additional support was provided by Fondazione Piemontese per la Ricerca sul Cancro-ONLUS grant 'Farmacogenomica-5 per mille 2009 MIUR' (F. D. N.); AIRC MFAG 11349 (F. D. N.); AIRC IG grant n. 12812 (A. B.); and Canadian Institutes of Health Research (CIHR) grant MOP-130540 (S.Hu).	Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Brummelkamp TR, 2003, NAT REV CANCER, V3, P781, DOI 10.1038/nrc1191; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cronin JC, 2009, PIGM CELL MELANOMA R, V22, P435, DOI 10.1111/j.1755-148X.2009.00578.x; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson AC, 2000, MOL MED, V6, P17, DOI 10.1007/BF03401931; Mialon A, 2005, MOL CELL BIOL, V25, P5040, DOI 10.1128/MCB.25.12.5040-5051.2005; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; REAL FX, 1986, CANCER RES, V46, P4726; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	29	544	556	5	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					118	+		10.1038/nature13121	http://dx.doi.org/10.1038/nature13121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670642	Green Submitted			2022-12-24	WOS:000333609900054
J	van de Pavert, SA; Ferreira, M; Domingues, RG; Ribeiro, H; Molenaar, R; Moreira-Santos, L; Almeida, FF; Ibiza, S; Barbosa, I; Goverse, G; Labao-Almeida, C; Godinho-Silva, C; Konijn, T; Schooneman, D; O'Toole, T; Mizee, MR; Habani, Y; Haak, E; Santori, FR; Littman, DR; Schulte-Merker, S; Dzierzak, E; Simas, JP; Mebius, RE; Veiga-Fernandes, H				van de Pavert, Serge A.; Ferreira, Manuela; Domingues, Rita G.; Ribeiro, Helder; Molenaar, Rosalie; Moreira-Santos, Lara; Almeida, Francisca F.; Ibiza, Sales; Barbosa, Ines; Goverse, Gera; Labao-Almeida, Carlos; Godinho-Silva, Cristina; Konijn, Tanja; Schooneman, Dennis; O'Toole, Tom; Mizee, Mark R.; Habani, Yasmin; Haak, Esther; Santori, Fabio R.; Littman, Dan R.; Schulte-Merker, Stefan; Dzierzak, Elaine; Simas, J. Pedro; Mebius, Reina E.; Veiga-Fernandes, Henrique			Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity	NATURE			English	Article							ROR-GAMMA-T; ACID; FETAL; MICE; RESPONSES; SURVIVAL; ORGANS; NOTCH; RET	The impact of nutritional status during fetal life on the overall health of adults has been recognized(1); however, dietary effects on the developing immune system are largely unknown. Development of secondary lymphoid organs occurs during embryogenesis and is considered to be developmentally programmed(2,3). Secondary lymphoid organ formation depends on a subset of type 3 innate lymphoid cells (ILC3) named lymphoid tissue inducer(LTi) cells(2-5). Here we show that mouse fetal ILC3s are controlled by cell-autonomous retinoic acid (RA) signalling in utero, which pre-sets the immune fitness in adulthood. We found that embryonic lymphoid organs contain ILC progenitors that differentiate locally into mature LTi cells. Local LTi cell differentiation was controlled by maternal retinoid intake and fetal RA signalling acting in a haematopoietic cell-autonomous manner. RA controlled LTi cell maturation upstream of the transcription factor ROR gamma t. Accordingly, enforced expression of Rorgt restored maturation of LTi cells with impaired RA signalling, whereas RA receptors directly regulated the Rorgt locus. Finally, we established that maternal levels of dietary retinoids control the size of secondary lymphoid organs and the efficiency of immune responses in the adult offspring. Our results reveal a molecular link between maternal nutrients and the formation of immune structures required for resistance to infection in the offspring.	[van de Pavert, Serge A.; Molenaar, Rosalie; Goverse, Gera; Konijn, Tanja; Schooneman, Dennis; O'Toole, Tom; Mizee, Mark R.; Habani, Yasmin; Mebius, Reina E.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [Ferreira, Manuela; Domingues, Rita G.; Ribeiro, Helder; Moreira-Santos, Lara; Almeida, Francisca F.; Ibiza, Sales; Barbosa, Ines; Labao-Almeida, Carlos; Godinho-Silva, Cristina; Simas, J. Pedro; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Med Mol, P-1649028 Lisbon, Portugal; [Haak, Esther; Dzierzak, Elaine] Erasmus MC, Erasmus Stem Cell Inst, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Santori, Fabio R.; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, Mol Pathogenesis Program,Skirball Inst Biomol Med, New York, NY 10016 USA; [Schulte-Merker, Stefan] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Schulte-Merker, Stefan] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Vrije Universiteit Amsterdam; Universidade de Lisboa; Erasmus University Rotterdam; Erasmus MC; Howard Hughes Medical Institute; New York University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Med Mol, Av Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal.	jhfernandes@medicina.ulisboa.pt	Ferreira, Manuela/AAF-5299-2020; Santori, Fabio/GRF-1002-2022; Ferreira, Manuela/I-7904-2018; Simas, J Pedro/M-5157-2013; van de Pavert, Serge A./A-7307-2008	Ferreira, Manuela/0000-0001-9498-8061; Ferreira, Manuela/0000-0001-9498-8061; Simas, J Pedro/0000-0001-6982-9253; van de Pavert, Serge A./0000-0002-7147-4380; Santori, Fabio/0000-0002-0220-8935; Ibiza, Sales/0000-0002-5748-382X; Barbosa, Ines/0000-0001-8977-0930; Labao-Almeida, Carlos/0000-0002-7797-3797; Ferreira, Manuela/0000-0002-0075-2400; Godinho-Silva, Cristina/0000-0002-0300-8839; F. de Almeida, Francisca/0000-0001-6632-7610; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Mebius, Reina/0000-0003-0451-7464; Ribeiro, Helder/0000-0002-7090-9274	FCT, Portugal; EMBO [1648]; ERC [207057]; NIH [RO1AI080885]; HHMI; Dutch MS research foundation [MS 12-797]; NGI Breakthrough Horizon [40-41009-98-9077]; VICI [918.56.612]; ALW-TOP [09.048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080885] Funding Source: NIH RePORTER	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Dutch MS research foundation; NGI Breakthrough Horizon; VICI(Netherlands Organization for Scientific Research (NWO)); ALW-TOP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the imaging, animal and flow cytometry facilities at IMM and UPC for technical assistance; C. Mendelsohn for providing ROSA26-RAR alpha 403 mice; N. Schmolka, J. G. van Rietschoten, R. E. van Kesteren, T. H. B. Geijtenbeek, S. Gringhuis, E. Keuning, J. Peterson-Maduro, M. G. Roukens, D. D'Astolfo, M. Vermunt, A. Rijerkerk, J. Koning, J. van der Meulen and B. Oliver for technical help; and G. Vilhais-Neto, M. C. Coles and G. Eberl for discussion. M. F., L.M.-S. and R. G. D. were supported by FCT, Portugal; H.V.-F. by EMBO (1648) and ERC (207057); D. R. L. by NIH (RO1AI080885) and HHMI; M. R. M. by Dutch MS research foundation (MS 12-797); S.A.vd.P. by NGI Breakthrough Horizon (40-41009-98-9077); and R. E. M. by a VICI (918.56.612) and ALW-TOP grant (09.048).	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Karrer U, 1997, J EXP MED, V185, P2157, DOI 10.1084/jem.185.12.2157; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meier D, 2007, IMMUNITY, V26, P643, DOI 10.1016/j.immuni.2007.04.009; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2010, METHODS MOL BIOL, V616, P161, DOI 10.1007/978-1-60761-461-6_11; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	42	256	261	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					123	+		10.1038/nature13158	http://dx.doi.org/10.1038/nature13158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670648	Green Accepted			2022-12-24	WOS:000333609900055
J	Plucain, J; Hindre, T; Le Gac, M; Tenaillon, O; Cruveiller, S; Medigue, C; Leiby, N; Harcombe, WR; Marx, CJ; Lenski, RE; Schneider, D				Plucain, Jessica; Hindre, Thomas; Le Gac, Mickael; Tenaillon, Olivier; Cruveiller, Stephane; Medigue, Claudine; Leiby, Nicholas; Harcombe, William R.; Marx, Christopher J.; Lenski, Richard E.; Schneider, Dominique			Epistasis and Allele Specificity in the Emergence of a Stable Polymorphism in Escherichia coli	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; EXPERIMENTAL POPULATIONS; BALANCED POLYMORPHISM; KEY INNOVATION; CONTINGENCY; ADAPTATION; EXPRESSION; DYNAMICS	Ecological opportunities promote population divergence into coexisting lineages. However, the genetic mechanisms that enable new lineages to exploit these opportunities are poorly understood except in cases of single mutations. We examined how two Escherichia coli lineages diverged from their common ancestor at the outset of a long-term coexistence. By sequencing genomes and reconstructing the genetic history of one lineage, we showed that three mutations together were sufficient to produce the frequency-dependent fitness effects that allowed this lineage to invade and stably coexist with the other. These mutations all affected regulatory genes and collectively caused substantial metabolic changes. Moreover, the particular derived alleles were critical for the initial divergence and invasion, indicating that the establishment of this polymorphism depended on specific epistatic interactions.	[Plucain, Jessica; Hindre, Thomas; Le Gac, Mickael; Schneider, Dominique] Univ Grenoble 1, Inst Jean Roget, Lab Adaptat & Pathogenie Microorganismes, F-38041 Grenoble, France; [Plucain, Jessica; Hindre, Thomas; Le Gac, Mickael; Schneider, Dominique] CNRS, UMR5163, F-38041 Grenoble, France; [Tenaillon, Olivier] Univ Paris 07, INSERM, UMR 1137, F-75018 Paris, France; [Tenaillon, Olivier] Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, F-75018 Paris, France; [Cruveiller, Stephane; Medigue, Claudine] CNRS, UMR 8030, F-91057 Evry, France; [Cruveiller, Stephane; Medigue, Claudine] CEA DSV IG Commissariat Energie Atom & Energies A, Direct Sci Vivant, Inst Genom, Genoscope LABGeM Lab Anal Bioinformat Genom & Met, F-91057 Evry, France; [Leiby, Nicholas; Harcombe, William R.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Leiby, Nicholas] Harvard Univ, Syst Biol Program, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard University; Harvard University; Michigan State University; Michigan State University	Schneider, D (corresponding author), Univ Grenoble 1, Inst Jean Roget, Lab Adaptat & Pathogenie Microorganismes, F-38041 Grenoble, France.	dominique.schneider@ujf-grenoble.fr	Tenaillon, Olivier/L-9857-2017; Hindré, Thomas/M-6026-2014; Schneider, Dominique/M-6019-2014	Tenaillon, Olivier/0000-0002-3796-1601; Lenski, Richard/0000-0002-1064-8375; Le Gac, Mickael/0000-0001-6451-5781	Agence Nationale de la Recherche (ANR) [ANR-08-BLAN-0283-01]; Centre National de la Recherche Scientifique; Universite Joseph Fourier; U.S. National Science Foundation [DEB-1019989]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; ANR; U.S. National Science Foundation; U.S. National Institutes of Health; French Ministry of Research	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier; U.S. National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; ANR(French National Research Agency (ANR)); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We are grateful to the late Evelyne Coursange, our dear laboratory manager and beloved friend. This work was Supported by grants from the Agence Nationale de la Recherche (ANR) (Program Blanc, grant ANR-08-BLAN-0283-01 to D.S.), the Centre National de la Recherche Scientifique (to D.S.), the Universite Joseph Fourier (to D.S.), the U.S. National Science Foundation (DEB-1019989 to R.E.L.), and the BEACON Center for the Study of Evolution in Action (DBI-0939454 to R.E.L.). For fellowships, J.P. thanks the French Ministry of Research and Universite Joseph Fourier, M.L.G. the ANR Program Blanc, N.L. the U.S. National Science Foundation, and W.R.H. the U.S. National Institutes of Health. R.E.L. and D.S. will make strains available to qualified recipients, subject to completion of a material transfer agreement that can be found at www.technologies.msu.edu/inventors/mta-cda/mta/mta-forms. Genomic data have been deposited to the ENA (European Nucleotide Archive) Short Read Archive (PRJEB5328). Other data are archived at the Dryad Digital Repository (www.datadryad.org, doi: 10.5061/dryad.12c6b).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Le Gac M, 2012, P NATL ACAD SCI USA, V109, P9487, DOI 10.1073/pnas.1207091109; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Rozen DE, 2009, ECOL LETT, V12, P34, DOI 10.1111/j.1461-0248.2008.01257.x; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Rozen DE, 2005, J MOL EVOL, V61, P171, DOI 10.1007/s00239-004-0322-2; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Spencer CC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030015; Spiers AJ, 2002, GENETICS, V161, P33; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357	24	81	81	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1366	1369		10.1126/science.1248688	http://dx.doi.org/10.1126/science.1248688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24603152				2022-12-24	WOS:000333108500041
J	Honeyman, JN; Simon, EP; Robine, N; Chiaroni-Clarke, R; Darcy, DG; Lim, IIP; Gleason, CE; Murphy, JM; Rosenberg, BR; Teegan, L; Takacs, CN; Botero, S; Belote, R; Germer, S; Emde, AK; Vacic, V; Bhanot, U; LaQuaglia, MP; Simon, SM				Honeyman, Joshua N.; Simon, Elana P.; Robine, Nicolas; Chiaroni-Clarke, Rachel; Darcy, David G.; Lim, Irene Isabel P.; Gleason, Caroline E.; Murphy, Jennifer M.; Rosenberg, Brad R.; Teegan, Lydia; Takacs, Constantin N.; Botero, Sergio; Belote, Rachel; Germer, Soren; Emde, Anne-Katrin; Vacic, Vladimir; Bhanot, Umesh; LaQuaglia, Michael P.; Simon, Sanford M.			Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma	SCIENCE			English	Article							PROTEIN-KINASE-A; COMPARATIVE GENOMIC HYBRIDIZATION; GROWTH-FACTOR RECEPTOR; PAIRED-END; CLINICOPATHOLOGICAL FEATURES; CANCER GENOMICS; BREAST-CANCER; LIVER; PHOSPHORYLATION; SURVIVAL	Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare liver tumor affecting adolescents and young adults with no history of primary liver disease or cirrhosis. We identified a chimeric transcript that is expressed in FL-HCC but not in adjacent normal liver and that arises as the result of a similar to 400-kilobase deletion on chromosome 19. The chimeric RNA is predicted to code for a protein containing the amino-terminal domain of DNAJB1, a homolog of the molecular chaperone DNAJ, fused in frame with PRKACA, the catalytic domain of protein kinase A. Immunoprecipitation and Western blot analyses confirmed that the chimeric protein is expressed in tumor tissue, and a cell culture assay indicated that it retains kinase activity. Evidence supporting the presence of the DNAJB1-PRKACA chimeric transcript in 100% of the FL-HCCs examined (15/15) suggests that this genetic alteration contributes to tumor pathogenesis.	[Honeyman, Joshua N.; Simon, Elana P.; Chiaroni-Clarke, Rachel; Darcy, David G.; Lim, Irene Isabel P.; Gleason, Caroline E.; Murphy, Jennifer M.; Teegan, Lydia; Takacs, Constantin N.; Botero, Sergio; Belote, Rachel; Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA; [Honeyman, Joshua N.; Darcy, David G.; Lim, Irene Isabel P.; Murphy, Jennifer M.; LaQuaglia, Michael P.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Pediat Surg, New York, NY 10065 USA; [Simon, Elana P.] Dalton Sch, New York, NY 10128 USA; [Robine, Nicolas; Germer, Soren; Emde, Anne-Katrin; Vacic, Vladimir] New York Genome Ctr, New York, NY 10013 USA; [Rosenberg, Brad R.] Rockefeller Univ, Whitehead Presidential Fellows Program, New York, NY 10065 USA; [Bhanot, Umesh] Mem Sloan Kettering Canc Ctr, Pathol Core Facil, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center	Simon, SM (corresponding author), Rockefeller Univ, Lab Cellular Biophys, 1230 York Ave, New York, NY 10065 USA.	simon@rockefeller.edu		Belote, Rachel/0000-0002-3001-0002; Robine, Nicolas/0000-0001-5698-8183; Rosenberg, Brad/0000-0002-5885-1276; Botero, Sergio/0000-0002-9298-8006; Simon, Elana/0000-0003-2433-4390; Vacic, Vladimir/0000-0001-6571-2293; Lim-Beutel, Irene Isabel/0000-0002-1711-443X; Bhanot, Umeshkumar/0000-0001-6656-1239; Simon, Sanford/0000-0002-8615-4224	Fibrolamellar Cancer Foundation; Rockefeller University Center for Clinical and Translational Science [2UL1RR024143]; Howard Hughes Medical Institute International Student Predoctoral Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Fibrolamellar Cancer Foundation; Rockefeller University Center for Clinical and Translational Science; Howard Hughes Medical Institute International Student Predoctoral Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Two coauthors on this study are patients with FL-HCC. We thank S. Tavazoie and H. Goodarzi for trouble-shooting, recommending protocols and software, and for helpful discussions of the data and the manuscript. We thank R. Darnell for support, insightful discussions of the data, and critical comments on the manuscript. We also thank the Pathology core facility at Memorial Sloan-Kettering Cancer Center (MSKCC), the Molecular Cytology core facility (MSKCC), and members of the fibrolamellar community for support. This work was funded by a grant from The Fibrolamellar Cancer Foundation, The Rockefeller University Center for Clinical and Translational Science grant 2UL1RR024143, and by an anonymous donor. We thank J. Panda for fund-raising efforts. C.N.T was supported by a Howard Hughes Medical Institute International Student Predoctoral Fellowship. The New York Genome Center and the authors (N.R., S. G., A.-K.E., and V. V.) have filed a patent application related to the use of the chimeric transcript in the detection of human cancers. Sequence data have been deposited into the database of Genotypes and Phenotypes, dbGaP (accession no. phs000709.v1.p1).	Adams DG, 2002, ARCH BIOCHEM BIOPHYS, V407, P103, DOI 10.1016/S0003-9861(02)00464-2; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang Celina S, 2013, Gastrointest Cancer Res, V6, P3; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bouchard MF, 2005, ENDOCRINOLOGY, V146, P4905, DOI 10.1210/en.2005-0187; Buckley AF, 2006, HUM PATHOL, V37, P410, DOI 10.1016/j.humpath.2005.12.009; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DS, 1999, MOL CELL BIOL, V19, P1002; CRAIG JR, 1980, CANCER, V46, P372, DOI 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; EDMONDSON HA, 1956, AMA J DIS CHILD, V91, P168, DOI 10.1001/archpedi.1956.02060020170015; El-Serag HB, 2004, HEPATOLOGY, V39, P798, DOI 10.1002/hep.20096; Emde AK, 2012, BIOINFORMATICS, V28, P619, DOI 10.1093/bioinformatics/bts019; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Kakar S, 2005, MODERN PATHOL, V18, P1417, DOI 10.1038/modpathol.3800449; Kakar S, 2009, MODERN PATHOL, V22, P134, DOI 10.1038/modpathol.2008.178; Katzenstein HM, 2003, CANCER-AM CANCER SOC, V97, P2006, DOI 10.1002/cncr.11292; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Marchio AS, 2000, ONCOGENE, V19, P3733, DOI 10.1038/sj.onc.1203713; Mavros MN, 2012, J AM COLL SURGEONS, V215, P820, DOI 10.1016/j.jamcollsurg.2012.08.001; Muramori K, 2011, J PEDIAT HEMATOL ONC, V33, pE195, DOI 10.1097/MPH.0b013e3182011676; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nesterova MV, 2006, CANCER RES, V66, P8971, DOI 10.1158/0008-5472.CAN-06-1049; Patonai A, 2013, PATHOL ONCOL RES, V19, P63, DOI 10.1007/s12253-012-9558-0; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Shaikh D, 2012, CELL SIGNAL, V24, P2396, DOI 10.1016/j.cellsig.2012.08.007; Stipa F, 2006, CANCER-AM CANCER SOC, V106, P1331, DOI 10.1002/cncr.21703; Torbenson M, 2007, ADV ANAT PATHOL, V14, P217, DOI 10.1097/PAP.0b013e3180504913; Tortora G, 1997, ONCOGENE, V14, P923, DOI 10.1038/sj.onc.1200906; Ward SC, 2011, SEMIN LIVER DIS, V31, P61, DOI 10.1055/s-0031-1272835; Weeda VB, 2013, EUR J CANCER, V49, P2698, DOI 10.1016/j.ejca.2013.04.012; Wilkens L, 2000, AM J CLIN PATHOL, V114, P867, DOI 10.1309/BMTT-JBPD-D13H-1UVD	39	264	276	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1010	1014		10.1126/science.1249484	http://dx.doi.org/10.1126/science.1249484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578576	Green Accepted			2022-12-24	WOS:000332309600042
J	Woo, SH; Ranade, S; Weyer, AD; Dubin, AE; Baba, Y; Qiu, ZZ; Petrus, M; Miyamoto, T; Reddy, K; Lumpkin, EA; Stucky, CL; Patapoutian, A				Woo, Seung-Hyun; Ranade, Sanjeev; Weyer, Andy D.; Dubin, Adrienne E.; Baba, Yoshichika; Qiu, Zhaozhu; Petrus, Matt; Miyamoto, Takashi; Reddy, Kritika; Lumpkin, Ellen A.; Stucky, Cheryl L.; Patapoutian, Ardem			Piezo2 is required for Merkel-cell mechanotransduction	NATURE			English	Article							SELECTIVE PHOTOTOXIC DESTRUCTION; HAIRY SKIN; CUTANEOUS MECHANORECEPTORS; SENSORY NEURONS; TOUCH; RESPONSES; CHANNELS; RECEPTOR; CURRENTS; TRANSMISSION	How we sense touch remains fundamentally unknown(1,2). The Merkel cell-neurite complex is a gentle touch receptor in the skin that mediates slowly adapting responses of A beta sensory fibres to encode fine details of objects(3-6). This mechanoreceptor complex was recognized to have an essential role in sensing gentle touch nearly 50 years ago(3,4). However, whether Merkel cells or afferent fibres themselves sense mechanical force is still debated, and the molecular mechanism of mechanotransduction is unknown(1,2,7-12). Synapse-like junctions are observed between Merkel cells and associated afferents(6,13-15), and yet it is unclear whether Merkel cells are inherently mechanosensitive or whether they can rapidly transmit such information to the neighbouring nerve(1,2,16,17). Here we show that Merkel cells produce touch-sensitive currents in vitro. Piezo2, a mechanically activated cation channel, is expressed in Merkel cells. We engineered mice deficient in Piezo2 in the skin, but not in sensory neurons, and show that Merkel-cell mechanosensitivity completely depends on Piezo2. In these mice, slowly adapting responses in vivo mediated by the Merkel cell-neurite complex show reduced static firing rates, and moreover, the mice display moderately decreased behavioural responses to gentle touch. Our results indicate that Piezo2 is the Merkel-cell mechanotransduction channel and provide the first line of evidence that Piezo channels have a physiological role in mechanosensation in mammals. Furthermore, our data present evidence for a two-receptor-site model, in which both Merkel cells and innervating afferents act together as mechanosensors. The two-receptor system could provide this mechanoreceptor complex with a tuning mechanism to achieve highly sophisticated responses to a given mechanical stimulus(15,18,19).	[Woo, Seung-Hyun; Ranade, Sanjeev; Dubin, Adrienne E.; Qiu, Zhaozhu; Miyamoto, Takashi; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Weyer, Andy D.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA; [Weyer, Andy D.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Neurobiol, Milwaukee, WI 53226 USA; [Weyer, Andy D.; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Anat, Milwaukee, WI 53226 USA; [Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Baba, Yoshichika; Lumpkin, Ellen A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Qiu, Zhaozhu; Petrus, Matt; Reddy, Kritika] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Howard Hughes Medical Institute; Scripps Research Institute; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Columbia University; Columbia University; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ardem@scripps.edu		Ranade, Sanjeev/0000-0001-8601-3563; Weyer, Andy/0000-0003-4485-9530; Lumpkin, Ellen/0000-0002-1166-3374	Howard Hughes Medical Institute; NIH [R01DE022358, R01AR051219]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535, R01AR051219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070711, R01NS040538] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Murthy and B. Coste for suggestions. Research was supported by the Howard Hughes Medical Institute (to A. P.) and NIH grants R01DE022358 (to A. P.) and R01AR051219 (to E.A.L.).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Cahusac PMB, 2009, NEUROSCIENCE, V163, P933, DOI 10.1016/j.neuroscience.2009.07.015; CHAMBERS MR, 1967, J PHYSIOL-LONDON, V192, pP26; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DIAMOND J, 1986, J PHYSIOL-LONDON, V376, P101, DOI 10.1113/jphysiol.1986.sp016144; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; GU J, 1981, AM J PATHOL, V104, P63; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HARTSCHUH W, 1980, J INVEST DERMATOL, V75, P159, DOI 10.1111/1523-1747.ep12522555; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Milenkovic N, 2008, J NEUROPHYSIOL, V100, P2771, DOI 10.1152/jn.90799.2008; MILLS LR, 1995, J NEUROCYTOL, V24, P117, DOI 10.1007/BF01181555; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Piskorowski R, 2008, PFLUG ARCH EUR J PHY, V457, P197, DOI 10.1007/s00424-008-0496-3; Press D, 2010, SOMATOSENS MOT RES, V27, P174, DOI 10.3109/08990220.2010.516670; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Senok SS, 1996, EXP BRAIN RES, V110, P325; Stucky CL, 1999, J NEUROSCI, V19, P8509; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Woo SH, 2010, DEVELOPMENT, V137, P3965, DOI 10.1242/dev.055970; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120; YAMASHITA Y, 1991, SOMATOSENS MOT RES, V8, P87, DOI 10.3109/08990229109144732	35	404	422	6	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					622	626		10.1038/nature13251	http://dx.doi.org/10.1038/nature13251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24717433	Green Accepted			2022-12-24	WOS:000336457100049
J	Watanabe, J; Hattori, M; Berriman, M; Lehane, MJ; Hall, N; Solano, P; Hide, W; Toure, Y; Attardo, GM; Darby, AC; Toyoda, A; Hertz-Fowler, C; Larkin, DM; Cotton, JA; Watanabe, J; Sanders, MJ; Swain, MT; Hattori, M; Berriman, M; Quail, MA; Inoue, N; Ravel, S; Taylor, TD; Srivastava, TP; Sharma, V; Warren, W; Wilson, RK; Suzuki, Y; Lawson, D; Hughes, DST; Megy, K; Masiga, DK; Mireji, PO; Attardo, GM; Hansen, IA; Van den Abbeele, J; Benoit, JB; Bourtzis, K; Lehane, MJ; Masiga, DK; Obiero, GFO; Robertson, HM; Jones, JW; Zhou, JJ; Field, LM; Friedrich, M; Mireji, PO; Nyanjom, SRG; Telleria, EL; Caljon, G; Van den Abbeele, J; Ribeiro, JMC; Acosta-Serrano, A; Benoit, JB; Ooi, CP; Rose, C; Price, DP; Haines, LR; Lehane, MJ; Christoffels, A; Sim, C; Pham, DQD; Denlinger, DL; Geiser, DL; Omedo, IA; Benoit, JB; Winzerling, JJ; Peyton, JT; Marucha, KK; Jonas, M; Meuti, ME; Rawlings, ND; Mireji, PO; Zhang, QR; Macharia, RW; Michalkova, V; Dashti, ZJS; Baumann, AA; Gade, G; Marco, HG; Hansen, IA; Caers, J; Schoofs, L; Riehle, MA; Hu, WQ; Tu, ZJ; Tarone, AM; Malacrida, AR; Kibet, CK; Benoit, JB; Scolari, F; Attardo, GM; Koekemoer, JJO; Willis, J; Gomulski, LM; Falchetto, M; Scott, MJ; Fu, SH; Sze, SH; Luiz, T; Weiss, B; Walshe, DP; Wang, JW; Benoit, JB; Attardo, GM; Wamalwa, M; Mwangi, S; Ramphul, UN; Snyder, AK; Brelsfoard, CL; Thomas, GH; Tsiamis, G; Bourtzis, K; Arensburger, P; Rio, RVM; Macdonald, SJ; Panji, S; Kruger, A; Christoffels, A; Benkahla, A; Balyeidhusa, ASP; Msangi, A; Ooi, CP; Okoro, CK; Masiga, DK; Stephens, D; Walshe, DP; Stanley, EJ; Mpondo, F; Wamwiri, F; Mramba, F; Attardo, GM; Siwo, G; Obiero, GFO; Githinji, G; Harkins, G; Murilla, G; Lehvaslaiho, H; Malele, I; Koekemoer, JJO; Auma, JE; Kinyua, JK; Ouma, J; Watanabe, J; Megy, K; Okedi, L; Manga, L; Jonas, M; Wamalwa, M; Aslett, M; Koffi, M; Berriman, M; Lehane, MJ; Gaunt, MW; Makgamathe, M; Hall, N; Mulder, N; Manangwa, O; Abila, PP; Wincker, P; Mireji, PO; Gregory, R; Rio, RVM; Bateta, R; Sakate, R; Aksoy, S; Ommeh, S; Lehane, S; Nyanjom, SRG; Imanishi, T; Taylor, TD; Osamor, VC; Sharma, V; Hide, W; Kawahara, Y; Benoit, JB				Watanabe, Junichi; Hattori, Masahira; Berriman, Matthew; Lehane, Michael J.; Hall, Neil; Solano, Philippe; Hide, Winston; Toure, Yeya; Attardo, Geoffrey M.; Darby, Alistair C.; Toyoda, Atsushi; Hertz-Fowler, Christiane; Larkin, Denis M.; Cotton, James A.; Watanabe, Junichi; Sanders, Mandy J.; Swain, Martin T.; Hattori, Masahira; Berriman, Matthew; Quail, Michael A.; Inoue, Noboru; Ravel, Sophie; Taylor, Todd D.; Srivastava, Tulika P.; Sharma, Vineet; Warren, Wesley; Wilson, Richard K.; Suzuki, Yutaka; Lawson, Daniel; Hughes, Daniel S. T.; Megy, Karyn; Masiga, Daniel K.; Mireji, Paul O.; Attardo, Geoffrey M.; Hansen, Imma A.; Van den Abbeele, Jan; Benoit, Joshua B.; Bourtzis, Kostas; Lehane, Michael J.; Masiga, Daniel K.; Obiero, George F. O.; Robertson, Hugh M.; Jones, Jeffery W.; Zhou, Jing-Jiang; Field, Linda M.; Friedrich, Markus; Mireji, Paul O.; Nyanjom, Steven R. G.; Telleria, Erich L.; Caljon, Guy; Van den Abbeele, Jan; Ribeiro, Jose M. C.; Acosta-Serrano, Alvaro; Benoit, Joshua B.; Ooi, Cher-Pheng; Rose, Clair; Price, David P.; Haines, Lee R.; Lehane, Michael J.; Christoffels, Alan; Sim, Cheolho; Pham, Daphne Q. D.; Denlinger, David L.; Geiser, Dawn L.; Omedo, Irene A.; Benoit, Joshua B.; Winzerling, Joy J.; Peyton, Justin T.; Marucha, Kevin K.; Jonas, Mario; Meuti, Megan E.; Rawlings, Neil D.; Mireji, Paul O.; Zhang, Qirui; Macharia, Rosaline W.; Michalkova, Veronika; Dashti, Zahra Jalali Sefid; Baumann, Aaron A.; Gaede, Gerd; Marco, Heather G.; Hansen, Immo A.; Caers, Jelle; Schoofs, Liliane; Riehle, Michael A.; Hu, Wanqi; Tu, Zhijian; Tarone, Aaron M.; Malacrida, Anna R.; Kibet, Caleb K.; Benoit, Joshua B.; Scolari, Francesca; Attardo, Geoffrey M.; Koekemoer, Jacobus J. O.; Willis, Judith; Gomulski, Ludvik M.; Falchetto, Marco; Scott, Maxwell J.; Fu, Shuhua; Sze, Sing-Hoi; Luiz, Thiago; Weiss, Brian; Walshe, Deirdre P.; Wang, Jingwen; Benoit, Joshua B.; Attardo, Geoffrey M.; Wamalwa, Mark; Mwangi, Sarah; Ramphul, Urvashi N.; Snyder, Anna K.; Brelsfoard, Corey L.; Thomas, Gavin H.; Tsiamis, George; Bourtzis, Kostas; Arensburger, Peter; Rio, Rita V. M.; Macdonald, Sandy J.; Panji, Sumir; Kruger, Adele; Christoffels, Alan; Benkahla, Alia; Balyeidhusa, Apollo S. P.; Msangi, Atway; Ooi, Cher-Pheng; Okoro, Chinyere K.; Masiga, Daniel K.; Stephens, Dawn; Walshe, Deirdre P.; Stanley, Eleanor J.; Mpondo, Feziwe; Wamwiri, Florence; Mramba, Furaha; Attardo, Geoffrey M.; Siwo, Geoffrey; Obiero, George F. O.; Githinji, George; Harkins, Gordon; Murilla, Grace; Lehvaeslaiho, Heikki; Malele, Imna; Koekemoer, Jacobus J. O.; Auma, Joanna E.; Kinyua, Johnson K.; Ouma, Johnson; Watanabe, Junichi; Megy, Karyn; Okedi, Loyce; Manga, Lucien; Jonas, Mario; Wamalwa, Mark; Aslett, Martin; Koffi, Mathurin; Berriman, Matthew; Lehane, Michael J.; Gaunt, Michael W.; Makgamathe, Mmule; Hall, Neil; Mulder, Nicola; Manangwa, Oliver; Abila, Patrick P.; Wincker, Patrick; Mireji, Paul O.; Gregory, Richard; Rio, Rita V. M.; Bateta, Rosemary; Sakate, Ryuichi; Aksoy, Serap; Ommeh, Sheila; Lehane, Stella; Nyanjom, Steven R. G.; Imanishi, Tadashi; Taylor, Todd D.; Osamor, Victor C.; Sharma, Vineet; Hide, Winston; Kawahara, Yoshihiro; Benoit, Joshua B.		IGGI	Genome Sequence of the Tsetse Fly (Glossina morsitans): Vector of African Trypanosomiasis	SCIENCE			English	Article							IMMUNE-RESPONSES; AQUAPORINS; PROTEINS; DIPTERA	Tsetse flies are the sole vectors of human African trypanosomiasis throughout sub-Saharan Africa. Both sexes of adult tsetse feed exclusively on blood and contribute to disease transmission. Notable differences between tsetse and other disease vectors include obligate microbial symbioses, viviparous reproduction, and lactation. Here, we describe the sequence and annotation of the 366-megabase Glossina morsitans morsitans genome. Analysis of the genome and the 12,308 predicted protein-encoding genes led to multiple discoveries, including chromosomal integrations of bacterial (Wolbachia) genome sequences, a family of lactation-specific proteins, reduced complement of host pathogen recognition proteins, and reduced olfaction/ chemosensory associated genes. These genome data provide a foundation for research into trypanosomiasis prevention and yield important insights with broad implications for multiple aspects of tsetse biology.	[Lehvaeslaiho, Heikki] KAUST, Thuwal 239556900, Saudi Arabia; [Arensburger, Peter] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Bourtzis, Kostas] Alexander Fleming Biomed Sci Res Ctr, Biomed Sci Res Ctr, Vari 16672, Greece; [Wincker, Patrick] CEA, F-91507 Evry, France; [Macharia, Rosaline W.] Univ Nairobi, Ctr Biotechnol & Bioinformat, Nairobi 00100, Kenya; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Ctr Om & Bioinformat, Kashiwa, Chiba 2778561, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Panji, Sumir; Mulder, Nicola] Univ Cape Town, Fac Hlth Sci, IIDMM, Computat Biol Grp, ZA-7925 Cape Town, South Africa; [Fu, Shuhua] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Marucha, Kevin K.; Bateta, Rosemary] Egerton Univ, Dept Biochem & Mol Biol, Njoro, Kenya; [Kinyua, Johnson K.] JKUAT, Dept Biochem, Nairobi, Kenya; [Hu, Wanqi; Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Zhou, Jing-Jiang; Field, Linda M.] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England; [Benoit, Joshua B.] Univ Cincinnati, McMicken Coll Arts & Sci, Dept Biol Sci, Cincinnati, OH 45221 USA; [Gaede, Gerd; Marco, Heather G.] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Pham, Daphne Q. D.] Univ Wisconsin Parkside, Dept Biol Sci, Kenosha, WI 53144 USA; [Jones, Jeffery W.; Friedrich, Markus] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Malacrida, Anna R.; Scolari, Francesca; Gomulski, Ludvik M.; Falchetto, Marco] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Sim, Cheolho] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Caers, Jelle; Schoofs, Liliane] Katholieke Univ Leuven, Dept Biol, B-3000 Louvain, Belgium; [Hansen, Imma A.; Price, David P.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Thomas, Gavin H.; Macdonald, Sandy J.] Univ York, Dept Biol, York Y010 5DD, N Yorkshire, England; [Snyder, Anna K.; Rio, Rita V. M.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Van den Abbeele, Jan; Caljon, Guy] Inst Trop Med Antwerp, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Willis, Judith] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Omedo, Irene A.] CGMRC, KEMRI Wellcome Trust Programme, Dept Clin Res, Kilifi, Kenya; [Osamor, Victor C.] Covenant Univ, Coll Sci & Technol, Dept Comp & Informat Sci, Ota, Ogun State, Nigeria; [Sze, Sing-Hoi] Texas A&M Univ, Dept Biochem & Biophys, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Scott, Maxwell J.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Tarone, Aaron M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Denlinger, David L.; Zhang, Qirui] Ohio State Univ, Dept Entomol, Aronoff Lab 400, Columbus, OH 43210 USA; [Riehle, Michael A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, A-1220 Vienna, Austria; [Tsiamis, George] Univ Patras, Dept Environm & Nat Resources Management, Agrinion 30100, Greece; [Telleria, Erich L.; Michalkova, Veronika; Luiz, Thiago; Weiss, Brian; Wang, Jingwen; Aksoy, Serap] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06520 USA; [Peyton, Justin T.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Aronoff Lab 300, Columbus, OH 43210 USA; [Brelsfoard, Corey L.] St Catharine Coll, Dept Nat Sci, St Catharine, KY 40061 USA; [Winzerling, Joy J.] Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Career Serv, Tucson, AZ 85721 USA; [Winzerling, Joy J.] Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Acad Serv, Tucson, AZ 85721 USA; [Geiser, Dawn L.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA; [Gaunt, Michael W.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Acosta-Serrano, Alvaro; Rose, Clair] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Acosta-Serrano, Alvaro; Haines, Lee R.; Walshe, Deirdre P.; Ramphul, Urvashi N.; Lehane, Stella] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Koekemoer, Jacobus J. O.] Onderstepoort Vet Inst, Entomol Sect, ZA-110 Onderstepoort, South Africa; [Siwo, Geoffrey] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; Univ Pretoria, Dept Vet Trop Dis, ZA-110 Onderstepoort, South Africa; [Lawson, Daniel; Hughes, Daniel S. T.; Stanley, Eleanor J.] European Bioinformat Inst EMBL EBI, European Mol Biol Labs, Cambridge CB10 1SA, Cambs, England; [Benkahla, Alia] Inst Pasteur Tunis, Lab Med Parasitol Biotechnol & Biomol, Grp Bioinformat & Modeling, Tunis 1002, Tunisia; [Solano, Philippe; Koffi, Mathurin] CIRDES Bobo Dioulasso, UMR IRD CIRAD INTERTRYP 177, IRD, Bobo Dioulasso, Burkina Faso; [Ravel, Sophie] LRCT Campus Int Baillarguet, UMR IRD CIRAD INTERTRYP 177, IRD, Montpellier, France; [Larkin, Denis M.; Swain, Martin T.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Ceredigion, Wales; [Ommeh, Sheila] JKUAT, Biotechnol Res Inst, Nairobi, Kenya; [Darby, Alistair C.; Gregory, Richard] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Michalkova, Veronika] Slovak Acad Sci, Inst Zool, Bratislava 84506, Slovakia; [Sakate, Ryuichi; Imanishi, Tadashi; Kawahara, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Integrated Database Team, Koto Ku, Tokyo 1350064, Japan; [Wamwiri, Florence; Murilla, Grace; Auma, Joanna E.; Ouma, Johnson] Kenya Agr Res Inst, Trypanosomiasis Res Ctr, Kikuyu 902, Kenya; [Ribeiro, Jose M. C.] NIAID, Lab Malaria & Vector Res, Rockville, MD 20852 USA; [Stephens, Dawn; Makgamathe, Mmule] Technol Innovat Agcy, Natl Genom Platform, ZA-4058 Durban, South Africa; [Balyeidhusa, Apollo S. P.] Makerere Univ, Dept Biochem & Sports Sci, Kampala, Uganda; [Rawlings, Neil D.] EMBL European Bioinformat Inst, Wellcome Trust Sanger Inst, Bateman Grp, Cambridge CB10 1SA, Cambs, England; [Obiero, George F. O.; Kibet, Caleb K.] Int Ctr Insect Physiol & Ecol, Mol Biol & Bioinformat Unit, Nairobi, Kenya; [Okedi, Loyce; Abila, Patrick P.] Natl Livestock Resources Res Inst NaLIRRI, Tororo, Uganda; [Inoue, Noboru] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Hertz-Fowler, Christiane; Cotton, James A.; Sanders, Mandy J.; Quail, Michael A.; Aslett, Martin] Wellcome Trust Sanger Inst, Parasite Genom Grp, Cambridge CB10 1SA, Cambs, England; [Baumann, Aaron A.] Howard Hughes Med Inst, Riddiford Lab, Ashburn, VA 20147 USA; [Srivastava, Tulika P.; Sharma, Vineet; Sharma, Vineet] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Christoffels, Alan; Macharia, Rosaline W.; Dashti, Zahra Jalali Sefid; Wamalwa, Mark; Mwangi, Sarah; Panji, Sumir; Kruger, Adele; Mpondo, Feziwe; Harkins, Gordon] Univ Western Cape, South African MRC Bioinformat Unit, South African Natl Bioinformat Inst, ZA-7530 Bellville, South Africa; [Toure, Yeya] WHO, Special Programme Res & Training Trop Dis TDR, CH-1211 Geneva 27, Switzerland; [Warren, Wesley; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Msangi, Atway; Mramba, Furaha; Malele, Imna; Manangwa, Oliver] TTRI, Tanga, Tanzania; [Ouma, Johnson] Vector Hlth Int, Arusha, Tanzania; [Okoro, Chinyere K.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, Cambs, England; [Manga, Lucien] WHO, WHO Reg Off Africa, Brazzaville, Rep Congo; [Srivastava, Tulika P.] Indian Inst Technol, Sch Basic Sci, Mandi 175001, Himachal Prades, India; [Githinji, George] CGMRC, KEMRI Wellcome Trust Programme, Dept Parasite Vector & Human Biol, Kilifi, Kenya; [Watanabe, Junichi] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Kenyatta Univ, Dept Biochem & Biotechnol, Nairobi, Kenya; [Sharma, Vineet; Sharma, Vineet] Indian Inst Sci Educ & Res, Dept Biol Sci, Bhopal 462066, Madhya Pradesh, India; King Abdulaziz Univ, Fac Sci, Jeddah 21589, Saudi Arabia; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02461 USA; [Kawahara, Yoshihiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Bioinformat Res Unit, Tsukuba, Ibaraki 3058602, Japan	King Abdullah University of Science & Technology; California State University System; California State Polytechnic University Pomona; Alexander Fleming Biomedical Sciences Research Center; CEA; University of Nairobi; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Cape Town; Texas A&M University System; Texas A&M University College Station; Egerton University; Jomo Kenyatta University of Agriculture & Technology; Virginia Polytechnic Institute & State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University System of Ohio; University of Cincinnati; University of Cape Town; University of Wisconsin System; University of Wisconsin Parkside; Wayne State University; University of Pavia; Baylor University; KU Leuven; New Mexico State University; University of York - UK; West Virginia University; Institute of Tropical Medicine (ITM); University System of Georgia; University of Georgia; Covenant University; Texas A&M University System; Texas A&M University College Station; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign; International Atomic Energy Agency; University of Patras; Yale University; University System of Ohio; Ohio State University; University of Arizona; University of Arizona; University of Arizona; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Notre Dame; University of Pretoria; European Molecular Biology Laboratory (EMBL); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; CIRAD; Institut de Recherche pour le Developpement (IRD); CIRAD; Institut de Recherche pour le Developpement (IRD); Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Jomo Kenyatta University of Agriculture & Technology; University of Liverpool; Slovak Academy of Sciences; National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; International Centre of Insect Physiology & Ecology (ICIPE); Obihiro University of Agriculture & Veterinary Medicine; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; RIKEN; University of the Western Cape; World Health Organization; Washington University (WUSTL); Wellcome Trust Sanger Institute; World Health Organization; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; University of Tokyo; Kenyatta University; Indian Institute of Science Education & Research (IISER) - Bhopal; King Abdulaziz University; Harvard University; Harvard T.H. Chan School of Public Health; National Institute of Agrobiological Sciences - Japan	Aksoy, S (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06520 USA.	geoffrey.attardo@yale.edu; mb4@sanger.ac.uk; serap.aksoy@yale.edu	Murilla, Grace/AAI-8944-2020; Scott, Maxwell J/J-1935-2015; Obiero, George F. O./ABF-9688-2020; Telleria, Erich L/F-1580-2015; Abila, Patrick P'Odyek/T-1294-2018; Aksoy, Serap/K-2244-2019; Zhang, Qirui/C-6579-2011; Hattori, Masahira/C-6958-2016; Attardo, Geoffrey Michael/I-3320-2019; Larkin, Denis/AAB-1633-2022; Gomulski, Ludvik/AFK-3930-2022; Geiser, Dawn L/J-9923-2012; Marco, Heather/AAN-6213-2020; Hide, Winston Hide/C-7217-2009; Scolari, Francesca/ABC-2285-2020; Thomas, Gavin H/E-5753-2011; solano, philippe/B-2328-2010; Quail, michael/ABE-6131-2020; Mireji, Paul/M-3830-2019; Walshe, Deirdre/AAD-7716-2019; Gomulski, Ludvik/AAG-2709-2022; Riehle, Michael A/O-2852-2017; Hide, Winston/R-3815-2019; Acosta-Serrano, Alvaro/L-5503-2015; Larkin, Denis/AAB-2249-2022; Caljon, Guy/E-1310-2017; Ommeh, Sheila C/H-1505-2015; Wilson, Richard K./AAF-4139-2019; Ooi, Cher-Pheng/Q-9635-2018; Taylor, Todd/A-7121-2009; schoofs, liliane/ABD-2943-2020; Imanishi, Tadashi/R-3076-2019; LA Silva, Thiago/L-7699-2016; Berriman, Matthew/A-7618-2011; Ribeiro, Jose/J-7011-2015; Osamor, Victor/P-1264-2019; Ouma, Johnson/AAS-5044-2020; Haines, Lee/K-9264-2017; Wang, Jingwen/E-6932-2018; Christoffels, Alan/C-3269-2014; Hattori, Masahira/AAD-3785-2019; Hide, Winston A/V-2727-2017; Cotton, James A/B-8806-2008; Darby, Alistair/I-6485-2012; Schoofs, Liliane/F-2815-2010; Rawlings, Neil/M-5566-2013	Murilla, Grace/0000-0002-4753-2819; Scott, Maxwell J/0000-0001-6536-4735; Obiero, George F. O./0000-0001-5628-7002; Telleria, Erich L/0000-0003-0006-0057; Abila, Patrick P'Odyek/0000-0002-4487-1217; Aksoy, Serap/0000-0001-9941-143X; Zhang, Qirui/0000-0002-2749-9740; Hattori, Masahira/0000-0001-9467-0344; Attardo, Geoffrey Michael/0000-0001-6265-2969; Larkin, Denis/0000-0001-7859-6201; Geiser, Dawn L/0000-0002-6004-8407; Marco, Heather/0000-0003-3000-3010; Hide, Winston Hide/0000-0002-8621-3271; Scolari, Francesca/0000-0003-3085-9038; Thomas, Gavin H/0000-0002-9763-1313; solano, philippe/0000-0002-4351-3506; Mireji, Paul/0000-0002-7965-2428; Walshe, Deirdre/0000-0001-5531-2368; Hide, Winston/0000-0002-8621-3271; Acosta-Serrano, Alvaro/0000-0002-2576-7959; Caljon, Guy/0000-0002-4870-3202; Ommeh, Sheila C/0000-0002-0780-0399; Wilson, Richard K./0000-0002-1992-1358; Ooi, Cher-Pheng/0000-0002-1503-1155; Taylor, Todd/0000-0003-4247-6253; LA Silva, Thiago/0000-0002-8520-5405; Berriman, Matthew/0000-0002-9581-0377; Haines, Lee/0000-0001-8821-6479; Wang, Jingwen/0000-0002-6794-2604; Christoffels, Alan/0000-0002-0420-2916; Hide, Winston A/0000-0002-8621-3271; Cotton, James A/0000-0001-5475-3583; Darby, Alistair/0000-0002-3786-6209; Megy, Karyn/0000-0002-2826-3879; Baumann, Aaron/0000-0002-7410-8482; harkins, gordon w/0000-0003-0041-8047; Wamalwa, Mark/0000-0001-7714-2697; Githinji, George/0000-0001-9640-7371; Macdonald, Sandy/0000-0002-4112-0987; Gade, Gerd/0000-0002-7048-9660; Ribeiro, Jose/0000-0002-9107-0818; malacrida, anna/0000-0003-4566-8795; Mulder, Nicola J/0000-0003-4905-0941; Osamor, Victor/0000-0003-1868-0967; Marucha, Kevin/0000-0003-1438-2735; Tarone, Aaron/0000-0003-0965-7634; Nyanjom, Steven/0000-0002-6290-991X; Okoro, Chinyere/0000-0002-2466-304X; Van Den Abbeele, Jan/0000-0002-4533-4480; Field, Linda/0000-0002-3328-2513; GOMULSKI, LUDVIK/0000-0002-1506-7051; Masiga, Daniel/0000-0001-7513-0887; Auma, Joanna/0000-0002-0717-5554; Schoofs, Liliane/0000-0002-1673-432X; Bateta, Rosemary/0000-0002-2793-4837; K. Sharma, Vineet/0000-0002-2958-6215; Riehle, Michael/0000-0001-9747-3872; Kibet, Caleb/0000-0002-0312-4282; Lawson, Daniel/0000-0001-7765-983X; Rawlings, Neil/0000-0001-5557-7665; Koekemoer, Otto/0000-0003-3223-9078; Hall, Neil/0000-0003-2808-0009; Hertz-Fowler, Christiane/0000-0002-0729-6479; Benkahla, Alia/0000-0001-9988-3250; Imanishi, Tadashi/0000-0002-1182-9127; Malele, Imna/0000-0002-9343-7150	Wellcome Trust [085775/Z/08/Z, 098051]; World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) [A90088]; Ambrose Monell Foundation; Food and Agriculture Organization/International Atomic Energy Agency Coordinated Research Program "Improving SIT for Tsetse Flies through Research on their Symbionts"; European Union Cooperation in Science and Technology (COST) Action [FA0701]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Biotechnology and Biological Sciences Research Council [BB/J017698/1, BBS/E/C/00005194, BBS/E/C/00005193] Funding Source: researchfish; Medical Research Council [MR/K002279/1] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R03TW009444, D43TW007391, R03TW008413] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F32CA091768] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051584, R01AI081774] Funding Source: NIH RePORTER; BBSRC [BBS/E/C/00005194, BB/J017698/1, BBS/E/C/00005193] Funding Source: UKRI; MRC [MR/K002279/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR); Ambrose Monell Foundation; Food and Agriculture Organization/International Atomic Energy Agency Coordinated Research Program "Improving SIT for Tsetse Flies through Research on their Symbionts"; European Union Cooperation in Science and Technology (COST) Action; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The public release and future updates of the genome sequence and associated information are hosted at VectorBase (www.vectorbase.org). The genome sequence can also be found at GenBank under the accession no. CCAG010000000. The Glossina morsitans genome project was funded by the Wellcome Trust (grants 085775/Z/08/Z and 098051) and World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR) (project no. A90088) and the Ambrose Monell Foundation. Authors also acknowledge support by the Food and Agriculture Organization/International Atomic Energy Agency Coordinated Research Program "Improving SIT for Tsetse Flies through Research on their Symbionts," the European Union Cooperation in Science and Technology (COST) Action FA0701 "Arthropod Symbiosis: From Fundamental Studies to Pest and Disease Management," and a grant-in-aid for Scientific Research on Priority Areas "Comprehensive Genomics" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. H.). BAC libraries were generated through National Institute of Allergy and Infectious Diseases resources, and sequencing was supported by RIKEN Japan. We thank the staff in the library construction, sequence production, and informatics support groups at the Wellcome Trust Sanger Institute.	Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Aksoy S, 2005, TRENDS PARASITOL, V21, P107, DOI 10.1016/j.pt.2005.01.006; Alam U, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002415; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Attardo GM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002645; Benoit JB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003874; Benoit JB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002517; Bosco-Drayon V, 2012, CELL HOST MICROBE, V12, P153, DOI 10.1016/j.chom.2012.06.002; BRADY J, 1991, PHYSIOL ENTOMOL, V16, P153, DOI 10.1111/j.1365-3032.1991.tb00551.x; Brelsfoard C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002728; Caljon G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047233; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Dyer NA, 2013, TRENDS PARASITOL, V29, P188, DOI 10.1016/j.pt.2013.02.003; Elsik CG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-106; Friedrich M., 2010, ELS, DOI [10.1002/9780470015902.a0022898, DOI 10.1002/9780470015902.A0022898]; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; HARDIE R, 1989, J INSECT PHYSIOL, V35, P423, DOI 10.1016/0022-1910(89)90117-0; Hens K, 2004, INSECT MOL BIOL, V13, P615, DOI 10.1111/j.0962-1075.2004.00520.x; KAMINKER JS, 2002, GENOME BIOL, V0003; Lehane MJ, 2004, TRENDS PARASITOL, V20, P433, DOI 10.1016/j.pt.2004.07.002; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Lindh JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001661; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Michalkova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087554; NORDEN DA, 1969, COMP BIOCHEM PHYSIOL, V31, P819, DOI 10.1016/0010-406X(69)92082-9; Obiero GFO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002663; Petersen FT, 2007, MOL PHYLOGENET EVOL, V45, P111, DOI 10.1016/j.ympev.2007.04.023; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Rio RVM, 2012, MBIO, V3, DOI 10.1128/mBio.00240-11; Rose C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002691; Schmitt A, 2005, J EXP BIOL, V208, P1247, DOI 10.1242/jeb.01527; Telleria EL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002649; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; Weiss BL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003318; Weiss BL, 2012, J IMMUNOL, V188, P3395, DOI 10.4049/jimmunol.1103691; Welburn SC, 2009, PARASITOLOGY, V136, P1943, DOI 10.1017/S0031182009006416; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108	38	171	173	5	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					380	386		10.1126/science.1249656	http://dx.doi.org/10.1126/science.1249656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763584	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000334867800033
J	Letourneau, A; Santoni, FA; Bonilla, X; Sailani, MR; Gonzalez, D; Kind, J; Chevalier, C; Thurman, R; Sandstrom, RS; Hibaoui, Y; Garieri, M; Popadin, K; Falconnet, E; Gagnebin, M; Gehrig, C; Vannier, A; Guipponi, M; Farinelli, L; Robyr, D; Migliavacca, E; Borel, C; Deutsch, S; Feki, A; Stamatoyannopoulos, JA; Herault, Y; van Steensel, B; Guigo, R; Antonarakis, SE				Letourneau, Audrey; Santoni, Federico A.; Bonilla, Ximena; Sailani, M. Reza; Gonzalez, David; Kind, Jop; Chevalier, Claire; Thurman, Robert; Sandstrom, Richard S.; Hibaoui, Youssef; Garieri, Marco; Popadin, Konstantin; Falconnet, Emilie; Gagnebin, Maryline; Gehrig, Corinne; Vannier, Anne; Guipponi, Michel; Farinelli, Laurent; Robyr, Daniel; Migliavacca, Eugenia; Borel, Christelle; Deutsch, Samuel; Feki, Anis; Stamatoyannopoulos, John A.; Herault, Yann; van Steensel, Bas; Guigo, Roderic; Antonarakis, Stylianos E.			Domains of genome-wide gene expression dysregulation in Down's syndrome	NATURE			English	Article							PARTIAL TRISOMY; CELL-TYPE; CHROMATIN; BIOTINYLATION; TRANSCRIPTOME; PROLIFERATION; CHROMOSOME; PLASTICITY; PHENOTYPES; PACKAGE	Trisomy 21 is the most frequent genetic cause of cognitive impairment. To assess the perturbations of gene expression in trisomy 21, and to eliminate the noise of genomic variability, we studied the transcriptome of fetal fibroblasts from a pair of monozygotic twins discordant for trisomy 21. Here we show that the differential expression between the twins is organized in domains along all chromosomes that are either upregulated or downregulated. These gene expression dysregulation domains (GEDDs)can be defined by the expression level of their gene content, and are well conserved in induced pluripotent stem cells derived from the twins' fibroblasts. Comparison of the transcriptome of the Ts65Dn mouse model of Down's syndrome and normal littermate mouse fibroblasts also showed GEDDs along the mouse chromosomes that were syntenic in human. The GEDDs correlate with the lamina- associated (LADs)and replication domains of mammalian cells. The overall position of LADs was not altered in trisomic cells; however, the H3K4me3 profile of the trisomic fibroblasts was modified and accurately followed the GEDD pattern. These results indicate that the nuclear compartments of trisomic cells undergo modifications of the chromatin environment influencing the overall transcriptome, and that GEDDs may therefore contribute to some trisomy 21 phenotypes.	[Letourneau, Audrey; Santoni, Federico A.; Bonilla, Ximena; Sailani, M. Reza; Garieri, Marco; Popadin, Konstantin; Falconnet, Emilie; Gagnebin, Maryline; Gehrig, Corinne; Vannier, Anne; Guipponi, Michel; Robyr, Daniel; Migliavacca, Eugenia; Borel, Christelle; Antonarakis, Stylianos E.] Univ Hosp Geneva, Univ Geneva Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Gonzalez, David; Guigo, Roderic] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Kind, Jop; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Chevalier, Claire; Herault, Yann] Univ Strasbourg, INSERM, CNRS, Translat Med & Neurosci Program,IGBMC,ICS,PHENOMI, F-67404 Illkirch Graffenstaden, France; [Thurman, Robert; Sandstrom, Richard S.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hibaoui, Youssef; Feki, Anis] Univ Hosp Geneva, Dept Obstet & Gynecol, Stem Cell Res Lab, CH-1211 Geneva, Switzerland; [Farinelli, Laurent] FASTERIS SA, CH-1228 Plan Les Ouates, Switzerland; [Migliavacca, Eugenia] Swiss Inst Bioinfomat, CH-1211 Geneva, Switzerland; [Deutsch, Samuel] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Antonarakis, Stylianos E.] iGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Netherlands Cancer Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Washington; University of Washington Seattle; University of Geneva; Swiss Institute of Bioinformatics; United States Department of Energy (DOE)	Antonarakis, SE (corresponding author), Univ Hosp Geneva, Univ Geneva Med Sch, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Stylianos.Antonarakis@unige.ch	Guigo, Roderic/D-1303-2010; Herault, Yann/B-5500-2012; Antonarakis, Stylianos E/N-8866-2014; Bonilla, Ximena/AAI-7910-2021; borel, christelle/AAC-9645-2019; Popadin, Konstantin/L-7459-2017	Guigo, Roderic/0000-0002-5738-4477; Herault, Yann/0000-0001-7049-6900; Antonarakis, Stylianos E/0000-0001-8907-5823; Deutsch, Samuel/0000-0001-9456-7101; Sandstrom, Richard/0000-0002-3356-1547; Santoni, Federico/0000-0002-3258-4747; Feki, Anis/0000-0002-9817-9445; Bonilla, Ximena/0000-0002-4950-6825	Swiss National Science Foundation [SNF-144082]; European Research Council [ERC-249968]; AnEUploidy grant; Lejeune foundation; ChildCare foundation; Spanish MICINN [BIO2011-26205, ERC-294653]; NWO-ALW-VICI; CNRS; INSERM; University of Strasbourg; NIH [U54HG007010]; Genico and Ernest Boninchi foundation; BluePrint EU grant;  [ANR-10-INBS-07]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007010] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); AnEUploidy grant; Lejeune foundation; ChildCare foundation; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NWO-ALW-VICI(Netherlands Organization for Scientific Research (NWO)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genico and Ernest Boninchi foundation; BluePrint EU grant; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Swiss National Science Foundation (SNF-144082), the European Research Council (ERC-249968), AnEUploidy and BluePrint EU grants, the Lejeune, and ChildCare foundations for supporting the S.E.A. laboratory. The laboratories of R.G. were supported by Spanish MICINN (BIO2011-26205) and ERC-294653, B.v.S. by NWO-ALW-VICI, Y. He. by CNRS, INSERM, University of Strasbourg and ANR-10-INBS-07, J.A.S. by NIH U54HG007010, and A.F. by Genico and Ernest Boninchi foundation. Wethank S. Dahoun and J.L. Blouin for the discordant twins sample collection.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bakshi R, 2010, J CELL PHYSIOL, V225, P569, DOI 10.1002/jcp.22240; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Costa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018493; Dahoun S, 2008, AM J MED GENET A, V146A, P2086, DOI 10.1002/ajmg.a.32431; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Grad I, 2011, Eur Cell Mater, V22, P258; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2003, DEV DYNAM, V227, P608, DOI 10.1002/dvdy.10344; John Sam, 2013, Curr Protoc Mol Biol, VChapter 27, DOI 10.1002/0471142727.mb2127s103; Knowles DG, 2013, BIOINFORMATICS, V29, P614, DOI 10.1093/bioinformatics/btt016; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Letourneau A, 2012, PROG BRAIN RES, V197, P15, DOI 10.1016/B978-0-444-54299-1.00002-9; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pestinger V, 2011, J NUTR BIOCHEM, V22, P328, DOI 10.1016/j.jnutbio.2010.02.011; Pope BD, 2012, HUM MOL GENET, V21, P4162, DOI 10.1093/hmg/dds232; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Pritchard MA, 1999, J NEURAL TRANSM-SUPP, P293; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SHAPIRO BL, 1983, AM J MED GENET, V14, P241, DOI 10.1002/ajmg.1320140206; Singh MP, 2013, ARCH BIOCHEM BIOPHYS, V529, P105, DOI 10.1016/j.abb.2012.11.005; Sommer CA, 2008, GENOME, V51, P19, DOI [10.1139/G07-100, 10.1139/g07-100]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zhu N, 2010, BBA-GENE REGUL MECH, V1799, P74, DOI 10.1016/j.bbagrm.2009.11.006; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	57	190	193	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					345	+		10.1038/nature13200	http://dx.doi.org/10.1038/nature13200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24740065				2022-12-24	WOS:000334403000042
J	Crawley, SW; Shifrin, DA; Grega-Larson, NE; McConnell, RE; Benesh, AE; Mao, SL; Zheng, YX; Zheng, QY; Nam, KT; Millis, BA; Kachar, B; Tyska, MJ				Crawley, Scott W.; Shifrin, David A., Jr.; Grega-Larson, Nathan E.; McConnell, Russell E.; Benesh, Andrew E.; Mao, Suli; Zheng, Yuxi; Zheng, Qing Yin; Nam, Ki Taek; Millis, Bryan A.; Kachar, Bechara; Tyska, Matthew J.			Intestinal Brush Border Assembly Driven by Protocadherin-Based Intermicrovillar Adhesion	CELL			English	Article							USHER-SYNDROME PROTEINS; SENSORY HAIR-CELLS; IN-VIVO; CADHERIN; LOCALIZATION; MECHANOTRANSDUCTION; ORGANIZATION; HARMONIN; DOMAIN; GENE	Transporting epithelial cells build apical microvilli to increase membrane surface area and enhance absorptive capacity. The intestinal brush border provides an elaborate example with tightly packed microvilli that function in nutrient absorption and host defense. Although the brush border is essential for physiological homeostasis, its assembly is poorly understood. We found that brush border assembly is driven by the formation of Ca2+-dependent adhesion links between adjacent microvilli. Intermicrovillar links are composed of protocadherin-24 and mucin-like protocadherin, which target to microvillar tips and interact to form a trans-heterophilic complex. The cytoplasmic domains of microvillar protocadherins interact with the scaffolding protein, harmonin, and myosin-7b, which promote localization to microvillar tips. Finally, a mouse model of Usher syndrome lacking harmonin exhibits microvillar protocadherin mislocalization and severe defects in brush border morphology. These data reveal an adhesion-based mechanism for brush border assembly and illuminate the basis of intestinal pathology in patients with Usher syndrome.	[Crawley, Scott W.; Shifrin, David A., Jr.; Grega-Larson, Nathan E.; McConnell, Russell E.; Benesh, Andrew E.; Mao, Suli; Tyska, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Zheng, Yuxi; Zheng, Qing Yin] Case Western Reserve Univ, Dept Otolaryngol HNS, Cleveland, OH 44106 USA; [Nam, Ki Taek] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea; [Millis, Bryan A.; Kachar, Bechara] NIDCD, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Case Western Reserve University; Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Tyska, MJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	matthew.tyska@vanderbilt.edu		/0000-0001-5063-8502; Millis, Bryan/0000-0002-5770-627X	NIDCD; NIH; American Heart Association (AHA); AHA [12GRNT12050314]; VUMC Digestive Diseases Research Center [NIH P30DK058404]; Vanderbilt University IDEAS award; NIH [DC009246, DK075555, DK095811]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095811, R56DK095811, R01DK075555, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000002, R01DC009246, ZIADC000009] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012324] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA(American Heart Association); VUMC Digestive Diseases Research Center; Vanderbilt University IDEAS award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank all members of the M.J.T. laboratory and the Vanderbilt Epithelial Biology Center for advice and support. Electron and light microscopy was performed in part through the use of the VUMC Cell Imaging Shared Resource. This work was supported by Intramural Programs of NIDCD, NIH (to B.K.), American Heart Association (AHA) predoctoral fellowships (to D.A.S. and R.E.M.), AHA postdoctoral fellowship (to S.W.C.), AHA grant-in-aid 12GRNT12050314 (to M.J.T.), the VUMC Digestive Diseases Research Center (NIH P30DK058404), a Vanderbilt University IDEAS award (to M.J.T.), and NIH DC009246 (to Q.Y.Z.), DK075555, and DK095811 (to M.J.T.).	Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; BAILEY DS, 1989, GUT, V30, P78, DOI 10.1136/gut.30.1.78; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; D'Alterio C, 2005, J CELL BIOL, V171, P549, DOI 10.1083/jcb.200507072; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Goldberg M, 2000, J BIOL CHEM, V275, P24622, DOI 10.1074/jbc.M000234200; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Grimm-Gunter EMS, 2009, MOL BIOL CELL, V20, P2549, DOI 10.1091/mbc.E08-10-1030; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Jeejeebhoy KN, 2002, CAN MED ASSOC J, V166, P1297; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Khubchandani SR, 2011, ULTRASTRUCT PATHOL, V35, P87, DOI 10.3109/01913123.2010.537438; Kobayashi I, 1999, GASTROENTEROLOGY, V117, P823, DOI 10.1016/S0016-5085(99)70340-9; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; MAROUX S, 1988, BIOCHIMIE, V70, P1297, DOI 10.1016/0300-9084(88)90198-8; McConnell RE, 2011, AM J PHYSIOL-GASTR L, V300, pG914, DOI 10.1152/ajpgi.00005.2011; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Pan LF, 2012, PHYSIOLOGY, V27, P25, DOI 10.1152/physiol.00037.2011; PETERSON MD, 1992, J CELL SCI, V102, P581; Revenu C, 2012, MOL BIOL CELL, V23, P324, DOI 10.1091/mbc.E11-09-0765; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shifrin DA, 2012, GUT MICROBES, V3, P460, DOI 10.4161/gmic.21247; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Tian C, 2010, BRAIN RES, V1328, P57, DOI 10.1016/j.brainres.2010.02.079; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.e04-12-1116; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Vallance BA, 2002, CAN J GASTROENTEROL, V16, P771, DOI 10.1155/2002/410980; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Widmark Jill M, 2007, Proc (Bayl Univ Med Cent), V20, P408	50	102	109	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					433	446		10.1016/j.cell.2014.01.067	http://dx.doi.org/10.1016/j.cell.2014.01.067			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725409	Bronze, Green Accepted			2022-12-24	WOS:000334304500016
J	Liu, BY; Chen, W; Evavold, BD; Zhu, C				Liu, Baoyu; Chen, Wei; Evavold, Brian D.; Zhu, Cheng			Accumulation of Dynamic Catch Bonds between TCR and Agonist Peptide-MHC Triggers T Cell Signaling	CELL			English	Article							LIGAND BINDING-KINETICS; CUTTING EDGE; ADHESION; REQUIRE; SURFACES; AFFINITY; WASP; ZETA	TCR-pMHC interactions initiate adaptive immune responses, but the mechanism of how such interactions under force induce T cell signaling is unclear. We show that force prolongs lifetimes of single TCR-pMHC bonds for agonists (catch bonds) but shortens those for antagonists (slip bonds). Both magnitude and duration of force are important, as the highest Ca2+ responses were induced by 10 pN via both pMHC catch bonds whose lifetime peaks at this force and anti-TCR slip bonds whose maximum lifetime occurs at 0 pN. High Ca2+ levels require early and rapid accumulation of bond lifetimes, whereas short-lived bonds that slow early accumulation of lifetimes correspond to low Ca2+ responses. Our data support a model in which force on the TCR induces signaling events depending on its magnitude, duration, frequency, and timing, such that agonists form catch bonds that trigger the T cell digitally, whereas antagonists form slip bonds that fail to activate.	[Liu, Baoyu; Chen, Wei; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Evavold, Brian D.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University	Zhu, C (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Liu, Baoyu/C-4911-2009; Chen, Wei/C-4823-2009	Liu, Baoyu/0000-0002-0798-6314; Evavold, Brian/0000-0002-3561-3494; Chen, Wei/0000-0001-5366-7253; Zhu, Cheng/0000-0002-1718-565X	NIH [AI38282, GM096187, NS071518, AI096879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610, R29AI038282, R01AI038282, R56AI038282, R01AI096879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the NIH Tetramer Core Facility at Emory University for providing pMHC monomers, John Altman for providing the H2-K<SUP>b</SUP>alpha 3A2 construct, Larissa Doudy for purifying T cells, Michelle Krogsgaard for advice on Ca<SUP>2+</SUP> imaging, Lining Ju for constructing the BFP-2, Jin-sung Hong for initial design of the Ca<SUP>2+</SUP> imaging system, Yunfeng Chen for designing the temperature control unit, Qinghua Ji for designing the cell chamber, Li Gu for help on statistical analysis, and Rodger P. McEver, Ellis L. Reinherz, Michelle Krogsgaard, Hai-Tao He, and Jeffrey A. Donnell for helpful comments. This work was supported by NIH grants AI38282 and GM096187 (to C.Z.) and NS071518 and AI096879 (to B.D.E.). The authors declare no competing financial interests.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Dushek O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000578; EVANS E, 1995, BIOPHYS J, V68, P2580, DOI 10.1016/S0006-3495(95)80441-8; Gascoigne N R, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002502; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Jansson Andreas, 2011, Self Nonself, V2, P1; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kilgore NE, 2003, J IMMUNOL, V170, P4891, DOI 10.4049/jimmunol.170.10.4891; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; Majstoravich S, 2004, BLOOD, V104, P1396, DOI 10.1182/blood-2004-02-0437; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Mukhopadhyay H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003004; Puech PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022344; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yao DK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021907; Zarnitsyna VI, 2007, P NATL ACAD SCI USA, V104, P18037, DOI 10.1073/pnas.0704811104; Zhang H, 2011, P NATL ACAD SCI USA, V108, P19323, DOI 10.1073/pnas.1108052108; Zhu C, 2013, IMMUNOL REV, V251, P49, DOI 10.1111/imr.12016	47	328	335	7	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					357	368		10.1016/j.cell.2014.02.053	http://dx.doi.org/10.1016/j.cell.2014.02.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725404	Bronze, Green Accepted			2022-12-24	WOS:000334304500010
J	Muller, D; Cherukuri, P; Henningfeld, K; Poh, CH; Wittler, L; Grote, P; Schluter, O; Schmidt, J; Laborda, J; Bauer, SR; Brownstone, RM; Marquardt, T				Mueller, Daniel; Cherukuri, Pitchaiah; Henningfeld, Kristine; Poh, Chor Hoon; Wittler, Lars; Grote, Phillip; Schlueter, Oliver; Schmidt, Jennifer; Laborda, Jorge; Bauer, Steven R.; Brownstone, Robert M.; Marquardt, Till			Dlk1 Promotes a Fast Motor Neuron Biophysical Signature Required for Peak Force Execution	SCIENCE			English	Article							MUSCLE; UNITS; INNERVATION; CHANNEL; PROTEIN; CELLS; SIZE	Motor neurons, which relay neural commands to drive skeletal muscle movements, encompass types ranging from "slow" to "fast," whose biophysical properties govern the timing, gradation, and amplitude of muscle force. Here we identify the noncanonical Notch ligand Delta-like homolog 1 (Dlk1) as a determinant of motor neuron functional diversification. Dlk1, expressed by similar to 30% of motor neurons, is necessary and sufficient to promote a fast biophysical signature in the mouse and chick. Dlk1 suppresses Notch signaling and activates expression of the K+ channel subunit Kcng4 to modulate delayed-rectifier currents. Dlk1 inactivation comprehensively shifts motor neurons toward slow biophysical and transcriptome signatures, while abolishing peak force outputs. Our findings provide insights into the development of motor neuron functional diversity and its contribution to the execution of movements.	[Mueller, Daniel; Cherukuri, Pitchaiah; Poh, Chor Hoon; Marquardt, Till] European Neurosci Inst ENI G, Dev Neurobiol Lab, D-37077 Gottingen, Germany; [Henningfeld, Kristine] Univ Med Ctr Gottingen, Inst Dev Biochem, D-37077 Gottingen, Germany; [Henningfeld, Kristine; Marquardt, Till] Ctr Nanoscale Microscopy & Mol Physiol Brain, Gottingen, Germany; [Wittler, Lars; Grote, Phillip] Max Planck Inst Mol Genet, Dept Dev Genet, D-14195 Berlin, Germany; [Schlueter, Oliver] ENI G, Mol Neurobiol Lab, D-37077 Gottingen, Germany; [Schmidt, Jennifer] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Laborda, Jorge] Univ Castilla La Mancha, Sch Med, Dept Inorgan & Organ Chem & Biochem, Albacete 02006, Spain; [Bauer, Steven R.] USDA, Cellular & Tissue Therapies Branch, Div Cellular & Gene Therapies, Ctr Biol & Res, Bethesda, MD 20892 USA; [Brownstone, Robert M.] Dalhousie Univ, QEII Hlth Sci Ctr, Dept Surg, Halifax, NS B3H 4R2, Canada; [Brownstone, Robert M.] Dalhousie Univ, QEII Hlth Sci Ctr, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada	University of Gottingen; Max Planck Society; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidad de Castilla-La Mancha; United States Department of Agriculture (USDA); Dalhousie University; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Queen Elizabeth II Health Sciences Centre	Marquardt, T (corresponding author), European Neurosci Inst ENI G, Dev Neurobiol Lab, Grisebachstr 5, D-37077 Gottingen, Germany.	t.marquardt@eni-g.de	Laborda, Jorge/L-5726-2014; Grote, Phillip/AAG-9188-2020	Laborda, Jorge/0000-0002-9210-838X; Grote, Phillip/0000-0002-9254-1458; Brownstone, Robert/0000-0001-5135-2725	European Research Council under the European Union [311710 MU TUNING]; Emmy-Noether Program of the Deutsche Forschungsgemeinschaft [MA4278/1-1]; Center for Biologics Evaluation and Research, Food and Drug Administration; Emmy-Noether Program [SCHL592-4]; Canadian Institutes of Health Research; Canada Research Chairs Program; Canada Foundation for Innovation; Nova Scotia Research and Innovation Trust; Ministerio de Educacion y Ciencia, Spain; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042013] Funding Source: NIH RePORTER	European Research Council under the European Union(European Research Council (ERC)); Emmy-Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biologics Evaluation and Research, Food and Drug Administration; Emmy-Noether Program(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Nova Scotia Research and Innovation Trust; Ministerio de Educacion y Ciencia, Spain(Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Klusowski, B. Veith, T. V. Bui, and T. G. Hampton for technical support; S. Schiaffino and K. Kawakami for reagents; P. D'Adamo for phenotyping service; and O. Shomroni and S. Bonn for bioinformatics advice. This research received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement 311710 MU TUNING and the Emmy-Noether Program of the Deutsche Forschungsgemeinschaft (MA4278/1-1). S.R.B. was supported by the Center for Biologics Evaluation and Research, Food and Drug Administration, operating funds; O.S. by the Emmy-Noether Program (SCHL592-4); R.M.B. by the Canadian Institutes of Health Research, Canada Research Chairs Program, Canada Foundation for Innovation, and Nova Scotia Research and Innovation Trust; and J.L. by the Ministerio de Educacion y Ciencia, Spain, from whom Dlk1<SUP>ko</SUP> mice are available through a materials transfer agreement. Dlk1<SUP>fx</SUP> mice are deposited at jaxmice.jax.org (no. 019074). Notch1:Gal4 is available Iron R. Kopan (Cincinnati Children's Hospital Medical Center). ENI-G is a cooperation of University Medical Center Gottingen and the Max-Planck Society.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; BAKELS R, 1993, J PHYSIOL-LONDON, V463, P307, DOI 10.1113/jphysiol.1993.sp019596; BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; ECCLES JC, 1957, NATURE, V179, P866, DOI 10.1038/179866b0; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; FLADBY T, 1990, DEVELOPMENT, V109, P723; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; GUSTAFSSON B, 1985, TRENDS NEUROSCI, V8, P431, DOI 10.1016/0166-2236(85)90152-3; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; KERNELL D, 1966, SCIENCE, V152, P1637, DOI 10.1126/science.152.3729.1637; Kernell D, 2006, MOTONEURON ITS MUSCL; Manuel M, 2011, J NEUROSCI, V31, P15188, DOI 10.1523/JNEUROSCI.2893-11.2011; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Rafuse VF, 1996, J NEUROSCI, V16, P6864; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; THOMPSON WJ, 1984, NATURE, V309, P709, DOI 10.1038/309709a0; Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089; ZENGEL JE, 1985, J NEUROPHYSIOL, V53, P1323, DOI 10.1152/jn.1985.53.5.1323	25	44	45	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1264	1266		10.1126/science.1246448	http://dx.doi.org/10.1126/science.1246448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626931	Green Submitted, Green Published			2022-12-24	WOS:000332728500040
J	Xu, TD; Dai, N; Chen, JS; Nagawa, S; Cao, M; Li, HJ; Zhou, ZM; Chen, X; De Rycke, R; Rakusova, H; Wang, WY; Jones, AM; Friml, J; Patterson, SE; Bleecker, AB; Yang, ZB				Xu, Tongda; Dai, Ning; Chen, Jisheng; Nagawa, Shingo; Cao, Min; Li, Hongjiang; Zhou, Zimin; Chen, Xu; De Rycke, Riet; Rakusova, Hana; Wang, Wuyi; Jones, Alan M.; Friml, Jiri; Patterson, Sara E.; Bleecker, Anthony B.; Yang, Zhenbiao			Cell Surface ABP1-TMK Auxin-Sensing Complex Activates ROP GTPase Signaling	SCIENCE			English	Article							BOX PROTEIN TIR1; BINDING PROTEIN-1; PLASMA-MEMBRANE; ARABIDOPSIS ROOTS; RECEPTOR; EXPANSION; ENDOCYTOSIS; DIVISION; PATHWAY; TOBACCO	Auxin-binding protein 1 (ABP1) was discovered nearly 40 years ago and was shown to be essential for plant development and morphogenesis, but its mode of action remains unclear. Here, we report that the plasma membrane-localized transmembrane kinase (TMK) receptor-like kinases interact with ABP1 and transduce auxin signal to activate plasma membrane-associated ROPs [Rho-like guanosine triphosphatases (GTPase) from plants], leading to changes in the cytoskeleton and the shape of leaf pavement cells in Arabidopsis. The interaction between ABP1 and TMK at the cell surface is induced by auxin and requires ABP1 sensing of auxin. These findings show that TMK proteins and ABP1 form a cell surface auxin perception complex that activates ROP signaling pathways, regulating nontranscriptional cytoplasmic responses and associated fundamental processes.	[Xu, Tongda; Chen, Jisheng; Nagawa, Shingo; Li, Hongjiang; Yang, Zhenbiao] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Xu, Tongda; Cao, Min; Zhou, Zimin] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Xu, Tongda; Nagawa, Shingo; Wang, Wuyi; Yang, Zhenbiao] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai 200032, Peoples R China; [Dai, Ning; Bleecker, Anthony B.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Li, Hongjiang; Chen, Xu; De Rycke, Riet; Rakusova, Hana; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Li, Hongjiang; Chen, Xu; De Rycke, Riet; Rakusova, Hana; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Li, Hongjiang; Chen, Xu; Rakusova, Hana; Friml, Jiri] IST Austria, A-3400 Klosterneuburg, Austria; [Wang, Wuyi; Patterson, Sara E.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Friml, Jiri] Masaryk Univ, CEITEC MU, Mendel Ctr Plant Genom & Prote, CZ-62500 Brno, Czech Republic; [Yang, Zhenbiao] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China	University of California System; University of California Riverside; National University of Singapore; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Institute of Science & Technology - Austria; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Masaryk University Brno; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, ZB (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	yang@ucr.edu	Friml, Jiri/D-9511-2012; Xu, Tongda/ABD-9589-2020	Friml, Jiri/0000-0002-8302-7596; Li, Hongjiang/0000-0001-5039-9660; Xu, Tongda/0000-0003-3398-9217; Chen, Xu/0000-0002-5166-083X	U.S. National Institute of General Medical Sciences [GM081451, GM065989]; European Research Council [ERC-2011-StG-20101109-PSDP]; CEITEC - Central European Institute of Technology [CZ.1.05/1.1.00/02.0068]; University of Wisconsin HATCH; Agency for Innovation by Science and Technology (IWT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM081451, R01GM100130] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Research Council(European Research Council (ERC)European Commission); CEITEC - Central European Institute of Technology; University of Wisconsin HATCH; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to X. Chen, N. Raikhel, V. Gonehal, and members of the Yang laboratory for their stimulating discussion and critical comments on this manuscript. This work is supported by grants from the U.S. National Institute of General Medical Sciences to Z.Y. (GM081451) and A.M.J. (GM065989), the European Research Council (project ERC-2011-StG-20101109-PSDP) and CEITEC - Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) to J.F., and University of Wisconsin HATCH support to S. E. P. Requests for tmk mutant seeds described in this work must be sent to N. D. (ning@molbio.mgh.harvard.edu). Predoctoral fellowship from the Agency for Innovation by Science and Technology (IWT) to H.R.	Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; Dai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060990; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DIEKMANN W, 1995, P NATL ACAD SCI USA, V92, P3425, DOI 10.1073/pnas.92.8.3425; Effendi Y, 2011, PLANT J, V65, P282, DOI 10.1111/j.1365-313X.2010.04420.x; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; KLAMBT D, 1990, PLANT MOL BIOL, V14, P1045, DOI 10.1007/BF00019401; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Lin DS, 2012, CURR BIOL, V22, P1319, DOI 10.1016/j.cub.2012.05.019; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; OLIVER SC, 1995, PLANTA, V197, P465, DOI 10.1007/BF00196668; RAY PM, 1977, PLANT PHYSIOL, V59, P357, DOI 10.1104/pp.59.3.357; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Shi JH, 2011, MOL PLANT, V4, P635, DOI 10.1093/mp/ssr050; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TIAN HC, 1995, J BIOL CHEM, V270, P26962, DOI 10.1074/jbc.270.45.26962; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233	30	185	205	13	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1025	1028		10.1126/science.1245125	http://dx.doi.org/10.1126/science.1245125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578577	Green Submitted, Green Accepted			2022-12-24	WOS:000332309600046
J	Brady, DC; Crowe, MS; Turski, ML; Hobbs, GA; Yao, XJ; Chaikuad, A; Knapp, S; Xiao, KH; Campbell, SL; Thiele, DJ; Counter, CM				Brady, Donita C.; Crowe, Matthew S.; Turski, Michelle L.; Hobbs, G. Aaron; Yao, Xiaojie; Chaikuad, Apirat; Knapp, Stefan; Xiao, Kunhong; Campbell, Sharon L.; Thiele, Dennis J.; Counter, Christopher M.			Copper is required for oncogenic BRAF signalling and tumorigenesis	NATURE			English	Article							CATALYZED OXIDATION REACTIONS; MEK INHIBITION; IN-VIVO; BETA(2)-ADRENERGIC RECEPTOR; MASS-SPECTROMETRY; RAS ONCOGENESIS; CANCER; MUTATIONS; ACTIVATION; MELANOMA	The BRAF kinase is mutated, typically Val 600 -> Glu (V600E), to induce an active oncogenic state in a large fraction of melanomas, thyroid cancers, hairy cell leukaemias and, to a smaller extent, a wide spectrum of other cancers(1,2). BRAF(V600E) phosphorylates and activates the MEK1 andMEK2 kinases, which in turn phosphorylate and activate the ERK1 and ERK2 kinases, stimulating the mitogen-activated protein kinase (MAPK) pathway to promote cancer(3). Targeting MEK1/2 is proving to be an important therapeutic strategy, given that a MEK1/2 inhibitor provides a survival advantage in metastatic melanoma(4), an effect that is increased when administered together with a BRAF(V600E) inhibitor(5). We previously found that copper (Cu) influx enhances MEK1 phosphorylation of ERK1/2 through a Cu-MEK1 interaction(6). Here we show decreasing the levels of CTR1 (Cu transporter 1), or mutations in MEK1 that disrupt Cu binding, decreased BRAF(V600E)-driven signalling and tumorigenesis in mice and human cell settings. Conversely, a MEK1-MEK5 chimaera that phosphorylated ERK1/2 independently of Cu or an active ERK2 restored the tumour growth of murine cells lacking Ctrl1. Cu chelators used in the treatment of Wilson disease(7) decreased tumour growth of human or murine cells transformed by BRAF(V600E) or engineered to be resistant to BRAF inhibition. Taken together, these results suggest that Cu-chelation therapy could be repurposed to treat cancers containing the BRAF(V600E) mutation.	[Brady, Donita C.; Crowe, Matthew S.; Turski, Michelle L.; Thiele, Dennis J.; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Hobbs, G. Aaron; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yao, Xiaojie; Xiao, Kunhong] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Chaikuad, Apirat; Knapp, Stefan] Univ Oxford, Target Discovery Inst, Nuffield Dept Clin Med, Oxford OX3 7DQ, England; [Chaikuad, Apirat; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Counter, Christopher M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Oxford; University of Oxford; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	chris.counter@duke.edu	Xiao, Kunhong/AAG-4275-2020; Knapp, Stefan/AAG-2347-2019	Xiao, Kunhong/0000-0002-1069-1226; Knapp, Stefan/0000-0001-5995-6494; Counter, Christopher M/0000-0003-0748-3079; campbell, sharon/0000-0003-0311-409X; Chaikuad, Apirat/0000-0003-1120-2209; Hobbs, Aaron/0000-0002-4751-9681; Crowe, Matthew/0000-0001-5251-0238	National Institutes of Health [CA178145, HL075443, DK074192, CA094184, CA172104]; Structural Genomics Consortium (Welcome Trust) [092809/Z/10/Z]; FP7 grant [278568]; Stewart Trust; Edward Spiegel Fund of the Lymphoma Foundation; NATIONAL CANCER INSTITUTE [R01CA094184, R21CA172104, R01CA089614, P30CA014236, P30CA016086, K01CA178145] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570, T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Genomics Consortium (Welcome Trust); FP7 grant; Stewart Trust; Edward Spiegel Fund of the Lymphoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. McMahon, C. Cronin, E. Johnson, A. Stewart, D. S. Tyler and D. G. Kirsch for reagents, and C. Cronin, L. E. Crose, A. M. Jaeger, M. A. Luftig, E. Johnson, D. F. Kashatus, B. L. Lampson, J. P. Madigan, N. I. Nicely, Y. Nose, C. W. Pemble, N. L. K. Pershing, A. Stewart and J. D. Weyandt for technical support, discussions and/or review of the manuscript. This work was supported by National Institutes of Health grants CA178145 (D. C. B.), HL075443 (Proteomic Core K. X.), DK074192 (D. J. T.), CA094184 and CA172104 (C. M. C.), the Structural Genomics Consortium (Welcome Trust 092809/Z/10/Z), FP7 grant 278568 'PRIMES' (S. K. and A. C.), the Stewart Trust (C. M. C.), the Edward Spiegel Fund of the Lymphoma Foundation (C. M. C.), and donations made in memory of Linda Woolfenden (C.M.C.).	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Augustine CK, 2010, MOL CANCER THER, V9, P2090, DOI 10.1158/1535-7163.MCT-10-0073; Bertinato J, 2003, J BIOL CHEM, V278, P35071, DOI 10.1074/jbc.M302242200; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Bridgewater JD, 2005, ANAL BIOCHEM, V341, P122, DOI 10.1016/j.ab.2005.02.034; Bridgewater JD, 2006, J AM SOC MASS SPECTR, V17, P1552, DOI 10.1016/j.jasms.2006.06.003; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; HUANG WD, 1995, MOL BIOL CELL, V6, P237, DOI 10.1091/mbc.6.3.237; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lampson BL, 2012, CANCER RES, V72, P4472, DOI 10.1158/0008-5472.CAN-12-0057; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; O'Hayer KM, 2009, CARCINOGENESIS, V30, P1841, DOI 10.1093/carcin/bgp198; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Scholl FA, 2004, CANCER RES, V64, P6035, DOI 10.1158/0008-5472.CAN-04-0017; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tsai CY, 2012, BIOCHEM PHARMACOL, V84, P1007, DOI 10.1016/j.bcp.2012.07.014; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zipfel PA, 2010, ONCOGENE, V29, P4859, DOI 10.1038/onc.2010.224	42	302	312	10	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					492	+		10.1038/nature13180	http://dx.doi.org/10.1038/nature13180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24717435	Green Accepted, Green Submitted			2022-12-24	WOS:000336126000039
J	Durruthy-Durruthy, R; Gottlieb, A; Hartman, BH; Waldhaus, J; Laske, RD; Altman, R; Heller, S				Durruthy-Durruthy, Robert; Gottlieb, Assaf; Hartman, Byron H.; Waldhaus, Joerg; Laske, Roman D.; Altman, Russ; Heller, Stefan			Reconstruction of the Mouse Otocyst and Early Neuroblast Lineage at Single-Cell Resolution	CELL			English	Article							MAMMALIAN INNER-EAR; AUDITORY-SYSTEM DEVELOPMENT; SENSORY EPITHELIA; GENE-EXPRESSION; MORPHOGENESIS; NEURONS; MICE; SPECIFICATION; INSIGHTS; EMBRYO	The otocyst harbors progenitors for most cell types of the mature inner ear. Developmental lineage analyses and gene expression studies suggest that distinct progenitor populations are compartmentalized to discrete axial domains in the early otocyst. Here, we conducted highly parallel quantitative RT-PCR measurements on 382 individual cells from the developing otocyst and neuroblast lineages to assay 96 genes representing established otic markers, signaling-pathway-associated transcripts, and novel otic-specific genes. By applying multivariate cluster, principal component, and network analyses to the data matrix, we were able to readily distinguish the delaminating neuroblasts and to describe progressive states of gene expression in this population at single-cell resolution. It further established a three-dimensional model of the otocyst in which each individual cell can be precisely mapped into spatial expression domains. Our bioinformatic modeling revealed spatial dynamics of different signaling pathways active during early neuroblast development and prosensory domain specification.	[Durruthy-Durruthy, Robert; Hartman, Byron H.; Waldhaus, Joerg; Laske, Roman D.; Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Durruthy-Durruthy, Robert; Hartman, Byron H.; Waldhaus, Joerg; Laske, Roman D.; Heller, Stefan] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Gottlieb, Assaf; Altman, Russ] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Gottlieb, Assaf; Altman, Russ] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	hellers@stanford.edu			NIH [DC006167, DC012250, DC013210]; P30 core support [DC010363]; Stanford Initiative to Cure Hearing Loss; FP7-Health-2013-Innovation; Deutsche Forschungsgemeinschaft [WA3420/1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006167, F32DC013210, R01DC012250, R01DC004563, P30DC010363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P30 core support; Stanford Initiative to Cure Hearing Loss; FP7-Health-2013-Innovation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the staff at the Stanford Shared FACS Facility for their help and support; Patrick Raphael for his help with implementing movies; and all members of the Heller laboratory for comments on the manuscript. This work was supported by NIH grants DC006167 and DC012250 to S.H., by P30 core support (DC010363), by the Stanford Initiative to Cure Hearing Loss, and, in part, by FP7-Health-2013-Innovation, a cooperative grant by the European Commission. B.H.H. is supported by NIH F32 grant DC013210. J.W. is supported, in part, by a fellowship (WA3420/1) from the Deutsche Forschungsgemeinschaft.	Abello G, 2007, MECH DEVELOP, V124, P631, DOI 10.1016/j.mod.2007.04.002; Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Alsina B, 2009, INT J DEV BIOL, V53, P1503, DOI 10.1387/ijdb.072422ba; Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Brigande JV, 2000, P NATL ACAD SCI USA, V97, P11700, DOI 10.1073/pnas.97.22.11700; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Brown AS, 2011, DEVELOPMENT, V138, P3967, DOI 10.1242/dev.066126; Chang WS, 1999, DEV BIOL, V216, P369, DOI 10.1006/dbio.1999.9457; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; CORWIN JT, 1989, J COMP NEUROL, V288, P529, DOI 10.1002/cne.902880402; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Fritzsch B, 2005, HEARING RES, V206, P52, DOI 10.1016/j.heares.2004.11.025; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; Gerlach LM, 2000, DEVELOPMENT, V127, P45; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hatch EP, 2007, DEVELOPMENT, V134, P3615, DOI 10.1242/dev.006627; Hidalgo-Sanchez M, 2000, MECH DEVELOP, V95, P225, DOI 10.1016/S0925-4773(00)00332-4; Holley M, 2010, DEV BIOL, V340, P547, DOI 10.1016/j.ydbio.2010.02.004; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Jolliffe, 2002, PRINCIPAL COMPONENT; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim WY, 2001, DEVELOPMENT, V128, P417; Koo SK, 2009, DEV BIOL, V333, P14, DOI 10.1016/j.ydbio.2009.06.016; Li HW, 2004, J COMP NEUROL, V477, P1, DOI 10.1002/cne.20190; Lin ZS, 2005, DEVELOPMENT, V132, P2309, DOI 10.1242/dev.01804; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Merlo GR, 2002, DEV BIOL, V248, P157, DOI 10.1006/dbio.2002.0713; Morsli H, 1998, J NEUROSCI, V18, P3327; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Murata J, 2012, ADV EXP MED BIOL, V727, P161, DOI 10.1007/978-1-4614-0899-4_12; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Radde-Gallwitz K, 2004, J COMP NEUROL, V477, P412, DOI 10.1002/cne.20257; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SWANSON GJ, 1990, DEV BIOL, V137, P243, DOI 10.1016/0012-1606(90)90251-D; Tischler J, 2013, CURR OPIN BIOTECH, V24, P69, DOI 10.1016/j.copbio.2012.09.013; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wu DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008409; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	52	99	101	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					964	978		10.1016/j.cell.2014.03.036	http://dx.doi.org/10.1016/j.cell.2014.03.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24768691	Green Accepted, Bronze			2022-12-24	WOS:000335765500022
J	Giering, SLC; Sanders, R; Lampitt, RS; Anderson, TR; Tamburini, C; Boutrif, M; Zubkov, MV; Marsay, CM; Henson, SA; Saw, K; Cook, K; Mayor, DJ				Giering, Sarah L. C.; Sanders, Richard; Lampitt, Richard S.; Anderson, Thomas R.; Tamburini, Christian; Boutrif, Mehdi; Zubkov, Mikhail V.; Marsay, Chris M.; Henson, Stephanie A.; Saw, Kevin; Cook, Kathryn; Mayor, Daniel J.			Reconciliation of the carbon budget in the ocean's twilight zone	NATURE			English	Article							PARTICULATE ORGANIC-MATTER; GROWTH EFFICIENCY; MESOPELAGIC ZONE; METABOLIC RATES; PARTICLE EXPORT; MICROBIAL LOOP; WATER-COLUMN; SPRING BLOOM; BODY-MASS; ZOOPLANKTON	Photosynthesis in the surface ocean produces approximately 100 gigatonnes of organic carbon per year, of which 5 to 15 per cent is exported to the deep ocean(1,2). The rate at which the sinking carbon is converted into carbon dioxide by heterotrophic organisms at depth is important in controlling oceanic carbon storage(3). It remains uncertain, however, to what extent surface ocean carbon supply meets the demand of water-column biota; the discrepancy between known carbon sources and sinks is as much as two orders of magnitude(4-8). Here we present field measurements, respiration rate estimates and a steady-state model that allow us to balance carbon sources and sinks to within observational uncertainties at the Porcupine Abyssal Plain site in the eastern North Atlantic Ocean. We find that prokaryotes are responsible for 70 to 92 per cent of the estimated remineralization in the twilight zone (depths of 50 to 1,000 metres) despite the fact that much of the organic carbon is exported in the form of large, fast-sinking particles accessible to larger zooplankton. We suggest that this occurs because zooplankton fragment and ingest half of the fast-sinking particles, of which more than 30 per cent may be released as suspended and slowly sinking matter, stimulating the deep-ocean microbial loop. The synergy between microbes and zooplankton in the twilight zone is important to our understanding of the processes controlling the oceanic carbon sink.	[Giering, Sarah L. C.; Sanders, Richard; Lampitt, Richard S.; Anderson, Thomas R.; Zubkov, Mikhail V.; Henson, Stephanie A.; Saw, Kevin] Univ Southampton, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton SO14 3ZH, Hants, England; [Giering, Sarah L. C.; Marsay, Chris M.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Giering, Sarah L. C.; Mayor, Daniel J.] Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Newburgh AB41 6AA, Scotland; [Tamburini, Christian; Boutrif, Mehdi] Aix Marseille Univ, Univ Toulon, CNRS INSU, IRD,MIO,UM110, F-13288 Marseille 09, France; [Marsay, Chris M.] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [Cook, Kathryn] Scottish Govt, Marine Lab, Marine Scotland Sci, Aberdeen AB11 9DB, Scotland	NERC National Oceanography Centre; University of Southampton; University of Southampton; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Marine Scotland Science (MSS)	Anderson, TR (corresponding author), Univ Southampton, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton SO14 3ZH, Hants, England.	s.giering@abdn.ac.uk; tra@noc.ac.uk	Henson, Stephanie/AAC-9709-2019; Zubkov, Mikhail/AAW-9674-2020; Sanders, Richard J/B-8717-2012; Mayor, Daniel/HDN-8520-2022; Tamburini, Christian/AAO-8577-2020; Tamburini, Christian/I-7821-2012; Anderson, Thomas/K-5487-2012	Zubkov, Mikhail/0000-0001-7723-6810; Sanders, Richard J/0000-0002-6884-7131; Mayor, Daniel/0000-0002-1295-0041; Tamburini, Christian/0000-0003-3752-7423; Tamburini, Christian/0000-0003-3752-7423; Anderson, Thomas/0000-0002-7408-1566; Cook, Kathryn/0000-0001-8590-3011; Giering, Sarah Lou Carolin/0000-0002-3090-1876; Marsay, Christopher/0000-0003-1244-0444; BOUTRIF, Mehdi/0000-0002-1355-4876	Oceans 2025; EU [264933]; ANR-POTES program [ANR-05-BLAN-0161-01]; Agence Nationale de la Recherche (ANR, France); NERC [NE/G014744/1]; Natural Environment Research Council [NE/J004383/1, NE/K001833/1, NE/H005196/1, NE/G014744/1, noc010009, noc010003, noc010013] Funding Source: researchfish; NERC [NE/J004383/1, noc010009, NE/H005196/1, noc010003, noc010013, NE/K001833/1] Funding Source: UKRI	Oceans 2025; EU(European Commission); ANR-POTES program(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the captain and crew of the RRS Discovery and scientists during D341, especially J. Hunter for executing the ARIES deployments and S. Ward for the PELAGRA deployments. We thank the OSCAR Project Office and BODC for providing data. Finally, we thank T. Cornulier for statistical help. This work was funded by Oceans 2025 and EU FP7-ENV-2010 Collaborative Project 264933 BASIN Basin-Scale Analysis, Synthesis and Integration. C. T. and M. B. were funded by the ANR-POTES program (no. ANR-05-BLAN-0161-01, awarded to C. T.) supported by the Agence Nationale de la Recherche (ANR, France). D.J.M. was funded by NERC (NE/G014744/1).	Al-Mutairi H, 2001, DEEP-SEA RES PT II, V48, P2083, DOI 10.1016/S0967-0645(00)00174-0; Alonso-Saez L, 2007, LIMNOL OCEANOGR, V52, P533, DOI 10.4319/lo.2007.52.2.0533; Anderson TR, 2010, DEEP-SEA RES PT II, V57, P1581, DOI 10.1016/j.dsr2.2010.02.024; Anderson TR, 2001, AQUAT MICROB ECOL, V26, P37, DOI 10.3354/ame026037; Aristegui J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021863; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baltar F, 2010, AQUAT MICROB ECOL, V60, P227, DOI 10.3354/ame01422; Baltar F, 2009, LIMNOL OCEANOGR, V54, P182, DOI 10.4319/lo.2009.54.1.0182; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Boyd PW, 1999, DEEP-SEA RES PT II, V46, P2761, DOI 10.1016/S0967-0645(99)00083-1; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Buesseler KO, 2009, LIMNOL OCEANOGR, V54, P1210, DOI 10.4319/lo.2009.54.4.1210; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; del Giorgio PA, 2011, LIMNOL OCEANOGR, V56, P1, DOI 10.4319/lo.2011.56.1.0001; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doval MD, 2000, MAR CHEM, V68, P249, DOI 10.1016/S0304-4203(99)00081-X; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Fileman E, 2007, J EXP MAR BIOL ECOL, V348, P70, DOI 10.1016/j.jembe.2007.04.003; Gasol JM, 2009, PROG OCEANOGR, V83, P189, DOI 10.1016/j.pocean.2009.07.014; Hansell DA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004069; Henson SA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046735; Henson SA, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005139; Ikeda T, 2001, MAR BIOL, V139, P587, DOI 10.1007/s002270100608; IKEDA T, 1985, MAR BIOL, V85, P1, DOI 10.1007/BF00396409; Ikeda T, 2006, MAR ECOL PROG SER, V322, P199, DOI 10.3354/meps322199; Iversen MH, 2010, DEEP-SEA RES PT I, V57, P771, DOI 10.1016/j.dsr.2010.03.007; JUMARS PA, 1989, DEEP-SEA RES, V36, P483, DOI 10.1016/0198-0149(89)90001-0; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Kwon EY, 2009, NAT GEOSCI, V2, P630, DOI 10.1038/NGEO612; Lampitt RS, 2008, DEEP-SEA RES PT I, V55, P1484, DOI 10.1016/j.dsr.2008.07.002; LAMPITT RS, 1990, MAR BIOL, V104, P15, DOI 10.1007/BF01313152; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Legendre L, 2008, MAR ECOL PROG SER, V365, P289, DOI 10.3354/meps07467; Martin AP, 2010, DEEP-SEA RES PT II, V57, P1293, DOI 10.1016/j.dsr2.2010.01.006; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Mayor DJ, 2006, J PLANKTON RES, V28, P1167, DOI 10.1093/plankt/fbl047; Mayor DJ, 2011, FUNCT ECOL, V25, P509, DOI 10.1111/j.1365-2435.2010.01791.x; Mayor DJ, 2009, J MARINE SYST, V78, P505, DOI 10.1016/j.jmarsys.2008.12.019; MCCLATCHIE S, 1986, LIMNOL OCEANOGR, V31, P469, DOI 10.4319/lo.1986.31.3.0469; OHMAN MD, 1984, MAR ECOL PROG SER, V19, P125, DOI 10.3354/meps019125; Reinthaler T, 2006, LIMNOL OCEANOGR, V51, P1262, DOI 10.4319/lo.2006.51.3.1262; Reinthaler T, 2010, DEEP-SEA RES PT II, V57, P1572, DOI 10.1016/j.dsr2.2010.02.023; Riley JS, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004085; SASAKI H, 1988, DEEP-SEA RES, V35, P505, DOI 10.1016/0198-0149(88)90128-8; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Steinberg DK, 2000, DEEP-SEA RES PT I, V47, P137, DOI 10.1016/S0967-0637(99)00052-7; STRAYER D, 1988, LIMNOL OCEANOGR, V33, P1217, DOI 10.4319/lo.1988.33.5.1217; Tamburini C, 2002, DEEP-SEA RES PT II, V49, P2109, DOI 10.1016/S0967-0645(02)00030-9; WRIGHT RT, 1966, ECOLOGY, V47, P447, DOI 10.2307/1932984; Yamaguchi A, 2002, DEEP-SEA RES PT I, V49, P1007, DOI 10.1016/S0967-0637(02)00008-0; Zubkov MV, 2008, J PLANKTON RES, V30, P211, DOI 10.1093/plankt/fbm091	53	218	224	19	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					480	+		10.1038/nature13123	http://dx.doi.org/10.1038/nature13123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670767	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000333402000036
J	Magill, SS; Edwards, JR; Bamberg, W; Beldavs, ZG; Dumyati, G; Kainer, MA; Lynfield, R; Maloney, M; McAllister-Hollod, L; Nadle, J; Ray, SM; Thompson, DL; Wilson, LE; Fridkin, SK				Magill, Shelley S.; Edwards, Jonathan R.; Bamberg, Wendy; Beldavs, Zintars G.; Dumyati, Ghinwa; Kainer, Marion A.; Lynfield, Ruth; Maloney, Meghan; McAllister-Hollod, Laura; Nadle, Joelle; Ray, Susan M.; Thompson, Deborah L.; Wilson, Lucy E.; Fridkin, Scott K.		Emerging Infect Program Healthcare	Multistate Point- Prevalence Survey of Health Care- Associated Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL-ACQUIRED INFECTIONS; NOSOCOMIAL INFECTIONS; CLOSTRIDIUM-DIFFICILE; RISK-FACTORS; SURVEILLANCE; MULTICENTER; PREVENTION; BURDEN	BackgroundCurrently, no single U.S. surveillance system can provide estimates of the burden of all types of health care-associated infections across acute care patient populations. We conducted a prevalence survey in 10 geographically diverse states to determine the prevalence of health care-associated infections in acute care hospitals and generate updated estimates of the national burden of such infections. MethodsWe defined health care-associated infections with the use of National Healthcare Safety Network criteria. One-day surveys of randomly selected inpatients were performed in participating hospitals. Hospital personnel collected demographic and limited clinical data. Trained data collectors reviewed medical records retrospectively to identify health care-associated infections active at the time of the survey. Survey data and 2010 Nationwide Inpatient Sample data, stratified according to patient age and length of hospital stay, were used to estimate the total numbers of health care-associated infections and of inpatients with such infections in U.S. acute care hospitals in 2011. ResultsSurveys were conducted in 183 hospitals. Of 11,282 patients, 452 had 1 or more health care-associated infections (4.0%; 95% confidence interval, 3.7 to 4.4). Of 504 such infections, the most common types were pneumonia (21.8%), surgical-site infections (21.8%), and gastrointestinal infections (17.1%). Clostridium difficile was the most commonly reported pathogen (causing 12.1% of health care-associated infections). Device-associated infections (i.e., central-catheter-associated bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneumonia), which have traditionally been the focus of programs to prevent health care-associated infections, accounted for 25.6% of such infections. We estimated that there were 648,000 patients with 721,800 health care-associated infections in U.S. acute care hospitals in 2011. ConclusionsResults of this multistate prevalence survey of health care-associated infections indicate that public health surveillance and prevention activities should continue to address C. difficile infections. As device- and procedure-associated infections decrease, consideration should be given to expanding surveillance and prevention activities to include other health care-associated infections. Hospital-acquired infections cause substantial morbidity in inpatient settings. On the basis of a 1-day point-prevalence survey, CDC investigators report the burden and types of health care-associated infection in 183 hospitals across 10 geographically diverse states. Elimination of health care-associated infections is a priority of the Department of Health and Human Services.(1) Considerable success in prevention has been reported for some infections, particularly central-catheter-associated bloodstream infections.(2)-(5) Continued improvements in patient safety depend on maintaining a comprehensive understanding of the epidemiology of health care-associated infections. Currently, no single U.S. surveillance system can provide estimates of the burden of all types of such infections across acute care patient populations. The most recent estimate produced by the Centers for Disease Control and Prevention (CDC) and published in 2007 1.7 million health care-associated infections per year relied ...	[Magill, Shelley S.; Edwards, Jonathan R.; McAllister-Hollod, Laura; Fridkin, Scott K.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Ray, Susan M.] Emory Univ, Sch Med, Atlanta, GA USA; [Bamberg, Wendy] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Beldavs, Zintars G.] Oregon Publ Hlth Author, Portland, OR USA; [Dumyati, Ghinwa] New York Rochester Emerging Infect Program, Rochester, NY USA; [Dumyati, Ghinwa] Univ Rochester, Rochester, NY 14627 USA; [Kainer, Marion A.] Tennessee Dept Hlth, Nashville, TN USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Maloney, Meghan] Connecticut Dept Publ Hlth, Hartford, CT USA; [Nadle, Joelle] Calif Emerging Infect Program, Oakland, CA USA; [Ray, Susan M.] Georgia Emerging Infect Program, Decatur, GA USA; [Ray, Susan M.] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Thompson, Deborah L.] New Mexico Dept Hlth, Santa Fe, NM USA; [Wilson, Lucy E.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Emory University; Colorado Department of Public Health & Environment; University of Rochester; Tennessee Department Health; Minnesota Department of Health (MHD); California Emerging Infections Program; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; New Mexico Department of Health; Maryland Department of Health & Mental Hygiene	Magill, SS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS A-24, Atlanta, GA 30333 USA.	smagill@cdc.gov		Ray, Susan/0000-0002-6327-088X	Infectious Disease Consulting Corporation	Infectious Disease Consulting Corporation	Dr. Kainer reports receiving consulting, lecture, and board membership fees from and owning stock in the Infectious Disease Consulting Corporation. Dr. Lynfield reports receiving travel support from Parexel. No other potential conflict of interest relevant to this article was reported.	American Hospital Association, FAST FACTS US HOSP; Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940; [Anonymous], 2012, 2011 NAT STAT HEALTH; Astagneau P, 2000, J HOSP INFECT, V46, P186, DOI 10.1053/jhin.2000.0833; Azzam R, 2001, J HOSP INFECT, V49, P74, DOI 10.1053/jhin.2001.1043; Centers for Disease Control and Prevention, 2011, ACT BACT COR SURV AB; Cohen J, 2012, IDWEEK 2012 SAN DIEG; Danchaivijitr Somwang, 2007, Journal of the Medical Association of Thailand, V90, P1524; Department of Health & Human Services, NAT ACT PLAN PREV HE; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Dubberke ER, 2011, CLIN INFECT DIS, V53, P20, DOI 10.1093/cid/cir246; Dubberke ER, 2010, INFECT CONT HOSP EP, V31, P1030, DOI 10.1086/656245; Duerink DO, 2006, J HOSP INFECT, V62, P219, DOI 10.1016/j.jhin.2005.08.004; Emmerson AM, 1996, J HOSP INFECT, V32, P175, DOI 10.1016/S0195-6701(96)90144-9; Faria S, 2007, J HOSP INFECT, V65, P244, DOI 10.1016/j.jhin.2006.11.007; Gastmeier P, 1998, J HOSP INFECT, V38, P37, DOI 10.1016/S0195-6701(98)90173-6; Gikas A, 2002, J HOSP INFECT, V50, P269, DOI 10.1053/jhin.2002.1181; Gravel D, 2007, J HOSP INFECT, V66, P243, DOI 10.1016/j.jhin.2007.04.008; Gravel D, 2007, AM J INFECT CONTROL, V35, P157, DOI 10.1016/j.ajic.2006.06.006; Hajdu A, 2007, J HOSP INFECT, V66, P378, DOI 10.1016/j.jhin.2007.04.018; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; Healthcare Cost and Utilization Project (HCUP), 2010, NAT INP SAMPL NIS; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kallel H, 2005, J HOSP INFECT, V59, P343, DOI 10.1016/j.jhin.2004.09.015; Klavs I, 2003, J HOSP INFECT, V54, P149, DOI 10.1016/S0195-6701(03)00112-9; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Lee MK, 2007, J HOSP INFECT, V65, P341, DOI 10.1016/j.jhin.2006.12.013; Lyytikainen O, 2008, J HOSP INFECT, V69, P288, DOI 10.1016/j.jhin.2008.03.005; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Marsteller JA, 2012, CRIT CARE MED, V40, P2933, DOI 10.1097/CCM.0b013e31825fd4d8; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Metintas S, 2004, AM J INFECT CONTROL, V32, P409, DOI 10.1016/j.ajic.2004.05.001; Pittet D, 1999, INFECT CONT HOSP EP, V20, P37, DOI 10.1086/501554; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268; RHAME FS, 1981, AM J EPIDEMIOL, V113, P1; Scheel O, 1999, J HOSP INFECT, V41, P331, DOI 10.1053/jhin.1998.0520; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243; Struwe J, 2006, Euro Surveill, V11, P167; Vaque J, 1999, J HOSP INFECT, V43, pS105, DOI 10.1016/S0195-6701(99)90073-7; Zarb P, 2012, EUROSURVEILLANCE, V17, P4; Zerey Marc, 2007, Surg Infect (Larchmt), V8, P557, DOI 10.1089/sur.2006.062; Zotti CM, 2004, J HOSP INFECT, V56, P142, DOI 10.1016/j.jhin.2003.10.001	44	2281	2387	11	288	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1198	1208		10.1056/NEJMoa1306801	http://dx.doi.org/10.1056/NEJMoa1306801			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670166	Green Accepted			2022-12-24	WOS:000333426000007
J	Coen, P; Clemens, J; Weinstein, AJ; Pacheco, DA; Deng, Y; Murthy, M				Coen, Philip; Clemens, Jan; Weinstein, Andrew J.; Pacheco, Diego A.; Deng, Yi; Murthy, Mala			Dynamic sensory cues shape song structure in Drosophila	NATURE			English	Article							COURTSHIP SONG; AUDITORY-FEEDBACK; MOTOR CONTROL; BEHAVIOR; NEUROBIOLOGY; MECHANISMS; DECISIONS; GENES	The generation of acoustic communication signals is widespread across the animal kingdom(1,2), and males of many species, including Drosophilidae, produce patterned courtship songs to increase their chance of success with a female. For some animals, song structure can vary considerably from one rendition to the next(3); neural noise within pattern generating circuits is widely assumed to be the primary source of such variability, and statistical models that incorporate neural noise are successful at reproducing the full variation present in natural songs(4). In direct contrast, here we demonstrate that much of the pattern variability in Drosophila courtship song can be explained by taking into account the dynamic sensory experience of the male. In particular, using a quantitative behavioural assay combined with computational modelling, we find that males use fast modulations in visual and self-motion signals to pattern their songs, a relationship that we show is evolutionarily conserved. Using neural circuit manipulations, we also identify the pathways involved in song patterning choices and show that females are sensitive to song features. Our data not only demonstrate that Drosophila song production is not a fixed action pattern(5,6), but establish Drosophila as a valuable new model for studies of rapid decision-making under both social and naturalistic conditions.	[Coen, Philip; Clemens, Jan; Weinstein, Andrew J.; Pacheco, Diego A.; Murthy, Mala] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Coen, Philip; Clemens, Jan; Weinstein, Andrew J.; Pacheco, Diego A.; Murthy, Mala] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Deng, Yi] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Murthy, M (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	mmurthy@princeton.edu	Deng, Yi/F-9358-2015; Clemens, Jan/AAE-4983-2019	Deng, Yi/0000-0002-6822-6343; Clemens, Jan/0000-0003-4200-8097; COEN, PHILIP/0000-0003-1495-1061; PACHECO PINEDO, DIEGO/0000-0003-1638-2376	HHMI International Predoctoral Fellowship; Alfred P. Sloan Foundation; Human Frontiers Science Program; NSF CAREER award; McKnight Endowment Fund; Klingenstein Foundation; Direct For Biological Sciences [1054578] Funding Source: National Science Foundation	HHMI International Predoctoral Fellowship; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Human Frontiers Science Program(Human Frontier Science Program); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); McKnight Endowment Fund; Klingenstein Foundation(Klingenstein Philanthropies); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank B. Arthur and D. Stern for assistance in establishing the song recording system; P. Andolfatto for wild-type fly strains; S. Kamal and V. Cheng for assistance with selecting and maintaining fly strains; G. Guan for technical assistance; T. Tayler for help with injections; J. Shaevitz for help with the fly tracker; R. da Silveira for early discussions on reverse correlation; and G. Laurent, C. Brody, D. Aronov, I. Fiete, M. Ryan, and the entire Murthy lab for thoughtful feedback and comments on the manuscript. Figure 1a was illustrated by K. Ris-Vicari. P. C. is funded by an HHMI International Predoctoral Fellowship and M. M. is funded by the Alfred P. Sloan Foundation, the Human Frontiers Science Program, an NSF CAREER award, the McKnight Endowment Fund, and the Klingenstein Foundation.	Aronov D, 2011, J NEUROSCI, V31, P16353, DOI 10.1523/JNEUROSCI.3009-11.2011; Arthur BJ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-11; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; BENTLEY D, 1974, SCI AM, V231, P34, DOI 10.1038/scientificamerican0874-34; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065769; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EWING AW, 1979, J COMP PHYSIOL, V130, P87, DOI 10.1007/BF02582977; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; MCFARLAND DJ, 1977, NATURE, V269, P15, DOI 10.1038/269015a0; Mineault PJ, 2009, J VISION, V9, DOI 10.1167/9.10.17; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Sakata JT, 2008, J NEUROSCI, V28, P11378, DOI 10.1523/JNEUROSCI.3254-08.2008; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Shirangi TR, 2013, CELL REP, V5, P678, DOI 10.1016/j.celrep.2013.09.039; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Tinbergen, 1951, STUDY INSTINCT; Trott AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046025; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Von Schilcher F., 1976, Animal Behav, V24, P18, DOI 10.1016/S0003-3472(76)80095-4; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Ziegler AB, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00072	34	90	88	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					233	+		10.1038/nature13131	http://dx.doi.org/10.1038/nature13131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598544				2022-12-24	WOS:000332651800039
J	Doria-Rose, NA; Schramm, CA; Gorman, J; Moore, PL; Bhiman, JN; DeKosky, BJ; Ernandes, MJ; Georgiev, IS; Kim, HJ; Pancera, M; Staupe, RP; Altae-Tran, HR; Bailer, RT; Crooks, ET; Cupo, A; Druz, A; Garrett, NJ; Hoi, KH; Kong, R; Louder, MK; Longo, NS; McKee, K; Nonyane, M; O'Dell, S; Roark, RS; Rudicell, RS; Schmidt, SD; Sheward, DJ; Soto, C; Wibmer, CK; Yang, YP; Zhang, ZH; Mullikin, JC; Binley, JM; Sanders, RW; Wilson, IA; Moore, JP; Ward, AB; Georgiou, G; Williamson, C; Karim, SSA; Morris, L; Kwong, PD; Shapiro, L; Mascola, JR				Doria-Rose, Nicole A.; Schramm, Chaim A.; Gorman, Jason; Moore, Penny L.; Bhiman, Jinal N.; DeKosky, Brandon J.; Ernandes, Michael J.; Georgiev, Ivelin S.; Kim, Helen J.; Pancera, Marie; Staupe, Ryan P.; Altae-Tran, Han R.; Bailer, Robert T.; Crooks, Ema T.; Cupo, Albert; Druz, Aliaksandr; Garrett, Nigel J.; Hoi, Kam H.; Kong, Rui; Louder, Mark K.; Longo, Nancy S.; McKee, Krisha; Nonyane, Molati; O'Dell, Sijy; Roark, Ryan S.; Rudicell, Rebecca S.; Schmidt, Stephen D.; Sheward, Daniel J.; Soto, Cinque; Wibmer, Constantinos Kurt; Yang, Yongping; Zhang, Zhenhai; Mullikin, James C.; Binley, James M.; Sanders, Rogier W.; Wilson, Ian A.; Moore, John P.; Ward, Andrew B.; Georgiou, George; Williamson, Carolyn; Karim, Salim S. Abdool; Morris, Lynn; Kwong, Peter D.; Shapiro, Lawrence; Mascola, John R.		NISC Comparative Sequencing	Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HIV-1-NEUTRALIZING ANTIBODIES; VACCINE EFFICACY; STRUCTURAL BASIS; BROAD; RECOGNITION; IMMUNOGLOBULIN; GENERATION; INFECTION	Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the HIV-1 envelope, but the mechanism of their elicitation has been unclear. Here we define the developmental pathway by which such antibodies are generated and acquire the requisite molecular characteristics for neutralization. Twelve somatically related neutralizing antibodies (CAP256-VRC26.01-12) were isolated from donor CAP256 (from the Centre for the AIDS Programme of Research in South Africa (CAPRISA)); each antibody contained the protruding tyrosine-sulphated, anionic antigen-binding loop (complementarity-determining region (CDR) H3) characteristic of this category of antibodies. Their unmutated ancestor emerged between weeks 30-38 post-infection with a 35-residue CDR H3, and neutralized the virus that superinfected this individual 15 weeks after initial infection. Improved neutralization breadth and potency occurred by week 59 with modest affinity maturation, and was preceded by extensive diversification of the virus population. HIV-1 V1V2-directed neutralizing antibodies can thus develop relatively rapidly through initial selection of B cells with a long CDR H3, and limited subsequent somatic hypermutation. These data provide important insights relevant to HIV-1 vaccine development.	[Doria-Rose, Nicole A.; Gorman, Jason; Ernandes, Michael J.; Georgiev, Ivelin S.; Pancera, Marie; Staupe, Ryan P.; Altae-Tran, Han R.; Bailer, Robert T.; Druz, Aliaksandr; Kong, Rui; Louder, Mark K.; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Roark, Ryan S.; Rudicell, Rebecca S.; Schmidt, Stephen D.; Soto, Cinque; Yang, Yongping; Kwong, Peter D.; Shapiro, Lawrence; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Schramm, Chaim A.; Zhang, Zhenhai; Shapiro, Lawrence] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Moore, Penny L.; Bhiman, Jinal N.; Nonyane, Molati; Wibmer, Constantinos Kurt; Morris, Lynn] NHLS, Natl Inst Communicable Dis, Ctr HIV & STIs, ZA-2131 Johannesburg, South Africa; [Moore, Penny L.; Bhiman, Jinal N.; Wibmer, Constantinos Kurt; Morris, Lynn] Univ Witwatersrand, Fac Hlth Sci, ZA-2050 Johannesburg, South Africa; [Moore, Penny L.; Garrett, Nigel J.; Williamson, Carolyn; Karim, Salim S. Abdool; Morris, Lynn] Univ KwaZulu Natal, CAPRISA, ZA-4013 Congella, South Africa; [DeKosky, Brandon J.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Kim, Helen J.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kim, Helen J.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Kim, Helen J.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Crooks, Ema T.; Binley, James M.] Torrey Pines Inst, San Diego, CA 92037 USA; [Cupo, Albert; Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Hoi, Kam H.; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Sheward, Daniel J.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Virol, ZA-7701 Cape Town, South Africa; [Sheward, Daniel J.] NHLS, ZA-7701 Cape Town, South Africa; [Mullikin, James C.] NIH, NISC Comparat Sequencing Program, Bethesda, MD 20892 USA; [Mullikin, James C.] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Kwazulu Natal; University of Texas System; University of Texas Austin; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Torrey Pines Institute for Molecular Studies, California; Cornell University; University of Texas System; University of Texas Austin; University of Cape Town; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute; University of Texas System; University of Texas Austin; Columbia University	Morris, L (corresponding author), NHLS, Natl Inst Communicable Dis, Ctr HIV & STIs, ZA-2131 Johannesburg, South Africa.	lynnm@nicd.ac.za; pdkwong@nih.gov; lss8@columbia.edu; jrmascola@nih.gov	Wibmer, Constantinos Kurt/AAO-3035-2021; Gorman, Jason/AGG-9417-2022; Mascola, John/AAI-7193-2021; Bhiman, Jinal/ABA-6029-2021; Zhang, Zhenhai/GRX-5887-2022; Ward, Andrew B/F-9203-2014; Wibmer, Constantinos Kurt/AAH-8669-2019; Morris, Lynn/V-3941-2018; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Schmidt, Stephen/B-5398-2012; Cheng, Yushao/E-6256-2011; Sheward, Daniel/GSJ-0708-2022; Schmidt, Stephen/AAC-6967-2019; Ward, Andrew/ABD-7728-2021; Shapiro, Lawrence/AAE-7172-2019	Wibmer, Constantinos Kurt/0000-0003-2329-2280; Bhiman, Jinal/0000-0001-6354-4003; Zhang, Zhenhai/0000-0002-4310-0525; Ward, Andrew B/0000-0001-7153-3769; Morris, Lynn/0000-0003-3961-7828; Karim, Salim Abdool/0000-0002-4986-2133; Sheward, Daniel/0000-0002-0227-5636; Ward, Andrew/0000-0001-7153-3769; Roark, Ryan/0000-0003-0586-103X; Hoi, Kam Hon/0000-0003-4158-0446; Moore, Penny/0000-0001-8719-4028; Gorman, Jason/0000-0002-3775-6560; , Carolyn/0000-0003-0125-1226; Staupe, Ryan/0000-0003-0793-524X; Kim, Helen/0000-0003-0096-7740; Ernandes, Michael/0000-0001-8218-0145	Vaccine Research Center; NIAID; Fogarty International Center; NHGRI; NIGMS of the National Institutes of Health, USA; International AIDS Vaccine Initiative; National Science Foundation; Scripps CHAV-ID; South African Department of Science and Technology; Wellcome Trust; Hertz Foundation; Donald D. Harrington Foundation; Poliomyelitis Research Foundation; National Research Foundation of South Africa; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005022, ZIAAI005095, ZIAAI005089, R01AI100790, UM1AI100663, P01AI082362, ZIAAI005010, ZICAI005111] Funding Source: NIH RePORTER	Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS of the National Institutes of Health, USA; International AIDS Vaccine Initiative; National Science Foundation(National Science Foundation (NSF)); Scripps CHAV-ID; South African Department of Science and Technology; Wellcome Trust(Wellcome TrustEuropean Commission); Hertz Foundation; Donald D. Harrington Foundation; Poliomyelitis Research Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the participants in the CAPRISA 002 study for their commitment. For technical assistance and advice, we thank: K. Mlisana, S. Sibeko, N. Naicker, the CAPRISA 002 clinical team, N. Samsunder, S. Heeralall, B. Lambson, M. Madzivhandila, T. Khoza, C. Mitchell Scheepers, E. Turk, C.-L. Lin, M. Roederer, J. Stuckey, B. Hartman, G. Loots, J. H. Lee, G. Ippolito, B. Briney, S. Hunicke-Smith and J. Wheeler, and members of the WCMC HIVRAD Core and the NIH Vaccine Research Center HIMS, HIMC, SBS and SBIS sections. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra and L. Zhang for contributing the HIV-1Envelope plasmids used in our neutralizationpanel. Funding was provided by the intramural research programs of the Vaccine Research Center and NIAID, the Fogarty International Center, NHGRI, and NIGMS of the National Institutes of Health, USA; the International AIDS Vaccine Initiative; the National Science Foundation; Scripps CHAV-ID; the South African Department of Science and Technology; and fellowships from the Wellcome Trust, Hertz Foundation, Donald D. Harrington Foundation, Poliomyelitis Research Foundation and the National Research Foundation of South Africa. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Alamyar E., 2012, IMMUNOME RES, V8; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doria-Rose N, 2013, PROTOCOL EXCHANGE; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kabat EA, 1991, SEQUENCES PROTEINS I; Kong Leopold, 2012, J AIDS Clin Res, VS8, P3; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315	83	521	535	1	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					55	+		10.1038/nature13036	http://dx.doi.org/10.1038/nature13036			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24590074	Green Accepted, Green Submitted			2022-12-24	WOS:000335199100038
J	Baldauf, D; Desimone, R				Baldauf, Daniel; Desimone, Robert			Neural Mechanisms of Object-Based Attention	SCIENCE			English	Article							TOP-DOWN MODULATION; VISUAL-CORTEX; NEURONAL SYNCHRONIZATION; SELECTIVE ATTENTION; PREFRONTAL CORTEX; FACE PERCEPTION; WORKING-MEMORY; OSCILLATIONS; AREA; REPRESENTATION	How we attend to objects and their features that cannot be separated by location is not understood. We presented two temporally and spatially overlapping streams of objects, faces versus houses, and used magnetoencephalography and functional magnetic resonance imaging to separate neuronal responses to attended and unattended objects. Attention to faces versus houses enhanced the sensory responses in the fusiform face area (FFA) and parahippocampal place area (PPA), respectively. The increases in sensory responses were accompanied by induced gamma synchrony between the inferior frontal junction, IFJ, and either FFA or PPA, depending on which object was attended. The IFJ appeared to be the driver of the synchrony, as gamma phases were advanced by 20 ms in IFJ compared to FFA or PPA. Thus, the IFJ may direct the flow of visual processing during object-based attention, at least in part through coupled oscillations with specialized areas such as FFA and PPA.	[Baldauf, Daniel; Desimone, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Baldauf, D (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	baldauf@mit.edu	Baldauf, Daniel/K-6717-2012; Desimone, Robert/G-1121-2018	Baldauf, Daniel/0000-0001-5764-506X; 	NIH [P30EY2621]; NSF [CCF-1231216]; NATIONAL EYE INSTITUTE [P30EY002621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Liang, D. Pantazis, M. Hamalainen, D. Dilks, D. Osher, Y. Zhang, C. Triantafyllou, S. Shannon, S. Arnold, C. Jennings. Supported by NIH (P30EY2621) and NSF (CCF-1231216), both to R.D.	Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Ciaramitaro VM, 2011, J NEUROPHYSIOL, V105, P1258, DOI 10.1152/jn.00680.2010; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Parkkonen L, 2008, P NATL ACAD SCI USA, V105, P20500, DOI 10.1073/pnas.0810966105; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Schoenfeld MA, 2014, NAT NEUROSCI, V17, P619, DOI 10.1038/nn.3656; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	31	254	257	9	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					424	427		10.1126/science.1247003	http://dx.doi.org/10.1126/science.1247003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763592				2022-12-24	WOS:000334867800044
J	Bellott, DW; Hughes, JF; Skaletsky, H; Brown, LG; Pyntikova, T; Cho, TJ; Koutseva, N; Zaghlul, S; Graves, T; Rock, S; Kremitzki, C; Fulton, RS; Dugan, S; Ding, Y; Morton, D; Khan, Z; Lewis, L; Buhay, C; Wang, QY; Watt, J; Holder, M; Lee, S; Nazareth, L; Rozen, S; Muzny, DM; Warren, WC; Gibbs, RA; Wilson, RK; Page, DC				Bellott, Daniel W.; Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Zaghlul, Sara; Graves, Tina; Rock, Susie; Kremitzki, Colin; Fulton, Robert S.; Dugan, Shannon; Ding, Yan; Morton, Donna; Khan, Ziad; Lewis, Lora; Buhay, Christian; Wang, Qiaoyan; Watt, Jennifer; Holder, Michael; Lee, Sandy; Nazareth, Lynne; Rozen, Steve; Muzny, Donna M.; Warren, Wesley C.; Gibbs, Richard A.; Wilson, Richard K.; Page, David C.			Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators	NATURE			English	Article							SEX-DETERMINING REGION; X-CHROMOSOMES; SHORT ARM; EMBRYONIC-DEVELOPMENT; GENE CONVERSION; 2 DAUGHTERS; INACTIVATION; PHENOTYPE; EVOLUTION; SEQUENCE	The human X and Y chromosomes evolved from an ordinary pair of autosomes, but millions of years ago genetic decay ravaged the Y chromosome, and only three per cent of its ancestral genes survived. We reconstructed the evolution of the Y chromosome across eight mammals to identify biases in gene content and the selective pressures that preserved the surviving ancestral genes. Our findings indicate that survival was nonrandom, and in two cases, convergent across placental and marsupial mammals. We conclude that the gene content of the Y chromosome became specialized through selection to maintain the ancestral dosage of homologous X-Y gene pairs that function as broadly expressed regulators of transcription, translation and protein stability. We propose that beyond its roles in testis determination and spermatogenesis, the Y chromosome is essential for male viability, and has unappreciated roles in Turner's syndrome and in phenotypic differences between the sexes in health and disease.	[Bellott, Daniel W.; Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Zaghlul, Sara; Rozen, Steve; Page, David C.] MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; [Bellott, Daniel W.; Hughes, Jennifer F.; Skaletsky, Helen; Brown, Laura G.; Pyntikova, Tatyana; Cho, Ting-Jan; Koutseva, Natalia; Zaghlul, Sara; Rozen, Steve; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Graves, Tina; Rock, Susie; Kremitzki, Colin; Fulton, Robert S.; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Dugan, Shannon; Ding, Yan; Morton, Donna; Khan, Ziad; Lewis, Lora; Buhay, Christian; Wang, Qiaoyan; Watt, Jennifer; Holder, Michael; Lee, Sandy; Nazareth, Lynne; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Baylor College of Medicine	Bellott, DW (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA.	bellott@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Kremitzki, Colin/0000-0001-9175-3136; Rozen, Steven G./0000-0002-4288-0056	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG003079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank W. J. Murphy, E. Owens and J. E. Womak for generating radiation hybrid panels and for assistance in mapping; L. Lyons and W. J. M. for providing the rhesus radiation hybrid panel; A. Kaur for a rhesus cell line; S. Austad, P. Hornsby and S. Tardif for marmoset cell lines; M. Brown for rat cell lines; J. E. W. for bull fibroblasts; W. Johnson and S. O'Neil for rhesus tissues samples; W. J., S.O. and S. T. for marmoset tissue samples; M. Turner for rat tissue samples; J. E. W. for bull tissue samples; P. Samollow for opossum tissue samples; E. Vallender for Tamarin DNA; B. Chowdhary and T. Raudsepp for FISH experiments in the bull; C. Friedman and B. Trask for flow-sorted marmoset Y chromosomes; B. T. for sizing rat Y chromosomes; C. Burge for permission to assemble transcriptome data from SRR594455, SRR594463 and SRR594508; J. Alfoldi for permission to assemble transcriptome data from SRR500909; R. B. Norgren for permission to assemble transcriptome data from SRR544870; and A. Godfrey, Y. Hu and B. Lesch for comments on the manuscript. Supported by National Institutes of Health and Howard Hughes Medical Institute.	Adachi M, 2000, HUM GENET, V106, P306, DOI 10.1007/s004390051042; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P381, DOI 10.1530/jrf.0.0680381; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P387, DOI 10.1530/jrf.0.0680387; BURGOYNE PS, 1981, J REPROD FERTIL, V61, P207, DOI 10.1530/jrf.0.0610207; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chocholska S, 2006, AM J MED GENET A, V140A, P604, DOI 10.1002/ajmg.a.31145; COCKWELL A, 1991, J MED GENET, V28, P151, DOI 10.1136/jmg.28.3.151; Dal Zotto L, 1998, HUM MOL GENET, V7, P489, DOI 10.1093/hmg/7.3.489; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HAYASHIDA H, 1992, J MOL EVOL, V35, P181, DOI 10.1007/BF00183228; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOOK EB, 1983, HUM GENET, V64, P24, DOI 10.1007/BF00289473; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; James RS, 1998, HUM GENET, V102, P507, DOI 10.1007/s004390050733; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kaiser VB, 2011, GENOME BIOL EVOL, V3, P1329, DOI 10.1093/gbe/evr103; Karere GM, 2008, GENOMICS, V92, P210, DOI 10.1016/j.ygeno.2008.05.013; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Lawson-Yuen A, 2008, EUR J HUM GENET, V16, P614, DOI 10.1038/sj.ejhg.5202006; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lindgren AM, 2013, HUM GENET, V132, P537, DOI 10.1007/s00439-013-1263-x; Marais G, 2003, CURR BIOL, V13, pR641, DOI 10.1016/S0960-9822(03)00570-0; MASSA G, 1992, EUR J PEDIATR, V151, P893, DOI 10.1007/BF01954124; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Murtagh VJ, 2012, GENOME RES, V22, P498, DOI 10.1101/gr.120790.111; Ohno S., 1967, SEX CHROMOSOMES SEX; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Rujirabanjerd S, 2010, EUR J HUM GENET, V18, P330, DOI 10.1038/ejhg.2009.175; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Wang X, 2014, GENOME RES, V24, P70, DOI 10.1101/gr.161919.113; WATANABE M, 1993, NAT GENET, V4, P268, DOI 10.1038/ng0793-268; WATSON JM, 1990, P NATL ACAD SCI USA, V87, P7125, DOI 10.1073/pnas.87.18.7125; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Xie D, 2010, GENOME RES, V20, P804, DOI 10.1101/gr.100594.109; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zinn AR, 1998, AM J HUM GENET, V63, P1757, DOI 10.1086/302152; Zinn AR, 1997, CLIN GENET, V52, P235	69	388	393	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					494	+		10.1038/nature13206	http://dx.doi.org/10.1038/nature13206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759411	Green Accepted, Green Published			2022-12-24	WOS:000334741600030
J	Quintana, EV; Barclay, T; Raymond, SN; Rowe, JF; Bolmont, E; Caldwell, DA; Howell, SB; Kane, SR; Huber, D; Crepp, JR; Lissauer, JJ; Ciardi, DR; Coughlin, JL; Everett, ME; Henze, CE; Horch, E; Isaacson, H; Ford, EB; Adams, FC; Still, M; Hunter, RC; Quarles, B; Selsis, F				Quintana, Elisa V.; Barclay, Thomas; Raymond, Sean N.; Rowe, Jason F.; Bolmont, Emeline; Caldwell, Douglas A.; Howell, Steve B.; Kane, Stephen R.; Huber, Daniel; Crepp, Justin R.; Lissauer, Jack J.; Ciardi, David R.; Coughlin, Jeffrey L.; Everett, Mark E.; Henze, Christopher E.; Horch, Elliott; Isaacson, Howard; Ford, Eric B.; Adams, Fred C.; Still, Martin; Hunter, Roger C.; Quarles, Billy; Selsis, Franck			An Earth-Sized Planet in the Habitable Zone of a Cool Star	SCIENCE			English	Article							LOW-MASS STARS; MAIN-SEQUENCE STARS; M-DWARF STARS; SUN-LIKE STAR; SUPER-EARTHS; ECLIPSING BINARY; GLIESE 581D; SYSTEMS; VALIDATION; RADII	The quest for Earth-like planets is a major focus of current exoplanet research. Although planets that are Earth-sized and smaller have been detected, these planets reside in orbits that are too close to their host star to allow liquid water on their surfaces. We present the detection of Kepler-186f, a 1.11 +/- 0.14 Earth-radius planet that is the outermost of five planets, all roughly Earth-sized, that transit a 0.47 +/- 0.05 solar-radius star. The intensity and spectrum of the star's radiation place Kepler-186f in the stellar habitable zone, implying that if Kepler-186f has an Earth-like atmosphere and water at its surface, then some of this water is likely to be in liquid form.	[Quintana, Elisa V.; Rowe, Jason F.; Caldwell, Douglas A.; Huber, Daniel; Coughlin, Jeffrey L.] SETI Inst, Mountain View, CA 94043 USA; [Quintana, Elisa V.; Barclay, Thomas; Rowe, Jason F.; Caldwell, Douglas A.; Howell, Steve B.; Huber, Daniel; Lissauer, Jack J.; Coughlin, Jeffrey L.; Henze, Christopher E.; Hunter, Roger C.; Quarles, Billy] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Barclay, Thomas; Still, Martin] Bay Area Environm Res Inst, West Sonoma, CA 95476 USA; [Raymond, Sean N.; Bolmont, Emeline; Selsis, Franck] Univ Bordeaux, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France; [Raymond, Sean N.; Bolmont, Emeline; Selsis, Franck] CNRS, Lab Astrophys Bordeaux, UMR 5804, F-33270 Floirac, France; [Kane, Stephen R.] San Francisco State Univ, San Francisco, CA 94132 USA; [Crepp, Justin R.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Lissauer, Jack J.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Ciardi, David R.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Everett, Mark E.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Horch, Elliott] So Connecticut State Univ, New Haven, CT 06515 USA; [Isaacson, Howard] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ford, Eric B.] Penn State Univ, Davey Lab 525, Ctr Exoplanets & Habitable, University Pk, PA 16802 USA; [Ford, Eric B.] Penn State Univ, Davey Lab 525, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Adams, Fred C.] Univ Michigan, Dept Phys, Michigan Ctr Theoret Phys, Ann Arbor, MI 48109 USA; [Adams, Fred C.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; California State University System; San Francisco State University; University of Notre Dame; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); National Optical Astronomy Observatory; Connecticut State University System; Southern Connecticut State University; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Quintana, EV (corresponding author), SETI Inst, 189 Bernardo Ave,Suite 100, Mountain View, CA 94043 USA.	elisa.quintana@nasa.gov	Quarles, Billy/AAI-3920-2020; Ford, Eric B./AAB-5479-2019; Caldwell, Douglas A/L-7911-2014; Huber, Daniel/AAE-9440-2019	Quarles, Billy/0000-0002-9644-8330; Ford, Eric B./0000-0001-6545-639X; Caldwell, Douglas A/0000-0003-1963-9616; Huber, Daniel/0000-0001-8832-4488; Barclay, Thomas/0000-0001-7139-2724; Rowe, Jason/0000-0002-5904-1865; Ciardi, David/0000-0002-5741-3047; Bolmont, Emeline/0000-0001-5657-4503; Selsis, Franck/0000-0001-9619-5356; Coughlin, Jeffrey/0000-0003-1634-9672; Raymond, Sean/0000-0001-8974-0758	Research Opportunities in Space and Earth Sciences Kepler Participating Scientist Program [NNX12AD21G]; NASA [NNA13AA93A, NAS5-26555]; NASA Postdoctoral Program at the Ames Research Center; Kepler Participating Scientist Program; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; European Research Council [209622: E3ARTHs]; NASA Science Mission directorate; NASA Office of Space Science [NNX13AC07G]; National Science Foundation (NSF); National Research Council (Canada); Comision Nacional de Investigacion Cientifica y Tecnologica (Chile); Australian Research Council (Australia); Ministerio da Ciencia, Tecnologia e Inovacao (Brazil); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina)	Research Opportunities in Space and Earth Sciences Kepler Participating Scientist Program; NASA(National Aeronautics & Space Administration (NASA)); NASA Postdoctoral Program at the Ames Research Center; Kepler Participating Scientist Program; Pennsylvania State University; Eberly College of Science; Pennsylvania Space Grant Consortium; European Research Council(European Research Council (ERC)European Commission); NASA Science Mission directorate(National Aeronautics & Space Administration (NASA)); NASA Office of Space Science(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Research Council (Canada); Comision Nacional de Investigacion Cientifica y Tecnologica (Chile); Australian Research Council (Australia)(Australian Research Council); Ministerio da Ciencia, Tecnologia e Inovacao (Brazil); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina)	The authors working at NASA Ames thank the SETI Institute for hosting them during the U. S. government shutdown. E. V. Q. and J.F.R. acknowledge support from the Research Opportunities in Space and Earth Sciences Kepler Participating Scientist Program Grant NNX12AD21G. S.N.R.'s contribution was performed as part of the NASA Astrobiology Institute's Virtual Planetary Laboratory Lead Team, supported by NASA under cooperative agreement no. NNA13AA93A. D. H. acknowledges support by an appointment to the NASA Postdoctoral Program at the Ames Research Center, administered by Oak Ridge Associated Universities through a contract with NASA, and the Kepler Participating Scientist Program. The Center for Exoplanets and Habitable Worlds is supported by the Pennsylvania State University, the Eberly College of Science, and the Pennsylvania Space Grant Consortium. F. S. acknowledges support from the European Research Council (Starting Grant 209622: E3ARTHs). This paper includes data collected by the Kepler mission. Funding for the Kepler mission is provided by the NASA Science Mission directorate. This research also made use of NASA's Astrophysics Data System. Some of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). The Space Telescope Science Institute is operated by the Association of Universities for Research in Astronomy, under NASA contract NAS5-26555. Support for MAST for non-Hubble Space Telescope data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts. This research made use of the NASA Exoplanet Archive, which is operated by the California Institute of Technology, under contract with NASA under the Exoplanet Exploration Program. The Gemini Observatory is operated by the Association of Universities for Research in Astronomy, under a cooperative agreement with the National Science Foundation (NSF) on behalf of the Gemini partnership: NSF (United States), the National Research Council (Canada), the Comision Nacional de Investigacion Cientifica y Tecnologica (Chile), the Australian Research Council (Australia), the Ministerio da Ciencia, Tecnologia e Inovacao (Brazil), and the Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina).	Andrews SM, 2007, ASTROPHYS J, V671, P1800, DOI 10.1086/522885; Barclay T, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/101; Bayless AJ, 2006, ASTROPHYS J, V651, P1155, DOI 10.1086/507981; Borucki WJ, 2013, SCIENCE, V340, P587, DOI 10.1126/science.1234702; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Cossou C., 2014, IAU S, V299, P360; David EM, 2003, PUBL ASTRON SOC PAC, V115, P825, DOI 10.1086/376395; Ferraz-Mello S, 2008, CELEST MECH DYN ASTR, V101, P171, DOI 10.1007/s10569-008-9133-x; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Heller R, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015809; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; HUT P, 1981, ASTRON ASTROPHYS, V99, P126; Irwin J, 2009, ASTROPHYS J, V701, P1436, DOI 10.1088/0004-637X/701/2/1436; Kane SR, 2012, PUBL ASTRON SOC PAC, V124, P323, DOI 10.1086/665271; KASTING JF, 1993, ICARUS, V101, P108, DOI 10.1006/icar.1993.1010; Kopparapu RK, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/131; KROUPA P, 1993, MON NOT R ASTRON SOC, V262, P545, DOI 10.1093/mnras/262.3.545; Lissauer JJ, 2007, ASTROPHYS J, V660, pL149, DOI 10.1086/518121; Lissauer JJ, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/44; Lopez ED, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/1/59; Lopez-Morales M, 2007, ASTROPHYS J, V660, P732, DOI 10.1086/513142; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; MAYOR M, 1995, NATURE, V378, P355, DOI 10.1038/378355a0; Muirhead PS, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/2/L37; Raymond S. N., 2014, MON NOT R ASTRON SOC; Raymond SN, 2008, MON NOT R ASTRON SOC, V384, P663, DOI 10.1111/j.1365-2966.2007.12712.x; Raymond SN, 2007, ASTROPHYS J, V669, P606, DOI 10.1086/521587; Rowe JF, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/45; Selsis F, 2007, ASTRON ASTROPHYS, V476, P1373, DOI 10.1051/0004-6361:20078091; Tarter JC, 2007, ASTROBIOLOGY, V7, P30, DOI 10.1089/ast.2006.0124; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Torres G, 2004, ASTROPHYS J, V614, P979, DOI 10.1086/423734; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; von Paris P, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015329; Wang J, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/4; Wordsworth RD, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L48	37	156	158	3	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					277	280		10.1126/science.1249403	http://dx.doi.org/10.1126/science.1249403			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744370	Green Submitted			2022-12-24	WOS:000334474500029
J	Wang, P; Xue, YQ; Han, YM; Lin, L; Wu, C; Xu, S; Jiang, ZP; Xu, JF; Liu, QY; Cao, XT				Wang, Pin; Xue, Yiquan; Han, Yanmei; Lin, Li; Wu, Cong; Xu, Sheng; Jiang, Zhengping; Xu, Junfang; Liu, Qiuyan; Cao, Xuetao			The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation	SCIENCE			English	Article							TRANSCRIPTION; EXPRESSION; REPRESSION; MICRORNAS; DISEASE; STAT3; PU.1; PTEN	Long noncoding RNAs (lncRNAs) play important roles in diverse biological processes; however, few have been identified that regulate immune cell differentiation and function. Here, we identified lnc-DC, which was exclusively expressed in human conventional dendritic cells (DCs). Knockdown of lnc-DC impaired DC differentiation from human monocytes in vitro and from mouse bone marrow cells in vivo and reduced capacity of DCs to stimulate T cell activation. lnc-DC mediated these effects by activating the transcription factor STAT3 (signal transducer and activator of transcription 3). lnc-DC bound directly to STAT3 in the cytoplasm, which promoted STAT3 phosphorylation on tyrosine-705 by preventing STAT3 binding to and dephosphorylation by SHP1. Our work identifies a lncRNA that regulates DC differentiation and also broadens the known mechanisms of lncRNA action.	[Wang, Pin; Xue, Yiquan; Han, Yanmei; Xu, Sheng; Jiang, Zhengping; Liu, Qiuyan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Wang, Pin; Xue, Yiquan; Han, Yanmei; Xu, Sheng; Jiang, Zhengping; Liu, Qiuyan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Wang, Pin; Lin, Li; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Mol Biol, Beijing 100005, Peoples R China; [Wang, Pin; Lin, Li; Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Wu, Cong; Xu, Junfang; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Zhejiang University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org	Han, Yanmei/D-8995-2016; Xu, Junfang/ABC-6562-2021	xu, sheng/0000-0002-9547-8052; wu, cong/0000-0003-4943-8786	National Key Basic Research Program of China [2013CB530502]; National Natural Science Foundation of China [31390431, 81230074, 81123006]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank M. Jin and P. Ma for technical assistance; W. Ge, P. Zhang, and X. Xu for helpful discussions; and Q. Li of Genminix Informatics for bioinformatics assistance. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Our transcriptome microarray data and RNA-seq data are deposited in Gene Expression Omnibus (GEO) under the accession nos. GSE54143 and GSE54401, respectively, and our ChIP-seq data are deposited in GEO under the accession no. GSE43036. This work is supported by grants from the National Key Basic Research Program of China (2013CB530502) and the National Natural Science Foundation of China (31390431, 81230074, and 81123006). X. C. and P. W. designed the experiments; P. W., Y.X., Y.H., L. L., C. W., S. X., Z.J., J.X., and Q. L. performed the experiments; X. C. and P. W. analyzed data and wrote the paper; and X. C. was responsible for research supervision, coordination, and strategy. We declare no competing financial interests.	Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001	27	753	823	8	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					310	313		10.1126/science.1251456	http://dx.doi.org/10.1126/science.1251456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744378				2022-12-24	WOS:000334474500039
J	Miller, JA; Ding, SL; Sunkin, SM; Smith, KA; Ng, L; Szafer, A; Ebbert, A; Riley, ZL; Royall, JJ; Aiona, K; Arnold, JM; Bennet, C; Bertagnolli, D; Brouner, K; Butler, S; Caldejon, S; Carey, A; Cuhaciyan, C; Dalley, RA; Dee, N; Dolbeare, TA; Facer, BAC; Feng, D; Fliss, TP; Gee, G; Goldy, J; Gourley, L; Gregor, BW; Gu, GY; Howard, RE; Jochim, JM; Kuan, CL; Lau, C; Lee, CK; Lee, F; Lemon, TA; Lesnar, P; McMurray, B; Mastan, N; Mosqueda, N; Naluai-Cecchini, T; Ngo, NK; Nyhus, J; Oldre, A; Olson, E; Parente, J; Parker, PD; Parry, SE; Stevens, A; Pletikos, M; Reding, M; Roll, K; Sandman, D; Sarreal, M; Shapouri, S; Shapovalova, NV; Shen, EH; Sjoquist, N; Slaughterbeck, CR; Smith, M; Sodt, AJ; Williams, D; Zollei, L; Fischl, B; Gerstein, MB; Geschwind, DH; Glass, IA; Hawrylycz, MJ; Hevner, RF; Huang, H; Jones, AR; Knowles, JA; Levitt, P; Phillips, JW; Sestan, N; Wohnoutka, P; Dang, C; Bernard, A; Hohmann, JG; Lein, ES				Miller, Jeremy A.; Ding, Song-Lin; Sunkin, Susan M.; Smith, Kimberly A.; Ng, Lydia; Szafer, Aaron; Ebbert, Amanda; Riley, Zackery L.; Royall, Joshua J.; Aiona, Kaylynn; Arnold, James M.; Bennet, Crissa; Bertagnolli, Darren; Brouner, Krissy; Butler, Stephanie; Caldejon, Shiella; Carey, Anita; Cuhaciyan, Christine; Dalley, Rachel A.; Dee, Nick; Dolbeare, Tim A.; Facer, Benjamin A. C.; Feng, David; Fliss, Tim P.; Gee, Garrett; Goldy, Jeff; Gourley, Lindsey; Gregor, Benjamin W.; Gu, Guangyu; Howard, Robert E.; Jochim, Jayson M.; Kuan, Chihchau L.; Lau, Christopher; Lee, Chang-Kyu; Lee, Felix; Lemon, Tracy A.; Lesnar, Phil; McMurray, Bergen; Mastan, Naveed; Mosqueda, Nerick; Naluai-Cecchini, Theresa; Ngo, Nhan-Kiet; Nyhus, Julie; Oldre, Aaron; Olson, Eric; Parente, Jody; Parker, Patrick D.; Parry, Sheana E.; Stevens, Allison; Pletikos, Mihovil; Reding, Melissa; Roll, Kate; Sandman, David; Sarreal, Melaine; Shapouri, Sheila; Shapovalova, Nadiya V.; Shen, Elaine H.; Sjoquist, Nathan; Slaughterbeck, Clifford R.; Smith, Michael; Sodt, Andy J.; Williams, Derric; Zoellei, Lilla; Fischl, Bruce; Gerstein, Mark B.; Geschwind, Daniel H.; Glass, Ian A.; Hawrylycz, Michael J.; Hevner, Robert F.; Huang, Hao; Jones, Allan R.; Knowles, James A.; Levitt, Pat; Phillips, John W.; Sestan, Nenad; Wohnoutka, Paul; Dang, Chinh; Bernard, Amy; Hohmann, John G.; Lein, Ed S.			Transcriptional landscape of the prenatal human brain	NATURE			English	Article							OUTER SUBVENTRICULAR ZONE; RADIAL GLIAL-CELLS; CEREBRAL-CORTEX; GENE-EXPRESSION; MESSENGER-RNA; NEURONS; NETWORKS; SUBPLATE; CONNECTIONS; ASTROCYTES	The anatomical and functional architecture of the human brain is mainly determined by prenatal transcriptional processes. We describe an anatomically comprehensive atlas of the mid-gestational human brain, including de novo reference atlases, in situ hybridization, ultra-high-resolution magnetic resonance imaging(MRI) and microarray analysis on highly discrete laser-microdissected brain regions. In developing cerebral cortex, transcriptional differences are found between different proliferative and post-mitotic layers, wherein laminar signatures reflect cellular composition and developmental processes. Cytoarchitectural differences between human and mouse have molecular correlates, including species differences in gene expression in subplate, although surprisingly we find minimal differences between the inner and outer subventricular zones even though the outer zone is expanded in humans. Both germinal and post-mitotic cortical layers exhibit fronto-temporal gradients, with particular enrichment in the frontal lobe. Finally, many neurodevelopmental disorder and human-evolution-related genes show patterned expression, potentially underlying unique features of human cortical formation. These data provide a rich, freely-accessible resource for understanding human brain development.	[Miller, Jeremy A.; Ding, Song-Lin; Sunkin, Susan M.; Smith, Kimberly A.; Ng, Lydia; Szafer, Aaron; Ebbert, Amanda; Riley, Zackery L.; Royall, Joshua J.; Aiona, Kaylynn; Arnold, James M.; Bennet, Crissa; Bertagnolli, Darren; Brouner, Krissy; Butler, Stephanie; Caldejon, Shiella; Carey, Anita; Cuhaciyan, Christine; Dalley, Rachel A.; Dee, Nick; Dolbeare, Tim A.; Facer, Benjamin A. C.; Feng, David; Fliss, Tim P.; Gee, Garrett; Goldy, Jeff; Gourley, Lindsey; Gregor, Benjamin W.; Gu, Guangyu; Howard, Robert E.; Jochim, Jayson M.; Kuan, Chihchau L.; Lau, Christopher; Lee, Chang-Kyu; Lee, Felix; Lemon, Tracy A.; Lesnar, Phil; McMurray, Bergen; Mastan, Naveed; Mosqueda, Nerick; Ngo, Nhan-Kiet; Nyhus, Julie; Oldre, Aaron; Olson, Eric; Parente, Jody; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Roll, Kate; Sandman, David; Sarreal, Melaine; Shapouri, Sheila; Shapovalova, Nadiya V.; Shen, Elaine H.; Sjoquist, Nathan; Slaughterbeck, Clifford R.; Smith, Michael; Sodt, Andy J.; Williams, Derric; Hawrylycz, Michael J.; Jones, Allan R.; Phillips, John W.; Wohnoutka, Paul; Dang, Chinh; Bernard, Amy; Hohmann, John G.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Naluai-Cecchini, Theresa; Glass, Ian A.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Stevens, Allison; Zoellei, Lilla; Fischl, Bruce] Harvard Univ, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol,Med Sch, Charlestown, MA 02129 USA; [Stevens, Allison; Fischl, Bruce] MIT, Comp Sci & AI Lab, Cambridge, MA 02139 USA; [Pletikos, Mihovil; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Pletikos, Mihovil; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hevner, Robert F.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Hevner, Robert F.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98105 USA; [Huang, Hao] UT Southwestern Med Ctr, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Knowles, James A.] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Knowles, James A.] Univ So Calif, Dept Psychiat, Los Angeles, CA 90033 USA; [Levitt, Pat] Childrens Hosp, Dept Pediat, Los Angeles, CA 90027 USA; [Levitt, Pat] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	Allen Institute for Brain Science; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Yale University; Yale University; Yale University; Yale University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Lein, ES (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	edl@alleninstitute.org	Ding, Song-Lin/F-7963-2013	Lesnar, Phil/0000-0002-2152-604X; Sjoquist, Nathan/0000-0002-2037-6828; Arnold, James/0000-0001-7011-591X; Feng, David/0000-0002-4920-8123; Ding, Song-Lin/0000-0002-7072-5272; Zollei, Lilla/0000-0002-6447-9626; Bernard, Amy/0000-0003-2540-1153; Parker, Patrick/0000-0001-5217-107X; Dee, Nick/0000-0002-2831-9254	National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R24HD0008836]; National Institute of Mental Health [RC2MH089921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD061485, R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089921, R37MH060233, R01MH092535] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement and support. We express our gratitude to past and present Allen Institute staff members R. Adams, A. Alpisa, A. Boe, E. Byrnes, M. Chapin, J. Chen, C. Copeland, N. Dotson, K. Fotheringham, E. Fulfs, M. Gasparrini, T. Gilbert, Z. Haradon, N. Hejazinia, N. Ivanov, J. Kinnunen, A. Kriedberg, J. Laoenkue, S. Levine, V. Menon, E. Mott, N. Motz, J. Pendergraft, L. Potekhina, J. Redmayne-Titley, D. Rosen, C. Simpson, S. Shi, L. Velasquez, U. Wagley, N. Wong and B. Youngstrom for their technical assistance. We would also like to thank J. Augustinack, T. Benner, A. Mayaram, M. Roy, A. van der Kouwe and L. Wald from the Fischl laboratory. Also, we wish to acknowledge Covance Genomics Laboratory (Seattle, Washington) for microarray probe generation, hybridization and scanning. In addition, we express our gratitude to Advanced Bioscience Resources, for providing tissue used for expression profiling and reference atlas generation as well as to the Laboratory of Developmental Biology, University of Washington, for providing tissue used for expression profiling and reference atlas generation. The Laboratory of Developmental Biology work was supported by the National Institutes of Health (NIH) Award Number 5R24HD0008836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The BrainSpan project was supported by Award Number RC2MH089921 (PIs: E. Lein and M. Hawrylycz, Allen Institute for Brain Science) from the National Institute of Mental Health. The content is solely the responsibility of the respective authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health.	ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Brun A., 1965, ACTA PATHOL MICROB S, V179, P3; Butler DM, 1998, J NEUROBIOL, V34, P135; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Dong H.W., 2008, ALLEN REFERENCE ATLA; Dubourg C, 2004, HUM MUTAT, V24, P43, DOI 10.1002/humu.20056; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Gaspard Nicolas, 2011, F1000 Biol Rep, V3, P6, DOI 10.3410/B3-6; Gerashchenko D, 2001, J NEUROSCI, V21, P7273, DOI 10.1523/JNEUROSCI.21-18-07273.2001; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hevner RF, 2005, ACTA NEUROPATHOL, V110, P208, DOI 10.1007/s00401-005-1059-8; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Inoue T, 2008, J NEUROSCI, V28, P4712, DOI 10.1523/JNEUROSCI.5735-07.2008; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kawaguchi A, 2008, DEVELOPMENT, V135, P3113, DOI 10.1242/dev.022616; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Mallamaci A, 2006, EUR J NEUROSCI, V23, P847, DOI 10.1111/j.1460-9568.2006.04634.x; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Montiel JF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00025; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Paxinos G, 2012, PAXINOS FRANKLINS MO; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2002, PROG BRAIN RES, V138, P3, DOI 10.1016/S0079-6123(02)38067-1; Saleem KS, 2012, COMBINED MRI HISTOLO; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Sorensen S. A., 2013, CEREB CORTEX; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Vogt Weisenhorn D. M., 1994, BRAIN RES DEV BRAIN, V82, P293; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang WZ, 2011, CEREB CORTEX, V21, P2187, DOI 10.1093/cercor/bhq278; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	64	719	728	8	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					199	+		10.1038/nature13185	http://dx.doi.org/10.1038/nature13185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695229	Green Submitted, Green Accepted			2022-12-24	WOS:000333979900036
J	Amunts, A; Brown, A; Bai, XC; Llacer, JL; Hussain, T; Emsley, P; Long, F; Murshudov, G; Scheres, SHW; Ramakrishnan, V				Amunts, Alexey; Brown, Alan; Bai, Xiao-chen; Llacer, Jose L.; Hussain, Tanweer; Emsley, Paul; Long, Fei; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.			Structure of the Yeast Mitochondrial Large Ribosomal Subunit	SCIENCE			English	Article							EM STRUCTURE DETERMINATION; CRYO-EM; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; EUKARYOTIC RIBOSOME; TRANSFER-RNA; TUNNEL EXIT; PROTEINS; EVOLUTION; PROTEOME	Mitochondria have specialized ribosomes that have diverged from their bacterial and cytoplasmic counterparts. We have solved the structure of the yeast mitoribosomal large subunit using single-particle cryo-electron microscopy. The resolution of 3.2 angstroms enabled a nearly complete atomic model to be built de novo and refined, including 39 proteins, 13 of which are unique to mitochondria, as well as expansion segments of mitoribosomal RNA. The structure reveals a new exit tunnel path and architecture, unique elements of the E site, and a putative membrane docking site.	[Amunts, Alexey; Brown, Alan; Bai, Xiao-chen; Llacer, Jose L.; Hussain, Tanweer; Emsley, Paul; Long, Fei; Murshudov, Garib; Scheres, Sjors H. W.; Ramakrishnan, V.] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Scheres, SHW (corresponding author), MRC Lab Mol Biol, Cambridge CB2 0QH, England.	scheres@mrc-lmb.cam.ac.uk; ramak@mrc-lmb.cam.ac.uk	Llacer, José Luis/K-4299-2017; Llácer, José Luis/AAB-8711-2022; Scheres, Sjors H.W./AAY-2265-2021; Amunts, A./AAZ-2279-2020; Bai, Xiao-chen/HGV-1244-2022; Brown, Alan/I-1473-2019	Llacer, José Luis/0000-0001-5304-1795; Llácer, José Luis/0000-0001-5304-1795; Scheres, Sjors H.W./0000-0002-0462-6540; Amunts, A./0000-0002-5302-1740; Bai, Xiao-chen/0000-0002-4234-5686; Brown, Alan/0000-0002-0021-0476; Hussain, Tanweer/0000-0003-4735-2380; Ramakrishnan, V/0000-0002-4699-2194	UK Medical Research Council [MC_U105184332, MC_UP_A025_1013, MC_UP_A025_1012]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; Human Frontiers Science Program; EU; FEBS; EMBO; MRC [MC_UP_A025_1013, MC_U105184332, MC_UP_A025_1012] Funding Source: UKRI; Medical Research Council [MC_U105184332, MC_UP_A025_1012, MC_UP_A025_1013] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; Human Frontiers Science Program(Human Frontier Science Program); EU(European Commission); FEBS; EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Walker for co-initiating this project and his support in the early phase of the work; G. McMullan, X. Chen, and C. Savva for help with data collection; I. S. Fernandez and D. Tourigny for help with preliminary modeling; S. Peak-Chew and M. Skehel for mass spectrometry; J. Grimmett and T. Darling for help with computing; and R. Nicholls for help with ProSMART. Supported by UK Medical Research Council grants MC_U105184332 (V. R.), MC_UP_A025_1013 (S. H. W. S.), and MC_UP_A025_1012 (G. M.); a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V. R.); and fellowships from Human Frontiers Science Program (A. A.), EU FP7 Marie Curie (X.-C. B.), FEBS (J. L. L.), and EMBO (T. H.). Cryo-EM density maps have been deposited with the EMDB (accession no. EMD-2566) and coordinates have been deposited with the Protein Data Bank (entry code 3J6B).	Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; DENSLOW ND, 1978, EUR J BIOCHEM, V91, P441, DOI 10.1111/j.1432-1033.1978.tb12696.x; Dontsova Olga A, 2005, Int J Biomed Sci, V1, P1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox GE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003483; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; Jones CN, 2009, MITOCHONDRION, V9, P429, DOI 10.1016/j.mito.2009.08.001; Keil M, 2012, J BIOL CHEM, V287, P34484, DOI 10.1074/jbc.M112.382630; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; MALY P, 1983, NUCLEIC ACIDS RES, V11, P7263, DOI 10.1093/nar/11.21.7263; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Prestele M, 2009, MOL BIOL CELL, V20, P2615, DOI 10.1091/mbc.E08-12-1162; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	38	400	445	1	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1485	1489		10.1126/science.1249410	http://dx.doi.org/10.1126/science.1249410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675956	Green Accepted, Green Submitted			2022-12-24	WOS:000333471000040
J	Ryan, KK; Tremaroli, V; Clemmensen, C; Kovatcheva-Datchary, P; Myronovych, A; Karns, R; Wilson-Perez, HE; Sandoval, DA; Kohli, R; Backhed, F; Seeley, RJ				Ryan, Karen K.; Tremaroli, Valentina; Clemmensen, Christoffer; Kovatcheva-Datchary, Petia; Myronovych, Andriy; Karns, Rebekah; Wilson-Perez, Hilary E.; Sandoval, Darleen A.; Kohli, Rohit; Backhed, Fredrik; Seeley, Randy J.			FXR is a molecular target for the effects of vertical sleeve gastrectomy	NATURE			English	Article							FARNESOID-X-RECEPTOR; Y GASTRIC BYPASS; BILE-ACID METABOLISM; HUMAN GUT MICROBIOTA; INSULIN-SENSITIVITY; WEIGHT-LOSS; BARIATRIC SURGERY; HIGH-FAT; GLUCOSE-HOMEOSTASIS; IMPROVES GLUCOSE	Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms contributing to these benefits remain largely undetermined, despite offering the potential to reveal new targets for therapeutic intervention. Substantial changes in circulating total bile acids are known to occur after VSG. Moreover, bile acids are known to regulate metabolism by binding to the nuclear receptor FXR (farsenoid-X receptor, also known as NR1H4). We therefore examined the results of VSG surgery applied to mice with diet-induced obesity and targeted genetic disruption of FXR. Here we demonstrate that the therapeutic value of VSG does not result from mechanical restriction imposed by a smaller stomach. Rather, VSG is associated with increased circulating bile acids, and associated changes to gut microbial communities. Moreover, in the absence of FXR, the ability of VSG to reduce body weight and improve glucose tolerance is substantially reduced. These results point to bile acids and FXR signalling as an important molecular underpinning for the beneficial effects of this weight-loss surgery.	[Ryan, Karen K.; Clemmensen, Christoffer; Wilson-Perez, Hilary E.; Sandoval, Darleen A.; Seeley, Randy J.] Univ Cincinnati, Div Endocrinol Diabet & Metab, Dept Internal Med, Cincinnati, OH 45237 USA; [Tremaroli, Valentina; Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-41345 Gothenburg, Sweden; [Tremaroli, Valentina; Kovatcheva-Datchary, Petia; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, S-41345 Gothenburg, Sweden; [Clemmensen, Christoffer] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Myronovych, Andriy; Kohli, Rohit] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Cincinnati, OH 45229 USA; [Karns, Rebekah] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Backhed, Fredrik] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	University System of Ohio; University of Cincinnati; University of Gothenburg; University of Gothenburg; University of Copenhagen; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Novo Nordisk Foundation; University of Copenhagen	Seeley, RJ (corresponding author), Univ Cincinnati, Div Endocrinol Diabet & Metab, Dept Internal Med, Cincinnati, OH 45237 USA.	randy.seeley@uc.edu	Tremaroli, Valentina/AAE-8001-2019; Clemmensen, Christoffer/AAM-3347-2020; kohli, Rohit/H-3020-2013; Clemmensen, Christoffer/N-4680-2017; Backhed, Fredrik/ABE-6613-2020	Tremaroli, Valentina/0000-0002-9150-4233; Clemmensen, Christoffer/0000-0003-2456-9667; kohli, Rohit/0000-0002-0198-7703; Clemmensen, Christoffer/0000-0003-2456-9667; Backhed, Fredrik/0000-0002-4871-8818; Seeley, Randy/0000-0002-3721-5625; Ryan, Karen/0000-0003-4563-3744	UNIK Food Fitness and Pharma for Health and Disease research programme; Torsten Soderberg foundation; NovoNordisk foundation; Ethicon Endo-Surgery; NIH [DK082173, HL111319, DK093848]; NIH (Bioinformatics Core of the Digestive Disease Research Core Center in Cincinnati) [DK078392]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL111319, R00HL111319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK082173, K08DK084310, P30DK078392, R01DK093848] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0008163] Funding Source: researchfish	UNIK Food Fitness and Pharma for Health and Disease research programme; Torsten Soderberg foundation; NovoNordisk foundation(Novo Nordisk Foundation); Ethicon Endo-Surgery; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Bioinformatics Core of the Digestive Disease Research Core Center in Cincinnati); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank J. Berger, A. Haller, B. Li, E. Orr and M. Toure for technical assistance. This work was supported by grants from the UNIK Food Fitness and Pharma for Health and Disease research programme (C. C.), the Torsten Soderberg and NovoNordisk foundations (F. B.), Ethicon Endo-Surgery (R. K., D. A. S., R. J. S.) and the NIH (DK082173, HL111319 to K. K. R., DK093848 to R. J. S. and the Bioinformatics Core of the Digestive Disease Research Core Center in Cincinnati DK078392).	Bradley D, 2012, J CLIN INVEST, V122, P4667, DOI 10.1172/JCI64895; Brodziak F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072317; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chambers AP, 2013, GASTROENTEROLOGY, V144, P50, DOI 10.1053/j.gastro.2012.09.009; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Cummings BP, 2012, ENDOCRINOLOGY, V153, P3620, DOI 10.1210/en.2012-1131; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jackness C, 2013, DIABETES, V62, P3027, DOI 10.2337/db12-1762; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lhoste EF, 2003, FOOD CHEM TOXICOL, V41, P695, DOI 10.1016/S0278-6915(03)00010-3; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Myronovych A, 2014, OBESITY, V22, P390, DOI 10.1002/oby.20548; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Pories WJ, 2008, J CLIN ENDOCR METAB, V93, pS89, DOI 10.1210/jc.2008-1641; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ryan KK, 2012, CELL METAB, V15, P137, DOI 10.1016/j.cmet.2011.12.013; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stefater MA, 2012, ENDOCR REV, V33, P595, DOI 10.1210/er.2011-1044; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	54	648	693	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					183	+		10.1038/nature13135	http://dx.doi.org/10.1038/nature13135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24670636	Green Accepted			2022-12-24	WOS:000335454300030
J	Maisonneuve, E; Gerdes, K				Maisonneuve, Etienne; Gerdes, Kenn			Molecular Mechanisms Underlying Bacterial Persisters	CELL			English	Review							ESCHERICHIA-COLI K-12; MEDIATE ANTIBIOTIC TOLERANCE; MESSENGER-RNA INTERFERASES; MULTIDRUG TOLERANCE; STRINGENT RESPONSE; AFFECTS LETHALITY; AFFECTS FREQUENCY; BETA-LACTAM; TOXIN; HIPA	All bacteria form persisters, cells that are multidrug tolerant and therefore able to survive antibiotic treatment. Due to the low frequencies of persisters in growing bacterial cultures and the complex underlying molecular mechanisms, the phenomenon has been challenging to study. However, recent technological advances in microfluidics and reporter genes have improved this scenario. Here, we summarize recent progress in the field, revealing the ubiquitous bacterial stress alarmone ppGpp as an emerging central regulator of multidrug tolerance and persistence, both in stochastically and environmentally induced persistence. In several different organisms, toxin-antitoxin modules function as effectors of ppGpp-induced persistence.	[Maisonneuve, Etienne; Gerdes, Kenn] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Gerdes, Kenn] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Newcastle University - UK; University of Copenhagen	Gerdes, K (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	kenn.gerdes@ncl.ac.uk	Gerdes, Kenn/AAS-5548-2021; Gerdes, Kenn/M-2420-2014	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; maisonneuve, Etienne/0000-0003-3451-1223	European Research Council Advanced Investigator [294517 "PERSIST']; Laureate Research; Novo Nordisk Fonden [NNF12OC0000638] Funding Source: researchfish	European Research Council Advanced Investigator; Laureate Research; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by a European Research Council Advanced Investigator Grant (294517 "PERSIST'') and by a Laureate Research Grant Award from Novo Nordisk to K.G. We thank David Holden and Namiko Mitarai for critical reading of the manuscript. We further thank the members of the Gerdes group and members of the Centre for Bacterial Cell Biology for stimulating discussions.	Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Cataudella I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003174; Cataudella I, 2012, NUCLEIC ACIDS RES, V40, P6424, DOI 10.1093/nar/gks297; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fung DKC, 2010, ANTIMICROB AGENTS CH, V54, P1082, DOI 10.1128/AAC.01218-09; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Gelens L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003190; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Harrison JJ, 2005, MICROBIOL-SGM, V151, P3181, DOI 10.1099/mic.0.27794-0; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; Mahoney TF, 2013, J BACTERIOL, V195, P1869, DOI 10.1128/JB.02197-12; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Nystrom T, 2003, MOL MICROBIOL, V48, P17, DOI 10.1046/j.1365-2958.2003.03385.x; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shyp V, 2012, EMBO REP, V13, P835, DOI 10.1038/embor.2012.106; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Vega NM, 2013, P NATL ACAD SCI USA, V110, P14420, DOI 10.1073/pnas.1308085110; Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/NCHEMBIO.915, 10.1038/nchembio.915]; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200	95	416	432	13	270	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					539	548		10.1016/j.cell.2014.02.050	http://dx.doi.org/10.1016/j.cell.2014.02.050			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766804	Bronze			2022-12-24	WOS:000335392100006
J	Woodward, A; Smith, KR; Campbell-Lendrum, D; Chadee, DD; Honda, Y; Liu, QY; Olwoch, J; Revich, B; Sauerborn, R; Chafe, Z; Confalonieri, U; Haines, A				Woodward, Alistair; Smith, Kirk R.; Campbell-Lendrum, Diarmid; Chadee, Dave D.; Honda, Yasushi; Liu, Qiyong; Olwoch, Jane; Revich, Boris; Sauerborn, Rainer; Chafe, Zoe; Confalonieri, Ulisses; Haines, Andy			Climate change and health: on the latest IPCC report	LANCET			English	Editorial Material									[Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand; [Smith, Kirk R.; Chafe, Zoe] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Campbell-Lendrum, Diarmid] WHO, Dept Publ Hlth Environm & Social Determinants Hlt, CH-1211 Geneva, Switzerland; [Chadee, Dave D.] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sports Sci, Tsukuba, Ibaraki, Japan; [Liu, Qiyong] China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Olwoch, Jane] South African Natl Space Agcy, SANSA Earth Observat, Pretoria, South Africa; [Revich, Boris] Russian Acad Sci, Inst Forecasting, Moscow, Russia; [Sauerborn, Rainer] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Confalonieri, Ulisses] FIOCRUZ Oswaldo Cruz Fdn, Lab Hlth Educ, Belo Horizonte, MG, Brazil; [Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England	University of Auckland; University of California System; University of California Berkeley; World Health Organization; University West Indies Mona Jamaica; University West Indies Saint Augustine; University of Tsukuba; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Russian Academy of Sciences; Umea University; Fundacao Oswaldo Cruz; University of London; London School of Hygiene & Tropical Medicine	Woodward, A (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand.	a.woodward@auckland.ac.nz	Olwoch, Jane/AAC-5073-2020	Haines, Andy/0000-0002-8053-4605; Chafe, Zoe/0000-0001-6670-6979; Woodward, Alistair/0000-0001-5425-6018				Anenberg SC, 2012, ENVIRON HEALTH PERSP, V120, P831, DOI 10.1289/ehp.1104301; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Ebi KL, 2012, CLIMATIC CHANGE, V114, P417, DOI 10.1007/s10584-012-0442-4; Hosking J, 2012, ENVIRON HEALTH PERSP, V120, P1076, DOI 10.1289/ehp.1104093; Ipsdgc C, 2013, CLIM CHANG 2013 PHYS, P1535, DOI [DOI 10.1017/CBO9781107415324, DOI 10.1017/cbo9781107415324]; Mastrandrea MD, 2011, CLIMATIC CHANGE, V108, P675, DOI 10.1007/s10584-011-0178-6; Parry ML, 2007, CLIMATE CHANGE 2007; Shaposhnikov D, 2014, EPIDEMIOLOGY, V25, P359, DOI 10.1097/EDE.0000000000000090; Teague B., 2010, 2009 VICTORIAN BUSHF; The World Bank,, 2012, TURN HEAT WHY 4C WAR	10	150	157	4	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1185	1189		10.1016/S0140-6736(14)60576-6	http://dx.doi.org/10.1016/S0140-6736(14)60576-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE6LO	24703554				2022-12-24	WOS:000334104600004
J	Cummings, SR; Studenski, S; Ferrucci, L				Cummings, Steven R.; Studenski, Stephanie; Ferrucci, Luigi			A Diagnosis of Dismobility-Giving Mobility Clinical Visibility A Mobility Working Group Recommendation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUBSEQUENT DISABILITY; PHYSICAL PERFORMANCE; OLDER-ADULTS; GAIT SPEED		[Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA 94107 USA; [Studenski, Stephanie; Ferrucci, Luigi] NIA, Intramural Program, Baltimore, MD 21224 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cummings, SR (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	scummings@sfcc-cpmc.net			NATIONAL INSTITUTE ON AGING [ZIAAG000015] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000015-49] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Cawthon PM, 2009, J AM GERIATR SOC, V57, P1411, DOI 10.1111/j.1532-5415.2009.02366.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Rydwik E., 2012, Physiotherapy Theory and Practice, V28, P238, DOI 10.3109/09593985.2011.601804; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33	10	165	168	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2061	2062		10.1001/jama.2014.3033	http://dx.doi.org/10.1001/jama.2014.3033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24763978	Green Accepted			2022-12-24	WOS:000336392400016
J	Song, F; Chen, P; Sun, DP; Wang, MZ; Dong, LP; Liang, D; Xu, RM; Zhu, P; Li, GH				Song, Feng; Chen, Ping; Sun, Dapeng; Wang, Mingzhu; Dong, Liping; Liang, Dan; Xu, Rui-Ming; Zhu, Ping; Li, Guohong			Cryo-EM Study of the Chromatin Fiber Reveals a Double Helix Twisted by Tetranucleosomal Units	SCIENCE			English	Article							HIGHER-ORDER STRUCTURE; LINKER HISTONE H5; X-RAY-DIFFRACTION; NUCLEOSOME; ORGANIZATION; MICROSCOPY; RESOLUTION; FILAMENT; LOCATION; OCTAMER	The hierarchical packaging of eukaryotic chromatin plays a central role in transcriptional regulation and other DNA-related biological processes. Here, we report the 11-angstrom-resolution cryogenic electron microscopy (cryo-EM) structures of 30-nanometer chromatin fibers reconstituted in the presence of linker histone H1 and with different nucleosome repeat lengths. The structures show a histone H1-dependent left-handed twist of the repeating tetranucleosomal structural units, within which the four nucleosomes zigzag back and forth with a straight linker DNA. The asymmetric binding and the location of histone H1 in chromatin play a role in the formation of the 30-nanometer fiber. Our results provide mechanistic insights into how nucleosomes compact into higher-order chromatin fibers.	[Song, Feng; Chen, Ping; Sun, Dapeng; Wang, Mingzhu; Dong, Liping; Liang, Dan; Xu, Rui-Ming; Zhu, Ping; Li, Guohong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Song, Feng; Sun, Dapeng; Dong, Liping; Liang, Dan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, P (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	zhup@ibp.ac.cn; liguohong@ibp.ac.cn	liang, dy/GZA-4770-2022; xu, rui/GRX-5734-2022	sun, dapeng/0000-0003-0220-8844; Chen, Ping/0000-0003-0295-0846	National Basic Research Program of China [2010CB912400, 2011CB966300, 2009CB825500]; National Natural Science Foundation of China [91219202, 31230018, 91019007, 21261130090, 31000566]; Strategic Priority Research Program from the Chinese Academy of Sciences [XDA01010304, XDB08010100]; Key Research Program from the Chinese Academy of Sciences [KJZD-EW-L05]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program from the Chinese Academy of Sciences; Key Research Program from the Chinese Academy of Sciences; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Basic Research Program of China (2010CB912400 to P.Z., 2011CB966300 to G. L., and 2009CB825500 to R. M. X. and P.Z.); the National Natural Science Foundation of China (91219202 to G. L., 31230018 to P.Z., 91019007 to G. L., 21261130090 to P.Z., and 31000566 to P. C.); Strategic Priority Research Program (XDA01010304 to G. L. and XDB08010100 to P.Z. and R. M. X.) and Key Research Program (KJZD-EW-L05 to P.Z., G. L., and R. M. X.) from the Chinese Academy of Sciences; and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, to P. C. All EM data were collected and processed at the Center for Bio-imaging, Institute of Biophysics, Chinese Academy of Sciences. We thank G. Ji and X. Huang for their technical help and support with electron microscopy and L. Ling for technical help and support with the data processing in the High Performance Computing Service Station. We are also indebted to the colleagues whose work could not be cited because of the limitation of space. The cryo-EM maps for the 12 x 177 bp, 12 x 187 bp and 24 x 177 bp chromatin fibers were deposited into the Electron Microscopy Data Bank with the accession codes EMD-2600, EMD-2601 and EMD-2602, respectively. The authors declare no conflicts of interest.	ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Carter GJ, 1998, BIOCHEMISTRY-US, V37, P12477, DOI 10.1021/bi980716v; DAVIES HG, 1968, NATURE, V217, P1122, DOI 10.1038/2171122a0; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Frouws TD, 2009, BIOPHYS J, V96, P3363, DOI 10.1016/j.bpj.2008.10.075; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Ghirlando R, 2008, J MOL BIOL, V376, P1417, DOI 10.1016/j.jmb.2007.12.051; GRAZIANO V, 1994, NATURE, V368, P351, DOI 10.1038/368351a0; LANGMORE JP, 1983, J CELL BIOL, V96, P1120, DOI 10.1083/jcb.96.4.1120; Leuba SH, 1998, BIOPHYS J, V74, P2830, DOI 10.1016/S0006-3495(98)77990-1; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; PEARSON EC, 1983, EMBO J, V2, P1367, DOI 10.1002/j.1460-2075.1983.tb01593.x; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Staynov DZ, 2008, BIOESSAYS, V30, P1003, DOI 10.1002/bies.20816; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110	28	380	406	2	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					376	380		10.1126/science.1251413	http://dx.doi.org/10.1126/science.1251413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763583				2022-12-24	WOS:000334867800032
J	Macho, AP; Schwessinger, B; Ntoukakis, V; Brutus, A; Segonzac, C; Roy, S; Kadota, Y; Oh, MH; Sklenar, J; Derbyshire, P; Lozano-Duran, R; Malinovsky, FG; Monaghan, J; Menke, FL; Huber, SC; He, SY; Zipfel, C				Macho, Alberto P.; Schwessinger, Benjamin; Ntoukakis, Vardis; Brutus, Alexandre; Segonzac, Cecile; Roy, Sonali; Kadota, Yasuhiro; Oh, Man-Ho; Sklenar, Jan; Derbyshire, Paul; Lozano-Duran, Rosa; Malinovsky, Frederikke Gro; Monaghan, Jacqueline; Menke, Frank L.; Huber, Steven C.; He, Sheng Yang; Zipfel, Cyril			A Bacterial Tyrosine Phosphatase Inhibits Plant Pattern Recognition Receptor Activation	SCIENCE			English	Article							IMMUNE RECEPTORS; INNATE IMMUNITY; KINASES; ARABIDOPSIS; PHOSPHORYLATION; PERCEPTION; EFFECTOR	Innate immunity relies on the perception of pathogen-associated molecular patterns (PAMPs) by pattern-recognition receptors (PRRs) located on the host cell's surface. Many plant PRRs are kinases. Here, we report that the Arabidopsis receptor kinase EF-TU RECEPTOR (EFR), which perceives the elf18 peptide derived from bacterial elongation factor Tu, is activated upon ligand binding by phosphorylation on its tyrosine residues. Phosphorylation of a single tyrosine residue, Y836, is required for activation of EFR and downstream immunity to the phytopathogenic bacterium Pseudomonas syringae. A tyrosine phosphatase, HopAO1, secreted by P. syringae, reduces EFR phosphorylation and prevents subsequent immune responses. Thus, host and pathogen compete to take control of PRR tyrosine phosphorylation used to initiate antibacterial immunity.	[Macho, Alberto P.; Schwessinger, Benjamin; Ntoukakis, Vardis; Segonzac, Cecile; Roy, Sonali; Kadota, Yasuhiro; Sklenar, Jan; Derbyshire, Paul; Lozano-Duran, Rosa; Malinovsky, Frederikke Gro; Monaghan, Jacqueline; Menke, Frank L.; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Brutus, Alexandre; He, Sheng Yang] Michigan State Univ, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA; [Oh, Man-Ho; Huber, Steven C.] Univ Illinois, USDA ARS, Urbana, IL 61801 USA; [Oh, Man-Ho; Huber, Steven C.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Oh, Man-Ho] Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon 305764, South Korea; [He, Sheng Yang] Michigan State Univ, Howard Hughes Med Inst, E Lansing, MI 48824 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Michigan State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chungnam National University; Howard Hughes Medical Institute; Michigan State University	Zipfel, C (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	cyril.zipfel@tsl.ac.uk	mailnovsky, frederikke gro/C-1959-2015; Kadota, Yasuhiro/AGJ-3017-2022; ZIPFEL, CYRIL/ABD-5076-2021; Kadota, Yasuhiro/A-9406-2011; Kadota, Yasuhiro/AAC-4545-2019; Roy, Sonali/I-1576-2019; Ntoukakis, Vardis/C-6296-2012; Schwessinger, Benjamin/R-5869-2018; Menke, Frank/F-2739-2014	mailnovsky, frederikke gro/0000-0002-9833-7968; Kadota, Yasuhiro/0000-0002-4782-1418; ZIPFEL, CYRIL/0000-0003-4935-8583; Kadota, Yasuhiro/0000-0002-4782-1418; Kadota, Yasuhiro/0000-0002-4782-1418; Roy, Sonali/0000-0002-8114-8300; Oh, Man-Ho/0000-0002-6524-3252; Ntoukakis, Vardis/0000-0003-0069-6004; Schwessinger, Benjamin/0000-0002-7194-2922; Segonzac, Cecile/0000-0002-5537-7556; Menke, Frank/0000-0003-2490-4824; Macho, Alberto P/0000-0001-9935-8026; He, Sheng Yang/0000-0003-1308-498X	United Kingdom Biotechnology and Biological Sciences Research Council; U.S. Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science) [DE-FG02-91ER20021]; U.S. National Institutes of Health [R01AI060761]; Gordon and Betty Moore Foundation [GBMF3037]; National Science Foundation [MCB-0742411, 0740211]; USDA-ARS; Federation of European Biochemical Societies (FEBS); KAKENHI [23580068]; Excellent Young Researcher Overseas Visit Program; Uehara memorial foundation; European Molecular Biology Organization; Fundacion Ramon Areces; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060761] Funding Source: NIH RePORTER; BBSRC [BB/G024944/1, BB/E017134/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017134/1, BB/G024944/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science)(United States Department of Energy (DOE)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Federation of European Biochemical Societies (FEBS); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Excellent Young Researcher Overseas Visit Program; Uehara memorial foundation(Uehara Memorial Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fundacion Ramon Areces; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Gatsby Charitable Foundation (C.Z.), the European Research Council (grant "PHOSPHinnATE") (C.Z.), grants BB/E024874/1 (ERA-PG "RLPRLKs") and BB/G024944/1 ERA-PG "Pathonet" from the United Kingdom Biotechnology and Biological Sciences Research Council (C.Z.), grants from U.S. Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science; DE-FG02-91ER20021 for infrastructural support to S.Y.H.), the U.S. National Institutes of Health R01AI060761 (S.Y.H.), the Gordon and Betty Moore Foundation GBMF3037 (S.Y.H.), and grants from the National Science Foundation (MCB-0742411 and 0740211) and USDA-ARS (S. C. H). A. P. M. was supported by a postdoctoral fellowship from the Federation of European Biochemical Societies (FEBS). Y.K. was supported by fellowships from KAKENHI (no. 23580068), the Excellent Young Researcher Overseas Visit Program, and the Uehara memorial foundation. B. S. and S. R. were/are part of the JIC/TSL rotation program. J.M. was supported by a long-term postdoctoral fellowship from the European Molecular Biology Organization. R.L-D. was supported by a postdoctoral fellowship from Fundacion Ramon Areces. We thank L. Stransfeld, K. Morehouse, the John Innes Centre horticultural service, and the TSL tissue culture service for technical assistance, and all members of the Zipfel laboratory for discussions and comments. A. P. M., B. S., V.N., A. B., S. C. H., S.Y.H., and C.Z. designed and conceived the experiments. A. P. M., B. S., V.N., A. B., C. S., S. R., Y.K., M.-H.O., R.L.-D., F. G. M., J.M., J.S., and F. L. M. performed the experiments. A. P. M. and C.Z. wrote the manuscript. All authors commented and agreed on the manuscript before submission.	Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Oh MH, 2010, P NATL ACAD SCI USA, V107, P17827, DOI 10.1073/pnas.0915064107; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Underwood W, 2007, PLANT J, V52, P658, DOI 10.1111/j.1365-313X.2007.03262.x; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	19	106	115	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1509	1512		10.1126/science.1248849	http://dx.doi.org/10.1126/science.1248849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24625928				2022-12-24	WOS:000333471000047
J	Lee, JH; Daugharthy, ER; Scheiman, J; Kalhor, R; Yang, JL; Ferrante, TC; Terry, R; Jeanty, SSF; Li, C; Amamoto, R; Peters, DT; Turczyk, BM; Marblestone, AH; Inverso, SA; Bernard, A; Mali, P; Rios, X; Aach, J; Church, GM				Lee, Je Hyuk; Daugharthy, Evan R.; Scheiman, Jonathan; Kalhor, Reza; Yang, Joyce L.; Ferrante, Thomas C.; Terry, Richard; Jeanty, Sauveur S. F.; Li, Chao; Amamoto, Ryoji; Peters, Derek T.; Turczyk, Brian M.; Marblestone, Adam H.; Inverso, Samuel A.; Bernard, Amy; Mali, Prashant; Rios, Xavier; Aach, John; Church, George M.			Highly Multiplexed Subcellular RNA Sequencing in Situ	SCIENCE			English	Article							GENE-EXPRESSION; TRANSCRIPTS; REVEALS; TISSUE	Understanding the spatial organization of gene expression with single-nucleotide resolution requires localizing the sequences of expressed RNA transcripts within a cell in situ. Here, we describe fluorescent in situ RNA sequencing (FISSEQ), in which stably cross-linked complementary DNA (cDNA) amplicons are sequenced within a biological sample. Using 30-base reads from 8102 genes in situ, we examined RNA expression and localization in human primary fibroblasts with a simulated wound-healing assay. FISSEQ is compatible with tissue sections and whole-mount embryos and reduces the limitations of optical resolution and noisy signals on single-molecule detection. Our platform enables massively parallel detection of genetic elements, including gene transcripts and molecular barcodes, and can be used to investigate cellular phenotype, gene regulation, and environment in situ.	[Lee, Je Hyuk; Daugharthy, Evan R.; Scheiman, Jonathan; Ferrante, Thomas C.; Terry, Richard; Jeanty, Sauveur S. F.; Li, Chao; Turczyk, Brian M.; Marblestone, Adam H.; Inverso, Samuel A.; Church, George M.] Harvard Univ, Sch Med, Wyss Inst, Boston, MA 02115 USA; [Lee, Je Hyuk; Daugharthy, Evan R.; Scheiman, Jonathan; Kalhor, Reza; Yang, Joyce L.; Marblestone, Adam H.; Mali, Prashant; Rios, Xavier; Aach, John; Church, George M.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Amamoto, Ryoji; Peters, Derek T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02138 USA; [Daugharthy, Evan R.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Bernard, Amy] Allen Inst Brain Sci, Seattle, WA 98103 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Allen Institute for Brain Science	Lee, JH (corresponding author), Harvard Univ, Sch Med, Wyss Inst, Boston, MA 02115 USA.	jehyuklee@mac.com; gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969; Bernard, Amy/0000-0003-2540-1153; Marblestone, Adam/0000-0001-9833-9931	NIH Centers of Excellence in Genomic Sciences [P50 HG005550]; National Heart, Lung, and Blood Institute, NIH [RC2HL102815]; Allen Institute for Brain Science; National Institute of Mental Health, NIH [MH098977]; NIH [GM080177]; NSF [DGE1144152]; Hertz Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM080177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH098977] Funding Source: NIH RePORTER	NIH Centers of Excellence in Genomic Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Allen Institute for Brain Science; National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Hertz Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data can be downloaded from http://arep.med.harvard.edu/FISSEQ_Science_2014/ and Gene Expression Omnibus (gene expression arrays: GSM313643, GSM313646, and GSM313657; RNA-seq: GSE54733). We thank S. Kosuri, K. Zhang, and M. Nilsson for discussions; A. DePace for Drosophila embryos; and I. Bachelet for antibody conjugation. Funded by NIH Centers of Excellence in Genomic Sciences grant P50 HG005550. J.H.L. and co-workers were funded by the National Heart, Lung, and Blood Institute, NIH, grant RC2HL102815; the Allen Institute for Brain Science, and the National Institute of Mental Health, NIH, grant MH098977. E.R.D. was funded by NIH grant GM080177 and NSF Graduate Research Fellowship Program grant DGE1144152. A.H.M. was funded by the Hertz Foundation. Potential conflicts of interests for G.M.C. are listed on http://arep.med.harvard.edu/gmc/tech.html. J.H.L., E.R.D., R.T., and G.M.C. are authors on a patent application from the Wyss Institute that covers the method of generating three-dimensional nucleic acid-containing matrix.	Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	19	552	654	17	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1360	1363		10.1126/science.1250212	http://dx.doi.org/10.1126/science.1250212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24578530	Green Accepted			2022-12-24	WOS:000333108500039
J	Dewey, FE; Grove, ME; Pan, CP; Goldstein, BA; Bernstein, JA; Chaib, H; Merker, JD; Goldfeder, RL; Enns, GM; David, SP; Pakdaman, N; Ormond, KE; Caleshu, C; Kingham, K; Klein, TE; Whirl-Carrillo, M; Sakamoto, K; Wheeler, MT; Butte, AJ; Ford, JM; Boxer, L; Ioannidis, JPA; Yeung, AC; Altman, RB; Assimes, TL; Snyder, M; Ashley, EA; Quertermous, T				Dewey, Frederick E.; Grove, Megan E.; Pan, Cuiping; Goldstein, Benjamin A.; Bernstein, Jonathan A.; Chaib, Hassan; Merker, Jason D.; Goldfeder, Rachel L.; Enns, Gregory M.; David, Sean P.; Pakdaman, Neda; Ormond, Kelly E.; Caleshu, Colleen; Kingham, Kerry; Klein, Teri E.; Whirl-Carrillo, Michelle; Sakamoto, Kenneth; Wheeler, Matthew T.; Butte, Atul J.; Ford, James M.; Boxer, Linda; Ioannidis, John P. A.; Yeung, Alan C.; Altman, Russ B.; Assimes, Themistocles L.; Snyder, Michael; Ashley, Euan A.; Quertermous, Thomas			Clinical Interpretation and Implications of Whole-Genome Sequencing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPLEMENTATION CONSORTIUM GUIDELINES; OF-FUNCTION VARIANTS; ACMG RECOMMENDATIONS; INCIDENTAL FINDINGS; EXOME; MUTATIONS; INSIGHTS; INDIVIDUALS; ASSOCIATION; STANDARDS	IMPORTANCE Whole-genome sequencing (WGS) is increasingly applied in clinical medicine and is expected to uncover clinically significant findings regardless of sequencing indication. OBJECTIVES To examine coverage and concordance of clinically relevant genetic variation provided by WGS technologies; to quantitate inherited disease risk and pharmacogenomic findings in WGS data and resources required for their discovery and interpretation; and to evaluate clinical action prompted by WGS findings. DESIGN, SETTING, AND PARTICIPANTS An exploratory study of 12 adult participants recruited at Stanford University Medical Center who underwent WGS between November 2011 and March 2012. A multidisciplinary team reviewed all potentially reportable genetic findings. Five physicians proposed initial clinical follow-up based on the genetic findings. MAIN OUTCOMES AND MEASURES Genome coverage and sequencing platform concordance in different categories of genetic disease risk, person-hours spent curating candidate disease-risk variants, interpretation agreement between trained curators and disease genetics databases, burden of inherited disease risk and pharmacogenomic findings, and burden and interrater agreement of proposed clinical follow-up. RESULTS Depending on sequencing platform, 10% to 19% of inherited disease genes were not covered to accepted standards for single nucleotide variant discovery. Genotype concordance was high for previously described single nucleotide genetic variants (99%-100%) but low for small insertion/deletion variants (53%-59%). Curation of 90 to 127 genetic variants in each participant required a median of 54 minutes (range, 5-223 minutes) per genetic variant, resulted in moderate classification agreement between professionals (Gross., 0.52; 95% CI, 0.40-0.64), and reclassified 69% of genetic variants cataloged as disease causing in mutation databases to variants of uncertain or lesser significance. Two to 6 personal disease-risk findings were discovered in each participant, including 1 frameshift deletion in the BRCA1 gene implicated in hereditary breast and ovarian cancer. Physician review of sequencing findings prompted consideration of a median of 1 to 3 initial diagnostic tests and referrals per participant, with fair interrater agreement about the suitability of WGS findings for clinical follow-up (Fleiss., 0.24; P < 001). CONCLUSIONS AND RELEVANCE In this exploratory study of 12 volunteer adults, the use of WGS was associated with incomplete coverage of inherited disease genes, low reproducibility of detection of genetic variation with the highest potential clinical effects, and uncertainty about clinically reportable findings. In certain cases, WGS will identify clinically actionable genetic variants warranting early medical intervention. These issues should be considered when determining the role of WGS in clinical medicine.	[Dewey, Frederick E.; Grove, Megan E.; Caleshu, Colleen; Wheeler, Matthew T.; Ashley, Euan A.; Quertermous, Thomas] Stanford Ctr Inherited Cardiovasc Dis, Stanford, CA USA; [Dewey, Frederick E.; Grove, Megan E.; Caleshu, Colleen; Wheeler, Matthew T.; Yeung, Alan C.; Assimes, Themistocles L.; Snyder, Michael; Ashley, Euan A.; Quertermous, Thomas] Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Dewey, Frederick E.; Grove, Megan E.; Caleshu, Colleen; Sakamoto, Kenneth; Wheeler, Matthew T.; Yeung, Alan C.; Assimes, Themistocles L.; Ashley, Euan A.; Quertermous, Thomas] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Dewey, Frederick E.; Grove, Megan E.; Pan, Cuiping; Chaib, Hassan; Wheeler, Matthew T.; Snyder, Michael; Ashley, Euan A.; Quertermous, Thomas] Stanford Ctr Genom & Personalized Med, Stanford, CA USA; [Pan, Cuiping; Chaib, Hassan; Ormond, Kelly E.; Klein, Teri E.; Whirl-Carrillo, Michelle; Altman, Russ B.; Snyder, Michael; Ashley, Euan A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Goldstein, Benjamin A.; David, Sean P.; Pakdaman, Neda; Sakamoto, Kenneth; Boxer, Linda; Ioannidis, John P. A.; Altman, Russ B.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Bernstein, Jonathan A.; Enns, Gregory M.; Caleshu, Colleen; Butte, Atul J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Merker, Jason D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Goldfeder, Rachel L.] Stanford Univ, Biomed Informat Training Program, Stanford, CA 94305 USA; [Ormond, Kelly E.] Stanford Ctr Biomed Eth, Stanford, CA USA; [Kingham, Kerry; Ford, James M.] Stanford Univ, Div Med Oncol, Stanford, CA 94305 USA; [Butte, Atul J.; Ioannidis, John P. A.] Stanford Univ, Div Syst Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Ashley, EA (corresponding author), Stanford Cardiovasc Inst, Falk CVRC, 300 Pasteur Dr, Stanford, CA 94305 USA.	euan@stanford.edu; tomq1@stanford.edu	Assimes, Themistocles Leonard/D-9696-2015; Ioannidis, John P. A./G-9836-2011; Ormond, Kelly E/I-5676-2019	Assimes, Themistocles Leonard/0000-0003-2349-0009; Ormond, Kelly E/0000-0002-1033-0818; Pan, Cuiping/0000-0002-8152-2489; Grove, Megan/0000-0002-7972-0005; David, Sean/0000-0002-4922-2603; Quertermous, Thomas/0000-0002-7645-9067; Snyder, Michael/0000-0003-0784-7987; Altman, Russ/0000-0003-3859-2905; Klein, Teri/0000-0001-5527-6475; Whirl-Carrillo, Michelle/0000-0003-2414-9312; Ford, James/0000-0002-2513-7025; Wheeler, Matthew/0000-0001-8721-3022	NHLBI [T32 HL094274-01A2]; NHGRI [P50 HG003389-05, U01 HG004267-03]; NIGMS [R24 GM61374]; NIH [R01 GM079719 9]; Director's New Innovator Award from the National Institutes of Health [DP2 OD004613, R01 HL113006, U01 HG007436, X01 HL115206, HL094274]; Breetwor Family Foundation; LeDucq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087647, T32HL094274, R01HL113006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004267, U01HG007436, P50HG003389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK097279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719, R24GM061374] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's New Innovator Award from the National Institutes of Health; Breetwor Family Foundation; LeDucq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by grants NHLBI T32 HL094274-01A2 (Dr Dewey), NHGRI P50 HG003389-05 (Ms Ormond), NIGMS R24 GM61374 (Drs Klein, Whirl-Carrillo, and Altman), NIH R01 GM079719 9 (Dr Butte), NHGRI U01 HG004267-03 (Dr Snyder), and Director's New Innovator Award DP2 OD004613, R01 HL113006, U01 HG007436, X01 HL115206, and HL094274 from the National Institutes of Health and by a grant from the Breetwor Family Foundation (Dr Ashley) and a grant from the LeDucq Foundation (Dr Quertermous).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Baudi F, 2001, Hum Mutat, V18, P163, DOI 10.1002/humu.1167; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Daly MB, 2010, J NATL COMPR CANC NE, V8, P562, DOI 10.6004/jnccn.2010.0043; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; GROSS ST, 1986, BIOMETRICS, V42, P883, DOI 10.2307/2530702; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Knowles JW, 2012, CIRC-CARDIOVASC GENE, V5, P368, DOI 10.1161/CIRCGENETICS.112.962746; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Quaresima B, 2008, CLIN CANCER RES, V14, P6797, DOI 10.1158/1078-0432.CCR-07-5208; Relling MV, 2013, CLIN PHARMACOL THER, V93, P324, DOI 10.1038/clpt.2013.4; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Riggs ER, 2013, HUM MUTAT, V34, P915, DOI 10.1002/humu.22306; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wilke RA, 2012, CLIN PHARMACOL THER, V92, P112, DOI 10.1038/clpt.2012.57; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	44	324	336	0	68	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1035	1044		10.1001/jama.2014.1717	http://dx.doi.org/10.1001/jama.2014.1717			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618965	Green Accepted, Bronze			2022-12-24	WOS:000332575800021
J	Raychaudhuri, S; Loew, C; Korner, R; Pinkert, S; Theis, M; Hayer-Hartl, M; Buchholz, F; Hartl, FU				Raychaudhuri, Swasti; Loew, Christian; Koerner, Roman; Pinkert, Stefan; Theis, Mirko; Hayer-Hartl, Manajit; Buchholz, Frank; Hartl, F. Ulrich			Interplay of Acetyltransferase EP300 and the Proteasome System in Regulating Heat Shock Transcription Factor 1	CELL			English	Article							MOLECULAR CHAPERONES; CAENORHABDITIS-ELEGANS; PROTEIN STABILITY; IN-VIVO; STRESS; PROTEOSTASIS; ACTIVATION; GENE; HSF1; LOCALIZATION	When exposed to proteotoxic environmental conditions, mammalian cells activate the cytosolic stress response in order to restore protein homeostasis. A key feature of this response is the heat shock transcription factor 1 (HSF1)-dependent expression of molecular chaperones. Here, we describe the results of an RNA interference screen in HeLa cells to identify modulators of stress response induction and attenuation. The modulator proteins are localized in multiple cellular compartments, with chromatin modifiers and nuclear protein quality control playing a central regulatory role. We find that the acetyltransferase, EP300, controls the cellular level of activatable HSF1. This involves acetylation of HSF1 at multiple lysines not required for function and results in stabilization of HSF1 against proteasomal turnover. Acetylation of functionally critical lysines during stress serves to fine-tune HSF1 activation. Finally, the nuclear proteasome system functions in attenuating the stress response by degrading activated HSF1 in a manner linked with the clearance of misfolded proteins.	[Raychaudhuri, Swasti; Loew, Christian; Koerner, Roman; Pinkert, Stefan; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Theis, Mirko; Buchholz, Frank] Univ Hosp, D-01307 Dresden, Germany; [Theis, Mirko; Buchholz, Frank] Carl Gustav Carus Univ Technol, Fac Med, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Buchholz, Frank/B-4700-2017; Raychaudhuri, Swasti/AAZ-2748-2020; Hayer-Hartl, Manajit/V-8078-2017; Körner, Roman/G-8565-2011	Buchholz, Frank/0000-0002-4577-3344; Hayer-Hartl, Manajit/0000-0001-8213-6742; Körner, Roman/0000-0001-9285-9290	EU; Human Frontier Science Program [HFSP RGP0048/2011]; Munich Cluster for Systems Neurology (SyNergy)	EU(European Commission); Human Frontier Science Program(Human Frontier Science Program); Munich Cluster for Systems Neurology (SyNergy)	The esiRNA interference screen reported in this study was performed at the High-Throughput Technology Development Studio (HT-TDS) at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden. We especially thank K. Korn and M. Bickle for their help with assay development and R. Zenke for assistance with cell cycle analysis. Expert technical assistance by V. Marcus is acknowledged. We thank M. Hipp, Y. Kim, and J. Verghese for critically reading the manuscript. Financial support from EU Framework 7 Integrated Project PROSPECTS, Human Frontier Science Program (HFSP RGP0048/2011), and the Munich Cluster for Systems Neurology (SyNergy) is acknowledged.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Batista-Nascimento L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015976; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Biamonti G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000695; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Finka A, 2012, PLANT CELL, V24, P3333, DOI 10.1105/tpc.112.095844; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mercier PA, 1999, J CELL SCI, V112, P2765; Morimoto RI, 2002, CELL, V110, P281, DOI 10.1016/S0092-8674(02)00860-7; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Raynes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054364; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; SAAD AH, 1992, P NATL ACAD SCI USA, V89, P9396, DOI 10.1073/pnas.89.20.9396; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	42	99	102	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					975	985		10.1016/j.cell.2014.01.055	http://dx.doi.org/10.1016/j.cell.2014.01.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581496	Bronze			2022-12-24	WOS:000332083900015
J	Baize, S; Pannetier, D; Oestereich, L; Rieger, T; Koivogui, L; Magassouba, N; Soropogui, B; Sow, MS; Keita, S; De Clerck, H; Tiffany, A; Dominguez, G; Loua, M; Traore, A; Kolie, M; Malano, ER; Heleze, E; Bocquin, A; Mely, S; Raoul, H; Caro, V; Cadar, D; Gabriel, M; Pahlmann, M; Tappe, D; Schmidt-Chanasit, J; Impouma, B; Diallo, AK; Formenty, P; Van Herp, M; Gunther, S				Baize, Sylvain; Pannetier, Delphine; Oestereich, Lisa; Rieger, Toni; Koivogui, Lamine; Magassouba, N'Faly; Soropogui, Barre; Sow, Mamadou Saliou; Keita, Sakoba; De Clerck, Hilde; Tiffany, Amanda; Dominguez, Gemma; Loua, Mathieu; Traore, Alexis; Kolie, Moussa; Malano, Emmanuel Roland; Heleze, Emmanuel; Bocquin, Anne; Mely, Stephane; Raoul, Herve; Caro, Valerie; Cadar, Daniel; Gabriel, Martin; Pahlmann, Meike; Tappe, Dennis; Schmidt-Chanasit, Jonas; Impouma, Benido; Diallo, Abdoul Karim; Formenty, Pierre; Van Herp, Michel; Guenther, Stephan			Emergence of Zaire Ebola Virus Disease in Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LASSA-VIRUS; FILOVIRUSES; INFECTION; ASSAY	In March 2014, the World Health Organization was notified of an outbreak of a communicable disease characterized by fever, severe diarrhea, vomiting, and a high fatality rate in Guinea. Virologic investigation identified Zaire ebolavirus (EBOV) as the causative agent. Full-length genome sequencing and phylogenetic analysis showed that EBOV from Guinea forms a separate clade in relationship to the known EBOV strains from the Democratic Republic of Congo and Gabon. Epidemiologic investigation linked the laboratory-confirmed cases with the presumed first fatality of the outbreak in December 2013. This study demonstrates the emergence of a new EBOV strain in Guinea.	[Baize, Sylvain; Pannetier, Delphine; Bocquin, Anne; Mely, Stephane] Univ Lyon 1, Natl Reference Ctr Viral Hemorrhag Fevers, F-69365 Lyon, France; [Baize, Sylvain] Univ Lyon 1, Inst Pasteur, Unite Biol Infect Virales Emergentes, F-69365 Lyon, France; [Baize, Sylvain] Univ Lyon 1, CIRI, Ecole Normale Super Lyon, INSERM,U1111, F-69365 Lyon, France; [Pannetier, Delphine; Bocquin, Anne; Mely, Stephane; Raoul, Herve] INSERM Jean Merieux, Lab P4, Lyon, France; [Tiffany, Amanda] Epictr, Paris, France; [Caro, Valerie] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infect, Paris, France; [Oestereich, Lisa; Rieger, Toni; Cadar, Daniel; Gabriel, Martin; Tappe, Dennis; Schmidt-Chanasit, Jonas; Guenther, Stephan] World Hlth Org WHO, Bernhard Nocht Inst Trop Med, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, Hamburg, Germany; [Oestereich, Lisa; Rieger, Toni; Cadar, Daniel; Gabriel, Martin; Pahlmann, Meike; Tappe, Dennis; Schmidt-Chanasit, Jonas; Guenther, Stephan] German Ctr Infect Res DZIF, Hamburg, Germany; [Koivogui, Lamine] Inst Natl Sante Publ, Conakry, Guinea; [Magassouba, N'Faly; Soropogui, Barre] Univ Gamal Abdel Nasser Conakry, Lab Fievres Hemorrag Guinee, Conakry, Guinea; [Sow, Mamadou Saliou] Hop Natl Donka, Serv Malad Infect & Trop, Conakry, Guinea; [Keita, Sakoba] Minist Hlth Guinea, Conakry, Guinea; [Malano, Emmanuel Roland; Heleze, Emmanuel; Diallo, Abdoul Karim] WHO, Conakry, Guinea; [Loua, Mathieu] Direct Reg Sante Nzerekore, Sect Prevent & Lutte Malad, Nzerekore, Guinea; [Traore, Alexis] Direct Prefectorale Sante Gueckedou, Sect Prevent & Lutte Malad, Gueckedou, Guinea; [Kolie, Moussa] Hop Prefectoral Gueckedou, Gueckedou, Guinea; [De Clerck, Hilde; Van Herp, Michel] Med Frontieres, Brussels, Belgium; [Tiffany, Amanda; Dominguez, Gemma] Med Frontieres, Geneva, Switzerland; [Formenty, Pierre] WHO, Geneva, Switzerland; [Impouma, Benido] African Reg Off, Brazzaville, DEM REP CONGO	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Bernhard Nocht Institut fur Tropenmedizin; World Health Organization; German Center for Infection Research; World Health Organization; World Health Organization	Gunther, S (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	guenther@bni.uni-hamburg.de	Daniel, Cadar/AAN-2658-2021	Baize, Sylvain/0000-0002-3234-7477; Cadar, Daniel/0000-0002-8063-2766; Oestereich, Lisa/0000-0003-0098-7485; Rieger, Toni/0000-0002-7863-1916; Gunther, Stephan/0000-0002-6562-0230; MELY, Stephane/0000-0002-3278-3455	European Community [228292]; Institut National de Veille Sanitaire	European Community(European Commission); Institut National de Veille Sanitaire	Supported by a grant (228292, to the European Virus Archive) from the European Community. The National Reference Center for Viral Hemorrhagic Fevers in Lyons, France, is supported by the Institut National de Veille Sanitaire.	Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Gibb TR, 2001, J CLIN MICROBIOL, V39, P4125, DOI 10.1128/JCM.39.11.4125-4130.2001; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Huang Yi, 2012, Virologica Sinica, V27, P273, DOI 10.1007/s12250-012-3252-y; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Miranda ME, 1999, J INFECT DIS, V179, pS115, DOI 10.1086/514314; Olschlager S, 2010, J CLIN MICROBIOL, V48, P2009, DOI 10.1128/JCM.02351-09; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Smith O, 2014, SCI REP-UK, V4, DOI 10.1038/srep04003; Vieth S, 2007, T ROY SOC TROP MED H, V101, P1253, DOI 10.1016/j.trstmh.2005.03.018	19	897	966	2	526	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2014	371	15					1418	1425		10.1056/NEJMoa1404505	http://dx.doi.org/10.1056/NEJMoa1404505			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ3FJ	24738640	Bronze			2022-12-24	WOS:000342674800010
J	Dick, KJ; Nelson, CP; Tsaprouni, L; Sandling, JK; Aissi, D; Wahl, S; Meduri, E; Morange, PE; Gagnon, F; Grallert, H; Waldenberger, M; Peters, A; Erdmann, J; Hengstenberg, C; Cambien, F; Goodall, AH; Ouwehand, WH; Schunkert, H; Thompson, JR; Spector, TD; Gieger, C; Tregouet, DA; Deloukas, P; Samani, NJ				Dick, Katherine J.; Nelson, Christopher P.; Tsaprouni, Loukia; Sandling, Johanna K.; Aissi, Dylan; Wahl, Simone; Meduri, Eshwar; Morange, Pierre-Emmanuel; Gagnon, France; Grallert, Harald; Waldenberger, Melanie; Peters, Annette; Erdmann, Jeanette; Hengstenberg, Christian; Cambien, Francois; Goodall, Alison H.; Ouwehand, Willem H.; Schunkert, Heribert; Thompson, John R.; Spector, Tim D.; Gieger, Christian; Tregout, David-Alexandre; Deloukas, Panos; Samani, Nilesh J.			DNA methylation and body-mass index: a genome-wide analysis	LANCET			English	Article							PAS DOMAIN PROTEIN; ADIPOSE-TISSUE; OBESITY; EXPRESSION; DISCOVERY; PATTERNS; OLIGONUCLEOTIDE; NORMALIZATION; ASSOCIATION; DRIVERS	Background Obesity is a major health problem that is determined by interactions between lifestyle and environmental and genetic factors. Although associations between several genetic variants and body-mass index (BMI) have been identified, little is known about epigenetic changes related to BMI. We undertook a genome-wide analysis of methylation at CpG sites in relation to BMI. Methods 479 individuals of European origin recruited by the Cardiogenics Consortium formed our discovery cohort. We typed their whole-blood DNA with the Infinium HumanMethylation450 array. After quality control, methylation levels were tested for association with BMI. Methylation sites showing an association with BMI at a false discovery rate q value of 0.05 or less were taken forward for replication in a cohort of 339 unrelated white patients of northern European origin from the MARTHA cohort. Sites that remained significant in this primary replication cohort were tested in a second replication cohort of 1789 white patients of European origin from the KORA cohort. We examined whether methylation levels at identified sites also showed an association with BMI in DNA from adipose tissue (n=635) and skin (n=395) obtained from white female individuals participating in the MuTHER study. Finally, we examined the association of methylation at BMI-associated sites with genetic variants and with gene expression. Findings 20 individuals from the discovery cohort were excluded from analyses after quality-control checks, leaving 459 participants. After adjustment for covariates, we identified an association (q value <= 0.05) between methylation at five probes across three different genes and BMI. The associations with three of these probes-cg22891070, cg27146050, and cg16672562, all of which are in intron 1 of HIF3A-were confirmed in both the primary and second replication cohorts. For every 0.1 increase in methylation beta value at cg22891070, BMI was 3.6% (95% CI 2.4-4.9) higher in the discovery cohort, 2.7% (1.2-4.2) higher in the primary replication cohort, and 0.8% (0.2-1.4) higher in the second replication cohort. For the MuTHER cohort, methylation at cg22891070 was associated with BMI in adipose tissue (p=1.72 x 10(-5)) but not in skin (p=0.882). We observed a significant inverse correlation (p=0.005) between methylation at cg22891070 and expression of one HIF3A gene-expression probe in adipose tissue. Two single nucleotide polymorphisms-rs8102595 and rs3826795-had independent associations with methylation at cg22891070 in all cohorts. However, these single nucleotide polymorphisms were not significantly associated with BMI. Interpretation Increased BMI in adults of European origin is associated with increased methylation at the HIF3A locus in blood cells and in adipose tissue. Our findings suggest that perturbation of hypoxia inducible transcription factor pathways could have an important role in the response to increased weight in people.	[Dick, Katherine J.; Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester LE3 9QP, Leics, England; [Dick, Katherine J.; Nelson, Christopher P.; Goodall, Alison H.; Samani, Nilesh J.] Glenfield Gen Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Tsaprouni, Loukia; Sandling, Johanna K.; Meduri, Eshwar; Ouwehand, Willem H.; Deloukas, Panos] Wellcome Trust Res Labs, Sanger Inst, Hinxton, England; [Tsaprouni, Loukia] Univ Bedforshire, ISPAR Inst, Bedford, England; [Sandling, Johanna K.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sandling, Johanna K.] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Aissi, Dylan; Cambien, Francois; Tregout, David-Alexandre] Univ Paris 06, Univ Sorbonne, UPMC, UMR S1166, F-75013 Paris, France; [Aissi, Dylan; Cambien, Francois; Tregout, David-Alexandre] INSERM, UMR S1166, F-75013 Paris, France; [Aissi, Dylan; Cambien, Francois; Tregout, David-Alexandre] ICAN Inst Cardiometab & Nutr, F-75013 Paris, France; [Wahl, Simone; Grallert, Harald] German Ctr Diabet Res, Neuherberg, Germany; [Wahl, Simone; Grallert, Harald; Waldenberger, Melanie; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Wahl, Simone; Grallert, Harald; Waldenberger, Melanie; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Morange, Pierre-Emmanuel] Aix Marseille Univ, INSERM, UMR S1062, Marseille, France; [Gagnon, France] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Peters, Annette; Hengstenberg, Christian; Schunkert, Heribert] Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany; [Erdmann, Jeanette] Univ Lubeck, Inst Integrat & Expt Genom, Lubeck, Germany; [Erdmann, Jeanette] German Ctr Cardiovasc Res, Hamburg, Germany; [Hengstenberg, Christian; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts London Sch Med & Dent, London, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21413, Saudi Arabia	University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Wellcome Trust Sanger Institute; University of Bedfordshire; Uppsala University; Uppsala University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Toronto; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Lubeck; German Centre for Cardiovascular Research; German Heart Centre Munich; Technical University of Munich; University of Cambridge; NHS Blood & Transplant (NHSBT); University of London; King's College London; University of London; Queen Mary University London; King Abdulaziz University	Samani, NJ (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Groby Rd, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk	Trégouët, David-Alexandre/P-9210-2019; Morange, Pierre/T-9070-2019; Aïssi, Dylan/AAH-1499-2019; Cambien, Francois/AAP-9751-2020; Hengstenberg, Christian/U-5485-2019; Waldenberger, Melanie/B-5355-2014; Erdmann, Jeanette/P-7513-2014; Sandling, Johanna/AAG-6376-2019; Deloukas, Panos/B-2922-2013; Sandling, Johanna K/B-2973-2016; Grallert, Harald/B-3424-2013; Erdmann, Jeanette/A-4417-2009; Peters, Annette/A-6117-2011; Tregouet, David-Alexandre/E-3961-2016	Trégouët, David-Alexandre/0000-0001-9084-7800; Morange, Pierre/0000-0002-9065-722X; Aïssi, Dylan/0000-0002-5858-6468; Waldenberger, Melanie/0000-0003-0583-5093; Erdmann, Jeanette/0000-0002-4486-6231; Sandling, Johanna/0000-0003-1382-2321; Deloukas, Panos/0000-0001-9251-070X; Sandling, Johanna K/0000-0003-1382-2321; Peters, Annette/0000-0001-6645-0985; Meduri, Eshwar/0000-0002-3821-312X; Nelson, Christopher/0000-0001-8025-2897; Gieger, Christian/0000-0001-6986-9554; Goodall, Alison/0000-0002-7883-9645; Ouwehand, Willem/0000-0002-7744-1790	European Commission; National Institute for Health Research; British Heart Foundation; Wellcome Trust [081917/Z/07/Z, 098051]; European Union [LSHM-CT 2006-037593]; Program Hospitalier de Recherche Clinique; Canadian Institutes of Health Research [MOP 86466]; Heart and Stroke Foundation of Canada [T6484]; Fondation pour la Recherche Medicale; Region Ile de France; Helmholtz Zentrum Munchen German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; National Institute for Health Research BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit; Region Ile de France (CORDDIM); Fondation Leducq Grant [12CVD02]; ERC; National Institute for Health Research Senior Investigator; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10170, NF-SI-0510-10214, NF-SI-0513-10151, RP-PG-0310-1002] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Program Hospitalier de Recherche Clinique; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Ile de France(Region Ile-de-France); Helmholtz Zentrum Munchen German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; National Institute for Health Research BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit; Region Ile de France (CORDDIM)(Region Ile-de-France); Fondation Leducq Grant(Leducq Foundation); ERC(European Research Council (ERC)European Commission); National Institute for Health Research Senior Investigator; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The European Commission, National Institute for Health Research, British Heart Foundation, and Wellcome Trust.; This work was done as part of the Cardiogenics Project, which is funded by the European Union (LSHM-CT 2006-037593). The MARTHA project was supported by a grant from the Program Hospitalier de Recherche Clinique, and the methylation array typing was funded by the Canadian Institutes of Health Research (grant MOP 86466) and the Heart and Stroke Foundation of Canada (grant T6484). Statistical analyses of the MARTHA datasets were done in the C2BIG computing centre (UPMC, Paris, France), which is funded by the Fondation pour la Recherche Medicale and Region Ile de France. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The MuTHER study was funded by a programme grant from the Wellcome Trust (081917/Z/07/Z), and receives support from the National Institute for Health Research BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. CPN is funded by the National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit, and this work comes under the portfolio of translational research supported by this unit. DA was supported by a PhD grant from the Region Ile de France (CORDDIM). FG holds a Canada Research Chair. JE, FC, HS, D-AT, and NJS collaborate under a Fondation Leducq Grant (12CVD02). TDS is a European Research Council Senior Investigator and is holder of an ERC Advanced Principal Investigator award. PD is supported by the Wellcome Trust core grant to the Wellcome Trust Sanger Institute (098051), which funded DNA methylation analysis for MuTHER. NJS holds a chair funded by the British Heart Foundation and is a National Institute for Health Research Senior Investigator. We thank the staff from the genotyping facilities at the Wellcome Trust Sanger Institute for sample preparation, quality control, and typing for the Cardiogenics and MuTHER cohorts.	Almen MS, 2012, GENOMICS, V99, P132, DOI 10.1016/j.ygeno.2011.12.007; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonsignore MR, 2012, EUR RESPIR J, V39, P746, DOI 10.1183/09031936.00047010; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cockerill PN, 2011, FEBS J, V278, P2182, DOI 10.1111/j.1742-4658.2011.08128.x; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Garnier S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003240; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hatanaka M, 2009, BIOL PHARM BULL, V32, P1166, DOI 10.1248/bpb.32.1166; Heidbreder M, 2007, BIOCHEM BIOPH RES CO, V352, P437, DOI 10.1016/j.bbrc.2006.11.027; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Moleres A, 2013, FASEB J, V27, P2504, DOI 10.1096/fj.12-215566; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Park YS, 2012, J CONTROL RELEASE, V161, P1, DOI 10.1016/j.jconrel.2012.04.026; Relton CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031821; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shin MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046562; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112	45	526	542	1	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1990	1998		10.1016/S0140-6736(13)62674-4	http://dx.doi.org/10.1016/S0140-6736(13)62674-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24630777	Green Accepted			2022-12-24	WOS:000336848200027
J	Rosas, M; Davies, LC; Giles, PJ; Liao, CT; Kharfan, B; Stone, TC; O'Donnell, VB; Fraser, DJ; Jones, SA; Taylor, PR				Rosas, Marcela; Davies, Luke C.; Giles, Peter J.; Liao, Chia-Te; Kharfan, Bashar; Stone, Timothy C.; O'Donnell, Valerie B.; Fraser, Donald J.; Jones, Simon A.; Taylor, Philip R.			The Transcription Factor Gata6 Links Tissue Macrophage Phenotype and Proliferative Renewal	SCIENCE			English	Article							RESIDENT MACROPHAGES; IN-VIVO; INFLAMMATION; RECEPTOR; MICE; EXPRESSION; MONOCYTES; LINEAGES; DECTIN-1; HEART	Tissue-resident macrophages are heterogeneous as a consequence of anatomical niche-specific functions. Many populations self-renew independently of bone marrow in the adult, but the molecular mechanisms of this are poorly understood. We determined a transcriptional profile for the major self-renewing population of peritoneal macrophages in mice. These cells specifically expressed the transcription factor Gata6. Selective deficiency of Gata6 in myeloid cells caused substantial alterations in the transcriptome of peritoneal macrophages. Gata6 deficiency also resulted in dysregulated peritoneal macrophage proliferative renewal during homeostasis and in response to inflammation, which was associated with delays in the resolution of inflammation. Our investigations reveal that the tissue macrophage phenotype is under discrete tissue-selective transcriptional control and that this is fundamentally linked to the regulation of their proliferation renewal.	[Rosas, Marcela; Davies, Luke C.; Liao, Chia-Te; Kharfan, Bashar; O'Donnell, Valerie B.; Jones, Simon A.; Taylor, Philip R.] Cardiff Univ, Cardiff Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Giles, Peter J.; Stone, Timothy C.] Cardiff Univ, Cent Biotechnol Serv, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Fraser, Donald J.] Cardiff Univ, Inst Mol Med, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University	Taylor, PR (corresponding author), Cardiff Univ, Cardiff Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	taylorpr@cf.ac.uk	Rosas Nexticapa, Marcela/HGU-1088-2022; Jones, Simon Arnett/Q-7017-2018	Taylor, Philip/0000-0003-0163-1421; Jones, Simon Arnett/0000-0001-7297-9711; Fraser, Donald/0000-0003-0102-9342; Davies, Luke/0000-0001-7767-4060; /0000-0003-4089-8460	Medical Research Council (MRC) UK [G0601617]; MRC project grant [MR/J002151/1]; Wellcome Trust Programme Grant; MRC Doctoral Training Grant; Medical Research Council [MR/K02003X/1, G0601617, MR/J002151/1, 984199] Funding Source: researchfish; MRC [MR/J002151/1, MR/K02003X/1, G0601617] Funding Source: UKRI	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC project grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); MRC Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of our animal facilities for the care of the animals. We also thank C. Pepper, J. Fisher, C. Watkins, and M. Musson for their help with cell purifications and Affymetrix analysis. P. R. T conceived and designed the project and wrote the manuscript; M. R., L. C. D, P. J. G, C.-T.L., B. K., T. C. S., and P. R. T designed and conducted the experiments; and all authors contributed to the analysis and interpretation of the data. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Microarray data has been deposited in the Gene Expression Omnibus (accession nos. GSE28621 and GSE47049). P. R. T. is a Medical Research Council (MRC) UK Senior Non-Clinical Fellow (grant G0601617). This work was also supported by an MRC project grant (MR/J002151/1). V.O.D. is supported by a Wellcome Trust Programme Grant. L. C. D. is an MRC Doctoral Training Grant recipient, Cardiff University 125 for 125 scholar, and MRC Centenary Award holder. All animal work was conducted in accordance with institutional and UK Home Office guidelines. The authors declare no conflicts of interest.	Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; GORDON S, 1971, J EXP MED, V133, P321, DOI 10.1084/jem.133.2.321; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; McDonald JU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045781; Mullaly SC, 2007, EUR J IMMUNOL, V37, P224, DOI 10.1002/eji.200636405; Pfau JC, 2004, AM J PHYSIOL-LUNG C, V286, pL354, DOI 10.1152/ajplung.00380.2002; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rosas M, 2007, EUR J IMMUNOL, V37, P2518, DOI 10.1002/eji.200636892; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Sodhi CP, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-19; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005	23	255	261	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2014	344	6184					645	648		10.1126/science.1251414	http://dx.doi.org/10.1126/science.1251414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6OD	24762537	Green Accepted			2022-12-24	WOS:000335537400047
J	Kashtan, N; Roggensack, SE; Rodrigue, S; Thompson, JW; Biller, SJ; Coe, A; Ding, HM; Marttinen, P; Malmstrom, RR; Stocker, R; Follows, MJ; Stepanauskas, R; Chisholm, SW				Kashtan, Nadav; Roggensack, Sara E.; Rodrigue, Sebastien; Thompson, Jessie W.; Biller, Steven J.; Coe, Allison; Ding, Huiming; Marttinen, Pekka; Malmstrom, Rex R.; Stocker, Roman; Follows, Michael J.; Stepanauskas, Ramunas; Chisholm, Sallie W.			Single-Cell Genomics Reveals Hundreds of Coexisting Subpopulations in Wild Prochlorococcus	SCIENCE			English	Article							ECOTYPES; MICROORGANISMS; PREDATION; DIVERSITY; ATLANTIC; PATTERNS	Extensive genomic diversity within coexisting members of a microbial species has been revealed through selected cultured isolates and metagenomic assemblies. Yet, the cell-by-cell genomic composition of wild uncultured populations of co-occurring cells is largely unknown. In this work, we applied large-scale single-cell genomics to study populations of the globally abundant marine cyanobacterium Prochlorococcus. We show that they are composed of hundreds of subpopulations with distinct "genomic backbones," each backbone consisting of a different set of core gene alleles linked to a small distinctive set of flexible genes. These subpopulations are estimated to have diverged at least a few million years ago, suggesting ancient, stable niche partitioning. Such a large set of coexisting subpopulations may be a general feature of free-living bacterial species with huge populations in highly mixed habitats.	[Kashtan, Nadav; Roggensack, Sara E.; Rodrigue, Sebastien; Thompson, Jessie W.; Biller, Steven J.; Coe, Allison; Ding, Huiming; Stocker, Roman; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Rodrigue, Sebastien] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Ding, Huiming; Chisholm, Sallie W.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Marttinen, Pekka] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, FI-00076 Aalto, Finland; [Malmstrom, Rex R.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA	Massachusetts Institute of Technology (MIT); University of Sherbrooke; Massachusetts Institute of Technology (MIT); Aalto University; University of Helsinki; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); Bigelow Laboratory for Ocean Sciences	Kashtan, N (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nadav.kashtan@gmail.com; chisholm@mit.edu	Marttinen, Pekka E/N-6234-2015; Biller, Steven/CAG-2216-2022; t, lf/AAJ-4924-2020; Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019; Biller, Steven/CAI-9174-2022	Marttinen, Pekka E/0000-0001-7078-7927; Stocker, Roman/0000-0002-3199-0508; Stepanauskas, Ramunas/0000-0003-4458-3108; Kashtan, Nadav/0000-0002-7475-1363; Malmstrom, Rex/0000-0002-4758-7369; Chisholm, Sallie/0000-0003-1480-2445	NSF Evolutionary Biology Section and Biological Oceanography Section; NSF Center for Microbial Oceanography Research and Education (C-MORE); U.S. Department of Energy (DOE)-GTL; Gordon and Betty Moore Foundation Marine Microbiology Initiative; NSF Biological Oceanography Section; DOE [DE-AC02-05CH11231]; Division Of Ocean Sciences [1232982] Funding Source: National Science Foundation	NSF Evolutionary Biology Section and Biological Oceanography Section; NSF Center for Microbial Oceanography Research and Education (C-MORE)(National Science Foundation (NSF)); U.S. Department of Energy (DOE)-GTL(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation Marine Microbiology Initiative(Gordon and Betty Moore Foundation); NSF Biological Oceanography Section(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); DOE(United States Department of Energy (DOE)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank S. Itzkovitz, P. H. R. Calil, D. Sher, R. Milo, P. M. Berube, A. P. Yelton, R. Braakman, and particularly M. F. Polz for comments on the manuscript. We thank the Bermuda Atlantic Time-series Study for sample collection, the Bigelow Laboratory Single Cell Genomics Center for single-cell sorting and whole-genome amplification, and the BioMicroCenter facility at MIT for their contributions to the generation of genomic data. N.K. acknowledges the Rothschild Foundation (Yad Hanadiv) and the National Oceanic and Atmospheric Administration "Climate and Global Change" Postdoctoral Research Fellowships. This work was supported by grants to S. W. C. from the NSF Evolutionary Biology Section and Biological Oceanography Section, the NSF Center for Microbial Oceanography Research and Education (C-MORE), the U.S. Department of Energy (DOE)-GTL, and the Gordon and Betty Moore Foundation Marine Microbiology Initiative; to R. Stepanauskas from the NSF Biological Oceanography Section; and to R. R. M from the DOE (contract number DE-AC02-05CH11231). Genomic data have been deposited in National Center for Biotechnology Information GenBank under accession numbers KJ477896 to KJ479276 and JFKN00000000 to JFOE00000000. Additional data files have been deposited to Dryad (doi:10.5061/dryad.9r0p6).	Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Gonzaga A, 2012, GENOME BIOL EVOL, V4, P1360, DOI 10.1093/gbe/evs112; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Malfatti F, 2009, AQUAT MICROB ECOL, V58, P1, DOI 10.3354/ame01355; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Mehra-Chaudhary R, 2011, J BACTERIOL, V193, P4081, DOI 10.1128/JB.00418-11; MICHAELS AF, 1994, DEEP-SEA RES PT I, V41, P1013, DOI 10.1016/0967-0637(94)90016-7; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Muhling M, 2012, ENVIRON MICROBIOL, V14, P567, DOI 10.1111/j.1462-2920.2011.02589.x; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Thompson CC, 2013, MICROB ECOL, V66, P752, DOI 10.1007/s00248-013-0270-8; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628	29	319	328	6	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					416	420		10.1126/science.1248575	http://dx.doi.org/10.1126/science.1248575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763590	Green Submitted			2022-12-24	WOS:000334867800042
J	Kostarelos, K; Novoselov, KS				Kostarelos, Kostas; Novoselov, Kostya S.			Exploring the Interface of Graphene and Biology	SCIENCE			English	Editorial Material							OXIDE; CELLS; INTERNALIZATION; NANOPLATELETS; CYTOTOXICITY; PROSPECTS		[Kostarelos, Kostas] Univ Manchester, Fac Med & Human Sci, Nanomed Lab, Manchester, Lancs, England; [Novoselov, Kostya S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Kostarelos, Kostas; Novoselov, Kostya S.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Kostarelos, K (corresponding author), Univ Manchester, Fac Med & Human Sci, Nanomed Lab, Manchester, Lancs, England.	kostas.kostarelos@manchester.ac.uk; kostya@manchester.ac.uk	Novoselov, Kostya S/G-9581-2014; Kostarelos, Kostas/AAP-6879-2021	Novoselov, Kostya S/0000-0003-4972-5371; Kostarelos, Kostas/0000-0002-2224-6672; hai yan, he/0000-0003-0366-6185				Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x; Ali-Boucetta H, 2013, ADV HEALTHC MATER, V2, P433, DOI 10.1002/adhm.201200248; Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700; Blake P, 2008, NANO LETT, V8, P1704, DOI 10.1021/nl080649i; Bussy C, 2013, ACCOUNTS CHEM RES, V46, P692, DOI 10.1021/ar300199e; First PN, 2010, MRS BULL, V35, P296, DOI 10.1557/mrs2010.552; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Girish CM, 2013, ADV HEALTHC MATER, V2, P1489, DOI 10.1002/adhm.201200489; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v; Kotchey GP, 2011, ACS NANO, V5, P2098, DOI 10.1021/nn103265h; Lammel T, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-27; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110; Liu SB, 2012, LANGMUIR, V28, P12364, DOI 10.1021/la3023908; Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x; Na HK, 2013, NANOSCALE, V5, P1669, DOI 10.1039/c2nr33800a; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Novoselov KS, 2011, REV MOD PHYS, V83, P837, DOI 10.1103/RevModPhys.83.837; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t; Russier J, 2013, NANOSCALE, V5, P11234, DOI 10.1039/c3nr03543c; Schinwald A, 2014, NANOTOXICOLOGY, V8, P824, DOI 10.3109/17435390.2013.831502; Schinwald A, 2012, ACS NANO, V6, P736, DOI 10.1021/nn204229f; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/NNANO.2013.125, 10.1038/nnano.2013.125]	25	252	258	3	326	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					261	263		10.1126/science.1246736	http://dx.doi.org/10.1126/science.1246736			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744363				2022-12-24	WOS:000334474500022
J	Geisler, JH; Colbert, MW; Carew, JL				Geisler, Jonathan H.; Colbert, Matthew W.; Carew, James L.			A new fossil species supports an early origin for toothed whale echolocation	NATURE			English	Article							FUNCTIONAL-MORPHOLOGY; NORTH-CAROLINA; NASAL COMPLEX; OLIGOCENE; CETACEAN; ASYMMETRY; EVOLUTION; EOCENE	Odontocetes (toothed whales, dolphins and porpoises) hunt and navigate through dark and turbid aquatic environments using echolocation; a key adaptation that relies on the same principles as sonar(1). Among echolocating vertebrates, odontocetes are unique in producing high-frequency vocalizations at the phonic lips, a constriction in the nasal passages just beneath the blowhole, and then using air sinuses and the melon to modulate their transmission(2,3). Allextant odontocetes seem to echolocate(2,4); however, exactly when and how this complex behaviour-and its underlying anatomy-evolved is largely unknown. Here we report an odontocete fossil, Oligocene in age (approximately 28 Myr ago), from South Carolina (Cotylocara macei, gen. et sp. nov.) that has several features suggestive of echolocation: a dense, thick and downturned rostrum; air sac fossae; cranial asymmetry; and exceptionally broad maxillae. Our phylogenetic analysis places Cotylocara in a basal clade of odontocetes, leading us to infer that a rudimentary form of echolocation evolved in the early Oligocene, shortly after odontocetes diverged from the ancestors of filter-feedingwhales (mysticetes). This was followed by enlargement of the facial muscles that modulate echolocation calls, which in turn led to marked, convergent changes in skull shape in the ancestors of Cotylocara, and in the lineage leading to extant odontocetes.	[Geisler, Jonathan H.] New York Inst Technol, Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Colbert, Matthew W.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Carew, James L.] Coll Charleston, Nat Hist Museum, Dept Geol & Environm Geosci, Charleston, SC 29424 USA	New York Institute Technology; University of Texas System; University of Texas Austin; College of Charleston	Geisler, JH (corresponding author), New York Inst Technol, Coll Osteopath Med, Dept Anat, Northern Blvd, Old Westbury, NY 11568 USA.	jgeisler@nyit.edu		Geisler, Jonathan/0000-0002-4880-1152	New York Institute of Technology, College of Charleston; NSF [IIS-987-4781]	New York Institute of Technology, College of Charleston; NSF(National Science Foundation (NSF))	This research was supported by funds from the New York Institute of Technology, College of Charleston, and M. Brown. During this project we benefitted from discussions with B. Beatty, P. Gingerich, W. Hillenius, M. Mihlbachler, A. Sanders and N. Solounias. We thank A. Sanders and The Charleston Museum for access to specimens under their care. B. Dulguun drew the skulls in Fig. 3. We acknowledge the Deptartment of Radiology, Medical University of South Carolina, and T. Holden in particular, for conducting CT scans of Cotylocara. We thank T. Rowe for access to the Tursiops scan data, which were scanned using his NSF digital libraries initiative grant (IIS-987-4781).	Au W. W., 1993, SONAR DOLPHINS; BARNES LG, 2001, W ASS VERTEBRATE PAL, V8, P91; Carter A., 1868, Philosophical Transactions, Vvol. clviii., P201; Cranford TW, 2011, J EXP MAR BIOL ECOL, V407, P81, DOI 10.1016/j.jembe.2011.07.010; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Cranford TW, 1996, J MORPHOL, V228, P223; Dubrovo IA, 2000, J VERTEBR PALEONTOL, V20, P577, DOI 10.1671/0272-4634(2000)020[0577:ANSOPM]2.0.CO;2; Fahlke JM, 2011, P NATL ACAD SCI USA, V108, P14545, DOI 10.1073/pnas.1108927108; Fordyce R. Ewan, 1994, Proceedings of the San Diego Society of Natural History, V29, P147; Fordyce RE, 2002, SM C PALEOB, P185; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Geisler Jonathan H., 2003, Journal of Mammalian Evolution, V10, P23, DOI 10.1023/A:1025552007291; Geisler JH, 2012, J VERTEBR PALEONTOL, V32, P198, DOI 10.1080/02724634.2012.629016; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Goloboff P, 2008, CLADISTICS, V24, P91; HEYNING J E, 1989, Contributions in Science (Los Angeles), P1; Huggenberger S, 2009, ANAT REC, V292, P902, DOI 10.1002/ar.20854; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P53; MacLeod CD, 2007, ANAT REC, V290, P539, DOI 10.1002/ar.20539; Madsen PT, 2010, J EXP BIOL, V213, P3105, DOI 10.1242/jeb.044420; Martinez-Caceres M, 2011, CR PALEVOL, V10, P517, DOI 10.1016/j.crpv.2011.03.006; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; McKenna MF, 2012, MAR MAMMAL SCI, V28, P690, DOI 10.1111/j.1748-7692.2011.00526.x; Mead J.G., 1975, Smithsonian Contributions to Zoology, VNo. 207, P1; Norberg RA., 2002, ECOLOGY CONSERVATION, P329; Reidenberg JS, 2008, ANAT REC, V291, P1389, DOI 10.1002/ar.20792; SANDERS AE, 1982, US GEOLOGICAL SURV H, V1529, P105; Uhen MD, 2008, J SYST PALAEONTOL, V6, P433, DOI 10.1017/S1477201908002472	30	72	74	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					383	+		10.1038/nature13086	http://dx.doi.org/10.1038/nature13086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24670659				2022-12-24	WOS:000334403000049
J	Gros, J; Tabin, CJ				Gros, Jerome; Tabin, Clifford J.			Vertebrate Limb Bud Formation Is Initiated by Localized Epithelial-to-Mesenchymal Transition	SCIENCE			English	Article							ADDITIONAL LIMB; CHICK-EMBRYOS; OUTGROWTH; FLANK; FGF10; TBX5	Vertebrate limbs first emerge as small buds at specific locations along the trunk. Although a fair amount is known about the molecular regulation of limb initiation and outgrowth, the cellular events underlying these processes have remained less clear. We show that the mesenchymal limb progenitors arise through localized epithelial-to-mesenchymal transition (EMT) of the coelomic epithelium specifically within the presumptive limb fields. This EMT is regulated at least in part by Tbx5 and Fgf10, two genes known to control limb initiation. This work shows that limb buds initiate earlier than previously thought, as a result of localized EMT rather than differential proliferation rates.	[Gros, Jerome; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Gros, Jerome/0000-0002-2264-2851	NIH [R01-HD045499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank F. Constantini for help rederiving the Fgf10 mutant mouse line, B. Bruneau for kindly providing Tbx5 mutant embryos, and J. deMelo and P. Tschopp for help with mouse work. J.G. was a fellow of the Human Frontier Science Program. This work was supported by NIH grant R01-HD045499 to C.J.T.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; MAUGER A, 1972, J EMBRYOL EXP MORPH, V28, P313; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; OHUCHI H, 1995, BIOCHEM BIOPH RES CO, V209, P809, DOI 10.1006/bbrc.1995.1572; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; SEARLS RL, 1971, DEV BIOL, V24, P198, DOI 10.1016/0012-1606(71)90095-9; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vogel A, 1996, DEVELOPMENT, V122, P1737	12	95	97	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1253	1256		10.1126/science.1248228	http://dx.doi.org/10.1126/science.1248228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626928	Green Accepted			2022-12-24	WOS:000332728500037
J	Brewster, RC; Weinert, FM; Garcia, HG; Song, D; Rydenfelt, M; Phillips, R				Brewster, Robert C.; Weinert, Franz M.; Garcia, Hernan G.; Song, Dan; Rydenfelt, Mattias; Phillips, Rob			The Transcription Factor Titration Effect Dictates Level of Gene Expression	CELL			English	Article							PLASMID COPY NUMBER; ESCHERICHIA-COLI K-12; EVOLUTION; RETROTRANSPOSONS; RETROACTIVITY; REPLICATION; MECHANISMS; REPRESSION; NETWORK; BIOLOGY	Models of transcription are often built around a picture of RNA polymerase and transcription factors (TFs) acting on a single copy of a promoter. However, most TFs are shared between multiple genes with varying binding affinities. Beyond that, genes often exist at high copy number-in multiple identical copies on the chromosome or on plasmids or viral vectors with copy numbers in the hundreds. Using a thermodynamic model, we characterize the interplay between TF copy number and the demand for that TF. We demonstrate the parameter-free predictive power of this model as a function of the copy number of the TF and the number and affinities of the available specific binding sites; such predictive control is important for the understanding of transcription and the desire to quantitatively design the output of genetic circuits. Finally, we use these experiments to dynamically measure plasmid copy number through the cell cycle.	[Brewster, Robert C.; Weinert, Franz M.; Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Garcia, Hernan G.] Princeton Univ, Dept Phys, Princeton, NJ 08540 USA; [Song, Dan] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Rydenfelt, Mattias] Harvard Univ, Sch Med, Harvard Biophys Program, Boston, MA 02115 USA; [Phillips, Rob] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Princeton University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; California Institute of Technology	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu		Brewster, Robert/0000-0002-7656-4086; Garcia, Hernan G./0000-0002-5212-3649	NIH [DP1 OD000217, R01 GM085286, 1 U54 CA143869]; La Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to James Boedicker, Michael Elowitz, Ron Milo, Nitzan Rosenfeld, Jon Young, and members of the Phillips group for helpful discussions. We are also grateful to the NIH for support through award numbers DP1 OD000217 (Director's Pioneer Award), R01 GM085286, and 1 U54 CA143869 (Northwestern PSOC Center) and to the La Fondation Pierre Gilles de Gennes (R.P.).	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Babu MM, 2003, TRENDS GENET, V19, P75, DOI 10.1016/S0168-9525(02)00039-2; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bremer H, 1996, ESCHERICHIA COLI SAL; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CESARENI G, 1982, P NATL ACAD SCI-BIOL, V79, P6313, DOI 10.1073/pnas.79.20.6313; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Daber R, 2011, J MOL BIOL, V409, P76, DOI 10.1016/j.jmb.2011.03.057; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Garcia HG, 2010, TRENDS CELL BIOL, V20, P723, DOI 10.1016/j.tcb.2010.07.002; Ghosh SK, 2006, ANNU REV BIOCHEM, V75, P211, DOI 10.1146/annurev.biochem.75.101304.124037; Ghozzi S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051916; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Hanada K, 2011, MOL BIOL EVOL, V28, P377, DOI 10.1093/molbev/msq204; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kentner D, 2010, ANNU REV MICROBIOL, V64, P373, DOI 10.1146/annurev.micro.112408.134205; Kim KH, 2011, BIOPHYS J, V100, P1167, DOI 10.1016/j.bpj.2010.12.3737; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Lee CL, 2006, J MICROBIOL METH, V65, P258, DOI 10.1016/j.mimet.2005.07.019; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7; LURIA SE, 1949, GENETICS, V34, P93; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Navarro-Quezada A, 2002, P NATL ACAD SCI USA, V99, P268, DOI 10.1073/pnas.012422299; Ng JW, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011909; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; PTASHNE M, 2002, GENES SIGNALS; Ricci F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002171; Rojo F, 2001, CURR OPIN MICROBIOL, V4, P145, DOI 10.1016/S1369-5274(00)00180-6; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2006, BIOPHYS J, V91, P759, DOI 10.1529/biophysj.105.073098; Rydenfelt M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012702; Sanchez A, 2011, EMBO J, V30, P3940, DOI 10.1038/emboj.2011.273; SCHLAX PJ, 1995, J MOL BIOL, V245, P331, DOI 10.1006/jmbi.1994.0028; STUEBER D, 1982, EMBO J, V1, P1399, DOI 10.1002/j.1460-2075.1982.tb01329.x; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Wang SP, 1999, P NATL ACAD SCI USA, V96, P6824, DOI 10.1073/pnas.96.12.6824	56	155	158	3	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1312	1323		10.1016/j.cell.2014.02.022	http://dx.doi.org/10.1016/j.cell.2014.02.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24612990	Green Accepted, Bronze			2022-12-24	WOS:000332945100019
J	McFadden, DG; Papagiannakopoulos, T; Taylor-Weiner, A; Stewart, C; Carter, SL; Cibulskis, K; Bhutkar, A; McKenna, A; Dooley, A; Vernon, A; Sougnez, C; Malstrom, S; Heimann, M; Park, J; Chen, F; Farago, AF; Dayton, T; Shefler, E; Gabriel, S; Getz, G; Jacks, T				McFadden, David G.; Papagiannakopoulos, Thales; Taylor-Weiner, Amaro; Stewart, Chip; Carter, Scott L.; Cibulskis, Kristian; Bhutkar, Arjun; McKenna, Aaron; Dooley, Alison; Vernon, Amanda; Sougnez, Carrie; Malstrom, Scott; Heimann, Megan; Park, Jennifer; Chen, Frances; Farago, Anna F.; Dayton, Talya; Shefler, Erica; Gabriel, Stacey; Getz, Gad; Jacks, Tyler			Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing	CELL			English	Article							COPY-NUMBER ALTERATION; PTEN TUMOR-SUPPRESSOR; SOMATIC MUTATIONS; MOUSE MODEL; CANCER; EVOLUTION; HETEROGENEITY; INACTIVATION; INSTABILITY; ABERRATIONS	Small cell lung carcinoma (SCLC) is a highly lethal, smoking-associated cancer with few known targetable genetic alterations. Using genome sequencing, we characterized the somatic evolution of a genetically engineered mouse model (GEMM) of SCLC initiated by loss of Trp53 and Rb1. We identified alterations in DNA copy number and complex genomic rearrangements and demonstrated a low somatic point mutation frequency in the absence of tobacco mutagens. Alterations targeting the tumor suppressor Pten occurred in the majority of murine SCLC studied, and engineered Pten deletion accelerated murine SCLC and abrogated loss of Chr19 in Trp53; Rb1; Pten compound mutant tumors. Finally, we found evidence for polyclonal and sequential metastatic spread of murine SCLC by comparative sequencing of families of related primary tumors and metastases. We propose a temporal model of SCLC tumorigenesis with implications for human SCLC therapeutics and the nature of cancer-genome evolution in GEMMs.	[McFadden, David G.; Papagiannakopoulos, Thales; Bhutkar, Arjun; Dooley, Alison; Vernon, Amanda; Malstrom, Scott; Heimann, Megan; Park, Jennifer; Chen, Frances; Farago, Anna F.; Dayton, Talya; Jacks, Tyler] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [McFadden, David G.; Papagiannakopoulos, Thales; Bhutkar, Arjun; Dooley, Alison; Vernon, Amanda; Malstrom, Scott; Heimann, Megan; Park, Jennifer; Chen, Frances; Farago, Anna F.; Dayton, Talya; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Taylor-Weiner, Amaro; Stewart, Chip; Carter, Scott L.; Cibulskis, Kristian; McKenna, Aaron; Sougnez, Carrie; Shefler, Erica; Gabriel, Stacey; Getz, Gad] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.	gadgetz@broadinstitute.org; tjacks@mit.edu	Cibulskis, Kristian/AAC-7380-2019	Dayton, Talya/0000-0002-7994-7963; Cibulskis, Kristian/0000-0003-1343-1582	Ludwig Center for Molecular Oncology at MIT; Howard Hughes Medical Institute; National Human Genome Research Institute; NIH-NCI Career Development award [K08CA160658]; Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA014051, K08CA160658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007484] Funding Source: NIH RePORTER	Ludwig Center for Molecular Oncology at MIT; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-NCI Career Development award; Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Denise Crowley and the Swanson Biotechnology Core Facility for histology preparation and IHC; Harold Varmus, Nadya Dimitrova, and Eric L. Snyder for critical review of the manuscript; and Peter Campbell for a fruitful discussion. This work was supported by the Ludwig Center for Molecular Oncology at MIT (to T.J.), the Howard Hughes Medical Institute (to T.J.), the National Human Genome Research Institute (to S. G. and G. G.), NIH-NCI Career Development award K08CA160658 (to D. G. M.), and a Hope Funds for Cancer Research Fellowship (to T. P.). G. G. is the Paul C. Zamecnik, MD, Chair in Oncology at Massachusetts General Hospital. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar at MIT. The authors wish to dedicate this paper to the memory of Officer Sean Collier, for his caring service to the MIT community and for his sacrifice.	Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Calbo J, 2005, COLD SH Q B, V70, P225, DOI 10.1101/sqb.2005.70.026; Califano R, 2012, DRUGS, V72, P471, DOI 10.2165/11597640-000000000-00000; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen SL, 2006, CA-CANCER J CLIN, V56, P292, DOI 10.3322/canjclin.56.5.292; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dacic S, 2002, HUM PATHOL, V33, P927, DOI 10.1053/hupa.2002.126875; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pilarski R, 2011, J MED GENET, V48, P505, DOI 10.1136/jmg.2011.088807; Podsypanina K, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-24; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Shepherd C, 2013, LEUKEMIA, V27, P650, DOI 10.1038/leu.2012.285; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Sweet-Cordero A, 2006, GENE CHROMOSOME CANC, V45, P338, DOI 10.1002/gcc.20296; To MD, 2011, MOL CANCER RES, V9, P1339, DOI 10.1158/1541-7786.MCR-11-0219; Tsou HC, 1998, HUM GENET, V102, P467, DOI 10.1007/s004390050723; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Wegmann F, 2004, EXP CELL RES, V300, P121, DOI 10.1016/j.yexcr.2004.07.010; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; Yuan W, 2013, ONCOGENE, V32, P318, DOI 10.1038/onc.2012.53; Zmajkovicova K, 2013, MOL CELL, V50, P43, DOI 10.1016/j.molcel.2013.01.037	55	191	204	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1298	1311		10.1016/j.cell.2014.02.031	http://dx.doi.org/10.1016/j.cell.2014.02.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630729	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000332945100018
J	Crowe, E; Pandeya, N; Brotherton, JML; Dobson, AJ; Kisely, S; Lambert, SB; Whiteman, DC				Crowe, Elizabeth; Pandeya, Nirmala; Brotherton, Julia M. L.; Dobson, Annette J.; Kisely, Stephen; Lambert, Stephen B.; Whiteman, David C.			Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARTICLE VACCINE; HPV VACCINATION; YOUNG-WOMEN; INFECTION; LESIONS; IMPACT; DURATION; EFFICACY; DISEASES; CANCER	Objective To measure the effectiveness of the quadrivalent human papillomavirus (HPV) vaccine against cervical abnormalities four years after implementation of a nationally funded vaccination programme in Queensland, Australia. Design Case-control analysis of linked administrative health datasets. Setting Queensland, Australia. Participants Women eligible for free vaccination (aged 12-26 years in 2007) and attending for their first cervical smear test between April 2007 and March 2011. High grade cases were women with histologically confirmed high grade cervical abnormalities (n=1062) and "other cases" were women with any other abnormality at cytology or histology (n=10 887). Controls were women with normal cytology (n=96 404). Main outcome measures Exposure odds ratio (ratio of odds of antecedent vaccination (one, two, or three vaccine doses compared with no doses) among cases compared with controls), vaccine effectiveness ((1-adjusted odds ratio)x100), and number needed to vaccinate to prevent one cervical abnormality at first screening round. We stratified by four age groups adjusted for follow-up time, year of birth, and measures of socioeconomic status and remoteness. The primary analysis concerned women whose first ever smear test defined their status as a case or a control. Results The adjusted odds ratio for exposure to three doses of HPV vaccine compared with no vaccine was 0.54 (95% confidence interval 0.43 to 0.67) for high grade cases and 0.66 (0.62 to 0.70) for other cases compared with controls with normal cytology, equating to vaccine effectiveness of 46% and 34%, respectively. The adjusted numbers needed to vaccinate were 125 (95% confidence interval 97 to 174) and 22 (19 to 25), respectively. The adjusted exposure odds ratios for two vaccine doses were 0.79 (95% confidence interval 0.64 to 0.98) for high grade cases and 0.79 (0.74 to 0.85) for other cases, equating to vaccine effectiveness of 21%. Conclusion The quadrivalent HPV vaccine conferred statistically significant protection against cervical abnormalities in young women who had not started screening before the implementation of the vaccination programme in Queensland, Australia.	[Crowe, Elizabeth; Pandeya, Nirmala; Dobson, Annette J.; Whiteman, David C.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Crowe, Elizabeth] NHS Borders, Dept Publ Hlth Melrose, Melrose, Scotland; [Brotherton, Julia M. L.] Victorian Cytol Serv, Melbourne, Vic, Australia; [Kisely, Stephen] Univ Queensland, Rural Sch, Woolloongabba, Australia; [Kisely, Stephen] Univ Queensland, Southern Clin Sch, Woolloongabba, Australia; [Lambert, Stephen B.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Lambert, Stephen B.] Childrens Hlth Queensland, Brisbane, Qld, Australia; [Lambert, Stephen B.] Queensland Hlth Immunisat Program, Brisbane, Qld, Australia; [Whiteman, David C.] QIMR Berghofer Med Res Inst, Populat Hlth Dept, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Queensland Health; QIMR Berghofer Medical Research Institute	Crowe, E (corresponding author), NHS Borders, Dept Publ Hlth Melrose, Melrose, Scotland.	e.crowe1@uq.edu.au	Whiteman, David C/P-2728-2014; Kisely, Steve/B-4680-2012; Lambert, Stephen/N-7819-2019; Pandeya, Nirmala/F-8054-2010	Whiteman, David C/0000-0003-2563-9559; Kisely, Steve/0000-0003-4021-2924; Lambert, Stephen/0000-0002-2709-193X; Pandeya, Nirmala/0000-0003-1462-4968	University of Queensland; NHS Borders; Australian Research Council [FT0990987]; National Health and Medical Research Council [631691, GNT1036231]; Victorian Cytology Service; Children's Health Foundation Queensland [50025]	University of Queensland(University of Queensland); NHS Borders; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cytology Service; Children's Health Foundation Queensland	No specific project funding was received but EC was supported by a salary from the University of Queensland and NHS Borders. DCW was supported by a Future Fellowship from the Australian Research Council (FT0990987). NP was supported by an early career fellowship from the National Health and Medical Research Council (631691). SK and AJD were supported by salaries from the University of Queensland. JMLB was supported by salary from the Victorian Cytology Service. SBL was supported by an early career fellowship from the National Health and Medical Research Council (GNT1036231) and is a Queensland Children's Medical Research Institute senior research fellow supported by the Children's Health Foundation Queensland (50025).	Australian Government Department of Health, 2013, NAT CERV SCREEN PROG; Bender R, 2002, J CLIN EPIDEMIOL, V55, P525, DOI 10.1016/S0895-4356(01)00510-8; Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Castle PE, 2012, GYNECOL ONCOL, V127, P437, DOI 10.1016/j.ygyno.2012.10.012; Chief Medical Officer Department of Health and Ageing Australian Government, 2009, GUID REV HPV VACC DO; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Hull Brynley P, 2003, Commun Dis Intell Q Rep, V27, P357; Joura EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1401; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Nitsch Dorothea, 2006, BMC Med Res Methodol, V6, P15; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Queensland Government, QUEENSL CERV SCREEN; Queensland Health, 2012, QUEENSL CERV SCREEN; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	23	138	144	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1458	10.1136/bmj.g1458	http://dx.doi.org/10.1136/bmj.g1458			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HV	24594809	hybrid, Green Published			2022-12-24	WOS:000332623400003
J	Maher, K; Chamberlain, CP				Maher, K.; Chamberlain, C. P.			Hydrologic Regulation of Chemical Weathering and the Geologic Carbon Cycle	SCIENCE			English	Article							ATMOSPHERIC CO2; RESIDENCE TIME; EROSION RATES; LARGE RIVERS; CHEMISTRY; EVOLUTION; FEEDBACK; CLIMATE; FLUXES; ZONE	Earth's temperature is thought to be regulated by a negative feedback between atmospheric CO2 levels and chemical weathering of silicate rocks that operates over million-year time scales. To explain variations in the strength of the weathering feedback, we present a model for silicate weathering that regulates climatic and tectonic forcing through hydrologic processes and imposes a thermodynamic limit on weathering fluxes, based on the physical and chemical properties of river basins. Climate regulation by silicate weathering is thus strongest when global topography is elevated, similar to the situation today, and lowest when global topography is more subdued, allowing planetary temperatures to vary depending on the global distribution of topography and mountain belts, even in the absence of appreciable changes in CO2 degassing rates.	[Maher, K.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Chamberlain, C. P.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Maher, K (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA.	kmaher@stanford.edu	Maher, Kate/B-3489-2010	Maher, Kate/0000-0002-5982-6064	U.S. NSF [EAR-1254156]	U.S. NSF(National Science Foundation (NSF))	The paper benefitted greatly from the reviews provided by several anonymous reviewers. This work was supported by the U.S. NSF (EAR-1254156 to K. M.). Data used in this study come from previously published studies, and the details of the model are provided in the supplementary materials.	BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Berner RA, 1997, GEOLOGY, V25, P955, DOI 10.1130/0091-7613(1997)025<0955:TNFMBA>2.3.CO;2; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BLUTH GJS, 1994, GEOCHIM COSMOCHIM AC, V58, P2341, DOI 10.1016/0016-7037(94)90015-9; Boucher D.F., 1959, CHEM ENG PROG, V55, P55; Bouchez J, 2012, CHEM GEOL, V332, P166, DOI 10.1016/j.chemgeo.2012.09.032; Brantley SL, 2011, ANNU REV EARTH PL SC, V39, P387, DOI 10.1146/annurev-earth-040809-152321; Edmond JM, 1997, TECTONIC UPLIFT CLIM, P329, DOI [DOI 10.1007/978-1-4615-5935-1_14, 10.1007/978-1-4615-5935-1_14]; Ferrier KL, 2008, EARTH PLANET SC LETT, V272, P591, DOI 10.1016/j.epsl.2008.05.024; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Godsey SE, 2009, HYDROL PROCESS, V23, P1844, DOI 10.1002/hyp.7315; Hilley GE, 2010, EARTH PLANET SC LETT, V293, P191, DOI 10.1016/j.epsl.2010.01.008; Kump L. R., 1997, TECTONIC UPLIFT CLIM, P399, DOI [DOI 10.1007/978-1-4615-5935-1, DOI 10.1007/978-1-4615-5935-1_18]; Kump LR, 2000, ANNU REV EARTH PL SC, V28, P611, DOI 10.1146/annurev.earth.28.1.611; Li GJ, 2013, GEOCHIM COSMOCHIM AC, V103, P11, DOI 10.1016/j.gca.2012.10.014; Maher K, 2011, EARTH PLANET SC LETT, V312, P48, DOI 10.1016/j.epsl.2011.09.040; Manabe S, 2004, CLIMATIC CHANGE, V64, P59, DOI 10.1023/B:CLIM.0000024674.37725.ca; McCauley S. E., 1997, GLOBAL TECTONICS CLI, P427; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Pagani M, 2009, NATURE, V460, P85, DOI 10.1038/nature08133; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; West AJ, 2012, GEOLOGY, V40, P811, DOI 10.1130/G33041.1; West AJ, 2002, GEOLOGY, V30, P355; Willenbring JK, 2010, NATURE, V465, P211, DOI 10.1038/nature09044; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248; Yoo K, 2008, GEOLOGY, V36, P35, DOI 10.1130/G24285A.1	29	332	350	24	375	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1502	1504		10.1126/science.1250770	http://dx.doi.org/10.1126/science.1250770			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24625927				2022-12-24	WOS:000333471000045
J	Kafsack, BFC; Rovira-Graells, N; Clark, TG; Bancells, C; Crowley, VM; Campino, SG; Williams, AE; Drought, LG; Kwiatkowski, DP; Baker, DA; Cortes, A; Llinas, M				Kafsack, Bjoern F. C.; Rovira-Graells, Nuria; Clark, Taane G.; Bancells, Cristina; Crowley, Valerie M.; Campino, Susana G.; Williams, April E.; Drought, Laura G.; Kwiatkowski, Dominic P.; Baker, David A.; Cortes, Alfred; Llinas, Manuel			A transcriptional switch underlies commitment to sexual development in malaria parasites	NATURE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; PROTEIN; GENES; EXPRESSION; TRANSMISSION; REGION	The life cycles of many parasites involve transitions between disparate host species, requiring these parasites to go through multiple developmental stages adapted to each of these specialized niches. Transmission of malaria parasites (Plasmodium spp.) from humans to the mosquito vector requires differentiation from asexual stages replicating within red blood cells into non-dividing male and female gametocytes. Although gametocytes were first described in 1880, our understanding of the molecular mechanisms involved in commitment to gametocyte formation is extremely limited, and disrupting this critical developmental transition remains a long-standing goal(1). Here we show that expression levels of the DNA-binding protein PfAP2-G correlate strongly with levels of gametocyte formation. Using independent forward and reverse genetics approaches, we demonstrate that PfAP2-G function is essential for parasite sexual differentiation. By combining genome-wide PfAP2-G cognate motif occurrence with global transcriptional changes resulting from PfAP2-G ablation, we identify early gametocyte genes as probable targets of PfAP2-G and show that their regulation by PfAP2-G is critical for their wild-type level expression. In the asexual blood-stage parasites pfap2-g appears to be among a set of epigenetically silenced loci(2,3) prone to spontaneous activation(4). Stochastic activation presents a simple mechanism for a low baseline of gametocyte production. Overall, these findings identify PfAP2-G as a master regulator of sexual-stage development in malaria parasites and mark the first discovery of a transcriptional switch controlling a differentiation decision in protozoan parasites.	[Kafsack, Bjoern F. C.; Crowley, Valerie M.; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rovira-Graells, Nuria; Bancells, Cristina; Cortes, Alfred] Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona 08036, Catalonia, Spain; [Rovira-Graells, Nuria; Crowley, Valerie M.; Cortes, Alfred] IRB, Barcelona 08028, Catalonia, Spain; [Clark, Taane G.; Drought, Laura G.; Baker, David A.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Campino, Susana G.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Williams, April E.; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kwiatkowski, Dominic P.] Wellcome Trust Sanger Ctr Human Genet, Oxford OX37BN, England; [Cortes, Alfred] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain	Princeton University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; Princeton University; University of Oxford; Wellcome Centre for Human Genetics; ICREA	Llinas, M (corresponding author), Penn State Univ, Dept Mol Biol, State Coll, PA 16802 USA.	manuel@psu.edu	Clark, Taane G./AAM-2570-2020; Closas, Alfred Cortes/I-8134-2015; Campino, Susana/AAM-2577-2020	Clark, Taane G./0000-0001-8985-9265; Closas, Alfred Cortes/0000-0003-0730-6582; Campino, Susana/0000-0003-1403-6138; Williams, April/0000-0001-9281-8528; Baker, David/0000-0002-5490-8933; Kafsack, Bjorn F.C./0000-0003-0089-1096; Kwiatkowski, Dominic/0000-0002-5023-0176; Bancells, Cristina/0000-0003-4819-218X; Crowley, Valerie/0000-0002-2593-1130	National Institutes of Health (NIH) [R01 AI076276]; Centre for Quantitative Biology [P50GM071508]; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; Wellcome Trust [094752, 098051, 090532/Z/09/Z]; European Commission [223044]; Biotechnology and Biological Sciences Research Council CASE PhD studentship; Spanish Ministry of Science and Innovation [SAF2010-20111]; IRB Barcelona; Medical Research Council UK [J005398, G0600230]; Catalan Government fellowship [2011-BP-B 00060]; MRC [G0600230, G0600718] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [971922] Funding Source: researchfish; Medical Research Council [G0600230, G0600718] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, P50GM071508] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Quantitative Biology; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council CASE PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IRB Barcelona; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Catalan Government fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	We would like to thank C. Klein, T. Campbell and A. Schieler for technical assistance and are grateful to O. Billker, C. Flueck, J. Kelly, C. Sutherland, A. Vaidya and A. Waters for discussion and reading of the manuscript. We would also like to thank P. Alano for providing P. falciparum clone F12, C. Taylor for providing the P. falciparum GNP-A4 clone, E. Thompson for isolating P. falciparum DNA for whole genome analysis, Z. Gorvett for assistance with confirming single nucleotide polymorphisms in gametocyte non-producing clones, M. Duraisingh for the ddFKBP tagging construct pJDD145, C. Ben Mamoun for the anti-PP2c antibody and D. Goldberg for Shld1. M. L. is funded by National Institutes of Health (NIH) grant R01 AI076276 with support from the Centre for Quantitative Biology (P50GM071508). B. F. C. K. was supported by a Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation. D. A. B. is funded by Wellcome Trust grant ref. 094752 and European Commission FP7 'MALSIG' (ref. 223044). L. G. D. is supported by a Biotechnology and Biological Sciences Research Council CASE PhD studentship with Pfizer as the Industrial partner. A. C. is funded by the Spanish Ministry of Science and Innovation grant SAF2010-20111. V. M. C. was supported by a fellowship from IRB Barcelona. T. G. C. is supported by the Medical Research Council UK (J005398). D. P. K. and S. G. C. are supported through the Wellcome Trust (098051; 090532/Z/09/Z) and the Medical Research Council UK (G0600230). C. B. is supported by the Catalan Government fellowship 2011-BP-B 00060 (AGAUR, Catalonia, Spain).	ALANO P, 1995, EXP PARASITOL, V81, P227, DOI 10.1006/expr.1995.1112; Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Avraham I, 2012, P NATL ACAD SCI USA, V109, pE3678, DOI 10.1073/pnas.1214572109; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Cortes A, 2004, BLOOD, V104, P2961, DOI 10.1182/blood-2004-06-2136; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Crowley VM, 2011, MOL MICROBIOL, V80, P391, DOI 10.1111/j.1365-2958.2011.07574.x; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; Dixon MWA, 2008, TRENDS PARASITOL, V24, P168, DOI 10.1016/j.pt.2008.01.004; Eksi S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002964; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Ikadai H, 2013, P NATL ACAD SCI USA, V110, pE1676, DOI 10.1073/pnas.1217712110; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107; Kafsack BFC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-187; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Me ' nard R., 2013, METHOD MOL BIOL, V923, P3; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Robinson T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023204; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Taylor C. J., 2007, THESIS U LONDON; Taylor CJ, 2008, MOL MICROBIOL, V69, P110, DOI 10.1111/j.1365-2958.2008.06267.x; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	40	281	281	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					248	+		10.1038/nature12920	http://dx.doi.org/10.1038/nature12920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24572369	Green Accepted			2022-12-24	WOS:000332651800042
J	Denniston, MM; Jiles, RB; Drobeniuc, J; Klevens, RM; Ward, JW; McQuillan, GM; Holmberg, SD				Denniston, Maxine M.; Jiles, Ruth B.; Drobeniuc, Jan; Klevens, R. Monina; Ward, John W.; McQuillan, Geraldine M.; Holmberg, Scott D.			Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010	ANNALS OF INTERNAL MEDICINE			English	Article							PREVALENCE; MORTALITY; TYPE-2	Background: Knowledge of the number of persons with chronic hepatitis C virus (HCV) infection in the United States is critical for public health and policy planning. Objective: To estimate the prevalence of chronic HCV infection between 2003 and 2010 and to identify factors associated with this condition. Design: Nationally representative household survey. Setting: U.S. noninstitutionalized civilian population. Participants: 30 074 NHANES (National Health and Nutrition Examination Survey) participants between 2003 and 2010. Measurements: Interviews to ascertain demographic characteristics and possible risks and exposures for HCV infection. Serum samples from participants aged 6 years or older were tested for antibody to HCV; if results were positive or indeterminate, the samples were tested for HCV RNA, which indicates current chronic infection. Results: Based on 273 participants who tested positive for HCV RNA, the estimated prevalence of HCV infection was 1.0% (95% CI, 0.8% to 1.2%), corresponding to 2.7 million chronically infected persons (CI, 2.2 to 3.2 million persons) in the U. S. noninstitutionalized civilian population. Infected persons were more likely to be aged 40 to 59 years, male, and non-Hispanic black and to have less education and lower family income. Factors significantly associated with chronic HCV infection were illicit drug use (including injection drugs) and receipt of a blood transfusion before 1992; 49% of persons with HCV infection did not report either risk factor. Limitation: Incarcerated and homeless persons were not surveyed. Conclusion: This analysis estimated that approximately 2.7 million U. S. residents in the population sampled by NHANES have chronic HCV infection, about 500 000 fewer than estimated in a similar analysis between 1999 and 2002. These data underscore the urgency of identifying the millions of persons who remain infected and linking them to appropriate care and treatment.	Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Holmberg, SD (corresponding author), 1600 Clifton Rd NE,Mail Stop G37, Atlanta, GA 30333 USA.	sdh1@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Fox AN, 2012, CLIN INFECT DIS, V55, pS16, DOI 10.1093/cid/cis391; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; Grant WC, 2005, HEPATOLOGY, V42, P1406, DOI 10.1002/hep.20941; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mahajan R., 2013, IDWEEK 2013 SAN FRAN; North CS, 2013, GEN HOSP PSYCHIAT, V35, P122, DOI 10.1016/j.genhosppsych.2012.11.002; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Pyenson B., 2009, CONSEQUENCES HEPATIT; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; Sie L, 2013, J VIRAL HEPATITIS, V20, P628, DOI 10.1111/jvh.12086; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100	21	562	566	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2014	160	5					293	+		10.7326/M13-1133	http://dx.doi.org/10.7326/M13-1133			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC8OT	24737271	Green Accepted			2022-12-24	WOS:000332793900001
J	Asangani, IA; Dommeti, VL; Wang, XJ; Malik, R; Cieslik, M; Yang, RD; Escara-Wilke, J; Wilder-Romans, K; Dhanireddy, S; Engelke, C; Iyer, MK; Jing, XJ; Wu, YM; Cao, XH; Qin, ZHS; Wang, SM; Feng, FY; Chinnaiyan, AM				Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Yang, Rendong; Escara-Wilke, June; Wilder-Romans, Kari; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Qin, Zhaohui S.; Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.			Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer	NATURE			English	Article							SELECTIVE-INHIBITION; INCREASED SURVIVAL; CHIP-SEQ; P-TEFB; BRD4; ANTIANDROGEN; RECRUITMENT; ABIRATERONE; GENE; TRANSCRIPTION	Men who develop metastatic castration-resistant prostate cancer(CRPC) invariably succumb to the disease. Progression to CRPC after androgen ablation therapy is predominantly driven by deregulated and rogen receptor (AR) signalling(1-3). Despite the success of recently approved therapies targeting AR signalling, such as abiraterone(4-6) and second generation anti-androgens including MDV3100 (also known as enzalutamide) 7,8, durable responses are limited, presumably owing to acquired resistance. Recently, JQ1 and I-BET762 two selective small-molecule inhibitors that target the amino-terminal bromodomains of BRD4, have been shown to exhibit anti-proliferative effects in a range of malignancies(9-12). Here we show that AR-signalling-competent human CRPC cell lines are preferentially sensitive to bromodomain and extraterminal (BET) inhibition. BRD4 physically interacts with the N-terminal domain of AR and can bedisrupted by JQ1(refs 11, 13). Like the direct AR antagonist MDV3100, JQ1 disrupted AR recruitment to target gene loci. By contrast with MDV3100, JQ1 functions downstream of AR, and more potently abrogated BRD4 localization to AR target loci and AR-mediated gene transcription, including induction of the TMPRSS2-ERG gene fusion and its oncogenic activity. In vivo, BET bromodomain inhibition was more efficacious than direct AR antagonism in CRPC xenograft mouse models. Taken together, these studies provide a novel epigenetic approach for the concerted blockade of oncogenic drivers in advanced prostate cancer.	[Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Escara-Wilke, June; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Asangani, Irfan A.; Wang, Xiaoju; Malik, Rohit; Wu, Yi-Mi; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Yang, Rendong; Qin, Zhaohui S.] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30329 USA; [Wilder-Romans, Kari; Feng, Felix Y.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Sch Med, Dept Med Chem, Ann Arbor, MI 48109 USA; [Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Emory University; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Qin, Zhaohui/Q-3133-2019	Qin, Zhaohui/0000-0002-1583-146X; asangani, irfan/0000-0001-5381-1702; Wang, Shaomeng/0000-0002-8782-6950	Movember-Prostate Cancer Foundation Challenge Award; Early Detection Research Network [UO1 CA111275]; NCI Prostate SPORE [P50CA69568]; Doris Duke Charitable Foundation; American Cancer Society; A. Alfred-Taubman Institute; PCF Young Investigator Award; NATIONAL CANCER INSTITUTE [U01CA111275, P50CA069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	Movember-Prostate Cancer Foundation Challenge Award; Early Detection Research Network; NCI Prostate SPORE; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Cancer Society(American Cancer Society); A. Alfred-Taubman Institute; PCF Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Paliakov, T. Barrette, Y. Qiao, P. Vats, R. Stender, X. Jiang, M. Pranithi and S. Han for technical assistance; C. Kumar-Sinha, M. Dhanasekaran, N. Palanisamy and P. Kunju for helpful discussions; J. Athanikar and K. Giles for critically reading the manuscript and submission of documents. This work was supported by a Movember-Prostate Cancer Foundation Challenge Award and in part by the Early Detection Research Network (UO1 CA111275) and the NCI Prostate SPORE (P50CA69568) to A. M. C. A. M. C. is also supported by the Doris Duke Charitable Foundation, American Cancer Society, and A. Alfred-Taubman Institute. I. A. A. and R. A. are supported by a PCF Young Investigator Award.	Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Attard G, 2011, CLIN CANCER RES, V17, P1649, DOI 10.1158/1078-0432.CCR-10-0567; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin TH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.270; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mukherji D, 2012, EXPERT OPIN INV DRUG, V21, P227, DOI 10.1517/13543784.2012.651125; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 1999, CANCER RES, V59, P2511; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; van der Horst EH, 2004, BIOTECHNIQUES, V37, P940, DOI 10.2144/04376ST02; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	42	634	670	9	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					278	+		10.1038/nature13229	http://dx.doi.org/10.1038/nature13229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24759320	Green Accepted			2022-12-24	WOS:000337032400052
J	Godinho, SA; Picone, R; Burute, M; Dagher, R; Su, Y; Leung, CT; Polyak, K; Brugge, JS; Thery, M; Pellman, D				Godinho, Susana A.; Picone, Remigio; Burute, Mithila; Dagher, Regina; Su, Ying; Leung, Cheuk T.; Polyak, Kornelia; Brugge, Joan S.; Thery, Manuel; Pellman, David			Oncogene-like induction of cellular invasion from centrosome amplification	NATURE			English	Article							HUMAN BREAST-CANCER; CENTRIOLE DUPLICATION; CHROMOSOMAL INSTABILITY; SPINDLE CHECKPOINT; JUNCTION FORMATION; CELLS; EXPRESSION; ROLES; RAC; TUMORIGENESIS	Centrosome amplification has long been recognized as a feature of human tumours; however, its role in tumorigenesis remains unclear(1). Centrosome amplification is poorly tolerated by non-transformed cells and, in the absence of selection, extra centrosomes are spontaneously lost(2). Thus, the high frequency of centrosome amplification, particularly in more aggressive tumours(3), raises the possibility that extra centrosomes could, in some contexts, confer advantageous characteristics that promote tumour progression. Using a three-dimensional model system and other approaches to culture human mammary epithelial cells, we find that centrosome amplification triggers cell invasion. This invasive behaviour is similar to that induced by overexpression of the breast cancer oncogene ERBB2 (ref.4) and indeed enhances invasiveness triggered by ERBB2. Our data indicate that, through increased centrosomal microtubule nucleation, centrosome amplification increases Rac1 activity, which disrupts normal cell-cell adhesion and promotes invasion. These findings demonstrate that centrosome amplification, a structural alteration of the cytoskeleton, can promote features of malignant transformation.	[Godinho, Susana A.; Picone, Remigio; Dagher, Regina; Pellman, David] Childrens Hosp, Howard Hughes Med Inst, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Godinho, Susana A.; Picone, Remigio; Dagher, Regina; Pellman, David] Childrens Hosp, Boston, MA 02115 USA; [Godinho, Susana A.; Picone, Remigio; Dagher, Regina; Leung, Cheuk T.; Brugge, Joan S.; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Burute, Mithila; Thery, Manuel] UMR5168 CEA UJF INRA CNRS, Inst Rech Technol & Sci Vivant, Grenoble, France; [Burute, Mithila; Thery, Manuel] U1160 INSERM AP HP Univ Paris Diderot, Inst Univ Hematol, Hop St Louis, F-75010 Paris, France; [Burute, Mithila] CYTOO SA, F-38054 Grenoble, France; [Su, Ying; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Godinho, SA (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	s.godinho@qmul.ac.uk; david_pellman@dfci.harvard.edu		Leung, Cheuk/0000-0002-5838-5535; Su, Ying/0000-0003-0462-3865; Godinho, Susana/0000-0003-0638-065X	FCT [HMSP-CT/SAU-ICT/0075/2009]; ERC [310472]; ISI program of BPIFrance; NIH [GM083299-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ERC(European Research Council (ERC)European Commission); ISI program of BPIFrance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Jhaveri-Schneider, S. Muthuswamy, M. Bettencourt-Dias, R. Basto, D. Calado, N. Ganem, A. Spektor, M. Kwon and B. Atkins for comments or discussion of the manuscript; the Nikon Imaging Center at Harvard Medical School; J. Waters, J. Rosenberg and H. Elliott from the Image and Data Analysis Core at Harvard Medical School for their help with FRET microscopy and analysis; L. Cameron of the Confocal and Light Microcopy Facility at Dana-Farber Cancer Institute; H. Li of SNP analysis; A. Bui for help establishing the 3D cultures; Q. Tseng for establishing MCF 10A doublets on micropatterns; and C. Sproat and J. Marshall for help with the organotypic cultures. Reagents were kindly provided by L. Pelletier, J. Locarek, M. Matsuda, A. Hall and J. Marshall. S. A. G. is supported by an FCT grant HMSP-CT/SAU-ICT/0075/2009. M. T. is supported by the ERC grant 310472 and the ISI program of BPIFrance. D.P. is an HHMI investigator and is supported by an NIH grant GM083299-1.	Azioune A, 2010, METHOD CELL BIOL, V97, P133, DOI 10.1016/S0091-679X(10)97008-8; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Mahjoub MR, 2012, CURR BIOL, V22, P1628, DOI 10.1016/j.cub.2012.06.057; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; PALACIOS J, 1995, VIRCHOWS ARCH, V427, P259; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Sluder G, 2004, CURR OPIN CELL BIOL, V16, P49, DOI 10.1016/j.ceb.2003.11.006; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Wallace SW, 2011, MOL CELL BIOL, V31, P81, DOI 10.1128/MCB.01001-10; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081; Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	46	271	275	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					167	+		10.1038/nature13277	http://dx.doi.org/10.1038/nature13277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24739973	Green Accepted			2022-12-24	WOS:000336768900050
J	Kumazaki, K; Chiba, S; Takemoto, M; Furukawa, A; Nishiyama, K; Sugano, Y; Mori, T; Dohmae, N; Hirata, K; Nakada-Nakura, Y; Maturana, AD; Tanaka, Y; Mori, H; Sugita, Y; Arisaka, F; Ito, K; Ishitani, R; Tsukazaki, T; Nureki, O				Kumazaki, Kaoru; Chiba, Shinobu; Takemoto, Mizuki; Furukawa, Arata; Nishiyama, Ken-ichi; Sugano, Yasunori; Mori, Takaharu; Dohmae, Naoshi; Hirata, Kunio; Nakada-Nakura, Yoshiko; Maturana, Andres D.; Tanaka, Yoshiki; Mori, Hiroyuki; Sugita, Yuji; Arisaka, Fumio; Ito, Koreaki; Ishitani, Ryuichiro; Tsukazaki, Tomoya; Nureki, Osamu			Structural basis of Sec-independent membrane protein insertion by YidC	NATURE			English	Article							ESCHERICHIA-COLI YIDC; MOLECULAR-DYNAMICS; SUBUNIT; TRANSLOCATION; BIOGENESIS; VALIDATION; REQUIRES; RECEPTOR; FEATURES; REGIONS	Newly synthesized membrane proteins must be accurately inserted into the membrane, folded and assembled for proper functioning. The protein YidC inserts its substrates into the membrane, thereby facilitating membrane protein assembly in bacteria; the homologous proteins Oxa1 and Alb3 have the same function in mitochondria and chloroplasts, respectively(1,2). In the bacterial cytoplasmic membrane, YidC functions as an independent insertase and a membrane chaperone in cooperation with the translocon SecYEG(3-5). Here we present the crystal structure of YidC from Bacillus halodurans, at 2.4 angstrom resolution. The structure reveals a novel fold, in which five conserved transmembrane helices form a positively charged hydrophilic groove that is open towards both the lipid bilayer and the cytoplasm but closed on the extracellular side. Structure-based in vivo analyses reveal that a conserved arginine residue in the groove is important for the insertion of membrane proteins by YidC. We propose an insertion mechanism for single-spanning membrane proteins, in which the hydrophilic environment generated by the groove recruits the extracellular regions of substrates into the low-dielectric environment of the membrane.	[Kumazaki, Kaoru; Takemoto, Mizuki; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kumazaki, Kaoru; Takemoto, Mizuki; Dohmae, Naoshi; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan; [Chiba, Shinobu; Ito, Koreaki] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Furukawa, Arata; Sugano, Yasunori; Tanaka, Yoshiki; Tsukazaki, Tomoya] Nara Inst Sci & Technol, Dept Syst Biol, Grad Sch Biol Sci, Nara 6300192, Japan; [Nishiyama, Ken-ichi] Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, Morioka, Iwate 0208550, Japan; [Sugano, Yasunori; Mori, Takaharu; Sugita, Yuji] RIKEN, Theoret Mol Sci Lab, Wako, Saitama 3510198, Japan; [Hirata, Kunio] RIKEN SPring 8 Ctr, SR Life Sci Instrumentat Unit, Sayo, Hyogo 6795148, Japan; [Nakada-Nakura, Yoshiko] Kyoto Univ, Dept Cell Biol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Mori, Hiroyuki] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Tsukazaki, Tomoya] PRESTO, JST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; RIKEN; Kyoto Sangyo University; Nara Institute of Science & Technology; Iwate University; RIKEN; RIKEN; Kyoto University; Nagoya University; Kyoto University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ttsukaza@bs.naist.jp; nureki@bs.s.u-tokyo.ac.jp	Tsukazaki, Tomoya/N-2299-2019; Sugita, Yuji/L-6726-2014; Mori, Takaharu/AAH-1234-2021; NUREKI, OSAMU/G-4960-2014; Dohmae, Naoshi/C-2040-2011	Tsukazaki, Tomoya/0000-0002-6386-723X; Sugita, Yuji/0000-0001-9738-9216; Dohmae, Naoshi/0000-0002-5242-9410; Hirata, Kunio/0000-0002-1491-6509; Mori, Takaharu/0000-0002-8717-2926; Takemoto, Mizuki/0000-0002-6339-6431; Mori, Hiroyuki/0000-0002-0429-1269; Chiba, Shinobu/0000-0003-3485-3477; Tanaka, Yoshiki/0000-0001-6960-5276	Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI [20247020, 20523517, 24687016, 24102503, 24121704, 24227004, 24657095, 25291006, 25291009, 25660073]; FIRST; PRESTO; JST; MEXT; Private University Strategic Research Foundation Support Program (MEXT); Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [13J08353, 26102532, 26119701, 24117003, 26102703] Funding Source: KAKEN	Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); FIRST; PRESTO; JST(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Private University Strategic Research Foundation Support Program (MEXT); Nagase Science and Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We wish to thank K. Watanabe from Shoko Scientific for assistance with the SEC-MALLS experiments; T. Nishizawa, T. Higuchi, H. E. Kato, M. Hattori, R. Ishii and H. Nishimasu for discussions; A. Kurabayashi, H. Nakamura, S. Hibino, T. Takino and C. Tsutsumi for technical support; A. Nakashima and R. Yamazaki for secretarial assistance; the RIKEN BioResource Center for providing B. halodurans genomic DNA; the RIKEN Integrated Cluster of Clusters (RICC) for providing computational resources; and the beamline staff members at BL32XU of SPring-8 for technical assistance during data collection. The synchrotron radiation experiments were performed at BL32XU of SPring-8 (proposal no. 2011A1125, 2011A1139, 2011B1062, 2011B1280, 2012A1093, 2012A1201, 2012B1146, 2012B1162 and 2013A1128), with approval from RIKEN. This work was supported by the Platform for Drug Discovery, Informatics and Structural Life Science by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by JSPS KAKENHI (grant no. 20247020, 20523517, 24687016, 24102503, 24121704, 24227004, 24657095, 25291006, 25291009 and 25660073), by the FIRST program, by PRESTO, by the JST, by a Grant-in-Aid for JSPS Fellows, by a grant for the HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development from MEXT, and by grants from the Private University Strategic Research Foundation Support Program (MEXT), the Nagase Science and Technology Foundation, and the Astellas Foundation for Research on Metabolic Disorders.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Chiba S, 2012, MOL CELL, V47, P863, DOI 10.1016/j.molcel.2012.06.034; Chiba S, 2011, P NATL ACAD SCI USA, V108, P6073, DOI 10.1073/pnas.1018343108; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; Hirata K, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/1/012002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kruger V, 2012, J BIOL CHEM, V287, P33314, DOI 10.1074/jbc.M112.387563; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Price CE, 2010, J BIOL CHEM, V285, P3575, DOI 10.1074/jbc.M109.051128; Rubio A, 2005, J BACTERIOL, V187, P5000, DOI 10.1128/JB.187.14.5000-5002.2005; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Saller MJ, 2012, BIOL CHEM, V393, P1279, DOI 10.1515/hsz-2012-0199; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431	50	134	138	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					516	+		10.1038/nature13167	http://dx.doi.org/10.1038/nature13167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24739968				2022-12-24	WOS:000336126000044
J	Cavanaugh, DJ; Geratowski, JD; Wooltorton, JRA; Spaethling, JM; Hector, CE; Zheng, XZ; Johnson, EC; Eberwine, JH; Sehgal, A				Cavanaugh, Daniel J.; Geratowski, Jill D.; Wooltorton, Julian R. A.; Spaethling, Jennifer M.; Hector, Clare E.; Zheng, Xiangzhong; Johnson, Erik C.; Eberwine, James H.; Sehgal, Amita			Identification of a Circadian Output Circuit for Rest: Activity Rhythms in Drosophila	CELL			English	Article							CHANNEL-BINDING-PROTEIN; PARS INTERCEREBRALIS; LOCOMOTOR BEHAVIOR; CLOCK NEURONS; ABLATION; GENE; ACTIVATION; EXPRESSION; PACEMAKER; RESPONSES	Though much is known about the cellular and molecular components of the circadian clock, output pathways that couple clock cells to overt behaviors have not been identified. We conducted a screen for circadian-relevant neurons in the Drosophila brain and report here that cells of the pars intercerebralis (PI), a functional homolog of the mammalian hypothalamus, comprise an important component of the circadian output pathway for rest: activity rhythms. GFP reconstitution across synaptic partners (GRASP) analysis demonstrates that PI cells are connected to the clock through a polysynaptic circuit extending from pacemaker cells to PI neurons. Molecular profiling of relevant PI cells identified the corticotropin-releasing factor (CRF) homolog, DH44, as a circadian output molecule that is specifically expressed by PI neurons and is required for normal rest: activity rhythms. Notably, selective activation or ablation of just six DH44+ PI cells causes arrhythmicity. These findings delineate a circuit through which clock cells can modulate locomotor rhythms.	[Cavanaugh, Daniel J.; Geratowski, Jill D.; Wooltorton, Julian R. A.; Zheng, Xiangzhong; Sehgal, Amita] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Spaethling, Jennifer M.; Eberwine, James H.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Spaethling, Jennifer M.; Eberwine, James H.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Hector, Clare E.; Johnson, Erik C.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Wake Forest University; Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Wooltorton, Julian/0000-0003-0778-0196	NIH [5F32GM100555, 2R01NS048471, U24NS057631]; NARSAD Young Investigator Award; NSF [IOS 092931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS048471, U24NS057631, R01NS048471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Young Investigator Award(NARSAD); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Wen-Feng Chen for the modified pattB plasmid; Dr. Ana Lia Obaid for help with the PI cell harvesting; Dr. Jan Veenstra for the SIFa antibody; Drs. Justin Blau, Leslie Griffith, Ralph Greenspan, Michael Rosbash, Kristin Scott, Paul Taghert, Scott Waddell, and Ben White for fly stocks; and members of the Sehgal laboratory for helpful discussions. This work was supported by NIH grant 5F32GM100555 to D.J.C., 2R01NS048471 to A.S., U24NS057631 to J.R.A.W, a 2010 NARSAD Young Investigator Award to X.Z., and NSF grant IOS 092931 to E.C.J.A.S. is an Investigator of the HHMI.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Cabrero P, 2002, J EXP BIOL, V205, P3799; Chang DC, 2006, BEHAV PROCESS, V71, P211, DOI 10.1016/j.beproc.2005.12.008; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eberwine J, 2011, PHARMACOL THERAPEUT, V129, P241, DOI 10.1016/j.pharmthera.2010.09.010; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kaneko H, 2012, CURR BIOL, V22, P1851, DOI 10.1016/j.cub.2012.08.006; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; Matsui T, 2009, PHYSIOL BEHAV, V96, P548, DOI 10.1016/j.physbeh.2008.12.009; Morris J, 2011, JOVE-J VIS EXP, DOI 10.3791/2634; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shahidullah M, 2009, J NEUROSCI, V29, P13328, DOI 10.1523/JNEUROSCI.3024-09.2009; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; SOKOLOVE PG, 1975, J INSECT PHYSIOL, V21, P785, DOI 10.1016/0022-1910(75)90009-8; Son GH, 2011, FRONT NEUROENDOCRIN, V32, P451, DOI 10.1016/j.yfrne.2011.07.003; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141	49	141	141	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					689	701		10.1016/j.cell.2014.02.024	http://dx.doi.org/10.1016/j.cell.2014.02.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766812	Green Accepted, Bronze			2022-12-24	WOS:000335392100017
J	Liu, Y; Samuel, BS; Breen, PC; Ruvkun, G				Liu, Ying; Samuel, Buck S.; Breen, Peter C.; Ruvkun, Gary			Caenorhabditis elegans pathways that surveil and defend mitochondria	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; C-ELEGANS; CERAMIDE SYNTHASE; APOPTOSIS; ACTIVATION; LONGEVITY; STRESS; UPR	Mitochondrial function is challenged by toxic by-products of metabolism as well as by pathogen attack(1,2). Caenorhabditis elegans normally responds to mitochondrial dysfunction with activation of mitochondrial-repair, drug-detoxification and pathogen-response pathways(1-7). Here, from a genome-wide RNA interference (RNAi) screen, we identified 45 C. elegans genes that are required to upregulate detoxification, pathogen-response and mitochondrial-repair pathways after inhibition of mitochondrial function by drug-induced or genetic disruption. Animals defective in ceramide biosynthesis are deficient in mitochondrial surveillance, and addition of particular ceramides can rescue the surveillance defects. Ceramide can also rescue the mitochondrial surveillance defects of other gene inactivations, mapping these gene activities upstream of ceramide. Inhibition of the mevalonate pathway, either by RNAi or statin drugs, also disrupts mitochondrial surveillance. Growth of C. elegans with a significant fraction of bacterial species from their natural habitat causes mitochondrial dysfunction. Other bacterial species inhibit C. elegans defence responses to a mitochondrial toxin, revealing bacterial countermeasures to animal defence.	[Liu, Ying; Samuel, Buck S.; Breen, Peter C.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Liu, Ying; Samuel, Buck S.; Breen, Peter C.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Samuel, Buck/I-3837-2019	Samuel, Buck/0000-0002-4347-3997	Helen Hay Whitney research fellowship; Charles King Trust postdoctoral fellowship; National Institutes of Health [NIH AG043184-16]; NATIONAL INSTITUTE ON AGING [R01AG043184] Funding Source: NIH RePORTER	Helen Hay Whitney research fellowship; Charles King Trust postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Haynes (Memorial Sloan Kettering Cancer Center), F. Ausubel (Massachusetts General Hospital) and the Caenorhabditis Genetics Center for providing strains; and the V. Mootha laboratory (Massachusetts General Hospital) for providing C2C12 cells. We thank J. Larkins-Ford, C. Phillips, S. Garcia and M. Pellegrino for technical support, as well as M. A. Felix for bacterial strains and for guidance in the collection of microbial strains from C. elegans natural habitats. Y.L. is supported by the Helen Hay Whitney research fellowship; B.S.S. is supported by the Charles King Trust postdoctoral fellowship. The work is supported by a grant from the National Institutes of Health, awarded to G.R. (NIH AG043184-16).	Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hage-Sleiman R, 2013, INT J MOL SCI, V14, P4982, DOI 10.3390/ijms14034982; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Moyer MW, 2010, NAT MED, V16, P150, DOI 10.1038/nm0210-150; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Phillips CM, 2009, METHODS MOL BIOL, V558, P171, DOI 10.1007/978-1-60761-103-5_11; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Runkel ED, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003346; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Wagner BK, 2011, ACS CHEM BIOL, V6, P900, DOI 10.1021/cb200206w	24	196	198	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					406	+		10.1038/nature13204	http://dx.doi.org/10.1038/nature13204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24695221	Green Submitted, Green Accepted			2022-12-24	WOS:000334403000054
J	Oh, SW; Harris, JA; Ng, L; Winslow, B; Cain, N; Mihalas, S; Wang, QX; Lau, C; Kuan, L; Henry, AM; Mortrud, MT; Ouellette, B; Nguyen, TN; Sorensen, SA; Slaughterbeck, CR; Wakeman, W; Li, Y; Feng, D; Ho, A; Nicholas, E; Hirokawa, KE; Bohn, P; Joines, KM; Peng, HC; Hawrylycz, MJ; Phillips, JW; Hohmann, JG; Wohnoutka, P; Koch, C; Bernard, A; Dang, C; Jones, AR; Zeng, HK; Gerfen, CR				Oh, Seung Wook; Harris, Julie A.; Ng, Lydia; Winslow, Brent; Cain, Nicholas; Mihalas, Stefan; Wang, Quanxin; Lau, Chris; Kuan, Leonard; Henry, Alex M.; Mortrud, Marty T.; Ouellette, Benjamin; Nguyen, Thuc Nghi; Sorensen, Staci A.; Slaughterbeck, Clifford R.; Wakeman, Wayne; Li, Yang; Feng, David; Ho, Anh; Nicholas, Eric; Hirokawa, Karla E.; Bohn, Phillip; Joines, Kevin M.; Peng, Hanchuan; Hawrylycz, Michael J.; Phillips, John W.; Hohmann, John G.; Wohnoutka, Paul; Koch, Christof; Bernard, Amy; Dang, Chinh; Jones, Allan R.; Zeng, Hongkui; Gerfen, Charles R.			A mesoscale connectome of the mouse brain	NATURE			English	Article							MEDIAL PREFRONTAL CORTEX; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; PARAFASCICULAR THALAMIC NUCLEUS; EFFERENT PROJECTIONS; THALAMOCORTICAL PROJECTIONS; BARREL CORTEX; AFFERENT CONNECTIONS; PERIRHINAL CORTEX; LIMBIC CORTEX; CORTICOTHALAMIC PROJECTIONS	Comprehensive knowledge of the brain's wiring diagram is fundamental for understanding how the nervous system processes information at both local and global scales. However, with the singular exception of the C. elegans microscale connectome, there are no complete connectivity data sets in other species. Here we report a brain-wide, cellular-level, mesoscale connectome for the mouse. The Allen Mouse Brain Connectivity Atlas uses enhanced green fluorescent protein (EGFP)-expressing adeno-associated viral vectors to trace axonal projections from defined regions and cell types, and high-throughput serial two-photon tomography to image the EGFP-labelled axons throughout the brain. This systematic and standardized approach allows spatial registration of individual experiments into a common three dimensional (3D) reference space, resulting in a whole-brain connectivity matrix. A computational model yields insights into connectional strength distribution, symmetry and other network properties. Virtual tractography illustrates 3D topography among interconnected regions. Cortico-thalamic pathway analysis demonstrates segregation and integration of parallel pathways. The Allen Mouse Brain Connectivity Atlas is a freely available, foundational resource for structural and functional investigations into the neural circuits that support behavioural and cognitive processes in health and disease.	[Oh, Seung Wook; Harris, Julie A.; Ng, Lydia; Winslow, Brent; Cain, Nicholas; Mihalas, Stefan; Wang, Quanxin; Lau, Chris; Kuan, Leonard; Henry, Alex M.; Mortrud, Marty T.; Ouellette, Benjamin; Nguyen, Thuc Nghi; Sorensen, Staci A.; Slaughterbeck, Clifford R.; Wakeman, Wayne; Li, Yang; Feng, David; Ho, Anh; Nicholas, Eric; Hirokawa, Karla E.; Bohn, Phillip; Joines, Kevin M.; Peng, Hanchuan; Hawrylycz, Michael J.; Phillips, John W.; Hohmann, John G.; Wohnoutka, Paul; Koch, Christof; Bernard, Amy; Dang, Chinh; Jones, Allan R.; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Gerfen, Charles R.] NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA	Allen Institute for Brain Science; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.			Koch, Christof/0000-0001-6482-8067; Feng, David/0000-0002-4920-8123; Hirokawa, Karla/0000-0002-9954-5515; Nguyen, Thuc Nghi/0000-0002-6466-5883; OH, SEUNG WOOK/0000-0001-7632-6822; Winslow, Brent/0000-0001-7098-6336; Bernard, Amy/0000-0003-2540-1153	Allen Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002497] Funding Source: NIH RePORTER	Allen Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank the Allen Mouse Brain Connectivity Atlas Advisory Council members, D. Anderson, E. M. Callaway, K. Svoboda, J. L. R. Rubenstein, C. B. Saper and M. P. Stryker for their insightful advice. We thank T. Ragan for providing invaluable support and advice in the development and customization of the TissueCyte 1000 systems. We are grateful for the technical support of the many staff members in the Allen Institute who are not part of the authorship of this paper. This work was funded by the Allen Institute for Brain Science. The authors wish to thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement and support.	Alloway KD, 2008, J COMP NEUROL, V510, P100, DOI 10.1002/cne.21782; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Azuma Michio, 1996, Acta Anatomica Nipponica, V71, P523; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barbas H, 1997, CEREB CORTEX, V7, P635, DOI 10.1093/cercor/7.7.635; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; BECKSTEAD RM, 1979, J COMP NEUROL, V184, P43, DOI 10.1002/cne.901840104; BENZINGER H, 1983, EXP BRAIN RES, V50, P1; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bokor H, 2008, J NEUROSCI, V28, P5169, DOI 10.1523/JNEUROSCI.0490-08.2008; Bollobas B., 2001, RANDOM GRAPHS; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Conte WL, 2008, BRAIN RES, V1240, P87, DOI 10.1016/j.brainres.2008.09.013; CORNWALL J, 1988, BRAIN RES BULL, V20, P139, DOI 10.1016/0361-9230(88)90171-2; Dang C, 2007, LECT N BIOINFORMAT, V4544, P17; DEACON TW, 1983, J COMP NEUROL, V220, P168, DOI 10.1002/cne.902200205; Desbois C, 2001, NEUROSCIENCE, V102, P885, DOI 10.1016/S0306-4522(00)00537-6; DONALDSON L, 1975, EXP NEUROL, V47, P448, DOI 10.1016/0014-4886(75)90077-1; Dong H.W., 2008, ALLEN REFERENCE ATLA; Ercsey-Ravasz M, 2013, NEURON, V80, P184, DOI 10.1016/j.neuron.2013.07.036; ERDOS P, 1960, B INT STATIST INST, V38, P343; FEGER J, 1994, NEUROSCIENCE, V60, P125, DOI 10.1016/0306-4522(94)90208-9; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Graziano A, 2008, J COMP NEUROL, V507, P1258, DOI 10.1002/cne.21592; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; GULDIN WO, 1983, J COMP NEUROL, V215, P135, DOI 10.1002/cne.902150203; Haque T, 2010, BRAIN RES, V1346, P69, DOI 10.1016/j.brainres.2010.05.034; Harris Julie A, 2012, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0120s59; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hoover WB, 2011, J COMP NEUROL, V519, P3766, DOI 10.1002/cne.22733; Hsu DT, 2007, J COMP NEUROL, V504, P89, DOI 10.1002/cne.21440; Hsu DT, 2009, J COMP NEUROL, V512, P825, DOI 10.1002/cne.21934; Huang ZJ, 2013, ANNU REV NEUROSCI, V36, P183, DOI 10.1146/annurev-neuro-062012-170307; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Jones E.G., 2012, THALAMUS; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; KAITZ SS, 1981, J COMP NEUROL, V195, P527, DOI 10.1002/cne.901950309; Kamishina H, 2009, BRAIN RES, V1264, P39, DOI 10.1016/j.brainres.2009.01.024; Kealy J, 2011, PROG NEUROBIOL, V93, P522, DOI 10.1016/j.pneurobio.2011.03.002; Killackey HP, 2003, J NEUROSCI, V23, P7381; Kolmac CI, 2000, J NEUROCYTOL, V29, P31, DOI 10.1023/A:1007160029506; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Li S, 2008, J COMP NEUROL, V506, P263, DOI 10.1002/cne.21502; Li S, 2012, BRAIN STRUCT FUNCT, V217, P257, DOI 10.1007/s00429-011-0360-7; Liao CC, 2010, J COMP NEUROL, V518, P2592, DOI 10.1002/cne.22354; Linke R, 2000, CEREB CORTEX, V10, P753, DOI 10.1093/cercor/10.8.753; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Mailly P, 2013, J NEUROSCI, V33, P5718, DOI 10.1523/JNEUROSCI.5248-12.2013; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MASON R, 1981, NEUROSCI LETT, V25, P107, DOI 10.1016/0304-3940(81)90316-5; McIntyre DC, 1996, J COMP NEUROL, V369, P302, DOI 10.1002/(SICI)1096-9861(19960527)369:2<302::AID-CNE10>3.0.CO;2-J; McKenna JT, 2004, J COMP NEUROL, V480, P115, DOI 10.1002/cne.20342; MILLER MW, 1984, J COMP NEUROL, V226, P184, DOI 10.1002/cne.902260204; Mitchell BD, 2001, BRAIN RES, V921, P68, DOI 10.1016/S0006-8993(01)03084-0; Monconduit L, 1999, J NEUROSCI, V19, P9063, DOI 10.1523/JNEUROSCI.19-20-09063.1999; Nakashima M, 2000, NEUROSCI RES, V36, P297, DOI 10.1016/S0168-0102(99)00129-7; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; REEP RL, 1994, EXP BRAIN RES, V100, P67; Reep RL, 1996, EXP BRAIN RES, V111, P215; Reep RL, 1999, BRAIN RES, V841, P43, DOI 10.1016/S0006-8993(99)01779-5; REEP RL, 1982, NEUROSCIENCE, V7, P2609, DOI 10.1016/0306-4522(82)90087-2; ROBERTSON RT, 1981, J COMP NEUROL, V195, P501, DOI 10.1002/cne.901950308; ROGER M, 1989, J COMP NEUROL, V287, P339, DOI 10.1002/cne.902870306; Samuelsen CL, 2013, J NEUROSCI, V33, P1815, DOI 10.1523/JNEUROSCI.4026-12.2013; SANDERSON KJ, 1991, EXP BRAIN RES, V85, P324; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schmitt O, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00081; SCHOBER W, 1981, Z MIKROSK ANAT FORSC, V95, P827; Seung S., 2012, CONNECTOME BRAINS WI, V359; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Shi CJ, 1997, J COMP NEUROL, V382, P153; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Shibata H, 2005, BRAIN RES, V1059, P93, DOI 10.1016/j.brainres.2005.08.025; SHIBATA H, 1993, J COMP NEUROL, V330, P533, DOI 10.1002/cne.903300409; Shibata H, 2012, J COMP NEUROL, V520, P2647, DOI 10.1002/cne.23057; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P221, DOI 10.1016/0361-9230(84)90049-2; SIMMONS PA, 1982, J COMP NEUROL, V211, P295, DOI 10.1002/cne.902110308; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; SPORNS O, 2011, NETWORKS BRAIN, P412; Swanson L. W., 2012, BRAIN ARCHITECTURE U, V331; TAKAGISHI M, 1991, BRAIN RES, V566, P26, DOI 10.1016/0006-8993(91)91677-S; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; van Groen T, 1999, BRAIN RES REV, V30, P1, DOI 10.1016/S0165-0173(99)00006-5; VANGROEN T, 1990, J COMP NEUROL, V300, P593, DOI 10.1002/cne.903000412; VANGROEN T, 1995, J COMP NEUROL, V358, P584, DOI 10.1002/cne.903580411; VAUDANO E, 1991, EUR J NEUROSCI, V3, P317, DOI 10.1111/j.1460-9568.1991.tb00818.x; Vertes RP, 2012, NEUROSCIENCE, V219, P120, DOI 10.1016/j.neuroscience.2012.04.067; Vertes RP, 2006, J COMP NEUROL, V499, P768, DOI 10.1002/cne.21135; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang Q., 2014, J COMP NEUROL; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Wright NF, 2013, J COMP NEUROL, V521, P2966, DOI 10.1002/cne.23325; YASUI Y, 1987, J COMP NEUROL, V257, P253, DOI 10.1002/cne.902570210; Zhang ZW, 1998, CEREB CORTEX, V8, P428, DOI 10.1093/cercor/8.5.428	127	1284	1299	9	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					207	+		10.1038/nature13186	http://dx.doi.org/10.1038/nature13186			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695228	Green Accepted			2022-12-24	WOS:000333979900037
J	Burgoine, T; Forouhi, NG; Griffin, SJ; Wareham, NJ; Monsivais, P				Burgoine, Thomas; Forouhi, Nita G.; Griffin, Simon J.; Wareham, Nicholas J.; Monsivais, Pablo			Associations between exposure to takeaway food outlets, takeaway food consumption, and body weight in Cambridgeshire, UK: population based, cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENERGY-INTAKE; MASS INDEX; HEART-RATE; ENVIRONMENT; ADULTS; NEIGHBORHOOD; DIETARY; RESTAURANTS; ESTABLISHMENTS; OBESITY	Objectives To examine the association between environmental exposure to takeaway food outlets, takeaway food consumption, and body weight, while accounting for home, work place, and commuting route environments. Design Population based, cross sectional study, using data on individual participants' diet and weight, and objective metrics of food environment exposure. Participants Working adults participating in the Fenland Study, Cambridgeshire, UK (n=5442, aged 29-62 years), who provided home and work addresses and commuting preferences. Takeaway food outlet exposure was derived using data from local authorities for individual environmental domains (at home, at work, and along commuting routes (the shortest route between home and work)), and for exposure in all three domains combined. Exposure was divided into quarters (Q); Q1 being the least exposed and Q4 being the most exposed. Main outcome measures Self reported consumption of takeaway type food (g/day; pizza, burgers, fried foods, and chips) using food frequency questionnaires, measured body mass index, and cut-offs for body mass index as defined by the World Health Organization. Results In multiple linear regression models, exposure to takeaway food outlets was positively associated with consumption of takeaway food. Among domains at home, at work, and along commuting routes, associations were strongest in work environments (Q4 v Q1; beta coefficient=5.3 g/day, 95% confidence interval 1.6 to 8.7; P<0.05), with evidence of a dose-response effect. Associations between exposure in all three domains combined and consumption were greater in magnitude across quarters of exposure (Q4 v Q1; 5.7 g/day, 2.6 to 8.8; P<0.001), with evidence of a dose-response effect. Combined exposure was especially strongly associated with increased body mass index (Q4 v Q1; body mass index 1.21, 0.68 to 1.74; P<0.001) and odds of obesity (Q4 v Q1; odds ratio 1.80, 1.28 to 2.53; P<0.05). There was no evidence of effect modification by sex. Conclusions Exposure to takeaway food outlets in home, work, and commuting environments combined was associated with marginally higher consumption of takeaway food, greater body mass index, and greater odds of obesity. Government strategies to promote healthier diets through planning restrictions for takeaway food could be most effective if focused around the workplace.	[Burgoine, Thomas; Forouhi, Nita G.; Griffin, Simon J.; Wareham, Nicholas J.; Monsivais, Pablo] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC,UKCRC Ctr Diet & Act Res,Epidemiol Unit, Cambridge CB2 0QQ, England; [Griffin, Simon J.; Monsivais, Pablo] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	University of Cambridge; University of Cambridge	Burgoine, T (corresponding author), Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC,UKCRC Ctr Diet & Act Res,Epidemiol Unit, Box 285,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	tb464@medschl.cam.ac.uk	Griffin, Simon/K-3106-2013	Griffin, Simon/0000-0002-2157-4797; Monsivais, Pablo/0000-0002-7088-6674; Forouhi, Nita/0000-0002-5041-248X	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under the UK Clinical Research Collaboration; Core MRC Epidemiology Unit [MC_UU_12015/1, MC_UU_12015/5]; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474, MC_UP_A100_1003, MC_UU_12015/1, MR/K023187/1, MC_UU_12015/4, MC_UU_12015/5] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/1, MC_U106179474, MC_U106179471, MC_UU_12015/4, MC_UU_12015/5, MC_UP_A100_1003, MR/K023187/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under the UK Clinical Research Collaboration(Wellcome Trust); Core MRC Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was undertaken by the Centre for Diet and Activity Research, a UK Clinical Research Collaboration Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, National Institute for Health Research, and Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. Core MRC Epidemiology Unit support through programmes MC_UU_12015/1 and MC_UU_12015/5 is acknowledged. All authors remain independent from funders.	[Anonymous], 2012, NAT STAT FAM FOOD 20; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Black JL, 2010, HEALTH PLACE, V16, P489, DOI 10.1016/j.healthplace.2009.12.007; Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244; Bonsall P, 2007, REV POTENTIAL ROLE N; Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Burgoine T, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-85; Burgoine T, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-2; Burgoine T, 2009, APPETITE, V53, P157, DOI 10.1016/j.appet.2009.05.012; Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; Cavill N, 2013, HLTH PEOPLE HLTH PLA; Chaix B, 2012, AM J PREV MED, V43, P440, DOI 10.1016/j.amepre.2012.06.026; Charreire H, 2010, PUBLIC HEALTH NUTR, V13, P1773, DOI 10.1017/S1368980010000753; Condon SK, 2013, BMJ-BRIT MED J, V346, pf2907; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; Duffey KJ, 2009, J NUTR, V139, P2113, DOI 10.3945/jn.109.109520; Dumanovsky T., 2011, BRIT MED J, V26, P343; Duncan MJ, 2007, AM J PREV MED, V33, P51, DOI 10.1016/j.amepre.2007.02.042; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Fraser LK, 2010, INT J ENV RES PUB HE, V7, P2290, DOI 10.3390/ijerph7052290; Giskes K, 2007, PUBLIC HEALTH NUTR, V10, P1005, DOI 10.1017/S1368980007665525; Harrison F, 2011, SOC SCI MED, V72, P1411, DOI 10.1016/j.socscimed.2011.02.023; Inagami S, 2007, SOC SCI MED, V65, P1779, DOI 10.1016/j.socscimed.2007.05.051; Jeffery RW, 2006, INT J BEHAV NUTR PHY, V3, P1; Kestens Y, 2010, HEALTH PLACE, V16, P1094, DOI 10.1016/j.healthplace.2010.06.016; Kirkpatrick SI, 2014, AM J PREV MED, V46, P94, DOI 10.1016/j.amepre.2013.08.015; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Lake AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-37; Lake AA, 2010, HEALTH PLACE, V16, P666, DOI 10.1016/j.healthplace.2010.02.004; Larsen K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-16; Let's move campaign, 2010, AM MOV RAIS HLTH GEN; London Borough of Barking and Dagenham, 2010, SAT POINT A IN PRESS; Lovasi GS, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-10; Matthews SA, 2009, AM J PREV MED, V36, pS171, DOI 10.1016/j.amepre.2009.01.011; McPherson K, 2007, TACKLING OBESITIES F; Mitchell C, 2011, OBES REV, V12, P660, DOI 10.1111/j.1467-789X.2011.00872.x; Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090; Moudon Anne Vernez, 2006, J Phys Act Health, V3, pS99, DOI 10.1123/jpah.3.s1.s99; Panter J, 2007, TACKLING OBESITIES F; Panter JR, 2010, AM J PREV MED, V38, P268, DOI 10.1016/j.amepre.2009.10.040; Patterson R, 2013, BMJ OPEN, V2, P1; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Powell LM, 2012, AM J PREV MED, V43, P498, DOI 10.1016/j.amepre.2012.07.041; Rolfe ED, 2010, AM J CLIN NUTR, V92, P347, DOI 10.3945/ajcn.2010.29247; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Seliske L, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-19; Smith D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-70; Smith G, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-34; Smith KJ, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-29; Stark JH, 2013, J EPIDEMIOL COMMUN H, V67, P736, DOI 10.1136/jech-2013-202354; Swinburn B, 2002, Obes Rev, V3, P289; The London Food Board Chartered Institute of Environmental Health, 2012, TAK TOOLK TOOLS INT; The strategy Unit Cabinet Office, 2008, FOOD AN ISS; Timperio A, 2006, AM J PREV MED, V30, P45, DOI 10.1016/j.amepre.2005.08.047; Townshend T, 2009, HEALTH PLACE, V15, P909, DOI 10.1016/j.healthplace.2008.12.002; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Waltham Forest SPD, 2009, WALTH FOR SPD HOT FO; White E, 2008, PRINCIPLES EXPOSURE; White M., 2004, N09010 DO FOOD DESER; Willett WC, 2007, CANCER EPIDEM BIOMAR, V16, P182, DOI 10.1158/1055-9965.EPI-06-0843; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	66	155	158	3	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2014	348								g1464	10.1136/bmj.g1464	http://dx.doi.org/10.1136/bmj.g1464			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZS	24625460	Green Published, hybrid			2022-12-24	WOS:000333032800001
J	Luksza, M; Lassig, M				Luksza, Marta; Laessig, Michael			A predictive fitness model for influenza	NATURE			English	Article							A VIRUS; EVOLUTIONARY DYNAMICS; LINKED GLYCOSYLATION; BENEFICIAL MUTATIONS; CLONAL INTERFERENCE; SEASONAL INFLUENZA; POSITIVE SELECTION; ASEXUAL EVOLUTION; RECEPTOR-BINDING; ANTIGENIC SITES	The seasonal human influenza A/H3N2 virus undergoes rapid evolution, which produces significant year-to-year sequence turnover in the population of circulating strains. Adaptive mutations respond to human immune challenge and occur primarily in antigenic epitopes, the antibody-binding domains of the viral surface protein haemagglutinin. Here we develop a fitness model for haemagglutinin that predicts the evolution of the viral population from one year to the next. Two factors are shown to determine the fitness of a strain: adaptive epitope changes and deleterious mutations outside the epitopes. We infer both fitness components for the strains circulating in a given year, using population-genetic data of all previous strains. From fitness and frequency of each strain, we predict the frequency of its descendent strains in the following year. This fitness model maps the adaptive history of influenza A and suggests a principled method for vaccine selection. Our results call for a more comprehensive epidemiology of influenza and other fast-evolving pathogens that integrates antigenic phenotypes with other viral functions coupled by genetic linkage.	[Luksza, Marta; Laessig, Michael] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany; [Luksza, Marta] Columbia Univ, Fairchild Ctr 607D, New York, NY 10027 USA	University of Cologne; Columbia University	Lassig, M (corresponding author), Univ Cologne, Inst Theoret Phys, Zulpicher Str 77, D-50937 Cologne, Germany.	lassig@thp.uni-koeln.de			Deutsche Forschungsgemeinschaft [SFB 680]; German Federal Ministry of Education and Research [0315893-Sybacol]; National Science Foundation [PHY05-51164]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF))	We acknowledge discussions with B. D. Greenbaum, B. Grenfell, C. Illingworth, A. Levine, J. W. McCauley, V. Mustonen, S. Pompei and R. Rabadan. This work has been partially supported by Deutsche Forschungsgemeinschaft grant SFB 680 and by German Federal Ministry of Education and Research grant 0315893-Sybacol. Part of this work was performed at the Kavli Institute of Theoretical Physics (Santa Barbara), which has been supported by National Science Foundation grant PHY05-51164.	Ampofo W. K., 2010, INFLUENZA OTHER RESP, V6, P147; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cui JK, 2009, P NATL ACAD SCI USA, V106, P13421, DOI 10.1073/pnas.0905818106; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Illingworth CJR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003091; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Meyer AG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0334; Minayev P, 2009, J R SOC INTERFACE, V6, P509, DOI 10.1098/rsif.2008.0333; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mustonen V, 2007, P NATL ACAD SCI USA, V104, P2277, DOI 10.1073/pnas.0607105104; Mustonen V, 2010, P NATL ACAD SCI USA, V107, P4248, DOI 10.1073/pnas.0907953107; Mustonen V, 2009, TRENDS GENET, V25, P111, DOI 10.1016/j.tig.2009.01.002; Myers JL, 2013, J VIROL, V87, P11168, DOI 10.1128/JVI.01414-13; Neher RA, 2013, P NATL ACAD SCI USA, V110, P437, DOI 10.1073/pnas.1213113110; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rasmussen DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002136; Rouzine IM, 2008, THEOR POPUL BIOL, V73, P24, DOI 10.1016/j.tpb.2007.10.004; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schiffels S, 2011, GENETICS, V189, P1361, DOI 10.1534/genetics.111.132027; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Strelkowa N, 2012, GENETICS, V192, P671, DOI 10.1534/genetics.112.143396; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Tsimring LS, 1996, PHYS REV LETT, V76, P4440, DOI 10.1103/PhysRevLett.76.4440; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	58	232	237	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					57	+		10.1038/nature13087	http://dx.doi.org/10.1038/nature13087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572367				2022-12-24	WOS:000332224400041
J	Gibson, EM; Purger, D; Mount, CW; Goldstein, AK; Lin, GL; Wood, LS; Inema, I; Miller, SE; Bieri, G; Zuchero, JB; Barres, BA; Woo, PJ; Vogel, H; Monje, M				Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Bieri, Gregor; Zuchero, J. Bradley; Barres, Ben A.; Woo, Pamelyn J.; Vogel, Hannes; Monje, Michelle			Neuronal Activity Promotes Oligodendrogenesis and Adaptive Myelination in the Mammalian Brain	SCIENCE			English	Article							WHITE-MATTER; ADULT BRAIN; ELECTRICAL-ACTIVITY; PROGENITOR CELLS; PRECURSOR CELLS; TRANSGENIC MICE; MICROGLIA; PROTEIN; DIFFERENTIATION; NEUROGENESIS	Myelination of the central nervous system requires the generation of functionally mature oligodendrocytes from oligodendrocyte precursor cells (OPCs). Electrically active neurons may influence OPC function and selectively instruct myelination of an active neural circuit. In this work, we use optogenetic stimulation of the premotor cortex in awake, behaving mice to demonstrate that neuronal activity elicits a mitogenic response of neural progenitor cells and OPCs, promotes oligodendrogenesis, and increases myelination within the deep layers of the premotor cortex and subcortical white matter. We further show that this neuronal activity-regulated oligodendrogenesis and myelination is associated with improved motor function of the corresponding limb. Oligodendrogenesis and myelination appear necessary for the observed functional improvement, as epigenetic blockade of oligodendrocyte differentiation and myelin changes prevents the activity-regulated behavioral improvement.	[Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Dept Neurol, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Dept Neurosurg, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gibson, Erin M.; Purger, David; Mount, Christopher W.; Goldstein, Andrea K.; Lin, Grant L.; Wood, Lauren S.; Inema, Ingrid; Miller, Sarah E.; Woo, Pamelyn J.; Monje, Michelle] Stanford Univ, Dept Pediat, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Purger, David] Stanford Univ, Sch Med, Grad Program Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Mount, Christopher W.; Lin, Grant L.; Bieri, Gregor] Stanford Univ, Sch Med, Grad Program Neurosci, Stanford, CA 94305 USA; [Zuchero, J. Bradley; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Zuchero, J. Bradley; Barres, Ben A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Monje, M (corresponding author), Stanford Univ, Dept Neurol, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mmonje@stanford.edu		Miller, Sarah/0000-0002-5558-1813; Lin, Grant/0000-0001-6888-2140; Zuchero, J. Bradley/0000-0002-4706-2538; Monje, Michelle/0000-0002-3547-237X; Mount, Christopher/0000-0003-1635-2492; Gibson, Erin/0000-0001-9749-3814; Vogel, Otto Hannes/0000-0002-0960-3508	National Institute of Neurological Disorders and Stroke [NINDS K08NS070926, R01 EY10257]; California Institute for Regenerative Medicine [CIRM RB4-06093, RN3-06510]; Alex's Lemonade Stand Foundation; McKenna Claire Foundation; Cure Starts Now; Lyla Nsouli Foundation; Dylan Jewett Fund; Connor Johnson Fund; Zoey Ganesh Fund; Dylan Frick Fund; Abigail Jensen Fund; Wayland Villars Fund; Jennifer Kranz Memorial Fund; Ludwig Foundation; Price Family Charitable Fund; Stanford Medical Scientist Training Program; Stanford Institute for Neuro-Innovation and Translational Neurosciences; Child Health Research Institute; Lucile Packard Foundation for Children's Health, Stanford University Clinical & Translation Science Award [UL1 RR025744]; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; Bezos Family Foundation; Child Health Research Institute at Stanford University, Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NIH [1S10RR02678001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alex's Lemonade Stand Foundation; McKenna Claire Foundation; Cure Starts Now; Lyla Nsouli Foundation; Dylan Jewett Fund; Connor Johnson Fund; Zoey Ganesh Fund; Dylan Frick Fund; Abigail Jensen Fund; Wayland Villars Fund; Jennifer Kranz Memorial Fund; Ludwig Foundation; Price Family Charitable Fund; Stanford Medical Scientist Training Program; Stanford Institute for Neuro-Innovation and Translational Neurosciences; Child Health Research Institute; Lucile Packard Foundation for Children's Health, Stanford University Clinical & Translation Science Award; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); Bezos Family Foundation; Child Health Research Institute at Stanford University, Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge support from the National Institute of Neurological Disorders and Stroke (NINDS K08NS070926 to M. M.; R01 EY10257 to B. A. B.); California Institute for Regenerative Medicine (CIRM RB4-06093 and RN3-06510 to M. M.); Alex's Lemonade Stand Foundation (M. M.); McKenna Claire Foundation (M. M.); The Cure Starts Now (M. M.); Lyla Nsouli Foundation (M. M.); the Dylan Jewett, Connor Johnson, Zoey Ganesh, Dylan Frick, Abigail Jensen, Wayland Villars, and Jennifer Kranz Memorial Funds (M. M.); Ludwig Foundation (M. M.); Price Family Charitable Fund (M. M.); Stanford Medical Scientist Training Program (D. P., C. W. M., G. L. L.); Stanford Institute for Neuro-Innovation and Translational Neurosciences (M. M.); the Child Health Research Institute (M. M. and E. M. G.); Lucile Packard Foundation for Children's Health, Stanford University Clinical & Translation Science Award (UL1 RR025744 to E. M. G.); Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation (J.B.Z.); the Bezos Family Foundation (I. I.); and the Child Health Research Institute at Stanford University, Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases (M. M.). We give special thanks to J. Perrino of the Electron Microscopy Core of the Stanford University Cell Sciences Imaging Facility for technical support with transmission electron microscopy NIH Shared Instrumentation Grant 1S10RR02678001; to S. Chen for the illustration accompanying the print summary of this work; and to J. Lennon, K. Lechtenberg, H. Venkatesh, and M. E. Freret for critical reading of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; De Biase LM, 2011, J NEUROSCI, V31, P12650, DOI 10.1523/JNEUROSCI.2455-11.2011; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Franklin B. J., 2008, THE MOUSE BRAIN; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Goldsberry G, 2011, EPILEPSY BEHAV, V22, P391, DOI 10.1016/j.yebeh.2011.06.025; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Gremel CM, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00110; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hill RA, 2013, J NEUROSCI, V33, P14558, DOI 10.1523/JNEUROSCI.2001-12.2013; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kingham PJ, 1999, J NEUROCHEM, V73, P538, DOI 10.1046/j.1471-4159.1999.0730538.x; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Mangin JM, 2008, J NEUROSCI, V28, P7610, DOI 10.1523/JNEUROSCI.1355-08.2008; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morris MJ, 2013, J NEUROSCI, V33, P6401, DOI 10.1523/JNEUROSCI.1001-12.2013; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Stevens B, 1998, J NEUROSCI, V18, P9303; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wu MZ, 2012, J NEUROSCI, V32, P6651, DOI 10.1523/JNEUROSCI.4876-11.2012; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854; Zuccaro E, 2013, NAT CELL BIOL, V15, P572, DOI 10.1038/ncb2750	57	764	775	6	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2014	344	6183					487	+	1252304	10.1126/science.1252304	http://dx.doi.org/10.1126/science.1252304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1EK	24727982	Green Accepted			2022-12-24	WOS:000335157700034
J	Dornelas, M; Gotelli, NJ; McGill, B; Shimadzu, H; Moyes, F; Sievers, C; Magurran, AE				Dornelas, Maria; Gotelli, Nicholas J.; McGill, Brian; Shimadzu, Hideyasu; Moyes, Faye; Sievers, Caya; Magurran, Anne E.			Assemblage Time Series Reveal Biodiversity Change but Not Systematic Loss	SCIENCE			English	Article							PLANET; SCALE; ECOSYSTEMS; DIVERSITY	The extent to which biodiversity change in local assemblages contributes to global biodiversity loss is poorly understood. We analyzed 100 time series from biomes across Earth to ask how diversity within assemblages is changing through time. We quantified patterns of temporal alpha diversity, measured as change in local diversity, and temporal beta diversity, measured as change in community composition. Contrary to our expectations, we did not detect systematic loss of alpha diversity. However, community composition changed systematically through time, in excess of predictions from null models. Heterogeneous rates of environmental change, species range shifts associated with climate change, and biotic homogenization may explain the different patterns of temporal alpha and beta diversity. Monitoring and understanding change in species composition should be a conservation priority.	[Dornelas, Maria; Shimadzu, Hideyasu; Moyes, Faye; Sievers, Caya; Magurran, Anne E.] Univ St Andrews, Ctr Biol Divers, St Andrews KY16 9TH, Fife, Scotland; [Dornelas, Maria; Shimadzu, Hideyasu; Moyes, Faye; Sievers, Caya; Magurran, Anne E.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 9TH, Fife, Scotland; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [McGill, Brian] Univ Maine, Sch Biol & Ecol, Sustainabil Solut Initiat, Orono, ME 04469 USA; [Shimadzu, Hideyasu] Keio Univ, Dept Math, Yokohama, Kanagawa 2238522, Japan	University of St Andrews; University of St Andrews; University of Vermont; University of Maine System; University of Maine Orono; Keio University	Dornelas, M (corresponding author), Univ St Andrews, Ctr Biol Divers, St Andrews KY16 9TH, Fife, Scotland.	maadd@st-andrews.ac.uk	Dornelas, Marcelo C/A-6104-2013; Moyes, Faye/AAE-8480-2019; Dornelas, Maria/E-3595-2010; Shimadzu, Hideyasu/E-5649-2010; McGill, Brian J/A-3476-2008	Dornelas, Marcelo C/0000-0002-6710-3050; Moyes, Faye/0000-0001-9687-0593; Dornelas, Maria/0000-0003-2077-7055; Shimadzu, Hideyasu/0000-0003-0919-8829; McGill, Brian J/0000-0002-0850-1913; Magurran, Anne/0000-0002-0036-2795	European Research Council [BioTIME 250189]; Scottish Funding Council (MASTS) [HR09011]; Royal Society; Belspo (Belgian Science Policy); NSF; NOAA Marine Fisheries Service [NA11NMF4540174]; Fisheries and Oceans Canada; Government of Nunavut; Nunavut Wildlife Management Board; Nunavut Tunngavik Inc.; Nunavut Emerging Fisheries Fund; Makivik Corporation; Smithsonian Institution; Atherton Seidell Grant Program; NSF [BSR-8811902, DEB 9411973, DEB 0080538, DEB 0218039, DEB 0620910, DEB 0963447]; Luquillo Long-Term Ecological Research Program; University of Puerto Rico; NSF's Long-Term Ecological Research program and Fishery Administration Agency; Council of Agriculture, Taiwan; Azores Fisheries Observer Program; Center of the Institute of Marine Research (IMAR) of the University of the Azores; NSF's Long-Term Ecological Research Program [DEB 08-23380]; U.S. Forest Service Pacific Northwest Research Station, and Oregon State University; Directorate For Geosciences [1236905] Funding Source: National Science Foundation	European Research Council(European Research Council (ERC)European Commission); Scottish Funding Council (MASTS); Royal Society(Royal Society of London); Belspo (Belgian Science Policy)(Belgian Federal Science Policy Office); NSF(National Science Foundation (NSF)); NOAA Marine Fisheries Service; Fisheries and Oceans Canada; Government of Nunavut; Nunavut Wildlife Management Board; Nunavut Tunngavik Inc.; Nunavut Emerging Fisheries Fund; Makivik Corporation; Smithsonian Institution(Smithsonian Institution); Atherton Seidell Grant Program; NSF(National Science Foundation (NSF)); Luquillo Long-Term Ecological Research Program; University of Puerto Rico; NSF's Long-Term Ecological Research program and Fishery Administration Agency; Council of Agriculture, Taiwan; Azores Fisheries Observer Program; Center of the Institute of Marine Research (IMAR) of the University of the Azores; NSF's Long-Term Ecological Research Program; U.S. Forest Service Pacific Northwest Research Station, and Oregon State University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by the European Research Council (BioTIME 250189), the Scottish Funding Council (MASTS, grant reference HR09011) (M. D.), and the Royal Society (A. E. M.). We are grateful to all the data providers for making data publicly available and to their funders: Belspo (Belgian Science Policy); NSF; NOAA Marine Fisheries Service (grant NA11NMF4540174); Fisheries and Oceans Canada; Government of Nunavut, Nunavut Wildlife Management Board, Nunavut Tunngavik Inc., and Nunavut Emerging Fisheries Fund; Makivik Corporation; Smithsonian Institution; Atherton Seidell Grant Program; grants BSR-8811902, DEB 9411973, DEB 0080538, DEB 0218039, DEB 0620910, and DEB 0963447 from NSF to the Institute for Tropical Ecosystem Studies, University of Puerto Rico, and to the International Institute of Tropical Forestry, U. S. Forest Service, as part of the Luquillo Long-Term Ecological Research Program; University of Puerto Rico; NSF's Long-Term Ecological Research program and Fishery Administration Agency; Council of Agriculture, Taiwan; Azores Fisheries Observer Program; and the Center of the Institute of Marine Research (IMAR) of the University of the Azores. In addition, data were provided by the H. J. Andrews Experimental Forest research program, funded by NSF's Long-Term Ecological Research Program (DEB 08-23380), P. Henderson (Pisces Conservation), U.S. Forest Service Pacific Northwest Research Station, and Oregon State University. Cruise data were collected through the logistical efforts of the Australian Antarctic Division and approved by the Australian Antarctic Research Advisory Committee (projects 2208 and 2953), the Australian Antarctic Data Centre of the Australian Antarctic Division, Tasmania. We are also grateful to the databases that compile these data: OBIS, Ecological Data Wiki, DATRAS, and LTER. Finally, we thank O. Mendivil-Ramos for advice on database design, L. Antao, and M. Barbosa and three anonymous referees for comments on earlier versions of the manuscript. The rarefied time series used in our analysis are included as Databases S1 and S2.	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Elton C S., 1958, THE ECOLOGY OF INVAS; Erasmus BFN, 1999, P ROY SOC B-BIOL SCI, V266, P315, DOI 10.1098/rspb.1999.0640; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Millennium Ecosystem Assessment, 2006, ECOSYSTEMS AND HUMAN; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Vellend M, 2013, P NATL ACAD SCI USA, V110, P19456, DOI 10.1073/pnas.1312779110; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563	21	728	740	28	649	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					296	299		10.1126/science.1248484	http://dx.doi.org/10.1126/science.1248484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744374	Green Accepted, Green Published			2022-12-24	WOS:000334474500035
J	Suzuki, H; Nishizawa, T; Tani, K; Yamazaki, Y; Tamura, A; Ishitani, R; Dohmae, N; Tsukita, S; Nureki, O; Fujiyoshi, Y				Suzuki, Hiroshi; Nishizawa, Tomohiro; Tani, Kazutoshi; Yamazaki, Yuji; Tamura, Atsushi; Ishitani, Ryuichiro; Dohmae, Naoshi; Tsukita, Sachiko; Nureki, Osamu; Fujiyoshi, Yoshinori			Crystal Structure of a Claudin Provides Insight into the Architecture of Tight Junctions	SCIENCE			English	Article							MEMBRANE-PROTEINS; MUTATIONS; TRANSPORT; CHANNELS; OCCLUDIN; STRANDS	Tight junctions are cell-cell adhesion structures in epithelial cell sheets that surround organ compartments in multicellular organisms and regulate the permeation of ions through the intercellular space. Claudins are the major constituents of tight junctions and form strands that mediate cell adhesion and function as paracellular barriers. We report the structure of mammalian claudin-15 at a resolution of 2.4 angstroms. The structure reveals a characteristic beta-sheet fold comprising two extracellular segments, which is anchored to a transmembrane four-helix bundle by a consensus motif. Our analyses suggest potential paracellular pathways with distinctive charges on the extracellular surface, providing insight into the molecular basis of ion homeostasis across tight junctions.	[Suzuki, Hiroshi; Tani, Kazutoshi; Fujiyoshi, Yoshinori] Nagoya Univ, Cellular & Struct Physiol Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nishizawa, Tomohiro; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Nishizawa, Tomohiro; Ishitani, Ryuichiro; Dohmae, Naoshi; Nureki, Osamu] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan; [Yamazaki, Yuji; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Lab Biol Sci, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yamazaki, Yuji; Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fujiyoshi, Yoshinori] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; University of Tokyo; RIKEN; Osaka University; Osaka University; Nagoya University	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan.	nureki@bs.s.u-tokyo.ac.jp; yoshi@cespi.nagoya-u.ac.jp	Suzuki, Hiroshi/D-5428-2013; Fujiyoshi, Yoshinori/E-5989-2012; Dohmae, Naoshi/C-2040-2011; Tani, Kazutoshi/B-3705-2008; NUREKI, OSAMU/G-4960-2014	Suzuki, Hiroshi/0000-0001-5371-6385; Fujiyoshi, Yoshinori/0000-0002-8070-1493; Dohmae, Naoshi/0000-0002-5242-9410; Tani, Kazutoshi/0000-0003-4835-154X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22227004, 24227004]; Japan New Energy and Industrial Technology Development Organization (NEDO); National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [26440024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Uji for technical support, T. Suzuki for mass spectrometry, T. Imasaki and Y. Takagi for sharing their unpublished protocol for SeMet incorporation and their technical advice, the beamline staff members at BL32XU of SPring-8 (Hyogo, Japan) for technical help during data collection, and T. Walz for critical reading of the manuscript. Supported by Grants-in-Aid for Scientific Research (S) (22227004, Y. F.; 24227004, O.N.) and (A) (S. T.), Grants-in-Aid for Scientific Research on Innovative Areas (S. T.), Grants-in-Aid for Young Scientists (B) (K. T.), and Platform for Drug Discovery, Information, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Japan New Energy and Industrial Technology Development Organization (NEDO) and the National Institute of Biomedical Innovation (Y.F.). H. S., Y.Y., and A. T. screened claudin genes; H. S. performed protein expression, purification, and electron microscopic studies; T.N. crystallized the mCldn15 protein in lipidic cubic phase, collected and processed diffraction data, and solved and refined the structure; K. T. analyzed the structure; R. I. assisted with x-ray data collection and structure determination; N.D. performed mass spectrometric analyses; H. S., T.N., K. T., S. T., O.N., and Y.F. wrote the manuscript; and S. T., O.N., and Y.F. supervised the research. The authors declare no competing financial interests. Coordinates and structure factors have been deposited in the Protein Data Bank under accession number 4P79.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirata K, 2010, AIP CONF PROC, V1234, P901, DOI 10.1063/1.3463362; Krug SM, 2012, ANN NY ACAD SCI, V1257, P20, DOI 10.1111/j.1749-6632.2012.06555.x; Li JH, 2013, AM J PHYSIOL-CELL PH, V305, pC190, DOI 10.1152/ajpcell.00074.2013; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Tamura A, 2011, GASTROENTEROLOGY, V140, P913, DOI 10.1053/j.gastro.2010.08.006; Tang VW, 2003, BIOPHYS J, V84, P1660, DOI 10.1016/S0006-3495(03)74975-3; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wada M, 2013, GASTROENTEROLOGY, V144, P369, DOI 10.1053/j.gastro.2012.10.035; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	28	234	239	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					304	307		10.1126/science.1248571	http://dx.doi.org/10.1126/science.1248571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744376				2022-12-24	WOS:000334474500037
J	Perez-Vargas, J; Krey, T; Valansi, C; Avinoam, O; Haouz, A; Jamin, M; Raveh-Barak, H; Podbilewicz, B; Rey, FA				Perez-Vargas, Jimena; Krey, Thomas; Valansi, Clari; Avinoam, Ori; Haouz, Ahmed; Jamin, Marc; Raveh-Barak, Hadas; Podbilewicz, Benjamin; Rey, Felix A.			Structural Basis of Eukaryotic Cell-Cell Fusion	CELL			English	Article							VIRUS ENVELOPE PROTEIN; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; DENGUE VIRUS; C-ELEGANS; ANGSTROM RESOLUTION; ENCEPHALITIS-VIRUS; HOMOTYPIC FUSION; SNARE COMPLEX	Cell-cell fusion proteins are essential in development. Here we show that the C. elegans cell-cell fusion protein EFF-1 is structurally homologous to viral class II fusion proteins. The 2.6 angstrom crystal structure of the EFF-1 trimer displays the same 3D fold and quaternary conformation of postfusion class II viral fusion proteins, although it lacks a nonpolar "fusion loop," indicating that it does not insert into the target membrane. EFF-1 was previously shown to be required in both cells for fusion, and we show that blocking EFF-1 trimerization blocks the fusion reaction. Together, these data suggest that whereas membrane fusion driven by viral proteins entails leveraging of a nonpolar loop, EFF-1-driven fusion of cells entails trans-trimerization such that transmembrane segments anchored in the two opposing membranes are brought into contact at the tip of the EFF-1 trimer to then, analogous to SNARE-mediated vesicle fusion, zip the two membranes into one.	[Perez-Vargas, Jimena; Krey, Thomas; Rey, Felix A.] Inst Pasteur, Unite Virol Struct, F-75724 Paris 15, France; [Perez-Vargas, Jimena; Krey, Thomas; Rey, Felix A.] CNRS UMR 3569, F-75724 Paris 15, France; [Valansi, Clari; Avinoam, Ori; Raveh-Barak, Hadas; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Haouz, Ahmed] Inst Pasteur, Proteopole Plateforme Cristallogenese, CNRS UMR 3528, F-75724 Paris 15, France; [Jamin, Marc] Univ Grenoble Alpes, F-38042 Grenoble 9, France; [Jamin, Marc] CNRS, UVHCI, F-38042 Grenoble 9, France; [Jamin, Marc] Univ Grenoble Alpes, EMBL, CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Technion Israel Institute of Technology; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Podbilewicz, B (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	podbilew@technion.ac.il; rey@pasteur.fr	Podbilewicz, Benjamin/N-4825-2014; Avinoam, Ori/AAX-7382-2020; Rey, Felix/B-6497-2012	Avinoam, Ori/0000-0003-3543-168X; Jamin, Marc/0000-0002-8677-2110; Podbilewicz, Benjamin/0000-0002-0411-4182; Rey, Felix/0000-0002-9953-7988; HAOUZ, Ahmed/0000-0003-1196-1635	French "Agence Nationale pour la Recherche" [ANR-2010-BLAN-1211 01]; Institut Pasteur; CNRS; Merck-Serono; ERC [268843]; Israel Science Foundation (ISF) [1542/07, 826/08]	French "Agence Nationale pour la Recherche"(French National Research Agency (ANR)); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Merck-Serono(Merck & Company); ERC(European Research Council (ERC)European Commission); Israel Science Foundation (ISF)(Israel Science Foundation)	F.A.R. was funded by the French "Agence Nationale pour la Recherche" grant ANR-2010-BLAN-1211 01 and by Institut Pasteur, CNRS, and Merck-Serono. B. P. was funded by the ERC Advanced grant 268843 and the Israel Science Foundation (ISF grants 1542/07 and 826/08). B.P. was a Grass fellow at Radcliffe Institute for Advanced Study, Harvard University. We thank Patrick England, Bertrand Raynal, and Patrick Weber of the Pasteur Proteopole for technical help; the staff of synchrotron beamlines PX-I at the Swiss Light Source, Proxima-1 at SOLEIL, and ID23-1 at the European Synchrotron Radiation Facility for help during data collection; Clemens Vonrhein and Gerard Bricogne from Global Phasing Ltd. for methodological concepts; Tom Rapoport and his lab for discussions and for hosting B. P. at Harvard Medical School; and Jorge Verdin Ramos from Technion and the members of the Rey and Podbilewicz labs for discussions.	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Avinoam O, 2011, CURR TOP MEMBR, V68, P209, DOI 10.1016/B978-0-12-385891-7.00009-X; Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; del Campo JJ, 2005, CURR BIOL, V15, P413, DOI 10.1016/j.cub.2005.01.054; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Frame IG, 2001, GENE, V263, P219, DOI 10.1016/S0378-1119(00)00567-9; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Moss TJ, 2011, TRENDS CELL BIOL, V21, P416, DOI 10.1016/j.tcb.2011.03.009; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Sanchez-San Martin C, 2013, J VIROL, V87, P7680, DOI 10.1128/JVI.00814-13; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	38	96	98	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					407	419		10.1016/j.cell.2014.02.020	http://dx.doi.org/10.1016/j.cell.2014.02.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725407	Bronze			2022-12-24	WOS:000334304500014
J	Chen, X; Iliopoulos, D; Zhang, Q; Tang, QZ; Greenblatt, MB; Hatziapostolou, M; Lim, E; Tam, WL; Ni, M; Chen, YW; Mai, JH; Shen, HF; Hu, DZ; Adoro, S; Hu, B; Song, MY; Tan, C; Landis, MD; Ferrari, M; Shin, SJ; Brown, M; Chang, JC; Liu, XS; Glimcher, LH				Chen, Xi; Iliopoulos, Dimitrios; Zhang, Qing; Tang, Qianzi; Greenblatt, Matthew B.; Hatziapostolou, Maria; Lim, Elgene; Tam, Wai Leong; Ni, Min; Chen, Yiwen; Mai, Junhua; Shen, Haifa; Hu, Dorothy Z.; Adoro, Stanley; Hu, Bella; Song, Minkyung; Tan, Chen; Landis, Melissa D.; Ferrari, Mauro; Shin, Sandra J.; Brown, Myles; Chang, Jenny C.; Liu, X. Shirley; Glimcher, Laurie H.			XBP1 promotes triple-negative breast cancer by controlling the HIF1 alpha pathway	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; STRESS-RESPONSE; STEM-CELLS; ER STRESS; METASTASIS; PHENOTYPE; THERAPY; GROWTH	Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization(1). One such adaptive pathway is the unfolded protein(UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE1 (ref. 2) and its substrate XBP1 (ref. 3). Previous studies report UPR activation in various human tumours(4-6), but the role of XBP1 in cancer progression in mammary epithelial cells is largely unknown. Triple-negative breast cancer (TNBC)-a form of breast cancer in which tumour cells do not express the genes for oestrogen receptor, progesterone receptor and HER2 (also called ERBB2 or NEU)-is a highly aggressive malignancy with limited treatment options(7,8). Here we report that XBP1 is activated in TNBC and has a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and reduced the CD44(high)CD24(low) population. Hypoxia-inducing factor 1 alpha (HIF1 alpha) is known to be hyperactivated in TNBCs9,10. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1 alpha that regulates the expression of HIF1 alpha targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1 alpha and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.	[Chen, Xi; Adoro, Stanley; Song, Minkyung; Tan, Chen; Glimcher, Laurie H.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Chen, Xi; Adoro, Stanley; Song, Minkyung; Tan, Chen; Ferrari, Mauro; Chang, Jenny C.; Glimcher, Laurie H.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Iliopoulos, Dimitrios; Hatziapostolou, Maria] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Syst Biomed, Los Angeles, CA 90095 USA; [Iliopoulos, Dimitrios; Hatziapostolou, Maria] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Zhang, Qing] Univ N Carolina, Dept Pathol & Lab Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tang, Qianzi] Tongji Univ, Dept Bioinformat, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Tang, Qianzi] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan 625014, Sichuan, Peoples R China; [Greenblatt, Matthew B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lim, Elgene; Ni, Min; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Lim, Elgene; Ni, Min; Brown, Myles] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Tam, Wai Leong] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chen, Yiwen; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chen, Yiwen; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Mai, Junhua; Shen, Haifa; Ferrari, Mauro] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Hu, Dorothy Z.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Hu, Bella] Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; [Landis, Melissa D.; Chang, Jenny C.] Houston Methodist Canc Ctr, Houston, TX 77030 USA; [Shin, Sandra J.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	Cornell University; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; Tongji University; Sichuan Agricultural University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University	Glimcher, LH (corresponding author), Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, 1300 York Ave, New York, NY 10065 USA.	lglimche@med.cornell.edu	Lim, Elgene/AAS-7280-2020; Iliopoulos, Dimitrios/AAE-9106-2019; Tam, Wai Leong/P-1497-2019; Tang, Qianzi/AAA-8021-2019; Hatziapostolou, Maria/N-1820-2015; ZHANG, QING/AGY-7972-2022; Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021; chang, jenny/G-7614-2015	Lim, Elgene/0000-0001-8065-8838; Tam, Wai Leong/0000-0003-2365-5264; Hatziapostolou, Maria/0000-0003-2493-7028; ZHANG, QING/0000-0002-6595-8995; Brown, Myles/0000-0002-8213-1658; chang, jenny/0000-0002-0890-9302; Song, Minkyung/0000-0003-2668-7528; Chen, Xi/0000-0002-7995-6202; Mai, Junhua/0000-0001-8374-4352	National Institutes of Health [CA112663, AI32412, R01HG004069, K99CA175290]; Leukemia and Lymphoma Society; National Natural Science Foundation of China [NSFC31329003]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA112663, R00CA160351, K99CA175290, P50CA058223] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. G. Kaelin, A.-H. Lee, F. Martinon, M. N. Wein and X. Li for critical review of the manuscript. We are grateful to A. L. Richardson, H. Xu and J. Wang for advice and discussions. We thank L. A. Paskett, X. Liu, R. Kim and Y. Liu for technical support. This work was supported by the National Institutes of Health (CA112663 and AI32412 to L. H. G.; R01HG004069 to X. S. L.; K99CA175290 to Y. C.), the Leukemia and Lymphoma Society (to X. C.) and the National Natural Science Foundation of China (NSFC31329003 to X.S.L.).	BARNARD GA, 1945, NATURE, V156, P177, DOI 10.1038/156177a0; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lin Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-59; Mahoney DJ, 2011, CANCER CELL, V20, P443, DOI 10.1016/j.ccr.2011.09.005; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Spiotto MT, 2010, CANCER RES, V70, P78, DOI 10.1158/0008-5472.CAN-09-2747; Tang QZ, 2011, CANCER RES, V71, P6940, DOI 10.1158/0008-5472.CAN-11-2091; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	30	531	556	4	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					103	+		10.1038/nature13119	http://dx.doi.org/10.1038/nature13119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670641	Green Accepted, Green Submitted			2022-12-24	WOS:000333609900051
J	Yao, Z; Shafer, OT				Yao, Z.; Shafer, O. T.			The Drosophila Circadian Clock Is a Variably Coupled Network of Multiple Peptidergic Units	SCIENCE			English	Article							NEURONS; OSCILLATORS; PACEMAKERS; RHYTHMS; SIGNAL; PDF	Daily rhythms in behavior emerge from networks of neurons that express molecular clocks. Drosophila's clock neuron network consists of a diversity of cell types, yet is modeled as two hierarchically organized groups, one of which serves as a master pacemaker. Here, we establish that the fly's clock neuron network consists of multiple units of independent neuronal oscillators, each unified by its neuropeptide transmitter and mode of coupling to other units. Our work reveals that the circadian clock neuron network is not orchestrated by a small group of master pacemakers but rather consists of multiple independent oscillators, each of which drives rhythms in activity.	[Yao, Z.; Shafer, O. T.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Shafer, OT (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	oshafer@umich.edu		Yao, Zepeng/0000-0002-0186-5503	NIH (National Institute of Neurological Disorders and Stroke) [R00NS062953, R01NS077933]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077933, R00NS062953] Funding Source: NIH RePORTER	NIH (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. L. Price, P. H. Taghert, M. Rosbash, F. Rouyer, N. R. Glossop, and the Bloomington Drosophila Stock Center for fly stocks; M. Rosbash for PER antisera; D. R. Nassel for sNPF antibody; the Developmental Studies Hybridoma Bank for PDF antibody; P. H. Taghert, M. Rosbash, E. D. Herzog, S. J. Aton, and J. Y. Kuwada for helpful comments on the manuscript; and M. Rosbash for communicating results before publication. This work was supported by NIH (National Institute of Neurological Disorders and Stroke) grants R00NS062953 and R01NS077933 to O.T.S. We declare no conflicting interests.	DESOUZA NJ, 1983, MED RES REV, V3, P201, DOI 10.1002/med.2610030205; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Im SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018974; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Muskus MJ, 2007, MOL CELL BIOL, V27, P8049, DOI 10.1128/MCB.00680-07; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Vansteensel MJ, 2008, BRAIN RES REV, V58, P18, DOI 10.1016/j.brainresrev.2007.10.009; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	19	135	137	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1516	1520		10.1126/science.1251285	http://dx.doi.org/10.1126/science.1251285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24675961	Green Accepted			2022-12-24	WOS:000333471000049
J	D'Acremont, V; Kilowoko, M; Kyungu, E; Philipina, S; Sangu, W; Kahama-Maro, J; Lengeler, C; Cherpillod, P; Kaiser, L; Genton, B				D'Acremont, Valerie; Kilowoko, Mary; Kyungu, Esther; Philipina, Sister; Sangu, Willy; Kahama-Maro, Judith; Lengeler, Christian; Cherpillod, Pascal; Kaiser, Laurent; Genton, Blaise			Beyond Malaria - Causes of Fever in Outpatient Tanzanian Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAPID DIAGNOSTIC-TESTS; DAR-ES-SALAAM; PLASMODIUM-FALCIPARUM; CLINICAL PRESENTATION; CASE-MANAGEMENT; INFECTIONS; INFANTS; BACTEREMIA; PNEUMONIA; EPIDEMIOLOGY	BackgroundAs the incidence of malaria diminishes, a better understanding of nonmalarial fever is important for effective management of illness in children. In this study, we explored the spectrum of causes of fever in African children. MethodsWe recruited children younger than 10 years of age with a temperature of 38 degrees C or higher at two outpatient clinics one rural and one urban in Tanzania. Medical histories were obtained and clinical examinations conducted by means of systematic procedures. Blood and nasopharyngeal specimens were collected to perform rapid diagnostic tests, serologic tests, culture, and molecular tests for potential pathogens causing acute fever. Final diagnoses were determined with the use of algorithms and a set of prespecified criteria. ResultsAnalyses of data derived from clinical presentation and from 25,743 laboratory investigations yielded 1232 diagnoses. Of 1005 children (22.6% of whom had multiple diagnoses), 62.2% had an acute respiratory infection; 5.0% of these infections were radiologically confirmed pneumonia. A systemic bacterial, viral, or parasitic infection other than malaria or typhoid fever was found in 13.3% of children, nasopharyngeal viral infection (without respiratory symptoms or signs) in 11.9%, malaria in 10.5%, gastroenteritis in 10.3%, urinary tract infection in 5.9%, typhoid fever in 3.7%, skin or mucosal infection in 1.5%, and meningitis in 0.2%. The cause of fever was undetermined in 3.2% of the children. A total of 70.5% of the children had viral disease, 22.0% had bacterial disease, and 10.9% had parasitic disease. ConclusionsThese results provide a description of the numerous causes of fever in African children in two representative settings. Evidence of a viral process was found more commonly than evidence of a bacterial or parasitic process. (Funded by the Swiss National Science Foundation and others.) As malaria is controlled in regions of sub-Saharan Africa, the causes of febrile illness are changing. In this report on febrile children in Tanzania, a broad array of possible pathogens are identified and stratified by presenting syndrome. With malaria transmission declining in many parts of Africa,(1),(2) there is increasing awareness that most acute febrile episodes are due to other infectious diseases some of which are life-threatening that must be identified and treated appropriately.(3),(4) World Health Organization (WHO) guidelines recommend malaria testing for all patients with febrile illness in areas where malaria is endemic.(5) The advent of point-of-care rapid diagnostic tests for malaria presents health care providers with a new and daunting challenge: the need to determine the causes of febrile illness and the appropriate course of action when treating children who test negative ...	[D'Acremont, Valerie; Kahama-Maro, Judith; Lengeler, Christian; Genton, Blaise] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [D'Acremont, Valerie; Kahama-Maro, Judith; Lengeler, Christian; Genton, Blaise] Univ Basel, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Cherpillod, Pascal; Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Cherpillod, Pascal; Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Cherpillod, Pascal; Kaiser, Laurent] Univ Geneva, Fac Med, Geneva, Switzerland; [D'Acremont, Valerie; Kahama-Maro, Judith] Dar Es Salaam City Council, City Med Off Hlth, Dar Es Salaam, Tanzania; [Kilowoko, Mary; Sangu, Willy] Amana Hosp, Dar Es Salaam, Tanzania; [Genton, Blaise] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Genton, Blaise] Ifakara Hlth Inst, Ifakara, Tanzania; [Kyungu, Esther; Philipina, Sister] St Francis Hosp, Ifakara, Tanzania	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva; University of Geneva; Ifakara Health Institute; Ifakara Health Institute	D'Acremont, V (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	valerie.dacremont@unibas.ch	Boillat-Blanco, Noémie/GLT-5579-2022		Swiss National Science Foundation [3270B0-109696, IZ70Z0-124023, 32003B_127160]; Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation; Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funded by the Swiss National Science Foundation and others.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Alba S, 2013, INT J EPIDEMIOL; [Anonymous], 2005, HOSP CAR CHILDR GUID; Baiden F, 2011, TROP MED INT HEALTH, V16, P142, DOI 10.1111/j.1365-3156.2010.02692.x; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Brodzinski H, 2009, PEDIATR EMERG CARE, V25, P352, DOI 10.1097/PEC.0b013e3181a3497e; Calvo Rey C, 2005, An Pediatr (Barc), V63, P22; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; English M, 2008, PLOS MED, V5, P1665, DOI 10.1371/journal.pmed.0050241; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lubell Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017439; Madhi SA, 2006, J INFECT DIS, V193, P1236, DOI 10.1086/503053; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; Mosha JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008707; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Peltola V, 2008, J CLIN VIROL, V43, P411, DOI 10.1016/j.jcv.2008.08.014; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Senn N, 2012, CLIN INFECT DIS, V54, P644, DOI 10.1093/cid/cir901; Stalkup JR, 2002, DERMATOL CLIN, V20, P217, DOI 10.1016/S0733-8635(01)00009-2; Wang SJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-28; World Health Organization, 2005, EM TRIAG ASS TREATM	35	278	281	3	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					809	817		10.1056/NEJMoa1214482	http://dx.doi.org/10.1056/NEJMoa1214482			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571753	Bronze, Green Published			2022-12-24	WOS:000332013000006
J	Hall, LL; Carone, DM; Gomez, AV; Kolpa, HJ; Byron, M; Mehta, N; Fackelmayer, FO; Lawrence, JB				Hall, Lisa L.; Carone, Dawn M.; Gomez, Alvin V.; Kolpa, Heather J.; Byron, Meg; Mehta, Nitish; Fackelmayer, Frank O.; Lawrence, Jeanne B.			Stable C0T-1 Repeat RNA Is Abundant and Is Associated with Euchromatic Interphase Chromosomes	CELL			English	Article							HUMAN XIST GENE; X-CHROMOSOME; NONCODING RNA; MESSENGER-RNA; NUCLEAR-RNA; TRANSCRIPTION; INACTIVATION; DNA; ORGANIZATION; TRANSPORT	Recent studies recognize a vast diversity of noncoding RNAs with largely unknown functions, but few have examined interspersed repeat sequences, which constitute almost half our genome. RNA hybridization in situ using C0T-1 (highly repeated) DNA probes detects surprisingly abundant euchromatin-associated RNA comprised predominantly of repeat sequences (C0T-1 RNA), including LINE-1. C0T-1-hybridizing RNA strictly localizes to the interphase chromosome territory in cis and remains stably associated with the chromosome territory following prolonged transcriptional inhibition. The C0T-1 RNA territory resists mechanical disruption and fractionates with the nonchromatin scaffold but can be experimentally released. Loss of repeat-rich, stable nuclear RNAs from euchromatin corresponds to aberrant chromatin distribution and condensation. C0T-1 RNA has several properties similar to XIST chromosomal RNA but is excluded from chromatin condensed by XIST. These findings impact two "black boxes" of genome science: the poorly understood diversity of noncoding RNA and the unexplained abundance of repetitive elements.	[Hall, Lisa L.; Carone, Dawn M.; Gomez, Alvin V.; Kolpa, Heather J.; Byron, Meg; Mehta, Nitish; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Fackelmayer, Frank O.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Lab Epigenet & Chromosome Biol, Ioannina 45110, Greece	University of Massachusetts System; University of Massachusetts Worcester; Foundation for Research & Technology - Hellas (FORTH)	Lawrence, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.	jeanne.lawrence@umassmed.edu		Lawrence, Jeanne/0000-0001-6572-3128; Carone, Dawn/0000-0002-4362-6690	NIH [GM053234, GM107604, S10RR027897]; NIH/NCI NRSA [1F32CA154086]; NATIONAL CANCER INSTITUTE [F32CA154086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107604, R01GM053234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM053234 and GM107604 to J.B.L. D.M.C. is supported by NIH/NCI NRSA 1F32CA154086. We wish to thank John Moran for the gift of L1 ORF1 and ORF2 plasmids and Laurie Lizotte for general technical assistance. A special thanks to Jeff Nickerson for helpful discussion of EM results and to Lara Strittmatter from the UMMS Electron Microscopy core for the EM fixation and analysis. The EM Core facility is supported by NIH award S10RR027897.	Aalto AP, 2012, CURR OPIN CELL BIOL, V24, P333, DOI 10.1016/j.ceb.2012.03.006; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BYNUM JW, 1980, BIOCHIM BIOPHYS ACTA, V607, P304, DOI 10.1016/0005-2787(80)90083-0; Byron Meg, 2013, Curr Protoc Hum Genet, VChapter 4, DOI 10.1002/0471142905.hg0415s76; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; CHEN TL, 1989, CHROMOSOMA, V98, P309, DOI 10.1007/BF00292382; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; FEDOROFF N, 1977, CELL, V10, P597, DOI 10.1016/0092-8674(77)90092-7; FEY EG, 1986, J CELL SCI, P99; Gardner EJ, 2012, GENE DEV, V26, P2550, DOI 10.1101/gad.202184.112; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Hadjiargyrou M, 2013, INT J MOL SCI, V14, P13307, DOI 10.3390/ijms140713307; Hall LL, 2010, COLD SH Q B, V75, P345, DOI 10.1101/sqb.2010.75.030; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Hall LL, 2009, J CELL BIOL, V186, P491, DOI 10.1083/jcb.200811143; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; JOHNSON CV, 1991, METHOD CELL BIOL, V35, P73; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Nickerson JA, 2001, J CELL SCI, V114, P463; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; Smith KP, 2007, J CELL BIOL, V178, P951, DOI 10.1083/jcb.200706048; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; Tam R., 2002, FISH PRACTICAL APPRO, P93; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035	45	113	114	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					907	919		10.1016/j.cell.2014.01.042	http://dx.doi.org/10.1016/j.cell.2014.01.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581492	Green Accepted, Bronze			2022-12-24	WOS:000332083900010
J	Valiente, M; Obenauf, AC; Jin, X; Chen, Q; Zhang, XHF; Lee, DJ; Chaft, JE; Kris, MG; Huse, JT; Brogi, E; Massague, J				Valiente, Manuel; Obenauf, Anna C.; Jin, Xin; Chen, Qing; Zhang, Xiang H. -F.; Lee, Derek J.; Chaft, Jamie E.; Kris, Mark G.; Huse, Jason T.; Brogi, Edi; Massague, Joan			Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis	CELL			English	Article							ADHESION MOLECULE L1; PLASMINOGEN-ACTIVATOR INHIBITOR-1; BREAST-CANCER; FAS LIGAND; EXPRESSION; SYSTEM; ADENOCARCINOMA; SUPERFAMILY; PROGRESSION; INDUCTION	Brain metastasis is an ominous complication of cancer, yet most cancer cells that infiltrate the brain die of unknown causes. Here, we identify plasmin from the reactive brain stroma as a defense against metastatic invasion, and plasminogen activator (PA) inhibitory serpins in cancer cells as a shield against this defense. Plasmin suppresses brain metastasis in two ways: by converting membrane-bound astrocytic FasL into a paracrine death signal for cancer cells, and by inactivating the axon pathfinding molecule L1CAM, which metastatic cells express for spreading along brain capillaries and for metastatic outgrowth. Brain metastatic cells from lung cancer and breast cancer express high levels of anti-PA serpins, including neuroserpin and serpin B2, to prevent plasmin generation and its metastasis-suppressive effects. By protecting cancer cells from death signals and fostering vascular co-option, anti-PA serpins provide a unifying mechanism for the initiation of brain metastasis in lung and breast cancers.	[Valiente, Manuel; Obenauf, Anna C.; Jin, Xin; Chen, Qing; Zhang, Xiang H. -F.; Lee, Derek J.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Chaft, Jamie E.; Kris, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Huse, Jason T.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Metastasis Res Ctr, New York, NY 10065 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 21205 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Valiente, Manuel/J-9523-2014	Valiente, Manuel/0000-0002-0647-7542; Kris, Mark/0000-0002-7317-5341; Obenauf, Anna/0000-0002-9556-5914; Massague, Joan/0000-0001-9324-8408; Chaft, Jamie/0000-0002-5838-9982; Zhang, Xiang/0000-0002-5674-8670	NIH [P01-CA129243, U54-163167]; DOD [W81XWH-12-0074]; Alan and Sandra Gerry Metastasis Research Initiative; FWF, Austrian Science Fund [J3013]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA129243, U54CA163167, P30CA008748] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3013] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Alan and Sandra Gerry Metastasis Research Initiative; FWF, Austrian Science Fund(Austrian Science Fund (FWF)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank A. Boire, P. Bos, L. DeAngelis, E. Holland, and J. Posner for helpful input; the Brain Tumor Center for tumor samples; Marija Drobnjak for establishing the tissue microarray from lung cancer brain metastasis; T. Jacks for cell lines; and A. Thorburn for reagents. This work was supported by NIH grants P01-CA129243 and U54-163167, DOD Innovator award W81XWH-12-0074, and the Alan and Sandra Gerry Metastasis Research Initiative (J.M.). M.V. is a Hope Funds for Cancer Research postdoctoral fellow. A.C.O. is an Erwin Schrodinger Fellowship awardee (J3013, FWF, Austrian Science Fund). X.H.-F.Z. is a McNair Scholar and the recipient of a grant from the Breast Cancer Research Foundation. J.M. is an investigator of the Howard Hughes Medical Institute.	Adhami F, 2008, AM J PATHOL, V172, P1704, DOI 10.2353/ajpath.2008.070979; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Baldini E, 2009, INT J ANDROL, V32, P123, DOI 10.1111/j.1365-2605.2007.00823.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Benarroch EE, 2007, NEUROLOGY, V69, P799, DOI 10.1212/01.wnl.0000269668.08747.78; Berger DH, 2002, WORLD J SURG, V26, P767, DOI 10.1007/s00268-002-4050-8; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Doberstein K, 2011, CARCINOGENESIS, V32, P262, DOI 10.1093/carcin/bgq249; Donier E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040674; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Fang H, 2012, JNCI-J NATL CANCER I, V104, P1470, DOI 10.1093/jnci/djs377; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; FOEKENS JA, 1995, J NATL CANCER I, V87, P751, DOI 10.1093/jnci/87.10.751; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gutierrez-Fernandez A, 2009, J NEUROSCI, V29, P12393, DOI 10.1523/JNEUROSCI.3553-09.2009; Harbeck N, 1999, BREAST CANCER RES TR, V54, P147, DOI 10.1023/A:1006118828278; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Li B, 2013, ONCOGENE, V32, P2952, DOI 10.1038/onc.2012.313; Lin QT, 2010, NEOPLASIA, V12, P748, DOI 10.1593/neo.10602; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nayeem N, 1999, J CELL SCI, V112, P4739; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Polleux F, 2002, SCI STKE, V136, P19; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schroder C, 2009, ONCOL REP, V22, P1109, DOI 10.3892/or_00000543; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Takehara S, 2009, J MOL BIOL, V388, P11, DOI 10.1016/j.jmb.2009.03.007; Teesalu T, 2001, AM J PATHOL, V159, P2227, DOI 10.1016/S0002-9440(10)63073-8; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Wang X, 2013, EUR J IMMUNOL, V43, P115, DOI 10.1002/eji.201242679; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yepes M, 2000, BLOOD, V96, P569	64	476	490	5	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1002	1016		10.1016/j.cell.2014.01.040	http://dx.doi.org/10.1016/j.cell.2014.01.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581498	Bronze, Green Accepted			2022-12-24	WOS:000332083900017
J	Igarashi, KM; Lu, L; Colgin, LL; Moser, MB; Moser, EI				Igarashi, Kei M.; Lu, Li; Colgin, Laura L.; Moser, May-Britt; Moser, Edvard I.			Coordination of entorhinal-hippocampal ensemble activity during associative learning	NATURE			English	Article							GAMMA-OSCILLATIONS; SPATIAL REPRESENTATION; OLFACTORY-BULB; BEHAVING RAT; CORTEX; SYNCHRONIZATION; DISCRIMINATION; INFORMATION; MEMORY; FREQUENCY	Accumulating evidence points to cortical oscillations as a mechanism for mediating interactions among functionally specialized neurons in distributed brain circuits(1-6). A brain function that may use such interactions is declarative memory-that is, memory that can be consciously recalled, such as episodes and facts. Declarative memory is enabled by circuits in the entorhinal cortex that interface the hippocampus with the neocortex(7,8). During encoding and retrieval of declarative memories, entorhinal and hippocampal circuits are thought to interact via theta and gamma oscillations(4,6,8), which in awake rodents predominate frequency spectra in both regions(9-12). In favour of this idea, theta-gamma coupling has been observed between entorhinal cortex and hippocampus under steady-state conditions inwell-trained rats(12); however, the relationship between interregional coupling and memory formation remains poorly understood. Here we show, by multisite recording at successive stages of associative learning, that the coherence of firing patterns in directly connected entorhinal-hippocampus circuits evolves as rats learn to use an odour cue to guide navigational behaviour, and that such coherence is invariably linked to the development of ensemble representations for unique trial outcomes in each area. Entorhinal-hippocampal coupling was observed specifically in the 20-40-hertz frequency band and specifically between the distal part of hippocampal area CA1 and the lateral part of entorhinal cortex, the subfields that receive the predominant olfactory input to the hippocampal region(13). Collectively, the results identify 20-40-hertz oscillations as a mechanism for synchronizing evolving representations in dispersed neural circuits during encoding and retrieval of olfactory-spatial associative memory.	[Igarashi, Kei M.; Lu, Li; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway; [Igarashi, Kei M.; Lu, Li; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Neural Computat, N-7491 Trondheim, Norway; [Colgin, Laura L.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Texas System; University of Texas Austin	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9,MTFS,7491, N-7491 Trondheim, Norway.	kei.igarashi@ntnu.no; edvard.moser@ntnu.no	Igarashi, Kei M/AAL-7116-2020; Igarashi, Kei/V-9383-2018	Igarashi, Kei M/0000-0002-5635-169X; Igarashi, Kei/0000-0001-5477-574X; Colgin, Laura/0000-0002-4853-8913	European Research Council [232608, 268598]; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation); Mishima Kaiun Memorial Foundation; Japan Society for the Promotion of Science	European Research Council(European Research Council (ERC)European Commission); Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank A. M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng and H. Waade for technical assistance, and M. Witter and members of the Moser laboratory for discussions. This work was supported by two Advanced Investigator grants from the European Research Council ('CIRCUIT', Grant Agreement no. 232608; 'ENSEMBLE', Grant Agreement no. 268598), the Kavli Foundation, the Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory and Centre for Neural Computation), the Mishima Kaiun Memorial Foundation, and the Japan Society for the Promotion of Science.	Ahmed OJ, 2012, J NEUROSCI, V32, P7373, DOI 10.1523/JNEUROSCI.5110-11.2012; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Macmillan N. A., 1991, DETECTION THEORY USE; Martin C, 2007, J NEUROPHYSIOL, V98, P2196, DOI 10.1152/jn.00524.2007; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Naya Y, 2011, SCIENCE, V333, P773, DOI 10.1126/science.1206773; Ravel N, 2003, EUR J NEUROSCI, V17, P350, DOI 10.1046/j.1460-9568.2003.02445.x; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]	45	226	230	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					143	+		10.1038/nature13162	http://dx.doi.org/10.1038/nature13162			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24739966	Green Accepted			2022-12-24	WOS:000336768900045
J	Forrest, ARR; Kawaji, H; Rehli, M; Baillie, JK; de Hoon, MJL; Haberle, V; Lassmann, T; Kulakovskiy, IV; Lizio, M; Itoh, M; Andersson, R; Mungall, CJ; Meehan, TF; Schmeier, S; Bertin, N; Jorgensen, M; Dimont, E; Arner, E; Schmidl, C; Schaefer, U; Medvedeva, YA; Plessy, C; Vitezic, M; Severin, J; Semple, CA; Ishizu, Y; Young, RS; Francescatto, M; Alam, I; Albanese, D; Altschuler, GM; Arakawa, T; Archer, JAC; Arner, P; Babina, M; Rennie, S; Balwierz, PJ; Beckhouse, AG; Pradhan-Bhatt, S; Blake, JA; Blumenthal, A; Bodega, B; Bonetti, A; Briggs, J; Brombacher, F; Burroughs, AM; Califano, A; Cannistraci, CV; Carbajo, D; Chen, Y; Chierici, M; Ciani, Y; Clevers, HC; Dalla, E; Davis, CA; Detmar, M; Diehl, AD; Dohi, T; Drablos, F; Edge, ASB; Edinger, M; Ekwall, K; Endoh, M; Enomoto, H; Fagiolini, M; Fairbairn, L; Fang, H; Farach-Carson, MC; Faulkner, GJ; Favorov, AV; Fisher, ME; Frith, MC; Fujita, R; Fukuda, S; Furlanello, C; Furuno, M; Furusawa, J; Geijtenbeek, TB; Gibson, AP; Gingeras, T; Goldowitz, D; Gough, J; Guhl, S; Guler, R; Gustincich, S; Ha, TJ; Hamaguchi, M; Hara, M; Harbers, M; Harshbarger, J; Hasegawa, A; Hasegawa, Y; Hashimoto, T; Herlyn, M; Hitchens, KJ; Sui, SJH; Hofmann, OM; Hoof, I; Hori, F; Huminiecki, L; Iida, K; Ikawa, T; Jankovic, BR; Jia, H; Joshi, A; Jurman, G; Kaczkowski, B; Kai, C; Kaida, K; Kaiho, A; Kajiyama, K; Kanamori-Katayama, M; Kasianov, A; Kasukawa, T; Katayama, S; Kato, S; Kawaguchi, S; Kawamoto, H; Kawamura, YI; Kawashima, T; Kempfle, JS; Kenna, TJ; Kere, J; Khachigian, LM; Kitamura, T; Klinken, SP; Knox, AJ; Kojima, M; Kojima, S; Kondo, N; Koseki, H; Koyasu, S; Krampitz, S; Kubosaki, A; Kwon, AT; Laros, JFJ; Lee, W; Lennartsson, A; Li, K; Lilje, B; Lipovich, L; Mackay-sim, A; Manabe, R; Mar, JC; Marchand, B; Mathelier, A; Mejhert, N; Meynert, A; Mizuno, Y; Morais, DAD; Morikawa, H; Morimoto, M; Moro, K; Motakis, E; Motohashi, H; Mummery, CL; Murata, M; Nagao-Sato, S; Nakachi, Y; Nakahara, F; Nakamura, T; Nakamura, Y; Nakazato, K; Van Nimwegen, E; Ninomiya, N; Nishiyori, H; Noma, S; Nozaki, T; Ogishima, S; Ohkura, N; Ohmiya, H; Ohno, H; Ohshima, M; Okada-Hatakeyama, M; Okazaki, Y; Orlando, V; Ovchinnikov, DA; Pain, A; Passier, R; Patrikakis, M; Persson, H; Piazza, S; Prendergast, JGD; Rackham, OJL; Ramilowski, JA; Rashid, M; Ravasi, T; Rizzu, P; Roncador, M; Roy, S; Rye, MB; Saijyo, E; Sajantila, A; Saka, A; Sakaguchi, S; Sakai, M; Sato, H; Satoh, H; Savvi, S; Saxena, A; Schneider, C; Schultes, EA; Schulze-Tanzil, GG; Schwegmann, A; Sengstag, T; Sheng, GJ; Shimoji, H; Shimoni, Y; Shin, JW; Simon, C; Sugiyama, D; Sugiyama, T; Suzuki, M; Suzuki, N; Swoboda, RK; 't Hoen, PAC; Tagami, M; Takahashi, N; Takai, J; Tanaka, H; Tatsukawa, H; Tatum, Z; Thompson, M; Toyoda, H; Toyoda, T; Valen, E; van de Wetering, M; van den Berg, LM; Verardo, R; Vijayan, D; Vorontsov, IE; Wasserman, WW; Watanabe, S; Wells, CA; Winteringham, LN; Wolvetang, E; Wood, EJ; Yamaguchi, Y; Yamamoto, M; Yoneda, M; Yonekura, Y; Yoshida, S; Zabierowski, SE; Zhang, PG; Zhao, XB; Zucchelli, S; Summers, KM; Suzuki, H; Daub, CO; Kawai, J; Heutink, P; Hide, W; Freeman, TC; Lenhard, B; Bajic, VB; Taylor, MS; Makeev, VJ; Sandelin, A; Hume, DA; Carninci, P; Hayashizaki, Y				Forrest, Alistair R. R.; Kawaji, Hideya; Rehli, Michael; Baillie, J. Kenneth; de Hoon, Michiel J. L.; Haberle, Vanja; Lassmann, Timo; Kulakovskiy, Ivan V.; Lizio, Marina; Itoh, Masayoshi; Andersson, Robin; Mungall, Christopher J.; Meehan, Terrence F.; Schmeier, Sebastian; Bertin, Nicolas; Jorgensen, Mette; Dimont, Emmanuel; Arner, Erik; Schmidl, Christian; Schaefer, Ulf; Medvedeva, Yulia A.; Plessy, Charles; Vitezic, Morana; Severin, Jessica; Semple, Colin A.; Ishizu, Yuri; Young, Robert S.; Francescatto, Margherita; Alam, Intikhab; Albanese, Davide; Altschuler, Gabriel M.; Arakawa, Takahiro; Archer, John A. C.; Arner, Peter; Babina, Magda; Rennie, Sarah; Balwierz, Piotr J.; Beckhouse, Anthony G.; Pradhan-Bhatt, Swati; Blake, Judith A.; Blumenthal, Antje; Bodega, Beatrice; Bonetti, Alessandro; Briggs, James; Brombacher, Frank; Burroughs, A. Maxwell; Califano, Andrea; Cannistraci, Carlo V.; Carbajo, Daniel; Chen, Yun; Chierici, Marco; Ciani, Yari; Clevers, Hans C.; Dalla, Emiliano; Davis, Carrie A.; Detmar, Michael; Diehl, Alexander D.; Dohi, Taeko; Drablos, Finn; Edge, Albert S. B.; Edinger, Matthias; Ekwall, Karl; Endoh, Mitsuhiro; Enomoto, Hideki; Fagiolini, Michela; Fairbairn, Lynsey; Fang, Hai; Farach-Carson, Mary C.; Faulkner, Geoffrey J.; Favorov, Alexander V.; Fisher, Malcolm E.; Frith, Martin C.; Fujita, Rie; Fukuda, Shiro; Furlanello, Cesare; Furuno, Masaaki; Furusawa, Jun-ichi; Geijtenbeek, Teunis B.; Gibson, Andrew P.; Gingeras, Thomas; Goldowitz, Daniel; Gough, Julian; Guhl, Sven; Guler, Reto; Gustincich, Stefano; Ha, Thomas J.; Hamaguchi, Masahide; Hara, Mitsuko; Harbers, Matthias; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hashimoto, Takehiro; Herlyn, Meenhard; Hitchens, Kelly J.; Sui, Shannan J. Ho; Hofmann, Oliver M.; Hoof, Ilka; Hori, Fumi; Huminiecki, Lukasz; Iida, Kei; Ikawa, Tomokatsu; Jankovic, Boris R.; Jia, Hui; Joshi, Anagha; Jurman, Giuseppe; Kaczkowski, Bogumil; Kai, Chieko; Kaida, Kaoru; Kaiho, Ai; Kajiyama, Kazuhiro; Kanamori-Katayama, Mutsumi; Kasianov, ArtemS.; Kasukawa, Takeya; Katayama, Shintaro; Kato, Sachi; Kawaguchi, Shuji; Kawamoto, Hiroshi; Kawamura, Yuki I.; Kawashima, Tsugumi; Kempfle, Judith S.; Kenna, Tony J.; Kere, Juha; Khachigian, Levon M.; Kitamura, Toshio; Klinken, S. Peter; Knox, Alan J.; Kojima, Miki; Kojima, Soichi; Kondo, Naoto; Koseki, Haruhiko; Koyasu, Shigeo; Krampitz, Sarah; Kubosaki, Atsutaka; Kwon, Andrew T.; Laros, Jeroen F. J.; Lee, Weonju; Lennartsson, Andreas; Li, Kang; Lilje, Berit; Lipovich, Leonard; Mackay-sim, Alan; Manabe, Ri-ichiroh; Mar, Jessica C.; Marchand, Benoit; Mathelier, Anthony; Mejhert, Niklas; Meynert, Alison; Mizuno, Yosuke; Morais, David A. de Lima; Morikawa, Hiromasa; Morimoto, Mitsuru; Moro, Kazuyo; Motakis, Efthymios; Motohashi, Hozumi; Mummery, Christine L.; Murata, Mitsuyoshi; Nagao-Sato, Sayaka; Nakachi, Yutaka; Nakahara, Fumio; Nakamura, Toshiyuki; Nakamura, Yukio; Nakazato, Kenichi; Van Nimwegen, Erik; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Nozaki, Tadasuke; Ogishima, Soichi; Ohkura, Naganari; Ohmiya, Hiroko; Ohno, Hiroshi; Ohshima, Mitsuhiro; Okada-Hatakeyama, Mariko; Okazaki, Yasushi; Orlando, Valerio; Ovchinnikov, Dmitry A.; Pain, Arnab; Passier, Robert; Patrikakis, Margaret; Persson, Helena; Piazza, Silvano; Prendergast, James G. D.; Rackham, Owen J. L.; Ramilowski, Jordan A.; Rashid, Mamoon; Ravasi, Timothy; Rizzu, Patrizia; Roncador, Marco; Roy, Sugata; Rye, Morten B.; Saijyo, Eri; Sajantila, Antti; Saka, Akiko; Sakaguchi, Shimon; Sakai, Mizuho; Sato, Hiroki; Satoh, Hironori; Savvi, Suzana; Saxena, Alka; Schneider, Claudio; Schultes, Erik A.; Schulze-Tanzil, Gundula G.; Schwegmann, Anita; Sengstag, Thierry; Sheng, Guojun; Shimoji, Hisashi; Shimoni, Yishai; Shin, Jay W.; Simon, Christophe; Sugiyama, Daisuke; Sugiyama, Takaaki; Suzuki, Masanori; Suzuki, Naoko; Swoboda, Rolf K.; 't Hoen, Peter A. C.; Tagami, Michihira; Takahashi, Naoko; Takai, Jun; Tanaka, Hiroshi; Tatsukawa, Hideki; Tatum, Zuotian; Thompson, Mark; Toyoda, Hiroo; Toyoda, Tetsuro; Valen, Eivind; van de Wetering, Marc; van den Berg, Linda M.; Verardo, Roberto; Vijayan, Dipti; Vorontsov, Ilya E.; Wasserman, Wyeth W.; Watanabe, Shoko; Wells, Christine A.; Winteringham, Louise N.; Wolvetang, Ernst; Wood, Emily J.; Yamaguchi, Yoko; Yamamoto, Masayuki; Yoneda, Misako; Yonekura, Yohei; Yoshida, Shigehiro; Zabierowski, Susan E.; Zhang, Peter G.; Zhao, Xiaobei; Zucchelli, Silvia; Summers, Kim M.; Suzuki, Harukazu; Daub, Carsten O.; Kawai, Jun; Heutink, Peter; Hide, Winston; Freeman, Tom C.; Lenhard, Boris; Bajic, Vladimir B.; Taylor, Martin S.; Makeev, Vsevolod J.; Sandelin, Albin; Hume, David A.; Carninci, Piero; Hayashizaki, Yoshihide		FANTOM Consortium; RIKEN PMI CLST DGT	A promoter-level mammalian expression atlas	NATURE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; HOMEOBOX GENE; MICE LACKING; DIFFERENTIATION; MOUSE; CLASSIFICATION; SIGNATURES; MUTATIONS; DEAFNESS	Regulated transcription controls the diversity, developmental pathways and spatial organization of the hundreds of cell types that make up a mammal. Using single-molecule cDNA sequencing, we mapped transcription start sites (TSSs) and their usage in human and mouse primary cells, cell lines and tissues to produce a comprehensive overview of mammalian gene expression across the human body. We find that few genes are truly 'housekeeping', whereas many mammalian promoters are composite entities composed of several closely separated TSSs, with independent cell-type-specific expression profiles. TSSs specific to different cell types evolve at different rates, whereas promoters of broadly expressed genes are the most conserved. Promoter-based expression analysis revealskey transcription factors defining cell states and links them to binding-site motifs. The functions of identified novel transcripts can be predicted by coexpression and sample ontology enrichment analyses. The functional annotation of the mammalian genome 5 (FANTOM5) project provides comprehensive expression profiles and functional annotation of mammalian cell-type-specific transcriptomes with wide applications in biomedical research.	[Forrest, Alistair R. R.; Kawaji, Hideya; de Hoon, Michiel J. L.; Lassmann, Timo; Lizio, Marina; Itoh, Masayoshi; Bertin, Nicolas; Arner, Erik; Plessy, Charles; Vitezic, Morana; Severin, Jessica; Ishizu, Yuri; Arakawa, Takahiro; Bonetti, Alessandro; Burroughs, A. Maxwell; Fukuda, Shiro; Furuno, Masaaki; Harbers, Matthias; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hashimoto, Takehiro; Hori, Fumi; Kaczkowski, Bogumil; Kaida, Kaoru; Kaiho, Ai; Kajiyama, Kazuhiro; Kanamori-Katayama, Mutsumi; Katayama, Shintaro; Kato, Sachi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Kubosaki, Atsutaka; Kwon, Andrew T.; Manabe, Ri-ichiroh; Motakis, Efthymios; Murata, Mitsuyoshi; Nagao-Sato, Sayaka; Nakazato, Kenichi; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Ohmiya, Hiroko; Ramilowski, Jordan A.; Roy, Sugata; Saijyo, Eri; Saka, Akiko; Sakai, Mizuho; Saxena, Alka; Sengstag, Thierry; Shimoji, Hisashi; Shin, Jay W.; Simon, Christophe; Suzuki, Masanori; Suzuki, Naoko; Tagami, Michihira; Takahashi, Naoko; Watanabe, Shoko; Yoshida, Shigehiro; Suzuki, Harukazu; Daub, Carsten O.; Kawai, Jun; Carninci, Piero; Hayashizaki, Yoshihide] RIKEN, OSC, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Forrest, Alistair R. R.; Kawaji, Hideya; de Hoon, Michiel J. L.; Lassmann, Timo; Lizio, Marina; Itoh, Masayoshi; Bertin, Nicolas; Arner, Erik; Plessy, Charles; Severin, Jessica; Ishizu, Yuri; Arakawa, Takahiro; Bonetti, Alessandro; Furuno, Masaaki; Harshbarger, Jayson; Hasegawa, Akira; Hasegawa, Yuki; Hori, Fumi; Kaczkowski, Bogumil; Kaida, Kaoru; Kajiyama, Kazuhiro; Kasukawa, Takeya; Kato, Sachi; Kawashima, Tsugumi; Kojima, Miki; Kondo, Naoto; Kwon, Andrew T.; Manabe, Ri-ichiroh; Motakis, Efthymios; Murata, Mitsuyoshi; Nishiyori, Hiromi; Noma, Shohei; Ohmiya, Hiroko; Ramilowski, Jordan A.; Roy, Sugata; Sakai, Mizuho; Shin, Jay W.; Simon, Christophe; Suzuki, Naoko; Tagami, Michihira; Takahashi, Naoko; Yoshida, Shigehiro; Suzuki, Harukazu; Carninci, Piero] RIKEN, CLST, DGT, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kawaji, Hideya; Itoh, Masayoshi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN, Prevent Med & Diag Innovat Program PMI, Wako, Saitama 3510198, Japan; [Rehli, Michael; Schmidl, Christian; Edinger, Matthias] Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany; [Rehli, Michael; Edinger, Matthias] Regensburg Ctr Intervent Immunol RCI, D-93042 Regensburg, Germany; [Baillie, J. Kenneth; Fairbairn, Lynsey; Fisher, Malcolm E.; Joshi, Anagha; Summers, Kim M.; Freeman, Tom C.; Hume, David A.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Baillie, J. Kenneth; Fairbairn, Lynsey; Fisher, Malcolm E.; Joshi, Anagha; Summers, Kim M.; Freeman, Tom C.; Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland; [Haberle, Vanja] Univ Bergen, Dept Biol, NO-5006 Bergen, Norway; [Haberle, Vanja; Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, MRC Clin Sci Ctr, London W12 0NN, England; [Kulakovskiy, Ivan V.; Makeev, Vsevolod J.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; [Kulakovskiy, Ivan V.; Medvedeva, Yulia A.; Favorov, Alexander V.; Kasianov, ArtemS.; Vorontsov, Ilya E.; Makeev, Vsevolod J.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Andersson, Robin; Jorgensen, Mette; Chen, Yun; Hoof, Ilka; Li, Kang; Lilje, Berit; Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, Bioinformat Ctr, Dept Biol, DK-2200 Copenhagen, Denmark; [Andersson, Robin; Jorgensen, Mette; Chen, Yun; Hoof, Ilka; Li, Kang; Lilje, Berit; Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Meehan, Terrence F.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Schmeier, Sebastian; Schaefer, Ulf; Medvedeva, Yulia A.; Alam, Intikhab; Archer, John A. C.; Jankovic, Boris R.; Marchand, Benoit; Pain, Arnab; Rashid, Mamoon; Bajic, Vladimir B.] KAUST, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia; [Schmeier, Sebastian] Massey Univ, North Shore Mail Ctr, Inst Nat & Math Sci, Auckland 0745, New Zealand; [Dimont, Emmanuel; Altschuler, Gabriel M.; Sui, Shannan J. Ho; Hofmann, Oliver M.; Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vitezic, Morana; Huminiecki, Lukasz] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Semple, Colin A.; Young, Robert S.; Rennie, Sarah; Meynert, Alison; Prendergast, James G. D.; Taylor, Martin S.] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, MRC IGMM, Edinburgh EH4 2XU, Midlothian, Scotland; [Francescatto, Margherita; Rizzu, Patrizia; Heutink, Peter] Vrije Univ Amsterdam, Dept Clin Genet, Med Ctr Amsterdam, NL-1081 BT Amsterdam, Netherlands; [Francescatto, Margherita] Univ Porto, Grad Program Areas Basic & Appl Biol, Abel Salazar Biomed Sci Inst, P-4050313 Oporto, Portugal; [Albanese, Davide; Chierici, Marco; Furlanello, Cesare; Jurman, Giuseppe; Roncador, Marco] Fdn Bruno Kessler, I-38123 Trento, Italy; [Arner, Peter; Mejhert, Niklas] Karolinska Inst, Dept Med, Karolinska Univ Hosp, SE-14186 Huddinge, Sweden; [Babina, Magda; Guhl, Sven] Univ Med Berlin, Dept Dermatol & Allergy, D-10117 Berlin, Germany; [Balwierz, Piotr J.; Van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Beckhouse, Anthony G.; Briggs, James; Hitchens, Kelly J.; Ovchinnikov, Dmitry A.; Vijayan, Dipti; Wells, Christine A.; Wolvetang, Ernst] Univ Queensland, AIBN, St Lucia, Qld 4072, Australia; [Beckhouse, Anthony G.; Blumenthal, Antje; Hitchens, Kelly J.; Vijayan, Dipti; Wells, Christine A.] Univ Queensland, Australian Infect Dis Res Ctr AID, St Lucia, Qld 4072, Australia; [Pradhan-Bhatt, Swati] Univ Delaware, Dept Biol Sci, Newark, DE 19713 USA; [Blake, Judith A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Blumenthal, Antje; Kenna, Tony J.] Univ Queensland, Diamantina Inst, St Lucia, Qld 4072, Australia; [Bodega, Beatrice; Orlando, Valerio] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy; [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Int Ctr Genet Engn & Biotechnol ICGEB Cape Town C, ZA-7925 Cape Town, South Africa; [Brombacher, Frank; Guler, Reto; Savvi, Suzana; Schwegmann, Anita] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Califano, Andrea; Shimoni, Yishai] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Inst Canc Genet, New York, NY 10032 USA; [Cannistraci, Carlo V.; Orlando, Valerio; Pain, Arnab; Rashid, Mamoon; Ravasi, Timothy] KAUST, Biol & Environm Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Cannistraci, Carlo V.; Ravasi, Timothy] KAUST, Appl Math & Computat Sci Program, Thuwal 239556900, Saudi Arabia; [Carbajo, Daniel; Mar, Jessica C.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Ciani, Yari; Dalla, Emiliano; Piazza, Silvano; Schneider, Claudio; Verardo, Roberto] LNCIB, I-34149 Trieste, Italy; [Clevers, Hans C.; van de Wetering, Marc] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans C.] Royal Netherlands Acad Arts & Sci, NL-1000 GC Amsterdam, Netherlands; [Clevers, Hans C.] Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands; [Davis, Carrie A.; Gingeras, Thomas] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11797 USA; [Detmar, Michael; Krampitz, Sarah] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Diehl, Alexander D.] SUNY Buffalo, Dept Neurol, Sch Med & Biomed Sci, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA; [Dohi, Taeko; Kawamura, Yuki I.] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol Res Inst, Ichikawa, Chiba 2728516, Japan; [Drablos, Finn; Rye, Morten B.] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, NO-7491 Trondheim, Norway; [Edge, Albert S. B.; Kempfle, Judith S.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol, Boston, MA 02114 USA; [Ekwall, Karl; Kere, Juha; Lennartsson, Andreas; Persson, Helena] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, SE-14183 Huddinge, Sweden; [Endoh, Mitsuhiro; Furusawa, Jun-ichi; Ikawa, Tomokatsu; Kawamoto, Hiroshi; Koseki, Haruhiko; Koyasu, Shigeo; Moro, Kazuyo; Ohno, Hiroshi; Okada-Hatakeyama, Mariko] RIKEN, RCAI, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Endoh, Mitsuhiro; Furusawa, Jun-ichi; Ikawa, Tomokatsu; Koseki, Haruhiko; Koyasu, Shigeo; Moro, Kazuyo; Ohno, Hiroshi; Okada-Hatakeyama, Mariko] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Enomoto, Hideki; Morimoto, Mitsuru; Sheng, Guojun; Yonekura, Yohei] RIKEN, CDB, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Fagiolini, Michela] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp Boston, Boston, MA 02115 USA; [Fang, Hai; Gough, Julian; Rackham, Owen J. L.] Univ Bristol, Dept Comp Sci, Bristol BS8 1UB, Avon, England; [Farach-Carson, Mary C.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Faulkner, Geoffrey J.] Mater Med Res Inst, Cancer Biol Program, South Brisbane, Qld 4101, Australia; [Favorov, Alexander V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Oncol Biostat & Bioinformat, Baltimore, MD 21205 USA; [Favorov, Alexander V.] State Res Inst Genet & Select Ind Microorganisms, Moscow 117545, Russia; [Frith, Martin C.] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Fujita, Rie; Satoh, Hironori; Takai, Jun; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Furusawa, Jun-ichi; Koyasu, Shigeo; Moro, Kazuyo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Geijtenbeek, Teunis B.; van den Berg, Linda M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Gibson, Andrew P.; Laros, Jeroen F. J.; Schultes, Erik A.; 't Hoen, Peter A. C.; Tatum, Zuotian; Thompson, Mark] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [Goldowitz, Daniel; Ha, Thomas J.; Mathelier, Anthony; Wasserman, Wyeth W.; Zhang, Peter G.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Gustincich, Stefano; Zucchelli, Silvia] SISSA, I-34136 Trieste, Italy; [Hamaguchi, Masahide; Morikawa, Hiromasa; Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Hara, Mitsuko; Kojima, Soichi] RIKEN, ASI, Wako, Saitama 3510198, Japan; [Herlyn, Meenhard; Swoboda, Rolf K.; Zabierowski, Susan E.] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Iida, Kei; Kawaguchi, Shuji; Toyoda, Tetsuro] RIKEN, Bioinformat & Syst Engn Div BASE, Yokohama, Kanagawa 2300045, Japan; [Jia, Hui; Lipovich, Leonard; Wood, Emily J.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Kai, Chieko; Nakamura, Toshiyuki; Sato, Hiroki; Sugiyama, Takaaki; Yoneda, Misako] Univ Tokyo, Lab Anim Res Ctr, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Kere, Juha] Sci Life Lab, SE-17121 Solna, Sweden; [Khachigian, Levon M.; Patrikakis, Margaret] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Kitamura, Toshio; Nakahara, Fumio] Univ Tokyo, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan; [Kitamura, Toshio; Nakahara, Fumio] Univ Tokyo, Div Stem Cell Signaling, Inst Med Sci, Tokyo 1088639, Japan; [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Perth, WA 6009, Australia; [Klinken, S. Peter; Winteringham, Louise N.] Univ Western Australia, Med Res Ctr, QEII Med Ctr, Perth, WA 6009, Australia; [Knox, Alan J.] Univ Nottingham, City Hosp, Nottingham NG5 1PB, England; [Lee, Weonju] Kyungpook Natl Univ, Sch Med, Dept Dermatol, Taegu 700721, South Korea; [Mackay-sim, Alan] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Mizuno, Yosuke; Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Morais, David A. de Lima] Univ Bristol, Fac Engn, Clifton BS81UB, England; [Moro, Kazuyo] Japanese Sci & Technol Agcy JST, PRESTO, Tokyo 1020076, Japan; [Motohashi, Hozumi] Tohoku Univ, Ctr Radioisotope Sci, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Mummery, Christine L.; Passier, Robert] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Univ, Div Translat Res, Res Ctr Genom Med, Hidaka, Saitama 3501241, Japan; [Nakamura, Yukio] RIKEN, BioResource Ctr BRC, Tsukuba, Ibaraki 3050074, Japan; [Nozaki, Tadasuke; Toyoda, Hiroo] Tokyo Univ Pharm & Life Sci, Dept Clin Mol Genet, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Ogishima, Soichi; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Ohshima, Mitsuhiro] Ohu Univ, Dept Biochem, Sch Pharmaceut Sci, Koriyama, Fukushima 9638611, Japan; [Sajantila, Antti] Univ Helsinki, Dept Forens Med, Hjelt Inst, Helsinki 003000, Finland; [Schneider, Claudio] Univ Udine, DSMB, I-33100 Udine, Italy; [Schulze-Tanzil, Gundula G.] Charite, Dept Orthoped Trauma & Reconstruct Surg, D-14195 Berlin, Germany; [Sugiyama, Daisuke] Kyushu Univ Hosp, Ctr Clin & Translat Reseach, Higashi Ku, Fukuoka 8128582, Japan; [Tatsukawa, Hideki] Nagoya Univ, Grad Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Valen, Eivind] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Yamaguchi, Yoko] Nihon Univ, Dept Biochem, Sch Dent, Chiyoda Ku, Tokyo 1018310, Japan; [Lenhard, Boris] Univ Bergen, Dept Informat, NO-5008 Bergen, Norway; [Makeev, Vsevolod J.] MIPT, Dept Biol & Med Phys, Dolgoprudnyi 141700, Moscow Region, Russia	RIKEN; RIKEN; RIKEN; University of Regensburg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Bergen; Imperial College London; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Vavilov Institute of General Genetics; University of Copenhagen; University of Copenhagen; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); King Abdullah University of Science & Technology; Massey University; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; University of Edinburgh; Vrije Universiteit Amsterdam; Universidade do Porto; Fondazione Bruno Kessler; Karolinska Institutet; Karolinska University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Basel; University of Queensland; University of Queensland; University of Delaware; Jackson Laboratory; University of Queensland; IRCCS Santa Lucia; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Columbia University; Columbia University; Columbia University; Columbia University; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Yeshiva University; Albert Einstein College of Medicine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cold Spring Harbor Laboratory; Swiss Federal Institutes of Technology Domain; ETH Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Center for Global Health & Medicine - Japan; Norwegian University of Science & Technology (NTNU); Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Karolinska Institutet; RIKEN; RIKEN; RIKEN; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Bristol; Rice University; Mater Research; Johns Hopkins University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; Keio University; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Child & Family Research Institute; University of British Columbia; International School for Advanced Studies (SISSA); Osaka University; RIKEN; The Wistar Institute; RIKEN; Wayne State University; University of Tokyo; University of New South Wales Sydney; University of Tokyo; University of Tokyo; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Kyungpook National University; Griffith University; Saitama Medical University; University of Bristol; Japan Science & Technology Agency (JST); Tohoku University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Saitama Medical University; RIKEN; Tokyo University of Pharmacy & Life Sciences; Tokyo Medical & Dental University (TMDU); University of Helsinki; University of Udine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Nagoya University; Harvard University; Nihon University; University of Bergen; Moscow Institute of Physics & Technology	Forrest, ARR (corresponding author), RIKEN, OSC, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	alistair.forrest@gmail.com; carninci@riken.jp; yosihide@gsc.riken.jp	Schmidl, Christian/HDO-6299-2022; Motakis, Efthymios/AAL-6863-2020; Rehli, Michael/E-9093-2011; Semple, Colin A M/A-5613-2009; Archer, John/D-5200-2012; Hayashizaki, Yoshihide/N-6590-2015; Morikawa, Hiromasa/AAU-9261-2020; Mathelier, Anthony/Y-4693-2019; Hide, Winston A/V-2727-2017; Vitezic, Morana/A-6165-2013; Valen, Eivind/A-8617-2011; Baillie, Kenneth/AEK-6650-2022; Suzuki, Harukazu/N-9553-2015; Koseki, Haruhiko/I-3825-2014; Mungall, Chris/I-6006-2019; Khachigian, Levon/AAZ-7458-2020; Ravasi, Timothy/B-8777-2008; Cannistraci, Carlo Vittorio/G-1710-2014; Lipovich, Leonard/B-2355-2019; Albanese, Davide/AAA-7295-2021; Kawaji, Hideya/N-5116-2015; Morikawa, Hiromasa/H-5958-2013; Kitamura, Toshio/AAA-2071-2021; Motohashi, Hozumi/AAZ-2628-2020; Kwon, Andrew/D-4625-2017; Arner, Erik/A-1895-2010; Kere, Juha/AAX-9117-2021; Ohno, Hiroshi/L-7899-2014; Itoh, Masayoshi/N-5363-2015; de Hoon, Michiel/A-6443-2013; Diehl, Alexander/G-9883-2016; Kulakovskiy, Ivan/A-1462-2014; Pain, Arnab/L-5766-2015; Dalla, Emiliano/AAH-3039-2020; Jurman, Giuseppe/GRS-8221-2022; Taylor, Martin S/C-3825-2009; Kojima, Soichi/N-7104-2015; Kaczkowski, Bogumil/D-5336-2017; Sandelin, Albin/G-2881-2011; Vorontsov, Ilya E/C-6333-2014; Sajantila, Antti/AAY-9084-2021; Sheng, Guojun/G-4116-2014; Kasukawa, Takeya/N-5070-2015; KONDO, NAOTO/A-5829-2016; Hoen, Peter A 't/D-3950-2018; Faulkner, Geoffrey J/M-3168-2014; Favorov, Alexander V/K-2699-2018; Archer, John/AAW-1990-2021; Persson, Helena/ABE-5003-2020; Drablos, Finn/L-4970-2019; Lassmann, Timo/HCH-4313-2022; Lassmann, Timo/A-8271-2008; Hitchens, Kelly/D-4320-2009; Koyasu, Shigeo/J-5583-2015; Kasianov, Artem S/R-3495-2016; Carninci, Piero/K-1568-2014; Andersson, Robin/B-5311-2009; Ramilowski, Jordan A./Z-3103-2019; Chierici, Marco/P-9949-2019; Hide, Winston/R-3815-2019; Blumenthal, Antje/A-3608-2011; Schmeier, Sebastian/D-4731-2011; Makeev, Vsevolod/E-8015-2013; Ovchinnikov, Dmitry/J-7963-2014; Zhao, Xiaobei/G-3567-2014; Moro, Kazuyo/A-5987-2016; Katayama, Shintaro/F-2958-2010; Medvedva, Yulia A/H-5947-2016; Summers, Kim M/M-4086-2015; Plessy, Charles/N-5054-2015; Nakamura, Yukio/A-5263-2016; Rackham, Owen/AAM-3108-2021; Sheng, Guojun/I-4900-2015; Wolvetang, Ernst jurgen/D-6644-2017; Kawai, Jun/A-6451-2016; Hide, Winston Hide/C-7217-2009; Yamamoto, Masayuki/A-4873-2010; Edge, Albert/Q-5448-2019; Kere, Juha/A-9179-2008; Mackay-Sim, Alan/C-3431-2008; Tomic, Nevena/AAA-2135-2021; Fisher, Malcolm Edgar/GQH-8954-2022; Bertin, Nicolas/O-9602-2019; Tatsukawa, Hideki/AAE-8377-2020; Wasserman, Wyeth/I-4866-2015; Sakaguchi, Shimon/C-9535-2009; Kenna, Tony/A-6035-2011; Baillie, John Kenneth/F-3124-2011; Bodega, Beatrice/I-4644-2018; van Nimwegen, Erik/ABF-1085-2021; Severin, Jessica/AAQ-2723-2020; Beckhouse, Anthony G/A-2601-2010; Daub, Carsten O/A-7436-2010; Nakachi, Yutaka/M-2446-2013; Wells, Christine/A-5071-2010; Bertin, Nicolas/C-3025-2008; Schultes, Erik/B-6035-2012; Bajic, Vladimir/D-2810-2009; Hofmann, Oliver/F-1800-2013	Schmidl, Christian/0000-0002-0522-202X; Rehli, Michael/0000-0003-3992-932X; Semple, Colin A M/0000-0003-1765-4118; Morikawa, Hiromasa/0000-0002-6793-5885; Mathelier, Anthony/0000-0001-5127-5459; Hide, Winston A/0000-0002-8621-3271; Vitezic, Morana/0000-0002-7994-9600; Baillie, Kenneth/0000-0001-5258-793X; Suzuki, Harukazu/0000-0002-8087-0836; Koseki, Haruhiko/0000-0001-8424-5854; Mungall, Chris/0000-0002-6601-2165; Cannistraci, Carlo Vittorio/0000-0003-0100-8410; Lipovich, Leonard/0000-0002-0531-3570; Albanese, Davide/0000-0002-9493-3850; Kawaji, Hideya/0000-0002-0575-0308; Morikawa, Hiromasa/0000-0002-6793-5885; Kwon, Andrew/0000-0001-5019-8156; Arner, Erik/0000-0003-1225-4908; Kere, Juha/0000-0003-1974-0271; Ohno, Hiroshi/0000-0001-8776-9661; Itoh, Masayoshi/0000-0002-1772-318X; Diehl, Alexander/0000-0001-9990-8331; Kulakovskiy, Ivan/0000-0002-6554-8128; Pain, Arnab/0000-0002-1755-2819; Dalla, Emiliano/0000-0002-4687-6011; Taylor, Martin S/0000-0001-7656-330X; Kojima, Soichi/0000-0002-5252-1612; Kaczkowski, Bogumil/0000-0001-6554-5608; Sandelin, Albin/0000-0002-7109-7378; Vorontsov, Ilya E/0000-0001-8888-0804; Kasukawa, Takeya/0000-0001-5085-0802; KONDO, NAOTO/0000-0001-9576-7615; Hoen, Peter A 't/0000-0003-4450-3112; Faulkner, Geoffrey J/0000-0001-5769-4494; Favorov, Alexander V/0000-0003-2595-1091; Archer, John/0000-0002-3302-3933; Drablos, Finn/0000-0001-5794-828X; Lassmann, Timo/0000-0002-0138-2691; Lassmann, Timo/0000-0002-0138-2691; Hitchens, Kelly/0000-0002-8777-6332; Koyasu, Shigeo/0000-0001-9585-3038; Kasianov, Artem S/0000-0001-8086-392X; Carninci, Piero/0000-0001-7202-7243; Andersson, Robin/0000-0003-1516-879X; Ramilowski, Jordan A./0000-0002-3156-6416; Chierici, Marco/0000-0001-9791-9301; Hide, Winston/0000-0002-8621-3271; Blumenthal, Antje/0000-0003-3673-7015; Schmeier, Sebastian/0000-0002-3947-8226; Makeev, Vsevolod/0000-0001-9405-9748; Ovchinnikov, Dmitry/0000-0001-9603-8385; Zhao, Xiaobei/0000-0002-5277-0846; Katayama, Shintaro/0000-0001-7581-5157; Medvedva, Yulia A/0000-0002-7587-1666; Summers, Kim M/0000-0002-7084-4386; Plessy, Charles/0000-0001-7410-6295; Nakamura, Yukio/0000-0001-8056-4946; Rackham, Owen/0000-0002-4390-0872; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Hide, Winston Hide/0000-0002-8621-3271; Yamamoto, Masayuki/0000-0002-9073-9436; Kere, Juha/0000-0003-1974-0271; Mackay-Sim, Alan/0000-0003-4446-5371; Fisher, Malcolm Edgar/0000-0003-1074-8103; Baillie, John Kenneth/0000-0001-5258-793X; Bodega, Beatrice/0000-0003-0527-9234; van Nimwegen, Erik/0000-0001-6338-1312; Severin, Jessica/0000-0003-1274-208X; Beckhouse, Anthony G/0000-0002-5141-8250; Daub, Carsten O/0000-0002-3295-8729; Nakachi, Yutaka/0000-0003-1964-2495; Rashid, Mamoon/0000-0003-4851-4994; Heutink, Peter/0000-0001-5218-1737; /0000-0002-6191-4709; Joshi, Anagha/0000-0003-1184-3305; Lennartsson, Andreas/0000-0002-3272-2505; Jankovic, Boris/0000-0003-1868-6007; Endoh, Mitsuhiro/0000-0003-0715-1701; Wells, Christine/0000-0003-3133-3628; Burroughs, A. Max/0000-0002-2229-8771; Sengstag, Thierry/0000-0002-7516-6246; Harbers, Matthias/0000-0002-5613-7220; Huminiecki, Lukasz/0000-0003-1943-4450; Nakahara, Fumio/0000-0003-1515-8284; Rashid, Mamoon/0000-0003-1457-477X; Alam, Intikhab/0000-0001-5306-847X; Khachigian, Levon/0000-0003-3446-0323; Gingeras, Thomas/0000-0001-9106-3573; Babina, Magda/0000-0002-4500-7615; Piazza, Silvano/0000-0002-7156-5434; Hamaguchi, Masahide/0000-0002-8651-4445; fagiolini, michela/0000-0003-2807-803X; Moro, Kazuyo/0000-0002-7377-1303; Sajantila, Antti/0000-0003-4117-5248; Furlanello, Cesare/0000-0002-5384-3605; Bertin, Nicolas/0000-0002-9835-9606; Meehan, Terrence/0000-0003-1980-3228; Ravasi, Timothy/0000-0002-9950-465X; Mar, Jessica/0000-0002-5147-9299; Jorgensen, Mette/0000-0002-2804-0560; Schultes, Erik/0000-0001-8888-635X; Edinger, Matthias/0000-0003-2889-2533; Wasserman, Wyeth/0000-0001-6098-6412; Hume, David/0000-0002-2615-1478; Mejhert, Niklas/0000-0003-1785-833X; Freeman, Thomas/0000-0001-5235-8483; Ekwall, Karl/0000-0002-3029-4041; Prendergast, James/0000-0001-8916-018X; Laros, Jeroen F.J./0000-0002-8715-7371; Ciani, Yari/0000-0002-9635-2830; Bajic, Vladimir/0000-0001-5435-4750; Valen, Eivind/0000-0003-1840-6108; Gustincich, Stefano/0000-0002-2749-2514; Goldowitz, Daniel/0000-0003-4756-4017; Okazaki, Yasushi/0000-0003-3241-5502; Persson, Helena/0000-0002-5187-6446; Knox, Alan/0000-0002-5906-4143; Frith, Martin/0000-0003-0998-2859; Forrest, Alistair/0000-0003-4543-1675; Mummery, Christine/0000-0002-4549-6535; Califano, Andrea/0000-0003-4742-3679; Kenna, Tony/0000-0001-6844-3463; Roy, Sugata/0000-0001-7183-7957; IIDA, Kei/0000-0001-7130-8705; Arner, Peter/0000-0002-6208-6220; Jurman, Giuseppe/0000-0002-2705-5728; de Hoon, Michiel/0000-0003-0489-2352; Winteringham, Louise/0000-0002-8117-5069; Zucchelli, Silvia/0000-0003-4556-2990; Haberle, Vanja/0000-0003-4191-3714; Francescatto, Margherita/0000-0003-1232-7302; Lenhard, Boris/0000-0002-1114-1509; Hofmann, Oliver/0000-0002-7738-1513; Farach-Carson, Mary/0000-0002-4526-3088	MEXT; MEXT, Japan; Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program(RIKEN PMI); RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT, Japan; BBSRC [BB/F003722/1, BBS/E/D/20231759, BBS/E/D/20211552, BB/I001107/1, BB/I025018/1, BBS/E/D/20211550, BBS/E/D/20251969, BBS/E/D/20211551, BB/G022771/1, BB/I024801/1] Funding Source: UKRI; MRC [MC_PC_U127597124, MC_UP_1102/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969, BBS/E/D/20211550, BB/G022771/1, BBS/E/D/20211552, BB/I001107/1, BBS/E/D/20211551, BB/I025018/1, BB/I024801/1, BB/F003722/1, BBS/E/D/20231759] Funding Source: researchfish; Lundbeck Foundation [R82-2010-6779] Funding Source: researchfish; Medical Research Council [MC_PC_U127597124, MC_UP_1102/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016371] Funding Source: researchfish; Wellcome Trust [103258/Z/13/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084875] Funding Source: NIH RePORTER	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program(RIKEN PMI); RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT, Japan; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to Y. Hayashizaki and a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to Y. Hayashizaki. It was also supported by Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program(RIKEN PMI) to Y. Hayashizaki and RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (RIKEN CLST (DGT)) from the MEXT, Japan. Extended acknowledgements are provided in the Supplementary Information.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chabchoub E, 2012, CLIN GENET, V81, P584, DOI 10.1111/j.1399-0004.2011.01684.x; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; He GY, 2010, DEV BIOL, V344, P720, DOI 10.1016/j.ydbio.2010.05.509; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Ioshikhes I, 2011, GENOME RES, V21, P1863, DOI 10.1101/gr.116228.110; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Kapoor S, 2011, INDIAN PEDIATR, V48, P727, DOI 10.1007/s13312-011-0108-8; Kawaji H., 2014, GENOME RES; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lee MS, 1999, J CELL BIOCHEM, V75, P566, DOI 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Lu MF, 1999, DEVELOPMENT, V126, P495; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Oja E., 2001, INDEPENDENT COMPONEN; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pringle IA, 2012, J MOL MED, V90, P1487, DOI 10.1007/s00109-012-0928-6; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Severin J., 2014, NATURE BIOTECHNOL; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shulha HP, 2012, ARCH GEN PSYCHIAT, V69, P314, DOI 10.1001/archgenpsychiatry.2011.151; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Talukder AH, 2012, CELL RES, V22, P1129, DOI 10.1038/cr.2012.45; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	54	1219	1231	5	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					462	+		10.1038/nature13182	http://dx.doi.org/10.1038/nature13182			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670764	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000333402000033
J	Poon, IKH; Chiu, YH; Armstrong, AJ; Kinchen, JM; Juncadella, IJ; Bayliss, DA; Ravichandran, KS				Poon, Ivan K. H.; Chiu, Yu-Hsin; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Bayliss, Douglas A.; Ravichandran, Kodi S.			Unexpected link between an antibiotic, pannexin channels and apoptosis	NATURE			English	Article							FIND-ME SIGNAL; ATP RELEASE; CELL-DEATH; IN-VIVO; ROCK-I; SAFETY; ACTIVATION; PHARMACOKINETICS; FLUOROQUINOLONES; TROVAFLOXACIN	Plasma membrane pannexin 1 channels (PANX1) release nucleotide find-me signals from apoptotic cells to attract phagocytes. Here we show that the quinolone antibiotic trovafloxacin is a novel PANX1 inhibitor, by using a small-molecule screen. Although quinolones are widely used to treat bacterial infections, some quinolones have unexplained side effects, including deaths among children. PANX1 is a direct target of trovafloxacin at drug concentrations seen in human plasma, and its inhibition led to dysregulated fragmentation of apoptotic cells. Genetic loss of PANX1 phenocopied trovafloxacin effects, revealing a non-redundant role for pannexin channels in regulating cellulardisassemblyduring apoptosis. Increase in drug-resistant bacteria worldwide and the dearth of new antibiotics is a major human health challenge. Comparing different quinolone antibiotics suggests that certain structural features may contribute to PANX1 blockade. These data identify a novel linkage between an antibiotic, pannexin channels and cellular integrity, and suggest that re-engineering certain quinolones might help develop newer antibacterials.	[Poon, Ivan K. H.; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Poon, Ivan K. H.; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Poon, Ivan K. H.; Armstrong, Allison J.; Kinchen, Jason M.; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Poon, Ivan K. H.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic, Australia; [Chiu, Yu-Hsin; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; La Trobe University; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021; Chiu, Yu-Hsin/AAT-8759-2021	Chiu, Yu-Hsin/0000-0002-4730-8104; Kinchen, Jason/0000-0001-8430-2265; Poon, Ivan/0000-0002-9119-7173; Ravichandran, Kodi/0000-0001-9049-1410	US National Institutes of Health [NIGMS 107848]; National Health & Medical Research Council of Australia; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107848, R01GM064709] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Isakson, M. Billaud, J. Lannigan and other colleagues for discussions. Grants from the US National Institutes of Health (NIGMS 107848 to K. S. R. and D. B.) and the National Health & Medical Research Council of Australia (I. K. H. P.), a training fellowship to I. K. H. P., and the American Heart Association (J. M. K.) supported this work.	Ahmed K, 2001, LANCET, V358, P815, DOI 10.1016/S0140-6736(01)06011-1; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Billaud M, 2012, TRENDS CARDIOVAS MED, V22, P68, DOI 10.1016/j.tcm.2012.06.014; Bortner CD, 1999, J BIOL CHEM, V274, P21953, DOI 10.1074/jbc.274.31.21953; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; CDC, 2013, ANTIBIOTIC RESISTANC; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Dubyak GR, 2004, ADV PHYSIOL EDUC, V28, P143, DOI 10.1152/advan.00046.2004; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Henry CM, 2013, METHODS, V61, P90, DOI 10.1016/j.ymeth.2013.01.008; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu HH, 2010, DRUG SAFETY, V33, P353, DOI 10.2165/11536360-000000000-00000; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Moss DK, 2006, J CELL SCI, V119, P2362, DOI 10.1242/jcs.02959; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Stahlmann R, 2010, DRUG AGING, V27, P193, DOI 10.2165/11531490-000000000-00000; Teng RL, 1996, J ANTIMICROB CHEMOTH, V37, P955, DOI 10.1093/jac/37.5.955; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Vincent J, 1997, J ANTIMICROB CHEMOTH, V39, P75, DOI 10.1093/jac/39.suppl_2.75; Wickman G, 2012, CELL DEATH DIFFER, V19, P735, DOI 10.1038/cdd.2012.25	40	161	165	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					329	+		10.1038/nature13147	http://dx.doi.org/10.1038/nature13147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646995	Green Accepted			2022-12-24	WOS:000333029000027
J	Akiyoshi, B; Gull, K				Akiyoshi, Bungo; Gull, Keith			Discovery of Unconventional Kinetochores in Kinetoplastids	CELL			English	Article							TRYPANOSOMA-BRUCEI; CELL-CYCLE; CENP-A; CENTROMERE; DNA; MINICHROMOSOMES; GENE; ARCHITECTURE; SEGREGATION; ALIGNMENT	The kinetochore is the macromolecular protein complex that directs chromosome segregation in eukaryotes. It has been widely assumed that the core kinetochore consists of proteins that are common to all eukaryotes. However, no conventional kinetochore components have been identified in any kinetoplastid genome, thus challenging this assumption of universality. Here, we report the identification of 19 kinetochore proteins (KKT1-19) in Trypanosoma brucei. The majority is conserved among kinetoplastids, but none of them has detectable homology to conventional kinetochore proteins. These proteins instead have a variety of features not found in conventional kinetochore proteins. We propose that kinetoplastids build kinetochores using a distinct set of proteins. These findings provide important insights into the longstanding problem of the position of the root of the eukaryotic tree of life.	[Akiyoshi, Bungo; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Akiyoshi, Bungo] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Akiyoshi, B (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	bungo.akiyoshi@bioch.ox.ac.uk		gull, keith/0000-0001-6954-9569; Akiyoshi, Bungo/0000-0001-6010-394X	EMBO; Human Frontier Science Program; Sir Henry Dale Fellowship; Wellcome Trust [098403/Z/12/Z]; Royal Society [098403/Z/12/Z]; Wellcome-Beit Prize Fellowship [098403/Z/12/A]	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Sir Henry Dale Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome-Beit Prize Fellowship	We thank Kim Nasmyth, Stuart Ferguson, Sue Biggins, and Hannah Long for comments on the manuscript. We also thank Vladimir Varga for discussion; Jonathan Higgins for advice on kinases; Takashi Sutani, Nicolai Siegel, and Mike Fiebig for advice on ChIP-seq; and the Central Proteomics Facility, Benjamin Thomas, and Gabriela Ridlova for mass spectrometry analysis. B. A. was supported by postdoctoral fellowships from the EMBO and Human Frontier Science Program and is currently supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 098403/Z/12/Z), as well as a Wellcome-Beit Prize Fellowship (grant 098403/Z/12/A). Research in the Gull laboratory is supported by the Wellcome Trust. The authors declare no competing financial interests.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biggins S, 2013, GENETICS, V194, P817, DOI 10.1534/genetics.112.145276; BRUN R, 1979, ACTA TROP, V36, P289; Buscaino A, 2010, CURR OPIN GENET DEV, V20, P118, DOI 10.1016/j.gde.2010.01.006; Cavalier-Smith T, 2013, EUR J PROTISTOL, V49, P115, DOI 10.1016/j.ejop.2012.06.001; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; Drechsler H, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120140; Durand-Dubief M, 2007, MOL BIOCHEM PARASIT, V156, P144, DOI 10.1016/j.molbiopara.2007.07.016; Echeverry MC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-29; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Ersfeld K, 2011, RES MICROBIOL, V162, P626, DOI 10.1016/j.resmic.2011.01.014; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gull K, 1998, TRENDS MICROBIOL, V6, P319, DOI 10.1016/S0966-842X(98)01314-6; Hayden KE, 2013, MOL CELL BIOL, V33, P763, DOI 10.1128/MCB.01198-12; Hori T, 2013, J CELL BIOL, V200, P45, DOI 10.1083/jcb.201210106; Hori T, 2012, CHROMOSOME RES, V20, P547, DOI 10.1007/s10577-012-9289-9; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Katz LA, 2012, SYST BIOL, V61, P653, DOI 10.1093/sysbio/sys026; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Maddox PS, 2012, CURR OPIN GENET DEV, V22, P139, DOI 10.1016/j.gde.2011.11.005; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Muller S, 2014, BBA-GENE REGUL MECH, V1839, P241, DOI 10.1016/j.bbagrm.2013.11.008; Nechemia-Arbely Y, 2012, EXP CELL RES, V318, P1353, DOI 10.1016/j.yexcr.2012.04.007; Nishino M, 2013, ELIFE, V2, DOI 10.7554/eLife.00712; Obado SO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r37; Obado SO, 2005, GENOME RES, V15, P36, DOI 10.1101/gr.2895105; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Ploubidou A, 1999, J CELL SCI, V112, P4641; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rogozin IB, 2009, GENOME BIOL EVOL, V1, P99, DOI 10.1093/gbe/evp011; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siegel TN, 2008, MOL BIOCHEM PARASIT, V160, P171, DOI 10.1016/j.molbiopara.2008.04.004; Siegel T Nicolai, 2009, Genes Dev, V23, P1063, DOI 10.1101/gad.1790409; SLOOF P, 1983, NUCLEIC ACIDS RES, V11, P3889, DOI 10.1093/nar/11.12.3889; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; Talbert Paul B., 2009, P193, DOI 10.1007/978-0-387-69076-6_7; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Tschudi C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-427; Unnikrishnan A, 2012, METHODS MOL BIOL, V833, P115, DOI 10.1007/978-1-61779-477-3_8; Walker G, 2011, PARASITOLOGY, V138, P1638, DOI 10.1017/S0031182010001708; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westermann S, 2013, TRENDS CELL BIOL, V23, P260, DOI 10.1016/j.tcb.2013.01.010; Westhorpe FG, 2013, CURR OPIN CELL BIOL, V25, P334, DOI 10.1016/j.ceb.2013.02.001; Wickstead B, 2003, MOL BIOCHEM PARASIT, V132, P97, DOI 10.1016/j.molbiopara.2003.08.007; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; WOODWARD R, 1990, J CELL SCI, V95, P49	66	153	153	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1247	1258		10.1016/j.cell.2014.01.049	http://dx.doi.org/10.1016/j.cell.2014.01.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24582333	hybrid, Green Published			2022-12-24	WOS:000332945100014
J	Chen, JJ; Zhang, ZJ; Li, L; Chen, BC; Revyakin, A; Hajj, B; Legant, W; Dahan, M; Lionnet, T; Betzig, E; Tjian, R; Liu, Z				Chen, Jiji; Zhang, Zhengjian; Li, Li; Chen, Bi-Chang; Revyakin, Andrey; Hajj, Bassam; Legant, Wesley; Dahan, Maxime; Lionnet, Timothee; Betzig, Eric; Tjian, Robert; Liu, Zhe			Single-Molecule Dynamics of Enhanceosome Assembly in Embryonic Stem Cells	CELL			English	Article							GENE-EXPRESSION; DNA; DIFFUSION; NETWORK; KINETICS; REGIONS; BINDING	Enhancer-binding pluripotency regulators (Sox2 and Oct4) play a seminal role in embryonic stem (ES) cell-specific gene regulation. Here, we combine in vivo and in vitro single-molecule imaging, transcription factor (TF) mutagenesis, and ChIP-exo mapping to determine how TFs dynamically search for and assemble on their cognate DNA target sites. We find that enhanceosome assembly is hierarchically ordered with kinetically favored Sox2 engaging the target DNA first, followed by assisted binding of Oct4. Sox2/Oct4 follow a trial-and-error sampling mechanism involving 84-97 events of 3D diffusion (3.3-3.7 s) interspersed with brief nonspecific collisions (0.75-0.9 s) before acquiring and dwelling at specific target DNA (12.0-14.6 s). Sox2 employs a 3D diffusion-dominated search mode facilitated by 1D sliding along open DNA to efficiently locate targets. Our findings also reveal fundamental aspects of gene and developmental regulation by fine-tuning TF dynamics and influence of the epigenome on target search parameters.	[Chen, Jiji; Revyakin, Andrey; Hajj, Bassam; Dahan, Maxime; Lionnet, Timothee; Tjian, Robert; Liu, Zhe] Howard Hughes Med Inst, Janelia Farm Res Campus, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Liu, Zhe] Howard Hughes Med Inst, Janelia Farm Res Campus, Junior Fellow Program, Ashburn, VA 20147 USA; [Zhang, Zhengjian; Li, Li; Chen, Bi-Chang; Legant, Wesley; Betzig, Eric; Tjian, Robert] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Tjian, Robert] Univ Calif Berkeley, CIRM Ctr Excellence, LKS Biomed & Hlth Sci Ctr, Berkeley, CA 94720 USA; [Hajj, Bassam; Dahan, Maxime] Inst Curie, CNRS, Lab Physo Chim Curie, Unite Mixte Rech 168, F-75794 Paris, France	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California Berkeley; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Liu, Z (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Transcript Imaging Consortium, 19700 Helix Dr, Ashburn, VA 20147 USA.	liuz11@janelia.hhmi.org	Chen, Bi-Chang/F-3480-2014; Dahan, Maxime/F-1740-2010	Chen, Bi-Chang/0000-0002-1876-7432; HAJJ, Bassam/0000-0002-5097-6832; Lionnet, Timothee/0000-0003-1508-0202; Dahan, Maxime/0000-0002-4943-2491	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; De-Leon SBT, 2007, ANNU REV BIOPH BIOM, V36, P191, DOI 10.1146/annurev.biophys.35.040405.102002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/NMETH.2411, 10.1038/nmeth.2411]; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Lam CS, 2012, BIOCHEM J, V448, P21, DOI 10.1042/BJ20120725; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Mueller F, 2013, CRIT REV BIOCHEM MOL, V48, P492, DOI 10.3109/10409238.2013.833891; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zakrzewska K, 2012, CURR OPIN STRUC BIOL, V22, P160, DOI 10.1016/j.sbi.2012.01.004	31	363	369	0	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1274	1285		10.1016/j.cell.2014.01.062	http://dx.doi.org/10.1016/j.cell.2014.01.062			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630727	Bronze, Green Accepted			2022-12-24	WOS:000332945100016
J	Zingg, B; Hintiryan, H; Gou, L; Song, MY; Bay, M; Bienkowski, MS; Foster, NN; Yamashita, S; Bowman, I; Toga, AW; Dong, HW				Zingg, Brian; Hintiryan, Houri; Gou, Lin; Song, Monica Y.; Bay, Maxwell; Bienkowski, Michael S.; Foster, Nicholas N.; Yamashita, Seita; Bowman, Ian; Toga, Arthur W.; Dong, Hong-Wei			Neural Networks of the Mouse Neocortex	CELL			English	Article							INSULAR CORTEX; NERVOUS-SYSTEM; MOTOR CORTEX; STRUCTURAL CONNECTIVITY; OBJECT RECOGNITION; LIMBIC CONNECTIONS; CEREBRAL-CORTEX; BRAIN NETWORKS; RAT; CIRCUITS	Numerous studies have examined the neuronal inputs and outputs of many areas within the mammalian cerebral cortex, but how these areas are organized into neural networks that communicate across the entire cortex is unclear. Over 600 labeled neuronal pathways acquired from tracer injections placed across the entire mouse neocortex enabled us to generate a cortical connectivity atlas. A total of 240 intracortical connections were manually reconstructed within a common neuroanatomic framework, forming a cortico-cortical connectivity map that facilitates comparison of connections from different cortical targets. Connectivity matrices were generated to provide an overview of all intracortical connections and subnetwork clusterings. The connectivity matrices and cortical map revealed that the entire cortex is organized into four somatic sensorimotor, two medial, and two lateral subnetworks that display unique topologies and can interact through select cortical areas. Together, these data provide a resource that can be used to further investigate cortical networks and their corresponding functions.	[Zingg, Brian] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90032 USA; [Hintiryan, Houri; Gou, Lin; Song, Monica Y.; Bay, Maxwell; Bienkowski, Michael S.; Foster, Nicholas N.; Yamashita, Seita; Bowman, Ian; Toga, Arthur W.; Dong, Hong-Wei] Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Los Angeles, CA 90032 USA; [Toga, Arthur W.; Dong, Hong-Wei] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90032 USA	University of Southern California; University of Southern California; University of Southern California	Dong, HW (corresponding author), Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Los Angeles, CA 90032 USA.	Hongwei.Dong@loni.usc.edu		Bienkowski, Michael/0000-0002-8231-8893; Song, Monica/0000-0002-3320-5550; Foster, Nicholas/0000-0003-1740-9788	NIH/NIMH [MH094360-01A1]; P41 Supplement [AWT 3P41RR013642-12S3]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094360] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); P41 Supplement; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank Drs. Larry Swanson and Harvey Karten for advising this project, Daren Lee, Anand A. Joshi, Nikhil G. Sane, and Queenie Ng for the initial development of the iConnectome visualization tool and Betty W. Lee, Carlos Mena, Vaughan Greer, and Robert De La Cruz for their contributions to the website. We acknowledge Arleen Grewal, Annie Chen, Amy Hwang, and Hyojin Ryu for their contributions in image processing. This work was supported by NIH/NIMH, MH094360-01A1 (HWD) and P41 Supplement (AWT 3P41RR013642-12S3). The Mouse Connectome Project (MCP) was initiated by the authors while still at the University of California, Los Angeles (UCLA), but the entire program and project now fully reside at the University of Southern California (USC). This manuscript is dedicated to Dr. Edward (Ted) G. Jones, a devoted scientist, colleague, and beloved friend who will be greatly missed.	Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bucci DJ, 2009, NEUROBIOL LEARN MEM, V91, P114, DOI 10.1016/j.nlm.2008.07.004; Carleton A, 2010, TRENDS NEUROSCI, V33, P326, DOI 10.1016/j.tins.2010.04.002; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gerdjikov TV, 2013, J NEUROSCI, V33, P14193, DOI 10.1523/JNEUROSCI.0337-13.2013; Hintiryan H, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00030; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jasmin L, 2004, J COMP NEUROL, V468, P425, DOI 10.1002/cne.10978; Jones E.G., 2012, THALAMUS; Jones EG, 2011, ANN NY ACAD SCI, V1225, pE147, DOI 10.1111/j.1749-6632.2011.06009.x; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Maffei A, 2012, CURR OPIN NEUROBIOL, V22, P709, DOI 10.1016/j.conb.2012.04.001; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Marx V, 2012, NATURE, V490, P293, DOI 10.1038/490293a; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Osten P, 2013, NAT METHODS, V10, P515, DOI [10.1038/NMETH.2477, 10.1038/nmeth.2477]; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pollock JD, 2014, TRENDS NEUROSCI, V37, P106, DOI 10.1016/j.tins.2013.11.001; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; Saleem KS, 2008, J COMP NEUROL, V506, P659, DOI 10.1002/cne.21577; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Swanson LW, 2010, P NATL ACAD SCI USA, V107, P20610, DOI 10.1073/pnas.1015128107; Thompson RH, 2010, P NATL ACAD SCI USA, V107, P15235, DOI 10.1073/pnas.1009112107; Toga AW, 2012, NEUROSURGERY, V71, P1, DOI 10.1227/NEU.0b013e318258e9ff; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Weible AP, 2013, BEHAV BRAIN RES, V245, P63, DOI 10.1016/j.bbr.2013.02.010; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Yamada Y, 2005, RESP PHYSIOL NEUROBI, V147, P177, DOI 10.1016/j.resp.2005.02.017; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	49	418	421	5	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1096	1111		10.1016/j.cell.2014.02.023	http://dx.doi.org/10.1016/j.cell.2014.02.023			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581503	Bronze, Green Accepted			2022-12-24	WOS:000332083900024
J	Orthwein, A; Fradet-Turcotte, A; Noordermeer, SM; Canny, MD; Brun, CM; Strecker, J; Escribano-Diaz, C; Durocher, D				Orthwein, Alexandre; Fradet-Turcotte, Amelie; Noordermeer, Sylvie M.; Canny, Marella D.; Brun, Catherine M.; Strecker, Jonathan; Escribano-Diaz, Cristina; Durocher, Daniel			Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions	SCIENCE			English	Article							DAMAGE RESPONSE; UBIQUITIN; CHECKPOINT; 53BP1; RIF1; RESECTION	Mitotic cells inactivate DNA double-strand break (DSB) repair, but the rationale behind this suppression remains unknown. Here, we unravel how mitosis blocks DSB repair and determine the consequences of repair reactivation. Mitotic kinases phosphorylate the E3 ubiquitin ligase RNF8 and the nonhomologous end joining factor 53BP1 to inhibit their recruitment to DSB-flanking chromatin. Restoration of RNF8 and 53BP1 accumulation at mitotic DSB sites activates DNA repair but is, paradoxically, deleterious. Aberrantly controlled mitotic DSB repair leads to Aurora B kinase-dependent sister telomere fusions that produce dicentric chromosomes and aneuploidy, especially in the presence of exogenous genotoxic stress. We conclude that the capacity of mitotic DSB repair to destabilize the genome explains the necessity for its suppression during mitosis, principally due to the fusogenic potential of mitotic telomeres.	[Orthwein, Alexandre; Fradet-Turcotte, Amelie; Noordermeer, Sylvie M.; Canny, Marella D.; Brun, Catherine M.; Strecker, Jonathan; Escribano-Diaz, Cristina; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Strecker, Jonathan; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Durocher, D (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	durocher@lunenfeld.ca	Noordermeer, Sylvie M/T-8095-2017; Noordermeer, Sylvie M/F-3517-2012; Durocher, Daniel/A-7733-2010; Fradet-Turcotte, Amelie/G-5790-2017	Noordermeer, Sylvie M/0000-0003-2737-9690; Noordermeer, Sylvie M/0000-0003-2737-9690; Durocher, Daniel/0000-0003-3863-8635; Orthwein, Alexandre/0000-0002-7350-3413; Fradet-Turcotte, Amelie/0000-0002-5431-8650	Canadian Institutes of Health Research (CIHR); Swiss National Science Foundation; CIHR [MOP89754]; Krembil Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CIHR(Canadian Institutes of Health Research (CIHR)); Krembil Foundation	All primary data are archived at the Lunenfeld-Tanenbaum Research Institute. We thank R. Szilard and Durocher lab members for critically reading the manuscript; A. Nussenzweig, J. Karlseder, D. Xu, J. Lukas, A.-C. Gingras, W. Dunham, M. Cook, A. Rosebrock, L. Harrington, F. Rossiello, F. d'Adda di Fagagna, S. Lawo, and L. Pelletier for reagents or technical advice; and D. Chowdhury for the pT1609/pS1618 antibody and for sharing unpublished data. A.O. and A.F.-T. received postdoctoral fellowships from the Canadian Institutes of Health Research (CIHR); S.M.N. is a scholar of the EIRR21st training program; C.M.B. received a fellowship from the Swiss National Science Foundation; J.S. received a doctoral award from the CIHR; and D.D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 1). The work was supported by CIHR grant MOP89754 and by the Krembil Foundation.	Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Heijink AM, 2013, MUTAT RES-FUND MOL M, V750, P45, DOI 10.1016/j.mrfmmm.2013.07.003; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; ZIRKLE RE, 1953, SCIENCE, V117, P487, DOI 10.1126/science.117.3045.487	25	216	223	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					189	193		10.1126/science.1248024	http://dx.doi.org/10.1126/science.1248024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24652939				2022-12-24	WOS:000334096300033
J	Tsai, L; Barnea, G				Tsai, Lulu; Barnea, Gilad			A Critical Period Defined by Axon-Targeting Mechanisms in the Murine Olfactory Bulb	SCIENCE			English	Article							RECEPTOR GENE-EXPRESSION; ODORANT RECEPTORS; TOPOGRAPHIC MAP; SELF-AVOIDANCE; SENSORY MAP; ORGANIZATION; EPITHELIUM; NEURONS; SYSTEM; BRAIN	The olfactory system remains plastic throughout life because of continuous neurogenesis of sensory neurons in the nose and inhibitory interneurons in the olfactory bulb. Here, we reveal that transgenic expression of an odorant receptor has non-cell autonomous effects on axons expressing this receptor from the endogenous gene. Perinatal expression of transgenic odorant receptor causes rerouting of like axons to new glomeruli, whereas expression after the sensory map is established does not lead to rerouting. Further, chemical ablation of the map after rerouting does not restore the normal map, even when the transgenic receptor is no longer expressed. Our results reveal that glomeruli are designated as targets for sensory neurons expressing specific odorant receptors during a critical period in the formation of the olfactory sensory map.	[Tsai, Lulu; Barnea, Gilad] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Barnea, G (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	gilad_barnea@brown.edu		Korsak, Lulu/0000-0001-7662-3448	NIH [T32GM007601, 5R01MH086920]; Pew Scholar in the Biomedical Sciences program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601, P30GM103410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086920] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar in the Biomedical Sciences program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank R. Axel, E. Morrow, and members of the Barnea laboratory for critical reading of the manuscript. We thank R. Y. Korsak and M. Talay for artwork for the figures. This work was supported by NIH grants T32GM007601 (L. T.) and 5R01MH086920 (G. B.), as well as by funds from the Pew Scholar in the Biomedical Sciences program.	Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; BRITTEBO EB, 1995, PHARMACOL TOXICOL, V76, P76, DOI 10.1111/j.1600-0773.1995.tb00107.x; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nguyen MQ, 2010, J NEUROSCI, V30, P9271, DOI 10.1523/JNEUROSCI.1502-10.2010; RAMING K, 1993, NATURE, V361, P353, DOI 10.1038/361353a0; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414	26	39	39	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					197	200		10.1126/science.1248806	http://dx.doi.org/10.1126/science.1248806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723611	Green Accepted			2022-12-24	WOS:000334096300035
J	Xu, PF; Houssin, N; Ferri-Lagneau, KF; Thisse, B; Thisse, C				Xu, Peng-Fei; Houssin, Nathalie; Ferri-Lagneau, Karine F.; Thisse, Bernard; Thisse, Christine			Construction of a Vertebrate Embryo from Two Opposing Morphogen Gradients	SCIENCE			English	Article							ZEBRAFISH ORGANIZER; MOLECULAR NATURE; BMP ACTIVITY; XENOPUS; AXIS; INDUCTION; ACTIVIN; PATTERN; SQUINT; RANGE	Development of vertebrate embryos involves tightly regulated molecular and cellular processes that progressively instruct proliferating embryonic cells about their identity and behavior. Whereas numerous gene activities have been found to be essential during early embryogenesis, little is known about the minimal conditions and factors that would be sufficient to instruct pluripotent cells to organize the embryo. Here, we show that opposing gradients of bone morphogenetic protein (BMP) and Nodal, two transforming growth factor family members that act as morphogens, are sufficient to induce molecular and cellular mechanisms required to organize, in vivo or in vitro, uncommitted cells of the zebrafish blastula animal pole into a well-developed embryo.	[Xu, Peng-Fei; Houssin, Nathalie; Ferri-Lagneau, Karine F.; Thisse, Bernard; Thisse, Christine] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia	Thisse, C (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA.	christhisse@virginia.edu	Houssin, Nathalie/AAU-7200-2020	THISSE, Christine/0000-0002-8684-1681; Xu, Pengf-Fei/0000-0002-7318-8548	European Molecular Biology Organization; University of Virginia	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); University of Virginia	We thank L. Solnica-Krezel for fruitful discussion; R. Bloodgood, R. Keller, and A. Sutherland for careful reading of the manuscript; S. Snyder for technical assistance; and S. Vecchio for taking care of the fish. K.F.F.-L. was supported by the European Molecular Biology Organization. This work was supported by funds from the University of Virginia.	Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Cox WG, 1995, DEVELOPMENT, V121, P4349; DALE L, 1992, DEVELOPMENT, V115, P573; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Fauny JD, 2009, DEVELOPMENT, V136, P3811, DOI 10.1242/dev.039693; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; HO RK, 1993, SCIENCE, V261, P109, DOI 10.1126/science.8316841; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Miyagi C, 2004, J CELL BIOL, V166, P975, DOI 10.1083/jcb.200403110; Schier AF, 2001, INT J DEV BIOL, V45, P289; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; SOKOL S, 1991, NATURE, V351, P409, DOI 10.1038/351409a0; Spemann H, 2001, INT J DEV BIOL, V45, P13; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	27	64	66	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					87	89		10.1126/science.1248252	http://dx.doi.org/10.1126/science.1248252			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700857				2022-12-24	WOS:000333746100058
J	Hitti, FL; Siegelbaum, SA				Hitti, Frederick L.; Siegelbaum, Steven A.			The hippocampal CA2 region is essential for social memory	NATURE			English	Article							VASOPRESSIN 1B RECEPTOR; SYNAPTIC PLASTICITY; GENE-EXPRESSION; AREA CA2; NEURONS; CELLS; BRAIN; DORSAL; MICE; PROJECTION	The hippocampus is critical for encoding declarative memory, our repository of knowledge of who, what, where and when(1). Mnemonic information is processed in the hippocampus through several parallel routes involving distinct subregions. In the classic trisynaptic pathway, information proceeds from entorhinal cortex (EC) to dentate gyrus to CA3 and then to CA1, the main hippocampal output(2). Genetic lesions of EC(ref. 3) and hippocampal dentate gyrus (ref. 4), CA3 (ref. 5) and CA1 (ref. 6) regions have revealed their distinct functions in learning and memory. In contrast, little is known about the role of CA2, a relatively small area interposed between CA3 and CA1 that forms the nexus of a powerful disynaptic circuit linking EC input with CA1 output(7). Here we report a novel transgenic mouse line that enabled us to selectively examine the synaptic connections and behavioural role of the CA2 region in adult mice. Genetically targeted inactivation of CA2 pyramidal neurons caused a pronounced loss of social memory-the ability of an animal to remember a conspecific-with no change in sociability or several other hippocampus-dependent behaviours, including spatial and contextual memory. These behavioural and anatomical results thus reveal CA2 as a critical hub of sociocognitive memory processing.	[Hitti, Frederick L.; Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu	Core, Vector/CAF-4832-2022	Hitti, Frederick L/0000-0002-5308-9817	Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098633] Funding Source: NIH RePORTER	Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. R. Reardon for providing the rabies virus; J. Kupferman and F. Lema for experimental assistance; and C. Denny, Z. Donaldson, R. Hen, J. Gordon, J. Basu and M. Russo for discussions and comments on the manuscript. This work was supported by a Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health (F. L. H.) and the Howard Hughes Medical Institute (S.A.S.).	Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Cui ZZ, 2013, J COMP NEUROL, V521, P1844, DOI 10.1002/cne.23263; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DeVito LM, 2009, J NEUROSCI, V29, P2676, DOI 10.1523/JNEUROSCI.5488-08.2009; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Heintz N., 2003, GENSAT BRAIN ATLAS G; Hensler JG, 2006, NEUROSCI BIOBEHAV R, V30, P203, DOI 10.1016/j.neubiorev.2005.06.007; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lein E. S., 2007, ISH DATA ALLEN BRAIN; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Pan WX, 2004, PROG NEUROBIOL, V74, P127, DOI 10.1016/j.pneurobio.2004.09.003; Rasband W.S., 1997, IMAGE J; Rowland DC, 2013, J NEUROSCI, V33, P14889, DOI 10.1523/JNEUROSCI.1046-13.2013; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Stevenson EL, 2012, HORM BEHAV, V61, P277, DOI 10.1016/j.yhbeh.2011.11.009; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Young WS, 2006, NEUROSCIENCE, V143, P1031, DOI 10.1016/j.neuroscience.2006.08.040	45	464	468	10	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					88	+		10.1038/nature13028	http://dx.doi.org/10.1038/nature13028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24572357	Green Accepted			2022-12-24	WOS:000333609900048
J	Lu, A; Magupalli, VG; Ruan, J; Yin, Q; Atianand, MK; Vos, MR; Schroder, GF; Fitzgerald, KA; Wu, H; Egelman, EH				Lu, Alvin; Magupalli, Venkat Giri; Ruan, Jianbin; Yin, Qian; Atianand, Maninjay K.; Vos, Matthijn R.; Schroeder, Gunnar F.; Fitzgerald, Katherine A.; Wu, Hao; Egelman, Edward H.			Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes	CELL			English	Article							CRYSTAL-STRUCTURE; PYRIN DOMAIN; ELECTRON-MICROSCOPY; AIM2 INFLAMMASOME; PROTEIN; DEATH; OLIGOMERIZATION; AUTOINHIBITION; ACTIVATION; MUTATIONS	Inflammasomes elicit host defense inside cells by activating caspase-1 for cytokine maturation and cell death. AIM2 and NLRP3 are representative sensor proteins in two major families of inflammasomes. The adaptor protein ASC bridges the sensor proteins and caspase-1 to form ternary inflammasome complexes, achieved through pyrin domain ( PYD) interactions between sensors and ASC and through caspase activation and recruitment domain ( CARD) interactions between ASC and caspase-1. We found that PYD and CARD both form filaments. Activated AIM2 and NLRP3 nucleate PYD filaments of ASC, which, in turn, cluster the CARD of ASC. ASC thus nucleates CARD filaments of caspase-1, leading to proximity-induced activation. Endogenous NLRP3 inflammasome is also filamentous. The cryoelectron microscopy structure of ASC(PYD) filament at near-atomic resolution provides a template for homo-and hetero-PYD/PYD associations, as confirmed by structure-guided mutagenesis. We propose that ASC-dependent inflammasomes in both families share a unified assembly mechanism that involves two successive steps of nucleation-induced polymerization.	[Lu, Alvin; Magupalli, Venkat Giri; Ruan, Jianbin; Yin, Qian; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lu, Alvin; Magupalli, Venkat Giri; Ruan, Jianbin; Yin, Qian; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Atianand, Maninjay K.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Vos, Matthijn R.] FEI Co, Nanoport Europe, NL-5651 GG Eindhoven, Netherlands; [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; [Schroeder, Gunnar F.] Univ Dusseldorf, Dept Phys, D-40225 Dusseldorf, Germany; [Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Massachusetts System; University of Massachusetts Worcester; Thermo Fisher Scientific; FEI Company; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; University of Virginia	Wu, H (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu	Atianand, Maninjay/AAF-7823-2019; Fitzgerald, Katherine/ABE-6317-2020; Schröder, Gunnar F/H-5261-2013	Atianand, Maninjay/0000-0003-4135-2515; Schröder, Gunnar F/0000-0003-1803-5431; Egelman, Edward/0000-0003-4844-5212; Magupalli, Venkat/0000-0003-4638-3062; Lu, Alvin/0000-0003-2353-848X; Ruan, Jianbin/0000-0001-5843-8273; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [AI050872, EB001567, AI083713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872, R37AI050872, R01AI083713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Natacha Opalka, Seth Darst, Leona Cohen-Gould, Maria Ericsson, William Rice, and Mariena Silvestry Ramos for help with EM imaging, Harry Leung for help with confocal microscopy, Gabriel Nunez for providing cDNAs, and the National Institutes of Health for funding support (AI050872 to H.W., EB001567 to E.H.E., and AI083713 to K.A.F.).	Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bammes BE, 2012, J STRUCT BIOL, V177, P589, DOI 10.1016/j.jsb.2012.01.008; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; EGELMAN EH, 1982, ACTA CRYSTALLOGR A, V38, P796, DOI 10.1107/S0567739482001624; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Zhou ZH, 2011, ADV PROTEIN CHEM STR, V82, P1, DOI 10.1016/B978-0-12-386507-6.00001-4	42	757	785	6	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1193	1206		10.1016/j.cell.2014.02.008	http://dx.doi.org/10.1016/j.cell.2014.02.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630722	Green Accepted, Bronze			2022-12-24	WOS:000332945100010
J	Yamamoto, J; Suh, J; Takeuchi, D; Tonegawa, S				Yamamoto, Jun; Suh, Junghyup; Takeuchi, Daigo; Tonegawa, Susumu			Successful Execution of Working Memory Linked to Synchronized High-Frequency Gamma Oscillations	CELL			English	Article							CAT VISUAL-CORTEX; TEMPORAL ASSOCIATION MEMORY; ENTORHINAL CORTEX; BEHAVING RAT; PREFRONTAL CORTEX; SINGLE NEURONS; HIPPOCAMPUS; INFORMATION; TASK; PERFORMANCE	Neuronal oscillations have been hypothesized to play an important role in cognition and its ensuing behavior, but evidence that links a specific neuronal oscillation to a discrete cognitive event is largely lacking. We measured neuronal activity in the entorhinal- hippocampal circuit while mice performed a reward-based spatial working memory task. During the memory retention period, a transient burst of high gamma synchronization preceded an animal's correct choice in both prospective planning and retrospective mistake correction, but not an animal's incorrect choice. Optogenetic inhibition of the circuit targeted to the choice point area resulted in a coordinated reduction in both high gamma synchrony and correct execution of a working-memory-guided behavior. These findings suggest that transient high gamma synchrony contributes to the successful execution of spatial working memory. Furthermore, our data are consistent with an association between transient high gamma synchrony and explicit awareness of the working memory content.	[Yamamoto, Jun; Suh, Junghyup; Takeuchi, Daigo; Tonegawa, Susumu] MIT, RIKEN Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA; [Yamamoto, Jun; Suh, Junghyup; Takeuchi, Daigo; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, RIKEN Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Dept Biol, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Suh, Junghyup/AAO-8265-2020	Yamamoto, Jun/0000-0002-9681-2841	RIKEN Brain Science Institute; Picower Institute Innovation Fund; Human Frontier Science Program (HFSP) fellowship	RIKEN Brain Science Institute; Picower Institute Innovation Fund; Human Frontier Science Program (HFSP) fellowship(Human Frontier Science Program)	We thank G. Das for the viral construction; C. Lovett, M. Serock, C. Ragion, N. Nayyar, and K. Kajikawa for help with the viral injections and histology; J. Young, C. MacDonald, M. Pignatelli, T. Kitamura, and C. Yokoyama for comments and discussions on the manuscript; and other members of the Tonegawa lab for their support. This work was supported by the RIKEN Brain Science Institute (to S.T.), the Picower Institute Innovation Fund (to S T.), and the Human Frontier Science Program (HFSP) fellowship (to D.T.).	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BRAGIN A, 1995, J NEUROSCI, V15, P47; Carr MF, 2012, NEURON, V75, P700, DOI 10.1016/j.neuron.2012.06.014; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dolleman-Van Der Weel M. J., 1996, Journal of Comparative Neurology, V364, P637, DOI 10.1002/(SICI)1096-9861(19960122)364:4<637::AID-CNE3>3.0.CO;2-4; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hirabayashi T, 2013, NEURON, V77, P192, DOI 10.1016/j.neuron.2012.10.031; Hirabayashi T, 2010, J NEUROSCI, V30, P10407, DOI 10.1523/JNEUROSCI.0135-10.2010; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jutras MJ, 2009, J NEUROSCI, V29, P12521, DOI 10.1523/JNEUROSCI.0640-09.2009; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kitamura T, 2014, SCIENCE, V343, P896, DOI 10.1126/science.1244634; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; MITZDORF U, 1978, EXP BRAIN RES, V33, P371; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Van Der Werf YD, 2003, CORTEX, V39, P1047, DOI 10.1016/S0010-9452(08)70877-3; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081	41	212	215	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 8	2014	157	4					845	857		10.1016/j.cell.2014.04.009	http://dx.doi.org/10.1016/j.cell.2014.04.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG9UN	24768692	Bronze, Green Submitted			2022-12-24	WOS:000335765500013
J	Bendall, SC; Davis, KL; Amir, ED; Tadmor, MD; Simonds, EF; Chen, TJ; Shenfeld, DK; Nolan, GP; Pe'er, D				Bendall, Sean C.; Davis, Kara L.; Amir, El-ad David; Tadmor, Michelle D.; Simonds, Erin F.; Chen, Tiffany J.; Shenfeld, Daniel K.; Nolan, Garry P.; Pe'er, Dana			Single-Cell Trajectory Detection Uncovers Progression and Regulatory Coordination in Human B Cell Development	CELL			English	Article							MASS CYTOMETRY; IMMUNOGLOBULIN; LYMPHOCYTES; MURINE; STAT5	Tissue regeneration is an orchestrated progression of cells from an immature state to amature one, conventionally represented as distinctive cell subsets. A continuum of transitional cell states exists between these discrete stages. We combine the depth of single-cell mass cytometry and an algorithm developed to leverage this continuumby aligning single cells of a given lineage onto a unified trajectory that accurately predicts the developmental path de novo. Applied to human B cell lymphopoiesis, the algorithm (termed Wanderlust) constructed trajectories spanning from hematopoietic stem cells through to naive B cells. This trajectory revealed nascent fractions of B cell progenitors and aligned them with developmentally cued regulatory signaling including IL-7/STAT5 and cellular events such as immunoglobulin rearrangement, highlighting checkpoints across which regulatory signals are rewired paralleling changes in cellular state. This study provides a comprehensive analysis of human B lymphopoiesis, laying a foundation to apply this approach to other tissues and "corrupted'' developmental processes including cancer.	[Bendall, Sean C.; Davis, Kara L.; Simonds, Erin F.; Chen, Tiffany J.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Bendall, Sean C.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Davis, Kara L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Amir, El-ad David; Tadmor, Michelle D.; Shenfeld, Daniel K.; Pe'er, Dana] Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA; [Chen, Tiffany J.] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Chen, Tiffany J.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Columbia University; Stanford University; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu; dpeer@biology.columbia.edu	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Bendall, Sean/0000-0003-1341-2453; Pe'er, Dana/0000-0002-9259-8817; Nolan, Garry/0000-0002-8862-9043; Simonds, Erin/0000-0002-3497-4861	St. Baldrick's Foundation Scholar Award; Alex's Lemonade Stand Young Investigator Award; Lucile Packard Foundation for Children's Health; NIH-NCATS-CTSA [UL1 TR001085]; Child Health Research Institute of Stanford University; Damon Runyon Cancer Research Foundation Fellowship [DRG-2017-09]; NIH [K99GM104148-01, S10 SIG S10RR027582-01, 152175.5041015.0412, DP2-OD002414-01, U54CA121852-01A1]; National Defense Science & Engineering Graduate Fellowship Program; Stanford University Graduate Fellowship; Google Anita Borg Memorial Scholarship; William Lawrence and Blanche Hughes Foundation; Entertainment Industry Foundation; Northrup-Grumman Corp; Alliance for Lupus Research; Lymphoma Research Foundation; Bill and Melinda Gates Foundation; NSF [MCB-1149728]; Packard Fellowship for Science and Engineering;  [0158 G KB065];  [1R01CA130826];  [5U54CA143907NIH];  [CIRM: DR1-01477];  [HEALTH.2010.1.2-1];  [HHSF223201210194C - FDA: BAA-12-00118];  [HHSN272200700038C];  [N01-HV-00242];  [NIH 41000411217];  [NIH 5-24927];  [P01 CA034233-22A1];  [PN2EY018228];  [RB2-01592];  [U19 AI057229];  [U54CA149145];  [W81XWH-12-1-0591]; NATIONAL CANCER INSTITUTE [P01CA034233, U54CA143907, U54CA121852, R01CA164729, U54CA149145, R01CA130826] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027582, UL1RR025744] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM104148, R00GM104148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER; Direct For Biological Sciences [1149728] Funding Source: National Science Foundation	St. Baldrick's Foundation Scholar Award; Alex's Lemonade Stand Young Investigator Award; Lucile Packard Foundation for Children's Health; NIH-NCATS-CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Child Health Research Institute of Stanford University; Damon Runyon Cancer Research Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science & Engineering Graduate Fellowship Program; Stanford University Graduate Fellowship(Stanford University); Google Anita Borg Memorial Scholarship(Google Incorporated); William Lawrence and Blanche Hughes Foundation; Entertainment Industry Foundation; Northrup-Grumman Corp; Alliance for Lupus Research; Lymphoma Research Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NSF(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We would like to thank Omer Angel, Antonio de-la-Hera, Astraea Jager, Ulf Klein, Smita Krishnaswamy, Jacob Levine, Eva Sanz, Peter Sims, and Angelica Trejo for their intellectual and technical contributions. K.L.D. is supported by a St. Baldrick's Foundation Scholar Award, Alex's Lemonade Stand Young Investigator Award and the Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA UL1 TR001085 and Child Health Research Institute of Stanford University. S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09) and the NIH K99GM104148-01. E.D.A. is a Howard Hughes Medical Institute International Student Research Fellow. T.J.C. is supported by National Defense Science & Engineering Graduate Fellowship Program, Stanford University Graduate Fellowship, and the Google Anita Borg Memorial Scholarship. This work was supported by 0158 G KB065; 1R01CA130826; 5U54CA143907NIH; CIRM: DR1-01477; HEALTH.2010.1.2-1; HHSF223201210194C - FDA: BAA-12-00118; HHSN272200700038C; N01-HV-00242; NIH 41000411217; NIH 5-24927; P01 CA034233-22A1; PN2EY018228; RB2-01592; U19 AI057229; U54CA149145; W81XWH-12-1-0591 OCRP-TIA NWC; NIH S10 SIG S10RR027582-01, William Lawrence and Blanche Hughes Foundation, Entertainment Industry Foundation, Northrup-Grumman Corp, Alliance for Lupus Research, Lymphoma Research Foundation, Bill and Melinda Gates Foundation, NIH 152175.5041015.0412 and the Rachford and Carlota A. Harris Endowment to G.P.N. This work was supported by NSF MCB-1149728, NIH DP2-OD002414-01, NIH U54CA121852-01A1 to D.P. D.P. holds a Packard Fellowship for Science and Engineering. G.P.N. has personal financial interest in and S.C.B. is a paid consultant for the company DVS Sciences, the manufacturers that produced some of the reagents and instrumentation used in this manuscript.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Cobaleda C, 2009, BIOESSAYS, V31, P600, DOI 10.1002/bies.200800234; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Johnson SE, 2005, J IMMUNOL, V175, P7325, DOI 10.4049/jimmunol.175.11.7325; Kang JS, 2004, CURR OPIN IMMUNOL, V16, P180, DOI 10.1016/j.coi.2004.02.002; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202	16	545	557	5	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					714	725		10.1016/j.cell.2014.04.005	http://dx.doi.org/10.1016/j.cell.2014.04.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766814	Bronze, Green Accepted			2022-12-24	WOS:000335392100019
J	Wahlquist, C; Jeong, D; Rojas-Munoz, A; Kho, C; Lee, A; Mitsuyama, S; van Mil, A; Park, WJ; Sluijter, JPG; Doevendans, PAF; Hajjar, RJ; Mercola, M				Wahlquist, Christine; Jeong, Dongtak; Rojas-Munoz, Agustin; Kho, Changwon; Lee, Ahyoung; Mitsuyama, Shinichi; van Mil, Alain; Park, Woo Jin; Sluijter, Joost P. G.; Doevendans, Pieter A. F.; Hajjar, Roger J.; Mercola, Mark			Inhibition of miR-25 improves cardiac contractility in the failing heart	NATURE			English	Article							MICRORNA EXPRESSION; FAILURE; DYSFUNCTION; SIGNATURE; REVERSAL; MYOCYTES; REVEALS; TARGETS; SERCA2A; NOX4	Heart failure is characterized by a debilitating decline in cardiac function(1), and recent clinical trial results indicate that improving the contractility of heart muscle cells by boosting intracellular calcium handling might be an effective therapy(2,3). MicroRNAs (miRNAs) are dysregulated in heart failure(4,5) but whether they control contractility or constitute therapeutic targets remains speculative. Using high-throughput functional screening of the human microRNAome, here we identify miRNAs that suppress intracellular calcium handling in heart muscle by interacting with messenger RNA encoding the sarcoplasmic reticulum calcium uptake pump SERCA2a (also known as ATP2A2). Of 875 miRNAs tested, miR-25 potently delayed calcium uptake kinetics in cardiomyocytes in vitro and was upregulated in heart failure, both in mice and humans. Whereas adeno-associated virus 9 (AAV9)-mediated overexpression of miR-25 in vivo resulted in a significant loss of contractile function, injection of an antisense oligonucleotide (antagomiR) against miR-25 markedly halted established heart failure in a mouse model, improving cardiac function and survival relative to a control antagomiR oligonucleotide. These data reveal that increased expression of endogenous miR-25 contributes to declining cardiac function during heart failure and suggest that it might be targeted therapeutically to restore function.	[Wahlquist, Christine; Rojas-Munoz, Agustin; van Mil, Alain; Mercola, Mark] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA; [Wahlquist, Christine; Rojas-Munoz, Agustin; van Mil, Alain; Mercola, Mark] Sanford Burnham Med Res Inst, Muscle Dev & Regenerat Program, La Jolla, CA 92037 USA; [Jeong, Dongtak; Kho, Changwon; Lee, Ahyoung; Mitsuyama, Shinichi; Hajjar, Roger J.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA; [van Mil, Alain; Sluijter, Joost P. G.; Doevendans, Pieter A. F.] Univ Med Ctr Utrecht, Dept Cardiol, NL-3584 CX Utrecht, Netherlands; [van Mil, Alain; Sluijter, Joost P. G.; Doevendans, Pieter A. F.] ICIN Netherlands Heart Inst, NL-3584 CX Utrecht, Netherlands; [Park, Woo Jin] Gwangju Inst Sci & Technol, Global Res Lab, Kwangju 500712, South Korea	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Icahn School of Medicine at Mount Sinai; Utrecht University; Utrecht University Medical Center; Gwangju Institute of Science & Technology (GIST)	Mercola, M (corresponding author), Univ Calif San Diego, Dept Bioengn, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mmercola@sanfordburnham.org	Jeong, Dongtak/AAK-4194-2020; Dongtak, Jeong/AGZ-5435-2022; Jeong, Dongtak/ABA-7745-2020	Jeong, Dongtak/0000-0003-4153-3498; Sluijter, Joost/0000-0003-2088-9102; van Mil, Alain/0000-0001-9906-5047	California Institute for Regenerative Medicine [RC1-000132]; National Institutes of Health (NIH) [R01HL113601, P01HL098053, R01HL108176]; Fondation Leducq; NIH [NIH R01HL093183, R01HL088434, P20HL100396, HHSN26820100045C, P50HL112324]; Global Research Laboratory Program of the South Korean Government [M6-0605-00-0001]; Netherlands Heart foundation; BioMedical Materials institute [P1.05 LUST]; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Spanish National Research Council;  [P30CA030199];  [P30AR061303]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021084] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098053, P20HL100396, R01HL093183, P50HL112324, R01HL108176, R01HL113601, R01HL088434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Research Laboratory Program of the South Korean Government; Netherlands Heart foundation(Netherlands Heart Foundation); BioMedical Materials institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Spanish National Research Council; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Aza-Blanc and F. Cerignoli; O. Kim, L. Liang and E. Kohlbrenner for their technical support; G. Christensen for providing the SERCA2a knockout mice; and H. el Azzouzi for TAC operations and histological sections. This work was supported by California Institute for Regenerative Medicine (RC1-000132), the National Institutes of Health (NIH) (R01HL113601, P01HL098053 and R01HL108176) and the Fondation Leducq to M. M.; by the NIH (NIH R01HL093183, R01HL088434, P20HL100396 and a Program of Excellence in Nanotechnology Contract no. HHSN26820100045C and P50HL112324) to R.J.H.; P30CA030199 and P30AR061303 for Sanford-Burnham Medical Research Institute functional genomics and cytometry. W.J.P. was supported by the Global Research Laboratory Program of the South Korean Government (M6-0605-00-0001). J.P. G. S. and P. A. F. D. were supported by the Netherlands Heart foundation and Project P1.05 LUST of the BioMedical Materials institute co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. C. W. was supported by a fellowship from the Spanish National Research Council. A. v. M. was a Netherlands Heart Institute ICIN fellow.	Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bonow RO, 2011, BRAUNWALDS HEART DIS; Bootman MD, 2008, AM J PHYSIOL-HEART C, V294, pH579, DOI 10.1152/ajpheart.01378.2007; Cerignoli F, 2012, J PHARMACOL TOX MET, V66, P246, DOI 10.1016/j.vascn.2012.08.167; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Colas AR, 2012, GENE DEV, V26, P2567, DOI 10.1101/gad.200758.112; Dirkx E, 2013, NAT CELL BIOL, V15, P1282, DOI 10.1038/ncb2866; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Greenstein JL, 2011, CIRC RES, V108, P70, DOI 10.1161/CIRCRESAHA.110.223578; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lemons D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00223; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; McKeithan W. L., 2012, CURR PROTOC STEM CEL, V13; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmidt HHHW, 2012, CIRC RES, V111, pE15, DOI 10.1161/CIRCRESAHA.112.271957; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429; Swift F, 2012, P NATL ACAD SCI USA, V109, P3997, DOI 10.1073/pnas.1120172109; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	44	298	320	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					531	+		10.1038/nature13073	http://dx.doi.org/10.1038/nature13073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670661	Green Accepted			2022-12-24	WOS:000334741600038
J	Chapman, EG; Costantino, DA; Rabe, JL; Moon, SL; Wilusz, J; Nix, JC; Kieft, JS				Chapman, Erich G.; Costantino, David A.; Rabe, Jennifer L.; Moon, Stephanie L.; Wilusz, Jeffrey; Nix, Jay C.; Kieft, Jeffrey S.			The Structural Basis of Pathogenic Subgenomic Flavivirus RNA (sfRNA) Production	SCIENCE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; MESSENGER-RNA; WEST-NILE; MOSQUITO CELLS; DENGUE; RESISTANT; XRN1	Flaviviruses are emerging human pathogens and worldwide health threats. During infection, pathogenic subgenomic flaviviral RNAs (sfRNAs) are produced by resisting degradation by the 5'-> 3' host cell exonuclease Xrn1 through an unknown RNA structure-based mechanism. Here, we present the crystal structure of a complete Xrn1-resistant flaviviral RNA, which contains interwoven pseudoknots within a compact structure that depends on highly conserved nucleotides. The RNA's three-dimensional topology creates a ringlike conformation, with the 5' end of the resistant structure passing through the ring from one side of the fold to the other. Disruption of this structure prevents formation of sfRNA during flaviviral infection. Thus, sfRNA formation results from an RNA fold that interacts directly with Xrn1, presenting the enzyme with a structure that confounds its helicase activity.	[Chapman, Erich G.; Costantino, David A.; Rabe, Jennifer L.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Chapman, Erich G.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Moon, Stephanie L.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kieft, JS (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jeffrey.kieft@ucdenver.edu		Moon, Stephanie/0000-0002-4989-0150	University of Colorado Cancer Center [P30CA046934]; NIH award through the Rocky Mountain Regional Center of Excellence [U54 AI-065357]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108257] Funding Source: NIH RePORTER	University of Colorado Cancer Center; NIH award through the Rocky Mountain Regional Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Kieft Lab for discussions and A. Ferre-d'Amare, M. Johnston, and R. Batey for critical reading of this manuscript. The University of Colorado Denver X-ray Facility is supported by University of Colorado Cancer Center Support Grant P30CA046934. J.S.K. is an Early Career Scientist of the Howard Hughes Medical Institute. J.W. was supported by a NIH award through the Rocky Mountain Regional Center of Excellence, U54 AI-065357. Coordinates and structure factors have been deposited with Protein Data Bank accession code 4PQV.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; NAEVE CW, 1978, J VIROL, V25, P535, DOI 10.1128/JVI.25.2.535-545.1978; Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; TAKEDA H, 1978, J GEN VIROL, V38, P281, DOI 10.1099/0022-1317-38-2-281; Urosevic N, 1997, J GEN VIROL, V78, P23, DOI 10.1099/0022-1317-78-1-23; WENGLER G, 1978, VIROLOGY, V89, P423, DOI 10.1016/0042-6822(78)90185-X	19	167	170	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					307	310		10.1126/science.1250897	http://dx.doi.org/10.1126/science.1250897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744377	Green Accepted			2022-12-24	WOS:000334474500038
J	Prindle, A; Selimkhanov, J; Li, H; Razinkov, I; Tsimring, LS; Hasty, J				Prindle, Arthur; Selimkhanov, Jangir; Li, Howard; Razinkov, Ivan; Tsimring, Lev S.; Hasty, Jeff			Rapid and tunable post-translational coupling of genetic circuits	NATURE			English	Article							PROTEIN; LOGIC; ULTRASENSITIVITY; DEGRADATION; PROTEOLYSIS; SIGMA(S); BIOLOGY; RSSB	One promise of synthetic biology is the creation of genetic circuitry that enables the execution of logical programming in living cells. Such 'wet programming'is positioned to transform a wide and diverse swathe of biotechnology ranging from therapeutics and diagnostics to water treatment strategies. Although progress in the development of a library of genetic modules continues apace(1-4), a major challenge for their integration into larger circuits is the generation of sufficiently fast and precise communication between modules(5,6). Anattractive approach is to integrate engineered circuits with host processes that facilitate robust cellular signalling(7). In this context, recent studies have demonstrated that bacterial protein degradation can trigger a precise response to stress by overloading a limited supply of intracellular proteases(8-10). Here we use protease competition to engineer rapid and tunable coupling of genetic circuits across multiple spatial and temporal scales. We characterize coupling delay times that are more than an order of magnitude faster than standard transcription factor- based coupling methods (less than 1 min compared with 2040 min) and demonstrate tunability through manipulation of the linker between the protein and its degradation tag. We use this mechanism as a platform to couple genetic clocks at the intracellular and colony level, then synchronize the multi-colony dynamics to reduce variability in both clocks. We show how the coupled clock network can be used to encode independent environmental inputs into a single time series output, thus enabling frequency multiplexing (information transmitted on a common channel by distinct frequencies) in a genetic circuit context. Our results establish a general framework for the rapid and tunable coupling of genetic circuits through the use of native `queueing' processes such as competitive protein degradation.	[Prindle, Arthur; Selimkhanov, Jangir; Li, Howard; Razinkov, Ivan; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Tsimring, Lev S.; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu			National Science Foundation [MCB-1121748]; San Diego Center for Systems Biology (NIH) [P50 GM085764]; US Department of Defense National Defense Science and Engineering Graduate Fellowship; Div Of Molecular and Cellular Bioscience [1121748] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); San Diego Center for Systems Biology (NIH); US Department of Defense National Defense Science and Engineering Graduate Fellowship; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (MCB-1121748) and by the San Diego Center for Systems Biology (NIH Grant P50 GM085764) and the US Department of Defense National Defense Science and Engineering Graduate Fellowship (A.P.). We would like to thank T. Danino, M. Jin, C. Rivera, O. Din and J. De Friel for critical reading of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ferry M. S., METHODS ENZYMOL, V497, P295; Fredriksson A, 2007, GENE DEV, V21, P862, DOI 10.1101/gad.409407; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2663, DOI 10.1093/nar/gkq139; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Merrikh H, 2009, P NATL ACAD SCI USA, V106, P611, DOI 10.1073/pnas.0803665106; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Pruteanu M, 2002, MOL MICROBIOL, V45, P1701, DOI 10.1046/j.1365-2958.2002.03123.x; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	30	111	112	0	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					387	+		10.1038/nature13238	http://dx.doi.org/10.1038/nature13238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24717442	Green Accepted			2022-12-24	WOS:000334403000050
J	Corley, DA; Jensen, CD; Marks, AR; Zhao, WK; Lee, JK; Doubeni, CA; Zauber, AG; de Boer, J; Fireman, BH; Schottinger, JE; Quinn, VP; Ghai, NR; Levin, TR; Quesenberry, CP				Corley, Douglas A.; Jensen, Christopher D.; Marks, Amy R.; Zhao, Wei K.; Lee, Jeffrey K.; Doubeni, Chyke A.; Zauber, Ann G.; de Boer, Jolanda; Fireman, Bruce H.; Schottinger, Joanne E.; Quinn, Virginia P.; Ghai, Nirupa R.; Levin, Theodore R.; Quesenberry, Charles P.			Adenoma Detection Rate and Risk of Colorectal Cancer and Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONOSCOPIC MISS RATES; FLEXIBLE SIGMOIDOSCOPY; QUALITY INDICATORS; INTERVAL; SURVEILLANCE; ENDOSCOPIST; POLYPECTOMY; PREVALENCE; PREDICTORS; PREVENTION	Background The proportion of screening colonoscopic examinations performed by a physician that detect one or more adenomas (the adenoma detection rate) is a recommended quality measure. However, little is known about the association between this rate and patients' risks of a subsequent colorectal cancer (interval cancer) and death. Methods Using data from an integrated health care delivery organization, we evaluated the associations between the adenoma detection rate and the risks of colorectal cancer diagnosed 6 months to 10 years after colonoscopy and of cancer-related death. With the use of Cox regression, our estimates of attributable risk were adjusted for the demographic characteristics of the patients, indications for colonoscopy, and coexisting conditions. Results We evaluated 314,872 colonoscopies performed by 136 gastroenterologists; the adenoma detection rates ranged from 7.4 to 52.5%. During the follow-up period, we identified 712 interval colorectal adenocarcinomas, including 255 advanced-stage cancers, and 147 deaths from interval colorectal cancer. The unadjusted risks of interval cancer according to quintiles of adenoma detection rates, from lowest to highest, were 9.8, 8.6, 8.0, 7.0, and 4.8 cases per 10,000 person-years of follow-up, respectively. Among patients of physicians with adenoma detection rates in the highest quintile, as compared with patients of physicians with detection rates in the lowest quintile, the adjusted hazard ratio for any interval cancer was 0.52 (95% confidence interval [CI], 0.39 to 0.69), for advanced-stage interval cancer, 0.43 (95% CI, 0.29 to 0.64), and for fatal interval cancer, 0.38 (95% CI, 0.22 to 0.65). Each 1.0% increase in the adenoma detection rate was associated with a 3.0% decrease in the risk of cancer (hazard ratio, 0.97; 95% CI, 0.96 to 0.98). Conclusions The adenoma detection rate was inversely associated with the risks of interval colorectal cancer, advanced-stage interval cancer, and fatal interval cancer. (Funded by the Kaiser Permanente Community Benefit program and the National Cancer Institute.)	[Corley, Douglas A.; Jensen, Christopher D.; Marks, Amy R.; Zhao, Wei K.; Lee, Jeffrey K.; de Boer, Jolanda; Fireman, Bruce H.; Levin, Theodore R.; Quesenberry, Charles P.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Schottinger, Joanne E.; Quinn, Virginia P.; Ghai, Nirupa R.] Kaiser Permanente So Calif, Res & Evaluat, Pasadena, CA 91101 USA; [Doubeni, Chyke A.] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Publ Hlth, New York, NY 10021 USA	Kaiser Permanente; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center	Corley, DA (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	douglas.corley@kp.org	Doubeni, Chyke A/W-6749-2019	Doubeni, Chyke A/0000-0001-7495-0285; Barret, Maximilien/0000-0002-0566-7870; Marks, Amy/0000-0002-3047-5379	Kaiser Permanente Community Benefit program; National Cancer Institute [U54 CA163262, U24 CA171524]; NATIONAL CANCER INSTITUTE [P30CA008748, U24CA171524, U01CA151736, U54CA163262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007007] Funding Source: NIH RePORTER	Kaiser Permanente Community Benefit program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the Kaiser Permanente Community Benefit program and the National Cancer Institute (U54 CA163262 [PROSPR] and U24 CA171524).	ADAMO MB, 2013, 2013 SEER PROGRAM CO; Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Bretthauer M, 2003, SCAND J GASTROENTERO, V38, P1268, DOI 10.1080/00365520310006513; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Cooper GS, 2012, CANCER-AM CANCER SOC, V118, P3044, DOI 10.1002/cncr.26602; Corley DA, 2013, CLIN GASTROENTEROL H, V11, P172, DOI 10.1016/j.cgh.2012.09.010; Corley DA, 2011, GASTROINTEST ENDOSC, V74, P656, DOI 10.1016/j.gie.2011.04.017; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Gordon N, 2006, KAISER PERMANENTE ME; Hewett David G, 2010, Gastrointest Endosc Clin N Am, V20, P673, DOI 10.1016/j.giec.2010.07.011; HIXSON LJ, 1990, JNCI-J NATL CANCER I, V82, P1769, DOI 10.1093/jnci/82.22.1769; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Imperiale TF, 2009, NEW ENGL J MED, V361, P2004; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Leaper M, 2004, ENDOSCOPY, V36, P499, DOI 10.1055/s-2004-814399; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Meester RG, 2013, GASTROENTEROLOGY, V144, pS190; Nakao SK, 2013, SURG ENDOSC, V27, P768, DOI 10.1007/s00464-012-2543-6; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Rex DK, 2006, AM J GASTROENTEROL, V101, P873, DOI 10.1111/j.1572-0241.2006.00673.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Rogal SS, 2013, CLIN GASTROENTEROL H, V11, P73, DOI 10.1016/j.cgh.2012.08.002; Sanchez W, 2004, AM J GASTROENTEROL, V99, P1941, DOI 10.1111/j.1572-0241.2004.40569.x; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Schoen RE, 2003, JAMA-J AM MED ASSOC, V290, P41, DOI 10.1001/jama.290.1.41; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh H, 2010, AM J GASTROENTEROL, V105, P2588, DOI 10.1038/ajg.2010.390; Wang YZR, 2013, AM J GASTROENTEROL, V108, P444, DOI 10.1038/ajg.2012.429; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; 2010, CPT CURR PROC TERM 2	44	1153	1199	6	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1298	1306		10.1056/NEJMoa1309086	http://dx.doi.org/10.1056/NEJMoa1309086			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693890	Green Accepted			2022-12-24	WOS:000333830000008
J	Cundy, T; Ackermann, E; Ryan, EA				Cundy, Tim; Ackermann, Evan; Ryan, Edmond A.			TOO MUCH MEDICINE Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLUCOSE-TOLERANCE; INTERNATIONAL ASSOCIATION; PREPREGNANCY OVERWEIGHT; RANDOMIZED-TRIAL; BIRTH-WEIGHT; PREGNANCY; MELLITUS; DIAGNOSIS; WOMEN; CLASSIFICATION		[Cundy, Tim] Univ Auckland, Dept Med, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Ackermann, Evan] Condamine Med Ctr, Warwick, Qld, Australia; [Ackermann, Evan; Ryan, Edmond A.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Auckland; University of Alberta	Ryan, EA (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada.	edmond.ryan@ualberta.ca		Cundy, Timothy/0000-0003-4890-9400				Balion CM, 2007, CLIN CHEM LAB MED, V45, P1180, DOI 10.1515/CCLM.2007.250; Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; CARRINGTON ER, 1957, OBSTET GYNECOL, V9, P664, DOI 10.1097/00006250-195706000-00008; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Cutchie WA, 2006, DIABETIC MED, V23, P460, DOI 10.1111/j.1464-5491.2006.01850.x; Falavigna M, 2012, DIABETES RES CLIN PR, V98, P396, DOI 10.1016/j.diabres.2012.09.002; Farrell T, 2002, DIABETIC MED, V19, P322, DOI 10.1046/j.1464-5491.2002.00700.x; Griffin ME, 2000, DIABETIC MED, V17, P26, DOI 10.1046/j.1464-5491.2000.00214.x; Grimes DA, 2012, OBSTET GYNECOL, V120, P920, DOI 10.1097/AOG.0b013e31826af61a; HARRIS M, 1979, DIABETES, V28, P1039; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mission JF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.048; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; NEIGER R, 1991, AM J OBSTET GYNECOL, V165, P787, DOI 10.1016/0002-9378(91)90418-Q; Pirkola J, 2010, J CLIN ENDOCR METAB, V95, P772, DOI 10.1210/jc.2009-1075; Quinlivan JA, 2011, AUST NZ J OBSTET GYN, V51, P141, DOI 10.1111/j.1479-828X.2010.01268.x; Ricart W, 2005, DIABETOLOGIA, V48, P1736, DOI 10.1007/s00125-005-1877-1; Ryan EA, 2011, DIABETOLOGIA, V54, P480, DOI 10.1007/s00125-010-2005-4; SPRATT IL, 1980, DIABETES CARE, V3, P499; Thompson D, 2013, CAN J DIABETES, V37, pS168, DOI 10.1016/j.jcjd.2013.01.044; THOMPSON DM, 1994, OBSTET GYNECOL, V83, P362; Vandorsten James P, 2013, NIH Consens State Sci Statements, V29, P1; Werner EF, 2012, DIABETES CARE, V35, P529, DOI 10.2337/dc11-1643; WHO Study Group, 2013, DIAGN CRIT CLASS HYP	29	91	91	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g1567	10.1136/bmj.g1567	http://dx.doi.org/10.1136/bmj.g1567			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24618099				2022-12-24	WOS:000333032100001
J	Bald, T; Quast, T; Landsberg, J; Rogava, M; Glodde, N; Lopez-Ramos, D; Kohlmeyer, J; Riesenberg, S; van den Boorn-Konijnenberg, D; Homig-Holzel, C; Reuten, R; Schadow, B; Weighardt, H; Wenzel, D; Helfrich, I; Schadendorf, D; Bloch, W; Bianchi, ME; Lugassy, C; Barnhill, RL; Koch, M; Fleischmann, BK; Forster, I; Kastenmuller, W; Kolanus, W; Holzel, M; Gaffal, E; Tuting, T				Bald, Tobias; Quast, Thomas; Landsberg, Jennifer; Rogava, Meri; Glodde, Nicole; Lopez-Ramos, Dorys; Kohlmeyer, Judith; Riesenberg, Stefanie; van den Boorn-Konijnenberg, Debby; Hoemig-Hoelzel, Cornelia; Reuten, Raphael; Schadow, Benjamin; Weighardt, Heike; Wenzel, Daniela; Helfrich, Iris; Schadendorf, Dirk; Bloch, Wilhelm; Bianchi, Marco E.; Lugassy, Claire; Barnhill, Raymond L.; Koch, Manuel; Fleischmann, Bernd K.; Foerster, Irmgard; Kastenmueller, Wolfgang; Kolanus, Waldemar; Hoelzel, Michael; Gaffal, Evelyn; Tueting, Thomas			Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma	NATURE			English	Article							CIRCULATING TUMOR-CELLS; MALIGNANT-MELANOMA; CYTOKINE RELEASE; ANGIOGENESIS; NEUTROPHILS; EXPRESSION; PROTEIN; IMMUNE; STAGE; MOUSE	Intermittent intense ultraviolet (UV) exposure represents an important aetiological factor in the development of malignant melanoma(1). The ability of UV radiation to cause tumour-initiating DNA mutations in melanocytes is now firmly established(2), but how the microenvironmental effects of UV radiation(3,4) influence melanoma pathogenesis is not fully understood. Here we report that repetitive UV exposure of primary cutaneous melanomas in a genetically engineered mouse model(5) promotes metastatic progression, independent of its tumour-initiating effects. UV irradiation enhanced the expansion of tumour cells along abluminal blood vessel surfaces and increased the number of lung metastases. This effect depended on the recruitment and activation of neutrophils, initiated by the release of high mobility group box 1 (HMGB1) from UV-damaged epidermal keratinocytes and driven by Toll-like receptor 4 (TLR4). The UV-induced neutrophilic inflammatory response stimulated angiogenesis and promoted the ability of melanoma cells to migrate towards endothelial cells and use selective motility cues on their surfaces. Our results not only reveal how UV irradiation of epidermal keratinocytes is sensed by the innate immune system, but also show that the resulting inflammatory response catalyses reciprocal melanoma-endothelial cell interactions leading to perivascular invasion, a phenomenon originally described as angiotropism in human melanomas by histopathologists(6). Angiotropism represents a hitherto underappreciated mechanism of metastasis(7) that also increases the likelihood of intravasation and haematogenous dissemination. Consistent with our findings, ulcerated primary human melanomas with abundant neutrophils and reactive angiogenesis frequently show angiotropism and a high risk for metastases. Our work indicates that targeting the inflammation-induced phenotypic plasticity of melanoma cells and their association with endothelial cells represent rational strategies to specifically interfere with metastatic progression.	[Bald, Tobias; Landsberg, Jennifer; Rogava, Meri; Glodde, Nicole; Lopez-Ramos, Dorys; Kohlmeyer, Judith; Gaffal, Evelyn; Tueting, Thomas] Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53115 Bonn, Germany; [Quast, Thomas; Schadow, Benjamin; Weighardt, Heike; Foerster, Irmgard; Kolanus, Waldemar] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany; [Riesenberg, Stefanie; van den Boorn-Konijnenberg, Debby; Hoemig-Hoelzel, Cornelia; Hoelzel, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53105 Bonn, Germany; [Reuten, Raphael; Koch, Manuel] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Wenzel, Daniela; Fleischmann, Bernd K.] Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany; [Helfrich, Iris; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany; [Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Dept Mol & Cellular Sport Med, D-50933 Cologne, Germany; [Bianchi, Marco E.] San Raffaele Univ & Sci Inst, Div Genet & Cell Biol, I-20132 Milan, Italy; [Lugassy, Claire; Barnhill, Raymond L.] Univ Calif Los Angeles, Med Ctr, Jonsson Comprehens Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kastenmueller, Wolfgang] Univ Bonn, Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; University of Bonn; University of Duisburg Essen; German Sport University Cologne; Vita-Salute San Raffaele University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Bonn	Holzel, M (corresponding author), Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53105 Bonn, Germany.	michael.hoelzel@ukb.uni-bonn.de; evelyn.gaffal@ukb.uni-bonn.de; thomas.tueting@ukb.uni-bonn.de	Reuten, Raphael/AAA-3235-2022; Landsberg, Jennifer/AAF-5113-2019; Schadendorf, Dirk/AAE-8206-2019; Bald, Tobias/H-9525-2018; Koch, Manuel/AAG-9914-2021; Bianchi, Marco Emilio/K-3417-2018; Wenzel, Daniela/B-7613-2014; Förster, Irmgard/P-8545-2016; Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022	Reuten, Raphael/0000-0002-9434-4108; Bald, Tobias/0000-0003-0061-235X; Koch, Manuel/0000-0002-2962-7814; Bianchi, Marco Emilio/0000-0002-5329-6445; Wenzel, Daniela/0000-0003-1100-6363; Förster, Irmgard/0000-0002-7644-5642; Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Sirokay, Judith/0000-0003-3945-845X; Rogava, Meri/0000-0002-0314-5323	Deutsche Krebshilfe P9 in the Melanoma Research Network; DFG [SFB832, SFB704, HO 4281/2-1, SFB829, SFB829 Z2]; BONFOR; NRW junior research group; Jurgen Manchot Stiftung; AIRC	Deutsche Krebshilfe P9 in the Melanoma Research Network(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); BONFOR; NRW junior research group; Jurgen Manchot Stiftung; AIRC(Fondazione AIRC per la ricerca sul cancro)	We would like to thank the following individuals for their support: G. Merlino, M. Barbacid, A. Nagy, M. Gertsenstein and J. Takeda for generously providing genetically engineered mice; S. Bald, A. Sporleder, C. Lemke, T. Artz and P. Aymans for managing the mouse colony and performing tumour analyses. This research was funded in part by the following grants: Deutsche Krebshilfe P9 in the Melanoma Research Network and DFG A12 in the SFB832 as well as A22 in the SFB704 to T.T., BONFOR to J.L., J.K. and C.H.-H., DFG SFB832 core support and HO 4281/2-1 to M.H., DFG A7 in the SFB832 and A2 in the SFB829 to M.K., DFG A8 in the SFB704 to W. Ko., DFG A1 in the SFB704 to I.F., DFG SFB829 Z2 to W.B., NRW junior research group to D.W., Jurgen Manchot Stiftung to H.W. and AIRC to M.E.B. Additionally, the DFG supports I.F., W.Ka., W.Ko., M.H. and T.T. as members of the Excellence Cluster ImmunoSensation.	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Barnhill R, 2002, J INVEST DERMATOL, V119, P705, DOI 10.1046/j.1523-1747.2002.01871.x; Barnhill RL, 2004, PATHOLOGY, V36, P485, DOI 10.1080/00313020412331282708; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Bloch W, 2000, FASEB J, V14, P2373; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Eggermont AMM, 2012, EUR J CANCER, V48, P218, DOI 10.1016/j.ejca.2011.09.028; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gaffal E, 2013, J IMMUNOL, V190, P4929, DOI 10.4049/jimmunol.1201777; Gaffal E, 2011, INT J CANCER, V129, P285, DOI 10.1002/ijc.25913; Gais P, 2012, J IMMUNOL, V188, P5833, DOI 10.4049/jimmunol.1200038; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo ZS, 2013, AM J CANCER RES, V3, P1; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Haass NK, 2005, J INVEST DERM SYMP P, V10, P153, DOI 10.1111/j.1087-0024.2005.200407.x; Hiratsuka S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2856; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jablonska J, 2010, J CLIN INVEST, V120, P1151, DOI 10.1172/JCI37223; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kholmanskikh O, 2010, INT J CANCER, V127, P1625, DOI 10.1002/ijc.25182; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kirschmann DA, 2012, CLIN CANCER RES, V18, P2726, DOI 10.1158/1078-0432.CCR-11-3237; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lugassy C, 2013, PIGM CELL MELANOMA R, V26, P746, DOI 10.1111/pcmr.12120; Lugassy C, 2013, CANCER MICROENVIRON, V6, P19, DOI 10.1007/s12307-012-0128-5; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Nagy N, 2009, DEV BIOL, V330, P263, DOI 10.1016/j.ydbio.2009.03.025; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Schmidt H, 2007, J CLIN ONCOL, V25, P1562, DOI 10.1200/JCO.2006.09.0274; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; TRONNIER M, 1995, J INVEST DERMATOL, V104, P475, DOI 10.1111/1523-1747.ep12605910; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	51	412	429	2	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					109	+		10.1038/nature13111	http://dx.doi.org/10.1038/nature13111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572365				2022-12-24	WOS:000332224400052
J	Signer, RAJ; Magee, JA; Salic, A; Morrison, SJ				Signer, Robert A. J.; Magee, Jeffrey A.; Salic, Adrian; Morrison, Sean J.			Haematopoietic stem cells require a highly regulated protein synthesis rate	NATURE			English	Article							DIAMOND-BLACKFAN ANEMIA; TRANSLATIONAL CONTROL; PROTEASOME ACTIVITY; PROGENITOR CELLS; S19 DEFICIENCY; MTOR PATHWAY; SELF-RENEWAL; BONE-MARROW; IN-VIVO; PTEN	Many aspects of cellular physiology remain unstudied in somatic stem cells, for example, there are almost no data on protein synthesis in any somatic stem cell. Here we set out to compare protein synthesis in haematopoietic stem cells (HSCs) and restricted haematopoietic progenitors. We found that the amount of protein synthesized per hour in HSCs in vivo was lower than in most other haematopoietic cells, even if we controlled for differences in cell cycle status or forced HSCs to undergo self-renewing divisions. Reduced ribosome function in Rpl24(Bst/+) mice further reduced protein synthesis in HSCs and impaired HSC function. Pten deletion increased protein synthesis in HSCs but also reduced HSC function. Rpl24(Bst/+) cell-autonomously rescued the effects of Pten deletion in HSCs; blocking the increase in protein synthesis, restoring HSC function, and delaying leukaemogenesis. Pten deficiency thus depletes HSCs and promotes leukaemia partly by increasing protein synthesis. Either increased or decreased protein synthesis impairs HSC function.	[Signer, Robert A. J.; Magee, Jeffrey A.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA; [Salic, Adrian] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	Morrison, Sean/ABD-5326-2021; Salic, Adrian/GXG-1611-2022	Morrison, Sean/0000-0003-1587-8329; Signer, Robert/0000-0003-3286-1334	Cancer Prevention and Research Institute of Texas; National Institute on Aging [R37 AG024945]; Leukemia & Lymphoma Society [5541-11]; Canadian Institutes of Health Research [MFE-106993]; UT Southwestern K12 Pediatrics Training Grant [K12-HD068369]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024945] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UT Southwestern K12 Pediatrics Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	S.J.M. is a Howard Hughes Medical Institute Investigator, the Mary McDermott Cook Chair in Pediatric Genetics, and the director of the Hamon Laboratory for Stem Cells and Cancer. This work was supported by the Cancer Prevention and Research Institute of Texas and the National Institute on Aging (R37 AG024945). R.A.J.S. was supported by fellowships from the Leukemia & Lymphoma Society (5541-11) and the Canadian Institutes of Health Research (MFE-106993). J.A.M. was supported by the UT Southwestern K12 Pediatrics Training Grant (K12-HD068369). We thank A. Pineda, K. Cowan, E. Daniel, M. Acar, H. Oguro, J. Peyer, K. Rajagopalan, M. Agathocleous and E. Piskounova for technical support and advice; N. Loof and the Moody Foundation Flow Cytometry Facility, L. Hynan and J. Reisch for advice regarding statistics; J. Shelton for histology; and R. Coolon, S. Manning, M. Gross and K. Correll for mouse colony management.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Fumagalli S, 2011, SEMIN HEMATOL, V48, P97, DOI 10.1053/j.seminhematol.2011.02.004; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huang J, 2012, NAT MED, V18, P1778, DOI 10.1038/nm.2984; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Payne EM, 2012, BLOOD, V120, P2214, DOI 10.1182/blood-2011-10-382986; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Sakamoto KM, 2010, BIOL BLOOD MARROW TR, V16, pS12, DOI 10.1016/j.bbmt.2009.09.012; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sen S, 2011, BLOOD, V118, P6407, DOI 10.1182/blood-2011-02-335190; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Starck SR, 2004, CHEM BIOL, V11, P999, DOI 10.1016/j.chembiol.2004.05.011; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	47	356	362	4	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					49	+		10.1038/nature13035	http://dx.doi.org/10.1038/nature13035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670665	Green Accepted, Green Submitted			2022-12-24	WOS:000335199100037
J	Karaca, E; Weitzer, S; Pehlivan, D; Shiraishi, H; Gogakos, T; Hanada, T; Jhangiani, SN; Wiszniewski, W; Withers, M; Campbell, IM; Erdin, S; Isikay, S; Franco, LM; Gonzaga-Jauregui, C; Gambin, T; Gelowani, V; Hunter, JV; Yesil, G; Koparir, E; Yilmaz, S; Brown, M; Briskin, D; Hafner, M; Morozov, P; Farazi, TA; Bernreuther, C; Glatzel, M; Trattnig, S; Friske, J; Kronnerwetter, C; Bainbridge, MN; Gezdirici, A; Seven, M; Muzny, DM; Boerwinkle, E; Ozen, M; Clausen, T; Tuschl, T; Yuksel, A; Hess, A; Gibbs, RA; Martinez, J; Penninger, JM; Lupski, JR				Karaca, Ender; Weitzer, Stefan; Pehlivan, Davut; Shiraishi, Hiroshi; Gogakos, Tasos; Hanada, Toshikatsu; Jhangiani, Shalini N.; Wiszniewski, Wojciech; Withers, Marjorie; Campbell, Ian M.; Erdin, Serkan; Isikay, Sedat; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Gambin, Tomasz; Gelowani, Violet; Hunter, Jill V.; Yesil, Gozde; Koparir, Erkan; Yilmaz, Sarenur; Brown, Miguel; Briskin, Daniel; Hafner, Markus; Morozov, Pavel; Farazi, Thalia A.; Bernreuther, Christian; Glatzel, Markus; Trattnig, Siegfried; Friske, Joachim; Kronnerwetter, Claudia; Bainbridge, Matthew N.; Gezdirici, Alper; Seven, Mehmet; Muzny, Donna M.; Boerwinkle, Eric; Ozen, Mustafa; Clausen, Tim; Tuschl, Thomas; Yuksel, Adnan; Hess, Andreas; Gibbs, Richard A.; Martinez, Javier; Penninger, Josef M.; Lupski, James R.		Baylor Hopkins Ctr Mendelian	Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function	CELL			English	Article							CAUSE PONTOCEREBELLAR HYPOPLASIA; SYNTHETASE MUTATIONS; PROTEIN FUNCTION; GENE; DISEASE; NEUROPATHY; COMPLEX	CLP1 is a RNA kinase involved in tRNA splicing. Recently, CLP1 kinase-dead mice were shown to display a neuromuscular disorder with loss of motor neurons and muscle paralysis. Human genome analyses now identified a CLP1 homozygous missense mutation (p. R140H) in five unrelated families, leading to a loss of CLP1 interaction with the tRNA splicing endonuclease (TSEN) complex, largely reduced pretRNA cleavage activity, and accumulation of linear tRNA introns. The affected individuals develop severe motor-sensory defects, cortical dysgenesis, and microcephaly. Mice carrying kinase-dead CLP1 also displayed microcephaly and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons. Our data elucidate a neurological syndrome defined by CLP1 mutations that impair tRNA splicing. Reduction of a founder mutation to homozygosity illustrates the importance of rare variations in disease and supports the clan genomics hypothesis.	[Karaca, Ender; Pehlivan, Davut; Wiszniewski, Wojciech; Withers, Marjorie; Campbell, Ian M.; Franco, Luis M.; Gonzaga-Jauregui, Claudia; Gambin, Tomasz; Gelowani, Violet; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Dept Human Mol Genet, Dept Mol & Human Genet, Houston, TX 77030 USA; [Karaca, Ender; Weitzer, Stefan; Shiraishi, Hiroshi; Hanada, Toshikatsu; Martinez, Javier; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria; [Gogakos, Tasos; Brown, Miguel; Briskin, Daniel; Hafner, Markus; Morozov, Pavel; Farazi, Thalia A.; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Jhangiani, Shalini N.; Bainbridge, Matthew N.; Muzny, Donna M.; Boerwinkle, Eric; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Erdin, Serkan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Isikay, Sedat] Gaziantep Childrens Hosp, TR-27560 Gaziantep, Turkey; [Franco, Luis M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Yesil, Gozde] Bezmialem Univ, Dept Med Genet, D-52425 Istanbul, Turkey; [Koparir, Erkan; Gezdirici, Alper; Seven, Mehmet; Ozen, Mustafa; Yuksel, Adnan] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, D-52425 Istanbul, Turkey; [Yilmaz, Sarenur] Istanbul Medeniyet Univ, Fac Med, Dept Med Genet, D-52425 Istanbul, Turkey; [Bernreuther, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Trattnig, Siegfried; Friske, Joachim; Kronnerwetter, Claudia] Med Univ Vienna, MR Ctr Excellence, Dept Radiobiol, A-1090 Vienna, Austria; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Clausen, Tim] Inst Mol Pathol, A-1030 Vienna, Austria; [Hess, Andreas] Univ Erlangen Nurnberg, Inst Expt Pharmacol, D-91054 Erlangen, Germany; [Hess, Andreas] Vienna BioCtr, CSF, A-1030 Vienna, Austria; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Hanada, Toshikatsu] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto 6068507, Japan	Baylor College of Medicine; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Howard Hughes Medical Institute; Rockefeller University; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; Cengiz Gokcek Obstetrics & Gynecology Hospital; Gaziantep Children's Hospital; Baylor College of Medicine; Baylor College of Medicine; Bezmialem Vakif University; Istanbul University; Istanbul University - Cerrahpasa; Istanbul Medeniyet University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna; University of Texas System; University of Texas Health Science Center Houston; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Erlangen Nuremberg; Vienna Biocenter (VBC); Baylor College of Medicine; Baylor College of Medicine; Kyoto University	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; josef.penninger@imba.oeaw.ac.at; jlupski@bcm.edu	Glatzel, Markus/G-3356-2011; ışıkay, sedat/AAA-9993-2020; Glatzel, Markus/V-8844-2019; Gambin, Tomasz/HDN-5840-2022; Pehlivan, Davut/I-3235-2019; Gonzaga-Jauregui, Claudia/H-4752-2019; YESIL, GOZDE/ABE-1615-2020; Hafner, Markus/O-7100-2018; Erdin, Serkan/B-4988-2008; Penninger, Josef M/I-6860-2013; Gezdirici, Alper/W-8459-2018; Erdin, Serkan/AAE-4288-2019; Seven, Mehmet/E-1017-2019; Gezdirici, Alper/AAG-5480-2019; Morozov, Pavel/GQP-7206-2022	Glatzel, Markus/0000-0002-7720-8817; ışıkay, sedat/0000-0003-0103-9612; Glatzel, Markus/0000-0002-7720-8817; Gambin, Tomasz/0000-0002-0941-4571; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; YESIL, GOZDE/0000-0003-1964-6306; Hafner, Markus/0000-0002-4336-6518; Erdin, Serkan/0000-0001-6587-2625; Penninger, Josef M/0000-0002-8194-3777; Gezdirici, Alper/0000-0002-2432-9279; Seven, Mehmet/0000-0001-7878-2039; Gezdirici, Alper/0000-0002-2432-9279; Ozen, Mustafa/0000-0002-6142-5294; Campbell, Ian/0000-0002-3749-2884; Clausen, Tim/0000-0003-1582-6924; Trattnig, Siegfried/0000-0003-1623-3303; Yuksel, Adnan/0000-0002-7275-8254; Martinez, Javier/0000-0001-9152-7323	US National Institute of Neurological Disorders and Stroke (NINDS) [R01NS058529]; US National Human Genome Research Institute (NHGRI) [U54HG006542]; Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research; NINDS [K23NS078056]; DFG [FG885, GRK 1459]; IMBA; Advanced ERC grant; NIAID [1K23AI087821- 01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI087821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS078056, R01NS058529] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DFG(German Research Foundation (DFG)); IMBA; Advanced ERC grant; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and families who participated in this study. We thank the CSF/PIF MRI imaging facility at the campus Vienna BioCenter. This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS058529 and US National Human Genome Research Institute (NHGRI) grant U54HG006542 to J.R.L.H.S. is supported in part by the fellowship of Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research. W.W. is supported by a K23NS078056 grant from the NINDS. M.G. is supported by grants from the DFG (FG885 and GRK 1459). J.M. and S.W. are supported by IMBA. J.M.P. is supported by an Advanced ERC grant and IMBA. L.M.F. is supported by a Career Development Award (1K23AI087821- 01) from the NIAID. J.R.L. is a paid consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems, and is a coinventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the clinical exome sequencing offered in the Medical Genetics Laboratory.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Cassandrini D, 2010, NEUROLOGY, V75, P1459, DOI 10.1212/WNL.0b013e3181f88173; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Gonzaga-Jauregui C, 2013, JAMA NEUROL, V70, P1491, DOI 10.1001/jamaneurol.2013.4598; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pehlivan D, 2012, GENET MED, V14, P313, DOI 10.1038/gim.2011.13; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; ROCHE AF, 1987, PEDIATRICS, V79, P706; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shiraishi H, 2010, BBA-GEN SUBJECTS, V1800, P405, DOI 10.1016/j.bbagen.2009.11.008; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777	33	135	139	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					636	650		10.1016/j.cell.2014.02.058	http://dx.doi.org/10.1016/j.cell.2014.02.058			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766809	Bronze, Green Accepted			2022-12-24	WOS:000335392100013
J	Low, HH; Gubellini, F; Rivera-Calzada, A; Braun, N; Connery, S; Dujeancourt, A; Lu, F; Redzej, A; Fronzes, R; Orlova, EV; Waksman, G				Low, Harry H.; Gubellini, Francesca; Rivera-Calzada, Angel; Braun, Nathalie; Connery, Sarah; Dujeancourt, Annick; Lu, Fang; Redzej, Adam; Fronzes, Remi; Orlova, Elena V.; Waksman, Gabriel			Structure of a type IV secretion system	NATURE			English	Article							ELECTRON-MICROSCOPY; CORE COMPLEX; SUBNANOMETER RESOLUTION; NEEDLE COMPLEX; IMAGE; VIRB4; DNA; INSIGHTS; ATPASE; VISUALIZATION	Bacterial type IV secretion systems translocate virulence factors into eukaryotic cells(1,2), distribute genetic material between bacteria and have shown potential as a tool for the genetic modification of human cells(3). Given the complex choreography of the substrate through the secretion apparatus(4), the molecular mechanism of the type IV secretion system has proved difficult to dissect in the absence of structural data for the entire machinery. Here we use electron microscopy to reconstruct the type IV secretion system encoded by the Escherichia coli R388 conjugative plasmid. We show that eight proteins assemble in an intricate stoichiometric relationship to form an approximately 3 megadalton nanomachine that spans the entire cell envelope. The structure comprises an outer membrane-associated core complex(1) connected by a central stalk to a substantial inner membrane complex that is dominated by a battery of 12 VirB4 ATPase subunits organized as side-by-side hexameric barrels. Our results show a secretion system with markedly different architecture, and consequently mechanism, to other known bacterial secretion systems(1,4-6).	[Low, Harry H.; Rivera-Calzada, Angel; Braun, Nathalie; Connery, Sarah; Lu, Fang; Redzej, Adam; Orlova, Elena V.; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Low, Harry H.; Rivera-Calzada, Angel; Braun, Nathalie; Connery, Sarah; Lu, Fang; Redzej, Adam; Orlova, Elena V.; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Gubellini, Francesca; Dujeancourt, Annick; Fronzes, Remi] Inst Pasteur, F-75015 Paris, France; [Gubellini, Francesca; Dujeancourt, Annick; Fronzes, Remi] CNRS, UMR 3528, F-75015 Paris, France	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, London WC1E 7HX, England.	remi.fronzes@pasteur.fr; e.orlova@mail.cryst.bbk.ac.uk; g.waksman@mail.cryst.bbk.ac.uk	Low, Harry/T-4482-2019; Fronzes, Rémi/GLS-0406-2022; Orlova, Elena/CAF-8290-2022; Rivera-Calzada, Angel/K-3617-2014; Fronzes, Remi/T-2578-2019	Rivera-Calzada, Angel/0000-0003-2472-5535; Gubellini, Francesca/0000-0002-2155-9765; Redzej, Adam/0000-0003-2471-289X; Fronzes, Remi/0000-0003-3031-9824; Orlova, Elena/0000-0003-3371-415X	Wellcome Trust [098302, 079605]; Institut Pasteur; CNRS; MRC [MR/K012401/1] Funding Source: UKRI; Medical Research Council [MR/K012401/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was financed by grant 098302 from the Wellcome Trust to G. W. and by equipment grant 079605 from the Wellcome Trust. R. F. and A. D. were financed by Institut Pasteur and the CNRS. F. G. was the recipient of 'Bourse Roux' from Institut Pasteur. We thank G. Pehau-Arnaudet for support with the electron microscopes at Institut Pasteur.	Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; De Carlo S, 2008, MICRON, V39, P934, DOI 10.1016/j.micron.2007.11.003; Durand E, 2010, J BACTERIOL, V192, P2315, DOI 10.1128/JB.01384-09; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Orlov S. S., 1976, Soviet Physics - Crystallography, V20, P312; Pantoja M, 2002, MOL MICROBIOL, V45, P1325, DOI 10.1046/j.1365-2958.2002.03098.x; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Pena A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413849; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ripoll-Rozada J, 2013, J BACTERIOL, V195, P4195, DOI 10.1128/JB.00437-13; Rivera-Calzada A, 2013, EMBO J, V32, P1195, DOI 10.1038/emboj.2013.58; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Schroder G, 2011, P NATL ACAD SCI USA, V108, P14643, DOI 10.1073/pnas.1019074108; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wallden K, 2012, P NATL ACAD SCI USA, V109, P11348, DOI 10.1073/pnas.1201428109	30	204	210	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					550	+		10.1038/nature13081	http://dx.doi.org/10.1038/nature13081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670658	Green Accepted			2022-12-24	WOS:000334741600042
J	Riddell, J; Gazit, R; Garrison, BS; Guo, GJ; Saadatpour, A; Mandal, PK; Ebina, W; Volchkov, P; Yuan, GC; Orkin, SH; Rossi, DJ				Riddell, Jonah; Gazit, Roi; Garrison, Brian S.; Guo, Guoji; Saadatpour, Assieh; Mandal, Pankaj K.; Ebina, Wataru; Volchkov, Pavel; Yuan, Guo-Cheng; Orkin, Stuart H.; Rossi, Derrick J.			Reprogramming Committed Murine Blood Cells to Induced Hematopoietic Stem Cells with Defined Factors	CELL			English	Article							SELF-RENEWAL; B-CELLS; PROGENITORS; DIFFERENTIATION; FIBROBLASTS; PRECURSORS; CONVERSION; INDUCTION; LEUKEMIA; LMO2	Hematopoietic stem cells (HSCs) sustain blood formation throughout life and are the functional units of bone marrow transplantation. We show that transient expression of six transcription factors Run1t1,Hlf, Lmo2, Prdm5, Pbx1, and Zfp37 imparts multilineage transplantation potential onto otherwise committed lymphoid and myeloid progenitors and myeloid effector cells. Inclusion of Mycn and Meis1 and use of polycistronic viruses increase reprogramming efficacy. The reprogrammed cells designated induced-HSCs (iHSCs) possess clonal multilineage differentiation potential reconstitute stem/progenitor compartments and are serially transplantable. Single-cell analysis revealed that iHSCs derived under optimal conditions exhibit a gene expression profile that is highly similar to endogenous HSCs. These findings demonstrate that expression of a set of defined factors is sufficient to activate the gene networks governing HSC functional identity in committed blood cells. Our results raise the prospect that blood cell reprogramming may be a strategy for derivation of transplantable stem cells for clinical application.	[Riddell, Jonah; Gazit, Roi; Garrison, Brian S.; Mandal, Pankaj K.; Ebina, Wataru; Volchkov, Pavel; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Orkin, Stuart H.; Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Riddell, Jonah; Gazit, Roi; Garrison, Brian S.; Mandal, Pankaj K.; Ebina, Wataru; Volchkov, Pavel; Rossi, Derrick J.] Boston Childrens Hosp, Div Hematol Oncol, Program Cellular & Mol Med, Boston, MA 02116 USA; [Guo, Guoji; Orkin, Stuart H.] Dana Farber Boston Childrens Hosp, Canc & Blood Disorders Ctr, Boston, MA 02116 USA; [Saadatpour, Assieh; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Saadatpour, Assieh; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Orkin, Stuart H.; Rossi, Derrick J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Harvard University	Rossi, DJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	derrick.rossi@childrens.harvard.edu	Volchkov, Pavel Y/H-4743-2013; mandal, pankaj/B-4885-2016; Gazit, Roi/J-3352-2017	Mandal, Pankaj/0000-0003-1993-9918; Gazit, Roi/0000-0002-0548-2147; Guo, Guoji/0000-0002-1716-4621	National Institutes of Health [RO1HL107630, R00AG029760, U01HL107440, U01HL100001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010000, U01HL100001, U01HL107440, R01HL107630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG029760, R00AG029760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We wish to thank Isabel Beerman, Lydia Fang, Mike Bamberg, Ana Zguro, Rab Prinjha, and Duane Wesemann for expertise, input and assistance.This work was supported by the National Institutes of Health RO1HL107630 (D.J.R.), R00AG029760 (D.J.R.), U01HL107440 (D.J.R.), and U01HL100001 (S.H.O.) and grants from GlaxoSmithKline (D.J.R.), The Leona M.and Harry B.Helmsley Charitable Trust (D.J.R.), The New York Stem Cell Foundation (D.J.R.), and The Harvard Stem Cell Institute (D.J.R., S.H.O., G.C.- Y.).S.H.O.is an Investigator of the Howard Hughes Medical Institute.D.J.R.is a New York Stem Cell Foundation Robertson Investigator.	Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890	31	232	246	0	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					549	564		10.1016/j.cell.2014.04.006	http://dx.doi.org/10.1016/j.cell.2014.04.006			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766805	Green Accepted, Bronze			2022-12-24	WOS:000335392100007
J	Mori, M; Triboulet, R; Mohseni, M; Schlegelmilch, K; Shrestha, K; Camargo, FD; Gregory, RI				Mori, Masaki; Triboulet, Robinson; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.; Gregory, Richard I.			Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer	CELL			English	Article							MICRORNA BIOGENESIS; YAP PATHWAY; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL COACTIVATOR; CONTACT INHIBITION; TUMOR-SUPPRESSOR; GROWTH-CONTROL; ALPHA-CATENIN; SIZE-CONTROL; ORGAN SIZE	Global downregulation of microRNAs (miRNAs) is commonly observed in human cancers and can have a causative role in tumorigenesis. The mechanisms responsible for this phenomenon remain poorly understood. Here, we show that YAP, the downstream target of the tumor-suppressive Hippo-signaling pathway regulates miRNA biogenesis in a cell-density-dependent manner. At low cell density, nuclear YAP binds and sequesters p72 (DDX17), a regulatory component of the miRNA-processing machinery. At high cell density, Hippo-mediated cytoplasmic retention of YAP facilitates p72 association with Microprocessor and binding to a specific sequence motif in pri-miRNAs. Inactivation of the Hippo pathway or expression of constitutively active YAP causes widespread miRNA suppression in cells and tumors and a corresponding posttranscriptional induction of MYC expression. Thus, the Hippo pathway links contact-inhibition regulation to miRNA biogenesis and may be responsible for the widespread miRNA repression observed in cancer.	[Mori, Masaki; Triboulet, Robinson; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.; Gregory, Richard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Mori, Masaki; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mori, Masaki; Triboulet, Robinson; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Mori, Masaki; Triboulet, Robinson; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Mori, Masaki; Triboulet, Robinson; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.; Gregory, Richard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Camargo, FD (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu; rgregory@enders.tch.harvard.edu		Mori, Masaki/0000-0001-7632-3875; camargo, fernando/0000-0002-5630-5909; Schlegelmilch, Karin/0000-0003-3173-0914	Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; Simeon Burt Wolbach Fellowship from Boston Children's Hospital; US National Institute of General Medical Sciences (NIGMS) [R01GM086386]; Stand Up to Cancer-AACR initiative; NIH [R01 CA131426]; Department of Defense [DOD W81XWH-09]; NATIONAL CANCER INSTITUTE [R01CA131426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; Simeon Burt Wolbach Fellowship from Boston Children's Hospital; US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stand Up to Cancer-AACR initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to Ralf Janknecht for HA-p72 plasmid, Tyler Jacks for pRL MYC 3'UTR plasmid, Kun-Liang Guan for YAP S94A and S94A/5SA plasmids, and Dae-Sik Lim for Lats1/2 knockout MEFs. M.M is supported by Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad. R.T. was supported by a Simeon Burt Wolbach Fellowship from Boston Children's Hospital. R.I.G is supported by a grant from the US National Institute of General Medical Sciences (NIGMS) (R01GM086386). F.D.C is supported by awards from Stand Up to Cancer-AACR initiative, NIH grant R01 CA131426, and Department of Defense (DOD W81XWH-09). F.D.C. is a Pew Scholar in the Biomedical Sciences.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hong SG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003706; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawai S, 2012, J CELL BIOL, V197, P201, DOI 10.1083/jcb.201110008; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsutsui M, 2008, BIOCHEM BIOPH RES CO, V372, P856, DOI 10.1016/j.bbrc.2008.05.141; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	59	264	267	1	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					893	906		10.1016/j.cell.2013.12.043	http://dx.doi.org/10.1016/j.cell.2013.12.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581491	Green Accepted, Bronze			2022-12-24	WOS:000332083900009
J	Meunier, E; Dick, MS; Dreier, RF; Schurmann, N; Broz, DK; Warming, S; Roose-Girma, M; Bumann, D; Kayagaki, N; Takeda, K; Yamamoto, M; Broz, P				Meunier, Etienne; Dick, Mathias S.; Dreier, Roland F.; Schuermann, Nura; Broz, Daniela Kenzelmann; Warming, Soren; Roose-Girma, Merone; Bumann, Dirk; Kayagaki, Nobuhiko; Takeda, Kiyoshi; Yamamoto, Masahiro; Broz, Petr			Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases	NATURE			English	Article							NONCANONICAL INFLAMMASOME ACTIVATION; TOXOPLASMA-GONDII; HOST-DEFENSE; IMMUNITY; SALMONELLA; INFECTION; AUTOPHAGY; NLRP3; RESISTANCE; PROTECTS	Lipopolysaccharide from Gram-negative bacteria is sensed in the host cell cytoplasm by a non-canonical inflammasome pathway that ultimately results in caspase-11 activation and cell death(1-3). In mouse macrophages, activation of this pathway requires the production of type-I interferons(4,5), indicating that interferon-induced genes have a critical role in initiating this pathway. Here we report that a cluster of small interferon-inducible GTPases, the so-called guanylate-binding proteins, is required for the full activity of the non-canonical caspase-11 inflammasome during infections with vacuolar Gram-negative bacteria. We show that guanylate-binding proteins are recruited to intracellular bacterial pathogens and are necessary to induce the lysis of the pathogen-containing vacuole. Lysis of the vacuole releases bacteria into the cytosol, thus allowing the detection of their lipopolysaccharide by a yet unknown lipopolysaccharide sensor. Moreover, recognition of the lysed vacuole by the danger sensor galectin-8 initiates the uptake of bacteria into autophagosomes, which results in a reduction of caspase-11 activation. These results indicate that host-mediated lysis of pathogen-containing vacuoles is an essential immune function and is necessary for efficient recognition of pathogens by inflammasome complexes in the cytosol.	[Meunier, Etienne; Dick, Mathias S.; Dreier, Roland F.; Schuermann, Nura; Bumann, Dirk; Broz, Petr] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland; [Broz, Daniela Kenzelmann] Univ Basel, Dept Biomed, CH-4056 Basel, Switzerland; [Warming, Soren; Roose-Girma, Merone; Kayagaki, Nobuhiko] Genentech Inc, San Francisco, CA 94080 USA; [Takeda, Kiyoshi; Yamamoto, Masahiro] Osaka Univ, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan	University of Basel; University of Basel; Roche Holding; Genentech; Osaka University	Broz, P (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	petr.broz@unibas.ch	Broz, Petr/AAC-7940-2019; Takeda, Kiyoshi/C-9331-2009; Warming, Soren/ABD-5729-2021	Broz, Petr/0000-0002-2334-7790; Warming, Soren/0000-0002-5721-0741; Takeda, Kiyoshi/0000-0002-1778-6332; Dick, Mathias/0000-0002-4070-9749	SNSF [PP00P3_139120/1]; University of Basel [ID2153162]; Marie Heim-Voegtlin Fellowship [145516]	SNSF(Swiss National Science Foundation (SNSF)); University of Basel; Marie Heim-Voegtlin Fellowship	We thank N. Mizushima and S. Virgin for Atg5-deficient BMDMs, K. Pfeffer for Gbp2-deficient BMDMs, J. Frey for B. thailandensis, the Biozentrum Proteomics and Imaging Core Facilities for technical assistance, K. Anderson, T. Soukup, R. Schwingendorf, J. C. Cox, V. M. Dixit for reagents and N. Personnic for discussions. This work was supported by an SNSF Professorship PP00P3_139120/1, University of Basel project grant ID2153162 to P. B. and a Marie Heim-Voegtlin Fellowship 145516 to D.K.B.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Burton NA, 2014, CELL HOST MICROBE, V15, P72, DOI 10.1016/j.chom.2013.12.006; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Coers J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003538; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Paetzold S, 2007, INFECT IMMUN, V75, P4826, DOI 10.1128/IAI.00454-07; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	26	316	327	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					366	+		10.1038/nature13157	http://dx.doi.org/10.1038/nature13157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24739961				2022-12-24	WOS:000336121200040
J	Nakamura, N; Lill, JR; Phung, Q; Jiang, ZS; Bakalarski, C; de Maziere, A; Klumperman, J; Schlatter, M; Delamarre, L; Mellman, I				Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; de Maziere, Ann; Klumperman, Judith; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira			Endosomes are specialized platforms for bacterial sensing and NOD2 signalling	NATURE			English	Article							MHC CLASS-II; DENDRITIC CELLS; HOST RECOGNITION; PLASMA-MEMBRANE; CROHNS-DISEASE; KAPPA-B; PROTEIN; SUSCEPTIBILITY; PEPTIDOGLYCAN; SALMONELLA	The detection of microbial pathogens involves the recognition of conserved microbial components by host cell sensors such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs). TLRs are membrane receptors that survey the extracellular environment for microbial infections, whereas NLRs are cytosolic complexes that detect microbial products that reach the cytosol. Upon detection, both sensor classes trigger innate inflammatory responses and allow the engagement of adaptive immunity(1,2). Endo-lysosomes are the entry sites for a variety of pathogens, and therefore the sites at which the immune system first senses their presence. Pathogens internalized by endocytosis are well known to activate TLRs 3 and 7-9 that are localized to endocytic compartments and detect ligands present in the endosomal lumen(3). Internalized pathogens also activate sensors in the cytosol such as NOD1 and NOD2 (ref. 2), indicating that endosomes also provide for the translocation of bacterial components across the endosomal membrane. Despite the fact that NOD2 is well understood to have a key role in regulating innate immune responses and that mutations at the NOD2 locus are a common risk factor in inflammatory bowel disease and possibly other chronic inflammatory states(4,5), little is known about how its ligands escape from endosomes. Here we show that two endo-lysosomal peptide transporters, SLC15A3 and SLC15A4, are preferentially expressed by dendritic cells, especially after TLR stimulation. The transporters mediate the egress of bacterially derived components, such as the NOD2 cognate ligand muramyl dipeptide (MDP)(6,7), and are selectively required for NOD2 responses to endosomally derived MDP. Enhanced expression of the transporters also generates endosomal membrane tubules characteristic of dendritic cells, which further enhanced the NOD2-dependent response to MDP. Finally, sensing required the recruitment of NOD2 and its effector kinase RIPK2 (refs 8, 9) to the endosomal membrane, possibly by forming a complex with SLC15A3 or SLC15A4. Thus, dendritic cell endosomes are specialized platforms for both the lumenal and cytosolic sensing of pathogens.	[Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [de Maziere, Ann; Klumperman, Judith] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Roche Holding; Genentech; Utrecht University; Utrecht University Medical Center	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020	Bakalarski, Corey/0000-0003-1085-7828	Genentech	Genentech(Roche HoldingGenentech)	The authors thank Mellman laboratory members for discussions, C. Chalouni for excellent advice and assistance with fluorescence microscopy, S. van Dijk and R. Scriwanek for immuno-electron microscopy, and R. Gentleman, V. Dixit and N. Kayagaki for advice. N. N., J.R.L., Q. P., Z.J., C. B., M. S., L. D. and I. M. are full-time employees of Genentech, which funded the research in its entirety.	Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Chow AY, 2005, TRENDS IMMUNOL, V26, P72, DOI 10.1016/j.it.2004.11.008; Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keestra AM, 2011, MBIO, V2, DOI 10.1128/mBio.00266-11; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Ma JK, 2012, P NATL ACAD SCI USA, V109, P8820, DOI 10.1073/pnas.1202977109; MARSH M, 1986, P NATL ACAD SCI USA, V83, P2899, DOI 10.1073/pnas.83.9.2899; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pham VC, 2012, J PROTEOME RES, V11, P2947, DOI 10.1021/pr300035k; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	40	183	190	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					240	+		10.1038/nature13133	http://dx.doi.org/10.1038/nature13133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24695226				2022-12-24	WOS:000335454300042
J	Berndt, A; Lee, SY; Ramakrishnan, C; Deisseroth, K				Berndt, Andre; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl			Structure-Guided Transformation of Channelrhodopsin into a Light-Activated Chloride Channel	SCIENCE			English	Article							POTASSIUM CHANNELS; GREEN-ALGAE; HALOBACTERIUM-HALOBIUM; ION SELECTIVITY; OPTICAL CONTROL; CATION CHANNEL; K+ CHANNEL; OPTOGENETICS; INHIBITION; EXCITATION	Using light to silence electrical activity in targeted cells is a major goal of optogenetics. Available optogenetic proteins that directly move ions to achieve silencing are inefficient, pumping only a single ion per photon across the cell membrane rather than allowing many ions per photon to flow through a channel pore. Building on high-resolution crystal-structure analysis, pore vestibule modeling, and structure-guided protein engineering, we designed and characterized a class of channelrhodopsins (originally cation-conducting) converted into chloride-conducting anion channels. These tools enable fast optical inhibition of action potentials and can be engineered to display step-function kinetics for stable inhibition, outlasting light pulses and for orders-of-magnitude-greater light sensitivity of inhibited cells. The resulting family of proteins defines an approach to more physiological, efficient, and sensitive optogenetic inhibition.	[Berndt, Andre; Lee, Soo Yeun; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Ritter, Stefanie L/D-9312-2012	Berndt, Andre/0000-0003-4758-5598	National Institute of Mental Health; Simons Foundation Autism Research Initiative; National Institute on Drug Abuse; Defense Advanced Research Projects Agency; Gatsby Charitable Foundation; Wiegers Family Fund; German Academic Exchange Service (DAAD); Fidelity Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086373, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377, R01DA020794] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Autism Research Initiative; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gatsby Charitable Foundation; Wiegers Family Fund; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Fidelity Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Perry and H. Swanson for technical assistance, the entire Deisseroth laboratory for helpful discussions, and T. Jardetzky for use of a Biotek Synergy4 plate reader. K. D. is supported by the National Institute of Mental Health, the Simons Foundation Autism Research Initiative, the National Institute on Drug Abuse, the Defense Advanced Research Projects Agency, the Gatsby Charitable Foundation, and the Wiegers Family Fund. A. B. received support from the German Academic Exchange Service (DAAD), and S.Y.L. received support from the Fidelity Foundation. Optogenetic tools and methods reported in this paper are distributed and supported freely (www.optogenetics.org).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Andrews-Zwilling Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040555; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bichet D, 2006, P NATL ACAD SCI USA, V103, P14355, DOI 10.1073/pnas.0606660103; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Herman AM, 2014, ELIFE, V3, DOI 10.7554/eLife.01481; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liske H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03110; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; Nonnengasser C, 1996, BIOPHYS J, V70, P932, DOI 10.1016/S0006-3495(96)79636-4; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Sauer DB, 2011, P NATL ACAD SCI USA, V108, P16634, DOI 10.1073/pnas.1111688108; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	41	251	288	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					420	424		10.1126/science.1252367	http://dx.doi.org/10.1126/science.1252367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763591	Green Accepted			2022-12-24	WOS:000334867800043
J	Forth, S; Hsia, KC; Shimamoto, Y; Kapoor, TM				Forth, Scott; Hsia, Kuo-Chiang; Shimamoto, Yuta; Kapoor, Tarun M.			Asymmetric Friction of Nonmotor MAPs Can Lead to Their Directional Motion in Active Microtubule Networks	CELL			English	Article							PLUS-END TRACKING; CYTOPLASMIC DYNEIN; SELF-ORGANIZATION; NUCLEOTIDE STATE; MEIOTIC SPINDLE; CROSS-LINKERS; IN-VITRO; NUMA; BINDING; PROTEIN	Diverse cellular processes require microtubules to be organized into distinct structures, such as asters or bundles. Within these dynamic motifs, microtubule-associated proteins (MAPs) are frequently under load, but how force modulates these proteins' function is poorly understood. Here, we combine optical trapping with TIRF-based microscopy to measure the force dependence of microtubule interaction for three nonmotor MAPs ( NuMA, PRC1, and EB1) required for cell division. We find that frictional forces increase nonlinearly with MAP velocity across microtubules and depend on filament polarity, with NuMA's friction being lower when moving toward minus ends, EB1's lower toward plus ends, and PRC1's exhibiting no directional preference. Mathematical models predict, and experiments confirm, that MAPs with asymmetric friction can move directionally within actively moving microtubule pairs they crosslink. Our findings reveal how nonmotor MAPs can generate frictional resistance in dynamic cytoskeletal networks via micromechanical adaptations whose anisotropy may be optimized for MAP localization and function within cellular structures.	[Forth, Scott; Hsia, Kuo-Chiang; Shimamoto, Yuta; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA	Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@rockefeller.edu	Shimamoto, Yuta/AAH-3281-2019; Hsia, Kuo-Chiang/AAS-8056-2021	Shimamoto, Yuta/0000-0003-0935-2793; Hsia, Kuo-Chiang/0000-0002-4409-6732; Forth, Scott/0000-0002-2630-8017	National Institutes of Health (NIH) [1S10RR023748-01]; NIH National Research Service Award Fellowship [F32GM099380]; Leukemia & Lymphoma Society; NIH [GM65933]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099380, R01GM065933] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank R. Subramanian for assistance with protein construct design, expression, and purification; D. Compton for the gift of NuMA cDNA; and K. Sato and M. Magnasco for helpful discussions about theoretical calculations. The SEC-LS/UV/RI instrumentation used for light-scattering analysis was supported by a National Institutes of Health (NIH) award (1S10RR023748-01). S.F. acknowledges postdoctoral support from an NIH National Research Service Award Fellowship (F32GM099380). K.-C.H. is supported by a Special Fellow Award from The Leukemia & Lymphoma Society. T.M.K. acknowledges support from the NIH (GM65933).	Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Braun M, 2011, NAT CELL BIOL, V13, P1259, DOI 10.1038/ncb2323; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Haren L, 2002, J CELL SCI, V115, P1815; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Jiang K, 2011, CURR OPIN CELL BIOL, V23, P94, DOI 10.1016/j.ceb.2010.08.008; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; MAGNASCO MO, 1993, PHYS REV LETT, V71, P1477, DOI 10.1103/PhysRevLett.71.1477; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Mitchison TJ, 2013, MOL BIOL CELL, V24, P1559, DOI 10.1091/mbc.E12-12-0850; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Subramanian R, 2013, CELL, V154, P377, DOI 10.1016/j.cell.2013.06.021; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uemura S, 2002, P NATL ACAD SCI USA, V99, P5977, DOI 10.1073/pnas.092546199; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038; Wollman R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.23; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585	45	50	50	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					420	432		10.1016/j.cell.2014.02.018	http://dx.doi.org/10.1016/j.cell.2014.02.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725408	Green Accepted, Bronze			2022-12-24	WOS:000334304500015
J	Wilkerson, CG; Mansfield, SD; Lu, F; Withers, S; Park, JY; Karlen, SD; Gonzales-Vigil, E; Padmakshan, D; Unda, F; Rencoret, J; Ralph, J				Wilkerson, C. G.; Mansfield, S. D.; Lu, F.; Withers, S.; Park, J. -Y.; Karlen, S. D.; Gonzales-Vigil, E.; Padmakshan, D.; Unda, F.; Rencoret, J.; Ralph, J.			Monolignol Ferulate Transferase Introduces Chemically Labile Linkages into the Lignin Backbone	SCIENCE			English	Article							BIOSYNTHETIC-PATHWAY; CONIFERYL FERULATE; ARABIDOPSIS; ALCOHOL; BIOMASS; ENZYME; LEADS; COMT	Redesigning lignin, the aromatic polymer fortifying plant cell walls, to be more amenable to chemical depolymerization can lower the energy required for industrial processing. We have engineered poplar trees to introduce ester linkages into the lignin polymer backbone by augmenting the monomer pool with monolignol ferulate conjugates. Herein, we describe the isolation of a transferase gene capable of forming these conjugates and its xylem-specific introduction into poplar. Enzyme kinetics, in planta expression, lignin structural analysis, and improved cell wall digestibility after mild alkaline pretreatment demonstrate that these trees produce the monolignol ferulate conjugates, export them to the wall, and use them during lignification. Tailoring plants to use such conjugates during cell wall biosynthesis is a promising way to produce plants that are designed for deconstruction.	[Wilkerson, C. G.; Withers, S.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Wilkerson, C. G.; Withers, S.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Wilkerson, C. G.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Mansfield, S. D.; Park, J. -Y.; Gonzales-Vigil, E.; Unda, F.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V6T 1Z4, Canada; [Rencoret, J.; Ralph, J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Karlen, S. D.; Padmakshan, D.; Rencoret, J.; Ralph, J.] Univ Wisconsin, US DOE, Great Lakes Bioenergy Res Ctr, Wisconsin Energy Inst, Madison, WI 53726 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University; University of British Columbia; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Ralph, J (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	jralph@wisc.edu	Lu, Fachuang/K-6487-2019; RENCORET, JORGE/E-1747-2013; Ralph, John/C-3161-2009; RENCORET, JORGE/ABE-4139-2020	RENCORET, JORGE/0000-0003-2728-7331; Ralph, John/0000-0002-6093-4521; RENCORET, JORGE/0000-0003-2728-7331; Gonzales-Vigil, Eliana/0000-0002-8267-9285; Mansfield, Shawn/0000-0002-0175-554X	DOE Great Lakes Bioenergy Research Center (DOE Basic Energy Research Office of Science) [DE-FC02-07ER64494]	DOE Great Lakes Bioenergy Research Center (DOE Basic Energy Research Office of Science)	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE Basic Energy Research Office of Science DE-FC02-07ER64494). We also thank Y. Zhu, M. Regner, and H. Kim for making some of the required conjugates as described (24); S. Liu for sample preparation; N. Santoro for the digestibility data determinations; and the original team, including J. Grabber and R. Hatfield, who embarked with us on the idea and demonstrated its potential in models systems as described (18). The redesigned polymer presented herein has become known as Zip-lignin; the method for plant modification and the use of the gene for altering plants have been patented (25-27). Angelica sinensis plants were obtained with the help of Joe Hollis at Mountain Garden Herbs in Burnsville, North Carolina. The DNA sequence for the AsFMT gene (see supplementary materials) has been deposited in GenBank under the accession number JA758320.1 (www.ncbi.nlm.nih.gov/nuccore/JA758320.1). Materials and methods, other figures, and further data are reported in the supplementary materials. Future use of materials involved with these projects is governed by material transfer agreements, available from Lauren Meyers, (Wisconsin Energy Institute, lmeyers@energy.wisc.edu) or from the University of Wisconsin's Office of Industrial Partnerships (oip@gran.wisc.edu).	Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Li EY, 2012, NEW PHYTOL, V194, P102, DOI 10.1111/j.1469-8137.2011.04016.x; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Lu FC, 1999, J AGR FOOD CHEM, V47, P1988, DOI 10.1021/jf981140j; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; Petrik DL, 2014, PLANT J, V77, P713, DOI 10.1111/tpj.12420; Ralph J., 2013, Patent, Patent No. [8,569,465 B2, 8569465, US8569465B2]; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ralph J, 2008, REC ADV POLYPHEN RES, V1, P36; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Santoro N, 2010, BIOENERG RES, V3, P93, DOI 10.1007/s12155-009-9074-6; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2010, PLANT J, V64, P885, DOI 10.1111/j.1365-313X.2010.04353.x; Weng JK, 2010, PLANT J, V64, P898, DOI 10.1111/j.1365-313X.2010.04391.x; Wilkerson C, 2013, Patent No. [US 2013-0219547 A12013, 20130219547]; Wilkerson C, 2013, Patent No. [US 2013-0203973 A1, 20130203973]; Withers S, 2012, J BIOL CHEM, V287, P8347, DOI 10.1074/jbc.M111.284497; Xie JJ, 2009, MOLECULES, V14, P555, DOI 10.3390/molecules14010555; Zhao Q, 2013, P NATL ACAD SCI USA, V110, P13660, DOI 10.1073/pnas.1312234110; Zhu YM, 2013, RSC ADV, V3, P21964, DOI 10.1039/c3ra42818d	27	255	264	10	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					90	93		10.1126/science.1250161	http://dx.doi.org/10.1126/science.1250161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700858	Green Submitted			2022-12-24	WOS:000333746100059
J	Stoner, R; Chow, ML; Boyle, MP; Sunkin, SM; Mouton, PR; Roy, S; Wynshaw-Boris, A; Colamarino, SA; Lein, ES; Courchesne, E				Stoner, Rich; Chow, Maggie L.; Boyle, Maureen P.; Sunkin, Susan M.; Mouton, Peter R.; Roy, Subhojit; Wynshaw-Boris, Anthony; Colamarino, Sophia A.; Lein, Ed S.; Courchesne, Eric			Patches of Disorganization in the Neocortex of Children with Autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRAIN OVERGROWTH; CORTEX; CONNECTIVITY; PATTERNS; NUMBER; SIZE; LIFE	BackgroundAutism involves early brain overgrowth and dysfunction, which is most strongly evident in the prefrontal cortex. As assessed on pathological analysis, an excess of neurons in the prefrontal cortex among children with autism signals a disturbance in prenatal development and may be concomitant with abnormal cell type and laminar development. MethodsTo systematically examine neocortical architecture during the early years after the onset of autism, we used RNA in situ hybridization with a panel of layer- and cell-type-specific molecular markers to phenotype cortical microstructure. We assayed markers for neurons and glia, along with genes that have been implicated in the risk of autism, in prefrontal, temporal, and occipital neocortical tissue from postmortem samples obtained from children with autism and unaffected children between the ages of 2 and 15 years. ResultsWe observed focal patches of abnormal laminar cytoarchitecture and cortical disorganization of neurons, but not glia, in prefrontal and temporal cortical tissue from 10 of 11 children with autism and from 1 of 11 unaffected children. We observed heterogeneity between cases with respect to cell types that were most abnormal in the patches and the layers that were most affected by the pathological features. No cortical layer was uniformly spared, with the clearest signs of abnormal expression in layers 4 and 5. Three-dimensional reconstruction of layer markers confirmed the focal geometry and size of patches. ConclusionsIn this small, explorative study, we found focal disruption of cortical laminar architecture in the cortexes of a majority of young children with autism. Our data support a probable dysregulation of layer formation and layer-specific neuronal differentiation at prenatal developmental stages. (Funded by the Simons Foundation and others.) Molecular analysis of postmortem samples of brain tissue obtained from 11 children with autism showed that the prefrontal and temporal cortexes in 10 of these children had patches of neuronal disorganization. Autism is, in part, a heritable developmental disorder involving macroscopic early brain overgrowth in the majority of cases(1)-(7) and dysfunction(8) that affects several cortical and subcortical regions mediating autistic symptoms, including prefrontal and temporal cortexes.(4),(9)-(11) The underlying cortical defects remain uncertain. Despite the early diagnosable onset, in more than 40 studies, the average age of patients with autism in postmortem analyses was 22 years.(4) Three previous case studies that evaluated Nissl-stained sections of brains obtained from patients with autism ranging in age from 4 to 60 years described individual instances of heterotopias, slight focal laminar disorganization,(12), ...	[Stoner, Rich; Chow, Maggie L.; Boyle, Maureen P.; Courchesne, Eric] Univ Calif San Diego, Autism Ctr Excellence, La Jolla, CA 92037 USA; [Stoner, Rich; Chow, Maggie L.; Boyle, Maureen P.; Roy, Subhojit; Courchesne, Eric] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92037 USA; [Roy, Subhojit] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92037 USA; [Boyle, Maureen P.; Sunkin, Susan M.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA USA; [Mouton, Peter R.] Univ S Florida, Sch Med, Dept Pathol & Cell Biol, Tampa, FL 33620 USA; [Mouton, Peter R.] Alzheimers Inst, Tampa, FL USA; [Mouton, Peter R.] Res Ctr, Tampa, FL USA; [Wynshaw-Boris, Anthony] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Colamarino, Sophia A.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Allen Institute for Brain Science; State University System of Florida; University of South Florida; Case Western Reserve University; Stanford University	Courchesne, E (corresponding author), Univ Calif San Diego, Sch Med, Autism Ctr Excellence, Dept Neurosci, 8110 La Jolla Shores Dr, La Jolla, CA 92037 USA.	ecourchesne@ucsd.edu			Simons Foundation; Peter Emch Family Foundation; Cure Autism Now/Autism Speaks; Thursday Club Juniors; Allen Institute for Brain Science; University of California, San Diego, Autism Center of Excellence [P50-MH081755]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755] Funding Source: NIH RePORTER	Simons Foundation; Peter Emch Family Foundation; Cure Autism Now/Autism Speaks; Thursday Club Juniors; Allen Institute for Brain Science; University of California, San Diego, Autism Center of Excellence; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the Simons Foundation (to Drs. Courchesne and Wynshaw-Boris), the Peter Emch Family Foundation (to Dr. Cour-chesne), Cure Autism Now/Autism Speaks (to Dr. Courchesne), the Thursday Club Juniors (to Dr. Courchesne), the Allen Institute for Brain Science (to Drs. Lein, Sunkin, and Boyle), and the University of California, San Diego, Autism Center of Excellence (P50-MH081755, to Dr. Courchesne). Tissue for this study was provided by the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders (Baltimore) (N01-HD-4-3368 and N01-HD-4-3383), the Brain and Tissue Bank for Developmental Disorders (Miami), Autism Tissue Program (Princeton, NJ), and Harvard Brain Tissue Resource Center (Belmont, MA).	Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Chow ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002592; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gohlke JM, 2007, CEREB CORTEX, V17, P2433, DOI 10.1093/cercor/bhl151; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; Hutsler JJ, 2007, BIOL PSYCHIAT, V61, P449, DOI 10.1016/j.biopsych.2006.01.015; Larsen CC, 2006, NEUROSCIENCE, V139, P999, DOI 10.1016/j.neuroscience.2006.01.005; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabinowicz T, 1996, J NEUROPATH EXP NEUR, V55, P320, DOI 10.1097/00005072-199603000-00007; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Santos M, 2011, BRAIN RES, V1380, P206, DOI 10.1016/j.brainres.2010.08.067; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	28	443	450	1	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1209	1219		10.1056/NEJMoa1307491	http://dx.doi.org/10.1056/NEJMoa1307491			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD7EW	24670167	Green Accepted			2022-12-24	WOS:000333426000008
J	Haeusler, AR; Donnelly, CJ; Periz, G; Simko, EAJ; Shaw, PG; Kim, MS; Maragakis, NJ; Troncoso, JC; Pandey, A; Sattler, R; Rothstein, JD; Wang, J				Haeusler, Aaron R.; Donnelly, Christopher J.; Periz, Goran; Simko, Eric A. J.; Shaw, Patrick G.; Kim, Min-Sik; Maragakis, Nicholas J.; Troncoso, Juan C.; Pandey, Akhilesh; Sattler, Rita; Rothstein, Jeffrey D.; Wang, Jiou			C9orf72 nucleotide repeat structures initiate molecular cascades of disease	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA G-QUADRUPLEX; FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; GGGGCC REPEAT; DNA REPEATS; EXPANSION; PROTEIN; ALS; ACIDS	A hexanucleotide repeat expansion (HRE), (GGGGCC)(n), inC9orf72 is the most common genetic cause of the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we identify a molecular mechanism by which structural polymorphism of the HRE leads to ALS/FTD pathology and defects. The HRE forms DNA and RNA G-quadruplexes with distinct structures and promotes RNA-DNA hybrids (R-loops). The structural polymorphism causes a repeat-length-dependent accumulation of transcripts aborted in the HRE region. These transcribed repeats bind to ribonucleoproteins in a conformation-dependent manner. Specifically, nucleolin, an essential nucleolar protein, preferentially binds the HRE G-quadruplex, and patient cells show evidence of nucleolar stress. Our results demonstrate that distinct C9orf72 HRE structural polymorphism at both DNA and RNA levels initiates molecular cascades leading to ALS/FTD pathologies, and provide the basis for a mechanistic model for repeat-associated neurodegenerative diseases.	[Haeusler, Aaron R.; Periz, Goran; Simko, Eric A. J.; Wang, Jiou] Johns Hopkins Univ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Haeusler, Aaron R.; Periz, Goran; Simko, Eric A. J.; Rothstein, Jeffrey D.; Wang, Jiou] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Donnelly, Christopher J.; Maragakis, Nicholas J.; Sattler, Rita; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Donnelly, Christopher J.; Sattler, Rita; Rothstein, Jeffrey D.] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21205 USA; [Shaw, Patrick G.; Kim, Min-Sik; Pandey, Akhilesh] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Troncoso, Juan C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wang, J (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	jiouw@jhmi.edu	Kim, Min-Sik/M-3488-2016; Donnelly, Christopher/AGI-7461-2022; Kim, Min-Sik/N-5010-2018	Kim, Min-Sik/0000-0001-7317-5360; Kim, Min-Sik/0000-0001-7317-5360; Haeusler, Aaron/0000-0001-5566-3707; Simko, Eric/0000-0001-8617-8608; Donnelly, Christopher/0000-0002-2383-9015	National Institutes of Health [NS07432, NS085207]; Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association; Target ALS; ALS Association; Johns Hopkins Alzheimer's Disease Research Center NIH [P50AG05146]; National Cancer Institute [5T32CA009110-36]; Maryland Stem Cell Research Fund; Judith & Jean Pape Adams Charitable Foundation; Samuel I. Newhouse Foundation; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085207, R01NS074324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association(Muscular Dystrophy Association); Target ALS; ALS Association; Johns Hopkins Alzheimer's Disease Research Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Stem Cell Research Fund; Judith & Jean Pape Adams Charitable Foundation; Samuel I. Newhouse Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B.J. Traynor for the information on the ALS patient cells, M. DeJesus-Hernandez and R. Rademakers for the genotyping PCR protocols on patient cells, P.J. Tienari for providing additional fibroblast/iPS cell lines, M.J. Matunis for the hnRNP F/H antibody, R. S. Nirujogi for his assistance with the SILAC LC-MS analysis, T. K. Chakravarty for his assistance with transfection of HEK293T cells, the S. Balasubramanian laboratory for generously providing the BG4 plasmid, P. L. Steinwald for purification and assistance in the validation of the BG4 protein, R. M. Powers for assistance in the staining and quantification of P bodies in iPS neurons, and O. Pletnikova for processing human tissues. This work was supported by National Institutes of Health grants NS07432 (J.W.) and NS085207 (R. S. and J.D.R.), the Robert Packard Center for ALS Research at Johns Hopkins and the Muscular Dystrophy Association (J.W.), Target ALS (J.D.R.), the ALS Association (J.W.), the Johns Hopkins Alzheimer's Disease Research Center NIH P50AG05146 (J.C.T.), National Cancer Institute training grant 5T32CA009110-36 (A. R. H. and E.A.J.S.), Maryland Stem Cell Research Fund (C.J.D.), Judith & Jean Pape Adams Charitable Foundation (R. S.), and the Samuel I. Newhouse Foundation (J.C.T.). We thank P. A. Coulumbe, V. C. Culotta, M. J. Matunis, P. S. Miller, B. A. Learn and members of the J. Wang laboratory for manuscript advice and discussions.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kohli MA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.003; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Li HB, 2013, BIOSENS BIOELECTRON, V50, P180, DOI 10.1016/j.bios.2013.06.041; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Majounie E, 2012, NEW ENGL J MED, V366, P283, DOI 10.1056/NEJMc1113592; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Moss DJH, 2014, NEUROLOGY, V82, P292, DOI 10.1212/WNL.0000000000000061; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rollinson S., 2012, NEUROBIOL AGING, V33; Rutherford NJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.005; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sun D, 2010, METHODS MOL BIOL, V608, P65, DOI 10.1007/978-1-59745-363-9_5; Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zu T., 2013, P NATL ACAD SCI US	46	615	627	5	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					195	+		10.1038/nature13124	http://dx.doi.org/10.1038/nature13124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598541	Green Accepted			2022-12-24	WOS:000332651800031
J	Zamudio, JR; Kelly, TJ; Sharp, PA				Zamudio, Jesse R.; Kelly, Timothy J.; Sharp, Phillip A.			Argonaute-Bound Small RNAs from Promoter-Proximal RNA Polymerase II	CELL			English	Article							LARGE GENE LISTS; MICRORNA PRECURSORS; TRANSCRIPTION; EXPRESSION; INTERFERENCE; DROSOPHILA; SIRNAS; CELLS; DNA; TERMINATION	Argonaute (Ago) proteins mediate posttranscriptional gene repression by binding guide miRNAs to regulate targeted RNAs. To confidently assess Ago-bound small RNAs, we adapted a mouse embryonic stem cell system to express a single epitope-tagged Ago protein family member in an inducible manner. Here, we report the small RNA profile of Ago-deficient cells and show that Ago-dependent stability is a common feature of mammalian miRNAs. Using this criteria and immunopurification, we identified an Ago-dependent class of noncanonical miRNAs derived from protein-coding gene promoters, which we name transcriptional start site miRNAs (TSS-miRNAs). A subset of promoter-proximal RNA polymerase II (RNAPII) complexes produces hairpin RNAs that are processed in a DiGeorge syndrome critical region gene 8 (Dgcr8)/Drosha-independent but Dicer-dependent manner. TSS-miRNA activity is detectable from endogenous levels and following overexpression of mRNA constructs. Finally, we present evidence of differential expression and conservation in humans, suggesting important roles in gene regulation.	[Zamudio, Jesse R.; Kelly, Timothy J.; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu			United States Public Health Service grants from the NIH [RO1 GM34277]; NCI [PO1-CA42063]; Institute Support (core) grant from the NCI [P30-CA14051]; NIH NSRA [F32CA139902, F32GM101872]; NATIONAL CANCER INSTITUTE [P30CA014051, P01CA042063, F32CA139902, R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, F32GM101872] Funding Source: NIH RePORTER	United States Public Health Service grants from the NIH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute Support (core) grant from the NCI; NIH NSRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Blelloch and X. Wang for cells and the Swanson Biotechnology Center at the Koch Institute and the MIT BioMicro Center for sequencing support. This work was supported by United States Public Health Service grants RO1 GM34277 from the NIH, PO1-CA42063 from the NCI (to P.A.S.), and partially by Koch Institute Support (core) grant P30-CA14051 from the NCI. J.R.Z. and T.J.K. were supported by NIH NSRA F32CA139902 and F32GM101872, respectively. The content of the project described is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The authors wish to dedicate this paper to the memory of MIT Police Officer Sean Collier for his caring service to the MIT community and for his sacrifice.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; HOFACKER IL, 2009, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1202S26; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Ladewig E, 2012, GENOME RES, V22, P1634, DOI 10.1101/gr.133553.111; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Okamura K, 2013, GENE DEV, V27, P778, DOI 10.1101/gad.211698.112; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665	52	80	84	2	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					920	934		10.1016/j.cell.2014.01.041	http://dx.doi.org/10.1016/j.cell.2014.01.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581493	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000332083900011
J	Suh, E; Daugherty, CK; Wroblewski, K; Lee, H; Kigin, ML; Rasinski, KA; Ford, JS; Tonorezos, ES; Nathan, PC; Oeffinger, KC; Henderson, TO				Suh, Eugene; Daugherty, Christopher K.; Wroblewski, Kristen; Lee, Hannah; Kigin, Mackenzie L.; Rasinski, Kenneth A.; Ford, Jennifer S.; Tonorezos, Emily S.; Nathan, Paul C.; Oeffinger, Kevin C.; Henderson, Tara O.			General Internists' Preferences and Knowledge About the Care of Adult Survivors of Childhood Cancer A Cross-sectional Survey	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM SURVIVORS; HEALTH-INSURANCE COVERAGE; FOLLOW-UP CARE; 5-YEAR SURVIVORS; PHYSICIAN PREFERENCES; ADOLESCENT CANCER; AMERICAN-SOCIETY; CHEST RADIATION; LATE MORTALITY; BREAST-CANCER	Background: Adult childhood cancer survivors (CCSs) are at high risk for illness and premature death. Little is known about the physicians who provide their routine medical care. Objective: To determine general internists' self-reported attitudes and knowledge about the care of CCSs. Design: Cross-sectional survey. Setting: Mailed survey delivered between September 2011 and August 2012. Participants: Random sample of 2000 U.S. general internists. Measurements: Care preferences, comfort levels with caring for CCSs (7-point Likert scale: 1 = very uncomfortable, 7 = very comfortable), familiarity with available surveillance guidelines (7-point Likert scale: 1 = very unfamiliar, 7 = very familiar), and concordance with Children's Oncology Group Long-Term Follow-Up Guidelines in response to a clinical vignette. Results: The response rate was 61.6% (1110 of 1801). More than half the internists (51.1%) reported caring for at least 1 CCS; 72.0% of these internists never received a treatment summary. On average, internists were "somewhat uncomfortable" caring for survivors of Hodgkin lymphoma, acute lymphoblastic leukemia, and osteosarcoma. Internists reported being "somewhat unfamiliar" with available surveillance guidelines. In response to a clinical vignette about a young adult survivor of Hodgkin lymphoma, 90.6% of respondents did not appropriately recommend yearly breast cancer surveillance, 85.1% did not appropriately recommended cardiac surveillance, and 23.6% did not appropriately recommend yearly thyroid surveillance. Access to surveillance guidelines and treatment summaries were identified as the most useful resources for caring for CCSs. Limitation: Findings, based on self-report, may not reflect actual clinical practice. Conclusion: Although most general internists report involvement in the care of CCSs, many seem unfamiliar with available surveillance guidelines and would prefer to follow patients in collaboration with a cancer center.	Univ Chicago, Med Comer Childrens Hosp, Chicago, IL 60637 USA; Univ Chicago, Chicago, IL 60637 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Henderson, TO (corresponding author), Univ Chicago, Med Comer Childrens Hosp, 5841 South Maryland Ave,MC 4060, Chicago, IL 60637 USA.	thenderson@peds.bsd.uchicago.edu	Nathan, Paul/GRR-2377-2022	Nathan, Paul/0000-0003-0334-0871	National Cancer Institute; NATIONAL CANCER INSTITUTE [K05CA160724, K07CA134935] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute.	American College of Surgeons Commission on Cancer, 2013, CANC PROGR STAND 201; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Brinkman TM, 2012, J CLIN ONCOL, V30; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; Daugherty CK, 2008, J CLIN ONCOL, V26, P5988, DOI 10.1200/JCO.2008.17.2221; Del Giudice ME, 2009, J CLIN ONCOL, V27, P3338, DOI 10.1200/JCO.2008.20.4883; Freyer DR, 2010, J CLIN ONCOL, V28, P4810, DOI 10.1200/JCO.2009.23.4278; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Friedman DL, 2002, PEDIATR CLIN N AM, V49, P1083, DOI 10.1016/S0031-3955(02)00032-9; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Helft PR, 2003, J CLIN ONCOL, V21, P942, DOI 10.1200/JCO.2003.08.007; Henderson TO, 2010, PEDIATRICS, V126, P129, DOI 10.1542/peds.2009-2802; Henderson TO, 2010, ANN INTERN MED, V152, P444, DOI 10.7326/0003-4819-152-7-201004060-00009; Henderson TO, 2010, J CLIN ONCOL, V28, P878, DOI 10.1200/JCO.2009.25.6107; Hewitt M, 2006, CANC PATIENT CANC SU, DOI DOI 10.17226/11613; Ishida Y, 2012, JPN J CLIN ONCOL, V42, P513, DOI 10.1093/jjco/hys038; Kadan-Lottick NS, 2002, JAMA-J AM MED ASSOC, V287, P1832, DOI 10.1001/jama.287.14.1832; Kirchhoff AC, 2010, MED CARE, V48, P1015, DOI 10.1097/MLR.0b013e3181eaf880; Kremer LCM, 2006, TIJDSCHRIFT KINDERGE, V6, P214; Kremer LCM, 2013, PEDIATR BLOOD CANCER, V60, P543, DOI 10.1002/pbc.24445; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Lawrence RE, 2011, CONTRACEPTION, V84, P259, DOI 10.1016/j.contraception.2010.12.002; Mariotto AB, 2009, CANCER EPIDEM BIOMAR, V18, P1033, DOI 10.1158/1055-9965.EPI-08-0988; McCabe MS, 2013, J CLIN ONCOL, V31, P631, DOI 10.1200/JCO.2012.46.6854; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Mertens AC, 2004, HEALTH POLICY, V69, P169, DOI 10.1016/j.healthpol.2003.12.008; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Nathan PC, 2008, J CLIN ONCOL, V26, P4401, DOI 10.1200/JCO.2008.16.9607; Nathan PC, 2013, J CANCER SURVIV, V7, P275, DOI 10.1007/s11764-013-0271-0; Nathan PC, 2010, ANN INTERN MED, V153, P442, DOI 10.7326/0003-4819-153-7-201010050-00007; Oeffinger KC, 2006, PEDIATR BLOOD CANCER, V46, P135, DOI 10.1002/pbc.20614; Oeffinger KC, 2004, ANN FAM MED, V2, P61, DOI 10.1370/afm.26; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oeffinger KC, 2011, PEDIATR BLOOD CANCER, V56, P818, DOI 10.1002/pbc.22696; Oeffinger KC, 2009, JAMA-J AM MED ASSOC, V301, P404, DOI 10.1001/jama.2008.1039; Park ER, 2012, J CANCER SURVIV, V6, P251, DOI 10.1007/s11764-012-0225-y; Park ER, 2005, J CLIN ONCOL, V23, P9187, DOI 10.1200/JCO.2005.01.7418; Potosky AL, 2011, J GEN INTERN MED, V26, P1403, DOI 10.1007/s11606-011-1808-4; Rebholz CE, 2011, J CLIN ONCOL, V29, P4181, DOI 10.1200/JCO.2011.36.5619; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Salz T, 2012, CA-CANCER J CLIN; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Scottish Intercollegiate Guidelines Network (SIGN), 2013, SIGN 132 LONG TERM F; Simone J.V., 2003, CHILDHOOD CANC SURVI; SKINNER R, 2005, THERAPY BASED LONG T; Spain PD, 2012, J ONCOL PRACT, V8, P196, DOI 10.1200/JOP.2011.000345; USDHHS, 2008, PHYS WORKFORCE PROJE; Yoon JD, 2010, ACAD MED, V85, P1475, DOI 10.1097/ACM.0b013e3181eabacc; Zebrack BJ, 2004, CANCER-AM CANCER SOC, V100, P843, DOI 10.1002/cncr.20033; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	52	121	121	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					11	+		10.7326/M13-1941	http://dx.doi.org/10.7326/M13-1941			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24573662	Green Accepted			2022-12-24	WOS:000330249700002
J	Liu, PD; Begley, M; Michowski, W; Inuzuka, H; Ginzberg, M; Gao, DM; Tsou, PL; Gan, WJ; Papa, A; Kim, BM; Wan, LX; Singh, A; Zhai, B; Yuan, M; Wang, ZW; Gygi, SP; Lee, TH; Lu, KP; Toker, A; Pandolfi, PP; Asara, JM; Kirschner, MW; Sicinski, P; Cantley, L; Wei, WY				Liu, Pengda; Begley, Michael; Michowski, Wojciech; Inuzuka, Hiroyuki; Ginzberg, Miriam; Gao, Daming; Tsou, Peiling; Gan, Wenjian; Papa, Antonella; Kim, Byeong Mo; Wan, Lixin; Singh, Amrik; Zhai, Bo; Yuan, Min; Wang, Zhiwei; Gygi, Steven P.; Lee, Tae Ho; Lu, Kun-Ping; Toker, Alex; Pandolfi, Pier Paolo; Asara, John M.; Kirschner, Marc W.; Sicinski, Piotr; Cantley, Lewis; Wei, Wenyi			Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus	NATURE			English	Article							PROMOTES; SKP2; IDENTIFICATION; MECHANISMS; INHIBITOR; PROTEINS; INSIGHTS; AKT/PKB; PATHWAY; COMPLEX	Akt, also known as protein kinase B, plays key roles in cell proliferation, survival and metabolism. Akt hyperactivation contributes to many pathophysiological conditions, including human cancers(1-3), and is closely associated with poor prognosis and chemo-or radio-therapeutic resistance(4). Phosphorylation of Akt at S473 (ref. 5) and T308 (ref. 6) activates Akt. However, it remains unclear whether further mechanisms account for full Akt activation, and whether Akt hyperactivation is linked to misregulated cell cycle progression, another cancer hallmark(7). Here we report that Akt activity fluctuates across the cell cycle, mirroring cyclin A expression. Mechanistically, phosphorylation of S477 and T479 at the Akt extreme carboxy terminus by cyclin-dependent kinase 2 (Cdk2)/cyclin A or mTORC2, under distinct physiological conditions, promotes Akt activation through facilitating, or functionally compensating for, S473 phosphorylation. Furthermore, deletion of the cyclin A2 allele in the mouse olfactory bulb leads to reduced S477/T479 phosphorylation and elevated cellular apoptosis. Notably, cyclin A2-deletion-induced cellular apoptosis in mouse embryonic stem cells is partly rescued by S477D/T479E-Akt1, supporting a physiological role for cyclin A2 in governing Akt activation. Together, the results of our study show Akt S477/T479 phosphorylation to be an essential layer of the Akt activation mechanism to regulate its physiological functions, thereby providing a new mechanistic link between aberrant cell cycle progression and Akt hyperactivation in cancer.	[Liu, Pengda; Inuzuka, Hiroyuki; Gao, Daming; Gan, Wenjian; Papa, Antonella; Wan, Lixin; Wang, Zhiwei; Toker, Alex; Pandolfi, Pier Paolo; Wei, Wenyi] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Begley, Michael; Tsou, Peiling; Papa, Antonella; Yuan, Min; Lu, Kun-Ping; Pandolfi, Pier Paolo; Asara, John M.; Cantley, Lewis] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Begley, Michael; Tsou, Peiling; Kirschner, Marc W.; Cantley, Lewis] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Michowski, Wojciech; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Michowski, Wojciech; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ginzberg, Miriam; Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Papa, Antonella; Pandolfi, Pier Paolo] Beth Israel Deaconess Med Ctr, Canc Genet Program, Dept Med, Boston, MA 02115 USA; [Papa, Antonella; Pandolfi, Pier Paolo] Beth Israel Deaconess Med Ctr, Div Genet, Dept Med, Boston, MA 02115 USA; [Singh, Amrik] Cell Signaling Technol, Danvers, MA 01923 USA; [Kim, Byeong Mo; Lee, Tae Ho] Beth Israel Deaconess Med Ctr, Div Gerontol, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Wei, WY (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Cantley, Lewis C/D-1800-2014; Lee, Tae Ho/AAT-1721-2020	Cantley, Lewis C/0000-0002-1298-7653; Ginzberg, Miriam/0000-0001-8431-3714; Papa, Antonella/0000-0001-8653-7121; Gan, Wenjian/0000-0001-7599-5020; Kim, Byeong Mo/0000-0002-0582-3132; Gao, Daming/0000-0003-4374-1055; Wang, Zhiwei/0000-0002-6465-7779; Pandolfi, Pier Paolo/0000-0002-5352-5295	National Institutes of Health [GM089763, GM094777, CA177910, 2P01CA120964, R01CA132740];  [5T32HL007893]; NATIONAL CANCER INSTITUTE [R01CA132740, R01CA167677, P01CA120964, R01CA177910] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111430, T32HL007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094777, R01GM089763, R01GM041890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041218] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Guo, J. J. Liu, A. W. Lau, S. Shaik, A. Tron, X. Dai and K. Xu for reading the manuscript, S. B. Breitkopf for help with mass spectrometry experiments, Y. Geng, L. Liu, K. Ran, R. Chin and S. Elloul for providing reagents, and members of the Wei, Toker, Sicinski, Pandolfi and Cantley laboratories for discussions. W. W. is an American Cancer Society and a Leukemia & Lymphoma Society research scholar. P. L. is supported by 5T32HL007893. This work was supported in part by National Institutes of Health grants to W. W. (GM089763, GM094777 and CA177910), J. M. A. (2P01CA120964) and P. S. (R01CA132740).	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Burgess DJ, 2011, NAT REV CANCER, V11, P389, DOI 10.1038/nrc3070; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gray CH, 2003, CELL CYCLE, V2, P500, DOI 10.4161/cc.2.6.556; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Liu PD, 2010, MOL BIOL EVOL, V27, P2628, DOI 10.1093/molbev/msq151; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Otero JJ, 2014, DEV BIOL, V385, P328, DOI 10.1016/j.ydbio.2013.10.019; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Toker A, 2008, TRENDS BIOCHEM SCI, V33, P356, DOI 10.1016/j.tibs.2008.05.003; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wei WY, 2003, MOL CELL BIOL, V23, P2859, DOI 10.1128/MCB.23.8.2859-2870.2003; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	223	232	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					541	+		10.1038/nature13079	http://dx.doi.org/10.1038/nature13079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670654	Green Accepted			2022-12-24	WOS:000334741600040
J	Gregg, EW; Li, YF; Wang, J; Burrows, NR; Ali, MK; Rolka, D; Williams, DE; Geiss, L				Gregg, Edward W.; Li, Yanfeng; Wang, Jing; Burrows, Nilka Rios; Ali, Mohammed K.; Rolka, Deborah; Williams, Desmond E.; Geiss, Linda			Changes in Diabetes-Related Complications in the United States, 1990-2010	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOWER-EXTREMITY AMPUTATIONS; US ADULTS; PUBLIC-HEALTH; LONG-TERM; TRENDS; INDIVIDUALS; DISEASE; RATES; RISK	Background: Preventive care for adults with diabetes has improved substantially in recent decades. We examined trends in the incidence of diabetes-related complications in the United States from 1990 through 2010. Methods: We used data from the National Health Interview Survey, the National Hospital Discharge Survey, the U.S. Renal Data System, and the U.S. National Vital Statistics System to compare the incidences of lower-extremity amputation, end-stage renal disease, acute myocardial infarction, stroke, and death from hyperglycemic crisis between 1990 and 2010, with age standardized to the U.S. population in the year 2000. Results: Rates of all five complications declined between 1990 and 2010, with the largest relative declines in acute myocardial infarction (-67.8%; 95% confidence interval [CI], -76.2 to -59.3) and death from hyperglycemic crisis (-64.4%; 95% CI, -68.0 to -60.9), followed by stroke and amputations, which each declined by approximately half (-52.7% and -51.4%, respectively); the smallest decline was in end-stage renal disease (-28.3%; 95% CI, -34.6 to -21.6). The greatest absolute decline was in the number of cases of acute myocardial infarction (95.6 fewer cases per 10,000 persons; 95% CI, 76.6 to 114.6), and the smallest absolute decline was in the number of deaths from hyperglycemic crisis (-2.7; 95% CI, -2.4 to -3.0). Rate reductions were larger among adults with diabetes than among adults without diabetes, leading to a reduction in the relative risk of complications associated with diabetes. When expressed as rates for the overall population, in which a change in prevalence also affects complication rates, there was a decline in rates of acute myocardial infarction and death from hyperglycemic crisis (2.7 and 0.1 fewer cases per 10,000, respectively) but not in rates of amputation, stroke, or end-stage renal disease. Conclusions: Rates of diabetes-related complications have declined substantially in the past two decades, but a large burden of disease persists because of the continued increase in the prevalence of diabetes. (Funded by the Centers for Disease Control and Prevention.)	[Gregg, Edward W.; Li, Yanfeng; Wang, Jing; Burrows, Nilka Rios; Ali, Mohammed K.; Rolka, Deborah; Williams, Desmond E.; Geiss, Linda] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30341 USA; [Ali, Mohammed K.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy, Atlanta, GA 30341 USA.	edg7@cdc.gov	Ali, Mohammed K/N-9833-2013; li, yan/GTI-4638-2022	Gregg, Edward/0000-0003-2381-6822; Ali, Mohammed/0000-0001-7266-2503				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Angell SY, 2012, ANN INTERN MED, V157, P81, DOI 10.7326/0003-4819-157-2-201207170-00004; [Anonymous], 2000, Vital Health Stat 2, P1; [Anonymous], 2013, NAT DIAB SURV SYST; [Anonymous], 2011, NAT DIAB FACT SHEET; Booth GL, 2006, DIABETES CARE, V29, P32, DOI 10.2337/diacare.29.1.32; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Cowie CC, 2011, DIABETES CARE, V34, P2338; Dennison C, 2000, Vital Health Stat 1, P1; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065228; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geiss LS, 2006, AM J PREV MED, V30, P371, DOI 10.1016/j.amepre.2005.12.009; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Ikonen TS, 2010, DIABETES CARE, V33, P2598, DOI 10.2337/dc10-0462; Kennon B, 2012, DIABETES CARE, V35, P2588, DOI 10.2337/dc12-0511; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Li YF, 2012, DIABETES CARE, V35, P273, DOI 10.2337/dc11-1360; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U. S. Renal Data System Coordinating Center, 2012, USRDS 2012 RES GUID; UK Prospective Diabetes Study Group, 1999, BMJ-BRIT MED J, V318, P29; Vamos EP, 2010, DIABETES CARE, V33, P2592, DOI 10.2337/dc10-0989; VINICOR F, 1994, DIABETES CARE, V17, P22; Wang J, 2011, DIABETES CARE, V34, P1579, DOI 10.2337/dc11-0178; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	41	1073	1109	4	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1514	1523		10.1056/NEJMoa1310799	http://dx.doi.org/10.1056/NEJMoa1310799			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AF3HE	24738668	Bronze			2022-12-24	WOS:000334601600008
J	Bidaye, SS; Machacek, C; Wu, Y; Dickson, BJ				Bidaye, Salil S.; Machacek, Christian; Wu, Yang; Dickson, Barry J.			Neuronal Control of Drosophila Walking Direction	SCIENCE			English	Article							STICK INSECT; JOINT COORDINATION; THORACIC REFLEXES; BACKWARD WALKING; DESCENDING INPUT; COCKROACH; EXPRESSION; MARKER; PATTERNS; LIGHT	Most land animals normally walk forward but switch to backward walking upon sensing an obstacle or danger in the path ahead. A change in walking direction is likely to be triggered by descending "command" neurons from the brain that act upon local motor circuits to alter the timing of leg muscle activation. Here we identify descending neurons for backward walking in Drosophila-the MDN neurons. MDN activity is required for flies to walk backward when they encounter an impassable barrier and is sufficient to trigger backward walking under conditions in which flies would otherwise walk forward. We also identify ascending neurons, MAN, that promote persistent backward walking, possibly by inhibiting forward walking. These findings provide an initial glimpse into the circuits and logic that control walking direction in Drosophila.	[Bidaye, Salil S.; Machacek, Christian; Wu, Yang; Dickson, Barry J.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol IMP, Dr Bohrgasse 7, A-1030 Vienna, Austria.	dicksonb@janelia.hhmi.org	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Bidaye, Salil/0000-0001-9494-6531; Wu, Yang/0000-0002-7782-8290	Boehringer Ingelheim GmbH	Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank L. Tirian and the entire VT project team for generating and staining VT GAL4 and split-GAL4 lines; A. Buschges and M. Palfreyman for insightful discussions and comments on the manuscript; M. Columbini and D. Kummerer for constructing the various assay chambers; K. Heinze for help with the laser sheet setup; and H. Grasberger and W. Li for help in developing the tracker. Basic research at the IMP is funded in part by Boehringer Ingelheim GmbH.	Akay T, 2007, J NEUROSCI, V27, P3285, DOI 10.1523/JNEUROSCI.5202-06.2007; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Burdohan JA, 1996, J NEUROSCI, V16, P5830; BUSCHGES A, 1995, J EXP BIOL, V198, P435; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHRACHRI A, 1987, NEUROSCI LETT, V77, P49, DOI 10.1016/0304-3940(87)90605-7; GRAHAM D, 1985, J EXP BIOL, V118, P287; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Mu LY, 2008, J COMP PHYSIOL A, V194, P283, DOI 10.1007/s00359-007-0307-x; Mu LY, 2008, J COMP PHYSIOL A, V194, P299, DOI 10.1007/s00359-007-0309-8; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; PEARSON KG, 1972, J EXP BIOL, V56, P173; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rosenbaum P, 2010, J NEUROPHYSIOL, V104, P1681, DOI 10.1152/jn.00362.2010; Schoneich S, 2011, J COMP NEUROL, V519, P1677, DOI 10.1002/cne.22594; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Toth TI, 2012, J NEUROPHYSIOL, V107, P3267, DOI 10.1152/jn.01124.2011; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	21	103	103	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					97	101		10.1126/science.1249964	http://dx.doi.org/10.1126/science.1249964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700860				2022-12-24	WOS:000333746100061
J	Xu, S; Zhang, YH; Jia, L; Mathewson, KE; Jang, KI; Kim, J; Fu, HR; Huang, X; Chava, P; Wang, RH; Bhole, S; Wang, LZ; Na, YJ; Guan, Y; Flavin, M; Han, ZS; Huang, YG; Rogers, JA				Xu, Sheng; Zhang, Yihui; Jia, Lin; Mathewson, Kyle E.; Jang, Kyung-In; Kim, Jeonghyun; Fu, Haoran; Huang, Xian; Chava, Pranav; Wang, Renhan; Bhole, Sanat; Wang, Lizhe; Na, Yoon Joo; Guan, Yue; Flavin, Matthew; Han, Zheshen; Huang, Yonggang; Rogers, John A.			Soft Microfluidic Assemblies of Sensors, Circuits, and Radios for the Skin	SCIENCE			English	Article							ELECTRONIC SKIN; EPIDERMAL ELECTRONICS; PRESSURE; TRANSPARENT; DESIGN; FILMS	When mounted on the skin, modern sensors, circuits, radios, and power supply systems have the potential to provide clinical-quality health monitoring capabilities for continuous use, beyond the confines of traditional hospital or laboratory facilities. The most well-developed component technologies are, however, broadly available only in hard, planar formats. As a result, existing options in system design are unable to effectively accommodate integration with the soft, textured, curvilinear, and time-dynamic surfaces of the skin. Here, we describe experimental and theoretical approaches for using ideas in soft microfluidics, structured adhesive surfaces, and controlled mechanical buckling to achieve ultralow modulus, highly stretchable systems that incorporate assemblies of high-modulus, rigid, state-of-the-art functional elements. The outcome is a thin, conformable device technology that can softly laminate onto the surface of the skin to enable advanced, multifunctional operation for physiological monitoring in a wireless mode.	[Xu, Sheng; Jia, Lin; Jang, Kyung-In; Kim, Jeonghyun; Huang, Xian; Chava, Pranav; Wang, Renhan; Bhole, Sanat; Wang, Lizhe; Na, Yoon Joo; Guan, Yue; Flavin, Matthew; Han, Zheshen; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Xu, Sheng; Jia, Lin; Jang, Kyung-In; Kim, Jeonghyun; Huang, Xian; Chava, Pranav; Wang, Renhan; Bhole, Sanat; Wang, Lizhe; Na, Yoon Joo; Guan, Yue; Flavin, Matthew; Han, Zheshen; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Zhang, Yihui; Fu, Haoran; Huang, Yonggang] Northwestern Univ, Ctr Engn & Hlth, Dept Mech Engn, Evanston, IL 60208 USA; [Zhang, Yihui; Fu, Haoran; Huang, Yonggang] Northwestern Univ, Ctr Engn & Hlth, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Zhang, Yihui; Fu, Haoran; Huang, Yonggang] Northwestern Univ, Skin Dis Res Ctr, Evanston, IL 60208 USA; [Zhang, Yihui] Tsinghua Univ, Ctr Mech & Mat, Beijing 100084, Peoples R China; [Mathewson, Kyle E.; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Fu, Haoran] Zhejiang Univ, Dept Civil Engn & Architecture, Hangzhou 310058, Peoples R China; [Kim, Jeonghyun] Hanyang Univ, Dept Energy Engn, Dept Mat Sci & Engn, Seoul 133791, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Northwestern University; Tsinghua University; University of Illinois System; University of Illinois Urbana-Champaign; Zhejiang University; Hanyang University	Huang, YG (corresponding author), Northwestern Univ, Ctr Engn & Hlth, Dept Mech Engn, Evanston, IL 60208 USA.	y-huang@northwestern.edu; jrogers@illinois.edu	Rogers, John/L-2798-2016; Flavin, Matthew/B-7196-2015; Zhang, Yihui/G-9876-2011; Xu, Sheng/D-7717-2011; huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; Fu, Haoran/ABA-6690-2021	Flavin, Matthew/0000-0001-6636-0445; Zhang, Yihui/0000-0003-0885-2067; Xu, Sheng/0000-0002-3120-4992; Fu, Haoran/0000-0002-5400-3042; Huang, Xian/0000-0002-8788-9185	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471]; Korean Foundation for International Cooperation of Science and Technology (KICOS) [Global Research Laboratory (GRL) Program], Korean ministry of Science and Technology (MOST) [K2070400000307A050000310]; Beckman Institute	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign; Korean Foundation for International Cooperation of Science and Technology (KICOS) [Global Research Laboratory (GRL) Program], Korean ministry of Science and Technology (MOST); Beckman Institute	This work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under Award DE-FG02-07ER46471 through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign, and the Korean Foundation for International Cooperation of Science and Technology (KICOS) through a grant [K2070400000307A050000310, Global Research Laboratory (GRL) Program] provided by the Korean ministry of Science and Technology (MOST). K. E. M was supported by a postdoctoral fellowship from the Beckman Institute. The authors thank V. Malyarchuk, S. H. Ali, Y. Song, T. Banks, and S. Xiang for technical support and stimulating discussions.	Axisa F., 2007, C P IEEE ENG MED BIO, V2011, P5687; Chow EY, 2013, IEEE MICROW MAG, V14, P64, DOI 10.1109/MMM.2013.2248586; Gonzalez M, 2011, MICROELECTRON RELIAB, V51, P1069, DOI 10.1016/j.microrel.2011.03.012; Jeong JW, 2013, ADV MATER, V25, P6839, DOI 10.1002/adma.201301921; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Keplinger C, 2013, SCIENCE, V341, P984, DOI 10.1126/science.1240228; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203905; Kubo M, 2010, ADV MATER, V22, P2749, DOI 10.1002/adma.200904201; Lacour SP, 2006, J APPL PHYS, V100, DOI 10.1063/1.2210170; Lee Y, 2013, IEEE J SOLID-ST CIRC, V48, P2511, DOI 10.1109/JSSC.2013.2275660; Lee Y, 2013, IEEE J SOLID-ST CIRC, V48, P229, DOI 10.1109/JSSC.2012.2221233; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; Mannoor MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1767; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/nmat2834, 10.1038/NMAT2834]; Palleau E, 2013, ADV MATER, V25, P1589, DOI 10.1002/adma.201203921; Pan CF, 2013, NAT PHOTONICS, V7, P752, DOI [10.1038/NPHOTON.2013.191, 10.1038/nphoton.2013.191]; Rogers JA, 2011, NATURE, V477, P45, DOI 10.1038/nature10381; Romeo A, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4799653; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Sekitani T, 2012, MRS BULL, V37, P236, DOI 10.1557/mrs.2012.42; Sterken T, 2011, IEEE ENG MED BIO, P6886, DOI 10.1109/IEMBS.2011.6091734; Sun Y, 2012, IEEE T DEPEND SECURE, V9, P785, DOI 10.1109/TDSC.2012.68; Thomas SJ, 2012, IEEE T BIOMED CIRC S, V6, P424, DOI 10.1109/TBCAS.2012.2222881; Vandeparre H, 2013, ADV MATER, V25, P3117, DOI 10.1002/adma.201300587; Vogt DM, 2013, IEEE SENS J, V13, P4056, DOI 10.1109/JSEN.2013.2272320; Wagner S, 2012, MRS BULL, V37, P207, DOI 10.1557/mrs.2012.37; Wang C, 2013, NAT MATER, V12, P899, DOI [10.1038/NMAT3711, 10.1038/nmat3711]; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/NPHOTON.2013.188, 10.1038/nphoton.2013.188]	29	826	884	67	1281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					70	74		10.1126/science.1250169	http://dx.doi.org/10.1126/science.1250169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700852	Green Submitted			2022-12-24	WOS:000333746100053
J	Eisler, MC; Lee, MRF; Tarlton, JF; Martin, GB; Beddington, J; Dungait, JAJ; Greathead, H; Liu, JX; Mathew, S; Miller, H; Misselbrook, T; Murray, P; Vinod, VK; Van Saun, R; Winter, M				Eisler, Mark C.; Lee, Michael R. F.; Tarlton, John F.; Martin, Graeme B.; Beddington, John; Dungait, Jennifer A. J.; Greathead, Henry; Liu, Jianxin; Mathew, Stephen; Miller, Helen; Misselbrook, Tom; Murray, Phil; Vinod, Valil K.; Van Saun, Robert; Winter, Michael			Steps to sustainable livestock	NATURE			English	Editorial Material									[Eisler, Mark C.; Lee, Michael R. F.; Tarlton, John F.] Univ Bristol, Sch Vet Sci, Bristol BS8 1TH, Avon, England; [Martin, Graeme B.] Univ Western Australia, UWA Inst Agr, Perth, WA 6009, Australia	University of Bristol; University of Western Australia	Eisler, MC (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS8 1TH, Avon, England.	mark.eisler@bristol.ac.uk	Eisler, Mark/AAK-1119-2020; Misselbrook, Tom/N-2385-2014; Dungait, Jenni/F-1110-2013; Dungait, Jennifer/AAV-7301-2021; Martin, Graeme B/A-2618-2008; Murray, Phil/B-1246-2009	Eisler, Mark/0000-0001-6843-3345; Misselbrook, Tom/0000-0002-4594-3606; Dungait, Jenni/0000-0001-9074-4174; Martin, Graeme B/0000-0002-1905-7934; Lee, Michael/0000-0001-7451-5611; Tarlton, John/0000-0002-4886-6634; Murray, Phil/0000-0002-5526-8317	Biotechnology and Biological Sciences Research Council [BB/K001906/1] Funding Source: researchfish; The British Council [GII108] Funding Source: researchfish; BBSRC [BBS/E/C/00005190, BBS/E/C/00005198, BB/K001906/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The British Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bickell S. L., 2010, Updates on ruminant production and medicine. XXVI World Buiatrics Congress, Santiago, Chile, 14-18 November 2010, P317; Bocquier F, 2010, ANIMAL, V4, P1258, DOI 10.1017/S1751731110001023; FAO, 2002, WORLD AGR 2015 2030; Garnett T, 2009, ENVIRON SCI POLICY, V12, P491, DOI 10.1016/j.envsci.2009.01.006; Grace D., 2012, MAPPING POVERTY LIKE; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Kenyon F, 2009, VET PARASITOL, V164, P3, DOI 10.1016/j.vetpar.2009.04.015; Lee MRF, 2009, ANIM FEED SCI TECH, V149, P250, DOI 10.1016/j.anifeedsci.2008.06.013; Otte J., 2012, LIVESTOCK SECTOR DEV; Smith J., 2013, Animal Frontiers, V3, P6, DOI 10.2527/af.2013-0002	10	200	207	8	168	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					32	34		10.1038/507032a	http://dx.doi.org/10.1038/507032a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24605375	Green Published, Bronze			2022-12-24	WOS:000332224400026
J	Karagoz, GE; Duarte, AMS; Akoury, E; Ippel, H; Biernat, J; Luengo, TM; Radli, M; Didenko, T; Nordhues, BA; Veprintsev, DB; Dickey, CA; Mandelkow, E; Zweckstetter, M; Boelens, R; Madl, T; Rudiger, SGD				Karagoz, G. Elif; Duarte, Afonso M. S.; Akoury, Elias; Ippel, Hans; Biernat, Jacek; Luengo, Tania Moran; Radli, Martina; Didenko, Tatiana; Nordhues, Bryce A.; Veprintsev, Dmitry B.; Dickey, Chad A.; Mandelkow, Eckhard; Zweckstetter, Markus; Boelens, Rolf; Madl, Tobias; Rudiger, Stefan G. D.			Hsp90-Tau Complex Reveals Molecular Basis for Specificity in Chaperone Action	CELL			English	Article							PAIRED HELICAL FILAMENTS; ESCHERICHIA-COLI HSP90; N-TERMINAL DOMAIN; X-RAY-SCATTERING; NMR-SPECTROSCOPY; TAU-PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL-ANALYSIS; INTRINSIC DISORDER; QUALITY-CONTROL	Protein folding in the cell relies on the orchestrated action of conserved families of molecular chaperones, the Hsp70 and Hsp90 systems. Hsp70 acts early and Hsp90 late in the folding path, yet the molecular basis of this timing is enigmatic, mainly because the substrate specificity of Hsp90 is poorly understood. Here, we obtained a structural model of Hsp90 in complex with its natural disease-associated substrate, the intrinsically disordered Tau protein. Hsp90 binds to a broad region in Tau that includes the aggregation-prone repeats. Complementarily, a 106-angstrom-long substrate-binding interface in Hsp90 enables many low-affinity contacts. This allows recognition of scattered hydrophobic residues in late folding intermediates that remain after early burial of the Hsp70 sites. Our model resolves the paradox of how Hsp90 specifically selects for late folding intermediates but also for some intrinsically disordered proteins-through the eyes of Hsp90 they look the same.	[Karagoz, G. Elif; Duarte, Afonso M. S.; Luengo, Tania Moran; Radli, Martina; Didenko, Tatiana; Rudiger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Karagoz, G. Elif] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Karagoz, G. Elif] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Duarte, Afonso M. S.] Univ Nova Lisboa, Inst Tecnol Quim Biol Antonio Xavier, P-2780157 Oeiras, Portugal; [Akoury, Elias; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Ippel, Hans; Boelens, Rolf; Madl, Tobias] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol NMR Spect, NL-3584 CH Utrecht, Netherlands; [Ippel, Hans] Maastricht Univ, Biochem Grp, CARIM Sch Cardiovasc Dis, NL-6229 ER Maastricht, Netherlands; [Biernat, Jacek; Mandelkow, Eckhard] DZNE, German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Nordhues, Bryce A.; Dickey, Chad A.] Univ S Florida, Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, Tampa, FL 33613 USA; [Nordhues, Bryce A.; Dickey, Chad A.] Univ S Florida, Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Veprintsev, Dmitry B.] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Mandelkow, Eckhard] CAESAR Res Ctr, D-53175 Bonn, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37073 Gottingen, Germany; [Madl, Tobias] Tech Univ Munich, Helmholtz Zentrum Munchen Neuherberg & Biomol NMR, Inst Struct Biol, D-85747 Garching, Germany; [Madl, Tobias] Graz Univ, Inst Chem, A-8010 Graz, Austria	Utrecht University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade Nova de Lisboa; Max Planck Society; Utrecht University; Maastricht University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen; Technical University of Munich; University of Graz	Madl, T (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol NMR Spect, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	t.madl@tum.de; s.g.d.rudiger@uu.nl	Madl, Tobias/B-1682-2012; Veprintsev, Dmitry B/H-2228-2012; Rüdiger, Stefan GD/G-4906-2012; Akoury, Elias/AAG-2881-2019; Boelens, Rolf/B-4702-2009; Ippel, Hans/D-6917-2016; Duarte, Afonso/G-3233-2010	Madl, Tobias/0000-0002-9725-5231; Veprintsev, Dmitry B/0000-0002-3583-5409; Rüdiger, Stefan GD/0000-0002-1807-2972; Akoury, Elias/0000-0001-5202-8935; Boelens, Rolf/0000-0002-6939-8913; Duarte, Afonso/0000-0003-2181-0187; Karagoz, Gulsun Elif/0000-0002-3392-2250; Zweckstetter, Markus/0000-0002-2536-6581	EU [25651, 317371, 608180]; Nederlands Organisation for Scientific Research NWO; Utrecht University; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/78075/2011]; project ITRANS from the Marie Curie Actions [PCIG11-GA-2012-322346]; NWO-CW; European Union (EU) [261863]; German Research Foundation [ZW71/7-1]; National Insitutes of Health [NS073899]; Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Austrian Academy of Sciences (APART-fellowship); German Research Foundation (Emmy Noether program) [MA 5703/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER	EU(European Commission); Nederlands Organisation for Scientific Research NWO; Utrecht University; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); project ITRANS from the Marie Curie Actions; NWO-CW(Netherlands Organization for Scientific Research (NWO)); European Union (EU)(CGIAREuropean Commission); German Research Foundation(German Research Foundation (DFG)); National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Austrian Academy of Sciences (APART-fellowship); German Research Foundation (Emmy Noether program)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Ineke Braakman for continuous support. We thank Assaf Friedler, Sander van den Heuvel, and Paul van Bergen en Henegouwen for comments on the manuscript. S.G.D.R. was supported by Marie-Curie Actions of the 6th and 7th Framework programme of the EU (Excellence Grant "chaperoning cascades'' [No. 25651], Innovative Doctoral Programme "ManiFold" [No. 317371] and Initial Training Network "WntsApp" [No. 608180]), a VIDI career development grant by the Nederlands Organisation for Scientific Research NWO and a High Potential Grant of Utrecht University. A.M.S.D. was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BPD/78075/2011) and by the project ITRANS from the Marie Curie Actions PCIG11-GA-2012-322346. R.B. was supported by NWO-CW for the 900 MHz NMR and the TCI cryoprobe. R.B., H.I., and T.M. were supported by the European Union (EU) project "BioNMR" (No. 261863). M.Z. was supported by the German Research Foundation (ZW71/7-1). C.A.D. was supported by the National Insitutes of Health (No. NS073899). T.M. was supported by the Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network), the Austrian Academy of Sciences (APART-fellowship), and the German Research Foundation (Emmy Noether program MA 5703/1-1). We are grateful to D. Svergun (EMBL Outstation at DESY, Hamburg) for providing access to SAXS measurements, and to the Leibniz Supercomputing Centre (LRZ; http://www.lrz.de) for providing computing time on the Linux Cluster.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Daturpalli S., 2013, J MOL BIOL; DEKKER N, 1993, NATURE, V362, P852, DOI 10.1038/362852a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Didenko T, 2012, BBA-MOL CELL RES, V1823, P636, DOI 10.1016/j.bbamcr.2011.11.009; Didenko T, 2011, PROTEIN ENG DES SEL, V24, P99, DOI 10.1093/protein/gzq091; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Dunker AK, 2011, CURR OPIN STRUC BIOL, V21, P379, DOI 10.1016/j.sbi.2011.04.002; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Miyata Y, 2011, FUTURE MED CHEM, V3, P1523, DOI [10.4155/fmc.11.88, 10.4155/FMC.11.88]; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Park SJ, 2011, J MOL BIOL, V411, P158, DOI 10.1016/j.jmb.2011.05.030; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Shkumatov AV, 2011, PROTEINS, V79, P2122, DOI 10.1002/prot.23033; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weibezahn J, 2005, BIOL CHEM, V386, P739, DOI 10.1515/BC.2005.086; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	64	190	191	0	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					963	974		10.1016/j.cell.2014.01.037	http://dx.doi.org/10.1016/j.cell.2014.01.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581495	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000332083900014
J	Ogden, CL; Carroll, MD; Kit, BK; Flegal, KM				Ogden, Cynthia L.; Carroll, Margaret D.; Kit, Brian K.; Flegal, Katherine M.			Prevalence of Childhood and Adult Obesity in the United States, 2011-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CHILDREN; TRENDS; ADOLESCENTS	IMPORTANCE More than one-third of adults and 17% of youth in the United States are obese, although the prevalence remained stable between 2003-2004 and 2009-2010. OBJECTIVE To provide the most recent national estimates of childhood obesity, analyze trends in childhood obesity between 2003 and 2012, and provide detailed obesity trend analyses among adults. DESIGN, SETTING, AND PARTICIPANTS Weight and height or recumbent length were measured in 9120 participants in the 2011-2012 nationally representative National Health and Nutrition Examination Survey. MAIN OUTCOMES AND MEASURES In infants and toddlers from birth to 2 years, high weight for recumbent length was defined as weight for length at or above the 95th percentile of the sex-specific Centers for Disease Control and Prevention (CDC) growth charts. In children and adolescents aged 2 to 19 years, obesity was defined as a body mass index (BMI) at or above the 95th percentile of the sex-specific CDC BMI-for-age growth charts. In adults, obesity was defined as a BMI greater than or equal to 30. Analyses of trends in high weight for recumbent length or obesity prevalence were conducted overall and separately by age across 5 periods (2003-2004, 2005-2006, 2007-2008, 2009-2010, and 2011-2012). RESULTS In 2011-2012, 8.1% (95% CI, 5.8%-11.1%) of infants and toddlers had high weight for recumbent length, and 16.9% (95% CI, 14.9%-19.2%) of 2- to 19-year-olds and 34.9% (95% CI, 32.0%-37.9%) of adults (age-adjusted) aged 20 years or older were obese. Overall, there was no significant change from 2003-2004 through 2011-2012 in high weight for recumbent length among infants and toddlers, obesity in 2- to 19-year-olds, or obesity in adults. Tests for an interaction between survey period and age found an interaction in children (P=.03) and women (P=.02). There was a significant decrease in obesity among 2- to 5-year-old children (from 13.9% to 8.4%; P=.03) and a significant increase in obesity among women aged 60 years and older (from 31.5% to 38.1%; P=.006). CONCLUSIONS AND RELEVANCE Overall, there have been no significant changes in obesity prevalence in youth or adults between 2003-2004 and 2011-2012. Obesity prevalence remains high and thus it is important to continue surveillance.	[Ogden, Cynthia L.; Carroll, Margaret D.; Kit, Brian K.; Flegal, Katherine M.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Kit, Brian K.] US PHS, Rockville, MD USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); United States Public Health Service	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4415, Hyattsville, MD 20782 USA.	cogden@cdc.gov	Flegal, Katherine M/A-4608-2013		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; [Anonymous], NATIONAL HEALTH AND; [Anonymous], 2010, THE SURGEON GENERALS; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; CDC National Center for Health Statistics, 2011, NHANES RESPONSE RATE; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1673; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, AM J CLIN NUTR, V91, P1020, DOI 10.3945/ajcn.2009.28589; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Food and Nutrition Service; USDA, 2007, SPECIAL SUPPLEMENTAL; Fryar CD, PREVALENCE OF OVERWE; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488; Institute of Medicine, 2012, ACCELERATING PROGRES; Khan Laura Kettel, 2009, Morbidity and Mortality Weekly Report, V58, P1; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; May AL, 2013, MMWR-MORBID MORTAL W, V62, P629; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Skinner CJ, 1989, ANALYSIS OF COMPLEX; Sperrin M, 2014, INT J OBESITY, V38, P818, DOI 10.1038/ijo.2013.161; Wen XZ, 2012, PEDIATRICS, V129, P823, DOI 10.1542/peds.2011-1833; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wolter KM, 1985, INTRODUCTION TO VARI	32	5912	6000	14	622	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					806	814		10.1001/jama.2014.732	http://dx.doi.org/10.1001/jama.2014.732			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570244	Green Accepted, Bronze			2022-12-24	WOS:000331793700020
J	Lee, H; Kim, DW; Remedios, R; Anthony, TE; Chang, A; Madisen, L; Zeng, HK; Anderson, DJ				Lee, Hyosang; Kim, Dong-Wook; Remedios, Ryan; Anthony, Todd E.; Chang, Angela; Madisen, Linda; Zeng, Hongkui; Anderson, David J.			Scalable control of mounting and attack by Esr1(+) neurons in the ventromedial hypothalamus	NATURE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MEDIAL AMYGDALA; AGGRESSION; NUCLEUS; IDENTIFICATION; MICE	Social behaviours, such as aggression or mating, proceed through a series of appetitive and consummatory phases(1) that are associated with increasing levels of arousal(2). How such escalation is encoded in the brain, and linked to behavioural action selection, remains an unsolved problem in neuroscience. The ventrolateral subdivision of the murine ventromedial hypothalamus(VMHvl) contains neurons whose activity increases during male-male and male-female social encounters. Non-cell-type-specific optogenetic activation of this region elicited attack behaviour, but not mounting(3). We have identified a subset of VMHvl neurons marked by the oestrogen receptor 1 (Esr1), and investigated their role in male social behaviour. Optogenetic manipulations indicated that Esr1(+) (but not Esr1(-)) neurons are sufficient to initiate attack, and that their activity is continuously required during ongoing agonistic behaviour. Surprisingly, weaker optogenetic activation of these neurons promoted mounting behaviour, rather than attack, towards both males and females, as well as sniffing and close investigation. Increasing photostimulation intensity could promote a transition from close investigation and mounting to attack, within a single social encounter. Importantly, time-resolved optogenetic inhibition experiments revealed requirements for Esr1(+) neurons in both the appetitive (investigative) and the consummatory phases of social interactions. Combined optogenetic activation and calcium imaging experiments in vitro, as well as c-Fos analysis in vivo, indicated that increasing photostimulation intensity increases both the number of active neurons and the average level of activity per neuron. These data suggest that Esr1(+) neurons in VMHvl control the progression of a social encounter from its appetitive through its consummatory phases, in a scalable manner that reflects the number or type of active neurons in the population.	[Lee, Hyosang; Remedios, Ryan; Anthony, Todd E.; Chang, Angela; Anderson, David J.] CALTECH, Div Biol & Biol Engn 156 29, Pasadena, CA 91125 USA; [Lee, Hyosang; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Kim, Dong-Wook; Anderson, David J.] CALTECH, Pasadena, CA 91125 USA; [Madisen, Linda; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Allen Institute for Brain Science	Anderson, DJ (corresponding author), CALTECH, Div Biol & Biol Engn 156 29, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Remedios, Ryan/AAA-2389-2020	Remedios, Ryan/0000-0001-6004-808X	NIH [R01MH070053, 1K99NS074077, 1F32HD055198-01]; Gordon Moore Foundation; Ellison Medical Research Foundation; Beckman Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD055198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070053, R01MH085082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS074077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon Moore Foundation; Ellison Medical Research Foundation(Lawrence Ellison Foundation); Beckman Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Park for behavioural scoring, R. Robertson for behavioural scoring and MATLAB programming, L. Lo for testing Cre-mediated recombination in Esr1<SUP>cre/+</SUP> male mice, C. Chiu and X. Wang for histology, M. McCardle for genotyping, J. S. Chang for technical assistance, S. Pease for generation of knock-in mice, H. Cai for training in slice electrophysiology, A. Wong for assistance with two-photon imaging, K. Deisseroth and J. Harris for AAV constructs, E. Boyden for advice on ferrule fibre fabrication, D. Lin and M. Boyle for their contributions to early stages of this project, W. Hong and R. Axel for comments on the manuscript, C. Chiu for laboratory management and G. Mancuso for administrative assistance. D. J. A. is an Investigator of the Howard Hughes Medical Institute and a Paul G. Allen Distinguished Investigator. This work was supported in part by NIH grant no. R01MH070053, and grants from the Gordon Moore Foundation and Ellison Medical Research Foundation. H. L. was supported by the NIH Pathway to Independence Award 1K99NS074077. T. E. A. was supported by NIH NRSA postdoctoral fellowship grant 1F32HD055198-01 and a Beckman Fellowship.	Anderson DJ, 2012, BIOL PSYCHIAT, V71, P1081, DOI 10.1016/j.biopsych.2011.11.012; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; BENTLEY D, 1978, ANNU REV NEUROSCI, V1, P35, DOI 10.1146/annurev.ne.01.030178.000343; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; COHEN RS, 1992, PROG NEUROBIOL, V38, P423, DOI 10.1016/0301-0082(92)90045-G; Devidze N, 2006, PHYSIOL BEHAV, V88, P283, DOI 10.1016/j.physbeh.2006.05.030; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Harris JA., 2012, CURR PROTOC NEUROSCI, V20, P21, DOI [10.1002/0471142301.ns0120-59, DOI 10.1002/0471142301.NS0120-59, 10.1002/0471142301.ns0120s59, DOI 10.1002/0471142301.NS0120S59]; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Kow LM, 2005, BRAIN RES, V1043, P124, DOI 10.1016/j.brainres.2005.02.068; Kristan WB, 2008, CURR BIOL, V18, pR928, DOI 10.1016/j.cub.2008.07.081; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Sano K, 2013, EUR J NEUROSCI, V37, P1308, DOI 10.1111/ejn.12131; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Spiteri T, 2010, BEHAV BRAIN RES, V210, P211, DOI 10.1016/j.bbr.2010.02.033; Spiteri T, 2010, NEUROENDOCRINOLOGY, V91, P142, DOI 10.1159/000255766; TINBERGEN N, 1950, SYM SOC EXP BIOL, V4, P305; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; Wu MV, 2011, CURR OPIN NEUROBIOL, V21, P116, DOI 10.1016/j.conb.2010.09.014; Wu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008054; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	36	251	252	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					627	+		10.1038/nature13169	http://dx.doi.org/10.1038/nature13169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24739975	Green Accepted			2022-12-24	WOS:000336457100050
J	Ikeda, R; Cha, M; Ling, J; Jia, ZF; Coyle, D; Gu, JGG				Ikeda, Ryo; Cha, Myeounghoon; Ling, Jennifer; Jia, Zhanfeng; Coyle, Dennis; Gu, Jianguo G.			Merkel Cells Transduce and Encode Tactile Stimuli to Drive A beta-Afferent Impulses	CELL			English	Article							SEROTONIN-LIKE IMMUNOREACTIVITY; DORSAL-ROOT GANGLION; CAENORHABDITIS-ELEGANS; MECHANOSENSORY TRANSDUCTION; MECHANICAL ALLODYNIA; HAIRY SKIN; SNOUT SKIN; RAT; NEURONS; RESPONSES	Sensory systems for detecting tactile stimuli have evolved from touch-sensing nerves in invertebrates to complicated tactile end organs in mammals. Merkel discs are tactile end organs consisting of Merkel cells and A beta-afferent nerve endings and are localized in fingertips, whisker hair follicles, and other touch-sensitive spots. Merkel discs transduce touch into slowly adapting impulses to enable tactile discrimination, but their transduction and encoding mechanisms remain unknown. Using rat whisker hair follicles, we show that Merkel cells rather than Ab-afferent nerve endings are primary sites of tactile transduction and identify the Piezo2 ion channel as the Merkel cell mechanical transducer. Piezo2 transduces tactile stimuli into Ca2+-action potentials in Merkel cells, which drive Ab-afferent nerve endings to fire slowly adapting impulses. We further demonstrate that Piezo2 and Ca2+-action potentials in Merkel cells are required for behavioral tactile responses. Our findings provide insights into how tactile end-organs function and have clinical implications for tactile dysfunctions.	[Ikeda, Ryo; Cha, Myeounghoon; Ling, Jennifer; Jia, Zhanfeng; Coyle, Dennis; Gu, Jianguo G.] Univ Cincinnati, Coll Med, Dept Anesthesiol, Pain Res Ctr, Cincinnati, OH 45267 USA; [Ikeda, Ryo] Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, Tokyo 1058461, Japan	University System of Ohio; University of Cincinnati; Jikei University	Gu, JGG (corresponding author), Univ Cincinnati, Coll Med, Dept Anesthesiol, Pain Res Ctr, POB 670531,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	gujo@uc.edu	Cha, Myeounghoon/ABI-2748-2020	cha, myeounghoon/0000-0002-7993-672X; Ikeda, Ryo/0000-0001-6603-7146	NIH [DE018661, DE023090]; Mochida Memorial Foundation for Medical and Pharmaceutical Research of Japan; NSF of China (NSFC) [31000376]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023090, R01DE018661] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mochida Memorial Foundation for Medical and Pharmaceutical Research of Japan; NSF of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Drs. A. MacDermott, M. Salter, J. Strong, and M. Baccei for comments on an earlier version of this manuscript. This work was supported by NIH grants DE018661 and DE023090 to J.G.G, a travel fellowship to R.I. from The Mochida Memorial Foundation for Medical and Pharmaceutical Research of Japan, and a scholarship to Z.J. from NSF of China (NSFC, 31000376).	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baumann KI, 1996, NEUROSCI LETT, V213, P1, DOI 10.1016/0304-3940(96)12813-5; Blake DT, 1997, J NEUROPHYSIOL, V78, P2503, DOI 10.1152/jn.1997.78.5.2503; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; CROWE R, 1978, CELL TISSUE RES, V190, P273; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; ENGLISH KB, 1992, ANAT REC, V232, P112, DOI 10.1002/ar.1092320112; Fricke B, 2000, CELL TISSUE RES, V299, P327; GARCIACABALLERO T, 1989, ANAT REC, V225, P267, DOI 10.1002/ar.1092250402; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HASHIMOTO K, 1972, J ANAT, V111, P99; Hogg RC, 1999, J PHARMACOL EXP THER, V289, P1502; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; MUNGER BL, 1965, J CELL BIOL, V26, P79, DOI 10.1083/jcb.26.1.79; Ogawa H, 1988, Prog Brain Res, V74, P63; Sang CN, 1996, ANESTHESIOLOGY, V85, P491, DOI 10.1097/00000542-199609000-00007; Senok SS, 1996, NEUROSCI LETT, V214, P167, DOI 10.1016/0304-3940(96)12906-2; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; Tachibana T, 2005, ARCH HISTOL CYTOL, V68, P383, DOI 10.1679/aohc.68.383; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Yu HW, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-63; ZACCONE G, 1986, HISTOCHEMISTRY, V85, P29, DOI 10.1007/BF00508650; ZACCONE G, 1995, NEUROPEPTIDES, V28, P257, DOI 10.1016/0143-4179(95)90041-1; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	45	193	198	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					664	675		10.1016/j.cell.2014.02.026	http://dx.doi.org/10.1016/j.cell.2014.02.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24746027	Bronze, Green Accepted			2022-12-24	WOS:000335392100015
J	Kemmeren, P; Sameith, K; van de Pasch, LAL; Benschop, JJ; Lenstra, TL; Margaritis, T; O'Duibhir, E; Apweiler, E; van Wageningen, S; Ko, CW; van Heesch, S; Kashani, MM; Ampatziadis-Michailidis, G; Brok, MO; Brabers, NACH; Miles, AJ; Bouwmeester, D; van Hooff, SR; van Bakel, H; Sluiters, E; Bakker, LV; Snel, B; Lijnzaad, P; van Leenen, D; Koerkamp, MJAG; Holstege, FCP				Kemmeren, Patrick; Sameith, Katrin; van de Pasch, Loes A. L.; Benschop, Joris J.; Lenstra, Tineke L.; Margaritis, Thanasis; O'Duibhir, Eoghan; Apweiler, Eva; van Wageningen, Sake; Ko, Cheuk W.; van Heesch, Sebastiaan; Kashani, Mehdi M.; Ampatziadis-Michailidis, Giannis; Brok, Mariel O.; Brabers, Nathalie A. C. H.; Miles, Anthony J.; Bouwmeester, Diane; van Hooff, Sander R.; van Bakel, Harm; Sluiters, Erik; Bakker, Linda V.; Snel, Berend; Lijnzaad, Philip; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.			Large-Scale Genetic Perturbations Reveal Regulatory Networks and an Abundance of Gene-Specific Repressors	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; EXPRESSION PROFILES; EUKARYOTIC GENOME; YEAST; MECHANISMS; PATHWAYS; INTERACTOME; CIRCUITRY; TARGETS	To understand regulatory systems, it would be useful to uniformly determine how different components contribute to the expression of all other genes. We therefore monitored mRNA expression genome-wide, for individual deletions of one-quarter of yeast genes, focusing on (putative) regulators. The resulting genetic perturbation signatures reflect many different properties. These include the architecture of protein complexes and pathways, identification of expression changes compatible with viability, and the varying responsiveness to genetic perturbation. The data are assembled into a genetic perturbation network that shows different connectivities for different classes of regulators. Four feed-forward loop (FFL) types are overrepresented, including incoherent type 2 FFLs that likely represent feedback. Systematic transcription factor classification shows a surprisingly high abundance of gene-specific repressors, suggesting that yeast chromatin is not as generally restrictive to transcription as is often assumed. The data set is useful for studying individual genes and for discovering properties of an entire regulatory system.	[Kemmeren, Patrick; Sameith, Katrin; van de Pasch, Loes A. L.; Benschop, Joris J.; Lenstra, Tineke L.; Margaritis, Thanasis; O'Duibhir, Eoghan; Apweiler, Eva; van Wageningen, Sake; Ko, Cheuk W.; van Heesch, Sebastiaan; Kashani, Mehdi M.; Ampatziadis-Michailidis, Giannis; Brok, Mariel O.; Brabers, Nathalie A. C. H.; Miles, Anthony J.; Bouwmeester, Diane; van Hooff, Sander R.; van Bakel, Harm; Sluiters, Erik; Bakker, Linda V.; Lijnzaad, Philip; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.] Univ Med Ctr Utrecht, NL-3584 CG Utrecht, Netherlands; [Snel, Berend] Univ Utrecht, Dept Biol, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Lijnzaad, Philip/ABE-4205-2021; Lenstra, Tineke/L-3958-2016; van Bakel, Harm/N-9561-2017; Holstege, Frank/AAM-9944-2021; Snel, Berend/B-8886-2011; Benschop, Joris j/C-7809-2012; van Heesch, Sebastiaan/AAT-6595-2020	Lijnzaad, Philip/0000-0002-7535-583X; Lenstra, Tineke/0000-0002-4440-9962; van Bakel, Harm/0000-0002-1376-6916; Snel, Berend/0000-0002-5804-8547; van Heesch, Sebastiaan/0000-0001-9593-1980; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Kemmeren, Patrick/0000-0003-2237-7354; Sameith, Katrin/0000-0003-4306-930X	Netherlands Bioinformatics Centre and the Netherlands Organization of Scientific Research [016108607, 81702015, 05071057, 91106009, 021002035, 863.07.007, 864.11.010, 70057407]	Netherlands Bioinformatics Centre and the Netherlands Organization of Scientific Research	This study was supported by the Netherlands Bioinformatics Centre and the Netherlands Organization of Scientific Research (grants 016108607, 81702015, 05071057, 91106009, and 021002035 to T.L.L.; grants 863.07.007 and 864.11.010 to P.K.; and grant 70057407 to J.J.B.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Benschop JJ, 2010, MOL CELL, V38, P916, DOI 10.1016/j.molcel.2010.06.002; Bonke M, 2013, G3-GENES GENOM GENET, V3, P75, DOI 10.1534/g3.112.004283; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2013, GENETICS, V195, P9, DOI 10.1534/genetics.113.153262; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; McIsaac RS, 2012, MOL BIOL CELL, V23, P2993, DOI 10.1091/mbc.E12-03-0232; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Teng X, 2013, MOL CELL, V52, P485, DOI 10.1016/j.molcel.2013.09.026; van Bakel H, 2004, EMBO REP, V5, P964, DOI 10.1038/sj.embor.7400253; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	54	161	163	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					740	752		10.1016/j.cell.2014.02.054	http://dx.doi.org/10.1016/j.cell.2014.02.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766815	Bronze			2022-12-24	WOS:000335392100021
J	Gad, H; Koolmeister, T; Jemth, AS; Eshtad, S; Jacques, SA; Strom, CE; Svensson, LM; Schultz, N; Lundback, T; Einarsdottir, BO; Saleh, A; Gokturk, C; Baranczewski, P; Svensson, R; Berntsson, RPA; Gustafsson, R; Stromberg, K; Sanjiv, K; Jacques-Cordonnier, MC; Desroses, M; Gustavsson, AL; Olofsson, R; Johansson, F; Homan, EJ; Loseva, O; Brautigam, L; Johansson, L; Hoglund, A; Hagenkort, A; Pham, T; Altun, M; Gaugaz, FZ; Vikingsson, S; Evers, B; Henriksson, M; Vallin, KSA; Wallner, OA; Hammarstrom, LGJ; Wiita, E; Almlof, I; Kalderen, C; Axelsson, H; Djureinovic, T; Puigvert, JC; Haggblad, M; Jeppsson, F; Martens, U; Lundin, C; Lundgren, B; Granelli, I; Jensen, AJ; Artursson, P; Nilsson, JA; Stenmark, P; Scobie, M; Berglund, UW; Helleday, T				Gad, Helge; Koolmeister, Tobias; Jemth, Ann-Sofie; Eshtad, Saeed; Jacques, Sylvain A.; Strom, Cecilia E.; Svensson, Linda M.; Schultz, Niklas; Lundback, Thomas; Einarsdottir, Berglind Osk; Saleh, Aljona; Gokturk, Camilla; Baranczewski, Pawel; Svensson, Richard; Berntsson, Ronnie P. -A.; Gustafsson, Robert; Stromberg, Kia; Sanjiv, Kumar; Jacques-Cordonnier, Marie-Caroline; Desroses, Matthieu; Gustavsson, Anna-Lena; Olofsson, Roger; Johansson, Fredrik; Homan, Evert J.; Loseva, Olga; Brautigam, Lars; Johansson, Lars; Hoglund, Andreas; Hagenkort, Anna; Pham, Therese; Altun, Mikael; Gaugaz, Fabienne Z.; Vikingsson, Svante; Evers, Bastiaan; Henriksson, Martin; Vallin, Karl S. A.; Wallner, Olov A.; Hammarstrom, Lars G. J.; Wiita, Elisee; Almlof, Ingrid; Kalderen, Christina; Axelsson, Hanna; Djureinovic, Tatjana; Puigvert, Jordi Carreras; Haggblad, Maria; Jeppsson, Fredrik; Martens, Ulf; Lundin, Cecilia; Lundgren, Bo; Granelli, Ingrid; Jensen, Annika Jenmalm; Artursson, Per; Nilsson, Jonas A.; Stenmark, Pal; Scobie, Martin; Berglund, Ulrika Warpman; Helleday, Thomas			MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool	NATURE			English	Article							MUTAGENIC SUBSTRATE; DNA; REPAIR; 8-OXOGUANINE; TARGET; CELLS; ACTIVATION; HYDROLYZES; ENZYME; HMTH1	Cancers have dysfunctional redox regulation resulting in reactive oxygen species production, damaging both DNA and free dNTPs. The MTH1 protein sanitizes oxidized dNTP pools to prevent incorporation of damaged bases during DNA replication. Although MTH1 is non-essential in normal cells, we show that cancer cells require MTH1 activity to avoid incorporation of oxidized dNTPs, resulting in DNA damage and cell death. We validate MTH1 as an anticancer target in vivo and describe small molecules TH287 and TH588 as first-in-class nudix hydrolase family inhibitors that potently and selectively engage and inhibit the MTH1 protein in cells. Protein co-crystal structures demonstrate that the inhibitors bindin the active site of MTH1. The inhibitors cause incorporation of oxidized dNTPs in cancer cells, leading to DNA damage, cytotoxicity and therapeutic responses in patient-derived mouse xenografts. This study exemplifies the non-oncogene addiction concept for anticancer treatment and validates MTH1 as being cancer phenotypic lethal.	[Gad, Helge; Koolmeister, Tobias; Jemth, Ann-Sofie; Eshtad, Saeed; Jacques, Sylvain A.; Strom, Cecilia E.; Schultz, Niklas; Lundback, Thomas; Gokturk, Camilla; Baranczewski, Pawel; Stromberg, Kia; Sanjiv, Kumar; Jacques-Cordonnier, Marie-Caroline; Desroses, Matthieu; Gustavsson, Anna-Lena; Homan, Evert J.; Loseva, Olga; Brautigam, Lars; Johansson, Lars; Hoglund, Andreas; Hagenkort, Anna; Pham, Therese; Altun, Mikael; Gaugaz, Fabienne Z.; Vikingsson, Svante; Evers, Bastiaan; Henriksson, Martin; Vallin, Karl S. A.; Wallner, Olov A.; Hammarstrom, Lars G. J.; Wiita, Elisee; Almlof, Ingrid; Kalderen, Christina; Axelsson, Hanna; Puigvert, Jordi Carreras; Jeppsson, Fredrik; Lundin, Cecilia; Jensen, Annika Jenmalm; Scobie, Martin; Berglund, Ulrika Warpman; Helleday, Thomas] Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden; [Svensson, Linda M.; Berntsson, Ronnie P. -A.; Gustafsson, Robert; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Lundback, Thomas; Svensson, Richard; Gustavsson, Anna-Lena; Johansson, Lars; Hammarstrom, Lars G. J.; Axelsson, Hanna; Jensen, Annika Jenmalm; Artursson, Per] Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys,Chem Biol Consortium S, S-17121 Stockholm, Sweden; [Einarsdottir, Berglind Osk; Olofsson, Roger; Nilsson, Jonas A.] Univ Gothenburg, Sahlgrenska Translat Melanoma Grp, Sahlgrenska Canc Ctr, Dept Surg, S-40530 Gothenburg, Sweden; [Einarsdottir, Berglind Osk; Olofsson, Roger; Nilsson, Jonas A.] Sahlgrens Univ Hosp, S-40530 Gothenburg, Sweden; [Saleh, Aljona; Granelli, Ingrid] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden; [Baranczewski, Pawel; Svensson, Richard; Gaugaz, Fabienne Z.; Artursson, Per] Uppsala Univ, Dept Pharm, Uppsala Univ Drug Optimizat & Pharmaceut Profilin, S-75123 Uppsala, Sweden; [Johansson, Fredrik; Djureinovic, Tatjana] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Vikingsson, Svante] Linkoping Univ, Dept Med & Hlth Sci, S-58185 Linkoping, Sweden; [Haggblad, Maria; Martens, Ulf; Lundgren, Bo] Stockholm Univ, Sci Life Lab, RNAi Cell Screening Facil, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; University of Gothenburg; Sahlgrenska University Hospital; Stockholm University; Uppsala University; Stockholm University; Linkoping University; Stockholm University	Helleday, T (corresponding author), Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden.	thomas.helleday@scilifelab.se	Altun, Mikael/AAI-9527-2020; Ström, Cecilia/M-9134-2019; Altun, Mikael/AAF-5496-2020; Lundbäck, Thomas/G-8076-2018; Höglund, Andreas/AAP-3372-2021; Bagge, Roger Olofsson/H-3481-2019; Schultz, Niklas/AFQ-8244-2022; Gad, Helge/J-2238-2014; Berntsson, Ronnie/J-3535-2019; Axelsson, Hanna/AGG-7882-2022	Altun, Mikael/0000-0002-6937-6124; Lundbäck, Thomas/0000-0002-8145-7808; Bagge, Roger Olofsson/0000-0001-5795-0355; Berntsson, Ronnie/0000-0001-6848-322X; Axelsson, Hanna/0000-0003-2365-1749; Gustavsson, Anna-Lena/0000-0003-4332-2336; Warpman Berglund, Ulrika/0000-0002-6372-1396; Desroses, Matthieu/0000-0003-4152-3855; Pham, Therese M/0000-0002-5577-6039; Helleday, Thomas/0000-0002-7384-092X; Stenmark, Pal/0000-0003-4777-3417; Hammarstrom, Lars/0000-0002-3903-7746; Homan, Evert/0000-0002-9057-1848; Gaugaz, Fabienne/0000-0001-9171-8891; Jemth, Ann-Sofie/0000-0002-7550-1833; Gustafsson, Robert/0000-0002-4854-5531; Wallner, Olov/0000-0002-6481-237X; Einarsdottir, Berglind Osk/0000-0002-5227-8149; Scobie, Martin/0000-0002-7073-8495; Nilsson, Jonas/0000-0003-0346-6837; Gad, Helge/0000-0001-6530-1443; Kalderen, Christina/0000-0001-7004-7048	Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; European Research Council; Swedish Cancer Society; Swedish Children's Cancer Foundation; AFA insurance; Swedish Pain Relief Foundation; Cancer Society in Stockholm; Wenner-Gren Foundations; Swedish Foundation for Strategic Research; Dutch Cancer Society; EMBO LTF; Region Vastra Gotaland; BioCARE; Swiss National Science Foundation; Nicholson Exchange Program	Torsten and Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation; AFA insurance; Swedish Pain Relief Foundation; Cancer Society in Stockholm; Wenner-Gren Foundations; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Dutch Cancer Society(KWF Kankerbestrijding); EMBO LTF(European Molecular Biology Organization (EMBO)); Region Vastra Gotaland; BioCARE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Nicholson Exchange Program	We thank scientists at BESSY, ESRF, Max-Lab and the Swiss Light Source for structural biology data collection support, PSF for protein purification, GE Healthcare for instrument access, HTSRC (Rockefeller University) for iTC<INF>200</INF> calorimeter access, S. Nordstrand for animal support, and L. Ny, U. Stierner and J. Mattsson for discussions. The Helleday Laboratory is primarily funded by the Torsten and Ragnar Soderberg Foundation (T. H.). This project is primarily supported by The Knut and Alice Wallenberg Foundation. Further support was received from the Swedish Research Council (T. H., A. J. J., P. A., P. S., J.A.N.), the European Research Council (T. H.), Swedish Cancer Society (T. H., J.A.N.), the Swedish Children's Cancer Foundation (T. H.), AFA insurance (T. H.), the Swedish Pain Relief Foundation (T. H.), The Cancer Society in Stockholm (T. H.), the Wenner-Gren Foundations (P. S.), the Swedish Foundation for Strategic Research (P. S.), the Dutch Cancer Society (B. E.), EMBO LTF (R. B.), Region Vastra Gotaland (J.A.N.), BioCARE (J.A.N.), the Swiss National Science Foundation (F.Z.G.) and the Nicholson Exchange Program (T. L.). Chemical Biology Consortium Sweden (CBCS) is primarily funded by the Swedish Research Council. CBCS acknowledge Swedish Orphan Biovitrum for their donation of a small-molecule infrastructure including a compound collection.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baranczewski P, 2006, PHARMACOL REP, V58, P453; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Britsun V.M., 2008, UKR KHIM ZH, V74, P126; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Collins A, 2003, FREE RADICAL BIO MED, V34, P1089, DOI 10.1016/s0891-5849(03)00041-8; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; De Luca G, 2013, AGING CELL, V12, P695, DOI 10.1111/acel.12094; De Luca G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000266; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Ichikawa J, 2008, DNA REPAIR, V7, P418, DOI 10.1016/j.dnarep.2007.11.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Sakumi K, 2003, CANCER RES, V63, P902; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Speina E, 2005, JNCI-J NATL CANCER I, V97, P384, DOI 10.1093/jnci/dji058; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; Tsuzuki T, 2001, MUTAT RES-FUND MOL M, V477, P71, DOI 10.1016/S0027-5107(01)00108-7; Ushijima Y, 2005, NUCLEIC ACIDS RES, V33, P672, DOI 10.1093/nar/gki214; Waters NJ, 2008, J PHARM SCI-US, V97, P4586, DOI 10.1002/jps.21317; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685	45	348	372	6	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					215	+		10.1038/nature13181	http://dx.doi.org/10.1038/nature13181			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24695224				2022-12-24	WOS:000333979900038
J	Spencer, JA; Ferraro, F; Roussakis, E; Klein, A; Wu, JW; Runnels, JM; Zaher, W; Mortensen, LJ; Alt, C; Turcotte, R; Yusuf, R; Cote, D; Vinogradov, SA; Scadden, DT; Lin, CP				Spencer, Joel A.; Ferraro, Francesca; Roussakis, Emmanuel; Klein, Alyssa; Wu, Juwell; Runnels, Judith M.; Zaher, Walid; Mortensen, Luke J.; Alt, Clemens; Turcotte, Raphael; Yusuf, Rushdia; Cote, Daniel; Vinogradov, Sergei A.; Scadden, David T.; Lin, Charles P.			Direct measurement of local oxygen concentration in the bone marrow of live animals	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; MODELING PO(2) DISTRIBUTIONS; PROGENITOR CELLS; NICHE; MICROSCOPY; PHOSPHORESCENCE; COMPARTMENT; GRADIENTS; TRACKING; HYPOXIA	Characterization of how the microenvironment, or niche, regulates stem cell activity is central to understanding stem cell biology and to developing strategies for the therapeutic manipulation of stem cells(1). Low oxygen tension (hypoxia) is commonly thought to be a shared niche characteristic in maintaining quiescence in multiple stem cell types(2-4). However, support for the existence of a hypoxic niche has largely come from indirect evidence such as proteomic analysis(5), expression of hypoxia inducible factor-1 alpha (Hif-1 alpha) and related genes(6), and staining with surrogate hypoxic markers (for example, pimonidazole)(6-8). Here we perform direct in vivo measurements of local oxygen tension (p(O2)) in the bone marrow of live mice. Using two-photon phosphorescence lifetime microscopy, we determined the absolute p(O2) of the bone marrow to be quite low (<32 mm Hg) despite very high vascular density. We further uncovered heterogeneities in local p(O2), with the lowest p(O2) (similar to 9.9 mm Hg, or 1.3%) found in deeper peri-sinusoidal regions. The endosteal region, by contrast, is less hypoxic as it is perfused with small arteries that are often positive for the marker nestin. These p(O2) values change markedly after radiation and chemotherapy, pointing to the role of stress in altering the stem cell metabolic microenvironment.	[Spencer, Joel A.; Roussakis, Emmanuel; Wu, Juwell; Runnels, Judith M.; Zaher, Walid; Mortensen, Luke J.; Alt, Clemens; Turcotte, Raphael; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Spencer, Joel A.; Wu, Juwell; Runnels, Judith M.; Zaher, Walid; Mortensen, Luke J.; Alt, Clemens; Turcotte, Raphael; Lin, Charles P.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Spencer, Joel A.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Ferraro, Francesca; Klein, Alyssa; Yusuf, Rushdia; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Ferraro, Francesca; Klein, Alyssa; Yusuf, Rushdia; Scadden, David T.; Lin, Charles P.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ferraro, Francesca; Klein, Alyssa; Yusuf, Rushdia; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Roussakis, Emmanuel; Vinogradov, Sergei A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Zaher, Walid] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [Turcotte, Raphael] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cote, Daniel] Univ Laval, Dept Phys Genie Phys & Opt, Quebec City, PQ G1J 2G3, Canada; [Cote, Daniel] Univ Laval, Ctr Rech, Inst Univ Sante Mentale Quebec, Quebec City, PQ G1J 2G3, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Tufts University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; University of Pennsylvania; King Saud University; Boston University; Laval University; Laval University	Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA.	charles_lin@hms.harvard.edu	Mortensen, Luke/N-2640-2018; Spencer, Joel/GLT-9687-2022	Mortensen, Luke/0000-0002-4331-4099; Spencer, Joel/0000-0002-4013-8763; Turcotte, Raphael/0000-0002-2257-4190; , Emmanouil/0000-0002-2824-2840	US National Institutes of Health [HL097748, EB017274, HL097794, HL096372, EB014703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097748, U01HL100402, R03HL096372, R01HL097794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017274, R01EB014703] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank S. Sakadzic for helpful discussion on setting up the 2PLM experiment. This work was supported by the US National Institutes of Health grant HL097748, EB017274 (to C. P. L.), HL097794, HL096372 and EB014703 (to D.T.S.).	Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Dewhirst MW, 1999, BRIT J CANCER, V79, P1717, DOI 10.1038/sj.bjc.6690273; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Finikova OS, 2008, CHEMPHYSCHEM, V9, P1673, DOI 10.1002/cphc.200800296; Kazmi SMS, 2013, BIOMED OPT EXPRESS, V4, P1061, DOI 10.1364/BOE.4.001061; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lebedev AY, 2009, ACS APPL MATER INTER, V1, P1292, DOI 10.1021/am9001698; Lebedev AY, 2008, J PORPHYR PHTHALOCYA, V12, P1261, DOI 10.1142/S1088424608000649; Lecoq J, 2011, NAT MED, V17, P893, DOI 10.1038/nm.2394; Lee KE, 2012, CURR OPIN CELL BIOL, V24, P232, DOI 10.1016/j.ceb.2012.01.005; LICHTMAN MA, 1981, EXP HEMATOL, V9, P391; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Sinks LE, 2010, J PHYS CHEM B, V114, P14373, DOI 10.1021/jp100353v; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184	32	698	717	10	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					269	+		10.1038/nature13034	http://dx.doi.org/10.1038/nature13034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24590072	Green Accepted, Green Submitted			2022-12-24	WOS:000333979900049
J	Meusch, D; Gatsogiannis, C; Efremov, RG; Lang, AE; Hofnagel, O; Vetter, IR; Aktories, K; Raunser, S				Meusch, Dominic; Gatsogiannis, Christos; Efremov, Rouslan G.; Lang, Alexander E.; Hofnagel, Oliver; Vetter, Ingrid R.; Aktories, Klaus; Raunser, Stefan			Mechanism of Tc toxin action revealed in molecular detail	NATURE			English	Article							ANTHRAX TOXIN; CRYSTAL-STRUCTURE; PROTEIN TRANSLOCATION; COMPLEX; PHOTORHABDUS; REFINEMENT; SYSTEM; MODEL; PREDICTION; QUALITY	Tripartite Tc toxin complexes of bacterial pathogens perforate the host membrane and translocate toxic enzymes into the host cell, including in humans. The underlying mechanism is complex but poorly understood. Here we report the first, to our knowledge, high-resolution structures of a TcA subunit in its prepore and pore state and of a complete 1.7 megadalton Tc complex. The structures reveal that, in addition to a translocation channel, TcA forms four receptor-binding sites and a neuraminidase-like region, which are important for its host specificity. pH-induced opening of the shell releases an entropic spring that drives the injection of the TcA channel into the membrane. Binding of TcB/TcC to TcA opens a gate formed by a six-bladed beta-propeller and results in a continuous protein translocation channel, whose architecture and properties suggest a novel mode of protein unfolding and translocation. Our results allow us to understand key steps of infections involving Tc toxins at the molecular level.	[Meusch, Dominic; Gatsogiannis, Christos; Efremov, Rouslan G.; Hofnagel, Oliver; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Vetter, Ingrid R.] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, D-44227 Dortmund, Germany; [Aktories, Klaus] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Raunser, Stefan] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Max Planck Society; University of Freiburg; Max Planck Society; University of Freiburg; Free University of Berlin	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Aktories, Klaus/CAJ-5682-2022; Raunser, Stefan/AHE-1573-2022; Efremov, Rouslan/P-9085-2015; Gatsogiannis, Christos/K-1012-2018	Aktories, Klaus/0000-0002-5397-0436; Efremov, Rouslan/0000-0001-7516-8658; Gatsogiannis, Christos/0000-0002-4922-4545; Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [RA 1781/1-1, AK 6/22-1]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We are grateful to R. S. Goody for continuous support and for useful comments on the manuscript. We thank V. Pfaumann for cloning, C. Schwan and S. Bergbrede for technical support and the Raunser laboratory for selecting particles. We thank the staff of beamline X10SA at the Paul Scherrer Institute, the X-ray communities at the Max Planck Institute (MPI) Dortmund and the MPI Heidelberg for help with data collection. This work was supported by the Deutsche Forschungsgemeinschaft, grants RA 1781/1-1 (to S. R.) and AK 6/22-1 (to K. A.), and by the Max Planck Society (to S.R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER D, 1993, ACTA CRYSTALLOGR D, V49, P429, DOI 10.1107/S0907444993004032; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; Ffrench-Constant RH, 2007, TRENDS PARASITOL, V23, P514, DOI 10.1016/j.pt.2007.08.021; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gatsogiannis C, 2013, BIOPHYS J, V104, p352A, DOI 10.1016/j.bpj.2013.06.003; Gatsogiannis C, 2013, NATURE, V495, P520, DOI 10.1038/nature11987; Hares MC, 2008, MICROBIOL-SGM, V154, P3503, DOI 10.1099/mic.0.2008/018440-0; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Jones DT, 2005, PROTEINS, V61, P143, DOI 10.1002/prot.20731; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Landsberg MJ, 2011, P NATL ACAD SCI USA, V108, P20544, DOI 10.1073/pnas.1111155108; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee SC, 2007, J MOL BIOL, V366, P1558, DOI 10.1016/j.jmb.2006.12.057; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy JR, 2011, TOXINS, V3, P294, DOI 10.3390/toxins3030294; Noy A., 2007, HDB MOL FORCE SPECTR; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Perez A., 2007, BIOPHYS J; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; Sheets JJ, 2011, J BIOL CHEM, V286, P22742, DOI 10.1074/jbc.M111.227009; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wang Z, 2012, BIOPOLYMERS, V97, P687, DOI 10.1002/bip.22046; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang B, 1999, BIOPHYS J, V77, P1306, DOI 10.1016/S0006-3495(99)76980-8; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	68	99	102	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					61	+		10.1038/nature13015	http://dx.doi.org/10.1038/nature13015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24572368				2022-12-24	WOS:000333609900042
J	Andersson, R; Gebhard, C; Miguel-Escalada, I; Hoof, I; Bornholdt, J; Boyd, M; Chen, Y; Zhao, X; Schmidl, C; Suzuki, T; Ntini, E; Arner, E; Valen, E; Li, K; Schwarzfischer, L; Glatz, D; Raithel, J; Lilje, B; Rapin, N; Bagger, FO; Jorgensen, M; Andersen, PR; Bertin, N; Rackham, O; Burroughs, AM; Baillie, JK; Ishizu, Y; Shimizu, Y; Furuhata, E; Maeda, S; Negishi, Y; Mungall, CJ; Meehan, TF; Lassmann, T; Itoh, M; Kawaji, H; Kondo, N; Kawai, J; Lennartsson, A; Daub, CO; Heutink, P; Hume, DA; Jensen, TH; Suzuki, H; Hayashizaki, Y; Muller, F; Forrest, ARR; Carninci, P; Rehli, M; Sandelin, A				Andersson, Robin; Gebhard, Claudia; Miguel-Escalada, Irene; Hoof, Ilka; Bornholdt, Jette; Boyd, Mette; Chen, Yun; Zhao, Xiaobei; Schmidl, Christian; Suzuki, Takahiro; Ntini, Evgenia; Arner, Erik; Valen, Eivind; Li, Kang; Schwarzfischer, Lucia; Glatz, Dagmar; Raithel, Johanna; Lilje, Berit; Rapin, Nicolas; Bagger, Frederik Otzen; Jorgensen, Mette; Andersen, Peter Refsing; Bertin, Nicolas; Rackham, Owen; Burroughs, A. Maxwell; Baillie, J. Kenneth; Ishizu, Yuri; Shimizu, Yuri; Furuhata, Erina; Maeda, Shiori; Negishi, Yutaka; Mungall, Christopher J.; Meehan, Terrence F.; Lassmann, Timo; Itoh, Masayoshi; Kawaji, Hideya; Kondo, Naoto; Kawai, Jun; Lennartsson, Andreas; Daub, Carsten O.; Heutink, Peter; Hume, David A.; Jensen, Torben Heick; Suzuki, Harukazu; Hayashizaki, Yoshihide; Mueller, Ferenc; Forrest, Alistair R. R.; Carninci, Piero; Rehli, Michael; Sandelin, Albin		FANTOM Consortium	An atlas of active enhancers across human cell types and tissues	NATURE			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; CAP-ANALYSIS; REGULATORY SEQUENCES; DNA METHYLATION; DISCOVERY; INFORMATION; LANDSCAPE; UPSTREAM; PATTERN	Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation.	[Andersson, Robin; Hoof, Ilka; Bornholdt, Jette; Boyd, Mette; Chen, Yun; Zhao, Xiaobei; Valen, Eivind; Li, Kang; Lilje, Berit; Rapin, Nicolas; Bagger, Frederik Otzen; Jorgensen, Mette; Sandelin, Albin] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Andersson, Robin; Hoof, Ilka; Bornholdt, Jette; Boyd, Mette; Chen, Yun; Zhao, Xiaobei; Valen, Eivind; Li, Kang; Lilje, Berit; Rapin, Nicolas; Bagger, Frederik Otzen; Jorgensen, Mette; Sandelin, Albin] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Gebhard, Claudia; Schmidl, Christian; Schwarzfischer, Lucia; Glatz, Dagmar; Raithel, Johanna; Rehli, Michael] Univ Hosp Regensburg, Dept Internal Med 3, D-93042 Regensburg, Germany; [Gebhard, Claudia; Rehli, Michael] Regensburg Ctr Intervent Immunol RCI, D-93042 Regensburg, Germany; [Miguel-Escalada, Irene; Mueller, Ferenc] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Zhao, Xiaobei] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Suzuki, Takahiro; Arner, Erik; Bertin, Nicolas; Rackham, Owen; Burroughs, A. Maxwell; Ishizu, Yuri; Shimizu, Yuri; Furuhata, Erina; Maeda, Shiori; Negishi, Yutaka; Lassmann, Timo; Itoh, Masayoshi; Kawaji, Hideya; Kondo, Naoto; Kawai, Jun; Daub, Carsten O.; Hume, David A.; Suzuki, Harukazu; Hayashizaki, Yoshihide; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Yokohama Inst, RIKEN OMICS Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Suzuki, Takahiro; Arner, Erik; Bertin, Nicolas; Rackham, Owen; Burroughs, A. Maxwell; Ishizu, Yuri; Shimizu, Yuri; Furuhata, Erina; Maeda, Shiori; Negishi, Yutaka; Lassmann, Timo; Itoh, Masayoshi; Daub, Carsten O.; Suzuki, Harukazu; Forrest, Alistair R. R.; Carninci, Piero] RIKEN Yokohama Inst, RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ntini, Evgenia; Andersen, Peter Refsing; Jensen, Torben Heick] Ctr mRNP Biogenesis & Metab, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Valen, Eivind] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Rapin, Nicolas; Bagger, Frederik Otzen] Univ Copenhagen, Finsen Lab, Rigshosp, DK-2200 Copenhagen, Denmark; [Rapin, Nicolas; Bagger, Frederik Otzen] Univ Copenhagen, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen, Denmark; [Baillie, J. Kenneth; Hume, David A.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Meehan, Terrence F.] EMBL Outstn Hinxton, European Bioinformat Inst, Cambridge CB10 1SD, England; [Itoh, Masayoshi; Kawaji, Hideya; Kondo, Naoto; Kawai, Jun] RIKEN Yokohama Inst, RIKEN Prevent Med & Diag Innovat Program, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Lennartsson, Andreas; Daub, Carsten O.] Karolinska Inst, Dept Biosci & Nutr, SE-4183 Stockholm, Sweden; [Hayashizaki, Yoshihide] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands	University of Copenhagen; University of Copenhagen; University of Regensburg; University of Birmingham; University of North Carolina; University of North Carolina Chapel Hill; RIKEN; RIKEN; Harvard University; Rigshospitalet; University of Copenhagen; University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); RIKEN; Karolinska Institutet; Vrije Universiteit Amsterdam	Forrest, ARR (corresponding author), RIKEN Yokohama Inst, RIKEN OMICS Sci Ctr, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	alistair.forrest@gmail.com; carninci@riken.jp; michael.rehli@ukr.de; albin@binf.ku.dk	Kere, Juha/A-9179-2008; Muller, Ferenc/C-6426-2009; Wolvetang, Ernst jurgen/D-6644-2017; Hide, Winston/R-3815-2019; Katayama, Shintaro/F-2958-2010; Itoh, Masayoshi/N-5363-2015; KONDO, NAOTO/A-5829-2016; Sandelin, Albin/G-2881-2011; Valen, Eivind/A-8617-2011; Rehli, Michael/E-9093-2011; Bodega, Beatrice/I-4644-2018; Mackay-Sim, Alan/C-3431-2008; Schmidl, Christian/HDO-6299-2022; Zhao, Xiaobei/G-3567-2014; Hide, Winston A/V-2727-2017; Andersson, Robin/B-5311-2009; Kawai, Jun/A-6451-2016; Dalla, Emiliano/AAH-3039-2020; Kawaji, Hideya/N-5116-2015; Suzuki, Harukazu/N-9553-2015; Carninci, Piero/K-1568-2014; Ovchinnikov, Dmitry/J-7963-2014; Mungall, Chris/I-6006-2019; Daub, Carsten O/A-7436-2010; Miguel-Escalada, Irene/J-6535-2014; Taylor, Martin S/C-3825-2009; Baillie, Kenneth/AEK-6650-2022; Faulkner, Geoffrey J/M-3168-2014; Lassmann, Timo/HCH-4313-2022; Baillie, John Kenneth/F-3124-2011; Lassmann, Timo/A-8271-2008; Ravasi, Timothy/B-8777-2008; Suzuki, Takahiro/AAW-8509-2020; Jensen, Torben H/G-2954-2017; Rackham, Owen/AAM-3108-2021; Arner, Erik/A-1895-2010; Hide, Winston Hide/C-7217-2009; Ohno, Hiroshi/L-7899-2014; Bertin, Nicolas/O-9602-2019; Kenna, Tony/A-6035-2011; Hayashizaki, Yoshihide/N-6590-2015; Wells, Christine/A-5071-2010; Bertin, Nicolas/C-3025-2008	Kere, Juha/0000-0003-1974-0271; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Hide, Winston/0000-0002-8621-3271; Katayama, Shintaro/0000-0001-7581-5157; Itoh, Masayoshi/0000-0002-1772-318X; KONDO, NAOTO/0000-0001-9576-7615; Sandelin, Albin/0000-0002-7109-7378; Rehli, Michael/0000-0003-3992-932X; Bodega, Beatrice/0000-0003-0527-9234; Mackay-Sim, Alan/0000-0003-4446-5371; Schmidl, Christian/0000-0002-0522-202X; Zhao, Xiaobei/0000-0002-5277-0846; Hide, Winston A/0000-0002-8621-3271; Andersson, Robin/0000-0003-1516-879X; Dalla, Emiliano/0000-0002-4687-6011; Kawaji, Hideya/0000-0002-0575-0308; Suzuki, Harukazu/0000-0002-8087-0836; Carninci, Piero/0000-0001-7202-7243; Ovchinnikov, Dmitry/0000-0001-9603-8385; Mungall, Chris/0000-0002-6601-2165; Daub, Carsten O/0000-0002-3295-8729; Miguel-Escalada, Irene/0000-0003-3461-6404; Taylor, Martin S/0000-0001-7656-330X; Baillie, Kenneth/0000-0001-5258-793X; Faulkner, Geoffrey J/0000-0001-5769-4494; Lassmann, Timo/0000-0002-0138-2691; Baillie, John Kenneth/0000-0001-5258-793X; Lassmann, Timo/0000-0002-0138-2691; Suzuki, Takahiro/0000-0002-0972-6911; Rackham, Owen/0000-0002-4390-0872; Arner, Erik/0000-0003-1225-4908; Hide, Winston Hide/0000-0002-8621-3271; Ohno, Hiroshi/0000-0001-8776-9661; Wasserman, Wyeth/0000-0001-6098-6412; Jorgensen, Mette/0000-0002-2804-0560; Laros, Jeroen F.J./0000-0002-8715-7371; Wells, Christine/0000-0003-3133-3628; Lennartsson, Andreas/0000-0002-3272-2505; Moro, Kazuyo/0000-0002-7377-1303; Otzen Bagger, Frederik/0000-0003-0636-8845; Forrest, Alistair/0000-0003-4543-1675; Freeman, Thomas/0000-0001-5235-8483; Hume, David/0000-0002-2615-1478; Winteringham, Louise/0000-0002-8117-5069; Jensen, Torben Heick/0000-0001-5127-1239; Burroughs, A. Max/0000-0002-2229-8771; Huminiecki, Lukasz/0000-0003-1943-4450; Ekwall, Karl/0000-0002-3029-4041; Prendergast, James/0000-0001-8916-018X; Andersen, Peter Ebert/0000-0001-5815-4860; Meehan, Terrence/0000-0003-1980-3228; Fisher, Malcolm/0000-0003-1074-8103; Arner, Peter/0000-0002-6208-6220; mueller, ferenc/0000-0002-0996-774X; Sajantila, Antti/0000-0003-4117-5248; Blake, Judith/0000-0001-8522-334X; Valen, Eivind/0000-0003-1840-6108; Rashid, Mamoon/0000-0003-4851-4994; Nakahara, Fumio/0000-0003-1515-8284; Ntini, Evgenia/0000-0002-4649-6051; Bertin, Nicolas/0000-0002-9835-9606; Lenhard, Boris/0000-0002-1114-1509; Rapin, Nicolas/0000-0001-5208-8874; Knox, Alan/0000-0002-5906-4143; Sengstag, Thierry/0000-0002-7516-6246; Hoof, Ilka/0000-0003-3827-7227; Heutink, Peter/0000-0001-5218-1737	MEXT; MEXT, Japan; European Research Council/ERC [204135]; Novo Nordisk foundation; Lundbeck foundation; Deutsche Forschungsgemeinschaft [RE1310/7, RE1310/11, RE1310/13]; Rudolf Bartling Stiftung; "BOLD" MarieCurie ITN; "ZF-Health" Integrated project of the European Commission; Biotechnology and Biological Sciences Research Council [BB/I024801/1, BBS/E/D/20251969] Funding Source: researchfish; Lundbeck Foundation [R167-2013-15058] Funding Source: researchfish; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0001211] Funding Source: researchfish; BBSRC [BB/I024801/1, BBS/E/D/20251969] Funding Source: UKRI; MRC [MC_UP_1102/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022969] Funding Source: NIH RePORTER	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Research Council/ERC(European Research Council (ERC)European Commission); Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck foundation(Lundbeckfonden); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Bartling Stiftung; "BOLD" MarieCurie ITN; "ZF-Health" Integrated project of the European Commission; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to Y.H. and a Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan, to Y.H. The A. S. group was supported by funds from the European Research Council FP7/2007-2013/ERC no. 204135, the Novo Nordisk and Lundbeck foundations. Work in the M. R. group was funded by grants from the Deutsche Forschungsgemeinschaft (RE1310/7,11,13) and Rudolf Bartling Stiftung. F. M. and I. M. E. were supported by "BOLD" MarieCurie ITN and "ZF-Health" Integrated project of the European Commission. We thank S. Noma, M. Sakai and H. Tarui for RNA-seq and sRNA-seq preparation, RIKEN GeNAS for generation and sequencing of the Heliscope CAGE libraries, Illumina RNA-seq and sRNA-seq, the Copenhagen National High-throughput DNA Sequencing Center for Illumina CAGE-seq, M. Edinger, P. Hoffmann and R. Eder for cell sorting, A. Albrechtsen, I. Moltke, W. Wasserman for advice, and the Netherlands Brain Bank for post-mortem human brain material.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Buckner J, 2010, BIOINFORMATICS, V26, P134, DOI 10.1093/bioinformatics/btp608; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fort A., NATURE GENE IN PRESS; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Groemping U., 2006, J STAT SOFTW, V17, DOI [http://dx.doi.org/10.18637/jss.v017.i01, DOI 10.1867/JSS.V017.I01]; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hollander M, 1973, NONPARAMETRIC STAT M; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronnerblad M., BLOOD IN PRESS; SCHAFFNER G, 1988, J MOL BIOL, V201, P81, DOI 10.1016/0022-2836(88)90440-8; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuber V, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1730	73	1493	1517	13	302	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					455	+		10.1038/nature12787	http://dx.doi.org/10.1038/nature12787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670763	Green Published, Green Accepted			2022-12-24	WOS:000333402000032
J	Di Angelantonio, E; Gao, P; Khan, H; Butterworth, AS; Wormser, D; Kaptoge, S; Seshasai, SRK; Thompson, A; Sarwar, N; Willeit, P; Ridker, PM; Barr, ELM; Khaw, KT; Psaty, BM; Brenner, H; Balkau, B; Dekker, JM; Lawlor, DA; Daimon, M; Willeit, J; Njolstad, I; Nissinen, A; Brunner, EJ; Kuller, LH; Price, JF; Sundstrom, J; Knuiman, MW; Feskens, EJM; Verschuren, WMM; Wald, N; Bakker, SJL; Whincup, PH; Ford, I; Goldbourt, U; Gomez-de-la-Camara, A; Gallacher, J; Simons, LA; Rosengren, A; Sutherland, SE; Bjorkelund, C; Blazer, DG; Wassertheil-Smoller, S; Onat, A; Ibanez, AM; Casiglia, E; Jukema, JW; Simpson, LM; Giampaoli, S; Nordestgaard, BG; Selmer, R; Wennberg, P; Kauhanen, J; Salonen, JT; Dankner, R; Barrett-Connor, E; Kavousi, M; Gudnason, V; Evans, D; Wallace, RB; Cushman, M; D'Agostino, RB; Umans, JG; Kiyohara, Y; Nakagawa, H; Sato, S; Gillum, RF; Folsom, AR; van der Schouw, YT; Moons, KG; Griffin, SJ; Sattar, N; Wareham, NJ; Selvin, E; Thompson, SG; Danesh, J				Di Angelantonio, Emanuele; Gao, Pei; Khan, Hassan; Butterworth, Adam S.; Wormser, David; Kaptoge, Stephen; Seshasai, Sreenivasa Rao Kondapally; Thompson, Alex; Sarwar, Nadeem; Willeit, Peter; Ridker, Paul M.; Barr, Elizabeth L. M.; Khaw, Kay-Tee; Psaty, Bruce M.; Brenner, Hermann; Balkau, Beverley; Dekker, Jacqueline M.; Lawlor, Debbie A.; Daimon, Makoto; Willeit, Johann; Njolstad, Inger; Nissinen, Aulikki; Brunner, Eric J.; Kuller, Lewis H.; Price, Jackie F.; Sundstrom, Johan; Knuiman, Matthew W.; Feskens, Edith J. M.; Verschuren, W. M. M.; Wald, Nicholas; Bakker, Stephan J. L.; Whincup, Peter H.; Ford, Ian; Goldbourt, Uri; Gomez-de-la-Camara, Agustin; Gallacher, John; Simons, Leon A.; Rosengren, Annika; Sutherland, Susan E.; Bjorkelund, Cecilia; Blazer, Dan G.; Wassertheil-Smoller, Sylvia; Onat, Altan; Ibanez, Alejandro Marin; Casiglia, Edoardo; Jukema, J. Wouter; Simpson, Lara M.; Giampaoli, Simona; Nordestgaard, Borge G.; Selmer, Randi; Wennberg, Patrik; Kauhanen, Jussi; Salonen, Jukka T.; Dankner, Rachel; Barrett-Connor, Elizabeth; Kavousi, Maryam; Gudnason, Vilmundur; Evans, Denis; Wallace, Robert B.; Cushman, Mary; D'Agostino, Ralph B., Sr.; Umans, Jason G.; Kiyohara, Yutaka; Nakagawa, Hidaeki; Sato, Shinichi; Gillum, Richard F.; Folsom, Aaron R.; van der Schouw, Yvonne T.; Moons, Karel G.; Griffin, Simon J.; Sattar, Naveed; Wareham, Nicholas J.; Selvin, Elizabeth; Thompson, Simon G.; Danesh, John		Emerging Risk Factors	Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STATISTICAL-METHODS; RISK; GLUCOSE; GUIDELINES	IMPORTANCE The value of measuring levels of glycated hemoglobin (HbA(1c)) for the prediction of first cardiovascular events is uncertain. OBJECTIVE To determine whether adding information on HbA(1c) values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS Analysis of individual-participant data available from 73 prospective studies involving 294 998 participants without a known history of diabetes mellitus or CVD at the baseline assessment. MAIN OUTCOMES AND MEASURES Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (<5%), intermediate (5% to <7.5%), and high (>= 7.5%) risk. RESULTS During a median follow-up of 9.9 (interquartile range, 7.6-13.2) years, 20 840 incident fatal and nonfatal CVD outcomes (13 237 coronary heart disease and 7603 stroke outcomes) were recorded. In analyses adjusted for several conventional cardiovascular risk factors, there was an approximately J-shaped association between HbA(1c) values and CVD risk. The association between HbA(1c) values and CVD risk changed only slightly after adjustment for total cholesterol and triglyceride concentrations or estimated glomerular filtration rate, but this association attenuated somewhat after adjustment for concentrations of high-density lipoprotein cholesterol and C-reactive protein. The C-index for a CVD risk prediction model containing conventional cardiovascular risk factors alone was 0.7434 (95% CI, 0.7350 to 0.7517). The addition of information on HbA(1c) was associated with a C-index change of 0.0018 (0.0003 to 0.0033) and a net reclassification improvement of 0.42 (-0.63 to 1.48) for the categories of predicted 10-year CVD risk. The improvement provided by HbA(1c) assessment in prediction of CVD risk was equal to or better than estimated improvements for measurement of fasting, random, or postload plasma glucose levels. CONCLUSIONS AND RELEVANCE In a study of individuals without known CVD or diabetes, additional assessment of HbA(1c) values in the context of CVD risk assessment provided little incremental benefit for prediction of CVD risk.	[Di Angelantonio, Emanuele; Gao, Pei; Khan, Hassan; Butterworth, Adam S.; Wormser, David; Kaptoge, Stephen; Thompson, Alex; Sarwar, Nadeem; Willeit, Peter; Khaw, Kay-Tee; Griffin, Simon J.; Wareham, Nicholas J.; Thompson, Simon G.; Danesh, John] Univ Cambridge, Cambridge, England; [Seshasai, Sreenivasa Rao Kondapally; Whincup, Peter H.] St Georges Univ London, London, England; [Ridker, Paul M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Barr, Elizabeth L. M.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Seattle, WA USA; [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Balkau, Beverley] INSERM, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Villejuif, France; [Dekker, Jacqueline M.] Vrije Univ Med Ctr, Amsterdam, Netherlands; [Lawlor, Debbie A.] Univ Bristol, Bristol, Avon, England; [Daimon, Makoto] Yamagata Univ, Yamagata 990, Japan; [Willeit, Johann] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Njolstad, Inger] Univ Tromso, Tromso, Norway; [Nissinen, Aulikki] Natl Inst Hlth & Welf, Helsinki, Finland; [Brunner, Eric J.] UCL, London, England; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Price, Jackie F.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Sundstrom, Johan] Uppsala Univ, Uppsala, Sweden; [Knuiman, Matthew W.] Univ Western Australia, Perth, WA 6009, Australia; [Feskens, Edith J. M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Verschuren, W. M. M.] Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands; [Wald, Nicholas] Wolfson Inst Prevent Med, London, England; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands; [Ford, Ian; Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Goldbourt, Uri] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Gomez-de-la-Camara, Agustin] Hosp 12 Octubre, E-28041 Madrid, Spain; [Gallacher, John] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Simons, Leon A.] Univ New S Wales, Kensington, NSW 2033, Australia; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Sutherland, Susan E.] Med Univ S Carolina, Charleston, SC USA; [Bjorkelund, Cecilia] Univ Gothenburg, Gothenburg, Sweden; [Blazer, Dan G.] Duke Univ, Med Ctr, Durham, NC USA; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, New York, NY USA; [Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Ibanez, Alejandro Marin] San Jose Norte Hlth Ctr, Zaragoza, Spain; [Casiglia, Edoardo] Univ Padua, Padua, Italy; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Leiden, Netherlands; [Simpson, Lara M.] Univ Texas Sch Publ Hlth, Houston, TX USA; [Giampaoli, Simona] Ist Super Sanita, I-00161 Rome, Italy; [Nordestgaard, Borge G.] Univ Copenhagen, Herlev Hosp, Copenhagen Univ Hosp, Copenhagen, Denmark; [Selmer, Randi] Norwegian Inst Publ Hlth, Oslo, Norway; [Wennberg, Patrik] Umea Univ, Umea, Sweden; [Kauhanen, Jussi] Univ Eastern Finland, Kuopio, Finland; [Salonen, Jukka T.] Univ Helsinki, Helsinki, Finland; [Dankner, Rachel] Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; [Dankner, Rachel] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Dankner, Rachel] Feinstein Inst Med Res, New York, NY USA; [Barrett-Connor, Elizabeth] Univ Calif San Diego, San Diego, CA 92103 USA; [Kavousi, Maryam] Erasmus MC, Rotterdam, Netherlands; [Gudnason, Vilmundur] Icelandic Heart Assoc, Reyjavik, Iceland; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Evans, Denis] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Cushman, Mary] Univ Vermont, Burlington, VT 05405 USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Boston, MA 02215 USA; [Umans, Jason G.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Kiyohara, Yutaka] Kyushu Univ, Kyushu, Japan; [Nakagawa, Hidaeki] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan; [Sato, Shinichi] Osaka Med Ctr Hlth Sci & Promot, Chiba Prefectural Inst Publ Hlth, Osaka, Japan; [Gillum, Richard F.] Howard Univ, Washington, DC 20059 USA; [Folsom, Aaron R.] Univ Minnesota, Minneapolis, MN USA; [van der Schouw, Yvonne T.; Moons, Karel G.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Selvin, Elizabeth] Johns Hopkins Univ, Baltimore, MD USA	University of Cambridge; St Georges University London; Harvard University; Brigham & Women's Hospital; Baker Heart and Diabetes Institute; University of Washington; University of Washington Seattle; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Bristol; Yamagata University; Medical University of Innsbruck; UiT The Arctic University of Tromso; Finland National Institute for Health & Welfare; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Uppsala University; University of Western Australia; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; University of London; Queen Mary University London; University of Groningen; University of Glasgow; Chaim Sheba Medical Center; Hospital Universitario 12 de Octubre; Cardiff University; University of New South Wales Sydney; University of Gothenburg; Medical University of South Carolina; University of Gothenburg; Duke University; Yeshiva University; Istanbul University; University of Padua; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Istituto Superiore di Sanita (ISS); University of Copenhagen; Herlev & Gentofte Hospital; Norwegian Institute of Public Health (NIPH); Umea University; University of Eastern Finland; University of Helsinki; Tel Aviv University; Northwell Health; University of California System; University of California San Diego; Erasmus University Rotterdam; Erasmus MC; Icelandic Heart Association; University of Iceland; Rush University; University of Iowa; University of Vermont; Boston University; Georgetown University; Kyushu University; Kanazawa Medical University; Howard University; University of Minnesota System; University of Minnesota Twin Cities; Utrecht University; Utrecht University Medical Center; Johns Hopkins University	Danesh, J (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	erfc@phpc.cam.ac.uk	Daimon, Makoto/AAY-1289-2020; Khan, Hassan/D-6267-2013; Sundstrom, Johan/R-2139-2019; Brunner, Eric/H-2114-2011; Rubio, Miguel Angel/GRJ-0134-2022; de la Camara, Agustin Gomez/S-7123-2018; Schöttker, Ben/F-8183-2014; Gudnason, Vilmundur/K-6885-2015; Gao, Pei/AAF-3065-2019; Knuiman, Matthew W/I-5549-2013; Dankner, Rachel/Q-5245-2019; Gao, Pei/R-4794-2018; Brenner, Hermann/B-4627-2017; Kavousi, Maryam/F-1174-2018; Harshfield, Eric L/AAG-8081-2020; Benn, Marianne/O-4164-2019; Gudnason, Vilmundur/AAE-7126-2019; Kauhanen, Jussi/ABC-4064-2021; Wald, Nicholas/AAY-8924-2021; Nordestgaard, Borge Gronne/ABF-1310-2020; Wald, Nicholas/AAY-2814-2021; Sundström, Johan/A-6286-2009; Bakker, Stephan J. L./J-4023-2015; van der Schouw, Yvonne T./F-8327-2014; Sakurai, Masaru/AAC-6551-2021; Ford, Ian/ABE-6145-2020; Cushman, Mary/K-1157-2019; Brenner, Hermann/ABE-6383-2020; Khaw, Kay-Tee/AAZ-3209-2021; Willeit, Peter/HCI-7091-2022; DiAngelantonio, Emanuele/ABE-6852-2020; Lennon, Lucy/ABB-9433-2020; Jukema, J. Wouter/ABD-6503-2021; Ademoglu, Evin/AAD-8990-2020; Feskens, Edith/ABI-1446-2020; Njolstad, Inger/X-3784-2019; Griffin, Simon/K-3106-2013	Daimon, Makoto/0000-0002-3775-1719; Khan, Hassan/0000-0003-1468-8654; Sundstrom, Johan/0000-0003-2247-8454; Brunner, Eric/0000-0002-0595-4474; Rubio, Miguel Angel/0000-0002-0495-6240; Schöttker, Ben/0000-0002-1217-4521; Gudnason, Vilmundur/0000-0001-5696-0084; Gao, Pei/0000-0001-8649-1290; Dankner, Rachel/0000-0001-6454-6000; Gao, Pei/0000-0001-8649-1290; Brenner, Hermann/0000-0002-6129-1572; Kavousi, Maryam/0000-0001-5976-6519; Harshfield, Eric L/0000-0001-8767-0928; Benn, Marianne/0000-0002-1701-595X; Gudnason, Vilmundur/0000-0001-5696-0084; Sundström, Johan/0000-0003-2247-8454; Bakker, Stephan J. L./0000-0003-3356-6791; van der Schouw, Yvonne T./0000-0002-4605-435X; Sakurai, Masaru/0000-0002-4929-3225; Cushman, Mary/0000-0002-7871-6143; Brenner, Hermann/0000-0002-6129-1572; Willeit, Peter/0000-0002-1866-7159; Lennon, Lucy/0000-0002-1738-1351; Jukema, J. Wouter/0000-0002-3246-8359; Ademoglu, Evin/0000-0003-2933-3119; Feskens, Edith/0000-0001-5819-2488; Burgess, Stephen/0000-0001-5365-8760; Franco, Oscar/0000-0002-4606-4929; Butterworth, Adam/0000-0002-6915-9015; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Whincup, Peter/0000-0002-5589-4107; Lawlor, Debbie A/0000-0002-6793-2262; Stehouwer, Coen/0000-0001-8752-3223; Nordestgaard, Borge/0000-0002-1954-7220; Rosengren, Annika/0000-0002-5409-6605; Price, Jackie/0000-0003-3251-3970; Griffin, Simon/0000-0002-2157-4797; Gomez de la Camara, Agustin/0000-0001-6827-6319; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Rothenbacher, Dietrich/0000-0002-3563-2791; Pennells, Lisa Anne/0000-0002-8594-3061; Woodward, Mark/0000-0001-9800-5296; Di Angelantonio, Emanuele/0000-0001-8776-6719; Knuiman, Matthew/0000-0001-8874-2305	British Heart Foundation; UK Medical Research Council; UK National Institute of Health Research; Cambridge Biomedical Research Centre; MRC [MC_U106179474, MC_UU_12015/4, MR/L003120/1, MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/16/30528, RG/13/2/30098, PG/13/66/30442, RG/08/014/24067, RG/08/013/25942] Funding Source: researchfish; Medical Research Council [MC_U106179474, MC_UU_12013/5, MR/K013351/1, G0401527, G1000143, MR/L003120/1, MC_UU_12015/4] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10165] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health Research(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was funded by the British Heart Foundation, the UK Medical Research Council, UK National Institute of Health Research, and the Cambridge Biomedical Research Centre. The collaboration's website (http://www.phpc.cam.ac.uk/ceu/research/erfc/studies/) has compiled a list provided by investigators of some of the funders of the component studies in this analysis.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Barr ELM, 2009, DIABETOLOGIA, V52, P415, DOI 10.1007/s00125-008-1246-y; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Christman AL, 2012, DIABETOLOGIA, V55, P2307; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Goff D. C., 2014, J AM COLL CARDIOL, V63, P25, DOI DOI 10.1161/01.CIR.0000437741.48606.98; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kissel CK, 2012, CAN J CARDIOL, V28, P251, DOI 10.1016/j.cjca.2011.12.008; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pennells L, 2014, AM J EPIDEMIOL, V179, P621, DOI 10.1093/aje/kwt298; Pfister R, 2011, DIABETOLOGIA, V54, P2025, DOI 10.1007/s00125-011-2162-0; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sarwar N, 2010, LANCET, V376, P957, DOI 10.1016/S0140-6736(10)61450-X; Schottker B, 2013, DIABETOLOGIA, V56, P92, DOI 10.1007/s00125-012-2707-x; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Simmons RK, 2008, ARCH INTERN MED, V168, P1209, DOI 10.1001/archinte.168.11.1209; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063	27	146	148	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1225	1233		10.1001/jama.2014.1873	http://dx.doi.org/10.1001/jama.2014.1873			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24668104	Green Accepted, Bronze			2022-12-24	WOS:000333340500026
J	Bushdid, C; Magnasco, MO; Vosshall, LB; Keller, A				Bushdid, C.; Magnasco, M. O.; Vosshall, L. B.; Keller, A.			Humans Can Discriminate More than 1 Trillion Olfactory Stimuli	SCIENCE			English	Article								Humans can discriminate several million different colors and almost half a million different tones, but the number of discriminable olfactory stimuli remains unknown. The lay and scientific literature typically claims that humans can discriminate 10,000 odors, but this number has never been empirically validated. We determined the resolution of the human sense of smell by testing the capacity of humans to discriminate odor mixtures with varying numbers of shared components. On the basis of the results of psychophysical testing, we calculated that humans can discriminate at least 1 trillion olfactory stimuli. This is far more than previous estimates of distinguishable olfactory stimuli. It demonstrates that the human olfactory system, with its hundreds of different olfactory receptors, far outperforms the other senses in the number of physically different stimuli it can discriminate.	[Bushdid, C.; Vosshall, L. B.; Keller, A.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Magnasco, M. O.] Rockefeller Univ, Phys Math Lab, New York, NY 10065 USA; [Vosshall, L. B.] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute	Keller, A (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	andreas.keller@rockefeller.edu		Keller, Andreas/0000-0001-5491-2214	Branco Weiss Science in Society Fellowship; NARSAD; National Center for Advancing Translational Sciences [NCATS, National Institutes of Health (NIH)] [UL1 TR000043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	Branco Weiss Science in Society Fellowship; NARSAD(NARSAD); National Center for Advancing Translational Sciences [NCATS, National Institutes of Health (NIH)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank A. N. Gilbert, J. D. Mainland, and members of the Vosshall Lab for discussion and comments on the manuscript. We also thank M. Hempstead for support with data collection. A.K. was supported by a Branco Weiss Science in Society Fellowship and a NARSAD Young Investigator Award. L.B.V. is an investigator of the Howard Hughes Medical Institute. This study was supported in part by grant UL1 TR000043 from the National Center for Advancing Translational Sciences [NCATS, National Institutes of Health (NIH)] Clinical and Translational Science Award (CTSA) program.	Conway J., 1999, GRUNDLEHREN MATH WIS; Crocker EC, 1927, AM PERFUMERY ESSENT, V22, P325; Gilbert A. N., 2008, WHAT NOSE KNOWS, P1; Gottfried J. A., 2006, TASTE SMELL UPDATE, P46; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; HILZ RL, 1974, J OPT SOC AM, V64, P763, DOI 10.1364/JOSA.64.000763; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Le Berre E, 2008, CHEM SENSES, V33, P389, DOI 10.1093/chemse/bjn006; Nickerson D, 1943, J OPT SOC AM, V33, P419, DOI 10.1364/JOSA.33.000419; Ohloff G., 1994, SCENT FRAGRANCES FAS; Pointer MR, 1998, COLOR RES APPL, V23, P52, DOI 10.1002/(SICI)1520-6378(199802)23:1<52::AID-COL8>3.0.CO;2-2; Snitz K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003184; Stevens SS, 1938, HEARING, P152; Weiss T, 2012, P NATL ACAD SCI USA, V109, P19959, DOI 10.1073/pnas.1208110109	15	404	417	12	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1370	1372		10.1126/science.1249168	http://dx.doi.org/10.1126/science.1249168			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653035	Green Accepted			2022-12-24	WOS:000333108500042
J	Diebolder, CA; Beurskens, FJ; de Jong, RN; Koning, RI; Strumane, K; Lindorfer, MA; Voorhorst, M; Ugurlar, D; Rosati, S; Heck, AJR; van de Winkel, JGJ; Wilson, IA; Koster, AJ; Taylor, RP; Saphire, EO; Burton, DR; Schuurman, J; Gros, P; Parren, PWHI				Diebolder, Christoph A.; Beurskens, Frank J.; de Jong, Rob N.; Koning, Roman I.; Strumane, Kristin; Lindorfer, Margaret A.; Voorhorst, Marleen; Ugurlar, Deniz; Rosati, Sara; Heck, Albert J. R.; van de Winkel, Jan G. J.; Wilson, Ian A.; Koster, Abraham J.; Taylor, Ronald P.; Saphire, Erica Ollmann; Burton, Dennis R.; Schuurman, Janine; Gros, Piet; Parren, Paul W. H. I.			Complement Is Activated by IgG Hexamers Assembled at the Cell Surface	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; MEDIATED LYSIS; IMMUNOGLOBULIN-G; HUMAN CD20; ANTIGEN; BINDING; HIV-1; SPECIFICITY; COMPLEXES; COMPONENT	Complement activation by antibodies bound to pathogens, tumors, and self antigens is a critical feature of natural immune defense, a number of disease processes, and immunotherapies. How antibodies activate the complement cascade, however, is poorly understood. We found that specific noncovalent interactions between Fc segments of immunoglobulin G (IgG) antibodies resulted in the formation of ordered antibody hexamers after antigen binding on cells. These hexamers recruited and activated C1, the first component of complement, thereby triggering the complement cascade. The interactions between neighboring Fc segments could be manipulated to block, reconstitute, and enhance complement activation and killing of target cells, using all four human IgG subclasses. We offer a general model for understanding antibody-mediated complement activation and the design of antibody therapeutics with enhanced efficacy.	[Diebolder, Christoph A.; Ugurlar, Deniz; Gros, Piet] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Diebolder, Christoph A.; Koning, Roman I.; Koster, Abraham J.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Electron Microscopy Sect, NL-2300 RC Leiden, Netherlands; [Beurskens, Frank J.; de Jong, Rob N.; Strumane, Kristin; Voorhorst, Marleen; van de Winkel, Jan G. J.; Schuurman, Janine; Parren, Paul W. H. I.] Genmab, NL-3584 CM Utrecht, Netherlands; [Lindorfer, Margaret A.; Taylor, Ronald P.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Rosati, Sara; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Rosati, Sara; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [van de Winkel, Jan G. J.] Univ Med Ctr, Dept Immunol, NL-3584 CX Utrecht, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Wilson, Ian A.; Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Saphire, Erica Ollmann; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Genmab; University of Virginia; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Gros, P (corresponding author), Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	p.gros@uu.nl; p.parren@genmab.com	Gros, Piet/AAD-6452-2019; Heck, Albert/D-7098-2011; Gros, Piet/I-5569-2016; Koster, Abraham/I-7665-2017	Gros, Piet/0000-0002-7782-2585; Heck, Albert/0000-0002-2405-4404; Gros, Piet/0000-0002-7782-2585; Parren, Paul/0000-0002-4365-3859; Diebolder, Christoph/0000-0001-7694-7362; Koster, Abraham/0000-0003-1717-2549; Saphire, Erica Ollmann/0000-0002-1206-7451; Koning, Roman/0000-0001-6736-7147; de Jong, Rob N./0000-0002-9300-6633	European Research Council [233229, FES0908]; Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden; Netherlands Organization for Scientific Research [NWO 175.010.2009.001]; European Regional Development Fund of the European Commission [21Z.014]; National Institute of Allergy and Infectious Diseases (NIAID) [AI055332]; NIAID [AI084817]; Genmab; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084817, R01AI055332, R37AI055332, R01AI084817] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund of the European Commission; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Genmab(Genmab); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Daha for purified C1, and F. G. A. Faas and W. Vossenaar-Horstman for technical support. Supported in part by European Research Council advanced grant 233229; Cyttron II (Life Sciences Health framework FES0908); the Netherlands Centre for Electron Nanoscopy (NeCEN), Leiden; the Netherlands Organization for Scientific Research (NWO 175.010.2009.001); and the European Regional Development Fund of the European Commission (21Z.014). D.R.B. is supported by National Institute of Allergy and Infectious Diseases (NIAID) grant AI055332. I.A.W. is supported by NIAID grant AI084817. The data presented are tabulated in the main paper and in the supplementary materials. The ET data presented are archived at EMDataBank, entries EMD-2506, EMD-2507, and EMD-2554. F.J.B., R.N.d.J., K.S., M.V., J.G.J.v.d.W., J.S., and P.W.H.I.P. are Genmab employees and own Genmab warrants and/or stock. M.A.L., R.P.T., S.R., and A.J.R.H. received Genmab funding. F.J.B., R.N.d.J., J.S., and P.W.H.I.P. are inventors on Genmab patent applications related to technology to enhance complement activation.	BINDON CI, 1988, EUR J IMMUNOL, V18, P1507, DOI 10.1002/eji.1830181006; BORSOS T, 1965, SCIENCE, V150, P505, DOI 10.1126/science.150.3695.505; BURTON DR, 1990, TRENDS BIOCHEM SCI, V15, P64, DOI 10.1016/0968-0004(90)90178-E; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; BURTON DR, 1986, IMMUNOL TODAY, V7, P165, DOI 10.1016/0167-5699(86)90166-0; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Czajkowsky DM, 2009, P NATL ACAD SCI USA, V106, P14960, DOI 10.1073/pnas.0903805106; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dechant M, 2008, CANCER RES, V68, P4998, DOI 10.1158/0008-5472.CAN-07-6226; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; FEINSTEIN A, 1986, IMMUNOL TODAY, V7, P169, DOI 10.1016/0167-5699(86)90168-4; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; HUGHESJONES NC, 1985, EUR J IMMUNOL, V15, P976, DOI 10.1002/eji.1830151003; HUGHESJONES NC, 1979, MOL IMMUNOL, V16, P697, DOI 10.1016/0161-5890(79)90010-5; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kushihata F, 2004, TRANSPLANTATION, V78, P995, DOI 10.1097/01.TP.0000136966.63957.E2; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; PARCE JW, 1983, BIOCHIM BIOPHYS ACTA, V736, P92; Pawluczkowycz AW, 2009, J IMMUNOL, V183, P749, DOI 10.4049/jimmunol.0900632; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROSSE WF, 1967, J IMMUNOL, V98, P1190; ROSSE WF, 1971, J CLIN INVEST, V50, P727, DOI 10.1172/JCI106543; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Saphire EO, 2001, ACTA CRYSTALLOGR D, V57, P168, DOI 10.1107/S0907444900017376; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; THOMPSON JJ, 1974, IMMUNOCHEMISTRY, V11, P537, DOI 10.1016/0019-2791(74)90244-4; WATTS HF, 1985, MOL IMMUNOL, V22, P803, DOI 10.1016/0161-5890(85)90146-4; Wu YJ, 2013, CELL REP, V5, P1443, DOI 10.1016/j.celrep.2013.11.015; XIA MQ, 1993, MOL IMMUNOL, V30, P1089	31	448	478	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1260	1263		10.1126/science.1248943	http://dx.doi.org/10.1126/science.1248943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626930	Green Accepted			2022-12-24	WOS:000332728500039
J	Supek, F; Minana, B; Valcarcel, J; Gabaldon, T; Lehner, B				Supek, Fran; Minana, Belen; Valcarcel, Juan; Gabaldon, Toni; Lehner, Ben			Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers	CELL			English	Article							SOMATIC MUTATIONS; TRANSLATION EFFICIENCY; SPLICING MUTATION; SILENT MUTATIONS; PROTEIN; GENE; GENOME; VARIANT; IDENTIFICATION; POLYMORPHISMS	Synonymous mutations change the sequence of a gene without directly altering the sequence of the encoded protein. Here, we present evidence that these "silent'' mutations frequently contribute to human cancer. Selection on synonymous mutations in oncogenes is cancer-type specific, and although the functional consequences of cancer-associated synonymous mutations may be diverse, they recurrently alter exonic motifs that regulate splicing and are associated with changes in oncogene splicing in tumors. The p53 tumor suppressor (TP53) also has recurrent synonymous mutations, but, in contrast to those in oncogenes, these are adjacent to splice sites and inactivate them. We estimate that between one in two and one in five silent mutations in oncogenes have been selected, equating to similar to 6%-8% of all selected single-nucleotide changes in these genes. In addition, our analyses suggest that dosage-sensitive oncogenes have selected mutations in their 3' UTRs.	[Supek, Fran; Lehner, Ben] Ctr Genom Regulat, EMBL CRG, Syst Biol Res Unit, Barcelona 08003, Spain; [Minana, Belen; Valcarcel, Juan] Ctr Genom Regulat, Gene Regulat Stem Cells & Canc Program, Barcelona 08003, Spain; [Gabaldon, Toni] Ctr Genom Regulat, Bioinformat & Genom Program, Barcelona 08003, Spain; [Supek, Fran; Minana, Belen; Valcarcel, Juan; Gabaldon, Toni; Lehner, Ben] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Spain; [Valcarcel, Juan; Gabaldon, Toni; Lehner, Ben] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Lehner, B (corresponding author), Ctr Genom Regulat, EMBL CRG, Syst Biol Res Unit, Dr Aiguader 88, Barcelona 08003, Spain.	ben.lehner@crg.eu	Lehner, Ben/ABH-6562-2020; Valcarcel, Juan/O-9814-2014; Lehner, Ben/L-3413-2014; minana, belen/K-5530-2015; Supek, Fran/B-2359-2012; Gabaldón, Toni/A-7336-2008	Lehner, Ben/0000-0002-8817-1124; Valcarcel, Juan/0000-0001-5398-3571; Lehner, Ben/0000-0002-8817-1124; minana, belen/0000-0001-7676-5788; Supek, Fran/0000-0002-7811-6711; Gabaldón, Toni/0000-0003-0019-1735	Marie Curie Actions (INTERPOD); ERC Starting Grant; ERASysBio+ ERANET; MICINN [BFU2011-26206, BIO2012-37161]; AGAUR; EMBO Young Investigator Program; EU Framework 7 project [277899 4DCellFate]; EMBL-CRG Systems Biology Program; ERC; Fundacion Botin; Fundacion Alicia Koplowicz; Consolider RNAREG; MINECO; ICREA Funding Source: Custom	Marie Curie Actions (INTERPOD); ERC Starting Grant(European Research Council (ERC)); ERASysBio+ ERANET; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); EU Framework 7 project; EMBL-CRG Systems Biology Program; ERC(European Research Council (ERC)European Commission); Fundacion Botin; Fundacion Alicia Koplowicz; Consolider RNAREG(Spanish Government); MINECO(Spanish Government); ICREA(ICREA)	F.S. was cofunded by Marie Curie Actions (INTERPOD). Work in the lab of B. L. is supported by an ERC Starting Grant, ERASysBio+ ERANET, MICINN BFU2011-26206, AGAUR, the EMBO Young Investigator Program, EU Framework 7 project 277899 4DCellFate, and the EMBL-CRG Systems Biology Program. Work in the lab of T. G. is supported by an ERC Starting Grant and MICINN BIO2012-37161. Work in the lab of J.V. is supported by Fundacion Botin, Fundacion Alicia Koplowicz, Consolider RNAREG, and MINECO.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druillennec S, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/639062; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Griseri P, 2011, HUM MOL GENET, V20, P4556, DOI 10.1093/hmg/ddr390; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kaida D, 2012, CANCER SCI, V103, P1611, DOI 10.1111/j.1349-7006.2012.02356.x; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Ke SD, 2011, GENOME RES, V21, P1360, DOI 10.1101/gr.119628.110; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lamolle G, 2006, MUTAT RES-FUND MOL M, V600, P102, DOI 10.1016/j.mrfmmm.2006.03.004; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Ma F, 2009, LUNG CANCER, V66, P114, DOI 10.1016/j.lungcan.2008.12.025; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Schutz FAB, 2013, LANCET ONCOL, V14, P81, DOI 10.1016/S1470-2045(12)70517-X; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stark M, 2011, J BIOL CHEM, V286, P3741, DOI 10.1074/jbc.M110.163444; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Strauss BS, 2000, MUTAT RES-FUND MOL M, V457, P93, DOI 10.1016/S0027-5107(00)00135-4; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Varley JM, 1998, ONCOGENE, V16, P3291, DOI 10.1038/sj.onc.1201878; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; WARNEFORD SG, 1992, CELL GROWTH DIFFER, V3, P839; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang J, 2011, DATABASE OXFORD, V2011; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	55	353	367	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1324	1335		10.1016/j.cell.2014.01.051	http://dx.doi.org/10.1016/j.cell.2014.01.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630730	Bronze			2022-12-24	WOS:000332945100020
J	Brown, JB; Boley, N; Eisman, R; May, GE; Stoiber, MH; Duff, MO; Booth, BW; Wen, JY; Park, S; Suzuki, AM; Wan, KH; Yu, C; Zhang, DY; Carlson, JW; Cherbas, L; Eads, BD; Miller, D; Mockaitis, K; Roberts, J; Davis, CA; Frise, E; Hammonds, AS; Olson, S; Shenker, S; Sturgill, D; Samsonova, AA; Weiszmann, R; Robinson, G; Hernandez, J; Andrews, J; Bickel, PJ; Carninci, P; Cherbas, P; Gingeras, TR; Hoskins, RA; Kaufman, TC; Lai, EC; Oliver, B; Perrimon, N; Graveley, BR; Celniker, SE				Brown, James B.; Boley, Nathan; Eisman, Robert; May, Gemma E.; Stoiber, Marcus H.; Duff, Michael O.; Booth, Ben W.; Wen, Jiayu; Park, Soo; Suzuki, Ana Maria; Wan, Kenneth H.; Yu, Charles; Zhang, Dayu; Carlson, Joseph W.; Cherbas, Lucy; Eads, Brian D.; Miller, David; Mockaitis, Keithanne; Roberts, Johnny; Davis, Carrie A.; Frise, Erwin; Hammonds, Ann S.; Olson, Sara; Shenker, Sol; Sturgill, David; Samsonova, Anastasia A.; Weiszmann, Richard; Robinson, Garret; Hernandez, Juan; Andrews, Justen; Bickel, Peter J.; Carninci, Piero; Cherbas, Peter; Gingeras, Thomas R.; Hoskins, Roger A.; Kaufman, Thomas C.; Lai, Eric C.; Oliver, Brian; Perrimon, Norbert; Graveley, Brenton R.; Celniker, Susan E.			Diversity and dynamics of the Drosophila transcriptome	NATURE			English	Article							GENOME-WIDE ANALYSIS; LONG NONCODING RNAS; EXPRESSION ANALYSIS; ENDOGENOUS SIRNAS; GENE-EXPRESSION; CAP-ANALYSIS; IDENTIFICATION; LANDSCAPE; REVEALS; GENCODE	Animal transcriptomes are dynamic with each cell type, tissue and organ system expressing an ensemble of transcript forms that give rise to substantial diversity. Here we have identified new genes, transcripts and proteins using poly(A)(+) RNA sequencing from Drosophila melanogaster in cultured cell lines, dissected organ systems and under environmental perturbations. We found that a small set of mostly neural-specific genes has the potential to encode thousands of transcripts each through extensive alternative promoter usage and RNA splicing. The magnitudes of splicing changes are larger between tissues than between developmental stages, and most sex-specific splicing is gonad-specific. Gonads express hundreds of previously unknown coding and long non-coding RNAs (lncRNAs), some of which are antisense to protein-coding genes and produce short regulatory RNAs. Furthermore, previously identified pervasive intergenic transcription occurs primarily within newly identified introns. The fly transcriptome is substantially more complex than previously recognized, with this complexity arising from combinatorial usage of promoters splice sites and polyaclenylation sites.	[Brown, James B.; Boley, Nathan; Stoiber, Marcus H.; Robinson, Garret; Hernandez, Juan; Bickel, Peter J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Brown, James B.; Booth, Ben W.; Park, Soo; Wan, Kenneth H.; Yu, Charles; Carlson, Joseph W.; Frise, Erwin; Hammonds, Ann S.; Weiszmann, Richard; Hoskins, Roger A.; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Eisman, Robert; Cherbas, Lucy; Eads, Brian D.; Miller, David; Mockaitis, Keithanne; Andrews, Justen; Cherbas, Peter; Kaufman, Thomas C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [May, Gemma E.; Duff, Michael O.; Olson, Sara; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Wen, Jiayu; Shenker, Sol; Lai, Eric C.] Sloan Kettering Inst, Rockefeller Res Labs 1017C, New York, NY 10065 USA; [Suzuki, Ana Maria; Carninci, Piero] RIKEN Omics Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Suzuki, Ana Maria; Carninci, Piero] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan; [Zhang, Dayu; Roberts, Johnny; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Davis, Carrie A.; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sturgill, David; Oliver, Brian] NIDDK, Sect Dev Genom, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [Samsonova, Anastasia A.; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Samsonova, Anastasia A.; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; University of Connecticut; Memorial Sloan Kettering Cancer Center; RIKEN; RIKEN; Indiana University System; Indiana University Bloomington; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Brown, JB (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	benbrownofberkeley@gmail.com; graveley@neuron.uchc.edu; celniker@fruitfly.org	Lai, Eric C/A-3412-2008; Samsonova, Anastasia/Q-7591-2016; Graveley, Brenton R/C-3108-2013; Samsonova, Anastasia/AAU-7269-2021; Carninci, Piero/K-1568-2014; Lai, Eric/AAO-1143-2021; Brown, James/H-2971-2015; Wen, Jiayu/R-1673-2017	Samsonova, Anastasia/0000-0002-9353-9173; Samsonova, Anastasia/0000-0002-9353-9173; Carninci, Piero/0000-0001-7202-7243; Lai, Eric/0000-0002-8432-5851; Wen, Jiayu/0000-0003-1249-6456; Gingeras, Thomas/0000-0001-9106-3573; Graveley, Brenton/0000-0001-5777-5892; Sturgill, David/0000-0002-7902-3605; Perrimon, Norbert/0000-0001-7542-472X	National Human Genome Research Institute; Department of Energy [U01 HG004271, U54 HG006944, R01 GM076655, DE-AC02-05CH11231]; NHGRI [K99 HG006698]; modENCODE DAC sub-award [5710003102, 1U01HG007031-01]; ENCODE DAC [5U01HG004695-04]; Indiana METACyt Initiative of Indiana University - Lilly Endowment;  [U01-HG004261];  [RC2-HG005639]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004695, K99HG006698, U01HG007031, U01HG004261, RC2HG005639, U01HG004271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076655, R01GM083300, R01GM097231] Funding Source: NIH RePORTER; Direct For Biological Sciences [1062432] Funding Source: National Science Foundation	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy(United States Department of Energy (DOE)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); modENCODE DAC sub-award; ENCODE DAC; Indiana METACyt Initiative of Indiana University - Lilly Endowment; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the members of the modENCODE transcription consortium, especially J. Landolin and J. Sandler for their early contributions to these studies. We also thank A. Kundaje and H. Huang for helpful discussions. This work was funded by a contract from the National Human Genome Research Institute modENCODE Project, contract U01 HG004271 and U54 HG006944, to S.E.C. (principal investigator) and P.C., T.R.G., R.A.H. and B.R.G. (co-principal investigators) with additional support from R01 GM076655 (S.E.C.) both under Department of Energy contract no. DE-AC02-05CH11231. J.B.B.'s work was supported by NHGRI K99 HG006698. Work in P.J.B.'s group was supported by the modENCODE DAC sub-award 5710003102, 1U01HG007031-01 and the ENCODE DAC 5U01HG004695-04. Work in Bloomington was supported in part by the Indiana METACyt Initiative of Indiana University, funded by an award from the Lilly Endowment. Work in E.C.L.'s group was supported by U01-HG004261 and RC2-HG005639.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bickel PJ, 2010, ANN APPL STAT, V4, P1660, DOI 10.1214/10-AOAS363; Boley N, 2014, NAT BIOTECHNOL, V32, P341, DOI 10.1038/nbt.2850; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Celniker SE, 2003, ANNU REV GENOM HUM G, V4, P89, DOI 10.1146/annurev.genom.4.070802.110323; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Spradling AC, 1999, GENETICS, V153, P135; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Takahashi H, 2012, METHODS MOL BIOL, V786, P181, DOI 10.1007/978-1-61779-292-2_11; Telonis-Scott M, 2009, GENETICS, V181, P421, DOI 10.1534/genetics.108.096743; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	50	391	400	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					393	399		10.1038/nature12962	http://dx.doi.org/10.1038/nature12962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	24670639	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-24	WOS:000340840600025
J	Mancias, JD; Wang, XX; Gygi, SP; Harper, JW; Kimmelman, AC				Mancias, Joseph D.; Wang, Xiaoxu; Gygi, Steven P.; Harper, J. Wade; Kimmelman, Alec C.			Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy	NATURE			English	Article							ANDROGEN RECEPTOR; RAT-LIVER; IRON; AUTOPHAGY; COACTIVATOR; MECHANISMS	Autophagy, the process by which proteins and organelles are sequestered in double-membrane structures called autophagosomes and delivered to lysosomes for degradation, is critical in diseases such as cancer and neurodegeneration(1,2). Much of our understanding of this process has emerged from analysis of bulk cytoplasmic autophagy, but our understanding of how specific cargo, including organelles, proteins or intracellular pathogens, are targeted for selective autophagy is limited(3). Here we use quantitative proteomics to identify a cohort of novel and known autophagosome-enriched proteins in human cells, including cargo receptors. Like known cargo receptors, nuclear receptor coactivator 4 (NCOA4) was highly enriched in autophagosomes, and associated with ATG8 proteins that recruit cargo-receptor complexes into autophagosomes. Unbiased identification of NCOA4-associated proteins revealed ferritin heavy and light chains, components of an iron-filled cage structure that protects cells from reactive iron species(4) but is degraded via autophagy to release iron(5,6) through an unknown mechanism. We found that delivery of ferritin to lysosomes required NCOA4, and an inability of NCOA4-deficient cells to degrade ferritin led to decreased bioavailable intracellular iron. This work identifies NCOA4 as a selective cargo receptor for autophagic turnover of ferritin (ferritinophagy), which is critical for iron homeostasis, and provides a resource for further dissection of autophagosomal cargo-receptor connectivity.	[Mancias, Joseph D.; Wang, Xiaoxu; Kimmelman, Alec C.] Dana Farber Canc Inst, Div Genom Stabil & DNA Repair, Dept Radiat Oncol, Boston, MA 02215 USA; [Mancias, Joseph D.; Gygi, Steven P.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Mancias, Joseph D.] Harvard Radiat Oncol Program, Boston, MA 02115 USA; [Mancias, Joseph D.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kimmelman, AC (corresponding author), Dana Farber Canc Inst, Div Genom Stabil & DNA Repair, Dept Radiat Oncol, Boston, MA 02215 USA.	wade_harper@hms.harvard.edu; alec_kimmelman@dfci.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [GM070565, GM095567]; National Cancer Institute [R01CA157490]; American Cancer Society [RSG-13-298-01-TBG]; Lustgarten Foundation; American Board of Radiology Holman Research Pathway Post-doctoral Fellowship; American Society of Radiation Oncology Junior Faculty Career Research Training Award [JF2013-2]; NATIONAL CANCER INSTITUTE [R01CA157490, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565, R01GM095567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Lustgarten Foundation; American Board of Radiology Holman Research Pathway Post-doctoral Fellowship; American Society of Radiation Oncology Junior Faculty Career Research Training Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Everley and E. Huttlin for assistance with LC-MS/MS, A. Cuervo for assistance with autophagosome purification protocol development, Y. Liu for technical support with cell culture, A. White, J. Lydeard and S. Hayes for interaction proteomics support, M. Haigis for access to nitrogen cavitation equipment, and the Nikon Imaging and Electron Microscopy Centers (Harvard Medical School) for imaging support. We thank Millennium Pharmaceuticals for the GABARAPL2 antibody. We acknowledge support from National Institutes of Health grants GM070565 and GM095567 to J. W. H., and National Cancer Institute grant R01CA157490, American Cancer Society Research Scholar grant RSG-13-298-01-TBG and the Lustgarten Foundation to A. C. K. J. D. M. was supported by an American Board of Radiology Holman Research Pathway Post-doctoral Fellowship and an American Society of Radiation Oncology Junior Faculty Career Research Training Award (JF2013-2). J. W. H. is a consultant for Millennium: The Takeda Oncology Company and Biogen Idec. A. C. K. is a consultant for Forma Therapeutics.	Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; Dengjel J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014035; Gao TS, 1999, MOL ENDOCRINOL, V13, P1645, DOI 10.1210/me.13.10.1645; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Griffiths RE, 2012, AUTOPHAGY, V8, P1150, DOI 10.4161/auto.20648; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Overbye A, 2007, AUTOPHAGY, V3, P300, DOI 10.4161/auto.3910; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Sandilands E, 2012, NAT CELL BIOL, V14, P51, DOI 10.1038/ncb2386; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; TRUMP BF, 1973, AM J PATHOL, V72, P295; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517	30	750	771	16	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					105	+		10.1038/nature13148	http://dx.doi.org/10.1038/nature13148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24695223	Green Accepted, Green Submitted			2022-12-24	WOS:000335199100048
J	Dominici, F; Greenstone, M; Sunstein, CR				Dominici, Francesca; Greenstone, Michael; Sunstein, Cass R.			Particulate Matter Matters	SCIENCE			English	Editorial Material							CLEAN-AIR ACT; CAUSAL INFERENCE; POLLUTION; MORTALITY; HEALTH; IMPACT; REGULATIONS; ASSOCIATION		[Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Greenstone, Michael] MIT, Dept Econ, Cambridge, MA 02142 USA; [Greenstone, Michael] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Sunstein, Cass R.] Harvard Univ, Sch Law, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Harvard University	Greenstone, M (corresponding author), MIT, Dept Econ, Cambridge, MA 02142 USA.	mgreenst@mit.edu	Sunstein, Cass/AAV-8196-2020		NIEHS NIH HHS [R01 ES012054, R01 ES019560, R21 ES020152, R21 ES02147, R21 ES022585] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020152, R01ES019560, R01ES012054, R21ES022585] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], 2009, RES REP HLTH EFF I; ASHENFELTER O, 1994, AM ECON REV, V84, P1157; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Chay K, 2003, J RISK UNCERTAINTY, V27, P279, DOI 10.1023/A:1025897327639; Chay K., 2003, NBER WORKING PAPER 1; Chay KY, 2005, J POLIT ECON, V113, P376, DOI 10.1086/427462; Chay KY, 2003, Q J ECON, V118, P1121, DOI 10.1162/00335530360698513; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Deschenes O., 2012, NBER WORKING PAPER 1; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; Greenstone M, 2002, J POLIT ECON, V110, P1175, DOI 10.1086/342808; Greenstone M, 2009, J ENVIRON ECON MANAG, V57, P21, DOI 10.1016/j.jeem.2008.02.004; Greven S, 2011, J AM STAT ASSOC, V106, P396, DOI 10.1198/jasa.2011.ap09392; Health Effects Institute, 2003, ASSESSING THE HEALTH; HECKMAN JJ, 1989, AM ECON REV, V79, P138; Janes H, 2007, EPIDEMIOLOGY, V18, P416, DOI 10.1097/EDE.0b013e31806462e9; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Moore K, 2010, AM J EPIDEMIOL, V171, P1233, DOI 10.1093/aje/kwq064; Office of Management and Budget, 2012, 2012 REPORT TO CONGR; Office of Management and Budget, 2013, 2013 DRAFT REPORT TO, p[14, 18, 19]; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Pope CA, 2007, EPIDEMIOLOGY, V18, P424, DOI 10.1097/EDE.0b013e318065c008; RANSOM MR, 1995, CONTEMP ECON POLICY, V13, P86, DOI 10.1111/j.1465-7287.1995.tb00745.x; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Rubin DB, 2008, ANN APPL STAT, V2, P808, DOI 10.1214/08-AOAS187; Samet JM, 2011, NEW ENGL J MED, V365, P198, DOI 10.1056/NEJMp1103332; Thomas D., 2009, STATISTICAL METHODS; Wang C, 2012, BIOMETRICS, V68, P661, DOI 10.1111/j.1541-0420.2011.01731.x; Zigler CM, 2012, BIOSTATISTICS, V13, P289, DOI 10.1093/biostatistics/kxr052	35	175	178	3	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					257	259		10.1126/science.1247348	http://dx.doi.org/10.1126/science.1247348			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF1LD	24744361	Green Accepted			2022-12-24	WOS:000334474500020
J	Kayser, MS; Yue, ZF; Sehgal, A				Kayser, Matthew S.; Yue, Zhifeng; Sehgal, Amita			A Critical Period of Sleep for Development of Courtship Circuitry and Behavior in Drosophila	SCIENCE			English	Article							INFANT-DEATH-SYNDROME; TRANSGENE EXPRESSION; TRANSCRIPTION FACTOR; ADULT DROSOPHILA; NEURAL CIRCUITRY; AROUSAL; BRAIN; PLASTICITY; DOPAMINE; IDENTIFICATION	Most animals sleep more early in life than in adulthood, but the function of early sleep is not known. Using Drosophila, we found that increased sleep in young flies was associated with an elevated arousal threshold and resistance to sleep deprivation. Excess sleep results from decreased inhibition of a sleep-promoting region by a specific dopaminergic circuit. Experimental hyperactivation of this circuit in young flies results in sleep loss and lasting deficits in adult courtship behaviors. These deficits are accompanied by impaired development of a single olfactory glomerulus, VA1v, which normally displays extensive sleep-dependent growth after eclosion. Our results demonstrate that sleep promotes normal brain development that gives rise to an adult behavior critical for species propagation and suggest that rapidly growing regions of the brain are most susceptible to sleep perturbations early in life.	[Kayser, Matthew S.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kayser, Matthew S.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yue, Zhifeng; Sehgal, Amita] Univ Penn, Howard Hughes Med Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sehgal, Amita] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Sehgal, A (corresponding author), Univ Penn, Howard Hughes Med Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Kayser, Matthew/0000-0003-2359-4967	National Institutes of Health [T32HL07713, R25MH060490]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Raizen, T. Abel, M. Frank, and members of the Sehgal lab for helpful input and advice. This work was supported by grants T32HL07713 and R25MH060490 from the National Institutes of Health (M. S. K.) and the Howard Hughes Medical Institute (A. S.). M. S. K. and A. S. designed the experiments. M. S. K. and Z.Y. performed the research. M. S. K., Z.Y., and A. S. collected, analyzed, and interpreted the data. M. S. K., Z.Y., and A. S. wrote and edited the paper. The authors have no patents pending or financial conflicts to disclose.	Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Ednick M, 2009, SLEEP, V32, P1449, DOI 10.1093/sleep/32.11.1449; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Frank MG, 2011, PROG BRAIN RES, V193, P221, DOI 10.1016/B978-0-444-53839-0.00014-4; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Halbower AC, 2006, PLOS MED, V3, P1391, DOI 10.1371/journal.pmed.0030301; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARPER RM, 1981, SCIENCE, V213, P1030, DOI 10.1126/science.7268406; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Kim WJ, 2013, NEURON, V80, P1190, DOI 10.1016/j.neuron.2013.09.034; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kumar S, 2012, GENE DEV, V26, P1224, DOI 10.1101/gad.186338.111; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; KUPFER DJ, 1995, BIOL PSYCHIAT, V38, P391, DOI 10.1016/0006-3223(94)00295-E; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; SCHECHTMAN VL, 1992, PEDIATRICS, V89, P865; Seugnet L, 2011, SLEEP, V34, P137, DOI 10.1093/sleep/34.2.137; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tanenhaus AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045130; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wu M. N., 2012, CURR BIOL; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	55	99	100	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					269	274		10.1126/science.1250553	http://dx.doi.org/10.1126/science.1250553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744368	Green Accepted			2022-12-24	WOS:000334474500027
J	Williams, SJ; Sohn, KH; Wan, L; Bernoux, M; Sarris, PF; Segonzac, C; Ve, T; Ma, Y; Saucet, SB; Ericsson, DJ; Casey, LW; Lonhienne, T; Winzor, DJ; Zhang, XX; Coerdt, A; Parker, JE; Dodds, PN; Kobe, B; Jones, JDG				Williams, Simon J.; Sohn, Kee Hoon; Wan, Li; Bernoux, Maud; Sarris, Panagiotis F.; Segonzac, Cecile; Ve, Thomas; Ma, Yan; Saucet, Simon B.; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Winzor, Donald J.; Zhang, Xiaoxiao; Coerdt, Anne; Parker, Jane E.; Dodds, Peter N.; Kobe, Bostjan; Jones, Jonathan D. G.			Structural Basis for Assembly and Function of a Heterodimeric Plant Immune Receptor	SCIENCE			English	Article							RESISTANCE PROTEIN; DISEASE RESISTANCE; TIR DOMAIN; CELL-DEATH; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; BLAST RESISTANCE; MOLECULAR-BASIS; EFFECTOR; BINDING	Cytoplasmic plant immune receptors recognize specific pathogen effector proteins and initiate effector-triggered immunity. In Arabidopsis, the immune receptors RPS4 and RRS1 are both required to activate defense to three different pathogens. We show that RPS4 and RRS1 physically associate. Crystal structures of the N-terminal Toll-interleukin-1 receptor/resistance (TIR) domains of RPS4 and RRS1, individually and as a heterodimeric complex (respectively at 2.05, 1.75, and 2.65 angstrom resolution), reveal a conserved TIR/TIR interaction interface. We show that TIR domain heterodimerization is required to form a functional RRS1/RPS4 effector recognition complex. The RPS4 TIR domain activates effector-independent defense, which is inhibited by the RRS1 TIR domain through the heterodimerization interface. Thus, RPS4 and RRS1 function as a receptor complex in which the two components play distinct roles in recognition and signaling.	[Williams, Simon J.; Wan, Li; Ve, Thomas; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Winzor, Donald J.; Zhang, Xiaoxiao; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Williams, Simon J.; Wan, Li; Ve, Thomas; Ericsson, Daniel J.; Casey, Lachlan W.; Lonhienne, Thierry; Winzor, Donald J.; Zhang, Xiaoxiao; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Sohn, Kee Hoon; Sarris, Panagiotis F.; Segonzac, Cecile; Ma, Yan; Saucet, Simon B.; Jones, Jonathan D. G.] John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Bernoux, Maud; Dodds, Peter N.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia; [Coerdt, Anne; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Sohn, Kee Hoon; Segonzac, Cecile] Massey Univ, Inst Agr & Environm, Bioprotect Res Ctr, Palmerston North 4442, New Zealand	University of Queensland; University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; University of Queensland; Massey University	Williams, SJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	s.williams8@uq.edu.au; k.sohn@massey.ac.nz; b.kobe@uq.edu.au; jonathan.jones@sainsbury-laboratory.ac.uk	Ericsson, Daniel/F-7458-2011; Williams, Simon/F-7447-2011; Lonhienne, Thierry/A-5828-2011; Bernoux, Maud/N-1360-2019; Jones, Jonathan DG/J-5129-2012; Ve, Thomas/AEK-1006-2022; Kobe, Bostjan/D-1292-2009; Sarris, Panagiotis F./N-9978-2015; Bernoux, Maud/D-4212-2009; SOHN, KEE HOON/H-5311-2013; Casey, Lachlan/N-3396-2015; Dodds, Peter/D-1181-2009; Zhang, Xiaoxiao/C-6002-2016	Ericsson, Daniel/0000-0001-5101-9244; Williams, Simon/0000-0003-4781-6261; Jones, Jonathan DG/0000-0002-4953-261X; Ve, Thomas/0000-0002-0113-1905; Kobe, Bostjan/0000-0001-9413-9166; Casey, Lachlan/0000-0002-4458-0137; Saucet, Simon/0000-0002-0255-3886; Segonzac, Cecile/0000-0002-5537-7556; Sarris, Panagiotis/0000-0001-7000-8997; Dodds, Peter/0000-0003-0620-5923; Bernoux, Maud/0000-0001-5416-4295; Ma, Yan/0000-0003-3663-9060; Zhang, Xiaoxiao/0000-0002-5417-6963	Australian Research Council (ARC) [DP120100685]; Rural Development Administration (Korea) [PJ007850201006]; Gatsby Foundation (United Kingdom); ARC Discovery Early Career Award [DE130101292]; European Commission [299621]	Australian Research Council (ARC)(Australian Research Council); Rural Development Administration (Korea)(Rural Development Administration (RDA), Republic of Korea); Gatsby Foundation (United Kingdom); ARC Discovery Early Career Award(Australian Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by the Australian Research Council (ARC) Discovery Project (DP120100685), by Rural Development Administration (Korea) Project PJ007850201006, and by the Gatsby Foundation (United Kingdom). M. B. was a recipient of an ARC Discovery Early Career Award (DE130101292). A. C. is an International Max-Planck Research School Ph.D. student. B. K. is a National Health and Medical Research Council Research Fellow (1003325). P. F. S is supported by the European Commission FP7-PEOPLE-2011-Intra-European Fellowships (299621). The x-ray diffraction and small-angle scattering data collection was undertaken on the Micro Crystallography and Small-and Wide-Angle X-Ray Scattering beamlines at the Australian Synchrotron. We thank the Australian Synchrotron beamline scientists for help with x-ray data collection, and we acknowledge the use of the University of Queensland Remote Operation Crystallization and X-ray Diffraction Facility (UQ ROCX). We thank R. Counago for valuable help and suggestions, K. Newell and J. Rajamony for providing excellent technical assistance, Icon Genetics and S. Marillonnet for early access to vectors, and J. Ellis and S. Cesari for critical reading of the manuscript. The coordinate and structure factor data for RPS4TIR, RRS1TIR, and RRS1/RPS4TIR have been deposited to the Protein Data Bank (PDB) with PDB IDs 4c6r, 4c6s, and 4c6t, respectively.	Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Noutoshi Y, 2005, PLANT J, V43, P873, DOI 10.1111/j.1365-313X.2005.02500.x; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Ve T, 2013, P NATL ACAD SCI USA, V110, P17594, DOI 10.1073/pnas.1307614110; Ve T, 2012, CURR DRUG TARGETS, V13, P1360, DOI 10.2174/138945012803530260; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Wan L, 2013, ACTA CRYSTALLOGR F, V69, P1275, DOI 10.1107/S1744309113026614; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x	35	219	226	7	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					299	303		10.1126/science.1247357	http://dx.doi.org/10.1126/science.1247357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744375				2022-12-24	WOS:000334474500036
J	Muijres, FT; Elzinga, MJ; Melis, JM; Dickinson, MH				Muijres, Florian T.; Elzinga, Michael J.; Melis, Johan M.; Dickinson, Michael H.			Flies Evade Looming Targets by Executing Rapid Visually Directed Banked Turns	SCIENCE			English	Article							MEDIATED EQUILIBRIUM REFLEXES; FRUIT-FLY; FLIGHT PERFORMANCE; YAW DYNAMICS; DROSOPHILA; MOTION; MODEL; AVOIDANCE; MANEUVERS; SACCADES	Avoiding predators is an essential behavior in which animals must quickly transform sensory cues into evasive actions. Sensory reflexes are particularly fast in flying insects such as flies, but the means by which they evade aerial predators is not known. Using high-speed videography and automated tracking of flies in combination with aerodynamic measurements on flapping robots, we show that flying flies react to looming stimuli with directed banked turns. The maneuver consists of a rapid body rotation followed immediately by an active counter-rotation and is enacted by remarkably subtle changes in wing motion. These evasive maneuvers of flies are substantially faster than steering maneuvers measured previously and indicate the existence of sensory-motor circuitry that can reorient the fly's flight path within a few wingbeats.	[Muijres, Florian T.; Elzinga, Michael J.; Melis, Johan M.; Dickinson, Michael H.] Univ Washington, Seattle, WA 98195 USA; [Melis, Johan M.] Delft Univ Technol, Fac Aerosp Engn, NL-2600 GB Delft, Netherlands	University of Washington; University of Washington Seattle; Delft University of Technology	Dickinson, MH (corresponding author), Univ Washington, Box 351800,24 Kincaid Hall, Seattle, WA 98195 USA.	flyman@uw.edu	Muijres, Florian Titus/N-6483-2015	Muijres, Florian Titus/0000-0002-5668-0653	Air Force Office of Scientific Research [FA9550-10-1-0368]; Paul G. Allen Family Foundation; Army Research Laboratory [DAAD 19-03-D-0004]; Swedish Research Council; Royal Physiographical Society in Lund	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Paul G. Allen Family Foundation; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographical Society in Lund(Royal Society of London)	This work was supported by grants from the Air Force Office of Scientific Research (FA9550-10-1-0368) to M. H. D., the Paul G. Allen Family Foundation to M. H. D., Army Research Laboratory (DAAD 19-03-D-0004) to M. H. D., Swedish Research Council to F. T. M., and the Royal Physiographical Society in Lund to F. T. M. We thank S. Safarik, X. Zabala, and J. Liu for their technical support, and B. van Oudheusden for co-supervising J. M. M. The data reported in this paper are tabulated in the supplementary materials: The body and wing kinematics data for all reported flight sequences, as well as forces and torques from the robotic fly experiments, are stored in Database S1, and the Fourier series coefficients required to reconstruct the here analyzed wingbeat kinematics (using eq. S1) are available in table S1.	Bender JA, 2006, J EXP BIOL, V209, P4597, DOI 10.1242/jeb.02583; Bender JA, 2006, J EXP BIOL, V209, P3170, DOI 10.1242/jeb.02369; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Cheng B, 2011, IEEE T ROBOT, V27, P849, DOI 10.1109/TRO.2011.2156170; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Dickson WB, 2010, J EXP BIOL, V213, P3047, DOI 10.1242/jeb.042978; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Elzinga MJ, 2012, J R SOC INTERFACE, V9, P1685, DOI 10.1098/rsif.2011.0699; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Frye MA, 2001, NEURON, V32, P385, DOI 10.1016/S0896-6273(01)00490-1; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GOTZ KG, 1984, BIOL CYBERN, V51, P135, DOI 10.1007/BF00357927; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Lehmann FO, 2006, MOL B INT U, P230; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Reiser MB, 2013, J EXP BIOL, V216, P719, DOI 10.1242/jeb.074732; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Sherman A, 2003, J EXP BIOL, V206, P295, DOI 10.1242/jeb.00075; Tammero LF, 2002, J EXP BIOL, V205, P327; Tu MS, 1996, J COMP PHYSIOL A, V178, P813, DOI 10.1007/BF00225830; van Breugel F, 2012, J EXP BIOL, V215, P1783, DOI 10.1242/jeb.066498; VOGEL S, 1966, J EXP BIOL, V44, P567	33	139	145	7	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					172	177		10.1126/science.1248955	http://dx.doi.org/10.1126/science.1248955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723606				2022-12-24	WOS:000334096300028
J	Kusumbe, AP; Ramasamy, SK; Adams, RH				Kusumbe, Anjali P.; Ramasamy, Saravana K.; Adams, Ralf H.			Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; LINDAU TUMOR-SUPPRESSOR; ENDOTHELIAL-CELLS; FRACTURE REPAIR; VASCULAR CONTRIBUTION; ANGIOCRINE FACTORS; PLASMA-MEMBRANE; TRABECULAR BONE; MARROW; HYPOXIA	The mammalian skeletal system harbours a hierarchical system of mesenchymal stem cells, osteoprogenitors and osteoblasts sustaining lifelong bone formation. Osteogenesis is indispensable for the homeostatic renewal of bone as well as regenerative fracture healing, but these processes frequently decline in ageing organisms, leading to loss of bone mass and increased fracture incidence. Evidence indicates that the growth of blood vessels in bone and osteogenesis are coupled, but relatively little is known about the underlying cellular and molecular mechanisms. Here we identify a new capillary subtype in the murine skeletal system with distinct morphological, molecular and functional properties. These vessels are found in specific locations, mediate growth of the bone vasculature, generate distinct metabolic and molecular microenvironments, maintain perivascular osteoprogenitors and couple angiogenesis to osteogenesis. The abundance of these vessels and associated osteoprogenitors was strongly reduced in bone from aged animals, and pharmacological reversal of this decline allowed the restoration of bone mass.	[Kusumbe, Anjali P.; Ramasamy, Saravana K.; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; University of Munster	Adams, RH (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	ralf.adams@mpi-muenster.mpg.de	Adams, Ralf H/AAE-9274-2019	Ramasamy, Saravana/0000-0003-2658-2945	Max Planck Society; University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council [AdG 339409 AngioBone]	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Munster; DFG cluster of excellence 'Cells in Motion'; European Research Council(European Research Council (ERC)European Commission)	We thank A. Medvinsky for kindly providing Flk1-GFP mice, M. Stehling for endothelial cell sorting and A. Borgscheiper for technical assistance. Funding was provided by the Max Planck Society, the University of Munster, the DFG cluster of excellence 'Cells in Motion' and the European Research Council (AdG 339409 AngioBone).	Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Boado RJ, 2002, J NEUROCHEM, V80, P552, DOI 10.1046/j.0022-3042.2001.00756.x; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; CROCK HV, 1965, J ANAT, V99, P77; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ellis SL, 2011, BLOOD, V118, P1516, DOI 10.1182/blood-2010-08-303800; Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Heaney RP, 1998, ENDOCRIN METAB CLIN, V27, P255, DOI 10.1016/S0889-8529(05)70004-9; Helisch A, 2003, MICROCIRCULATION, V10, P83, DOI 10.1038/sj.mn.7800173; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Jones DT, 2006, MOL CANCER THER, V5, P2193, DOI 10.1158/1535-7163.MCT-05-0443; KATAOKA M, 1985, BLOOD, V65, P1163; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; LIPS P, 1978, CALC TISS RES, V26, P13, DOI 10.1007/BF02013227; Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Ribatti D, 2002, J HEMATOTH STEM CELL, V11, P81, DOI 10.1089/152581602753448559; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Sale S, 2013, NAT CELL BIOL, V15, P451, DOI 10.1038/ncb2725; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; SKAWINA A, 1994, J ANAT, V185, P369; SMITH DM, 1975, J CLIN INVEST, V56, P311, DOI 10.1172/JCI108095; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tashiro Y, 2012, BLOOD, V119, P6382, DOI 10.1182/blood-2011-12-399659; TRUETA J, 1953, J BONE JOINT SURG BR, V35, P442, DOI 10.1302/0301-620X.35B3.442; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P97, DOI 10.1302/0301-620X.42B1.97; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	50	971	1033	35	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					323	+		10.1038/nature13145	http://dx.doi.org/10.1038/nature13145			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24646994	Green Accepted			2022-12-24	WOS:000333029000026
J	Han, YC; Donovan, J; Rath, S; Whitney, G; Chitrakar, A; Korennykh, A				Han, Yuchen; Donovan, Jesse; Rath, Sneha; Whitney, Gena; Chitrakar, Alisha; Korennykh, Alexei			Structure of Human RNase L Reveals the Basis for Regulated RNA Decay in the IFN Response	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; DOUBLE-STRANDED-RNA; RIBONUCLEASE-L; CLEAVAGE; KINASE; IRE1; ACTIVATION; ENZYME; VIRUS; MICE	One of the hallmark mechanisms activated by type I interferons (IFNs) in human tissues involves cleavage of intracellular RNA by the kinase homology endoribonuclease RNase L. We report 2.8 and 2.1 angstrom crystal structures of human RNase L in complexes with synthetic and natural ligands and a fragment of an RNA substrate. RNase L forms a crossed homodimer stabilized by ankyrin (ANK) and kinase homology (KH) domains, which positions two kinase extension nuclease (KEN) domains for asymmetric RNA recognition. One KEN protomer recognizes an identity nucleotide (U), whereas the other protomer cleaves RNA between nucleotides +1 and +2. The coordinated action of the ANK, KH, and KEN domains thereby provides regulated, sequence-specific cleavage of viral and host RNA targets by RNase L.	[Han, Yuchen; Donovan, Jesse; Rath, Sneha; Whitney, Gena; Chitrakar, Alisha; Korennykh, Alexei] Princeton Univ, Dept Mol Biol, Schultz Lab 216, Princeton, NJ 08540 USA	Princeton University	Korennykh, A (corresponding author), Princeton Univ, Dept Mol Biol, Schultz Lab 216, Princeton, NJ 08540 USA.	akorenny@princeton.edu	Rath, Sneha/AAC-4493-2019; Han, Yu/GZA-9220-2022	Rath, Sneha/0000-0001-8839-1285	Princeton University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, T32GM007388, R01GM110161] Funding Source: NIH RePORTER	Princeton University(Princeton University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Hughson (Princeton University) and A. Korostelev (University of Massachusetts, Worcester) for reading the manuscript and making valuable suggestions. We thank the staff of Brookhaven National Laboratory for providing access to a synchrotron x-ray source. We are grateful to our colleagues at the Department of Molecular Biology for stimulating discussions and an excellent research environment. We thank Princeton University for supporting and funding our work. Coordinates have been deposited to the Protein Data Bank with accession codes 4OAU and 4OAU. Author contributions: Y.H., J.D., and A.K. determined the structures of RNase L. S.R. carried out biochemical studies of model RNA substrates. G.W. and A.C. carried out studies in HeLa cells Y.H. and A.K. wrote the manuscript A.K. supervised the work.	Carroll SS, 1996, J BIOL CHEM, V271, P4988; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Han YC, 2012, CELL REP, V2, P902, DOI 10.1016/j.celrep.2012.09.004; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Iordanov MS, 2000, MOL CELL BIOL, V20, P617, DOI 10.1128/MCB.20.2.617-627.2000; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-47; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Tanaka N, 2004, EMBO J, V23, P3929, DOI 10.1038/sj.emboj.7600420; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0	20	102	104	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1244	1248		10.1126/science.1249845	http://dx.doi.org/10.1126/science.1249845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24578532	Green Accepted			2022-12-24	WOS:000332728500035
J	Harper, L				Harper, Luke			We should start to quantify the environmental impact of different treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp St Denis La Reunion, Dept Pediat Surg, St Denis, Reunion, France	CHU Reunion	Harper, L (corresponding author), Univ Hosp St Denis La Reunion, Dept Pediat Surg, St Denis, Reunion, France.	harper_luke@hotmail.com						[Anonymous], 2013, LANCET, V382, P1154, DOI 10.1016/S0140-6736(13)62046-2; [Anonymous], 2013, LANCET, V381, P700, DOI 10.1016/S0140-6736(13)60564-4; Holmes D, 2013, LANCET DIABETES ENDO, V1, P93, DOI 10.1016/S2213-8587(13)70057-3; Huijbregts MAJ, 2008, ECOL ECON, V64, P798, DOI 10.1016/j.ecolecon.2007.04.017; Van der Vorst G, 2011, ENVIRON SCI TECHNOL, V45, P3040, DOI 10.1021/es1015907	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2014	348								g1997	10.1136/bmj.g1997	http://dx.doi.org/10.1136/bmj.g1997			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6IP	24603961				2022-12-24	WOS:000332625700008
J	Riol-Blanco, L; Ordovas-Montanes, J; Perro, M; Naval, E; Thiriot, A; Alvarez, D; Paust, S; Wood, JN; von Andrian, UH				Riol-Blanco, Lorena; Ordovas-Montanes, Jose; Perro, Mario; Naval, Elena; Thiriot, Aude; Alvarez, David; Paust, Silke; Wood, John N.; von Andrian, Ulrich H.			Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation	NATURE			English	Article							DELTA T-CELLS; PERIPHERAL LYMPHOID ORGANS; DENDRITIC CELLS; PLAQUE-FORMATION; NERVOUS-SYSTEM; RECEPTOR; MICE; IDENTIFICATION; MONOCYTES; CYTOKINE	The skin has a dual function as a barrier and a sensory interface between the body and the environment. To protect against invading pathogens, the skin harbours specialized immune cells, including dermal dendritic cells (DDCs) and interleukin (IL)-17-producing gamma delta T (gamma delta T17) cells, the aberrant activation of which by IL-23 can provoke psoriasis-like inflammation(1-4). The skin is also innervated by a meshwork of peripheral nerves consisting of relatively sparse autonomic and abundant sensory fibres. Interactions between the autonomic nervous system and immune cells in lymphoid organs are known to contribute to systemic immunity, but how peripheral nerves regulate cutaneous immune responses remains unclear(5,6). We exposed the skin of mice to imiquimod, which induces IL-23-dependent psoriasis-like inflammation(7,8). Hereweshowthat a subset of sensory neurons expressing the ion channels TRPV1 and Na(v)1.8 is essential to drive this inflammatory response. Imaging of intact skin revealed that a large fraction of DDCs, the principal source of IL-23, is in close contact with these nociceptors. Upon selective pharmacological or genetic ablation of nociceptors(9-11), DDCs failed to produce IL-23 in imiquimod-exposed skin. Consequently, the local production of IL-23-dependent inflammatory cytokines by dermal gamma delta T17 cells and the subsequent recruitment of inflammatory cells to the skin were markedly reduced. Intradermal injection of IL-23 bypassed the requirement for nociceptor communicationwithDDCs and restored the inflammatory response(12). These findings indicate that TRPV1(+)Na(v)1.8(+) nociceptors, by interacting with DDCs, regulate the IL-23/IL-17 pathway andcontrol cutaneousimmune responses.	[Riol-Blanco, Lorena; Ordovas-Montanes, Jose; Perro, Mario; Naval, Elena; Thiriot, Aude; Alvarez, David; Paust, Silke; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Wood, John N.] UCL, Inst Biomed Res, London WC1E 6BT, England	Harvard University; Harvard Medical School; University of London; University College London	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA.	uva@hms.harvard.edu	Perro, Mario/AAB-5554-2021	Perro, Mario/0000-0003-1375-8155; Ordovas-Montanes, Jose/0000-0001-5444-5601; Paust, Silke/0000-0002-0526-3999	National Institutes of Health (NIH) [AI069259, AI078897, AI095261, AI111595]; NIH [5F31AR063546-02]; Human Frontiers Science Program; Charles A. King Trust; National Psoriasis Foundation; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078897, P01AI112521, R01AI111595, U19AI095261, R01AI069259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR063546] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Charles A. King Trust; National Psoriasis Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Cheng, M. Flynn and S. Omid for technical support; M. Perdue, L. Jones and E. Nigro for secretarial assistance; E. Gray for providing detailed protocols for flow cytometry of skin samples; J. Harris for discussion and providing detailed RNA isolation protocols of skin samples; R. T. Roderick for histopathology analysis; T. Liu and J. Ru-Rong for providing the RTX denervation protocol; M. Ghebremichael for statistical advice; F. Winau and J. L. Rodriguez-Fernandez for critical reading of the manuscript and members of the von Andrian laboratory for discussion and advice. This work was supported by National Institutes of Health (NIH) grants AI069259, AI078897, AI095261 and AI111595 (to U.H.v.A.), NIH 5F31AR063546-02 (to J.O.-M.) and the Human Frontiers Science Program, Charles A. King Trust and National Psoriasis Foundation (to L.R.-B.).	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chiu I.M., 2013, NATURE; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; FARBER EM, 1990, INT J DERMATOL, V29, P418, DOI 10.1111/j.1365-4362.1990.tb03825.x; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; Guilliams M, 2010, EUR J IMMUNOL, V40, P2089, DOI 10.1002/eji.201040498; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MULLER G, 1995, J IMMUNOL, V155, P4661; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sandor K, 2009, NEUROSCI LETT, V451, P204, DOI 10.1016/j.neulet.2009.01.016; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	36	305	314	6	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					157	+		10.1038/nature13199	http://dx.doi.org/10.1038/nature13199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24759321	Green Accepted, Green Submitted			2022-12-24	WOS:000336768900048
J	Petrillo, E; Herz, MAG; Fuchs, A; Reifer, D; Fuller, J; Yanovsky, MJ; Simpson, C; Brown, JWS; Barta, A; Kalyna, M; Kornblihtt, AR				Petrillo, Ezequiel; Godoy Herz, Micaela A.; Fuchs, Armin; Reifer, Dominik; Fuller, John; Yanovsky, Marcelo J.; Simpson, Craig; Brown, John W. S.; Barta, Andrea; Kalyna, Maria; Kornblihtt, Alberto R.			A Chloroplast Retrograde Signal Regulates Nuclear Alternative Splicing	SCIENCE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; LIGHT; PROTEINS; TRANSCRIPTS; PLANTS	Light is a source of energy and also a regulator of plant physiological adaptations. We show here that light/dark conditions affect alternative splicing of a subset of Arabidopsis genes preferentially encoding proteins involved in RNA processing. The effect requires functional chloroplasts and is also observed in roots when the communication with the photosynthetic tissues is not interrupted, suggesting that a signaling molecule travels through the plant. Using photosynthetic electron transfer inhibitors with different mechanisms of action, we deduce that the reduced pool of plastoquinones initiates a chloroplast retrograde signaling that regulates nuclear alternative splicing and is necessary for proper plant responses to varying light conditions.	[Petrillo, Ezequiel; Godoy Herz, Micaela A.; Kornblihtt, Alberto R.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Fisiol & Biol Mol,IFIBYNE,CONICET, Buenos Aires, DF, Argentina; [Fuchs, Armin; Reifer, Dominik; Barta, Andrea; Kalyna, Maria] Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Fuller, John; Simpson, Craig; Brown, John W. S.] James Hutton Inst, Dundee, Scotland; [Yanovsky, Marcelo J.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, IIBBA, RA-1033 Buenos Aires, DF, Argentina; [Brown, John W. S.] Univ Dundee, Div Plant Sci, James Hutton Inst, Dundee, Scotland	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); James Hutton Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; James Hutton Institute; University of Dundee	Kornblihtt, AR (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Fisiol & Biol Mol,IFIBYNE,CONICET, Ciudad Univ,Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	ark@fbmc.fcen.uba.ar	Kalyna, Maria/N-7051-2017	Kalyna, Maria/0000-0003-4702-7625; Petrillo, Ezequiel/0000-0002-0025-3708; Kornblihtt, Alberto/0000-0003-4322-0831; Barta, Andrea/0000-0002-8851-406X; Simpson, Craig/0000-0002-1723-1492	Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina; University of Buenos Aires; King Abdulaziz University; European Network on Alternative Splicing; Austrian Science Fund FWF [P26333, DK W1207, SFBF43-P10, ERA-NET I254]; U.K. Biotechnology and Biological Sciences Research Council; Scottish Government Rural and Environment Science and Analytical Services division; Austrian Science Fund (FWF) [I 254] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/G024979/1] Funding Source: researchfish; BBSRC [BB/G024979/1] Funding Source: UKRI	Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina(ANPCyT); University of Buenos Aires(University of Buenos Aires); King Abdulaziz University; European Network on Alternative Splicing; Austrian Science Fund FWF(Austrian Science Fund (FWF)); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Science and Analytical Services division; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Casal, J. Estevez, N. Iusem, J. Palermo, G. Cabrera, G. Siless, N. Carrillo, F. Rolland, J. Chory, J.-S. Jeon, R. Hausler, J. Sheen, A. Kohler, A. Trebst, and S. Smeekens for materials and advice. This work was supported by the Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina, the University of Buenos Aires, the King Abdulaziz University, the European Network on Alternative Splicing, the Austrian Science Fund FWF (P26333 to M. K.; DK W1207, SFBF43-P10, ERA-NET I254 to A. B.), the U.K. Biotechnology and Biological Sciences Research Council, and the Scottish Government Rural and Environment Science and Analytical Services division. M. G. H. is a fellow and A. R. K. is a career investigator from the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina. E. P. is an EMBO postdoctoral fellow. A. R. K. is a senior international research scholar of the Howard Hughes Medical Institute (for detailed acknowledgments, see the supplementary text).	Casal JJ, 2005, INT J DEV BIOL, V49, P501, DOI 10.1387/ijdb.051973jc; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Domon C, 1998, J BIOL CHEM, V273, P34603, DOI 10.1074/jbc.273.51.34603; ELICH TD, 1993, EMBO J, V12, P4857, DOI 10.1002/j.1460-2075.1993.tb06175.x; Finazzi G, 2001, J BIOL CHEM, V276, P9770, DOI 10.1074/jbc.M010092200; Gyula N, 2003, CURR OPIN PLANT BIOL, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; Hanson J, 2009, CURR OPIN PLANT BIOL, V12, P562, DOI 10.1016/j.pbi.2009.07.014; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Khandelwal A, 2008, PLANT PHYSIOL, V148, P2050, DOI 10.1104/pp.108.128488; Kim SH, 2009, PLANT CELL, V21, P2045, DOI 10.1105/tpc.109.067736; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Lopato S, 1996, PLANT CELL, V8, P2255, DOI 10.1105/tpc.8.12.2255; Ruckle ME, 2012, PLANT PHYSIOL, V159, P366, DOI 10.1104/pp.112.193599; Schansker G, 2005, BBA-BIOENERGETICS, V1706, P250, DOI 10.1016/j.bbabio.2004.11.006; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001	17	130	138	5	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					427	430		10.1126/science.1250322	http://dx.doi.org/10.1126/science.1250322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763593	Green Accepted			2022-12-24	WOS:000334867800045
J	Stroka, KM; Jiang, HY; Chen, SH; Tong, ZQ; Wirtz, D; Sun, SX; Konstantopoulos, K				Stroka, Kimberly M.; Jiang, Hongyuan; Chen, Shih-Hsun; Tong, Ziqiu; Wirtz, Denis; Sun, Sean X.; Konstantopoulos, Konstantinos			Water Permeation Drives Tumor Cell Migration in Confined Microenvironments	CELL			English	Article							ACTIN-POLYMERIZATION; NA+/H+ ANTIPORTER; INTRACELLULAR PH; MOTILITY DRIVEN; ION CHANNELS; CANCER; VOLUME; LOCALIZATION; INVASION; TRANSPORTERS	Cell migration is a critical process for diverse (patho) physiological phenomena. Intriguingly, cell migration through physically confined spaces can persist even when typical hallmarks of 2D planar migration, such as actin polymerization and myosin II-mediated contractility, are inhibited. Here, we present an integrated experimental and theoretical approach ("Osmotic Engine Model") and demonstrate that directed water permeation is a major mechanism of cell migration in confined microenvironments. Using microfluidic and imaging techniques along with mathematical modeling, we show that tumor cells confined in a narrow channel establish a polarized distribution of Na+/H+ pumps and aquaporins in the cell membrane, which creates a net inflow of water and ions at the cell leading edge and a net outflow of water and ions at the trailing edge, leading to net cell displacement. Collectively, this study presents an alternate mechanism of cell migration in confinement that depends on cell-volume regulation via water permeation.	[Stroka, Kimberly M.; Tong, Ziqiu; Wirtz, Denis; Sun, Sean X.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Stroka, Kimberly M.; Tong, Ziqiu; Wirtz, Denis; Sun, Sean X.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Stroka, Kimberly M.; Chen, Shih-Hsun; Tong, Ziqiu; Wirtz, Denis; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Jiang, Hongyuan; Sun, Sean X.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Sun, Sean X.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Jiang, Hongyuan] Univ Sci & Technol China, CAS Key Lab Mech Behav & Design Mat, Hefei 230026, Anhui, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, SX (corresponding author), Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD 21218 USA.	ssun@jhu.edu; konstant@jhu.edu	Tong, Ziqiu/AAR-6182-2020	Tong, Ziqiu/0000-0003-4183-1858	National Science Foundation [NSF-1159823]; National Cancer Institute [U54-CA143868, RO1GM075305, RO1CA174388, T32-CA130840, F32-CA177756]; Kleberg Foundation; National Natural Science Foundation of China [NSFC 11342010]; NATIONAL CANCER INSTITUTE [F32CA177756, T32CA130840, U54CA143868, R01CA174388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1159823] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Jean Paul Thiery for providing S180 cells, Antonio LLombart-Bosch for CH2879 cells, Ramana Sidhaye for AQP5 siRNA adenovirus, and Helim Aranda-Espinoza for use of the Micro-Osmometer. This work was supported by awards from the National Science Foundation (NSF-1159823 to K.K.), the National Cancer Institute (U54-CA143868 to D.W., K.K., and S.X.S.; RO1GM075305 to S.X.S.; RO1CA174388 to D. W.; T32-CA130840 to K.M.S.; and F32-CA177756 to K.M.S.), the Kleberg Foundation (to K. K. and S.X.S.), and the National Natural Science Foundation of China (NSFC 11342010 to H.J.).	Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Atzberger PJ, 2009, PHYSICA D, V238, P1168, DOI 10.1016/j.physd.2009.03.018; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; GOSS GG, 1994, J BIOL CHEM, V269, P8741; GRINSTEIN S, 1993, EMBO J, V12, P5209, DOI 10.1002/j.1460-2075.1993.tb06216.x; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Iwasaki T, 2008, BIOPHYS J, V94, pL35, DOI 10.1529/biophysj.107.124479; Jaeger M, 1999, BIOPHYS J, V77, P1257, DOI 10.1016/S0006-3495(99)76977-8; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Konstantopoulos K, 2013, BIOPHYS J, V104, P279, DOI 10.1016/j.bpj.2012.12.016; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; OSTER GF, 1987, J CELL SCI, P35; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prentice-Mott HV, 2013, P NATL ACAD SCI USA, V110, P21006, DOI 10.1073/pnas.1317441110; Ritter M, 1998, BRIT J PHARMACOL, V124, P627, DOI 10.1038/sj.bjp.0701864; Schwab A, 2001, NEWS PHYSIOL SCI, V16, P29, DOI 10.1152/physiologyonline.2001.16.1.29; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Sidhaye VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038717; Spagnolie SE, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3469786; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Stroka KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061377; Taber LA, 2011, J MECH MATER STRUCT, V6, P569, DOI 10.2140/jomms.2011.6.569; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077	45	302	308	6	167	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					611	623		10.1016/j.cell.2014.02.052	http://dx.doi.org/10.1016/j.cell.2014.02.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24726433	Green Accepted, Bronze			2022-12-24	WOS:000335392100011
J	Wen, H; Li, YY; Xi, YX; Jiang, SM; Stratton, S; Peng, DN; Tanaka, K; Ren, YF; Xia, Z; Wu, J; Li, B; Barton, MC; Li, W; Li, HT; Shi, XB				Wen, Hong; Li, Yuanyuan; Xi, Yuanxin; Jiang, Shiming; Stratton, Sabrina; Peng, Danni; Tanaka, Kaori; Ren, Yongfeng; Xia, Zheng; Wu, Jun; Li, Bing; Barton, Michelle C.; Li, Wei; Li, Haitao; Shi, Xiaobing			ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression	NATURE			English	Article							ADENOVIRUS E1A-ASSOCIATED PROTEIN; HIGH-AFFINITY BINDING; PWWP DOMAIN; LYSINE 36; PLANT HOMEODOMAIN; H3; RECOGNITION; BS69; METHYLATION; MUTATIONS	Recognition of modified histones by 'reader' proteins plays a critical role in the regulation of chromatin(1). H3K36 trimethylation (H3K36me3) is deposited onto the nucleosomes in the transcribed regions after RNA polymerase II elongation. In yeast, this mark in turn recruits epigenetic regulators to reset the chromatin to a relatively repressive state, thus suppressing cryptic transcription(2). However, much less is known about the role of H3K36me3 in transcription regulation in mammals. This is further complicated by the transcription-coupled incorporation of the histone variant H3.3 in gene bodies(3). Here we show that the candidate tumour suppressor ZMYND11 specifically recognizes H3K36me3 on H3.3 (H3.3K36me3) and regulates RNA polymerase II elongation. Structural studies show that in addition to the trimethyl-lysine binding by an aromatic cage within the PWWP domain, the H3.3-dependent recognition is mediated by the encapsulation of the H3.3-specific 'Ser 31' residue in a composite pocket formed by the tandem bromo-PWWP domains of ZMYND11. Chromatin immunoprecipitation followed by sequencing shows a genome-wide co-localization of ZMYND11 with H3K36me3 and H3.3 in gene bodies, and its occupancy requires the pre-deposition of H3.3K36me3. Although ZMYND11 is associated with highly expressed genes, it functions as an unconventional transcription corepressor by modulating RNA polymerase II at the elongation stage. ZMYND11 is critical for the repression of a transcriptional program that is essential for tumour cell growth; low expression levels of ZMYND11 in breast cancer patients correlate with worse prognosis. Consistently, overexpression of ZMYND11 suppresses cancer cell growth in vitro and tumour formation in mice. Together, this study identifies ZMYND11 as an H3.3-specific reader of H3K36me3 that links the histone-variant-mediated transcription elongation control to tumour suppression.	[Wen, Hong; Jiang, Shiming; Stratton, Sabrina; Peng, Danni; Tanaka, Kaori; Barton, Michelle C.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wen, Hong; Barton, Michelle C.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Ctr Genet & Genom, Houston, TX 77030 USA; [Wen, Hong; Barton, Michelle C.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Li, Yuanyuan; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Xi, Yuanxin; Xia, Zheng; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Wu, Jun; Li, Bing] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Barton, Michelle C.; Shi, Xiaobing] Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev Grad Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; Tsinghua University; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston	Shi, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	hwen@mdanderson.org; WL1@bcm.edu; lht@tsinghua.edu.cn; xbshi@mdanderson.org	Xia, Zheng/AAC-5360-2022; Xia, Zheng/F-6561-2014; Li, Haitao/B-2668-2012	Xia, Zheng/0000-0003-3364-8324; Xia, Zheng/0000-0003-3364-8324; Li, Haitao/0000-0001-6741-293X; Wen, Hong/0000-0001-8739-4572; Li, Wei/0000-0001-9931-5990; Barton, Michelle/0000-0002-4042-1374; Shi, Xiaobing/0000-0001-5242-8189	American Cancer Society [RSG-13-290-01-TBE]; National institutes of Health (NIH)/MDACC [CCSG CA016672]; Major State Basic Research Development Program in China [2011CB965300]; Program for New Century Excellent Talents in University; China Postdoctoral Science Foundation [2012M510413]; Kimmel Scholar Award;  [CPRITRP110471];  [Welch G1719];  [NIH R01HG007538];  [NIH R01GM090077];  [Welch I1713]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090077] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National institutes of Health (NIH)/MDACC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Major State Basic Research Development Program in China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Kimmel Scholar Award; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lipsick, Y. Shi, P. Chi, C. D. Allis, D. J. Patel, S. R. Dent, J. Tyler, M. Galko, T. Westbrook, M. Lee, T. Yao and E. Guccione for comments and reagents. We thank the staff at beamlines 1W2B of the Beijing Synchrotron Radiation Facility and BL17U of the Shanghai Synchrotron Radiation Facility for their assistance in data collection. We thank J. Munch for editing the manuscript. This work was supported by grants to X. S. (CPRITRP110471, Welch G1719, American Cancer Society RSG-13-290-01-TBE, and National institutes of Health (NIH)/MDACC CCSG CA016672), H. L. (The Major State Basic Research Development Program in China, 2011CB965300 and Program for New Century Excellent Talents in University), W. L. (CPRITRP110471, NIH R01HG007538), B. L. (NIH R01GM090077, Welch I1713), Y. L. (China Postdoctoral Science Foundation, 2012M510413) and H. W. (MD Anderson IRG, Center for Cancer Epigenetics pilot grant). W. L. is a recipient of a Duncan Scholar Award and X. S. is a recipient of a Kimmel Scholar Award.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Ansieau S, 2003, PATHOL BIOL, V51, P397, DOI 10.1016/S0369-8114(03)00019-1; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fish PV, 2012, J MED CHEM, V55, P9831, DOI 10.1021/jm3010515; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HATEBOER G, 1995, EMBO J, V14, P3159, DOI 10.1002/j.1460-2075.1995.tb07318.x; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Ladendorff NE, 2001, ONCOGENE, V20, P125, DOI 10.1038/sj.onc.1204048; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wei G, 2003, ANTICANCER RES, V23, P2173; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	202	212	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					263	+		10.1038/nature13045	http://dx.doi.org/10.1038/nature13045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24590075	Green Accepted			2022-12-24	WOS:000333979900048
J	Birsoy, K; Possemato, R; Lorbeer, FK; Bayraktar, EC; Thiru, P; Yucel, B; Wang, T; Chen, WW; Clish, CB; Sabatini, DM				Birsoy, Kivanc; Possemato, Richard; Lorbeer, Franziska K.; Bayraktar, Erol C.; Thiru, Prathapan; Yucel, Burcu; Wang, Tim; Chen, Walter W.; Clish, Clary B.; Sabatini, David M.			Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides	NATURE			English	Article							OXIDATIVE-PHOSPHORYLATION; COMPLEX I; RESPIRATORY-CHAIN; PANCREATIC-CANCER; DIABETIC-PATIENTS; BREAST-CANCER; METFORMIN; MUTATIONS; DEFICIENCY; TUMORS	As the concentrations of highly consumed nutrients, particularly glucose, are generally lower in tumours than in normal tissues(1,2), cancer cells must adapt their metabolism to the tumour microenvironment. Abetter understanding of these adaptations might reveal cancer cell liabilities that can be exploited for therapeutic benefit. Here we developed a continuous-flow culture apparatus (Nutrostat) for maintaining proliferating cells in low-nutrient media for long periods of time, and used it to undertake competitive proliferation assays on a pooled collection of barcoded cancer cell lines cultured in low-glucose conditions. Sensitivity to low glucose varies amongst cell lines, and an RNA interference (RNAi) screen pinpointed mitochondrial oxidative phosphorylation (OXPHOS) as the major pathway required for optimal proliferation in low glucose. We found that cell lines most sensitive to low glucose are defective in the OXPHOS upregulation that is normally caused by glucose limitation as a result of either mitochondrial DNA (mtDNA) mutations in complex I genes or impaired glucose utilization. These defects predict sensitivity to biguanides, antidiabetic drugs that inhibit OXPHOS3,4, when cancer cells are grown in low glucose or as tumour xenografts. Notably, the biguanide sensitivity of cancer cells with mtDNA mutations was reversed by ectopic expression of yeast NDI1, a ubiquinone oxidoreductase that allows bypass of complex I function(5). Thus, we conclude that mtDNA mutations and impaired glucose utilization are potential biomarkers for identifying tumours with increased sensitivity to OXPHOS inhibitors.	[Birsoy, Kivanc; Possemato, Richard; Lorbeer, Franziska K.; Bayraktar, Erol C.; Thiru, Prathapan; Yucel, Burcu; Wang, Tim; Chen, Walter W.; Clish, Clary B.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Clish, Clary B.; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Possemato, Richard; Wang, Tim; Chen, Walter W.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021; BAYRAKTAR, EROL CAN/AAD-4986-2019	Clish, Clary B/0000-0001-8259-9245; Wang, Timothy/0000-0001-5730-3019; Chen, Walter/0000-0002-7752-9581; Lorbeer, Franziska/0000-0002-3152-6852; /0000-0002-1446-7256; Possemato, Richard/0000-0002-2401-0030; BAYRAKTAR, EROL/0000-0002-2950-0215	Leukemia and Lymphoma Society; Jane Coffin Childs Fund; Council of Higher Education Turkey; Karadeniz T. University Scholarships; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH [K99 CA168940, CA103866, CA129105, AI07389]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105, K99CA168940, R00CA168940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Jane Coffin Childs Fund; Council of Higher Education Turkey(Ministry of National Education - Turkey); Karadeniz T. University Scholarships; David H. Koch Institute for Integrative Cancer Research at MIT; Alexander and Margaret Stewart Trust Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Stephanopoulos for assistance with Nutrostat design, M. Holland for mtDNA sequencing consultation, L. Garraway for assistance identifying mtDNA mutant cell lines, T. Yagi for the NDI1 antibody, T. DiCesare for diagrams, and members of the Sabatini Laboratory for assistance (particularly A. Saucedo, C. Koch, O. Yilmaz, Y. Gultekin and A. Hutchins for technical assistance, and D. Lamming and W. Comb for critical reading of the manuscript). This research is supported by fellowships from The Leukemia and Lymphoma Society and The Jane Coffin Childs Fund to K. B., the Council of Higher Education Turkey and Karadeniz T. University Scholarships to B. Y. and grants from the David H. Koch Institute for Integrative Cancer Research at MIT, The Alexander and Margaret Stewart Trust Fund, the NIH (K99 CA168940 to R. P. and CA103866, CA129105, and AI07389 to D. M. S.) and the Starr Cancer Consortium. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Birsoy K, 2012, NAT MED, V18, P1022, DOI 10.1038/nm.2870; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; GULLINO PM, 1967, CANCER RES, V27, P1031; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Javeshghani S, 2012, CANCER RES, V72, P6257, DOI 10.1158/0008-5472.CAN-12-2907; Jones JB, 2001, CANCER RES, V61, P1299; Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pollak M, 2012, CLIN CANCER RES, V18, P2723, DOI 10.1158/1078-0432.CCR-12-0694; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Urasaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036775	27	474	490	5	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					108	+		10.1038/nature13110	http://dx.doi.org/10.1038/nature13110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670634	Green Submitted, Green Accepted			2022-12-24	WOS:000333609900052
J	Silvente-Poirot, S; Poirot, M				Silvente-Poirot, Sandrine; Poirot, Marc			Cholesterol and Cancer, in the Balance	SCIENCE			English	Editorial Material							BREAST-CANCER; METABOLISM; TAMOXIFEN; PATHWAY; GROWTH; CELLS		[Silvente-Poirot, Sandrine] Univ Toulouse 3, INSERM, UMR 1037, Canc Res Ctr Toulouse, F-31052 Toulouse, France; Inst Claudius Regaud, F-31052 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Institut Claudius Regaud	Silvente-Poirot, S (corresponding author), Univ Toulouse 3, INSERM, UMR 1037, Canc Res Ctr Toulouse, F-31052 Toulouse, France.	sandrine.poirot@inserm.fr; marc.poirot@inserm.fr	Poirot, Sandrine/D-5448-2017; Poirot, Marc/C-7613-2009; Poirot, Marc/K-3551-2012	Poirot, Marc/0000-0002-5711-6624; Poirot, Marc/0000-0002-5711-6624; Silvente-Poirot, Sandrine/0000-0003-2245-9069				Alikhani N, 2013, ONCOGENE, V32, P961, DOI 10.1038/onc.2012.113; de Medina P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2835; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gabitova L, 2014, CLIN CANCER RES, V20, P28, DOI 10.1158/1078-0432.CCR-13-0122; Lasuncion MA, 2012, CURR OPIN PHARMACOL, V12, P717, DOI 10.1016/j.coph.2012.07.001; Liu J, 2013, ONCOTARGET, V4, P1804, DOI 10.18632/oncotarget.1364; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; McDougall JA, 2013, CANCER EPIDEM BIOMAR, V22, P1529, DOI 10.1158/1055-9965.EPI-13-0414; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Pitroda SP, 2009, P NATL ACAD SCI USA, V106, P5837, DOI 10.1073/pnas.0812029106; Poirot M, 2012, CURR OPIN PHARMACOL, V12, P683, DOI 10.1016/j.coph.2012.09.007; Segala G, 2013, BIOCHEM PHARMACOL, V86, P175, DOI 10.1016/j.bcp.2013.02.031; Silvente-Poirot S, 2012, CURR OPIN PHARMACOL, V12, P673, DOI 10.1016/j.coph.2012.10.004; Sukhanova A, 2013, CANCER DISCOV, V3, P96, DOI 10.1158/2159-8290.CD-12-0031; Wu Q, 2013, CELL REP, V5, P637, DOI 10.1016/j.celrep.2013.10.006	15	142	143	5	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1445	1446		10.1126/science.1252787	http://dx.doi.org/10.1126/science.1252787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD7TZ	24675946				2022-12-24	WOS:000333471000026
J	Lieberman, PM				Lieberman, Paul M.			Epstein-Barr Virus Turns 50	SCIENCE			English	Editorial Material									Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Lieberman, PM (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	lieberman@wistar.org			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017336] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE017336] Funding Source: Medline; Wellcome Trust [096496] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bollard CM, 2012, NAT REV CLIN ONCOL, V9, P510, DOI 10.1038/nrclinonc.2012.111; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; Dreyfus DH, 2011, AUTOIMMUN REV, V11, P88, DOI 10.1016/j.autrev.2011.08.005; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PATTENGALE PK, 1973, LANCET, V2, P93; Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001; Schiller JT, 2004, NAT REV MICROBIOL, V2, P343, DOI 10.1038/nrmicro867; Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Tsai MH, 2013, CELL REP, V5, P458, DOI 10.1016/j.celrep.2013.09.012; Varmus H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005899; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	15	61	64	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1323	1325		10.1126/science.1252786	http://dx.doi.org/10.1126/science.1252786			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AD3AI	24653027	Green Accepted			2022-12-24	WOS:000333108500025
J	Bhattacharya, S				Bhattacharya, Shaoni			Disease detectives	NATURE			English	News Item							SEQUENCES; OUTBREAK; HIV-1											de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; 2004, NATURE, V430, P277; 2008, NATURE, V454, P672	6	6	6	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					424	426		10.1038/506424a	http://dx.doi.org/10.1038/506424a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572408	Bronze			2022-12-24	WOS:000332165100014
J	Rodriguez-Bravo, V; Maciejowski, J; Corona, J; Buch, HK; Collin, P; Kanemaki, MT; Shah, JV; Jallepalli, PV				Rodriguez-Bravo, Veronica; Maciejowski, John; Corona, Jennifer; Buch, Hakon Kirkeby; Collin, Philippe; Kanemaki, Masato T.; Shah, Jagesh V.; Jallepalli, Prasad V.			Nuclear Pores Protect Genome Integrity by Assembling a Premitotic and Mad1-Dependent Anaphase Inhibitor	CELL			English	Article							CHROMOSOME SEGREGATION ERRORS; MITOTIC SPINDLE CHECKPOINT; AURORA-B; GENE-REGULATION; KINETOCHORE PROTEINS; PROMOTING COMPLEX; SOMATIC-CELLS; CORE COMPLEX; IN-VIVO; CENP-E	The spindle assembly checkpoint (SAC) delays anaphase until all chromosomes are bioriented on the mitotic spindle. Under current models, unattached kinetochores transduce the SAC by catalyzing the intramitotic production of a diffusible inhibitor of APC/C Cdc20 (the anaphase-promoting complex/cyclosome and its coactivator Cdc20, a large ubiquitin ligase). Here we show that nuclear pore complexes (NPCs) in interphase cells also function as scaffolds for anaphase-inhibitory signaling. This role is mediated by Mad1-Mad2 complexes tethered to the nuclear basket, which activate soluble Mad2 as a binding partner and inhibitor of Cdc20 in the cytoplasm. Displacing Mad1-Mad2 from nuclear pores accelerated anaphase onset, prevented effective correction of merotelic errors, and increased the threshold of kinetochore-dependent signaling needed to halt mitosis in response to spindle poisons. A heterologous Mad1-NPC tether restored Cdc20 inhibitor production and normal M phase control. We conclude that nuclear pores and kinetochores both emit "wait anaphase" signals that preserve genome integrity.	[Rodriguez-Bravo, Veronica; Maciejowski, John; Corona, Jennifer; Jallepalli, Prasad V.] Mem Sloan Kettering Canc Ctr, Jr Grad Sch Biomed Sci, Mol Biol Program, New York, NY 10065 USA; [Buch, Hakon Kirkeby] Swiss Fed Inst Technol Zurich, CH-8093 Zurich, Switzerland; [Collin, Philippe] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Collin, Philippe] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; [Kanemaki, Masato T.] SOKENDAI, ROIS, Natl Inst Genet, Ctr Frontier Res, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Buch, Hakon Kirkeby; Shah, Jagesh V.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge; University of Cambridge; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Harvard University; Harvard Medical School	Jallepalli, PV (corresponding author), Mem Sloan Kettering Canc Ctr, Jr Grad Sch Biomed Sci, Mol Biol Program, New York, NY 10065 USA.	jallepap@mskcc.org	Kanemaki, Masato/Q-3246-2019	Kanemaki, Masato/0000-0002-7657-1649; Rodriguez-Bravo, Veronica/0000-0002-7363-3672; Maciejowski, John/0000-0001-8134-9308	BBSRC; NIH [R01GM077238, R01GM094972]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077238, R01GM094972] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Gray, J. Hanover, A. Musacchio, and E. Nigg for generous gifts of reagents, M. Leversha (MSKCC Cytogenetics Core) for performing FISH, and A. North (Bio-Imaging Resource Center, Rockefeller University) and K. Manova (MSKCC Molecular Cytology Core) for help with confocal imaging. We are grateful to F. Cubizolles for help in preparing the Venus-Mad2 targeting construct and E. Foley for assistance with live-cell imaging. P.C. was funded via a BBSRC project grant. This work was supported by NIH grants R01GM077238 to J.V.S. and R01GM094972 to P.V.J.	Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Berdougo E, 2009, METHODS MOL BIOL, V545, P21, DOI 10.1007/978-1-60327-993-2_2; Cairo LV, 2013, MOL CELL, V49, P109, DOI 10.1016/j.molcel.2012.10.017; Campbell MS, 2001, J CELL SCI, V114, P953; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Dieckmann R., 2005, PROTEOMICS PROTOCOLS, P79; Dieppois G, 2010, J CELL SCI, V123, P1989, DOI 10.1242/jcs.053694; Ding DF, 2012, PLANT MOL BIOL, V79, P203, DOI 10.1007/s11103-012-9903-4; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Gascoigne KE, 2013, J CELL BIOL, V201, P23, DOI 10.1083/jcb.201301006; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kim SJ, 2012, P NATL ACAD SCI USA, V109, P6549, DOI 10.1073/pnas.1118210109; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Kusano A, 2001, DEV CELL, V1, P351, DOI 10.1016/S1534-5807(01)00042-9; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Phadnis N, 2012, MOL BIOL EVOL, V29, P1429, DOI 10.1093/molbev/msr306; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Samereier M., 2011, CELL BIOL; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schweizer N, 2013, J CELL BIOL, V203, P883, DOI 10.1083/jcb.201309076; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tracy C, 2010, GENETICS, V184, P1067, DOI 10.1534/genetics.109.113522; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	80	103	106	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1017	1031		10.1016/j.cell.2014.01.010	http://dx.doi.org/10.1016/j.cell.2014.01.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581499	Green Accepted, Bronze			2022-12-24	WOS:000332083900018
J	Zhou, YX; Zhu, SY; Cai, CZ; Yuan, PF; Li, CM; Huang, YY; Wei, WS				Zhou, Yuexin; Zhu, Shiyou; Cai, Changzu; Yuan, Pengfei; Li, Chunmei; Huang, Yanyi; Wei, Wensheng			High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells	NATURE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; ANTHRAX TOXIN; RECEPTOR; NUCLEASE; LETHALITY; CAS9	Targeted genome editing technologies are powerful tools for studying biology and disease, and have a broad range of research applications(1-7). In contrast to the rapid development of toolkits to manipulate individual genes, large-scale screening methods based on the complete loss of gene expression are only now beginning to be developed(8,9). Here we report the development of a focused CRISPR/Cas-based (clustered regularly interspaced short palindromic repeats/CRISPR-associated) lentiviral library in human cells and a method of gene identification based on functional screening and high-throughput sequencing analysis. Using knockout library screens, we successfully identified the host genes essential for the intoxication of cells by anthrax and diphtheria toxins, which were confirmed by functional validation. The broad application of this powerful genetic screening strategy will not only facilitate the rapid identification of genes important for bacterial toxicity but will also enable the discovery of genes that participate in other biological processes.	[Zhou, Yuexin; Zhu, Shiyou; Cai, Changzu; Yuan, Pengfei; Wei, Wensheng] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Li, Chunmei; Huang, Yanyi] Peking Univ, Biodynam Opt Imaging Ctr BIOPIC, Coll Engn, Beijing 100871, Peoples R China	Peking University; Peking University	Wei, WS (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	wswei@pku.edu.cn	Huang, Yanyi/D-1832-2009; Wei, Wensheng/AAF-1325-2020	Huang, Yanyi/0000-0002-7297-1266; Wei, Wensheng/0000-0002-8053-2423	National Basic Research Program of China [2010CB911800]; National Science Foundation of China [NSFC31170126, NSFC31070115]; Peking-Tsinghua Centre for Life Sciences	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Centre for Life Sciences	We thank J. Xi for providing the Cas9-encoding construct, F. Tang for technical advice regarding the high-throughput sequencing analysis, Z. Jiang for aid with the cell lines, Y. Yang for assistance in primer design, Y. Wang for data analysis, and D. Trono for aid with the lentivirus packaging system. We thank Peking University High-throughput Sequencing Center operated by BIOPIC. This work was supported by funds from the National Basic Research Program of China (2010CB911800), the National Science Foundation of China (NSFC31170126, NSFC31070115), and the Peking-Tsinghua Centre for Life Sciences.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lin BR, 2012, GENE, V497, P200, DOI 10.1016/j.gene.2012.01.041; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075649; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	26	488	581	11	383	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					487	+		10.1038/nature13166	http://dx.doi.org/10.1038/nature13166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4VE	24717434				2022-12-24	WOS:000336126000038
J	Lin, IW; Sosso, D; Chen, LQ; Gase, K; Kim, SG; Kessler, D; Klinkenberg, PM; Gorder, MK; Hou, BH; Qu, XQ; Carter, CJ; Baldwin, IT; Frommer, WB				Lin, I. Winnie; Sosso, Davide; Chen, Li-Qing; Gase, Klaus; Kim, Sang-Gyu; Kessler, Danny; Klinkenberg, Peter M.; Gorder, Molly K.; Hou, Bi-Huei; Qu, Xiao-Qing; Carter, Clay J.; Baldwin, Ian T.; Frommer, Wolf B.			Nectar secretion requires sucrose phosphate synthases and the sugar transporter SWEET9	NATURE			English	Article							DIFFERENTIAL GENE-EXPRESSION; TRANSFORMATION; GENERATION; SELECTION; PROTEINS; EXCHANGE; SEQUENCE; FLOWERS; LINES	Angiosperms developed floral nectaries that reward pollinating insects(1). Although nectar function and composition have been characterized, the mechanism of nectar secretion has remained unclear(2). Here we identify SWEET9 as a nectary-specific sugar transporter in three eudicot species: Arabidopsis thaliana, Brassica rapa (extrastaminal nectaries) and Nicotiana attenuata (gynoecial nectaries). We show that SWEET9 is essential for nectar production and can function as an efflux transporter. We also show that sucrose phosphate synthase genes, encoding key enzymes for sucrose biosynthesis, are highly expressed in nectaries and that their expression is also essential for nectar secretion. Together these data are consistent with a model in which sucrose is synthesized in the nectary parenchyma and subsequently secreted into the extracellular space via SWEET9, where sucrose is hydrolysed by an apoplasmic invertase to produce a mixture of sucrose, glucose and fructose. The recruitment of SWEET9 for sucrose export may have been a key innovation, and could have coincided with the evolution of core eudicots and contributed to the evolution of nectar secretion to reward pollinators.	[Lin, I. Winnie; Sosso, Davide; Frommer, Wolf B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Lin, I. Winnie; Sosso, Davide; Chen, Li-Qing; Hou, Bi-Huei; Qu, Xiao-Qing; Frommer, Wolf B.] Carnegie Inst Sci, Stanford, CA 94305 USA; [Gase, Klaus; Kim, Sang-Gyu; Kessler, Danny; Baldwin, Ian T.] Max Planck Inst Chem Oekol, D-07745 Jena, Germany; [Klinkenberg, Peter M.; Gorder, Molly K.; Carter, Clay J.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA; [Qu, Xiao-Qing] China Agr Univ, Key Lab Plant & Soil Interact, Coll Resources & Environm Sci, Beijing 100193, Peoples R China	Stanford University; Carnegie Institution for Science; Max Planck Society; University of Minnesota System; University of Minnesota Duluth; China Agricultural University	Frommer, WB (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008; Baldwin, Ian T/K-1809-2013; Kim, Sang-Gyu/T-5925-2017	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Baldwin, Ian/0000-0001-5371-2974	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy [DE-FG02-04ER15542]; Department of Biology, Stanford University; Carnegie; Carnegie Institution; Chinese Scholarship Council [2009635108]; US National Science Foundation [0820730]; European Research Council [293926]; Max Planck Gesellschaft; Division Of Integrative Organismal Systems [0820730] Funding Source: National Science Foundation	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy; Department of Biology, Stanford University; Carnegie; Carnegie Institution; Chinese Scholarship Council(China Scholarship Council); US National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Max Planck Gesellschaft(Max Planck Society); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to D. Ehrhardt, H. Cartwright, J. Lindeboom, K. Barton and T. Liu for help with confocal and scanning electron microscopy. We thank D. Ehrhardt for providing specific endomembrane markers and M. Jia for conducting nectar sugar assays. We thank J. Danielson for help with phylogenetic analyses. This work was made possible by support from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy under grant number DE-FG02-04ER15542 to W. B. F. I. W. L. was supported by the fellowship of Department of Biology, Stanford University and Carnegie. X.-Q.Q. was supported by the Carnegie Institution and Scholarship Program of the Chinese Scholarship Council (2009635108). C.J.C.'s work was supported by a grant from the US National Science Foundation (#0820730). I. T. B. was supported by European Research Council advanced grant ClockworkGreen (293926) and the Max Planck Gesellschaft, and thanks C. Diezel for technical assistance.	Bauby H, 2007, PLANT CELL PHYSIOL, V48, P97, DOI 10.1093/pcp/pcl045; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bender R, 2012, FLORA, V207, P491, DOI 10.1016/j.flora.2012.06.005; Bender RL, 2013, PLANT J, V74, P893, DOI 10.1111/tpj.12184; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Davis AR, 1998, PLANTA, V205, P305, DOI 10.1007/s004250050325; De la Barrera E, 2004, TRENDS PLANT SCI, V9, P65, DOI 10.1016/j.tplants.2003.12.003; Escalante-Perez M, 2012, PLANT PHYSIOL, V159, P1176, DOI 10.1104/pp.112.196014; Fahn A, 2000, ADV BOT RES, V31, P37, DOI 10.1016/S0065-2296(00)31006-0; Fior S, 2013, NEW PHYTOL, V198, P579, DOI 10.1111/nph.12163; Friedman WE, 2009, AM J BOT, V96, P5, DOI 10.3732/ajb.0800150; Gallagher S.R., 1992, GUS PROTOCOLS USING; Gase K, 2011, MOL ECOL RESOUR, V11, P890, DOI 10.1111/j.1755-0998.2011.03017.x; Ge YX, 2000, PLANT J, V24, P725, DOI 10.1046/j.1365-313x.2000.00926.x; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Hampton M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008782; Heil M, 2005, SCIENCE, V308, P560, DOI 10.1126/science.1107536; Hoffmann MH, 2003, PLANT BIOLOGY, V5, P491, DOI 10.1055/s-2003-44784; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Huang M, 2012, NEW PHYTOL, V193, P997, DOI 10.1111/j.1469-8137.2011.04001.x; Isokawa S, 2010, GENES GENET SYST, V85, P87, DOI 10.1266/ggs.85.87; Johnson SD, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0500; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kasaras A, 2010, PLANT BIOLOGY, V12, P140, DOI 10.1111/j.1438-8677.2010.00381.x; Kay K. M., 2006, FLORAL CHARACTERS SP; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Kram BW, 2009, SEX PLANT REPROD, V22, P235, DOI 10.1007/s00497-009-0112-5; Kram BW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-92; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Langenberger MW, 2002, AM J BOT, V89, P1588, DOI 10.3732/ajb.89.10.1588; Lee JY, 2005, DEVELOPMENT, V132, P5021, DOI 10.1242/dev.02067; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; Nicolson S.W., 2007, NECTARIES NECTAR; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Ren G, 2007, PLANT SCI, V173, P277, DOI 10.1016/j.plantsci.2007.05.008; Rizzardo RAG, 2012, AN ACAD BRAS CIENC, V84, P1137, DOI 10.1590/S0001-37652012005000057; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Sime Karen R, 2003, BMC Ecol, V3, P6, DOI 10.1186/1472-6785-3-6; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62	47	221	250	8	229	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					1	+		10.1038/nature13082	http://dx.doi.org/10.1038/nature13082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24670640				2022-12-24	WOS:000334741600041
J	Liu, SX; Chistol, G; Hetherington, CL; Tafoya, S; Aathavan, K; Schnitzbauer, J; Grimes, S; Jardine, PJ; Bustamante, C				Liu, Shixin; Chistol, Gheorghe; Hetherington, Craig L.; Tafoya, Sara; Aathavan, K.; Schnitzbauer, Joerg; Grimes, Shelley; Jardine, Paul J.; Bustamante, Carlos			A Viral Packaging Motor Varies Its DNA Rotation and Step Size to Preserve Subunit Coordination as the Capsid Fills	CELL			English	Article							HOMOMERIC RING ATPASE; BACTERIOPHAGE PHI-29; INTERSUBUNIT COORDINATION; OPTICAL TWEEZERS; INTERNAL FORCE; PORTAL MOTOR; EJECTION; PHAGE; MECHANISM; MOLECULE	Multimeric, ring-shaped molecular motors rely on the coordinated action of their subunits to perform crucial biological functions. During these tasks, motors often change their operation in response to regulatory signals. Here, we investigate a viral packaging machine as it fills the capsid with DNA and encounters increasing internal pressure. We find that the motor rotates the DNA during packaging and that the rotation per base pair increases with filling. This change accompanies a reduction in the motor's step size. We propose that these adjustments preserve motor coordination by allowing one subunit to make periodic, specific, and regulatory contacts with the DNA. At high filling, we also observe the downregulation of the ATP-binding rate and the emergence of long-lived pauses, suggesting a throttling-down mechanism employed by the motor near the completion of packaging. This study illustrates how a biological motor adjusts its operation in response to changing conditions, while remaining highly coordinated.	[Liu, Shixin; Chistol, Gheorghe; Hetherington, Craig L.; Tafoya, Sara; Aathavan, K.; Schnitzbauer, Joerg; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Liu, Shixin; Hetherington, Craig L.; Schnitzbauer, Joerg; Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Chistol, Gheorghe; Hetherington, Craig L.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Tafoya, Sara; Aathavan, K.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Grimes, Shelley; Jardine, Paul J.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Jardine, Paul/0000-0002-1090-0550; Chistol, Gheorghe/0000-0003-4868-3667; Bustamante, Carlos/0000-0002-2970-0073	U.S. National Institutes of Health [R01-GM071552, R01-GM059604]; U.S. Department of Energy [DE-AC02-05CH11231]; Howard Hughes Medical Institute; NIH [K99-GM107365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM107365, R01GM071552, R01GM059604] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Lionberger, N. Liu, J. Moffitt, and M. Sen for critical readings of the manuscript; Z. Bryant, A. Lee, C. Lee, J. Moffitt, M. Nollmann, and D. Reid for help with preliminary experiments and analysis; J. Kittleson for plasmids; and L. Comolli, A. Edelstein, Y. Mejia, M. Morais, and S. Smith for discussions. This work is supported in part by the U.S. National Institutes of Health under grants R01-GM071552 (to C.B.) and R01-GM059604 (to S.G.), the U.S. Department of Energy under contract number DE-AC02-05CH11231 (to C.B.), and the Howard Hughes Medical Institute (to C.B.). S.L. acknowledges support from the NIH Pathway to Independence Award K99-GM107365.	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao S, 2014, J VIROL, V88, P3986, DOI 10.1128/JVI.03203-13; Casjens Sherwood, 2005, P80; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chistol G, 2012, CELL, V151, P1017, DOI 10.1016/j.cell.2012.10.031; Droege Anja, 2005, P89; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Evilevitch A, 2004, J PHYS CHEM B, V108, P6838, DOI 10.1021/jp0376525; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Gonzalez-Huici V, 2004, MOL MICROBIOL, V52, P529, DOI 10.1111/j.1365-2958.2004.03993.x; Happel J., 1965, LOW REYNOLDS NUMBER; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hetherington CL, 2012, MOL MOTORS MOTILITY, P420; Iino R, 2013, CURR OPIN STRUC BIOL, V23, P229, DOI 10.1016/j.sbi.2013.01.004; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2010, P NATL ACAD SCI USA, V107, P15739, DOI 10.1073/pnas.1006997107; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Molineux IJ, 2013, NAT REV MICROBIOL, V11, P194, DOI 10.1038/nrmicro2988; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Morais MC, 2012, ADV EXP MED BIOL, V726, P511, DOI 10.1007/978-1-4614-0980-9_23; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Purohit PK, 2005, BIOPHYS J, V88, P851, DOI 10.1529/biophysj.104.047134; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Saleh OA, 2005, NAT STRUCT MOL BIOL, V12, P436, DOI 10.1038/nsmb926; Sao-Jose C, 2007, J MOL BIOL, V374, P346, DOI 10.1016/j.jmb.2007.09.045; Schwartz C, 2013, VIROLOGY, V443, P28, DOI 10.1016/j.virol.2013.04.019; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Spakowitz AJ, 2005, BIOPHYS J, V88, P3912, DOI 10.1529/biophysj.104.052738; Strick T, 1999, PHYSICA A, V263, P392, DOI 10.1016/S0378-4371(98)00540-8; Tolic-Norrelykke IM, 2004, COMPUT PHYS COMMUN, V159, P225, DOI 10.1016/j.cpc.2004.02.012; Van Valen D, 2012, CURR BIOL, V22, P1339, DOI 10.1016/j.cub.2012.05.023; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200; Zhao W, 2008, J MOL BIOL, V383, P520, DOI 10.1016/j.jmb.2008.08.056	50	95	96	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					702	713		10.1016/j.cell.2014.02.034	http://dx.doi.org/10.1016/j.cell.2014.02.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766813	Bronze, Green Accepted			2022-12-24	WOS:000335392100018
J	Kraus, D; Yang, Q; Kong, D; Banks, AS; Zhang, L; Rodgers, JT; Pirinen, E; Pulinilkunnil, TC; Gong, FY; Wang, YC; Cen, YN; Sauve, AA; Asara, JM; Peroni, OD; Monia, BP; Bhanot, S; Alhonen, L; Puigserver, P; Kahn, BB				Kraus, Daniel; Yang, Qin; Kong, Dong; Banks, Alexander S.; Zhang, Lin; Rodgers, Joseph T.; Pirinen, Eija; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Cen, Yana; Sauve, Anthony A.; Asara, John M.; Peroni, Odile D.; Monia, Brett P.; Bhanot, Sanjay; Alhonen, Leena; Puigserver, Pere; Kahn, Barbara B.			Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity	NATURE			English	Article							ADIPOSE-TISSUE; CDNA CLONING; EXPRESSION; MOUSE; LIVER; SIRT1; MICE; METABOLISM; RESISTANCE; CANCER	In obesity and type 2 diabetes, Glut4 glucose transporter expression is decreased selectively in adipocytes(1). Adipose-specific knockout or overexpression of Glut4 alters systemic insulin sensitivity(2). Here we show, using DNA array analyses, that nicotinamide N-methyltransferase (Nnmt) is the most strongly reciprocally regulated gene when comparing gene expression in white adipose tissue(WAT) from adipose-specific Glut4k-nockout or adipose-specific Glut4-overexpressing mice with their respective controls. NNMT methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor(3,4). Nicotinamide is a precursor of NAD(+), an important cofactor linking cellular redox states with energy metabolism(5). SAM provides propylamine for polyamine biosynthesis and donates a methyl group for histone methylation(6). Polyamine flux including synthesis, catabolism and excretion, is controlled by the rate-limiting enzymes ornithine decarboxylase (ODC) and spermidine-spermine N-1-acetyltransferase (SSAT; encoded by Sat1) and by polyamine oxidase (PAO), and has a major role in energy metabolism(7,8). We report that NNMT expression is increased in WAT and liver of obese and diabetic mice. Nnmt knockdown in WAT and liver protects against diet-induced obesity by augmenting cellular energy expenditure. NNMT inhibition increases adipose SAM and NAD(+) levels and upregulates ODC and SSAT activity as well as expression, owing to the effects of NNMT on histone H3 lysine 4 methylation in adipose tissue. Direct evidence for increased polyamine flux resulting from NNMT inhibition includes elevated urinary excretion and adipocyte secretion of diacetylspermine, a product of polyamine metabolism. NNMT inhibition in adipocytes increases oxygen consumption in an ODC-, SSAT- and PAO-dependent manner. Thus, NNMT is a novel regulator of histone methylation, polyamine flux and NAD(+)-dependent SIRT1 signalling, and is a unique and attractive target for treating obesity and type 2 diabetes.	[Kraus, Daniel; Yang, Qin; Kong, Dong; Zhang, Lin; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Peroni, Odile D.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kraus, Daniel; Yang, Qin; Kong, Dong; Zhang, Lin; Pulinilkunnil, Thomas C.; Gong, Fengying; Wang, Ya-chin; Asara, John M.; Peroni, Odile D.; Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Banks, Alexander S.; Rodgers, Joseph T.; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Pirinen, Eija; Alhonen, Leena] Univ Eastern Finland, Bioctr Kuopio, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland; [Cen, Yana; Sauve, Anthony A.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Monia, Brett P.; Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Eastern Finland; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Isis Pharmaceuticals Inc	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, 330 Brookline Ave, Boston, MA 02215 USA.	qin.yang@uci.edu; bkahn@bidmc.harvard.edu	Pulinilkunnil, Thomas C/L-5511-2016; Banks, Alexander/B-4832-2012; Cen, Yana/F-4731-2014; Pirinen, Eija/H-9153-2015; Pulinilkunnil, Thomas/H-4387-2019	Pulinilkunnil, Thomas C/0000-0003-1228-893X; Banks, Alexander/0000-0003-1787-6925; Cen, Yana/0000-0001-6436-5744; Pirinen, Eija/0000-0003-1495-3972; Pulinilkunnil, Thomas/0000-0003-1228-893X; Rodgers, Joseph/0000-0002-6598-5520	Deutsche Forschungsgemeinschaft [KR 3475/1-1]; American Heart Association (AHA) [09POST2250499]; NIH [R37 DK43051, P30 DK57521, KO8 DK090149, R01 DK100385, BNORC P30 DK046200, NORCH P30 DK040561]; JPB foundation; AHA [13SDG14620005, PF P30 DK0460200]; Ellison Medical Foundation New Scholar in Aging Award; academy of Finland [118590];  [RO1 DK69966];  [P01CA120964];  [P30CA006516-46]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100385, P30DK046200, R01DK069966, K08DK090149, K01DK094943, R37DK043051, P30DK057521, P30DK040561, T32DK007516] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; AHA(American Heart Association); Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); academy of Finland(Academy of Finland); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Weinshilboum for NNMT antibody; P. Woster for DFMO; M. Yuan for tandem mass spectrometry; A. Karppinen, A. Korhonen, T. Reponen, A. Uimari, S. Pirnes-Karhu and T. Koponen for measurements of ODC and SSAT activity; C. Semenkovich and S. Fried for protocols for FAS activity measurements; and P. Aryal for assistance with real-time qPCR. D. Kr. is supported by the Deutsche Forschungsgemeinschaft (KR 3475/1-1) and American Heart Association (AHA) (09POST2250499); Q.Y. is a Klarman Scholar at the Beth Israel Deaconess Medical Center. This work is supported by grants from the NIH (R37 DK43051, P30 DK57521) and a grant from the JPB foundation to B. B. K.; grants from the NIH (KO8 DK090149, R01 DK100385, BNORC P30 DK046200 and NORCH P30 DK040561) to Q.Y.; grant RO1 DK69966 to P. P.; P01CA120964 and P30CA006516-46 to J.M.A.; AHA 13SDG14620005 and P&F P30 DK0460200 to D.K.; the Ellison Medical Foundation New Scholar in Aging Award to A. A. S.; and academy of Finland grant 118590 to L.A.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; AKSOY S, 1994, J BIOL CHEM, V269, P14835; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bernacki RJ, 1995, CLIN CANCER RES, V1, P847; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Chen HC, 2002, J LIPID RES, V43, P986; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Endo A, 2006, CONTEMP CLIN TRIALS, V27, P420, DOI 10.1016/j.cct.2006.05.002; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; JANNE J, 1971, J BIOL CHEM, V246, P1725; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; KANGLEE YA, 1983, J NUTR, V113, P215, DOI 10.1093/jn/113.2.215; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Koponen T, 2012, AMINO ACIDS, V42, P427, DOI 10.1007/s00726-011-1013-0; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Pirinen E, 2007, MOL CELL BIOL, V27, P4953, DOI 10.1128/MCB.02034-06; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; Riederer M, 2009, ATHEROSCLEROSIS, V204, P412, DOI 10.1016/j.atherosclerosis.2008.09.015; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Sartini D, 2013, CELL BIOCHEM BIOPHYS, V67, P865, DOI 10.1007/s12013-013-9574-z; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/nchembio.1204, 10.1038/NCHEMBIO.1204]; Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639; Williams AC, 2005, QJM-INT J MED, V98, P215, DOI 10.1093/qjmed/hci027; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yaguchi H, 2005, GENOMICS, V85, P591, DOI 10.1016/j.ygeno.2005.01.006; Yan L, 1997, BIOCHEM PHARMACOL, V54, P1139, DOI 10.1016/S0006-2952(97)00325-0; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang XM, 2011, CANCER RES, V71, P5965, DOI 10.1158/0008-5472.CAN-11-0445	43	306	316	4	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					258	+		10.1038/nature13198	http://dx.doi.org/10.1038/nature13198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24717514	Green Accepted			2022-12-24	WOS:000333979900047
J	Yang, Y; Torchinsky, MB; Gobert, M; Xiong, HZ; Xu, M; Linehan, JL; Alonzo, F; Ng, C; Chen, A; Lin, XY; Sczesnak, A; Liao, JJ; Torres, VJ; Jenkins, MK; Lafaille, JJ; Littman, DR				Yang, Yi; Torchinsky, Miriam B.; Gobert, Michael; Xiong, Huizhong; Xu, Mo; Linehan, Jonathan L.; Alonzo, Francis; Ng, Charles; Chen, Alessandra; Lin, Xiyao; Sczesnak, Andrew; Liao, Jia-Jun; Torres, Victor J.; Jenkins, Marc K.; Lafaille, Juan J.; Littman, Dan R.			Focused specificity of intestinal T(H)17 cells towards commensal bacterial antigens	NATURE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; T-CELLS; MICROBIOTA; TH17; INDUCTION; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; MATURATION; PREDICTION	T-helper-17 (T(H)17) cells have critical roles in mucosal defence and in autoimmune disease pathogenesis(1-3). They are most abundant in the small intestine lamina propria, where their presence requires colonization of mice with microbiota(4-7). Segmented filamentous bacteria (SFB) are sufficient to induce T(H)17 cells and to promote T(H)17-dependent autoimmune disease in animal models(8-14). However, the specificity of T(H)17 cells, the mechanism of their induction by distinct bacteria, and the means by which they foster tissue-specific inflammation remain unknown. Here we show that the T-cell antigen receptor (TCR) repertoire of intestinal T(H)17 cells in SFB-colonized mice has minimal overlap with that of other intestinal CD4(+) T cells and that most T(H)17 cells, but not other T cells, recognize antigens encoded by SFB. T cells with antigen receptors specific for SFB-encoded peptides differentiated into ROR gamma t-expressing T(H)17 cells, even if SFB-colonized mice also harboured a strong T(H)1 cell inducer, Listeria monocytogenes, in their intestine. The match of T-cell effector function with antigen specificity is thus determined by the type of bacteria that produce the antigen. These findings have significant implications for understanding how commensal microbiota contribute to organ-specific autoimmunity and for developing novel mucosal vaccines.	[Yang, Yi; Torchinsky, Miriam B.; Gobert, Michael; Xiong, Huizhong; Xu, Mo; Ng, Charles; Chen, Alessandra; Lin, Xiyao; Sczesnak, Andrew; Liao, Jia-Jun; Lafaille, Juan J.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Linehan, Jonathan L.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; [Alonzo, Francis; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; University of Minnesota System; University of Minnesota Twin Cities; New York University; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	dan.littman@med.nyu.edu	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Torres, Victor/0000-0002-7126-0489; Sczesnak, Andrew/0000-0002-0152-9745	National Center for Advancing Translational Sciences [UL1 TR00038]; National Cancer Institute [5P30CA016087-32]; NIH [R01 AI039614]; Arthritis National Research Foundation; Irvington Institute fellowship program of the Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA077598, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); Irvington Institute fellowship program of the Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Yong Kim for generating TCR transgenic mice, A. Viale for 454 pyrosequencing, R. Myers for RNA-seq, N. Freitag for providing the Listeria strain and expression vector, Y. Umesaki for SFB samples, and K. Murphy for providing the 58 alpha<SUP>-</SUP>beta<SUP>-</SUP> hybridoma line. The Immune Monitoring Core New York University (NYU) is supported in part by grant UL1 TR00038 from the National Center for Advancing Translational Sciences and grant 5P30CA016087-32 from the National Cancer Institute; the NYU Histology Core is supported in part by grant 5P30CA016087-32 from the National Cancer Institute. M.K.J. was supported by grant R01 AI039614 from the NIH. Y. Y. was supported by the Arthritis National Research Foundation. M. X. is supported by the Irvington Institute fellowship program of the Cancer Research Institute. D. R. L. is a Howard Hughes Medical Institute Investigator.	Alamyar E., 2012, IMMUNOME RES, V8, P26, DOI [DOI 10.1007/978-1-61779-842-9_32, 10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Currier J. R., 2001, CURR PROTOCOLS IMMUN; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; SANDERSON S, 1995, J EXP MED, V182, P1751, DOI 10.1084/jem.182.6.1751; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Schnupf P, 2013, SEMIN IMMUNOL, V25, P342, DOI 10.1016/j.smim.2013.09.001; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	36	325	340	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					152	+		10.1038/nature13279	http://dx.doi.org/10.1038/nature13279			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24739972	Green Accepted			2022-12-24	WOS:000336768900047
J	Palumbi, SR; Barshis, DJ; Traylor-Knowles, N; Bay, RA				Palumbi, Stephen R.; Barshis, Daniel J.; Traylor-Knowles, Nikki; Bay, Rachael A.			Mechanisms of reef coral resistance to future climate change	SCIENCE			English	Article							PORITES-LOBATA; RESILIENCE; RESPONSES; IMPACTS; GROWTH	Reef corals are highly sensitive to heat, yet populations resistant to climate change have recently been identified. To determine the mechanisms of temperature tolerance, we reciprocally transplanted corals between reef sites experiencing distinct temperature regimes and tested subsequent physiological and gene expression profiles. Local acclimatization and fixed effects, such as adaptation, contributed about equally to heat tolerance and are reflected in patterns of gene expression. In less than 2 years, acclimatization achieves the same heat tolerance that we would expect from strong natural selection over many generations for these long-lived organisms. Our results show both short-term acclimatory and longer-term adaptive acquisition of climate resistance. Adding these adaptive abilities to ecosystem models is likely to slow predictions of demise for coral reef ecosystems.	[Palumbi, Stephen R.; Barshis, Daniel J.; Traylor-Knowles, Nikki; Bay, Rachael A.] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Stanford University	Palumbi, SR (corresponding author), Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	spalumbi@stanford.edu	Traylor-Knowles, Nikki G/D-4354-2012		Gordon and Betty Moore Foundation [GBMF2629]; Schmidt Ocean Institute; NSF	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Schmidt Ocean Institute; NSF(National Science Foundation (NSF))	The transcriptome data are archived at NCBI's Gene Expression Omnibus database (series record GSE56278: www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56278). Funding was provided by The Gordon and Betty Moore Foundation through grant GBMF2629, the Schmidt Ocean Institute, and a fellowship from the NSF to N.T.K. We thank M. van Oppen, I. Baums, M. De Salvo, L. Bay, M. Morikawa, and O. Hoegh-Guldberg for comments on earlier versions of the manuscript. We also thank the U.S. National Park of American Samoa for permission to work on Ofu reefs and C. Caruso for logistical and research help.	Barshis D. J., 2014, MOL BIOL EVOL; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; COLES SL, 1976, PAC SCI, V30, P159; Craig P, 2001, CORAL REEFS, V20, P185, DOI 10.1007/s003380100159; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Endler J.A., 1986, Monographs in Population Biology, pviii; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Honnay O, 2002, ECOL LETT, V5, P525, DOI 10.1046/j.1461-0248.2002.00346.x; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Ladner JT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-217; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Shamberger KEF, 2014, GEOPHYS RES LETT, V41, P499, DOI 10.1002/2013GL058489; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Smith LW, 2008, PAC SCI, V62, P57, DOI 10.2984/1534-6188(2008)62[57:EVGIOG]2.0.CO;2; Smith LW, 2007, CORAL REEFS, V26, P559, DOI 10.1007/s00338-007-0216-z; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073	30	501	503	25	657	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					895	898		10.1126/science.1251336	http://dx.doi.org/10.1126/science.1251336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24762535				2022-12-24	WOS:000336233800046
J	Ding, T; Schloss, PD				Ding, Tao; Schloss, Patrick D.			Dynamics and associations of microbial community types across the human body	NATURE			English	Article							VAGINAL MICROBIOME; GUT MICROBIOME; SEX	A primary goal of the Human Microbiome Project (HMP) was to provide a reference collection of 16S ribosomal RNA gene sequences collected from sites across the human body that would allow micro-biologists to better associate changes in the microbiome with changes in health(1). The HMP Consortium has reported the structure and function of the human microbiome in 300 healthy adults at 18 body sites from a single time point(2,3). Using additional data collected over the course of 12-18 months, we used Dirichlet multinomial mixture models(4) to partition the data into community types for each body site and made three important observations. First, there were strong associations between whether individuals had been breastfed as an infant, their gender, and their level of education with their community types at several body sites. Second, although the specific taxonomic compositions of the oral and gut microbiomes were different, the community types observed at these sites were predictive of each other. Finally, over the course of the sampling period, the community types from sites within the oral cavity were the least stable, whereas those in the vagina and gut were the most stable. Our results demonstrate that even with the considerable intra-and interpersonal variation in the human microbiome, this variation can be partitioned into community types that are predictive of each other and are probably the result of life-history characteristics. Understanding the diversity of community types and the mechanisms that result in an individual having a particular type or changing types, will allow us to use their community types to assess disease risk and to personalize therapies.	[Ding, Tao; Schloss, Patrick D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Schloss, PD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, 1500 W Med Ctr, Ann Arbor, MI 48109 USA.	pschloss@umich.edu		Ding, Tao/0000-0002-2200-0496; Schloss, Patrick/0000-0002-6935-4275	National Institutes of Health [R01HG005975, R01GM099514, P30DK034933]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Crabtree of the HMP Data Analysis and Coordination Center for his assistance in obtaining the sequencing and metadata files. The analysis described in this study was supported by grants from the National Institutes of Health (R01HG005975, R01GM099514 and P30DK034933).	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Arumugam M, 2014, NATURE, V506, DOI 10.1038/nature13075; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moeller AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2159; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2013, GUT, V62, P952, DOI 10.1136/gutjnl-2012-304214; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schloss PD, 2013, ISME J, V7, P457, DOI 10.1038/ismej.2012.102; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Statnikov A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02620; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	32	489	522	9	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					357	+		10.1038/nature13178	http://dx.doi.org/10.1038/nature13178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24739969	Green Accepted			2022-12-24	WOS:000336121200038
J	Tomassy, GS; Berger, DR; Chen, HH; Kasthuri, N; Hayworth, KJ; Vercelli, A; Seung, HS; Lichtman, JW; Arlotta, P				Tomassy, Giulio Srubek; Berger, Daniel R.; Chen, Hsu-Hsin; Kasthuri, Narayanan; Hayworth, Kenneth J.; Vercelli, Alessandro; Seung, H. Sebastian; Lichtman, Jeff W.; Arlotta, Paola			Distinct Profiles of Myelin Distribution Along Single Axons of Pyramidal Neurons in the Neocortex	SCIENCE			English	Article							MOUSE; OLIGODENDROCYTE; SCRAMBLER; CORTEX; BRAIN; MOTOR	Myelin is a defining feature of the vertebrate nervous system. Variability in the thickness of the myelin envelope is a structural feature affecting the conduction of neuronal signals. Conversely, the distribution of myelinated tracts along the length of axons has been assumed to be uniform. Here, we traced high-throughput electron microscopy reconstructions of single axons of pyramidal neurons in the mouse neocortex and built high-resolution maps of myelination. We find that individual neurons have distinct longitudinal distribution of myelin. Neurons in the superficial layers displayed the most diversified profiles, including a new pattern where myelinated segments are interspersed with long, unmyelinated tracts. Our data indicate that the profile of longitudinal distribution of myelin is an integral feature of neuronal identity and may have evolved as a strategy to modulate long-distance communication in the neocortex.	[Tomassy, Giulio Srubek; Chen, Hsu-Hsin; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Berger, Daniel R.; Kasthuri, Narayanan; Hayworth, Kenneth J.; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Berger, Daniel R.; Seung, H. Sebastian] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Vercelli, Alessandro] Neurosci Inst Turin, Neurosci Inst Cavalieri Ottolenghi, I-10126 Turin, Italy	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT)	Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	paola_arlotta@harvard.edu	Vercelli, Alessandro/A-1926-2012	Vercelli, Alessandro/0000-0002-5909-2128	Howard Hughes Medical Institute; Human Frontier Science Program; Gatsby Foundation; NIH [NS062849, NS078164]; New York Stem Cell Foundation; Harvard Stem Cell Institute; Conte Centers for Basic and Translational Mental Health Research, National Institute for Mental Health, NIH [1P50MH094271]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090449, R01NS062849, R01NS078164] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); Gatsby Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Harvard Stem Cell Institute; Conte Centers for Basic and Translational Mental Health Research, National Institute for Mental Health, NIH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to S. Lodato, C. Rouaux, B. Sannino, and all members of the Arlotta laboratory for insightful discussions and comments on the manuscript. We thank, in particular, Z. Trayes-Gibson for outstanding technical support; J. Macklis and W. Richardson for sharing riboprobes; and M. Gotz and S. Cappello for sharing tissue from the Emx1-Cre; RhoA<SUP>fl/fl</SUP> line. D. R. B. and H. S. S. were supported by the Howard Hughes Medical Institute, the Human Frontier Science Program, and the Gatsby Foundation. This work was supported by grants from NIH (NS062849 and NS078164), the New York Stem Cell Foundation, and the Harvard Stem Cell Institute to P. A. and Silvio O. Conte Centers for Basic and Translational Mental Health Research, National Institute for Mental Health, NIH (1P50MH094271); P. A. is a New York Stem Cell Foundation-Robertson Investigator.	Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; FAIREN A, 1977, J NEUROCYTOL, V6, P311, DOI 10.1007/BF01175194; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lang J, 2013, J NEUROSCI, V33, P3113, DOI 10.1523/JNEUROSCI.3467-12.2013; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P173, DOI 10.1098/rstb.1979.0004; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P123, DOI 10.1098/rstb.1979.0002; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Sweet HO, 1996, MAMM GENOME, V7, P798, DOI 10.1007/s003359900240; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8	25	322	322	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 18	2014	344	6181					319	324		10.1126/science.1249766	http://dx.doi.org/10.1126/science.1249766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF1LD	24744380	Green Accepted			2022-12-24	WOS:000334474500041
J	Perrin, S				Perrin, Steve			Make mouse studies work	NATURE			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; LITHIUM; ALS; TRIAL; MICE; PROGRESSION; TDP-43; MODEL		ALS Therapy Dev Inst, Cambridge, MA USA		Perrin, S (corresponding author), ALS Therapy Dev Inst, Cambridge, MA USA.	sperrin@als.net						Aggarwal SP, 2010, LANCET NEUROL, V9, P481, DOI 10.1016/S1474-4422(10)70068-5; Allen C, 2013, LANCET NEUROL, V12, P339, DOI [10.1016/S1474-4422(13)70037-1, 10.1016/S1474-4422(13)700374]; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Hatzipetros T., 2013, BRAIN RES; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P557, DOI 10.1136/jnnp-2011-302021; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106	13	390	405	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					423	425		10.1038/507423a	http://dx.doi.org/10.1038/507423a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24678540	Bronze			2022-12-24	WOS:000333402000014
J	Cai, HQ; Katoh-Kurasawa, M; Muramoto, T; Santhanam, B; Long, Y; Li, L; Ueda, M; Iglesias, PA; Shaulsky, G; Devreotes, PN				Cai, Huaqing; Katoh-Kurasawa, Mariko; Muramoto, Tetsuya; Santhanam, Balaji; Long, Yu; Li, Lei; Ueda, Masahiro; Iglesias, Pablo A.; Shaulsky, Gad; Devreotes, Peter N.			Nucleocytoplasmic Shuttling of a GATA Transcription Factor Functions as a Development Timer	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM; CYCLIC-AMP; ADENYLYL-CYCLASE; OSCILLATIONS; DYNAMICS; AGGREGATION; ACTIVATION; EXPRESSION; INDUCTION; CELLS	Biological oscillations are observed at many levels of cellular organization. In the social amoeba Dictyostelium discoideum, starvation-triggered multicellular development is organized by periodic cyclic adenosine 3',5'-monophosphate (cAMP) waves, which provide both chemoattractant gradients and developmental signals. We report that GtaC, a GATA transcription factor, exhibits rapid nucleocytoplasmic shuttling in response to cAMP waves. This behavior requires coordinated action of a nuclear localization signal and reversible G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor-mediated phosphorylation. Although both are required for developmental gene expression, receptor occupancy promotes nuclear exit of GtaC, which leads to a transient burst of transcription at each cAMP cycle. We demonstrate that this biological circuit filters out high-frequency signals and counts those admitted, thereby enabling cells to modulate gene expression according to the dynamic pattern of the external stimuli.	[Cai, Huaqing; Long, Yu; Iglesias, Pablo A.; Devreotes, Peter N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Katoh-Kurasawa, Mariko; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Muramoto, Tetsuya; Ueda, Masahiro] RIKEN Quantitat Biol Ctr, Lab Cell Signaling Dynam, Osaka 5650874, Japan; [Santhanam, Balaji; Shaulsky, Gad] Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Li, Lei] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Ueda, Masahiro] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5650043, Japan; [Iglesias, Pablo A.] Johns Hopkins Univ, Whiting Sch Engn, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Baylor College of Medicine; RIKEN; Baylor College of Medicine; University of Virginia; Osaka University; Johns Hopkins University	Devreotes, PN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	pnd@jhmi.edu	Iglesias, Pablo A/A-5202-2008; Muramoto, Tetsuya/C-9127-2011	Iglesias, Pablo A/0000-0002-0840-155X; Muramoto, Tetsuya/0000-0001-9624-8577; Cai, Huaqing/0000-0001-8434-6639; Ueda, Masahiro/0000-0002-9354-3404; Shaulsky, Gad/0000-0002-0532-0551	NIH [GM 28007, GM 34933, HD 039691]; Helen Hay Whitney postdoctoral fellowship; JSPS KAKENHI [25840095]; RIKEN Incentive Research Projects; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM034933, R01GM028007] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney postdoctoral fellowship; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Incentive Research Projects; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. R. Kay for providing the library used for the genetic screen and S. Willard and J. Borleis from the Devreotes laboratory for the initial characterization of the library. We thank J. A. Hadwiger and the Dictyostelium stock center (www.dictybase.org) for providing the erkA<SUP>-</SUP>, erkB<SUP>-</SUP>, erkA<SUP>-</SUP>B<SUP>-</SUP>, and gskA<SUP>-</SUP> cell lines; the proteomics core facility in Johns Hopkins University, School of Medicine, for phosphoproteomic analysis; the microscope facility in Johns Hopkins University, School of Medicine, Institute for Basic Biomedical Sciences, for assistance with imaging; and B. Zupan and G. Rot (University of Ljubljana) for assistance with RNA-Seq analyses. Antibody to CsaA (33-294-17-s) was a gift from the Developmental Studies Hybridoma Bank. We also thank P. J. Espenshade and D. J. Andrew for critical reading of the manuscript. This work was supported by NIH grants GM 28007 and GM 34933 (to P.N.D.), HD 039691 (to G.S.), Helen Hay Whitney postdoctoral fellowship (to H.C.), and JSPS KAKENHI 25840095 and RIKEN Incentive Research Projects (to T.M.). RNA-Seq data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GSE54866).	ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321, DOI 10.1099/00221287-85-2-321; Artemenko Y, 2011, METHODS MOL BIOL, V769, P287, DOI 10.1007/978-1-61779-207-6_20; Bader S, 2007, BIOCHEM J, V402, P153, DOI 10.1042/BJ20061153; BARKLEY DS, 1969, SCIENCE, V165, P1133, DOI 10.1126/science.165.3898.1133; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Cai HQ, 2011, METHODS MOL BIOL, V757, P451, DOI 10.1007/978-1-61779-166-6_26; Cai HQ, 2010, J CELL BIOL, V190, P233, DOI 10.1083/jcb.201001129; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dormann D, 2002, CURR BIOL, V12, P1178, DOI 10.1016/S0960-9822(02)00950-8; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang EY, 2011, DEV BIOL, V358, P137, DOI 10.1016/j.ydbio.2011.07.017; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; KONIJN TM, 1969, NATURE, V224, P1211, DOI 10.1038/2241211a0; Kuspa Adam, 2006, V346, P201; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lim CJ, 2001, EMBO J, V20, P4490, DOI 10.1093/emboj/20.16.4490; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; Muramoto T, 2012, P NATL ACAD SCI USA, V109, P7350, DOI 10.1073/pnas.1117603109; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Otsuka H, 1998, GENE DEV, V12, P1738, DOI 10.1101/gad.12.11.1738; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; ROSSIER C, 1979, J CELL SCI, V35, P321; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Teo R, 2010, MOL BIOL CELL, V21, P2788, DOI 10.1091/mbc.E09-10-0891; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Veltman DM, 2009, PLASMID, V61, P119, DOI 10.1016/j.plasmid.2008.11.002; WURSTER B, 1983, J CELL BIOL, V96, P1566, DOI 10.1083/jcb.96.6.1566; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440	40	48	48	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1329	+	1249531	10.1126/science.1249531	http://dx.doi.org/10.1126/science.1249531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24653039	Green Accepted			2022-12-24	WOS:000333108500029
J	Kunte, K; Zhang, W; Tenger-Trolander, A; Palmer, DH; Martin, A; Reed, RD; Mullen, SP; Kronforst, MR				Kunte, K.; Zhang, W.; Tenger-Trolander, A.; Palmer, D. H.; Martin, A.; Reed, R. D.; Mullen, S. P.; Kronforst, M. R.			doublesex is a mimicry supergene	NATURE			English	Article							TIGER SWALLOWTAIL BUTTERFLIES; DNA-SEQUENCING DATA; SEXUAL-DIMORPHISM; EVOLUTION; GENETICS; GENOME; DROSOPHILA; POLYMORPHISMS; ADAPTATION; SPECIATION	One of the most striking examples of sexual dimorphism is sex-limited mimicry in butterflies, a phenomenon in which one sex-usually the female-mimics a toxic model species, whereas the other sex displays a different wing pattern(1). Sex-limited mimicry is phylogenetically widespread in the swallowtail butterfly genus Papilio, in which it is often associated with female mimetic polymorphism(1-3). In multiple polymorphic species, the entire wing pattern phenotype is controlled by a single Mendelian 'supergene'(4). Although theoretical work has explored the evolutionary dynamics of supergene mimicry(5-9), there are almost no empirical data that address the critical issue of what a mimicry supergene actually is at a functional level. Using an integrative approach combining genetic and association mapping, transcriptome and genome sequencing, and gene expression analyses, we show that a single gene, doublesex, controls supergene mimicry in Papilio polytes. This is in contrast to the long-held view that supergenes are likely to be controlled by a tightly linked cluster of loci(4). Analysis of gene expression and DNA sequence variation indicates that isoform expression differences contribute to the functional differences between dsx mimicry alleles, and protein sequence evolution may also have a role. Our results combine elements from different hypotheses for the identity of supergenes, showing that a single gene can switch the entire wing pattern among mimicry phenotypes but may require multiple, tightly linked mutations to do so.	[Kunte, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, Karnataka, India; [Zhang, W.; Tenger-Trolander, A.; Kronforst, M. R.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Palmer, D. H.; Kronforst, M. R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Martin, A.; Reed, R. D.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Mullen, S. P.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Chicago; University of Chicago; Cornell University; Boston University	Kronforst, MR (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	krushnamegh@ncbs.res.in; mkronforst@uchicago.edu	Zhang, Wei/AAV-6724-2021; Tenger-Trolander, Ayse/L-2413-2014; Zhang, Wei/P-1532-2015	Zhang, Wei/0000-0002-6644-7046; Reed, Robert/0000-0002-6065-6728; Kunte, Krushnamegh/0000-0002-3860-6118; Martin, Arnaud/0000-0002-5980-2249; Tenger-Trolander, Ayse/0000-0001-8319-0273	National Science Foundation [DEB-1316037]; Division Of Environmental Biology [1020136] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank W. Wang for sharing genome sequence data, C. Robinett for providing the Dsx-DM monoclonal antibody, and E. Westerman, S. Nallu, M. Zhang, G. Garcia and N. Pierce for assistance and discussion. This project was funded by National Science Foundation grant DEB-1316037 to M.R.K.	Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; Benjamini Y, 2001, ANN STAT, V29, P1165; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; Charlesworth D, 2011, CURR BIOL, V21, pR846, DOI 10.1016/j.cub.2011.09.004; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; Clark R, 2008, P R SOC B, V275, P1181, DOI 10.1098/rspb.2007.1762; CLARKE C. A., 1960, HEREDITY, V14, P175, DOI 10.1038/hdy.1960.15; CLARKE CA, 1972, PHILOS T ROY SOC B, V263, P431, DOI 10.1098/rstb.1972.0006; CLARKE CA, 1968, PHILOS T ROY SOC B, V254, P37, DOI 10.1098/rstb.1968.0013; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fisher R.A., 1930, GENETICAL THEORY NAT; FORD EB, 1953, ADV GENET, V5, P43, DOI 10.1016/S0065-2660(08)60405-8; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; HUDSON RR, 1987, GENETICS, V116, P153; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kijimoto T, 2012, P NATL ACAD SCI USA, V109, P20526, DOI 10.1073/pnas.1118589109; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Kunte K, 2009, ANIM BEHAV, V78, P1029, DOI 10.1016/j.anbehav.2009.08.013; Kunte K, 2009, EVOLUTION, V63, P2707, DOI 10.1111/j.1558-5646.2009.00752.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390; Loehlin DW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000821; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellert DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051489; NIJHOUT HF, 1994, BIOSCIENCE, V44, P148, DOI 10.2307/1312251; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scriber JM, 1996, EVOLUTION, V50, P222, DOI 10.1111/j.1558-5646.1996.tb04487.x; SHEPPARD PM, 1959, COLD SPRING HARB SYM, V24, P131, DOI 10.1101/SQB.1959.024.01.013; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; TURNER JRG, 1984, BIOL BUTTERFLIES, P141; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang W, 2013, GENOME BIOL EVOL, V5, P1233, DOI 10.1093/gbe/evt090	44	213	216	5	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					229	+		10.1038/nature13112	http://dx.doi.org/10.1038/nature13112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598547				2022-12-24	WOS:000332651800038
J	Peisley, A; Wu, B; Xu, H; Chen, ZJJ; Hur, S				Peisley, Alys; Wu, Bin; Xu, Hui; Chen, Zhijian J.; Hur, Sun			Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I	NATURE			English	Article							RNA RECOGNITION; PROTEIN; OLIGOMERIZATION; SEQUENCE; REVEALS; COMPLEX; SENSORS; MAVS	Ubiquitin (Ub) has important roles in a wide range of intracellular signalling pathways. In the conventional view, ubiquitin alters the signalling activity of the target protein through covalent modification, but accumulating evidence points to the emerging role of noncovalent interaction between ubiquitin and the target. In the innate immune signalling pathway of a viral RNA sensor, RIG-I, both covalent and non-covalent interactions with K63-linked ubiquitin chains (K63-Ub(n)) were shown to occur in its signalling domain, a tandem caspase activation and recruitment domain (hereafter referred to as 2CARD)(1,2). Non-covalent binding of K63-Ub(n) to 2CARD induces its tetramer formation, a requirement for downstream signal activation(3). Here we report the crystal structure of the tetramer of human RIG-I 2CARD bound by three chains of K63-Ub(2). 2CARD assembles into a helical tetramer resembling a 'lock-washer', in which the tetrameric surface serves as a signalling platform for recruitment and activation of the downstream signalling molecule, MAVS. Ubiquitin chains are bound along the outer rim of the helical trajectory, bridging adjacent subunits of 2CARD and stabilizing the 2CARD tetramer. The combination of structural and functional analyses reveals that binding avidity dictates the K63-linkage and chain-length specificity of 2CARD, and that covalent ubiquitin conjugation of 2CARD further stabilizes the Ub-2CARD interaction and thus the 2CARD tetramer. Our work provides unique insights into the novel types of ubiquitin-mediated signal-activation mechanism, and previously unexpected synergism between the covalent and non-covalent ubiquitin interaction modes.	[Peisley, Alys; Wu, Bin; Hur, Sun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Peisley, Alys; Wu, Bin; Hur, Sun] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Xu, Hui; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Hur, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Sun.Hur@childrens.harvard.edu	Chen, Zhijian/C-6039-2012; Wu, Bin/C-4715-2015	Chen, Zhijian/0000-0002-8475-8251; Wu, Bin/0000-0002-0883-8006; Peisley, Alys/0000-0002-8999-5440	GSK; Welch Foundation [I-1389]; NIH [R01-GM63692]; Pew Scholarship; BCH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	GSK(GlaxoSmithKline); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholarship; BCH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Meigs at ALS BL 8.3.1 for data collection, and H. Wu and M. Eck for comments on the manuscript. This work was supported by GSK fellowship (B. W.), The Welch Foundation (I-1389; Z.J.C.), NIH (R01-GM63692; Z.J.C), Pew Scholarship (S. H.) and Career Development Award from BCH (S. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreani J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002677; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	30	231	234	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					110	+		10.1038/nature13140	http://dx.doi.org/10.1038/nature13140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24590070	Green Accepted			2022-12-24	WOS:000335199100049
J	Babbin, AR; Keil, RG; Devol, AH; Ward, BB				Babbin, Andrew R.; Keil, Richard G.; Devol, Allan H.; Ward, Bess B.			Organic Matter Stoichiometry, Flux, and Oxygen Control Nitrogen Loss in the Ocean	SCIENCE			English	Article							DEFICIENT ZONE; MINIMUM-ZONE; CARBON; DENITRIFICATION; ANAMMOX; DEGRADATION; OXIDATION; WATERS; CYCLE	Biologically available nitrogen limits photosynthesis in much of the world ocean. Organic matter (OM) stoichiometry had been thought to control the balance between the two major nitrogen removal pathways-denitrification and anammox-but the expected proportion of 30% anammox derived from mean oceanic OM is rarely observed in the environment. With incubations designed to directly test the effects of stoichiometry, however, we showed that the ratio of anammox to denitrification depends on the stoichiometry of OM supply, as predicted. Furthermore, observed rates of nitrogen loss increase with the magnitude of OM supply. The variable ratios between denitrification and anammox previously observed in the ocean are thus attributable to localized variations in OM quality and quantity and do not necessitate a revision to the global nitrogen cycle.	[Babbin, Andrew R.; Ward, Bess B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Keil, Richard G.; Devol, Allan H.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Princeton University; University of Washington; University of Washington Seattle	Babbin, AR (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.	babbin@princeton.edu	Keil, Richard/AAN-4140-2021	Babbin, Andrew/0000-0002-5046-0609	NSF; National Defense Science and Engineering Graduate Fellowship; Division Of Ocean Sciences [1029316, 1153935] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captain and crew of the R/V Thomas G. Thompson for assistance in sampling; C. Buchwald and A. Morello for nutrient measurements; and B. X. Chang, D. Bianchi, and D. M. Sigman for useful discussions of this work. F. M. M. Morel provided invaluable advice in honing and improving this paper. The data presented in this paper are available in the supplementary materials. This study was supported by an NSF grant to A. H. D. and B. B. W. and a National Defense Science and Engineering Graduate Fellowship to A. R. B. A. R. B., A. H. D., and B. B. W. designed and conducted the experiments; R. G. K. collected and analyzed sediment trap material; and A. R. B. and B. B. W. wrote the manuscript with input from all authors.	ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; BENDER M, 1989, GEOCHIM COSMOCHIM AC, V53, P685, DOI 10.1016/0016-7037(89)90011-2; Berelson W., 2001, OCEANOGRAPHY, V14, P59, DOI DOI 10.5670/0CEAN0G.2001.07; Bianchi D, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004209; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Codispoti LA, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P225, DOI 10.1093/acprof:oso/9780198527084.003.0012; Dalsgaard T., 2013, ASS SCI LIMN OC AQ S; Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; Devol AH, 2001, LIMNOL OCEANOGR, V46, P1684, DOI 10.4319/lo.2001.46.7.1684; Hartnett HE, 2003, GEOCHIM COSMOCHIM AC, V67, P247, DOI 10.1016/S0016-7037(02)01076-1; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/NGEO1739, 10.1038/ngeo1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Kartal B, 2007, ENVIRON MICROBIOL, V9, P635, DOI 10.1111/j.1462-2920.2006.01183.x; Koeve W, 2010, BIOGEOSCIENCES, V7, P2327, DOI 10.5194/bg-7-2327-2010; Kortzinger A, 2001, DEEP-SEA RES PT I, V48, P661, DOI 10.1016/S0967-0637(00)00051-0; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Richards F. A., 1965, CHEM OCEANOGR, V1, P611; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589, DOI 10.1007/s002530051340; Strous M, 1997, APPL ENVIRON MICROB, V63, P2446, DOI 10.1128/AEM.63.6.2446-2448.1997; Van Mooy BAS, 2002, GEOCHIM COSMOCHIM AC, V66, P457, DOI 10.1016/S0016-7037(01)00787-6; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	30	162	166	10	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					406	408		10.1126/science.1248364	http://dx.doi.org/10.1126/science.1248364			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24763588				2022-12-24	WOS:000334867800039
J	MacArthur, DG; Manolio, TA; Dimmock, DP; Rehm, HL; Shendure, J; Abecasis, GR; Adams, DR; Altman, RB; Antonarakis, SE; Ashley, EA; Barrett, JC; Biesecker, LG; Conrad, DF; Cooper, GM; Cox, NJ; Daly, MJ; Gerstein, MB; Goldstein, DB; Hirschhorn, JN; Leal, SM; Pennacchio, LA; Stamatoyannopoulos, JA; Sunyaev, SR; Valle, D; Voight, BF; Winckler, W; Gunter, C				MacArthur, D. G.; Manolio, T. A.; Dimmock, D. P.; Rehm, H. L.; Shendure, J.; Abecasis, G. R.; Adams, D. R.; Altman, R. B.; Antonarakis, S. E.; Ashley, E. A.; Barrett, J. C.; Biesecker, L. G.; Conrad, D. F.; Cooper, G. M.; Cox, N. J.; Daly, M. J.; Gerstein, M. B.; Goldstein, D. B.; Hirschhorn, J. N.; Leal, S. M.; Pennacchio, L. A.; Stamatoyannopoulos, J. A.; Sunyaev, S. R.; Valle, D.; Voight, B. F.; Winckler, W.; Gunter, C.			Guidelines for investigating causality of sequence variants in human disease	NATURE			English	Article							DE-NOVO MUTATIONS; RARE VARIANTS; GENES; PHENOTYPE; INDIVIDUALS; ASSOCIATION; POPULATION; DISSECTION; EVOLUTION; GENCODE	The discovery of rare genetic variants is accelerating, and clear guidelines for distinguishing disease-causing sequence variants from the many potentially functional variants present in any human genome are urgently needed. Without rigorous standards we risk an acceleration of false-positive reports of causality, which would impede the translation of genomic research findings into the clinical diagnostic setting and hinder biological understanding of disease. Here we discuss the key challenges of assessing sequence variants in human disease, integrating both gene-level and variant-level support for causality. We propose guidelines for summarizing confidence in variant pathogenicity and highlight several areas that require further resource development.	[MacArthur, D. G.; Daly, M. J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [MacArthur, D. G.; Daly, M. J.; Hirschhorn, J. N.; Winckler, W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Manolio, T. A.] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Dimmock, D. P.] Med Coll Wisconsin, Dept Pediat, Div Genet, Milwaukee, WI 53226 USA; [Rehm, H. L.] Partners Healthcare Ctr Personalized Genet Med, Mol Med Lab, Cambridge, MA 02139 USA; [Rehm, H. L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Shendure, J.] Univ Washington, Dept Genome Sci, Seattle, WA 98115 USA; [Abecasis, G. R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Adams, D. R.] NIH, NIH Undiagnosed Dis Program, Off Rare Dis Res, Bethesda, MD 20892 USA; [Adams, D. R.] NHGRI, Bethesda, MD 20892 USA; [Adams, D. R.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Altman, R. B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Altman, R. B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Antonarakis, S. E.] Univ Geneva, Sch Med, Dept Med Genet, CH-1211 Geneva, Switzerland; [Antonarakis, S. E.] iGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Ashley, E. A.] Stanford Univ, Sch Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA; [Barrett, J. C.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Biesecker, L. G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Conrad, D. F.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Conrad, D. F.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Conrad, D. F.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; [Cooper, G. M.; Gunter, C.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Cox, N. J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Gerstein, M. B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, M. B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Gerstein, M. B.] Yale Univ, Dept Mol Biophys, New Haven, CT 06520 USA; [Gerstein, M. B.] Yale Univ, Dept Biochem, New Haven, CT 06520 USA; [Goldstein, D. B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Hirschhorn, J. N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, J. N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Leal, S. M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pennacchio, L. A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Pennacchio, L. A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Stamatoyannopoulos, J. A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sunyaev, S. R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sunyaev, S. R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Valle, D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Voight, B. F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Voight, B. F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Medical College of Wisconsin; Partners Healthcare System; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; Stanford University; University of Geneva; Stanford University; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); HudsonAlpha Institute for Biotechnology; University of Chicago; Yale University; Yale University; Yale University; Yale University; Duke University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	macarthur@atgu.mgh.harvard.edu; drchrisgunter@gmail.com	Dimmock, David/I-7913-2015; Gunter, Chris/AHA-7271-2022; Antonarakis, Stylianos E/N-8866-2014; Daly, Mark J/B-2453-2017; Goldstein, David/AAY-8125-2020; Shendure, Jay/AAU-3684-2021; Cooper, Gregory/D-6914-2011	Dimmock, David/0000-0001-6690-2523; Antonarakis, Stylianos E/0000-0001-8907-5823; Daly, Mark J/0000-0002-0949-8752; Gunter, Chris/0000-0001-9369-7537; Pennacchio, Len/0000-0002-8748-3732; Altman, Russ/0000-0003-3859-2905; Barrett, Jeffrey/0000-0002-1152-370X; MacArthur, Daniel/0000-0002-5771-2290; Cooper, Gregory/0000-0001-5509-9923; Shendure, Jay/0000-0002-1516-1865; Voight, Benjamin/0000-0002-6205-9994; Rehm, Heidi L./0000-0002-6025-0015	NHGRI NIH HHS [U01 HG007301, U54 HG006997, R01 HG007022] Funding Source: Medline; NHLBI NIH HHS [R01 HL117626] Funding Source: Medline; NIDDK NIH HHS [P30 DK020595] Funding Source: Medline; NIMH NIH HHS [R01 MH101810] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007022, ZIAHG200387, ZIAHG200328, U54HG006997, ZIAHG200359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101810] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2012, NATURE, V490, P143; [Anonymous], 2013, CREAT GLOB ALL EN RE; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Boulding H, 2012, HUM MUTAT, V33, P874, DOI 10.1002/humu.22069; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Giallourakis C, 2005, ANNU REV GENOM HUM G, V6, P381, DOI 10.1146/annurev.genom.6.080604.162234; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hunt KA, 2012, NAT GENET, V44, P3, DOI 10.1038/ng.1037; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Li BA, 2012, BIOINFORMATICS, V28, P2703, DOI 10.1093/bioinformatics/bts499; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Norton N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805; O'Connor TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065834; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Rehm H. L., 2013, GENET MED IN PRESS; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Webber C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000531; Weng L, 2005, J CLIN INVEST, V115, P1016, DOI 10.1172/JCI24186; Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	60	849	873	1	121	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					469	476		10.1038/nature13127	http://dx.doi.org/10.1038/nature13127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24759409	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-24	WOS:000334741600026
J	Cleary, AS; Leonard, TL; Gestl, SA; Gunther, EJ				Cleary, Allison S.; Leonard, Travis L.; Gestl, Shelley A.; Gunther, Edward J.			Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers	NATURE			English	Article							CLONAL EVOLUTION; PROGENITOR CELLS; TRANSGENIC MICE; BREAST-TUMORS; PROGRESSION; ACTIVATION; TUMORIGENESIS; RECURRENCE; EXPRESSION; INDUCE	Cancer genome sequencing studies indicate that a single breast cancer typically harbours multiple genetically distinct subclones(1-4). As carcinogenesis involves a breakdown in the cell-cell cooperation that normally maintains epithelial tissue architecture, individual subclones within a malignant microenvironment are commonly depicted as self-interested competitors(5,6). Alternatively, breast cancer subclones might interact cooperatively to gain a selective growth advantage in some cases. Although interclonal cooperation has been shown to drive tumorigenesis in fruitfly models(7,8), definitive evidence for functional cooperation between epithelial tumour cell subclones in mammals is lacking. Here we use mouse models of breast cancer to show that interclonal cooperation can be essential for tumour maintenance. Aberrant expression of the secreted signalling molecule Wnt1 generates mixed-lineage mammary tumours composed of basal and luminal tumour cell subtypes, which purportedly derive from a bipotent malignant progenitor cell residing atop a tumour cell hierarchy(9). Using somatic Hras mutations as clonal markers, we show that some Wnt tumours indeed conform to a hierarchical configuration, but that others unexpectedly harbour genetically distinct basal Hras mutant and luminal Hras wild-type subclones. Both subclones are required for efficient tumour propagation, which strictly depends on luminally produced Wnt1. When biclonal tumours were challenged with Wnt withdrawal to simulate targeted therapy, analysis of tumour regression and relapse revealed that basal subclones recruit heterologous Wnt-producing cells to restore tumour growth. Alternatively, in the absence of a substitute Wnt source, the original subclones often evolve to rescue Wnt pathway activation and drive relapse, either by restoring cooperation or by switching to a defector strategy. Uncovering similar modes of interclonal cooperation in human cancers may inform efforts aimed at eradicating tumour cell communities.	[Cleary, Allison S.; Leonard, Travis L.; Gestl, Shelley A.; Gunther, Edward J.] Penn State Univ, Coll Med, Jake Gittlen Labs Canc Res, Hershey, PA 17033 USA; [Cleary, Allison S.; Leonard, Travis L.; Gestl, Shelley A.; Gunther, Edward J.] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Gunther, Edward J.] Penn State Univ, Coll Med, Dept Med Hematol Oncol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gunther, EJ (corresponding author), Penn State Univ, Coll Med, Jake Gittlen Labs Canc Res, Hershey, PA 17033 USA.	ejg12@psu.edu	Kessenbrock, Kai/B-6936-2011		National Institutes of Health/National Cancer Institute; Mary Kay Foundation; Donald B. and Dorothy L. Stabler Foundation; Pennsylvania Department of Health; Department of Defense Predoctoral Traineeship Award [W81XWH-11-1-0038]; NATIONAL CANCER INSTITUTE [R01CA152222] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mary Kay Foundation; Donald B. and Dorothy L. Stabler Foundation; Pennsylvania Department of Health; Department of Defense Predoctoral Traineeship Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the benefactors of the Jake Gittlen Laboratories for Cancer Research and the following Penn State College of Medicine staff: L. Budgeon of the Gittlen Histology Core, N. Sheaffer and J. Bednarczyk of the Flow Cytometry Core, D. Stanford of the Molecular Genetics Core, and J. Mohl of the Barrier Rodent Facility. This project was funded with grant support from the National Institutes of Health/National Cancer Institute, the Mary Kay Foundation, the Donald B. and Dorothy L. Stabler Foundation, and the Pennsylvania Department of Health. A. S. C. is supported by Department of Defense Predoctoral Traineeship Award W81XWH-11-1-0038.	Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; HEPPNER GH, 1993, STEM CELLS, V11, P199, DOI 10.1002/stem.5530110306; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jang JW, 2006, MOL CELL BIOL, V26, P8109, DOI 10.1128/MCB.00404-06; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030979; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; MESTER J, 1987, J VIROL, V61, P1073, DOI 10.1128/JVI.61.4.1073-1078.1987; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Podsypanina K, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-24; ROELINK H, 1992, ONCOGENE, V7, P487; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	30	309	318	3	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					113	+		10.1038/nature13187	http://dx.doi.org/10.1038/nature13187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24695311	Green Accepted			2022-12-24	WOS:000333609900053
J	Li, YL; Schwab, C; Ryan, SL; Papaemmanuil, E; Robinson, HM; Jacobs, P; Moorman, AV; Dyer, S; Borrow, J; Griffiths, M; Heerema, NA; Carroll, AJ; Talley, P; Bown, N; Telford, N; Ross, FM; Gaunt, L; McNally, RJQ; Young, BD; Sinclair, P; Rand, V; Teixeira, MR; Joseph, O; Robinson, B; Maddison, M; Dastugue, N; Vandenberghe, P; Haferlach, C; Stephens, PJ; Cheng, JQ; Van Loo, P; Stratton, MR; Campbell, PJ; Harrison, CJ				Li, Yilong; Schwab, Claire; Ryan, Sarra L.; Papaemmanuil, Elli; Robinson, Hazel M.; Jacobs, Patricia; Moorman, Anthony V.; Dyer, Sara; Borrow, Julian; Griffiths, Mike; Heerema, Nyla A.; Carroll, Andrew J.; Talley, Polly; Bown, Nick; Telford, Nick; Ross, Fiona M.; Gaunt, Lorraine; McNally, Richard J. Q.; Young, Bryan D.; Sinclair, Paul; Rand, Vikki; Teixeira, Manuel R.; Joseph, Olivia; Robinson, Ben; Maddison, Mark; Dastugue, Nicole; Vandenberghe, Peter; Haferlach, Claudia; Stephens, Philip J.; Cheng, Jiqiu; Van Loo, Peter; Stratton, Michael R.; Campbell, Peter J.; Harrison, Christine J.			Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia	NATURE			English	Article							INTRACHROMOSOMAL AMPLIFICATION; CANCER GENOMES; CHILDREN; IAMP21; ABNORMALITIES; EVENT; RISK	Changes in gene dosage are a major driver of cancer, known to be caused by a finite, but increasingly well annotated, repertoire of mutational mechanisms(1). This can potentially generate correlated copy-number alterations across hundreds of linked genes, as exemplified by the 2% of childhood acute lymphoblastic leukaemia (ALL) with recurrent amplification of megabase regions of chromosome 21 (iAMP21)(2,3). We used genomic, cytogenetic and transcriptional analysis, coupled with novel bioinformatic approaches, to reconstruct the evolution of iAMP21 ALL. Here we show that individuals born with the rare constitutional Robertsonian translocation between chromosomes 15 and 21, rob(15;21)(q10;q10)c, have approximately 2,700-fold increased risk of developing iAMP21 ALL compared to the general population. In such cases, amplification is initiated by a chromothripsis event involving both sister chromatids of the Robertsonian chromosome, a novel mechanism for cancer predisposition. In sporadic iAMP21, breakage-fusion-bridge cycles are typically the initiating event, often followed by chromothripsis. In both sporadic and rob(15;21)c-associated iAMP21, the final stages frequently involve duplications of the entire abnormal chromosome. The end-product is a derivative of chromosome 21 or the rob(15;21)c chromosome with gene dosage optimized for leukaemic potential, showing constrained copy-number levels over multiple linked genes. Thus, dicentric chromosomes may be an important precipitant of chromothripsis, as we show rob(15;21) c to be constitutionally dicentric and breakage-fusion-bridge cycles generate dicentric chromosomes somatically. Furthermore, our data illustrate that several cancer-specific mutational processes, applied sequentially, can coordinate to fashion copy-number profiles over large genomic scales, incrementally refining the fitness benefits of aggregated gene dosage changes.	[Li, Yilong; Papaemmanuil, Elli; Joseph, Olivia; Robinson, Ben; Maddison, Mark; Stephens, Philip J.; Van Loo, Peter; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Schwab, Claire; Ryan, Sarra L.; Moorman, Anthony V.; Young, Bryan D.; Sinclair, Paul; Rand, Vikki; Harrison, Christine J.] Newcastle Univ, Northern Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Robinson, Hazel M.; Dyer, Sara; Borrow, Julian; Griffiths, Mike] Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham B15 2TG, W Midlands, England; [Jacobs, Patricia; Ross, Fiona M.] Salisbury NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; [Dyer, Sara; Borrow, Julian; Griffiths, Mike] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Heerema, Nyla A.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Carroll, Andrew J.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Talley, Polly] Sheffield Childrens NHS Fdn Trust, Sheffield Diagnost Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Bown, Nick] Northern Genet Serv, Cytogenet Lab, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Telford, Nick] Christie NHS Fdn Trust, Manchester M20 4BX, Lancs, England; [Gaunt, Lorraine] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Reg Cytogenet Unit, Manchester M13 9WL, Lancs, England; [McNally, Richard J. Q.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Teixeira, Manuel R.] Univ Porto, Portuguese Oncol Inst, Dept Genet, P-4200072 Oporto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, P-4200072 Oporto, Portugal; [Dastugue, Nicole] Hop Purpan, Lab Hematol, F-31059 Toulouse, France; [Vandenberghe, Peter; Cheng, Jiqiu; Van Loo, Peter] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Vandenberghe, Peter; Cheng, Jiqiu; Van Loo, Peter] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Haferlach, Claudia] MLL Munich Leukemia Lab, D-81377 Munich, Germany; [Cheng, Jiqiu] Katholieke Univ Leuven, Dept Elect Engn ESAT, B-3000 Louvain, Belgium; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Newcastle University - UK; Salisbury District Hospital; University of Birmingham; University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; Sheffield Children's NHS Foundation Trust; Newcastle University - UK; Christie NHS Foundation Trust; University of Manchester; Newcastle University - UK; Portuguese Institute of Oncology; Universidade do Porto; Universidade do Porto; CHU de Toulouse; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; MLL Munich Leukemia Laboratory; KU Leuven; University of Cambridge	Harrison, CJ (corresponding author), Newcastle Univ, Northern Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	pc8@sanger.ac.uk; christine.harrison@newcastle.ac.uk	Moorman, Anthony/G-1468-2014; Moorman, Anthony/F-5518-2010; Teixeira, Manuel António Rodrigues/E-4885-2011; Teixeira, Manuel AC/AAZ-7251-2020	Moorman, Anthony/0000-0002-9781-6107; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Teixeira, Manuel AC/0000-0002-1959-0624; McNally, Richard/0000-0001-6685-6467; Rand, Vikki/0000-0002-2198-8949; Joseph, Olivia/0000-0002-5751-2002; Vandenberghe, Peter/0000-0003-4719-1935; Van Loo, Peter/0000-0003-0292-1949; Harrison, Christine/0000-0002-0526-6794	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Leukaemia and Lymphoma Research Specialist Programme; European Research Council [249891]; Research Foundation - Flanders (F.W.O.); NATIONAL CANCER INSTITUTE [U10CA098543, U10CA180886] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Leukaemia and Lymphoma Research Specialist Programme; European Research Council(European Research Council (ERC)European Commission); Research Foundation - Flanders (F.W.O.)(FWO); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank member laboratories of the United Kingdom Cancer Cytogenetic Group (UKCCG) for providing cytogenetic data and material. Primary childhood leukaemia samples used in this study were provided by the Leukaemia and Lymphoma Research Childhood Leukaemia Cell Bank working with the laboratory teams in the Bristol Genetics Laboratory, Southmead Hospital, Bristol, UK; Molecular Biology Laboratory, Royal Hospital for Sick Children, Glasgow, UK; Molecular Haematology Laboratory, Royal London Hospital, London, UK; Molecular Genetics Service and Sheffield Children's Hospital, Sheffield, UK. We also thank all the members of the NCRI Childhood Cancer and Leukaemia Group (CCLG) Leukaemia Subgroup for access to material and data on clinical trial patients. This work was supported by the Wellcome Trust (077012/Z/05/Z); Leukaemia and Lymphoma Research Specialist Programme and European Research Council (249891). P.J.C. has a Wellcome Trust Senior Clinical Research Fellowship (WT088340MA). P. V. L. is supported by a postdoctoral research fellowship and P. V. is a Senior Clinical Investigator funded by the Research Foundation - Flanders (F.W.O.). P. S. is funded by the European Research Council (grant 249891).	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; HAMERTON JL, 1975, CLIN GENET, V8, P223; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Heerema NA, 2013, J CLIN ONCOL, V31, P3397, DOI 10.1200/JCO.2013.49.1308; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Moorman AV, 2007, BLOOD, V109, P2327, DOI 10.1182/blood-2006-08-040436; Moorman AV, 2013, J CLIN ONCOL, V31, P3389, DOI 10.1200/JCO.2013.48.9377; Rand V, 2011, BLOOD, V117, P6848, DOI 10.1182/blood-2011-01-329961; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Robinson HM, 2007, GENE CHROMOSOME CANC, V46, P318, DOI 10.1002/gcc.20412; Sinclair PB, 2011, HUM MOL GENET, V20, P2591, DOI 10.1093/hmg/ddr159; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stiller CA, 2008, BRIT J CANCER, V98, P1006, DOI 10.1038/sj.bjc.6604237; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Strefford JC, 2006, P NATL ACAD SCI USA, V103, P8167, DOI 10.1073/pnas.0602360103	21	176	179	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					98	+		10.1038/nature13115	http://dx.doi.org/10.1038/nature13115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670643	Green Accepted, Green Submitted			2022-12-24	WOS:000333609900050
J	Guydosh, NR; Green, R				Guydosh, Nicholas R.; Green, Rachel			Dom34 Rescues Ribosomes in 3 ' Untranslated Regions	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA DECAY; NO-GO DECAY; QUALITY-CONTROL PATHWAYS; IN-VIVO; TRANSLATIONAL ATTENUATION; SACCHAROMYCES-CEREVISIAE; SUBUNIT DISSOCIATION; NASCENT PEPTIDES; YEAST DOM34	Ribosomes that stall before completing peptide synthesis must be recycled and returned to the cytoplasmic pool. The protein Dom34 and cofactors Hbs1 and Rli1 can dissociate stalled ribosomes in vitro, but the identity of targets in the cell is unknown. Here, we extend ribosome profiling methodology to reveal a high-resolution molecular characterization of Dom34 function in vivo. Dom34 removes stalled ribosomes from truncated mRNAs, but, in contrast, does not generally dissociate ribosomes on coding sequences known to trigger stalling, such as polyproline. We also show that Dom34 targets arrested ribosomes near the ends of 3' UTRs. These ribosomes appear to gain access to the 3' UTR via a mechanism that does not require decoding of the mRNA. These results suggest that ribosomes frequently enter downstream noncoding regions and that Dom34 carries out the important task of rescuing them.	[Guydosh, Nicholas R.; Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu	Guydosh, Nicholas/AFQ-5807-2022	Guydosh, Nicholas/0000-0001-7116-326X	NIH; HHMI; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059425, R01GM059425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Allen Buskirk and Kristin Smith-Koutmou for comments on the manuscript; Nick Ingolia, Gloria Brar, and Jonathan Weissman for protocols and helpful discussions about ribosome profiling; Toshi Inada for thoughtful discussions; Roy Parker for wild-type, dom34 Delta, and hbs1 Delta yeast strains; Peter Walter for informative discussions about HAC1; Mick Tuite for advice on creating the suppressor tRNA strain; Alan Hinnebusch for advice on use of 3-AT; Pavan Vaidyanathan for advice on performing the runoff experiment; Grace Yeo for preliminary calculations of reading frame and help with choosing rRNA subtraction oligos; and Carla Connelly for assistance with tetrad dissection. The work was supported by the NIH and HHMI (R.G.) and the Damon Runyon Cancer Research Foundation (N.R.G.).	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bhattacharya A, 2010, MOL CELL BIOL, V30, P5562, DOI 10.1128/MCB.00618-10; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Davis L, 1998, GENETICS, V149, P45; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; Fernandez-Ricaud L, 2007, NUCLEIC ACIDS RES, V35, pD463, DOI 10.1093/nar/gkl1029; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gandhi R, 2008, J BIOL CHEM, V283, P32218, DOI 10.1074/jbc.M803785200; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Harigaya Y, 2012, P NATL ACAD SCI USA, V109, P11764, DOI 10.1073/pnas.1119741109; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; KLOPOTOW.T, 1965, ARCH BIOCHEM BIOPHYS, V112, P562, DOI 10.1016/0003-9861(65)90096-2; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; PIERCE MK, 1987, MUTAT RES, V182, P65, DOI 10.1016/0165-1161(87)90055-0; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Skabkin MA, 2013, MOL CELL, V51, P249, DOI 10.1016/j.molcel.2013.05.026; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; van den Elzen AMG, 2010, NAT STRUCT MOL BIOL, V17, P1446, DOI 10.1038/nsmb.1963; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	64	232	234	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					950	962		10.1016/j.cell.2014.02.006	http://dx.doi.org/10.1016/j.cell.2014.02.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581494	Green Accepted, Bronze			2022-12-24	WOS:000332083900013
J	Thacker, D; Mohibullah, N; Zhu, X; Keeney, S				Thacker, Drew; Mohibullah, Neeman; Zhu, Xuan; Keeney, Scott			Homologue engagement controls meiotic DNA break number and distribution	NATURE			English	Article							DOUBLE-STRAND BREAKS; SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; MUTS HOMOLOG; ZMM PROTEINS; RECOMBINATION; MEIOSIS; PACHYTENE; MUTANTS	Meiotic recombination promotes genetic diversification as well as pairing and segregation of homologous chromosomes, but the double-strand breaks (DSBs) that initiate recombination are dangerous lesions that can cause mutation or meiotic failure. How cells control DSBs to balance between beneficial and deleterious outcomes is not well understood. Here we test the hypothesis that DSB control involves a network of intersecting negative regulatory circuits. Using multiple complementary methods, we show that DSBs form in greater numbers in Saccharomyces cerevisiae cells lacking ZMM proteins, a suite of recombination-promoting factors traditionally regarded as acting strictly downstream of DSB formation. ZMM-dependent DSB control is genetically distinct from a pathway tying break formation to meiotic progression through the Ndt80 transcription factor. These counterintuitive findings suggest that homologous chromosomes that have successfully engaged one another stop making breaks. Genome-wide DSB maps uncover distinct responses by different subchromosomal domains to the ZMM mutation zip3 (also known as cst9), and show that Zip3 is required for the previously unexplained tendency of DSB density to vary with chromosome size. Thus, feedback tied to ZMM function contributes in unexpected ways to spatial patterning of recombination.	[Thacker, Drew; Mohibullah, Neeman; Zhu, Xuan; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Thacker, Drew; Zhu, Xuan; Keeney, Scott] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Mohibullah, Neeman; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417; Zhu, Xuan/0000-0002-8422-2828	National Institutes of Health [R01 GM058673]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Burgess, N. Hunter, N. Kleckner, K. Ohta, M. Rout and A. Shinohara for strains or epitope tagging constructs; F. Klein for sharing data; S. Shuman for gifts of T4 RNA ligase; A. Viale and the Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Laboratory for sequencing; and N. Socci and the MSKCC Bioinformatics Core for assistance mapping Spo11 oligos. This work was supported by National Institutes of Health grant R01 GM058673. S. K. is an Investigator of the Howard Hughes Medical Institute.	Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bhagat R, 2004, CYTOGENET GENOME RES, V107, P160, DOI 10.1159/000080594; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 2013, CURR OPIN GENET DEV, V23, P147, DOI 10.1016/j.gde.2012.12.002; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Cotton VE, 2009, METHODS MOL BIOL, V557, P3, DOI 10.1007/978-1-59745-527-5_1; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Henzel JV, 2011, GENETICS, V187, P685, DOI 10.1534/genetics.110.124958; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Neale MJ, 2009, METHODS MOL BIOL, V557, P183, DOI 10.1007/978-1-59745-527-5_12; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Pineda-Krch M, 2005, GENETICS, V169, P2319, DOI 10.1534/genetics.104.034363; R Development Core Team, 2012, R LANG ENV STAT COMP; Rockmill B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003932; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Rosu S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003674; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Serrentino ME, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003416; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Stamper EL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003679; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Thacker D, 2012, THESIS CORNELL U; Tsubouchi T, 2006, DEV CELL, V10, P809, DOI 10.1016/j.devcel.2006.04.003; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108	54	125	125	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					241	+		10.1038/nature13120	http://dx.doi.org/10.1038/nature13120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24717437	Green Accepted			2022-12-24	WOS:000337032400044
J	Corbett, AJ; Eckle, SBG; Birkinshaw, RW; Liu, LG; Patel, O; Mahony, J; Chen, ZJ; Reantragoon, R; Meehan, B; Cao, HW; Williamson, NA; Strugnell, RA; Van Sinderen, D; Mak, JYW; Fairlie, DP; Kjer-Nielsen, L; Rossjohn, J; McCluskey, J				Corbett, Alexandra J.; Eckle, Sidonia B. G.; Birkinshaw, Richard W.; Liu, Ligong; Patel, Onisha; Mahony, Jennifer; Chen, Zhenjun; Reantragoon, Rangsima; Meehan, Bronwyn; Cao, Hanwei; Williamson, Nicholas A.; Strugnell, Richard A.; Van Sinderen, Douwe; Mak, Jeffrey Y. W.; Fairlie, David P.; Kjer-Nielsen, Lars; Rossjohn, Jamie; McCluskey, James			T-cell activation by transitory neo-antigens derived from distinct microbial pathways	NATURE			English	Article							VITAMIN-B METABOLITES; SALMONELLA-TYPHIMURIUM; RECOGNITION; MR1; RIBOFLAVIN; BIOSYNTHESIS; SYNTHASE	T cells discriminate between foreign and host molecules by recognizing distinct microbial molecules, predominantly peptides and lipids(1-4). Riboflavin precursors found in many bacteria and yeast also selectively activate mucosal-associated invariant T (MAIT) cells(5,6), an abundant population of innate-like T cells in humans(7-9). However, the genesis of these small organic molecules and their mode of presentation to MAIT cells by the major histocompatibility complex (MHC)-related protein MR1 (ref. 8) are not well understood. Here we show that MAIT-cell activation requires key genes encoding enzymes that form 5-amino-6-D-ribitylaminouracil (5-A-RU), an early intermediate in bacterial riboflavin synthesis. Although 5-A-RU does not bind MR1 or activate MAIT cells directly, it does form potent MAIT-activating antigens via non-enzymatic reactions with small molecules, such as glyoxal and methylglyoxal, which are derived from other metabolic pathways. The MAIT antigens formed by the reactions between 5-A-RU and glyoxal/methylglyoxal were simple adducts, 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), respectively, which bound to MR1 as shown by crystal structures of MAIT TCR ternary complexes. Although 5-OP-RU and 5-OE-RU are unstable intermediates, they became trapped by MR1 as reversible covalent Schiff base complexes. Mass spectra supported the capture by MR1 of 5-OP-RU and 5-OE-RU from bacterial cultures that activate MAIT cells, but not from non-activating bacteria, indicating that these MAIT antigens are present in a range of microbes. Thus, MR1 is able to capture, stabilize and present chemically unstable pyrimidine intermediates, which otherwise convert to lumazines, as potent antigens to MAIT cells. These pyrimidine adducts are microbial signatures for MAIT-cell immunosurveillance.	[Corbett, Alexandra J.; Eckle, Sidonia B. G.; Chen, Zhenjun; Reantragoon, Rangsima; Meehan, Bronwyn; Cao, Hanwei; Strugnell, Richard A.; Kjer-Nielsen, Lars; McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Birkinshaw, Richard W.; Patel, Onisha; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Liu, Ligong; Mak, Jeffrey Y. W.; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Mahony, Jennifer; Van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Williamson, Nicholas A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Fairlie, David P.] Univ Queensland, Australian Res Council Ctr Excellence Adv Mol Ima, Brisbane, Qld 4072, Australia; [Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Monash University; University of Queensland; University College Cork; University of Melbourne; University College Cork; University of Queensland; Monash University; Cardiff University	Fairlie, DP (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia.	d.fairlie@imb.uq.edu.au; lkn@unimelb.edu.au; jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	Birkinshaw, Richard/AAC-7809-2019; Fairlie, David P/F-8865-2014; Reantragoon, Rangsima/GON-4001-2022; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; mahony, jennifer/AAG-8357-2020; Williamson, Nicholas A/O-9812-2016; liu, ligong/B-1690-2010; Eckle, Sidonia BG/O-8146-2014; Van Sinderen, Douwe/A-6778-2015; Mak, Jeffrey YW/E-8764-2011; Corbett, Alexandra/A-1225-2019	Birkinshaw, Richard/0000-0003-1825-0182; Fairlie, David P/0000-0002-7856-8566; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; mahony, jennifer/0000-0001-5846-6303; Williamson, Nicholas A/0000-0002-2173-3452; liu, ligong/0000-0002-2693-1896; Eckle, Sidonia BG/0000-0003-0766-171X; Van Sinderen, Douwe/0000-0003-1823-7957; Mak, Jeffrey YW/0000-0002-8011-4539; Corbett, Alexandra/0000-0003-1618-4337; Patel, Onisha/0000-0001-6701-7139; Meehan, Bronwyn/0000-0001-7368-2979; Strugnell, Richard/0000-0003-0614-5641	Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC); Science Foundation Ireland (SFI) [08/IN.1/B1909]; ARC; NHMRC [1027369]; NHMRC Australia	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Science Foundation Ireland (SFI)(Science Foundation Ireland); ARC(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank the staff of the Monash crystallization facility and the Australian Synchrotron for assistance with crystallization and data collection, respectively, and M. J. McConville, P. O'Donnell and C.-S. Ang from the University of Melbourne Bio21 Institute mass spectrometry platform for assistance with mass spectrometry experiments. The Australian Research Council (ARC), a Program Grant and Project Grant of the National Health and Medical Research Council of Australia (NHMRC) supported this research; D. V. S. is a recipient of a Science Foundation Ireland (SFI) Principal Investigator award (ref. no. 08/IN.1/B1909); O.P. was supported by an ARC Future Fellowship; D. P. F. was supported by an NHMRC Senior Principal Research Fellowship (1027369); J. R. was supported by an NHMRC Australia Fellowship.	Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Burgess C, 2004, APPL ENVIRON MICROB, V70, P5769, DOI 10.1128/AEM.70.10.5769-5777.2004; Cushman M, 2002, J ORG CHEM, V67, P5807, DOI 10.1021/jo0201631; Eckle SBG, 2013, CURR OPIN IMMUNOL, V25, P653, DOI 10.1016/j.coi.2013.07.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang SX, 2005, J BIOL CHEM, V280, P21183, DOI 10.1074/jbc.M501087200; Kis K, 2001, J ORG CHEM, V66, P2555, DOI 10.1021/jo001120s; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; Plaut GWE, 1971, METHODS ENZYMOL B, V18, P515; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; STRUGNELL R, 1992, INFECT IMMUN, V60, P3994, DOI 10.1128/IAI.60.10.3994-4002.1992; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wang Y, 2012, CHEM SOC REV, V41, P4140, DOI 10.1039/c2cs35025d; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	27	501	508	7	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					361	+		10.1038/nature13160	http://dx.doi.org/10.1038/nature13160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24695216				2022-12-24	WOS:000336121200039
J	Vogelstein, JT; Park, Y; Ohyama, T; Kerr, RA; Truman, JW; Priebe, CE; Zlatic, M				Vogelstein, Joshua T.; Park, Youngser; Ohyama, Tomoko; Kerr, Rex A.; Truman, James W.; Priebe, Carey E.; Zlatic, Marta			Discovery of Brainwide Neural-Behavioral Maps via Multiscale Unsupervised Structure Learning	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; COMMAND NEURON; DROSOPHILA; PROTEIN; TOOLS	A single nervous system can generate many distinct motor patterns. Identifying which neurons and circuits control which behaviors has been a laborious piecemeal process, usually for one observer-defined behavior at a time. We present a fundamentally different approach to neuron-behavior mapping. We optogenetically activated 1054 identified neuron lines in Drosophila larvae and tracked the behavioral responses from 37,780 animals. Application of multiscale unsupervised structure learning methods to the behavioral data enabled us to identify 29 discrete, statistically distinguishable, observer-unbiased behavioral phenotypes. Mapping the neural lines to the behavior(s) they evoke provides a behavioral reference atlas for neuron subsets covering a large fraction of larval neurons. This atlas is a starting point for connectivity- and activity-mapping studies to further investigate the mechanisms by which neurons mediate diverse behaviors.	[Vogelstein, Joshua T.; Park, Youngser; Priebe, Carey E.] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD 21218 USA; [Vogelstein, Joshua T.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA; [Ohyama, Tomoko; Kerr, Rex A.; Truman, James W.; Zlatic, Marta] Janelia Farm Res Campus, Ashburn, VA 20147 USA	Johns Hopkins University; Duke University; Howard Hughes Medical Institute	Priebe, CE (corresponding author), Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD 21218 USA.	cep@jhu.edu; zlaticm@janelia.hhmi.org	Vogelstein, Joshua/AAG-5489-2019	Vogelstein, Joshua/0000-0003-2487-6237; Park, Youngser/0000-0002-3978-5533; Zlatic, Marta/0000-0002-3149-2250; Ohyama, Tomoko/0000-0003-1697-1138	Larval Olympiad Project and Janelia HHMI; XDATA program of the Defense Advanced Research Projects Agency [FA8750-12-2-0303]; National Security Science and Engineering Faculty Fellowship	Larval Olympiad Project and Janelia HHMI; XDATA program of the Defense Advanced Research Projects Agency; National Security Science and Engineering Faculty Fellowship	We thank G. M. Rubin, B. D. Pfeiffer, A. Nern, and B. Condron for fly stocks; B. D. Mensh for exceptionally helpful comments on the manuscript; A. Cardona, J. H. Simpson, and K. Branson for helpful discussions; C. Sullivan and A. Mondal for help with editing; H. Li and Fly Light Project Team at Janelia HHMI for images of neuronal lines; Janelia Fly Core for setting up the fly crosses for the activation screen; and Janelia Scientific Computing for help with data processing and storage, especially E. Trautman, R. Svirskas, and D. Olbris. Supported by the Larval Olympiad Project and Janelia HHMI, the XDATA program of the Defense Advanced Research Projects Agency administered through Air Force Research Laboratory contract FA8750-12-2-0303, and a National Security Science and Engineering Faculty Fellowship. All raw data, data derivatives, and code are freely available from http://openconnecto.me/behaviotypes.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/nmeth.2434, 10.1038/NMETH.2434]; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Allard WK, 2012, APPL COMPUT HARMON A, V32, P435, DOI 10.1016/j.acha.2011.08.001; [Anonymous], MODERN MULTIDIMENSIO; Bendich P, 2007, ANN IEEE SYMP FOUND, P536, DOI 10.1109/FOCS.2007.45; Benjamini Y, 2001, ANN STAT, V29, P1165; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Giles KE, 2008, COMPUTATION STAT, V23, P497, DOI 10.1007/s00180-007-0090-8; Good P. I., 2010, PERMUTATION PARAMETR; Healy D. M., 2003, MOD SIGNAL PROCESS, V46, P223; Hedwig B, 2000, J NEUROPHYSIOL, V83, P712, DOI 10.1152/jn.2000.83.2.712; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kabra M, 2013, NAT METHODS, V10, P64, DOI [10.1038/NMETH.2281, 10.1038/nmeth.2281]; Kane EA, 2013, P NATL ACAD SCI USA, V110, pE3868, DOI 10.1073/pnas.1215295110; Karakos D, 2005, INT CONF ACOUST SPEE, P1081; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KUPFERMANN I, 1978, BEHAV BRAIN SCI, V1, P3, DOI 10.1017/S0140525X00059057; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Priebe CE, 2004, IEEE T PATTERN ANAL, V26, P699, DOI 10.1109/TPAMI.2004.12; Priebe CE, 2001, IEEE T PATTERN ANAL, V23, P404, DOI 10.1109/34.917575; Schrodel T, 2013, NAT METHODS, V10, P1013, DOI [10.1038/NMETH.2637, 10.1038/nmeth.2637]; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Wu CWH, 2011, NEURON, V70, P229, DOI 10.1016/j.neuron.2011.03.010	34	138	140	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					386	392		10.1126/science.1250298	http://dx.doi.org/10.1126/science.1250298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24674869				2022-12-24	WOS:000334867800034
J	Li, GW; Burkhardt, D; Gross, C; Weissman, JS				Li, Gene-Wei; Burkhardt, David; Gross, Carol; Weissman, Jonathan S.			Quantifying Absolute Protein Synthesis Rates Reveals Principles Underlying Allocation of Cellular Resources	CELL			English	Article							SINGLE-MOLECULE LEVEL; ESCHERICHIA-COLI; GENE-EXPRESSION; UNEQUAL SYNTHESIS; ALPHA-SPECTRIN; BETA-SPECTRIN; LIVING CELLS; IN-VIVO; TRANSLATION; YEAST	Quantitative views of cellular functions require precise measures of rates of biomolecule production, especially proteins-the direct effectors of biological processes. Here, we present a genome-wide approach, based on ribosome profiling, for measuring absolute protein synthesis rates. The resultant E. coli data set transforms our understanding of the extent to which protein synthesis is precisely controlled to optimize function and efficiency. Members of multiprotein complexes are made in precise proportion to their stoichiometry, whereas components of functional modules are produced differentially according to their hierarchical role. Estimates of absolute protein abundance also reveal principles for optimizing design. These include how the level of different types of transcription factors is optimized for rapid response and how a metabolic pathway (methionine biosynthesis) balances production cost with activity requirements. Our studies reveal how general principles, important both for understanding natural systems and for synthesizing new ones, emerge from quantitative analyses of protein synthesis.	[Li, Gene-Wei; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Li, Gene-Wei; Burkhardt, David; Gross, Carol; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Li, Gene-Wei; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Burkhardt, David; Gross, Carol] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Burkhardt, David; Gross, Carol] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Li, GW (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	gene-wei.li@ucsf.edu; weissman@cmp.ucsf.edu		Li, Gene-Wei/0000-0001-7036-8511; Weissman, Jonathan/0000-0003-2445-670X	Helen Hay Whitney Foundation; NIH [GM105913]; NIH Center for RNA Systems Biology; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM105913, P50GM102706, K99GM105913] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Qi for providing material for CRISPRi knockdown; R. Milo, K. C. Huang, J. Elf, J. Dunn, G. Brar, O. Brandman, C. Jan, J. Rabinowitz, and members of the J.S.W. and C.G. labs for discussions; and P. Choi and H. Chen for critical reading of the manuscript. We also thank J. Lund and E. Chow for help on sequencing and C. Reiger and M. DeVera for administrative support. This research was supported by the Helen Hay Whitney Foundation (to G.-W.L.), NIH Pathway to Independence Award (GM105913 to G.-W.L.), NIH Center for RNA Systems Biology (to J.S.W.), and Howard Hughes Medical Institute (to J.S.W.).	Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; BAUGHMAN G, 1983, CELL, V34, P979, DOI 10.1016/0092-8674(83)90555-X; BLIKSTAD I, 1983, CELL, V32, P1081, DOI 10.1016/0092-8674(83)90292-1; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; BRUSILOW WSA, 1982, J BACTERIOL, V151, P1363, DOI 10.1128/JB.151.3.1363-1371.1982; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; DENNIS PP, 1974, J MOL BIOL, V88, P25, DOI 10.1016/0022-2836(74)90293-9; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fell D., 1997, UNDERSTANDING CONTRO; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; GROSSMAN AD, 1987, GENE DEV, V1, P179, DOI 10.1101/gad.1.2.179; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hart Y, 2011, MOL CELL, V41, P117, DOI 10.1016/j.molcel.2010.12.023; Hu JC, 2014, NUCLEIC ACIDS RES, V42, pD677, DOI 10.1093/nar/gkt1203; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; LARRABEE KL, 1980, J BIOL CHEM, V255, P4125; LEHNERT ME, 1988, J CELL BIOL, V107, P413, DOI 10.1083/jcb.107.2.413; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; PETERSEN C, 1990, J BACTERIOL, V172, P431, DOI 10.1128/JB.172.1.431-436.1990; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Quax TEF, 2013, CELL REP, V4, P938, DOI 10.1016/j.celrep.2013.07.049; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHAPIRO AL, 1966, NATURE, V211, P243, DOI 10.1038/211243a0; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Shinar G, 2006, P NATL ACAD SCI USA, V103, P3999, DOI 10.1073/pnas.0506610103; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; von Hippel PH, 2007, ANNU REV BIOPH BIOM, V36, P79, DOI 10.1146/annurev.biophys.34.040204.144521; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446	63	749	760	8	137	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					624	635		10.1016/j.cell.2014.02.033	http://dx.doi.org/10.1016/j.cell.2014.02.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766808	Bronze, Green Accepted			2022-12-24	WOS:000335392100012
J	Wang, LX; Zhang, H; Ruan, YZ; Chin, DP; Xia, YY; Cheng, SM; Chen, MT; Zhao, YL; Jiang, SW; Du, X; He, GX; Li, J; Wang, SF; Chen, W; Xu, CH; Huang, F; Liu, XQ; Wang, Y				Wang, Lixia; Zhang, Hui; Ruan, Yunzhou; Chin, Daniel P.; Xia, Yinyin; Cheng, Shiming; Chen, Mingting; Zhao, Yanlin; Jiang, Shiwen; Du, Xin; He, Guangxue; Li, Jun; Wang, Shengfen; Chen, Wei; Xu, Caihong; Huang, Fei; Liu, Xiaoqiu; Wang, Yu			Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data	LANCET			English	Article							PUBLIC-HEALTH SYSTEM; PROGRESS	Background China scaled up a tuberculosis control programme (based on the directly observed treatment, short-course [DOTS] strategy) to cover half the population during the 1990s, and to the entire population after 2000. We assessed the effect of the programme. Methods In this longitudinal analysis, we compared data from three national tuberculosis prevalence surveys done in 1990, 2000, and 2010. The 2010 survey screened 252 940 eligible individuals aged 15 years and older at 176 investigation points, chosen by stratified random sampling from all 31 mainland provinces. All individuals had chest radiographs taken. Those with abnormal radiographs, persistent cough, or both, were classified as having suspected tuberculosis. Tuberculosis was diagnosed by chest radiograph, sputum-smear microscopy, and culture. Trained staff interviewed each patient with tuberculosis. The 1990 and 2000 surveys were reanalysed and compared with the 2010 survey. Findings From 1990 to 2010, the prevalence of smear-positive tuberculosis decreased from 170 cases (95% CI 166-174) to 59 cases (49-72) per 100 000 population. During the 1990s, smear-positive prevalence fell only in the provinces with the DOTS programme; after 2000, prevalence decreased in all provinces. The percentage reduction in smear-positive prevalence was greater for the decade after 2000 than the decade before (57% vs 19%; p<0.0001). 70% of the total reduction in smear-positive prevalence (78 of 111 cases per 100 000 population) occurred after 2000. Of these cases, 68 (87%) were in known cases-ie, cases diagnosed with tuberculosis before the survey. Of the known cases, the proportion treated by the public health system (using the DOTS strategy) increased from 59 (15%) of 370 cases in 2000 to 79 (66%) of 123 cases in 2010, contributing to reduced proportions of treatment default (from 163 [43%] of 370 cases to 35 [22%] of 123 cases) and retreatment cases (from 312 [84%] of 374 cases to 48 [31%] of 137 cases; both p<0.0001). Interpretation In 20 years, China more than halved its tuberculosis prevalence. Marked improvement in tuberculosis treatment, driven by a major shift in treatment from hospitals to the public health centres (that implemented the DOTS strategy) was largely responsible for this epidemiological effect.	[Wang, Lixia; Zhang, Hui; Ruan, Yunzhou; Xia, Yinyin; Cheng, Shiming; Chen, Mingting; Zhao, Yanlin; Jiang, Shiwen; Du, Xin; He, Guangxue; Li, Jun; Wang, Shengfen; Chen, Wei; Xu, Caihong; Huang, Fei; Liu, Xiaoqiu; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China; [Chin, Daniel P.] Bill & Melinda Gates Fdn, China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.	wangyu@chinacdc.cn			Chinese Ministry of Health	Chinese Ministry of Health	Chinese Ministry of Health.	Chen XY, 2004, LANCET, V364, P417; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Diel R, 2013, EUR RESPIR J, V42, P785, DOI 10.1183/09031936.00205512; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Dye C, 2013, NATURE, V502, pS13, DOI 10.1038/502S13a; He GX, 2011, CLIN INFECT DIS, V52, pE153, DOI 10.1093/cid/cir075; Li Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-156; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Ministry of Public Health of the People's Republic of China, 2000, REP NAT RAND SURV EP; Ministry of Public Health of the People's Republic of China, 1990, NAT RAND SURV EP TUB; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Tupasi TE, 2009, INT J TUBERC LUNG D, V13, P1224; UNAIDS, 2012 CHIN AIDS RESP; Wan LY, 2007, B WORLD HEALTH ORGAN, V85, P401, DOI 10.2471/BLT.06.036376; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WHO, DEV POST2015 TB STRA; WHO, 13 M STRAT TECHN ADV; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2007, ASS TB PREV POP BAS; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1	22	363	391	7	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2057	2064		10.1016/S0140-6736(13)62639-2	http://dx.doi.org/10.1016/S0140-6736(13)62639-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24650955				2022-12-24	WOS:000337292400025
J	Lee, HM; Brott, BK; Kirkby, LA; Adelson, JD; Cheng, S; Feller, MB; Datwani, A; Shatz, CJ				Lee, Hanmi; Brott, Barbara K.; Kirkby, Lowry A.; Adelson, Jaimie D.; Cheng, Sarah; Feller, Marla B.; Datwani, Akash; Shatz, Carla J.			Synapse elimination and learning rules co-regulated by MHC class I H2-D-b	NATURE			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTORS; RETINAL WAVES; RETINOGENICULATE; PLASTICITY; LTP; CNS; TRANSMISSION; SEGREGATION; REQUIREMENT	The formation of precise connections between retina and lateral geniculate nucleus (LGN) involves the activity-dependent elimination of some synapses, with strengthening and retention of others. Here we show that the major histocompatibility complex (MHC) class I molecule H2-D-b is necessary and sufficient for synapse elimination in the retinogeniculate system. In mice lacking both H2-K-b and H2-D-b ((KDb-/-)-D-b), despite intact retinal activity and basal synaptic transmission, the developmentally regulated decrease in functional convergence of retinal ganglion cell synaptic inputs to LGN neurons fails and eye-specific layers do not form. Neuronal expression of just H2-Db in (KDb-/-)-D-b mice rescues both synapse elimination and eye-specific segregation despite a compromised immune system. When patterns of stimulation mimicking endogenous retinal waves are used to probe synaptic learning rules at retinogeniculate synapses, long-term potentiation (LTP) is intact but long-term depression (LTD) is impaired in (KDb-/-)-D-b mice. This change is due to an increase in Ca2+-permeable AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors. Restoring H2-D-b to (KDb-/-)-D-b neurons renders AMPA receptors Ca2+ impermeable and rescues LTD. These observations reveal an MHC-class-I-mediated link between developmental synapse pruning and balanced synaptic learning rules enabling both LTD and LTP, and demonstrate a direct requirement for H2-D-b in functional and structural synapse pruning in CNS neurons.	[Lee, Hanmi; Brott, Barbara K.; Adelson, Jaimie D.; Cheng, Sarah; Datwani, Akash; Shatz, Carla J.] James H Clark Ctr, Dept Biol & Neurobiol, Stanford, CA 94305 USA; [Lee, Hanmi; Brott, Barbara K.; Adelson, Jaimie D.; Cheng, Sarah; Datwani, Akash; Shatz, Carla J.] James H Clark Ctr, Dept BioX, Stanford, CA 94305 USA; [Kirkby, Lowry A.; Feller, Marla B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kirkby, Lowry A.; Feller, Marla B.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shatz, CJ (corresponding author), James H Clark Ctr, Dept Biol & Neurobiol, 318 Campus Dr, Stanford, CA 94305 USA.	cshatz@stanford.edu		Steinmetz, Jaimie/0000-0003-2397-4070	NIH [R01 MH071666, EY02858, RO1 EY13528]; G. Harold and Leila Y. Mathers Charitable Foundation; NDSEG; NSF; NATIONAL EYE INSTITUTE [R37EY002858, R01EY002858, R01EY013528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071666, T32MH020016] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NDSEG; NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Shatz laboratory for helpful comments. For technical assistance, we thank N. Sotelo-Kury, C. Chechelski and P. Kemper. For training in retinogeniculate slice methods, we thank C. Chen, P. Kanold and D. Butts. This work was supported by NIH grants R01 MH071666 and EY02858, and the G. Harold and Leila Y. Mathers Charitable Foundation (C.J.S.); NIH grant RO1 EY13528 (M. B. F.); NDSEG and NSF Graduate Research Fellowships (J.D.A.); and an NSF Graduate Research Fellowship (L.A.K.).	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Bastrikova N, 2008, P NATL ACAD SCI USA, V105, P3123, DOI 10.1073/pnas.0800027105; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Hohnke CD, 2000, J NEUROSCI, V20, P8051; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RALL GF, 1995, J EXP MED, V182, P1201, DOI 10.1084/jem.182.5.1201; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1984, J NEUROSCI, V4, P1378; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Toyoda H, 2007, J CELL PHYSIOL, V211, P336, DOI 10.1002/jcp.20940; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Viesselmann C, 2011, JOVE-J VIS EXP, DOI 10.3791/2373; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziburkus J, 2009, J NEUROPHYSIOL, V102, P3082, DOI 10.1152/jn.90618.2008	49	148	152	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					195	+		10.1038/nature13154	http://dx.doi.org/10.1038/nature13154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24695230	Green Submitted, Green Accepted			2022-12-24	WOS:000335454300032
J	Soares, B; Rajao, R; Macedo, M; Carneiro, A; Costa, W; Coe, M; Rodrigues, H; Alencar, A				Soares-Filho, Britaldo; Rajao, Raoni; Macedo, Marcia; Carneiro, Arnaldo; Costa, William; Coe, Michael; Rodrigues, Hermann; Alencar, Ane			LAND USE Cracking Brazil's Forest Code	SCIENCE			English	Editorial Material							CONSERVATION		[Soares-Filho, Britaldo; Rajao, Raoni; Macedo, Marcia; Costa, William; Rodrigues, Hermann] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil; [Macedo, Marcia; Coe, Michael] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Carneiro, Arnaldo] Secretaria Assuntos Estrateg Presidencia Republ, BR-70052900 Brasilia, DF, Brazil; [Alencar, Ane] Inst Pesquisa Ambiental Amazonia, BR-71503505 Brasilia, DF, Brazil	Universidade Federal de Minas Gerais; Woods Hole Research Center	Soares, B (corresponding author), Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil.	britaldo@csr.ufmg.br	/AAX-3684-2020; Noojipady, Praveen/B-2511-2010; Rajão, Raoni/GPX-3719-2022; Macedo, Marcia N/N-3044-2017	/0000-0001-5605-7469; Rajão, Raoni/0000-0002-1133-4837; Macedo, Marcia N/0000-0001-8102-5901; Silveira Soares Filho, Britaldo/0000-0002-7703-946X; Coe, Michael/0000-0002-7470-0697				[Anonymous], 2005, EC HUM WELL BEING SY; Cury R., 2011, MANUAL RESTAURO FLOR; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Rajao R, 2012, PUBLIC ADMIN DEVELOP, V32, P229, DOI 10.1002/pad.1620; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Stickler CM, 2013, P NATL ACAD SCI USA, V110, P9601, DOI 10.1073/pnas.1215331110	7	636	657	5	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					363	364		10.1126/science.1246663	http://dx.doi.org/10.1126/science.1246663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AF7BG	24763575				2022-12-24	WOS:000334867800023
J	Wietek, J; Wiegert, JS; Adeishvili, N; Schneider, F; Watanabe, H; Tsunoda, SP; Vogt, A; Elstner, M; Oertner, TG; Hegemann, P				Wietek, Jonas; Wiegert, J. Simon; Adeishvili, Nona; Schneider, Franziska; Watanabe, Hiroshi; Tsunoda, Satoshi P.; Vogt, Arend; Elstner, Marcus; Oertner, Thomas G.; Hegemann, Peter			Conversion of Channelrhodopsin into a Light-Gated Chloride Channel	SCIENCE			English	Article							ION SELECTIVITY	The field of optogenetics uses channelrhodopsins (ChRs) for light-induced neuronal activation. However, optimized tools for cellular inhibition at moderate light levels are lacking. We found that replacement of E90 in the central gate of ChR with positively charged residues produces chloride-conducting ChRs (ChloCs) with only negligible cation conductance. Molecular dynamics modeling unveiled that a high-affinity Cl--binding site had been generated near the gate. Stabilizing the open state dramatically increased the operational light sensitivity of expressing cells (slow ChloC). In CA1 pyramidal cells, ChloCs completely inhibited action potentials triggered by depolarizing current injections or synaptic stimulation. Thus, by inverting the charge of the selectivity filter, we have created a class of directly light-gated anion channels that can be used to block neuronal output in a fully reversible fashion.	[Wietek, Jonas; Adeishvili, Nona; Schneider, Franziska; Tsunoda, Satoshi P.; Vogt, Arend; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Wiegert, J. Simon; Oertner, Thomas G.] Ctr Mol Neurobiol Hamburg, Inst Synapt Physiol, D-20251 Hamburg, Germany; [Watanabe, Hiroshi; Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, D-76131 Karlsruhe, Germany	Humboldt University of Berlin; Helmholtz Association; Karlsruhe Institute of Technology	Oertner, TG (corresponding author), Ctr Mol Neurobiol Hamburg, Inst Synapt Physiol, Falkenried 94, D-20251 Hamburg, Germany.	thomas.oertner@zmnh.uni-hamburg.de; hegemann@rz.hu-berlin.de	Watanabe, Hiroshi/Q-3928-2019; Wietek, Jonas/AFQ-6404-2022; Wiegert, J. Simon/ABE-4199-2020; Tsunoda, Satoshi/AAN-7023-2021; Watanabe, Hiroshi/E-3724-2017; Oertner, Thomas/F-2214-2010; Wietek, Jonas/I-5911-2015; Elstner, Marcus/H-3463-2013; Vogt, Arend/M-4849-2015	Watanabe, Hiroshi/0000-0003-4379-8633; Wietek, Jonas/0000-0002-8079-7042; Watanabe, Hiroshi/0000-0003-4379-8633; Oertner, Thomas/0000-0002-2312-7528; Wietek, Jonas/0000-0002-8079-7042; Vogt, Arend/0000-0003-0925-0308; Wiegert, J. Simon/0000-0003-0893-9349; Tsunoda, Satoshi/0000-0003-3636-1521	Leibniz Graduate school; Deutsche Forschungsgemeinschaft [SFB1078, FOR1279, SPP1665]	Leibniz Graduate school; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Reh, A. Klein and I. Ohmert for excellent technical support and R. Schwarzer and A. Herrmann for assistance with confocal microscopy. This work was supported by the Leibniz Graduate school (A. V.) and the Deutsche Forschungsgemeinschaft (SFB1078, B2 to P. H., FOR1279 to M. E. and P. H., and SPP1665 to P. H. and T.G.O.).	Beglov D, 1997, J PHYS CHEM B, V101, P7821, DOI 10.1021/jp971083h; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Eisenhauer K, 2012, J BIOL CHEM, V287, P6904, DOI 10.1074/jbc.M111.327700; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Grossman N, 2011, IEEE T BIO-MED ENG, V58, P1742, DOI 10.1109/TBME.2011.2114883; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Ito S, 2014, J AM CHEM SOC, V136, P3475, DOI 10.1021/ja410836g; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kovalenko A, 1999, J CHEM PHYS, V110, P10095, DOI 10.1063/1.478883; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Plazzo AP, 2012, J BIOL CHEM, V287, P4818, DOI 10.1074/jbc.M111.326207; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Schneider F, 2013, BIOPHYS J, V105, P91, DOI 10.1016/j.bpj.2013.05.042; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Ullrich S, 2013, BIOL CHEM, V394, P271, DOI 10.1515/hsz-2012-0256; Watanabe H, 2013, J COMPUT CHEM, V34, P198, DOI 10.1002/jcc.23119; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Watanabe HC, 2012, J BIOL CHEM, V287, P7456, DOI 10.1074/jbc.M111.320309; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	29	239	250	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2014	344	6182					409	412		10.1126/science.1249375	http://dx.doi.org/10.1126/science.1249375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF7BG	24674867				2022-12-24	WOS:000334867800040
J	Ma, LM; Wu, YM; Qiu, Q; Scheerer, H; Moran, A; Yu, CR				Ma, Limei; Wu, Yunming; Qiu, Qiang; Scheerer, Hayley; Moran, Andrea; Yu, C. Ron			A Developmental Switch of Axon Targeting in the Continuously Regenerating Mouse Olfactory System	SCIENCE			English	Article							SENSORY MAP; NEURONAL-ACTIVITY; GLOMERULI; BULB; NEUROGENESIS; TOPOGRAPHY; EXPRESSION; PLASTICITY; ABLATION; ABSENCE	The mammalian olfactory system has the natural capacity to regenerate throughout the animal's life span. Despite constant neurogenesis, olfactory sensory neurons project to precise, stereotypical positions in the brain. Here, we identify a critical period of olfactory sensory axon targeting during postnatal development in mouse. Perturbing axon projection beyond postnatal day 7 permanently disrupts targeting specificity of the sensory neurons. In addition, we find that the establishment of the convergence map requires perinatal sensory neurons. Late-born neurons appear to connect with prospective glomeruli based on homotypic interactions among neurons expressing the same odorant receptor. Our results reveal a developmental switch in axon guidance and a mechanism of circuit integration of adult-born neurons.	[Ma, Limei; Wu, Yunming; Qiu, Qiang; Scheerer, Hayley; Moran, Andrea; Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Yu, C. Ron] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Yu, CR (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	cry@stowers.org			Stowers Institute	Stowers Institute	We thank L. Nay, E. S. Gillespie, and the Laboratory Animal Services at the Stowers Institute for technical assistance and S. Lomvardas, R. Axel, N. Ryba, and P. Mombaerts for sharing transgenic mice. We appreciate helpful discussions with H. Taniguchi, H. Sakano, Y. Zou, and members of the Yu lab. This work fulfills, in part, requirements for Y.W.'s Ph.D. thesis with the Open University, United Kingdom. This work is supported by funding from Stowers Institute.	Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Costanzo RM, 2005, CHEM SENSES, V30, pI133, DOI 10.1093/chemse/bjh150; COSTANZO RM, 1991, CIBA F SYMP, V160, P233; Costanzo RM, 2000, CHEM SENSES, V25, P199, DOI 10.1093/chemse/25.2.199; Costanzo RM, 1991, CIBA F SYMP, V160, P243; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; GRAZIADEI PPC, 1985, ANN NY ACAD SCI, V457, P127, DOI 10.1111/j.1749-6632.1985.tb20802.x; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Imai T, 2011, EUR J NEUROSCI, V34, P1647, DOI 10.1111/j.1460-9568.2011.07817.x; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Ma LM, 2012, P NATL ACAD SCI USA, V109, P5481, DOI 10.1073/pnas.1117491109; MACKAYSIM A, 1991, EUR J NEUROSCI, V3, P209, DOI 10.1111/j.1460-9568.1991.tb00081.x; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Royal SJ, 1999, J NEUROSCI, V19, P9856; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; St John JA, 2003, CHEM SENSES, V28, P773, DOI 10.1093/chemse/bjg068; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	31	51	52	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					194	197		10.1126/science.1248805	http://dx.doi.org/10.1126/science.1248805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723610				2022-12-24	WOS:000334096300034
J	Morais, VA; Haddad, D; Craessaerts, K; De Bock, PJ; Swerts, J; Vilain, S; Aerts, L; Overbergh, L; Grunewald, A; Seibler, P; Klein, C; Gevaert, K; Verstreken, P; De Strooper, B				Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; De Bock, Pieter-Jan; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Overbergh, Lut; Gruenewald, Anne; Seibler, Philip; Klein, Christine; Gevaert, Kris; Verstreken, Patrik; De Strooper, Bart			PINK1 Loss-of-Function Mutations Affect Mitochondrial Complex I Activity via NdufA10 Ubiquinone Uncoupling	SCIENCE			English	Article							PARKIN; DROSOPHILA; MITOPHAGY; PATHOLOGY; MACHINERY; MUTANTS; FISSION	Under resting conditions, Pink1 knockout cells and cells derived from patients with PINK1 mutations display a loss of mitochondrial complex I reductive activity, causing a decrease in the mitochondrial membrane potential. Analyzing the phosphoproteome of complex I in liver and brain from Pink1(-/-) mice, we found specific loss of phosphorylation of serine-250 in complex I subunit NdufA10. Phosphorylation of serine-250 was needed for ubiquinone reduction by complex I. Phosphomimetic NdufA10 reversed Pink1 deficits in mouse knockout cells and rescued mitochondrial depolarization and synaptic transmission defects in pink(B9)-null mutant Drosophila. Complex I deficits and adenosine triphosphate synthesis were also rescued in cells derived from PINK1 patients. Thus, this evolutionary conserved pathway may contribute to the pathogenic cascade that eventually leads to Parkinson's disease in patients with PINK1 mutations.	[Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Morais, Vanessa A.; Haddad, Dominik; Craessaerts, Katleen; Swerts, Jef; Vilain, Sven; Aerts, Liesbeth; Verstreken, Patrik; De Strooper, Bart] Leuven Res Inst Neurosci & Dis LIND, B-3000 Louvain, Belgium; [De Bock, Pieter-Jan; Gevaert, Kris] Dept Med Prot Res, B-9000 Ghent, Belgium; [De Bock, Pieter-Jan; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Overbergh, Lut] Katholieke Univ Leuven, Lab Clin & Expt Endocrinol, B-3000 Louvain, Belgium; [Gruenewald, Anne; Seibler, Philip; Klein, Christine] Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Klein, Christine] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [De Strooper, Bart] UCL, Inst Neurol, London, England	Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; Ghent University; KU Leuven; University of Lubeck; Newcastle University - UK; University of London; University College London	Morais, VA (corresponding author), VIB Ctr Biol Dis, B-3000 Louvain, Belgium.	vanessa.morais@cme.vib-kuleuven.be; bart.destrooper@cme.vib-kuleuven.be	Vilain, Sven/AHA-7944-2022; Klein, Christine/AGK-8003-2022; Verstreken, Patrik/AAC-7591-2022; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/D-6489-2017; Seibler, Philip/AAB-5097-2022; Seibler, Philip/K-4142-2019; Overbergh, Lut/AAC-3515-2020; Grünewald, Anne/ABD-1255-2021; de+Strooper, Bart/Z-1638-2019; Aerts, Liesbeth/J-7946-2015	Verstreken, Patrik/0000-0002-5073-5393; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Grünewald, Anne/0000-0002-4179-2994; Morais, Vanessa/0000-0002-0830-0548; Aerts, Liesbeth/0000-0002-7981-8176; Klein, Christine/0000-0003-2102-3431; Seibler, Philip/0000-0002-3496-7194	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham	Biotechnology and Biological Sciences Research Council, Medical Research Council; University of Nottingham	All data are available from the authors' Web site at www.nottingham.ac.uk/similar to plzloose/phyloinc and are deposited at http://datadryad.org (DOI: 10.5061/dryad.rd70f). The authors thank B. Crother, G. Morgan, and M. Blythe for helpful discussion. Sequencing was carried out at the Genome Centre, Queen Mary, University of London by L. Bhaw-Rosun and M. Struegbig. This work was supported by the Biotechnology and Biological Sciences Research Council, Medical Research Council, and University of Nottingham.	Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; SLED VD, 1993, BIOCHIM BIOPHYS ACTA, V1141, P262, DOI 10.1016/0005-2728(93)90051-G; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P1883, DOI 10.1016/j.bbabio.2010.05.009; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	30	244	249	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					203	207		10.1126/science.1249161	http://dx.doi.org/10.1126/science.1249161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24652937				2022-12-24	WOS:000334096300037
J	Lu, T; Aron, L; Zullo, J; Pan, Y; Kim, H; Chen, YW; Yang, TH; Kim, HM; Drake, D; Liu, XS; Bennett, DA; Colaiacovo, MP; Yankner, BA				Lu, Tao; Aron, Liviu; Zullo, Joseph; Pan, Ying; Kim, Haeyoung; Chen, Yiwen; Yang, Tun-Hsiang; Kim, Hyun-Min; Drake, Derek; Liu, X. Shirley; Bennett, David A.; Colaiacovo, Monica P.; Yankner, Bruce A.			REST and stress resistance in ageing and Alzheimer's disease	NATURE			English	Article							GENOME-WIDE ANALYSIS; SEL-12 PRESENILIN; LIFE-SPAN; PROTEIN; REPRESSOR; EXPRESSION; CORTEX; TRANSCRIPTION; SUPPRESSORS; CHROMATIN	Human neurons are functional over an entire lifetime, yet the mechanisms that preserve function and protect against neurodegeneration during ageing are unknown. Here we show that induction of the repressor element 1-silencing transcription factor (REST; also known as neuron-restrictive silencer factor, NRSF) is a universal feature of normal ageing in human cortical and hippocampal neurons. REST is lost, however, in mild cognitive impairment and Alzheimer's disease. Chromatin immunoprecipitation with deep sequencing and expression analysis show that REST represses genes that promote cell death and Alzheimer's disease pathology, and induces the expression of stress response genes. Moreover, REST potently protects neurons from oxidative stress and amyloid beta-protein toxicity, and conditional deletion of REST in the mouse brain leads to age-related neurodegeneration. A functional orthologue of REST, Caenorhabditis elegans SPR-4, also protects against oxidative stress and amyloid beta-protein toxicity. During normal ageing, REST is induced in part by cell non-autonomous Wnt signalling. However, in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies, REST is lost from the nucleus and appears in autophagosomes together with pathological misfolded proteins. Finally, REST levels during ageing are closely correlated with cognitive preservation and longevity. Thus, the activation state of REST may distinguish neuroprotection from neurodegeneration in the ageing brain.	[Lu, Tao; Aron, Liviu; Zullo, Joseph; Pan, Ying; Kim, Haeyoung; Yang, Tun-Hsiang; Kim, Hyun-Min; Drake, Derek; Colaiacovo, Monica P.; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chen, Yiwen; Liu, X. Shirley] Dana Faber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Kim, Haeyoung; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Rush University	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	Bruce_Yankner@hms.harvard.edu	Kim, Hyun-Min/AAL-2435-2021; Aron, LIviu/E-5192-2013; Kim, Haeyoung/C-3069-2008	Kim, Hyun-Min/0000-0003-4610-3606; lu, tao/0000-0002-8247-8387	NIH [DP1OD006849, PO1AG27916, RO1AG26651, RO1GM072551, P30AG10161, R01AG15819, R01AG17917]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072551, R01GM105853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG044161, R01AG015819, P01AG027916, P30AG010161, T32AG000222, R01AG026651, R01AG017917] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Yankner laboratory for suggestions and discussion, Monlan Yuan, Allison Harwick, Kelly Dakin and Gregory Klein for assistance, and Cheng Li and Dana Gabuzda for helpful discussion. We also acknowledge the Rush Alzheimer's Disease Center, the Brigham and Women's Hospital Brain Bank, the Massachusetts General Hospital ADRC Brain Bank, and the Kathleen Price Bryan Brain Bank at Duke University for providing tissue samples. This work was supported by an NIH Director's Pioneer Award (DP1OD006849) and NIH grants PO1AG27916 and RO1AG26651 to B.A.Y., RO1GM072551 to M. P. C., P30AG10161, R01AG15819 and R01AG17917 to D. A. B., and a grant from the Glenn Foundation for Medical Research to B.A.Y. J.Z. is a Molecular Biology of Neurodegeneration fellow at Harvard Medical School.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007936; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRENNER S, 1974, GENETICS, V77, P71; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lakowski B, 2003, DEVELOPMENT, V130, P2117, DOI 10.1242/dev.00429; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mao CA, 2011, DEV BIOL, V349, P90, DOI 10.1016/j.ydbio.2010.10.008; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Peters A, 1998, CEREB CORTEX, V8, P671, DOI 10.1093/cercor/8.8.671; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shimojo M, 2006, J NEUROCHEM, V96, P1130, DOI 10.1111/j.1471-4159.2005.03608.x; Shimojo M, 2006, NEUROSCI LETT, V398, P161, DOI 10.1016/j.neulet.2005.12.080; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Wen CH, 2000, P NATL ACAD SCI USA, V97, P14524, DOI 10.1073/pnas.011446498; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu M, 2013, NEUROBIOL AGING, V34, P916, DOI 10.1016/j.neurobiolaging.2012.06.002; Yu M, 2009, NEUROSCI RES, V65, P236, DOI 10.1016/j.neures.2009.07.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	459	473	1	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					448	+		10.1038/nature13163	http://dx.doi.org/10.1038/nature13163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670762	Green Submitted, Green Accepted			2022-12-24	WOS:000333402000031
J	Zirnsak, M; Steinmetz, NA; Noudoost, B; Xu, KZ; Moore, T				Zirnsak, Marc; Steinmetz, Nicholas A.; Noudoost, Behrad; Xu, Kitty Z.; Moore, Tirin			Visual space is compressed in prefrontal cortex before eye movements	NATURE			English	Article							PERI-SACCADIC PERCEPTION; MACAQUE AREA V4; SPATIAL ATTENTION; RECEPTIVE-FIELDS; FRONTAL-CORTEX; BOTTOM-UP; NEURONS; SIGNALS; SEARCH; TARGET	We experience the visual world through a series of saccadic eye movements, each one shifting our gaze to bring objects of interest to the fovea for further processing. Although such movements lead to frequent and substantial displacements of the retinal image, these displacements go unnoticed. It is widely assumed that a primary mechanism underlying this apparent stability is an anticipatory shifting of visual receptive fields (RFs) from their presaccadic to their post-saccadic locations before movement onset(1). Evidence of this predictive 'remapping' of RFs has been particularly apparent within brain structures involved in gaze control(2-4). However, critically absent among that evidence are detailed measurements of visual RFs before movement onset. Here we show that during saccade preparation, rather than remap, RFs of neurons in a prefrontal gaze control area massively converge towards the saccadic target. We mapped the visual RFs of prefrontal neurons during stable fixation and immediately before the onset of eye movements, using multi-electrode recordings in monkeys. Following movements from an initial fixation point to a target, RFs remained stationary in retinocentric space. However, in the period immediately before movement onset, RFs shifted by as much as 18 degrees of visual angle, and converged towards the target location. This convergence resulted in a threefold increase in the proportion of RFs responding to stimuli near the target region. In addition, like in human observers(5,6), the population of prefrontal neurons grossly mislocalized presaccadic stimuli as being closer to the target. Our results show that RF shifts do not predict the retinal displacements due to saccades, but instead reflect the overriding perception of target space during eye movements.	[Zirnsak, Marc; Steinmetz, Nicholas A.; Noudoost, Behrad; Xu, Kitty Z.; Moore, Tirin] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Zirnsak, Marc; Moore, Tirin] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Zirnsak, M (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	mzirnsak@stanford.edu	Steinmetz, Nick/B-8555-2018	Steinmetz, Nick/0000-0001-7029-2908	National Institutes of Health [EY014924]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R56EY014924, R01EY014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant EY014924 and the Howard Hughes Medical Institute (T.M.). We thank D.S. Aldrich for technical assistance.	ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Conner CE, 1997, J NEUROSCI, V17, P3201; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dodge R, 1905, PSYCHOL BULL, V2, P193, DOI 10.1037/h0070501; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Gregoriou GG, 2012, NEURON, V73, P581, DOI 10.1016/j.neuron.2011.12.019; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Kaiser M, 2004, NEURON, V41, P293, DOI 10.1016/S0896-6273(03)00849-3; Khavat P. S., 2004, VISION RES, V44, P2901; Khayat PS, 2004, P NATL ACAD SCI USA, V101, P12712, DOI 10.1073/pnas.0301935101; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Rao J. S., 2001, SERIES MULTIVARIATE, V5, P175; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Rolfs M, 2012, J NEUROSCI, V32, P13744, DOI 10.1523/JNEUROSCI.2676-12.2012; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Thompson KG, 2005, J NEUROPHYSIOL, V93, P337, DOI 10.1152/jn.00330.2004; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Zirnsak M, 2010, VISION RES, V50, P1328, DOI 10.1016/j.visres.2010.02.002	36	129	130	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					504	+		10.1038/nature13149	http://dx.doi.org/10.1038/nature13149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24670771	Green Accepted			2022-12-24	WOS:000333402000042
J	Lazer, D; Kennedy, R; King, G; Vespignani, A				Lazer, David; Kennedy, Ryan; King, Gary; Vespignani, Alessandro			The Parable of Google Flu: Traps in Big Data Analysis	SCIENCE			English	Editorial Material							INFLUENZA; SURVEILLANCE; BEHAVIOR		[Lazer, David; Kennedy, Ryan] Northeastern Univ, Lazer Lab, Boston, MA 02115 USA; [Lazer, David] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Kennedy, Ryan; King, Gary; Vespignani, Alessandro] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Kennedy, Ryan] Univ Houston, Houston, TX 77204 USA; [Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Vespignani, Alessandro] Inst Sci Interchange Fdn, Turin, Italy	Northeastern University; Harvard University; Harvard University; University of Houston System; University of Houston; Northeastern University	Lazer, D (corresponding author), Northeastern Univ, Lazer Lab, Boston, MA 02115 USA.	d.lazer@neu.edu		Vespignani, Alessandro/0000-0003-3419-4205				[Anonymous], ORG LISTS REL SEARCH; [Anonymous], IMPR HLTH SEARCH BEC; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Boyd DA, 2012, ARAB AND JEWISH WOMEN IN KENTUCKY: STORIES OF ACCOMMODATION AND AUDACITY, P15; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Copeland P., 2013, INT SOC NEGL TROP DI, V2013, P3; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hannak A., 2013, P 22 INT C WORLD WID, P527, DOI [https://doi.org/10.1145/2488388.2488435, 10.1145/2488388.2488435]; KING G, 1995, PS POLITICAL SCI POL, V0028; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; McAfee A, 2012, HARVARD BUS REV, V90, P60; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; Mustafaraj E., 2010, P WEB SCI10 RAL NC 2; Nsoesie EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067164; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Ratkiewicz J., 2011, ICWSM, P297; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Voosen P., 2013, CHRONICLE HIGHER ED	35	1230	1285	27	830	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1203	1205		10.1126/science.1248506	http://dx.doi.org/10.1126/science.1248506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626916	Green Submitted			2022-12-24	WOS:000332728500021
J	Alegre-Cebollada, J; Kosuri, P; Giganti, D; Eckels, E; Rivas-Pardo, JA; Hamdani, N; Warren, CM; Solaro, RJ; Linke, WA; Fernandez, JM				Alegre-Cebollada, Jorge; Kosuri, Pallav; Giganti, David; Eckels, Edward; Rivas-Pardo, Jaime Andres; Hamdani, Nazha; Warren, Chad M.; Solaro, R. John; Linke, Wolfgang A.; Fernandez, Julio M.			S-Glutathionylation of Cryptic Cysteines Enhances Titin Elasticity by Blocking Protein Folding	CELL			English	Article							FORCE-CLAMP SPECTROSCOPY; DILATED CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; SINGLE PROTEIN; HEART-FAILURE; NITRIC-OXIDE; MUSCLE; MUTATIONS	The giant elastic protein titin is a determinant factor in how much blood fills the left ventricle during diastole and thus in the etiology of heart disease. Titin has been identified as a target of S-glutathionylation, an end product of the nitric-oxide-signaling cascade that increases cardiac muscle elasticity. However, it is unknown how S-glutathionylation may regulate the elasticity of titin and cardiac tissue. Here, we show that mechanical unfolding of titin immunoglobulin (Ig) domains exposes buried cysteine residues, which then can be S-glutathionylated. S-glutathionylation of cryptic cysteines greatly decreases the mechanical stability of the parent Ig domain as well as its ability to fold. Both effects favor a more extensible state of titin. Furthermore, we demonstrate that S-glutathionylation of cryptic cysteines in titin mediates mechanochemical modulation of the elasticity of human cardiomyocytes. We propose that post-translational modification of cryptic residues is a general mechanism to regulate tissue elasticity.	[Alegre-Cebollada, Jorge; Kosuri, Pallav; Giganti, David; Eckels, Edward; Rivas-Pardo, Jaime Andres; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kosuri, Pallav] Columbia Univ, Grad Program Biochem & Mol Biophys, New York, NY 10032 USA; [Eckels, Edward] Columbia Univ, Columbia Coll Phy & Surg, New York, NY 10032 USA; [Hamdani, Nazha; Linke, Wolfgang A.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, D-44780 Bochum, Germany; [Warren, Chad M.; Solaro, R. John] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA	Columbia University; Columbia University; Columbia University; Ruhr University Bochum; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alegre-Cebollada, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ja2544@columbia.edu; jfernandez@columbia.edu	Linke, Wolfgang A/E-8662-2012; Alegre-Cebollada, Jorge/I-4301-2014; Kosuri, Pallav/J-8279-2012	Alegre-Cebollada, Jorge/0000-0003-0542-0170; Kosuri, Pallav/0000-0002-7025-3543; Giganti, David/0000-0001-5735-5679; Rivas Pardo, Andres/0000-0002-8304-3238; Linke, Wolfgang/0000-0003-0801-3773	NIH [HL66030, HL61228, P01 HL062426, AI106072]; European Union; German Research Foundation [SFB 1002/TP-B03]; Fundacion Ibercaja; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062426, R01HL066030, R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI106072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); German Research Foundation(German Research Foundation (DFG)); Fundacion Ibercaja; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Sergi Garcia-Manyes for his original observation that mixed disulfides prevent refolding of Ig domains. We thank Thomas Kahn for the SUMO-191 fusion protein. GRX from E. coli was a kind gift from Arne Holmgren. Monoclonal antibodies MF20 (D.A. Fischman) and 9D10 (M.L. Greaser) were obtained from the Developmental Studies Hybridoma Bank. This work was supported by the NIH grants HL66030, HL61228 (to J.M.F.), and P01 HL062426 (to R.J.S. and C. M. W.) and grants FP7-MEDIA from the European Union and SFB 1002/TP-B03 from the German Research Foundation (to W.A.L.). J.A.-C. was the recipient of a fellowship from Fundacion Ibercaja and a K99 career development award (AI106072) from NIH.	Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Anderson BR, 2013, J BIOL CHEM, V288, P5303, DOI 10.1074/jbc.M112.401372; Avner BS, 2012, MOL CELL BIOCHEM, V363, P203, DOI 10.1007/s11010-011-1172-z; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Chen FC, 2006, AM J PHYSIOL-CELL PH, V290, pC719, DOI 10.1152/ajpcell.00419.2005; Chung CS, 2013, CIRCULATION, V128, P19, DOI 10.1161/CIRCULATIONAHA.112.001268; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Efron B., 1982, JACKKNIFE BOOTSTRAP; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Freiburg A, 2000, CIRC RES, V86, P1114; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Hamdani N, 2013, CIRC RES, V112, P664, DOI 10.1161/CIRCRESAHA.111.300105; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kellermayer MSZ, 2002, J MUSCLE RES CELL M, V23, P499, DOI 10.1023/A:1023414624092; Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Krieger CC, 2011, P NATL ACAD SCI USA, V108, P8269, DOI 10.1073/pnas.1018887108; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; LINKE WA, 1994, BIOPHYS J, V67, P782, DOI 10.1016/S0006-3495(94)80538-7; Linke WA, 2010, PHYSIOLOGY, V25, P186, DOI 10.1152/physiol.00005.2010; Lovelock JD, 2012, CIRC RES, V110, P841, DOI 10.1161/CIRCRESAHA.111.258251; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Matsumoto Y, 2005, J MUSCLE RES CELL M, V26, P367, DOI 10.1007/s10974-005-9018-5; Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3; McNally EM, 2012, NATURE, V483, P281, DOI 10.1038/483281a; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Mollica JP, 2012, J PHYSIOL-LONDON, V590, P1443, DOI 10.1113/jphysiol.2011.224535; Nedrud J, 2011, BIOPHYS J, V101, P1385, DOI 10.1016/j.bpj.2011.06.054; Norton N, 2013, CIRC-CARDIOVASC GENE, V6, P144, DOI 10.1161/CIRCGENETICS.111.000062; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Rastaldo R, 2007, LIFE SCI, V81, P779, DOI 10.1016/j.lfs.2007.07.019; RODRIGUEZ EK, 1992, AM J PHYSIOL, V263, pH293, DOI 10.1152/ajpheart.1992.263.1.H293; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Somkuti J, 2013, BBA-PROTEINS PROTEOM, V1834, P112, DOI 10.1016/j.bbapap.2012.10.001; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wu CL, 2011, CHEM-EUR J, V17, P10064, DOI 10.1002/chem.201101024	54	128	129	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1235	1246		10.1016/j.cell.2014.01.056	http://dx.doi.org/10.1016/j.cell.2014.01.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630725	Bronze, Green Accepted			2022-12-24	WOS:000332945100013
J	Maksimovic, S; Nakatani, M; Baba, Y; Nelson, AM; Marshall, KL; Wellnitz, SA; Firozi, P; Woo, SH; Ranade, S; Patapoutian, A; Lumpkin, EA				Maksimovic, Srdjan; Nakatani, Masashi; Baba, Yoshichika; Nelson, Aislyn M.; Marshall, Kara L.; Wellnitz, Scott A.; Firozi, Pervez; Woo, Seung-Hyun; Ranade, Sanjeev; Patapoutian, Ardem; Lumpkin, Ellen A.			Epidermal Merkel cells are mechanosensory cells that tune mammalian touch receptors	NATURE			English	Article							SENSORY NEURONS; TRANSDUCTION; DISCRIMINATION; MECHANISMS; COMPONENTS; CHANNELS	Touch submodalities, such as flutter and pressure, are mediated by somatosensory afferents whose terminal specializations extract tactile features and encode them as action potential trains with unique activity patterns(1). Whether non-neuronal cells tune touch receptors through active or passive mechanisms is debated. Terminal specializations are thought to function as passive mechanical filters analogous to the cochlea's basilar membrane, which deconstructs complex sounds into tones that are transduced by mechanosensory hair cells. The model that cutaneous specializations are merely passive has been recently challenged because epidermal cells express sensory ion channels and neurotransmitters(2,3); however, direct evidence that epidermal cells excite tactile afferents is lacking. Epidermal Merkel cells display features of sensory receptor cells(4,5) and make 'synapse-like' contacts(5,6) with slowly adapting type I (SAI) afferents(7-9). These complexes, which encode spatial features such as edges and texture(1), localize to skin regions with high tactile acuity, including whisker follicles, fingertips and touch domes. Here we show that Merkel cells actively participate in touch reception in mice. Merkel cells display fast, touch-evoked mechanotransduction currents. Optogenetic approaches in intact skin show that Merkel cells are both necessary and sufficient for sustained action-potential firing in tactile afferents. Recordings from touch-dome afferents lacking Merkel cells demonstrate that Merkel cells confer high-frequency responses to dynamic stimuli and enable sustained firing. These data are the first, to our knowledge, to directly demonstrate a functional, excitatory connection between epidermal cells and sensory neurons. Together, these findings indicate that Merkel cells actively tune mechanosensory responses to facilitate high spatio-temporal acuity. Moreover, our results indicate a division of labour in the Merkel cell-neurite complex: Merkel cells signal static stimuli, such as pressure, whereas sensory afferents transduce dynamic stimuli, such as moving gratings. Thus, the Merkel cell-neurite complex is an unique sensory structure composed of two different receptor cell types specialized for distinct elements of discriminative touch.	[Maksimovic, Srdjan; Nakatani, Masashi; Baba, Yoshichika; Nelson, Aislyn M.; Marshall, Kara L.; Lumpkin, Ellen A.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Nakatani, Masashi] Keio Univ, Grad Sch Syst Design & Management, Yokohama, Kanagawa 2238526, Japan; [Nelson, Aislyn M.; Wellnitz, Scott A.; Firozi, Pervez] Baylor Coll Med, Dept Neurosci, Houston, TX 77006 USA; [Woo, Seung-Hyun; Ranade, Sanjeev; Patapoutian, Ardem] Scripps Res Inst, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Lumpkin, Ellen A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Lumpkin, Ellen A.] Columbia Univ, Program Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Keio University; Baylor College of Medicine; Howard Hughes Medical Institute; Scripps Research Institute; Columbia University; Columbia University	Lumpkin, EA (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.	eal2166@columbia.edu		Ranade, Sanjeev/0000-0001-8601-3563; Nakatani, Masashi/0000-0002-0749-2883; Lumpkin, Ellen/0000-0002-1166-3374	NIH/NIAMS [R01AR051219, R21AR062307, R01DE022358]; NIH/NINDS [F32NS080544]; JSPS [24-7585]; McNair Foundation;  [5T32HL087745-05]; NATIONAL CANCER INSTITUTE [P30CA125123, P30CA013696] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535, R01AR051219, R21AR062307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080544] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); McNair Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thanks to R. Axel, A. MacDermott and the Lumpkin laboratory for helpful discussions and to D. Florez and R. Piskorowski for advice on whole-cell recordings. Funding was provided by NIH/NIAMS grants R01AR051219 and R21AR062307 (to E. A. L.), R01DE022358 (to A. P.) and fellowships to S. M. (5T32HL087745-05 and NIH/NINDS F32NS080544), M.N. (JSPS Research Fellowships for Young Scientists 24-7585), and A. M.N. (McNair Foundation). Microscopy and flow cytometry was performed with core support from the Columbia SDRC (P30AR044535) and Cancer Center (P30CA013696). Initial studies were performed at Baylor College of Medicine with assistance from Flow Cytometry and Genetically Engineered Mouse Shared Resources (P30CA125123).	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Haeberle H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001750; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; HARTSCHUH W, 1980, J INVEST DERMATOL, V75, P159, DOI 10.1111/1523-1747.ep12522555; Holt JR, 1997, J NEUROSCI, V17, P8739; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117, DOI 10.1113/jphysiol.1981.sp013540; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lesniak DR, 2014, ELIFE, V3, DOI 10.7554/eLife.01488; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; Meyers JR, 2003, J NEUROSCI, V23, P4054; Morrison KM, 2009, DEV BIOL, V336, P76, DOI 10.1016/j.ydbio.2009.09.032; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1192, DOI 10.1152/jn.1981.46.6.1192; Piskorowski R, 2008, PFLUG ARCH EUR J PHY, V457, P197, DOI 10.1007/s00424-008-0496-3; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Woo SH, 2012, DEVELOPMENT, V139, P740, DOI 10.1242/dev.070847; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; YAMASHITA Y, 1991, SOMATOSENS MOT RES, V8, P87, DOI 10.3109/08990229109144732; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004	37	307	315	6	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					617	621		10.1038/nature13250	http://dx.doi.org/10.1038/nature13250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24717432	Green Accepted			2022-12-24	WOS:000336457100048
J	Tan, AYY; Chen, YZ; Scholl, B; Seidemann, E; Priebe, NJ				Tan, Andrew Y. Y.; Chen, Yuzhi; Scholl, Benjamin; Seidemann, Eyal; Priebe, Nicholas J.			Sensory stimulation shifts visual cortex from synchronous to asynchronous states	NATURE			English	Article							NEURAL POPULATION RESPONSES; IN-VIVO; NEOCORTICAL NEURONS; STIMULUS CONTRAST; CORTICAL CIRCUITS; AUDITORY-CORTEX; BARREL CORTEX; COMPLEX CELLS; NETWORKS; DYNAMICS	In the mammalian cerebral cortex, neural responses are highly variable during spontaneous activity and sensory stimulation. To explain this variability, the cortex of alert animals has been proposed to be in an asynchronous high-conductance state in which irregular spiking arises from the convergence of large numbers of uncorrelated excitatory and inhibitory inputs onto individual neurons(1-4). Signatures of this state are that a neuron's membrane potential (V-m) hovers just below spike threshold, and its aggregate synaptic input is nearly Gaussian, arising from many uncorrelated inputs(1-4). Alternatively, irregular spiking could arise from infrequent correlated input events that elicit large fluctuations in V-m (refs 5, 6). To distinguish between these hypotheses, we developed a technique to perform whole-cell V-m measurements from the cortex of behaving monkeys, focusing on primary visual cortex (V1) of monkeys performing a visual fixation task. Here we show that, contrary to the predictions of an asynchronous state, mean V-m during fixation was far from threshold (14 mV) and spiking was triggered by occasional large spontaneous fluctuations. Distributions of V-m values were skewed beyond that expected for a range of Gaussian input(6,7), but were consistent with synaptic input arising from infrequent correlated events(5,6). Furthermore, spontaneous fluctuations in V-m were correlated with the surrounding network activity, as reflected in simultaneously recorded nearby local field potential. Visual stimulation, however, led to responses more consistent with an asynchronous state: mean V-m approached threshold, fluctuations became more Gaussian, and correlations between single neurons and the surrounding network were disrupted. These observations show that sensory drive can shift a common cortical circuitry from a synchronous to an asynchronous state.	[Tan, Andrew Y. Y.; Chen, Yuzhi; Scholl, Benjamin; Seidemann, Eyal; Priebe, Nicholas J.] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Tan, Andrew Y. Y.; Chen, Yuzhi; Scholl, Benjamin; Seidemann, Eyal; Priebe, Nicholas J.] Univ Texas Austin, Coll Nat Sci, Dept Neurosci, Austin, TX 78712 USA; [Chen, Yuzhi; Seidemann, Eyal] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Tan, AYY (corresponding author), Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA.	atyy@alum.mit.edu; nico@austin.utexas.edu	Tan, Andrew/E-7752-2011	Tan, Andrew/0000-0002-4696-1347; Seidemann, Eyal/0000-0003-2841-5948	National Institutes of Health (NIH) [EY-019288]; Pew Charitable Trusts; NIH [EY-016454, EY-16752]; NATIONAL EYE INSTITUTE [R01EY016752, R01EY016454, T32EY021462, R01EY019288] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank T. Cakic for assistance with this project, and J. Hanover, D. Ferster, K. D. Miller and A. C. Huk for discussions and comments. A.Y.Y.T., B. S. and N.J.P. were supported by grants from the National Institutes of Health (NIH) (EY-019288) and the Pew Charitable Trusts; Y.C. and E. S. were supported by grants from the NIH (EY-016454 and EY-16752).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Chen DF, 2005, J NEUROPHYSIOL, V94, P2713, DOI 10.1152/jn.00024.2005; Chen YZ, 2008, J NEUROPHYSIOL, V99, P1366, DOI 10.1152/jn.00698.2007; Chen YZ, 2006, NAT NEUROSCI, V9, P1412, DOI 10.1038/nn1792; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; FERSTER D, 1992, J NEUROSCI, V12, P1262; Goodman Dan, 2008, Front Neuroinform, V2, P5, DOI 10.3389/neuro.11.005.2008; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hromadka T, 2013, J NEUROPHYSIOL, V109, P1989, DOI 10.1152/jn.00600.2012; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Legenstein R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000180; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MATSUMURA M, 1979, BRAIN RES, V163, P33, DOI 10.1016/0006-8993(79)90149-5; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mehring C, 2003, BIOL CYBERN, V88, P395, DOI 10.1007/s00422-002-0384-4; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Mitra P., 2007, OBSERVED BRAIN DYNAM; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Peyrache A, 2012, P NATL ACAD SCI USA, V109, P1731, DOI 10.1073/pnas.1109895109; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Richardson MJE, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.178102; Richardson MJE, 2006, CHAOS, V16, DOI 10.1063/1.2203409; Richardson MJE, 2005, NEURAL COMPUT, V17, P923, DOI 10.1162/0899766053429444; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rudolph M, 2003, NEURAL COMPUT, V15, P2577, DOI 10.1162/089976603322385081; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wolff L, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041913; XING P, 1991, NEUROREPORT, V2, P485; Yang ZY, 2007, J NEUROPHYSIOL, V98, P1002, DOI 10.1152/jn.00417.2007	51	141	142	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					226	+		10.1038/nature13159	http://dx.doi.org/10.1038/nature13159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24695217	Green Accepted			2022-12-24	WOS:000335454300039
J	Horwich, AL				Horwich, Arthur L.			Molecular Chaperones in Cellular Protein Folding: The Birth of a Field	CELL			English	Editorial Material							HEAT-SHOCK PROTEIN; RIBULOSE BISPHOSPHATE CARBOXYLASE; ESCHERICHIA-COLI; MESSENGER-RNA; UNCOATING ATPASE; STRESS PROTEINS; HSP70; HSP60; POLYPEPTIDES; MITOCHONDRIA		[Horwich, Arthur L.] Yale Univ, Sch Med, Boyer Ctr, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Horwich, Arthur L.] Yale Univ, Sch Med, Boyer Ctr, Dept Genet, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, Boyer Ctr, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.	arthur.horwich@yale.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; GEORGOPOULOS CP, 1972, NATURE-NEW BIOL, V239, P38, DOI 10.1038/newbio239038a0; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAASEPETTINGELL CA, 1988, J BIOL CHEM, V263, P4977; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Horwich A.L., 2011, MOL MACHINES BIOL, P191; KELLEY PM, 1978, CELL, V15, P1277, DOI 10.1016/0092-8674(78)90053-3; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LEMAUX PG, 1978, CELL, V13, P427, DOI 10.1016/0092-8674(78)90317-3; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; LINDQUIST S, 1975, P NATL ACAD SCI USA, V72, P1117, DOI 10.1073/pnas.72.3.1117; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; SCHEDL P, 1978, CELL, V14, P921, DOI 10.1016/0092-8674(78)90346-X; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SPRADLING A, 1975, CELL, V4, P395, DOI 10.1016/0092-8674(75)90160-9; TAKANO T, 1972, NATURE-NEW BIOL, V239, P34, DOI 10.1038/newbio239034a0; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; WILLIAMS DC, 1982, SCIENCE, V215, P687, DOI 10.1126/science.7036343; Xing Y, 2010, EMBO J, V29, P655, DOI 10.1038/emboj.2009.383; YAMAMORI T, 1978, J BACTERIOL, V134, P1133, DOI 10.1128/JB.134.3.1133-1140.1978; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	40	31	34	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					285	288		10.1016/j.cell.2014.03.029	http://dx.doi.org/10.1016/j.cell.2014.03.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725397	Bronze			2022-12-24	WOS:000334304500002
J	Linster, M; Boheemen, S; de Graaf, M; Schrauwen, EJA; Lexmond, P; Manz, B; Bestebroer, TM; Baumann, J; van Riel, D; Rimmelzwaan, GF; Osterhaus, ADME; Matrosovich, M; Fouchier, RAM; Herfst, S				Linster, Martin; van Boheemen, Sander; de Graaf, Miranda; Schrauwen, Eefje J. A.; Lexmond, Pascal; Manz, Benjamin; Bestebroer, Theo M.; Baumann, Jan; van Riel, Debby; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Matrosovich, Mikhail; Fouchier, Ron A. M.; Herfst, Sander			Identification, Characterization, and Natural Selection of Mutations Driving Airborne Transmission of A/H5N1 Virus	CELL			English	Article							AVIAN INFLUENZA-VIRUS; RECEPTOR-BINDING PROPERTIES; UPPER RESPIRATORY-TRACT; A VIRUS; HEMAGGLUTININ PROTEIN; H5 HA; FERRETS; SPECIFICITY; DROPLET; HOST	Recently, A/H5N1 influenza viruses were shown to acquire airborne transmissibility between ferrets upon targeted mutagenesis and virus passage. The critical genetic changes in airborne A/Indonesia/5/05 were not yet identified. Here, five substitutions proved to be sufficient to determine this airborne transmission phenotype. Substitutions in PB1 and PB2 collectively caused enhanced transcription and virus replication. One substitution increased HA thermostability and lowered the pH of membrane fusion. Two substitutions independently changed HA binding preference from a2,3-linked to a2,6-linked sialic acid receptors. The loss of a glycosylation site in HA enhanced overall binding to receptors. The acquired substitutions emerged early during ferret passage as minor variants and became dominant rapidly. Identification of substitutions that are essential for airborne transmission of avian influenza viruses between ferrets and their associated phenotypes advances our fundamental understanding of virus transmission and will increase the value of future surveillance programs and public health risk assessments.	[Linster, Martin; van Boheemen, Sander; de Graaf, Miranda; Schrauwen, Eefje J. A.; Lexmond, Pascal; Manz, Benjamin; Bestebroer, Theo M.; van Riel, Debby; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Herfst, Sander] Erasmus MC, Postgrad Sch Mol Med, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Baumann, Jan; Matrosovich, Mikhail] Univ Marburg, Inst Virol, D-35043 Marburg, Germany	Erasmus University Rotterdam; Erasmus MC; Philipps University Marburg	Fouchier, RAM (corresponding author), Erasmus MC, Postgrad Sch Mol Med, Dept Virosci, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	de Graaf, Miranda/AFM-6878-2022; Linster, Martin/AAY-9088-2020; Fouchier, Ron A/A-1911-2014; de Graaf, Miranda/K-1262-2018	de Graaf, Miranda/0000-0002-7831-0098; Fouchier, Ron A/0000-0001-8095-2869; de Graaf, Miranda/0000-0002-7831-0098; van Riel, Debby/0000-0001-9753-3564; Matrosovich, Mikhail/0000-0003-1618-2083; Linster, Martin/0000-0003-2636-2512; Herfst, Sander/0000-0001-9866-8903	NIH/NIAID [HHSN266200700010C]; EU [223498, 278976, 258084, 278433]; Marie Curie fellowship [PIEF-GA-2009-237505]; NIH/NIAID	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EU(European Commission); Marie Curie fellowship(European Commission); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dennis de Meulder for excellent technical assistance, Nicolai Bovin (Institute of Bio-organic Chemistry, Moscow, Russia) for providing sialylglycopolymers, and Malik Peiris (University of Hong Kong) for providing A/Indonesia/5/2005 with permission from I. Kandun of the Indonesian government. This work was supported by NIH/NIAID contract HHSN266200700010C, EU FP7 grants EMPERIE (223498), ANTIGONE (278976), FLUPIG (258084), and PREDEMICS (278433). MdG was funded in part by a Marie Curie fellowship (PIEF-GA-2009-237505). All experiments involving A/H5N1 virus were performed before January 2012 in agreement with a moratorium on A/H5N1 gain-of-function research and restarted after February 2013 but without NIH/NIAID funding. Special arrangements are in place with the NIH and the contractor at Icahn School of Medicine at Mount Sinai, New York, for sharing the viruses (and plasmids) in the present paper. A.D.M.E.O. and G. F. R. are CSO and part-time employees of ViroClinics Bio-sciences B. V. A.D.M.E.O. has advisory affiliations on behalf of ViroClinics Biosciences B. V. with GlaxoSmithKline, Novartis, and Roche. A.D.M.E.O. and R. A. M. F. are holders of certificates of shares in ViroClinics Biosciences B. V. To avoid any possible conflict of interests, Erasmus MC policy dictates that the shares as such are held by the Stichting Administratiekantoor Erasmus Personeelsparticipaties. The board of this foundation is appointed by the Board of Governors of the Erasmus MC and exercises all voting rights with regard to these shares.	Aggarwal S, 2011, J BIOL CHEM, V286, P34504, DOI 10.1074/jbc.M111.262048; Belser JA, 2013, FUTURE MICROBIOL, V8, P961, DOI [10.2217/FMB.13.64, 10.2217/fmb.13.64]; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Vries RP, 2014, J VIROL, V88, P768, DOI 10.1128/JVI.02690-13; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Krenn BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018577; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Lu XS, 2013, PROTEIN CELL, V4, P502, DOI 10.1007/s13238-013-3906-z; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich Mikhail N, 2012, Methods Mol Biol, V865, P71, DOI 10.1007/978-1-61779-621-0_5; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Nishiura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055358; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Russell WMS., 1959, MED J AUSTRALIA; Shaw ML., 2013, FIELDS VIROLOGY, V6th, P1151; Shelton H, 2013, J GEN VIROL, V94, P1220, DOI 10.1099/vir.0.050526-0; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; van Riel D, 2013, AM J PATHOL, V183, P1137, DOI 10.1016/j.ajpath.2013.06.011; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Zaraket H, 2013, J VIROL, V87, P9911, DOI 10.1128/JVI.01175-13; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	44	178	187	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2								10.1016/j.cell.2014.02.040	http://dx.doi.org/10.1016/j.cell.2014.02.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725402	Green Accepted, Bronze			2022-12-24	WOS:000334304500008
J	Schmick, M; Vartak, N; Papke, B; Kovacevic, M; Truxius, DC; Rossmannek, L; Bastiaens, PIH				Schmick, Malte; Vartak, Nachiket; Papke, Bjoern; Kovacevic, Marija; Truxius, Dina C.; Rossmannek, Lisaweta; Bastiaens, Philippe I. H.			KRas Localizes to the Plasma Membrane by Spatial Cycles of Solubilization, Trapping and Vesicular Transport	CELL			English	Article							SMALL-MOLECULE INHIBITION; LIPID-BILAYERS; PROTEINS; RAS; MECHANISMS; DIFFUSION; ACTIVATION; VESICLES; K-RAS4B; SURFACE	KRas is a major proto-oncogene product whose signaling activity depends on its level of enrichment on the plasma membrane (PM). This PM localization relies on posttranslational prenylation for membrane affinity, while PM specificity has been attributed to electrostatic interactions between negatively charged phospholipids in the PM and basic aminoacids in the C terminus of KRas. By measuring kinetic parameters of KRas dynamics in living cells with a cellular-automata-based data-fitting approach in realistic cell-geometries, we show that charge-based specificity is not sufficient to generate PM enrichment in light of the total surface area of endomembranes. Instead, mislocalized KRas is continuously sequestered from endomembranes by cytosolic PDE delta to be unloaded in an Arl2-dependent manner to perinuclear membranes. Electrostatic interactions then trap KRas at the recycling endosome (RE), from where vesicular transport restores enrichment on the PM. This energy driven reaction-diffusion cycle explains how small molecule targeting of PDEd affects the spatial organization of KRas.	[Schmick, Malte; Vartak, Nachiket; Papke, Bjoern; Kovacevic, Marija; Truxius, Dina C.; Rossmannek, Lisaweta; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Bastiaens, Philippe I. H.] Tech Univ Dortmund, Fak Chem, D-44221 Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Bastiaens, PIH (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de		Vartak, Nachiket/0000-0001-8813-4799; Papke, Bjoern/0000-0001-8156-7508	DFG [SFB642]	DFG(German Research Foundation (DFG))	The project was partly funded by the DFG (SFB642). We kindly thank Prof. Dr. Herbert Waldmann for providing deltarasin.	Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Colarusso P, 2002, BIOPHYS J, V82, P752, DOI 10.1016/S0006-3495(02)75437-4; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Markus M, 1999, MATH BIOSCI, V156, P191, DOI 10.1016/S0025-5564(98)10066-4; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; NIR S, 1983, PROG SURF SCI, V13, P1, DOI 10.1016/0079-6816(83)90010-2; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Ravoo BJ, 1999, BIOPHYS J, V76, P374, DOI 10.1016/S0006-3495(99)77204-8; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Toffoli T, 1987, CELLULAR AUTOMATA MA; von Neumann J, 1966, THEORY SELF PRODUCIN; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zamir E., 2013, VESICLE TRAFFICKING, P57; Ziemba BP, 2013, CHEM PHYS LIPIDS, V172, P67, DOI 10.1016/j.chemphyslip.2013.04.005; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	33	151	155	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					459	471		10.1016/j.cell.2014.02.051	http://dx.doi.org/10.1016/j.cell.2014.02.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725411	Bronze			2022-12-24	WOS:000334304500018
J	Wu, HX; Wang, C; Gregory, KJ; Han, GW; Cho, HP; Xia, Y; Niswender, CM; Katritch, V; Meiler, J; Cherezov, V; Conn, PJ; Stevens, RC				Wu, Huixian; Wang, Chong; Gregory, Karen J.; Han, Gye Won; Cho, Hyekyung P.; Xia, Yan; Niswender, Colleen M.; Katritch, Vsevolod; Meiler, Jens; Cherezov, Vadim; Conn, P. Jeffrey; Stevens, Raymond C.			Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; NONCOMPETITIVE ANTAGONISTS; BINDING POCKETS; SMALL-MOLECULE; DISCOVERY; ACTIVATION; EXPRESSION; DIVERSITY; AFFINITY	The excitatory neurotransmitter glutamate induces modulatory actions via the metabotropic glutamate receptors (mGlus), which are class C G protein-coupled receptors (GPCRs). We determined the structure of the human mGlu(1) receptor seven-transmembrane (7TM) domain bound to a negative allosteric modulator, FITM, at a resolution of 2.8 angstroms. The modulator binding site partially overlaps with the orthosteric binding sites of class A GPCRs but is more restricted than most other GPCRs. We observed a parallel 7TM dimer mediated by cholesterols, which suggests that signaling initiated by glutamate's interaction with the extracellular domain might be mediated via 7TM interactions within the full-length receptor dimer. A combination of crystallography, structure-activity relationships, mutagenesis, and full-length dimer modeling provides insights about the allosteric modulation and activation mechanism of class C GPCRs.	[Wu, Huixian; Wang, Chong; Han, Gye Won; Katritch, Vsevolod; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Gregory, Karen J.; Cho, Hyekyung P.; Niswender, Colleen M.; Conn, P. Jeffrey] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Gregory, Karen J.; Cho, Hyekyung P.; Niswender, Colleen M.; Conn, P. Jeffrey] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Gregory, Karen J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Xia, Yan; Meiler, Jens] Vanderbilt Univ, Med Ctr, Ctr Struct Biol, Nashville, TN 37232 USA; [Xia, Yan; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA; [Xia, Yan; Meiler, Jens] Vanderbilt Univ, Med Ctr, Inst Chem Biol, Nashville, TN 37232 USA	Scripps Research Institute; Vanderbilt University; Vanderbilt University; Monash University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Stevens, RC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016; Han, Gye Won/GLQ-8673-2022; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8724-2022; Wu, Huixian/N-6353-2014	Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Wu, Huixian/0000-0003-1357-9747; Meiler, Jens/0000-0001-8945-193X; Gregory, Karen/0000-0002-3833-2137	National Institute of General Medical Sciences (NIGMS) [U54 GM094618]; NIH [P50 GM073197, R01 NS031373, R01 MH062646, R21 NS078262, R01 MH090192, R01 GM080403, R01 GM099842, R01 DK097376]; International Rett Syndrome Foundation; NHMRC (Australia); NARSAD; NSF [CHE 1305874]; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, R01GM099842, P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062646, R01MH090192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031373, R21NS078262, R01NS031373] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); NARSAD(NARSAD); NSF(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of General Medical Sciences (NIGMS) PSI: Biology grant U54 GM094618 for biological studies and structure production (target GPCR-68) (V. K., V. C., and R. C. S.); NIH Common Fund in Structural Biology grant P50 GM073197 for technology development (V. C. and R. C. S.); NIH grants R01 NS031373 (P.J.C.), R01 MH062646 (P.J.C.), and R21 NS078262 (C.M.N.); a basic research grant from the International Rett Syndrome Foundation (C.M.N.); an NHMRC (Australia) Overseas Biomedical postdoctoral fellowship (K.J.G.); and a NARSAD Maltz Young Investigator award (K.J.G.). Work in the Meiler laboratory on computational modeling of membrane proteins and their ligand interactions is supported by NIH grants R01 MH090192, R01 GM080403, R01 GM099842, and R01 DK097376 and by NSF grant CHE 1305874. We thank K. Emmitte and P. Garcia for the synthesis of RO0711401 and FITM; J. Velasquez for help on molecular biology; T. Trinh and M. Chu for help on baculovirus expression; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; Q. Xu for help on SHARP density modification; and J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and NIGMS grant Y1-GM-1104. Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4OR2.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Chen Y, 2008, MOL PHARMACOL, V73, P909, DOI 10.1124/mol.107.040097; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Fukuda J, 2009, NEUROPHARMACOLOGY, V57, P438, DOI 10.1016/j.neuropharm.2009.06.017; Gregory KJ, 2013, MOL PHARMACOL, V83, P991, DOI 10.1124/mol.112.083949; Gregory KJ, 2012, MOL PHARMACOL, V82, P860, DOI 10.1124/mol.112.080531; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Litschig S, 1999, MOL PHARMACOL, V55, P453; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2006, J NEUROCHEM, V98, P601, DOI 10.1111/j.1471-4159.2006.03886.x; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Molck C, 2012, MOL PHARMACOL, V82, P929, DOI 10.1124/mol.112.078808; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Satoh A, 2009, BIOORG MED CHEM LETT, V19, P5464, DOI 10.1016/j.bmcl.2009.07.097; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Surin A, 2007, NEUROPHARMACOLOGY, V52, P744, DOI 10.1016/j.neuropharm.2006.09.018; Suzuki G, 2007, J PHARMACOL EXP THER, V321, P1144, DOI 10.1124/jpet.106.116574; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	34	404	416	6	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					58	64		10.1126/science.1249489	http://dx.doi.org/10.1126/science.1249489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24603153	Green Accepted			2022-12-24	WOS:000333746100051
J	Cohen, PA				Cohen, Pieter A.			Hazards of Hindsight - Monitoring the Safety of Nutritional Supplements	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Americans spend more than $32 billion a year on dietary supplements, which do not require premarketing approval before they reach store shelves. Under current law, the FDA must identify and remove dangerous supplements only after they have caused harm. Epidemiologists at the Centers for Disease Control and Prevention (CDC) recently confirmed what an astute liver-transplant surgeon in Honolulu already suspected: OxyElite Pro, a popular over-the-counter supplement, was responsible for a cluster of cases of severe hepatitis and liver failure.(1) Although patients began to develop severe hepatitis in May 2013, the Food and Drug Administration (FDA), whose job it is to remove dangerous supplements from store shelves, did not learn of the cases until mid-September, 4 months later. By February 2014, the CDC had linked 97 cases, resulting in 47 hospitalizations, three liver transplantations, and one death, to OxyElite Pro. . . .	[Cohen, Pieter A.] Cambridge Hlth Alliance, Somerville, MA 02145 USA; [Cohen, Pieter A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School	Cohen, PA (corresponding author), Cambridge Hlth Alliance, Somerville, MA 02145 USA.							[Anonymous], 2013, Morbidity and Mortality Weekly Report, V62, P817; [Anonymous], TAINT SUPPL CDER; Cohen PA, 2013, DRUG TEST ANAL; Haller CA, 2008, J MED TOXICOL, V4, P84, DOI 10.1007/BF03160960; Pawar RS, 2014, J PHARMACEUT BIOMED, V88, P457, DOI 10.1016/j.jpba.2013.09.012	5	104	104	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 3	2014	370	14					1277	1280		10.1056/NEJMp1315559	http://dx.doi.org/10.1056/NEJMp1315559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE2VA	24693886	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000333830000003
J	Fu, Y; Tucciarone, JM; Espinosa, JS; Sheng, NY; Darcy, DP; Nicoll, RA; Huang, ZJ; Stryker, MP				Fu, Yu; Tucciarone, Jason M.; Espinosa, J. Sebastian; Sheng, Nengyin; Darcy, Daniel P.; Nicoll, Roger A.; Huang, Z. Josh; Stryker, Michael P.			A Cortical Circuit for Gain Control by Behavioral State	CELL			English	Article							CRITICAL-PERIOD PLASTICITY; CHOLINERGIC MODULATION; DISINHIBITORY MICROCIRCUIT; GABAERGIC NEURONS; VISUAL RESPONSES; CORTEX; INTERNEURONS; OSCILLATIONS; INTEGRATION; ATTENTION	The brain's response to sensory input is strikingly modulated by behavioral state. Notably, the visual response of mouse primary visual cortex (V1) is enhanced by locomotion, a tractable and accessible example of a time-locked change in cortical state. The neural circuits that transmit behavioral state to sensory cortex to produce this modulation are unknown. In vivo calcium imaging of behaving animals revealed that locomotion activates vasoactive intestinal peptide (VIP)-positive neurons in mouse V1 independent of visual stimulation and largely through nicotinic inputs from basal forebrain. Optogenetic activation of VIP neurons increased V1 visual responses in stationary awake mice, artificially mimicking the effect of locomotion, and photolytic damage of VIP neurons abolished the enhancement of V1 responses by locomotion. These findings establish a cortical circuit for the enhancement of visual response by locomotion and provide a potential common circuit for the modulation of sensory processing by behavioral state.	[Fu, Yu; Espinosa, J. Sebastian; Darcy, Daniel P.; Stryker, Michael P.] Univ Calif San Francisco, Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94158 USA; [Tucciarone, Jason M.; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tucciarone, Jason M.] SUNY Stony Brook, MSTP Neurosci Grad Program, Stony Brook, NY 11790 USA; [Sheng, Nengyin; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Sheng, Nengyin; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fu, Y (corresponding author), Univ Calif San Francisco, Ctr Integrat Neurosci, Dept Physiol, 675 Nelson Rising Rd, San Francisco, CA 94158 USA.	yufu@phy.ucsf.edu; stryker@phy.ucsf.edu		Huang, Z. Josh/0000-0003-0592-028X; Sheng, Nengyin/0000-0003-3086-3950; Tucciarone, Jason/0000-0002-6053-2952; Stryker, Michael/0000-0003-1546-5831	National Institute of Health [EY002874]; NATIONAL EYE INSTITUTE [P30EY002162, R37EY002874, R01EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256, R01MH094705] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Drs. Megumi Kaneko and Cristopher M. Niell for their insightful discussion and comments. This work was supported by the National Institute of Health grant EY002874 to M.P.S.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fontanini A, 2008, J NEUROPHYSIOL, V100, P1160, DOI 10.1152/jn.90592.2008; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; GARCIARILL E, 1991, PROG NEUROBIOL, V36, P363, DOI 10.1016/0301-0082(91)90016-T; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; METHERATE R, 1992, J NEUROSCI, V12, P4701; MINK JW, 1983, BEHAV BRAIN RES, V8, P85, DOI 10.1016/0166-4328(83)90173-0; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Newman EL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00024; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601	51	517	520	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1139	1152		10.1016/j.cell.2014.01.050	http://dx.doi.org/10.1016/j.cell.2014.01.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630718	Bronze, Green Accepted			2022-12-24	WOS:000332945100006
J	Song, YM; Li, L; Ou, YW; Gao, ZB; Li, EM; Li, XC; Zhang, WM; Wang, JQ; Xu, LY; Zhou, Y; Ma, XJ; Liu, LY; Zhao, ZT; Huang, XL; Fan, J; Dong, LJ; Chen, G; Ma, LY; Yang, J; Chen, LY; He, MH; Li, M; Zhuang, XH; Huang, K; Qiu, KL; Yin, GL; Guo, GW; Feng, Q; Chen, PS; Wu, ZY; Wu, JY; Ma, L; Zhao, JY; Luo, LH; Fu, M; Xu, BN; Chen, B; Li, YR; Tong, T; Wang, MR; Liu, ZH; Lin, DX; Zhang, XQ; Yang, HM; Wang, J; Zhan, QM				Song, Yongmei; Li, Lin; Ou, Yunwei; Gao, Zhibo; Li, Enmin; Li, Xiangchun; Zhang, Weimin; Wang, Jiaqian; Xu, Liyan; Zhou, Yong; Ma, Xiaojuan; Liu, Lingyan; Zhao, Zitong; Huang, Xuanlin; Fan, Jing; Dong, Lijia; Chen, Gang; Ma, Liying; Yang, Jie; Chen, Longyun; He, Minghui; Li, Miao; Zhuang, Xuehan; Huang, Kai; Qiu, Kunlong; Yin, Guangliang; Guo, Guangwu; Feng, Qiang; Chen, Peishan; Wu, Zhiyong; Wu, Jianyi; Ma, Ling; Zhao, Jinyang; Luo, Longhai; Fu, Ming; Xu, Bainan; Chen, Bo; Li, Yingrui; Tong, Tong; Wang, Mingrong; Liu, Zhihua; Lin, Dongxin; Zhang, Xiuqing; Yang, Huanming; Wang, Jun; Zhan, Qimin			Identification of genomic alterations in oesophageal squamous cell cancer	NATURE			English	Article							CIRCULAR BINARY SEGMENTATION; SOMATIC MUTATION; ADENOCARCINOMA; IMMORTALIZATION; ABERRATIONS; PATTERNS; EXOME	Oesophageal cancer is one of the most aggressive cancers and is the sixth leading cause of cancer death worldwide(1). Approximately 70% of global oesophageal cancer cases occur in China, with oesophageal squamous cell carcinoma (ESCC) being the histopathological form in the vast majority of cases (>90%)(2,3). Currently, there are limited clinical approaches for the early diagnosis and treatment of ESCC, resulting in a 10% five-year survival rate for patients. However, the full repertoire of genomic events leading to the pathogenesis of ESCC remains unclear. Here we describe a comprehensive genomic analysis of 158 ESCC cases, as part of the International Cancer Genome Consortium research project. We conducted whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases, of which 53 cases, plus an additional 70 ESCC cases not used in the whole-genome and whole-exome sequencing, were subjected to array comparative genomic hybridization analysis. We identified eight significantly mutated genes, of which six are well known tumour-associated genes (TP53, RB1, CDKN2A, PIK3CA, NOTCH1, NFE2L2), and two have not previously been described in ESCC (ADAM29 and FAM135B). Notably, FAM135B is identified as a novel cancer-implicated gene as assayed for its ability to promote malignancy of ESCC cells. Additionally, MIR548K, a microRNA encoded in the amplified 11q13.3-13.4 region, is characterized as a novel oncogene, and functional assays demonstrate that MIR548K enhances malignant phenotypes of ESCC cells. Moreover, we have found that several important histone regulator genes (MLL2 (also called KMT2D), ASH1L, MLL3 (KMT2C), SETD1B, CREBBP and EP300) are frequently altered in ESCC. Pathway assessment reveals that somatic aberrations are mainly involved in the Wnt, cell cycle and Notch pathways. Genomic analyses suggest that ESCC and head and neck squamous cell carcinoma share some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking. This study has explored novel biological markers and tumorigenic pathways that would greatly improve therapeutic strategies for ESCC.	[Song, Yongmei; Ou, Yunwei; Zhang, Weimin; Ma, Xiaojuan; Liu, Lingyan; Zhao, Zitong; Fan, Jing; Dong, Lijia; Ma, Liying; Ma, Ling; Fu, Ming; Tong, Tong; Wang, Mingrong; Liu, Zhihua; Lin, Dongxin; Zhan, Qimin] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Canc Hosp, Beijing 100021, Peoples R China; [Song, Yongmei; Ou, Yunwei; Zhang, Weimin; Ma, Xiaojuan; Liu, Lingyan; Zhao, Zitong; Fan, Jing; Dong, Lijia; Ma, Liying; Ma, Ling; Fu, Ming; Tong, Tong; Wang, Mingrong; Liu, Zhihua; Lin, Dongxin; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Lin; Gao, Zhibo; Li, Xiangchun; Wang, Jiaqian; Zhou, Yong; Huang, Xuanlin; Chen, Gang; Yang, Jie; Chen, Longyun; He, Minghui; Li, Miao; Zhuang, Xuehan; Huang, Kai; Qiu, Kunlong; Yin, Guangliang; Guo, Guangwu; Feng, Qiang; Chen, Peishan; Zhao, Jinyang; Luo, Longhai; Li, Yingrui; Zhang, Xiuqing; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Ou, Yunwei; Xu, Bainan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China; [Li, Enmin; Wu, Jianyi] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Key Lab Mol Biol High Canc Incidence Coastal Chao, Shantou 515041, Guangdong, Peoples R China; [Xu, Liyan; Chen, Bo] Shantou Univ, Coll Med, Inst Oncol Pathol, Shantou 515041, Guangdong, Peoples R China; [Wu, Zhiyong] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Dept Tumor Surg, Shantou 515041, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Genomics Institute (BGI); Chinese People's Liberation Army General Hospital; Shantou University; Shantou University; Sun Yat Sen University	Zhan, QM (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Canc Hosp, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn	Wang, Jiaqian/AHA-3427-2022; xu, li/GNH-3667-2022; Wang, Jun/A-7261-2013; Chen, Bo/GRS-7546-2022; Li, Yingrui/K-1064-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Lin, Dongxin/0000-0002-8723-8868; song, yongmei/0000-0002-7789-0158; Li, Xiangchun/0000-0002-2230-2152; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	National High Technology Research and Development Program of China (863 program) [2012AA02A209, 2012AA02A503]; National Natural Science Foundation Fund [81021061]; Guangdong Innovative Research Team Program [2009010016]; National Natural Science Foundation of China [U0932001]; National Key Basic Research Program of China (973 program) [2011CB911004, 2009CB521801, 2012CB526608]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation Fund(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 program)(National Basic Research Program of China)	This work is supported by the funding from the National High Technology Research and Development Program of China (863 program no. 2012AA02A209 and 2012AA02A503), National Natural Science Foundation Fund (81021061), Guangdong Innovative Research Team Program (2009010016), the National Natural Science Foundation of China-GuangDong Joint Fund (U0932001), and the National Key Basic Research Program of China (973 program no. 2011CB911004, 2009CB521801 and 2012CB526608). The ESCC cell lines (KYSE30, KYSE70, KYSE180, KYSE410, KYSE450, KYSE140, COLO680N and KYSE510) were provided by Y. Shimada of Kyoto University. We also acknowledge International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) for sharing the EAC, HNSCC and lung SQCC data.	Agrawal N, 2012, CANCER DISCOV, V2, P899, DOI 10.1158/2159-8290.CD-12-0189; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Forde PM, 2013, ONCOLOGIST, V18, P823, DOI 10.1634/theoncologist.2013-0130; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Komatsu Y, 2006, ANTICANCER RES, V26, P2029; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longman D, 2012, ONCOL RES, V20, P1, DOI 10.3727/096504012X13425470196010; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaughlin-Drubin ME, 2012, CURR OPIN VIROL, V2, P459, DOI 10.1016/j.coviro.2012.05.004; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ou YW, 2012, J BIOL CHEM, V287, P32394, DOI 10.1074/jbc.M112.393900; Panagiotakis GI, 2013, TUMOR BIOL, V34, P71, DOI 10.1007/s13277-012-0512-2; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Shen ZY, 2002, WORLD J GASTROENTERO, V8, P357; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei XM, 2011, HUM MUTAT, V32, pE2148, DOI 10.1002/humu.21477; Wittchen ES, 2011, INVEST OPHTH VIS SCI, V52, P7455, DOI 10.1167/iovs.11-7295; WORKMAN C, 2002, GENOME BIOL, V0003; Xu YP, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-173; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Zhang H, 2006, CANCER GENET CYTOGEN, V165, P25, DOI 10.1016/j.cancergencyto.2005.07.016; Zhang S., 2012, CHINA CANC, V21, P241	37	717	763	20	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					91	+		10.1038/nature13176	http://dx.doi.org/10.1038/nature13176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24670651				2022-12-24	WOS:000335199100045
J	Bianchi, E; Doe, B; Goulding, D; Wright, GJ				Bianchi, Enrica; Doe, Brendan; Goulding, David; Wright, Gavin J.			Juno is the egg Izumo receptor and is essential for mammalian fertilization	NATURE			English	Article							REGULATORY T-CELLS; MEMBRANE BLOCK; SPERM PENETRATION; PLASMA-MEMBRANE; MYOBLAST FUSION; FOLIC-ACID; FOLATE; POLYSPERMY; CD9; SURFACE	Fertilization occurs when sperm and egg recognize each other and fuse to form a new, genetically distinct organism. The molecular basis of sperm-egg recognition is unknown, but is likely to require interactions between receptor proteins displayed on their surface. Izumo1 is an essential sperm cell-surface protein, but its receptor on the egg has not been described. Here we identify folate receptor 4 (Folr4) as the receptor for Izumo1 on the mouse egg, and propose to rename it Juno. We show that the Izumo1-Juno interaction is conserved within several mammalian species, including humans. Female mice lacking Juno are infertile and Juno-deficient eggs do not fuse with normal sperm. Rapid shedding of Juno from the oolemma after fertilization suggests a mechanism for the membrane block to polyspermy, ensuring eggs normally fuse with just a single sperm. Our discovery of an essential receptor pair at the nexus of conception provides opportunities for the rational development of new fertility treatments and contraceptives.	[Bianchi, Enrica; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England; [Doe, Brendan] Wellcome Trust Sanger Inst, Mouse Prod Team, Cambridge CB10 1SA, England; [Goulding, David] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute	Wright, GJ (corresponding author), Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1SA, England.	gw2@sanger.ac.uk	Bianchi, Enrica/P-2379-2019	Bianchi, Enrica/0000-0001-8124-7328; Wright, Gavin/0000-0003-0537-0863	Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust grant number 098051. Juno-deficient mice were generated by the Sanger Institute Mouse Genetics Project. We thank W. Skarnes and J. Bussell for advice on transgenic mice; J. Kerr for construct design; A. Bradley and L. Jovine for helpful comments on the manuscript; and M. Okabe and N. Inoue for the OBF13 antibody.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Alfieri JA, 2003, J CELL SCI, V116, P2149, DOI 10.1242/jcs.00430; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Chen C, 2013, NATURE, V500, P486, DOI 10.1038/nature12327; Coonrod SA, 1999, DEV BIOL, V207, P334, DOI 10.1006/dbio.1998.9161; Crosnier C, 2013, MOL CELL PROTEOMICS, V12, P3976, DOI 10.1074/mcp.O113.028357; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Gardner AJ, 2007, REPRODUCTION, V133, P383, DOI 10.1530/REP-06-0304; Golemis E., 2001, PROTEIN PROTEIN INTE; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HORVATH PM, 1993, MOL REPROD DEV, V34, P65, DOI 10.1002/mrd.1080340111; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2013, DEVELOPMENT, V140, P3221, DOI 10.1242/dev.094854; JACKOWSKI S, 1979, BIOL REPROD, V20, P150, DOI 10.1095/biolreprod20.2.150; JAFFE LA, 1976, NATURE, V261, P68, DOI 10.1038/261068a0; Jegou A, 2011, P NATL ACAD SCI USA, V108, P10946, DOI 10.1073/pnas.1017400108; Jia ZC, 2009, IMMUNOL INVEST, V38, P718, DOI 10.3109/08820130903171003; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Kerr JS, 2012, JOVE-J VIS EXP, DOI 10.3791/3881; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kinoshita M, 2012, J IMMUNOL, V189, P2869, DOI 10.4049/jimmunol.1200420; Kunisawa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032094; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Liang SC, 2013, CLIN IMMUNOL, V148, P287, DOI 10.1016/j.clim.2013.05.011; Martin S, 2010, MOL CELL PROTEOMICS, V9, P2654, DOI 10.1074/mcp.M110.004119; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Nagy A., 2003, MANIPULATING MOUSE E; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Sabharanjak S, 2004, ADV DRUG DELIVER REV, V56, P1099, DOI 10.1016/j.addr.2004.01.010; Salbaum JM, 2013, BBA-MOL BASIS DIS, V1832, P1653, DOI 10.1016/j.bbadis.2013.04.028; Satouh Y, 2012, J CELL SCI, V125, P4985, DOI 10.1242/jcs.100867; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sun Y, 2012, ANAL BIOCHEM, V424, P45, DOI 10.1016/j.ab.2012.01.034; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Wibowo AS, 2013, P NATL ACAD SCI USA, V110, P15180, DOI 10.1073/pnas.1308827110; WOLF DP, 1978, DEV BIOL, V64, P1, DOI 10.1016/0012-1606(78)90056-8; Wortzman-Show GB, 2007, MOL HUM REPROD, V13, P557, DOI 10.1093/molehr/gam042; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zylkiewicz E, 2010, ZYGOTE, V18, P195, DOI 10.1017/S0967199409990189	50	329	346	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					483	+		10.1038/nature13203	http://dx.doi.org/10.1038/nature13203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24739963	Green Accepted			2022-12-24	WOS:000334741600028
J	Puente, BN; Kimura, W; Muralidhar, SA; Moon, J; Amatruda, JF; Phelps, KL; Grinsfelder, D; Rothermel, BA; Chen, R; Garcia, JA; Santos, CX; Thet, S; Mori, E; Kinter, MT; Rindler, PM; Zacchigna, S; Mukherjee, S; Chen, DJ; Mahmoud, AI; Giacca, M; Rabinovitch, PS; Aroumougame, A; Shah, AM; Szweda, LI; Sadek, HA				Puente, Bao N.; Kimura, Wataru; Muralidhar, Shalini A.; Moon, Jesung; Amatruda, James F.; Phelps, Kate L.; Grinsfelder, David; Rothermel, Beverly A.; Chen, Rui; Garcia, Joseph A.; Santos, Celio X.; Thet, SuWannee; Mori, Eiichiro; Kinter, Michael T.; Rindler, Paul M.; Zacchigna, Serena; Mukherjee, Shibani; Chen, David J.; Mahmoud, Ahmed I.; Giacca, Mauro; Rabinovitch, Peter S.; Aroumougame, Asaithamby; Shah, Ajay M.; Szweda, Luke I.; Sadek, Hesham A.			The Oxygen-Rich Postnatal Environment Induces Cardiomyocyte Cell-Cycle Arrest through DNA Damage Response	CELL			English	Article							HEART REGENERATION; GROWTH-FACTOR; MYOCARDIAL REGENERATION; MAMMALIAN HEART; HYPOXIA; PROLIFERATION; GENERATION; ZEBRAFISH; DIFFERENTIATION; OVEREXPRESSION	The mammalian heart has a remarkable regenerative capacity for a short period of time after birth, after which the majority of cardiomyocytes permanently exit cell cycle. We sought to determine the primary postnatal event that results in cardiomyocyte cell-cycle arrest. We hypothesized that transition to the oxygen-rich postnatal environment is the upstream signal that results in cell-cycle arrest of cardiomyocytes. Here, we show that reactive oxygen species (ROS), oxidative DNA damage, and DNA damage response (DDR) markers significantly increase in the heart during the first postnatal week. Intriguingly, postnatal hypoxemia, ROS scavenging, or inhibition of DDR all prolong the postnatal proliferative window of cardiomyocytes, whereas hyperoxemia and ROS generators shorten it. These findings uncover a protective mechanism that mediates cardiomyocyte cell-cycle arrest in exchange for utilization of oxygen-dependent aerobic metabolism. Reduction of mitochondrial-dependent oxidative stress should be an important component of cardiomyocyte proliferation-based therapeutic approaches.	[Puente, Bao N.; Kimura, Wataru; Muralidhar, Shalini A.; Amatruda, James F.; Rothermel, Beverly A.; Chen, Rui; Garcia, Joseph A.; Thet, SuWannee; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.; Rothermel, Beverly A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Puente, Bao N.; Moon, Jesung; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Phelps, Kate L.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Grinsfelder, David] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Mori, Eiichiro; Mukherjee, Shibani; Chen, David J.; Aroumougame, Asaithamby] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Santos, Celio X.; Shah, Ajay M.] Kings Coll London, BHF Ctr Res Excellence, Sch Med, Cardiovasc Div,James Black Ctr, London SE5 9NU, England; [Kinter, Michael T.; Rindler, Paul M.; Szweda, Luke I.] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; [Zacchigna, Serena; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34149 Trieste, Italy; [Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Mahmoud, Ahmed I.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02115 USA; [Mahmoud, Ahmed I.] Harvard Univ, Sch Med, Cambridge, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; King's College London; Oklahoma Medical Research Foundation; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University	Sadek, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	hesham.sadek@utsouthwestern.edu	Giacca, Mauro/J-9287-2016; Mori, Eiichiro/AAY-6830-2020; ZACCHIGNA, SERENA/E-9496-2017	Giacca, Mauro/0000-0003-2927-7225; Mori, Eiichiro/0000-0003-0945-196X; Mahmoud, Ahmed/0000-0003-1528-7393; ZACCHIGNA, SERENA/0000-0001-6705-3076; Shah, Ajay/0000-0002-6547-0631; Kimura, Wataru/0000-0001-6548-6353; Garcia, Joseph/0000-0002-5621-7538; Kinter, Michael/0000-0001-7409-8918	National Aeronautics and Space Administration (NASA) [NNX13AD57G, 20090506]; European Research Council (ERC); British Heart Foundation and a Fondation Leducq Transatlantic Network; American Heart Association; Foundation for Heart Failure Research (NY); NIH [1R01HL115275-01]; British Heart Foundation [RG/13/11/30384] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104, R01HL072016, R01HL115275, R01HL097768] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); European Research Council (ERC)(European Research Council (ERC)European Commission); British Heart Foundation and a Fondation Leducq Transatlantic Network; American Heart Association(American Heart Association); Foundation for Heart Failure Research (NY); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. James Richardson and John Shelton for their valuable input.This work is supported by National Aeronautics and Space Administration (NASA) grant NNX13AD57G (A.A.), Advanced grant 20090506 from the European Research Council (ERC) (M.G.), the British Heart Foundation and a Fondation Leducq Transatlantic Network (A.M.S.), as well as grants from the American Heart Association (Grant in Aid), Foundation for Heart Failure Research (NY), and the NIH (grant 1R01HL115275- 01) (H.A.S.).	BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Birket MJ, 2013, STEM CELL REP, V1, P560, DOI 10.1016/j.stemcr.2013.11.008; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; DAWES GS, 1954, J PHYSIOL-LONDON, V126, P563, DOI 10.1113/jphysiol.1954.sp005227; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; FISHER DJ, 1980, AM J PHYSIOL, V238, pH399, DOI 10.1152/ajpheart.1980.238.3.H399; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; JACKSON T, 1990, MOL CELL BIOL, V10, P3709, DOI 10.1128/MCB.10.7.3709; Jopling C, 2012, CIRCULATION, V126, P3017, DOI 10.1161/CIRCULATIONAHA.112.107888; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Kirshenbaum R., 1997, J CLIN INVEST, V100, P2722; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lawrence J, 2008, J PHARMACOL EXP THER, V324, P331, DOI 10.1124/jpet.107.132175; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Leslie NR, 2006, ANTIOXID REDOX SIGN, V8, P1765, DOI 10.1089/ars.2006.8.1765; Liao HS, 2001, CIRC RES, V88, P443; Liu ZP, 2010, CIRC RES, V106, P1498, DOI 10.1161/CIRCRESAHA.109.211888; LOPASCHUK GD, 1992, CARDIOVASC RES, V26, P1172, DOI 10.1093/cvr/26.12.1172; LOPASCHUK GD, 1994, BBA-LIPID LIPID MET, V1213, P263, DOI 10.1016/0005-2760(94)00082-4; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Marques IJ, 2008, J COMP PHYSIOL B, V178, P77, DOI 10.1007/s00360-007-0201-4; Mills EM, 1998, J BIOL CHEM, V273, P22165, DOI 10.1074/jbc.273.35.22165; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MITCHELL JA, 1992, ALCOHOL CLIN EXP RES, V16, P308, DOI 10.1111/j.1530-0277.1992.tb01382.x; Moos PJ, 2000, P NATL ACAD SCI USA, V97, P9215, DOI 10.1073/pnas.160241897; Nadal-Ginard B, 2001, REV ESP CARDIOL, V54, P543, DOI 10.1016/S0300-8932(01)76354-3; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Pi Y, 2013, LAB INVEST, V93, P880, DOI 10.1038/labinvest.2013.79; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Puceat M, 2003, MOL BIOL CELL, V14, P2781, DOI 10.1091/mbc.E02-09-0562; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rees BB, 2001, J EXP ZOOL, V289, P266, DOI 10.1002/1097-010X(20010401/30)289:4&lt;266::AID-JEZ7&gt;3.0.CO;2-5; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Reynolds JD, 1996, ALCOHOL, V13, P251, DOI 10.1016/0741-8329(95)02051-9; Roesner A, 2006, J EXP BIOL, V209, P2129, DOI 10.1242/jeb.02243; RUDOLPH AM, 1974, ANNU REV PHYSIOL, V36, P187, DOI 10.1146/annurev.ph.36.030174.001155; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; WISNESKI JA, 1985, J CLIN INVEST, V76, P1819, DOI 10.1172/JCI112174; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yoneyama M, 2010, NEUROCHEM INT, V56, P740, DOI 10.1016/j.neuint.2009.11.018; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	72	474	484	3	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					565	579		10.1016/j.cell.2014.03.032	http://dx.doi.org/10.1016/j.cell.2014.03.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766806	Bronze, Green Accepted			2022-12-24	WOS:000335392100008
J	Schaffer, AE; Eggens, VRC; Caglayan, AO; Reuter, MS; Scott, E; Coufal, NG; Silhavy, JL; Xue, YC; Kayserili, H; Yasuno, K; Rosti, RO; Abdellateef, M; Caglar, C; Kasher, PR; Cazemier, JL; Weterman, MA; Cantagrel, V; Cai, N; Zweier, C; Altunoglu, U; Satkin, NB; Aktar, F; Tuysuz, B; Yalcinkaya, C; Caksen, H; Bilguvar, K; Fu, XD; Trotta, CR; Gabriel, S; Reis, A; Gunel, M; Baas, F; Gleeson, JG				Schaffer, Ashleigh E.; Eggens, Veerle R. C.; Caglayan, Ahmet Okay; Reuter, Miriam S.; Scott, Eric; Coufal, Nicole G.; Silhavy, Jennifer L.; Xue, Yuanchao; Kayserili, Hulya; Yasuno, Katsuhito; Rosti, Rasim Ozgur; Abdellateef, Mostafa; Caglar, Caner; Kasher, Paul R.; Cazemier, J. Leonie; Weterman, Marian A.; Cantagrel, Vincent; Cai, Na; Zweier, Christiane; Altunoglu, Umut; Satkin, N. Bilge; Aktar, Fesih; Tuysuz, Beyhan; Yalcinkaya, Cengiz; Caksen, Huseyin; Bilguvar, Kaya; Fu, Xiang-Dong; Trotta, Christopher R.; Gabriel, Stacey; Reis, Andre; Gunel, Murat; Baas, Frank; Gleeson, Joseph G.			CLP1 Founder Mutation Links tRNA Splicing and Maturation to Cerebellar Development and Neurodegeneration	CELL			English	Article							CAUSE PONTOCEREBELLAR HYPOPLASIA; OXIDATIVE STRESS; IN-VIVO; ENDONUCLEASE; ZEBRAFISH; CLEAVAGE; GENE; IDENTIFICATION; EUKARYOTES; REVEALS	Neurodegenerative diseases can occur so early as to affect neurodevelopment. From a cohort of more than 2,000 consanguineous families with childhood neurological disease, we identified a founder mutation in four independent pedigrees in cleavage and polyadenylation factor I subunit 1 (CLP1). CLP1 is a multifunctional kinase implicated in tRNA, mRNA, and siRNA maturation. Kinase activity of the CLP1 mutant protein was defective, and the tRNA endonuclease complex (TSEN) was destabilized, resulting in impaired pre-tRNA cleavage. Germline clp1 null zebrafish showed cerebellar neurodegeneration that was rescued by wild-type, but not mutant, human CLP1 expression. Patient-derived induced neurons displayed both depletion of mature tRNAs and accumulation of unspliced pre-tRNAs. Transfection of partially processed tRNA fragments into patient cells exacerbated an oxidative stress-induced reduction in cell survival. Our data link tRNA maturation to neuronal development and neurodegeneration through defective CLP1 function in humans.	[Schaffer, Ashleigh E.; Scott, Eric; Coufal, Nicole G.; Silhavy, Jennifer L.; Rosti, Rasim Ozgur; Abdellateef, Mostafa; Cantagrel, Vincent; Cai, Na; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA; [Eggens, Veerle R. C.; Kasher, Paul R.; Cazemier, J. Leonie; Weterman, Marian A.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Caglayan, Ahmet Okay; Yasuno, Katsuhito; Caglar, Caner; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Neurosurg, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Yasuno, Katsuhito; Caglar, Caner; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Neurobiol, New Haven, CT 06510 USA; [Caglayan, Ahmet Okay; Yasuno, Katsuhito; Caglar, Caner; Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, Dept Genet, New Haven, CT 06510 USA; [Reuter, Miriam S.; Zweier, Christiane; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Xue, Yuanchao; Fu, Xiang-Dong] Univ Calif San Diego, La Jolla, CA 92093 USA; [Kayserili, Hulya; Altunoglu, Umut; Satkin, N. Bilge] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Fatih Istanbul, Turkey; [Cantagrel, Vincent] Fac Paris Descartes, INSERM, U1163, Inst IMAGINE, F-75015 Paris, France; [Aktar, Fesih] Diyarbakir State Hosp, Dept Pediat, TR-21100 Diyarbakir, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Med Sch, Dept Pediat Genet, TR-34098 Istanbul, Turkey; [Yalcinkaya, Cengiz] Istanbul Univ, Cerrahpasa Med Sch, Div Child Neurol, Dept Neurol, TR-34098 Istanbul, Turkey; [Caksen, Huseyin] Necmettin Erbakan Univ, Meram Med Sch, Dept Pediat, TR-42080 Konya, Turkey; [Trotta, Christopher R.] PTC Therapeut, South Plainfield, NJ 07080 USA; [Gabriel, Stacey] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam; Yale University; Yale University; Yale University; University of Erlangen Nuremberg; University of California System; University of California San Diego; Istanbul University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Diyarbakir Lice Halis Toprak Foundation State Hospital; Diyarbakir Training & Research Hospital; Saladin Diyarbakir State Hospital; Tigris Memorial Hospital; Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Istanbul University - Cerrahpasa; Necmettin Erbakan University; Selcuk University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, Neurogenet Lab, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Coufal, Nicole/ABA-9471-2021; Zweier, Christiane/F-2202-2015; Baas, Frank/F-9574-2010; Yasuno, Katsuhito/E-1960-2012; Yalcinkaya, Cengiz/B-6288-2012; Aktar, Fesih/G-5921-2016; Tüysüz, Beyhan/AAN-4858-2020; Wang, Guilin/G-8794-2018; Kayserili, Hülya/AAA-5593-2021; Caglar, Caner/ABE-5815-2021; Vincent, Cantagrel/H-8698-2017; Caglayan, Ahmet O/D-1066-2012; Reis, André/D-2309-2009	Zweier, Christiane/0000-0001-8002-2020; Baas, Frank/0000-0003-3912-5428; Yasuno, Katsuhito/0000-0002-3606-532X; Yalcinkaya, Cengiz/0000-0002-3443-8524; Aktar, Fesih/0000-0002-0760-5681; Kayserili, Hülya/0000-0003-0376-499X; Vincent, Cantagrel/0000-0002-5180-4848; Caglayan, Ahmet O/0000-0002-2332-322X; Reis, André/0000-0002-6301-6363; Cazemier, Leonie/0000-0003-2875-6283; Schaffer, Ashleigh/0000-0002-1164-697X; Altunoglu, Umut/0000-0002-3172-5368; caglar, caner/0000-0002-5857-757X; Kasher, Paul/0000-0002-9213-502X; XUE, YUANCHAO/0000-0002-8113-2333; Tuysuz, Beyhan/0000-0002-9620-5021; Coufal, Nicole/0000-0001-6547-1733	National Institutes of Health (NIH) [P01HD070494, R01NS048453, P30NS047101]; Broad Institute [U54HG003067, GM049369]; Yale Center for Mendelian Disorders [U54HG006504, RC2NS070477]; Gregory M. Kiez and Mehmet Kutman Foundation; French National Research Agency [ANRRVP13016KKA]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, P30NS047101, RC2NS070477, R01NS052455, R01NS098004] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Yale Center for Mendelian Disorders; Gregory M. Kiez and Mehmet Kutman Foundation; French National Research Agency(French National Research Agency (ANR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) (P01HD070494, R01NS048453, and P30NS047101 for imaging support to J.G.G., Broad Institute grant U54HG003067 to Eric Lander, GM049369 to X.-D.F., the Yale Center for Mendelian Disorders U54HG006504 to R. Lifton and M.G., RC2NS070477) and the Gregory M. Kiez and Mehmet Kutman Foundation to M.G. We acknowledge M. Gerstein, S. Mane, A.B. Ekici, and S. Uebe for sequencing support and analysis; the Yale Biomedical High Performance Computing Center for data analysis and storage; the Yale Program on Neurogenetics and the Yale Center for Human Genetics andGenomics; the Center for Inherited Disease Research for genotyping; and the Simons Foundation Autism Research Initiative. Consortium for Autosomal Recessive Intellectual Disability (CARID) supported patient ascertainment. We thank E.W.E. Verweij for zebrafish analysis, E. Cuppen and H. van Roekel for support with ENU Tilling, and ZF Health funding for tilling. A.E.S. is the recipient of an A. P. Gianinni Fellowship. V.C. was supported by the French National Research Agency (ANRRVP13016KKA). J.G.G. is an Investigator of the Howard Hughes Medical Institute. We thank patients and parents for participation and J. Lupski, J. Martinez, and S. Weitzer for communicating unpublished results and sharing reagents.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; GOUTIERES F, 1977, J NEUROL NEUROSUR PS, V40, P370, DOI 10.1136/jnnp.40.4.370; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kasher PR, 2011, HUM MOL GENET, V20, P1574, DOI 10.1093/hmg/ddr034; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez A, 2008, RNA, V14, P1737, DOI 10.1261/rna.1142908; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Trotta CR, 2006, NATURE, V441, P375, DOI 10.1038/nature04741; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	40	163	169	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 24	2014	157	3					651	663		10.1016/j.cell.2014.03.049	http://dx.doi.org/10.1016/j.cell.2014.03.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AG4LT	24766810	Green Accepted, Bronze			2022-12-24	WOS:000335392100014
J	Lee, AY; St Onge, RP; Proctor, MJ; Wallace, IM; Nile, AH; Spagnuolo, PA; Jitkova, Y; Gronda, M; Wu, Y; Kim, MK; Cheung-Ong, K; Torres, NP; Spear, ED; Han, MKL; Schlecht, U; Suresh, S; Duby, G; Heisler, LE; Surendra, A; Fung, E; Urbanus, ML; Gebbia, M; Lissina, E; Miranda, M; Chiang, JH; Aparicio, AM; Zeghouf, M; Davis, RW; Cherfils, J; Boutry, M; Kaiser, CA; Cummins, CL; Trimble, WS; Brown, GW; Schimmer, AD; Bankaitis, VA; Nislow, C; Bader, GD; Giaever, G				Lee, Anna Y.; St. Onge, Robert P.; Proctor, Michael J.; Wallace, Iain M.; Nile, Aaron H.; Spagnuolo, Paul A.; Jitkova, Yulia; Gronda, Marcela; Wu, Yan; Kim, Moshe K.; Cheung-Ong, Kahlin; Torres, Nikko P.; Spear, Eric D.; Han, Mitchell K. L.; Schlecht, Ulrich; Suresh, Sundari; Duby, Geoffrey; Heisler, Lawrence E.; Surendra, Anuradha; Fung, Eula; Urbanus, Malene L.; Gebbia, Marinella; Lissina, Elena; Miranda, Molly; Chiang, Jennifer H.; Aparicio, Ana Maria; Zeghouf, Mahel; Davis, Ronald W.; Cherfils, Jacqueline; Boutry, Marc; Kaiser, Chris A.; Cummins, Carolyn L.; Trimble, William S.; Brown, Grant W.; Schimmer, Aaron D.; Bankaitis, Vytas A.; Nislow, Corey; Bader, Gary D.; Giaever, Guri			Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures	SCIENCE			English	Article							DRUG-INDUCED PHOSPHOLIPIDOSIS; YEAST; DISCOVERY; PATHWAY; PROTEIN; GENOME; GENES	Genome-wide characterization of the in vivo cellular response to perturbation is fundamental to understanding how cells survive stress. Identifying the proteins and pathways perturbed by small molecules affects biology and medicine by revealing the mechanisms of drug action. We used a yeast chemogenomics platform that quantifies the requirement for each gene for resistance to a compound in vivo to profile 3250 small molecules in a systematic and unbiased manner. We identified 317 compounds that specifically perturb the function of 121 genes and characterized the mechanism of specific compounds. Global analysis revealed that the cellular response to small molecules is limited and described by a network of 45 major chemogenomic signatures. Our results provide a resource for the discovery of functional interactions among genes, chemicals, and biological processes.	[Lee, Anna Y.; Wallace, Iain M.; Cheung-Ong, Kahlin; Torres, Nikko P.; Heisler, Lawrence E.; Surendra, Anuradha; Gebbia, Marinella; Lissina, Elena; Brown, Grant W.; Nislow, Corey; Bader, Gary D.; Giaever, Guri] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Lee, Anna Y.; Cheung-Ong, Kahlin; Urbanus, Malene L.; Lissina, Elena; Nislow, Corey; Bader, Gary D.; Giaever, Guri] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [St. Onge, Robert P.; Proctor, Michael J.; Schlecht, Ulrich; Suresh, Sundari; Fung, Eula; Miranda, Molly; Aparicio, Ana Maria; Davis, Ronald W.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Nile, Aaron H.; Bankaitis, Vytas A.] Texas A&M Univ, Dept Mol & Cell Med, Coll Med, Hlth Sci Ctr, College Stn, TX 77843 USA; [Spagnuolo, Paul A.] Univ Waterloo, Sch Pharm, Kitchener, ON N2G 1CS, Canada; [Jitkova, Yulia; Gronda, Marcela; Wu, Yan; Schimmer, Aaron D.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Kim, Moshe K.; Torres, Nikko P.; Trimble, William S.; Brown, Grant W.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kim, Moshe K.; Trimble, William S.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Spear, Eric D.; Kaiser, Chris A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Han, Mitchell K. L.; Giaever, Guri] Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Duby, Geoffrey; Boutry, Marc] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Chiang, Jennifer H.; Nislow, Corey; Giaever, Guri] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada; [Cherfils, Jacqueline] CNRS, Lab Enzymol & Biochim Structur, Gif Sur Yvette, France	University of Toronto; University of Toronto; Stanford University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Waterloo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Massachusetts Institute of Technology (MIT); University of Toronto; Universite Catholique Louvain; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Giaever, G (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada.	g.giaever@ubc.ca	Bader, Gary/C-1176-2009; Wallace, Iain/B-9464-2009	Bader, Gary/0000-0003-0185-8861; Nile, Aaron/0000-0002-7370-8769; Wallace, Iain/0000-0002-9491-7025; Schimmer, Aaron/0000-0003-4023-3899; Heisler, Lawrence/0000-0002-1332-1802; Boutry, Marc/0000-0002-2315-6900; Spagnuolo, Paul/0000-0002-2431-4368; Zeghouf, Mahel/0000-0003-3686-2510; Cummins, Carolyn/0000-0001-7603-6577; Brown, Grant/0000-0002-9002-5003; Han, Mitchell/0000-0002-9243-1136	National Human Genome Research Institute [RO1 003317-07]; Canadian Cancer Society Research Institute [020380]; Canadian Institute for Health Research [MOP-81340, MOP-79368, MOP-700724]; Canadian Research Chair; Charles H. Best Institute; Belgian National Fund for Scientific Research; French National Research Agency; Marie Curie Fellowship; Leukemia and Lymphoma Society; Robert A. Welch Foundation; NIH [GM103504, GM44530]; Interuniversity Poles of Attraction Program; NATIONAL CANCER INSTITUTE [R01CA157456] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG003317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504, R01GM044530] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair(Canada Research Chairs); Charles H. Best Institute; Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); French National Research Agency(French National Research Agency (ANR)); Marie Curie Fellowship(European Commission); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interuniversity Poles of Attraction Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Human Genome Research Institute (RO1 003317-07) (C.N., G. G., and R. W. D.); Canadian Cancer Society Research Institute (#020380) (C.N. and G. G.); Canadian Institute for Health Research (MOP-81340) (G. G.), MOP-79368 (G. W. B.), and MOP-700724 (W. S. T.); Canadian Research Chair (G. G.); Charles H. Best Institute (A.Y.L.); Belgian National Fund for Scientific Research and the Interuniversity Poles of Attraction Program (M. B.); French National Research Agency (J.C.); Marie Curie Fellowship (I. M. W.); Leukemia and Lymphoma Society (A. D. S.); Robert A. Welch Foundation (V. A. B.); and NIH grants (GM103504) (G. D. B.) and GM44530 (V. A. B.). The data reported in this paper are tabulated in the supplementary materials, and access to the entire data set is available for query and in a variety of downloadable formats at http://chemogenomics.pharmacy.ubc.ca/HIPHOP/. The raw microarray data are archived in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession no. E-MTAB-2391.	Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Barrett PM, 2012, HUM MOL GENET, V21, pR66, DOI 10.1093/hmg/dds345; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Nile AH, 2014, NAT CHEM BIOL, V10, P76, DOI [10.1038/NCHEMBIO.1389, 10.1038/nchembio.1389]; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846; Reasor MJ, 2001, EXP BIOL MED, V226, P825, DOI 10.1177/153537020122600903; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Torres NP, 2013, ASSAY DRUG DEV TECHN, V11, P299, DOI 10.1089/adt.2012.503; Wallace IM, 2011, CHEM BIOL, V18, P1273, DOI 10.1016/j.chembiol.2011.07.018	22	160	165	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2014	344	6180					208	211		10.1126/science.1250217	http://dx.doi.org/10.1126/science.1250217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6JD	24723613	Green Accepted, Green Published			2022-12-24	WOS:000334096300038
J	Crowley, MJ; McCrory, DC; Chatterjee, R; Gierisch, JM; Myers, ER; Schmit, KM; Coeytaux, RR; Correll, CU; Kendrick, AS; Sanders, GD				Crowley, Matthew J.; McCrory, Douglas C.; Chatterjee, Ranee; Gierisch, Jennifer M.; Myers, Evan R.; Schmit, Kristine M.; Coeytaux, Remy R.; Correll, Christoph U.; Kendrick, Amy S.; Sanders, Gillian D.			Prioritization of Research Addressing Antipsychotics for Adolescents and Young Adults With Bipolar Disorder	ANNALS OF INTERNAL MEDICINE			English	Article							LONGITUDINAL COURSE; SPECTRUM DISORDERS; NATIONAL TRENDS; I DISORDER; CHILDREN; DIVALPROEX; MANIA; SCHIZOPHRENIA; RISPERIDONE; DIAGNOSIS	Despite a paucity of high-quality evidence about benefits and harms, antipsychotic medication use among adolescents and young adults with bipolar disorder is increasing. The Patient-Centered Outcomes Research Institute tasked the Duke Evidence Synthesis Group with creating a prioritized agenda for research in this area that would incorporate the perspectives of relevant stakeholders. We identified a list of potential evidence gaps by reviewing existing literature and engaged a diverse group of 9 stakeholders to expand and refine this list. Using a forced-ranking prioritization method, stakeholders prioritized 10 of 23 potential evidence gaps as the (m)ost pressing for future research. These evidence gaps relate to 3 areas: the comparative effectiveness of intervention strategies, the effect of antipsychotics on patient-centered outcomes, and the influence of various patient characteristics on antipsychotic effectiveness. In addition to presenting these findings, we suggest appropriate study designs for addressing the stakeholder-prioritized research questions.	Duke Clin Res Inst, Durham Vet Affairs Med Ctr, Durham, NC 27705 USA; Duke Univ, Sch Med, Durham, NC USA; Hofstra North Shore Long Isl Jewish Sch Med, Hempstead, NY USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Hofstra University	Sanders, GD (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	gillian.sanders@duke.edu	Correll, Christoph/D-3530-2011; Correll, Christoph U/AAY-3179-2021; Gierisch, Jennifer/GLU-1269-2022	Correll, Christoph/0000-0002-7254-5646; Kendrick, Amy/0000-0001-8769-1702; Gierisch, Jennifer/0000-0002-5057-4964	PCORI	PCORI(Patient-Centered Outcomes Research Institute - PCORI)	By a contract from PCORI	Abou-Setta A, 2012, COMP EFFECTIVENESS R; Agency for Healthcare Research and Quality, 2012, ANT MED CHILDR TEENS; Axelson D, 2003, J CHILD ADOL PSYCHOP, V13, P463, DOI 10.1089/104454603322724850; Axelson D, 2012, J CLIN PSYCHIAT, V73, P1342, DOI 10.4088/JCP.12m07674; Birmaher B, 2006, ARCH GEN PSYCHIAT, V63, P175, DOI 10.1001/archpsyc.63.2.175; Birmaher B, 2007, AM J PSYCHIAT, V164, P537, DOI 10.1176/appi.ajp.164.4.537; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Blader JC, 2007, BIOL PSYCHIAT, V62, P107, DOI 10.1016/j.biopsych.2006.11.006; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; Christian R., 2012, 13 AG HEALTHC RES QU; Correll CU, 2008, J AM ACAD CHILD PSY, V47, P9, DOI 10.1097/chi.0b013e31815b5cb1; Correll CU, 2010, BIPOLAR DISORD, V12, P116, DOI 10.1111/j.1399-5618.2010.00798.x; DelBello MP, 2007, AM J PSYCHIAT, V164, P582, DOI 10.1176/appi.ajp.164.4.582; Delbello MP, 2006, J AM ACAD CHILD PSY, V45, P305, DOI 10.1097/01.chi.0000194567.63289.97; Freedman R, 2013, AM J PSYCHIAT, V170, P1, DOI 10.1176/appi.ajp.2012.12091189; Geller B, 2008, ARCH GEN PSYCHIAT, V65, P1125, DOI 10.1001/archpsyc.65.10.1125; Geller B, 2012, ARCH GEN PSYCHIAT, V69, P515, DOI 10.1001/archgenpsychiatry.2011.1508; Gierisch JM, 2014, ANN INTERN MED, V160, P484, DOI 10.7326/M13-2548; Ip S, 2013, AHRQ PUBLICATION, V13-EHC007-EF; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Moreno C, 2007, ARCH GEN PSYCHIAT, V64, P1032, DOI 10.1001/archpsyc.64.9.1032; Olfson M, 2012, ARCH GEN PSYCHIAT, V69, P1247, DOI 10.1001/archgenpsychiatry.2012.647; Pavuluri MN, 2010, BIPOLAR DISORD, V12, P593, DOI 10.1111/j.1399-5618.2010.00850.x; Perlis RH, 2004, BIOL PSYCHIAT, V55, P875, DOI 10.1016/j.biopsych.2004.01.022; Van Meter AR, 2011, J CLIN PSYCHIAT, V72, P1250, DOI 10.4088/JCP.10m06290; Youngstrom E, 2005, BIPOLAR DISORD, V7, P507, DOI 10.1111/j.1399-5618.2005.00269.x	27	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					492	+		10.7326/M13-2549	http://dx.doi.org/10.7326/M13-2549			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24567115				2022-12-24	WOS:000334093800007
J	Shen, P; Roch, T; Lampropoulou, V; O'Connor, RA; Stervbo, U; Hilgenberg, E; Ries, S; Dang, VD; Jaimes, Y; Daridon, C; Li, R; Jouneau, L; Boudinot, P; Wilantri, S; Sakwa, I; Miyazaki, Y; Leech, MD; McPherson, RC; Wirtz, S; Neurath, M; Hoehlig, K; Meinl, E; Grutzkau, A; Grun, JR; Horn, K; Kuhl, AA; Dorner, T; Bar-Or, A; Kaufmann, SHE; Anderton, SM; Fillatreau, S				Shen, Ping; Roch, Toralf; Lampropoulou, Vicky; O'Connor, Richard A.; Stervbo, Ulrik; Hilgenberg, Ellen; Ries, Stefanie; Van Duc Dang; Jaimes, Yarua; Daridon, Capucine; Li, Rui; Jouneau, Luc; Boudinot, Pierre; Wilantri, Siska; Sakwa, Imme; Miyazaki, Yusei; Leech, Melanie D.; McPherson, Rhoanne C.; Wirtz, Stefan; Neurath, Markus; Hoehlig, Kai; Meinl, Edgar; Gruetzkau, Andreas; Gruen, Joachim R.; Horn, Katharina; Kuehl, Anja A.; Doerner, Thomas; Bar-Or, Amit; Kaufmann, Stefan H. E.; Anderton, Stephen M.; Fillatreau, Simon			IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases	NATURE			English	Article							T-CELLS; SALMONELLA-TYPHIMURIUM; ULCERATIVE-COLITIS; DEPLETION; RITUXIMAB; CYTOKINE; ACTIVATION; EXPRESSION; PREVENTION; ARTHRITIS	B lymphocytes have critical roles as positive and negative regulators of immunity. Their inhibitory function has been associated primarily with interleukin 10 (IL-10) because B-cell-derived IL-10 can protect against autoimmune disease and increase susceptibility to pathogens(1,2). Here we identify IL-35-producing B cells as key players in the negative regulation of immunity. Mice in which only B cells did not express IL-35 lost their ability to recover from the T-cell mediated demyelinating autoimmune disease experimental autoimmune encephalomyelitis (EAE). In contrast, these mice displayed a markedly improved resistance to infection with the intracellular bacterial pathogen Salmonella enterica serovar Typhimurium as shown by their superior containment of the bacterial growth and their prolonged survival after primary infection, and upon secondary challenge, compared to control mice. The increased immunity found in mice lacking IL-35 production by B cells was associated with a higher activation of macrophages and inflammatory T cells, as well as an increased function of B cells as antigen-presenting cells (APCs). During Salmonella infection, IL-35- and IL-10-producing B cells corresponded to two largely distinct sets of surface-IgM1 CD138(hi)TACI(+)CXCR4(+)CD1d(int)Tim1(int) plasma cells expressing the transcription factor Blimp1 (also known as Prdm1). During EAE, CD138(+) plasma cells were also the main source of B-cell-derived IL-35 and IL-10. Collectively, our data show the importance of IL-35 producing B cells in regulation of immunity and highlight IL-35 production by B cells as a potential therapeutic target for autoimmune and infectious diseases. This study reveals the central role of activated B cells, particularly plasma cells, and their production of cytokines in the regulation of immune responses in health and disease.	[Shen, Ping; Roch, Toralf; Lampropoulou, Vicky; Stervbo, Ulrik; Hilgenberg, Ellen; Ries, Stefanie; Van Duc Dang; Jaimes, Yarua; Daridon, Capucine; Wilantri, Siska; Sakwa, Imme; Hoehlig, Kai; Gruetzkau, Andreas; Gruen, Joachim R.; Horn, Katharina; Doerner, Thomas; Fillatreau, Simon] Deutsch Rheuma Forschungszentrum, Charite Pl 1, D-10117 Berlin, Germany; [O'Connor, Richard A.; Leech, Melanie D.; McPherson, Rhoanne C.; Anderton, Stephen M.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [O'Connor, Richard A.; Leech, Melanie D.; McPherson, Rhoanne C.; Anderton, Stephen M.] Univ Edinburgh, Ctr Multiple Sclerosis Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Daridon, Capucine; Doerner, Thomas] Charite, Dept Med Rheumatol & Clin Immunol, CC12, D-10117 Berlin, Germany; [Li, Rui; Miyazaki, Yusei; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ H3A 2B4, Canada; [Jouneau, Luc; Boudinot, Pierre] INRA, Virol & Immunol Mol, F-78352 Jouy En Josas, France; [Wirtz, Stefan; Neurath, Markus] Univ Erlangen Nurnberg, Med Clin 1, D-91054 Erlangen, Germany; [Meinl, Edgar] Univ Munich, Inst Klin Neuroimmunol Klinikum, D-81377 Munich, Germany; [Kuehl, Anja A.] Res Ctr ImmunoSci, D-12203 Berlin, Germany; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); University of Edinburgh; University of Edinburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Erlangen Nuremberg; University of Munich; Max Planck Society	Fillatreau, S (corresponding author), Deutsch Rheuma Forschungszentrum, Charite Pl 1, D-10117 Berlin, Germany.	fillatreau@drfz.de	Bar-Or, Amit/AIC-1416-2022; Stervbo, Ulrik/AAV-1561-2020; Roch, Toralf/AAQ-7480-2021; Li, Rui/O-7397-2016; Jouneau, Luc/AAC-4711-2020; boudinot, pierre/L-4246-2016; Kaufmann, Stefan HE/I-5454-2014	Stervbo, Ulrik/0000-0002-2831-8868; Li, Rui/0000-0002-7210-8358; Dang, Van Duc/0000-0002-0403-6479; Meinl, Edgar/0000-0002-2570-6785; O'Connor, Richard/0000-0001-7100-0233; Kaufmann, Stefan HE/0000-0001-9866-8268; Shen, Ping/0000-0003-3046-3818; Kuhl, Anja/0000-0003-2293-5387; Wirtz, Stefan/0000-0001-6936-7431; Grun, Joachim R./0000-0002-2875-3691; boudinot, pierre/0000-0002-7490-9677; Roch, Toralf/0000-0003-2948-8700; Fillatreau, Simon/0000-0002-7730-9917	Deutsche Forschungsgemeinschaft [SFB-650, TRR-36, TRR-130, FI-1238/02, Do491/7-2, Do491/8-2]; Hertie Stiftung; Merieux Institute; INRA; CIHR/MSSC New Emerging Team grant in Clinical Autoimmunity; UK Medical Research Council; Wellcome Trust; Clinical Competence Network for Multiple Sclerosis;  [SFB-TR128]; MRC [G1100084, G0801924, G0901697] Funding Source: UKRI; Medical Research Council [G0801924, G0901697, G1100084] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie Stiftung(Austrian Science Fund (FWF)); Merieux Institute; INRA; CIHR/MSSC New Emerging Team grant in Clinical Autoimmunity; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Clinical Competence Network for Multiple Sclerosis; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Schliemann, H. Ruebsamen, M. Spadaro and D. Jenne for assistance and support. We thank M. Loehning for providing IL-12 p40-deficient mice, and S. Akira for providing TLR2- and TLR4-deficient mice. We thank O. Neyrolles for help with some of the in vivo experiments. We thank E. Schott for help with the AST/ALT measurements. S. F. is supported by grants from the Deutsche Forschungsgemeinschaft (SFB-650, TRR-36, TRR-130, FI-1238/02), Hertie Stiftung, and an advanced grant from the Merieux Institute. C. D and T. D. are supported by the Deutsche Forschungsgemeinschaft (SFB-650, Do491/7-2, 8-2). P. B. and L.J. are supported by INRA. A.B.-O. is supported by a CIHR/MSSC New Emerging Team grant in Clinical Autoimmunity. Work in S.M.A.'s laboratory was supported by grants from the UK Medical Research Council and the Wellcome Trust. E. M. is supported by the Clinical Competence Network for Multiple Sclerosis and SFB-TR128.	Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Benedetti L, 2007, ARCH NEUROL-CHICAGO, V64, P1531, DOI 10.1001/archneur.64.10.1531; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Brentano F, 2009, ANN RHEUM DIS, V68, P143, DOI 10.1136/ard.2007.082081; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dass S, 2007, ARTHRITIS RHEUM, V56, P2715, DOI 10.1002/art.22811; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; El Fassi D, 2008, GUT, V57, P714, DOI 10.1136/gut.2007.138305; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Fillatreau S, 2011, IMMUNOL REV, V240, P52, DOI 10.1111/j.1600-065X.2010.00991.x; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Hoehlig K, 2012, EUR J IMMUNOL, V42, P1164, DOI 10.1002/eji.201142242; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Su Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00154; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Wilson MS, 2010, EUR J IMMUNOL, V40, P1682, DOI 10.1002/eji.200939721	31	686	748	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					366	+		10.1038/nature12979	http://dx.doi.org/10.1038/nature12979			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24572363	Green Accepted			2022-12-24	WOS:000333029000036
J	McMeniman, CJ; Corfas, RA; Matthews, BJ; Ritchie, SA; Vosshall, LB				McMeniman, Conor J.; Corfas, Roman A.; Matthews, Benjamin J.; Ritchie, Scott A.; Vosshall, Leslie B.			Multimodal Integration of Carbon Dioxide and Other Sensory Cues Drives Mosquito Attraction to Humans	CELL			English	Article							AEDES-AEGYPTI; CHEMOSENSORY RECEPTORS; MAXILLARY PALP; RESPONSES; NEURONS; DIPTERA; SKIN; ACTIVATION; DROSOPHILA; CULICIDAE	Multiple sensory cues emanating from humans are thought to guide blood-feeding female mosquitoes to a host. To determine the relative contribution of carbon dioxide (CO2) detection to mosquito host-seeking behavior, we mutated the AaegGr3 gene, a subunit of the heteromeric CO2 receptor in Aedes aegypti mosquitoes. Gr3 mutants lack electrophysiological and behavioral responses to CO2. These mutants also fail to show CO2-evoked responses to heat and lactic acid, a human-derived attractant, suggesting that CO2 can gate responses to other sensory stimuli. Whereas attraction of Gr3 mutants to live humans in a large semi-field environment was only slightly impaired, responses to an animal host were greatly reduced in a spatial-scale-dependent manner. Synergistic integration of heat and odor cues likely drive host-seeking behavior in the absence of CO2 detection. We reveal a networked series of interactions by which multimodal integration of CO2, human odor, and heat orchestrates mosquito attraction to humans.	[McMeniman, Conor J.; Corfas, Roman A.; Matthews, Benjamin J.; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Ritchie, Scott A.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabilitat Sci, Cairns, Qld 4870, Australia; [Vosshall, Leslie B.] Howard Hughes Med Inst, Chevy Chase, MD USA	Rockefeller University; James Cook University; Howard Hughes Medical Institute	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	leslie.vosshall@rockefeller.edu		Matthews, Benjamin/0000-0002-8697-699X; Vosshall, Leslie/0000-0002-6060-8099; Corfas, Roman/0000-0002-3096-6813; McMeniman, Conor/0000-0001-8502-8712	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontier Science Program Long-Term Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontier Science Program Long-Term Postdoctoral Fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Matthew DeGennaro, Jeff Liesch, Carolyn McBride, and other members of the Vosshall Lab for helpful discussions and comments on the manuscript; Deborah Beck, Allison Goff, Emma Mullen, Jason Pitts, Laura Seeholzer, and Sarah Yeoh-Wang for expert technical assistance; Lindsay Bellani for collaborating to establish the membrane-feeding assay; and Scott Dewell for bioinformatic support. At James Cook University, Jessica Dickie, Chris Paton, and Michael Townsend provided valuable support with Australian importation, regulatory inspections, and mosquito rearing, and Mark Pearson facilitated sample processing. Zach Adelman of Virginia Tech University provided plasmids. C.J.M. was supported by a Marie-Josee and Henry Kravis Postdoctoral Fellowship and a Human Frontier Science Program Long-Term Postdoctoral Fellowship. B.J.M. is a Jane Coffin Childs Postdoctoral Fellow. L.B.V. is an Investigator of the Howard Hughes Medical Institute.	ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; Anton S, 2003, ARTHROPOD STRUCT DEV, V32, P319, DOI 10.1016/j.asd.2003.09.002; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; BURGESS L, 1959, NATURE, V184, P1968, DOI 10.1038/1841968a0; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186; EIRAS AE, 1991, B ENTOMOL RES, V81, P151, DOI 10.1017/S0007485300051221; Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Geier M, 1999, J EXP BIOL, V202, P1639; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; HEALY TP, 1995, MED VET ENTOMOL, V9, P331, DOI 10.1111/j.1365-2915.1995.tb00143.x; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Keller A, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-8; Kennedy JS, 1940, P ZOOL SOC LOND A-GE, V109, P221, DOI 10.1111/j.1096-3642.1940.tb00831.x; Krober T, 2010, J AM MOSQUITO CONTR, V26, P381, DOI 10.2987/10-6044.1; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LEWIS HE, 1969, LANCET, V1, P1273; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Maekawa E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-10; MCIVER SB, 1972, CAN J ZOOLOG, V50, P571, DOI 10.1139/z72-078; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; SNOW WF, 1970, B ENTOMOL RES, V60, P43, DOI 10.1017/S0007485300034131; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; TRPIS M, 1973, B WORLD HEALTH ORGAN, V48, P623; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Woke P.A., 1937, LINN J PARASITOL, V23, P310	40	241	251	7	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1060	1071		10.1016/j.cell.2013.12.044	http://dx.doi.org/10.1016/j.cell.2013.12.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581501	Bronze, Green Accepted			2022-12-24	WOS:000332083900021
J	Noubade, R; Wong, K; Ota, N; Rutz, S; Eidenschenk, C; Valdez, PA; Ding, JB; Peng, I; Sebrell, A; Caplazi, P; DeVoss, J; Soriano, RH; Sai, T; Lu, RZ; Modrusan, Z; Hackney, J; Ouyang, WJ				Noubade, Rajkumar; Wong, Kit; Ota, Naruhisa; Rutz, Sascha; Eidenschenk, Celine; Valdez, Patricia A.; Ding, Jiabing; Peng, Ivan; Sebrell, Andrew; Caplazi, Patrick; DeVoss, Jason; Soriano, Robert H.; Sai, Tao; Lu, Rongze; Modrusan, Zora; Hackney, Jason; Ouyang, Wenjun			NRROS negatively regulates reactive oxygen species during host defence and autoimmunity	NATURE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NEUTROPHIL NADPH OXIDASE; PLASMA-MEMBRANE; LYSOSOMAL MEMBRANE; MACROPHAGES; ENCEPHALOMYELITIS; PHOSPHORYLATION; ACTIVATION; EXPRESSION; APOPTOSIS	Reactive oxygen species (ROS) produced by phagocytes are essential for host defence against bacterial and fungal infections. Individuals with defective ROS production machinery develop chronic granulomatous disease(1,2). Conversely, excessive ROS can cause collateral tissue damage during inflammatory processes and therefore needs to be tightly regulated. Here we describe a protein, we termed negative regulator of ROS (NRROS), which limits ROS generation by phagocytes during inflammatory responses. NRROS expression in phagocytes can be repressed by inflammatory signals. NRROS-deficient phagocytes produce increased ROS upon inflammatory challenges, and mice lacking NRROS in their phagocytes show enhanced bactericidal activity against Escherichia coli and Listeria monocytogenes. Conversely, these mice develop severe experimental autoimmune encephalomyelitis owing to oxidative tissue damage in the central nervous system. Mechanistically, NRROS is localized to the endoplasmic reticulum, where it directly interactswith nascent NOX2 (also known as gp91(phox) and encoded by Cybb) monomer, one of the membrane-bound subunits of the NADPH oxidase complex, and facilitates the degradation of NOX2 through the endoplasmic-reticulum-associated degradation pathway. Thus, NRROS provides a hitherto undefined mechanism for regulating ROS prodution-one that enables phagocytes to produce higher amounts of ROS, if required to control invading pathogens, while minimizing unwanted collateral tissue damage.	[Noubade, Rajkumar; Wong, Kit; Ota, Naruhisa; Rutz, Sascha; Eidenschenk, Celine; Valdez, Patricia A.; Ding, Jiabing; Peng, Ivan; DeVoss, Jason; Lu, Rongze; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Sebrell, Andrew; Sai, Tao] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Caplazi, Patrick] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Soriano, Robert H.; Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Hackney, Jason] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	ouyang.wenjun@gene.com	Ouyang, Wenjun/ABA-8763-2020; Lu, Rongze/R-2149-2016	Ouyang, Wenjun/0000-0002-1811-5864; Caplazi, Patrick/0000-0002-3411-1257; Hackney, Jason/0000-0002-5922-563X				Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Barabutis N, 2008, P NATL ACAD SCI USA, V105, P20470, DOI 10.1073/pnas.0811209106; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Chen F, 2012, ARTERIOSCL THROM VAS, V32, P2989, DOI 10.1161/ATVBAHA.112.300361; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; CZUPRYNSKI CJ, 1985, IMMUNOLOGY, V55, P511; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Dinauer MC, 1997, J IMMUNOL, V158, P5581; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; GREEN SA, 1987, J CELL BIOL, V105, P1227, DOI 10.1083/jcb.105.3.1227; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Mantei A, 2008, EUR J IMMUNOL, V38, P2616, DOI 10.1002/eji.200738075; MCPHAIL LC, 1984, J BIOL CHEM, V259, P5768; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; PARKOS CA, 1989, BLOOD, V73, P1416; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tse HM, 2010, J IMMUNOL, V185, P5247, DOI 10.4049/jimmunol.1001472; Wallberg M, 2007, EUR J IMMUNOL, V37, P1986, DOI 10.1002/eji.200636912; Wang GX, 2012, J IMMUNOL, V188, P5829, DOI 10.4049/jimmunol.1102620; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	38	148	155	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2014	509	7499					235	+		10.1038/nature13152	http://dx.doi.org/10.1038/nature13152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG5JC	24739962				2022-12-24	WOS:000335454300041
J	Tsang, JS; Schwartzberg, PL; Kotliarov, Y; Biancotto, A; Xie, Z; Germain, RN; Wang, E; Olnes, MJ; Narayanan, M; Golding, H; Moir, S; Dickler, HB; Perl, S; Cheung, F				Tsang, John S.; Schwartzberg, Pamela L.; Kotliarov, Yuri; Biancotto, Angelique; Xie, Zhi; Germain, Ronald N.; Wang, Ena; Olnes, Matthew J.; Narayanan, Manikandan; Golding, Hana; Moir, Susan; Dickler, Howard B.; Perl, Shira; Cheung, Foo		Baylor HIPC Ctr; CHI Consortium	Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination Responses	CELL			English	Article							PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN RESPONSE; H1N1 INFLUENZA VACCINE; YELLOW-FEVER VACCINE; SYSTEMS BIOLOGY; GENE-EXPRESSION; B-CELLS; SEASONAL INFLUENZA; ANTIBODY; IMMUNIZATION	A major goal of systems biology is the development of models that accurately predict responses to perturbation. Constructing such models requires the collection of dense measurements of system states, yet transformation of data into predictive constructs remains a challenge. To begin to model human immunity, we analyzed immune parameters in depth both at baseline and in response to influenza vaccination. Peripheral blood mononuclear cell transcriptomes, serum titers, cell subpopulation frequencies, and B cell responses were assessed in 63 individuals before and after vaccination and were used to develop a systematic framework to dissect inter- and intra-individual variation and build predictive models of postvaccination antibody responses. Strikingly, independent of age and pre-existing antibody titers, accurate models could be constructed using pre-perturbation cell populations alone, which were validated using independent baseline time points. Most of the parameters contributing to prediction delineated temporally stable baseline differences across individuals, raising the prospect of immune monitoring before intervention.	[Tsang, John S.; Schwartzberg, Pamela L.; Kotliarov, Yuri; Biancotto, Angelique; Xie, Zhi; Germain, Ronald N.; Wang, Ena; Olnes, Matthew J.; Dickler, Howard B.; Perl, Shira; Cheung, Foo] NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA; [Tsang, John S.; Narayanan, Manikandan] NIAID, Lab Syst Biol, Syst Genom & Bioinformat Unit, NIH, Bethesda, MD 20892 USA; [Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Wang, Ena] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Olnes, Matthew J.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Golding, Hana] US FDA, Lab Retrovirus Res, Bethesda, MD 20892 USA; [Moir, Susan] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tsang, JS (corresponding author), NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA.	john.tsang@nih.gov; pams@nhgri.nih.gov	Trinchieri, Giorgio/F-9369-2015; Pós, Zoltán/C-3623-2014; Moir, Susan/AAC-3676-2020; Kotliarov, Yuri/B-6938-2017; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; biancotto, angelique/C-4632-2011	Trinchieri, Giorgio/0000-0001-5892-7464; Pós, Zoltán/0000-0002-2574-7616; biancotto, angelique/0000-0003-2271-009X; Narayanan, Manikandan/0000-0002-8490-4087; Xie, Zhi/0000-0002-5589-4836; Kotliarov, Yuri/0000-0002-6558-8883	NIAID; NCI; NHLBI; NIAMS; NICHD; NIDDK; NINDS; NIEHS; NEI; NHGRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, ZIAHG200391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000974, U19AI089987, ZIAAI000825] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Connors, K. Subbarao, R. Seder, M. Roederer, D. Douek, J. Bennink, I. Fraser, J. Mandl, members of the Systems Genomics and Bioinformatics Unit (NIAID), and M. Eichelberger (FDA) for helpful advice and feedback; the staff of the NIH Clinical Center for outstanding clinical support; and NIAID's high-performance computing team for outstanding support. This work is funded by the Intramural Programs of NIAID, NCI, NHLBI, NIAMS, NICHD, NIDDK, NINDS, NIEHS, NEI, and NHGRI.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biancotto A, 2011, J IMMUNOL METHODS, V363, P245, DOI 10.1016/j.jim.2010.06.010; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Clutterbuck EA, 2006, IMMUNOLOGY, V119, P328, DOI 10.1111/j.1365-2567.2006.02436.x; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gass JN, 2004, TRENDS IMMUNOL, V25, P17, DOI 10.1016/j.it.2003.11.004; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Germain RN, 2011, NAT IMMUNOL, V12, P369, DOI 10.1038/ni0511-369; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nauta J., 2011, STAT CLIN VACCINE TR; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Shi YH, 2003, CLIN IMMUNOL, V108, P128, DOI 10.1016/S1521-6616(03)00092-5; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; TULP A, 1986, EMBO J, V5, P1783, DOI 10.1002/j.1460-2075.1986.tb04427.x; van Duin D, 2007, J INFECT DIS, V195, P1590, DOI 10.1086/516788; Withers DR, 2007, BLOOD, V109, P4856, DOI 10.1182/blood-2006-08-043414	41	278	279	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 10	2014	157	2					499	513		10.1016/j.cell.2014.03.031	http://dx.doi.org/10.1016/j.cell.2014.03.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AE9DK	24725414	Green Accepted, Bronze			2022-12-24	WOS:000334304500021
J	Annaluru, N; Muller, H; Mitchell, LA; Ramalingam, S; Stracquadanio, G; Richardson, SM; Dymond, JS; Kuang, Z; Scheifele, LZ; Cooper, EM; Cai, YZ; Zeller, K; Agmon, N; Han, JS; Hadjithomas, M; Tullman, J; Caravelli, K; Cirelli, K; Guo, ZY; London, V; Yeluru, A; Murugan, S; Kandavelou, K; Agier, N; Fischer, G; Yang, K; Martin, JA; Bilgel, M; Bohutski, P; Boulier, KM; Capaldo, BJ; Chang, J; Charoen, K; Choi, WJ; Deng, P; DiCarlo, JE; Doong, J; Dunn, J; Feinberg, JI; Fernandez, C; Floria, CE; Gladowski, D; Hadidi, P; Ishizuka, I; Jabbari, J; Lau, CYL; Lee, PA; Li, S; Lin, D; Linder, ME; Ling, J; Liu, J; Liu, J; London, M; Ma, H; Mao, J; McDade, JE; McMillan, A; Moore, AM; Oh, WC; Ouyang, Y; Patel, R; Paul, M; Paulsen, LC; Qiu, J; Rhee, A; Rubashkin, MG; Soh, IY; Sotuyo, NE; Srinivas, V; Suarez, A; Wong, A; Wong, R; Xie, WR; Xu, YJ; Yu, AT; Koszul, R; Bader, JS; Boeke, JD; Chandrasegaran, S				Annaluru, Narayana; Muller, Heloise; Mitchell, Leslie A.; Ramalingam, Sivaprakash; Stracquadanio, Giovanni; Richardson, Sarah M.; Dymond, Jessica S.; Kuang, Zheng; Scheifele, Lisa Z.; Cooper, Eric M.; Cai, Yizhi; Zeller, Karen; Agmon, Neta; Han, Jeffrey S.; Hadjithomas, Michalis; Tullman, Jennifer; Caravelli, Katrina; Cirelli, Kimberly; Guo, Zheyuan; London, Viktoriya; Yeluru, Apurva; Murugan, Sindurathy; Kandavelou, Karthikeyan; Agier, Nicolas; Fischer, Gilles; Yang, Kun; Martin, J. Andrew; Bilgel, Murat; Bohutski, Pavlo; Boulier, Kristin M.; Capaldo, Brian J.; Chang, Joy; Charoen, Kristie; Choi, Woo Jin; Deng, Peter; DiCarlo, James E.; Doong, Judy; Dunn, Jessilyn; Feinberg, Jason I.; Fernandez, Christopher; Floria, Charlotte E.; Gladowski, David; Hadidi, Pasha; Ishizuka, Isabel; Jabbari, Javaneh; Lau, Calvin Y. L.; Lee, Pablo A.; Li, Sean; Lin, Denise; Linder, Matthias E.; Ling, Jonathan; Liu, Jaime; Liu, Jonathan; London, Mariya; Ma, Henry; Mao, Jessica; McDade, Jessica E.; McMillan, Alexandra; Moore, Aaron M.; Oh, Won Chan; Ouyang, Yu; Patel, Ruchi; Paul, Marina; Paulsen, Laura C.; Qiu, Judy; Rhee, Alex; Rubashkin, Matthew G.; Soh, Ina Y.; Sotuyo, Nathaniel E.; Srinivas, Venkatesh; Suarez, Allison; Wong, Andy; Wong, Remus; Xie, Wei Rose; Xu, Yijie; Yu, Allen T.; Koszul, Romain; Bader, Joel S.; Boeke, Jef D.; Chandrasegaran, Srinivasan			Total Synthesis of a Functional Designer Eukaryotic Chromosome	SCIENCE			English	Article							MYCOPLASMA-GENITALIUM GENOME; CHEMICAL-SYNTHESIS; YEAST; DNA; RECOMBINATION; PLASMID; CLONING; GENES; SITES	Rapid advances in DNA synthesis techniques have made it possible to engineer viruses, biochemical pathways and assemble bacterial genomes. Here, we report the synthesis of a functional 272,871-base pair designer eukaryotic chromosome, synIII, which is based on the 316,617-base pair native Saccharomyces cerevisiae chromosome III. Changes to synIII include TAG/TAA stop-codon replacements, deletion of subtelomeric regions, introns, transfer RNAs, transposons, and silent mating loci as well as insertion of loxPsym sites to enable genome scrambling. SynIII is functional in S. cerevisiae. Scrambling of the chromosome in a heterozygous diploid reveals a large increase in a-mater derivatives resulting from loss of the MAT alpha allele on synIII. The complete design and synthesis of synIII establishes S. cerevisiae as the basis for designer eukaryotic genome biology.	[Annaluru, Narayana; Muller, Heloise; Ramalingam, Sivaprakash; Cirelli, Kimberly; Guo, Zheyuan; London, Viktoriya; Yeluru, Apurva; Kandavelou, Karthikeyan; Chandrasegaran, Srinivasan] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Muller, Heloise; Mitchell, Leslie A.; Stracquadanio, Giovanni; Dymond, Jessica S.; Kuang, Zheng; Scheifele, Lisa Z.; Cooper, Eric M.; Cai, Yizhi; Zeller, Karen; Agmon, Neta; Caravelli, Katrina; Yang, Kun; Martin, J. Andrew; Bader, Joel S.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Muller, Heloise; Koszul, Romain] Inst Pasteur, Dept Genomes Genet, Grp Spatial Regulat Genomes, F-75015 Paris, France; [Muller, Heloise; Koszul, Romain] CNRS, UMR 3525, F-75015 Paris, France; [Mitchell, Leslie A.; Agmon, Neta; Boeke, Jef D.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Stracquadanio, Giovanni; Richardson, Sarah M.; Tullman, Jennifer; Murugan, Sindurathy; Yang, Kun; Martin, J. Andrew; Bader, Joel S.] Johns Hopkins Univ, Whiting Sch Engn, Dept Biomed Engn, Baltimore, MD 21218 USA; [Stracquadanio, Giovanni; Richardson, Sarah M.; Tullman, Jennifer; Murugan, Sindurathy; Yang, Kun; Martin, J. Andrew; Bader, Joel S.] Johns Hopkins Univ, Whiting Sch Engn, Inst Med Genet, Baltimore, MD 21218 USA; [Dymond, Jessica S.] Johns Hopkins Univ, Appl Phys Lab, Biol Sci Res & Exploratory Dev Dept, Laurel, MD 20723 USA; [Scheifele, Lisa Z.] Loyola Univ Maryland, Dept Biol, Baltimore, MD 21210 USA; [Cai, Yizhi] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Han, Jeffrey S.] Carnegie Inst Sci, Baltimore, MD 21218 USA; [Hadjithomas, Michalis; Deng, Peter; Boeke, Jef D.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Caravelli, Katrina; Cirelli, Kimberly; Boulier, Kristin M.; Feinberg, Jason I.; Fernandez, Christopher; Floria, Charlotte E.; Gladowski, David; Ishizuka, Isabel; Jabbari, Javaneh; Lin, Denise; Linder, Matthias E.; London, Mariya; McMillan, Alexandra; Moore, Aaron M.; Paul, Marina; Soh, Ina Y.; Sotuyo, Nathaniel E.; Xie, Wei Rose; Yu, Allen T.] Johns Hopkins Univ, Krieger Sch Arts & Sci, Baltimore, MD 21218 USA; [Guo, Zheyuan; London, Viktoriya; Yeluru, Apurva; Bilgel, Murat; Bohutski, Pavlo; Capaldo, Brian J.; Chang, Joy; Charoen, Kristie; Choi, Woo Jin; DiCarlo, James E.; Doong, Judy; Dunn, Jessilyn; Hadidi, Pasha; Lau, Calvin Y. L.; Lee, Pablo A.; Li, Sean; Ling, Jonathan; Liu, Jaime; Liu, Jonathan; Ma, Henry; Mao, Jessica; McDade, Jessica E.; Oh, Won Chan; Ouyang, Yu; Patel, Ruchi; Paulsen, Laura C.; Qiu, Judy; Rhee, Alex; Rubashkin, Matthew G.; Srinivas, Venkatesh; Suarez, Allison; Wong, Andy; Wong, Remus; Xu, Yijie] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD 21218 USA; [Kandavelou, Karthikeyan] Pondicherry Biotech Private Ltd, Pillaichavady 605014, Puducherry, India; [Agier, Nicolas; Fischer, Gilles] Univ Paris 06, Sorbonne Univ, UMR 7238, F-75005 Paris, France; [Agier, Nicolas; Fischer, Gilles] CNRS, UMR 7238, F-75005 Paris, France	Johns Hopkins University; Johns Hopkins University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); New York University; NYU Langone Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Loyola University Maryland; University of Edinburgh; Carnegie Institution for Science; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jef.boeke@nyumc.org; schandra@jhsph.edu	Stracquadanio, Giovanni/AAL-2648-2021; Bilgel, Murat/T-8645-2017; C, WJ/ABD-5987-2021; Fischer, Gilles/Q-4603-2019; Kuang, Zheng/ABG-3667-2021; Fischer, Gilles/G-6654-2016; DiCarlo, James/AAJ-1579-2021; Cai, Yizhi/A-3550-2010	Stracquadanio, Giovanni/0000-0001-9819-3645; Bilgel, Murat/0000-0001-5042-7422; Fischer, Gilles/0000-0001-5732-2682; DiCarlo, James/0000-0003-4728-3186; Pan, Deng/0000-0002-7061-9744; Yang, Kun/0000-0002-1060-8082; Mitchell, Leslie/0000-0001-7869-9817; McDade, Jessica/0000-0003-2260-7113; /0000-0003-3023-592X; Agmon, Neta/0000-0002-2590-3033; Liu, Jonathan/0000-0002-5761-8704; Ling, Jonathan/0000-0003-1927-9729; Guo, Zheyuan/0000-0003-0944-7813; Cai, Yizhi/0000-0003-1663-2865; Yu, Allen/0000-0002-1842-857X; Koszul, Romain/0000-0002-3086-1173; Richardson, Sarah/0000-0002-9820-9421; Capaldo, Brian/0000-0003-1244-8884; Scheifele, Lisa/0000-0003-1400-6895	NSF [MCB 0718846]; Microsoft; NIH [GM077291]; Fondation pour la Recherche Medicale and a Pasteur-Roux fellowship; Maryland Stem Cell Research Fund; National Sciences and Engineering Research Council of Canada; U.S. Department of Energy; JHU Applied Physics Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077291, R01GM090192] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1441866, 1443299] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Microsoft(Microsoft); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale and a Pasteur-Roux fellowship(Fondation pour la Recherche Medicale); Maryland Stem Cell Research Fund; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Department of Energy(United States Department of Energy (DOE)); JHU Applied Physics Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from NSF (MCB 0718846) to J.D.B., J.S.B., and S.C. and from Microsoft to J.S.B.S.M. and S.C. were supported by a grant from NIH (GM077291 to S.C.); H. Muller, by a fellowship from Fondation pour la Recherche Medicale and a Pasteur-Roux fellowship; S.R., by an Exploratory Research Grant from the Maryland Stem Cell Research Fund; L.A.M., by a fellowship from the National Sciences and Engineering Research Council of Canada; S.M.R., by a fellowship from the U.S. Department of Energy; and J.S.D., by a fellowship from JHU Applied Physics Laboratory. We thank D. Gibson for helpful suggestions regarding the isothermal assembly reaction, E. Louis and D. Gottschling for advice on synthetic telomere design, and L. Teytelman and J. Rine for advice on silent cassette DNA. The synIII sequences have been deposited at GenBank with accession numbers KJ463385 (the as-designed reference sequence version 3.3_41) and KC880027 (the actual physical sequence in strain HMSY011, sequence version 3.3_42). The authors declare no competing financial interests. Requests for materials should be addressed to J.D.B. (boekej01@nyumc.org). We dedicate this publication to the memory of Har Gobind Khorana, who synthesized the first yeast tRNA gene. N. Annaluru, H. Muller, J.S.B., J.D.B., and S.C. designed experiments. J.D.B. and S.M.R. designed synIII. N. Annaluru, H.M., L.A.M., S.R., G.S., S.M.R., J.S.D., Z.K., Y.C., Z.G., V.L., S.M., K.K., N. Agmon, G.F., and S.C. performed experiments. N. Annaluru, H.M., G.S., R.K., J.D.B., and S.C. analyzed data. N. Annaluru, H.M., J.D.B., and S.C. wrote the manuscript. JHU Build-A-Genome course students (K. Caravelli, K. Cirelli, Z.G., V.L., A.Y., M.B., P.B., K.M.B., B.J.C., J.C., K. Charoen, W.J.C., P.D., J.E.D., J. Doong, J. Dunn, J.I.F., C. F., C. E. F., D. G., P. H., I. I., J. J., C.Y.L.L., P.A.L., S.L., D.L., M.E.L., J. Ling, Jaime Liu, Jonathan Liu, M.L., H.Ma, J.M., J.E.M., A.M., A.M.M., W.C.O., Y.O., R.P., M.P., L.C.P., J.Q., A.R., M.G.R., I.Y.S., N.E.S., V.S., A.S., A.W., R.W., W.R.X., Y.X., A.T.Y.) synthesized most of the building blocks for synIII; H. Muller, G.S., S.M.R., J.S.D., L.Z.S., E.M.C., Y.C., K.Z., J.S.H., M.H., J.T. and J.D.B. taught the Build-A-Genome course. S.C. led the effort on the construction and assembly of synIII.	Annaluru Narayana, 2012, Methods Mol Biol, V852, P77, DOI 10.1007/978-1-61779-564-0_7; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Dymond J, 2012, BIOENGINEERED, V3, P168, DOI 10.4161/bbug.19543; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Larionov V, 1996, P NATL ACAD SCI USA, V93, P491, DOI 10.1073/pnas.93.1.491; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Muller Heloise, 2012, Methods Mol Biol, V852, P133, DOI 10.1007/978-1-61779-564-0_11; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	26	340	381	6	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					55	58		10.1126/science.1249252	http://dx.doi.org/10.1126/science.1249252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24674868	Green Accepted			2022-12-24	WOS:000333746100050
J	Iess, L; Stevenson, DJ; Parisi, M; Hemingway, D; Jacobson, RA; Lunine, JI; Nimmo, F; Armstrong, JW; Asmar, SW; Ducci, M; Tortora, P				Iess, L.; Stevenson, D. J.; Parisi, M.; Hemingway, D.; Jacobson, R. A.; Lunine, J. I.; Nimmo, F.; Armstrong, J. W.; Asmar, S. W.; Ducci, M.; Tortora, P.			The Gravity Field and Interior Structure of Enceladus	SCIENCE			English	Article							WATER RESERVOIR; SOUTH-POLE; PLUME	The small and active Saturnian moon Enceladus is one of the primary targets of the Cassini mission. We determined the quadrupole gravity field of Enceladus and its hemispherical asymmetry using Doppler data from three spacecraft flybys. Our results indicate the presence of a negative mass anomaly in the south-polar region, largely compensated by a positive subsurface anomaly compatible with the presence of a regional subsurface sea at depths of 30 to 40 kilometers and extending up to south latitudes of about 50 degrees. The estimated values for the largest quadrupole harmonic coefficients (10(6)J(2) = 5435.2 +/- 34.9, 10(6)C(22) = 1549.8 +/- 15.6, 1 sigma) and their ratio (J(2)/C-22 = 3.51 +/- 0.05) indicate that the body deviates mildly from hydrostatic equilibrium. The moment of inertia is around 0.335MR(2), where M is the mass and R is the radius, suggesting a differentiated body with a low-density core.	[Iess, L.; Parisi, M.; Ducci, M.] Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerospaziale, I-00184 Rome, Italy; [Stevenson, D. J.] CALTECH, Pasadena, CA 91125 USA; [Hemingway, D.; Nimmo, F.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Jacobson, R. A.; Armstrong, J. W.; Asmar, S. W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Lunine, J. I.] Cornell Univ, Dept Astron, Ithaca, NY 14850 USA; [Tortora, P.] Univ Bologna, Dipartimento Ingn Ind, I-47121 Forli, Italy	Sapienza University Rome; California Institute of Technology; University of California System; University of California Santa Cruz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; University of Bologna	Iess, L (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerospaziale, Via Eudossiana 18, I-00184 Rome, Italy.	luciano.iess@uniroma1.it	IESS, Luciano/F-4902-2011; Hemingway, Douglas/F-6332-2014; Tortora, Paolo/J-6191-2012	IESS, Luciano/0000-0002-6230-5825; Hemingway, Douglas/0000-0001-5617-207X; Tortora, Paolo/0000-0001-9259-7673; Lunine, Jonathan/0000-0003-2279-4131; Ducci, Marco/0000-0003-2586-1037	Italian Space Agency; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA))	L.I., M.P., M.D., and P.T. acknowledge support from the Italian Space Agency. D.H., F.N., and J.I.L. are grateful to NASA for support through the Cassini Project. The work of R.A.J., J.W.A., and S.W.A. was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. The Doppler data and ancillary information used in this analysis are archived in NASA's Planetary Data System.	Bland MT, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052736; Giese B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036149; Hedman MM, 2013, NATURE, V500, P182, DOI 10.1038/nature12371; Howett CJA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003718; Iess L, 2012, SCIENCE, V337, P457, DOI 10.1126/science.1219631; Iess L, 2010, SCIENCE, V327, P1367, DOI 10.1126/science.1182583; Lu W, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017004; McKinnon WB, 2013, J GEOPHYS RES-PLANET, V118, P1775, DOI 10.1002/jgre.20122; Meyer J, 2007, ICARUS, V188, P535, DOI 10.1016/j.icarus.2007.03.001; Nimmo F, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003835; OJAKANGAS GW, 1986, ICARUS, V66, P341, DOI 10.1016/0019-1035(86)90163-6; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Postberg F, 2011, NATURE, V474, P620, DOI 10.1038/nature10175; Rambaux N, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041465; Roberts JH, 2008, ICARUS, V194, P675, DOI 10.1016/j.icarus.2007.11.010; Schubert G, 2007, ICARUS, V188, P345, DOI 10.1016/j.icarus.2006.12.012; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217; Tobie G, 2008, ICARUS, V196, P642, DOI 10.1016/j.icarus.2008.03.008; Wisdom J, 2004, ASTRON J, V128, P484, DOI 10.1086/421360; Zhang K, 2009, ICARUS, V204, P597, DOI 10.1016/j.icarus.2009.07.007	21	221	227	0	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					78	80		10.1126/science.1250551	http://dx.doi.org/10.1126/science.1250551			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24700854				2022-12-24	WOS:000333746100055
J	Hall, CN; Reynell, C; Gesslein, B; Hamilton, NB; Mishra, A; Sutherland, BA; O'Farrell, FM; Buchan, AM; Lauritzen, M; Attwell, D				Hall, Catherine N.; Reynell, Clare; Gesslein, Bodil; Hamilton, Nicola B.; Mishra, Anusha; Sutherland, Brad A.; O'Farrell, Fergus M.; Buchan, Alastair M.; Lauritzen, Martin; Attwell, David			Capillary pericytes regulate cerebral blood flow in health and disease	NATURE			English	Article							IN-VIVO; NEURONAL-ACTIVITY; ISCHEMIC-STROKE; BRAIN; CELLS; STIMULATION; REPERFUSION; GLYCOLYSIS; PERFUSION; DIAMETER	Increases in brain blood flow, evoked by neuronal activity, power neural computation and form the basis of BOLD(blood-oxygen-level-dependent) functional imaging. Whether blood flow is controlled solely by arteriole smooth muscle, or also by capillary pericytes, is controversial. We demonstrate that neuronal activity and the neurotransmitter glutamate evoke the release of messengers that dilate capillaries by actively relaxing pericytes. Dilation is mediated by prostaglandin E-2, but requires nitric oxide release to suppress vasoconstricting 20-HETE synthesis. In vivo, when sensory input increases blood flow, capillaries dilate before arterioles and are estimated to produce 84% of the blood flow increase. In pathology, ischaemia evokes capillary constriction by pericytes. We show that this is followed by pericyte death in rigor, which may irreversibly constrict capillaries and damage the blood-brain barrier. Thus, pericytes are major regulators of cerebral blood flow and initiators of functional imaging signals. Prevention of pericyte constriction and death may reduce the long-lasting blood flow decrease that damages neurons after stroke.	[Hall, Catherine N.; Reynell, Clare; Hamilton, Nicola B.; Mishra, Anusha; O'Farrell, Fergus M.; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Gesslein, Bodil; Lauritzen, Martin] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Gesslein, Bodil; Lauritzen, Martin] Univ Copenhagen, Ctr Hlth Aging, DK-2200 Copenhagen N, Denmark; [Sutherland, Brad A.; Buchan, Alastair M.] Univ Oxford, Radcliffe Dept Med, Acute Stroke Programme, Oxford OX3 9DU, England; [Lauritzen, Martin] Glostrup Univ Hosp, Dept Clin Neurophysiol, DK-2600 Glostrup, Denmark	University of London; University College London; University of Copenhagen; University of Copenhagen; University of Oxford; University of Copenhagen	Attwell, D (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	mlauritz@sund.ku.dk; d.attwell@ucl.ac.uk	Hall, Catherine/AAK-9652-2020; Attwell, David/ABE-6750-2020; Sutherland, Brad/AAX-2725-2020; Sutherland, Brad/J-3920-2014; Mishra, Anusha/AAR-6128-2020; Hall, Catherine/A-5802-2016; Buchan, Alastair M/B-9095-2009; Hamilton-Whitaker, Nicola/H-8867-2012	Hall, Catherine/0000-0002-2316-7714; Sutherland, Brad/0000-0002-0791-0950; Hall, Catherine/0000-0002-2316-7714; Buchan, Alastair M/0000-0002-2918-5200; Hamilton-Whitaker, Nicola/0000-0002-0168-8068; O'Farrell, Fergus/0000-0002-7378-9175; Mishra, Anusha/0000-0002-3642-5049; Lauritzen, Martin/0000-0002-1517-1131; reynell, clare/0000-0003-2733-3334; Gesslein, Bodil/0000-0001-6698-8603	Fondation Leducq; European Research Council; Wellcome Trust; UK Medical Research Council; Rosetrees Trust; Nordea Foundation via the Center for Healthy Aging; Lundbeck Foundation; NOVO-Nordisk Foundation; Danish Medical Research Council; Medical Research Council [1075001, G0500495] Funding Source: researchfish	Fondation Leducq(Leducq Foundation); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust(Rosetrees Trust); Nordea Foundation via the Center for Healthy Aging; Lundbeck Foundation(Lundbeckfonden); NOVO-Nordisk Foundation(Novo Nordisk Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank B. Clark, A. Gibb, A. Gourine, C. Howarth, R. Jolivet, C. Madry, P. Mobbs, B. Richardson and A. Silver for comments on the manuscript. This work was supported by the Fondation Leducq, European Research Council, Wellcome Trust, UK Medical Research Council, Rosetrees Trust, Nordea Foundation via the Center for Healthy Aging, the Lundbeck Foundation, NOVO-Nordisk Foundation and Danish Medical Research Council.	Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; BAIRD AE, 1994, STROKE, V25, P79, DOI 10.1161/01.STR.25.1.79; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; Crawford C, 2012, NEPHRON PHYSIOL, V120, P17, DOI 10.1159/000339110; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gupta R, 2013, J NEUROINTERV SURG, V5, P294, DOI 10.1136/neurintsurg-2011-010245; Hall CN, 2008, J PHYSIOL-LONDON, V586, P3597, DOI 10.1113/jphysiol.2008.154724; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Harrison TC, 2009, J NEUROSCI METH, V182, P211, DOI 10.1016/j.jneumeth.2009.06.021; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; Iadecola C, 1997, J NEUROPHYSIOL, V78, P651, DOI 10.1152/jn.1997.78.2.651; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH266, DOI 10.1152/ajpheart.1989.257.1.H266; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Lovick TA, 1999, NEUROSCIENCE, V92, P47, DOI 10.1016/S0306-4522(98)00737-4; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Mathiesen C, 2013, J CEREBR BLOOD F MET, V33, P161, DOI 10.1038/jcbfm.2012.175; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; PETERS BP, 1979, EXP CELL RES, V120, P321, DOI 10.1016/0014-4827(79)90392-6; Puro DG, 2007, MICROCIRCULATION, V14, P1, DOI 10.1080/10739680601072099; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schulte ML, 2003, BRAIN RES, V963, P81, DOI 10.1016/S0006-8993(02)03848-9; SEREBRYAKOV V, 1994, PROSTAGLANDINS, V47, P353, DOI 10.1016/0090-6980(94)90053-1; Vates GE, 2010, NAT MED, V16, P959, DOI 10.1038/nm0910-959; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	50	1037	1063	7	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					55	+		10.1038/nature13165	http://dx.doi.org/10.1038/nature13165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24670647	Green Submitted, Green Accepted			2022-12-24	WOS:000333609900041
J	Mortha, A; Chudnovskiy, A; Hashimoto, D; Bogunovic, M; Spencer, SP; Belkaid, Y; Merad, M				Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Spencer, Sean P.; Belkaid, Yasmine; Merad, Miriam			Microbiota-Dependent Crosstalk Between Macrophages and ILC3 Promotes Intestinal Homeostasis	SCIENCE			English	Article							COLONY-STIMULATING FACTOR; ROR-GAMMA-T; DENDRITIC-CELL; GM-CSF; STEADY-STATE; COMMENSAL MICROFLORA; T(H)17 CELLS; DIFFERENTIATION; SUBSETS; LYMPH	The intestinal microbiota and tissue-resident myeloid cells promote immune responses that maintain intestinal homeostasis in the host. However, the cellular cues that translate microbial signals into intestinal homeostasis remain unclear. Here, we show that deficient granulocyte-macrophage colony-stimulating factor (GM-CSF) production altered mononuclear phagocyte effector functions and led to reduced regulatory T cell (T-reg) numbers and impaired oral tolerance. We observed that ROR gamma t(+) innate lymphoid cells (ILCs) are the primary source of GM-CSF in the gut and that ILC-driven GM-CSF production was dependent on the ability of macrophages to sense microbial signals and produce interleukin-1 beta. Our findings reveal that commensal microbes promote a crosstalk between innate myeloid and lymphoid cells that leads to immune homeostasis in the intestine.	[Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Merad, Miriam] Dept Oncol Sci, New York, NY 10029 USA; [Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Merad, Miriam] Tisch Canc Inst, New York, NY 10029 USA; [Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Spencer, Sean P.; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Lab Parasit Dis, Bethesda, MD 20892 USA	Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Merad, M (corresponding author), Dept Oncol Sci, 1470 Madison Ave, New York, NY 10029 USA.	miriam.merad@mssm.edu	Hashimoto, Daigo/O-1013-2013; Mortha, Arthur/ABE-6250-2020	Hashimoto, Daigo/0000-0001-9489-9704; Belkaid, Yasmine/0000-0001-9962-3571; Spencer, Sean/0000-0002-7328-5399; Mortha, Arthur/0000-0003-2673-0485	NIH [R01 CA154947A, R01 CA173861, U01 AI095611]; German Research Foundation (DFG) [MO2380/1-1]; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases; NATIONAL CANCER INSTITUTE [R01CA154947, R01CA173861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001133, ZIAAI001115, ZIAAI001132, U01AI095611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); Division of Intramural Research of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Merad laboratory for helpful discussions and input. We are grateful to W.-H. Kwan and W. van der Touw for assistance with the T<INF>reg</INF> induction assay. We thank R. Huq and L. O'Rourke at the Icahn School of Medicine at Mount Sinai Microscopy Shared Resource Facility for their training, helpful advice, and support with microscopy imaging. We are grateful to C. Berin and A. Belen Blazquez for support with the oral tolerance and DTH models. We thank J. Ochando and the Flow Cytometry facility for technical support and assistance with cell sorting. The data presented in this paper are tabulated in the main paper and in the supporting materials. M. M. is funded by NIH grants R01 CA154947A, R01 CA173861, and U01 AI095611. A. M. is funded by the German Research Foundation (DFG) grant MO2380/1-1. Y.B. was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bogunovic M, 2012, IMMUNOL RES, V54, P37, DOI 10.1007/s12026-012-8323-5; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Egea L, 2013, J IMMUNOL, V190, P1702, DOI 10.4049/jimmunol.1202368; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Enzler T, 2007, BLOOD, V110, P954, DOI 10.1182/blood-2006-08-043786; Fukuzawa H, 2003, BIOCHEM BIOPH RES CO, V312, P897, DOI 10.1016/j.bbrc.2003.11.009; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Han XN, 2009, GASTROENTEROLOGY, V136, P1261, DOI 10.1053/j.gastro.2008.12.046; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jinushi M, 2008, IMMUNOL REV, V222, P287, DOI 10.1111/j.1600-065X.2008.00618.x; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009	58	523	556	9	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1477	+	1249288	10.1126/science.1249288	http://dx.doi.org/10.1126/science.1249288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24625929	Green Accepted			2022-12-24	WOS:000333471000038
J	Condon, MA; Scheffer, SJ; Lewis, ML; Wharton, R; Adams, DC; Forbes, AA				Condon, Marty A.; Scheffer, Sonja J.; Lewis, Matthew L.; Wharton, Robert; Adams, Dean C.; Forbes, Andrew A.			Lethal Interactions Between Parasites and Prey Increase Niche Diversity in a Tropical Community	SCIENCE			English	Article							HOST-SPECIFICITY; DROSOPHILA; PLANTS	Ecological specialization should minimize niche overlap, yet herbivorous neotropical flies (Blepharoneura) and their lethal parasitic wasps (parasitoids) exhibit both extreme specialization and apparent niche overlap in host plants. From just two plant species at one site in Peru, we collected 3636 flowers yielding 1478 fly pupae representing 14 Blepharoneura fly species, 18 parasitoid species (14 Bellopius species), and parasitoid-host associations, all discovered through analysis of molecular data. Multiple sympatric species specialize on the same sex flowers of the same fly host-plant species-which suggests extreme niche overlap; however, niche partitioning was exposed by interactions between wasps and flies. Most Bellopius species emerged as adults from only one fly species, yet evidence from pupae (preadult emergence samples) show that most Bellopius also attacked additional fly species but never emerged as adults from those flies.	[Condon, Marty A.] Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA; [Scheffer, Sonja J.; Lewis, Matthew L.] USDA ARS, Systemat Entomol Lab, Beltsville, MD 20705 USA; [Wharton, Robert] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Adams, Dean C.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Adams, Dean C.] Univ Iowa, Dept Stat, Ames, IA 50011 USA; [Forbes, Andrew A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Cornell University; Smithsonian Institution; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Iowa State University; University of Iowa; University of Iowa	Condon, MA (corresponding author), Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA.	mcondon@cornellcollege.edu		Dean, Adams/0000-0001-9172-7894; Forbes, Andrew/0000-0001-8332-6652	NSF [0919027]; NSF ROA [1145355]; University of Iowa;  [NSF-0330845];  [0949361]; Direct For Biological Sciences [0949361] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF ROA(National Science Foundation (NSF)); University of Iowa; ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NSF-0330845, 0949361 to M.A.C; NSF 0919027 to R.W.; NSF ROA (1145355), University of Iowa to A.A.F. Data are available in supplementary materials and archived at National Center for Biotechnology Information, NIH, GenBank (accession numbers: KF473465 to KF475237). The Institute Nacional de Recursos Naturales-Intendencia Forestal y de Fauna Silvestre del Peru authorized collections (autorizacion no. 110-2008-INRENA-IFFS-DCB) and exportation of specimens (permiso no 011832-AG-INRENA). T. Litwak assisted with illustrations. The authors declare no conflicts of interest. USDA is an equal opportunity provider and employer.	Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Chase J.M., 2009, ECOLOGICAL NICHES LI; Condon MA, 2008, SCIENCE, V320, P928, DOI 10.1126/science.1155832; Darwin C., 1859, ORIGIN SPECIES MEANS; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Forbes AA, 2009, SCIENCE, V323, P776, DOI 10.1126/science.1166981; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Mohamed SA, 2003, BIOL CONTROL, V28, P155, DOI 10.1016/S1049-9644(03)00099-9; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Singer MS, 2005, ECOL LETT, V8, P1247, DOI 10.1111/j.1461-0248.2005.00835.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Strong D.R., 1984, INSECTS PLANTS COMMU; Thompson J. N., 2005, INTERSPEC INTERACT; Veijalainen A, 2012, P ROY SOC B-BIOL SCI, V279, P4694, DOI 10.1098/rspb.2012.1664; Wilson EO, 1999, DIVERSITY LIFE	20	50	52	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1240	1244		10.1126/science.1245007	http://dx.doi.org/10.1126/science.1245007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626926				2022-12-24	WOS:000332728500034
J	Haldar, M; Kohyama, M; So, AYL; Wumesh, KC; Wu, XD; Briseno, CG; Satpathy, AT; Kretzer, NM; Arase, H; Rajasekaran, NS; Wang, L; Egawa, T; Igarashi, K; Baltimore, D; Murphy, TL; Murphy, KM				Haldar, Malay; Kohyama, Masako; So, Alex Yick-Lun; Wumesh, K. C.; Wu, Xiaodi; Briseno, Carlos G.; Satpathy, Ansuman T.; Kretzer, Nicole M.; Arase, Hisashi; Rajasekaran, Namakkal S.; Wang, Li; Egawa, Takeshi; Igarashi, Kazuhiko; Baltimore, David; Murphy, Theresa L.; Murphy, Kenneth M.			Heme-Mediated SPI-C Induction Promotes Monocyte Differentiation into Iron-Recycling Macrophages	CELL			English	Article							COLONY-STIMULATING FACTOR; HEMOLYTIC-ANEMIA; GENE-EXPRESSION; DENDRITIC CELLS; MYELOID CELLS; BACH1; HOMEOSTASIS; MOUSE; TRANSCRIPTION; RECEPTOR	Splenic red pulp macrophages (RPM) degrade senescent erythrocytes and recycle heme-associated iron. The transcription factor SPI-C is selectively expressed by RPM and is required for their development, but the physiologic stimulus inducing Spic is unknown. Here, we report that Spic also regulated the development of F4/80(+)VCAM1(+) bone marrow macrophages (BMM) and that Spic expression in BMM and RPM development was induced by heme, a metabolite of erythrocyte degradation. Pathologic hemolysis induced loss of RPM and BMM due to excess heme but induced Spic in monocytes to generate new RPM and BMM. Spic expression in monocytes was constitutively inhibited by the transcriptional repressor BACH1. Heme induced proteasome-dependent BACH1 degradation and rapid Spic derepression. Furthermore, cysteine-proline dipeptide motifs in BACH1 that mediate hemedependent degradation were necessary for Spic induction by heme. These findings are the first example of metabolite-driven differentiation of a tissue-resident macrophage subset and provide new insights into iron homeostasis.	[Haldar, Malay; Wumesh, K. C.; Wu, Xiaodi; Briseno, Carlos G.; Satpathy, Ansuman T.; Kretzer, Nicole M.; Egawa, Takeshi; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kohyama, Masako; Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochemi, Suita, Osaka 5650871, Japan; [So, Alex Yick-Lun; Baltimore, David] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Rajasekaran, Namakkal S.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Div Cardiol & Pulm, Salt Lake City, UT 84132 USA; [Wang, Li] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Div Gastroenterol, Salt Lake City, UT 84132 USA; [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Osaka University; California Institute of Technology; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Tohoku University; Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Arase, Hisashi/C-8442-2009	Arase, Hisashi/0000-0002-1153-3166; Igarashi, Kazuhiko/0000-0002-2470-2475; Satpathy, Ansuman/0000-0002-5167-537X; Briseno, Carlos/0000-0002-4159-3864	Howard Hughes Medical Institute; Department of Defence [W81XWH-09-1-0185]; National Institutes of Health [AI076427-02, T32 CA 9547-27, 1K08AI106953, K99HL118754, 5R01AI093531]; Physician Scientist Training Program in the Department of Pathology and Immunology at the Washington University School of Medicine; American Heart Association [12PRE8610005, 12PRE12050419]; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL118754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI106953, T32AI007163, R01AI076427, R01AI093531, R01AI097244] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25670143] Funding Source: KAKEN	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Defence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Physician Scientist Training Program in the Department of Pathology and Immunology at the Washington University School of Medicine; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Howard Hughes Medical Institute (K.M.M.), Department of Defence (W81XWH-09-1-0185 to K.M.M.), National Institutes of Health (AI076427-02 to K.M.M., T32 CA 9547-27 to M.H., 1K08AI106953 to M. H., K99HL118754 to A.Y.-L.S., and 5R01AI093531 to D.B.), the Physician Scientist Training Program in the Department of Pathology and Immunology at the Washington University School of Medicine (M. H.), and the American Heart Association (12PRE8610005 to A.T.S. and 12PRE12050419 to W.K.).	Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Beaumont C, 2009, SEMIN HEMATOL, V46, P328, DOI 10.1053/j.seminhematol.2009.06.004; Bemark M, 1999, J BIOL CHEM, V274, P10259, DOI 10.1074/jbc.274.15.10259; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; Carlsson R, 2002, GENE, V299, P271, DOI 10.1016/S0378-1119(02)01078-8; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Delaby C, 2008, BIOCHEM J, V411, P123, DOI 10.1042/BJ20071474; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guillaud C, 2012, EXPERT REV HEMATOL, V5, P229, DOI [10.1586/ehm.12.3, 10.1586/EHM.12.3]; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; ITANO HA, 1975, NATURE, V256, P665, DOI 10.1038/256665a0; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schulz S, 2012, PEDIATR RES, V72, P161, DOI 10.1038/pr.2012.62; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; VANPUTTEN LM, 1958, BLOOD, V13, P789, DOI 10.1182/blood.V13.8.789.789; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	44	261	266	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1223	1234		10.1016/j.cell.2014.01.069	http://dx.doi.org/10.1016/j.cell.2014.01.069			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24630724	Green Accepted, Bronze			2022-12-24	WOS:000332945100012
J	Lee, MN; Ye, C; Villani, AC; Raj, T; Li, WB; Eisenhaure, TM; Imboywa, SH; Chipendo, PI; Ran, FA; Slowikowski, K; Ward, LD; Raddassi, K; McCabe, C; Lee, MH; Frohlich, IY; Hafler, DA; Kellis, M; Raychaudhuri, S; Zhang, F; Stranger, BE; Benoist, CO; De Jager, PL; Regev, A; Hacohen, N				Lee, Mark N.; Ye, Chun; Villani, Alexandra-Chloe; Raj, Towfique; Li, Weibo; Eisenhaure, Thomas M.; Imboywa, Selina H.; Chipendo, Portia I.; Ran, F. Ann; Slowikowski, Kamil; Ward, Lucas D.; Raddassi, Khadir; McCabe, Cristin; Lee, Michelle H.; Frohlich, Irene Y.; Hafler, David A.; Kellis, Manolis; Raychaudhuri, Soumya; Zhang, Feng; Stranger, Barbara E.; Benoist, Christophe O.; De Jager, Philip L.; Regev, Aviv; Hacohen, Nir			Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells	SCIENCE			English	Article							PATTERN-RECOGNITION RECEPTORS; MYCOBACTERIUM-TUBERCULOSIS INFECTION; GENOME-WIDE ASSOCIATION; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; EXPRESSION; LOCI; ARCHITECTURE; RESISTANCE; INFLUENZA	Little is known about how human genetic variation affects the responses to environmental stimuli in the context of complex diseases. Experimental and computational approaches were applied to determine the effects of genetic variation on the induction of pathogen-responsive genes in human dendritic cells. We identified 121 common genetic variants associated in cis with variation in expression responses to Escherichia coli lipopolysaccharide, influenza, or interferon-beta (IFN-beta). We localized and validated causal variants to binding sites of pathogen-activated STAT ( signal transducer and activator of transcription) and IRF (IFN-regulatory factor) transcription factors. We also identified a common variant in IRF7 that is associated in trans with type I IFN induction in response to influenza infection. Our results reveal common alleles that explain interindividual variation in pathogen sensing and provide functional annotation for genetic variants that alter susceptibility to inflammatory diseases.	[Lee, Mark N.; Ye, Chun; Villani, Alexandra-Chloe; Raj, Towfique; Li, Weibo; Eisenhaure, Thomas M.; Ran, F. Ann; Ward, Lucas D.; McCabe, Cristin; Kellis, Manolis; Raychaudhuri, Soumya; De Jager, Philip L.; Regev, Aviv; Hacohen, Nir] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA; [Lee, Mark N.; Villani, Alexandra-Chloe; Raj, Towfique; Imboywa, Selina H.; Chipendo, Portia I.; Lee, Michelle H.; Frohlich, Irene Y.; Raychaudhuri, Soumya; Benoist, Christophe O.; De Jager, Philip L.; Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lee, Mark N.; Li, Weibo; Eisenhaure, Thomas M.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Raj, Towfique; McCabe, Cristin; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Ran, F. Ann] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ran, F. Ann] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ran, F. Ann; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ran, F. Ann; Hafler, David A.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Slowikowski, Kamil] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Raddassi, Khadir] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Musculoskeletal Res Grp, Arthrit Res UK Epidemiol Unit, Manchester M13 9NT, Lancs, England; [Stranger, Barbara E.] Univ Chicago, Med Genet Sect, Chicago, IL 60637 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Manchester; University of Chicago; University of Chicago; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Regev, A (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; nhacohen@partners.org	Raj, Towfique/ABD-7620-2021; Chipendo, Portia/B-5457-2018; Kellis, Manolis/ABE-7385-2020; Slowikowski, Kamil/K-3728-2016; Macrae, Rhiannon/AAX-1536-2020; Ye, Chun/AAK-4868-2021	Kellis, Manolis/0000-0001-7113-9630; Slowikowski, Kamil/0000-0002-2843-6370; Ye, Chun/0000-0001-6560-3783; Raychaudhuri, Soumya/0000-0002-1901-8265; Stranger, Barbara/0000-0001-9021-7331; Ward, Lucas/0000-0002-8017-809X; Lee, Mark/0000-0002-9576-9589	National Institute of General Medical Sciences, NIH [RC2 GM093080]; National Institute of Allergy and Infectious Diseases [U19 AI082630]; NIH [DP2 OD002230, DP1 CA174427, R01 HG004037, DP1 MH100706, R01 DK097768, T32 GM007753, F32 AG043267, T32 HG002295]; National Human Genome Research Institute [P50 HG006193]; Howard Hughes Medical Institute; Keck Foundation; McKnight Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; Direct For Biological Sciences [0644282] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, R01HG004037, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091568, U19AI082630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG043267] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all study participants in the PhenoGenetic project for their contributions. We are grateful to Q. Sievers and C. Wu for advice about preparing primary cells and V. Agarwala and D. A. Landau for valuable discussions. This work was supported by the National Institute of General Medical Sciences, NIH, grant RC2 GM093080 (C.O.B. and N.H.); the National Institute of Allergy and Infectious Diseases grant U19 AI082630 and NIH Director's New Innovator Award DP2 OD002230 (N.H.); the National Human Genome Research Institute grant P50 HG006193, NIH Director's Pioneer Award DP1 CA174427, and Howard Hughes Medical Institute (A.R.); and NIH grant R01 HG004037 (M.K.). F.Z. is supported by an NIH Director's Pioneer Award (DP1 MH100706), an NIH Transformative R01 grant (R01 DK097768), the Keck, McKnight, Merkin, Vallee, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations, Bob Metcalfe, and Jane Pauley. M.N.L. is supported by the NIH Medical Scientist Training Program fellowship (T32 GM007753). T.R. is supported by NIH fellowship F32 AG043267. K.S. is supported by NIH grant T32 HG002295. Gene expression data are deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession no. GSE53166.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Donner Y, 2012, NAT METHODS, V9, P1120, DOI [10.1038/NMETH.2207, 10.1038/nmeth.2207]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gat-Viks I, 2013, NAT BIOTECHNOL, V31, P342, DOI 10.1038/nbt.2519; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hindorff LA, CATALOG PUBLISHED GE; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Rai E, 2011, SEMIN IMMUNOL, V23, P67, DOI 10.1016/j.smim.2011.01.015; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stower H, 2013, NAT REV GENET, V14, DOI 10.1038/nrg3622; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	44	275	277	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1119	+	1246980	10.1126/science.1246980	http://dx.doi.org/10.1126/science.1246980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604203	Green Accepted, Green Submitted			2022-12-24	WOS:000332331500042
J	Savage, N				Savage, Neil			LOGISTICS Keeping cool	NATURE			English	Editorial Material																			0	30	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S8	S9		10.1038/507S8a	http://dx.doi.org/10.1038/507S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611169	Bronze			2022-12-24	WOS:000332224400004
